Label,category,Vocabulary ID,Parent,GrandParent,n
Humans,B,B01.050.150.900.649.313.988.400.112.400.400,Hominidae,Catarrhini,50737
Female,A,A81CF24FDE62658168B073581F98796BEDC98D99,NULL,NULL,26104
Male,2,2867EB5BBDE26F3789F208E36C016A8A2960CF04,NULL,NULL,21508
Adult,M,M01.060.116,Age Groups,Persons,16320
Middle Aged,M,M01.060.116.630,Adult,Age Groups,12208
Adolescent,M,M01.060.057,Age Groups,Persons,10026
Child,M,M01.060.406,Age Groups,Persons,8040
Aged,M,M01.060.116.100,Adult,Age Groups,7849
Animals,B,B01.050,Eukaryota,NULL,6555
"Child, Preschool",M,M01.060.406.448,Child,Age Groups,6316
Infant,M,M01.060.703,Age Groups,Persons,6238
Young Adult,M,M01.060.116.815,Adult,Age Groups,6190
Risk Factors,N,N05.715.350.200.700,Causality,Epidemiologic Factors,5882
Risk Factors,N,N05.715.360.750.625.700.700,Risk,Probability,5882
Risk Factors,N,N06.850.490.625.750,Causality,Epidemiologic Factors,5882
Risk Factors,E,E05.318.740.600.800.725,Risk,Probability,5882
Risk Factors,N,N06.850.520.830.600.800.725,Risk,Probability,5882
HIV Infections,C,C01.221.250.875,Blood-Borne Infections,Communicable Diseases,5549
HIV Infections,C,C01.221.812.640.400,"Sexually Transmitted Diseases, Viral",Sexually Transmitted Diseases,5549
HIV Infections,C,C01.778.640.400,"Sexually Transmitted Diseases, Viral",Sexually Transmitted Diseases,5549
HIV Infections,C,C01.925.782.815.616.400,Lentivirus Infections,Retroviridae Infections,5549
HIV Infections,C,C01.925.813.400,"Sexually Transmitted Diseases, Viral",Virus Diseases,5549
HIV Infections,C,C20.673.480,Immunologic Deficiency Syndromes,Immune System Diseases,5549
Prevalence,E,E05.318.308.985.525.750,Morbidity,Vital Statistics,4351
Prevalence,N,N06.850.505.400.975.525.750,Morbidity,Vital Statistics,4351
Prevalence,N,N06.850.520.308.985.525.750,Morbidity,Vital Statistics,4351
Prevalence,N,N01.224.935.597.750,Morbidity,Vital Statistics,4351
Cross-Sectional Studies,N,N05.715.360.330.500.875,Epidemiologic Studies,Epidemiologic Study Characteristics,4271
Cross-Sectional Studies,E,E05.318.372.500.875,Epidemiologic Studies,Epidemiologic Study Characteristics,4271
Cross-Sectional Studies,N,N06.850.520.450.500.875,Epidemiologic Studies,Epidemiologic Study Characteristics,4271
Pregnancy,G,G08.686.784.769,Reproduction,Reproductive Physiological Phenomena,4226
"Infant, Newborn",M,M01.060.703.520,Infant,Age Groups,4067
United Kingdom,Z,Z01.542.363,Europe,Geographic Locations,3788
Cohort Studies,N,N06.850.520.450.500.750,Epidemiologic Studies,Epidemiologic Study Characteristics,2994
Cohort Studies,N,N05.715.360.330.500.750,Epidemiologic Studies,Epidemiologic Study Characteristics,2994
Cohort Studies,E,E05.318.372.500.750,Epidemiologic Studies,Epidemiologic Study Characteristics,2994
"Aged, 80 and over",M,M01.060.116.100.080,Aged,Adult,2968
Surveys and Questionnaires,N,N05.715.360.300.800,Data Collection,Health Care Evaluation Mechanisms,2849
Surveys and Questionnaires,N,N06.850.520.308.980,Data Collection,Epidemiologic Methods,2849
Surveys and Questionnaires,E,E05.318.308.980,Data Collection,Epidemiologic Methods,2849
Incidence,E,E05.318.308.985.525.375,Morbidity,Vital Statistics,2761
Incidence,N,N06.850.520.308.985.525.375,Morbidity,Vital Statistics,2761
Incidence,N,N06.850.505.400.975.525.375,Morbidity,Vital Statistics,2761
Incidence,N,N01.224.935.597.500,Morbidity,Vital Statistics,2761
Malaria,C,C01.920.875,Vector Borne Diseases,Infections,2572
Malaria,C,C01.610.752.530,Protozoan Infections,Parasitic Diseases,2572
Treatment Outcome,E,E01.789.800,Prognosis,Diagnosis,2498
Treatment Outcome,N,N05.715.360.575.575.800,"Outcome Assessment, Health Care","Outcome and Process Assessment, Health Care",2498
Treatment Outcome,N,N04.761.559.590.800,"Outcome Assessment, Health Care","Outcome and Process Assessment, Health Care",2498
Prospective Studies,N,N05.715.360.330.500.750.650,Cohort Studies,Epidemiologic Studies,2479
Prospective Studies,E,E05.318.372.500.750.625,Cohort Studies,Epidemiologic Studies,2479
Prospective Studies,N,N06.850.520.450.500.750.650,Cohort Studies,Epidemiologic Studies,2479
England,Z,Z01.542.363.300,United Kingdom,Europe,2441
Developing Countries,I,I01.615.500.300,International Cooperation,Internationality,2308
Time Factors,G,G01.910.857,Time,Physical Phenomena,2269
Socioeconomic Factors,I,I01.880.853.996,Sociological Factors,Sociology,2210
Socioeconomic Factors,N,N01.824,Population Characteristics,NULL,2210
Global Health,N,N01.400.337,Health,Population Characteristics,2081
Global Health,H,H02.403.371,Medicine,Health Occupations,2081
Age Factors,N,N06.850.490.250,Epidemiologic Factors,Public Health,1845
Age Factors,N,N05.715.350.075,Epidemiologic Factors,Quality of Health Care,1845
Rural Population,N,N01.600.725,Population,Population Characteristics,1840
Retrospective Studies,N,N05.715.360.330.500.750.825,Cohort Studies,Epidemiologic Studies,1785
Retrospective Studies,N,N05.715.360.330.500.500.500,Case-Control Studies,Epidemiologic Studies,1785
Retrospective Studies,E,E05.318.372.500.750.750,Cohort Studies,Epidemiologic Studies,1785
Retrospective Studies,E,E05.318.372.500.500.500,Case-Control Studies,Epidemiologic Studies,1785
Retrospective Studies,N,N06.850.520.450.500.750.825,Cohort Studies,Epidemiologic Studies,1785
Retrospective Studies,N,N06.850.520.450.500.500.500,Case-Control Studies,Epidemiologic Studies,1785
COVID-19,C,C01.748.214,Respiratory Tract Infections,Infections,1750
COVID-19,C,C01.748.610.763.500,"Pneumonia, Viral",Pneumonia,1750
COVID-19,C,C01.925.782.600.550.200.163,Coronavirus Infections,Coronaviridae Infections,1750
COVID-19,C,C01.925.705.500,"Pneumonia, Viral",Virus Diseases,1750
COVID-19,C,C08.381.677.807.500,"Pneumonia, Viral",Pneumonia,1750
COVID-19,C,C08.730.214,Respiratory Tract Infections,Respiratory Tract Diseases,1750
COVID-19,C,C08.730.610.763.500,"Pneumonia, Viral",Pneumonia,1750
Uganda,Z,Z01.058.290.120.880,"Africa, Eastern",Africa South of the Sahara,1702
Plasmodium falciparum,B,B01.043.075.380.611.561,Plasmodium,Haemosporida,1689
Case-Control Studies,N,N06.850.520.450.500.500,Epidemiologic Studies,Epidemiologic Study Characteristics,1686
Case-Control Studies,E,E05.318.372.500.500,Epidemiologic Studies,Epidemiologic Study Characteristics,1686
Case-Control Studies,N,N05.715.360.330.500.500,Epidemiologic Studies,Epidemiologic Study Characteristics,1686
"Malaria, Falciparum",C,C01.920.875.650,Malaria,Vector Borne Diseases,1648
"Malaria, Falciparum",C,C01.610.752.530.650,Malaria,Protozoan Infections,1648
Cost-Benefit Analysis,N,N03.219.151.125,Costs and Cost Analysis,Economics,1602
Randomized Controlled Trials as Topic,N,N05.715.360.330.250.250.365.500,Controlled Clinical Trials as Topic,Clinical Trials as Topic,1595
Randomized Controlled Trials as Topic,E,E05.318.372.250.250.365.500,Controlled Clinical Trials as Topic,Clinical Trials as Topic,1595
Randomized Controlled Trials as Topic,N,N06.850.520.450.250.250.365.500,Controlled Clinical Trials as Topic,Clinical Trials as Topic,1595
Follow-Up Studies,N,N06.850.520.450.500.750.350,Cohort Studies,Epidemiologic Studies,1574
Follow-Up Studies,E,E05.318.372.500.750.249,Cohort Studies,Epidemiologic Studies,1574
Follow-Up Studies,N,N05.715.360.330.500.750.350,Cohort Studies,Epidemiologic Studies,1574
Tuberculosis,C,C01.150.252.410.040.552.846,Mycobacterium Infections,Actinomycetales Infections,1563
Health Policy,N,N03.623.500.608.428,Public Policy,Social Control Policies,1525
Health Policy,I,I01.655.500.608.400,Public Policy,Social Control Policies,1525
Health Policy,I,I01.880.604.825.608.400,Public Policy,Social Control Policies,1525
India,Z,Z01.252.245.393,"Asia, Western",Asia,1524
Public Health,H,H02.403.720,Medicine,Health Occupations,1506
Public Health,N,N06.850,Environment and Public Health,NULL,1506
Public Health,N,N01.400.550,Health,Population Characteristics,1506
Antimalarials,D,D27.505.954.122.250.100.085,Antiprotozoal Agents,Antiparasitic Agents,1427
South Africa,Z,Z01.058.290.175.735,"Africa, Southern",Africa South of the Sahara,1406
Delivery of Health Care,N,N04.590.374,Patient Care Management,Health Services Administration,1405
Delivery of Health Care,N,N05.300,"Health Care Quality, Access, and Evaluation",NULL,1405
Vaccination,N,N02.421.726.758.310.890,Immunization,Primary Prevention,1388
Vaccination,E,E05.478.550.600.890,"Immunotherapy, Active",Immunization,1388
Vaccination,N,N06.850.780.200.425.900,Immunization,Communicable Disease Control,1388
Vaccination,N,N06.850.780.680.310.890,Immunization,Primary Prevention,1388
Vaccination,E,E02.095.465.425.400.530.890,"Immunotherapy, Active",Immunization,1388
Europe,Z,Z01.542,Geographic Locations,NULL,1387
Health Services Accessibility,N,N05.300.430,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",1374
Health Services Accessibility,N,N04.590.374.350,Delivery of Health Care,Patient Care Management,1374
Tanzania,Z,Z01.058.290.120.840,"Africa, Eastern",Africa South of the Sahara,1364
Risk Assessment,N,N06.850.520.830.600.800.715,Risk,Probability,1325
Risk Assessment,N,N04.452.871.715,Risk Management,Organization and Administration,1325
Risk Assessment,N,N06.850.505.715,Epidemiologic Measurements,Public Health,1325
Risk Assessment,N,N05.715.360.750.625.700.690,Risk,Probability,1325
Risk Assessment,E,E05.318.740.600.800.715,Risk,Probability,1325
Disease Outbreaks,N,N06.850.290,Public Health,Environment and Public Health,1294
Sensitivity and Specificity,N,N05.715.360.750.725,Statistics as Topic,Health Care Evaluation Mechanisms,1244
Sensitivity and Specificity,N,N05.715.360.325.700,Epidemiologic Research Design,Health Care Evaluation Mechanisms,1244
Sensitivity and Specificity,G,G17.800,Mathematical Concepts,NULL,1244
Sensitivity and Specificity,E,E05.318.740.872,Statistics as Topic,Epidemiologic Methods,1244
Sensitivity and Specificity,E,E05.318.370.800,Epidemiologic Research Design,Epidemiologic Methods,1244
Sensitivity and Specificity,N,N06.850.520.830.872,Statistics as Topic,Epidemiologic Methods,1244
Sensitivity and Specificity,N,N06.850.520.445.800,Epidemiologic Research Design,Epidemiologic Methods,1244
Qualitative Research,H,H01.770.644.241.850,Empirical Research,Research,1219
SARS-CoV-2,B,B04.820.578.500.540.150.113.968,Betacoronavirus,Coronavirus,1210
Longitudinal Studies,N,N05.715.360.330.500.750.500,Cohort Studies,Epidemiologic Studies,1192
Longitudinal Studies,E,E05.318.372.500.750.500,Cohort Studies,Epidemiologic Studies,1192
Longitudinal Studies,N,N06.850.520.450.500.750.500,Cohort Studies,Epidemiologic Studies,1192
Logistic Models,N,N06.850.520.830.750.450,Regression Analysis,Statistics as Topic,1174
Logistic Models,N,N06.850.520.830.600.800.450,Risk,Probability,1174
Logistic Models,N,N06.850.520.830.500.525,"Models, Statistical",Statistics as Topic,1174
Logistic Models,E,E05.318.740.500.525,"Models, Statistical",Statistics as Topic,1174
Logistic Models,E,E05.318.740.750.450,Regression Analysis,Statistics as Topic,1174
Logistic Models,E,E05.318.740.600.800.450,Risk,Probability,1174
Logistic Models,E,E05.599.835.875,"Models, Statistical","Models, Theoretical",1174
Logistic Models,N,N05.715.360.750.530.480,"Models, Statistical",Statistics as Topic,1174
Logistic Models,N,N05.715.360.750.695.470,Regression Analysis,Statistics as Topic,1174
Logistic Models,N,N05.715.360.750.625.700.450,Risk,Probability,1174
Genotype,G,G05.380,Genetic Phenomena,NULL,1170
Anti-Bacterial Agents,D,D27.505.954.122.085,Anti-Infective Agents,Therapeutic Uses,1167
Research Design,E,E05.581.500,Methods,Investigative Techniques,1155
Research Design,H,H01.770.644.728,Research,Science,1155
Gambia,Z,Z01.058.290.190.300,"Africa, Western",Africa South of the Sahara,1146
Sex Factors,N,N06.850.490.875,Epidemiologic Factors,Public Health,1085
Sex Factors,N,N05.715.350.675,Epidemiologic Factors,Quality of Health Care,1085
"Health Knowledge, Attitudes, Practice",N,N05.300.150.410,Attitude to Health,Delivery of Health Care,1083
"Health Knowledge, Attitudes, Practice",F,F01.100.150.500,Attitude to Health,Attitude,1083
Sexual Behavior,F,F01.145.802,Behavior,Behavior and Behavior Mechanisms,1078
Population Surveillance,E,E05.318.308.980.438.700,Health Surveys,Surveys and Questionnaires,1073
Population Surveillance,N,N06.850.520.308.980.438.700,Health Surveys,Surveys and Questionnaires,1073
Population Surveillance,N,N05.715.360.300.800.438.625,Health Surveys,Surveys and Questionnaires,1073
Population Surveillance,N,N06.850.780.675,Public Health Practice,Public Health,1073
Mycobacterium tuberculosis,B,B03.510.024.962.500.702,Mycobacterium,Mycobacteriaceae,1045
Mycobacterium tuberculosis,B,B03.510.460.400.410.552.552.702,Mycobacterium,Mycobacteriaceae,1045
Kenya,Z,Z01.058.290.120.400,"Africa, Eastern",Africa South of the Sahara,1032
Pandemics,N,N06.850.290.200.600,Epidemics,Disease Outbreaks,1030
Reproducibility of Results,N,N05.715.360.325.685,Epidemiologic Research Design,Health Care Evaluation Mechanisms,990
Reproducibility of Results,E,E05.318.370.725,Epidemiologic Research Design,Epidemiologic Methods,990
Reproducibility of Results,E,E05.337.851,Evaluation Studies as Topic,Investigative Techniques,990
Reproducibility of Results,N,N06.850.520.445.725,Epidemiologic Research Design,Epidemiologic Methods,990
Mice,B,B01.050.150.900.649.313.992.635.505.500,Murinae,Muridae,989
Primary Health Care,N,N04.590.233.727,Comprehensive Health Care,Patient Care Management,984
Odds Ratio,N,N05.715.360.750.625.590,Probability,Statistics as Topic,973
Odds Ratio,G,G17.680.500,Probability,Mathematical Concepts,973
Odds Ratio,E,E05.318.740.600.600,Probability,Statistics as Topic,973
Odds Ratio,N,N06.850.520.830.600.600,Probability,Statistics as Topic,973
HIV-1,B,B04.820.650.589.650.350.400,HIV,"Lentiviruses, Primate",972
Patient Acceptance of Health Care,F,F01.145.488.887.500,Treatment Adherence and Compliance,Health Behavior,969
Patient Acceptance of Health Care,F,F01.100.150.750.500,Treatment Adherence and Compliance,Attitude to Health,969
Patient Acceptance of Health Care,N,N05.300.150.800.500,Treatment Adherence and Compliance,Attitude to Health,969
Mass Screening,N,N05.715.360.300.800.438.500,Health Surveys,Surveys and Questionnaires,968
Mass Screening,N,N06.850.520.308.980.438.580,Health Surveys,Surveys and Questionnaires,968
Mass Screening,N,N02.421.726.233.443,Diagnostic Services,Preventive Health Services,968
Mass Screening,E,E05.318.308.980.438.580,Health Surveys,Surveys and Questionnaires,968
Mass Screening,N,N06.850.780.500,Public Health Practice,Public Health,968
Mass Screening,E,E01.370.500,Diagnostic Techniques and Procedures,Diagnosis,968
Africa,Z,Z01.058,Geographic Locations,NULL,967
Interviews as Topic,E,E05.318.308.420,Data Collection,Epidemiologic Methods,955
Interviews as Topic,L,L01.399.250.520,Data Collection,Information Management,955
Interviews as Topic,N,N06.850.520.308.420,Data Collection,Epidemiologic Methods,955
Interviews as Topic,N,N05.715.360.300.400,Data Collection,Health Care Evaluation Mechanisms,955
Cardiovascular Diseases,C,C14,NULL,NULL,948
"Models, Statistical",N,N05.715.360.750.530,Statistics as Topic,Health Care Evaluation Mechanisms,945
"Models, Statistical",E,E05.318.740.500,Statistics as Topic,Epidemiologic Methods,945
"Models, Statistical",E,E05.599.835,"Models, Theoretical",Investigative Techniques,945
"Models, Statistical",N,N06.850.520.830.500,Statistics as Topic,Epidemiologic Methods,945
Hospitalization,N,N02.421.585.400,Patient Care,Health Services,923
Hospitalization,E,E02.760.400,Patient Care,Therapeutics,923
Anti-HIV Agents,D,D27.505.954.122.388.077.088,Anti-Retroviral Agents,Antiviral Agents,900
Molecular Sequence Data,L,L01.453.245.667,Documentation,Information Services,890
Age Distribution,N,N01.224.033,Demography,Population Characteristics,884
Age Distribution,N,N06.850.505.400.050,Demography,Epidemiologic Measurements,884
Age Distribution,I,I01.240.050,Demography,Social Sciences,884
"Polymorphism, Single Nucleotide",G,G05.365.795.598,"Polymorphism, Genetic",Genetic Variation,883
Prognosis,E,E01.789,Diagnosis,NULL,880
Poverty,I,I01.880.735.634,Social Problems,Sociology,879
Poverty,I,I01.880.853.996.535,Socioeconomic Factors,Sociological Factors,879
Poverty,N,N01.824.600,Socioeconomic Factors,Population Characteristics,879
Phylogeny,L,L01.100.697,Classification,Information Science,878
Phylogeny,G,G16.075.605,Biological Evolution,Biological Phenomena,878
Phylogeny,G,G05.697,Genetic Phenomena,NULL,878
World Health Organization,N,N03.540.514.718.800,United Nations,International Agencies,866
Africa South of the Sahara,Z,Z01.058.290,Africa,Geographic Locations,864
Seasons,N,N06.230.300.100.250.525,Climate,Atmosphere,836
Seasons,G,G16.500.275.071.590,Climate,Environment,836
Seasons,G,G01.910.645.661,Periodicity,Time,836
State Medicine,N,N03.858,Health Care Economics and Organizations,NULL,832
State Medicine,N,N03.349.550.902,National Health Programs,Health Planning,832
Registries,N,N04.452.859.819,Records,Organization and Administration,826
Registries,N,N05.715.360.300.715.700,Records,Data Collection,826
Registries,N,N06.850.520.308.970,Data Collection,Epidemiologic Methods,826
Registries,E,E05.318.308.970,Data Collection,Epidemiologic Methods,826
United States,Z,Z01.107.567.875,North America,Americas,822
Health Promotion,N,N02.421.726.407.579,Health Education,Preventive Health Services,796
Health Promotion,I,I02.233.332.445,Health Education,"Education, Nonprofessional",796
Brazil,Z,Z01.107.757.176,South America,Americas,793
Quality of Life,K,K01.752.400.750,Life,Philosophy,791
Quality of Life,I,I01.800,Social Sciences,NULL,791
Quality of Life,N,N06.850.505.400.425.837,Health Status,Demography,791
"Models, Theoretical",E,E05.599,Investigative Techniques,NULL,785
Neoplasms,C,C04,NULL,NULL,779
Health Surveys,E,E05.318.308.980.438,Surveys and Questionnaires,Data Collection,776
Health Surveys,N,N06.850.520.308.980.438,Surveys and Questionnaires,Data Collection,776
Health Surveys,N,N05.715.360.300.800.438,Surveys and Questionnaires,Data Collection,776
Polymerase Chain Reaction,E,E05.393.620.500,Nucleic Acid Amplification Techniques,Genetic Techniques,768
Biomarkers,D,D23.101,Biological Factors,NULL,765
Regression Analysis,E,E05.318.740.750,Statistics as Topic,Epidemiologic Methods,755
Regression Analysis,N,N05.715.360.750.695,Statistics as Topic,Health Care Evaluation Mechanisms,755
Regression Analysis,N,N06.850.520.830.750,Statistics as Topic,Epidemiologic Methods,755
Mortality,N,N06.850.520.308.985.550,Vital Statistics,Data Collection,745
Mortality,N,N06.850.505.400.975.550,Vital Statistics,Demography,745
Mortality,N,N01.224.935.698,Vital Statistics,Demography,745
Mortality,E,E05.318.308.985.550,Vital Statistics,Data Collection,745
Survival Analysis,E,E05.318.740.998,Statistics as Topic,Epidemiologic Methods,743
Survival Analysis,N,N05.715.360.750.795,Statistics as Topic,Health Care Evaluation Mechanisms,743
Survival Analysis,N,N06.850.520.830.998,Statistics as Topic,Epidemiologic Methods,743
London,Z,Z01.433.553,Cities,Geographic Locations,741
London,Z,Z01.542.363.300.553,England,United Kingdom,741
Severity of Illness Index,N,N05.715.360.300.800.438.375.364.500,Patient Acuity,Health Status Indicators,740
Severity of Illness Index,N,N06.850.520.308.980.438.475.364.500,Patient Acuity,Health Status Indicators,740
Severity of Illness Index,E,E05.318.308.980.438.475.456.500,Patient Acuity,Health Status Indicators,740
Urban Population,N,N01.600.900,Population,Population Characteristics,738
"Tuberculosis, Pulmonary",C,C01.150.252.410.040.552.846.899,Tuberculosis,Mycobacterium Infections,733
"Tuberculosis, Pulmonary",C,C01.748.939,Respiratory Tract Infections,Infections,733
"Tuberculosis, Pulmonary",C,C08.730.939,Respiratory Tract Infections,Respiratory Tract Diseases,733
"Tuberculosis, Pulmonary",C,C08.381.922,Lung Diseases,Respiratory Tract Diseases,733
Antitubercular Agents,D,D27.505.954.122.085.255,Anti-Bacterial Agents,Anti-Infective Agents,727
Malawi,Z,Z01.058.290.175.500,"Africa, Southern",Africa South of the Sahara,717
Health Personnel,M,M01.526.485,Occupational Groups,Persons,710
Health Personnel,N,N02.360,"Health Care Facilities, Manpower, and Services",NULL,710
Body Mass Index,N,N06.850.505.200.100.175,Anthropometry,Biometry,706
Body Mass Index,E,E05.041.124.125,Body Weights and Measures,Anthropometry,706
Body Mass Index,G,G07.100.100.125,Body Weights and Measures,Body Constitution,706
Body Mass Index,E,E01.370.600.115.100.125,Body Weights and Measures,Body Constitution,706
Obesity,E,E01.370.600.115.100.160.120.699.500,Overweight,Body Weight,706
Obesity,C,C18.654.726.500,Overnutrition,Nutrition Disorders,706
Obesity,C,C23.888.144.699.500,Overweight,Body Weight,706
Obesity,G,G07.100.100.160.120.699.500,Overweight,Body Weight,706
Data Collection,E,E05.318.308,Epidemiologic Methods,Investigative Techniques,701
Data Collection,N,N06.850.520.308,Epidemiologic Methods,Public Health,701
Data Collection,N,N05.715.360.300,Health Care Evaluation Mechanisms,Quality of Health Care,701
Data Collection,L,L01.399.250,Information Management,Information Science,701
Risk,N,N05.715.360.750.625.700,Probability,Statistics as Topic,693
Risk,G,G17.680.750,Probability,Mathematical Concepts,693
Risk,E,E05.318.740.600.800,Probability,Statistics as Topic,693
Risk,N,N06.850.520.830.600.800,Probability,Statistics as Topic,693
China,Z,Z01.252.474.164,Far East,Asia,690
Cause of Death,E,E05.318.308.985.550.250,Mortality,Vital Statistics,688
Cause of Death,N,N06.850.505.400.975.550.250,Mortality,Vital Statistics,688
Cause of Death,N,N06.850.520.308.985.550.250,Mortality,Vital Statistics,688
Cause of Death,N,N01.224.935.698.100,Mortality,Vital Statistics,688
Clinical Trials as Topic,N,N05.715.360.330.250.250,Clinical Studies as Topic,Epidemiologic Study Characteristics,688
Clinical Trials as Topic,E,E05.318.372.250.250,Clinical Studies as Topic,Epidemiologic Study Characteristics,688
Clinical Trials as Topic,N,N06.850.520.450.250.250,Clinical Studies as Topic,Epidemiologic Study Characteristics,688
Smoking,F,F01.145.805,Behavior,Behavior and Behavior Mechanisms,686
Genetic Predisposition to Disease,G,G05.380.355,Genotype,Genetic Phenomena,683
Genetic Predisposition to Disease,C,C23.550.291.687.500,Disease Susceptibility,Disease Attributes,683
"Drug Therapy, Combination",E,E02.319.310,Drug Therapy,Therapeutics,676
Sexually Transmitted Diseases,C,C23.550.291.531.937,Communicable Diseases,Disease Attributes,675
Sexually Transmitted Diseases,C,C12.294.668,"Genital Diseases, Male",Male Urogenital Diseases,675
Sexually Transmitted Diseases,C,C13.351.500.711,"Genital Diseases, Female",Female Urogenital Diseases,675
Sexually Transmitted Diseases,C,C01.778,Infections,NULL,675
Sexually Transmitted Diseases,C,C01.221.812,Communicable Diseases,Infections,675
Family Characteristics,F,F01.829.263.315,Family,"Psychology, Social",673
Family Characteristics,N,N06.850.505.400.400,Demography,Epidemiologic Measurements,673
Family Characteristics,N,N01.224.361,Demography,Population Characteristics,673
Family Characteristics,N,N01.824.308,Socioeconomic Factors,Population Characteristics,673
Family Characteristics,I,I01.240.361,Demography,Social Sciences,673
Family Characteristics,I,I01.880.853.150.423,Family,Sociological Factors,673
Genetic Variation,G,G05.365,Genetic Phenomena,NULL,670
Multivariate Analysis,E,E05.318.740.150.500,Analysis of Variance,Statistics as Topic,670
Multivariate Analysis,N,N05.715.360.750.125.500,Analysis of Variance,Statistics as Topic,670
Multivariate Analysis,N,N06.850.520.830.150.500,Analysis of Variance,Statistics as Topic,670
Ghana,Z,Z01.058.290.190.320,"Africa, Western",Africa South of the Sahara,664
Anopheles,B,B01.050.500.131.617.720.500.500.750.712.500.875.120,Culicidae,Culicomorpha,656
Health Status,N,N06.850.505.400.425,Demography,Epidemiologic Measurements,656
Health Status,N,N01.224.425,Demography,Population Characteristics,656
Health Status,I,I01.240.425,Demography,Social Sciences,656
Program Evaluation,N,N05.715.360.650,Health Care Evaluation Mechanisms,Quality of Health Care,656
Program Evaluation,N,N04.761.685,Quality of Health Care,Health Services Administration,656
Program Evaluation,E,E05.337.820,Evaluation Studies as Topic,Investigative Techniques,656
Communicable Disease Control,N,N06.850.780.200,Public Health Practice,Public Health,655
Mosquito Control,N,N06.850.780.200.650.425.500,Insect Control,Pest Control,655
Protozoan Proteins,D,D12.776.820,Proteins,"Amino Acids, Peptides, and Proteins",645
Hypertension,C,C14.907.489,Vascular Diseases,Cardiovascular Diseases,641
Cluster Analysis,N,N06.850.520.830.250,Statistics as Topic,Epidemiologic Methods,620
Cluster Analysis,E,E05.318.740.250,Statistics as Topic,Epidemiologic Methods,620
Cluster Analysis,N,N05.715.360.750.200,Statistics as Topic,Health Care Evaluation Mechanisms,620
Health Services Research,N,N05.425,"Health Care Quality, Access, and Evaluation",NULL,619
Health Services Research,N,N03.349.380,Health Planning,Health Care Economics and Organizations,619
Health Services Research,H,H01.770.644.145.360,Biomedical Research,Research,619
Sex Distribution,I,I01.240.800,Demography,Social Sciences,619
Sex Distribution,N,N01.224.803,Demography,Population Characteristics,619
Sex Distribution,N,N06.850.505.400.850,Demography,Epidemiologic Measurements,619
International Cooperation,I,I01.615.500,Internationality,Social Sciences,613
Double-Blind Method,N,N05.715.360.325.320,Epidemiologic Research Design,Health Care Evaluation Mechanisms,607
Double-Blind Method,E,E05.318.370.300,Epidemiologic Research Design,Epidemiologic Methods,607
Double-Blind Method,E,E05.581.500.300,Research Design,Methods,607
Double-Blind Method,N,N06.850.520.445.300,Epidemiologic Research Design,Epidemiologic Methods,607
Wales,Z,Z01.542.363.914,United Kingdom,Europe,604
"Pregnancy Complications, Infectious",C,C13.703.700,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,602
"Pregnancy Complications, Infectious",C,C01.674,Infections,NULL,602
Proportional Hazards Models,N,N06.850.520.830.600.700,Probability,Statistics as Topic,602
Proportional Hazards Models,N,N06.850.520.830.500.700,"Models, Statistical",Statistics as Topic,602
Proportional Hazards Models,N,N06.850.520.830.750.725,Regression Analysis,Statistics as Topic,602
Proportional Hazards Models,N,N06.850.520.830.998.912,Survival Analysis,Statistics as Topic,602
Proportional Hazards Models,E,E05.599.835.900,"Models, Statistical","Models, Theoretical",602
Proportional Hazards Models,E,E05.318.740.500.700,"Models, Statistical",Statistics as Topic,602
Proportional Hazards Models,E,E05.318.740.600.700,Probability,Statistics as Topic,602
Proportional Hazards Models,E,E05.318.740.750.725,Regression Analysis,Statistics as Topic,602
Proportional Hazards Models,E,E05.318.740.998.825,Survival Analysis,Statistics as Topic,602
Proportional Hazards Models,N,N05.715.360.750.625.650,Probability,Statistics as Topic,602
Proportional Hazards Models,N,N05.715.360.750.530.650,"Models, Statistical",Statistics as Topic,602
Proportional Hazards Models,N,N05.715.360.750.695.650,Regression Analysis,Statistics as Topic,602
Proportional Hazards Models,N,N05.715.360.750.795.825,Survival Analysis,Statistics as Topic,602
"Sequence Analysis, DNA",E,E05.393.760.700,Sequence Analysis,Genetic Techniques,601
Insecticides,D,D27.888.723.491,Pesticides,Toxic Actions,593
Insecticides,D,D27.720.031.700.491,Pesticides,Agrochemicals,593
Mutation,G,G05.365.590,Genetic Variation,Genetic Phenomena,591
Diet,G,G07.203.650.240,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",587
Predictive Value of Tests,E,E05.318.370.800.650,Sensitivity and Specificity,Epidemiologic Research Design,577
Predictive Value of Tests,N,N05.715.360.325.700.640,Sensitivity and Specificity,Epidemiologic Research Design,577
Predictive Value of Tests,N,N06.850.520.445.800.650,Sensitivity and Specificity,Epidemiologic Research Design,577
Drug Combinations,D,D26.310,Pharmaceutical Preparations,NULL,576
Sexual Partners,M,M01.778,Persons,NULL,576
CD4 Lymphocyte Count,G,G09.188.105.595.500.150,Lymphocyte Count,Leukocyte Count,573
CD4 Lymphocyte Count,E,E05.242.195.107.595.500.150,Lymphocyte Count,Leukocyte Count,573
CD4 Lymphocyte Count,E,E05.200.625.107.595.500.150,Lymphocyte Count,Leukocyte Count,573
CD4 Lymphocyte Count,E,E05.200.500.195.107.595.500.150,Lymphocyte Count,Leukocyte Count,573
CD4 Lymphocyte Count,G,G04.140.107.595.500.150,Lymphocyte Count,Leukocyte Count,573
CD4 Lymphocyte Count,E,E01.370.225.500.195.107.595.500.150,Lymphocyte Count,Leukocyte Count,573
CD4 Lymphocyte Count,E,E01.370.225.625.107.595.500.150,Lymphocyte Count,Leukocyte Count,573
Social Class,I,I01.880.853.996.755,Socioeconomic Factors,Sociological Factors,571
Social Class,N,N01.824.782,Socioeconomic Factors,Population Characteristics,571
Quality of Health Care,N,N05.715,"Health Care Quality, Access, and Evaluation",NULL,569
Quality of Health Care,N,N04.761,Health Services Administration,NULL,569
"Antibodies, Viral",D,D12.776.124.486.485.114.254,Antibodies,Immunoglobulins,566
"Antibodies, Viral",D,D12.776.124.790.651.114.254,Antibodies,Immunoglobulins,566
"Antibodies, Viral",D,D12.776.377.715.548.114.254,Antibodies,Immunoglobulins,566
Nigeria,Z,Z01.058.290.190.565,"Africa, Western",Africa South of the Sahara,565
"Models, Biological",E,E05.599.395,"Models, Theoretical",Investigative Techniques,564
Breast Neoplasms,C,C04.588.180,Neoplasms by Site,Neoplasms,558
Breast Neoplasms,C,C17.800.090.500,Breast Diseases,Skin Diseases,558
Travel,I,I03.883,Human Activities,NULL,556
Infant Mortality,N,N06.850.505.400.975.550.475,Mortality,Vital Statistics,555
Infant Mortality,N,N06.850.520.308.985.550.475,Mortality,Vital Statistics,555
Infant Mortality,N,N01.224.935.698.489,Mortality,Vital Statistics,555
Infant Mortality,E,E05.318.308.985.550.475,Mortality,Vital Statistics,555
Enzyme-Linked Immunosorbent Assay,E,E05.601.470.350.170,Immunoenzyme Techniques,Immunoassay,554
Enzyme-Linked Immunosorbent Assay,E,E05.601.470.380.360,Immunosorbent Techniques,Immunoassay,554
Enzyme-Linked Immunosorbent Assay,E,E05.478.566.350.170,Immunoenzyme Techniques,Immunoassay,554
Enzyme-Linked Immunosorbent Assay,E,E05.478.566.380.360,Immunosorbent Techniques,Immunoassay,554
Enzyme-Linked Immunosorbent Assay,E,E05.478.583.400.170,Immunoenzyme Techniques,Immunohistochemistry,554
Health Care Costs,N,N03.219.151.400,Costs and Cost Analysis,Economics,552
Health Care Costs,N,N05.300.375,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",552
"Databases, Factual",L,L01.470.750.750,Databases as Topic,Information Storage and Retrieval,551
"Databases, Factual",L,L01.313.500.750.300.188.400,Databases as Topic,Information Systems,551
"Outcome Assessment, Health Care",H,H01.770.644.145.431,Biomedical Research,Research,551
"Outcome Assessment, Health Care",N,N04.761.559.590,"Outcome and Process Assessment, Health Care",Quality of Health Care,551
"Outcome Assessment, Health Care",N,N05.715.360.575.575,"Outcome and Process Assessment, Health Care",Health Care Evaluation Mechanisms,551
Survival Rate,N,N06.850.505.400.975.550.900,Mortality,Vital Statistics,540
Survival Rate,N,N01.224.935.698.826,Mortality,Vital Statistics,540
Survival Rate,E,E05.318.308.985.550.900,Mortality,Vital Statistics,540
Survival Rate,N,N06.850.520.308.985.550.900,Mortality,Vital Statistics,540
Chronic Disease,C,C23.550.291.500,Disease Attributes,Pathologic Processes,533
"Diabetes Mellitus, Type 2",C,C19.246.300,Diabetes Mellitus,Endocrine System Diseases,531
"Diabetes Mellitus, Type 2",C,C18.452.394.750.149,Diabetes Mellitus,Glucose Metabolism Disorders,531
Algorithms,G,G17.035,Mathematical Concepts,NULL,525
Algorithms,L,L01.224.050,Computing Methodologies,Information Science,525
Residence Characteristics,N,N01.224.791,Demography,Population Characteristics,522
Residence Characteristics,N,N06.850.505.400.800,Demography,Epidemiologic Measurements,522
Disease Progression,C,C23.550.291.656,Disease Attributes,Pathologic Processes,521
Artemisinins,D,D01.248.497.158.685.750.212,Peroxides,Oxides,520
Artemisinins,D,D01.339.431.374.212,Peroxides,Reactive Oxygen Species,520
Artemisinins,D,D01.650.550.750.200,Peroxides,Oxides,520
Artemisinins,D,D02.389.338.055,Peroxides,Free Radicals,520
Artemisinins,D,D02.455.849.765.211,Sesquiterpenes,Terpenes,520
Practice Guidelines as Topic,N,N04.761.700.350.650,Guidelines as Topic,"Quality Assurance, Health Care",518
Practice Guidelines as Topic,N,N05.700.350.650,Guidelines as Topic,"Quality Assurance, Health Care",518
Cost of Illness,N,N06.850.520.308.980.438.475.046,Health Status Indicators,Health Surveys,512
Cost of Illness,N,N05.715.360.300.800.438.375.182,Health Status Indicators,Health Surveys,512
Cost of Illness,N,N03.219.151.165,Costs and Cost Analysis,Economics,512
Viral Load,E,E05.200.875.950,Microbiological Techniques,Clinical Laboratory Techniques,512
Viral Load,G,G06.920.850,Virus Physiological Phenomena,Microbiological Phenomena,512
Viral Load,E,E01.370.225.875.950,Microbiological Techniques,Clinical Laboratory Techniques,512
Base Sequence,G,G05.360.080,Genetic Structures,Genetic Phenomena,511
Base Sequence,G,G02.111.570.080,Molecular Structure,Biochemical Phenomena,511
Base Sequence,L,L01.453.245.667.080,Molecular Sequence Data,Documentation,511
Alcohol Drinking,F,F01.145.317.269,Drinking Behavior,Behavior,510
Ethiopia,Z,Z01.058.290.120.310,"Africa, Eastern",Africa South of the Sahara,509
"Influenza, Human",C,C08.730.310,Respiratory Tract Infections,Respiratory Tract Diseases,507
"Influenza, Human",C,C01.925.782.620.365,Orthomyxoviridae Infections,RNA Virus Infections,507
"Influenza, Human",C,C01.748.310,Respiratory Tract Infections,Infections,507
Comorbidity,N,N06.850.490.687,Epidemiologic Factors,Public Health,505
Comorbidity,N,N05.715.350.225,Epidemiologic Factors,Quality of Health Care,505
"Homosexuality, Male",F,F01.145.802.975.500.600,Homosexuality,Sexuality,504
"Homosexuality, Male",G,G08.686.867.500.600,Homosexuality,Sexuality,504
Pilot Projects,E,E05.318.372.750,Epidemiologic Study Characteristics,Epidemiologic Methods,493
Pilot Projects,E,E05.337.737,Evaluation Studies as Topic,Investigative Techniques,493
Pilot Projects,N,N05.715.360.330.720,Epidemiologic Study Characteristics,Health Care Evaluation Mechanisms,493
Pilot Projects,N,N06.850.520.450.720,Epidemiologic Study Characteristics,Epidemiologic Methods,493
Anti-Retroviral Agents,D,D27.505.954.122.388.077,Antiviral Agents,Anti-Infective Agents,489
Decision Making,F,F02.463.785.373,Thinking,Mental Processes,489
Immunoglobulin G,D,D12.776.377.715.548.114.619.393,Immunoglobulin Isotypes,Antibodies,487
Immunoglobulin G,D,D12.776.124.790.651.114.619.393,Immunoglobulin Isotypes,Antibodies,487
Immunoglobulin G,D,D12.776.124.486.485.114.619.393,Immunoglobulin Isotypes,Antibodies,487
Acquired Immunodeficiency Syndrome,C,C01.778.640.400.040,HIV Infections,"Sexually Transmitted Diseases, Viral",485
Acquired Immunodeficiency Syndrome,C,C01.221.250.875.040,HIV Infections,Blood-Borne Infections,485
Acquired Immunodeficiency Syndrome,C,C01.221.812.640.400.040,HIV Infections,"Sexually Transmitted Diseases, Viral",485
Acquired Immunodeficiency Syndrome,C,C01.925.782.815.616.400.040,HIV Infections,Lentivirus Infections,485
Acquired Immunodeficiency Syndrome,C,C01.925.813.400.040,HIV Infections,"Sexually Transmitted Diseases, Viral",485
Acquired Immunodeficiency Syndrome,C,C01.925.839.040,Slow Virus Diseases,Virus Diseases,485
Acquired Immunodeficiency Syndrome,C,C20.673.480.040,HIV Infections,Immunologic Deficiency Syndromes,485
Zambia,Z,Z01.058.290.175.920,"Africa, Southern",Africa South of the Sahara,484
Amino Acid Sequence,G,G02.111.570.060,Molecular Structure,Biochemical Phenomena,483
Amino Acid Sequence,L,L01.453.245.667.060,Molecular Sequence Data,Documentation,483
Rural Health,N,N01.400.548.750,Population Health,Health,481
Schools,J,J03.832,Non-Medical Public and Private Facilities,NULL,478
Schools,I,I02.783,Education,NULL,478
Bacterial Proteins,D,D12.776.097,Proteins,"Amino Acids, Peptides, and Proteins",476
Asthma,C,C20.543.480.680.095,Respiratory Hypersensitivity,"Hypersensitivity, Immediate",473
Asthma,C,C08.674.095,Respiratory Hypersensitivity,Respiratory Tract Diseases,473
Asthma,C,C08.127.108,Bronchial Diseases,Respiratory Tract Diseases,473
Asthma,C,C08.381.495.108,"Lung Diseases, Obstructive",Lung Diseases,473
Peru,Z,Z01.107.757.702,South America,Americas,473
Microbial Sensitivity Tests,E,E05.337.550.400,"Drug Evaluation, Preclinical",Evaluation Studies as Topic,471
Microbial Sensitivity Tests,E,E05.200.875.595,Microbiological Techniques,Clinical Laboratory Techniques,471
Microbial Sensitivity Tests,E,E01.370.225.875.595,Microbiological Techniques,Clinical Laboratory Techniques,471
Focus Groups,E,E05.318.308.112,Data Collection,Epidemiologic Methods,469
Focus Groups,N,N06.850.520.308.112,Data Collection,Epidemiologic Methods,469
Focus Groups,N,N05.715.360.300.269,Data Collection,Health Care Evaluation Mechanisms,469
Insect Vectors,N,N06.850.520.203.375.100.500,Arthropod Vectors,Disease Vectors,468
Insect Vectors,N,N06.850.335.188.100.500,Arthropod Vectors,Disease Vectors,468
Genome-Wide Association Study,E,E05.393.385.500,Genetic Association Studies,Genetic Techniques,465
Genome-Wide Association Study,E,E05.393.522.500,Molecular Epidemiology,Genetic Techniques,465
Genome-Wide Association Study,E,E05.318.416.249,Molecular Epidemiology,Epidemiologic Methods,465
Genome-Wide Association Study,E,E05.318.370.392,Epidemiologic Research Design,Epidemiologic Methods,465
Genome-Wide Association Study,E,E05.393.760.640.500,Oligonucleotide Array Sequence Analysis,Sequence Analysis,465
Genome-Wide Association Study,N,N06.850.520.470.500,Molecular Epidemiology,Epidemiologic Methods,465
Genome-Wide Association Study,N,N06.850.520.445.392,Epidemiologic Research Design,Epidemiologic Methods,465
Attitude of Health Personnel,F,F01.100.050,Attitude,Behavior and Behavior Mechanisms,464
Attitude of Health Personnel,N,N05.300.100,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",464
Blood Pressure,G,G09.330.380.076,Hemodynamics,Cardiovascular Physiological Phenomena,463
Blood Pressure,E,E01.370.600.875.249,Vital Signs,Physical Examination,463
Quality-Adjusted Life Years,N,N01.224.935.530.700,Life Tables,Vital Statistics,462
Quality-Adjusted Life Years,E,E05.318.740.100.500.700,Life Tables,Actuarial Analysis,462
Drug Resistance,G,G07.690.773.984,Pharmacological Phenomena,Pharmacological and Toxicological Phenomena,457
Educational Status,N,N01.824.196,Socioeconomic Factors,Population Characteristics,456
Epidemiologic Methods,N,N06.850.520,Public Health,Environment and Public Health,455
Epidemiologic Methods,E,E05.318,Investigative Techniques,NULL,455
Health Behavior,F,F01.145.488,Behavior,Behavior and Behavior Mechanisms,455
Myocardial Infarction,C,C14.907.585.500,Myocardial Ischemia,Vascular Diseases,455
Myocardial Infarction,C,C14.280.647.500,Myocardial Ischemia,Heart Diseases,455
Myocardial Infarction,C,C23.550.513.355.750,Infarction,Ischemia,455
Myocardial Infarction,C,C23.550.717.489.750,Infarction,Necrosis,455
Biomedical Research,H,H01.770.644.145,Research,Science,452
Health Services Needs and Demand,N,N05.300.450,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",449
Health Services Needs and Demand,N,N03.349.380.420,Health Services Research,Health Planning,449
Bayes Theorem,N,N05.715.360.750.625.150,Probability,Statistics as Topic,448
Bayes Theorem,E,E05.318.740.600.200,Probability,Statistics as Topic,448
Bayes Theorem,N,N06.850.520.830.600.200,Probability,Statistics as Topic,448
"Drug Resistance, Bacterial",G,G07.690.773.984.269.347,"Drug Resistance, Microbial",Drug Resistance,448
"Drug Resistance, Bacterial",G,G06.099.225,Bacterial Physiological Phenomena,Microbiological Phenomena,448
"Drug Resistance, Bacterial",G,G06.225.347,"Drug Resistance, Microbial",Microbiological Phenomena,448
Seroepidemiologic Studies,E,E05.318.372.500.950,Epidemiologic Studies,Epidemiologic Study Characteristics,447
Seroepidemiologic Studies,N,N05.715.360.330.500.950,Epidemiologic Studies,Epidemiologic Study Characteristics,447
Seroepidemiologic Studies,N,N06.850.520.450.500.950,Epidemiologic Studies,Epidemiologic Study Characteristics,447
Environmental Exposure,N,N06.850.460.350,Environmental Pollution,Public Health,446
HIV Seropositivity,C,C20.673.480.500,HIV Infections,Immunologic Deficiency Syndromes,445
HIV Seropositivity,C,C01.925.813.400.500,HIV Infections,"Sexually Transmitted Diseases, Viral",445
HIV Seropositivity,C,C01.925.782.815.616.400.500,HIV Infections,Lentivirus Infections,445
HIV Seropositivity,C,C01.221.812.640.400.500,HIV Infections,"Sexually Transmitted Diseases, Viral",445
HIV Seropositivity,C,C01.221.250.875.500,HIV Infections,Blood-Borne Infections,445
HIV Seropositivity,C,C01.778.640.400.500,HIV Infections,"Sexually Transmitted Diseases, Viral",445
Mental Disorders,F,F03,NULL,NULL,445
Income,N,N01.824.417,Socioeconomic Factors,Population Characteristics,444
Diarrhea,C,C23.888.821.214,"Signs and Symptoms, Digestive",Signs and Symptoms,443
Stroke,C,C14.907.253.855,Cerebrovascular Disorders,Vascular Diseases,439
Stroke,C,C10.228.140.300.775,Cerebrovascular Disorders,Brain Diseases,439
Mental Health,N,N01.400.500,Health,Population Characteristics,437
Mental Health,F,F02.418,Psychological Phenomena,NULL,437
Immunization Programs,N,N02.421.726.608,Preventive Health Services,Health Services,436
Maternal Health Services,N,N02.421.800.500,Reproductive Health Services,Health Services,436
Maternal Health Services,N,N02.421.143.620,Community Health Services,Health Services,436
Prenatal Care,N,N02.421.143.620.704,Maternal Health Services,Community Health Services,436
Prenatal Care,N,N02.421.585.786,Patient Care,Health Services,436
Prenatal Care,E,E02.760.786,Patient Care,Therapeutics,436
Communicable Diseases,C,C23.550.291.531,Disease Attributes,Pathologic Processes,434
Communicable Diseases,C,C01.221,Infections,NULL,434
Mothers,F,F01.829.263.500.320.200,Parents,Nuclear Family,434
Mothers,M,M01.620.630,Parents,Persons,434
Mothers,I,I01.880.853.150.500.340.270,Parents,Nuclear Family,434
"Data Interpretation, Statistical",L,L01.313.500.750.190.380,Decision Support Techniques,Medical Informatics Applications,433
"Data Interpretation, Statistical",N,N05.715.360.750.300,Statistics as Topic,Health Care Evaluation Mechanisms,433
"Data Interpretation, Statistical",E,E05.245.380,Decision Support Techniques,Investigative Techniques,433
"Data Interpretation, Statistical",E,E05.318.740.300,Statistics as Topic,Epidemiologic Methods,433
"Data Interpretation, Statistical",N,N06.850.520.830.300,Statistics as Topic,Epidemiologic Methods,433
"RNA, Viral",D,D13.444.735.828,RNA,Nucleic Acids,433
Trachoma,C,C01.375.354.220.800,"Conjunctivitis, Bacterial","Eye Infections, Bacterial",432
Trachoma,C,C01.150.252.289.225.800,"Conjunctivitis, Bacterial","Eye Infections, Bacterial",432
Trachoma,C,C01.150.252.400.210.125.745,Chlamydia Infections,Chlamydiaceae Infections,432
Trachoma,C,C11.187.183.220.889,"Conjunctivitis, Bacterial",Conjunctivitis,432
Trachoma,C,C11.204.813,Corneal Diseases,Eye Diseases,432
Trachoma,C,C11.294.354.220.800,"Conjunctivitis, Bacterial","Eye Infections, Bacterial",432
Zimbabwe,Z,Z01.058.290.175.960,"Africa, Southern",Africa South of the Sahara,431
Computer Simulation,L,L01.224.160,Computing Methodologies,Information Science,427
Hospitals,N,N02.278.421,Health Facilities,"Health Care Facilities, Manpower, and Services",424
Evidence-Based Medicine,H,H02.249.750,Evidence-Based Practice,Health Occupations,416
Evidence-Based Medicine,H,H02.403.200.400,Clinical Medicine,Medicine,416
"Antiretroviral Therapy, Highly Active",E,E02.319.310.075,"Drug Therapy, Combination",Drug Therapy,413
"Genome, Bacterial",G,G05.360.340.358.207,"Genome, Microbial",Genome,412
Feces,A,A12.459,Fluids and Secretions,NULL,411
Nutritional Status,G,G07.203.650.650,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",409
Nutritional Status,N,N01.224.425.525,Health Status,Demography,409
Attitude to Health,N,N05.300.150,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",406
Attitude to Health,F,F01.100.150,Attitude,Behavior and Behavior Mechanisms,406
"Antigens, Protozoan",D,D23.050.293,Antigens,Biological Factors,401
Diabetes Mellitus,C,C18.452.394.750,Glucose Metabolism Disorders,Metabolic Diseases,401
Diabetes Mellitus,C,C19.246,Endocrine System Diseases,NULL,401
"Tuberculosis, Multidrug-Resistant",C,C01.150.252.410.040.552.846.775,Tuberculosis,Mycobacterium Infections,396
Bangladesh,Z,Z01.252.245.131,"Asia, Western",Asia,394
Research,H,H01.770.644,Science,Natural Science Disciplines,394
"Antibodies, Bacterial",D,D12.776.124.486.485.114.107,Antibodies,Immunoglobulins,389
"Antibodies, Bacterial",D,D12.776.124.790.651.114.125,Antibodies,Immunoglobulins,389
"Antibodies, Bacterial",D,D12.776.377.715.548.114.125,Antibodies,Immunoglobulins,389
Community Health Services,N,N02.421.143,Health Services,"Health Care Facilities, Manpower, and Services",389
Phenotype,G,G05.695,Genetic Phenomena,NULL,389
"Infectious Disease Transmission, Vertical",N,N06.850.335.875,"Disease Transmission, Infectious",Public Health,388
Asia,Z,Z01.252,Geographic Locations,NULL,387
Depression,F,F01.145.126.350,Behavioral Symptoms,Behavior,387
Risk-Taking,F,F01.145.722,Behavior,Behavior and Behavior Mechanisms,387
Interferon-gamma,D,D12.644.276.374.440.893,Interferons,Cytokines,385
Interferon-gamma,D,D12.644.276.374.480.615.350,Macrophage-Activating Factors,Lymphokines,385
Interferon-gamma,D,D12.776.467.374.440.893,Interferons,Cytokines,385
Interferon-gamma,D,D12.776.467.374.480.615.350,Macrophage-Activating Factors,Lymphokines,385
Interferon-gamma,D,D23.529.374.440.893,Interferons,Cytokines,385
Interferon-gamma,D,D23.529.374.480.615.350,Macrophage-Activating Factors,Lymphokines,385
Referral and Consultation,N,N04.452.758.849,Professional Practice,Organization and Administration,385
Social Support,I,I01.880.853.500.600,Social Environment,Sociological Factors,385
Dengue,C,C01.925.782.350.250.214,Flavivirus Infections,Flaviviridae Infections,378
Dengue,C,C01.925.782.417.214,"Hemorrhagic Fevers, Viral",RNA Virus Infections,378
Dengue,C,C01.925.081.270,Arbovirus Infections,Virus Diseases,378
Dengue,C,C01.920.500.270,Arbovirus Infections,Vector Borne Diseases,378
Anemia,C,C15.378.071,Hematologic Diseases,Hemic and Lymphatic Diseases,377
Policy Making,N,N03.706.742,"Social Control, Formal",Health Care Economics and Organizations,376
Streptococcus pneumoniae,B,B03.510.550.737.872.550,Streptococcus,Streptococcaceae,373
Streptococcus pneumoniae,B,B03.510.400.800.872.550,Streptococcus,Streptococcaceae,373
Streptococcus pneumoniae,B,B03.353.750.737.872.550,Streptococcus,Streptococcaceae,373
Birth Weight,C,C23.888.144.186,Body Weight,Signs and Symptoms,371
Birth Weight,E,E01.370.600.115.100.160.120.186,Body Weight,Body Size,371
Birth Weight,E,E05.041.124.160.750.149,Body Weight,Body Size,371
Birth Weight,G,G07.100.100.160.120.186,Body Weight,Body Size,371
Birth Weight,G,G07.345.249.314.120.186,Body Weight,Body Size,371
"Polymorphism, Genetic",G,G05.365.795,Genetic Variation,Genetic Phenomena,370
Alleles,G,G05.360.340.024.340.030,Genes,Genome Components,364
Linear Models,E,E05.318.740.500.500,"Models, Statistical",Statistics as Topic,363
Linear Models,E,E05.318.740.750.425,Regression Analysis,Statistics as Topic,363
Linear Models,E,E05.599.835.750,"Models, Statistical","Models, Theoretical",363
Linear Models,N,N05.715.360.750.530.460,"Models, Statistical",Statistics as Topic,363
Linear Models,N,N05.715.360.750.695.460,Regression Analysis,Statistics as Topic,363
Linear Models,N,N06.850.520.830.500.500,"Models, Statistical",Statistics as Topic,363
Linear Models,N,N06.850.520.830.750.425,Regression Analysis,Statistics as Topic,363
Geography,H,H01.277.500,Earth Sciences,Natural Science Disciplines,362
Chlamydia trachomatis,B,B03.440.190.190.190.750,Chlamydia,Chlamydiaceae,360
Recurrence,C,C23.550.291.937,Disease Attributes,Pathologic Processes,358
"History, 20th Century",K,K01.400.504.968,"History, Modern 1601-",History,357
Politics,I,I01.738,Social Sciences,NULL,357
Epidemics,N,N06.850.290.200,Disease Outbreaks,Public Health,356
Life Style,F,F01.829.458,"Psychology, Social",Behavior and Behavior Mechanisms,356
Feasibility Studies,E,E05.337.675,Evaluation Studies as Topic,Investigative Techniques,355
Feasibility Studies,E,E05.318.372.550,Epidemiologic Study Characteristics,Epidemiologic Methods,355
Feasibility Studies,N,N05.715.360.330.550,Epidemiologic Study Characteristics,Health Care Evaluation Mechanisms,355
Feasibility Studies,N,N06.850.520.450.550,Epidemiologic Study Characteristics,Epidemiologic Methods,355
"Antigens, Bacterial",D,D23.050.161,Antigens,Biological Factors,354
Pneumococcal Vaccines,D,D20.215.894.135.750.600,Streptococcal Vaccines,Bacterial Vaccines,354
Forecasting,I,I01.320,Social Sciences,NULL,353
AIDS-Related Opportunistic Infections,C,C20.673.480.100,HIV Infections,Immunologic Deficiency Syndromes,352
AIDS-Related Opportunistic Infections,C,C01.221.250.875.100,HIV Infections,Blood-Borne Infections,352
AIDS-Related Opportunistic Infections,C,C01.597.050,Opportunistic Infections,Infections,352
AIDS-Related Opportunistic Infections,C,C01.610.684.050,Opportunistic Infections,Parasitic Diseases,352
AIDS-Related Opportunistic Infections,C,C01.925.597.050,Opportunistic Infections,Virus Diseases,352
AIDS-Related Opportunistic Infections,C,C01.925.782.815.616.400.100,HIV Infections,Lentivirus Infections,352
Coronavirus Infections,C,C01.925.782.600.550.200,Coronaviridae Infections,Nidovirales Infections,351
"Hemorrhagic Fever, Ebola",C,C01.925.782.580.250.400,Filoviridae Infections,Mononegavirales Infections,350
"Hemorrhagic Fever, Ebola",C,C01.925.782.417.415,"Hemorrhagic Fevers, Viral",RNA Virus Infections,350
Breast Feeding,F,F01.145.407.199,Feeding Behavior,Behavior,348
Breast Feeding,G,G07.203.650.353.199,Feeding Behavior,Nutritional Physiological Phenomena,348
Breast Feeding,G,G07.203.650.220.500.500,Infant Nutritional Physiological Phenomena,Child Nutritional Physiological Phenomena,348
Breast Feeding,G,G07.203.650.195,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",348
"Pneumonia, Viral",C,C01.925.705,Virus Diseases,Infections,348
"Pneumonia, Viral",C,C01.748.610.763,Pneumonia,Respiratory Tract Infections,348
"Pneumonia, Viral",C,C08.381.677.807,Pneumonia,Lung Diseases,348
"Pneumonia, Viral",C,C08.730.610.763,Pneumonia,Respiratory Tract Infections,348
Coronary Disease,C,C14.907.585.250,Myocardial Ischemia,Vascular Diseases,346
Coronary Disease,C,C14.280.647.250,Myocardial Ischemia,Heart Diseases,346
Demography,I,I01.240,Social Sciences,NULL,341
Demography,N,N06.850.505.400,Epidemiologic Measurements,Public Health,341
Demography,N,N01.224,Population Characteristics,NULL,341
Health Education,N,N02.421.726.407,Preventive Health Services,Health Services,341
Health Education,I,I02.233.332,"Education, Nonprofessional",Education,341
New Zealand,Z,Z01.639.760.747,Pacific Islands,Islands,339
New Zealand,Z,Z01.678.100.747,Australasia,Oceania,339
Pneumococcal Infections,C,C01.150.252.410.890.670,Streptococcal Infections,Gram-Positive Bacterial Infections,339
"Disease Transmission, Infectious",N,N06.850.335,Public Health,Environment and Public Health,334
Health Services,N,N02.421,"Health Care Facilities, Manpower, and Services",NULL,334
Drug Administration Schedule,E,E02.319.283,Drug Therapy,Therapeutics,333
Health Facilities,N,N02.278,"Health Care Facilities, Manpower, and Services",NULL,332
Body Weight,G,G07.100.100.160.120,Body Size,Body Weights and Measures,330
Body Weight,G,G07.345.249.314.120,Body Size,Growth,330
Body Weight,E,E05.041.124.160.750,Body Size,Body Weights and Measures,330
Body Weight,E,E01.370.600.115.100.160.120,Body Size,Body Weights and Measures,330
Body Weight,C,C23.888.144,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",330
Endemic Diseases,N,N06.850.392,Public Health,Environment and Public Health,330
Patient Compliance,N,N05.300.150.800.500.600,Patient Acceptance of Health Care,Treatment Adherence and Compliance,330
Patient Compliance,F,F01.145.488.887.500.600,Patient Acceptance of Health Care,Treatment Adherence and Compliance,330
Patient Compliance,F,F01.100.150.750.500.600,Patient Acceptance of Health Care,Treatment Adherence and Compliance,330
Pyrimethamine,D,D03.383.742.675,Pyrimidines,"Heterocyclic Compounds, 1-Ring",330
Vaccines,D,D20.215.894,Biological Products,Complex Mixtures,330
"Antibodies, Protozoan",D,D12.776.377.715.548.114.252,Antibodies,Immunoglobulins,328
"Antibodies, Protozoan",D,D12.776.124.790.651.114.252,Antibodies,Immunoglobulins,328
"Antibodies, Protozoan",D,D12.776.124.486.485.114.252,Antibodies,Immunoglobulins,328
Visual Acuity,E,E01.370.380.850.950,Vision Tests,"Diagnostic Techniques, Ophthalmological",328
Visual Acuity,F,F02.463.593.932.901,Visual Perception,Perception,328
Visual Acuity,G,G14.940,Ocular Physiological Phenomena,NULL,328
Pregnancy Outcome,G,G08.686.784.769.496,Pregnancy,Reproduction,327
Pregnancy Outcome,E,E01.789.700,Prognosis,Diagnosis,327
Cytokines,D,D23.529.374,Intercellular Signaling Peptides and Proteins,Biological Factors,326
Cytokines,D,D12.776.467.374,Intercellular Signaling Peptides and Proteins,Proteins,326
Cytokines,D,D12.644.276.374,Intercellular Signaling Peptides and Proteins,Peptides,326
Cell Line,A,A11.251.210,"Cells, Cultured",Cells,325
Patient Satisfaction,F,F01.100.150.750.625,Treatment Adherence and Compliance,Attitude to Health,324
Patient Satisfaction,F,F01.145.488.887.625,Treatment Adherence and Compliance,Health Behavior,324
Patient Satisfaction,N,N05.300.150.800.625,Treatment Adherence and Compliance,Attitude to Health,324
Patient Satisfaction,N,N04.452.822.700,Public Relations,Organization and Administration,324
Patient Satisfaction,N,N05.715.360.600,Health Care Evaluation Mechanisms,Quality of Health Care,324
BCG Vaccine,D,D20.215.894.135.825.100,Tuberculosis Vaccines,Bacterial Vaccines,323
Bias,N,N06.850.490.500,Epidemiologic Factors,Public Health,323
Bias,N,N05.715.350.150,Epidemiologic Factors,Quality of Health Care,323
Sputum,A,A12.200.808,Bodily Secretions,Fluids and Secretions,323
Acute Disease,C,C23.550.291.125,Disease Attributes,Pathologic Processes,322
Counseling,N,N02.421.143.303,Community Health Services,Health Services,321
Counseling,N,N02.421.461.363,Mental Health Services,Health Services,321
Counseling,F,F02.784.176,"Psychology, Applied",Psychological Phenomena,321
Counseling,F,F04.408.413,Mental Health Services,Behavioral Disciplines and Activities,321
Australia,Z,Z01.678.100.373,Australasia,Oceania,320
Australia,Z,Z01.639.100,Islands,Geographic Locations,320
Leprosy,C,C01.150.252.410.040.552.475.371,"Mycobacterium Infections, Nontuberculous",Mycobacterium Infections,319
Blindness,C,C23.888.592.763.941.162,Vision Disorders,Sensation Disorders,318
Blindness,C,C10.597.751.941.162,Vision Disorders,Sensation Disorders,318
Blindness,C,C11.966.075,Vision Disorders,Eye Diseases,318
Magnetic Resonance Imaging,E,E01.370.350.825.500,Tomography,Diagnostic Imaging,318
"Cells, Cultured",A,A11.251,Cells,NULL,317
Sanitation,N,N06.850.860,Public Health,Environment and Public Health,316
Sanitation,N,N06.850.780.200.800,Communicable Disease Control,Public Health Practice,316
Sanitation,H,H02.229.782,Environmental Health,Health Occupations,316
Feeding Behavior,G,G07.203.650.353,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",314
Feeding Behavior,F,F01.145.407,Behavior,Behavior and Behavior Mechanisms,314
Feeding Behavior,F,F01.145.113.547,"Behavior, Animal",Behavior,314
Health Expenditures,N,N03.219.151.450,Costs and Cost Analysis,Economics,314
Health Expenditures,N,N05.300.385,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",314
Uterine Cervical Neoplasms,C,C04.588.945.418.948.850,Uterine Neoplasms,"Genital Neoplasms, Female",314
Uterine Cervical Neoplasms,C,C13.351.500.852.593.131,Uterine Cervical Diseases,Uterine Diseases,314
Uterine Cervical Neoplasms,C,C13.351.500.852.762.850,Uterine Neoplasms,Uterine Diseases,314
Uterine Cervical Neoplasms,C,C13.351.937.418.875.850,Uterine Neoplasms,"Genital Neoplasms, Female",314
Condoms,E,E07.190.270.150,"Contraceptive Devices, Male",Contraceptive Devices,312
"Diagnostic Tests, Routine",E,E01.370.395,Diagnostic Techniques and Procedures,Diagnosis,311
Dietary Supplements,G,G07.203.300.456,Food,"Diet, Food, and Nutrition",311
Dietary Supplements,J,J02.500.456,Food,Food and Beverages,311
Hepatitis C,C,C06.552.380.705.440,"Hepatitis, Viral, Human",Hepatitis,311
Hepatitis C,C,C01.925.440.440,"Hepatitis, Viral, Human",Virus Diseases,311
Hepatitis C,C,C01.925.782.350.350,Flaviviridae Infections,RNA Virus Infections,311
Hepatitis C,C,C01.221.250.750,Blood-Borne Infections,Communicable Diseases,311
Family Practice,H,H02.403.340.500,General Practice,Medicine,310
Medication Adherence,N,N05.300.150.800.500.600.500,Patient Compliance,Patient Acceptance of Health Care,310
Medication Adherence,F,F01.100.150.750.500.600.500,Patient Compliance,Patient Acceptance of Health Care,310
Medication Adherence,F,F01.145.488.887.500.600.500,Patient Compliance,Patient Acceptance of Health Care,310
Scotland,Z,Z01.542.363.766,United Kingdom,Europe,310
Morbidity,E,E05.318.308.985.525,Vital Statistics,Data Collection,309
Morbidity,N,N06.850.505.400.975.525,Vital Statistics,Demography,309
Morbidity,N,N06.850.520.308.985.525,Vital Statistics,Data Collection,309
Morbidity,N,N01.224.935.597,Vital Statistics,Demography,309
Hygiene,N,N06.850.670,Public Health,Environment and Public Health,308
Hygiene,E,E02.547,Therapeutics,NULL,308
Maternal Mortality,N,N06.850.520.308.985.550.500,Mortality,Vital Statistics,307
Maternal Mortality,N,N01.224.935.698.653,Mortality,Vital Statistics,307
Maternal Mortality,N,N06.850.505.400.975.550.500,Mortality,Vital Statistics,307
Maternal Mortality,E,E05.318.308.985.550.500,Mortality,Vital Statistics,307
National Health Programs,N,N03.349.550,Health Planning,Health Care Economics and Organizations,307
Confidence Intervals,N,N05.715.360.750.220,Statistics as Topic,Health Care Evaluation Mechanisms,306
Confidence Intervals,E,E05.318.740.275,Statistics as Topic,Epidemiologic Methods,306
Confidence Intervals,N,N06.850.520.830.275,Statistics as Topic,Epidemiologic Methods,306
Pregnancy Complications,C,C13.703,Female Urogenital Diseases and Pregnancy Complications,NULL,303
"DNA, Bacterial",D,D13.444.308.212,DNA,Nucleic Acids,301
Community Health Workers,N,N02.360.067.080,Allied Health Personnel,Health Personnel,300
Community Health Workers,M,M01.526.485.067.080,Allied Health Personnel,Health Personnel,300
Health Status Disparities,N,N01.224.425.437,Health Status,Demography,300
Health Status Disparities,N,N06.850.505.400.425.675,Health Status,Demography,300
Health Status Disparities,I,I01.240.425.675,Health Status,Demography,300
"Evolution, Molecular",G,G16.075.250,Biological Evolution,Biological Phenomena,299
"Evolution, Molecular",G,G05.045.250,Biological Evolution,Genetic Phenomena,299
Parasitemia,C,C23.550.470.790.500.580,Sepsis,Systemic Inflammatory Response Syndrome,299
Parasitemia,C,C01.610.695,Parasitic Diseases,Infections,299
Healthcare Disparities,N,N04.590.374.380,Delivery of Health Care,Patient Care Management,297
Healthcare Disparities,N,N05.300.493,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",297
Syphilis,C,C01.778.281.859,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,297
Syphilis,C,C01.221.812.281.859,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,297
Syphilis,C,C01.150.252.400.794.840.500,Treponemal Infections,Spirochaetales Infections,297
Syphilis,C,C01.150.252.400.840.500,Treponemal Infections,Gram-Negative Bacterial Infections,297
Syphilis,C,C01.150.252.734.859,"Sexually Transmitted Diseases, Bacterial",Bacterial Infections,297
Syphilis,C,C13.351.500.711.281.859,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,297
Syphilis,C,C12.294.668.281.859,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,297
Water Supply,J,J01.293.821.500,Sanitary Engineering,Engineering,297
HIV,B,B04.820.650.589.650.350,"Lentiviruses, Primate",Lentivirus,296
Motivation,F,F01.752.543.500.750,Emotional Intelligence,Intelligence,296
Motivation,F,F01.658,Behavior and Behavior Mechanisms,NULL,296
Sulfadoxine,D,D02.092.146.807.765,Sulfanilamides,Aniline Compounds,296
Sulfadoxine,D,D02.065.884.725.765,Sulfanilamides,Sulfonamides,296
Sulfadoxine,D,D02.886.590.700.725.765,Sulfanilamides,Sulfonamides,296
Cattle,B,B01.050.150.900.649.313.500.380.271,Ruminants,Artiodactyla,294
Lung Neoplasms,C,C04.588.894.797.520,Respiratory Tract Neoplasms,Thoracic Neoplasms,294
Lung Neoplasms,C,C08.785.520,Respiratory Tract Neoplasms,Respiratory Tract Diseases,294
Lung Neoplasms,C,C08.381.540,Lung Diseases,Respiratory Tract Diseases,294
Pakistan,Z,Z01.252.245.723,"Asia, Western",Asia,293
Malnutrition,C,C18.654.521,Nutrition Disorders,Nutritional and Metabolic Diseases,292
Aging,G,G07.345.124,Growth and Development,Physiological Phenomena,291
Internet,L,L01.224.230.110.500,Computer Communication Networks,Computer Systems,291
"Practice Patterns, Physicians'",N,N05.300.625,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",291
"Practice Patterns, Physicians'",N,N04.590.374.577,Delivery of Health Care,Patient Care Management,291
Coinfection,C,C01.218,Infections,NULL,290
Housing,N,N06.850.505.400.800.400,Residence Characteristics,Demography,290
Housing,N,N06.230.150.360,"Environment, Controlled",Environment,290
Housing,N,N01.224.791.400,Residence Characteristics,Demography,290
Housing,J,J03.340,Non-Medical Public and Private Facilities,NULL,290
"Substance Abuse, Intravenous",F,F03.900.793,Substance-Related Disorders,Mental Disorders,290
"Substance Abuse, Intravenous",C,C25.775.793,Substance-Related Disorders,Chemically-Induced Disorders,290
Costs and Cost Analysis,N,N03.219.151,Economics,Health Care Economics and Organizations,287
Heart Failure,C,C14.280.434,Heart Diseases,Cardiovascular Diseases,287
Species Specificity,G,G16.824,Biological Phenomena,NULL,287
Thailand,Z,Z01.252.145.841,"Asia, Southeastern",Asia,287
Transients and Migrants,M,M01.920,Persons,NULL,286
Carrier State,N,N06.850.520.169,Epidemiologic Methods,Public Health,285
Burkina Faso,Z,Z01.058.290.190.245,"Africa, Western",Africa South of the Sahara,284
Gestational Age,G,G07.345.500.325.235.968,Fetal Development,Embryonic and Fetal Development,283
Gestational Age,G,G08.686.320,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,283
Papillomavirus Infections,C,C01.925.256.650,DNA Virus Infections,Virus Diseases,282
Papillomavirus Infections,C,C01.925.928.725,Tumor Virus Infections,Virus Diseases,282
"Dose-Response Relationship, Drug",G,G07.690.936.500,Toxicological Phenomena,Pharmacological and Toxicological Phenomena,281
"Dose-Response Relationship, Drug",G,G07.690.773.875,Pharmacological Phenomena,Pharmacological and Toxicological Phenomena,281
Mosquito Vectors,N,N06.850.520.203.375.100.500.500,Insect Vectors,Arthropod Vectors,281
Mosquito Vectors,N,N06.850.335.188.100.500.500,Insect Vectors,Arthropod Vectors,281
"Disease Models, Animal",E,E05.599.395.080,"Models, Biological","Models, Theoretical",280
"Disease Models, Animal",E,E05.598.500,"Models, Animal",Investigative Techniques,280
"Disease Models, Animal",C,C22.232,Animal Diseases,NULL,280
"Delivery, Obstetric",E,E04.520.252,Obstetric Surgical Procedures,"Surgical Procedures, Operative",279
Health Care Reform,N,N04.590.374.285,Delivery of Health Care,Patient Care Management,279
Health Care Reform,N,N05.300.380,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",279
Health Care Reform,N,N03.623.500.608.428.285,Health Policy,Public Policy,279
Health Care Reform,N,N03.349.285,Health Planning,Health Care Economics and Organizations,279
Health Care Reform,I,I01.655.500.608.400.285,Health Policy,Public Policy,279
Health Care Reform,I,I01.880.604.825.608.400.285,Health Policy,Public Policy,279
Health Priorities,N,N03.349.330,Health Planning,Health Care Economics and Organizations,277
Health Priorities,N,N05.300.400,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",277
Exercise,I,I03.350,Human Activities,NULL,276
Exercise,G,G11.427.410.698.277,Motor Activity,Movement,276
Trypanosoma cruzi,B,B01.268.475.868.887.140,Trypanosoma,Trypanosomatina,276
Communication,L,L01.143,Information Science,NULL,275
Communication,F,F01.145.209,Behavior,Behavior and Behavior Mechanisms,275
Pneumonia,C,C01.748.610,Respiratory Tract Infections,Infections,274
Pneumonia,C,C08.381.677,Lung Diseases,Respiratory Tract Diseases,274
Pneumonia,C,C08.730.610,Respiratory Tract Infections,Respiratory Tract Diseases,274
Antiviral Agents,D,D27.505.954.122.388,Anti-Infective Agents,Therapeutic Uses,272
Life Expectancy,E,E05.318.308.985.450,Vital Statistics,Data Collection,272
Life Expectancy,N,N06.850.505.400.975.450,Vital Statistics,Demography,272
Life Expectancy,N,N06.850.520.308.985.450,Vital Statistics,Data Collection,272
Life Expectancy,N,N01.224.935.464,Vital Statistics,Demography,272
Parents,M,M01.620,Persons,NULL,272
Parents,I,I01.880.853.150.500.340,Nuclear Family,Family,272
Parents,F,F01.829.263.500.320,Nuclear Family,Family,272
Caregivers,M,M01.526.485.200,Health Personnel,Occupational Groups,271
Caregivers,M,M01.085,Persons,NULL,271
Caregivers,N,N02.360.200,Health Personnel,"Health Care Facilities, Manpower, and Services",271
"DNA, Protozoan",D,D13.444.308.442,DNA,Nucleic Acids,271
COVID-19 Vaccines,D,D20.215.894.899.085,Viral Vaccines,Vaccines,270
Health Care Surveys,N,N03.349.380.210,Health Services Research,Health Planning,270
Health Care Surveys,N,N06.850.520.308.980.344,Surveys and Questionnaires,Data Collection,270
Health Care Surveys,N,N05.715.360.300.800.344,Surveys and Questionnaires,Data Collection,270
Health Care Surveys,N,N05.425.210,Health Services Research,"Health Care Quality, Access, and Evaluation",270
Health Care Surveys,E,E05.318.308.980.344,Surveys and Questionnaires,Data Collection,270
Insecticide-Treated Bednets,E,E07.700.510.500,Mosquito Nets,Protective Devices,270
Erythrocytes,A,A15.145.229.334,Blood Cells,Blood,267
Erythrocytes,A,A11.118.290,Blood Cells,Cells,267
Erythrocytes,A,A11.443.240,Erythroid Cells,Cells,267
Fever,C,C23.888.119.344,Body Temperature Changes,Signs and Symptoms,267
Genomics,H,H01.158.273.180.350,Computational Biology,Biology,267
Genomics,H,H01.158.273.343.350,Genetics,Biology,267
Kaplan-Meier Estimate,N,N05.715.360.750.795.650,Survival Analysis,Statistics as Topic,267
Kaplan-Meier Estimate,E,E05.318.740.998.650,Survival Analysis,Statistics as Topic,267
Kaplan-Meier Estimate,N,N06.850.520.830.998.650,Survival Analysis,Statistics as Topic,267
Occupational Diseases,C,C24,NULL,NULL,267
Disabled Persons,M,M01.150,Persons,NULL,266
Malaria Vaccines,D,D20.215.894.582.500,Protozoan Vaccines,Vaccines,266
Respiratory Tract Infections,C,C08.730,Respiratory Tract Diseases,NULL,264
Respiratory Tract Infections,C,C01.748,Infections,NULL,264
Patient Selection,N,N04.590.731,Patient Care Management,Health Services Administration,263
Patient Selection,E,E05.581.500.653,Research Design,Methods,263
Quality Improvement,N,N04.761.744,Quality of Health Care,Health Services Administration,263
Quality Improvement,J,J01.293.754,Engineering,"Technology, Industry, and Agriculture",263
Brain,A,A08.186.211,Central Nervous System,Nervous System,262
Chlamydia Infections,C,C01.778.281.301,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,262
Chlamydia Infections,C,C01.221.812.281.301,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,262
Chlamydia Infections,C,C01.150.252.734.301,"Sexually Transmitted Diseases, Bacterial",Bacterial Infections,262
Chlamydia Infections,C,C01.150.252.400.210.125,Chlamydiaceae Infections,Gram-Negative Bacterial Infections,262
Chlamydia Infections,C,C12.294.668.281.301,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,262
Chlamydia Infections,C,C13.351.500.711.281.301,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,262
Occupational Exposure,N,N06.850.460.350.600,Environmental Exposure,Environmental Pollution,262
Gene Frequency,G,G05.330,Genetic Phenomena,NULL,261
Internationality,I,I01.615,Social Sciences,NULL,261
Urban Health,N,N01.400.548.875,Population Health,Health,261
Virulence,G,G06.930,Microbiological Phenomena,NULL,260
"Mice, Inbred BALB C",B,B01.050.050.199.520.520.338,"Mice, Inbred Strains","Animals, Inbred Strains",258
"Mice, Inbred BALB C",B,B01.050.150.900.649.313.992.635.505.500.400.338,"Mice, Inbred Strains",Mice,258
Pyrethrins,D,D02.455.849.575.188.750,Cyclopentane Monoterpenes,Monoterpenes,258
Self Report,E,E05.318.308.980.500,Surveys and Questionnaires,Data Collection,257
Self Report,N,N06.850.520.308.980.500,Surveys and Questionnaires,Data Collection,257
Self Report,N,N05.715.360.300.800.500,Surveys and Questionnaires,Data Collection,257
Betacoronavirus,B,B04.820.578.500.540.150.113,Coronavirus,Coronaviridae,256
Vietnam,Z,Z01.252.145.945,"Asia, Southeastern",Asia,255
Commerce,J,J01.219,"Technology, Industry, and Agriculture",NULL,254
Temperature,G,G16.500.750.775.710,Weather,Meteorological Concepts,250
Temperature,G,G16.500.275.063.725.710,Weather,Atmosphere,250
Temperature,N,N06.230.150.450,"Environment, Controlled",Environment,250
Temperature,N,N06.230.300.100.725.710,Weather,Atmosphere,250
Temperature,G,G01.906.595,Thermodynamics,Physical Phenomena,250
Family,F,F01.829.263,"Psychology, Social",Behavior and Behavior Mechanisms,249
Family,I,I01.880.853.150,Sociological Factors,Sociology,249
Substance-Related Disorders,F,F03.900,Mental Disorders,NULL,249
Substance-Related Disorders,C,C25.775,Chemically-Induced Disorders,NULL,249
"Vaccines, Conjugate",D,D20.215.894.865.900,"Vaccines, Synthetic",Vaccines,249
"Vaccines, Conjugate",D,D23.050.865.900,"Vaccines, Synthetic",Antigens,249
Child Mortality,E,E05.318.308.985.550.287,Mortality,Vital Statistics,248
Child Mortality,N,N06.850.520.308.985.550.287,Mortality,Vital Statistics,248
Child Mortality,N,N06.850.505.400.975.550.287,Mortality,Vital Statistics,248
Child Mortality,N,N01.224.935.698.150,Mortality,Vital Statistics,248
Rural Health Services,N,N02.421.816,Health Services,"Health Care Facilities, Manpower, and Services",248
T-Lymphocytes,A,A15.145.229.637.555.567.569,Lymphocytes,"Leukocytes, Mononuclear",248
T-Lymphocytes,A,A15.382.490.555.567.569,Lymphocytes,"Leukocytes, Mononuclear",248
T-Lymphocytes,A,A11.118.637.555.567.569,Lymphocytes,"Leukocytes, Mononuclear",248
Family Planning Services,N,N02.421.800.249,Reproductive Health Services,Health Services,247
Family Planning Services,N,N02.421.143.401,Community Health Services,Health Services,247
Body Height,E,E05.041.124.160.500,Body Size,Body Weights and Measures,246
Body Height,G,G07.100.100.160.100,Body Size,Body Weights and Measures,246
Body Height,G,G07.345.249.314.100,Body Size,Growth,246
Body Height,E,E01.370.600.115.100.160.100,Body Size,Body Weights and Measures,246
Students,M,M01.848,Persons,NULL,246
Escherichia coli,B,B03.440.450.425.325.300,Escherichia,Enterobacteriaceae,244
Escherichia coli,B,B03.660.250.150.180.100,Escherichia,Enterobacteriaceae,244
Postoperative Complications,C,C23.550.767,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",244
Recombinant Proteins,D,D12.776.828,Proteins,"Amino Acids, Peptides, and Proteins",244
Refugees,M,M01.755,Persons,NULL,244
Cross Infection,C,C23.550.291.875.500,Iatrogenic Disease,Disease Attributes,243
Cross Infection,C,C01.248,Infections,NULL,243
Guidelines as Topic,N,N04.761.700.350,"Quality Assurance, Health Care",Quality of Health Care,242
Guidelines as Topic,N,N05.700.350,"Quality Assurance, Health Care","Health Care Quality, Access, and Evaluation",242
Cities,N,N06.230.069,Environment,Environment and Public Health,241
Cities,G,G16.500.275.069,Environment,Ecological and Environmental Phenomena,241
Cities,Z,Z01.433,Geographic Locations,NULL,241
Gonorrhea,C,C01.221.812.281.401,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,241
Gonorrhea,C,C01.150.252.734.401,"Sexually Transmitted Diseases, Bacterial",Bacterial Infections,241
Gonorrhea,C,C01.150.252.400.625.275,Neisseriaceae Infections,Gram-Negative Bacterial Infections,241
Gonorrhea,C,C01.778.281.401,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,241
Gonorrhea,C,C13.351.500.711.281.401,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,241
Gonorrhea,C,C12.294.668.281.401,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,241
Nepal,Z,Z01.252.245.674,"Asia, Western",Asia,240
Serotyping,E,E05.200.812.742,Immunologic Tests,Clinical Laboratory Techniques,239
Serotyping,E,E05.200.875.150.125.890,Bacterial Typing Techniques,Bacteriological Techniques,239
Serotyping,E,E05.478.594.780,Immunologic Tests,Immunologic Techniques,239
Serotyping,E,E01.370.225.875.150.125.890,Bacterial Typing Techniques,Bacteriological Techniques,239
Serotyping,E,E01.370.225.812.742,Immunologic Tests,Clinical Laboratory Techniques,239
Climate Change,G,G16.500.175.374,Climatic Processes,Ecological and Environmental Phenomena,237
Haplotypes,G,G05.380.360,Genotype,Genetic Phenomena,237
Probability,E,E05.318.740.600,Statistics as Topic,Epidemiologic Methods,237
Probability,G,G17.680,Mathematical Concepts,NULL,237
Probability,N,N05.715.360.750.625,Statistics as Topic,Health Care Evaluation Mechanisms,237
Probability,N,N06.850.520.830.600,Statistics as Topic,Epidemiologic Methods,237
Social Stigma,F,F01.145.813.840,Social Behavior,Behavior,237
"Stress, Psychological",F,F01.145.126.990,Behavioral Symptoms,Behavior,237
"Stress, Psychological",F,F02.830.900,Psychophysiology,Psychological Phenomena,237
Child Health Services,N,N02.421.143.130,Community Health Services,Health Services,236
Italy,Z,Z01.542.489,Europe,Geographic Locations,236
Child Development,F,F01.525.200,Human Development,Behavior and Behavior Mechanisms,235
Child Development,G,G07.345.374.750,Human Development,Growth and Development,235
Developed Countries,I,I01.615.500.250,International Cooperation,Internationality,234
Environment,G,G16.500.275,Ecological and Environmental Phenomena,Biological Phenomena,234
Environment,N,N06.230,Environment and Public Health,NULL,234
"Africa, Western",Z,Z01.058.290.190,Africa South of the Sahara,Africa,233
Blood Glucose,D,D09.947.875.359.448.500,Glucose,Hexoses,232
Private Sector,N,N04.452.633.390,Ownership,Organization and Administration,232
Private Sector,I,I01.791,Social Sciences,NULL,232
Analysis of Variance,N,N05.715.360.750.125,Statistics as Topic,Health Care Evaluation Mechanisms,231
Analysis of Variance,E,E05.318.740.150,Statistics as Topic,Epidemiologic Methods,231
Analysis of Variance,N,N06.850.520.830.150,Statistics as Topic,Epidemiologic Methods,231
Health Resources,N,N05.300.420,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",231
Health Resources,N,N03.349.340,Health Planning,Health Care Economics and Organizations,231
Hemoglobins,D,D12.776.124.400,Blood Proteins,Proteins,231
Hemoglobins,D,D12.776.422.316.762,Globins,Hemeproteins,231
"Pregnancy Complications, Parasitic",C,C13.703.700.680,"Pregnancy Complications, Infectious",Pregnancy Complications,231
"Pregnancy Complications, Parasitic",C,C01.610.718,Parasitic Diseases,Infections,231
Sex Workers,M,M01.776,Persons,NULL,231
Helminthiasis,C,C01.610.335,Parasitic Diseases,Infections,230
Hospital Mortality,N,N01.224.935.698.400,Mortality,Vital Statistics,230
Hospital Mortality,N,N06.850.505.400.975.550.400,Mortality,Vital Statistics,230
Hospital Mortality,N,N06.850.520.308.985.550.400,Mortality,Vital Statistics,230
Hospital Mortality,E,E05.318.308.985.550.400,Mortality,Vital Statistics,230
Cataract,C,C11.510.245,Lens Diseases,Eye Diseases,229
Chloroquine,D,D03.633.100.810.050.180,Aminoquinolines,Quinolines,229
Sex Work,F,F01.145.802.790,Sexual Behavior,Behavior,229
Sex Work,I,I01.880.735.679,Social Problems,Sociology,229
Wounds and Injuries,C,C26,NULL,NULL,229
Statistics as Topic,H,H01.548.832,Mathematics,Natural Science Disciplines,228
Statistics as Topic,N,N05.715.360.750,Health Care Evaluation Mechanisms,Quality of Health Care,228
Statistics as Topic,E,E05.318.740,Epidemiologic Methods,Investigative Techniques,228
Statistics as Topic,N,N06.850.520.830,Epidemiologic Methods,Public Health,228
DNA Methylation,G,G05.206,Genetic Phenomena,NULL,227
DNA Methylation,G,G02.111.035.538.161,Methylation,Alkylation,227
DNA Methylation,G,G02.111.218,Biochemical Phenomena,Chemical Phenomena,227
DNA Methylation,G,G03.059.538.161,Methylation,Alkylation,227
Length of Stay,N,N02.421.585.400.480,Hospitalization,Patient Care,227
Length of Stay,E,E02.760.400.480,Hospitalization,Patient Care,227
Canada,Z,Z01.107.567.176,North America,Americas,226
Contact Tracing,N,N06.850.780.200.225,Communicable Disease Control,Public Health Practice,225
Contact Tracing,N,N06.850.520.270,Epidemiologic Methods,Public Health,225
Contact Tracing,E,E05.318.270,Epidemiologic Methods,Investigative Techniques,225
European Union,I,I01.615.500.475,International Cooperation,Internationality,225
Russia,Z,Z01.252.122.500,"Asia, Northern",Asia,225
Russia,Z,Z01.542.248.775,"Europe, Eastern",Europe,225
Influenza Vaccines,D,D20.215.894.899.302,Viral Vaccines,Vaccines,223
"Models, Economic",N,N06.850.520.830.500.600,"Models, Statistical",Statistics as Topic,223
"Models, Economic",N,N05.715.360.750.530.500,"Models, Statistical",Statistics as Topic,223
"Models, Economic",E,E05.318.740.500.600,"Models, Statistical",Statistics as Topic,223
"Models, Economic",E,E05.599.835.890,"Models, Statistical","Models, Theoretical",223
Anthropometry,E,E05.041,Investigative Techniques,NULL,222
Anthropometry,N,N06.850.505.200.100,Biometry,Epidemiologic Measurements,222
Anthropometry,E,E01.370.600.024,Physical Examination,Diagnostic Techniques and Procedures,222
Guideline Adherence,N,N05.715.360.395,Health Care Evaluation Mechanisms,Quality of Health Care,221
Guideline Adherence,N,N04.761.337,Quality of Health Care,Health Services Administration,221
Insecticide Resistance,G,G07.690.773.984.491,Drug Resistance,Pharmacological Phenomena,220
"Administration, Oral",E,E02.319.267.100,Drug Administration Routes,Drug Therapy,219
Immunization Schedule,E,E02.095.465.425.400.470,Immunization,Immunotherapy,219
Immunization Schedule,E,E05.478.550.545,Immunization,Immunologic Techniques,219
Plasmodium,B,B01.043.075.380.611,Haemosporida,Apicomplexa,218
"Leishmaniasis, Visceral",C,C01.610.752.300.500.510,Leishmaniasis,Euglenozoa Infections,217
"Leishmaniasis, Visceral",C,C01.920.813.510,Leishmaniasis,Vector Borne Diseases,217
Lymphocyte Activation,E,E01.370.225.812.482,Immunologic Tests,Clinical Laboratory Techniques,217
Lymphocyte Activation,E,E05.478.594.530,Immunologic Tests,Immunologic Techniques,217
Lymphocyte Activation,E,E05.200.812.482,Immunologic Tests,Clinical Laboratory Techniques,217
Lymphocyte Activation,G,G12.565,Immune System Phenomena,NULL,217
Lymphocyte Activation,G,G12.450.050.400.545,"Immunity, Cellular",Adaptive Immunity,217
"Mice, Inbred C57BL",B,B01.050.150.900.649.313.992.635.505.500.400.420,"Mice, Inbred Strains",Mice,217
"Mice, Inbred C57BL",B,B01.050.050.199.520.520.420,"Mice, Inbred Strains","Animals, Inbred Strains",217
CD4-Positive T-Lymphocytes,A,A15.382.490.555.567.569.200,T-Lymphocytes,Lymphocytes,216
CD4-Positive T-Lymphocytes,A,A15.145.229.637.555.567.569.200,T-Lymphocytes,Lymphocytes,216
CD4-Positive T-Lymphocytes,A,A11.118.637.555.567.569.200,T-Lymphocytes,Lymphocytes,216
Molecular Epidemiology,H,H01.158.201.636.475.500,Molecular Medicine,Molecular Biology,216
Molecular Epidemiology,H,H01.158.273.343.595.475.500,Molecular Medicine,Molecular Biology,216
Molecular Epidemiology,H,H01.181.122.650.475.550,Molecular Medicine,Molecular Biology,216
Molecular Epidemiology,H,H02.403.720.500.300,Epidemiology,Public Health,216
Molecular Epidemiology,E,E05.393.522,Genetic Techniques,Investigative Techniques,216
Molecular Epidemiology,E,E05.318.416,Epidemiologic Methods,Investigative Techniques,216
Molecular Epidemiology,N,N06.850.520.470,Epidemiologic Methods,Public Health,216
Rats,B,B01.050.150.900.649.313.992.635.505.700,Murinae,Muridae,216
Azithromycin,D,D02.540.576.500.992.050,Erythromycin,Macrolides,215
Air Pollution,N,N06.850.460.100,Environmental Pollution,Public Health,214
Public Policy,N,N03.623.500.608,Social Control Policies,Policy,214
Public Policy,I,I01.655.500.608,Social Control Policies,Policy,214
Public Policy,I,I01.880.604.825.608,Social Control Policies,"Social Control, Formal",214
Bedding and Linens,J,J01.494.221,Household Articles,"Technology, Industry, and Agriculture",213
Bedding and Linens,E,E07.325.137,"Equipment and Supplies, Hospital",Equipment and Supplies,213
Immunization,E,E05.478.550,Immunologic Techniques,Investigative Techniques,213
Immunization,N,N02.421.726.758.310,Primary Prevention,Preventive Health Services,213
Immunization,N,N06.850.780.200.425,Communicable Disease Control,Public Health Practice,213
Immunization,N,N06.850.780.680.310,Primary Prevention,Public Health Practice,213
Immunization,E,E02.095.465.425.400,Immunotherapy,Immunomodulation,213
Antiprotozoal Agents,D,D27.505.954.122.250.100,Antiparasitic Agents,Anti-Infective Agents,212
Software,L,L01.224.900,Computing Methodologies,Information Science,212
Violence,I,I01.880.735.900,Social Problems,Sociology,212
Violence,I,I01.198.240.856,Crime,Criminology,212
Cooperative Behavior,F,F01.145.813.115,Social Behavior,Behavior,211
Epidemiological Monitoring,E,E05.318.375,Epidemiologic Methods,Investigative Techniques,211
Epidemiological Monitoring,N,N06.850.520.460,Epidemiologic Methods,Public Health,211
Gene Expression Regulation,G,G05.308,Genetic Phenomena,NULL,211
"Malaria, Vivax",C,C01.920.875.700,Malaria,Vector Borne Diseases,211
"Malaria, Vivax",C,C01.610.752.530.700,Malaria,Protozoan Infections,211
Meta-Analysis as Topic,E,E05.318.370.500,Epidemiologic Research Design,Epidemiologic Methods,211
Meta-Analysis as Topic,E,E05.581.500.501,Research Design,Methods,211
Meta-Analysis as Topic,N,N05.715.360.325.515,Epidemiologic Research Design,Health Care Evaluation Mechanisms,211
Meta-Analysis as Topic,N,N06.850.520.445.500,Epidemiologic Research Design,Epidemiologic Methods,211
Zika Virus Infection,C,C01.920.500.990,Arbovirus Infections,Vector Borne Diseases,211
Zika Virus Infection,C,C01.925.081.990,Arbovirus Infections,Virus Diseases,211
Zika Virus Infection,C,C01.925.782.350.250.990,Flavivirus Infections,Flaviviridae Infections,211
Air Pollutants,D,D27.888.284.101,Environmental Pollutants,Toxic Actions,209
Anthelmintics,D,D27.505.954.122.250.075,Antiparasitic Agents,Anti-Infective Agents,209
Electronic Health Records,N,N05.715.360.300.715.500.530.250,"Medical Records Systems, Computerized",Medical Records,209
Electronic Health Records,N,N06.850.520.308.940.968.625.250,"Medical Records Systems, Computerized",Medical Records,209
Electronic Health Records,N,N04.452.859.564.650.125,"Medical Records Systems, Computerized",Medical Records,209
Electronic Health Records,E,E05.318.308.940.968.625.500,"Medical Records Systems, Computerized",Medical Records,209
Disease Eradication,N,N06.850.275,Public Health,Environment and Public Health,207
Food Supply,J,J01.576.423.750,Food Industry,Industry,207
"RNA, Messenger",D,D13.444.735.544,RNA,Nucleic Acids,207
Treatment Failure,E,E01.789.800.760,Treatment Outcome,Prognosis,206
Treatment Failure,N,N05.715.360.575.575.800.760,Treatment Outcome,"Outcome Assessment, Health Care",206
Treatment Failure,N,N04.761.559.590.800.760,Treatment Outcome,"Outcome Assessment, Health Care",206
"Quality Assurance, Health Care",N,N04.761.700,Quality of Health Care,Health Services Administration,205
"Quality Assurance, Health Care",N,N05.700,"Health Care Quality, Access, and Evaluation",NULL,205
Contraception,E,E02.875.194,Reproductive Techniques,Therapeutics,204
Spain,Z,Z01.542.846,Europe,Geographic Locations,204
Bacterial Infections,C,C01.150.252,Bacterial Infections and Mycoses,Infections,203
Culicidae,B,B01.050.500.131.617.720.500.500.750.712.500.875,Culicomorpha,Nematocera,203
France,Z,Z01.542.286,Europe,Geographic Locations,203
"History, 21st Century",K,K01.400.504.984,"History, Modern 1601-",History,203
Patient Education as Topic,I,I02.233.332.500,Health Education,"Education, Nonprofessional",203
Patient Education as Topic,N,N02.421.726.407.680,Health Education,Preventive Health Services,203
Evaluation Studies as Topic,N,N05.715.360.335,Health Care Evaluation Mechanisms,Quality of Health Care,202
Evaluation Studies as Topic,E,E05.337,Investigative Techniques,NULL,202
Prostatic Neoplasms,C,C04.588.945.440.770,"Genital Neoplasms, Male",Urogenital Neoplasms,202
Prostatic Neoplasms,C,C12.294.565.625,Prostatic Diseases,"Genital Diseases, Male",202
Prostatic Neoplasms,C,C12.294.260.750,"Genital Neoplasms, Male","Genital Diseases, Male",202
Prostatic Neoplasms,C,C12.758.409.750,"Genital Neoplasms, Male",Urogenital Neoplasms,202
Women's Health,N,N01.400.900,Health,Population Characteristics,202
Gene Expression Profiling,E,E05.393.332,Genetic Techniques,Investigative Techniques,201
"Infant, Low Birth Weight",M,M01.060.703.520.460,"Infant, Newborn",Infant,201
Mental Health Services,N,N02.421.461,Health Services,"Health Care Facilities, Manpower, and Services",201
Mental Health Services,F,F04.408,Behavioral Disciplines and Activities,NULL,201
Chagas Disease,C,C01.920.625,Vector Borne Diseases,Infections,200
Chagas Disease,C,C01.610.752.300.900.200,Trypanosomiasis,Euglenozoa Infections,200
Decision Support Techniques,E,E05.245,Investigative Techniques,NULL,200
Decision Support Techniques,L,L01.313.500.750.190,Medical Informatics Applications,Medical Informatics,200
Plasmodium vivax,B,B01.043.075.380.611.761,Plasmodium,Haemosporida,200
Workforce,N,N04.452.525,Organization and Administration,Health Services Administration,200
Clinical Competence,N,N05.715.175,Quality of Health Care,"Health Care Quality, Access, and Evaluation",198
Clinical Competence,N,N04.761.210,Quality of Health Care,Health Services Administration,198
Clinical Competence,I,I02.399.630.210,Professional Competence,Educational Measurement,198
"DNA, Viral",D,D13.444.308.568,DNA,Nucleic Acids,198
"Models, Genetic",E,E05.599.395.397,"Models, Biological","Models, Theoretical",198
Population Dynamics,I,I01.240.600,Demography,Social Sciences,198
Population Dynamics,N,N06.850.505.400.700,Demography,Epidemiologic Measurements,198
Population Dynamics,N,N01.224.625,Demography,Population Characteristics,198
Universal Health Insurance,N,N03.219.521.576.265.500,Insurance Coverage,Insurance,198
Ambulatory Care Facilities,N,N02.278.035,Health Facilities,"Health Care Facilities, Manpower, and Services",197
Anti-Infective Agents,D,D27.505.954.122,Therapeutic Uses,Pharmacologic Actions,197
Netherlands,Z,Z01.542.651,Europe,Geographic Locations,197
Lung,A,A04.411,Respiratory System,NULL,196
Infection Control,N,N06.850.780.200.450,Communicable Disease Control,Public Health Practice,195
Poverty Areas,N,N01.824.600.550,Poverty,Socioeconomic Factors,195
Poverty Areas,I,I01.880.853.996.535.550,Poverty,Socioeconomic Factors,195
Sexual and Gender Minorities,M,M01.777,Persons,NULL,195
"Delivery of Health Care, Integrated",N,N04.590.374.142,Delivery of Health Care,Patient Care Management,194
"Delivery of Health Care, Integrated",N,N05.300.262,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",194
Bacteria,B,B03,NULL,NULL,193
Democratic Republic of the Congo,Z,Z01.058.290.100.220,"Africa, Central",Africa South of the Sahara,193
"Drug Resistance, Multiple, Bacterial",G,G07.690.773.984.300.500,"Drug Resistance, Multiple",Drug Resistance,193
"Drug Resistance, Multiple, Bacterial",G,G07.690.773.984.269.347.812,"Drug Resistance, Bacterial","Drug Resistance, Microbial",193
"Drug Resistance, Multiple, Bacterial",G,G06.225.347.812,"Drug Resistance, Bacterial","Drug Resistance, Microbial",193
"Drug Resistance, Multiple, Bacterial",G,G06.099.225.812,"Drug Resistance, Bacterial",Bacterial Physiological Phenomena,193
Antihypertensive Agents,D,D27.505.954.411.162,Cardiovascular Agents,Therapeutic Uses,192
Bluetongue virus,B,B04.820.223.719.550.100,Orbivirus,Reoviridae,192
Colorectal Neoplasms,C,C04.588.274.476.411.307,Intestinal Neoplasms,Gastrointestinal Neoplasms,192
Colorectal Neoplasms,C,C06.301.371.411.307,Intestinal Neoplasms,Gastrointestinal Neoplasms,192
Colorectal Neoplasms,C,C06.405.249.411.307,Intestinal Neoplasms,Gastrointestinal Neoplasms,192
Colorectal Neoplasms,C,C06.405.469.158.356,Colonic Diseases,Intestinal Diseases,192
Colorectal Neoplasms,C,C06.405.469.491.307,Intestinal Neoplasms,Intestinal Diseases,192
Colorectal Neoplasms,C,C06.405.469.860.180,Rectal Diseases,Intestinal Diseases,192
Dengue Virus,B,B04.820.578.344.350.270,Flavivirus,Flaviviridae,192
"Diagnosis, Differential",E,E01.171,Diagnosis,NULL,192
Emigration and Immigration,N,N06.850.505.400.700.525.500,Human Migration,Population Dynamics,192
Emigration and Immigration,N,N01.224.625.525.500,Human Migration,Population Dynamics,192
Emigration and Immigration,I,I01.240.600.525.500,Human Migration,Population Dynamics,192
Sweden,Z,Z01.542.816.500,Scandinavian and Nordic Countries,Europe,192
Hot Temperature,G,G16.500.750.775.710.380,Temperature,Weather,191
Hot Temperature,G,G16.500.275.063.725.710.380,Temperature,Weather,191
Hot Temperature,N,N06.230.300.100.725.710.380,Temperature,Weather,191
Hot Temperature,N,N06.230.300.100.725.232,Weather,Atmosphere,191
Hot Temperature,G,G01.906.595.543,Temperature,Thermodynamics,191
Inflammation,C,C23.550.470,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",191
Physicians,M,M01.526.485.810,Health Personnel,Occupational Groups,190
Physicians,N,N02.360.810,Health Personnel,"Health Care Facilities, Manpower, and Services",190
Prenatal Exposure Delayed Effects,C,C13.703.824.500,Prenatal Injuries,Pregnancy Complications,190
Host-Pathogen Interactions,G,G16.527.200,Host Microbial Interactions,Biological Phenomena,189
Host-Pathogen Interactions,G,G06.462,Microbiological Phenomena,NULL,189
"Immunity, Innate",G,G12.450.564,Immunity,Immune System Phenomena,189
Macrophages,A,A15.382.670.522,Mononuclear Phagocyte System,Immune System,187
Macrophages,A,A15.382.680.397,Phagocytes,Immune System,187
Macrophages,A,A11.627.482,Myeloid Cells,Cells,187
Macrophages,A,A11.329.372,Connective Tissue Cells,Cells,187
Macrophages,A,A11.733.397,Phagocytes,Cells,187
Anxiety,F,F01.470.132,Emotions,Behavior and Behavior Mechanisms,186
Environmental Monitoring,N,N06.850.460.350.080,Environmental Exposure,Environmental Pollution,186
Environmental Monitoring,N,N06.850.780.375,Public Health Practice,Public Health,186
Measles,C,C01.925.782.580.600.500.500,Morbillivirus Infections,Paramyxoviridae Infections,186
Sepsis,C,C01.757,Infections,NULL,186
Sepsis,C,C23.550.470.790.500,Systemic Inflammatory Response Syndrome,Inflammation,186
Government Programs,I,I01.451,Social Sciences,NULL,185
Membrane Proteins,D,D12.776.543,Proteins,"Amino Acids, Peptides, and Proteins",185
Program Development,N,N04.452.760,Organization and Administration,Health Services Administration,184
Reference Values,E,E05.978.810,Weights and Measures,Investigative Techniques,184
Signal Transduction,G,G02.111.820,Biochemical Phenomena,Chemical Phenomena,184
Signal Transduction,G,G04.835,Cell Physiological Phenomena,NULL,184
Reverse Transcriptase Polymerase Chain Reaction,E,E05.393.620.500.725,Polymerase Chain Reaction,Nucleic Acid Amplification Techniques,182
Iron,D,D01.268.956.287,Transition Elements,Elements,181
Iron,D,D01.268.556.412,"Metals, Heavy",Elements,181
Iron,D,D01.552.544.412,"Metals, Heavy",Metals,181
Sample Size,E,E05.581.500.902,Research Design,Methods,181
Sample Size,E,E05.318.370.762,Epidemiologic Research Design,Epidemiologic Methods,181
Sample Size,N,N05.715.360.325.692,Epidemiologic Research Design,Health Care Evaluation Mechanisms,181
Sample Size,N,N06.850.520.445.762,Epidemiologic Research Design,Epidemiologic Methods,181
Telemedicine,N,N04.590.374.800,Delivery of Health Care,Patient Care Management,181
Telemedicine,H,H02.403.840,Medicine,Health Occupations,181
Telemedicine,L,L01.178.847.652,Telecommunications,Communications Media,181
Cataract Extraction,E,E04.540.825.249,Refractive Surgical Procedures,Ophthalmologic Surgical Procedures,180
Causality,N,N05.715.350.200,Epidemiologic Factors,Quality of Health Care,180
Causality,N,N06.850.490.625,Epidemiologic Factors,Public Health,180
C-Reactive Protein,D,D12.776.124.050.120,Acute-Phase Proteins,Blood Proteins,180
C-Reactive Protein,D,D12.776.034.145,Albumins,Proteins,180
C-Reactive Protein,D,D12.776.124.486.157,Immunoproteins,Blood Proteins,180
Indonesia,Z,Z01.252.145.380,"Asia, Southeastern",Asia,180
Indonesia,Z,Z01.639.580,Islands,Geographic Locations,180
Clinical Protocols,N,N05.715.360.330.125,Epidemiologic Study Characteristics,Health Care Evaluation Mechanisms,179
Clinical Protocols,E,E02.183,Therapeutics,NULL,179
Health Status Indicators,N,N05.715.360.300.800.438.375,Health Surveys,Surveys and Questionnaires,179
Health Status Indicators,N,N06.850.520.308.980.438.475,Health Surveys,Surveys and Questionnaires,179
Health Status Indicators,E,E05.318.308.980.438.475,Health Surveys,Surveys and Questionnaires,179
Hepatitis B,C,C01.221.250.500,Blood-Borne Infections,Communicable Diseases,179
Hepatitis B,C,C01.925.440.435,"Hepatitis, Viral, Human",Virus Diseases,179
Hepatitis B,C,C01.925.256.430.400,Hepadnaviridae Infections,DNA Virus Infections,179
Hepatitis B,C,C06.552.380.705.437,"Hepatitis, Viral, Human",Hepatitis,179
"Confounding Factors, Epidemiologic",N,N06.850.490.718,Epidemiologic Factors,Public Health,178
"Confounding Factors, Epidemiologic",N,N05.715.350.240,Epidemiologic Factors,Quality of Health Care,178
"Emergency Service, Hospital",N,N04.452.442.452.422.336,Hospital Departments,Hospital Administration,178
"Emergency Service, Hospital",N,N02.421.297.195,Emergency Medical Services,Health Services,178
"Emergency Service, Hospital",N,N02.278.216.500.968.336,Hospital Departments,Hospital Administration,178
Papillomavirus Vaccines,D,D20.215.894.899.498,Viral Vaccines,Vaccines,178
Latin America,Z,Z01.107.424,Americas,Geographic Locations,177
Self Care,N,N02.421.784.680,Rehabilitation,Health Services,177
Self Care,I,I03.050.563,Activities of Daily Living,Human Activities,177
Self Care,E,E02.900,Therapeutics,NULL,177
Gene Expression,G,G05.297,Genetic Phenomena,NULL,176
"Abortion, Induced",E,E04.520.050,Obstetric Surgical Procedures,"Surgical Procedures, Operative",175
"Genome, Viral",G,G05.360.340.358.840,"Genome, Microbial",Genome,175
Mozambique,Z,Z01.058.290.175.545,"Africa, Southern",Africa South of the Sahara,175
Community Participation,N,N03.540.245.360,Consumer Organizations,Organizations,174
Community Participation,N,N02.421.143.212,Community Health Services,Health Services,174
Computational Biology,L,L01.313.124,Informatics,Information Science,173
Computational Biology,H,H01.158.273.180,Biology,Biological Science Disciplines,173
Overweight,G,G07.100.100.160.120.699,Body Weight,Body Size,173
Overweight,E,E01.370.600.115.100.160.120.699,Body Weight,Body Size,173
Overweight,C,C23.888.144.699,Body Weight,Signs and Symptoms,173
Plasmids,G,G05.360.600,Genetic Structures,Genetic Phenomena,173
Point-of-Care Systems,N,N04.452.442.452.452.680,Hospital Information Systems,Hospital Administration,173
Point-of-Care Systems,N,N04.452.515.360.652,Hospital Information Systems,Management Information Systems,173
Point-of-Care Systems,N,N04.590.874,Patient Care Management,Health Services Administration,173
Likelihood Functions,N,N05.715.360.750.625.450,Probability,Statistics as Topic,172
Likelihood Functions,N,N05.715.360.750.530.450,"Models, Statistical",Statistics as Topic,172
Likelihood Functions,E,E05.318.740.500.475,"Models, Statistical",Statistics as Topic,172
Likelihood Functions,E,E05.318.740.600.400,Probability,Statistics as Topic,172
Likelihood Functions,E,E05.599.835.500,"Models, Statistical","Models, Theoretical",172
Likelihood Functions,N,N06.850.520.830.500.475,"Models, Statistical",Statistics as Topic,172
Likelihood Functions,N,N06.850.520.830.600.400,Probability,Statistics as Topic,172
Neoplasm Staging,E,E01.789.625,Prognosis,Diagnosis,172
Review Literature as Topic,L,L01.178.682.759,Publications,Communications Media,172
Disease Susceptibility,G,G07.100.250,Body Constitution,Physiological Phenomena,171
Disease Susceptibility,C,C23.550.291.687,Disease Attributes,Pathologic Processes,171
"Infant, Premature",M,M01.060.703.520.520,"Infant, Newborn",Infant,171
Cognition,F,F02.463.188,Mental Processes,Psychological Phenomena,170
Platelet Aggregation Inhibitors,D,D27.505.954.502.780,Hematologic Agents,Therapeutic Uses,170
Rifampin,D,D03.633.400.811.700,Rifamycins,"Heterocyclic Compounds, 4 or More Rings",170
Rifampin,D,D04.345.295.750.700,Rifamycins,"Lactams, Macrocyclic",170
Stillbirth,C,C23.550.260.585.630,Fetal Death,Death,170
Stillbirth,C,C13.703.223.650,Fetal Death,Pregnancy Complications,170
Stillbirth,G,G08.686.784.769.496.500,Pregnancy Outcome,Pregnancy,170
United Nations,N,N03.540.514.718,International Agencies,Organizations,170
Hepacivirus,B,B04.820.578.344.475,Flaviviridae,Positive-Strand RNA Viruses,169
Hepacivirus,B,B04.450.380,Hepatitis Viruses,Viruses,169
Needs Assessment,N,N03.349.380.565,Health Services Research,Health Planning,169
Needs Assessment,N,N05.300.537,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",169
Needs Assessment,I,I02.594,Education,NULL,169
Unsafe Sex,F,F01.145.802.987,Sexual Behavior,Behavior,169
Whole Genome Sequencing,E,E05.393.760.700.825,"Sequence Analysis, DNA",Sequence Analysis,169
Tuberculin Test,E,E05.478.594.890.800,Skin Tests,Immunologic Tests,168
Tuberculin Test,E,E05.200.812.871.800,Skin Tests,Immunologic Tests,168
Tuberculin Test,E,E01.370.225.812.871.800,Skin Tests,Immunologic Tests,168
"Genes, Bacterial",G,G05.360.340.358.207.249,"Genome, Bacterial","Genome, Microbial",167
"Genes, Bacterial",G,G05.360.340.358.024.249,"Genes, Microbial","Genome, Microbial",167
"Genes, Bacterial",G,G05.360.340.024.340.364.249,"Genes, Microbial",Genes,167
Host-Parasite Interactions,G,G16.527.200.400,Host-Pathogen Interactions,Host Microbial Interactions,167
Premature Birth,C,C13.703.420.491.500,"Obstetric Labor, Premature",Obstetric Labor Complications,167
Interpersonal Relations,F,F01.829.401,"Psychology, Social",Behavior and Behavior Mechanisms,166
Linkage Disequilibrium,G,G05.348.500,Genetic Linkage,Genetic Phenomena,166
Nasopharynx,A,A04.623.557,Pharynx,Respiratory System,166
Nasopharynx,A,A14.724.557,Pharynx,Stomatognathic System,166
Quality Control,J,J01.897.608,Technology,"Technology, Industry, and Agriculture",166
Tumor Necrosis Factor-alpha,D,D23.529.374.500.800,Monokines,Cytokines,166
Tumor Necrosis Factor-alpha,D,D23.529.374.750.626,Tumor Necrosis Factors,Cytokines,166
Tumor Necrosis Factor-alpha,D,D12.776.395.930,Glycoproteins,Proteins,166
Tumor Necrosis Factor-alpha,D,D12.776.467.374.500.800,Monokines,Cytokines,166
Tumor Necrosis Factor-alpha,D,D12.776.467.374.750.626,Tumor Necrosis Factors,Cytokines,166
Tumor Necrosis Factor-alpha,D,D12.776.124.900,Blood Proteins,Proteins,166
Tumor Necrosis Factor-alpha,D,D12.644.276.374.500.800,Monokines,Cytokines,166
Tumor Necrosis Factor-alpha,D,D12.644.276.374.750.626,Tumor Necrosis Factors,Cytokines,166
Zoonoses,C,C01.973,Infections,NULL,166
Zoonoses,C,C22.969,Animal Diseases,NULL,166
Agriculture,J,J01.040,"Technology, Industry, and Agriculture",NULL,164
"Renal Insufficiency, Chronic",C,C13.351.968.419.780.750,Renal Insufficiency,Kidney Diseases,164
"Renal Insufficiency, Chronic",C,C12.777.419.780.750,Renal Insufficiency,Kidney Diseases,164
"Pulmonary Disease, Chronic Obstructive",C,C08.381.495.389,"Lung Diseases, Obstructive",Lung Diseases,163
Zika Virus,B,B04.820.578.344.350.995,Flavivirus,Flaviviridae,163
Acute Coronary Syndrome,C,C14.280.647.124,Myocardial Ischemia,Heart Diseases,162
Acute Coronary Syndrome,C,C14.907.585.124,Myocardial Ischemia,Vascular Diseases,162
Alcoholism,C,C25.775.100.250,Alcohol-Related Disorders,Substance-Related Disorders,162
Alcoholism,F,F03.900.100.350,Alcohol-Related Disorders,Substance-Related Disorders,162
Employment,N,N01.824.245,Socioeconomic Factors,Population Characteristics,162
General Practice,H,H02.403.340,Medicine,Health Occupations,162
Aedes,B,B01.050.500.131.617.720.500.500.750.712.500.875.100,Culicidae,Culicomorpha,161
Melioidosis,C,C01.150.252.400.170.531,Burkholderia Infections,Gram-Negative Bacterial Infections,161
Micronutrients,D,D27.505.696.494,Physiological Effects of Drugs,Pharmacologic Actions,161
Micronutrients,J,J02.500.681.500,Nutrients,Food,161
Micronutrients,G,G07.203.300.681.500,Nutrients,Food,161
Patient Participation,F,F01.145.488.887.500.620,Patient Acceptance of Health Care,Treatment Adherence and Compliance,161
Patient Participation,F,F01.100.150.750.500.620,Patient Acceptance of Health Care,Treatment Adherence and Compliance,161
Patient Participation,N,N03.540.245.360.300,Community Participation,Consumer Organizations,161
Patient Participation,N,N02.421.143.212.300,Community Participation,Community Health Services,161
Patient Participation,N,N05.300.150.800.500.620,Patient Acceptance of Health Care,Treatment Adherence and Compliance,161
Pre-Exposure Prophylaxis,N,N02.421.726.758.655,Primary Prevention,Preventive Health Services,161
Pre-Exposure Prophylaxis,N,N06.850.780.680.655,Primary Prevention,Public Health Practice,161
Hemorrhage,C,C23.550.414,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",160
Isoniazid,D,D02.442.436,Hydrazines,Organic Chemicals,160
Isoniazid,D,D03.383.725.394.582,Isonicotinic Acids,Pyridines,160
Isoniazid,D,D03.066.349.410,Isonicotinic Acids,"Acids, Heterocyclic",160
Markov Chains,N,N06.850.520.830.600.500,Probability,Statistics as Topic,160
Markov Chains,N,N06.850.520.830.996.500,Stochastic Processes,Statistics as Topic,160
Markov Chains,N,N05.715.360.750.625.500,Probability,Statistics as Topic,160
Markov Chains,N,N05.715.360.750.770.500,Stochastic Processes,Statistics as Topic,160
Markov Chains,G,G17.830.500,Stochastic Processes,Mathematical Concepts,160
Markov Chains,E,E05.318.740.600.500,Probability,Statistics as Topic,160
Markov Chains,E,E05.318.740.996.500,Stochastic Processes,Statistics as Topic,160
Meningococcal Vaccines,D,D20.215.894.135.500,Bacterial Vaccines,Vaccines,160
Random Allocation,E,E05.318.370.700,Epidemiologic Research Design,Epidemiologic Methods,160
Random Allocation,E,E05.581.500.805,Research Design,Methods,160
Random Allocation,N,N05.715.360.325.675,Epidemiologic Research Design,Health Care Evaluation Mechanisms,160
Random Allocation,N,N06.850.520.445.700,Epidemiologic Research Design,Epidemiologic Methods,160
Ebolavirus,B,B04.820.480.937.300.200,Filoviridae,Mononegavirales,159
"Adaptation, Psychological",F,F01.058,Behavior and Behavior Mechanisms,NULL,158
CD8-Positive T-Lymphocytes,A,A15.145.229.637.555.567.569.220,T-Lymphocytes,Lymphocytes,158
CD8-Positive T-Lymphocytes,A,A15.382.490.555.567.569.220,T-Lymphocytes,Lymphocytes,158
CD8-Positive T-Lymphocytes,A,A11.118.637.555.567.569.220,T-Lymphocytes,Lymphocytes,158
"Insurance, Health",N,N03.219.521.576.343,Insurance,"Financing, Organized",158
Parity,N,N06.850.490.812.600,Reproductive History,Epidemiologic Factors,158
Parity,G,G08.686.784.769.472,Pregnancy,Reproduction,158
Parity,G,G08.686.677,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,158
Flow Cytometry,E,E05.242.386.350,Cytophotometry,Cytological Techniques,157
Flow Cytometry,E,E05.242.363.342,Cell Separation,Cytological Techniques,157
Flow Cytometry,E,E05.200.500.363.342,Cell Separation,Cytological Techniques,157
Flow Cytometry,E,E05.200.500.386.350,Cytophotometry,Cytological Techniques,157
Flow Cytometry,E,E05.196.712.516.600.240.350,Cytophotometry,Fluorometry,157
Flow Cytometry,E,E01.370.225.500.386.350,Cytophotometry,Cytological Techniques,157
Flow Cytometry,E,E01.370.225.500.363.342,Cell Separation,Cytological Techniques,157
Social Environment,I,I01.880.853.500,Sociological Factors,Sociology,157
Cambodia,Z,Z01.252.145.182,"Asia, Southeastern",Asia,156
Dementia,F,F03.615.400,Neurocognitive Disorders,Mental Disorders,156
Dementia,C,C10.228.140.380,Brain Diseases,Central Nervous System Diseases,156
"Epigenesis, Genetic",G,G05.308.203,Gene Expression Regulation,Genetic Phenomena,156
Health Planning,N,N03.706.615.302,Legislation as Topic,"Social Control, Formal",156
Health Planning,N,N03.349,Health Care Economics and Organizations,NULL,156
Noncommunicable Diseases,C,C23.550.291.898,Disease Attributes,Pathologic Processes,156
Early Detection of Cancer,E,E01.390.500,Early Diagnosis,Diagnosis,155
Global Burden of Disease,N,N05.425.184,Health Services Research,"Health Care Quality, Access, and Evaluation",155
Global Burden of Disease,N,N06.850.520.308.980.438.475.091,Health Status Indicators,Health Surveys,155
Microscopy,H,H01.671.617.562,Optics and Photonics,Physics,155
Microscopy,E,E05.595,Investigative Techniques,NULL,155
Microscopy,E,E01.370.350.515,Diagnostic Imaging,Diagnostic Techniques and Procedures,155
Multicenter Studies as Topic,E,E05.318.372.658,Epidemiologic Study Characteristics,Epidemiologic Methods,155
Multicenter Studies as Topic,N,N05.715.360.330.643,Epidemiologic Study Characteristics,Health Care Evaluation Mechanisms,155
Multicenter Studies as Topic,N,N06.850.520.450.643,Epidemiologic Study Characteristics,Epidemiologic Methods,155
Quinolines,D,D03.633.100.810,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",155
Bacteremia,C,C23.550.470.790.500.100,Sepsis,Systemic Inflammatory Response Syndrome,154
Bacteremia,C,C01.150.252.100,Bacterial Infections,Bacterial Infections and Mycoses,154
Bacteremia,C,C01.757.100,Sepsis,Infections,154
"Influenza A Virus, H1N1 Subtype",B,B04.820.480.968.405.400.214,Influenza A virus,Influenzavirus A,154
Liver,A,A03.620,Digestive System,NULL,154
Maternal Age,N,N06.850.490.250.550,Age Factors,Epidemiologic Factors,154
Maternal Age,N,N05.715.350.075.550,Age Factors,Epidemiologic Factors,154
Maternal Age,G,G08.686.560,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,154
Periodicals as Topic,L,L01.178.682.829.678,Serial Publications,Publications,154
Public Sector,I,I01.795,Social Sciences,NULL,154
Public Sector,N,N04.452.633.890,Ownership,Organization and Administration,154
Sierra Leone,Z,Z01.058.290.190.725,"Africa, Western",Africa South of the Sahara,153
DNA Primers,D,D27.720.470.530.600.223.600,DNA Probes,Nucleic Acid Probes,152
DNA Primers,D,D13.695.578.424.450.275,Oligodeoxyribonucleotides,Oligonucleotides,152
Activities of Daily Living,E,E02.760.169.063.500.067,Rehabilitation,Aftercare,151
Activities of Daily Living,N,N02.421.784.110,Rehabilitation,Health Services,151
Activities of Daily Living,I,I03.050,Human Activities,NULL,151
Activities of Daily Living,E,E02.831.067,Rehabilitation,Therapeutics,151
Energy Intake,G,G07.203.650.240.340,Diet,Nutritional Physiological Phenomena,151
Leadership,F,F01.752.609,Personality,Behavior and Behavior Mechanisms,151
Chi-Square Distribution,E,E05.318.740.994.300,Statistical Distributions,Statistics as Topic,150
Chi-Square Distribution,G,G17.820.300,Statistical Distributions,Mathematical Concepts,150
Chi-Square Distribution,N,N05.715.360.750.750.200,Statistical Distributions,Statistics as Topic,150
Chi-Square Distribution,N,N06.850.520.830.994.300,Statistical Distributions,Statistics as Topic,150
Disease Management,N,N04.590.607,Patient Care Management,Health Services Administration,150
"Drug Resistance, Microbial",G,G06.225,Microbiological Phenomena,NULL,150
"Drug Resistance, Microbial",G,G07.690.773.984.269,Drug Resistance,Pharmacological Phenomena,150
Plasmodium berghei,B,B01.043.075.380.611.461,Plasmodium,Haemosporida,150
Reproductive Health,N,N01.400.625,Health,Population Characteristics,150
Specimen Handling,E,E05.200.998,Clinical Laboratory Techniques,Investigative Techniques,150
Specimen Handling,E,E01.370.225.998,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,150
Adolescent Behavior,F,F01.145.022,Behavior,Behavior and Behavior Mechanisms,149
Child Health,N,N01.400.225,Health,Population Characteristics,149
Genetic Markers,G,G05.695.450,Phenotype,Genetic Phenomena,149
Genetic Markers,D,D23.101.387,Biomarkers,Biological Factors,149
Oligonucleotide Array Sequence Analysis,E,E05.588.570.660,Microarray Analysis,Microchip Analytical Procedures,149
Oligonucleotide Array Sequence Analysis,E,E05.601.640,Molecular Probe Techniques,Investigative Techniques,149
Oligonucleotide Array Sequence Analysis,E,E05.393.661.640,Nucleic Acid Hybridization,Genetic Techniques,149
Oligonucleotide Array Sequence Analysis,E,E05.393.760.640,Sequence Analysis,Genetic Techniques,149
Particulate Matter,D,D20.633,Complex Mixtures,NULL,149
Physician-Patient Relations,F,F01.829.401.650.675,Professional-Patient Relations,Interpersonal Relations,149
Physician-Patient Relations,N,N05.300.660.625,Professional-Patient Relations,Delivery of Health Care,149
Viral Proteins,D,D12.776.964,Proteins,"Amino Acids, Peptides, and Proteins",149
Glomerular Filtration Rate,E,E01.370.390.400.300,Kidney Function Tests,"Diagnostic Techniques, Urological",148
Glomerular Filtration Rate,G,G08.852.357,Urinary Tract Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,148
Psychometrics,F,F04.711.780,Psychological Tests,Behavioral Disciplines and Activities,148
"Selection, Genetic",G,G05.783,Genetic Phenomena,NULL,148
Alzheimer Disease,F,F03.615.400.100,Dementia,Neurocognitive Disorders,147
Alzheimer Disease,C,C10.228.140.380.100,Dementia,Brain Diseases,147
Alzheimer Disease,C,C10.574.945.249,Tauopathies,Neurodegenerative Diseases,147
Cesarean Section,E,E04.520.252.500,"Delivery, Obstetric",Obstetric Surgical Procedures,147
Sequence Alignment,E,E05.393.751,Genetic Techniques,Investigative Techniques,147
Systematic Reviews as Topic,L,L01.178.682.759.575,Review Literature as Topic,Publications,147
Bacteriological Techniques,E,E05.200.875.150,Microbiological Techniques,Clinical Laboratory Techniques,146
Bacteriological Techniques,E,E01.370.225.875.150,Microbiological Techniques,Clinical Laboratory Techniques,146
Cholesterol,D,D04.210.500.247.222.284,Cholestenes,Cholestanes,146
Cholesterol,D,D04.210.500.247.808.197,Sterols,Cholestanes,146
Cholesterol,D,D10.570.938.208,Sterols,Membrane Lipids,146
Hand Disinfection,N,N06.850.670.150.500,Hand Hygiene,Hygiene,146
Immunoglobulin M,D,D12.776.124.790.651.114.619.574,Immunoglobulin Isotypes,Antibodies,146
Immunoglobulin M,D,D12.776.124.486.485.114.619.574,Immunoglobulin Isotypes,Antibodies,146
Immunoglobulin M,D,D12.776.377.715.548.114.619.574,Immunoglobulin Isotypes,Antibodies,146
Latent Tuberculosis,C,C01.550.500,Latent Infection,Infections,146
Latent Tuberculosis,C,C01.150.252.410.040.552.846.122,Tuberculosis,Mycobacterium Infections,146
Leishmania donovani,B,B01.268.475.868.488.230,Leishmania,Trypanosomatina,146
Perception,F,F02.463.593,Mental Processes,Psychological Phenomena,146
Publishing,L,L01.737,Information Science,NULL,146
Serogroup,G,G05.695.825,Phenotype,Genetic Phenomena,146
ROC Curve,E,E05.318.740.872.750,Sensitivity and Specificity,Statistics as Topic,145
ROC Curve,E,E05.318.370.800.750,Sensitivity and Specificity,Epidemiologic Research Design,145
ROC Curve,N,N05.715.360.325.700.680,Sensitivity and Specificity,Epidemiologic Research Design,145
ROC Curve,N,N06.850.520.445.800.750,Sensitivity and Specificity,Epidemiologic Research Design,145
Structure-Activity Relationship,G,G07.690.773.997,Pharmacological Phenomena,Pharmacological and Toxicological Phenomena,145
Structure-Activity Relationship,G,G02.111.830,Biochemical Phenomena,Chemical Phenomena,145
Neisseria gonorrhoeae,B,B03.440.400.425.550.550.474,Neisseria,Neisseriaceae,144
Neisseria gonorrhoeae,B,B03.660.075.525.520.400,Neisseria,Neisseriaceae,144
Preventive Health Services,N,N02.421.726,Health Services,"Health Care Facilities, Manpower, and Services",144
Schistosomiasis,C,C01.610.335.865.859,Trematode Infections,Helminthiasis,144
Schistosomiasis,C,C01.920.922,Vector Borne Diseases,Infections,144
Vulnerable Populations,M,M01.965,Persons,NULL,144
Coronary Artery Disease,C,C14.907.585.250.260,Coronary Disease,Myocardial Ischemia,143
Coronary Artery Disease,C,C14.907.137.126.339,Arteriosclerosis,Arterial Occlusive Diseases,143
Coronary Artery Disease,C,C14.280.647.250.260,Coronary Disease,Myocardial Ischemia,143
Human Rights,N,N03.706.437,"Social Control, Formal",Health Care Economics and Organizations,143
Human Rights,I,I01.880.604.473,"Social Control, Formal",Sociology,143
Occupations,N,N01.824.547,Socioeconomic Factors,Population Characteristics,143
Primary Prevention,N,N02.421.726.758,Preventive Health Services,Health Services,143
Primary Prevention,N,N06.850.780.680,Public Health Practice,Public Health,143
"Reagent Kits, Diagnostic",E,E07.720,Equipment and Supplies,NULL,143
"Reagent Kits, Diagnostic",D,D27.505.259.875,Diagnostic Uses of Chemicals,Pharmacologic Actions,143
"Reagent Kits, Diagnostic",D,D27.720.470.410.680,Indicators and Reagents,Laboratory Chemicals,143
Sentinel Surveillance,E,E05.318.308.980.438.700.650,Population Surveillance,Health Surveys,143
Sentinel Surveillance,E,E05.318.650,Epidemiologic Methods,Investigative Techniques,143
Sentinel Surveillance,N,N05.715.360.300.800.438.625.650,Population Surveillance,Health Surveys,143
Sentinel Surveillance,N,N06.850.520.308.980.438.700.650,Population Surveillance,Health Surveys,143
Sentinel Surveillance,N,N06.850.780.675.650,Population Surveillance,Public Health Practice,143
Sentinel Surveillance,N,N06.850.520.699,Epidemiologic Methods,Public Health,143
Bacterial Vaccines,D,D20.215.894.135,Vaccines,Biological Products,142
Drug Costs,N,N05.300.375.300,Health Care Costs,Delivery of Health Care,142
Drug Costs,N,N03.219.151.400.350,Health Care Costs,Costs and Cost Analysis,142
Lipids,D,D10,NULL,NULL,142
Measles Vaccine,D,D20.215.894.899.404,Viral Vaccines,Vaccines,142
Midwifery,H,H02.478.676.416,"Specialties, Nursing",Nursing,142
Single-Blind Method,N,N05.715.360.325.730,Epidemiologic Research Design,Health Care Evaluation Mechanisms,142
Single-Blind Method,E,E05.318.370.850,Epidemiologic Research Design,Epidemiologic Methods,142
Single-Blind Method,N,N06.850.520.445.850,Epidemiologic Research Design,Epidemiologic Methods,142
Vision Disorders,C,C10.597.751.941,Sensation Disorders,Neurologic Manifestations,142
Vision Disorders,C,C11.966,Eye Diseases,NULL,142
Vision Disorders,C,C23.888.592.763.941,Sensation Disorders,Neurologic Manifestations,142
"Antibodies, Monoclonal",D,D12.776.377.715.548.114.224,Antibodies,Immunoglobulins,141
"Antibodies, Monoclonal",D,D12.776.124.486.485.114.224,Antibodies,Immunoglobulins,141
"Antibodies, Monoclonal",D,D12.776.124.790.651.114.224,Antibodies,Immunoglobulins,141
Burkholderia pseudomallei,B,B03.660.075.090.688.100.600,Burkholderia,Burkholderiaceae,141
Emergency Medical Services,N,N02.421.297,Health Services,"Health Care Facilities, Manpower, and Services",141
"Models, Molecular",E,E05.599.595,"Models, Theoretical",Investigative Techniques,141
Public Health Administration,N,N04.452.794,Organization and Administration,Health Services Administration,141
"Asia, Southeastern",Z,Z01.252.145,Asia,Geographic Locations,140
Choice Behavior,F,F02.463.785.373.346,Decision Making,Thinking,140
Climate,N,N06.230.300.100.250,Atmosphere,Meteorological Concepts,140
Climate,G,G16.500.275.071,Environment,Ecological and Environmental Phenomena,140
Ecosystem,G,G16.500.275.157,Environment,Ecological and Environmental Phenomena,140
Ecosystem,N,N06.230.124,Environment,Environment and Public Health,140
Virus Replication,G,G06.920.925,Virus Physiological Phenomena,Microbiological Phenomena,140
"Drug Resistance, Viral",G,G06.920.225,Virus Physiological Phenomena,Microbiological Phenomena,139
"Drug Resistance, Viral",G,G06.225.420,"Drug Resistance, Microbial",Microbiological Phenomena,139
"Drug Resistance, Viral",G,G07.690.773.984.269.420,"Drug Resistance, Microbial",Drug Resistance,139
Germany,Z,Z01.542.315,Europe,Geographic Locations,139
Infant Nutritional Physiological Phenomena,G,G07.203.650.220.500,Child Nutritional Physiological Phenomena,Nutritional Physiological Phenomena,139
Singapore,Z,Z01.252.145.774,"Asia, Southeastern",Asia,139
Amodiaquine,D,D03.633.100.810.050.060,Aminoquinolines,Quinolines,138
Growth Disorders,C,C23.550.393,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",138
"Immunity, Cellular",G,G12.450.050.400,Adaptive Immunity,Immunity,138
Ambulatory Care,N,N02.421.585.106,Patient Care,Health Services,137
Ambulatory Care,E,E02.760.106,Patient Care,Therapeutics,137
DNA,D,D13.444.308,Nucleic Acids,"Nucleic Acids, Nucleotides, and Nucleosides",137
"Immunization, Secondary",E,E02.095.465.425.400.485,Immunization,Immunotherapy,137
"Immunization, Secondary",E,E05.478.550.550,Immunization,Immunologic Techniques,137
Postpartum Period,G,G08.686.702,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,137
Rwanda,Z,Z01.058.290.120.680,"Africa, Eastern",Africa South of the Sahara,137
Serologic Tests,E,E05.478.594.760,Immunologic Tests,Immunologic Techniques,137
Serologic Tests,E,E05.200.812.735,Immunologic Tests,Clinical Laboratory Techniques,137
Serologic Tests,E,E01.370.225.812.735,Immunologic Tests,Clinical Laboratory Techniques,137
"Technology Assessment, Biomedical",N,N05.715.360.825,Health Care Evaluation Mechanisms,Quality of Health Care,137
"Technology Assessment, Biomedical",N,N03.880,Health Care Economics and Organizations,NULL,137
Benin,Z,Z01.058.290.190.200,"Africa, Western",Africa South of the Sahara,136
Contraception Behavior,F,F01.145.688.500,Reproductive Behavior,Behavior,136
Contraception Behavior,G,G08.686.784.891.500,Reproductive Behavior,Reproduction,136
Energy Metabolism,G,G03.295,Metabolism,NULL,136
Meningococcal Infections,C,C01.150.252.400.625.549,Neisseriaceae Infections,Gram-Negative Bacterial Infections,136
Neisseria meningitidis,B,B03.660.075.525.520.500,Neisseria,Neisseriaceae,136
Neisseria meningitidis,B,B03.440.400.425.550.550.641,Neisseria,Neisseriaceae,136
Public Health Surveillance,E,E05.318.308.980.438.700.324,Population Surveillance,Health Surveys,136
Public Health Surveillance,N,N05.715.360.300.800.438.625.324,Population Surveillance,Health Surveys,136
Public Health Surveillance,N,N06.850.520.308.980.438.700.324,Population Surveillance,Health Surveys,136
Public Health Surveillance,N,N06.850.780.675.487,Population Surveillance,Public Health Practice,136
School Health Services,N,N02.421.726.809,Preventive Health Services,Health Services,136
"Leishmaniasis, Cutaneous",C,C01.610.752.300.500.400,Leishmaniasis,Euglenozoa Infections,135
"Leishmaniasis, Cutaneous",C,C01.610.858.560.400,Leishmaniasis,"Skin Diseases, Parasitic",135
"Leishmaniasis, Cutaneous",C,C01.920.813.400,Leishmaniasis,Vector Borne Diseases,135
"Leishmaniasis, Cutaneous",C,C17.800.838.775.560.400,Leishmaniasis,"Skin Diseases, Parasitic",135
"Leukocytes, Mononuclear",A,A15.382.490.555,Leukocytes,Immune System,135
"Leukocytes, Mononuclear",A,A15.145.229.637.555,Leukocytes,Blood Cells,135
"Leukocytes, Mononuclear",A,A11.118.637.555,Leukocytes,Blood Cells,135
Protein Binding,G,G03.808,Metabolism,NULL,135
Protein Binding,G,G02.111.679,Biochemical Phenomena,Chemical Phenomena,135
Real-Time Polymerase Chain Reaction,E,E05.393.620.500.706,Polymerase Chain Reaction,Nucleic Acid Amplification Techniques,135
Soil,G,G01.311.820,Geological Phenomena,Physical Phenomena,135
Soil,N,N06.230.600,Environment,Environment and Public Health,135
Soil,G,G16.500.275.815,Environment,Ecological and Environmental Phenomena,135
Soil,D,D20.721,Complex Mixtures,NULL,135
Critical Care,E,E02.760.190,Patient Care,Therapeutics,134
Critical Care,N,N02.421.585.190,Patient Care,Health Services,134
Hydroxymethylglutaryl-CoA Reductase Inhibitors,D,D27.505.954.557.500.202.370,Anticholesteremic Agents,Hypolipidemic Agents,134
Hydroxymethylglutaryl-CoA Reductase Inhibitors,D,D27.505.519.186.071.202.370,Anticholesteremic Agents,Hypolipidemic Agents,134
Hydroxymethylglutaryl-CoA Reductase Inhibitors,D,D27.505.519.389.370,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,134
Infections,C,C01,NULL,NULL,134
"Quality Indicators, Health Care",N,N05.715.760,Quality of Health Care,"Health Care Quality, Access, and Evaluation",134
"Quality Indicators, Health Care",N,N04.761.789,Quality of Health Care,Health Services Administration,134
Risk Reduction Behavior,F,F01.145.699,Behavior,Behavior and Behavior Mechanisms,134
Warfare,I,I01.880.735.950.500,Warfare and Armed Conflicts,Social Problems,134
Disease Reservoirs,N,N06.850.520.203.250,Chain of Infection,Epidemiologic Methods,133
Larva,G,G07.345.500.550.500.500,Life Cycle Stages,"Metamorphosis, Biological",133
Larva,B,B05.500.500,Life Cycle Stages,Organism Forms,133
Parasite Egg Count,E,E01.370.225.932.600,Parasite Load,Clinical Laboratory Techniques,133
Parasite Egg Count,E,E05.200.932.600,Parasite Load,Clinical Laboratory Techniques,133
Typhoid Fever,C,C01.150.252.400.310.821.873,Salmonella Infections,Enterobacteriaceae Infections,133
Fertility,G,G08.686.210,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,132
High-Throughput Nucleotide Sequencing,E,E05.393.760.319,Sequence Analysis,Genetic Techniques,132
Informed Consent,N,N03.706.437.650.312,Patient Rights,Human Rights,132
Informed Consent,N,N03.706.535.489,Jurisprudence,"Social Control, Formal",132
Informed Consent,I,I01.880.604.473.650.718,Patient Rights,Human Rights,132
Informed Consent,I,I01.880.604.583.427,Jurisprudence,"Social Control, Formal",132
Water,D,D01.045.250.875,Hydroxides,Alkalies,132
Water,D,D01.248.497.158.459.650,Hydroxides,Anions,132
Water,D,D01.650.550.925,Oxides,Oxygen Compounds,132
Biological Evolution,G,G16.075,Biological Phenomena,NULL,130
Biological Evolution,G,G05.045,Genetic Phenomena,NULL,130
Chromosome Mapping,E,E05.393.183,Genetic Techniques,Investigative Techniques,130
"Cloning, Molecular",E,E05.393.220,Genetic Techniques,Investigative Techniques,130
Information Dissemination,L,L01.143.443,Communication,Information Science,130
Chemoprevention,E,E02.319.162,Drug Therapy,Therapeutics,129
Child Welfare,I,I01.880.787.293,Social Welfare,Sociology,129
"Financing, Personal",N,N03.219.559,Economics,Health Care Economics and Organizations,129
Medical Audit,N,N04.761.700.250.500,Clinical Audit,"Quality Assurance, Health Care",129
Medical Audit,N,N05.700.175.500,Clinical Audit,"Quality Assurance, Health Care",129
"Recombination, Genetic",G,G05.728,Genetic Phenomena,NULL,129
Uncertainty,F,F02.463.785.373.820,Decision Making,Thinking,129
Uncertainty,E,E05.318.740.600.900,Probability,Statistics as Topic,129
Uncertainty,N,N05.715.360.750.625.850,Probability,Statistics as Topic,129
Uncertainty,G,G17.680.875,Probability,Mathematical Concepts,129
Uncertainty,N,N06.850.520.830.600.900,Probability,Statistics as Topic,129
Intensive Care Units,N,N02.278.388.493,Hospital Units,Health Facilities,128
Intimate Partner Violence,I,I01.198.240.856.575,Violence,Crime,128
Intimate Partner Violence,I,I01.880.735.900.688,Violence,Social Problems,128
Poisson Distribution,G,G17.820.750,Statistical Distributions,Mathematical Concepts,128
Poisson Distribution,N,N05.715.360.750.750.620,Statistical Distributions,Statistics as Topic,128
Poisson Distribution,E,E05.318.740.994.750,Statistical Distributions,Statistics as Topic,128
Poisson Distribution,N,N06.850.520.830.994.750,Statistical Distributions,Statistics as Topic,128
Schistosomiasis mansoni,C,C01.610.335.865.859.576,Schistosomiasis,Trematode Infections,128
Schistosomiasis mansoni,C,C01.920.922.576,Schistosomiasis,Vector Borne Diseases,128
Swine,B,B01.050.150.900.649.313.500.880,Artiodactyla,Eutheria,128
Toilet Facilities,N,N06.850.780.200.800.800.795,Sanitary Engineering,Sanitation,128
Toilet Facilities,N,N06.850.860.510.490,Sanitary Engineering,Sanitation,128
Toilet Facilities,J,J03.962,Non-Medical Public and Private Facilities,NULL,128
Tropical Medicine,H,H02.403.879,Medicine,Health Occupations,128
Afghanistan,Z,Z01.252.245.500.125,Middle East,"Asia, Western",127
"Air Pollution, Indoor",N,N06.850.460.100.080,Air Pollution,Environmental Pollution,127
Culture,I,I01.076.201.450,"Anthropology, Cultural",Anthropology,127
Culture,I,I01.880.853.100,Sociological Factors,Sociology,127
"Hospitals, Public",N,N02.278.421.510,Hospitals,Health Facilities,127
"Outcome and Process Assessment, Health Care",N,N05.715.360.575,Health Care Evaluation Mechanisms,Quality of Health Care,127
"Outcome and Process Assessment, Health Care",N,N04.761.559,Quality of Health Care,Health Services Administration,127
"History, 19th Century",K,K01.400.504.937,"History, Modern 1601-",History,126
HIV Antibodies,D,D12.776.124.790.651.114.254.150.440,Deltaretrovirus Antibodies,"Antibodies, Viral",126
HIV Antibodies,D,D12.776.124.486.485.114.254.150.440,Deltaretrovirus Antibodies,"Antibodies, Viral",126
HIV Antibodies,D,D12.776.377.715.548.114.254.150.440,Deltaretrovirus Antibodies,"Antibodies, Viral",126
Patient Admission,E,E02.760.400.600,Hospitalization,Patient Care,126
Patient Admission,N,N02.421.585.400.600,Hospitalization,Patient Care,126
Public Health Practice,N,N06.850.780,Public Health,Environment and Public Health,126
Rotavirus Infections,C,C01.925.782.791.814,Reoviridae Infections,RNA Virus Infections,126
Antibody Formation,G,G12.450.050.370.250,"Immunity, Active",Adaptive Immunity,125
Depressive Disorder,F,F03.600.300,Mood Disorders,Mental Disorders,125
"Herpesvirus 2, Human",B,B04.280.382.100.750.440,Simplexvirus,Alphaherpesvirinae,125
Motor Activity,F,F01.145.632,Behavior,Behavior and Behavior Mechanisms,125
Motor Activity,G,G11.427.410.698,Movement,Musculoskeletal Physiological Phenomena,125
Neuropsychological Tests,F,F04.711.513,Psychological Tests,Behavioral Disciplines and Activities,125
Population Density,N,N01.224.600,Demography,Population Characteristics,125
Population Density,N,N06.850.505.400.600,Demography,Epidemiologic Measurements,125
"Anemia, Iron-Deficiency",C,C18.452.565.100,Iron Metabolism Disorders,Metabolic Diseases,124
"Anemia, Iron-Deficiency",C,C15.378.071.196.300,"Anemia, Hypochromic",Anemia,124
Cross-Cultural Comparison,I,I01.076.201.450.281,Culture,"Anthropology, Cultural",124
Cross-Cultural Comparison,I,I01.880.853.100.257,Culture,Sociological Factors,124
"Genetics, Population",H,H01.158.273.343.335,Genetics,Biology,124
"Meningitis, Meningococcal",C,C10.228.228.180.500.750,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,124
"Meningitis, Meningococcal",C,C10.228.614.280.505,"Meningitis, Bacterial",Meningitis,124
"Meningitis, Meningococcal",C,C01.150.252.223.500.750,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,124
"Meningitis, Meningococcal",C,C01.150.252.400.625.549.449,Meningococcal Infections,Neisseriaceae Infections,124
"Meningitis, Meningococcal",C,C01.207.180.500.750,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,124
Parasitic Sensitivity Tests,E,E01.370.225.940,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,124
Parasitic Sensitivity Tests,E,E05.337.550.700,"Drug Evaluation, Preclinical",Evaluation Studies as Topic,124
Parasitic Sensitivity Tests,E,E05.200.940,Clinical Laboratory Techniques,Investigative Techniques,124
Percutaneous Coronary Intervention,E,E04.502.382.968,Endovascular Procedures,Minimally Invasive Surgical Procedures,124
Percutaneous Coronary Intervention,E,E04.100.814.529.968,Endovascular Procedures,Vascular Surgical Procedures,124
Schizophrenia,F,F03.700.750,Schizophrenia Spectrum and Other Psychotic Disorders,Mental Disorders,124
Skin,A,A17.815,Integumentary System,NULL,124
Staphylococcal Infections,C,C01.150.252.410.868,Gram-Positive Bacterial Infections,Bacterial Infections,124
Attitude,F,F01.100,Behavior and Behavior Mechanisms,NULL,123
Epidemiologic Studies,E,E05.318.372.500,Epidemiologic Study Characteristics,Epidemiologic Methods,123
Epidemiologic Studies,N,N05.715.360.330.500,Epidemiologic Study Characteristics,Health Care Evaluation Mechanisms,123
Epidemiologic Studies,N,N06.850.520.450.500,Epidemiologic Study Characteristics,Epidemiologic Methods,123
Health Workforce,N,N05.300.420.400,Health Resources,Delivery of Health Care,123
Health Workforce,N,N04.452.525.500,Workforce,Organization and Administration,123
Health Workforce,N,N02.350,"Health Care Facilities, Manpower, and Services",NULL,123
Herpes Genitalis,C,C01.221.812.640.350,"Sexually Transmitted Diseases, Viral",Sexually Transmitted Diseases,123
Herpes Genitalis,C,C01.778.640.350,"Sexually Transmitted Diseases, Viral",Sexually Transmitted Diseases,123
Herpes Genitalis,C,C01.925.813.350,"Sexually Transmitted Diseases, Viral",Virus Diseases,123
Herpes Genitalis,C,C01.925.256.466.382.290,Herpes Simplex,Herpesviridae Infections,123
Herpes Genitalis,C,C12.294.329,"Genital Diseases, Male",Male Urogenital Diseases,123
Herpes Genitalis,C,C13.351.500.342,"Genital Diseases, Female",Female Urogenital Diseases,123
Mendelian Randomization Analysis,E,E05.318.416.500,Molecular Epidemiology,Epidemiologic Methods,123
Early Diagnosis,E,E01.390,Diagnosis,NULL,122
Ethanolamines,D,D02.033.100.291,Amino Alcohols,Alcohols,122
Ethanolamines,D,D02.033.375.291,Ethanol,Alcohols,122
Ethanolamines,D,D02.092.063.291,Amino Alcohols,Amines,122
Patient Discharge,E,E02.760.400.610,Hospitalization,Patient Care,122
Patient Discharge,E,E02.760.169.125,Continuity of Patient Care,Patient Care,122
Patient Discharge,N,N02.421.585.400.610,Hospitalization,Patient Care,122
Patient Discharge,N,N02.421.585.169.125,Continuity of Patient Care,Patient Care,122
Patient Discharge,N,N04.590.233.727.210.125,Continuity of Patient Care,Primary Health Care,122
Philippines,Z,Z01.252.145.671,"Asia, Southeastern",Asia,122
Philippines,Z,Z01.639.790,Islands,Geographic Locations,122
Poliomyelitis,C,C10.668.864,Neuromuscular Diseases,Nervous System Diseases,122
Poliomyelitis,C,C10.228.228.618.750,Myelitis,Central Nervous System Infections,122
Poliomyelitis,C,C10.228.854.525.850,Myelitis,Spinal Cord Diseases,122
Poliomyelitis,C,C01.925.782.687.359.764,Enterovirus Infections,Picornaviridae Infections,122
Poliomyelitis,C,C01.207.618.750,Myelitis,Central Nervous System Infections,122
Disability Evaluation,E,E01.370.400,Diagnostic Techniques and Procedures,Diagnosis,121
Hypoglycemic Agents,D,D27.505.696.422,Physiological Effects of Drugs,Pharmacologic Actions,121
Neglected Diseases,C,C23.550.291.890,Disease Attributes,Pathologic Processes,121
AIDS Serodiagnosis,E,E01.370.225.875.408.500,HIV Testing,Microbiological Techniques,120
AIDS Serodiagnosis,E,E01.370.225.812.735.060,Serologic Tests,Immunologic Tests,120
AIDS Serodiagnosis,E,E05.478.594.760.060,Serologic Tests,Immunologic Tests,120
AIDS Serodiagnosis,E,E05.200.875.408.500,HIV Testing,Microbiological Techniques,120
AIDS Serodiagnosis,E,E05.200.812.735.060,Serologic Tests,Immunologic Tests,120
Artesunate,D,D02.455.849.765.211.500,Artemisinins,Sesquiterpenes,120
Artesunate,D,D02.389.338.055.500,Artemisinins,Peroxides,120
Artesunate,D,D01.650.550.750.200.500,Artemisinins,Peroxides,120
Artesunate,D,D01.339.431.374.212.500,Artemisinins,Peroxides,120
Artesunate,D,D01.248.497.158.685.750.212.500,Artemisinins,Peroxides,120
Child Nutrition Disorders,C,C18.654.180,Nutrition Disorders,Nutritional and Metabolic Diseases,120
Heterosexuality,F,F01.145.802.975.400,Sexuality,Sexual Behavior,120
Heterosexuality,G,G08.686.867.400,Sexuality,Reproductive Physiological Phenomena,120
Ivermectin,D,D02.540.576.500.997,Macrolides,Polyketides,120
Mass Drug Administration,E,E02.319.162.575,Chemoprevention,Drug Therapy,120
Mass Drug Administration,N,N06.850.275.500,Disease Eradication,Public Health,120
Mass Drug Administration,N,N06.850.780.200.600,Communicable Disease Control,Public Health Practice,120
Molecular Diagnostic Techniques,E,E05.393.520,Genetic Techniques,Investigative Techniques,120
Molecular Diagnostic Techniques,E,E05.200.880,Clinical Laboratory Techniques,Investigative Techniques,120
Molecular Diagnostic Techniques,E,E01.370.225.880,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,120
Policy,N,N03.623,Health Care Economics and Organizations,NULL,120
Policy,I,I01.655,Social Sciences,NULL,120
"Transcription, Genetic",G,G05.297.700,Gene Expression,Genetic Phenomena,120
"Transcription, Genetic",G,G02.111.873,Biochemical Phenomena,Chemical Phenomena,120
Drug Utilization,N,N04.452.706.477,Pharmacy Administration,Organization and Administration,119
"Gene Expression Regulation, Bacterial",G,G05.308.300,Gene Expression Regulation,Genetic Phenomena,119
Goals,F,F01.658.500,Motivation,Behavior and Behavior Mechanisms,119
Japan,Z,Z01.252.474.463,Far East,Asia,119
Japan,Z,Z01.639.595,Islands,Geographic Locations,119
Pregnant Women,M,M01.975.807,Women,Persons,119
Smoking Cessation,F,F01.145.488.732,Health Behavior,Behavior,119
Viral Vaccines,D,D20.215.894.899,Vaccines,Biological Products,119
Atrophy,C,C23.300.070,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",118
Fluorenes,D,D02.455.426.559.847.389,Polycyclic Aromatic Hydrocarbons,"Hydrocarbons, Aromatic",118
Fluorenes,D,D04.615.389,Polycyclic Aromatic Hydrocarbons,Polycyclic Compounds,118
"Meningitis, Cryptococcal",C,C10.228.614.300.500,"Meningitis, Fungal",Meningitis,118
"Meningitis, Cryptococcal",C,C10.228.228.198.500.500,"Meningitis, Fungal",Central Nervous System Fungal Infections,118
"Meningitis, Cryptococcal",C,C01.207.198.500.500,"Meningitis, Fungal",Central Nervous System Fungal Infections,118
"Meningitis, Cryptococcal",C,C01.150.703.181.500.500,"Meningitis, Fungal",Central Nervous System Fungal Infections,118
"Meningitis, Cryptococcal",C,C01.150.703.248.290,Cryptococcosis,Mycoses,118
Stroke Volume,E,E01.370.370.380.150.700,Cardiac Output,Heart Function Tests,118
Stroke Volume,G,G09.330.380.124.882,Cardiac Output,Hemodynamics,118
Aspirin,D,D02.455.426.559.389.657.410.595.176,Salicylates,Hydroxybenzoates,117
Blood,A,A15.145,Hemic and Immune Systems,NULL,117
Blood,A,A12.207.152,Body Fluids,Fluids and Secretions,117
"Blotting, Western",E,E05.478.566.320.200,Immunoblotting,Immunoassay,117
"Blotting, Western",E,E05.601.262,Molecular Probe Techniques,Investigative Techniques,117
"Blotting, Western",E,E05.601.470.320.200,Immunoblotting,Immunoassay,117
"Blotting, Western",E,E05.301.300.096,Electrophoresis,Electrochemical Techniques,117
"Blotting, Western",E,E05.196.401.143,Electrophoresis,"Chemistry Techniques, Analytical",117
Folic Acid,D,D03.633.100.733.631.400,Pterins,Pteridines,117
Papillomaviridae,B,B04.280.210.655,DNA Tumor Viruses,DNA Viruses,117
Papillomaviridae,B,B04.613.204.655,DNA Tumor Viruses,Oncogenic Viruses,117
Respiratory Syncytial Virus Infections,C,C01.925.782.580.600.550.750,Pneumovirus Infections,Paramyxoviridae Infections,117
Schistosoma mansoni,B,B01.050.500.500.736.715.770.680.700,Schistosoma,Schistosomatidae,117
Senegal,Z,Z01.058.290.190.710,"Africa, Western",Africa South of the Sahara,117
Trypanocidal Agents,D,D27.505.954.122.250.100.875,Antiprotozoal Agents,Antiparasitic Agents,117
Dogs,B,B01.050.150.900.649.313.750.250.216.200,Canidae,Caniformia,116
Genetic Loci,G,G05.360.340.024.380,Genome Components,Genome,116
Kidney,A,A05.810.453,Urinary Tract,Urogenital System,116
Marriage,F,F01.829.263.315.500.500,Marital Status,Family Characteristics,116
Marriage,I,I01.240.361.500.500,Marital Status,Family Characteristics,116
Marriage,I,I01.880.853.150.423.500.500,Marital Status,Family Characteristics,116
Marriage,N,N01.224.361.500.500,Marital Status,Family Characteristics,116
Marriage,N,N01.824.308.500.500,Marital Status,Family Characteristics,116
Microsatellite Repeats,G,G02.111.570.080.708.800.500,Tandem Repeat Sequences,"Repetitive Sequences, Nucleic Acid",116
Microsatellite Repeats,G,G05.360.340.024.850.500,Tandem Repeat Sequences,Genome Components,116
Microsatellite Repeats,G,G05.360.080.708.800.500,Tandem Repeat Sequences,"Repetitive Sequences, Nucleic Acid",116
Observer Variation,N,N02.421.450.600,Medical Errors,Health Services,116
Observer Variation,N,N05.715.350.150.675,Bias,Epidemiologic Factors,116
Observer Variation,N,N06.850.490.500.250,Bias,Epidemiologic Factors,116
Observer Variation,E,E01.354.753,Diagnostic Errors,Diagnosis,116
Peptide Fragments,D,D12.644.541,Peptides,"Amino Acids, Peptides, and Proteins",116
"Accidents, Traffic",N,N06.850.135.392,Accidents,Public Health,115
Nucleic Acid Amplification Techniques,E,E05.393.620,Genetic Techniques,Investigative Techniques,115
Observational Studies as Topic,E,E05.318.372.250.500,Clinical Studies as Topic,Epidemiologic Study Characteristics,115
Observational Studies as Topic,N,N05.715.360.330.250.500,Clinical Studies as Topic,Epidemiologic Study Characteristics,115
Observational Studies as Topic,N,N06.850.520.450.250.500,Clinical Studies as Topic,Epidemiologic Study Characteristics,115
"Statistics, Nonparametric",N,N06.850.520.830.995,Statistics as Topic,Epidemiologic Methods,115
"Statistics, Nonparametric",N,N05.715.360.750.760,Statistics as Topic,Health Care Evaluation Mechanisms,115
"Statistics, Nonparametric",E,E05.318.740.995,Statistics as Topic,Epidemiologic Methods,115
Trypanosoma brucei brucei,B,B01.268.475.868.887.080,Trypanosoma,Trypanosomatina,115
Consensus,F,F01.829.316.068,Group Processes,"Psychology, Social",114
Consensus,F,F02.463.785.373.433,Decision Making,Thinking,114
Cross-Over Studies,E,E05.318.370.150,Epidemiologic Research Design,Epidemiologic Methods,114
Cross-Over Studies,N,N05.715.360.325.150,Epidemiologic Research Design,Health Care Evaluation Mechanisms,114
Cross-Over Studies,N,N06.850.520.445.150,Epidemiologic Research Design,Epidemiologic Methods,114
Insulin,D,D12.644.548.586.200.500.625,Proinsulin,Insulins,114
Insulin,D,D06.472.699.587.200.500.625,Proinsulin,Insulins,114
Lipopolysaccharides,D,D10.494,Lipids,NULL,114
Lipopolysaccharides,D,D09.400.500,Glycoconjugates,Carbohydrates,114
Lipopolysaccharides,D,D09.698.718.450,"Polysaccharides, Bacterial",Polysaccharides,114
Lipopolysaccharides,D,D23.946.123.329.500,Endotoxins,Bacterial Toxins,114
Lipopolysaccharides,D,D23.050.161.616.525,"Polysaccharides, Bacterial","Antigens, Bacterial",114
"Malaria, Cerebral",C,C01.920.875.620,Malaria,Vector Borne Diseases,114
"Malaria, Cerebral",C,C01.207.205.300.500,Central Nervous System Protozoal Infections,Central Nervous System Parasitic Infections,114
"Malaria, Cerebral",C,C01.610.752.530.620,Malaria,Protozoan Infections,114
"Malaria, Cerebral",C,C01.610.105.300.500,Central Nervous System Protozoal Infections,Central Nervous System Parasitic Infections,114
"Malaria, Cerebral",C,C10.228.228.205.300.500,Central Nervous System Protozoal Infections,Central Nervous System Parasitic Infections,114
Marital Status,N,N01.824.308.500,Family Characteristics,Socioeconomic Factors,114
Marital Status,N,N01.224.361.500,Family Characteristics,Demography,114
Marital Status,I,I01.880.853.150.423.500,Family Characteristics,Family,114
Marital Status,I,I01.240.361.500,Family Characteristics,Demography,114
Marital Status,F,F01.829.263.315.500,Family Characteristics,Family,114
Mycobacterium leprae,B,B03.510.460.400.410.552.552.502,Mycobacterium,Mycobacteriaceae,114
Mycobacterium leprae,B,B03.510.024.962.500.502,Mycobacterium,Mycobacteriaceae,114
Healthcare Financing,N,N03.219.483.500,Financial Support,Economics,113
Trust,F,F01.829.401.825,Interpersonal Relations,"Psychology, Social",113
Virus Diseases,C,C01.925,Infections,NULL,113
"Anemia, Sickle Cell",C,C15.378.071.141.150.150,"Anemia, Hemolytic, Congenital","Anemia, Hemolytic",112
"Anemia, Sickle Cell",C,C15.378.420.155,Hemoglobinopathies,Hematologic Diseases,112
"Anemia, Sickle Cell",C,C16.320.070.150,"Anemia, Hemolytic, Congenital","Genetic Diseases, Inborn",112
"Anemia, Sickle Cell",C,C16.320.365.155,Hemoglobinopathies,"Genetic Diseases, Inborn",112
"Antibodies, Neutralizing",D,D12.776.377.715.548.114.244,Antibodies,Immunoglobulins,112
"Antibodies, Neutralizing",D,D12.776.124.486.485.114.244,Antibodies,Immunoglobulins,112
"Antibodies, Neutralizing",D,D12.776.124.790.651.114.244,Antibodies,Immunoglobulins,112
"Antigens, Viral",D,D23.050.327,Antigens,Biological Factors,112
Cameroon,Z,Z01.058.290.100.110,"Africa, Central",Africa South of the Sahara,112
"Genome, Human",G,G05.360.340.350,Genome,Genetic Structures,112
Haemophilus Vaccines,D,D20.215.894.135.450,Bacterial Vaccines,Vaccines,112
Bacterial Typing Techniques,E,E01.370.225.875.150.125,Bacteriological Techniques,Microbiological Techniques,111
Bacterial Typing Techniques,E,E05.200.875.150.125,Bacteriological Techniques,Microbiological Techniques,111
Cell Phone,L,L01.178.847.698.300,Telephone,Telecommunications,111
Emergencies,N,N06.230.100.083,Disasters,Environment,111
Emergencies,N,N06.850.376,Public Health,Environment and Public Health,111
Emergencies,C,C23.550.291.781,Disease Attributes,Pathologic Processes,111
"Financing, Government",N,N03.219.521.346,"Financing, Organized",Economics,111
Monte Carlo Method,L,L01.906.394.422,Operations Research,Systems Analysis,111
Monte Carlo Method,N,N05.715.360.750.540,Statistics as Topic,Health Care Evaluation Mechanisms,111
Monte Carlo Method,E,E05.318.740.525,Statistics as Topic,Epidemiologic Methods,111
Monte Carlo Method,N,N06.850.520.830.525,Statistics as Topic,Epidemiologic Methods,111
Parturition,G,G08.686.784.769.490,Pregnancy,Reproduction,111
Sexual Health,N,N01.400.663,Health,Population Characteristics,111
Social Responsibility,K,K01.752.566.869,Morals,Philosophy,111
Social Responsibility,F,F01.829.500.760,Morals,"Psychology, Social",111
"Diabetes Mellitus, Type 1",C,C19.246.267,Diabetes Mellitus,Endocrine System Diseases,110
"Diabetes Mellitus, Type 1",C,C20.111.327,Autoimmune Diseases,Immune System Diseases,110
"Diabetes Mellitus, Type 1",C,C18.452.394.750.124,Diabetes Mellitus,Glucose Metabolism Disorders,110
Health Plan Implementation,N,N03.349.300,Health Planning,Health Care Economics and Organizations,110
Immunohistochemistry,H,H01.181.122.605.512,Immunochemistry,Biochemistry,110
Immunohistochemistry,H,H01.181.122.573.512,Histocytochemistry,Biochemistry,110
Immunohistochemistry,H,H01.158.201.486.512,Immunochemistry,Biochemistry,110
Immunohistochemistry,H,H01.158.100.656.234.512,Histocytochemistry,Histology,110
Immunohistochemistry,H,H01.158.201.344.512,Histocytochemistry,Biochemistry,110
Immunohistochemistry,E,E05.478.583,Immunologic Techniques,Investigative Techniques,110
Immunohistochemistry,E,E05.200.750.551.512,Histocytochemistry,Histological Techniques,110
Immunohistochemistry,E,E05.200.500.607.512,Histocytochemistry,Cytological Techniques,110
Immunohistochemistry,E,E01.370.225.500.607.512,Histocytochemistry,Cytological Techniques,110
Immunohistochemistry,E,E01.370.225.750.551.512,Histocytochemistry,Histological Techniques,110
Saliva,A,A12.200.666,Bodily Secretions,Fluids and Secretions,110
Smoking Prevention,I,I02.233.332.812,Health Education,"Education, Nonprofessional",110
Smoking Prevention,N,N02.421.726.407.840,Health Education,Preventive Health Services,110
Sudan,Z,Z01.058.290.120.760,"Africa, Eastern",Africa South of the Sahara,110
Clinical Laboratory Techniques,E,E05.200,Investigative Techniques,NULL,109
Clinical Laboratory Techniques,E,E01.370.225,Diagnostic Techniques and Procedures,Diagnosis,109
Community-Acquired Infections,C,C01.234,Infections,NULL,109
Electrocardiography,E,E01.370.370.380.240,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",109
Electrocardiography,E,E01.370.405.240,Electrodiagnosis,Diagnostic Techniques and Procedures,109
Mali,Z,Z01.058.290.190.500,"Africa, Western",Africa South of the Sahara,109
Patient Safety,N,N06.850.135.060.075.399,Safety,Accident Prevention,109
Peer Group,F,F01.829.316.483,Group Processes,"Psychology, Social",109
Safety,N,N06.850.135.060.075,Accident Prevention,Accidents,109
Salmonella typhi,B,B03.660.250.150.710.160.750,Salmonella enterica,Salmonella,109
Salmonella typhi,B,B03.440.450.425.800.200.800,Salmonella enterica,Salmonella,109
Body Composition,G,G03.180,Metabolism,NULL,108
Body Composition,G,G02.111.130,Biochemical Phenomena,Chemical Phenomena,108
Body Composition,G,G07.100.049,Body Constitution,Physiological Phenomena,108
Epitopes,D,D23.050.550,Antigens,Biological Factors,108
Gastroenteritis,C,C06.405.205,Gastrointestinal Diseases,Digestive System Diseases,108
Government,N,N03.540.348,Organizations,Health Care Economics and Organizations,108
Government,I,I01.409,Social Sciences,NULL,108
Drug-Related Side Effects and Adverse Reactions,C,C25.100,Chemically-Induced Disorders,NULL,107
Epidemiologic Research Design,N,N05.715.360.325,Health Care Evaluation Mechanisms,Quality of Health Care,107
Epidemiologic Research Design,E,E05.318.370,Epidemiologic Methods,Investigative Techniques,107
Epidemiologic Research Design,N,N06.850.520.445,Epidemiologic Methods,Public Health,107
Eye Diseases,C,C11,NULL,NULL,107
"Intestinal Diseases, Parasitic",C,C06.405.469.452,Intestinal Diseases,Gastrointestinal Diseases,107
"Intestinal Diseases, Parasitic",C,C01.610.432,Parasitic Diseases,Infections,107
Nutrition Policy,N,N03.623.500.608.428.650,Health Policy,Public Policy,107
Nutrition Policy,I,I01.655.500.608.400.650,Health Policy,Public Policy,107
Nutrition Policy,I,I01.880.604.825.608.400.650,Health Policy,Public Policy,107
Psychiatric Status Rating Scales,F,F04.711.513.653,Neuropsychological Tests,Psychological Tests,107
Sheep,B,B01.050.150.900.649.313.500.380.791,Ruminants,Artiodactyla,107
"Circumcision, Male",E,E02.218.085.170,"Body Modification, Non-Therapeutic",Cosmetic Techniques,106
"Circumcision, Male",E,E04.950.774.860.226,"Urologic Surgical Procedures, Male",Urologic Surgical Procedures,106
"Circumcision, Male",E,E04.085.170,"Body Modification, Non-Therapeutic","Surgical Procedures, Operative",106
Drug Prescriptions,N,N02.421.668.778.500,Prescriptions,Pharmaceutical Services,106
Drug Prescriptions,E,E02.319.307,Drug Therapy,Therapeutics,106
"Genes, Protozoan",G,G05.360.340.397.500,"Genome, Protozoan",Genome,106
"Genes, Protozoan",G,G05.360.340.024.340.396,Genes,Genome Components,106
Radiography,E,E01.370.350.700,Diagnostic Imaging,Diagnostic Techniques and Procedures,106
"Trypanosomiasis, African",C,C01.610.752.300.900.719,Trypanosomiasis,Euglenozoa Infections,106
"Trypanosomiasis, African",C,C01.920.937,Vector Borne Diseases,Infections,106
"Vaccines, Synthetic",D,D23.050.865,Antigens,Biological Factors,106
"Vaccines, Synthetic",D,D20.215.894.865,Vaccines,Biological Products,106
"Vaccines, Synthetic",D,D12.776.828.868,Recombinant Proteins,Proteins,106
"Communicable Diseases, Emerging",C,C01.221.500,Communicable Diseases,Infections,105
"Communicable Diseases, Emerging",C,C23.550.291.531.750,Communicable Diseases,Disease Attributes,105
Diabetic Retinopathy,C,C19.246.099.500.382,Diabetic Angiopathies,Diabetes Complications,105
Diabetic Retinopathy,C,C11.768.257,Retinal Diseases,Eye Diseases,105
Diabetic Retinopathy,C,C14.907.320.382,Diabetic Angiopathies,Vascular Diseases,105
Drinking Water,D,D01.248.497.158.459.650.300,Water,Hydroxides,105
Drinking Water,D,D01.045.250.875.300,Water,Hydroxides,105
Drinking Water,D,D01.650.550.925.199,Water,Oxides,105
Drinking Water,G,G07.203.100.418,Beverages,"Diet, Food, and Nutrition",105
Drinking Water,J,J02.200.418,Beverages,Food and Beverages,105
Medical Records,N,N04.452.859.564,Records,Organization and Administration,105
Medical Records,N,N05.715.360.300.715.500,Records,Data Collection,105
Medical Records,N,N06.850.520.308.940.968,Records,Data Collection,105
Medical Records,E,E05.318.308.940.968,Records,Data Collection,105
"Milk, Human",G,G07.203.100.700.500,Milk,Beverages,105
"Milk, Human",G,G07.203.300.350.525.500,Milk,Dairy Products,105
"Milk, Human",J,J02.200.700.500,Milk,Beverages,105
"Milk, Human",J,J02.500.350.525.500,Milk,Dairy Products,105
"Milk, Human",A,A12.200.467,Bodily Secretions,Fluids and Secretions,105
"Milk, Human",A,A12.790.500,Milk,Fluids and Secretions,105
Reproductive Health Services,N,N02.421.800,Health Services,"Health Care Facilities, Manpower, and Services",105
Sex Characteristics,G,G08.686.815,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,105
Transportation,J,J01.937,"Technology, Industry, and Agriculture",NULL,105
Tuberculosis Vaccines,D,D20.215.894.135.825,Bacterial Vaccines,Vaccines,105
Campylobacter jejuni,B,B03.440.180.425,Campylobacter,Gram-Negative Bacteria,104
Campylobacter jejuni,B,B03.660.150.235.250.500.375,Campylobacter,Campylobacteraceae,104
Chile,Z,Z01.107.757.235,South America,Americas,104
Congresses as Topic,N,N03.540.199,Organizations,Health Care Economics and Organizations,104
Family Health,N,N01.400.300,Health,Population Characteristics,104
Health Care Rationing,N,N03.349.270,Health Planning,Health Care Economics and Organizations,104
Health Care Rationing,N,N05.300.430.375,Health Services Accessibility,Delivery of Health Care,104
Health Care Rationing,I,I01.261.750.500,Resource Allocation,Economics,104
"Models, Organizational",N,N04.452.534,Organization and Administration,Health Services Administration,104
"Models, Organizational",E,E05.599.670,"Models, Theoretical",Investigative Techniques,104
Research Personnel,M,M01.526.839,Occupational Groups,Persons,104
Secondary Prevention,N,N02.421.726.825,Preventive Health Services,Health Services,104
Secondary Prevention,E,E02.897,Therapeutics,NULL,104
Secondary Prevention,N,N06.850.780.750,Public Health Practice,Public Health,104
Skin Neoplasms,C,C04.588.805,Neoplasms by Site,Neoplasms,104
Skin Neoplasms,C,C17.800.882,Skin Diseases,Skin and Connective Tissue Diseases,104
Staphylococcus aureus,B,B03.510.100.750.750.100,Staphylococcus,Staphylococcaceae,104
Staphylococcus aureus,B,B03.510.400.790.750.100,Staphylococcus,Staphylococcaceae,104
Staphylococcus aureus,B,B03.300.390.400.800.750.100,Staphylococcus,Staphylococcaceae,104
Staphylococcus aureus,B,B03.353.500.750.750.100,Staphylococcus,Staphylococcaceae,104
"Stress Disorders, Post-Traumatic",F,F03.950.750.500,"Stress Disorders, Traumatic",Trauma and Stressor Related Disorders,104
Antifungal Agents,D,D27.505.954.122.136,Anti-Infective Agents,Therapeutic Uses,103
Immunologic Memory,G,G12.450.050.500,Adaptive Immunity,Immunity,103
Social Determinants of Health,N,N01.224.425.762,Health Status,Demography,103
Social Determinants of Health,N,N01.400.675,Health,Population Characteristics,103
Virulence Factors,D,D23.946.896,"Toxins, Biological",Biological Factors,103
Weight Gain,C,C23.888.144.243.926,Body Weight Changes,Body Weight,103
Weight Gain,G,G07.345.249.314.120.200.926,Body Weight Changes,Body Weight,103
Workplace,N,N01.824.245.925,Employment,Socioeconomic Factors,103
Workplace,N,N04.452.677.975,Personnel Management,Organization and Administration,103
Ireland,Z,Z01.542.467,Europe,Geographic Locations,102
Ireland,Z,Z01.639.587,Islands,Geographic Locations,102
Malaysia,Z,Z01.252.145.487,"Asia, Southeastern",Asia,102
Ophthalmology,H,H02.403.810.468,"Specialties, Surgical",Medicine,102
Placebos,E,E02.785,Therapeutics,NULL,102
Placebos,D,D26.660,Pharmaceutical Preparations,NULL,102
"Promoter Regions, Genetic",G,G05.360.340.024.340.137.750.680,"Regulatory Elements, Transcriptional",Gene Components,102
"Promoter Regions, Genetic",G,G05.360.080.689.675,"Regulatory Sequences, Nucleic Acid",Base Sequence,102
"Promoter Regions, Genetic",G,G02.111.570.080.689.675,"Regulatory Sequences, Nucleic Acid",Base Sequence,102
"Artemether, Lumefantrine Drug Combination",D,D26.310.110,Drug Combinations,Pharmaceutical Preparations,101
"Artemether, Lumefantrine Drug Combination",D,D04.615.389.650.500,Lumefantrine,Fluorenes,101
"Artemether, Lumefantrine Drug Combination",D,D02.455.426.559.847.389.650.500,Lumefantrine,Fluorenes,101
"Artemether, Lumefantrine Drug Combination",D,D02.455.849.765.211.250.500,Artemether,Artemisinins,101
"Artemether, Lumefantrine Drug Combination",D,D01.650.550.750.200.250.500,Artemether,Artemisinins,101
"Artemether, Lumefantrine Drug Combination",D,D01.248.497.158.685.750.212.250.500,Artemether,Artemisinins,101
"Artemether, Lumefantrine Drug Combination",D,D01.339.431.374.212.250.500,Artemether,Artemisinins,101
"Artemether, Lumefantrine Drug Combination",D,D02.389.338.055.250.500,Artemether,Artemisinins,101
Cognition Disorders,F,F03.615.250,Neurocognitive Disorders,Mental Disorders,101
Denmark,Z,Z01.542.816.124,Scandinavian and Nordic Countries,Europe,101
Forced Expiratory Volume,G,G09.772.650.430,Pulmonary Ventilation,Respiratory Physiological Phenomena,101
Forced Expiratory Volume,E,E01.370.386.700.660.230,Pulmonary Ventilation,Respiratory Function Tests,101
Organizational Innovation,N,N04.452.610,Organization and Administration,Health Services Administration,101
Rotavirus Vaccines,D,D20.215.894.899.760,Viral Vaccines,Vaccines,101
Tobacco Industry,J,J01.576.655.968,Manufacturing Industry,Industry,101
Vitamin A,D,D23.767.261.700.860,Retinoids,Carotenoids,101
Vitamin A,D,D02.455.849.291.925,Diterpenes,Terpenes,101
Vitamin A,D,D02.455.849.131.495.818,Retinoids,Carotenoids,101
Vitamin A,D,D02.455.326.271.665.202.495.818,Retinoids,Carotenoids,101
Vitamin A,D,D02.455.426.392.368.367.379.249.700.860,Retinoids,Carotenoids,101
Walking,I,I03.350.937,Exercise,Human Activities,101
Walking,I,I03.450.642.845.940,Sports,Recreation,101
Walking,G,G11.427.410.568.900,Locomotion,Movement,101
Walking,G,G11.427.410.698.277.937,Exercise,Motor Activity,101
Diffusion of Innovation,L,L01.143.320,Communication,Information Science,100
Genetic Vectors,G,G05.360.337,Genetic Structures,Genetic Phenomena,100
Interleukin-10,D,D12.644.276.374.465.510,Interleukins,Cytokines,100
Interleukin-10,D,D23.529.374.465.510,Interleukins,Cytokines,100
Interleukin-10,D,D12.776.467.374.465.510,Interleukins,Cytokines,100
Macular Degeneration,C,C11.768.585.439,Retinal Degeneration,Retinal Diseases,100
Praziquantel,D,D03.633.100.531.690,Isoquinolines,"Heterocyclic Compounds, 2-Ring",100
Survivors,M,M01.860,Persons,NULL,100
Tranexamic Acid,D,D02.241.223.268.860,Cyclohexanecarboxylic Acids,"Acids, Carbocyclic",100
Antifibrinolytic Agents,D,D27.505.519.421.500,Fibrin Modulating Agents,Molecular Mechanisms of Pharmacological Action,99
Antifibrinolytic Agents,D,D27.505.954.502.270.463.091,Hemostatics,Coagulants,99
Continuity of Patient Care,E,E02.760.169,Patient Care,Therapeutics,99
Continuity of Patient Care,N,N02.421.585.169,Patient Care,Health Services,99
Continuity of Patient Care,N,N04.590.233.727.210,Primary Health Care,Comprehensive Health Care,99
Cricetinae,B,B01.050.150.900.649.313.992.635.075.250,Arvicolinae,Muridae,99
Interprofessional Relations,F,F01.829.401.205,Interpersonal Relations,"Psychology, Social",99
Middle East,Z,Z01.252.245.500,"Asia, Western",Asia,99
Organizational Case Studies,N,N05.715.360.455,Health Care Evaluation Mechanisms,Quality of Health Care,99
Organizational Case Studies,N,N03.349.380.710,Health Services Research,Health Planning,99
Patient Preference,N,N05.300.150.800.625.500,Patient Satisfaction,Treatment Adherence and Compliance,99
Patient Preference,N,N04.452.822.700.500,Patient Satisfaction,Public Relations,99
Patient Preference,F,F01.145.488.887.625.500,Patient Satisfaction,Treatment Adherence and Compliance,99
Patient Preference,F,F01.100.150.750.625.500,Patient Satisfaction,Treatment Adherence and Compliance,99
Research Support as Topic,N,N03.219.483.645,Financial Support,Economics,99
"Vaccines, Attenuated",D,D20.215.894.811,Vaccines,Biological Products,99
Whooping Cough,C,C01.150.252.400.143.500,Bordetella Infections,Gram-Negative Bacterial Infections,99
Whooping Cough,C,C01.748.969,Respiratory Tract Infections,Infections,99
Whooping Cough,C,C08.730.969,Respiratory Tract Infections,Respiratory Tract Diseases,99
Antineoplastic Agents,D,D27.505.954.248,Therapeutic Uses,Pharmacologic Actions,98
Biopsy,E,E01.370.388.100,"Diagnostic Techniques, Surgical",Diagnostic Techniques and Procedures,98
Biopsy,E,E01.370.225.998.054,Specimen Handling,Clinical Laboratory Techniques,98
Biopsy,E,E01.370.225.500.384.100,Cytodiagnosis,Cytological Techniques,98
Biopsy,E,E04.074,"Surgical Procedures, Operative",NULL,98
Biopsy,E,E05.242.384.100,Cytodiagnosis,Cytological Techniques,98
Biopsy,E,E05.200.998.054,Specimen Handling,Clinical Laboratory Techniques,98
Biopsy,E,E05.200.500.384.100,Cytodiagnosis,Cytological Techniques,98
Combined Modality Therapy,E,E02.186,Therapeutics,NULL,98
Eczema,C,C17.800.174.620,Dermatitis,Skin Diseases,98
Eczema,C,C17.800.815.620,"Skin Diseases, Eczematous",Skin Diseases,98
Hookworm Infections,C,C01.610.335.508.700.775.455,Strongylida Infections,Secernentea Infections,98
Maternal Welfare,I,I01.880.787.678,Social Welfare,Sociology,98
Nitriles,D,D02.626,Organic Chemicals,NULL,98
Resource Allocation,I,I01.261.750,Economics,Social Sciences,98
Water Microbiology,H,H01.158.273.540.274.777,Environmental Microbiology,Microbiology,98
Water Microbiology,N,N06.850.425.450,Environmental Microbiology,Public Health,98
Autopsy,I,I01.198.780.937.120,Forensic Medicine,Forensic Sciences,97
Autopsy,E,E05.070,Investigative Techniques,NULL,97
Autopsy,E,E01.370.060,Diagnostic Techniques and Procedures,Diagnosis,97
Helminths,B,B01.050.500.500,Invertebrates,Animals,97
Insect Bites and Stings,C,C25.723.127.071,Bites and Stings,Poisoning,97
Insect Bites and Stings,C,C26.176.143,Bites and Stings,Wounds and Injuries,97
Safe Sex,F,F01.145.802.845,Sexual Behavior,Behavior,97
Trichuriasis,C,C01.610.335.508.100.275.895,Enoplida Infections,Adenophorea Infections,97
"Africa, Eastern",Z,Z01.058.290.120,Africa South of the Sahara,Africa,96
Dietary Fats,G,G07.203.300.375,Food,"Diet, Food, and Nutrition",96
Dietary Fats,J,J02.500.375,Food,Food and Beverages,96
Dietary Fats,D,D10.212.302,Fats,Lipids,96
"Infant, Newborn, Diseases",C,C16.614,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NULL,96
Mycobacterium bovis,B,B03.510.460.400.410.552.552.402,Mycobacterium,Mycobacteriaceae,96
Mycobacterium bovis,B,B03.510.024.962.500.402,Mycobacterium,Mycobacteriaceae,96
Sampling Studies,N,N05.715.360.330.875,Epidemiologic Study Characteristics,Health Care Evaluation Mechanisms,96
Sampling Studies,E,E05.318.372.875,Epidemiologic Study Characteristics,Epidemiologic Methods,96
Sampling Studies,N,N06.850.520.450.875,Epidemiologic Study Characteristics,Epidemiologic Methods,96
Capacity Building,N,N04.452.105,Organization and Administration,Health Services Administration,95
Capacity Building,N,N02.138,"Health Care Facilities, Manpower, and Services",NULL,95
Case Management,N,N04.590.233.624.250,Patient Care Planning,Comprehensive Health Care,95
Cross Reactions,G,G12.122.281,Antigen-Antibody Reactions,Immune System Phenomena,95
Peptides,D,D12.644,"Amino Acids, Peptides, and Proteins",NULL,95
Suicide,I,I01.880.735.856,Social Problems,Sociology,95
Suicide,F,F01.145.126.980.875,Self-Injurious Behavior,Behavioral Symptoms,95
"Trimethoprim, Sulfamethoxazole Drug Combination",D,D02.886.590.700.725.867.500,Sulfamethoxazole,Sulfanilamides,95
"Trimethoprim, Sulfamethoxazole Drug Combination",D,D03.383.742.906.500,Trimethoprim,Pyrimidines,95
"Trimethoprim, Sulfamethoxazole Drug Combination",D,D26.310.875,Drug Combinations,Pharmaceutical Preparations,95
"Trimethoprim, Sulfamethoxazole Drug Combination",D,D02.092.146.807.867.500,Sulfamethoxazole,Sulfanilamides,95
"Trimethoprim, Sulfamethoxazole Drug Combination",D,D02.065.884.725.867.500,Sulfamethoxazole,Sulfanilamides,95
Cholera,C,C01.150.252.400.959.347,Vibrio Infections,Gram-Negative Bacterial Infections,94
Colombia,Z,Z01.107.757.284,South America,Americas,94
Coronary Angiography,E,E01.370.350.130.625,Cardiac Imaging Techniques,Diagnostic Imaging,94
Coronary Angiography,E,E01.370.350.700.060.200,Angiography,Radiography,94
Coronary Angiography,E,E01.370.370.380.200,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",94
Coronary Angiography,E,E01.370.370.050.200,Angiography,"Diagnostic Techniques, Cardiovascular",94
Emigrants and Immigrants,M,M01.189,Persons,NULL,94
Fetal Development,G,G07.345.500.325.235,Embryonic and Fetal Development,Morphogenesis,94
Fetal Development,G,G08.686.784.170.157,Embryonic and Fetal Development,Reproduction,94
Haemophilus Infections,C,C01.150.252.400.700.433,Pasteurellaceae Infections,Gram-Negative Bacterial Infections,94
Postnatal Care,E,E02.760.703.500,Perinatal Care,Patient Care,94
Postnatal Care,N,N02.421.585.703.500,Perinatal Care,Patient Care,94
Postnatal Care,N,N02.421.143.620.550.500,Perinatal Care,Maternal Health Services,94
Social Justice,N,N05.350.958.750,Principle-Based Ethics,Ethics,94
Social Justice,N,N03.706.437.700,Human Rights,"Social Control, Formal",94
Social Justice,K,K01.752.566.479.830.750,Principle-Based Ethics,Ethics,94
Social Justice,I,I01.880.604.473.700,Human Rights,"Social Control, Formal",94
Advisory Committees,N,N03.706.742.500,Policy Making,"Social Control, Formal",93
Alcoholic Beverages,J,J02.200.100,Beverages,Food and Beverages,93
Alcoholic Beverages,G,G07.203.100.100,Beverages,"Diet, Food, and Nutrition",93
Disease Vectors,N,N06.850.335.188,"Disease Transmission, Infectious",Public Health,93
Disease Vectors,N,N06.850.520.203.375,Chain of Infection,Epidemiologic Methods,93
Fetal Blood,A,A15.145.300,Blood,Hemic and Immune Systems,93
Fetal Blood,A,A16.378.200,Fetus,Embryonic Structures,93
Fetal Blood,A,A12.207.152.200,Blood,Body Fluids,93
Life Cycle Stages,B,B05.500,Organism Forms,NULL,93
Life Cycle Stages,G,G07.345.500.550.500,"Metamorphosis, Biological",Morphogenesis,93
Lung Diseases,C,C08.381,Respiratory Tract Diseases,NULL,93
Mexico,Z,Z01.107.567.589,North America,Americas,93
"Polysaccharides, Bacterial",D,D23.050.161.616,"Antigens, Bacterial",Antigens,93
"Polysaccharides, Bacterial",D,D09.698.718,Polysaccharides,Carbohydrates,93
Postpartum Hemorrhage,C,C13.703.420.725,Obstetric Labor Complications,Pregnancy Complications,93
Postpartum Hemorrhage,C,C13.703.844.700,Puerperal Disorders,Pregnancy Complications,93
Postpartum Hemorrhage,C,C23.550.414.993.850,Uterine Hemorrhage,Hemorrhage,93
Streptococcal Infections,C,C01.150.252.410.890,Gram-Positive Bacterial Infections,Bacterial Infections,93
Terminology as Topic,L,L01.559.598.400,Linguistics,Language,93
Vegetables,J,J02.500.850,Food,Food and Beverages,93
Vegetables,G,G07.203.300.850,Food,"Diet, Food, and Nutrition",93
Vegetables,B,B01.650.160.956,"Crops, Agricultural",Plants,93
Vegetables,B,B01.650.510.956,"Plants, Edible",Plants,93
Vitamins,D,D27.505.696.494.600,Micronutrients,Physiological Effects of Drugs,93
Vitamins,G,G07.203.300.681.500.600,Micronutrients,Nutrients,93
Vitamins,J,J02.500.681.500.600,Micronutrients,Nutrients,93
"Mice, Knockout",B,B01.050.150.900.649.313.992.635.505.500.800.500,"Mice, Transgenic",Mice,92
"Mice, Knockout",B,B01.050.150.900.649.313.992.635.505.500.550.455,"Mice, Mutant Strains",Mice,92
"Mice, Knockout",B,B01.050.050.136.500.500,"Mice, Transgenic","Animals, Genetically Modified",92
Prejudice,F,F01.829.595,"Psychology, Social",Behavior and Behavior Mechanisms,92
Prejudice,F,F01.145.813.550,Social Behavior,Behavior,92
Public Opinion,I,I01.880.630.548,"Social Control, Informal",Sociology,92
Recombinant Fusion Proteins,D,D12.776.828.300,Recombinant Proteins,Proteins,92
Respiratory Tract Diseases,C,C08,NULL,NULL,92
Skin Tests,E,E01.370.225.812.871,Immunologic Tests,Clinical Laboratory Techniques,92
Skin Tests,E,E05.478.594.890,Immunologic Tests,Immunologic Techniques,92
Skin Tests,E,E05.200.812.871,Immunologic Tests,Clinical Laboratory Techniques,92
Transfection,E,E05.393.350.810,Gene Transfer Techniques,Genetic Techniques,92
Transfection,G,G05.728.860,"Recombination, Genetic",Genetic Phenomena,92
Ultrasonography,E,E01.370.350.850,Diagnostic Imaging,Diagnostic Techniques and Procedures,92
Age of Onset,N,N06.850.490.250.100,Age Factors,Epidemiologic Factors,91
Age of Onset,N,N05.715.350.075.100,Age Factors,Epidemiologic Factors,91
Chickens,B,B01.050.150.900.248.350.150,Galliformes,Birds,91
Chickens,B,B01.050.150.900.248.690.192,Poultry,Birds,91
Cooking,J,J01.576.423.200.200,Food Handling,Food Industry,91
Critical Illness,C,C23.550.291.625,Disease Attributes,Pathologic Processes,91
Curriculum,I,I02.158,Education,NULL,91
Evidence-Based Practice,H,H02.249,Health Occupations,NULL,91
Immunoglobulin E,D,D12.776.124.790.651.114.619.312,Immunoglobulin Isotypes,Antibodies,91
Immunoglobulin E,D,D12.776.124.486.485.114.619.312,Immunoglobulin Isotypes,Antibodies,91
Immunoglobulin E,D,D12.776.377.715.548.114.619.312,Immunoglobulin Isotypes,Antibodies,91
Kinetics,G,G02.111.490,Biochemical Phenomena,Chemical Phenomena,91
Kinetics,G,G01.374.661,Mechanical Phenomena,Physical Phenomena,91
Leishmania,B,B01.268.475.868.488,Trypanosomatina,Kinetoplastida,91
Maternal Health,N,N01.400.900.500,Women's Health,Health,91
"Models, Econometric",N,N05.715.360.750.530.500.500,"Models, Economic","Models, Statistical",91
"Models, Econometric",E,E05.318.740.500.600.500,"Models, Economic","Models, Statistical",91
"Models, Econometric",E,E05.599.835.890.500,"Models, Economic","Models, Statistical",91
"Models, Econometric",N,N06.850.520.830.500.600.500,"Models, Economic","Models, Statistical",91
Reference Standards,E,E05.978.808,Weights and Measures,Investigative Techniques,91
"Sequence Homology, Amino Acid",G,G02.111.810.200,Sequence Homology,Biochemical Phenomena,91
"Sequence Homology, Amino Acid",G,G05.810.200,Sequence Homology,Genetic Phenomena,91
Coronary Artery Bypass,E,E04.100.376.719.332,Myocardial Revascularization,Cardiac Surgical Procedures,90
Coronary Artery Bypass,E,E04.100.814.868.750,Vascular Grafting,Vascular Surgical Procedures,90
Coronary Artery Bypass,E,E04.928.220.520.220,Myocardial Revascularization,Cardiac Surgical Procedures,90
Economic Recession,I,I01.261.425,Economics,Social Sciences,90
Food,J,J02.500,Food and Beverages,NULL,90
Food,G,G07.203.300,"Diet, Food, and Nutrition",Physiological Phenomena,90
Geographic Information Systems,L,L01.313.500.750.300.314,Information Systems,Medical Informatics Applications,90
Geographic Information Systems,L,L01.470.750.750.462,"Databases, Factual",Databases as Topic,90
Maternal Exposure,N,N06.850.460.350.145,Environmental Exposure,Environmental Pollution,90
Parasitology,H,H01.158.273.688,Biology,Biological Science Disciplines,90
Respiratory Sounds,G,G09.772.775,Respiratory Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,90
Respiratory Sounds,C,C23.888.852.779,"Signs and Symptoms, Respiratory",Signs and Symptoms,90
Respiratory Sounds,E,E01.370.386.720,"Diagnostic Techniques, Respiratory System",Diagnostic Techniques and Procedures,90
Schistosomiasis haematobia,C,C12.777.892.775,Urinary Tract Infections,Urologic Diseases,90
Schistosomiasis haematobia,C,C13.351.968.892.775,Urinary Tract Infections,Urologic Diseases,90
Schistosomiasis haematobia,C,C01.610.335.865.859.427,Schistosomiasis,Trematode Infections,90
Schistosomiasis haematobia,C,C01.920.922.427,Schistosomiasis,Vector Borne Diseases,90
Schistosomiasis haematobia,C,C01.915.775,Urinary Tract Infections,Infections,90
Social Behavior,F,F01.145.813,Behavior,Behavior and Behavior Mechanisms,90
"Tomography, X-Ray Computed",E,E01.370.350.825.810.810,"Tomography, X-Ray",Tomography,90
"Tomography, X-Ray Computed",E,E01.370.350.700.700.810,Radiographic Image Enhancement,Radiography,90
"Tomography, X-Ray Computed",E,E01.370.350.700.810.810,"Tomography, X-Ray",Radiography,90
"Tomography, X-Ray Computed",E,E01.370.350.600.350.700.810,Radiographic Image Enhancement,Image Enhancement,90
"Tomography, X-Ray Computed",E,E01.370.350.350.810,"Image Interpretation, Computer-Assisted",Diagnostic Imaging,90
B-Lymphocytes,A,A15.382.032.438,Antibody-Producing Cells,Immune System,89
B-Lymphocytes,A,A15.382.490.555.567.562,Lymphocytes,"Leukocytes, Mononuclear",89
B-Lymphocytes,A,A15.145.229.637.555.567.562,Lymphocytes,"Leukocytes, Mononuclear",89
B-Lymphocytes,A,A11.118.637.555.567.562,Lymphocytes,"Leukocytes, Mononuclear",89
B-Lymphocytes,A,A11.063.438,Antibody-Producing Cells,Cells,89
Carrier Proteins,D,D12.776.157,Proteins,"Amino Acids, Peptides, and Proteins",89
Diphtheria-Tetanus-Pertussis Vaccine,D,D20.215.894.691.824.300,Tetanus Toxoid,Toxoids,89
Diphtheria-Tetanus-Pertussis Vaccine,D,D20.215.894.691.263.300,Diphtheria Toxoid,Toxoids,89
Diphtheria-Tetanus-Pertussis Vaccine,D,D20.215.894.815.300,"Vaccines, Combined",Vaccines,89
Diphtheria-Tetanus-Pertussis Vaccine,D,D20.215.894.135.535.300,Pertussis Vaccine,Bacterial Vaccines,89
Genetic Association Studies,E,E05.393.385,Genetic Techniques,Investigative Techniques,89
Inpatients,M,M01.643.470,Patients,Persons,89
"Killer Cells, Natural",A,A11.118.637.555.567.537,Lymphocytes,"Leukocytes, Mononuclear",89
"Killer Cells, Natural",A,A15.145.229.637.555.567.537,Lymphocytes,"Leukocytes, Mononuclear",89
"Killer Cells, Natural",A,A15.382.490.555.567.537,Lymphocytes,"Leukocytes, Mononuclear",89
Onchocerciasis,C,C01.610.335.508.700.750.361.699,Filariasis,Spirurida Infections,89
Onchocerciasis,C,C01.610.858.650,"Skin Diseases, Parasitic",Parasitic Diseases,89
Onchocerciasis,C,C17.800.838.775.690,"Skin Diseases, Parasitic","Skin Diseases, Infectious",89
Pain,C,C23.888.592.612,Neurologic Manifestations,Signs and Symptoms,89
Pain,G,G11.561.790.444,Sensation,Nervous System Physiological Phenomena,89
Pain,F,F02.830.816.444,Sensation,Psychophysiology,89
Palliative Care,N,N02.421.585.666,Patient Care,Health Services,89
Palliative Care,E,E02.760.666,Patient Care,Therapeutics,89
Patient-Centered Care,N,N04.590.233.727.407,Primary Health Care,Comprehensive Health Care,89
"Pneumonia, Pneumococcal",C,C08.381.677.540.550,"Pneumonia, Bacterial",Pneumonia,89
"Pneumonia, Pneumococcal",C,C08.730.610.540.550,"Pneumonia, Bacterial",Pneumonia,89
"Pneumonia, Pneumococcal",C,C01.748.610.540.550,"Pneumonia, Bacterial",Pneumonia,89
"Pneumonia, Pneumococcal",C,C01.150.252.410.890.670.750,Pneumococcal Infections,Streptococcal Infections,89
"Pneumonia, Pneumococcal",C,C01.150.252.620.550,"Pneumonia, Bacterial",Bacterial Infections,89
Trichiasis,C,C11.338.912,Eyelid Diseases,Eye Diseases,89
AIDS Vaccines,D,D20.215.894.899.050,Viral Vaccines,Vaccines,88
Anticoagulants,D,D27.505.954.502.119,Hematologic Agents,Therapeutic Uses,88
Ascariasis,C,C01.610.335.508.700.100.070,Ascaridida Infections,Secernentea Infections,88
Cold Temperature,N,N06.230.300.100.725.154,Weather,Atmosphere,88
Cold Temperature,N,N06.230.300.100.725.710.300,Temperature,Weather,88
Cold Temperature,G,G16.500.750.775.710.300,Temperature,Weather,88
Cold Temperature,G,G16.500.275.063.725.710.300,Temperature,Weather,88
Cold Temperature,G,G01.906.595.272,Temperature,Thermodynamics,88
Disasters,N,N06.230.100,Environment,Environment and Public Health,88
Environmental Health,H,H02.229,Health Occupations,NULL,88
Epidemiology,H,H02.403.720.500,Public Health,Medicine,88
Escherichia coli Infections,C,C01.150.252.400.310.330,Enterobacteriaceae Infections,Gram-Negative Bacterial Infections,88
Hypersensitivity,C,C20.543,Immune System Diseases,NULL,88
In Vitro Techniques,E,E05.481,Investigative Techniques,NULL,88
"Microscopy, Electron",E,E05.595.402,Microscopy,Investigative Techniques,88
"Microscopy, Electron",E,E01.370.350.515.402,Microscopy,Diagnostic Imaging,88
Myocardial Ischemia,C,C14.280.647,Heart Diseases,Cardiovascular Diseases,88
Myocardial Ischemia,C,C14.907.585,Vascular Diseases,Cardiovascular Diseases,88
"Antigens, Helminth",D,D23.050.223,Antigens,Biological Factors,87
Biological Assay,E,E05.091,Investigative Techniques,NULL,87
Clostridioides difficile,B,B03.353.625.657.500,Clostridioides,Clostridiales,87
Culex,B,B01.050.500.131.617.720.500.500.750.712.500.875.225,Culicidae,Culicomorpha,87
Domestic Violence,I,I01.198.240.856.350,Violence,Crime,87
Domestic Violence,I,I01.880.735.900.350,Violence,Social Problems,87
"Financing, Organized",N,N03.219.521,Economics,Health Care Economics and Organizations,87
"Genome, Protozoan",G,G05.360.340.397,Genome,Genetic Structures,87
Health Equity,N,N04.590.374.350.500,Health Services Accessibility,Delivery of Health Care,87
Health Equity,N,N05.300.430.383,Health Services Accessibility,Delivery of Health Care,87
Home Care Services,N,N02.421.539.089,Nursing Services,Health Services,87
Home Care Services,N,N02.421.143.524,Community Health Services,Health Services,87
Patient Care Team,N,N04.590.715,Patient Care Management,Health Services Administration,87
Perinatal Care,N,N02.421.088.120.180,Infant Care,Child Care,87
Perinatal Care,N,N02.421.143.620.550,Maternal Health Services,Community Health Services,87
Perinatal Care,N,N02.421.585.703,Patient Care,Health Services,87
Perinatal Care,E,E02.760.703,Patient Care,Therapeutics,87
Pharmaceutical Preparations,D,D26,NULL,NULL,87
Spatial Analysis,E,E05.318.740.933,Statistics as Topic,Epidemiologic Methods,87
Spatial Analysis,N,N05.715.360.750.746,Statistics as Topic,Health Care Evaluation Mechanisms,87
Spatial Analysis,N,N06.850.520.830.933,Statistics as Topic,Epidemiologic Methods,87
"Dermatitis, Atopic",C,C17.800.827.210,"Skin Diseases, Genetic",Skin Diseases,86
"Dermatitis, Atopic",C,C17.800.815.193,"Skin Diseases, Eczematous",Skin Diseases,86
"Dermatitis, Atopic",C,C17.800.174.193,Dermatitis,Skin Diseases,86
"Dermatitis, Atopic",C,C16.320.850.210,"Skin Diseases, Genetic","Genetic Diseases, Inborn",86
"Dermatitis, Atopic",C,C20.543.480.343,"Hypersensitivity, Immediate",Hypersensitivity,86
"Europe, Eastern",Z,Z01.542.248,Europe,Geographic Locations,86
"Food, Fortified",J,J02.500.515,Food,Food and Beverages,86
"Food, Fortified",G,G07.203.300.515,Food,"Diet, Food, and Nutrition",86
"Kidney Failure, Chronic",C,C13.351.968.419.780.750.500,"Renal Insufficiency, Chronic",Renal Insufficiency,86
"Kidney Failure, Chronic",C,C12.777.419.780.750.500,"Renal Insufficiency, Chronic",Renal Insufficiency,86
Point-of-Care Testing,N,N04.590.874.500,Point-of-Care Systems,Patient Care Management,86
Glaucoma,C,C11.525.381,Ocular Hypertension,Eye Diseases,85
Hepatitis B Vaccines,D,D20.215.894.899.955.400,Viral Hepatitis Vaccines,Viral Vaccines,85
HIV Seroprevalence,N,N05.715.360.330.500.950.375,Seroepidemiologic Studies,Epidemiologic Studies,85
HIV Seroprevalence,E,E05.318.372.500.950.375,Seroepidemiologic Studies,Epidemiologic Studies,85
HIV Seroprevalence,N,N06.850.520.450.500.950.375,Seroepidemiologic Studies,Epidemiologic Studies,85
"Image Processing, Computer-Assisted",L,L01.224.308,Computing Methodologies,Information Science,85
Mass Vaccination,N,N02.421.726.758.310.890.500,Vaccination,Immunization,85
Mass Vaccination,N,N02.421.726.608.500,Immunization Programs,Preventive Health Services,85
Mass Vaccination,E,E05.478.550.600.890.500,Vaccination,"Immunotherapy, Active",85
Mass Vaccination,N,N06.850.780.680.310.890.500,Vaccination,Immunization,85
Mass Vaccination,N,N06.850.780.200.425.900.500,Vaccination,Immunization,85
Mass Vaccination,E,E02.095.465.425.400.530.890.500,Vaccination,"Immunotherapy, Active",85
Multilocus Sequence Typing,E,E01.370.225.875.150.125.457.500,Molecular Typing,Bacterial Typing Techniques,85
Multilocus Sequence Typing,E,E05.393.760.700.650,"Sequence Analysis, DNA",Sequence Analysis,85
Multilocus Sequence Typing,E,E05.393.542.500,Molecular Typing,Genetic Techniques,85
Multilocus Sequence Typing,E,E05.200.875.150.125.457.500,Molecular Typing,Bacterial Typing Techniques,85
Obstetric Labor Complications,C,C13.703.420,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,85
Ovarian Neoplasms,C,C13.351.937.418.685,"Genital Neoplasms, Female",Urogenital Neoplasms,85
Ovarian Neoplasms,C,C13.351.500.056.630.705,Ovarian Diseases,Adnexal Diseases,85
Ovarian Neoplasms,C,C19.344.410,Endocrine Gland Neoplasms,Endocrine System Diseases,85
Ovarian Neoplasms,C,C19.391.630.705,Ovarian Diseases,Gonadal Disorders,85
Ovarian Neoplasms,C,C04.588.322.455,Endocrine Gland Neoplasms,Neoplasms by Site,85
Placenta,A,A16.710,Embryonic Structures,NULL,85
Belgium,Z,Z01.542.115,Europe,Geographic Locations,84
Culture Media,E,E07.206,Equipment and Supplies,NULL,84
Culture Media,D,D27.720.470.305,Laboratory Chemicals,Specialty Uses of Chemicals,84
Diagnostic Errors,E,E01.354,Diagnosis,NULL,84
Diagnostic Errors,N,N02.421.450.280,Medical Errors,Health Services,84
Disease-Free Survival,N,N05.715.360.575.575.800.190,Treatment Outcome,"Outcome Assessment, Health Care",84
Disease-Free Survival,N,N05.715.360.750.795.300,Survival Analysis,Statistics as Topic,84
Disease-Free Survival,N,N04.761.559.590.800.190,Treatment Outcome,"Outcome Assessment, Health Care",84
Disease-Free Survival,E,E05.318.740.998.300,Survival Analysis,Statistics as Topic,84
Disease-Free Survival,N,N06.850.520.830.998.300,Survival Analysis,Statistics as Topic,84
Disease-Free Survival,E,E01.789.800.190,Treatment Outcome,Prognosis,84
Gene Deletion,G,G05.558.800.320,Sequence Deletion,Mutagenesis,84
Gene Deletion,G,G05.365.590.762.320,Sequence Deletion,Mutation,84
Infant Care,N,N02.421.088.120,Child Care,Health Services,84
Lactation,G,G08.686.702.500,Postpartum Period,Reproductive Physiological Phenomena,84
Lactation,G,G08.686.523,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,84
Membrane Transport Proteins,D,D12.776.543.585,Membrane Proteins,Proteins,84
Membrane Transport Proteins,D,D12.776.157.530,Carrier Proteins,Proteins,84
Sex Education,F,F04.096.837.500,Sexology,Behavioral Sciences,84
Sex Education,I,I02.233.332.749,Health Education,"Education, Nonprofessional",84
Spatio-Temporal Analysis,N,N05.715.360.750.746.500,Spatial Analysis,Statistics as Topic,84
Spatio-Temporal Analysis,E,E05.318.740.933.500,Spatial Analysis,Statistics as Topic,84
Spatio-Temporal Analysis,N,N06.850.520.830.933.500,Spatial Analysis,Statistics as Topic,84
Water Purification,N,N06.850.780.200.800.800.900.900,Waste Management,Sanitary Engineering,84
Water Purification,N,N06.850.860.510.900.900,Waste Management,Sanitary Engineering,84
Amphotericin B,D,D02.540.576.500.500,Macrolides,Polyketides,83
Asymptomatic Infections,C,C01.125,Infections,NULL,83
Asymptomatic Infections,C,C23.550.291.187.500,Asymptomatic Diseases,Disease Attributes,83
"Carcinoma, Squamous Cell",C,C04.557.470.200.400,Carcinoma,"Neoplasms, Glandular and Epithelial",83
"Carcinoma, Squamous Cell",C,C04.557.470.700.400,"Neoplasms, Squamous Cell","Neoplasms, Glandular and Epithelial",83
Confidentiality,F,F04.096.544.335.240,Forensic Psychiatry,Psychiatry,83
Confidentiality,N,N03.706.535.230,Jurisprudence,"Social Control, Formal",83
Confidentiality,N,N03.706.437.650.124,Patient Rights,Human Rights,83
Confidentiality,I,I01.880.604.473.650.500,Patient Rights,Human Rights,83
Confidentiality,I,I01.880.604.583.080,Jurisprudence,"Social Control, Formal",83
Conservation of Natural Resources,J,J01.256,"Technology, Industry, and Agriculture",NULL,83
Conservation of Natural Resources,N,N06.230.080,Environment,Environment and Public Health,83
Creatinine,D,D03.383.129.308.207,Imidazoles,Azoles,83
Data Accuracy,N,N05.715.360.325.685.250,Reproducibility of Results,Epidemiologic Research Design,83
Data Accuracy,N,N05.715.360.300.202,Data Collection,Health Care Evaluation Mechanisms,83
Data Accuracy,L,L01.399.250.202,Data Collection,Information Management,83
Data Accuracy,E,E05.318.370.725.250,Reproducibility of Results,Epidemiologic Research Design,83
Data Accuracy,E,E05.318.308.028,Data Collection,Epidemiologic Methods,83
Fiji,Z,Z01.639.760.590.373,Melanesia,Pacific Islands,83
HIV-2,B,B04.820.650.589.650.350.410,HIV,"Lentiviruses, Primate",83
International Agencies,N,N03.540.514,Organizations,Health Care Economics and Organizations,83
Organizational Objectives,N,N04.452.615,Organization and Administration,Health Services Administration,83
Quantitative Trait Loci,G,G05.360.340.024.380.937,Genetic Loci,Genome Components,83
Spleen,A,A15.382.520.604.700,Lymphoid Tissue,Lymphatic System,83
Spleen,A,A10.549.700,Lymphoid Tissue,Tissues,83
"Hepatitis C, Chronic",C,C01.221.250.750.120,Hepatitis C,Blood-Borne Infections,82
"Hepatitis C, Chronic",C,C01.925.440.440.120,Hepatitis C,"Hepatitis, Viral, Human",82
"Hepatitis C, Chronic",C,C01.925.782.350.350.120,Hepatitis C,Flaviviridae Infections,82
"Hepatitis C, Chronic",C,C06.552.380.350.120,"Hepatitis, Chronic",Hepatitis,82
"Hepatitis C, Chronic",C,C06.552.380.705.440.120,Hepatitis C,"Hepatitis, Viral, Human",82
Industry,J,J01.576,"Technology, Industry, and Agriculture",NULL,82
Melanoma,C,C04.557.580.625.650.510,Neuroendocrine Tumors,Neuroectodermal Tumors,82
Melanoma,C,C04.557.665.510,Nevi and Melanomas,Neoplasms by Histologic Type,82
Melanoma,C,C04.557.465.625.650.510,Neuroendocrine Tumors,Neuroectodermal Tumors,82
Mining,J,J01.576.655.875.500,Extraction and Processing Industry,Manufacturing Industry,82
Propensity Score,N,N05.715.360.750.625.620,Probability,Statistics as Topic,82
Propensity Score,E,E05.318.740.600.675,Probability,Statistics as Topic,82
Propensity Score,N,N06.850.520.830.600.650,Probability,Statistics as Topic,82
Universities,I,I02.783.830,Schools,Education,82
Universities,J,J03.832.830,Schools,Non-Medical Public and Private Facilities,82
Urbanization,I,I01.880.853.400.726,Social Change,Sociological Factors,82
Vitamin D,D,D04.210.500.812.768,Secosteroids,Steroids,82
Zinc,D,D01.552.544.940,"Metals, Heavy",Metals,82
Zinc,D,D01.268.956.906,Transition Elements,Elements,82
Zinc,D,D01.268.556.940,"Metals, Heavy",Elements,82
Awareness,F,F02.463.188.150,Cognition,Mental Processes,81
Binding Sites,G,G02.111.570.120,Molecular Structure,Biochemical Phenomena,81
Blood Transfusion,E,E02.095.135,Biological Therapy,Therapeutics,81
"Depressive Disorder, Major",F,F03.600.300.375,Depressive Disorder,Mood Disorders,81
DNA-Binding Proteins,D,D12.776.260,Proteins,"Amino Acids, Peptides, and Proteins",81
Monocytes,A,A11.148.580,Bone Marrow Cells,Cells,81
Monocytes,A,A11.118.637.555.652,"Leukocytes, Mononuclear",Leukocytes,81
Monocytes,A,A11.733.547,Phagocytes,Cells,81
Monocytes,A,A11.627.624,Myeloid Cells,Cells,81
Monocytes,A,A15.382.670.547,Mononuclear Phagocyte System,Immune System,81
Monocytes,A,A15.382.490.555.652,"Leukocytes, Mononuclear",Leukocytes,81
Monocytes,A,A15.382.680.547,Phagocytes,Immune System,81
Monocytes,A,A15.378.316.580,Bone Marrow Cells,Hematopoietic System,81
Monocytes,A,A15.145.229.637.555.652,"Leukocytes, Mononuclear",Leukocytes,81
Principal Component Analysis,E,E05.318.740.562,Statistics as Topic,Epidemiologic Methods,81
Sesquiterpenes,D,D02.455.849.765,Terpenes,Hydrocarbons,81
Text Messaging,L,L01.178.847.698.300.500,Cell Phone,Telephone,81
Text Messaging,L,L01.559.423.906.377.666,Correspondence as Topic,Writing,81
Child Nutritional Physiological Phenomena,G,G07.203.650.220,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",80
"Cholesterol, HDL",D,D04.210.500.247.808.197.238,Cholesterol,Sterols,80
"Cholesterol, HDL",D,D10.532.432.400,"Lipoproteins, HDL",Lipoproteins,80
"Cholesterol, HDL",D,D10.570.938.208.270,Cholesterol,Sterols,80
"Cholesterol, HDL",D,D12.776.521.479.470,"Lipoproteins, HDL",Lipoproteins,80
Eating,G,G07.203.650.283,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",80
Eating,G,G10.261.330,Digestive System Physiological Phenomena,Digestive System and Oral Physiological Phenomena,80
Leishmaniasis,C,C01.920.813,Vector Borne Diseases,Infections,80
Leishmaniasis,C,C01.610.752.300.500,Euglenozoa Infections,Protozoan Infections,80
Leishmaniasis,C,C01.610.858.560,"Skin Diseases, Parasitic",Parasitic Diseases,80
Leishmaniasis,C,C17.800.838.775.560,"Skin Diseases, Parasitic","Skin Diseases, Infectious",80
Mammography,E,E01.370.350.700.500,Radiography,Diagnostic Imaging,80
Nurses,M,M01.526.485.650,Health Personnel,Occupational Groups,80
Nurses,N,N02.360.650,Health Personnel,"Health Care Facilities, Manpower, and Services",80
Permethrin,D,D02.455.849.575.188.750.636,Pyrethrins,Cyclopentane Monoterpenes,80
Permethrin,D,D02.355.726.713,Phenyl Ethers,Ethers,80
Permethrin,D,D02.455.426.559.389.657.654.713,Phenyl Ethers,Phenols,80
Professional-Patient Relations,N,N05.300.660,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",80
Professional-Patient Relations,F,F01.829.401.650,Interpersonal Relations,"Psychology, Social",80
Quarantine,N,N06.850.780.200.725,Communicable Disease Control,Public Health Practice,80
Spouse Abuse,I,I01.198.240.856.350.750,Domestic Violence,Violence,80
Spouse Abuse,I,I01.198.240.856.575.500,Intimate Partner Violence,Violence,80
Spouse Abuse,I,I01.880.735.900.688.500,Intimate Partner Violence,Violence,80
Spouse Abuse,I,I01.880.735.900.350.750,Domestic Violence,Violence,80
Sri Lanka,Z,Z01.252.245.840,"Asia, Western",Asia,80
Sri Lanka,Z,Z01.639.520.875,Indian Ocean Islands,Islands,80
Triglycerides,D,D10.351.801,Glycerides,Lipids,80
Altruism,F,F01.145.813.090,Social Behavior,Behavior,79
Bacterial Capsules,A,A20.186,Bacterial Structures,NULL,79
Cell Differentiation,G,G04.152,Cell Physiological Phenomena,NULL,79
"Cell Line, Tumor",A,A11.251.210.190,Cell Line,"Cells, Cultured",79
"Cell Line, Tumor",A,A11.251.860.180,"Tumor Cells, Cultured","Cells, Cultured",79
Checklist,N,N05.715.360.300.179,Data Collection,Health Care Evaluation Mechanisms,79
CpG Islands,G,G05.360.340.024.159,Genome Components,Genome,79
CpG Islands,G,G05.360.080.380.160,GC Rich Sequence,Base Sequence,79
CpG Islands,G,G02.111.570.080.380.160,GC Rich Sequence,Base Sequence,79
"Electrophoresis, Polyacrylamide Gel",E,E05.301.300.319,Electrophoresis,Electrochemical Techniques,79
"Electrophoresis, Polyacrylamide Gel",E,E05.196.401.402,Electrophoresis,"Chemistry Techniques, Analytical",79
Fruit,G,G07.203.300.562,Food,"Diet, Food, and Nutrition",79
Fruit,J,J02.500.562,Food,Food and Beverages,79
Fruit,A,A18.024.500,"Plant Components, Aerial",Plant Structures,79
Multiple Sclerosis,C,C20.111.258.250.500,"Demyelinating Autoimmune Diseases, CNS",Autoimmune Diseases of the Nervous System,79
Multiple Sclerosis,C,C10.114.375.500,"Demyelinating Autoimmune Diseases, CNS",Autoimmune Diseases of the Nervous System,79
Multiple Sclerosis,C,C10.314.350.500,"Demyelinating Autoimmune Diseases, CNS",Demyelinating Diseases,79
Pediatric Obesity,C,C18.654.726.500.720,Obesity,Overnutrition,79
Pediatric Obesity,C,C23.888.144.699.500.750,Obesity,Overweight,79
Pediatric Obesity,E,E01.370.600.115.100.160.120.699.500.750,Obesity,Overweight,79
Pediatric Obesity,G,G07.100.100.160.120.699.500.750,Obesity,Overweight,79
"Polymorphism, Restriction Fragment Length",G,G05.365.795.595,"Polymorphism, Genetic",Genetic Variation,79
Portugal,Z,Z01.542.727,Europe,Geographic Locations,79
Refractive Errors,C,C11.744,Eye Diseases,NULL,79
Rotavirus,B,B04.820.223.719.790,Reoviridae,Double Stranded RNA Viruses,79
"Vision, Low",C,C11.966.905,Vision Disorders,Eye Diseases,79
"Vision, Low",C,C10.597.751.941.905,Vision Disorders,Sensation Disorders,79
"Vision, Low",C,C23.888.592.763.941.848,Vision Disorders,Sensation Disorders,79
Administrative Personnel,M,M01.526.070,Occupational Groups,Persons,78
Health,N,N01.400,Population Characteristics,NULL,78
Herpes Zoster,C,C01.925.256.466.930.750,Varicella Zoster Virus Infection,Herpesviridae Infections,78
HIV Testing,E,E01.370.225.875.408,Microbiological Techniques,Clinical Laboratory Techniques,78
HIV Testing,E,E05.200.875.408,Microbiological Techniques,Clinical Laboratory Techniques,78
Measles-Mumps-Rubella Vaccine,D,D20.215.894.899.779.500,Rubella Vaccine,Viral Vaccines,78
Measles-Mumps-Rubella Vaccine,D,D20.215.894.899.488.500,Mumps Vaccine,Viral Vaccines,78
Measles-Mumps-Rubella Vaccine,D,D20.215.894.899.404.500,Measles Vaccine,Viral Vaccines,78
Measles-Mumps-Rubella Vaccine,D,D20.215.894.815.500,"Vaccines, Combined",Vaccines,78
Neutrophils,A,A15.382.680.689,Phagocytes,Immune System,78
Neutrophils,A,A15.382.490.315.583,Granulocytes,Leukocytes,78
Neutrophils,A,A15.145.229.637.415.583,Granulocytes,Leukocytes,78
Neutrophils,A,A11.118.637.415.583,Granulocytes,Leukocytes,78
Neutrophils,A,A11.627.340.583,Granulocytes,Myeloid Cells,78
Neutrophils,A,A11.733.689,Phagocytes,Cells,78
Norway,Z,Z01.542.816.374,Scandinavian and Nordic Countries,Europe,78
Plasmodium knowlesi,B,B01.043.075.380.611.610,Plasmodium,Haemosporida,78
"Power, Psychological",F,F01.658.780,Motivation,Behavior and Behavior Mechanisms,78
Salmonella Infections,C,C01.150.252.400.310.821,Enterobacteriaceae Infections,Gram-Negative Bacterial Infections,78
Sustainable Development,N,N06.230.080.900,Conservation of Natural Resources,Environment,78
Sustainable Development,I,I01.655.500.608.700,Public Policy,Social Control Policies,78
Weather,G,G16.500.275.063.725,Atmosphere,Environment,78
Weather,G,G16.500.750.775,Meteorological Concepts,Ecological and Environmental Phenomena,78
Weather,N,N06.230.300.100.725,Atmosphere,Meteorological Concepts,78
Cough,C,C23.888.852.293,"Signs and Symptoms, Respiratory",Signs and Symptoms,77
Cough,C,C08.618.248,Respiration Disorders,Respiratory Tract Diseases,77
False Positive Reactions,E,E01.354.506,Diagnostic Errors,Diagnosis,77
Insect Control,N,N06.850.780.200.650.425,Pest Control,Communicable Disease Control,77
Insulin Resistance,G,G07.690.773.984.617,Drug Resistance,Pharmacological Phenomena,77
Insulin Resistance,C,C18.452.394.968.500,Hyperinsulinism,Glucose Metabolism Disorders,77
Klebsiella pneumoniae,B,B03.660.250.150.400.590,Klebsiella,Enterobacteriaceae,77
Klebsiella pneumoniae,B,B03.440.450.425.425.600,Klebsiella,Enterobacteriaceae,77
Pedigree,E,E05.393.673,Genetic Techniques,Investigative Techniques,77
Pertussis Vaccine,D,D20.215.894.135.535,Bacterial Vaccines,Vaccines,77
Sex Offenses,I,I01.198.240.748,Crime,Criminology,77
South America,Z,Z01.107.757,Americas,Geographic Locations,77
Chlorocebus aethiops,B,B01.050.150.900.649.313.988.400.112.199.120.126.110,Cercopithecus,Cercopithecinae,76
COVID-19 Testing,E,E01.370.225.312,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,76
COVID-19 Testing,E,E05.200.312,Clinical Laboratory Techniques,Investigative Techniques,76
Extensively Drug-Resistant Tuberculosis,C,C01.150.252.410.040.552.846.775.500,"Tuberculosis, Multidrug-Resistant",Tuberculosis,76
Gender Identity,F,F01.393.446.250,"Identification, Psychological",Defense Mechanisms,76
Gender Identity,F,F01.752.747.385.200,"Identification, Psychological",Personality Development,76
Gender Identity,F,F01.752.747.722.200,Psychosexual Development,Personality Development,76
Gender Identity,F,F02.739.794.793.200,Psychosexual Development,Psychoanalytic Theory,76
Geriatric Assessment,E,E05.318.308.225,Data Collection,Epidemiologic Methods,76
Geriatric Assessment,I,I01.240.425.350,Health Status,Demography,76
Geriatric Assessment,N,N06.850.520.308.225,Data Collection,Epidemiologic Methods,76
Geriatric Assessment,N,N06.850.505.400.425.350,Health Status,Demography,76
Geriatric Assessment,N,N05.715.360.300.360,Data Collection,Health Care Evaluation Mechanisms,76
Geriatric Assessment,N,N01.224.425.350,Health Status,Demography,76
Organizations,N,N03.540,Health Care Economics and Organizations,NULL,76
Primaquine,D,D03.633.100.810.050.650,Aminoquinolines,Quinolines,76
Rabbits,B,B01.050.150.900.649.313.968.700,Lagomorpha,Eutheria,76
Rain,N,N06.230.300.100.725.450,Weather,Atmosphere,76
Rain,N,N06.230.520,Environment,Environment and Public Health,76
Rain,G,G16.500.750.775.450,Weather,Meteorological Concepts,76
Rain,G,G16.500.175.859,Climatic Processes,Ecological and Environmental Phenomena,76
Rain,G,G16.500.275.063.725.395,Weather,Atmosphere,76
Angina Pectoris,C,C14.280.647.187,Myocardial Ischemia,Heart Diseases,75
Angina Pectoris,C,C14.907.585.187,Myocardial Ischemia,Vascular Diseases,75
Angina Pectoris,C,C23.888.592.612.233.500,Chest Pain,Pain,75
Capsid Proteins,D,D12.776.964.970.600.550,Nucleocapsid Proteins,Viral Structural Proteins,75
"Cholesterol, LDL",D,D12.776.521.550.500,"Lipoproteins, LDL",Lipoproteins,75
"Cholesterol, LDL",D,D04.210.500.247.808.197.244,Cholesterol,Sterols,75
"Cholesterol, LDL",D,D10.532.515.500,"Lipoproteins, LDL",Lipoproteins,75
"Cholesterol, LDL",D,D10.570.938.208.275,Cholesterol,Sterols,75
Cultural Characteristics,I,I01.076.201.450.324,Culture,"Anthropology, Cultural",75
Cultural Characteristics,I,I01.880.853.100.329,Culture,Sociological Factors,75
Emotions,F,F01.470,Behavior and Behavior Mechanisms,NULL,75
Food Industry,J,J01.576.423,Industry,"Technology, Industry, and Agriculture",75
Government Regulation,I,I01.880.604.394,"Social Control, Formal",Sociology,75
Government Regulation,N,N03.706.358,"Social Control, Formal",Health Care Economics and Organizations,75
Harm Reduction,F,F01.145.477,Behavior,Behavior and Behavior Mechanisms,75
HIV Seronegativity,G,G12.400,Immune System Phenomena,NULL,75
Immunity,G,G12.450,Immune System Phenomena,NULL,75
Liver Neoplasms,C,C04.588.274.623,Digestive System Neoplasms,Neoplasms by Site,75
Liver Neoplasms,C,C06.552.697,Liver Diseases,Digestive System Diseases,75
Liver Neoplasms,C,C06.301.623,Digestive System Neoplasms,Digestive System Diseases,75
Protein Conformation,G,G02.111.570.820.709,Molecular Conformation,Molecular Structure,75
"Protein Structure, Tertiary",G,G02.111.570.820.709.610,Protein Conformation,Molecular Conformation,75
Research Report,H,H01.770.644.864,Research,Science,75
Research Report,L,L01.559.423.906.769,Writing,Language Arts,75
Reverse Transcriptase Inhibitors,D,D27.505.954.122.388.308,Antiviral Agents,Anti-Infective Agents,75
Reverse Transcriptase Inhibitors,D,D27.505.519.389.675.850,Nucleic Acid Synthesis Inhibitors,Enzyme Inhibitors,75
Social Norms,I,I01.880.853.903,Sociological Factors,Sociology,75
Social Norms,F,F01.829.750,"Psychology, Social",Behavior and Behavior Mechanisms,75
Switzerland,Z,Z01.542.883,Europe,Geographic Locations,75
Transcription Factors,D,D12.776.930,Proteins,"Amino Acids, Peptides, and Proteins",75
"Abortion, Spontaneous",C,C13.703.039,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,74
"Abortion, Spontaneous",G,G08.686.784.769.496.125,Pregnancy Outcome,Pregnancy,74
Cognitive Behavioral Therapy,F,F04.754.137.350,Behavior Therapy,Psychotherapy,74
Disaster Planning,N,N06.230.100.035,Disasters,Environment,74
"Dysentery, Bacillary",C,C06.405.205.331.479,Dysentery,Gastroenteritis,74
"Dysentery, Bacillary",C,C06.405.469.300.479,Dysentery,Intestinal Diseases,74
"Dysentery, Bacillary",C,C01.150.252.400.310.229,Enterobacteriaceae Infections,Gram-Negative Bacterial Infections,74
Genetic Testing,E,E01.370.225.562,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,74
Genetic Testing,N,N02.421.308.430,Genetic Services,Health Services,74
Genetic Testing,N,N02.421.726.233.221,Diagnostic Services,Preventive Health Services,74
Genetic Testing,E,E05.393.435,Genetic Techniques,Investigative Techniques,74
Genetic Testing,E,E05.200.562,Clinical Laboratory Techniques,Investigative Techniques,74
Glucocorticoids,D,D27.505.696.399.472.488,Hormones,"Hormones, Hormone Substitutes, and Hormone Antagonists",74
Glucocorticoids,D,D06.472.040.543,Adrenal Cortex Hormones,Hormones,74
Glycoproteins,D,D09.400.430,Glycoconjugates,Carbohydrates,74
Glycoproteins,D,D12.776.395,Proteins,"Amino Acids, Peptides, and Proteins",74
Haemophilus influenzae,B,B03.660.250.550.290.330,Haemophilus,Pasteurellaceae,74
Haemophilus influenzae,B,B03.440.450.600.450.330,Haemophilus,Pasteurellaceae,74
Heterozygote,G,G05.380.383,Genotype,Genetic Phenomena,74
Immunoassay,E,E05.478.566,Immunologic Techniques,Investigative Techniques,74
Immunoassay,E,E05.601.470,Molecular Probe Techniques,Investigative Techniques,74
Infant Health,N,N01.400.388,Health,Population Characteristics,74
Laboratories,N,N02.278.487,Health Facilities,"Health Care Facilities, Manpower, and Services",74
Laboratories,J,J03.520,Non-Medical Public and Private Facilities,NULL,74
Membrane Glycoproteins,D,D12.776.395.550,Glycoproteins,Proteins,74
Membrane Glycoproteins,D,D12.776.543.550,Membrane Proteins,Proteins,74
Merozoite Surface Protein 1,D,D12.776.820.500,Protozoan Proteins,Proteins,74
Merozoite Surface Protein 1,D,D23.050.293.500,"Antigens, Protozoan",Antigens,74
Metabolic Syndrome,C,C18.452.394.968.500.570,Insulin Resistance,Hyperinsulinism,74
Metabolic Syndrome,C,C18.452.625,Metabolic Diseases,Nutritional and Metabolic Diseases,74
Neutralization Tests,E,E01.370.225.812.735.550,Serologic Tests,Immunologic Tests,74
Neutralization Tests,E,E05.478.594.760.550,Serologic Tests,Immunologic Tests,74
Neutralization Tests,E,E05.200.812.735.550,Serologic Tests,Immunologic Tests,74
Nutrition Surveys,E,E05.318.308.980.485,Surveys and Questionnaires,Data Collection,74
Nutrition Surveys,N,N05.715.360.300.800.469,Surveys and Questionnaires,Data Collection,74
Nutrition Surveys,N,N06.850.505.616,Epidemiologic Measurements,Public Health,74
Nutrition Surveys,N,N06.850.520.308.980.469,Surveys and Questionnaires,Data Collection,74
Phylogeography,H,H01.277.500.589,Geography,Earth Sciences,74
Phylogeography,H,H01.158.273.343.335.500,"Genetics, Population",Genetics,74
"RNA, Ribosomal, 16S",D,D13.444.735.686.670,"RNA, Ribosomal",RNA,74
Stents,E,E07.695.750,Prostheses and Implants,Equipment and Supplies,74
Tertiary Care Centers,N,N02.278.421.830,Hospitals,Health Facilities,74
Trichuris,B,B01.050.500.500.294.100.275.780.628,Trichuroidea,Enoplida,74
Adrenal Cortex Hormones,D,D06.472.040,Hormones,"Hormones, Hormone Substitutes, and Hormone Antagonists",73
Albendazole,D,D03.633.100.103.070,Benzimidazoles,"Heterocyclic Compounds, 2-Ring",73
Albendazole,D,D02.241.081.251.022,Carbamates,"Acids, Acyclic",73
"Angioplasty, Balloon, Coronary",E,E02.148.050.060.100,"Angioplasty, Balloon",Angioplasty,73
"Angioplasty, Balloon, Coronary",E,E05.157.016.060.100,"Angioplasty, Balloon",Angioplasty,73
"Angioplasty, Balloon, Coronary",E,E04.100.814.529.968.050,Percutaneous Coronary Intervention,Endovascular Procedures,73
"Angioplasty, Balloon, Coronary",E,E04.100.814.529.124.060.100,"Angioplasty, Balloon",Angioplasty,73
"Angioplasty, Balloon, Coronary",E,E04.100.376.719.100,Myocardial Revascularization,Cardiac Surgical Procedures,73
"Angioplasty, Balloon, Coronary",E,E04.928.220.520.100,Myocardial Revascularization,Cardiac Surgical Procedures,73
"Angioplasty, Balloon, Coronary",E,E04.502.382.968.050,Percutaneous Coronary Intervention,Endovascular Procedures,73
"Angioplasty, Balloon, Coronary",E,E04.502.382.124.060.100,"Angioplasty, Balloon",Angioplasty,73
"Antibodies, Helminth",D,D12.776.377.715.548.114.185,Antibodies,Immunoglobulins,73
"Antibodies, Helminth",D,D12.776.124.790.651.114.185,Antibodies,Immunoglobulins,73
"Antibodies, Helminth",D,D12.776.124.486.485.114.185,Antibodies,Immunoglobulins,73
beta-Lactamases,D,D08.811.277.087.180,Amidohydrolases,Hydrolases,73
Cystic Fibrosis,C,C16.614.213,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",73
Cystic Fibrosis,C,C16.320.190,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",73
Cystic Fibrosis,C,C08.381.187,Lung Diseases,Respiratory Tract Diseases,73
Cystic Fibrosis,C,C06.689.202,Pancreatic Diseases,Digestive System Diseases,73
HeLa Cells,A,A11.436.340,Epithelial Cells,Cells,73
HeLa Cells,A,A11.251.210.190.400,"Cell Line, Tumor",Cell Line,73
Hela Cells,A,A11.251.860.180.400,"Cell Line, Tumor","Tumor Cells, Cultured",73
Immunosuppressive Agents,D,D27.505.696.477.656,Immunologic Factors,Physiological Effects of Drugs,73
Maternal Nutritional Physiological Phenomena,G,G07.203.650.566,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",73
Multigene Family,G,G05.360.340.024.340.645,Genes,Genome Components,73
Pediatrics,H,H02.403.670,Medicine,Health Occupations,73
"Poliovirus Vaccine, Oral",D,D20.215.894.899.623.750,Poliovirus Vaccines,Viral Vaccines,73
Pregnancy in Adolescence,G,G08.686.784.769.494,Pregnancy,Reproduction,73
Rubella,C,C01.925.782.930.700.700,Rubivirus Infections,Togaviridae Infections,73
Vagina,A,A05.360.319.779,"Genitalia, Female",Genitalia,73
Waist Circumference,E,E01.370.600.115.100.160.560,Body Size,Body Weights and Measures,73
Waist Circumference,G,G07.100.100.160.560,Body Size,Body Weights and Measures,73
Waist Circumference,E,E05.041.124.160.875,Body Size,Body Weights and Measures,73
Drug Monitoring,E,E01.370.520.200,"Monitoring, Physiologic",Diagnostic Techniques and Procedures,72
Immunoglobulin A,D,D12.776.124.486.485.114.619.026,Immunoglobulin Isotypes,Antibodies,72
Immunoglobulin A,D,D12.776.124.790.651.114.619.026,Immunoglobulin Isotypes,Antibodies,72
Immunoglobulin A,D,D12.776.377.715.548.114.619.026,Immunoglobulin Isotypes,Antibodies,72
Parasites,B,B01.050.500.714,Invertebrates,Animals,72
Reproduction,G,G08.686.784,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,72
Social Media,L,L01.178.751,Communications Media,Information Science,72
Social Media,L,L01.224.230.110.500.750,Internet,Computer Communication Networks,72
T-Lymphocyte Subsets,A,A15.382.490.555.567.569.500,T-Lymphocytes,Lymphocytes,72
T-Lymphocyte Subsets,A,A15.145.229.637.555.567.550.500,Lymphocyte Subsets,Lymphocytes,72
T-Lymphocyte Subsets,A,A15.382.490.555.567.550.500,Lymphocyte Subsets,Lymphocytes,72
T-Lymphocyte Subsets,A,A15.145.229.637.555.567.569.500,T-Lymphocytes,Lymphocytes,72
T-Lymphocyte Subsets,A,A11.118.637.555.567.550.500,Lymphocyte Subsets,Lymphocytes,72
T-Lymphocyte Subsets,A,A11.118.637.555.567.569.500,T-Lymphocytes,Lymphocytes,72
Tobacco Smoke Pollution,D,D20.633.937.680,Smoke,Particulate Matter,72
Tobacco Smoke Pollution,N,N06.850.460.100.555,Air Pollution,Environmental Pollution,72
Transcriptome,G,G05.360.920,Genetic Structures,Genetic Phenomena,72
Transcriptome,G,G05.297.700.750,"Transcription, Genetic",Gene Expression,72
Transcriptome,G,G02.111.873.750,"Transcription, Genetic",Biochemical Phenomena,72
Visually Impaired Persons,M,M01.150.850,Disabled Persons,Persons,72
Angiotensin-Converting Enzyme Inhibitors,D,D27.505.519.389.745.085,Protease Inhibitors,Enzyme Inhibitors,71
Antibody Specificity,G,G12.100,Immune System Phenomena,NULL,71
Atrial Fibrillation,C,C14.280.067.198,"Arrhythmias, Cardiac",Heart Diseases,71
Atrial Fibrillation,C,C23.550.073.198,"Arrhythmias, Cardiac",Pathologic Processes,71
Behavior Therapy,F,F04.754.137,Psychotherapy,Behavioral Disciplines and Activities,71
Birth Rate,E,E05.318.308.985.775.500,Pregnancy Rate,Vital Statistics,71
Birth Rate,N,N01.224.935.849.500,Pregnancy Rate,Vital Statistics,71
Birth Rate,N,N06.850.505.400.975.775.500,Pregnancy Rate,Vital Statistics,71
Birth Rate,N,N06.850.520.308.985.775.500,Pregnancy Rate,Vital Statistics,71
Guinea-Bissau,Z,Z01.058.290.190.380,"Africa, Western",Africa South of the Sahara,71
Information Storage and Retrieval,L,L01.470,Information Science,NULL,71
Information Storage and Retrieval,L,L01.313.500.750.280,Medical Informatics Applications,Medical Informatics,71
Laos,Z,Z01.252.145.435,"Asia, Southeastern",Asia,71
Leukocyte Count,G,G09.188.105.595,Blood Cell Count,Blood Physiological Phenomena,71
Leukocyte Count,E,E05.200.500.195.107.595,Blood Cell Count,Cell Count,71
Leukocyte Count,E,E05.200.625.107.595,Blood Cell Count,Hematologic Tests,71
Leukocyte Count,E,E05.242.195.107.595,Blood Cell Count,Cell Count,71
Leukocyte Count,G,G04.140.107.595,Blood Cell Count,Cell Count,71
Leukocyte Count,E,E01.370.225.625.107.595,Blood Cell Count,Hematologic Tests,71
Leukocyte Count,E,E01.370.225.500.195.107.595,Blood Cell Count,Cell Count,71
Microcephaly,C,C16.131.621.207.620,Craniofacial Abnormalities,Musculoskeletal Abnormalities,71
Microcephaly,C,C16.131.666.507.400.500,"Malformations of Cortical Development, Group I",Malformations of Cortical Development,71
Microcephaly,C,C10.500.507.400.500,"Malformations of Cortical Development, Group I",Malformations of Cortical Development,71
Microcephaly,C,C05.660.207.620,Craniofacial Abnormalities,Musculoskeletal Abnormalities,71
Prenatal Diagnosis,E,E01.370.378.630,"Diagnostic Techniques, Obstetrical and Gynecological",Diagnostic Techniques and Procedures,71
Social Change,I,I01.076.201.450.776,Culture,"Anthropology, Cultural",71
Social Change,I,I01.880.853.400,Sociological Factors,Sociology,71
Social Change,N,N01.824.737,Socioeconomic Factors,Population Characteristics,71
"Societies, Medical",N,N03.540.828.589,Societies,Organizations,71
"Adaptation, Physiological",G,G16.012.500,"Adaptation, Biological",Biological Phenomena,70
"Adaptation, Physiological",G,G07.025,Physiological Phenomena,NULL,70
Adipose Tissue,A,A10.165.114,Connective Tissue,Tissues,70
Area Under Curve,G,G07.690.725.064,Pharmacokinetics,Pharmacological and Toxicological Phenomena,70
Area Under Curve,G,G03.787.101,Pharmacokinetics,Metabolism,70
Area Under Curve,E,E05.318.740.200,Statistics as Topic,Epidemiologic Methods,70
Area Under Curve,N,N06.850.520.830.200,Statistics as Topic,Epidemiologic Methods,70
Campylobacter Infections,C,C01.150.252.400.177,Gram-Negative Bacterial Infections,Bacterial Infections,70
Capsid,A,A21.249.500.250,Nucleocapsid,Virion,70
Cell Proliferation,G,G07.345.249.410.750,Cell Growth Processes,Growth,70
Cell Proliferation,G,G04.161.750,Cell Growth Processes,Cell Physiological Phenomena,70
Community Networks,I,I01.880.853.500.300,Social Environment,Sociological Factors,70
Community Networks,L,L01.313.500.750.300.184,Information Systems,Medical Informatics Applications,70
Community Networks,N,N02.421.143.202,Community Health Services,Health Services,70
Cote d'Ivoire,Z,Z01.058.290.190.272,"Africa, Western",Africa South of the Sahara,70
Environment Design,N,N06.230.145,Environment,Environment and Public Health,70
Environment Design,I,I01.880.709.359,Social Planning,Sociology,70
Environment Design,I,I01.283,Social Sciences,NULL,70
Greece,Z,Z01.542.383,Europe,Geographic Locations,70
Haemophilus influenzae type b,B,B03.440.450.600.450.330.150,Haemophilus influenzae,Haemophilus,70
Haemophilus influenzae type b,B,B03.660.250.550.290.330.150,Haemophilus influenzae,Haemophilus,70
Heart Rate,E,E01.370.600.875.500,Vital Signs,Physical Examination,70
Heart Rate,G,G09.330.380.500,Hemodynamics,Cardiovascular Physiological Phenomena,70
Interrupted Time Series Analysis,N,N05.715.360.330.500.912,Epidemiologic Studies,Epidemiologic Study Characteristics,70
Interrupted Time Series Analysis,E,E05.318.372.500.931,Epidemiologic Studies,Epidemiologic Study Characteristics,70
Interrupted Time Series Analysis,N,N06.850.520.450.500.912,Epidemiologic Studies,Epidemiologic Study Characteristics,70
Lymphocytes,A,A15.382.490.555.567,"Leukocytes, Mononuclear",Leukocytes,70
Lymphocytes,A,A15.145.229.637.555.567,"Leukocytes, Mononuclear",Leukocytes,70
Lymphocytes,A,A11.118.637.555.567,"Leukocytes, Mononuclear",Leukocytes,70
Oxygen,D,D01.268.185.550,Chalcogens,Elements,70
Oxygen,D,D01.362.670,Gases,Inorganic Chemicals,70
Parasitic Diseases,C,C01.610,Infections,NULL,70
Pharmacies,N,N02.278.678,Health Facilities,"Health Care Facilities, Manpower, and Services",70
"Pneumonia, Bacterial",C,C01.748.610.540,Pneumonia,Respiratory Tract Infections,70
"Pneumonia, Bacterial",C,C01.150.252.620,Bacterial Infections,Bacterial Infections and Mycoses,70
"Pneumonia, Bacterial",C,C08.381.677.540,Pneumonia,Lung Diseases,70
"Pneumonia, Bacterial",C,C08.730.610.540,Pneumonia,Respiratory Tract Infections,70
Proteins,D,D12.776,"Amino Acids, Peptides, and Proteins",NULL,70
Self-Testing,I,I03.733,Human Activities,NULL,70
Self-Testing,E,E02.900.950,Self Care,Therapeutics,70
Amino Acid Substitution,E,E05.393.420.601.035,Protein Engineering,Genetic Engineering,69
Amino Acid Substitution,G,G05.558.109,Mutagenesis,Genetic Phenomena,69
"Arthroplasty, Replacement, Hip",E,E04.680.101.110.110,"Arthroplasty, Replacement",Arthroplasty,69
"Arthroplasty, Replacement, Hip",E,E04.555.110.110.110,"Arthroplasty, Replacement",Arthroplasty,69
"Arthroplasty, Replacement, Hip",E,E04.650.110.110,"Arthroplasty, Replacement",Prosthesis Implantation,69
Budgets,N,N03.219.463.060,Financial Management,Economics,69
"Efficiency, Organizational",N,N04.452.209.500,Efficiency,Organization and Administration,69
"Elephantiasis, Filarial",C,C15.604.496.490,Lymphedema,Lymphatic Diseases,69
"Elephantiasis, Filarial",C,C01.610.335.508.700.750.361.350,Filariasis,Spirurida Infections,69
"Elephantiasis, Filarial",C,C01.920.750,Vector Borne Diseases,Infections,69
Food Contamination,N,N06.850.460.400,Environmental Pollution,Public Health,69
Food Contamination,J,J01.576.423.850.730.500.249,Food Safety,Food Quality,69
Food Contamination,N,N06.850.601.500.249,Food Safety,Food Quality,69
Immunocompromised Host,G,G12.470,Immune System Phenomena,NULL,69
Minority Groups,I,I01.880.853.300,Sociological Factors,Sociology,69
Outpatients,M,M01.643.630,Patients,Persons,69
"Reimbursement, Incentive",N,N03.219.521.710.305.380,Reimbursement Mechanisms,"Insurance, Health, Reimbursement",69
"Topography, Medical",H,H02.403.352.500,"Geography, Medical",Medicine,69
"Topography, Medical",H,H01.277.500.097.500,"Geography, Medical",Geography,69
Vaginal Smears,E,E04.074.800,Biopsy,"Surgical Procedures, Operative",69
Vaginal Smears,E,E05.200.998.054.800,Biopsy,Specimen Handling,69
Vaginal Smears,E,E05.242.384.100.800,Biopsy,Cytodiagnosis,69
Vaginal Smears,E,E05.200.500.384.100.800,Biopsy,Cytodiagnosis,69
Vaginal Smears,E,E01.370.378.900,"Diagnostic Techniques, Obstetrical and Gynecological",Diagnostic Techniques and Procedures,69
Vaginal Smears,E,E01.370.225.998.054.800,Biopsy,Specimen Handling,69
Vaginal Smears,E,E01.370.225.500.384.100.800,Biopsy,Cytodiagnosis,69
Viremia,C,C01.925.937,Virus Diseases,Infections,69
Viremia,C,C23.550.470.790.500.900,Sepsis,Systemic Inflammatory Response Syndrome,69
Workload,I,I03.946.225.500,Personnel Staffing and Scheduling,Work,69
Workload,N,N04.452.677.650.500,Personnel Staffing and Scheduling,Personnel Management,69
Adiposity,G,G07.100.049.134.500,Body Fat Distribution,Body Composition,68
Adiposity,G,G03.180.134.500,Body Fat Distribution,Body Composition,68
Adiposity,G,G02.111.130.134.500,Body Fat Distribution,Body Composition,68
Adiposity,E,E01.370.600.115.100.062.500,Body Fat Distribution,Body Weights and Measures,68
"Anthropology, Cultural",I,I01.076.201,Anthropology,Social Sciences,68
"Antigens, CD",D,D23.101.100.110,"Antigens, Differentiation",Biomarkers,68
"Antigens, CD",D,D23.050.301.264.035,"Antigens, Differentiation","Antigens, Surface",68
Anxiety Disorders,F,F03.080,Mental Disorders,NULL,68
Arsenic,D,D01.268.513.249,Metalloids,Elements,68
Bacterial Outer Membrane Proteins,D,D12.776.543.100,Membrane Proteins,Proteins,68
Bacterial Outer Membrane Proteins,D,D12.776.097.120,Bacterial Proteins,Proteins,68
Biometry,E,E05.318.740.225,Statistics as Topic,Epidemiologic Methods,68
Biometry,N,N06.850.505.200,Epidemiologic Measurements,Public Health,68
Consumer Behavior,F,F01.145.236,Behavior,Behavior and Behavior Mechanisms,68
Delayed Diagnosis,N,N02.421.585.273,Patient Care,Health Services,68
Delayed Diagnosis,E,E02.760.273,Patient Care,Therapeutics,68
Delayed Diagnosis,E,E01.110,Diagnosis,NULL,68
Fetal Death,C,C23.550.260.585,Death,Pathologic Processes,68
Fetal Death,C,C13.703.223,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,68
Greenhouse Effect,N,N06.230.265,Environment,Environment and Public Health,68
Greenhouse Effect,G,G16.500.175.827,Climatic Processes,Ecological and Environmental Phenomena,68
Home Childbirth,G,G08.686.784.769.490.062.500,Birth Setting,Parturition,68
Military Personnel,M,M01.526.625,Occupational Groups,Persons,68
North America,Z,Z01.107.567,Americas,Geographic Locations,68
Nutrition Disorders,C,C18.654,Nutritional and Metabolic Diseases,NULL,68
Schistosoma haematobium,B,B01.050.500.500.736.715.770.680.510,Schistosoma,Schistosomatidae,68
Stochastic Processes,N,N06.850.520.830.996,Statistics as Topic,Epidemiologic Methods,68
Stochastic Processes,N,N05.715.360.750.770,Statistics as Topic,Health Care Evaluation Mechanisms,68
Stochastic Processes,G,G17.830,Mathematical Concepts,NULL,68
Stochastic Processes,E,E05.318.740.996,Statistics as Topic,Epidemiologic Methods,68
Volunteers,M,M01.955,Persons,NULL,68
"Water Pollutants, Chemical",D,D27.888.284.903.655,Water Pollutants,Environmental Pollutants,68
Weight Loss,C,C23.888.144.243.963,Body Weight Changes,Body Weight,68
Weight Loss,G,G07.345.249.314.120.200.963,Body Weight Changes,Body Weight,68
Absenteeism,F,F02.784.692.107,"Psychology, Industrial","Psychology, Applied",67
Antibiotic Prophylaxis,E,E02.319.703.150,Premedication,Drug Therapy,67
Antibiotic Prophylaxis,E,E02.319.162.150,Chemoprevention,Drug Therapy,67
Conjunctiva,A,A09.371.060.200,Anterior Eye Segment,Eye,67
Conjunctiva,A,A09.371.337.168,Eyelids,Eye,67
Economics,N,N03.219,Health Care Economics and Organizations,NULL,67
Economics,I,I01.261,Social Sciences,NULL,67
Epilepsy,C,C10.228.140.490,Brain Diseases,Central Nervous System Diseases,67
Fluorescent Antibody Technique,E,E01.370.225.500.607.512.240,Immunohistochemistry,Histocytochemistry,67
Fluorescent Antibody Technique,E,E01.370.225.750.551.512.240,Immunohistochemistry,Histocytochemistry,67
Fluorescent Antibody Technique,E,E05.478.583.375,Immunohistochemistry,Immunologic Techniques,67
Fluorescent Antibody Technique,E,E05.200.500.607.512.240,Immunohistochemistry,Histocytochemistry,67
Fluorescent Antibody Technique,E,E05.200.750.551.512.240,Immunohistochemistry,Histocytochemistry,67
Molecular Structure,G,G02.111.570,Biochemical Phenomena,Chemical Phenomena,67
Molecular Structure,G,G02.466,Chemical Phenomena,NULL,67
Vaccination Coverage,N,N02.421.726.758.310.890.750,Vaccination,Immunization,67
Vaccination Coverage,N,N02.421.726.930,Preventive Health Services,Health Services,67
Benchmarking,N,N05.715.360.650.150,Program Evaluation,Health Care Evaluation Mechanisms,66
Benchmarking,N,N04.452.500.150,Management Audit,Organization and Administration,66
Benchmarking,N,N05.700.150,"Quality Assurance, Health Care","Health Care Quality, Access, and Evaluation",66
Benchmarking,N,N04.761.700.150,"Quality Assurance, Health Care",Quality of Health Care,66
Benchmarking,N,N04.761.685.150,Program Evaluation,Quality of Health Care,66
"Databases, Genetic",L,L01.470.750.750.325,"Databases, Factual",Databases as Topic,66
"Databases, Genetic",L,L01.313.500.750.300.188.400.325,"Databases, Factual",Databases as Topic,66
Disclosure,L,L01.143.335,Communication,Information Science,66
Disclosure,I,I01.880.604.583.080.134,Confidentiality,Jurisprudence,66
Disclosure,F,F01.829.401.046,Interpersonal Relations,"Psychology, Social",66
Disease,C,C23.550.288,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",66
Disease Notification,E,E05.318.362,Epidemiologic Methods,Investigative Techniques,66
Disease Notification,N,N06.850.520.373,Epidemiologic Methods,Public Health,66
Disease Notification,N,N06.850.780.200.262,Communicable Disease Control,Public Health Practice,66
Drug Discovery,E,E05.295,Investigative Techniques,NULL,66
Drug Discovery,H,H01.181.466.675,"Chemistry, Pharmaceutical",Chemistry,66
Drug Discovery,H,H01.158.703.007.675,"Chemistry, Pharmaceutical",Pharmacology,66
Finland,Z,Z01.542.816.186,Scandinavian and Nordic Countries,Europe,66
Guinea,Z,Z01.058.290.190.375,"Africa, Western",Africa South of the Sahara,66
Kidney Diseases,C,C12.777.419,Urologic Diseases,Male Urogenital Diseases,66
Kidney Diseases,C,C13.351.968.419,Urologic Diseases,Female Urogenital Diseases,66
Language,L,L01.559,Information Science,NULL,66
Language,F,F01.145.209.399,Communication,Behavior,66
Papua New Guinea,Z,Z01.639.760.590.715,Melanesia,Pacific Islands,66
Antineoplastic Combined Chemotherapy Protocols,E,E02.319.077.500,Antineoplastic Protocols,Drug Therapy,65
Antineoplastic Combined Chemotherapy Protocols,E,E02.183.750.500,Antineoplastic Protocols,Clinical Protocols,65
Antineoplastic Combined Chemotherapy Protocols,E,E02.319.310.037,"Drug Therapy, Combination",Drug Therapy,65
Caribbean Region,Z,Z01.107.084,Americas,Geographic Locations,65
Clinical Decision-Making,E,E01.055,Diagnosis,NULL,65
Delphi Technique,L,L01.906.197,Systems Analysis,Information Science,65
Education,I,I02,NULL,NULL,65
"Education, Medical",I,I02.358.399,"Education, Professional",Education,65
Heart Transplantation,E,E04.100.376.475,Cardiac Surgical Procedures,Cardiovascular Surgical Procedures,65
Heart Transplantation,E,E04.928.220.390,Cardiac Surgical Procedures,Thoracic Surgical Procedures,65
Heart Transplantation,E,E04.936.450.475,Organ Transplantation,Transplantation,65
Hepatitis B Surface Antigens,D,D23.050.327.495.500.475,Hepatitis B Antigens,Hepatitis Antigens,65
Hepatitis B virus,B,B04.450.390.650.425,Orthohepadnavirus,Hepadnaviridae,65
Hepatitis B virus,B,B04.280.375.650.425,Orthohepadnavirus,Hepadnaviridae,65
"Immunogenicity, Vaccine",G,G12.513,Immune System Phenomena,NULL,65
Lost to Follow-Up,E,E05.318.370.438,Epidemiologic Research Design,Epidemiologic Methods,65
Psychotherapy,F,F04.754,Behavioral Disciplines and Activities,NULL,65
Retinopathy of Prematurity,C,C16.614.521.731,"Infant, Premature, Diseases","Infant, Newborn, Diseases",65
Retinopathy of Prematurity,C,C11.768.836,Retinal Diseases,Eye Diseases,65
"Sarcoma, Kaposi",C,C04.557.450.795.850,Sarcoma,"Neoplasms, Connective and Soft Tissue",65
"Sarcoma, Kaposi",C,C04.557.645.750,"Neoplasms, Vascular Tissue",Neoplasms by Histologic Type,65
"Sarcoma, Kaposi",C,C01.925.256.466.860,Herpesviridae Infections,DNA Virus Infections,65
Sporozoites,B,B05.775.740.600.800,Oocysts,"Spores, Protozoan",65
Sporozoites,B,B05.500.675.800,Oocysts,Life Cycle Stages,65
Sporozoites,A,A11.870.740.600.800,Oocysts,"Spores, Protozoan",65
Sporozoites,G,G07.345.500.550.500.675.800,Oocysts,Life Cycle Stages,65
Th1 Cells,A,A11.118.637.555.567.550.500.400.900,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,65
Th1 Cells,A,A11.118.637.555.567.569.200.400.900,"T-Lymphocytes, Helper-Inducer",CD4-Positive T-Lymphocytes,65
Th1 Cells,A,A11.118.637.555.567.569.500.400.900,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,65
Th1 Cells,A,A15.145.229.637.555.567.550.500.400.500,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,65
Th1 Cells,A,A15.382.490.555.567.550.500.400.900,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,65
Th1 Cells,A,A15.382.490.555.567.569.200.400.900,"T-Lymphocytes, Helper-Inducer",CD4-Positive T-Lymphocytes,65
Th1 Cells,A,A15.145.229.637.555.567.569.500.400.500,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,65
Th1 Cells,A,A15.145.229.637.555.567.569.200.400.500,"T-Lymphocytes, Helper-Inducer",CD4-Positive T-Lymphocytes,65
Th1 Cells,A,A15.382.490.555.567.569.500.400.900,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,65
Apoptosis,G,G04.146.954.035,Regulated Cell Death,Cell Death,64
Cattle Diseases,C,C22.196,Animal Diseases,NULL,64
Cervix Uteri,A,A05.360.319.679.256,Uterus,"Genitalia, Female",64
Community Mental Health Services,F,F04.408.307,Mental Health Services,Behavioral Disciplines and Activities,64
Community Mental Health Services,N,N02.421.461.232,Mental Health Services,Health Services,64
Community Mental Health Services,N,N02.421.143.183,Community Health Services,Health Services,64
Enzyme Inhibitors,D,D27.505.519.389,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,64
Methicillin-Resistant Staphylococcus aureus,B,B03.353.500.750.750.100.500,Staphylococcus aureus,Staphylococcus,64
Methicillin-Resistant Staphylococcus aureus,B,B03.300.390.400.800.750.100.500,Staphylococcus aureus,Staphylococcus,64
Methicillin-Resistant Staphylococcus aureus,B,B03.510.100.750.750.100.500,Staphylococcus aureus,Staphylococcus,64
Methicillin-Resistant Staphylococcus aureus,B,B03.510.400.790.750.100.500,Staphylococcus aureus,Staphylococcus,64
Nutritional Requirements,G,G07.203.650.620,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",64
Parent-Child Relations,F,F01.829.263.370.290,Family Relations,Family,64
Thinness,G,G07.100.100.160.120.828,Body Weight,Body Size,64
Thinness,C,C23.888.144.828,Body Weight,Signs and Symptoms,64
Thinness,E,E01.370.600.115.100.160.120.828,Body Weight,Body Size,64
Unemployment,N,N01.824.245.850,Employment,Socioeconomic Factors,64
Up-Regulation,G,G07.690.773.998,Pharmacological Phenomena,Pharmacological and Toxicological Phenomena,64
Up-Regulation,G,G05.308.850,Gene Expression Regulation,Genetic Phenomena,64
Up-Regulation,G,G02.111.905,Biochemical Phenomena,Chemical Phenomena,64
Adenocarcinoma,C,C04.557.470.200.025,Carcinoma,"Neoplasms, Glandular and Epithelial",63
Animal Husbandry,J,J01.040.090,Agriculture,"Technology, Industry, and Agriculture",63
Bacterial Toxins,D,D23.946.123,"Toxins, Biological",Biological Factors,63
Cell Membrane,A,A11.284.149,Cellular Structures,Cells,63
Decision Trees,G,G17.162.500,Decision Theory,Mathematical Concepts,63
Equipment Design,E,E05.320,Investigative Techniques,NULL,63
"Ethics, Medical",K,K01.752.566.479.171.132.750,"Ethics, Clinical","Ethics, Professional",63
"Ethics, Medical",N,N05.350.340.162.500,"Ethics, Clinical","Ethics, Professional",63
Hong Kong,Z,Z01.252.474.164.450,China,Far East,63
Mobile Applications,L,L01.224.900.685,Software,Computing Methodologies,63
Obstetrics,H,H02.403.810.450,"Specialties, Surgical",Medicine,63
Self Concept,F,F01.752.747.792,Personality Development,Personality,63
Allergens,D,D23.050.063,Antigens,Biological Factors,62
Diabetes Complications,C,C19.246.099,Diabetes Mellitus,Endocrine System Diseases,62
Drug Industry,J,J01.576.655.750,Manufacturing Industry,Industry,62
"Ethics, Research",K,K01.752.566.479.173,Ethics,Morals,62
"Ethics, Research",N,N05.350.670,Ethics,"Health Care Quality, Access, and Evaluation",62
Fluoroquinolones,D,D03.633.100.810.835.322,Quinolones,Quinolines,62
Genotyping Techniques,E,E05.393.442,Genetic Techniques,Investigative Techniques,62
Growth,G,G07.345.249,Growth and Development,Physiological Phenomena,62
Hydrogen-Ion Concentration,G,G02.300,Chemical Phenomena,NULL,62
"Hypersensitivity, Immediate",C,C20.543.480,Hypersensitivity,Immune System Diseases,62
Interleukin-4,D,D12.644.276.374.465.186,Interleukins,Cytokines,62
Interleukin-4,D,D12.776.467.374.465.178,Interleukins,Cytokines,62
Interleukin-4,D,D23.529.374.465.186,Interleukins,Cytokines,62
Livestock,B,B01.050.050.116.500,"Animals, Domestic",Animal Population Groups,62
Maternal-Child Health Services,N,N02.421.143.130.660,Child Health Services,Community Health Services,62
Maternal-Child Health Services,N,N02.421.143.620.275,Maternal Health Services,Community Health Services,62
"Medical Staff, Hospital",N,N02.360.740.422,"Personnel, Hospital",Health Personnel,62
"Medical Staff, Hospital",N,N02.360.630.490,Medical Staff,Health Personnel,62
"Medical Staff, Hospital",M,M01.526.485.630.490,Medical Staff,Health Personnel,62
"Medical Staff, Hospital",M,M01.526.485.740.422,"Personnel, Hospital",Health Personnel,62
Observation,E,E05.581.249,Methods,Investigative Techniques,62
Quinine,D,D03.633.100.810.762,Quinolines,"Heterocyclic Compounds, 2-Ring",62
Quinine,D,D03.605.687.762,Quinuclidines,"Heterocyclic Compounds, Bridged-Ring",62
Quinine,D,D03.132.206.719,Cinchona Alkaloids,Alkaloids,62
Safety Management,N,N04.452.871.900,Risk Management,Organization and Administration,62
Safety Management,N,N06.850.135.060.075.800,Safety,Accident Prevention,62
Spouses,M,M01.816,Persons,NULL,62
Spouses,I,I01.880.853.150.500.670,Nuclear Family,Family,62
Spouses,F,F01.829.263.500.660,Nuclear Family,Family,62
Viral Nonstructural Proteins,D,D12.776.964.900,Viral Proteins,Proteins,62
Vitamin A Deficiency,C,C18.654.521.500.133.628,Avitaminosis,Deficiency Diseases,62
"Adjuvants, Immunologic",D,D27.505.696.477.067,Immunologic Factors,Physiological Effects of Drugs,61
Cytomegalovirus Infections,C,C01.925.256.466.245,Herpesviridae Infections,DNA Virus Infections,61
Diet Surveys,E,E05.318.308.980.485.350,Nutrition Surveys,Surveys and Questionnaires,61
Diet Surveys,N,N06.850.505.616.300,Nutrition Surveys,Epidemiologic Measurements,61
Diet Surveys,N,N06.850.520.308.980.469.350,Nutrition Surveys,Surveys and Questionnaires,61
Diet Surveys,N,N05.715.360.300.800.469.300,Nutrition Surveys,Surveys and Questionnaires,61
Drug Users,M,M01.169,Persons,NULL,61
Environmental Pollutants,D,D27.888.284,Toxic Actions,Chemical Actions and Uses,61
"Factor Analysis, Statistical",N,N05.715.360.750.350,Statistics as Topic,Health Care Evaluation Mechanisms,61
"Factor Analysis, Statistical",E,E05.318.740.400,Statistics as Topic,Epidemiologic Methods,61
"Factor Analysis, Statistical",N,N06.850.520.830.400,Statistics as Topic,Epidemiologic Methods,61
Financial Support,N,N03.219.483,Economics,Health Care Economics and Organizations,61
Gastrointestinal Diseases,C,C06.405,Digestive System Diseases,NULL,61
Graft Rejection,G,G12.875.545.328,Host vs Graft Reaction,Transplantation Immunology,61
Heart Diseases,C,C14.280,Cardiovascular Diseases,NULL,61
Heptavalent Pneumococcal Conjugate Vaccine,D,D20.215.894.135.750.600.500,Pneumococcal Vaccines,Streptococcal Vaccines,61
Heptavalent Pneumococcal Conjugate Vaccine,D,D20.215.894.815.410,"Vaccines, Combined",Vaccines,61
Immunoenzyme Techniques,E,E05.601.470.350,Immunoassay,Molecular Probe Techniques,61
Immunoenzyme Techniques,E,E05.478.583.400,Immunohistochemistry,Immunologic Techniques,61
Immunoenzyme Techniques,E,E05.478.566.350,Immunoassay,Immunologic Techniques,61
"Meningitis, Bacterial",C,C10.228.228.180.500,Central Nervous System Bacterial Infections,Central Nervous System Infections,61
"Meningitis, Bacterial",C,C10.228.614.280,Meningitis,Central Nervous System Diseases,61
"Meningitis, Bacterial",C,C01.150.252.223.500,Central Nervous System Bacterial Infections,Bacterial Infections,61
"Meningitis, Bacterial",C,C01.207.180.500,Central Nervous System Bacterial Infections,Central Nervous System Infections,61
Molecular Weight,G,G02.494,Chemical Phenomena,NULL,61
Myanmar,Z,Z01.252.145.570,"Asia, Southeastern",Asia,61
Nucleic Acid Hybridization,G,G02.111.611,Biochemical Phenomena,Chemical Phenomena,61
Nucleic Acid Hybridization,E,E05.393.661,Genetic Techniques,Investigative Techniques,61
Phagocytosis,G,G04.417.350,Endocytosis,Cell Physiological Phenomena,61
Phagocytosis,G,G12.688,Immune System Phenomena,NULL,61
Phagocytosis,G,G12.450.564.809,"Immunity, Innate",Immunity,61
Phagocytosis,G,G09.188.665,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,61
Proteomics,H,H01.158.201.843,Biochemistry,Biological Science Disciplines,61
Proteomics,H,H01.158.273.180.350.700,Genomics,Computational Biology,61
Proteomics,H,H01.158.273.343.350.700,Genomics,Genetics,61
Proteomics,H,H01.181.122.738,Biochemistry,Chemistry,61
Treponema pallidum,B,B03.851.595.795.840,Treponema,Spirochaetaceae,61
Treponema pallidum,B,B03.440.425.410.711.795.840,Treponema,Spirochaetaceae,61
Triage,N,N02.421.297.900,Emergency Medical Services,Health Services,61
Uterine Cervical Dysplasia,C,C04.834.818,Precancerous Conditions,Neoplasms,61
Uterine Cervical Dysplasia,C,C13.351.500.852.593.074,Uterine Cervical Diseases,Uterine Diseases,61
Virus Shedding,G,G07.925,Physiological Phenomena,NULL,61
Waiting Lists,N,N04.452.095.738,Appointments and Schedules,Organization and Administration,61
"Arthritis, Rheumatoid",C,C17.300.775.099,Rheumatic Diseases,Connective Tissue Diseases,60
"Arthritis, Rheumatoid",C,C20.111.199,Autoimmune Diseases,Immune System Diseases,60
"Arthritis, Rheumatoid",C,C05.799.114,Rheumatic Diseases,Musculoskeletal Diseases,60
"Arthritis, Rheumatoid",C,C05.550.114.154,Arthritis,Joint Diseases,60
Bicycling,I,I03.450.642.845.140,Sports,Recreation,60
Coitus,G,G08.686.784.041,Reproduction,Reproductive Physiological Phenomena,60
Coitus,F,F01.145.802.188,Sexual Behavior,Behavior,60
DNA Fingerprinting,E,E05.318.740.225.500.500,Biometric Identification,Biometry,60
DNA Fingerprinting,E,E05.393.290,Genetic Techniques,Investigative Techniques,60
DNA Fingerprinting,I,I01.198.780.937.375,Forensic Medicine,Forensic Sciences,60
DNA Fingerprinting,N,N04.452.910.099.750,Biometric Identification,Security Measures,60
"Drug Evaluation, Preclinical",E,E05.337.550,Evaluation Studies as Topic,Investigative Techniques,60
"Drug Evaluation, Preclinical",E,E05.290.750,Drug Development,Investigative Techniques,60
General Practitioners,N,N02.360.810.485,Physicians,Health Personnel,60
General Practitioners,M,M01.526.485.810.485,Physicians,Health Personnel,60
"Injections, Intramuscular",E,E02.319.267.530.460,Injections,Drug Administration Routes,60
Prednisolone,D,D04.210.500.745.432.769.795,Pregnadienetriols,Pregnadienes,60
Psychodidae,B,B01.050.500.131.617.720.500.500.750.781,Diptera,Holometabola,60
Stomach Neoplasms,C,C06.301.371.767,Gastrointestinal Neoplasms,Digestive System Neoplasms,60
Stomach Neoplasms,C,C06.405.249.767,Gastrointestinal Neoplasms,Gastrointestinal Diseases,60
Stomach Neoplasms,C,C06.405.748.789,Stomach Diseases,Gastrointestinal Diseases,60
Stomach Neoplasms,C,C04.588.274.476.767,Gastrointestinal Neoplasms,Digestive System Neoplasms,60
"Administration, Inhalation",E,E02.319.267.050,Drug Administration Routes,Drug Therapy,59
"Africa, Northern",Z,Z01.058.266,Africa,Geographic Locations,59
"Animals, Wild",B,B01.050.050.300,Animal Population Groups,Animals,59
Antibodies,D,D12.776.124.486.485.114,Immunoglobulins,Immunoproteins,59
Antibodies,D,D12.776.124.790.651.114,Immunoglobulins,Serum Globulins,59
Antibodies,D,D12.776.377.715.548.114,Immunoglobulins,Serum Globulins,59
Ascaris lumbricoides,B,B01.050.500.500.294.400.500.100.108.425,Ascaris,Ascaridoidea,59
Bone Density,G,G11.427.100,Musculoskeletal Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,59
"Carcinoma, Hepatocellular",C,C04.588.274.623.160,Liver Neoplasms,Digestive System Neoplasms,59
"Carcinoma, Hepatocellular",C,C04.557.470.200.025.255,Adenocarcinoma,Carcinoma,59
"Carcinoma, Hepatocellular",C,C06.552.697.160,Liver Neoplasms,Liver Diseases,59
"Carcinoma, Hepatocellular",C,C06.301.623.160,Liver Neoplasms,Digestive System Neoplasms,59
Cerebrospinal Fluid,A,A12.207.270.210,Extracellular Fluid,Body Fluids,59
"Clinical Trials, Phase III as Topic",N,N05.715.360.330.250.250.220,Clinical Trials as Topic,Clinical Studies as Topic,59
"Clinical Trials, Phase III as Topic",E,E05.318.372.250.250.220,Clinical Trials as Topic,Clinical Studies as Topic,59
"Clinical Trials, Phase III as Topic",N,N06.850.520.450.250.250.220,Clinical Trials as Topic,Clinical Studies as Topic,59
"Diarrhea, Infantile",C,C23.888.821.214.500,Diarrhea,"Signs and Symptoms, Digestive",59
"DNA, Mitochondrial",D,D13.444.308.283.225,"DNA, Circular",DNA,59
Drug Design,E,E05.290.500,Drug Development,Investigative Techniques,59
Drug Design,H,H01.181.466.338.500,Drug Development,"Chemistry, Pharmaceutical",59
Drug Design,H,H01.158.703.007.338.500,Drug Development,"Chemistry, Pharmaceutical",59
Drug Interactions,G,G07.690.773.968,Pharmacological Phenomena,Pharmacological and Toxicological Phenomena,59
Echocardiography,E,E01.370.350.130.750,Cardiac Imaging Techniques,Diagnostic Imaging,59
Echocardiography,E,E01.370.370.380.220,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",59
Echocardiography,E,E01.370.350.850.220,Ultrasonography,Diagnostic Imaging,59
Eyeglasses,E,E07.632.500.300,Lenses,Optical Devices,59
"Hospitals, District",N,N02.278.421.510.140,"Hospitals, Public",Hospitals,59
House Calls,N,N04.452.758.307,Professional Practice,Organization and Administration,59
Inhibitory Concentration 50,E,E05.940.350,Toxicity Tests,Investigative Techniques,59
Inhibitory Concentration 50,G,G07.690.936.563,Toxicological Phenomena,Pharmacological and Toxicological Phenomena,59
Interleukin-6,D,D23.529.374.465.224,Interleukins,Cytokines,59
Interleukin-6,D,D12.776.467.374.465.202,Interleukins,Cytokines,59
Interleukin-6,D,D12.644.276.374.465.224,Interleukins,Cytokines,59
Marketing,J,J01.219.687,Commerce,"Technology, Industry, and Agriculture",59
Pre-Eclampsia,C,C13.703.395.249,"Hypertension, Pregnancy-Induced",Pregnancy Complications,59
"Pregnancy Trimester, First",G,G08.686.707.408,Pregnancy Trimesters,Reproductive Physiological Phenomena,59
Time-to-Treatment,E,E02.760.928,Patient Care,Therapeutics,59
Time-to-Treatment,N,N02.421.585.928,Patient Care,Health Services,59
Viruses,B,B04,NULL,NULL,59
Advertising,J,J01.219.687.274,Marketing,Commerce,58
Advertising,L,L01.143.050,Communication,Information Science,58
Altitude,G,G16.500.275.058,Environment,Ecological and Environmental Phenomena,58
Altitude,N,N06.230.058,Environment,Environment and Public Health,58
Circadian Rhythm,G,G07.180.562.190,Periodicity,Chronobiology Phenomena,58
Community-Based Participatory Research,N,N05.425.104,Health Services Research,"Health Care Quality, Access, and Evaluation",58
Community-Based Participatory Research,H,H01.770.644.193,Research,Science,58
Dapsone,D,D02.886.590.263,Sulfones,Sulfur Compounds,58
"Infant, Small for Gestational Age",M,M01.060.703.520.460.560,"Infant, Low Birth Weight","Infant, Newborn",58
Milk,J,J02.500.350.525,Dairy Products,Food,58
Milk,J,J02.200.700,Beverages,Food and Beverages,58
Milk,G,G07.203.100.700,Beverages,"Diet, Food, and Nutrition",58
Milk,G,G07.203.300.350.525,Dairy Products,Food,58
Milk,A,A12.790,Fluids and Secretions,NULL,58
Milk,A,A12.200.455,Bodily Secretions,Fluids and Secretions,58
Mycobacterium,B,B03.510.460.400.410.552.552,Mycobacteriaceae,"Gram-Positive Asporogenous Rods, Regular",58
Mycobacterium,B,B03.510.024.962.500,Mycobacteriaceae,Actinobacteria,58
Nitric Oxide,D,D01.339.387,Free Radicals,Inorganic Chemicals,58
Nitric Oxide,D,D01.625.550.500,Nitrogen Oxides,Nitrogen Compounds,58
Nitric Oxide,D,D01.625.700.500,Reactive Nitrogen Species,Nitrogen Compounds,58
Nitric Oxide,D,D01.650.550.587.600,Nitrogen Oxides,Oxides,58
Norovirus,B,B04.820.578.298.550,Caliciviridae,Positive-Strand RNA Viruses,58
Occupational Health,N,N01.400.525,Health,Population Characteristics,58
Patient Readmission,N,N02.421.585.400.620,Hospitalization,Patient Care,58
Patient Readmission,E,E02.760.400.620,Hospitalization,Patient Care,58
Public-Private Sector Partnerships,N,N03.540.706,Organizations,Health Care Economics and Organizations,58
Public-Private Sector Partnerships,J,J01.219.843,Commerce,"Technology, Industry, and Agriculture",58
"Respiratory Syncytial Virus, Human",B,B04.820.480.937.600.670.600.750.730,Respiratory Syncytial Viruses,Pneumovirus,58
Severe Acute Respiratory Syndrome,C,C01.748.730,Respiratory Tract Infections,Infections,58
Severe Acute Respiratory Syndrome,C,C01.925.782.600.550.200.750,Coronavirus Infections,Coronaviridae Infections,58
Severe Acute Respiratory Syndrome,C,C08.730.730,Respiratory Tract Infections,Respiratory Tract Diseases,58
Stakeholder Participation,I,I03.743,Human Activities,NULL,58
Stakeholder Participation,I,I01.738.805,Politics,Social Sciences,58
Taxes,N,N03.219.900,Economics,Health Care Economics and Organizations,58
Tetanus Toxoid,D,D20.215.894.691.824,Toxoids,Vaccines,58
Th2 Cells,A,A15.382.490.555.567.569.500.400.905,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,58
Th2 Cells,A,A15.145.229.637.555.567.569.200.400.750,"T-Lymphocytes, Helper-Inducer",CD4-Positive T-Lymphocytes,58
Th2 Cells,A,A15.145.229.637.555.567.569.500.400.750,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,58
Th2 Cells,A,A15.382.490.555.567.569.200.400.905,"T-Lymphocytes, Helper-Inducer",CD4-Positive T-Lymphocytes,58
Th2 Cells,A,A15.382.490.555.567.550.500.400.905,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,58
Th2 Cells,A,A15.145.229.637.555.567.550.500.400.750,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,58
Th2 Cells,A,A11.118.637.555.567.569.500.400.905,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,58
Th2 Cells,A,A11.118.637.555.567.569.200.400.905,"T-Lymphocytes, Helper-Inducer",CD4-Positive T-Lymphocytes,58
Th2 Cells,A,A11.118.637.555.567.550.500.400.905,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,58
Viral Envelope Proteins,D,D12.776.964.970.880,Viral Structural Proteins,Viral Proteins,58
Viral Envelope Proteins,D,D12.776.543.550.993,Membrane Glycoproteins,Membrane Proteins,58
Viral Envelope Proteins,D,D09.400.430.968,Glycoproteins,Glycoconjugates,58
Viral Envelope Proteins,D,D12.776.395.550.993,Membrane Glycoproteins,Glycoproteins,58
Acute Kidney Injury,C,C12.777.419.780.050,Renal Insufficiency,Kidney Diseases,57
Acute Kidney Injury,C,C13.351.968.419.780.050,Renal Insufficiency,Kidney Diseases,57
Adolescent Health,N,N01.400.075,Health,Population Characteristics,57
"Animals, Domestic",B,B01.050.050.116,Animal Population Groups,Animals,57
"Chromatography, High Pressure Liquid",E,E05.196.181.400.300,"Chromatography, Liquid",Chromatography,57
Clopidogrel,D,D02.886.778.823.500.500,Ticlopidine,Thienopyridines,57
Clopidogrel,D,D03.383.903.830.500.500,Ticlopidine,Thienopyridines,57
Clopidogrel,D,D03.383.725.849.500.500,Ticlopidine,Thienopyridines,57
Clopidogrel,D,D03.633.100.928.500.500,Ticlopidine,Thienopyridines,57
DNA Mutational Analysis,E,E05.393.760.700.300,"Sequence Analysis, DNA",Sequence Analysis,57
Ebola Vaccines,D,D20.215.894.899.205,Viral Vaccines,Vaccines,57
Elective Surgical Procedures,E,E04.249,"Surgical Procedures, Operative",NULL,57
Fetal Growth Retardation,C,C13.703.277.370,Fetal Diseases,Pregnancy Complications,57
Fetal Growth Retardation,C,C16.300.390,Fetal Diseases,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",57
Fetal Growth Retardation,C,C23.550.393.450,Growth Disorders,Pathologic Processes,57
Genetic Linkage,G,G05.348,Genetic Phenomena,NULL,57
Lebanon,Z,Z01.252.245.500.450,Middle East,"Asia, Western",57
Mass Media,L,L01.178.590,Communications Media,Information Science,57
Medically Underserved Area,N,N03.349.650.340,Regional Health Planning,Health Planning,57
Medically Underserved Area,N,N05.300.450.520,Health Services Needs and Demand,Delivery of Health Care,57
Protein Transport,G,G03.143.700,Biological Transport,Metabolism,57
Seizures,C,C23.888.592.742,Neurologic Manifestations,Signs and Symptoms,57
Seizures,C,C10.597.742,Neurologic Manifestations,Nervous System Diseases,57
"Ventricular Function, Left",G,G09.330.955.800,Ventricular Function,Cardiovascular Physiological Phenomena,57
Anti-Inflammatory Agents,D,D27.505.954.158,Therapeutic Uses,Pharmacologic Actions,56
Automobile Driving,I,I03.125,Human Activities,NULL,56
Bibliometrics,L,L01.178.682.099.325,Bibliographies as Topic,Publications,56
Bibliometrics,L,L01.453.183.291,Bibliographies as Topic,Information Services,56
Cell Survival,G,G04.346,Cell Physiological Phenomena,NULL,56
Chickenpox,C,C01.925.256.466.930.250,Varicella Zoster Virus Infection,Herpesviridae Infections,56
Creutzfeldt-Jakob Syndrome,C,C01.207.800.230,Prion Diseases,Central Nervous System Infections,56
Creutzfeldt-Jakob Syndrome,C,C10.228.228.800.230,Prion Diseases,Central Nervous System Infections,56
Creutzfeldt-Jakob Syndrome,C,C10.228.140.380.165,Dementia,Brain Diseases,56
Creutzfeldt-Jakob Syndrome,F,F03.615.400.300,Dementia,Neurocognitive Disorders,56
Directly Observed Therapy,F,F01.145.488.887.500.600.500.500,Medication Adherence,Patient Compliance,56
Directly Observed Therapy,F,F01.100.150.750.500.600.500.500,Medication Adherence,Patient Compliance,56
Directly Observed Therapy,N,N05.300.150.800.500.600.500.500,Medication Adherence,Patient Compliance,56
"DNA, Ribosomal",D,D13.444.308.475,DNA,Nucleic Acids,56
Enterobacteriaceae,B,B03.660.250.150,Gammaproteobacteria,Proteobacteria,56
Enterobacteriaceae,B,B03.440.450.425,Gram-Negative Facultatively Anaerobic Rods,Gram-Negative Bacteria,56
Fibrinogen,D,D12.776.811.300,Protein Precursors,Proteins,56
Fibrinogen,D,D23.119.490,Blood Coagulation Factors,Biological Factors,56
Fibrinogen,D,D12.776.124.050.250,Acute-Phase Proteins,Blood Proteins,56
Fibrinogen,D,D12.776.124.125.500,Blood Coagulation Factors,Blood Proteins,56
Fluid Therapy,E,E02.319.360,Drug Therapy,Therapeutics,56
"Hospitals, Teaching",N,N02.278.020.300,Academic Medical Centers,Health Facilities,56
"Hospitals, Teaching",N,N02.278.421.639,Hospitals,Health Facilities,56
"Immunity, Herd",G,G12.450.400,Immunity,Immune System Phenomena,56
Intraocular Pressure,G,G14.440,Ocular Physiological Phenomena,NULL,56
Nervous System Diseases,C,C10,NULL,NULL,56
Nutrition Assessment,N,N05.715.360.300.560,Data Collection,Health Care Evaluation Mechanisms,56
Nutrition Assessment,N,N06.850.520.308.585,Data Collection,Epidemiologic Methods,56
Nutrition Assessment,N,N06.850.505.557,Epidemiologic Measurements,Public Health,56
Nutrition Assessment,E,E05.318.308.585,Data Collection,Epidemiologic Methods,56
Nutritional Physiological Phenomena,G,G07.203.650,"Diet, Food, and Nutrition",Physiological Phenomena,56
Patients,M,M01.643,Persons,NULL,56
Prisoners,M,M01.729,Persons,NULL,56
Relief Work,N,N06.230.100.300,Disasters,Environment,56
Relief Work,I,I01.880.787.839,Social Welfare,Sociology,56
Truth Disclosure,I,I01.880.604.583.080.134.800,Disclosure,Confidentiality,56
Truth Disclosure,F,F01.829.401.046.800,Disclosure,Interpersonal Relations,56
Urban Health Services,N,N02.421.914,Health Services,"Health Care Facilities, Manpower, and Services",56
Adrenergic beta-Antagonists,D,D27.505.696.577.050.200.200,Adrenergic Antagonists,Adrenergic Agents,55
Adrenergic beta-Antagonists,D,D27.505.519.625.050.200.200,Adrenergic Antagonists,Adrenergic Agents,55
Antioxidants,D,D27.505.519.217,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,55
Antioxidants,D,D27.505.696.706.125,Protective Agents,Physiological Effects of Drugs,55
Antioxidants,D,D27.720.799.047,Protective Agents,Specialty Uses of Chemicals,55
Cardiac Surgical Procedures,E,E04.928.220,Thoracic Surgical Procedures,"Surgical Procedures, Operative",55
Cardiac Surgical Procedures,E,E04.100.376,Cardiovascular Surgical Procedures,"Surgical Procedures, Operative",55
Cicatrix,G,G16.762.891.249,Wound Healing,Regeneration,55
Cicatrix,C,C23.550.355.274,Fibrosis,Pathologic Processes,55
Cicatrix,A,A10.165.450.300,Granulation Tissue,Connective Tissue,55
"Decision Making, Organizational",N,N04.452.190,Organization and Administration,Health Services Administration,55
Dietary Proteins,J,J02.500.428,Food,Food and Beverages,55
Dietary Proteins,G,G07.203.300.428,Food,"Diet, Food, and Nutrition",55
Dietary Proteins,D,D12.776.256,Proteins,"Amino Acids, Peptides, and Proteins",55
Glycosylation,G,G03.191.812,Carbohydrate Metabolism,Metabolism,55
Glycosylation,G,G02.607.299,Organic Chemistry Phenomena,Chemical Phenomena,55
Glycosylation,G,G02.111.158.812,Carbohydrate Metabolism,Biochemical Phenomena,55
Health Services for the Aged,N,N02.421.320,Health Services,"Health Care Facilities, Manpower, and Services",55
Homosexuality,G,G08.686.867.500,Sexuality,Reproductive Physiological Phenomena,55
Homosexuality,F,F01.145.802.975.500,Sexuality,Sexual Behavior,55
"Immunity, Maternally-Acquired",G,G12.450.570,Immunity,Immune System Phenomena,55
Leukemia,C,C04.557.337,Neoplasms by Histologic Type,Neoplasms,55
"Lymphoma, Non-Hodgkin",C,C04.557.386.480,Lymphoma,Neoplasms by Histologic Type,55
"Lymphoma, Non-Hodgkin",C,C20.683.515.761.480,Lymphoma,Lymphoproliferative Disorders,55
"Lymphoma, Non-Hodgkin",C,C15.604.515.569.480,Lymphoma,Lymphoproliferative Disorders,55
Microbiota,G,G16.500.275.157.049.100.500,Biota,Biodiversity,55
Microbiota,N,N06.230.124.049.100.500,Biota,Biodiversity,55
Microbiota,G,G06.591,Microbiological Phenomena,NULL,55
Northern Ireland,Z,Z01.542.363.602,United Kingdom,Europe,55
Point Mutation,G,G05.365.590.675,Mutation,Genetic Variation,55
"Radiography, Thoracic",E,E01.370.350.700.730,Radiography,Diagnostic Imaging,55
Renal Dialysis,E,E02.912.800,Sorption Detoxification,Therapeutics,55
Renal Dialysis,E,E02.870.300,Renal Replacement Therapy,Therapeutics,55
Social Welfare,I,I01.880.787,Sociology,Social Sciences,55
Tetrahydrofolate Dehydrogenase,D,D08.811.682.662.825,Oxidoreductases Acting on CH-NH Group Donors,Oxidoreductases,55
Tropical Climate,G,G16.500.275.071.600,Climate,Environment,55
Tropical Climate,N,N06.230.300.100.250.600,Climate,Atmosphere,55
Troponin I,D,D05.500.945.925,Troponin,Multiprotein Complexes,55
Troponin I,D,D05.750.078.730.825.925,Troponin,Microfilament Proteins,55
Troponin I,D,D12.776.220.525.825.925,Troponin,Microfilament Proteins,55
Troponin I,D,D12.776.210.500.910.925,Troponin,Muscle Proteins,55
Women,M,M01.975,Persons,NULL,55
"Biomarkers, Tumor",D,D23.101.140,Biomarkers,Biological Factors,54
Caliciviridae Infections,C,C01.925.782.160,RNA Virus Infections,Virus Diseases,54
Conflict of Interest,N,N05.350.225,Ethics,"Health Care Quality, Access, and Evaluation",54
Conflict of Interest,K,K01.752.566.479.095,Ethics,Morals,54
Cyclopropanes,D,D02.455.426.392.368.533,Cycloparaffins,"Hydrocarbons, Alicyclic",54
"Drug Resistance, Multiple",G,G07.690.773.984.300,Drug Resistance,Pharmacological Phenomena,54
Entamoeba histolytica,B,B01.046.500.100.700.335.330,Entamoeba,Tubulina,54
Hearing Loss,C,C23.888.592.763.393.341,Hearing Disorders,Sensation Disorders,54
Hearing Loss,C,C09.218.458.341,Hearing Disorders,Ear Diseases,54
Hearing Loss,C,C10.597.751.418.341,Hearing Disorders,Sensation Disorders,54
"Hemorrhagic Fever Virus, Crimean-Congo",B,B04.820.480.750.565.400,Nairovirus,Bunyaviridae,54
Intention to Treat Analysis,E,E05.318.372.250.250.365.500.500,Randomized Controlled Trials as Topic,Controlled Clinical Trials as Topic,54
Intention to Treat Analysis,N,N05.715.360.330.250.250.365.500.500,Randomized Controlled Trials as Topic,Controlled Clinical Trials as Topic,54
Intention to Treat Analysis,N,N06.850.520.450.250.250.365.500.500,Randomized Controlled Trials as Topic,Controlled Clinical Trials as Topic,54
Kidney Transplantation,E,E02.870.500,Renal Replacement Therapy,Therapeutics,54
Kidney Transplantation,E,E04.936.450.485,Organ Transplantation,Transplantation,54
Kidney Transplantation,E,E04.950.774.400,Urologic Surgical Procedures,Urogenital Surgical Procedures,54
Medical Record Linkage,E,E05.318.308.940.968.500,Medical Records,Records,54
Medical Record Linkage,N,N05.715.360.300.715.500.500,Medical Records,Records,54
Medical Record Linkage,N,N06.850.520.308.940.968.500,Medical Records,Records,54
Medical Record Linkage,N,N04.452.859.564.550,Medical Records,Records,54
Myocardial Revascularization,E,E04.928.220.520,Cardiac Surgical Procedures,Thoracic Surgical Procedures,54
Myocardial Revascularization,E,E04.100.376.719,Cardiac Surgical Procedures,Cardiovascular Surgical Procedures,54
Phosphorylation,G,G02.607.780,Organic Chemistry Phenomena,Chemical Phenomena,54
Phosphorylation,G,G03.796,Metabolism,NULL,54
Phosphorylation,G,G02.111.665,Biochemical Phenomena,Chemical Phenomena,54
"Receptors, Cell Surface",D,D12.776.543.750,Membrane Proteins,Proteins,54
Selection Bias,N,N05.715.350.150.775,Bias,Epidemiologic Factors,54
Selection Bias,N,N06.850.490.500.500,Bias,Epidemiologic Factors,54
Sleep,G,G11.561.803,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,54
Sleep,F,F02.830.855,Psychophysiology,Psychological Phenomena,54
Social Isolation,F,F01.145.813.781,Social Behavior,Behavior,54
Social Isolation,I,I01.880.853.748,Sociological Factors,Sociology,54
Streptococcus agalactiae,B,B03.510.550.737.872.100,Streptococcus,Streptococcaceae,54
Streptococcus agalactiae,B,B03.353.750.737.872.100,Streptococcus,Streptococcaceae,54
Streptococcus agalactiae,B,B03.510.400.800.872.100,Streptococcus,Streptococcaceae,54
Adverse Drug Reaction Reporting Systems,N,N02.421.668.320.120,Drug Information Services,Pharmaceutical Services,53
Adverse Drug Reaction Reporting Systems,E,E05.337.800.120,"Product Surveillance, Postmarketing",Evaluation Studies as Topic,53
Cognitive Dysfunction,F,F03.615.250.700,Cognition Disorders,Neurocognitive Disorders,53
Dengue Vaccines,D,D20.215.894.899.162,Viral Vaccines,Vaccines,53
"Epitopes, T-Lymphocyte",D,D23.050.550.402,Epitopes,Antigens,53
Gold,D,D01.268.956.186,Transition Elements,Elements,53
Gold,D,D01.268.556.322,"Metals, Heavy",Elements,53
Gold,D,D01.552.544.322,"Metals, Heavy",Metals,53
Haiti,Z,Z01.107.084.900.425,West Indies,Caribbean Region,53
Haiti,Z,Z01.639.880.425,West Indies,Islands,53
Helicobacter pylori,B,B03.440.500.550,Helicobacter,Gram-Negative Bacteria,53
Helicobacter pylori,B,B03.660.150.235.500.250.550,Helicobacter,Helicobacteraceae,53
Homozygote,G,G05.380.554,Genotype,Genetic Phenomena,53
Inservice Training,I,I02.574,Education,NULL,53
Interferon-gamma Release Tests,E,E05.478.594.475,Immunologic Tests,Immunologic Techniques,53
Interferon-gamma Release Tests,E,E05.200.812.453,Immunologic Tests,Clinical Laboratory Techniques,53
Interferon-gamma Release Tests,E,E01.370.225.812.453,Immunologic Tests,Clinical Laboratory Techniques,53
Klebsiella Infections,C,C01.150.252.400.310.503,Enterobacteriaceae Infections,Gram-Negative Bacterial Infections,53
Population Groups,M,M01.686,Persons,NULL,53
Population Groups,N,N01.224.708,Demography,Population Characteristics,53
Stereotyping,F,F01.145.813.854,Social Behavior,Behavior,53
Stereotyping,F,F01.100.920,Attitude,Behavior and Behavior Mechanisms,53
Syphilis Serodiagnosis,E,E05.478.594.760.850,Serologic Tests,Immunologic Tests,53
Syphilis Serodiagnosis,E,E05.200.812.735.850,Serologic Tests,Immunologic Tests,53
Syphilis Serodiagnosis,E,E01.370.225.812.735.850,Serologic Tests,Immunologic Tests,53
"T-Lymphocytes, Cytotoxic",A,A15.382.490.555.567.569.500.200,T-Lymphocyte Subsets,T-Lymphocytes,53
"T-Lymphocytes, Cytotoxic",A,A15.145.229.637.555.567.550.500.200,T-Lymphocyte Subsets,Lymphocyte Subsets,53
"T-Lymphocytes, Cytotoxic",A,A15.145.229.637.555.283.875,Cytokine-Induced Killer Cells,"Leukocytes, Mononuclear",53
"T-Lymphocytes, Cytotoxic",A,A15.382.490.555.567.550.500.200,T-Lymphocyte Subsets,Lymphocyte Subsets,53
"T-Lymphocytes, Cytotoxic",A,A15.382.490.555.567.569.220.200,CD8-Positive T-Lymphocytes,T-Lymphocytes,53
"T-Lymphocytes, Cytotoxic",A,A15.382.490.555.283.875,Cytokine-Induced Killer Cells,"Leukocytes, Mononuclear",53
"T-Lymphocytes, Cytotoxic",A,A15.145.229.637.555.567.569.500.200,T-Lymphocyte Subsets,T-Lymphocytes,53
"T-Lymphocytes, Cytotoxic",A,A15.145.229.637.555.567.569.220.200,CD8-Positive T-Lymphocytes,T-Lymphocytes,53
"T-Lymphocytes, Cytotoxic",A,A11.118.637.555.567.550.500.200,T-Lymphocyte Subsets,Lymphocyte Subsets,53
"T-Lymphocytes, Cytotoxic",A,A11.118.637.555.283.875,Cytokine-Induced Killer Cells,"Leukocytes, Mononuclear",53
"T-Lymphocytes, Cytotoxic",A,A11.118.637.555.567.569.500.200,T-Lymphocyte Subsets,T-Lymphocytes,53
"T-Lymphocytes, Cytotoxic",A,A11.118.637.555.567.569.220.200,CD8-Positive T-Lymphocytes,T-Lymphocytes,53
Ukraine,Z,Z01.586.950.960,USSR,Historical Geographic Locations,53
Ukraine,Z,Z01.542.248.960,"Europe, Eastern",Europe,53
Ukraine,Z,Z01.542.931.960,USSR,Europe,53
"Vaccines, DNA",D,D23.050.865.910,"Vaccines, Synthetic",Antigens,53
"Vaccines, DNA",D,D20.215.894.865.910,"Vaccines, Synthetic",Vaccines,53
"Vaccines, DNA",D,D12.776.828.868.910,"Vaccines, Synthetic",Recombinant Proteins,53
"Africa, Southern",Z,Z01.058.290.175,Africa South of the Sahara,Africa,52
Antigenic Variation,G,G05.365.073,Genetic Variation,Genetic Phenomena,52
Antigenic Variation,G,G12.500.249,Immunogenetic Phenomena,Immune System Phenomena,52
Biodiversity,G,G16.500.275.157.049,Ecosystem,Environment,52
Biodiversity,N,N06.230.124.049,Ecosystem,Environment,52
Cell Adhesion,G,G04.022,Cell Physiological Phenomena,NULL,52
Colonic Neoplasms,C,C04.588.274.476.411.307.180,Colorectal Neoplasms,Intestinal Neoplasms,52
Colonic Neoplasms,C,C06.301.371.411.307.180,Colorectal Neoplasms,Intestinal Neoplasms,52
Colonic Neoplasms,C,C06.405.469.158.356.180,Colorectal Neoplasms,Colonic Diseases,52
Colonic Neoplasms,C,C06.405.249.411.307.180,Colorectal Neoplasms,Intestinal Neoplasms,52
Colonic Neoplasms,C,C06.405.469.491.307.180,Colorectal Neoplasms,Intestinal Neoplasms,52
"Colony Count, Microbial",E,E01.370.225.875.220,Microbiological Techniques,Clinical Laboratory Techniques,52
"Colony Count, Microbial",E,E05.200.875.220,Microbiological Techniques,Clinical Laboratory Techniques,52
Dendritic Cells,A,A11.066.270,Antigen-Presenting Cells,Cells,52
Dendritic Cells,A,A11.436.270,Epithelial Cells,Cells,52
Dendritic Cells,A,A15.382.066.270,Antigen-Presenting Cells,Immune System,52
Dendritic Cells,A,A15.382.670.260,Mononuclear Phagocyte System,Immune System,52
"DNA, Complementary",D,D27.720.470.530.600.223.260,DNA Probes,Nucleic Acid Probes,52
"DNA, Complementary",D,D13.444.308.497.220,"DNA, Single-Stranded",DNA,52
"DNA, Complementary",D,D13.444.600.223.500,DNA Probes,Nucleic Acid Probes,52
Ecuador,Z,Z01.107.757.362,South America,Americas,52
Ethanol,D,D02.033.375,Alcohols,Organic Chemicals,52
Fasting,F,F01.145.407.400,Feeding Behavior,Behavior,52
Fasting,G,G07.203.650.240.587,Diet,Nutritional Physiological Phenomena,52
Fasting,G,G07.203.650.353.400,Feeding Behavior,Nutritional Physiological Phenomena,52
Fluorocarbons,D,D02.455.526.510.435,"Hydrocarbons, Fluorinated","Hydrocarbons, Halogenated",52
"Fractures, Bone",C,C26.404,Wounds and Injuries,NULL,52
Health Care Sector,N,N03.219.650,Economics,Health Care Economics and Organizations,52
Health Care Sector,J,J01.576.489,Industry,"Technology, Industry, and Agriculture",52
"Herpesvirus 3, Human",B,B04.280.382.100.900.460,Varicellovirus,Alphaherpesvirinae,52
Hodgkin Disease,C,C04.557.386.355,Lymphoma,Neoplasms by Histologic Type,52
Hodgkin Disease,C,C20.683.515.761.355,Lymphoma,Lymphoproliferative Disorders,52
Hodgkin Disease,C,C15.604.515.569.355,Lymphoma,Lymphoproliferative Disorders,52
Insect Repellents,D,D27.888.723.441,Pesticides,Toxic Actions,52
Insect Repellents,D,D27.505.696.706.434,Protective Agents,Physiological Effects of Drugs,52
Insect Repellents,D,D27.720.031.700.441,Pesticides,Agrochemicals,52
Intention,F,F02.463.306,Mental Processes,Psychological Phenomena,52
Intention,F,F01.658.650,Motivation,Behavior and Behavior Mechanisms,52
Job Satisfaction,F,F02.784.692.425,"Psychology, Industrial","Psychology, Applied",52
Machine Learning,L,L01.224.050.375.530,Artificial Intelligence,Algorithms,52
Machine Learning,G,G17.035.250.500,Artificial Intelligence,Algorithms,52
"Meningitis, Pneumococcal",C,C10.228.614.280.560,"Meningitis, Bacterial",Meningitis,52
"Meningitis, Pneumococcal",C,C10.228.228.180.500.875,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,52
"Meningitis, Pneumococcal",C,C01.150.252.223.500.875,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,52
"Meningitis, Pneumococcal",C,C01.207.180.500.875,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,52
"Meningitis, Pneumococcal",C,C01.150.252.410.890.670.595,Pneumococcal Infections,Streptococcal Infections,52
Molecular Typing,E,E01.370.225.875.150.125.457,Bacterial Typing Techniques,Bacteriological Techniques,52
Molecular Typing,E,E05.393.542,Genetic Techniques,Investigative Techniques,52
Molecular Typing,E,E05.200.875.150.125.457,Bacterial Typing Techniques,Bacteriological Techniques,52
Quebec,Z,Z01.107.567.176.791,Canada,North America,52
Respiratory Function Tests,E,E01.370.386.700,"Diagnostic Techniques, Respiratory System",Diagnostic Techniques and Procedures,52
Respiratory Syncytial Viruses,B,B04.820.480.937.600.670.600.750,Pneumovirus,Pneumovirinae,52
Sequence Deletion,G,G05.365.590.762,Mutation,Genetic Variation,52
Sequence Deletion,G,G05.558.800,Mutagenesis,Genetic Phenomena,52
Spirometry,E,E01.370.386.700.750,Respiratory Function Tests,"Diagnostic Techniques, Respiratory System",52
Zidovudine,D,D13.570.230.500.950,Dideoxynucleosides,Deoxyribonucleosides,52
Zidovudine,D,D13.570.230.855.950,Thymidine,Deoxyribonucleosides,52
Zidovudine,D,D13.570.685.705.950,Thymidine,Pyrimidine Nucleosides,52
Zidovudine,D,D03.383.742.680.705.950,Thymidine,Pyrimidine Nucleosides,52
Access to Information,I,I01.880.604.473.352.500.030,Privacy,Civil Rights,51
Access to Information,L,L01.143.024,Communication,Information Science,51
Access to Information,L,L01.737.030,Publishing,Information Science,51
Antipsychotic Agents,D,D27.505.954.427.210.950.040,Tranquilizing Agents,Central Nervous System Depressants,51
Antipsychotic Agents,D,D27.505.954.427.700.872.331,Tranquilizing Agents,Psychotropic Drugs,51
Antipsychotic Agents,D,D27.505.696.277.950.040,Tranquilizing Agents,Central Nervous System Depressants,51
Basic Reproduction Number,N,N01.224.935.597.080,Morbidity,Vital Statistics,51
Basic Reproduction Number,N,N06.850.335.125,"Disease Transmission, Infectious",Public Health,51
Basic Reproduction Number,N,N06.850.520.308.985.525.080,Morbidity,Vital Statistics,51
Basic Reproduction Number,N,N06.850.505.400.975.525.080,Morbidity,Vital Statistics,51
Basic Reproduction Number,E,E05.318.308.985.525.080,Morbidity,Vital Statistics,51
Cardiology,H,H02.403.429.163,Internal Medicine,Medicine,51
Crime,I,I01.198.240,Criminology,Social Sciences,51
Crime,I,I01.880.735.191,Social Problems,Sociology,51
Developmental Disabilities,F,F03.625.421,Neurodevelopmental Disorders,Mental Disorders,51
"Education, Medical, Continuing",I,I02.358.399.250,"Education, Medical","Education, Professional",51
"Education, Medical, Continuing",I,I02.358.212.350,"Education, Continuing","Education, Professional",51
Egypt,Z,Z01.058.266.317,"Africa, Northern",Africa,51
"Genital Diseases, Female",C,C13.351.500,Female Urogenital Diseases,Female Urogenital Diseases and Pregnancy Complications,51
HLA Antigens,D,D23.050.301.500.450,Histocompatibility Antigens,"Antigens, Surface",51
HLA Antigens,D,D23.050.705.552.450,Histocompatibility Antigens,Isoantigens,51
Infant Food,J,J02.500.525.500,"Foods, Specialized",Food,51
Infant Food,G,G07.203.300.525.500,"Foods, Specialized",Food,51
Influenza A virus,B,B04.820.480.968.405.400,Influenzavirus A,Orthomyxoviridae,51
Interdisciplinary Communication,F,F01.829.401.205.249,Interprofessional Relations,Interpersonal Relations,51
Interdisciplinary Communication,L,L01.143.865.500,Scholarly Communication,Communication,51
Interinstitutional Relations,N,N04.452.822.400,Public Relations,Organization and Administration,51
Long-Term Care,N,N02.421.585.476,Patient Care,Health Services,51
Long-Term Care,E,E02.760.476,Patient Care,Therapeutics,51
Niger,Z,Z01.058.290.190.560,"Africa, Western",Africa South of the Sahara,51
Organizational Culture,N,N04.452.606,Organization and Administration,Health Services Administration,51
Patient Dropouts,N,N05.300.150.800.500.610,Patient Acceptance of Health Care,Treatment Adherence and Compliance,51
Patient Dropouts,F,F01.145.488.887.500.610,Patient Acceptance of Health Care,Treatment Adherence and Compliance,51
Patient Dropouts,F,F01.100.150.750.500.610,Patient Acceptance of Health Care,Treatment Adherence and Compliance,51
Physician's Role,F,F01.829.316.616.625.600,Professional Role,Role,51
Poliovirus,B,B04.820.578.750.284.184.500,"Enterovirus C, Human",Enterovirus,51
Reoperation,E,E04.690,"Surgical Procedures, Operative",NULL,51
Syria,Z,Z01.252.245.500.795,Middle East,"Asia, Western",51
Turkey,Z,Z01.252.245.500.850,Middle East,"Asia, Western",51
Artemether,D,D01.650.550.750.200.250,Artemisinins,Peroxides,50
Artemether,D,D01.339.431.374.212.250,Artemisinins,Peroxides,50
Artemether,D,D01.248.497.158.685.750.212.250,Artemisinins,Peroxides,50
Artemether,D,D02.389.338.055.250,Artemisinins,Peroxides,50
Artemether,D,D02.455.849.765.211.250,Artemisinins,Sesquiterpenes,50
Baculoviridae,B,B04.525.100,Insect Viruses,Viruses,50
Baculoviridae,B,B04.280.065,DNA Viruses,Viruses,50
Brain Ischemia,C,C10.228.140.300.150,Cerebrovascular Disorders,Brain Diseases,50
Brain Ischemia,C,C14.907.253.092,Cerebrovascular Disorders,Vascular Diseases,50
Comprehension,F,F02.463.188.357,Cognition,Mental Processes,50
Datasets as Topic,E,E05.318.308.056,Data Collection,Epidemiologic Methods,50
Datasets as Topic,N,N05.715.360.300.224,Data Collection,Health Care Evaluation Mechanisms,50
Datasets as Topic,N,N06.850.520.308.056,Data Collection,Epidemiologic Methods,50
Datasets as Topic,L,L01.399.250.224,Data Collection,Information Management,50
Datasets as Topic,L,L01.470.750.750.431,"Databases, Factual",Databases as Topic,50
Datasets as Topic,L,L01.313.500.750.300.188.400.500,"Databases, Factual",Databases as Topic,50
Dyslipidemias,C,C18.452.584.500,Lipid Metabolism Disorders,Metabolic Diseases,50
Ecology,H,H01.277.249,Earth Sciences,Natural Science Disciplines,50
Ecology,H,H01.158.273.248,Biology,Biological Science Disciplines,50
Eswatini,Z,Z01.058.290.175.300,"Africa, Southern",Africa South of the Sahara,50
"Genes, Viral",G,G05.360.340.358.840.500,"Genome, Viral","Genome, Microbial",50
"Genes, Viral",G,G05.360.340.358.024.875,"Genes, Microbial","Genome, Microbial",50
"Genes, Viral",G,G05.360.340.024.340.364.875,"Genes, Microbial",Genes,50
Isoenzymes,D,D08.811.348,Enzymes,Enzymes and Coenzymes,50
Isoenzymes,D,D12.776.800.300,Protein Isoforms,Proteins,50
Lumefantrine,D,D04.615.389.650,Fluorenes,Polycyclic Aromatic Hydrocarbons,50
Lumefantrine,D,D02.455.426.559.847.389.650,Fluorenes,Polycyclic Aromatic Hydrocarbons,50
Mediterranean Region,Z,Z01.542.580,Europe,Geographic Locations,50
Menstruation,G,G08.686.605.428,Menstrual Cycle,Reproductive Physiological Phenomena,50
Nitroimidazoles,D,D02.640.672,Nitro Compounds,Organic Chemicals,50
Nitroimidazoles,D,D03.383.129.308.658,Imidazoles,Azoles,50
Personal Satisfaction,F,F01.145.677,Behavior,Behavior and Behavior Mechanisms,50
Physical Examination,E,E01.370.600,Diagnostic Techniques and Procedures,Diagnosis,50
Population,N,N01.600,Population Characteristics,NULL,50
Risk Management,N,N03.219.463.800,Financial Management,Economics,50
Risk Management,N,N04.452.871,Organization and Administration,Health Services Administration,50
Urinary Tract Infections,C,C13.351.968.892,Urologic Diseases,Female Urogenital Diseases,50
Urinary Tract Infections,C,C12.777.892,Urologic Diseases,Male Urogenital Diseases,50
Urinary Tract Infections,C,C01.915,Infections,NULL,50
Virion,A,A21.249,Viral Structures,NULL,50
Vitamin D Deficiency,C,C18.654.521.500.133.770,Avitaminosis,Deficiency Diseases,50
Adaptive Immunity,G,G12.450.050,Immunity,Immune System Phenomena,49
Calcium,D,D01.268.552.100,"Metals, Alkaline Earth",Elements,49
Calcium,D,D01.552.539.288,"Metals, Alkaline Earth",Metals,49
Calcium,D,D23.119.100,Blood Coagulation Factors,Biological Factors,49
Ceftriaxone,D,D02.886.665.074.190.190.155,Cefotaxime,Cephacetrile,49
Ceftriaxone,D,D03.633.100.300.249.190.190.155,Cefotaxime,Cephacetrile,49
Ceftriaxone,D,D02.065.589.099.249.190.190.155,Cefotaxime,Cephacetrile,49
Cerebrovascular Disorders,C,C10.228.140.300,Brain Diseases,Central Nervous System Diseases,49
Cerebrovascular Disorders,C,C14.907.253,Vascular Diseases,Cardiovascular Diseases,49
Child Behavior,F,F01.145.179,Behavior,Behavior and Behavior Mechanisms,49
Contraceptive Agents,D,D27.505.954.705.360,Reproductive Control Agents,Therapeutic Uses,49
Contraceptive Agents,D,D27.505.696.875.360,Reproductive Control Agents,Physiological Effects of Drugs,49
Fetus,A,A16.378,Embryonic Structures,NULL,49
"Herpesvirus 8, Human",B,B04.613.204.500.700.330,Rhadinovirus,Gammaherpesvirinae,49
"Herpesvirus 8, Human",B,B04.280.382.400.700.330,Rhadinovirus,Gammaherpesvirinae,49
"Herpesvirus 8, Human",B,B04.280.210.400.700.330,Rhadinovirus,Gammaherpesvirinae,49
Hospital Costs,N,N05.300.375.500,Health Care Costs,Delivery of Health Care,49
Hospital Costs,N,N03.219.262.500,"Economics, Hospital",Economics,49
Hospital Costs,N,N03.219.151.400.687,Health Care Costs,Costs and Cost Analysis,49
Longevity,G,G07.540,Physiological Phenomena,NULL,49
Longevity,G,G07.345.124.519,Aging,Growth and Development,49
"Microscopy, Fluorescence",E,E05.595.458,Microscopy,Investigative Techniques,49
"Microscopy, Fluorescence",E,E01.370.350.515.458,Microscopy,Diagnostic Imaging,49
Misoprostol,D,D23.469.050.175.725.775.450.500,"Prostaglandins E, Synthetic","Prostaglandins, Synthetic",49
Misoprostol,D,D23.469.700.660.500,"Prostaglandins E, Synthetic","Prostaglandins, Synthetic",49
Misoprostol,D,D10.251.355.255.550.775.450.500,"Prostaglandins E, Synthetic","Prostaglandins, Synthetic",49
"Mutation, Missense",G,G05.365.590.650,Mutation,Genetic Variation,49
Neonatal Screening,E,E05.318.308.980.438.580.580,Mass Screening,Health Surveys,49
Neonatal Screening,E,E05.200.910,Clinical Laboratory Techniques,Investigative Techniques,49
Neonatal Screening,N,N02.421.726.233.443.816,Mass Screening,Diagnostic Services,49
Neonatal Screening,N,N06.850.520.308.980.438.580.580,Mass Screening,Health Surveys,49
Neonatal Screening,N,N05.715.360.300.800.438.500.575,Mass Screening,Health Surveys,49
Neonatal Screening,N,N06.850.780.500.580,Mass Screening,Public Health Practice,49
Neonatal Screening,E,E01.370.225.910,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,49
Neonatal Screening,E,E01.370.500.580,Mass Screening,Diagnostic Techniques and Procedures,49
Ownership,N,N04.452.633,Organization and Administration,Health Services Administration,49
Ownership,I,I01.880.604.583.594,Jurisprudence,"Social Control, Formal",49
Plasmodium malariae,B,B01.043.075.380.611.661,Plasmodium,Haemosporida,49
"Process Assessment, Health Care",N,N04.761.559.650,"Outcome and Process Assessment, Health Care",Quality of Health Care,49
"Process Assessment, Health Care",N,N05.715.360.575.625,"Outcome and Process Assessment, Health Care",Health Care Evaluation Mechanisms,49
Proguanil,D,D02.078.370.141.710,Biguanides,Guanidines,49
Psoriasis,C,C17.800.859.675,"Skin Diseases, Papulosquamous",Skin Diseases,49
Psychotic Disorders,F,F03.700.675,Schizophrenia Spectrum and Other Psychotic Disorders,Mental Disorders,49
Sedentary Behavior,F,F01.829.458.705,Life Style,"Psychology, Social",49
Sedentary Behavior,F,F01.145.749,Behavior,Behavior and Behavior Mechanisms,49
Skin Diseases,C,C17.800,Skin and Connective Tissue Diseases,NULL,49
Soaps,D,D27.720.877.265.861,Detergents,Surface-Active Agents,49
Soaps,J,J01.516.872,Household Products,"Technology, Industry, and Agriculture",49
"Surgical Procedures, Operative",E,E04,NULL,NULL,49
Systems Analysis,L,L01.906,Information Science,NULL,49
Tenofovir,D,D03.633.100.759.138.881,Adenine,Purines,49
Tenofovir,D,D02.705.429.906,Organophosphonates,Organophosphorus Compounds,49
Vero Cells,A,A11.436.955,Epithelial Cells,Cells,49
Vero Cells,A,A11.251.210.955,Cell Line,"Cells, Cultured",49
Zebrafish,B,B01.050.150.900.493.200.244.828,Cyprinidae,Cypriniformes,49
Alcohol-Related Disorders,C,C25.775.100,Substance-Related Disorders,Chemically-Induced Disorders,48
Alcohol-Related Disorders,F,F03.900.100,Substance-Related Disorders,Mental Disorders,48
Antiparasitic Agents,D,D27.505.954.122.250,Anti-Infective Agents,Therapeutic Uses,48
Biostatistics,E,E05.318.740.237,Statistics as Topic,Epidemiologic Methods,48
Blood Platelets,A,A15.145.229.188,Blood Cells,Blood,48
Blood Platelets,A,A11.118.188,Blood Cells,Cells,48
Cost Savings,N,N03.219.151.160.200,Cost Control,Costs and Cost Analysis,48
Equatorial Guinea,Z,Z01.058.290.100.300,"Africa, Central",Africa South of the Sahara,48
Fees and Charges,N,N03.219.442,Economics,Health Care Economics and Organizations,48
Financial Management,N,N03.219.463,Economics,Health Care Economics and Organizations,48
"Hemorrhagic Fever, Crimean",C,C01.920.500.528,Arbovirus Infections,Vector Borne Diseases,48
"Hemorrhagic Fever, Crimean",C,C01.920.930.430,Tick-Borne Diseases,Vector Borne Diseases,48
"Hemorrhagic Fever, Crimean",C,C01.925.081.522,Arbovirus Infections,Virus Diseases,48
"Hemorrhagic Fever, Crimean",C,C01.925.782.417.412,"Hemorrhagic Fevers, Viral",RNA Virus Infections,48
"Hemorrhagic Fever, Crimean",C,C01.925.782.147.444,Bunyaviridae Infections,RNA Virus Infections,48
Insurance Coverage,N,N03.219.521.576.265,Insurance,"Financing, Organized",48
Liberia,Z,Z01.058.290.190.425,"Africa, Western",Africa South of the Sahara,48
Life Change Events,F,F01.829.458.410,Life Style,"Psychology, Social",48
Menarche,G,G08.686.760.410,Puberty,Reproductive Physiological Phenomena,48
Menarche,G,G08.686.841.374.410,Puberty,Sexual Development,48
Metformin,D,D02.078.370.141.450,Biguanides,Guanidines,48
Nonlinear Dynamics,E,E05.599.850,"Models, Theoretical",Investigative Techniques,48
Nonlinear Dynamics,H,H01.548.675,Mathematics,Natural Science Disciplines,48
"Physicians, Family",N,N02.360.810.770,Physicians,Health Personnel,48
"Physicians, Family",M,M01.526.485.810.770,Physicians,Health Personnel,48
Prisons,I,I01.880.604.787,"Social Control, Formal",Sociology,48
Prisons,J,J03.220.500,Correctional Facilities,Non-Medical Public and Private Facilities,48
Republic of Korea,Z,Z01.252.474.557.750,Korea,Far East,48
Swine Diseases,C,C22.905,Animal Diseases,NULL,48
Tissue Donors,M,M01.898,Persons,NULL,48
Tuberculin,D,D23.050.161.845,"Antigens, Bacterial",Antigens,48
"Tumor Cells, Cultured",A,A11.251.860,"Cells, Cultured",Cells,48
USSR,Z,Z01.586.950,Historical Geographic Locations,Geographic Locations,48
USSR,Z,Z01.542.931,Europe,Geographic Locations,48
Viral Core Proteins,D,D12.776.964.970.600.850,Nucleocapsid Proteins,Viral Structural Proteins,48
Aftercare,E,E02.760.169.063,Continuity of Patient Care,Patient Care,47
Aftercare,N,N02.421.585.169.063,Continuity of Patient Care,Patient Care,47
Aftercare,N,N04.590.233.727.210.063,Continuity of Patient Care,Primary Health Care,47
Benzhydryl Compounds,D,D02.455.426.559.389.115,Benzene Derivatives,"Hydrocarbons, Aromatic",47
Blood Donors,M,M01.898.313,Tissue Donors,Persons,47
Child Abuse,I,I01.880.735.900.350.250,Domestic Violence,Violence,47
Child Abuse,I,I01.198.240.856.350.250,Domestic Violence,Violence,47
Congenital Abnormalities,C,C16.131,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NULL,47
Epithelial Cells,A,A11.436,Cells,NULL,47
Eye,A,A09.371,Sense Organs,NULL,47
Eye,A,A01.456.505.420,Face,Head,47
Frontotemporal Dementia,C,C10.228.140.380.266.299,Frontotemporal Lobar Degeneration,Dementia,47
Frontotemporal Dementia,C,C10.574.950.300.299,Frontotemporal Lobar Degeneration,TDP-43 Proteinopathies,47
Frontotemporal Dementia,C,C18.452.845.800.300.299,Frontotemporal Lobar Degeneration,TDP-43 Proteinopathies,47
Frontotemporal Dementia,F,F03.615.400.380.299,Frontotemporal Lobar Degeneration,Dementia,47
Gastrointestinal Microbiome,G,G06.591.375,Microbiota,Microbiological Phenomena,47
Gastrointestinal Microbiome,G,G16.500.275.157.049.100.500.375,Microbiota,Biota,47
Gastrointestinal Microbiome,N,N06.230.124.049.100.500.250,Microbiota,Biota,47
Genome,G,G05.360.340,Genetic Structures,Genetic Phenomena,47
Glucosides,D,D09.408.348,Glycosides,Carbohydrates,47
Humidity,N,N06.230.150.372,"Environment, Controlled",Environment,47
Humidity,N,N06.230.300.100.725.310,Weather,Atmosphere,47
Humidity,G,G16.500.275.063.725.310,Weather,Atmosphere,47
Humidity,G,G16.500.750.775.310,Weather,Meteorological Concepts,47
Hungary,Z,Z01.542.248.495,"Europe, Eastern",Europe,47
Infant Nutrition Disorders,C,C18.654.422,Nutrition Disorders,Nutritional and Metabolic Diseases,47
Lamivudine,D,D03.383.742.680.245.500.950.500,Zalcitabine,Deoxycytidine,47
Lamivudine,D,D13.570.685.245.500.950.500,Zalcitabine,Deoxycytidine,47
Lamivudine,D,D13.570.230.500.925.500,Zalcitabine,Dideoxynucleosides,47
Lamivudine,D,D13.570.230.329.950.500,Zalcitabine,Deoxycytidine,47
Leprostatic Agents,D,D27.505.954.122.085.777,Anti-Bacterial Agents,Anti-Infective Agents,47
Life Tables,N,N06.850.520.308.985.475,Vital Statistics,Data Collection,47
Life Tables,N,N06.850.505.400.975.475,Vital Statistics,Demography,47
Life Tables,N,N01.224.935.530,Vital Statistics,Demography,47
Life Tables,E,E05.318.740.100.500,Actuarial Analysis,Statistics as Topic,47
Life Tables,E,E05.318.308.985.475,Vital Statistics,Data Collection,47
Lymph Nodes,A,A10.549.400,Lymphoid Tissue,Tissues,47
Lymph Nodes,A,A15.382.520.604.412,Lymphoid Tissue,Lymphatic System,47
Lymphocyte Count,E,E01.370.225.500.195.107.595.500,Leukocyte Count,Blood Cell Count,47
Lymphocyte Count,E,E01.370.225.625.107.595.500,Leukocyte Count,Blood Cell Count,47
Lymphocyte Count,E,E05.200.625.107.595.500,Leukocyte Count,Blood Cell Count,47
Lymphocyte Count,E,E05.242.195.107.595.500,Leukocyte Count,Blood Cell Count,47
Lymphocyte Count,E,E05.200.500.195.107.595.500,Leukocyte Count,Blood Cell Count,47
Lymphocyte Count,G,G04.140.107.595.500,Leukocyte Count,Blood Cell Count,47
Lymphocyte Count,G,G09.188.105.595.500,Leukocyte Count,Blood Cell Count,47
Magnetic Resonance Spectroscopy,E,E05.196.867.519,Spectrum Analysis,"Chemistry Techniques, Analytical",47
Mefloquine,D,D03.633.100.810.410,Quinolines,"Heterocyclic Compounds, 2-Ring",47
"Models, Immunological",E,E05.599.395.500,"Models, Biological","Models, Theoretical",47
Nevirapine,D,D03.383.725.506,Pyridines,"Heterocyclic Compounds, 1-Ring",47
Nutritive Value,G,G07.203.650.660,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",47
Nutritive Value,J,J01.576.423.850.730.750,Food Quality,Food Technology,47
Nutritive Value,N,N06.850.601.750,Food Quality,Public Health,47
Organizational Policy,I,I01.880.604.825.550,Social Control Policies,"Social Control, Formal",47
Organizational Policy,I,I01.655.500.550,Social Control Policies,Policy,47
Organizational Policy,N,N03.623.500.550,Social Control Policies,Policy,47
Parenting,F,F01.829.263.370.310,Family Relations,Family,47
"Poliovirus Vaccine, Inactivated",D,D20.215.894.830.614,"Vaccines, Inactivated",Vaccines,47
"Poliovirus Vaccine, Inactivated",D,D20.215.894.899.623.500,Poliovirus Vaccines,Viral Vaccines,47
RNA,D,D13.444.735,Nucleic Acids,"Nucleic Acids, Nucleotides, and Nucleosides",47
Shigella,B,B03.440.450.425.850,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,47
Shigella,B,B03.660.250.150.730,Enterobacteriaceae,Gammaproteobacteria,47
Specialization,H,H02.811,Health Occupations,NULL,47
Syndrome,C,C23.550.288.500,Disease,Pathologic Processes,47
Ticlopidine,D,D03.383.725.849.500,Thienopyridines,Pyridines,47
Ticlopidine,D,D03.383.903.830.500,Thienopyridines,Thiophenes,47
Ticlopidine,D,D03.633.100.928.500,Thienopyridines,"Heterocyclic Compounds, 2-Ring",47
Ticlopidine,D,D02.886.778.823.500,Thienopyridines,Thiophenes,47
Vision Screening,E,E01.370.380.850.900,Vision Tests,"Diagnostic Techniques, Ophthalmological",47
Vision Screening,N,N06.850.520.308.980.438.580.925,Mass Screening,Health Surveys,47
Vision Screening,N,N05.715.360.300.800.438.500.825,Mass Screening,Health Surveys,47
Vision Screening,E,E05.318.308.980.438.580.925,Mass Screening,Health Surveys,47
Vision Screening,N,N06.850.780.500.950,Mass Screening,Public Health Practice,47
Yaws,C,C17.800.838.765.910,"Skin Diseases, Bacterial","Skin Diseases, Infectious",47
Yaws,C,C01.150.252.819.910,"Skin Diseases, Bacterial",Bacterial Infections,47
Yaws,C,C01.150.252.400.840.750,Treponemal Infections,Gram-Negative Bacterial Infections,47
Yaws,C,C01.150.252.400.794.840.750,Treponemal Infections,Spirochaetales Infections,47
Yaws,C,C01.800.720.910,"Skin Diseases, Bacterial","Skin Diseases, Infectious",47
Americas,Z,Z01.107,Geographic Locations,NULL,46
Argentina,Z,Z01.107.757.077,South America,Americas,46
Body Size,E,E05.041.124.160,Body Weights and Measures,Anthropometry,46
Body Size,G,G07.100.100.160,Body Weights and Measures,Body Constitution,46
Body Size,G,G07.345.249.314,Growth,Growth and Development,46
Body Size,E,E01.370.600.115.100.160,Body Weights and Measures,Body Constitution,46
"Contraceptives, Oral",D,D27.505.696.875.360.276.210,"Contraceptive Agents, Female",Contraceptive Agents,46
"Contraceptives, Oral",D,D27.505.954.705.360.276.210,"Contraceptive Agents, Female",Contraceptive Agents,46
Death Certificates,E,E05.318.308.940.350,Records,Data Collection,46
Death Certificates,N,N06.850.520.308.940.350,Records,Data Collection,46
Death Certificates,N,N05.715.360.300.715.315,Records,Data Collection,46
Death Certificates,N,N04.452.859.264,Records,Organization and Administration,46
Death Certificates,L,L01.399.250.900.350,Records,Data Collection,46
Dietary Carbohydrates,J,J02.500.362,Food,Food and Beverages,46
Dietary Carbohydrates,G,G07.203.300.362,Food,"Diet, Food, and Nutrition",46
Dietary Carbohydrates,D,D09.301,Carbohydrates,NULL,46
"Economics, Medical",N,N03.219.300,Economics,Health Care Economics and Organizations,46
Endpoint Determination,E,E05.315,Investigative Techniques,NULL,46
Escherichia coli Proteins,D,D12.776.097.275,Bacterial Proteins,Proteins,46
Fathers,F,F01.829.263.500.320.100,Parents,Nuclear Family,46
Fathers,M,M01.620.390,Parents,Persons,46
Fathers,I,I01.880.853.150.500.340.210,Parents,Nuclear Family,46
Ferritins,D,D12.776.157.427.249,Iron-Binding Proteins,Carrier Proteins,46
Ferritins,D,D12.776.556.579.249,Iron-Binding Proteins,Metalloproteins,46
Interleukin-2,D,D12.776.467.374.465.021,Interleukins,Cytokines,46
Interleukin-2,D,D12.776.467.374.480.372,Lymphokines,Cytokines,46
Interleukin-2,D,D23.529.374.465.155,Interleukins,Cytokines,46
Interleukin-2,D,D23.529.374.480.372,Lymphokines,Cytokines,46
Interleukin-2,D,D12.644.276.374.480.372,Lymphokines,Cytokines,46
Interleukin-2,D,D12.644.276.374.465.021,Interleukins,Cytokines,46
Lassa Fever,C,C01.925.782.082.545,Arenaviridae Infections,RNA Virus Infections,46
Lassa Fever,C,C01.925.782.417.505,"Hemorrhagic Fevers, Viral",RNA Virus Infections,46
Mass Spectrometry,E,E05.196.566,"Chemistry Techniques, Analytical",Investigative Techniques,46
Meat,G,G07.203.300.600,Food,"Diet, Food, and Nutrition",46
Meat,J,J02.500.600,Food,Food and Beverages,46
Medical Errors,N,N02.421.450,Health Services,"Health Care Facilities, Manpower, and Services",46
Meningitis,C,C10.228.614,Central Nervous System Diseases,Nervous System Diseases,46
Mental Recall,F,F02.463.425.540.641,Memory,Learning,46
Myocardium,A,A10.690.552.750,"Muscle, Striated",Muscles,46
Myocardium,A,A02.633.580,Muscles,Musculoskeletal System,46
Myocardium,A,A07.541.704,Heart,Cardiovascular System,46
Professional Role,F,F01.829.316.616.625,Role,Group Processes,46
Prostate-Specific Antigen,D,D08.811.277.656.959.350.442.750,Kallikreins,Serine Endopeptidases,46
Prostate-Specific Antigen,D,D08.811.277.656.300.760.442.750,Kallikreins,Serine Endopeptidases,46
Prostate-Specific Antigen,D,D23.101.140.625,"Biomarkers, Tumor",Biomarkers,46
Prostate-Specific Antigen,D,D12.776.866.249.500,Prostatic Secretory Proteins,Seminal Plasma Proteins,46
Prostate-Specific Antigen,D,D23.050.285.625,"Antigens, Neoplasm",Antigens,46
Restriction Mapping,E,E05.393.183.620.650,Physical Chromosome Mapping,Chromosome Mapping,46
Restriction Mapping,E,E05.393.712,Genetic Techniques,Investigative Techniques,46
"RNA, Ribosomal",D,D13.444.735.686,RNA,Nucleic Acids,46
Saudi Arabia,Z,Z01.252.245.500.750,Middle East,"Asia, Western",46
Telephone,L,L01.178.847.698,Telecommunications,Communications Media,46
"Tuberculosis, Meningeal",C,C01.150.252.410.040.552.846.570.600,"Tuberculosis, Central Nervous System",Tuberculosis,46
"Tuberculosis, Meningeal",C,C01.207.180.500.937,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,46
"Tuberculosis, Meningeal",C,C01.207.180.850.800,"Tuberculosis, Central Nervous System",Central Nervous System Bacterial Infections,46
"Tuberculosis, Meningeal",C,C01.150.252.223.500.937,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,46
"Tuberculosis, Meningeal",C,C01.150.252.223.850.800,"Tuberculosis, Central Nervous System",Central Nervous System Bacterial Infections,46
"Tuberculosis, Meningeal",C,C10.228.614.280.915,"Meningitis, Bacterial",Meningitis,46
"Tuberculosis, Meningeal",C,C10.228.228.180.500.937,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,46
"Tuberculosis, Meningeal",C,C10.228.228.180.850.800,"Tuberculosis, Central Nervous System",Central Nervous System Bacterial Infections,46
Water Quality,N,N06.850.460.790.730,Water Pollution,Environmental Pollution,46
Water Quality,N,N06.850.460.350.080.750,Environmental Monitoring,Environmental Exposure,46
"Administration, Topical",E,E02.319.267.120,Drug Administration Routes,Drug Therapy,45
Amoxicillin,D,D02.886.108.750.750.050.050,Ampicillin,Penicillin G,45
Amoxicillin,D,D03.633.100.300.750.750.050.050,Ampicillin,Penicillin G,45
Amoxicillin,D,D02.065.589.099.750.750.050.050,Ampicillin,Penicillin G,45
Benzimidazoles,D,D03.633.100.103,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",45
Beverages,J,J02.200,Food and Beverages,NULL,45
Beverages,G,G07.203.100,"Diet, Food, and Nutrition",Physiological Phenomena,45
Birth Intervals,I,I01.240.361.150,Family Characteristics,Demography,45
Birth Intervals,N,N01.224.361.150,Family Characteristics,Demography,45
Crowdsourcing,L,L01.399.250.179,Data Collection,Information Management,45
"Crystallography, X-Ray",E,E05.196.309.742.225,X-Ray Diffraction,Crystallography,45
"Decision Support Systems, Clinical",L,L01.313.500.750.300.190,Information Systems,Medical Informatics Applications,45
"Depression, Postpartum",F,F03.600.300.350,Depressive Disorder,Mood Disorders,45
"Depression, Postpartum",C,C13.703.844.253,Puerperal Disorders,Pregnancy Complications,45
Dog Diseases,C,C22.268,Animal Diseases,NULL,45
Drug Approval,E,E05.290.250,Drug Development,Investigative Techniques,45
Drug Approval,E,E05.337.300,Evaluation Studies as Topic,Investigative Techniques,45
Drug Approval,I,I01.880.604.605.250.250,Drug and Narcotic Control,"Legislation, Drug",45
Epigenomics,H,H01.158.273.180.350.074,Genomics,Computational Biology,45
Epigenomics,H,H01.158.273.343.350.042,Genomics,Genetics,45
Fibrinolytic Agents,D,D27.505.954.502.427,Hematologic Agents,Therapeutic Uses,45
Fibrinolytic Agents,D,D27.505.954.411.320,Cardiovascular Agents,Therapeutic Uses,45
Fibrinolytic Agents,D,D27.505.519.421.750,Fibrin Modulating Agents,Molecular Mechanisms of Pharmacological Action,45
Green Fluorescent Proteins,D,D12.776.532.265,Luminescent Proteins,Proteins,45
Hysterectomy,E,E04.950.300.399,Gynecologic Surgical Procedures,Urogenital Surgical Procedures,45
Iran,Z,Z01.252.245.500.350,Middle East,"Asia, Western",45
Leukocytes,A,A11.118.637,Blood Cells,Cells,45
Leukocytes,A,A15.145.229.637,Blood Cells,Blood,45
Leukocytes,A,A15.382.490,Immune System,Hemic and Immune Systems,45
Liver Diseases,C,C06.552,Digestive System Diseases,NULL,45
Organ Size,E,E01.370.600.115.100.660,Body Weights and Measures,Body Constitution,45
Organ Size,E,E05.041.124.715,Body Weights and Measures,Anthropometry,45
Organ Size,G,G07.100.100.660,Body Weights and Measures,Body Constitution,45
Organ Size,G,G07.345.249.690,Growth,Growth and Development,45
Patient Care,N,N02.421.585,Health Services,"Health Care Facilities, Manpower, and Services",45
Patient Care,E,E02.760,Therapeutics,NULL,45
Penicillins,D,D03.633.100.300.750,beta-Lactams,"Heterocyclic Compounds, 2-Ring",45
Penicillins,D,D02.886.108.750,beta-Lactams,Sulfur Compounds,45
Penicillins,D,D02.065.589.099.750,beta-Lactams,Lactams,45
"Pregnancy, Unplanned",G,G08.686.784.769.570,Pregnancy,Reproduction,45
"Product Surveillance, Postmarketing",E,E05.337.800,Evaluation Studies as Topic,Investigative Techniques,45
Prostatectomy,E,E04.950.774.860.625,"Urologic Surgical Procedures, Male",Urologic Surgical Procedures,45
"Receptors, Estrogen",D,D12.776.826.750.350,"Receptors, Steroid","Receptors, Cytoplasmic and Nuclear",45
"Receptors, Estrogen",D,D12.776.930.778.350,"Receptors, Steroid",Transcription Factors,45
Reoviridae,B,B04.820.223.719,Double Stranded RNA Viruses,RNA Viruses,45
Salmonella typhimurium,B,B03.660.250.150.710.160.760,Salmonella enterica,Salmonella,45
Salmonella typhimurium,B,B03.440.450.425.800.200.825,Salmonella enterica,Salmonella,45
"T-Lymphocytes, Regulatory",A,A15.382.490.555.567.550.500.700,T-Lymphocyte Subsets,Lymphocyte Subsets,45
"T-Lymphocytes, Regulatory",A,A15.145.229.637.555.567.569.200.700,CD4-Positive T-Lymphocytes,T-Lymphocytes,45
"T-Lymphocytes, Regulatory",A,A15.145.229.637.555.567.569.500.700,T-Lymphocyte Subsets,T-Lymphocytes,45
"T-Lymphocytes, Regulatory",A,A15.145.229.637.555.567.550.500.700,T-Lymphocyte Subsets,Lymphocyte Subsets,45
"T-Lymphocytes, Regulatory",A,A15.382.490.555.567.569.200.700,CD4-Positive T-Lymphocytes,T-Lymphocytes,45
"T-Lymphocytes, Regulatory",A,A15.382.490.555.567.569.500.700,T-Lymphocyte Subsets,T-Lymphocytes,45
"T-Lymphocytes, Regulatory",A,A11.118.637.555.567.569.200.700,CD4-Positive T-Lymphocytes,T-Lymphocytes,45
"T-Lymphocytes, Regulatory",A,A11.118.637.555.567.550.500.700,T-Lymphocyte Subsets,Lymphocyte Subsets,45
"T-Lymphocytes, Regulatory",A,A11.118.637.555.567.569.500.700,T-Lymphocyte Subsets,T-Lymphocytes,45
"Ultrasonography, Prenatal",E,E01.370.378.630.865,Prenatal Diagnosis,"Diagnostic Techniques, Obstetrical and Gynecological",45
"Ultrasonography, Prenatal",E,E01.370.350.850.865,Ultrasonography,Diagnostic Imaging,45
Vital Capacity,E,E01.370.386.700.485.750.900,Total Lung Capacity,Lung Volume Measurements,45
Vital Capacity,G,G09.772.850.970,Total Lung Capacity,Respiratory Physiological Phenomena,45
Antidepressive Agents,D,D27.505.954.427.700.122,Psychotropic Drugs,Central Nervous System Agents,44
Cardiovascular Agents,D,D27.505.954.411,Therapeutic Uses,Pharmacologic Actions,44
Communication Barriers,L,L01.143.230,Communication,Information Science,44
Community Health Centers,N,N02.278.035.128,Ambulatory Care Facilities,Health Facilities,44
Cytomegalovirus,B,B04.280.382.150.150,Betaherpesvirinae,Herpesviridae,44
DNA Transposable Elements,D,D13.444.308.520,DNA,Nucleic Acids,44
DNA Transposable Elements,G,G05.360.080.708.330.200,Interspersed Repetitive Sequences,"Repetitive Sequences, Nucleic Acid",44
DNA Transposable Elements,G,G05.360.340.024.425.200,Interspersed Repetitive Sequences,Genome Components,44
DNA Transposable Elements,G,G02.111.570.080.708.330.200,Interspersed Repetitive Sequences,"Repetitive Sequences, Nucleic Acid",44
Environmental Pollution,N,N06.850.460,Public Health,Environment and Public Health,44
"Gene Expression Regulation, Developmental",G,G05.308.310,Gene Expression Regulation,Genetic Phenomena,44
Glucosephosphate Dehydrogenase Deficiency,C,C18.452.648.202.402,"Carbohydrate Metabolism, Inborn Errors","Metabolism, Inborn Errors",44
Glucosephosphate Dehydrogenase Deficiency,C,C15.378.071.141.150.480,"Anemia, Hemolytic, Congenital","Anemia, Hemolytic",44
Glucosephosphate Dehydrogenase Deficiency,C,C16.320.070.480,"Anemia, Hemolytic, Congenital","Genetic Diseases, Inborn",44
Glucosephosphate Dehydrogenase Deficiency,C,C16.320.565.202.402,"Carbohydrate Metabolism, Inborn Errors","Metabolism, Inborn Errors",44
Health Information Systems,L,L01.313.500.750.300.361,Information Systems,Medical Informatics Applications,44
Healthy Volunteers,M,M01.955.236,Volunteers,Persons,44
Healthy Volunteers,M,M01.774.500,Research Subjects,Persons,44
Hypoxia,C,C23.888.852.079,"Signs and Symptoms, Respiratory",Signs and Symptoms,44
Islam,K,K01.844.275,Religion,Humanities,44
Maternal-Fetal Exchange,G,G08.686.784.769.455,Pregnancy,Reproduction,44
Mathematics,H,H01.548,Natural Science Disciplines,NULL,44
"Mice, Transgenic",B,B01.050.050.136.500,"Animals, Genetically Modified",Animal Population Groups,44
"Mice, Transgenic",B,B01.050.150.900.649.313.992.635.505.500.800,Mice,Murinae,44
Pharmacists,M,M01.526.485.780,Health Personnel,Occupational Groups,44
Pharmacists,N,N02.360.780,Health Personnel,"Health Care Facilities, Manpower, and Services",44
Poland,Z,Z01.542.248.679,"Europe, Eastern",Europe,44
Professional Practice,N,N04.452.758,Organization and Administration,Health Services Administration,44
Pyridines,D,D03.383.725,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,44
Respiratory Insufficiency,C,C08.618.846,Respiration Disorders,Respiratory Tract Diseases,44
Salmonella,B,B03.440.450.425.800,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,44
Salmonella,B,B03.660.250.150.710,Enterobacteriaceae,Gammaproteobacteria,44
Scabies,C,C01.610.858.211.480.708,Mite Infestations,Ectoparasitic Infestations,44
Scabies,C,C17.800.838.775.800,"Skin Diseases, Parasitic","Skin Diseases, Infectious",44
"Sodium Chloride, Dietary",D,D01.857.650.705,Sodium Chloride,Sodium Compounds,44
"Sodium Chloride, Dietary",D,D01.857.875.705,"Sodium, Dietary",Sodium Compounds,44
Teaching,I,I02.903,Education,NULL,44
Trypanosoma,B,B01.268.475.868.887,Trypanosomatina,Kinetoplastida,44
Vehicle Emissions,D,D20.832,Complex Mixtures,NULL,44
Wuchereria bancrofti,B,B01.050.500.500.294.400.937.463.708.150,Wuchereria,Filarioidea,44
"Absorptiometry, Photon",E,E01.370.350.700.024,Radiography,Diagnostic Imaging,43
"Absorptiometry, Photon",E,E05.196.712.224.187,Densitometry,Photometry,43
Adenoviridae,B,B04.280.030,DNA Viruses,Viruses,43
"Arthroplasty, Replacement, Knee",E,E04.680.101.110.115,"Arthroplasty, Replacement",Arthroplasty,43
"Arthroplasty, Replacement, Knee",E,E04.650.110.115,"Arthroplasty, Replacement",Prosthesis Implantation,43
"Arthroplasty, Replacement, Knee",E,E04.555.110.110.115,"Arthroplasty, Replacement",Arthroplasty,43
"Behavior, Animal",F,F01.145.113,Behavior,Behavior and Behavior Mechanisms,43
Brain Injuries,C,C26.915.300.200,Craniocerebral Trauma,"Trauma, Nervous System",43
Brain Injuries,C,C10.228.140.199,Brain Diseases,Central Nervous System Diseases,43
Brain Injuries,C,C10.900.300.087,Craniocerebral Trauma,"Trauma, Nervous System",43
Bronchoalveolar Lavage Fluid,E,E05.927.100.500,Bronchoalveolar Lavage,Therapeutic Irrigation,43
Clostridium Infections,C,C01.150.252.410.222,Gram-Positive Bacterial Infections,Bacterial Infections,43
Diarylquinolines,D,D03.633.100.810.087,Quinolines,"Heterocyclic Compounds, 2-Ring",43
Esophageal Neoplasms,C,C06.405.117.430,Esophageal Diseases,Gastrointestinal Diseases,43
Esophageal Neoplasms,C,C06.405.249.205,Gastrointestinal Neoplasms,Gastrointestinal Diseases,43
Esophageal Neoplasms,C,C06.301.371.205,Gastrointestinal Neoplasms,Digestive System Neoplasms,43
Esophageal Neoplasms,C,C04.588.443.353,Head and Neck Neoplasms,Neoplasms by Site,43
Esophageal Neoplasms,C,C04.588.274.476.205,Gastrointestinal Neoplasms,Digestive System Neoplasms,43
Family Relations,F,F01.829.263.370,Family,"Psychology, Social",43
Family Relations,I,I01.880.853.150.439,Family,Sociological Factors,43
"Geography, Medical",H,H01.277.500.097,Geography,Earth Sciences,43
"Geography, Medical",H,H02.403.352,Medicine,Health Occupations,43
"Hepatitis B, Chronic",C,C01.925.440.435.100,Hepatitis B,"Hepatitis, Viral, Human",43
"Hepatitis B, Chronic",C,C01.925.256.430.400.100,Hepatitis B,Hepadnaviridae Infections,43
"Hepatitis B, Chronic",C,C06.552.380.705.437.100,Hepatitis B,"Hepatitis, Viral, Human",43
"Hepatitis B, Chronic",C,C06.552.380.350.100,"Hepatitis, Chronic",Hepatitis,43
"Hepatitis B, Chronic",C,C01.221.250.500.100,Hepatitis B,Blood-Borne Infections,43
"Herpesvirus 4, Human",B,B04.280.210.400.500.450,Lymphocryptovirus,Gammaherpesvirinae,43
"Herpesvirus 4, Human",B,B04.280.382.400.500.400,Lymphocryptovirus,Gammaherpesvirinae,43
"Herpesvirus 4, Human",B,B04.613.204.500.500.400,Lymphocryptovirus,Gammaherpesvirinae,43
"History, 18th Century",K,K01.400.504.875,"History, Modern 1601-",History,43
Immunophenotyping,E,E05.478.594.450,Immunologic Tests,Immunologic Techniques,43
Immunophenotyping,E,E05.200.812.447,Immunologic Tests,Clinical Laboratory Techniques,43
Immunophenotyping,E,E01.370.225.812.447,Immunologic Tests,Clinical Laboratory Techniques,43
"Influenza A Virus, H3N2 Subtype",B,B04.820.480.968.405.400.300,Influenza A virus,Influenzavirus A,43
"Influenza A Virus, H5N1 Subtype",B,B04.820.480.968.405.400.500,Influenza A virus,Influenzavirus A,43
"Infusions, Intravenous",E,E02.319.267.082.500,"Administration, Intravenous",Drug Administration Routes,43
"Infusions, Intravenous",E,E02.319.267.510.590,"Infusions, Parenteral",Drug Administration Routes,43
Multifactorial Inheritance,G,G05.420.590,Inheritance Patterns,Genetic Phenomena,43
Nursing Homes,N,N02.278.825.610,Residential Facilities,Health Facilities,43
Pain Measurement,E,E01.370.600.550.324,Neurologic Examination,Physical Examination,43
Pesticides,D,D27.888.723,Toxic Actions,Chemical Actions and Uses,43
Pesticides,D,D27.720.031.700,Agrochemicals,Specialty Uses of Chemicals,43
Photography,E,E01.370.350.600,Diagnostic Imaging,Diagnostic Techniques and Procedures,43
Photography,E,E05.712,Investigative Techniques,NULL,43
Preventive Medicine,H,H02.403.720.750,Public Health,Medicine,43
Respiration Disorders,C,C08.618,Respiratory Tract Diseases,NULL,43
Rhinitis,C,C08.460.799,Nose Diseases,Respiratory Tract Diseases,43
Rhinitis,C,C08.730.674,Respiratory Tract Infections,Respiratory Tract Diseases,43
Rhinitis,C,C09.603.799,Nose Diseases,Otorhinolaryngologic Diseases,43
Rhinitis,C,C01.748.674,Respiratory Tract Infections,Infections,43
Social Values,F,F01.829.873,"Psychology, Social",Behavior and Behavior Mechanisms,43
Social Work,I,I01.880.792,Sociology,Social Sciences,43
Social Work,N,N02.421.849,Health Services,"Health Care Facilities, Manpower, and Services",43
"Students, Medical",M,M01.848.769.602,"Students, Health Occupations",Students,43
Urine,A,A12.207.927,Body Fluids,Fluids and Secretions,43
Adolescent Health Services,N,N02.421.044,Health Services,"Health Care Facilities, Manpower, and Services",42
"Antibiotics, Antitubercular",D,D27.505.954.122.085.255.135,Antitubercular Agents,Anti-Bacterial Agents,42
"Antibodies, Monoclonal, Humanized",D,D12.776.124.790.651.114.224.060,"Antibodies, Monoclonal",Antibodies,42
"Antibodies, Monoclonal, Humanized",D,D12.776.124.486.485.114.224.060,"Antibodies, Monoclonal",Antibodies,42
"Antibodies, Monoclonal, Humanized",D,D12.776.377.715.548.114.224.200,"Antibodies, Monoclonal",Antibodies,42
Appointments and Schedules,N,N04.452.095,Organization and Administration,Health Services Administration,42
Asbestos,D,D01.837.725.700.760.070,Silicates,Silicic Acid,42
Asbestos,D,D01.578.725.050,Silicates,Minerals,42
Atherosclerosis,C,C14.907.137.126.307,Arteriosclerosis,Arterial Occlusive Diseases,42
Autoantibodies,D,D12.776.377.715.548.114.323,Antibodies,Immunoglobulins,42
Autoantibodies,D,D12.776.124.486.485.114.323,Antibodies,Immunoglobulins,42
Autoantibodies,D,D12.776.124.790.651.114.323,Antibodies,Immunoglobulins,42
Bisexuality,G,G08.686.867.200,Sexuality,Reproductive Physiological Phenomena,42
Bisexuality,F,F01.145.802.975.200,Sexuality,Sexual Behavior,42
Ciprofloxacin,D,D03.633.100.810.835.322.186,Fluoroquinolones,Quinolones,42
Community Health Planning,N,N03.349.650.185,Regional Health Planning,Health Planning,42
Conserved Sequence,G,G02.111.570.580,Molecular Structure,Biochemical Phenomena,42
Crime Victims,M,M01.135,Persons,NULL,42
Databases as Topic,L,L01.470.750,Information Storage and Retrieval,Information Science,42
Databases as Topic,L,L01.313.500.750.300.188,Information Systems,Medical Informatics Applications,42
Down-Regulation,G,G02.111.240,Biochemical Phenomena,Chemical Phenomena,42
Down-Regulation,G,G07.690.773.937,Pharmacological Phenomena,Pharmacological and Toxicological Phenomena,42
Down-Regulation,G,G05.308.200,Gene Expression Regulation,Genetic Phenomena,42
Entamoeba,B,B01.046.500.100.700.335,Tubulina,Amoebida,42
Fear,F,F01.470.361,Emotions,Behavior and Behavior Mechanisms,42
Fenoterol,D,D02.033.100.291.465.300,Metaproterenol,Ethanolamines,42
Fenoterol,D,D02.455.426.559.389.657.166.175.660.300,Metaproterenol,Catecholamines,42
Fenoterol,D,D02.092.063.291.465.300,Metaproterenol,Ethanolamines,42
Fenoterol,D,D02.092.311.660.300,Metaproterenol,Catecholamines,42
Gastrointestinal Tract,A,A03.556,Digestive System,NULL,42
"Immunity, Humoral",G,G12.450.050.420,Adaptive Immunity,Immunity,42
Interleukin-12,D,D12.644.276.374.465.512,Interleukins,Cytokines,42
Interleukin-12,D,D23.529.374.465.512,Interleukins,Cytokines,42
Interleukin-12,D,D12.776.467.374.465.512,Interleukins,Cytokines,42
Investments,N,N03.219.702,Economics,Health Care Economics and Organizations,42
Local Government,N,N03.540.348.750,Government,Organizations,42
Local Government,I,I01.409.700,Government,Social Sciences,42
Menopause,G,G08.686.841.249.500,Climacteric,Sexual Development,42
Menopause,G,G08.686.157.500,Climacteric,Reproductive Physiological Phenomena,42
Merozoites,G,G07.345.500.550.500.800.500,Schizonts,Life Cycle Stages,42
Merozoites,A,A11.870.740.800.500,Schizonts,"Spores, Protozoan",42
Merozoites,B,B05.775.740.800.500,Schizonts,"Spores, Protozoan",42
Merozoites,B,B05.500.800.500,Schizonts,Life Cycle Stages,42
"Multiple Sclerosis, Chronic Progressive",C,C20.111.258.250.500.200,Multiple Sclerosis,"Demyelinating Autoimmune Diseases, CNS",42
"Multiple Sclerosis, Chronic Progressive",C,C10.114.375.500.200,Multiple Sclerosis,"Demyelinating Autoimmune Diseases, CNS",42
"Multiple Sclerosis, Chronic Progressive",C,C10.314.350.500.200,Multiple Sclerosis,"Demyelinating Autoimmune Diseases, CNS",42
"Mycobacterium Infections, Nontuberculous",C,C01.150.252.410.040.552.475,Mycobacterium Infections,Actinomycetales Infections,42
Parasite Load,E,E01.370.225.932,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,42
Parasite Load,E,E05.200.932,Clinical Laboratory Techniques,Investigative Techniques,42
Patient Advocacy,I,I01.880.604.631,"Social Control, Formal",Sociology,42
Patient Advocacy,N,N03.706.678,"Social Control, Formal",Health Care Economics and Organizations,42
Patient Outcome Assessment,N,N04.761.559.590.399,"Outcome Assessment, Health Care","Outcome and Process Assessment, Health Care",42
Patient Outcome Assessment,N,N05.715.360.575.575.399,"Outcome Assessment, Health Care","Outcome and Process Assessment, Health Care",42
Patient Reported Outcome Measures,N,N05.715.360.575.575.399.875,Patient Outcome Assessment,"Outcome Assessment, Health Care",42
Patient Reported Outcome Measures,N,N05.715.360.300.800.344.500,Health Care Surveys,Surveys and Questionnaires,42
Patient Reported Outcome Measures,N,N06.850.520.308.980.344.500,Health Care Surveys,Surveys and Questionnaires,42
Patient Reported Outcome Measures,N,N04.761.559.590.399.875,Patient Outcome Assessment,"Outcome Assessment, Health Care",42
Patient Reported Outcome Measures,N,N05.425.210.500,Health Care Surveys,Health Services Research,42
Patient Reported Outcome Measures,N,N03.349.380.210.750,Health Care Surveys,Health Services Research,42
Patient Reported Outcome Measures,E,E05.318.308.980.344.500,Health Care Surveys,Surveys and Questionnaires,42
Perinatal Death,C,C13.703.572,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,42
Perinatal Death,C,C23.550.260.865,Death,Pathologic Processes,42
Salaries and Fringe Benefits,N,N01.824.417.700,Income,Socioeconomic Factors,42
Salaries and Fringe Benefits,N,N04.452.677.800,Personnel Management,Organization and Administration,42
Siblings,M,M01.781,Persons,NULL,42
Siblings,I,I01.880.853.150.500.505,Nuclear Family,Family,42
Siblings,F,F01.829.263.500.490,Nuclear Family,Family,42
Sickness Impact Profile,E,E05.318.308.980.438.475.730,Health Status Indicators,Health Surveys,42
Sickness Impact Profile,N,N06.850.520.308.980.438.475.730,Health Status Indicators,Health Surveys,42
Sickness Impact Profile,N,N05.715.360.300.800.438.375.730,Health Status Indicators,Health Surveys,42
Sports,I,I03.450.642.845,Recreation,Leisure Activities,42
Substrate Specificity,G,G02.111.835,Biochemical Phenomena,Chemical Phenomena,42
Waist-Hip Ratio,G,G07.100.100.960,Body Weights and Measures,Body Constitution,42
Waist-Hip Ratio,E,E05.041.124.946,Body Weights and Measures,Anthropometry,42
Waist-Hip Ratio,E,E01.370.600.115.100.960,Body Weights and Measures,Body Constitution,42
Albuminuria,C,C23.888.942.750.269,Proteinuria,Urological Manifestations,41
Albuminuria,C,C13.351.968.934.734.269,Proteinuria,Urination Disorders,41
Albuminuria,C,C12.777.934.734.269,Proteinuria,Urination Disorders,41
"Antigens, Surface",D,D23.050.301,Antigens,Biological Factors,41
"Anti-Inflammatory Agents, Non-Steroidal",D,D27.505.954.158.030,Anti-Inflammatory Agents,Therapeutic Uses,41
"Anti-Inflammatory Agents, Non-Steroidal",D,D27.505.954.329.030,Antirheumatic Agents,Therapeutic Uses,41
"Anti-Inflammatory Agents, Non-Steroidal",D,D27.505.696.663.850.014.040.500,"Analgesics, Non-Narcotic",Analgesics,41
Antirheumatic Agents,D,D27.505.954.329,Therapeutic Uses,Pharmacologic Actions,41
Behavior,F,F01.145,Behavior and Behavior Mechanisms,NULL,41
Benzoxazines,D,D03.633.100.209,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",41
Benzoxazines,D,D03.383.533.249,Oxazines,"Heterocyclic Compounds, 1-Ring",41
Bronchodilator Agents,D,D27.505.696.663.050.110,Autonomic Agents,Peripheral Nervous System Agents,41
Bronchodilator Agents,D,D27.505.954.796.050.100,Anti-Asthmatic Agents,Respiratory System Agents,41
Carbon Monoxide,D,D01.200.250,"Carbon Compounds, Inorganic",Inorganic Chemicals,41
Carbon Monoxide,D,D01.650.550.250,Oxides,Oxygen Compounds,41
Carbon Monoxide,D,D01.362.200,Gases,Inorganic Chemicals,41
Community-Institutional Relations,N,N04.452.822.210,Public Relations,Organization and Administration,41
Diet Records,N,N04.452.859.360,Records,Organization and Administration,41
Dihydropteroate Synthase,D,D08.811.913.225.300,Alkyl and Aryl Transferases,Transferases,41
Documentation,L,L01.453.245,Information Services,Information Science,41
Drug and Narcotic Control,N,N04.452.706.310,Pharmacy Administration,Organization and Administration,41
Drug and Narcotic Control,N,N03.706.615.402.250,"Legislation, Drug",Legislation as Topic,41
Drug and Narcotic Control,I,I01.880.604.605.250,"Legislation, Drug","Social Control, Formal",41
Food Preferences,F,F01.145.407.516,Feeding Behavior,Behavior,41
Food Preferences,G,G07.203.650.353.516,Feeding Behavior,Nutritional Physiological Phenomena,41
"Genes, Reporter",G,G05.360.340.024.340.435,Genes,Genome Components,41
Glucose,D,D09.947.875.359.448,Hexoses,Monosaccharides,41
Helicobacter Infections,C,C01.150.252.400.466,Gram-Negative Bacterial Infections,Bacterial Infections,41
Herpes Simplex,C,C01.925.256.466.382,Herpesviridae Infections,DNA Virus Infections,41
Herpes Simplex,C,C01.925.825.320,"Skin Diseases, Viral",Virus Diseases,41
Herpes Simplex,C,C17.800.838.790.320,"Skin Diseases, Viral","Skin Diseases, Infectious",41
Homeostasis,G,G07.410,Physiological Phenomena,NULL,41
Huntington Disease,F,F03.615.250.400,Cognition Disorders,Neurocognitive Disorders,41
Huntington Disease,F,F03.615.400.390,Dementia,Neurocognitive Disorders,41
Huntington Disease,C,C16.320.400.430,"Heredodegenerative Disorders, Nervous System","Genetic Diseases, Inborn",41
Huntington Disease,C,C10.574.500.497,"Heredodegenerative Disorders, Nervous System",Neurodegenerative Diseases,41
Huntington Disease,C,C10.228.662.262.249.750,Chorea,Dyskinesias,41
Huntington Disease,C,C10.228.140.079.545,Basal Ganglia Diseases,Brain Diseases,41
Huntington Disease,C,C10.228.140.380.278,Dementia,Brain Diseases,41
Hypoglycemia,C,C18.452.394.984,Glucose Metabolism Disorders,Metabolic Diseases,41
Insect Proteins,D,D12.776.093.500,Arthropod Proteins,Proteins,41
"Lens Implantation, Intraocular",E,E04.540.825.600,Refractive Surgical Procedures,Ophthalmologic Surgical Procedures,41
Liver Cirrhosis,C,C23.550.355.412,Fibrosis,Pathologic Processes,41
Liver Cirrhosis,C,C06.552.630,Liver Diseases,Digestive System Diseases,41
"Outpatient Clinics, Hospital",N,N04.452.442.452.422.527,Hospital Departments,Hospital Administration,41
"Outpatient Clinics, Hospital",N,N02.278.035.380,Ambulatory Care Facilities,Health Facilities,41
"Outpatient Clinics, Hospital",N,N02.278.216.500.968.527,Hospital Departments,Hospital Administration,41
Pacific Islands,Z,Z01.639.760,Islands,Geographic Locations,41
Pacific Islands,Z,Z01.678.100.873,Australasia,Oceania,41
Potassium,D,D01.552.547.650,"Metals, Light",Metals,41
Potassium,D,D01.552.528.652,"Metals, Alkali",Metals,41
Potassium,D,D01.268.549.550,"Metals, Alkali",Elements,41
Potassium,D,D01.268.557.575,"Metals, Light",Elements,41
Publication Bias,L,L01.737.813,Publishing,Information Science,41
"Rats, Wistar",B,B01.050.150.900.649.313.992.635.505.700.900,Rats,Murinae,41
Restaurants,J,J01.576.423.500.700,Food Services,Food Industry,41
Restaurants,J,J03.813,Non-Medical Public and Private Facilities,NULL,41
Rubella Vaccine,D,D20.215.894.899.779,Viral Vaccines,Vaccines,41
Self Efficacy,F,F01.752.747.792.700,Self Concept,Personality Development,41
"Sequence Analysis, RNA",E,E05.393.760.710,Sequence Analysis,Genetic Techniques,41
Smoke,D,D20.633.937,Particulate Matter,Complex Mixtures,41
Sunlight,G,G01.750.250.650.836,Light,Electromagnetic Radiation,41
Sunlight,G,G01.750.770.578.836,Light,"Radiation, Nonionizing",41
Sunlight,G,G01.358.500.505.650.836,Light,Electromagnetic Radiation,41
Sunlight,G,G16.500.750.775.525,Weather,Meteorological Concepts,41
Sunlight,G,G16.500.275.063.725.525,Weather,Atmosphere,41
Sunlight,N,N06.230.300.100.725.525,Weather,Atmosphere,41
User-Computer Interface,L,L01.224.900.910,Software,Computing Methodologies,41
Vibrio cholerae,B,B03.440.450.900.859.225,Vibrio,Vibrionaceae,41
Vibrio cholerae,B,B03.660.250.830.830.100,Vibrio,Vibrionaceae,41
Alkynes,D,D02.455.326.397,"Hydrocarbons, Acyclic",Hydrocarbons,40
Aortic Valve Stenosis,C,C14.280.484.048.750,Aortic Valve Disease,Heart Valve Diseases,40
Aortic Valve Stenosis,C,C14.280.955.249,Ventricular Outflow Obstruction,Heart Diseases,40
Bacterial Load,E,E01.370.225.875.220.115,"Colony Count, Microbial",Microbiological Techniques,40
Bacterial Load,E,E01.370.225.875.150.115,Bacteriological Techniques,Microbiological Techniques,40
Bacterial Load,G,G06.099.100,Bacterial Physiological Phenomena,Microbiological Phenomena,40
Bacterial Load,E,E05.200.875.220.115,"Colony Count, Microbial",Microbiological Techniques,40
Bacterial Load,E,E05.200.875.150.115,Bacteriological Techniques,Microbiological Techniques,40
Biological Transport,G,G03.143,Metabolism,NULL,40
Blood Pressure Determination,E,E01.370.370.140,"Diagnostic Techniques, Cardiovascular",Diagnostic Techniques and Procedures,40
Blood Pressure Determination,E,E01.370.600.100,Physical Examination,Diagnostic Techniques and Procedures,40
Bluetongue,C,C22.836.120,Sheep Diseases,Animal Diseases,40
Bluetongue,C,C01.925.081.125,Arbovirus Infections,Virus Diseases,40
Bluetongue,C,C01.920.500.125,Arbovirus Infections,Vector Borne Diseases,40
Bluetongue,C,C01.925.782.791.315,Reoviridae Infections,RNA Virus Infections,40
Bone and Bones,A,A02.835.232,Skeleton,Musculoskeletal System,40
Bone and Bones,A,A10.165.265,Connective Tissue,Tissues,40
Bullying,F,F01.145.813.213.500,"Harassment, Non-Sexual",Social Behavior,40
Bullying,F,F01.145.126.125.550,Aggression,Behavioral Symptoms,40
Bullying,I,I01.880.735.070,Social Problems,Sociology,40
Codon,G,G05.360.340.024.340.137.190,Gene Components,Genes,40
Codon,G,G05.360.335.355,Genetic Code,Genetic Structures,40
Codon,D,D13.444.735.544.355,"RNA, Messenger",RNA,40
"Education, Medical, Graduate",I,I02.358.399.350,"Education, Medical","Education, Professional",40
"Education, Medical, Graduate",I,I02.358.337.350,"Education, Graduate","Education, Professional",40
Exercise Test,E,E05.333.250,Ergometry,Investigative Techniques,40
Exercise Test,E,E01.370.386.700.250,Respiratory Function Tests,"Diagnostic Techniques, Respiratory System",40
Exercise Test,E,E01.370.370.380.250,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",40
Gabon,Z,Z01.058.290.100.380,"Africa, Central",Africa South of the Sahara,40
HIV Envelope Protein gp120,D,D23.050.327.520.350,HIV Antigens,"Antigens, Viral",40
HIV Envelope Protein gp120,D,D12.776.964.970.880.325.164.249,"env Gene Products, Human Immunodeficiency Virus","Gene Products, env",40
HIV Envelope Protein gp120,D,D12.776.964.775.562.500.500,"env Gene Products, Human Immunodeficiency Virus",Human Immunodeficiency Virus Proteins,40
HIV Envelope Protein gp120,D,D12.776.964.775.325.164.249,"env Gene Products, Human Immunodeficiency Virus","Gene Products, env",40
"Hospitals, General",N,N02.278.421.389,Hospitals,Health Facilities,40
Immune Tolerance,G,G12.535.425,Immunomodulation,Immune System Phenomena,40
"Injections, Intravenous",E,E02.319.267.530.540,Injections,Drug Administration Routes,40
"Injections, Intravenous",E,E02.319.267.082.750,"Administration, Intravenous",Drug Administration Routes,40
"Intensive Care Units, Neonatal",N,N02.278.388.493.390.380,"Intensive Care Units, Pediatric",Intensive Care Units,40
"Labor, Obstetric",G,G08.686.784.769.326,Pregnancy,Reproduction,40
Liver Transplantation,E,E04.210.650,Digestive System Surgical Procedures,"Surgical Procedures, Operative",40
Liver Transplantation,E,E04.936.450.490,Organ Transplantation,Transplantation,40
Liver Transplantation,E,E04.936.580.490,Tissue Transplantation,Transplantation,40
Liver Transplantation,E,E02.095.147.725.490,Tissue Transplantation,Cell- and Tissue-Based Therapy,40
"Medicine, African Traditional",E,E02.190.488.505,"Medicine, Traditional",Complementary Therapies,40
"Medicine, African Traditional",E,E02.190.901.433,Spiritual Therapies,Complementary Therapies,40
"Medicine, African Traditional",I,I01.076.201.450.654.505,"Medicine, Traditional",Culture,40
Melanesia,Z,Z01.639.760.590,Pacific Islands,Islands,40
Mesothelioma,C,C04.557.470.035.510,Adenoma,"Neoplasms, Glandular and Epithelial",40
Mesothelioma,C,C04.557.470.660.510,"Neoplasms, Mesothelial","Neoplasms, Glandular and Epithelial",40
Methods,E,E05.581,Investigative Techniques,NULL,40
Microbial Viability,G,G06.580,Microbiological Phenomena,NULL,40
Mifepristone,D,D04.210.500.365.415.580,Estrenes,Estranes,40
"Monitoring, Physiologic",E,E01.370.520,Diagnostic Techniques and Procedures,Diagnosis,40
Oxidation-Reduction,G,G02.700,Chemical Phenomena,NULL,40
Oxidation-Reduction,G,G03.295.531,Energy Metabolism,Metabolism,40
"Personnel, Hospital",M,M01.526.485.740,Health Personnel,Occupational Groups,40
"Personnel, Hospital",N,N02.360.740,Health Personnel,"Health Care Facilities, Manpower, and Services",40
Phosphoproteins,D,D12.776.744,Proteins,"Amino Acids, Peptides, and Proteins",40
Piperazines,D,D03.383.606,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,40
Poliovirus Vaccines,D,D20.215.894.899.623,Viral Vaccines,Vaccines,40
Preoperative Care,N,N02.421.585.795,Patient Care,Health Services,40
Preoperative Care,E,E04.604.750,Perioperative Care,"Surgical Procedures, Operative",40
Preoperative Care,E,E02.760.795,Patient Care,Therapeutics,40
Religion,K,K01.844,Humanities,NULL,40
"RNA, Bacterial",D,D13.444.735.473,RNA,Nucleic Acids,40
Smartphone,L,L01.178.847.698.300.250,Cell Phone,Telephone,40
Smartphone,L,L01.224.230.260.550.500.750,"Computers, Handheld",Microcomputers,40
Social Marketing,J,J01.219.687.750,Marketing,Commerce,40
Social Marketing,N,N05.300.430.500.500,Marketing of Health Services,Health Services Accessibility,40
Venezuela,Z,Z01.107.757.943,South America,Americas,40
Virus Assembly,G,G06.920.925.950,Virus Replication,Virus Physiological Phenomena,40
Withholding Treatment,E,E02.760.952,Patient Care,Therapeutics,40
Withholding Treatment,N,N02.421.585.952,Patient Care,Health Services,40
Wolbachia,B,B03.660.050.783.500.762,Anaplasmataceae,Rickettsiales,40
Academies and Institutes,N,N03.540.052,Organizations,Health Care Economics and Organizations,39
Anticonvulsants,D,D27.505.954.427.080,Central Nervous System Agents,Therapeutic Uses,39
Armed Conflicts,I,I01.880.735.950.250,Warfare and Armed Conflicts,Social Problems,39
Autophagy,G,G04.011,Cell Physiological Phenomena,NULL,39
Cerebral Hemorrhage,C,C23.550.414.913.100,Intracranial Hemorrhages,Hemorrhage,39
Cerebral Hemorrhage,C,C14.907.253.573.200,Intracranial Hemorrhages,Cerebrovascular Disorders,39
Cerebral Hemorrhage,C,C10.228.140.300.535.200,Intracranial Hemorrhages,Cerebrovascular Disorders,39
Chikungunya Fever,C,C01.925.782.930.100.184,Alphavirus Infections,Togaviridae Infections,39
Chikungunya Fever,C,C01.920.500.078.184,Alphavirus Infections,Arbovirus Infections,39
Chikungunya Fever,C,C01.925.081.198,Arbovirus Infections,Virus Diseases,39
"Contraceptive Agents, Female",D,D27.505.954.705.360.276,Contraceptive Agents,Reproductive Control Agents,39
"Contraceptive Agents, Female",D,D27.505.696.875.360.276,Contraceptive Agents,Reproductive Control Agents,39
"Endothelium, Vascular",A,A10.272.491.355,Endothelium,Epithelium,39
"Endothelium, Vascular",A,A07.015.700.500,Tunica Intima,Blood Vessels,39
Glucosephosphate Dehydrogenase,D,D08.811.682.047.150.300,Carbohydrate Dehydrogenases,Alcohol Oxidoreductases,39
Government Agencies,I,I01.409.418,Government,Social Sciences,39
Government Agencies,N,N03.540.400,Organizations,Health Care Economics and Organizations,39
Guatemala,Z,Z01.107.169.454,Central America,Americas,39
Hepatitis B Antibodies,D,D12.776.124.486.485.114.254.450.504,Hepatitis Antibodies,"Antibodies, Viral",39
Hepatitis B Antibodies,D,D12.776.124.790.651.114.254.450.504,Hepatitis Antibodies,"Antibodies, Viral",39
Hepatitis B Antibodies,D,D12.776.377.715.548.114.254.450.504,Hepatitis Antibodies,"Antibodies, Viral",39
Hydrocortisone,D,D04.210.500.745.745.654.600,Pregnenediones,Pregnenes,39
Hydrocortisone,D,D06.472.040.585.353.476,11-Hydroxycorticosteroids,Hydroxycorticosteroids,39
Hydrocortisone,D,D06.472.040.585.478.392,17-Hydroxycorticosteroids,Hydroxycorticosteroids,39
Hyperglycemia,C,C18.452.394.952,Glucose Metabolism Disorders,Metabolic Diseases,39
Illicit Drugs,D,D26.878,Pharmaceutical Preparations,NULL,39
Immunoglobulins,D,D12.776.377.715.548,Serum Globulins,Globulins,39
Immunoglobulins,D,D12.776.124.486.485,Immunoproteins,Blood Proteins,39
Immunoglobulins,D,D12.776.124.790.651,Serum Globulins,Blood Proteins,39
Intestines,A,A03.556.124,Gastrointestinal Tract,Digestive System,39
Lipid Metabolism,G,G03.458,Metabolism,NULL,39
"Lupus Erythematosus, Systemic",C,C17.300.480,Connective Tissue Diseases,Skin and Connective Tissue Diseases,39
"Lupus Erythematosus, Systemic",C,C20.111.590,Autoimmune Diseases,Immune System Diseases,39
Mammals,B,B01.050.150.900.649,Vertebrates,Chordata,39
Measles virus,B,B04.820.480.937.600.650.500.500,Morbillivirus,Paramyxovirinae,39
Mineralocorticoid Receptor Antagonists,D,D06.347.700,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",39
Mineralocorticoid Receptor Antagonists,D,D27.505.696.399.450.600,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",39
Mineralocorticoid Receptor Antagonists,D,D27.505.696.560.500.726.249,"Diuretics, Potassium Sparing",Diuretics,39
Minerals,D,D01.578,Inorganic Chemicals,NULL,39
"Models, Psychological",E,E05.599.695,"Models, Theoretical",Investigative Techniques,39
"Mortality, Premature",E,E05.318.308.985.550.550,Mortality,Vital Statistics,39
"Mortality, Premature",N,N01.224.935.698.700,Mortality,Vital Statistics,39
"Mortality, Premature",N,N06.850.505.400.975.550.550,Mortality,Vital Statistics,39
"Mortality, Premature",N,N06.850.520.308.985.550.550,Mortality,Vital Statistics,39
Multimorbidity,N,N06.850.490.687.500,Comorbidity,Epidemiologic Factors,39
Multimorbidity,N,N05.715.350.225.500,Comorbidity,Epidemiologic Factors,39
"Multiple Sclerosis, Relapsing-Remitting",C,C20.111.258.250.500.600,Multiple Sclerosis,"Demyelinating Autoimmune Diseases, CNS",39
"Multiple Sclerosis, Relapsing-Remitting",C,C10.314.350.500.600,Multiple Sclerosis,"Demyelinating Autoimmune Diseases, CNS",39
"Multiple Sclerosis, Relapsing-Remitting",C,C10.114.375.500.600,Multiple Sclerosis,"Demyelinating Autoimmune Diseases, CNS",39
Negotiating,N,N04.452.677.430,Personnel Management,Organization and Administration,39
Negotiating,L,L01.143.620,Communication,Information Science,39
Negotiating,F,F01.145.209.520,Communication,Behavior,39
Negotiating,F,F01.829.401.520,Interpersonal Relations,"Psychology, Social",39
Negotiating,F,F02.463.785.373.520,Decision Making,Thinking,39
Nuclear Proteins,D,D12.776.660,Proteins,"Amino Acids, Peptides, and Proteins",39
Perinatal Mortality,E,E05.318.308.985.550.475.500,Infant Mortality,Mortality,39
Perinatal Mortality,N,N06.850.505.400.975.550.475.500,Infant Mortality,Mortality,39
Perinatal Mortality,N,N06.850.520.308.985.550.475.500,Infant Mortality,Mortality,39
Perinatal Mortality,N,N01.224.935.698.489.500,Infant Mortality,Mortality,39
Professional Competence,I,I02.399.630,Educational Measurement,Education,39
Proteome,D,D12.776.817,Proteins,"Amino Acids, Peptides, and Proteins",39
Pyrimidines,D,D03.383.742,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,39
Reminder Systems,L,L01.143.820,Communication,Information Science,39
Reminder Systems,L,L01.313.500.750.300.790,Information Systems,Medical Informatics Applications,39
Salmonella enterica,B,B03.660.250.150.710.160,Salmonella,Enterobacteriaceae,39
Salmonella enterica,B,B03.440.450.425.800.200,Salmonella,Enterobacteriaceae,39
Severe Acute Malnutrition,C,C18.654.521.719,Malnutrition,Nutrition Disorders,39
Shigella flexneri,B,B03.440.450.425.850.450,Shigella,Enterobacteriaceae,39
Shigella flexneri,B,B03.660.250.150.730.210,Shigella,Enterobacteriaceae,39
Social Networking,L,L01.143.910,Communication,Information Science,39
Staining and Labeling,E,E05.200.750.600.670,Histocytological Preparation Techniques,Histological Techniques,39
Staining and Labeling,E,E05.200.500.620.670,Histocytological Preparation Techniques,Cytological Techniques,39
Staining and Labeling,E,E01.370.225.750.600.670,Histocytological Preparation Techniques,Histological Techniques,39
Staining and Labeling,E,E01.370.225.500.620.670,Histocytological Preparation Techniques,Cytological Techniques,39
Testicular Neoplasms,C,C04.588.322.762,Endocrine Gland Neoplasms,Neoplasms by Site,39
Testicular Neoplasms,C,C04.588.945.440.915,"Genital Neoplasms, Male",Urogenital Neoplasms,39
Testicular Neoplasms,C,C19.391.829.782,Testicular Diseases,Gonadal Disorders,39
Testicular Neoplasms,C,C19.344.762,Endocrine Gland Neoplasms,Endocrine System Diseases,39
Testicular Neoplasms,C,C12.758.409.937,"Genital Neoplasms, Male",Urogenital Neoplasms,39
Testicular Neoplasms,C,C12.294.260.937,"Genital Neoplasms, Male","Genital Diseases, Male",39
Tobacco Products,J,J01.637.767.844,Smoking Devices,Manufactured Materials,39
Ulcer,C,C23.550.891,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",39
Urinary Bladder Neoplasms,C,C12.758.820.968,Urologic Neoplasms,Urogenital Neoplasms,39
Urinary Bladder Neoplasms,C,C12.777.829.813,Urinary Bladder Diseases,Urologic Diseases,39
Urinary Bladder Neoplasms,C,C13.351.968.829.707,Urinary Bladder Diseases,Urologic Diseases,39
Urinary Bladder Neoplasms,C,C13.351.937.820.945,Urologic Neoplasms,Urogenital Neoplasms,39
Urinary Bladder Neoplasms,C,C04.588.945.947.960,Urologic Neoplasms,Urogenital Neoplasms,39
"Angina, Unstable",C,C14.280.647.187.150,Angina Pectoris,Myocardial Ischemia,38
"Angina, Unstable",C,C14.907.585.187.150,Angina Pectoris,Myocardial Ischemia,38
"Angina, Unstable",C,C23.888.592.612.233.500.150,Angina Pectoris,Chest Pain,38
Arginine,D,D12.125.068.050,"Amino Acids, Basic",Amino Acids,38
Arginine,D,D12.125.095.104,"Amino Acids, Diamino",Amino Acids,38
Arginine,D,D12.125.142.087,"Amino Acids, Essential",Amino Acids,38
Autistic Disorder,F,F03.625.164.113.500,Autism Spectrum Disorder,"Child Development Disorders, Pervasive",38
Botswana,Z,Z01.058.290.175.230,"Africa, Southern",Africa South of the Sahara,38
Brain Neoplasms,C,C10.551.240.250,Central Nervous System Neoplasms,Nervous System Neoplasms,38
Brain Neoplasms,C,C10.228.140.211,Brain Diseases,Central Nervous System Diseases,38
Brain Neoplasms,C,C04.588.614.250.195,Central Nervous System Neoplasms,Nervous System Neoplasms,38
California,Z,Z01.107.567.875.760.200,Southwestern United States,United States,38
California,Z,Z01.107.567.875.580.200,Pacific States,United States,38
Chancroid,C,C01.150.252.400.700.433.308,Haemophilus Infections,Pasteurellaceae Infections,38
Chancroid,C,C01.150.252.734.201,"Sexually Transmitted Diseases, Bacterial",Bacterial Infections,38
Chancroid,C,C01.221.812.281.201,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,38
Chancroid,C,C01.778.281.201,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,38
Chancroid,C,C13.351.500.711.281.201,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,38
Chancroid,C,C12.294.668.281.201,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,38
Contract Services,N,N03.219.463.100,Financial Management,Economics,38
Coronavirus,B,B04.820.578.500.540.150,Coronaviridae,Nidovirales,38
"Diabetes, Gestational",C,C13.703.170,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,38
"Diabetes, Gestational",C,C18.452.394.750.448,Diabetes Mellitus,Glucose Metabolism Disorders,38
"Diabetes, Gestational",C,C19.246.200,Diabetes Mellitus,Endocrine System Diseases,38
"Education, Medical, Undergraduate",I,I02.358.399.450,"Education, Medical","Education, Professional",38
False Negative Reactions,E,E01.354.340,Diagnostic Errors,Diagnosis,38
Fatty Acids,D,D10.251,Lipids,NULL,38
Haemophilus ducreyi,B,B03.660.250.550.290.125,Haemophilus,Pasteurellaceae,38
Haemophilus ducreyi,B,B03.440.450.600.450.125,Haemophilus,Pasteurellaceae,38
Hepcidins,D,D12.776.494.249,Iron-Regulatory Proteins,Proteins,38
Hepcidins,D,D12.776.543.695.054.425,Antimicrobial Cationic Peptides,Pore Forming Cytotoxic Proteins,38
Hip Fractures,C,C26.404.061.425,Femoral Fractures,"Fractures, Bone",38
Hip Fractures,C,C26.531.750,Hip Injuries,Wounds and Injuries,38
Hip Fractures,C,C26.558.276.425,Femoral Fractures,Leg Injuries,38
Lactones,D,D02.540,Organic Chemicals,NULL,38
Leishmania major,B,B01.268.475.868.488.405,Leishmania,Trypanosomatina,38
"Medicine, Traditional",E,E02.190.488,Complementary Therapies,Therapeutics,38
"Medicine, Traditional",I,I01.076.201.450.654,Culture,"Anthropology, Cultural",38
Multidrug Resistance-Associated Proteins,D,D12.776.543.585.100.304,ATP-Binding Cassette Transporters,Membrane Transport Proteins,38
Multidrug Resistance-Associated Proteins,D,D12.776.543.585.450.074.500.500.500,"Organic Anion Transporters, ATP-Dependent",Organic Anion Transporters,38
Multidrug Resistance-Associated Proteins,D,D12.776.157.530.100.304,ATP-Binding Cassette Transporters,Membrane Transport Proteins,38
Multidrug Resistance-Associated Proteins,D,D12.776.157.530.450.074.500.500.500,"Organic Anion Transporters, ATP-Dependent",Organic Anion Transporters,38
"Neoplasm Recurrence, Local",C,C04.697.655,Neoplastic Processes,Neoplasms,38
"Neoplasm Recurrence, Local",C,C23.550.727.655,Neoplastic Processes,Pathologic Processes,38
Osteopontin,D,D12.776.395.700.837,Sialoglycoproteins,Glycoproteins,38
Osteopontin,D,D12.644.276.374.625,Cytokines,Intercellular Signaling Peptides and Proteins,38
Osteopontin,D,D12.776.467.374.625,Cytokines,Intercellular Signaling Peptides and Proteins,38
Osteopontin,D,D12.776.860.300.762,Extracellular Matrix Proteins,Scleroproteins,38
Osteopontin,D,D23.529.374.625,Cytokines,Intercellular Signaling Peptides and Proteins,38
Postmenopause,G,G08.686.841.249.500.625,Menopause,Climacteric,38
Postmenopause,G,G08.686.157.500.625,Menopause,Climacteric,38
Postoperative Period,E,E04.614.750,Perioperative Period,"Surgical Procedures, Operative",38
Postoperative Period,N,N02.421.585.753.750,Perioperative Period,Patient Care,38
Precursor Cell Lymphoblastic Leukemia-Lymphoma,C,C20.683.515.528.600,"Leukemia, Lymphoid",Lymphoproliferative Disorders,38
Precursor Cell Lymphoblastic Leukemia-Lymphoma,C,C15.604.515.560.600,"Leukemia, Lymphoid",Lymphoproliferative Disorders,38
Precursor Cell Lymphoblastic Leukemia-Lymphoma,C,C04.557.337.428.600,"Leukemia, Lymphoid",Leukemia,38
"Respiration, Artificial",E,E02.365.647.729,Resuscitation,Emergency Treatment,38
"Respiration, Artificial",E,E02.041.625,Airway Management,Therapeutics,38
"Respiration, Artificial",E,E02.880.820,Respiratory Therapy,Therapeutics,38
Rodentia,B,B01.050.150.900.649.313.992,Eutheria,Mammals,38
"Sequence Homology, Nucleic Acid",G,G05.810.550,Sequence Homology,Genetic Phenomena,38
"Sequence Homology, Nucleic Acid",G,G02.111.810.550,Sequence Homology,Biochemical Phenomena,38
Solubility,G,G02.805,Chemical Phenomena,NULL,38
Tetracycline,D,D02.455.426.559.847.562.900.875,Tetracyclines,Naphthacenes,38
Tetracycline,D,D04.615.562.900.875,Tetracyclines,Naphthacenes,38
"Vaccines, Combined",D,D20.215.894.815,Vaccines,Biological Products,38
"Ventricular Dysfunction, Left",C,C14.280.945.900,Ventricular Dysfunction,Heart Diseases,38
Vitamin B 12,D,D04.345.783.437.777,Corrinoids,Tetrapyrroles,38
Vitamin B 12,D,D03.383.129.578.840.437.777,Corrinoids,Tetrapyrroles,38
Vitamin B 12,D,D03.633.400.909.437.777,Corrinoids,Tetrapyrroles,38
Actins,D,D05.750.078.730.250,Microfilament Proteins,Biopolymers,37
Actins,D,D12.776.210.500.100,Muscle Proteins,Contractile Proteins,37
Actins,D,D12.776.220.525.255,Microfilament Proteins,Cytoskeletal Proteins,37
Adrenergic beta-Agonists,D,D27.505.696.577.050.100.200,Adrenergic Agonists,Adrenergic Agents,37
Adrenergic beta-Agonists,D,D27.505.519.625.050.100.200,Adrenergic Agonists,Adrenergic Agents,37
Antigens,D,D23.050,Biological Factors,NULL,37
Autoimmune Diseases,C,C20.111,Immune System Diseases,NULL,37
Biological Specimen Banks,N,N02.278.065,Health Facilities,"Health Care Facilities, Manpower, and Services",37
Cell Movement,G,G04.198,Cell Physiological Phenomena,NULL,37
Cell Movement,G,G07.568.500.180,Locomotion,Movement,37
Cerebral Palsy,C,C10.228.140.140.254,"Brain Damage, Chronic",Brain Diseases,37
Dust,D,D20.633.222,Particulate Matter,Complex Mixtures,37
Economic Competition,N,N03.219.188,Economics,Health Care Economics and Organizations,37
Endocytosis,G,G04.417,Cell Physiological Phenomena,NULL,37
"Fatigue Syndrome, Chronic",C,C10.228.440.600,Encephalomyelitis,Central Nervous System Diseases,37
"Fatigue Syndrome, Chronic",C,C10.668.364,Neuromuscular Diseases,Nervous System Diseases,37
"Fatigue Syndrome, Chronic",C,C01.925.330,Virus Diseases,Infections,37
"Fatigue Syndrome, Chronic",C,C05.651.310,Muscular Diseases,Musculoskeletal Diseases,37
Fluconazole,D,D03.383.129.799.450,Triazoles,Azoles,37
Friends,M,M01.252,Persons,NULL,37
Hospital Administration,N,N02.278.216.500,Health Facility Administration,Health Facilities,37
Hospital Administration,N,N04.452.442.452,Health Facility Administration,Organization and Administration,37
Hospital Administration,H,H02.309,Health Occupations,NULL,37
"Hospitals, University",N,N02.278.020.300.310,"Hospitals, Teaching",Academic Medical Centers,37
"Hospitals, University",N,N02.278.421.639.725,"Hospitals, Teaching",Hospitals,37
"Image Interpretation, Computer-Assisted",L,L01.313.500.750.100.158.600,"Diagnosis, Computer-Assisted","Decision Making, Computer-Assisted",37
"Image Interpretation, Computer-Assisted",E,E01.158.600,"Diagnosis, Computer-Assisted",Diagnosis,37
"Image Interpretation, Computer-Assisted",E,E01.370.350.350,Diagnostic Imaging,Diagnostic Techniques and Procedures,37
Leishmania infantum,B,B01.268.475.868.488.325,Leishmania,Trypanosomatina,37
Mentors,M,M01.395,Persons,NULL,37
Mutagenesis,G,G05.558,Genetic Phenomena,NULL,37
"Neoplasms, Radiation-Induced",G,G01.750.748.500.476,Radiation Injuries,Radiation Exposure,37
"Neoplasms, Radiation-Induced",C,C04.682,Neoplasms,NULL,37
"Neoplasms, Radiation-Induced",C,C26.733.476,Radiation Injuries,Wounds and Injuries,37
Oxidative Stress,G,G03.673,Metabolism,NULL,37
Oxidative Stress,G,G07.775.750,"Stress, Physiological",Physiological Phenomena,37
Phosphorylcholine,D,D02.092.877.883.333.700,Choline,Trimethyl Ammonium Compounds,37
Phosphorylcholine,D,D02.675.276.232.700,Choline,Quaternary Ammonium Compounds,37
Postoperative Care,E,E02.760.731.700,Perioperative Care,Patient Care,37
Postoperative Care,E,E04.604.500,Perioperative Care,"Surgical Procedures, Operative",37
Postoperative Care,N,N02.421.585.722.700,Perioperative Care,Patient Care,37
"Pregnancy Trimester, Second",G,G08.686.707.490,Pregnancy Trimesters,Reproductive Physiological Phenomena,37
Recovery of Function,G,G16.757,Biological Phenomena,NULL,37
Repressor Proteins,D,D12.776.260.703,DNA-Binding Proteins,Proteins,37
Repressor Proteins,D,D12.776.930.780,Transcription Factors,Proteins,37
Research Subjects,M,M01.774,Persons,NULL,37
Self Disclosure,F,F01.752.747.792.662,Self Concept,Personality Development,37
Thrombocytopenia,C,C15.378.140.855,Blood Platelet Disorders,Hematologic Diseases,37
Thrombolytic Therapy,E,E02.319.913,Drug Therapy,Therapeutics,37
Thrombosis,C,C14.907.355.830,Embolism and Thrombosis,Vascular Diseases,37
Travel Medicine,H,H02.403.850,Medicine,Health Occupations,37
Trypanosoma brucei gambiense,B,B01.268.475.868.887.110,Trypanosoma,Trypanosomatina,37
Angiotensin Receptor Antagonists,D,D27.505.519.162,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,36
"Aortic Aneurysm, Abdominal",C,C14.907.055.239.075,Aortic Aneurysm,Aneurysm,36
"Aortic Aneurysm, Abdominal",C,C14.907.109.139.075,Aortic Aneurysm,Aortic Diseases,36
Arm,A,A01.378.800.075,Upper Extremity,Extremities,36
"Asia, Western",Z,Z01.252.245,Asia,Geographic Locations,36
Caprylates,D,D02.241.081.222,"Acids, Acyclic",Carboxylic Acids,36
Caprylates,D,D10.251.122,Fatty Acids,Lipids,36
Carotid Stenosis,C,C14.907.137.230,Arterial Occlusive Diseases,Vascular Diseases,36
Carotid Stenosis,C,C14.907.253.123.360,Carotid Artery Diseases,Cerebrovascular Disorders,36
Carotid Stenosis,C,C10.228.140.300.200.360,Carotid Artery Diseases,Cerebrovascular Disorders,36
"Catchment Area, Health",N,N01.224.791.200,Residence Characteristics,Demography,36
"Catchment Area, Health",N,N03.349.650.095,Regional Health Planning,Health Planning,36
"Catchment Area, Health",N,N06.850.505.400.800.200,Residence Characteristics,Demography,36
Cell Division,G,G07.345.249.410.750.500,Cell Proliferation,Cell Growth Processes,36
Cell Division,G,G04.161.750.500,Cell Proliferation,Cell Growth Processes,36
Cell Division,G,G04.144.220,Cell Cycle,Cell Physiological Phenomena,36
Cell Division,G,G05.113,Genetic Phenomena,NULL,36
Censuses,N,N06.850.505.400.225,Demography,Epidemiologic Measurements,36
Censuses,N,N01.224.175,Demography,Population Characteristics,36
Censuses,I,I01.240.205,Demography,Social Sciences,36
Dexamethasone,D,D04.210.500.745.432.769.344,Pregnadienetriols,Pregnadienes,36
Dexamethasone,D,D04.210.500.908.238,"Steroids, Fluorinated",Steroids,36
Disabled Children,M,M01.150.200,Disabled Persons,Persons,36
Drug-Eluting Stents,E,E07.695.750.500,Stents,Prostheses and Implants,36
Empirical Research,H,H01.770.644.241,Research,Science,36
Feedback,L,L01.906.394.211,Operations Research,Systems Analysis,36
"Gene Transfer, Horizontal",G,G05.728.390,"Recombination, Genetic",Genetic Phenomena,36
Gene-Environment Interaction,G,G05.695.337,Phenotype,Genetic Phenomena,36
Health Services Administration,N,N04,NULL,NULL,36
Health Services Administration,H,H02.269,Health Occupations,NULL,36
Hematocrit,G,G09.188.370.374,Hemorheology,Blood Physiological Phenomena,36
Hematocrit,E,E05.200.625.400,Hematologic Tests,Clinical Laboratory Techniques,36
Hematocrit,E,E01.370.225.625.400,Hematologic Tests,Clinical Laboratory Techniques,36
HLA-DR Antigens,D,D23.050.301.500.400.400.440,HLA-D Antigens,Histocompatibility Antigens Class II,36
HLA-DR Antigens,D,D23.050.301.500.450.400.440,HLA-D Antigens,HLA Antigens,36
HLA-DR Antigens,D,D23.050.705.552.410.400.440,HLA-D Antigens,Histocompatibility Antigens Class II,36
HLA-DR Antigens,D,D23.050.705.552.450.400.440,HLA-D Antigens,HLA Antigens,36
HLA-DR Antigens,D,D12.776.543.550.440.400.440,HLA-D Antigens,Histocompatibility Antigens Class II,36
HLA-DR Antigens,D,D12.776.395.550.509.400.440,HLA-D Antigens,Histocompatibility Antigens Class II,36
Immunologic Tests,E,E01.370.225.812,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,36
Immunologic Tests,E,E05.200.812,Clinical Laboratory Techniques,Investigative Techniques,36
Immunologic Tests,E,E05.478.594,Immunologic Techniques,Investigative Techniques,36
Intelligence,F,F01.752.543,Personality,Behavior and Behavior Mechanisms,36
Ligands,D,D27.720.470.480,Laboratory Chemicals,Specialty Uses of Chemicals,36
Medical Assistance,N,N03.219.521.346.506.564,Public Assistance,"Financing, Government",36
Medicine,H,H02.403,Health Occupations,NULL,36
"Microscopy, Confocal",E,E05.595.395,Microscopy,Investigative Techniques,36
"Microscopy, Confocal",E,E01.370.350.515.395,Microscopy,Diagnostic Imaging,36
Narration,F,F01.145.209.459,Communication,Behavior,36
Narration,E,E05.318.308.502,Data Collection,Epidemiologic Methods,36
Narration,L,L01.399.250.660,Data Collection,Information Management,36
Narration,N,N05.715.360.300.480,Data Collection,Health Care Evaluation Mechanisms,36
Narration,N,N06.850.520.308.502,Data Collection,Epidemiologic Methods,36
Nicaragua,Z,Z01.107.169.690,Central America,Americas,36
Nurse's Role,N,N05.300.100.337,Attitude of Health Personnel,Delivery of Health Care,36
Nurse's Role,F,F01.829.316.616.625.450,Professional Role,Role,36
Precision Medicine,E,E02.782,Therapeutics,NULL,36
Precision Medicine,H,H02.403.200.700,Clinical Medicine,Medicine,36
Prenatal Nutritional Physiological Phenomena,G,G08.686.784.769.600,Pregnancy,Reproduction,36
Prenatal Nutritional Physiological Phenomena,G,G07.203.650.566.624,Maternal Nutritional Physiological Phenomena,Nutritional Physiological Phenomena,36
"RNA, Protozoan",D,D13.444.735.650,RNA,Nucleic Acids,36
Self Administration,E,E02.319.890,Drug Therapy,Therapeutics,36
Self Administration,E,E02.900.890,Self Care,Therapeutics,36
Simuliidae,B,B01.050.500.131.617.720.500.500.750.712.500.937,Culicomorpha,Nematocera,36
Social Conditions,I,I01.880.853.450,Sociological Factors,Sociology,36
Social Conditions,N,N01.824.827,Socioeconomic Factors,Population Characteristics,36
Social Perception,F,F02.463.593.752,Perception,Mental Processes,36
Sodium,D,D01.552.547.725,"Metals, Light",Metals,36
Sodium,D,D01.552.528.850,"Metals, Alkali",Metals,36
Sodium,D,D01.268.557.650,"Metals, Light",Elements,36
Sodium,D,D01.268.549.750,"Metals, Alkali",Elements,36
Sodium-Glucose Transporter 2 Inhibitors,D,D27.505.519.936,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,36
Sodium-Glucose Transporter 2 Inhibitors,D,D27.505.696.422.750,Hypoglycemic Agents,Physiological Effects of Drugs,36
"Spike Glycoprotein, Coronavirus",D,D12.776.964.970.880.910.665,Viral Fusion Proteins,Viral Envelope Proteins,36
"Spike Glycoprotein, Coronavirus",D,D12.776.543.512.500.665,Viral Fusion Proteins,Membrane Fusion Proteins,36
Treatment Refusal,F,F01.145.488.887.750,Treatment Adherence and Compliance,Health Behavior,36
Treatment Refusal,F,F01.100.150.750.750,Treatment Adherence and Compliance,Attitude to Health,36
Treatment Refusal,N,N05.300.150.800.750,Treatment Adherence and Compliance,Attitude to Health,36
Treatment Refusal,N,N03.706.437.650.875,Patient Rights,Human Rights,36
Treatment Refusal,I,I01.880.604.473.650.968,Patient Rights,Human Rights,36
Tsetse Flies,B,B01.050.500.131.617.720.500.500.750.400.700,Glossinidae,Diptera,36
"Vaginosis, Bacterial",C,C01.150.252.954,Bacterial Infections,Bacterial Infections and Mycoses,36
"Vaginosis, Bacterial",C,C13.351.500.894.906.800,Vaginitis,Vaginal Diseases,36
Veterans,M,M01.930,Persons,NULL,36
Women's Rights,N,N03.706.437.850,Human Rights,"Social Control, Formal",36
Women's Rights,I,I01.880.604.473.850,Human Rights,"Social Control, Formal",36
Yellow Fever,C,C01.925.782.417.881,"Hemorrhagic Fevers, Viral",RNA Virus Infections,36
Yellow Fever,C,C01.925.782.350.250.980,Flavivirus Infections,Flaviviridae Infections,36
Yellow Fever,C,C01.920.500.980,Arbovirus Infections,Vector Borne Diseases,36
Yellow Fever,C,C01.925.081.980,Arbovirus Infections,Virus Diseases,36
Acyclovir,D,D03.633.100.759.758.399.454.250,Guanine,Hypoxanthines,35
Biofilms,A,A20.593,Bacterial Structures,NULL,35
Biofilms,G,G06.120,Microbiological Phenomena,NULL,35
Bipolar Disorder,F,F03.084.500,Bipolar and Related Disorders,Mental Disorders,35
Carbon,D,D01.268.150,Elements,Inorganic Chemicals,35
Chikungunya virus,B,B04.820.578.875.054.198,Alphavirus,Togaviridae,35
Crowding,F,F01.145.875.281,Spatial Behavior,Behavior,35
Data Analysis,H,H01.548.338,Mathematics,Natural Science Disciplines,35
"Databases, Bibliographic",L,L01.313.500.750.300.188.300,Databases as Topic,Information Systems,35
"Databases, Bibliographic",L,L01.470.750.500,Databases as Topic,Information Storage and Retrieval,35
"Diet, Healthy",F,F01.829.458.205.500,Healthy Lifestyle,Life Style,35
"Diet, Healthy",G,G07.203.650.240.629,Diet,Nutritional Physiological Phenomena,35
Electronic Nicotine Delivery Systems,J,J01.637.767.500,Smoking Devices,Manufactured Materials,35
Foodborne Diseases,C,C25.723.415,Poisoning,Chemically-Induced Disorders,35
Health Communication,L,L01.143.350,Communication,Information Science,35
Health Communication,N,N02.208,"Health Care Facilities, Manpower, and Services",NULL,35
Heparin,D,D09.698.373.400,Glycosaminoglycans,Polysaccharides,35
Hippocampus,A,A08.186.211.180.405,Limbic System,Brain,35
Hippocampus,A,A08.186.211.200.885.287.500.345,Cerebral Cortex,Cerebrum,35
Immunoblotting,E,E05.601.470.320,Immunoassay,Molecular Probe Techniques,35
Immunoblotting,E,E05.478.566.320,Immunoassay,Immunologic Techniques,35
"Infertility, Female",C,C13.351.500.365.700,Infertility,"Genital Diseases, Female",35
Injections,E,E02.319.267.530,Drug Administration Routes,Drug Therapy,35
Laser Therapy,E,E02.594,Therapeutics,NULL,35
Laser Therapy,E,E04.014.520,Ablation Techniques,"Surgical Procedures, Operative",35
"Leprosy, Lepromatous",C,C01.150.252.410.040.552.475.371.775.500,"Leprosy, Multibacillary",Leprosy,35
"Mice, SCID",B,B01.050.150.900.649.313.992.635.505.500.550.780,"Mice, Mutant Strains",Mice,35
Multiplex Polymerase Chain Reaction,E,E05.393.620.500.487,Polymerase Chain Reaction,Nucleic Acid Amplification Techniques,35
"Mutagenesis, Site-Directed",E,E05.393.420.601.575,Protein Engineering,Genetic Engineering,35
Nematode Infections,C,C01.610.335.508,Helminthiasis,Parasitic Diseases,35
Nerve Tissue Proteins,D,D12.776.631,Proteins,"Amino Acids, Peptides, and Proteins",35
Nitrogen Dioxide,D,D01.362.635.600,Nitrogen Oxides,Gases,35
Nitrogen Dioxide,D,D01.650.550.587.625,Nitrogen Oxides,Oxides,35
Nitrogen Dioxide,D,D01.625.550.525,Nitrogen Oxides,Nitrogen Compounds,35
Ozone,D,D01.362.670.600,Oxygen,Gases,35
Patient Isolation,E,E02.770,Therapeutics,NULL,35
Patient Isolation,N,N06.850.780.200.450.650,Infection Control,Communicable Disease Control,35
Peer Review,F,F01.829.316.549,Group Processes,"Psychology, Social",35
Peer Review,N,N03.706.700,"Social Control, Formal",Health Care Economics and Organizations,35
Peer Review,I,I01.880.604.640,"Social Control, Formal",Sociology,35
Personnel Staffing and Scheduling,I,I03.946.225,Work,Human Activities,35
Personnel Staffing and Scheduling,N,N04.452.677.650,Personnel Management,Organization and Administration,35
Primates,B,B01.050.150.900.649.313.988,Eutheria,Mammals,35
Protective Devices,J,J01.637.708,Manufactured Materials,"Technology, Industry, and Agriculture",35
Protective Devices,E,E07.700,Equipment and Supplies,NULL,35
Resuscitation,E,E02.365.647,Emergency Treatment,Therapeutics,35
"Rhinitis, Allergic, Seasonal",C,C20.543.480.680.443.750,"Rhinitis, Allergic",Respiratory Hypersensitivity,35
"Rhinitis, Allergic, Seasonal",C,C09.603.799.315.750,"Rhinitis, Allergic",Rhinitis,35
"Rhinitis, Allergic, Seasonal",C,C08.674.453.750,"Rhinitis, Allergic",Respiratory Hypersensitivity,35
"Rhinitis, Allergic, Seasonal",C,C08.460.799.315.750,"Rhinitis, Allergic",Rhinitis,35
Romania,Z,Z01.542.248.764,"Europe, Eastern",Europe,35
Schistosoma,B,B01.050.500.500.736.715.770.680,Schistosomatidae,Trematoda,35
Serum Amyloid A Protein,D,D12.776.049.407.750,Amyloidogenic Proteins,Amyloid,35
Serum Amyloid A Protein,D,D12.776.124.050.725,Acute-Phase Proteins,Blood Proteins,35
Terminal Care,E,E02.760.905,Patient Care,Therapeutics,35
Terminal Care,N,N02.421.585.905,Patient Care,Health Services,35
Troponin T,D,D12.776.220.525.825.962,Troponin,Microfilament Proteins,35
Troponin T,D,D12.776.210.500.910.962,Troponin,Muscle Proteins,35
Troponin T,D,D05.500.945.962,Troponin,Multiprotein Complexes,35
Troponin T,D,D05.750.078.730.825.962,Troponin,Microfilament Proteins,35
Yersinia pestis,B,B03.440.450.425.900.600,Yersinia,Enterobacteriaceae,35
Yersinia pestis,B,B03.660.250.150.950.580,Yersinia,Enterobacteriaceae,35
"Administration, Intravaginal",E,E02.319.267.120.500,"Administration, Topical",Drug Administration Routes,34
"Antigens, Fungal",D,D23.050.202,Antigens,Biological Factors,34
Asphyxia Neonatorum,C,C16.614.092,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",34
Calibration,E,E05.978.155,Weights and Measures,Investigative Techniques,34
Carcinoma,C,C04.557.470.200,"Neoplasms, Glandular and Epithelial",Neoplasms by Histologic Type,34
Cell Nucleus,A,A11.284.430.214.190.875.117,Organelles,Cytoplasmic Structures,34
Cell Nucleus,A,A11.284.430.106,Intracellular Space,Cellular Structures,34
"Chemotherapy, Adjuvant",E,E02.319.170,Drug Therapy,Therapeutics,34
"Chemotherapy, Adjuvant",E,E02.186.170,Combined Modality Therapy,Therapeutics,34
Cultural Diversity,I,I01.880.853.100.450,Culture,Sociological Factors,34
Cultural Diversity,I,I01.076.201.450.350,Culture,"Anthropology, Cultural",34
Faculty,M,M01.526.702.250,Educational Personnel,Occupational Groups,34
Georgia (Republic),Z,Z01.542.900.420,Transcaucasia,Europe,34
Georgia (Republic),Z,Z01.542.931.420,USSR,Europe,34
Georgia (Republic),Z,Z01.586.950.420,USSR,Historical Geographic Locations,34
Goats,B,B01.050.150.900.649.313.500.380.513,Ruminants,Artiodactyla,34
Hemodynamics,G,G09.330.380,Cardiovascular Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,34
High-Throughput Screening Assays,E,E05.916.680,"Technology, Pharmaceutical",Investigative Techniques,34
Human papillomavirus 16,B,B04.280.210.655.050.616,Alphapapillomavirus,Papillomaviridae,34
Human papillomavirus 16,B,B04.613.204.655.050.616,Alphapapillomavirus,Papillomaviridae,34
Influenza in Birds,C,C01.925.782.620.300,Orthomyxoviridae Infections,RNA Virus Infections,34
Influenza in Birds,C,C22.131.450,Bird Diseases,Animal Diseases,34
Intellectual Disability,C,C23.888.592.604.646,Neurobehavioral Manifestations,Neurologic Manifestations,34
Intellectual Disability,C,C10.597.606.360,Neurobehavioral Manifestations,Neurologic Manifestations,34
Intellectual Disability,F,F01.700.687,Neurobehavioral Manifestations,Behavior and Behavior Mechanisms,34
Intellectual Disability,F,F03.625.539,Neurodevelopmental Disorders,Mental Disorders,34
Intestinal Mucosa,A,A10.615.550.444,Mucous Membrane,Membranes,34
Intestinal Mucosa,A,A03.556.124.369,Intestines,Gastrointestinal Tract,34
Lopinavir,D,D03.383.742.698.553,Pyrimidinones,Pyrimidines,34
Maternal Death,C,C13.703.401,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,34
Maternal Death,C,C23.550.260.730.500,Parental Death,Death,34
Maternal Death,I,I01.880.735.607.500,Parental Death,Social Problems,34
Moths,B,B01.050.500.131.617.720.500.500.937.650,Lepidoptera,Holometabola,34
Needle Sharing,I,I01.880.735.580,Social Problems,Sociology,34
Nucleic Acid Conformation,G,G02.111.570.820.486,Molecular Conformation,Molecular Structure,34
Nucleic Acid Conformation,G,G05.360.580,Genetic Structures,Genetic Phenomena,34
Opioid-Related Disorders,F,F03.900.647.500,Narcotic-Related Disorders,Substance-Related Disorders,34
Opioid-Related Disorders,C,C25.775.643.500,Narcotic-Related Disorders,Substance-Related Disorders,34
Plasmodium yoelii,B,B01.043.075.380.611.780,Plasmodium,Haemosporida,34
Poultry,B,B01.050.050.116.625,"Animals, Domestic",Animal Population Groups,34
Poultry,B,B01.050.150.900.248.690,Birds,Vertebrates,34
Poultry,G,G07.203.300.600.750,Meat,Food,34
Poultry,J,J02.500.600.750,Meat,Food,34
Prasugrel Hydrochloride,D,D03.383.903.600,Thiophenes,"Heterocyclic Compounds, 1-Ring",34
Prasugrel Hydrochloride,D,D03.383.606.800,Piperazines,"Heterocyclic Compounds, 1-Ring",34
Prasugrel Hydrochloride,D,D02.886.778.600,Thiophenes,Sulfur Compounds,34
Protein Kinase Inhibitors,D,D27.505.519.389.755,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,34
Remission Induction,E,E02.860,Therapeutics,NULL,34
Shigella sonnei,B,B03.440.450.425.850.800,Shigella,Enterobacteriaceae,34
Shigella sonnei,B,B03.660.250.150.730.710,Shigella,Enterobacteriaceae,34
Tobacco,B,B01.650.940.800.575.912.250.908.500.900,Solanaceae,Solanales,34
Ultraviolet Rays,G,G01.750.250.650.891,Light,Electromagnetic Radiation,34
Ultraviolet Rays,G,G01.750.770.578.891,Light,"Radiation, Nonionizing",34
Ultraviolet Rays,G,G01.750.750.659,"Radiation, Ionizing",Radiation,34
Ultraviolet Rays,G,G01.358.500.505.650.891,Light,Electromagnetic Radiation,34
Ultraviolet Rays,G,G01.590.540.891,Light,Optical Phenomena,34
Ultraviolet Rays,G,G16.500.750.775.525.600,Sunlight,Weather,34
Ultraviolet Rays,G,G16.500.275.063.725.525.600,Sunlight,Weather,34
Ultraviolet Rays,N,N06.230.300.100.725.525.600,Sunlight,Weather,34
Visual Fields,G,G14.950,Ocular Physiological Phenomena,NULL,34
Visual Fields,F,F02.463.593.932.934,Visual Perception,Perception,34
Weaning,G,G07.203.650.220.500.750,Infant Nutritional Physiological Phenomena,Child Nutritional Physiological Phenomena,34
Weaning,G,G07.203.650.915,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",34
West Indies,Z,Z01.107.084.900,Caribbean Region,Americas,34
West Indies,Z,Z01.639.880,Islands,Geographic Locations,34
Amino Acid Motifs,G,G02.111.570.820.709.275.500,Protein Structural Elements,Protein Conformation,33
Amino Acid Motifs,G,G02.111.570.820.709.600.500,"Protein Structure, Secondary",Protein Conformation,33
Anti-Asthmatic Agents,D,D27.505.954.796.050,Respiratory System Agents,Therapeutic Uses,33
Biomass,G,G16.500.275.157.100,Ecosystem,Environment,33
Biomass,N,N06.230.124.100,Ecosystem,Environment,33
Birds,B,B01.050.150.900.248,Vertebrates,Chordata,33
Brain Diseases,C,C10.228.140,Central Nervous System Diseases,Nervous System Diseases,33
Breast,A,A01.236,Body Regions,NULL,33
Carbon Dioxide,D,D01.200.200,"Carbon Compounds, Inorganic",Inorganic Chemicals,33
Carbon Dioxide,D,D01.362.150,Gases,Inorganic Chemicals,33
Carbon Dioxide,D,D01.650.550.200,Oxides,Oxygen Compounds,33
Career Choice,F,F02.463.785.373.346.400,Choice Behavior,Decision Making,33
Cell Culture Techniques,E,E05.242.223,Cytological Techniques,Investigative Techniques,33
Cell Culture Techniques,E,E05.200.500.265,Cytological Techniques,Clinical Laboratory Techniques,33
Cell Culture Techniques,E,E05.481.500.249,Culture Techniques,In Vitro Techniques,33
Cell Culture Techniques,E,E01.370.225.500.223,Cytological Techniques,Clinical Laboratory Techniques,33
Chloramphenicol,D,D02.640.529.175,Nitrobenzenes,Nitro Compounds,33
Chloramphenicol,D,D02.033.455.706.300,Propylene Glycols,Glycols,33
Chloramphenicol,D,D02.455.426.559.389.565.175,Nitrobenzenes,Benzene Derivatives,33
Chromosomes,A,A11.284.430.106.279.345.190,Intranuclear Space,Cell Nucleus Structures,33
Chromosomes,A,A11.284.187,Cellular Structures,Cells,33
Chromosomes,G,G05.360.162,Genetic Structures,Genetic Phenomena,33
Corneal Ulcer,C,C01.375.177,Eye Infections,Infections,33
Corneal Ulcer,C,C11.294.177,Eye Infections,Eye Diseases,33
Corneal Ulcer,C,C11.204.564.225,Keratitis,Corneal Diseases,33
DDT,D,D02.455.526.439.255,"Hydrocarbons, Chlorinated","Hydrocarbons, Halogenated",33
Diabetic Angiopathies,C,C14.907.320,Vascular Diseases,Cardiovascular Diseases,33
Diabetic Angiopathies,C,C19.246.099.500,Diabetes Complications,Diabetes Mellitus,33
Diagnosis-Related Groups,N,N03.219.521.710.305.200.080,Prospective Payment System,Reimbursement Mechanisms,33
Embryonic and Fetal Development,G,G08.686.784.170,Reproduction,Reproductive Physiological Phenomena,33
Embryonic and Fetal Development,G,G07.345.500.325,Morphogenesis,Growth and Development,33
"Endarterectomy, Carotid",E,E04.100.814.456.250,Endarterectomy,Vascular Surgical Procedures,33
Epigenome,G,G05.360.340.006,Genome,Genetic Structures,33
"Eye Infections, Bacterial",C,C11.294.354,Eye Infections,Eye Diseases,33
"Eye Infections, Bacterial",C,C01.375.354,Eye Infections,Infections,33
"Eye Infections, Bacterial",C,C01.150.252.289,Bacterial Infections,Bacterial Infections and Mycoses,33
Glucose Tolerance Test,E,E01.370.225.124.100.355,Blood Chemical Analysis,Clinical Chemistry Tests,33
Glucose Tolerance Test,E,E01.370.374.355,"Diagnostic Techniques, Endocrine",Diagnostic Techniques and Procedures,33
Glucose Tolerance Test,E,E05.200.124.100.355,Blood Chemical Analysis,Clinical Chemistry Tests,33
Gram-Negative Bacteria,B,B03.440,Bacteria,NULL,33
Hypercholesterolemia,C,C18.452.584.500.500.396,Hyperlipidemias,Dyslipidemias,33
Immune Reconstitution Inflammatory Syndrome,C,C20.608,Immune System Diseases,NULL,33
Implementation Science,L,L01.143.320.400,Diffusion of Innovation,Communication,33
Information Services,L,L01.453,Information Science,NULL,33
Intrauterine Devices,E,E07.190.250.510,"Contraceptive Devices, Female",Contraceptive Devices,33
Lakes,G,G01.311.580,Geological Phenomena,Physical Phenomena,33
Lakes,N,N06.230.232.500,Fresh Water,Environment,33
Lakes,G,G16.500.275.280.500,Fresh Water,Environment,33
Learning,F,F02.784.629.529,"Psychology, Educational","Psychology, Applied",33
Learning,F,F02.463.425,Mental Processes,Psychological Phenomena,33
Live Birth,G,G08.686.784.769.496.249,Pregnancy Outcome,Pregnancy,33
Lung Transplantation,E,E04.936.450.495,Organ Transplantation,Transplantation,33
Lung Transplantation,E,E04.928.600.495,Pulmonary Surgical Procedures,Thoracic Surgical Procedures,33
Macrolides,D,D02.540.576.500,Polyketides,Lactones,33
Macrolides,D,D02.540.505,Lactones,Organic Chemicals,33
Macrolides,D,D04.345.674.500,Polyketides,Macrocyclic Compounds,33
Metagenomics,H,H01.158.273.343.350.261,Genomics,Genetics,33
Mosquito Nets,J,J01.494.221.750,Bedding and Linens,Household Articles,33
Mosquito Nets,E,E07.700.510,Protective Devices,Equipment and Supplies,33
Oocysts,G,G07.345.500.550.500.675,Life Cycle Stages,"Metamorphosis, Biological",33
Oocysts,A,A11.870.740.600,"Spores, Protozoan",Spores,33
Oocysts,B,B05.775.740.600,"Spores, Protozoan",Spores,33
Oocysts,B,B05.500.675,Life Cycle Stages,Organism Forms,33
Open Reading Frames,G,G05.360.335.760.640,Reading Frames,Genetic Code,33
Open Reading Frames,G,G05.360.340.024.340.137.650,Gene Components,Genes,33
Pharmacoepidemiology,H,H02.628.413,Pharmacology,Health Occupations,33
Pharmacoepidemiology,H,H01.158.703.045,Pharmacology,Biological Science Disciplines,33
Pharmacoepidemiology,H,H02.403.720.500.650,Epidemiology,Public Health,33
Polysaccharides,D,D09.698,Carbohydrates,NULL,33
Poultry Diseases,C,C22.131.728,Bird Diseases,Animal Diseases,33
"Pregnancy Complications, Hematologic",C,C15.378.785,Hematologic Diseases,Hemic and Lymphatic Diseases,33
"Pregnancy Complications, Hematologic",C,C13.703.667,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,33
Prosthesis Design,E,E07.695.680,Prostheses and Implants,Equipment and Supplies,33
Prosthesis Design,E,E05.320.550,Equipment Design,Investigative Techniques,33
"Sexually Transmitted Diseases, Bacterial",C,C13.351.500.711.281,Sexually Transmitted Diseases,"Genital Diseases, Female",33
"Sexually Transmitted Diseases, Bacterial",C,C12.294.668.281,Sexually Transmitted Diseases,"Genital Diseases, Male",33
"Sexually Transmitted Diseases, Bacterial",C,C23.550.291.531.937.281,Sexually Transmitted Diseases,Communicable Diseases,33
"Sexually Transmitted Diseases, Bacterial",C,C01.778.281,Sexually Transmitted Diseases,Infections,33
"Sexually Transmitted Diseases, Bacterial",C,C01.150.252.734,Bacterial Infections,Bacterial Infections and Mycoses,33
"Sexually Transmitted Diseases, Bacterial",C,C01.221.812.281,Sexually Transmitted Diseases,Communicable Diseases,33
Surgical Wound Infection,C,C01.947.692,Wound Infection,Infections,33
Surgical Wound Infection,C,C23.550.767.925,Postoperative Complications,Pathologic Processes,33
Transferrin,D,D12.776.377.715.182.839,Beta-Globulins,Serum Globulins,33
Transferrin,D,D12.776.124.050.800,Acute-Phase Proteins,Blood Proteins,33
Transferrin,D,D12.776.124.790.223.839,Beta-Globulins,Serum Globulins,33
Transferrin,D,D12.776.157.427.750.500,Transferrins,Iron-Binding Proteins,33
Transferrin,D,D12.776.556.579.750.500,Transferrins,Iron-Binding Proteins,33
Trichomonas vaginalis,B,B01.630.800.808.717,Trichomonas,Trichomonadida,33
Vaccinia virus,B,B04.280.650.160.650.900,Orthopoxvirus,Chordopoxvirinae,33
Vascular Diseases,C,C14.907,Cardiovascular Diseases,NULL,33
Vital Statistics,E,E05.318.308.985,Data Collection,Epidemiologic Methods,33
Vital Statistics,N,N06.850.520.308.985,Data Collection,Epidemiologic Methods,33
Vital Statistics,N,N06.850.505.400.975,Demography,Epidemiologic Measurements,33
Vital Statistics,N,N01.224.935,Demography,Population Characteristics,33
Vomiting,C,C23.888.821.937,"Signs and Symptoms, Digestive",Signs and Symptoms,33
"Abortion, Legal",E,E04.520.050.055,"Abortion, Induced",Obstetric Surgical Procedures,32
"Administration, Intravenous",E,E02.319.267.082,Drug Administration Routes,Drug Therapy,32
Alanine Transaminase,D,D08.811.913.477.700.100,Transaminases,Nitrogenous Group Transferases,32
Angola,Z,Z01.058.290.175.095,"Africa, Southern",Africa South of the Sahara,32
"Anthropology, Medical",F,F04.096.879.201.500,Anthropology,Social Sciences,32
"Anthropology, Medical",I,I01.076.284,Anthropology,Social Sciences,32
Asymptomatic Diseases,C,C23.550.291.187,Disease Attributes,Pathologic Processes,32
Bacterial Adhesion,G,G06.099.050,Bacterial Physiological Phenomena,Microbiological Phenomena,32
Cats,B,B01.050.150.900.649.313.750.377.750.250.125,Felis,Felidae,32
Cell Count,E,E01.370.225.500.195,Cytological Techniques,Clinical Laboratory Techniques,32
Cell Count,G,G04.140,Cell Physiological Phenomena,NULL,32
Cell Count,E,E05.200.500.195,Cytological Techniques,Clinical Laboratory Techniques,32
Cell Count,E,E05.242.195,Cytological Techniques,Investigative Techniques,32
Child Behavior Disorders,F,F03.625.141,Neurodevelopmental Disorders,Mental Disorders,32
Coercion,I,I01.880.604.316,"Social Control, Formal",Sociology,32
Coercion,I,I01.880.630.200,"Social Control, Informal",Sociology,32
Craniocerebral Trauma,C,C26.915.300,"Trauma, Nervous System",Wounds and Injuries,32
Craniocerebral Trauma,C,C10.900.300,"Trauma, Nervous System",Nervous System Diseases,32
Cryptosporidiosis,C,C22.674.710.235,"Protozoan Infections, Animal","Parasitic Diseases, Animal",32
Cryptosporidiosis,C,C01.610.752.625.235,"Protozoan Infections, Animal",Protozoan Infections,32
Cryptosporidiosis,C,C01.610.752.250.269,Coccidiosis,Protozoan Infections,32
Cryptosporidiosis,C,C01.610.701.688.235,"Protozoan Infections, Animal","Parasitic Diseases, Animal",32
Cryptosporidiosis,C,C01.610.432.269,"Intestinal Diseases, Parasitic",Parasitic Diseases,32
Cryptosporidiosis,C,C06.405.469.452.269,"Intestinal Diseases, Parasitic",Intestinal Diseases,32
DNA Repair,G,G02.111.222,Biochemical Phenomena,Chemical Phenomena,32
DNA Repair,G,G05.219,Genetic Phenomena,NULL,32
"Dose-Response Relationship, Immunologic",G,G12.300,Immune System Phenomena,NULL,32
Erythema Nodosum,C,C20.543.206.380.375,Drug Eruptions,Drug Hypersensitivity,32
Erythema Nodosum,C,C25.100.468.380.375,Drug Eruptions,Drug Hypersensitivity,32
Erythema Nodosum,C,C17.800.229.413,Erythema,Skin Diseases,32
Erythema Nodosum,C,C17.800.174.600.375,Drug Eruptions,Dermatitis,32
Estonia,Z,Z01.542.248.136.360,Baltic States,"Europe, Eastern",32
Food Microbiology,N,N06.850.601.500.249.300,Food Contamination,Food Safety,32
Food Microbiology,H,H01.158.273.540.274.332,Environmental Microbiology,Microbiology,32
Food Microbiology,J,J01.576.423.850.730.500.249.300,Food Contamination,Food Safety,32
Food Microbiology,N,N06.850.425.200,Environmental Microbiology,Public Health,32
Food Microbiology,N,N06.850.460.400.300,Food Contamination,Environmental Pollution,32
Guinea Pigs,B,B01.050.150.900.649.313.992.550,Rodentia,Eutheria,32
Hand Hygiene,E,E02.547.300,Hygiene,Therapeutics,32
Hand Hygiene,N,N06.850.670.150,Hygiene,Public Health,32
Heart Disease Risk Factors,N,N06.850.520.830.600.800.725.500,Risk Factors,Risk,32
Heart Disease Risk Factors,N,N06.850.490.625.750.500,Risk Factors,Causality,32
Heart Disease Risk Factors,N,N05.715.360.750.625.700.700.500,Risk Factors,Risk,32
Heart Disease Risk Factors,N,N05.715.350.200.700.500,Risk Factors,Causality,32
Heart Disease Risk Factors,E,E05.318.740.600.800.725.500,Risk Factors,Risk,32
Hepatitis C Antibodies,D,D12.776.124.790.651.114.254.450.510,Hepatitis Antibodies,"Antibodies, Viral",32
Hepatitis C Antibodies,D,D12.776.124.486.485.114.254.450.510,Hepatitis Antibodies,"Antibodies, Viral",32
Hepatitis C Antibodies,D,D12.776.377.715.548.114.254.450.510,Hepatitis Antibodies,"Antibodies, Viral",32
Histocompatibility Antigens Class I,D,D12.776.395.550.489,Membrane Glycoproteins,Glycoproteins,32
Histocompatibility Antigens Class I,D,D23.050.705.552.100,Histocompatibility Antigens,Isoantigens,32
Histocompatibility Antigens Class I,D,D23.050.301.500.100,Histocompatibility Antigens,"Antigens, Surface",32
Histocompatibility Antigens Class I,D,D12.776.543.550.439,Membrane Glycoproteins,Membrane Proteins,32
Human papillomavirus 18,B,B04.280.210.655.050.618,Alphapapillomavirus,Papillomaviridae,32
Human papillomavirus 18,B,B04.613.204.655.050.618,Alphapapillomavirus,Papillomaviridae,32
Interferon-alpha,D,D12.776.467.374.440.890.250,Interferon Type I,Interferons,32
Interferon-alpha,D,D23.529.374.440.890.250,Interferon Type I,Interferons,32
Interferon-alpha,D,D12.644.276.374.440.890.250,Interferon Type I,Interferons,32
Interleukin-8,D,D12.644.276.374.200.120.800,"Chemokines, CXC",Chemokines,32
Interleukin-8,D,D12.644.276.374.465.312,Interleukins,Cytokines,32
Interleukin-8,D,D23.529.374.465.312,Interleukins,Cytokines,32
Interleukin-8,D,D23.469.200.120.800,"Chemokines, CXC",Chemokines,32
Interleukin-8,D,D23.529.374.200.120.800,"Chemokines, CXC",Chemokines,32
Interleukin-8,D,D23.125.300.120.800,"Chemokines, CXC",Chemokines,32
Interleukin-8,D,D12.776.467.374.465.246,Interleukins,Cytokines,32
Interleukin-8,D,D12.776.467.374.200.120.800,"Chemokines, CXC",Chemokines,32
International Classification of Diseases,L,L01.453.245.945.400,"Vocabulary, Controlled",Documentation,32
"Interview, Psychological",F,F04.669.599,Psychological Techniques,Behavioral Disciplines and Activities,32
"Iron, Dietary",D,D01.490.600,Iron Compounds,Inorganic Chemicals,32
"Lenses, Intraocular",E,E07.695.460,Prostheses and Implants,Equipment and Supplies,32
"Lenses, Intraocular",E,E07.632.500.460,Lenses,Optical Devices,32
Leptospirosis,C,C01.150.252.400.794.511,Spirochaetales Infections,Gram-Negative Bacterial Infections,32
Marketing of Health Services,N,N03.219.463.548,Financial Management,Economics,32
Marketing of Health Services,N,N05.300.430.500,Health Services Accessibility,Delivery of Health Care,32
Marketing of Health Services,J,J01.219.687.550,Marketing,Commerce,32
Masculinity,F,F01.145.813.376,Social Behavior,Behavior,32
Masculinity,F,F01.752.747.385.200.750,Gender Identity,"Identification, Psychological",32
Masculinity,F,F01.393.446.250.750,Gender Identity,"Identification, Psychological",32
Medical Oncology,H,H02.403.429.515,Internal Medicine,Medicine,32
Mitochondria,A,A11.284.430.214.190.875.564,Organelles,Cytoplasmic Structures,32
Mitochondria,A,A11.284.835.626,Subcellular Fractions,Cellular Structures,32
Musculoskeletal Diseases,C,C05,NULL,NULL,32
Neuroimaging,E,E01.370.376.537,"Diagnostic Techniques, Neurological",Diagnostic Techniques and Procedures,32
Neuroimaging,E,E01.370.350.578,Diagnostic Imaging,Diagnostic Techniques and Procedures,32
Neuroimaging,E,E05.629,Investigative Techniques,NULL,32
Odorants,G,G16.500.275.640,Environment,Ecological and Environmental Phenomena,32
Odorants,N,N06.230.480,Environment,Environment and Public Health,32
Opiate Substitution Treatment,E,E02.319.620,Drug Therapy,Therapeutics,32
Physical Distancing,N,N06.850.780.200.688,Communicable Disease Control,Public Health Practice,32
Post-Exposure Prophylaxis,N,N02.421.726.755,Preventive Health Services,Health Services,32
"Pregnancy Trimester, Third",G,G08.686.707.520,Pregnancy Trimesters,Reproductive Physiological Phenomena,32
Prostatic Hyperplasia,C,C12.294.565.500,Prostatic Diseases,"Genital Diseases, Male",32
Psychomotor Performance,F,F02.808,Psychological Phenomena,NULL,32
Psychomotor Performance,G,G11.561.660,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,32
Psychomotor Performance,G,G11.427.700,Musculoskeletal Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,32
Retina,A,A09.371.729,Eye,Sense Organs,32
RNA Interference,G,G05.308.203.374.790,Gene Silencing,"Epigenesis, Genetic",32
Sewage,D,D20.944.932.500,Waste Water,Waste Products,32
Social Problems,I,I01.880.735,Sociology,Social Sciences,32
Somalia,Z,Z01.058.290.120.730,"Africa, Eastern",Africa South of the Sahara,32
Spironolactone,D,D04.210.500.745.745.855,Pregnenes,Pregnanes,32
Spironolactone,D,D02.540.679,Lactones,Organic Chemicals,32
Stroke Rehabilitation,E,E02.760.169.063.500.477.500,Neurological Rehabilitation,Rehabilitation,32
Stroke Rehabilitation,H,H02.403.680.600.750.500,Neurological Rehabilitation,Rehabilitation,32
Stroke Rehabilitation,N,N02.421.784.511.500,Neurological Rehabilitation,Rehabilitation,32
Stroke Rehabilitation,E,E02.831.477.500,Neurological Rehabilitation,Rehabilitation,32
Strongyloidiasis,C,C01.610.335.508.700.700.799,Rhabditida Infections,Secernentea Infections,32
Taiwan,Z,Z01.252.474.872,Far East,Asia,32
Taiwan,Z,Z01.639.850,Islands,Geographic Locations,32
Transfusion Reaction,C,C15.378.962,Hematologic Diseases,Hemic and Lymphatic Diseases,32
Transfusion Reaction,C,C20.920,Immune System Diseases,NULL,32
"Air Pollutants, Occupational",D,D27.888.284.101.268,Air Pollutants,Environmental Pollutants,31
Alkanesulfonic Acids,D,D02.886.645.600.055,Sulfonic Acids,Sulfur Acids,31
Alkanesulfonic Acids,D,D02.455.326.146.100,Alkanes,"Hydrocarbons, Acyclic",31
"Analgesics, Opioid",D,D27.505.954.427.040.550.500,Narcotics,Analgesics,31
"Analgesics, Opioid",D,D27.505.954.427.210.600.500,Narcotics,Central Nervous System Depressants,31
"Analgesics, Opioid",D,D27.505.696.663.850.014.760.500,Narcotics,Analgesics,31
"Analgesics, Opioid",D,D27.505.696.277.600.500,Narcotics,Central Nervous System Depressants,31
Ancylostomatoidea,B,B01.050.500.500.294.400.968.100,Strongylida,Chromadorea,31
Ascorbic Acid,D,D02.241.511.902.107,Sugar Acids,Hydroxy Acids,31
Ascorbic Acid,D,D02.241.081.844.107,Sugar Acids,"Acids, Acyclic",31
Ascorbic Acid,D,D09.811.100,Sugar Acids,Carbohydrates,31
Biomedical Technology,J,J01.897.120.050,Biotechnology,Technology,31
Bolivia,Z,Z01.107.757.136,South America,Americas,31
"Calcification, Physiologic",G,G11.427.578.050.500.175,Bone Development,Biomineralization,31
"Calcification, Physiologic",G,G07.345.500.325.377.625.050.500.175,Bone Development,Biomineralization,31
"Calcification, Physiologic",G,G07.345.155.500,Biomineralization,Growth and Development,31
Copper,D,D01.552.544.195,"Metals, Heavy",Metals,31
Copper,D,D01.268.556.195,"Metals, Heavy",Elements,31
Copper,D,D01.268.956.170,Transition Elements,Elements,31
Cyclic GMP-Dependent Protein Kinases,D,D08.811.913.696.620.682.700.150.150,Cyclic Nucleotide-Regulated Protein Kinases,Protein-Serine-Threonine Kinases,31
Cyclic GMP-Dependent Protein Kinases,D,D12.644.360.200.150,Cyclic Nucleotide-Regulated Protein Kinases,Intracellular Signaling Peptides and Proteins,31
Cyclic GMP-Dependent Protein Kinases,D,D12.776.476.200.150,Cyclic Nucleotide-Regulated Protein Kinases,Intracellular Signaling Peptides and Proteins,31
Death,C,C23.550.260,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",31
Diptera,B,B01.050.500.131.617.720.500.500.750,Holometabola,Neoptera,31
"Drugs, Essential",D,D26.355,Pharmaceutical Preparations,NULL,31
Economic Development,I,I01.261.262,Economics,Social Sciences,31
Economic Development,N,N03.219.206,Economics,Health Care Economics and Organizations,31
Entamoebiasis,C,C01.610.752.049.407,Amebiasis,Protozoan Infections,31
Enterobacteriaceae Infections,C,C01.150.252.400.310,Gram-Negative Bacterial Infections,Bacterial Infections,31
Entomology,H,H01.158.273.943.409,Zoology,Biology,31
Enzyme Activation,G,G02.111.263,Biochemical Phenomena,Chemical Phenomena,31
Enzyme Activation,G,G03.328,Metabolism,NULL,31
Erythrocyte Transfusion,E,E02.095.135.140.275,Blood Component Transfusion,Blood Transfusion,31
Extracellular Matrix,A,A11.284.295.310,Extracellular Space,Cellular Structures,31
Filaricides,D,D27.505.954.122.250.075.080.275,Antinematodal Agents,Anthelmintics,31
Gambling,F,F03.250.400,"Disruptive, Impulse Control, and Conduct Disorders",Mental Disorders,31
Gambling,F,F01.145.722.408,Risk-Taking,Behavior,31
"Genital Diseases, Male",C,C12.294,Male Urogenital Diseases,NULL,31
Geographic Mapping,E,E05.318.740.933.249,Spatial Analysis,Statistics as Topic,31
Geographic Mapping,E,E05.318.389,Epidemiologic Methods,Investigative Techniques,31
Geographic Mapping,N,N05.715.360.750.746.249,Spatial Analysis,Statistics as Topic,31
Geographic Mapping,N,N06.850.520.830.933.249,Spatial Analysis,Statistics as Topic,31
Gram-Negative Bacterial Infections,C,C01.150.252.400,Bacterial Infections,Bacterial Infections and Mycoses,31
Healthy People Programs,N,N02.421.726.407.579.300,Health Promotion,Health Education,31
Healthy People Programs,I,I02.233.332.445.300,Health Promotion,Health Education,31
Heat Stress Disorders,C,C26.522,Wounds and Injuries,NULL,31
"Hospitals, Pediatric",N,N02.278.421.556.437,"Hospitals, Special",Hospitals,31
Infant Welfare,I,I01.880.787.539,Social Welfare,Sociology,31
Lassa virus,B,B04.820.480.500.070.100.500,"Arenaviruses, Old World",Arenavirus,31
Licensure,N,N05.700.200.450,Credentialing,"Quality Assurance, Health Care",31
Licensure,N,N03.706.110.510,Credentialing,"Social Control, Formal",31
Minisatellite Repeats,G,G02.111.570.080.708.800.550,Tandem Repeat Sequences,"Repetitive Sequences, Nucleic Acid",31
Minisatellite Repeats,G,G05.360.080.708.800.550,Tandem Repeat Sequences,"Repetitive Sequences, Nucleic Acid",31
Minisatellite Repeats,G,G05.360.340.024.850.550,Tandem Repeat Sequences,Genome Components,31
"Obesity, Abdominal",G,G07.100.100.160.120.699.500.249,Obesity,Overweight,31
"Obesity, Abdominal",C,C18.654.726.500.615,Obesity,Overnutrition,31
"Obesity, Abdominal",E,E01.370.600.115.100.160.120.699.500.249,Obesity,Overweight,31
Patient Care Planning,N,N04.590.233.624,Comprehensive Health Care,Patient Care Management,31
"Peer Review, Research",N,N03.706.700.700,Peer Review,"Social Control, Formal",31
"Peer Review, Research",L,L01.737.640,Publishing,Information Science,31
"Peer Review, Research",I,I01.880.604.640.700,Peer Review,"Social Control, Formal",31
"Peer Review, Research",L,L01.143.865.750,Scholarly Communication,Communication,31
"Peer Review, Research",H,H01.770.644.487,Research,Science,31
"Peer Review, Research",F,F01.829.316.549.700,Peer Review,Group Processes,31
Personal Autonomy,F,F02.600,Psychological Phenomena,NULL,31
Personal Autonomy,I,I01.880.604.473.380.500,Freedom,Human Rights,31
Personal Autonomy,K,K01.752.566.479.830.650,Principle-Based Ethics,Ethics,31
Personal Autonomy,N,N03.706.437.380.500,Freedom,Human Rights,31
Personal Autonomy,N,N05.350.958.650,Principle-Based Ethics,Ethics,31
Phacoemulsification,E,E04.540.825.249.704,Cataract Extraction,Refractive Surgical Procedures,31
Phacoemulsification,E,E04.943.875,Ultrasonic Surgical Procedures,"Surgical Procedures, Operative",31
Plasma,A,A12.207.152.693,Blood,Body Fluids,31
Plasma,A,A12.207.270.695,Extracellular Fluid,Body Fluids,31
Plasma,A,A15.145.693,Blood,Hemic and Immune Systems,31
Rare Diseases,C,C23.550.291.906,Disease Attributes,Pathologic Processes,31
Regional Health Planning,N,N03.349.650,Health Planning,Health Care Economics and Organizations,31
Septins,D,D12.776.220.932,Cytoskeletal Proteins,Proteins,31
Septins,D,D12.776.157.325.757,GTP-Binding Proteins,Carrier Proteins,31
Septins,D,D08.811.277.040.330.300.700,GTP-Binding Proteins,GTP Phosphohydrolases,31
Sialoglycoproteins,D,D12.776.395.700,Glycoproteins,Proteins,31
Sialoglycoproteins,D,D12.644.233.800,Glycopeptides,Peptides,31
"Sociology, Medical",I,I01.880.859,Sociology,Social Sciences,31
"Sociology, Medical",H,H02.790,Health Occupations,NULL,31
"Sociology, Medical",F,F04.096.879.757.400,Sociology,Social Sciences,31
Telomere,G,G05.360.160.845,Chromosome Structures,Genetic Structures,31
Telomere,A,A11.284.430.106.279.345.190.160.845,Chromosome Structures,Chromosomes,31
Testosterone,D,D04.210.500.054.079.429.824,Androstenols,Androstenes,31
Testosterone,D,D06.472.334.851.968.984,Testosterone Congeners,Gonadal Steroid Hormones,31
Time,G,G01.910,Physical Phenomena,NULL,31
Trabeculectomy,E,E04.540.450.700,Filtering Surgery,Ophthalmologic Surgical Procedures,31
Travel-Related Illness,I,I03.883.855,Travel,Human Activities,31
Travel-Related Illness,C,C23.888.914,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",31
Triatominae,B,B01.050.500.131.617.412.420.700.850,Reduviidae,Heteroptera,31
White Matter,A,A08.186.211.204,Brain,Central Nervous System,31
White Matter,A,A08.186.854.880,Spinal Cord,Central Nervous System,31
Work,I,I03.946,Human Activities,NULL,31
"Adaptor Proteins, Signal Transducing",D,D12.644.360.024,Intracellular Signaling Peptides and Proteins,Peptides,30
"Adaptor Proteins, Signal Transducing",D,D12.776.157.057,Carrier Proteins,Proteins,30
"Adaptor Proteins, Signal Transducing",D,D12.776.476.024,Intracellular Signaling Peptides and Proteins,Proteins,30
Allied Health Personnel,N,N02.360.067,Health Personnel,"Health Care Facilities, Manpower, and Services",30
Allied Health Personnel,M,M01.526.485.067,Health Personnel,Occupational Groups,30
"Anti-Infective Agents, Local",D,D27.505.954.122.187,Anti-Infective Agents,Therapeutic Uses,30
Aortic Valve,A,A07.541.510.110,Heart Valves,Heart,30
Bordetella pertussis,B,B03.440.400.425.115.425.600,Bordetella,Alcaligenaceae,30
Bordetella pertussis,B,B03.660.075.090.344.425.600,Bordetella,Alcaligenaceae,30
Carbapenems,D,D02.065.589.099.124,beta-Lactams,Lactams,30
Carbapenems,D,D03.633.100.300.124,beta-Lactams,"Heterocyclic Compounds, 2-Ring",30
Carbonated Beverages,J,J02.200.300,Beverages,Food and Beverages,30
Carbonated Beverages,G,G07.203.100.300,Beverages,"Diet, Food, and Nutrition",30
Contrast Media,D,D27.720.259,Specialty Uses of Chemicals,Chemical Actions and Uses,30
Contrast Media,D,D27.505.259.500,Diagnostic Uses of Chemicals,Pharmacologic Actions,30
Cytoskeleton,A,A11.284.430.214.190.750,Cytoplasmic Structures,Cytoplasm,30
"Cytotoxicity, Immunologic",G,G12.287,Immune System Phenomena,NULL,30
Diuretics,D,D27.505.696.560.500,Natriuretic Agents,Physiological Effects of Drugs,30
DNA Copy Number Variations,G,G05.365.795.297.500,Genomic Structural Variation,"Polymorphism, Genetic",30
DNA-Directed RNA Polymerases,D,D08.811.913.696.445.735.270,RNA Nucleotidyltransferases,Nucleotidyltransferases,30
Drug Synergism,G,G07.690.773.968.477,Drug Interactions,Pharmacological Phenomena,30
Educational Measurement,I,I02.399,Education,NULL,30
Efficiency,N,N04.452.209,Organization and Administration,Health Services Administration,30
Efficiency,F,F02.784.692.351,"Psychology, Industrial","Psychology, Applied",30
Enzyme-Linked Immunospot Assay,E,E05.200.500.508,Cytological Techniques,Clinical Laboratory Techniques,30
Enzyme-Linked Immunospot Assay,E,E05.242.551,Cytological Techniques,Investigative Techniques,30
Enzyme-Linked Immunospot Assay,E,E05.601.470.380.360.500,Enzyme-Linked Immunosorbent Assay,Immunosorbent Techniques,30
Enzyme-Linked Immunospot Assay,E,E05.601.470.350.170.500,Enzyme-Linked Immunosorbent Assay,Immunoenzyme Techniques,30
Enzyme-Linked Immunospot Assay,E,E05.478.583.400.170.500,Enzyme-Linked Immunosorbent Assay,Immunoenzyme Techniques,30
Enzyme-Linked Immunospot Assay,E,E05.478.566.380.360.500,Enzyme-Linked Immunosorbent Assay,Immunosorbent Techniques,30
Enzyme-Linked Immunospot Assay,E,E05.478.566.350.170.500,Enzyme-Linked Immunosorbent Assay,Immunoenzyme Techniques,30
Enzyme-Linked Immunospot Assay,E,E01.370.225.500.508,Cytological Techniques,Clinical Laboratory Techniques,30
Extracorporeal Membrane Oxygenation,E,E04.292.451,Extracorporeal Circulation,"Surgical Procedures, Operative",30
Extracorporeal Membrane Oxygenation,E,E02.880.301,Respiratory Therapy,Therapeutics,30
Fast Foods,G,G07.203.300.477,Food,"Diet, Food, and Nutrition",30
Fast Foods,J,J02.500.477,Food,Food and Beverages,30
Fatal Outcome,N,N06.850.505.400.975.550.325,Mortality,Vital Statistics,30
Fatal Outcome,N,N06.850.520.308.985.550.325,Mortality,Vital Statistics,30
Fatal Outcome,N,N01.224.935.698.201,Mortality,Vital Statistics,30
Fatal Outcome,E,E05.318.308.985.550.325,Mortality,Vital Statistics,30
Fishes,B,B01.050.150.900.493,Vertebrates,Chordata,30
"Gene Expression Regulation, Enzymologic",G,G05.308.320,Gene Expression Regulation,Genetic Phenomena,30
"Genes, BRCA1",G,G05.360.340.024.340.415.400.100,"Genes, Tumor Suppressor","Genes, Recessive",30
"Genes, BRCA1",G,G05.360.340.024.340.375.249.100,"Genes, Tumor Suppressor","Genes, Neoplasm",30
Growth Charts,E,E05.978.808.500,Reference Standards,Weights and Measures,30
Head and Neck Neoplasms,C,C04.588.443,Neoplasms by Site,Neoplasms,30
Homes for the Aged,N,N02.278.825.462,Residential Facilities,Health Facilities,30
Homes for the Aged,J,J03.775.462,Residential Facilities,Non-Medical Public and Private Facilities,30
"Hospitals, Rural",N,N02.278.421.518,Hospitals,Health Facilities,30
HTLV-I Infections,C,C01.925.782.815.200.470,Deltaretrovirus Infections,Retroviridae Infections,30
HTLV-I Infections,C,C20.673.483.470,Deltaretrovirus Infections,Immunologic Deficiency Syndromes,30
Immune System,A,A15.382,Hemic and Immune Systems,NULL,30
"Infectious Disease Transmission, Patient-to-Professional",N,N06.850.335.500,"Disease Transmission, Infectious",Public Health,30
Interleukins,D,D23.529.374.465,Cytokines,Intercellular Signaling Peptides and Proteins,30
Interleukins,D,D12.776.467.374.465,Cytokines,Intercellular Signaling Peptides and Proteins,30
Interleukins,D,D12.644.276.374.465,Cytokines,Intercellular Signaling Peptides and Proteins,30
Jamaica,Z,Z01.107.084.900.525,West Indies,Caribbean Region,30
Jamaica,Z,Z01.639.880.525,West Indies,Islands,30
Knowledge,K,K01.468,Humanities,NULL,30
Kyrgyzstan,Z,Z01.252.100.450,"Asia, Central",Asia,30
Kyrgyzstan,Z,Z01.586.950.450,USSR,Historical Geographic Locations,30
Kyrgyzstan,Z,Z01.542.931.450,USSR,Europe,30
Macaca mulatta,B,B01.050.150.900.649.313.988.400.112.199.120.510.550,Macaca,Cercopithecinae,30
"Meningitis, Haemophilus",C,C01.150.252.223.500.425,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,30
"Meningitis, Haemophilus",C,C01.150.252.400.700.433.615,Haemophilus Infections,Pasteurellaceae Infections,30
"Meningitis, Haemophilus",C,C01.207.180.500.425,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,30
"Meningitis, Haemophilus",C,C10.228.614.280.393,"Meningitis, Bacterial",Meningitis,30
"Meningitis, Haemophilus",C,C10.228.228.180.500.425,"Meningitis, Bacterial",Central Nervous System Bacterial Infections,30
Metabolic Networks and Pathways,G,G03.493,Metabolism,NULL,30
Microarray Analysis,E,E05.588.570,Microchip Analytical Procedures,Investigative Techniques,30
Motor Vehicles,J,J01.937.500,Transportation,"Technology, Industry, and Agriculture",30
Mumps,C,C01.925.782.580.600.680.500,Rubulavirus Infections,Paramyxoviridae Infections,30
Mumps,C,C07.465.815.470.800.630,Parotitis,Parotid Diseases,30
Mycobacterium Infections,C,C01.150.252.410.040.552,Actinomycetales Infections,Gram-Positive Bacterial Infections,30
Needle-Exchange Programs,N,N02.421.726.708,Preventive Health Services,Health Services,30
Neoplasm Invasiveness,C,C04.697.645,Neoplastic Processes,Neoplasms,30
Neoplasm Invasiveness,C,C23.550.727.645,Neoplastic Processes,Pathologic Processes,30
"Nursing Staff, Hospital",N,N02.360.680.490,Nursing Staff,Health Personnel,30
"Nursing Staff, Hospital",N,N02.360.740.523,"Personnel, Hospital",Health Personnel,30
"Nursing Staff, Hospital",M,M01.526.485.680.490,Nursing Staff,Health Personnel,30
"Nursing Staff, Hospital",M,M01.526.485.740.523,"Personnel, Hospital",Health Personnel,30
Patient Transfer,N,N02.421.585.400.630,Hospitalization,Patient Care,30
Patient Transfer,N,N02.421.585.169.624,Continuity of Patient Care,Patient Care,30
Patient Transfer,N,N04.590.233.727.210.624,Continuity of Patient Care,Primary Health Care,30
Patient Transfer,E,E02.760.169.624,Continuity of Patient Care,Patient Care,30
Patient Transfer,E,E02.760.400.630,Hospitalization,Patient Care,30
Peripheral Nervous System Diseases,C,C10.668.829,Neuromuscular Diseases,Nervous System Diseases,30
Physical Fitness,N,N01.400.545,Health,Population Characteristics,30
Physical Fitness,I,I03.450.642.845.054.800,Athletic Performance,Sports,30
Physical Fitness,G,G11.427.685,Musculoskeletal Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,30
Private Practice,N,N04.452.758.745,Professional Practice,Organization and Administration,30
Privatization,N,N04.452.633.780,Ownership,Organization and Administration,30
"Protein Structure, Secondary",G,G02.111.570.820.709.600,Protein Conformation,Molecular Conformation,30
Pyrazinamide,D,D03.383.679.750,Pyrazines,"Heterocyclic Compounds, 1-Ring",30
Renal Insufficiency,C,C12.777.419.780,Kidney Diseases,Urologic Diseases,30
Renal Insufficiency,C,C13.351.968.419.780,Kidney Diseases,Urologic Diseases,30
Ritonavir,D,D02.886.675.653,Thiazoles,Sulfur Compounds,30
Ritonavir,D,D03.383.129.708.653,Thiazoles,Azoles,30
Self-Injurious Behavior,F,F01.145.126.980,Behavioral Symptoms,Behavior,30
Self-Management,N,N02.421.784.760,Rehabilitation,Health Services,30
Severe Dengue,C,C01.925.782.350.250.214.200,Dengue,Flavivirus Infections,30
Severe Dengue,C,C01.925.782.417.214.200,Dengue,"Hemorrhagic Fevers, Viral",30
Severe Dengue,C,C01.920.500.270.200,Dengue,Arbovirus Infections,30
Severe Dengue,C,C01.925.081.270.200,Dengue,Arbovirus Infections,30
Splenomegaly,C,C23.300.775.750,Hypertrophy,"Pathological Conditions, Anatomical",30
Streptococcus pyogenes,B,B03.510.550.737.872.575,Streptococcus,Streptococcaceae,30
Streptococcus pyogenes,B,B03.510.400.800.872.575,Streptococcus,Streptococcaceae,30
Streptococcus pyogenes,B,B03.353.750.737.872.575,Streptococcus,Streptococcaceae,30
"Suicide, Attempted",I,I01.880.735.856.600,Suicide,Social Problems,30
"Suicide, Attempted",F,F01.145.126.980.875.600,Suicide,Self-Injurious Behavior,30
Tandem Mass Spectrometry,E,E05.196.566.880,Mass Spectrometry,"Chemistry Techniques, Analytical",30
Tetanus,C,C01.150.252.410.222.864,Clostridium Infections,Gram-Positive Bacterial Infections,30
Tobacco Use Disorder,C,C25.775.912,Substance-Related Disorders,Chemically-Induced Disorders,30
Tobacco Use Disorder,F,F03.900.912,Substance-Related Disorders,Mental Disorders,30
Trauma Centers,N,N02.421.297.195.480,"Emergency Service, Hospital",Emergency Medical Services,30
Trauma Centers,N,N02.278.216.500.968.336.500,"Emergency Service, Hospital",Hospital Departments,30
Trauma Centers,N,N04.452.442.452.422.336.400,"Emergency Service, Hospital",Hospital Departments,30
Trypanosoma brucei rhodesiense,B,B01.268.475.868.887.115,Trypanosoma,Trypanosomatina,30
Wasting Syndrome,C,C18.452.915,Metabolic Diseases,Nutritional and Metabolic Diseases,30
Wasting Syndrome,C,C18.654.940,Nutrition Disorders,Nutritional and Metabolic Diseases,30
Adenine,D,D03.633.100.759.138,Purines,"Heterocyclic Compounds, 2-Ring",29
Adenosine Triphosphate,D,D03.633.100.759.646.138.236,Adenine Nucleotides,Purine Nucleotides,29
Adenosine Triphosphate,D,D13.695.667.138.236,Adenine Nucleotides,Purine Nucleotides,29
Adenosine Triphosphate,D,D13.695.827.068.236,Adenine Nucleotides,Ribonucleotides,29
Alphapapillomavirus,B,B04.280.210.655.050,Papillomaviridae,DNA Tumor Viruses,29
Alphapapillomavirus,B,B04.613.204.655.050,Papillomaviridae,DNA Tumor Viruses,29
Amino Acids,D,D12.125,"Amino Acids, Peptides, and Proteins",NULL,29
Aminoquinolines,D,D03.633.100.810.050,Quinolines,"Heterocyclic Compounds, 2-Ring",29
"Animals, Newborn",B,B01.050.050.282,Animal Population Groups,Animals,29
Basal Metabolism,G,G03.295.154,Energy Metabolism,Metabolism,29
Blood Chemical Analysis,E,E05.200.124.100,Clinical Chemistry Tests,Clinical Laboratory Techniques,29
Blood Chemical Analysis,E,E01.370.225.124.100,Clinical Chemistry Tests,Clinical Laboratory Techniques,29
Chickenpox Vaccine,D,D20.215.894.899.290.130,Herpesvirus Vaccines,Viral Vaccines,29
Community Health Nursing,N,N02.421.143.150,Community Health Services,Health Services,29
Community Health Nursing,H,H02.478.676.150,"Specialties, Nursing",Nursing,29
Critical Pathways,N,N04.590.275,Patient Care Management,Health Services Administration,29
Critical Pathways,N,N04.590.233.624.625,Patient Care Planning,Comprehensive Health Care,29
Dehydration,C,C18.452.950.179,Water-Electrolyte Imbalance,Metabolic Diseases,29
Dehydration,C,C23.550.274,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",29
Dried Blood Spot Testing,E,E01.370.225.124.100.232,Blood Chemical Analysis,Clinical Chemistry Tests,29
Dried Blood Spot Testing,E,E05.200.124.100.232,Blood Chemical Analysis,Clinical Chemistry Tests,29
Electromagnetic Fields,G,G01.358.500.260,Electromagnetic Phenomena,Magnetic Phenomena,29
Electromagnetic Fields,G,G01.358.750.500,Magnetic Fields,Magnetic Phenomena,29
"Electrophoresis, Gel, Pulsed-Field",E,E05.196.401.220,Electrophoresis,"Chemistry Techniques, Analytical",29
"Electrophoresis, Gel, Pulsed-Field",E,E05.301.300.220,Electrophoresis,Electrochemical Techniques,29
Equipment and Supplies,E,E07,NULL,NULL,29
Extracellular Matrix Proteins,D,D12.776.860.300,Scleroproteins,Proteins,29
Food Handling,J,J01.576.423.200,Food Industry,Industry,29
Food Services,J,J01.576.423.500,Food Industry,Industry,29
Fresh Water,G,G16.500.275.280,Environment,Ecological and Environmental Phenomena,29
Fresh Water,N,N06.230.232,Environment,Environment and Public Health,29
"gag Gene Products, Human Immunodeficiency Virus",D,D12.776.775.330.650,"Gene Products, gag",Polyproteins,29
"gag Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.350.362,"Gene Products, gag",Retroviridae Proteins,29
"gag Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.562.750,Human Immunodeficiency Virus Proteins,Retroviridae Proteins,29
"gag Gene Products, Human Immunodeficiency Virus",D,D12.776.964.970.600.850.350.362,"Gene Products, gag",Viral Core Proteins,29
"Gene Expression Regulation, Neoplastic",G,G05.308.370,Gene Expression Regulation,Genetic Phenomena,29
"Genes, env",G,G05.360.340.024.340.364.875.172,"Genes, Viral","Genes, Microbial",29
"Genes, env",G,G05.360.340.358.024.875.172,"Genes, Viral","Genes, Microbial",29
"Genes, env",G,G05.360.340.358.840.500.172,"Genes, Viral","Genome, Viral",29
Genomic Islands,G,G05.360.340.024.425.500,Interspersed Repetitive Sequences,Genome Components,29
Genomic Islands,G,G05.360.080.708.330.330,Interspersed Repetitive Sequences,"Repetitive Sequences, Nucleic Acid",29
Genomic Islands,G,G02.111.570.080.708.330.330,Interspersed Repetitive Sequences,"Repetitive Sequences, Nucleic Acid",29
"Glaucoma, Angle-Closure",C,C11.525.381.056,Glaucoma,Ocular Hypertension,29
"Glaucoma, Open-Angle",C,C11.525.381.407,Glaucoma,Ocular Hypertension,29
Hand Strength,E,E01.370.600.425.500,Muscle Strength,Physical Examination,29
Hand Strength,G,G11.427.560.500,Muscle Strength,Musculoskeletal Physiological Phenomena,29
Health Transition,I,I01.240.600.400,Population Dynamics,Demography,29
Health Transition,N,N06.850.505.400.700.400,Population Dynamics,Demography,29
Health Transition,N,N01.224.625.400,Population Dynamics,Demography,29
Health Transition,N,N06.850.650,Public Health,Environment and Public Health,29
Herpesviridae Infections,C,C01.925.256.466,DNA Virus Infections,Virus Diseases,29
Homicide,I,I01.198.240.470,Crime,Criminology,29
Homicide,I,I01.880.735.344,Social Problems,Sociology,29
"Hospitals, Private",N,N02.278.421.481,Hospitals,Health Facilities,29
Immune Sera,A,A12.207.152.846.500,Serum,Blood,29
Immune Sera,D,D20.215.401,Biological Products,Complex Mixtures,29
Immune Sera,D,D12.776.124.790.651.114.573,Antibodies,Immunoglobulins,29
Immune Sera,D,D12.776.124.486.485.114.573,Antibodies,Immunoglobulins,29
Immune Sera,D,D12.776.377.715.548.114.573,Antibodies,Immunoglobulins,29
Infertility,C,C12.294.365,"Genital Diseases, Male",Male Urogenital Diseases,29
Infertility,C,C13.351.500.365,"Genital Diseases, Female",Female Urogenital Diseases,29
Israel,Z,Z01.252.245.500.375,Middle East,"Asia, Western",29
Lipoproteins,D,D10.532,Lipids,NULL,29
Lipoproteins,D,D12.776.521,Proteins,"Amino Acids, Peptides, and Proteins",29
Medical Informatics,L,L01.313.500,Informatics,Information Science,29
"Medical Records Systems, Computerized",L,L01.313.500.750.300.695,Information Systems,Medical Informatics Applications,29
"Medical Records Systems, Computerized",N,N06.850.520.308.940.968.625,Medical Records,Records,29
"Medical Records Systems, Computerized",N,N05.715.360.300.715.500.530,Medical Records,Records,29
"Medical Records Systems, Computerized",N,N04.452.859.564.650,Medical Records,Records,29
"Medical Records Systems, Computerized",E,E05.318.308.940.968.625,Medical Records,Records,29
Methadone,D,D02.522.675,Ketones,Organic Chemicals,29
Microbiological Techniques,E,E01.370.225.875,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,29
Microbiological Techniques,E,E05.200.875,Clinical Laboratory Techniques,Investigative Techniques,29
Microfilariae,B,B01.050.500.500.294.400.937.463.470,Filarioidea,Spirurida,29
Microfilariae,B,B05.525,Organism Forms,NULL,29
MicroRNAs,D,D13.150.650.319,"RNA, Antisense",Antisense Elements (Genetics),29
MicroRNAs,D,D13.444.735.790.552.500,"RNA, Small Untranslated","RNA, Untranslated",29
MicroRNAs,D,D13.444.735.150.319,"RNA, Antisense",RNA,29
Mother-Child Relations,F,F01.829.263.370.290.170,Parent-Child Relations,Family Relations,29
"Mutagenesis, Insertional",G,G05.365.590.575,Mutation,Genetic Variation,29
"Mutagenesis, Insertional",G,G05.558.550,Mutagenesis,Genetic Phenomena,29
"Mutagenesis, Insertional",E,E05.393.420.601.550,Protein Engineering,Genetic Engineering,29
"Obstetric Labor, Premature",C,C13.703.420.491,Obstetric Labor Complications,Pregnancy Complications,29
One Health,N,N01.400.530,Health,Population Characteristics,29
Ophthalmia Neonatorum,C,C16.614.677,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",29
Ophthalmia Neonatorum,C,C11.187.183.220.538,"Conjunctivitis, Bacterial",Conjunctivitis,29
Ophthalmia Neonatorum,C,C11.294.354.220.625,"Conjunctivitis, Bacterial","Eye Infections, Bacterial",29
Ophthalmia Neonatorum,C,C01.150.252.289.225.625,"Conjunctivitis, Bacterial","Eye Infections, Bacterial",29
Ophthalmia Neonatorum,C,C01.150.252.400.625.774,Neisseriaceae Infections,Gram-Negative Bacterial Infections,29
Ophthalmia Neonatorum,C,C01.375.354.220.625,"Conjunctivitis, Bacterial","Eye Infections, Bacterial",29
Organophosphonates,D,D02.705.429,Organophosphorus Compounds,Organic Chemicals,29
Pelvic Inflammatory Disease,C,C01.635.500,Pelvic Infection,Infections,29
Pelvic Inflammatory Disease,C,C13.351.500.056.750,Adnexal Diseases,"Genital Diseases, Female",29
"Physicians, Primary Care",M,M01.526.485.810.800,Physicians,Health Personnel,29
"Physicians, Primary Care",N,N02.360.810.795,Physicians,Health Personnel,29
Pregnancy Rate,N,N01.224.935.849,Vital Statistics,Demography,29
Pregnancy Rate,N,N06.850.505.400.975.775,Vital Statistics,Demography,29
Pregnancy Rate,E,E05.318.308.985.775,Vital Statistics,Data Collection,29
Pregnancy Rate,G,G08.686.705,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,29
Pregnancy Rate,N,N06.850.520.308.985.775,Vital Statistics,Data Collection,29
Problem Solving,F,F02.463.425.725,Learning,Mental Processes,29
Problem Solving,F,F02.463.785.810,Thinking,Mental Processes,29
Pseudomonas aeruginosa,B,B03.660.250.580.590.050,Pseudomonas,Pseudomonadaceae,29
Pseudomonas aeruginosa,B,B03.440.400.425.625.625.100,Pseudomonas,Pseudomonadaceae,29
Psychology,F,F04.096.628,Behavioral Sciences,Behavioral Disciplines and Activities,29
"Rats, Sprague-Dawley",B,B01.050.150.900.649.313.992.635.505.700.750,Rats,Murinae,29
Remote Consultation,N,N04.452.758.849.550,Referral and Consultation,Professional Practice,29
Remote Consultation,N,N04.590.374.800.550,Telemedicine,Delivery of Health Care,29
Remote Consultation,L,L01.178.847.652.550,Telemedicine,Telecommunications,29
Reproductive Behavior,G,G08.686.784.891,Reproduction,Reproductive Physiological Phenomena,29
Reproductive Behavior,F,F01.145.688,Behavior,Behavior and Behavior Mechanisms,29
Selenium,D,D01.268.185.850,Chalcogens,Elements,29
Selenium,D,D01.578.700,Minerals,Inorganic Chemicals,29
Self Medication,E,E02.319.900,Drug Therapy,Therapeutics,29
Self Medication,E,E02.900.900,Self Care,Therapeutics,29
Serum Albumin,D,D12.776.124.727,Blood Proteins,Proteins,29
Serum Albumin,D,D12.776.034.841,Albumins,Proteins,29
"Shock, Septic",C,C23.550.470.790.500.800,Sepsis,Systemic Inflammatory Response Syndrome,29
"Shock, Septic",C,C23.550.835.900.712,Systemic Inflammatory Response Syndrome,Shock,29
"Shock, Septic",C,C01.757.800,Sepsis,Infections,29
"Sodium, Dietary",D,D01.857.875,Sodium Compounds,Inorganic Chemicals,29
tau Proteins,D,D12.776.220.600.450.510,Microtubule-Associated Proteins,Microtubule Proteins,29
tau Proteins,D,D12.776.631.560.510,Microtubule-Associated Proteins,Nerve Tissue Proteins,29
Thymus Gland,A,A15.382.520.604.750,Lymphoid Tissue,Lymphatic System,29
Thymus Gland,A,A10.549.750,Lymphoid Tissue,Tissues,29
Transgender Persons,M,M01.777.500,Sexual and Gender Minorities,Persons,29
"Vaccines, Inactivated",D,D20.215.894.830,Vaccines,Biological Products,29
"Vaccines, Subunit",D,D20.215.894.860,Vaccines,Biological Products,29
Vasodilator Agents,D,D27.505.954.411.918,Cardiovascular Agents,Therapeutic Uses,29
Accidental Falls,N,N06.850.135.122,Accidents,Public Health,28
Acinetobacter baumannii,B,B03.440.400.425.537.050.099,Acinetobacter,Moraxellaceae,28
Acinetobacter baumannii,B,B03.660.250.530.050.099,Acinetobacter,Moraxellaceae,28
Aerosols,D,D26.255.165.055,Colloids,Dosage Forms,28
Aerosols,D,D20.280.055,Colloids,Complex Mixtures,28
Antibody Affinity,G,G12.122.125,Antigen-Antibody Reactions,Immune System Phenomena,28
Antibody Affinity,G,G12.040,Immune System Phenomena,NULL,28
Arabs,M,M01.686.754.167,Ethnic Groups,Population Groups,28
Blood Proteins,D,D12.776.124,Proteins,"Amino Acids, Peptides, and Proteins",28
"Blotting, Southern",E,E05.301.300.087,Electrophoresis,Electrochemical Techniques,28
"Blotting, Southern",E,E05.196.401.114,Electrophoresis,"Chemistry Techniques, Analytical",28
"Blotting, Southern",E,E05.601.150,Molecular Probe Techniques,Investigative Techniques,28
Body Weights and Measures,E,E05.041.124,Anthropometry,Investigative Techniques,28
Body Weights and Measures,G,G07.100.100,Body Constitution,Physiological Phenomena,28
Body Weights and Measures,E,E01.370.600.115.100,Body Constitution,Physical Examination,28
Carotid Intima-Media Thickness,E,E01.370.370.180,"Diagnostic Techniques, Cardiovascular",Diagnostic Techniques and Procedures,28
Carotid Intima-Media Thickness,E,E01.370.350.850.150,Ultrasonography,Diagnostic Imaging,28
Carotid Intima-Media Thickness,G,G09.330.210,Cardiovascular Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,28
Community Pharmacy Services,N,N02.421.143.221,Community Health Services,Health Services,28
Community Pharmacy Services,N,N02.421.668.274,Pharmaceutical Services,Health Services,28
Dairying,J,J01.040.246,Agriculture,"Technology, Industry, and Agriculture",28
DNA Probes,D,D27.720.470.530.600.223,Nucleic Acid Probes,Molecular Probes,28
DNA Probes,D,D27.505.259.750.600.223,Nucleic Acid Probes,Molecular Probes,28
DNA Probes,D,D13.444.600.223,Nucleic Acid Probes,Nucleic Acids,28
Early Medical Intervention,N,N02.421.726.363,Preventive Health Services,Health Services,28
Exons,G,G05.360.340.024.340.137.232,Gene Components,Genes,28
Filtration,G,G01.280,Physical Phenomena,NULL,28
Filtration,G,G02.263,Chemical Phenomena,NULL,28
Filtration,E,E05.196.454,"Chemistry Techniques, Analytical",Investigative Techniques,28
Floods,N,N06.230.100.230.250,Natural Disasters,Disasters,28
Floods,G,G16.500.175.812,Climatic Processes,Ecological and Environmental Phenomena,28
"Genes, Insect",G,G05.360.340.024.340.340,Genes,Genome Components,28
"Genes, Insect",G,G05.360.340.357.500,"Genome, Insect",Genome,28
Graft Survival,G,G12.875.545.340,Host vs Graft Reaction,Transplantation Immunology,28
Health Planning Guidelines,N,N03.349.315,Health Planning,Health Care Economics and Organizations,28
Heart,A,A07.541,Cardiovascular System,NULL,28
HIV Protease Inhibitors,D,D27.505.519.389.745.900.500,Viral Protease Inhibitors,Protease Inhibitors,28
HIV Protease Inhibitors,D,D27.505.954.122.388.077.088.420,Anti-HIV Agents,Anti-Retroviral Agents,28
Human Trafficking,I,I01.198.240.748.470,Sex Offenses,Crime,28
Human Trafficking,I,I01.880.735.384.399,Human Rights Abuses,Social Problems,28
Inappropriate Prescribing,N,N02.421.450.500.249,Medication Errors,Medical Errors,28
Inappropriate Prescribing,E,E02.319.490,Drug Therapy,Therapeutics,28
Inflammation Mediators,D,D23.469,Biological Factors,NULL,28
Internship and Residency,I,I02.358.337.350.500,"Education, Medical, Graduate","Education, Graduate",28
Internship and Residency,I,I02.358.399.350.750,"Education, Medical, Graduate","Education, Medical",28
Luminescent Proteins,D,D12.776.532,Proteins,"Amino Acids, Peptides, and Proteins",28
Lymphoma,C,C04.557.386,Neoplasms by Histologic Type,Neoplasms,28
Lymphoma,C,C20.683.515.761,Lymphoproliferative Disorders,Immunoproliferative Disorders,28
Lymphoma,C,C15.604.515.569,Lymphoproliferative Disorders,Lymphatic Diseases,28
"Mice, Inbred CBA",B,B01.050.150.900.649.313.992.635.505.500.400.440,"Mice, Inbred Strains",Mice,28
"Mice, Inbred CBA",B,B01.050.050.199.520.520.440,"Mice, Inbred Strains","Animals, Inbred Strains",28
Multilevel Analysis,N,N06.850.520.830.562,Statistics as Topic,Epidemiologic Methods,28
"Natriuretic Peptide, Brain",D,D12.776.631.590,Nerve Tissue Proteins,Proteins,28
"Natriuretic Peptide, Brain",D,D12.644.548.585.625,Natriuretic Peptides,Peptide Hormones,28
"Natriuretic Peptide, Brain",D,D06.472.699.584.625,Natriuretic Peptides,Peptide Hormones,28
Nurse Midwives,N,N02.360.650.648.762,Nurse Specialists,Nurses,28
Nurse Midwives,M,M01.526.485.650.648.762,Nurse Specialists,Nurses,28
Nurse-Patient Relations,N,N05.300.660.560,Professional-Patient Relations,Delivery of Health Care,28
Nurse-Patient Relations,F,F01.829.401.650.600,Professional-Patient Relations,Interpersonal Relations,28
Onchocerca volvulus,B,B01.050.500.500.294.400.937.463.510.850,Onchocerca,Filarioidea,28
Particle Size,G,G02.712,Chemical Phenomena,NULL,28
"Pest Control, Biological",N,N06.850.780.200.650.650,Pest Control,Communicable Disease Control,28
Plant Extracts,D,D20.215.784.500,Plant Preparations,Biological Products,28
Plant Extracts,D,D26.667,Pharmaceutical Preparations,NULL,28
Police,M,M01.526.760,Occupational Groups,Persons,28
Police,M,M01.526.373.750,Emergency Responders,Occupational Groups,28
Prostate,A,A05.360.444.575,"Genitalia, Male",Genitalia,28
Prostate,A,A10.336.707,Exocrine Glands,Tissues,28
Psychiatry,H,H02.403.690,Medicine,Health Occupations,28
Psychiatry,F,F04.096.544,Behavioral Sciences,Behavioral Disciplines and Activities,28
Reproductive History,N,N05.715.350.575,Epidemiologic Factors,Quality of Health Care,28
Reproductive History,N,N06.850.490.812,Epidemiologic Factors,Public Health,28
Reproductive History,E,E01.370.510.700,Medical History Taking,Diagnostic Techniques and Procedures,28
"Schools, Medical",N,N02.278.020.578,Academic Medical Centers,Health Facilities,28
"Schools, Medical",I,I02.783.495.552,"Schools, Health Occupations",Schools,28
Sheep Diseases,C,C22.836,Animal Diseases,NULL,28
Spodoptera,B,B01.050.500.131.617.720.500.500.937.650.700,Moths,Lepidoptera,28
Suicidal Ideation,I,I01.880.735.856.149,Suicide,Social Problems,28
Suicidal Ideation,F,F01.145.126.980.875.149,Suicide,Self-Injurious Behavior,28
Sulfonylurea Compounds,D,D02.065.950.828,Urea,Amides,28
Sulfonylurea Compounds,D,D02.886.590.795,Sulfones,Sulfur Compounds,28
Thiazoles,D,D02.886.675,Sulfur Compounds,Organic Chemicals,28
Thiazoles,D,D03.383.129.708,Azoles,"Heterocyclic Compounds, 1-Ring",28
Triatoma,B,B01.050.500.131.617.412.420.700.850.800,Triatominae,Reduviidae,28
Vascular Endothelial Growth Factor A,D,D12.644.276.100.800.200,Vascular Endothelial Growth Factors,Angiogenic Proteins,28
Vascular Endothelial Growth Factor A,D,D23.529.100.800.200,Vascular Endothelial Growth Factors,Angiogenic Proteins,28
Vascular Endothelial Growth Factor A,D,D12.776.467.100.800.200,Vascular Endothelial Growth Factors,Angiogenic Proteins,28
Acute-Phase Proteins,D,D12.776.124.050,Blood Proteins,Proteins,27
"Adaptation, Biological",G,G16.012,Biological Phenomena,NULL,27
Anticholesteremic Agents,D,D27.505.519.186.071.202,Hypolipidemic Agents,Antimetabolites,27
Anticholesteremic Agents,D,D27.505.954.557.500.202,Hypolipidemic Agents,Lipid Regulating Agents,27
Antimicrobial Stewardship,N,N05.700.900.300.500,Drug Utilization Review,Utilization Review,27
Antimicrobial Stewardship,N,N04.761.879.300.500,Drug Utilization Review,Utilization Review,27
Antimicrobial Stewardship,N,N04.452.706.477.400.500,Drug Utilization Review,Drug Utilization,27
"Antineoplastic Agents, Hormonal",D,D27.505.954.248.169,Antineoplastic Agents,Therapeutic Uses,27
Attention Deficit Disorder with Hyperactivity,F,F03.625.094.150,Attention Deficit and Disruptive Behavior Disorders,Neurodevelopmental Disorders,27
Automation,J,J01.897.104,Technology,"Technology, Industry, and Agriculture",27
Blood Cell Count,G,G09.188.105,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,27
Blood Cell Count,G,G04.140.107,Cell Count,Cell Physiological Phenomena,27
Blood Cell Count,E,E05.200.500.195.107,Cell Count,Cytological Techniques,27
Blood Cell Count,E,E05.242.195.107,Cell Count,Cytological Techniques,27
Blood Cell Count,E,E05.200.625.107,Hematologic Tests,Clinical Laboratory Techniques,27
Blood Cell Count,E,E01.370.225.500.195.107,Cell Count,Cytological Techniques,27
Blood Cell Count,E,E01.370.225.625.107,Hematologic Tests,Clinical Laboratory Techniques,27
"Blood Pressure Monitoring, Ambulatory",E,E01.370.370.140.100,Blood Pressure Determination,"Diagnostic Techniques, Cardiovascular",27
"Blood Pressure Monitoring, Ambulatory",E,E01.370.520.500.100,"Monitoring, Ambulatory","Monitoring, Physiologic",27
Bulgaria,Z,Z01.542.248.180,"Europe, Eastern",Europe,27
Calorimetry,E,E05.196.131,"Chemistry Techniques, Analytical",Investigative Techniques,27
Chemokines,D,D23.529.374.200,Cytokines,Intercellular Signaling Peptides and Proteins,27
Chemokines,D,D23.469.200,Inflammation Mediators,Biological Factors,27
Chemokines,D,D23.125.300,Chemotactic Factors,Biological Factors,27
Chemokines,D,D12.776.467.374.200,Cytokines,Intercellular Signaling Peptides and Proteins,27
Chemokines,D,D12.644.276.374.200,Cytokines,Intercellular Signaling Peptides and Proteins,27
Chiroptera,B,B01.050.150.900.649.313.937,Eutheria,Mammals,27
"Chromosomes, Bacterial",A,A20.812,Bacterial Structures,NULL,27
"Chromosomes, Bacterial",A,A11.284.187.190,Chromosomes,Cellular Structures,27
"Chromosomes, Bacterial",G,G05.360.162.190,Chromosomes,Genetic Structures,27
Complement System Proteins,D,D12.776.124.486.274,Immunoproteins,Blood Proteins,27
Condylomata Acuminata,C,C01.925.825.810.110,Warts,"Skin Diseases, Viral",27
Condylomata Acuminata,C,C01.925.928.914.217,Warts,Tumor Virus Infections,27
Condylomata Acuminata,C,C01.925.256.650.810.217,Warts,Papillomavirus Infections,27
Condylomata Acuminata,C,C01.925.813.220,"Sexually Transmitted Diseases, Viral",Virus Diseases,27
Condylomata Acuminata,C,C01.778.640.220,"Sexually Transmitted Diseases, Viral",Sexually Transmitted Diseases,27
Condylomata Acuminata,C,C01.221.812.640.220,"Sexually Transmitted Diseases, Viral",Sexually Transmitted Diseases,27
Condylomata Acuminata,C,C17.800.838.790.810.110,Warts,"Skin Diseases, Viral",27
Cryptococcus,B,B01.300.381.258,Mitosporic Fungi,Fungi,27
Cryptococcus,B,B01.300.930.316,Yeasts,Fungi,27
Cryptococcus neoformans,B,B01.300.930.316.366,Cryptococcus,Yeasts,27
Cryptococcus neoformans,B,B01.300.381.258.366,Cryptococcus,Mitosporic Fungi,27
Culture Techniques,E,E05.481.500,In Vitro Techniques,Investigative Techniques,27
"Death, Sudden, Cardiac",C,C14.280.383.220,Heart Arrest,Heart Diseases,27
"Death, Sudden, Cardiac",C,C23.550.260.322.250,"Death, Sudden",Death,27
Diagnostic and Statistical Manual of Mental Disorders,L,L01.453.245.945.200,"Vocabulary, Controlled",Documentation,27
Diagnostic Techniques and Procedures,E,E01.370,Diagnosis,NULL,27
Drug Evaluation,E,E05.337.425,Evaluation Studies as Topic,Investigative Techniques,27
Drug Evaluation,E,E05.290.625,Drug Development,Investigative Techniques,27
Drug Therapy,E,E02.319,Therapeutics,NULL,27
Dysentery,C,C06.405.469.300,Intestinal Diseases,Gastrointestinal Diseases,27
Dysentery,C,C06.405.205.331,Gastroenteritis,Gastrointestinal Diseases,27
Eukaryota,B,B01,NULL,NULL,27
Farmers,M,M01.526.390,Occupational Groups,Persons,27
Fibroblasts,A,A11.329.228,Connective Tissue Cells,Cells,27
Forests,N,N06.230.124.343,Ecosystem,Environment,27
Forests,G,G16.500.275.157.437,Ecosystem,Environment,27
Gene Library,G,G05.360.325,Genetic Structures,Genetic Phenomena,27
Heart Valve Prosthesis Implantation,E,E04.100.376.485,Cardiac Surgical Procedures,Cardiovascular Surgical Procedures,27
Heart Valve Prosthesis Implantation,E,E04.928.220.410,Cardiac Surgical Procedures,Thoracic Surgical Procedures,27
Heart Valve Prosthesis Implantation,E,E04.650.410,Prosthesis Implantation,"Surgical Procedures, Operative",27
Hematologic Neoplasms,C,C04.588.448,Neoplasms by Site,Neoplasms,27
Hematologic Neoplasms,C,C15.378.400,Hematologic Diseases,Hemic and Lymphatic Diseases,27
Hematologic Tests,E,E01.370.225.625,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,27
Hematologic Tests,E,E05.200.625,Clinical Laboratory Techniques,Investigative Techniques,27
Household Articles,J,J01.494,"Technology, Industry, and Agriculture",NULL,27
Insulin-Like Growth Factor I,D,D23.529.937.400,Somatomedins,Intercellular Signaling Peptides and Proteins,27
Insulin-Like Growth Factor I,D,D12.776.467.937.400,Somatomedins,Intercellular Signaling Peptides and Proteins,27
Insulin-Like Growth Factor I,D,D12.776.124.862.400,Somatomedins,Blood Proteins,27
Insulin-Like Growth Factor I,D,D12.644.276.937.400,Somatomedins,Intercellular Signaling Peptides and Proteins,27
Kidney Function Tests,E,E01.370.390.400,"Diagnostic Techniques, Urological",Diagnostic Techniques and Procedures,27
"Lipoproteins, HDL",D,D12.776.521.479,Lipoproteins,Proteins,27
"Lipoproteins, HDL",D,D10.532.432,Lipoproteins,Lipids,27
Medical History Taking,E,E01.370.510,Diagnostic Techniques and Procedures,Diagnosis,27
Medical Tourism,N,N05.300.515,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",27
Methicillin Resistance,G,G06.099.225.500.600.525,Penicillin Resistance,beta-Lactam Resistance,27
Methicillin Resistance,G,G06.225.347.500.600.525,Penicillin Resistance,beta-Lactam Resistance,27
Methicillin Resistance,G,G07.690.773.984.269.347.500.600.525,Penicillin Resistance,beta-Lactam Resistance,27
Mongolia,Z,Z01.252.474.651,Far East,Asia,27
Otitis Media,C,C09.218.705.663,Otitis,Ear Diseases,27
Oxygen Inhalation Therapy,E,E02.880.690,Respiratory Therapy,Therapeutics,27
Patient Rights,N,N03.706.437.650,Human Rights,"Social Control, Formal",27
Patient Rights,I,I01.880.604.473.650,Human Rights,"Social Control, Formal",27
Pharynx,A,A04.623,Respiratory System,NULL,27
Pharynx,A,A03.556.750,Gastrointestinal Tract,Digestive System,27
Pharynx,A,A14.724,Stomatognathic System,NULL,27
"Plants, Medicinal",B,B01.650.560,Plants,Eukaryota,27
Population Growth,I,I01.240.600.660,Population Dynamics,Demography,27
Population Growth,N,N06.850.505.400.700.660,Population Dynamics,Demography,27
Population Growth,N,N01.224.625.660,Population Dynamics,Demography,27
Prescription Drugs,D,D26.670,Pharmaceutical Preparations,NULL,27
Radiotherapy,E,E02.815,Therapeutics,NULL,27
"Refraction, Ocular",G,G01.590.775,Optical Phenomena,Physical Phenomena,27
"Refraction, Ocular",G,G14.760,Ocular Physiological Phenomena,NULL,27
"Refraction, Ocular",E,E01.370.380.850.700,Vision Tests,"Diagnostic Techniques, Ophthalmological",27
Salmonella paratyphi A,B,B03.440.450.425.800.200.600,Salmonella enterica,Salmonella,27
Salmonella paratyphi A,B,B03.660.250.150.710.160.580,Salmonella enterica,Salmonella,27
Secondary Care,N,N04.452.758.849.775,Referral and Consultation,Professional Practice,27
Secondary Care,N,N05.300.745,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",27
Simian immunodeficiency virus,B,B04.820.650.589.650.800,"Lentiviruses, Primate",Lentivirus,27
Simian Immunodeficiency Virus,B,B04.820.650.805.700,"Retroviruses, Simian",Retroviridae,27
Soil Microbiology,N,N06.850.425.300,Environmental Microbiology,Public Health,27
Soil Microbiology,H,H01.158.273.540.274.555,Environmental Microbiology,Microbiology,27
Space-Time Clustering,N,N06.850.290.600,Disease Outbreaks,Public Health,27
Space-Time Clustering,N,N05.715.360.750.746.500.500,Spatio-Temporal Analysis,Spatial Analysis,27
Space-Time Clustering,E,E05.318.740.933.500.500,Spatio-Temporal Analysis,Spatial Analysis,27
Space-Time Clustering,N,N06.850.520.830.933.500.500,Spatio-Temporal Analysis,Spatial Analysis,27
Spinal Cord,A,A08.186.854,Central Nervous System,Nervous System,27
Systole,G,G09.330.580.880,Myocardial Contraction,Cardiovascular Physiological Phenomena,27
Systole,G,G11.427.494.570.880,Myocardial Contraction,Muscle Contraction,27
Ticks,B,B01.050.500.131.166.132.832,Acari,Arachnida,27
Trees,B,B01.650.915,Plants,Eukaryota,27
Value of Life,K,K01.752.400.900,Life,Philosophy,27
Viral Structural Proteins,D,D12.776.964.970,Viral Proteins,Proteins,27
Vision Tests,E,E01.370.380.850,"Diagnostic Techniques, Ophthalmological",Diagnostic Techniques and Procedures,27
Warfarin,D,D03.633.100.150.446.520.914,4-Hydroxycoumarins,Coumarins,27
Warfarin,D,D03.383.663.283.446.520.914,4-Hydroxycoumarins,Coumarins,27
Amyloid beta-Peptides,D,D12.644.024,Peptides,"Amino Acids, Peptides, and Proteins",26
Amyloid beta-Peptides,D,D12.776.049.407.249.500,Amyloid beta-Protein Precursor,Amyloidogenic Proteins,26
Amyloid beta-Peptides,D,D12.776.543.039.500,Amyloid beta-Protein Precursor,Membrane Proteins,26
Anal Canal,A,A03.556.249.249.070,"Intestine, Large",Lower Gastrointestinal Tract,26
Anal Canal,A,A03.556.124.526.070,"Intestine, Large",Intestines,26
Artificial Intelligence,L,L01.224.050.375,Algorithms,Computing Methodologies,26
Artificial Intelligence,G,G17.035.250,Algorithms,Mathematical Concepts,26
Body Constitution,G,G07.100,Physiological Phenomena,NULL,26
Body Constitution,E,E01.370.600.115,Physical Examination,Diagnostic Techniques and Procedures,26
Burkitt Lymphoma,C,C01.925.256.466.313.165,Epstein-Barr Virus Infections,Herpesviridae Infections,26
Burkitt Lymphoma,C,C01.925.928.313.165,Epstein-Barr Virus Infections,Tumor Virus Infections,26
Burkitt Lymphoma,C,C04.557.386.480.150.165,"Lymphoma, B-Cell","Lymphoma, Non-Hodgkin",26
Burkitt Lymphoma,C,C15.604.515.569.480.150.165,"Lymphoma, B-Cell","Lymphoma, Non-Hodgkin",26
Burkitt Lymphoma,C,C20.683.515.761.480.150.165,"Lymphoma, B-Cell","Lymphoma, Non-Hodgkin",26
Calcium Channel Blockers,D,D27.505.519.562.249,Membrane Transport Modulators,Molecular Mechanisms of Pharmacological Action,26
Calcium Channel Blockers,D,D27.505.696.260.500,Calcium-Regulating Hormones and Agents,Physiological Effects of Drugs,26
Calcium Channel Blockers,D,D27.505.954.411.192,Cardiovascular Agents,Therapeutic Uses,26
Campylobacter,B,B03.660.150.235.250.500,Campylobacteraceae,Campylobacterales,26
Campylobacter,B,B03.440.180,Gram-Negative Bacteria,Bacteria,26
"Chemistry, Pharmaceutical",H,H01.158.703.007,Pharmacology,Biological Science Disciplines,26
"Chemistry, Pharmaceutical",H,H01.181.466,Chemistry,Natural Science Disciplines,26
"Child Abuse, Sexual",I,I01.198.240.856.350.250.255,Child Abuse,Domestic Violence,26
"Child Abuse, Sexual",I,I01.198.240.748.300,Sex Offenses,Crime,26
"Child Abuse, Sexual",I,I01.880.735.900.350.250.255,Child Abuse,Domestic Violence,26
Comparative Effectiveness Research,H,H01.770.644.145.360.500,Health Services Research,Biomedical Research,26
Comparative Effectiveness Research,N,N05.425.157,Health Services Research,"Health Care Quality, Access, and Evaluation",26
Cornea,A,A09.371.060.217,Anterior Eye Segment,Eye,26
Crohn Disease,C,C06.405.205.731.500,Inflammatory Bowel Diseases,Gastroenteritis,26
Crohn Disease,C,C06.405.469.432.500,Inflammatory Bowel Diseases,Intestinal Diseases,26
Disinfection,N,N06.850.780.200.450.850.375,Sterilization,Infection Control,26
Editorial Policies,L,L01.737.484,Publishing,Information Science,26
Enterotoxins,D,D23.946.330,"Toxins, Biological",Biological Factors,26
Epstein-Barr Virus Infections,C,C01.925.928.313,Tumor Virus Infections,Virus Diseases,26
Epstein-Barr Virus Infections,C,C01.925.256.466.313,Herpesviridae Infections,DNA Virus Infections,26
Equipment Contamination,N,N06.850.540,Public Health,Environment and Public Health,26
Exercise Therapy,E,E02.779.483,Physical Therapy Modalities,Therapeutics,26
Exercise Therapy,E,E02.831.535.483,Physical Therapy Modalities,Rehabilitation,26
Exercise Therapy,E,E02.760.169.063.500.387,Rehabilitation,Aftercare,26
Fatigue,C,C23.888.369,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",26
"Fatty Acids, Omega-3",D,D10.627.430.450,Fish Oils,Oils,26
"Fatty Acids, Omega-3",D,D10.212.302.380.410,"Dietary Fats, Unsaturated",Dietary Fats,26
"Fatty Acids, Omega-3",D,D10.251.355.337,"Fatty Acids, Unsaturated",Fatty Acids,26
Fibrosis,C,C23.550.355,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",26
"Gene Expression Regulation, Viral",G,G05.308.385,Gene Expression Regulation,Genetic Phenomena,26
"Gene Products, gag",D,D12.776.964.970.600.850.350,Viral Core Proteins,Nucleocapsid Proteins,26
"Gene Products, gag",D,D12.776.775.330,Polyproteins,Proteins,26
"Gene Products, gag",D,D12.776.964.775.350,Retroviridae Proteins,Viral Proteins,26
Genes,G,G05.360.340.024.340,Genome Components,Genome,26
Giardiasis,C,C06.405.469.452.481,"Intestinal Diseases, Parasitic",Intestinal Diseases,26
Giardiasis,C,C01.610.752.400,Protozoan Infections,Parasitic Diseases,26
Giardiasis,C,C01.610.432.481,"Intestinal Diseases, Parasitic",Parasitic Diseases,26
Glasgow Coma Scale,E,E05.318.308.940.968.875.250,Trauma Severity Indices,Medical Records,26
Glasgow Coma Scale,E,E05.944.500,Trauma Severity Indices,Investigative Techniques,26
Glasgow Coma Scale,N,N04.452.859.564.800.250,Trauma Severity Indices,Medical Records,26
Glasgow Coma Scale,N,N05.715.360.300.715.500.800.325,Trauma Severity Indices,Medical Records,26
Glucose Intolerance,C,C18.452.394.952.500,Hyperglycemia,Glucose Metabolism Disorders,26
Gross Domestic Product,I,I01.261.587,Economics,Social Sciences,26
Group Processes,F,F01.829.316,"Psychology, Social",Behavior and Behavior Mechanisms,26
Guillain-Barre Syndrome,C,C10.314.750.450,Polyradiculoneuropathy,Demyelinating Diseases,26
Guillain-Barre Syndrome,C,C10.114.750.100,Polyradiculoneuropathy,Autoimmune Diseases of the Nervous System,26
Guillain-Barre Syndrome,C,C10.668.829.350,Peripheral Nervous System Diseases,Neuromuscular Diseases,26
Guillain-Barre Syndrome,C,C10.668.829.800.750.300,Polyradiculoneuropathy,Polyneuropathies,26
Guillain-Barre Syndrome,C,C20.111.258.750.400,Polyradiculoneuropathy,Autoimmune Diseases of the Nervous System,26
Histocompatibility Testing,E,E01.370.225.812.385,Immunologic Tests,Clinical Laboratory Techniques,26
Histocompatibility Testing,E,E05.478.594.385,Immunologic Tests,Immunologic Techniques,26
Histocompatibility Testing,E,E05.200.812.385,Immunologic Tests,Clinical Laboratory Techniques,26
Histones,D,D12.776.664.469,Nucleoproteins,Proteins,26
Histones,D,D12.776.660.720.485,Poly-ADP-Ribose Binding Proteins,Nuclear Proteins,26
Histones,D,D12.776.157.687.485,Poly-ADP-Ribose Binding Proteins,Carrier Proteins,26
"Hypertension, Pulmonary",C,C08.381.423,Lung Diseases,Respiratory Tract Diseases,26
"Hypertension, Pulmonary",C,C14.907.489.556,Hypertension,Vascular Diseases,26
Immunotherapy,E,E02.095.465.425,Immunomodulation,Biological Therapy,26
Keratitis,C,C11.204.564,Corneal Diseases,Eye Diseases,26
"Legislation, Drug",I,I01.880.604.605,"Social Control, Formal",Sociology,26
"Legislation, Drug",N,N03.706.615.402,Legislation as Topic,"Social Control, Formal",26
Leisure Activities,I,I03.450,Human Activities,NULL,26
Luciferases,D,D12.776.532.510,Luminescent Proteins,Proteins,26
Luciferases,D,D08.811.682.517,Oxidoreductases,Enzymes,26
Lymphogranuloma Venereum,C,C13.351.500.711.281.301.490,Chlamydia Infections,"Sexually Transmitted Diseases, Bacterial",26
Lymphogranuloma Venereum,C,C12.294.668.281.301.490,Chlamydia Infections,"Sexually Transmitted Diseases, Bacterial",26
Lymphogranuloma Venereum,C,C01.778.281.301.490,Chlamydia Infections,"Sexually Transmitted Diseases, Bacterial",26
Lymphogranuloma Venereum,C,C01.221.812.281.301.490,Chlamydia Infections,"Sexually Transmitted Diseases, Bacterial",26
Lymphogranuloma Venereum,C,C01.150.252.734.301.490,Chlamydia Infections,"Sexually Transmitted Diseases, Bacterial",26
Lymphogranuloma Venereum,C,C01.150.252.400.210.125.490,Chlamydia Infections,Chlamydiaceae Infections,26
Men,M,M01.390,Persons,NULL,26
Metabolic Diseases,C,C18.452,Nutritional and Metabolic Diseases,NULL,26
Methotrexate,D,D03.633.100.733.631.192.500,Aminopterin,Pterins,26
Mobile Health Units,N,N02.278.421.702,Hospitals,Health Facilities,26
Mobile Health Units,N,N02.421.726.233.628,Diagnostic Services,Preventive Health Services,26
Mumps Vaccine,D,D20.215.894.899.488,Viral Vaccines,Vaccines,26
"Muscle, Skeletal",A,A02.633.567,Muscles,Musculoskeletal System,26
"Muscle, Skeletal",A,A10.690.552.500,"Muscle, Striated",Muscles,26
Otitis Media with Effusion,C,C09.218.705.663.670,Otitis Media,Otitis,26
Oximetry,E,E01.370.386.700.100.600,Blood Gas Analysis,Respiratory Function Tests,26
Oximetry,E,E01.370.225.124.100.100.600,Blood Gas Analysis,Blood Chemical Analysis,26
Oximetry,E,E01.370.370.380.600,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",26
Oximetry,E,E05.200.124.100.100.600,Blood Gas Analysis,Blood Chemical Analysis,26
Pleural Neoplasms,C,C08.785.640,Respiratory Tract Neoplasms,Respiratory Tract Diseases,26
Pleural Neoplasms,C,C08.528.694,Pleural Diseases,Respiratory Tract Diseases,26
Pleural Neoplasms,C,C04.588.894.797.640,Respiratory Tract Neoplasms,Thoracic Neoplasms,26
Polymers,D,D25.720,Biomedical and Dental Materials,NULL,26
Polymers,D,D05.750,Macromolecular Substances,NULL,26
Polymers,J,J01.637.051.720,Biomedical and Dental Materials,Manufactured Materials,26
Population Health,N,N01.400.548,Health,Population Characteristics,26
Prediabetic State,C,C18.452.394.750.774,Diabetes Mellitus,Glucose Metabolism Disorders,26
Prediabetic State,C,C19.246.774,Diabetes Mellitus,Endocrine System Diseases,26
Protective Factors,N,N05.715.350.200.675,Causality,Epidemiologic Factors,26
Protective Factors,N,N05.715.360.750.625.700.570,Risk,Probability,26
Protective Factors,N,N06.850.490.625.625,Causality,Epidemiologic Factors,26
Protective Factors,E,E05.318.740.600.800.582,Risk,Probability,26
Protective Factors,N,N06.850.520.830.600.800.582,Risk,Probability,26
Protein Kinases,D,D08.811.913.696.620.682,Phosphotransferases (Alcohol Group Acceptor),Phosphotransferases,26
"Protein Processing, Post-Translational",G,G03.734.871.790.600,"Protein Modification, Translational",Protein Biosynthesis,26
"Protein Processing, Post-Translational",G,G02.111.691.600,"Protein Modification, Translational",Biochemical Phenomena,26
"Protein Processing, Post-Translational",G,G02.111.660.871.790.600,"Protein Modification, Translational",Protein Biosynthesis,26
"Protein Processing, Post-Translational",G,G05.308.670.600,"Protein Modification, Translational",Gene Expression Regulation,26
Proteinuria,C,C23.888.942.750,Urological Manifestations,Signs and Symptoms,26
Proteinuria,C,C13.351.968.934.734,Urination Disorders,Urologic Diseases,26
Proteinuria,C,C12.777.934.734,Urination Disorders,Urologic Diseases,26
Publications,L,L01.178.682,Communications Media,Information Science,26
"Repetitive Sequences, Nucleic Acid",G,G05.360.080.708,Base Sequence,Genetic Structures,26
"Repetitive Sequences, Nucleic Acid",G,G02.111.570.080.708,Base Sequence,Molecular Structure,26
Reproductive Medicine,H,H02.403.763,Medicine,Health Occupations,26
"Resilience, Psychological",F,F02.940,Psychological Phenomena,NULL,26
Retirement,I,I03.702,Human Activities,NULL,26
"RNA, Double-Stranded",G,G02.111.570.820.486.775,Nucleic Acid Conformation,Molecular Conformation,26
"RNA, Double-Stranded",G,G05.360.580.775,Nucleic Acid Conformation,Genetic Structures,26
"RNA, Double-Stranded",D,D13.444.735.490,RNA,Nucleic Acids,26
"Rubella Syndrome, Congenital",C,C16.131.077.790,"Abnormalities, Multiple",Congenital Abnormalities,26
"Rubella Syndrome, Congenital",C,C01.925.782.930.700.700.700,Rubella,Rubivirus Infections,26
Sequence Analysis,E,E05.393.760,Genetic Techniques,Investigative Techniques,26
Sexuality,F,F01.145.802.975,Sexual Behavior,Behavior,26
Sexuality,G,G08.686.867,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,26
Toll-Like Receptor 4,D,D12.776.543.750.705.910.500.400,Toll-Like Receptors,"Receptors, Pattern Recognition",26
"Tomography, Optical Coherence",E,E01.370.350.825.805.500,"Tomography, Optical",Tomography,26
"Tomography, Optical Coherence",E,E01.370.350.589.249.500,"Tomography, Optical",Optical Imaging,26
"Tomography, Optical Coherence",E,E05.642.249.500,"Tomography, Optical",Optical Imaging,26
Toxoplasma,B,B01.043.075.189.250.750.800,Sarcocystidae,Eimeriida,26
Trinidad and Tobago,Z,Z01.107.084.900.900,West Indies,Caribbean Region,26
Trinidad and Tobago,Z,Z01.639.880.900,West Indies,Islands,26
"Tuberculosis, Bovine",C,C01.150.252.410.040.552.846.538,Tuberculosis,Mycobacterium Infections,26
"Tuberculosis, Bovine",C,C22.196.927,Cattle Diseases,Animal Diseases,26
"Twins, Monozygotic",M,M01.438.873.940,Twins,Multiple Birth Offspring,26
Typhoid-Paratyphoid Vaccines,D,D20.215.894.135.685.910,Salmonella Vaccines,Bacterial Vaccines,26
Vacuoles,A,A11.284.430.214.190.875.190.920,Cytoplasmic Vesicles,Organelles,26
Video Recording,L,L01.280.960,Copying Processes,Information Science,26
"Vision, Ocular",G,G14.935,Ocular Physiological Phenomena,NULL,26
"Vision, Ocular",G,G11.561.790.964,Sensation,Nervous System Physiological Phenomena,26
"Vision, Ocular",G,G04.835.480.900,Light Signal Transduction,Signal Transduction,26
"Vision, Ocular",G,G02.111.820.480.900,Light Signal Transduction,Signal Transduction,26
"Vision, Ocular",F,F02.830.816.964,Sensation,Psychophysiology,26
Women's Health Services,N,N02.421.920,Health Services,"Health Care Facilities, Manpower, and Services",26
Antimony Sodium Gluconate,D,D02.241.081.844.322.060,Gluconates,Sugar Acids,25
Antimony Sodium Gluconate,D,D02.125,Organic Chemicals,NULL,25
Antimony Sodium Gluconate,D,D02.241.511.902.322.060,Gluconates,Sugar Acids,25
Antimony Sodium Gluconate,D,D09.811.308.060,Gluconates,Sugar Acids,25
Birth Order,N,N01.224.361.160,Family Characteristics,Demography,25
Birth Order,N,N06.850.505.400.400.160,Family Characteristics,Demography,25
Birth Order,I,I01.240.361.160,Family Characteristics,Demography,25
Birth Order,F,F01.829.263.132,Family,"Psychology, Social",25
Bone Marrow,A,A15.382.216,Immune System,Hemic and Immune Systems,25
BRCA1 Protein,D,D12.776.313.125,Fanconi Anemia Complementation Group Proteins,Proteins,25
BRCA1 Protein,D,D12.776.660.100,Nuclear Proteins,Proteins,25
BRCA1 Protein,D,D12.776.744.100,Phosphoproteins,Proteins,25
BRCA1 Protein,D,D12.776.624.776.100,Tumor Suppressor Proteins,Neoplasm Proteins,25
BRCA1 Protein,D,D12.776.930.137,Transcription Factors,Proteins,25
Chest Pain,C,C23.888.592.612.233,Pain,Neurologic Manifestations,25
"Chromatography, Liquid",E,E05.196.181.400,Chromatography,"Chemistry Techniques, Analytical",25
City Planning,I,I01.880.709.202,Social Planning,Sociology,25
Clone Cells,A,A11.251.353,"Cells, Cultured",Cells,25
Collagen,D,D12.776.860.300.250,Extracellular Matrix Proteins,Scleroproteins,25
Collagen,D,D05.750.078.280,Biopolymers,Polymers,25
Complementary Therapies,E,E02.190,Therapeutics,NULL,25
"Diagnostic Techniques, Ophthalmological",E,E01.370.380,Diagnostic Techniques and Procedures,Diagnosis,25
Diphtheria-Tetanus-acellular Pertussis Vaccines,D,D20.215.894.135.535.295,Pertussis Vaccine,Bacterial Vaccines,25
Diphtheria-Tetanus-acellular Pertussis Vaccines,D,D20.215.894.860.900.267,"Vaccines, Acellular","Vaccines, Subunit",25
Diphtheria-Tetanus-acellular Pertussis Vaccines,D,D20.215.894.691.263.290,Diphtheria Toxoid,Toxoids,25
Diphtheria-Tetanus-acellular Pertussis Vaccines,D,D20.215.894.815.149,"Vaccines, Combined",Vaccines,25
Diphtheria-Tetanus-acellular Pertussis Vaccines,D,D20.215.894.691.824.290,Tetanus Toxoid,Toxoids,25
Drug Development,H,H01.181.466.338,"Chemistry, Pharmaceutical",Chemistry,25
Drug Development,H,H01.158.703.007.338,"Chemistry, Pharmaceutical",Pharmacology,25
Drug Development,E,E05.290,Investigative Techniques,NULL,25
Emergency Treatment,E,E02.365,Therapeutics,NULL,25
Endothelial Cells,A,A11.436.275,Epithelial Cells,Cells,25
"env Gene Products, Human Immunodeficiency Virus",D,D12.776.964.970.880.325.164,"Gene Products, env",Viral Envelope Proteins,25
"env Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.325.164,"Gene Products, env",Retroviridae Proteins,25
"env Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.562.500,Human Immunodeficiency Virus Proteins,Retroviridae Proteins,25
Eosinophils,A,A11.627.340.345,Granulocytes,Myeloid Cells,25
Eosinophils,A,A11.118.637.415.345,Granulocytes,Leukocytes,25
Eosinophils,A,A15.382.490.315.251,Granulocytes,Leukocytes,25
Eosinophils,A,A15.145.229.637.415.345,Granulocytes,Leukocytes,25
Frail Elderly,M,M01.060.116.100.540,Aged,Adult,25
Germ Cells,A,A11.497,Cells,NULL,25
Germ Cells,A,A05.360.490,Genitalia,Urogenital System,25
Helminth Proteins,D,D12.776.419,Proteins,"Amino Acids, Peptides, and Proteins",25
"Hemoglobin, Sickle",D,D12.776.422.316.762.426.588,"Hemoglobins, Abnormal",Hemoglobins,25
"Hemoglobin, Sickle",D,D12.776.124.400.463.588,"Hemoglobins, Abnormal",Hemoglobins,25
"History, Ancient",K,K01.400.470,History,Humanities,25
Homocysteine,D,D12.125.166.498,"Amino Acids, Sulfur",Amino Acids,25
Homocysteine,D,D02.886.030.498,"Amino Acids, Sulfur",Sulfur Compounds,25
Human Experimentation,H,H01.770.644.145.365,Biomedical Research,Research,25
Human Experimentation,E,E05.445,Investigative Techniques,NULL,25
Immune Evasion,G,G06.462.400,Host-Pathogen Interactions,Microbiological Phenomena,25
Immune Evasion,G,G12.413,Immune System Phenomena,NULL,25
Immune Evasion,G,G16.527.200.700,Host-Pathogen Interactions,Host Microbial Interactions,25
"Immunity, Mucosal",G,G12.450.573,Immunity,Immune System Phenomena,25
Immunologic Factors,D,D27.505.696.477,Physiological Effects of Drugs,Pharmacologic Actions,25
Indoles,D,D03.633.100.473,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",25
Infant Formula,J,J02.200.712.249,Milk Substitutes,Beverages,25
Infant Formula,J,J02.500.525.350.500,"Food, Formulated","Foods, Specialized",25
Infant Formula,J,J02.500.525.500.500,Infant Food,"Foods, Specialized",25
Infant Formula,G,G07.203.100.712.249,Milk Substitutes,Beverages,25
Infant Formula,G,G07.203.300.525.500.500,Infant Food,"Foods, Specialized",25
Infant Formula,G,G07.203.300.525.350.500,"Food, Formulated","Foods, Specialized",25
"Intensive Care Units, Pediatric",N,N02.278.388.493.390,Intensive Care Units,Hospital Units,25
Iraq,Z,Z01.252.245.500.360,Middle East,"Asia, Western",25
Lectins,D,D12.776.503,Proteins,"Amino Acids, Peptides, and Proteins",25
"Lectins, C-Type",D,D12.776.503.280,Lectins,Proteins,25
Leg,A,A01.378.610.500,Lower Extremity,Extremities,25
Marburg Virus Disease,C,C01.925.782.580.250.500,Filoviridae Infections,Mononegavirales Infections,25
Marburg Virus Disease,C,C01.925.782.417.560,"Hemorrhagic Fevers, Viral",RNA Virus Infections,25
Marburg Virus Disease,C,C22.735.500.500,Monkey Diseases,Primate Diseases,25
Molecular Sequence Annotation,L,L01.453.245.667.580,Molecular Sequence Data,Documentation,25
Molecular Sequence Annotation,E,E05.393.760.479,Sequence Analysis,Genetic Techniques,25
Morals,F,F01.829.500,"Psychology, Social",Behavior and Behavior Mechanisms,25
Morals,K,K01.752.566,Philosophy,Humanities,25
Mycoplasma Infections,C,C01.150.252.400.610.610,Mycoplasmatales Infections,Gram-Negative Bacterial Infections,25
Mycoses,C,C01.150.703,Bacterial Infections and Mycoses,Infections,25
New South Wales,Z,Z01.678.100.373.750,Australia,Australasia,25
New South Wales,Z,Z01.639.100.750,Australia,Islands,25
"Onchocerciasis, Ocular",C,C01.610.335.508.700.750.361.699.500,Onchocerciasis,Filariasis,25
"Onchocerciasis, Ocular",C,C01.610.300.562,"Eye Infections, Parasitic",Parasitic Diseases,25
"Onchocerciasis, Ocular",C,C01.920.891,Vector Borne Diseases,Infections,25
"Onchocerciasis, Ocular",C,C11.294.725.562,"Eye Infections, Parasitic",Eye Infections,25
Oryza,B,B01.650.940.800.575.912.250.822.616,Poaceae,Magnoliopsida,25
Oxytocics,D,D27.505.696.875.737,Reproductive Control Agents,Physiological Effects of Drugs,25
Oxytocics,D,D27.505.954.705.737,Reproductive Control Agents,Therapeutic Uses,25
Pancreatic Neoplasms,C,C04.588.274.761,Digestive System Neoplasms,Neoplasms by Site,25
Pancreatic Neoplasms,C,C04.588.322.475,Endocrine Gland Neoplasms,Neoplasms by Site,25
Pancreatic Neoplasms,C,C06.301.761,Digestive System Neoplasms,Digestive System Diseases,25
Pancreatic Neoplasms,C,C06.689.667,Pancreatic Diseases,Digestive System Diseases,25
Pancreatic Neoplasms,C,C19.344.421,Endocrine Gland Neoplasms,Endocrine System Diseases,25
Phlebotomus,B,B01.050.500.131.617.720.500.500.750.781.602,Psychodidae,Diptera,25
Premenopause,G,G08.686.841.249.500.812,Menopause,Climacteric,25
Premenopause,G,G08.686.157.500.812,Menopause,Climacteric,25
Prescriptions,N,N02.421.668.778,Pharmaceutical Services,Health Services,25
Protease Inhibitors,D,D27.505.519.389.745,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,25
Public Assistance,N,N03.219.521.346.506,"Financing, Government","Financing, Organized",25
"Quantitative Trait, Heritable",G,G05.420.720,Inheritance Patterns,Genetic Phenomena,25
"Receptors, IgG",D,D12.776.543.750.705.871.300,"Receptors, Fc","Receptors, Immunologic",25
"Receptors, Progesterone",D,D12.776.826.750.765,"Receptors, Steroid","Receptors, Cytoplasmic and Nuclear",25
Retinal Diseases,C,C11.768,Eye Diseases,NULL,25
Ribavirin,D,D13.570.800.790,Ribonucleosides,Nucleosides,25
Self-Help Groups,N,N03.540.782,Organizations,Health Care Economics and Organizations,25
Sequence Homology,G,G05.810,Genetic Phenomena,NULL,25
Sequence Homology,G,G02.111.810,Biochemical Phenomena,Chemical Phenomena,25
Sickle Cell Trait,C,C16.320.070.150.670,"Anemia, Sickle Cell","Anemia, Hemolytic, Congenital",25
Sickle Cell Trait,C,C16.320.365.155.668,"Anemia, Sickle Cell",Hemoglobinopathies,25
Sickle Cell Trait,C,C15.378.420.155.668,"Anemia, Sickle Cell",Hemoglobinopathies,25
Sickle Cell Trait,C,C15.378.071.141.150.150.670,"Anemia, Sickle Cell","Anemia, Hemolytic, Congenital",25
Silicosis,C,C08.381.520.702.760,Pneumoconiosis,Lung Injury,25
Silicosis,C,C08.381.483.581.760,Pneumoconiosis,"Lung Diseases, Interstitial",25
Silicosis,C,C24.800.834,Pneumoconiosis,Occupational Diseases,25
Sodium Chloride,D,D01.210.450.150.875,Chlorides,Hydrochloric Acid,25
Sodium Chloride,D,D01.857.650,Sodium Compounds,Inorganic Chemicals,25
Strongyloides stercoralis,B,B01.050.500.500.294.400.875.640.680.700,Strongyloides,Rhabdiasoidea,25
Symbiosis,G,G06.550.800,Microbial Interactions,Microbiological Phenomena,25
Symbiosis,G,G16.840,Biological Phenomena,NULL,25
Symptom Assessment,E,E01.370.872,Diagnostic Techniques and Procedures,Diagnosis,25
Urinalysis,E,E01.370.390.810,"Diagnostic Techniques, Urological",Diagnostic Techniques and Procedures,25
Urinalysis,E,E01.370.225.124.810,Clinical Chemistry Tests,Clinical Laboratory Techniques,25
Urinalysis,E,E05.200.124.810,Clinical Chemistry Tests,Clinical Laboratory Techniques,25
Virology,H,H01.158.273.540.859,Microbiology,Biology,25
Yellow Fever Vaccine,D,D20.215.894.899.970,Viral Vaccines,Vaccines,25
Accidents,N,N06.850.135,Public Health,Environment and Public Health,24
"Administration, Cutaneous",E,E02.319.267.120.060,"Administration, Topical",Drug Administration Routes,24
Agricultural Workers' Diseases,C,C24.080,Occupational Diseases,NULL,24
Aircraft,J,J01.937.285.100,Aviation,Transportation,24
Albuterol,D,D02.033.100.291.057,Ethanolamines,Amino Alcohols,24
Albuterol,D,D02.092.063.291.057,Ethanolamines,Amino Alcohols,24
Albuterol,D,D02.092.471.683.061,Phenethylamines,Ethylamines,24
Apolipoproteins E,D,D12.776.521.120.500,Apolipoproteins,Lipoproteins,24
Apolipoproteins E,D,D10.532.091.500,Apolipoproteins,Lipoproteins,24
Apolipoproteins E,D,D12.776.070.400.500,Apolipoproteins,Apoproteins,24
"Arrhythmias, Cardiac",C,C23.550.073,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",24
"Arrhythmias, Cardiac",C,C14.280.067,Heart Diseases,Cardiovascular Diseases,24
Biphenyl Compounds,D,D02.455.426.559.389.185,Benzene Derivatives,"Hydrocarbons, Aromatic",24
Breast Density,E,E01.370.600.115.275,Body Constitution,Physical Examination,24
Breast Density,G,G07.100.138,Body Constitution,Physiological Phenomena,24
British Columbia,Z,Z01.107.567.176.160,Canada,North America,24
Calcinosis,C,C18.452.174.130,Calcium Metabolism Disorders,Metabolic Diseases,24
Carcinogens,D,D27.888.569.100,Noxae,Toxic Actions,24
Chemical Industry,J,J01.576.655.437,Manufacturing Industry,Industry,24
Coculture Techniques,E,E05.481.500.374,Culture Techniques,In Vitro Techniques,24
Conjunctivitis,C,C11.187.183,Conjunctival Diseases,Eye Diseases,24
"Contraceptives, Oral, Hormonal",D,D27.505.954.705.360.360.500,"Contraceptive Agents, Hormonal",Contraceptive Agents,24
"Contraceptives, Oral, Hormonal",D,D27.505.954.705.360.276.210.277,"Contraceptives, Oral","Contraceptive Agents, Female",24
"Contraceptives, Oral, Hormonal",D,D27.505.696.875.360.276.210.277,"Contraceptives, Oral","Contraceptive Agents, Female",24
"Contraceptives, Oral, Hormonal",D,D27.505.696.875.360.360.500,"Contraceptive Agents, Hormonal",Contraceptive Agents,24
Coronary Vessels,A,A07.015.114.269,Arteries,Blood Vessels,24
Coronary Vessels,A,A07.015.908.194,Veins,Blood Vessels,24
Cost Control,N,N03.219.151.160,Costs and Cost Analysis,Economics,24
Cryptococcosis,C,C01.150.703.248,Mycoses,Bacterial Infections and Mycoses,24
Cyclic AMP,D,D13.695.827.068.395,Adenine Nucleotides,Ribonucleotides,24
Cyclic AMP,D,D13.695.667.138.395,Adenine Nucleotides,Purine Nucleotides,24
Cyclic AMP,D,D13.695.462.200,"Nucleotides, Cyclic",Nucleotides,24
Cyclic AMP,D,D03.633.100.759.646.138.395,Adenine Nucleotides,Purine Nucleotides,24
Dermatology,H,H02.403.225,Medicine,Health Occupations,24
Doxycycline,D,D02.455.426.559.847.562.900.200,Tetracyclines,Naphthacenes,24
Doxycycline,D,D04.615.562.900.200,Tetracyclines,Naphthacenes,24
Drug Delivery Systems,E,E02.319.300,Drug Therapy,Therapeutics,24
Ethambutol,D,D02.092.782.258.368.265,Ethylenediamines,Diamines,24
"Ethics Committees, Research",K,K01.752.566.479.147.750,Ethics Committees,Ethics,24
"Ethics Committees, Research",N,N05.700.685.300.750,Ethics Committees,Professional Staff Committees,24
"Ethics Committees, Research",N,N05.350.268.750,Ethics Committees,Ethics,24
"Ethics Committees, Research",N,N04.452.758.788.300.750,Ethics Committees,Professional Staff Committees,24
Femur,A,A02.835.232.043.150,Bones of Lower Extremity,Bone and Bones,24
Flucytosine,D,D03.383.742.698.421.431,Cytosine,Pyrimidinones,24
Gas Chromatography-Mass Spectrometry,E,E05.196.566.500,Mass Spectrometry,"Chemistry Techniques, Analytical",24
Gas Chromatography-Mass Spectrometry,E,E05.196.181.349.500,"Chromatography, Gas",Chromatography,24
Head,A,A01.456,Body Regions,NULL,24
Health Impact Assessment,E,E05.318.308.237,Data Collection,Epidemiologic Methods,24
Health Impact Assessment,N,N03.349.380.210.500,Health Care Surveys,Health Services Research,24
Health Literacy,N,N02.421.726.407.229.500,Consumer Health Information,Health Education,24
Health Literacy,L,L01.143.450.500,Information Literacy,Communication,24
Health Literacy,I,I02.233.332.186.500,Consumer Health Information,Health Education,24
HEK293 Cells,A,A11.436.334,Epithelial Cells,Cells,24
HEK293 Cells,A,A11.251.210.172.750,"Cell Line, Transformed",Cell Line,24
Hemagglutination Tests,E,E01.370.225.812.735.050.375,Agglutination Tests,Serologic Tests,24
Hemagglutination Tests,E,E05.200.812.735.050.375,Agglutination Tests,Serologic Tests,24
Hemagglutination Tests,E,E05.478.594.760.050.375,Agglutination Tests,Serologic Tests,24
Hepatitis A,C,C06.552.380.705.422,"Hepatitis, Viral, Human",Hepatitis,24
Hepatitis A,C,C01.925.440.420,"Hepatitis, Viral, Human",Virus Diseases,24
Hepatitis A,C,C01.925.782.687.359.500,Enterovirus Infections,Picornaviridae Infections,24
Imidazoles,D,D03.383.129.308,Azoles,"Heterocyclic Compounds, 1-Ring",24
Interferon Type I,D,D12.644.276.374.440.890,Interferons,Cytokines,24
Interferon Type I,D,D23.529.374.440.890,Interferons,Cytokines,24
Interferon Type I,D,D12.776.467.374.440.890,Interferons,Cytokines,24
Interferons,D,D12.776.467.374.440,Cytokines,Intercellular Signaling Peptides and Proteins,24
Interferons,D,D23.529.374.440,Cytokines,Intercellular Signaling Peptides and Proteins,24
Interferons,D,D12.644.276.374.440,Cytokines,Intercellular Signaling Peptides and Proteins,24
Intersectoral Collaboration,N,N04.226,Health Services Administration,NULL,24
Kazakhstan,Z,Z01.252.100.420,"Asia, Central",Asia,24
Kazakhstan,Z,Z01.542.931.440,USSR,Europe,24
Kazakhstan,Z,Z01.586.950.440,USSR,Historical Geographic Locations,24
Leishmania braziliensis,B,B01.268.475.868.488.080,Leishmania,Trypanosomatina,24
Lymphatic Metastasis,C,C04.697.650.560,Neoplasm Metastasis,Neoplastic Processes,24
Lymphatic Metastasis,C,C23.550.727.650.560,Neoplasm Metastasis,Neoplastic Processes,24
Macrophage Activation,G,G12.287.500,"Cytotoxicity, Immunologic",Immune System Phenomena,24
Mycoplasma genitalium,B,B03.440.860.580.553.553.355,Mycoplasma,Mycoplasmataceae,24
Neoplasm Grading,E,E01.789.612,Prognosis,Diagnosis,24
Neoplasm Metastasis,C,C04.697.650,Neoplastic Processes,Neoplasms,24
Neoplasm Metastasis,C,C23.550.727.650,Neoplastic Processes,Pathologic Processes,24
Neoplasm Proteins,D,D12.776.624,Proteins,"Amino Acids, Peptides, and Proteins",24
Nuclear Family,I,I01.880.853.150.500,Family,Sociological Factors,24
Nuclear Family,F,F01.829.263.500,Family,"Psychology, Social",24
Organelles,A,A11.284.430.214.190.875,Cytoplasmic Structures,Cytoplasm,24
Osteoporosis,C,C05.116.198.579,"Bone Diseases, Metabolic",Bone Diseases,24
Osteoporosis,C,C18.452.104.579,"Bone Diseases, Metabolic",Metabolic Diseases,24
Petroleum,D,D20.345.630,Fossil Fuels,Complex Mixtures,24
Petroleum,N,N06.230.132.258.630,Fossil Fuels,Energy-Generating Resources,24
"Plaque, Atherosclerotic",C,C23.300.823,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",24
Positron-Emission Tomography,E,E01.370.384.730.800.399,"Tomography, Emission-Computed",Radionuclide Imaging,24
Positron-Emission Tomography,E,E01.370.350.600.350.800.399,"Tomography, Emission-Computed",Image Enhancement,24
Positron-Emission Tomography,E,E01.370.350.350.800.700,"Tomography, Emission-Computed","Image Interpretation, Computer-Assisted",24
Positron-Emission Tomography,E,E01.370.350.825.800.399,"Tomography, Emission-Computed",Tomography,24
Positron-Emission Tomography,E,E01.370.350.710.800.399,"Tomography, Emission-Computed",Radionuclide Imaging,24
"Pregnancy, Unwanted",G,G08.686.784.769.580,Pregnancy,Reproduction,24
Puberty,G,G08.686.841.374,Sexual Development,Reproductive Physiological Phenomena,24
Puberty,G,G08.686.760,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,24
"Receptors, Immunologic",D,D12.776.543.750.705,"Receptors, Cell Surface",Membrane Proteins,24
"Receptors, Transferrin",D,D12.776.543.750.800,"Receptors, Cell Surface",Membrane Proteins,24
"Receptors, Transferrin",D,D12.776.157.905.500,Transferrin-Binding Proteins,Carrier Proteins,24
Rectum,A,A03.556.124.526.767,"Intestine, Large",Intestines,24
Rectum,A,A03.556.249.249.767,"Intestine, Large",Lower Gastrointestinal Tract,24
"RNA, Ribosomal, 18S",D,D13.444.735.686.675,"RNA, Ribosomal",RNA,24
Schizophrenic Psychology,F,F04.824,Behavioral Disciplines and Activities,NULL,24
Seroconversion,G,G12.800,Immune System Phenomena,NULL,24
Sex Ratio,I,I01.240.800.815,Sex Distribution,Demography,24
Sex Ratio,N,N06.850.505.400.850.815,Sex Distribution,Demography,24
Sex Ratio,N,N01.224.803.815,Sex Distribution,Demography,24
Sex Ratio,G,G05.815,Genetic Phenomena,NULL,24
Skinfold Thickness,G,G07.100.100.803,Body Weights and Measures,Body Constitution,24
Skinfold Thickness,E,E05.041.124.803,Body Weights and Measures,Anthropometry,24
Skinfold Thickness,E,E01.370.600.115.100.803,Body Weights and Measures,Body Constitution,24
Steroids,D,D04.210.500,Fused-Ring Compounds,Polycyclic Compounds,24
Streptococcal Vaccines,D,D20.215.894.135.750,Bacterial Vaccines,Vaccines,24
Sulfonamides,D,D02.886.590.700,Sulfones,Sulfur Compounds,24
Sulfonamides,D,D02.065.884,Amides,Organic Chemicals,24
Superoxide Dismutase,D,D08.811.682.881,Oxidoreductases,Enzymes,24
Technology,J,J01.897,"Technology, Industry, and Agriculture",NULL,24
Transforming Growth Factor beta,D,D12.644.276.374.687,Cytokines,Intercellular Signaling Peptides and Proteins,24
Transforming Growth Factor beta,D,D12.644.276.954.775,TGF-beta Superfamily Proteins,Intercellular Signaling Peptides and Proteins,24
Transforming Growth Factor beta,D,D12.776.467.942.775,TGF-beta Superfamily Proteins,Intercellular Signaling Peptides and Proteins,24
Transforming Growth Factor beta,D,D12.776.467.374.687,Cytokines,Intercellular Signaling Peptides and Proteins,24
Transforming Growth Factor beta,D,D23.529.374.687,Cytokines,Intercellular Signaling Peptides and Proteins,24
Transforming Growth Factor beta,D,D23.529.942.775,TGF-beta Superfamily Proteins,Intercellular Signaling Peptides and Proteins,24
Urban Renewal,I,I01.880.709.876,Social Planning,Sociology,24
Venous Thromboembolism,C,C14.907.355.590.700,Thromboembolism,Embolism and Thrombosis,24
Victoria,Z,Z01.639.100.992,Australia,Islands,24
Victoria,Z,Z01.678.100.373.992,Australia,Australasia,24
Weight Reduction Programs,I,I02.233.332.445.650,Health Promotion,Health Education,24
Weight Reduction Programs,N,N02.421.726.407.579.650,Health Promotion,Health Education,24
Abdomen,A,A01.923.047,Torso,Body Regions,23
Alkaline Phosphatase,D,D08.811.277.352.650.035,Phosphoric Monoester Hydrolases,Esterases,23
"Animals, Genetically Modified",B,B01.050.050.136,Animal Population Groups,Animals,23
"Animals, Genetically Modified",B,B05.620.136,"Organisms, Genetically Modified",Organism Forms,23
Biological Availability,G,G07.690.725.129,Pharmacokinetics,Pharmacological and Toxicological Phenomena,23
Biological Availability,G,G03.787.151,Pharmacokinetics,Metabolism,23
Blastocystis,B,B01.046.500.100.200.200,Blastocystina,Amoebida,23
Bronchitis,C,C01.748.099,Respiratory Tract Infections,Infections,23
Bronchitis,C,C08.381.495.146,"Lung Diseases, Obstructive",Lung Diseases,23
Bronchitis,C,C08.127.446,Bronchial Diseases,Respiratory Tract Diseases,23
Bronchitis,C,C08.730.099,Respiratory Tract Infections,Respiratory Tract Diseases,23
Cardiac Catheterization,E,E02.148.442,Catheterization,Therapeutics,23
Cardiac Catheterization,E,E01.370.370.380.140,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",23
Cardiac Catheterization,E,E05.157.250,Catheterization,Investigative Techniques,23
Cardiopulmonary Resuscitation,E,E02.365.647.110,Resuscitation,Emergency Treatment,23
Cell Separation,E,E01.370.225.500.363,Cytological Techniques,Clinical Laboratory Techniques,23
Cell Separation,E,E05.200.500.363,Cytological Techniques,Clinical Laboratory Techniques,23
Cell Separation,E,E05.242.363,Cytological Techniques,Investigative Techniques,23
Cephalometry,E,E05.041.250,Anthropometry,Investigative Techniques,23
Cephalometry,N,N06.850.505.200.100.300,Anthropometry,Biometry,23
Cephalometry,E,E01.370.600.024.250,Anthropometry,Physical Examination,23
Chaperonin 60,D,D12.776.580.216.210.590.750,Group I Chaperonins,Chaperonins,23
Chaperonin 60,D,D08.811.277.040.025.142.500.500,Group I Chaperonins,Chaperonins,23
"Child, Hospitalized",M,M01.643.259,Patients,Persons,23
Controlled Clinical Trials as Topic,N,N05.715.360.330.250.250.365,Clinical Trials as Topic,Clinical Studies as Topic,23
Controlled Clinical Trials as Topic,E,E05.318.372.250.250.365,Clinical Trials as Topic,Clinical Studies as Topic,23
Controlled Clinical Trials as Topic,N,N06.850.520.450.250.250.365,Clinical Trials as Topic,Clinical Studies as Topic,23
Corneal Diseases,C,C11.204,Eye Diseases,NULL,23
Defecation,G,G10.261.165,Digestive System Physiological Phenomena,Digestive System and Oral Physiological Phenomena,23
Diphtheria,C,C01.150.252.410.040.246.388,Corynebacterium Infections,Actinomycetales Infections,23
DNA Damage,G,G05.200,Genetic Phenomena,NULL,23
Docosahexaenoic Acids,D,D10.627.430.450.375,"Fatty Acids, Omega-3",Fish Oils,23
Docosahexaenoic Acids,D,D10.251.355.337.250,"Fatty Acids, Omega-3","Fatty Acids, Unsaturated",23
Docosahexaenoic Acids,D,D10.212.302.380.410.210,"Fatty Acids, Omega-3","Dietary Fats, Unsaturated",23
Down Syndrome,C,C10.597.606.360.220,Intellectual Disability,Neurobehavioral Manifestations,23
Down Syndrome,C,C16.320.180.260,Chromosome Disorders,"Genetic Diseases, Inborn",23
Down Syndrome,C,C16.131.077.327,"Abnormalities, Multiple",Congenital Abnormalities,23
Down Syndrome,C,C16.131.260.260,Chromosome Disorders,Congenital Abnormalities,23
Drug Storage,E,E05.916.350,"Technology, Pharmaceutical",Investigative Techniques,23
Empathy,F,F01.752.543.500.500,Emotional Intelligence,Intelligence,23
Empathy,F,F01.752.355,Personality,Behavior and Behavior Mechanisms,23
Endoplasmic Reticulum,A,A11.284.430.214.190.875.248,Organelles,Cytoplasmic Structures,23
Environmental Microbiology,H,H01.158.273.540.274,Microbiology,Biology,23
Environmental Microbiology,N,N06.850.425,Public Health,Environment and Public Health,23
Facilities and Services Utilization,N,N05.715.360.750.344,Statistics as Topic,Health Care Evaluation Mechanisms,23
Facilities and Services Utilization,N,N04.452.289,Organization and Administration,Health Services Administration,23
Facilities and Services Utilization,H,H01.548.832.625,Statistics as Topic,Mathematics,23
Facilities and Services Utilization,E,E05.318.740.388,Statistics as Topic,Epidemiologic Methods,23
Facilities and Services Utilization,N,N06.850.520.830.375,Statistics as Topic,Epidemiologic Methods,23
Feeding and Eating Disorders,F,F03.400,Mental Disorders,NULL,23
Food Assistance,I,I01.880.787.839.500,Relief Work,Social Welfare,23
Food Assistance,N,N03.219.521.346.506.281,Public Assistance,"Financing, Government",23
Gene Dosage,G,G05.380.350,Genotype,Genetic Phenomena,23
Gene Knockdown Techniques,E,E05.393.335.500,Gene Targeting,Genetic Techniques,23
Gene Knockout Techniques,E,E05.393.335.750,Gene Targeting,Genetic Techniques,23
Gene Regulatory Networks,G,G05.360.080.689.360,"Regulatory Sequences, Nucleic Acid",Base Sequence,23
General Surgery,H,H02.403.810.300,"Specialties, Surgical",Medicine,23
"Genitalia, Female",A,A05.360.319,Genitalia,Urogenital System,23
Granuloma,C,C15.604.515.292,Lymphoproliferative Disorders,Lymphatic Diseases,23
Granuloma,C,C23.550.382,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",23
Hemolysis,C,C23.550.403,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",23
Hemolysis,G,G12.122.545,Antigen-Antibody Reactions,Immune System Phenomena,23
HIV Reverse Transcriptase,D,D08.811.913.696.445.308.300.750.187,RNA-Directed DNA Polymerase,DNA-Directed DNA Polymerase,23
HIV Reverse Transcriptase,D,D12.776.964.775.375.545.875,"pol Gene Products, Human Immunodeficiency Virus","Gene Products, pol",23
HIV Reverse Transcriptase,D,D12.776.964.775.375.750.187,RNA-Directed DNA Polymerase,"Gene Products, pol",23
HIV Reverse Transcriptase,D,D12.776.964.775.562.764.875,"pol Gene Products, Human Immunodeficiency Virus",Human Immunodeficiency Virus Proteins,23
HIV Reverse Transcriptase,D,D12.776.964.900.750.500.545.875,"pol Gene Products, Human Immunodeficiency Virus","Gene Products, pol",23
HIV Reverse Transcriptase,D,D12.776.964.900.750.500.750.187,RNA-Directed DNA Polymerase,"Gene Products, pol",23
HIV Reverse Transcriptase,D,D12.776.964.970.600.850.375.545.875,"pol Gene Products, Human Immunodeficiency Virus","Gene Products, pol",23
HIV Reverse Transcriptase,D,D12.776.964.970.600.850.375.750.187,RNA-Directed DNA Polymerase,"Gene Products, pol",23
Home Nursing,E,E02.760.611.470,Nursing Care,Patient Care,23
Home Nursing,N,N02.421.533.320,Nursing Care,Health Services,23
Home Nursing,N,N02.421.143.524.470,Home Care Services,Community Health Services,23
Horses,B,B01.050.150.900.649.313.984.235.472,Equidae,Perissodactyla,23
Host Specificity,G,G16.527.200.380,Host-Pathogen Interactions,Host Microbial Interactions,23
Host Specificity,G,G06.462.380,Host-Pathogen Interactions,Microbiological Phenomena,23
Iatrogenic Disease,C,C23.550.291.875,Disease Attributes,Pathologic Processes,23
Kidney Neoplasms,C,C13.351.968.419.473,Kidney Diseases,Urologic Diseases,23
Kidney Neoplasms,C,C13.351.937.820.535,Urologic Neoplasms,Urogenital Neoplasms,23
Kidney Neoplasms,C,C12.758.820.750,Urologic Neoplasms,Urogenital Neoplasms,23
Kidney Neoplasms,C,C12.777.419.473,Kidney Diseases,Urologic Diseases,23
Kidney Neoplasms,C,C04.588.945.947.535,Urologic Neoplasms,Urogenital Neoplasms,23
Laparoscopy,E,E01.370.388.250.520,Endoscopy,"Diagnostic Techniques, Surgical",23
Laparoscopy,E,E04.502.250.520,Endoscopy,Minimally Invasive Surgical Procedures,23
Leptin,D,D23.529.024.500,Adipokines,Intercellular Signaling Peptides and Proteins,23
Leptin,D,D12.776.467.024.500,Adipokines,Intercellular Signaling Peptides and Proteins,23
Leptin,D,D12.644.276.024.500,Adipokines,Intercellular Signaling Peptides and Proteins,23
Leptin,D,D12.644.548.011.500,Adipokines,Peptide Hormones,23
Leptin,D,D06.472.699.042.500,Adipokines,Peptide Hormones,23
Leptospira,B,B03.851.475.475,Leptospiraceae,Spirochaetales,23
Leptospira,B,B03.440.400.425.475.475,Leptospiraceae,Gram-Negative Aerobic Rods and Cocci,23
Linezolid,D,D02.065.064.463,Acetamides,Amides,23
Linezolid,D,D02.241.081.018.110.525,Acetamides,Acetates,23
Linezolid,D,D03.383.129.462.600.550,Oxazolidinones,Oxazoles,23
Lobbying,I,I01.738.610,Politics,Social Sciences,23
Locomotion,G,G11.427.410.568,Movement,Musculoskeletal Physiological Phenomena,23
Locomotion,G,G07.568.500,Movement,Physiological Phenomena,23
Luminescent Measurements,E,E05.196.712.516,Photometry,"Chemistry Techniques, Analytical",23
Macaca,B,B01.050.150.900.649.313.988.400.112.199.120.510,Cercopithecinae,Cercopithecidae,23
Mastectomy,E,E04.466,"Surgical Procedures, Operative",NULL,23
Memory,F,F02.463.425.540,Learning,Mental Processes,23
Monkey Diseases,C,C22.735.500,Primate Diseases,Animal Diseases,23
Neonatal Sepsis,C,C23.550.470.790.500.470,Sepsis,Systemic Inflammatory Response Syndrome,23
Neonatal Sepsis,C,C16.614.627,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",23
Neonatal Sepsis,C,C01.757.580,Sepsis,Infections,23
Network Meta-Analysis,E,E05.318.370.500.500,Meta-Analysis as Topic,Epidemiologic Research Design,23
Network Meta-Analysis,E,E05.581.500.501.500,Meta-Analysis as Topic,Research Design,23
Network Meta-Analysis,N,N05.715.360.325.515.500,Meta-Analysis as Topic,Epidemiologic Research Design,23
Network Meta-Analysis,N,N06.850.520.445.500.500,Meta-Analysis as Topic,Epidemiologic Research Design,23
Parkinson Disease,C,C10.574.928.750,Synucleinopathies,Neurodegenerative Diseases,23
Parkinson Disease,C,C10.228.140.079.862.500,Parkinsonian Disorders,Basal Ganglia Diseases,23
Parkinson Disease,C,C10.228.662.600.400,Parkinsonian Disorders,Movement Disorders,23
Peak Expiratory Flow Rate,E,E01.370.386.700.660.225.600,Forced Expiratory Flow Rates,Pulmonary Ventilation,23
Peak Expiratory Flow Rate,G,G09.772.650.300.790,Forced Expiratory Flow Rates,Pulmonary Ventilation,23
Peptide Hydrolases,D,D08.811.277.656,Hydrolases,Enzymes,23
Personnel Selection,N,N04.452.677.500,Personnel Management,Organization and Administration,23
Phenylcarbamates,D,D02.241.081.251.583,Carbamates,"Acids, Acyclic",23
Piperonyl Butoxide,D,D03.633.100.115.600,Benzodioxoles,"Heterocyclic Compounds, 2-Ring",23
Piperonyl Butoxide,D,D03.383.246.118.600,Benzodioxoles,Dioxoles,23
Preconception Care,N,N02.421.143.620.620,Maternal Health Services,Community Health Services,23
Preconception Care,N,N02.421.585.775,Patient Care,Health Services,23
Preconception Care,N,N02.421.920.660,Women's Health Services,Health Services,23
Preconception Care,E,E02.760.775,Patient Care,Therapeutics,23
Prednisone,D,D04.210.500.745.432.719.702,Pregnadienediols,Pregnadienes,23
Protein Isoforms,D,D12.776.800,Proteins,"Amino Acids, Peptides, and Proteins",23
Pulmonary Embolism,C,C08.381.746,Lung Diseases,Respiratory Tract Diseases,23
Pulmonary Embolism,C,C14.907.355.350.700,Embolism,Embolism and Thrombosis,23
"Receptors, Antigen, T-Cell",D,D12.776.543.750.705.816.824,"Receptors, Antigen","Receptors, Immunologic",23
Reimbursement Mechanisms,N,N03.219.521.710.305,"Insurance, Health, Reimbursement","Financing, Organized",23
Renin-Angiotensin System,G,G09.330.380.813,Hemodynamics,Cardiovascular Physiological Phenomena,23
Renin-Angiotensin System,G,G03.820,Metabolism,NULL,23
"Rhinitis, Allergic, Perennial",C,C08.460.799.315.500,"Rhinitis, Allergic",Rhinitis,23
"Rhinitis, Allergic, Perennial",C,C08.674.453.500,"Rhinitis, Allergic",Respiratory Hypersensitivity,23
"Rhinitis, Allergic, Perennial",C,C09.603.799.315.500,"Rhinitis, Allergic",Rhinitis,23
"Rhinitis, Allergic, Perennial",C,C20.543.480.680.443.500,"Rhinitis, Allergic",Respiratory Hypersensitivity,23
Risk Adjustment,N,N04.452.871.715.800,Risk Assessment,Risk Management,23
Risk Adjustment,N,N04.761.789.800,"Quality Indicators, Health Care",Quality of Health Care,23
Risk Adjustment,N,N05.715.360.750.625.700.690.800,Risk Assessment,Risk,23
Rivers,N,N06.230.232.650,Fresh Water,Environment,23
Rivers,G,G16.500.275.280.650,Fresh Water,Environment,23
Rivers,G,G01.311.750,Geological Phenomena,Physical Phenomena,23
Sexism,F,F01.829.595.750,Prejudice,"Psychology, Social",23
Sexism,F,F01.145.813.550.750,Prejudice,Social Behavior,23
Sexism,F,F01.145.813.629.750,Social Discrimination,Social Behavior,23
Ships,J,J01.937.817,Transportation,"Technology, Industry, and Agriculture",23
Social Sciences,I,I01,NULL,NULL,23
Social Sciences,F,F04.096.879,Behavioral Sciences,Behavioral Disciplines and Activities,23
ST Elevation Myocardial Infarction,C,C23.550.513.355.750.875,Myocardial Infarction,Infarction,23
ST Elevation Myocardial Infarction,C,C23.550.717.489.750.875,Myocardial Infarction,Infarction,23
ST Elevation Myocardial Infarction,C,C14.907.585.500.875,Myocardial Infarction,Myocardial Ischemia,23
ST Elevation Myocardial Infarction,C,C14.280.647.500.875,Myocardial Infarction,Myocardial Ischemia,23
Standard of Care,N,N05.715.840,Quality of Health Care,"Health Care Quality, Access, and Evaluation",23
Standard of Care,N,N04.761.789.900,"Quality Indicators, Health Care",Quality of Health Care,23
"Stress, Physiological",G,G07.775,Physiological Phenomena,NULL,23
"Syphilis, Congenital",C,C16.614.868,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",23
"Syphilis, Congenital",C,C01.150.252.400.794.840.500.937,Syphilis,Treponemal Infections,23
"Syphilis, Congenital",C,C01.150.252.400.840.500.937,Syphilis,Treponemal Infections,23
Tablets,D,D26.255.830,Dosage Forms,Pharmaceutical Preparations,23
Tetrazoles,D,D03.383.129.617,Azoles,"Heterocyclic Compounds, 1-Ring",23
Tissue Distribution,G,G07.690.725.949,Pharmacokinetics,Pharmacological and Toxicological Phenomena,23
Tissue Distribution,G,G03.787.917,Pharmacokinetics,Metabolism,23
Toll-Like Receptors,D,D12.776.543.750.705.910.500,"Receptors, Pattern Recognition","Receptors, Immunologic",23
Trypanosomiasis,C,C01.610.752.300.900,Euglenozoa Infections,Protozoan Infections,23
Yemen,Z,Z01.252.245.500.950,Middle East,"Asia, Western",23
"Africa, Central",Z,Z01.058.290.100,Africa South of the Sahara,Africa,22
Aggression,F,F01.145.813.045,Social Behavior,Behavior,22
Aggression,F,F01.145.126.125,Behavioral Symptoms,Behavior,22
ATP-Binding Cassette Transporters,D,D12.776.543.585.100,Membrane Transport Proteins,Membrane Proteins,22
ATP-Binding Cassette Transporters,D,D12.776.543.550.192,Membrane Glycoproteins,Membrane Proteins,22
ATP-Binding Cassette Transporters,D,D12.776.395.550.020,Membrane Glycoproteins,Glycoproteins,22
ATP-Binding Cassette Transporters,D,D12.776.157.530.100,Membrane Transport Proteins,Carrier Proteins,22
Authorship,L,L01.559.423.906.215,Writing,Language Arts,22
Bacteriophages,B,B04.123,Viruses,NULL,22
Battered Women,M,M01.975.155,Women,Persons,22
"Behavior, Addictive",F,F01.145.527.100.120,Compulsive Behavior,Impulsive Behavior,22
Blood Bactericidal Activity,G,G09.188.100,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,22
Blood Bactericidal Activity,G,G12.450.564.204,"Immunity, Innate",Immunity,22
Blood Coagulation,G,G09.188.390.150,Hemostasis,Blood Physiological Phenomena,22
Blood Specimen Collection,E,E04.665.150,Punctures,"Surgical Procedures, Operative",22
Blood Specimen Collection,E,E05.200.998.110,Specimen Handling,Clinical Laboratory Techniques,22
Blood Specimen Collection,E,E01.370.225.998.110,Specimen Handling,Clinical Laboratory Techniques,22
Body Temperature,E,E01.370.600.875.374,Vital Signs,Physical Examination,22
Body Temperature,G,G07.110,Physiological Phenomena,NULL,22
BRCA2 Protein,D,D12.776.624.776.101,Tumor Suppressor Proteins,Neoplasm Proteins,22
BRCA2 Protein,D,D12.776.660.105,Nuclear Proteins,Proteins,22
BRCA2 Protein,D,D12.776.313.249,Fanconi Anemia Complementation Group Proteins,Proteins,22
"Carcinoma, Non-Small-Cell Lung",C,C04.588.894.797.520.109.220.249,"Carcinoma, Bronchogenic",Bronchial Neoplasms,22
"Carcinoma, Non-Small-Cell Lung",C,C08.785.520.100.220.500,"Carcinoma, Bronchogenic",Bronchial Neoplasms,22
"Carcinoma, Non-Small-Cell Lung",C,C08.381.540.140.500,"Carcinoma, Bronchogenic",Lung Neoplasms,22
Cell Cycle Proteins,D,D12.776.167,Proteins,"Amino Acids, Peptides, and Proteins",22
Chick Embryo,A,A16.331.200,"Embryo, Nonmammalian",Embryonic Structures,22
Chick Embryo,A,A13.350.150,"Embryo, Nonmammalian",Animal Structures,22
"Chromatography, Affinity",E,E05.196.181.400.170,"Chromatography, Liquid",Chromatography,22
Colposcopy,E,E04.950.300.210,Gynecologic Surgical Procedures,Urogenital Surgical Procedures,22
Colposcopy,E,E04.502.250.150,Endoscopy,Minimally Invasive Surgical Procedures,22
Colposcopy,E,E04.520.150,Obstetric Surgical Procedures,"Surgical Procedures, Operative",22
Colposcopy,E,E01.370.388.250.150,Endoscopy,"Diagnostic Techniques, Surgical",22
Colposcopy,E,E01.370.378.150,"Diagnostic Techniques, Obstetrical and Gynecological",Diagnostic Techniques and Procedures,22
Concept Formation,F,F02.463.785.233,Thinking,Mental Processes,22
"Conflict, Psychological",F,F01.658.209,Motivation,Behavior and Behavior Mechanisms,22
Cryptosporidium,B,B01.043.075.189.250.150.160,Cryptosporidiidae,Eimeriida,22
Cultural Competency,I,I01.880.853.100.364,Culture,Sociological Factors,22
Cyclosporine,D,D12.644.641.235.300,Cyclosporins,"Peptides, Cyclic",22
Cyclosporine,D,D04.345.566.235.300,Cyclosporins,"Peptides, Cyclic",22
Diagnostic Self Evaluation,E,E01.370.360,Diagnostic Techniques and Procedures,Diagnosis,22
Diagnostic Self Evaluation,F,F01.752.747.792.220,Self Concept,Personality Development,22
Directive Counseling,F,F02.784.176.279,Counseling,"Psychology, Applied",22
Directive Counseling,F,F04.408.413.349,Counseling,Mental Health Services,22
Directive Counseling,N,N02.421.461.363.349,Counseling,Mental Health Services,22
Diseases in Twins,C,C23.550.291.750,Disease Attributes,Pathologic Processes,22
Dyspnea,C,C23.888.852.371,"Signs and Symptoms, Respiratory",Signs and Symptoms,22
Dyspnea,C,C08.618.326,Respiration Disorders,Respiratory Tract Diseases,22
Electricity,G,G01.358.500.249,Electromagnetic Phenomena,Magnetic Phenomena,22
"Encephalopathy, Bovine Spongiform",C,C10.228.228.800.260,Prion Diseases,Central Nervous System Infections,22
"Encephalopathy, Bovine Spongiform",C,C10.574.843.300,Prion Diseases,Neurodegenerative Diseases,22
"Encephalopathy, Bovine Spongiform",C,C22.196.250,Cattle Diseases,Animal Diseases,22
"Encephalopathy, Bovine Spongiform",C,C01.207.800.260,Prion Diseases,Central Nervous System Infections,22
"Enterocolitis, Pseudomembranous",C,C01.150.252.410.222.310,Clostridium Infections,Gram-Positive Bacterial Infections,22
"Enterocolitis, Pseudomembranous",C,C06.405.205.596.800,Enterocolitis,Gastroenteritis,22
"Enterocolitis, Pseudomembranous",C,C06.405.469.363.800,Enterocolitis,Intestinal Diseases,22
Eosinophilia,C,C15.378.553.231,Leukocyte Disorders,Hematologic Diseases,22
Erythrocyte Indices,E,E01.370.225.625.230,Hematologic Tests,Clinical Laboratory Techniques,22
Erythrocyte Indices,E,E05.200.625.230,Hematologic Tests,Clinical Laboratory Techniques,22
Erythrocyte Indices,G,G09.188.260,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,22
Federal Government,I,I01.409.418.625,Government Agencies,Government,22
Federal Government,I,I01.409.137,Government,Social Sciences,22
Federal Government,N,N03.540.400.750,Government Agencies,Organizations,22
Federal Government,N,N03.540.348.500,Government,Organizations,22
Fetal Diseases,C,C13.703.277,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,22
Fetal Diseases,C,C16.300,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NULL,22
Fever of Unknown Origin,C,C23.888.119.344.345,Fever,Body Temperature Changes,22
Flagella,A,A11.284.180.290,Cell Surface Extensions,Cellular Structures,22
Fungi,B,B01.300,Eukaryota,NULL,22
Gentamicins,D,D09.408.051.374,Aminoglycosides,Glycosides,22
Heart-Lung Transplantation,E,E04.928.220.390.450,Heart Transplantation,Cardiac Surgical Procedures,22
Heart-Lung Transplantation,E,E04.928.600.495.450,Lung Transplantation,Pulmonary Surgical Procedures,22
Heart-Lung Transplantation,E,E04.936.450.495.450,Lung Transplantation,Organ Transplantation,22
Heart-Lung Transplantation,E,E04.936.450.475.450,Heart Transplantation,Organ Transplantation,22
Heart-Lung Transplantation,E,E04.100.376.475.450,Heart Transplantation,Cardiac Surgical Procedures,22
Heat-Shock Proteins,D,D12.776.580.216,Molecular Chaperones,Proteins,22
"Hepatitis, Viral, Human",C,C06.552.380.705,Hepatitis,Liver Diseases,22
"Hepatitis, Viral, Human",C,C01.925.440,Virus Diseases,Infections,22
Hepatocytes,A,A11.436.348,Epithelial Cells,Cells,22
"History, 17th Century",K,K01.400.504.750,"History, Modern 1601-",History,22
HLA-DQ Antigens,D,D23.050.301.500.400.400.430,HLA-D Antigens,Histocompatibility Antigens Class II,22
HLA-DQ Antigens,D,D12.776.543.550.440.400.430,HLA-D Antigens,Histocompatibility Antigens Class II,22
HLA-DQ Antigens,D,D23.050.705.552.410.400.430,HLA-D Antigens,Histocompatibility Antigens Class II,22
HLA-DQ Antigens,D,D23.050.705.552.450.400.430,HLA-D Antigens,HLA Antigens,22
HLA-DQ Antigens,D,D23.050.301.500.450.400.430,HLA-D Antigens,HLA Antigens,22
HLA-DQ Antigens,D,D12.776.395.550.509.400.430,HLA-D Antigens,Histocompatibility Antigens Class II,22
Inflammatory Bowel Diseases,C,C06.405.469.432,Intestinal Diseases,Gastrointestinal Diseases,22
Inflammatory Bowel Diseases,C,C06.405.205.731,Gastroenteritis,Gastrointestinal Diseases,22
Insecta,B,B01.050.500.131.617,Arthropods,Invertebrates,22
Interleukin-13,D,D12.644.276.374.465.513,Interleukins,Cytokines,22
Interleukin-13,D,D23.529.374.465.513,Interleukins,Cytokines,22
Interleukin-13,D,D12.776.467.374.465.513,Interleukins,Cytokines,22
Lead,D,D01.552.544.435,"Metals, Heavy",Metals,22
Lead,D,D01.268.556.435,"Metals, Heavy",Elements,22
Least-Squares Analysis,N,N05.715.360.750.695.440,Regression Analysis,Statistics as Topic,22
Least-Squares Analysis,E,E05.318.740.750.400,Regression Analysis,Statistics as Topic,22
Least-Squares Analysis,N,N06.850.520.830.750.400,Regression Analysis,Statistics as Topic,22
Medically Uninsured,M,M01.385,Persons,NULL,22
Moldova,Z,Z01.542.248.540,"Europe, Eastern",Europe,22
Moldova,Z,Z01.586.950.540,USSR,Historical Geographic Locations,22
Moldova,Z,Z01.542.931.540,USSR,Europe,22
Monkeypox,C,C22.735.750,Primate Diseases,Animal Diseases,22
Monkeypox,C,C22.795.600,Rodent Diseases,Animal Diseases,22
Monkeypox,C,C01.925.256.743.615,Poxviridae Infections,DNA Virus Infections,22
Mucocutaneous Lymph Node Syndrome,C,C15.604.560,Lymphatic Diseases,Hemic and Lymphatic Diseases,22
Mucocutaneous Lymph Node Syndrome,C,C17.800.862.560,"Skin Diseases, Vascular",Skin Diseases,22
Mucocutaneous Lymph Node Syndrome,C,C14.907.940.560,Vasculitis,Vascular Diseases,22
Neuroprotective Agents,D,D27.505.696.706.548,Protective Agents,Physiological Effects of Drugs,22
Neuroprotective Agents,D,D27.505.954.427.575,Central Nervous System Agents,Therapeutic Uses,22
O Antigens,D,D23.946.123.329.500.600,Lipopolysaccharides,Endotoxins,22
O Antigens,D,D23.050.161.616.525.600,Lipopolysaccharides,"Polysaccharides, Bacterial",22
O Antigens,D,D09.698.718.450.600,Lipopolysaccharides,"Polysaccharides, Bacterial",22
O Antigens,D,D10.494.600,Lipopolysaccharides,Lipids,22
Office Visits,N,N04.452.758.635,Professional Practice,Organization and Administration,22
Ofloxacin,D,D03.633.100.810.835.322.500,Fluoroquinolones,Quinolones,22
Onchocerca,B,B01.050.500.500.294.400.937.463.510,Filarioidea,Spirurida,22
Ontario,Z,Z01.107.567.176.639,Canada,North America,22
Opportunistic Infections,C,C01.925.597,Virus Diseases,Infections,22
Opportunistic Infections,C,C01.610.684,Parasitic Diseases,Infections,22
Opportunistic Infections,C,C01.597,Infections,NULL,22
Optic Neuritis,C,C11.640.576,Optic Nerve Diseases,Eye Diseases,22
Optic Neuritis,C,C10.292.700.550,Optic Nerve Diseases,Cranial Nerve Diseases,22
Organ Specificity,G,G07.650,Physiological Phenomena,NULL,22
Pain Management,N,N04.590.607.500,Disease Management,Patient Care Management,22
Pain Management,E,E02.745,Therapeutics,NULL,22
Pan troglodytes,B,B01.050.150.900.649.313.988.400.112.400.620,Hominidae,Catarrhini,22
Plants,B,B01.650,Eukaryota,NULL,22
"Pneumonia, Pneumocystis",C,C01.748.610.675,Pneumonia,Respiratory Tract Infections,22
"Pneumonia, Pneumocystis",C,C01.748.435.700,"Lung Diseases, Fungal",Respiratory Tract Infections,22
"Pneumonia, Pneumocystis",C,C01.150.703.534.700,"Lung Diseases, Fungal",Mycoses,22
"Pneumonia, Pneumocystis",C,C01.150.703.770.700,Pneumocystis Infections,Mycoses,22
"Pneumonia, Pneumocystis",C,C08.381.677.675,Pneumonia,Lung Diseases,22
"Pneumonia, Pneumocystis",C,C08.381.472.700,"Lung Diseases, Fungal",Lung Diseases,22
"Pneumonia, Pneumocystis",C,C08.730.610.675,Pneumonia,Respiratory Tract Infections,22
"Pneumonia, Pneumocystis",C,C08.730.435.700,"Lung Diseases, Fungal",Respiratory Tract Infections,22
Polyethylene Glycols,D,D02.033.455.250.700,Ethylene Glycols,Glycols,22
Polyethylene Glycols,D,D25.720.741,Polymers,Biomedical and Dental Materials,22
Polyethylene Glycols,D,D05.750.741,Polymers,Macromolecular Substances,22
Polyethylene Glycols,J,J01.637.051.720.741,Polymers,Biomedical and Dental Materials,22
Prosthesis Failure,E,E05.325.771,Equipment Failure,Investigative Techniques,22
Prosthesis Failure,C,C23.550.767.865,Postoperative Complications,Pathologic Processes,22
Protective Clothing,E,E07.700.600,Protective Devices,Equipment and Supplies,22
Protective Clothing,J,J01.637.708.560.875,Personal Protective Equipment,Protective Devices,22
Protective Clothing,J,J01.637.215.600,Clothing,Manufactured Materials,22
Reagent Strips,E,E07.720.720,"Reagent Kits, Diagnostic",Equipment and Supplies,22
Reagent Strips,D,D27.720.470.410.680.680,"Reagent Kits, Diagnostic",Indicators and Reagents,22
Reagent Strips,D,D27.505.259.875.680,"Reagent Kits, Diagnostic",Diagnostic Uses of Chemicals,22
Refugee Camps,J,J03.340.825,Housing,Non-Medical Public and Private Facilities,22
Renal Replacement Therapy,E,E02.870,Therapeutics,NULL,22
Republic of Belarus,Z,Z01.542.248.700,"Europe, Eastern",Europe,22
Science,H,H01.770,Natural Science Disciplines,NULL,22
"Sexually Transmitted Diseases, Viral",C,C23.550.291.531.937.640,Sexually Transmitted Diseases,Communicable Diseases,22
"Sexually Transmitted Diseases, Viral",C,C01.221.812.640,Sexually Transmitted Diseases,Communicable Diseases,22
"Sexually Transmitted Diseases, Viral",C,C01.778.640,Sexually Transmitted Diseases,Infections,22
"Sexually Transmitted Diseases, Viral",C,C01.925.813,Virus Diseases,Infections,22
Small-Area Analysis,N,N05.715.360.750.200.750,Cluster Analysis,Statistics as Topic,22
Small-Area Analysis,E,E05.318.740.250.675,Cluster Analysis,Statistics as Topic,22
Small-Area Analysis,N,N06.850.520.830.250.675,Cluster Analysis,Statistics as Topic,22
Streptococcus,B,B03.510.550.737.872,Streptococcaceae,Lactobacillales,22
Streptococcus,B,B03.353.750.737.872,Streptococcaceae,Lactobacillales,22
Streptococcus,B,B03.510.400.800.872,Streptococcaceae,Gram-Positive Cocci,22
Suburban Population,N,N01.600.775,Population,Population Characteristics,22
Sugars,D,D09.947,Carbohydrates,NULL,22
Trichomonas Vaginitis,C,C01.610.752.890.633,Trichomonas Infections,Protozoan Infections,22
Trichomonas Vaginitis,C,C13.351.500.894.906.633,Vaginitis,Vaginal Diseases,22
Tumor Virus Infections,C,C01.925.928,Virus Diseases,Infections,22
Virus Internalization,G,G06.920.881,Virus Physiological Phenomena,Microbiological Phenomena,22
Yersinia enterocolitica,B,B03.660.250.150.950.160,Yersinia,Enterobacteriaceae,22
Yersinia enterocolitica,B,B03.440.450.425.900.300,Yersinia,Enterobacteriaceae,22
Yersinia pseudotuberculosis,B,B03.440.450.425.900.615,Yersinia,Enterobacteriaceae,22
Yersinia pseudotuberculosis,B,B03.660.250.150.950.590,Yersinia,Enterobacteriaceae,22
African Horse Sickness Virus,B,B04.820.223.719.550.050,Orbivirus,Reoviridae,21
Alternative Splicing,G,G05.308.700.700.100,RNA Splicing,"RNA Processing, Post-Transcriptional",21
Alternative Splicing,G,G03.839.700.100,RNA Splicing,"RNA Processing, Post-Transcriptional",21
Alternative Splicing,G,G02.111.760.700.100,RNA Splicing,"RNA Processing, Post-Transcriptional",21
Anniversaries and Special Events,N,N04.452.822.070,Public Relations,Organization and Administration,21
Anniversaries and Special Events,K,K01.400.095,History,Humanities,21
beta-Lactam Resistance,G,G06.225.347.500,"Drug Resistance, Bacterial","Drug Resistance, Microbial",21
beta-Lactam Resistance,G,G06.099.225.500,"Drug Resistance, Bacterial",Bacterial Physiological Phenomena,21
beta-Lactam Resistance,G,G07.690.773.984.269.347.500,"Drug Resistance, Bacterial","Drug Resistance, Microbial",21
Bioterrorism,I,I01.880.735.950.500.226.100,Biological Warfare,Warfare,21
Bioterrorism,I,I01.880.735.900.800.100,Terrorism,Violence,21
Bioterrorism,I,I01.198.240.856.800.100,Terrorism,Violence,21
"Blood Loss, Surgical",C,C23.550.414.300,Hemorrhage,Pathologic Processes,21
"Blood Loss, Surgical",C,C23.550.505.300,Intraoperative Complications,Pathologic Processes,21
C9orf72 Protein,D,D12.776.141,Proteins,"Amino Acids, Peptides, and Proteins",21
Caco-2 Cells,A,A11.436.140,Epithelial Cells,Cells,21
Caco-2 Cells,A,A11.251.860.180.160,"Cell Line, Tumor","Tumor Cells, Cultured",21
Caco-2 Cells,A,A11.251.210.190.160,"Cell Line, Tumor",Cell Line,21
CD4 Antigens,D,D23.101.100.894.100,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",21
CD4 Antigens,D,D23.050.301.264.894.100,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",21
CD4 Antigens,D,D12.776.543.750.705.852.420.810.500,"Receptors, Interleukin-16","Receptors, Interleukin",21
CD4 Antigens,D,D12.776.543.750.830.700.025,"Receptors, HIV","Receptors, Virus",21
Chemokine CXCL10,D,D12.776.467.374.200.120.500,"Chemokines, CXC",Chemokines,21
Chemokine CXCL10,D,D23.125.300.120.500,"Chemokines, CXC",Chemokines,21
Chemokine CXCL10,D,D23.469.200.120.500,"Chemokines, CXC",Chemokines,21
Chemokine CXCL10,D,D23.529.374.200.120.500,"Chemokines, CXC",Chemokines,21
Chemokine CXCL10,D,D12.644.276.374.200.120.500,"Chemokines, CXC",Chemokines,21
Chlamydophila pneumoniae,B,B03.440.190.190.230.249,Chlamydophila,Chlamydiaceae,21
Civil Defense,I,I01.451.227,Government Programs,Social Sciences,21
Computed Tomography Angiography,E,E01.370.350.825.810.810.499,"Tomography, X-Ray Computed","Tomography, X-Ray",21
Computed Tomography Angiography,E,E01.370.350.350.810.335,"Tomography, X-Ray Computed","Image Interpretation, Computer-Assisted",21
Computed Tomography Angiography,E,E01.370.350.700.810.810.568,"Tomography, X-Ray Computed","Tomography, X-Ray",21
Computed Tomography Angiography,E,E01.370.350.700.700.810.335,"Tomography, X-Ray Computed",Radiographic Image Enhancement,21
Computed Tomography Angiography,E,E01.370.350.600.350.700.810.335,"Tomography, X-Ray Computed",Radiographic Image Enhancement,21
Computed Tomography Angiography,E,E01.370.350.567.250,Multimodal Imaging,Diagnostic Imaging,21
Conjunctival Neoplasms,C,C04.588.364.235,Eye Neoplasms,Neoplasms by Site,21
Conjunctival Neoplasms,C,C11.187.169,Conjunctival Diseases,Eye Diseases,21
Conjunctival Neoplasms,C,C11.319.217,Eye Neoplasms,Eye Diseases,21
"Conjunctivitis, Allergic",C,C11.187.183.200,Conjunctivitis,Conjunctival Diseases,21
"Conjunctivitis, Allergic",C,C20.543.480.200,"Hypersensitivity, Immediate",Hypersensitivity,21
Contraindications,E,E02.208,Therapeutics,NULL,21
"Crops, Agricultural",B,B01.650.160,Plants,Eukaryota,21
"Crops, Agricultural",J,J02.500.300,Food,Food and Beverages,21
"Crops, Agricultural",G,G07.203.300.300,Food,"Diet, Food, and Nutrition",21
Delayed-Action Preparations,E,E02.319.300.253,Drug Delivery Systems,Drug Therapy,21
Delayed-Action Preparations,D,D26.255.210,Dosage Forms,Pharmaceutical Preparations,21
Edible Grain,B,B01.650.160.250,"Crops, Agricultural",Plants,21
Edible Grain,B,B01.650.510.250,"Plants, Edible",Plants,21
Edible Grain,A,A18.024.500.750.500,Seeds,Fruit,21
Edible Grain,G,G07.203.300.300.550,"Crops, Agricultural",Food,21
Edible Grain,G,G07.203.300.775.500,Seeds,Food,21
Edible Grain,J,J02.500.300.550,"Crops, Agricultural",Food,21
Edible Grain,J,J02.500.775.500,Seeds,Food,21
"Education, Nursing",I,I02.358.462,"Education, Professional",Education,21
Erythromycin,D,D02.540.576.500.992,Macrolides,Polyketides,21
"Eye Infections, Fungal",C,C01.375.450,Eye Infections,Infections,21
"Eye Infections, Fungal",C,C01.150.703.320,Mycoses,Bacterial Infections and Mycoses,21
"Eye Infections, Fungal",C,C11.294.450,Eye Infections,Eye Diseases,21
Gastrointestinal Hemorrhage,C,C23.550.414.788,Hemorrhage,Pathologic Processes,21
Gastrointestinal Hemorrhage,C,C06.405.227,Gastrointestinal Diseases,Digestive System Diseases,21
Gene Flow,G,G05.330.159,Gene Frequency,Genetic Phenomena,21
"Genes, BRCA2",G,G05.360.340.024.340.375.249.105,"Genes, Tumor Suppressor","Genes, Neoplasm",21
"Genes, BRCA2",G,G05.360.340.024.340.415.400.105,"Genes, Tumor Suppressor","Genes, Recessive",21
Genetic Fitness,G,G05.347,Genetic Phenomena,NULL,21
Georgia,Z,Z01.107.567.875.075.250,Appalachian Region,United States,21
Georgia,Z,Z01.107.567.875.750.370,Southeastern United States,United States,21
Germ-Line Mutation,G,G05.365.590.350,Mutation,Genetic Variation,21
Gram-Positive Bacterial Infections,C,C01.150.252.410,Bacterial Infections,Bacterial Infections and Mycoses,21
Gravidity,G,G08.686.784.769.213,Pregnancy,Reproduction,21
Gravidity,G,G08.686.340,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,21
Gravidity,N,N06.850.490.812.250,Reproductive History,Epidemiologic Factors,21
Haptoglobins,D,D12.776.124.050.300,Acute-Phase Proteins,Blood Proteins,21
Haptoglobins,D,D12.776.124.790.106.394,Alpha-Globulins,Serum Globulins,21
Haptoglobins,D,D12.776.395.560.373,Mucoproteins,Glycoproteins,21
Haptoglobins,D,D12.776.377.715.085.394,Alpha-Globulins,Serum Globulins,21
"Health Services, Indigenous",N,N02.421.330,Health Services,"Health Care Facilities, Manpower, and Services",21
Heart Ventricles,A,A07.541.560,Heart,Cardiovascular System,21
Hemagglutination Inhibition Tests,E,E01.370.225.812.735.370,Serologic Tests,Immunologic Tests,21
Hemagglutination Inhibition Tests,E,E05.478.594.760.370,Serologic Tests,Immunologic Tests,21
Hemagglutination Inhibition Tests,E,E05.200.812.735.370,Serologic Tests,Immunologic Tests,21
"Herpesvirus 1, Human",B,B04.280.382.100.750.390,Simplexvirus,Alphaherpesvirinae,21
HLA-DRB1 Chains,D,D23.050.301.500.450.400.440.333.500,HLA-DR beta-Chains,HLA-DR Antigens,21
HLA-DRB1 Chains,D,D23.050.301.500.400.400.440.200.010,HLA-DR beta-Chains,HLA-DR Antigens,21
HLA-DRB1 Chains,D,D23.050.705.552.450.400.440.333.500,HLA-DR beta-Chains,HLA-DR Antigens,21
HLA-DRB1 Chains,D,D23.050.705.552.410.400.440.200.010,HLA-DR beta-Chains,HLA-DR Antigens,21
HLA-DRB1 Chains,D,D12.776.543.550.440.400.440.200.010,HLA-DR beta-Chains,HLA-DR Antigens,21
HLA-DRB1 Chains,D,D12.776.395.550.509.400.440.200.010,HLA-DR beta-Chains,HLA-DR Antigens,21
Holidays,I,I03.450.345,Leisure Activities,Human Activities,21
"Hospitals, Special",N,N02.278.421.556,Hospitals,Health Facilities,21
"Hypersensitivity, Delayed",C,C20.543.418,Hypersensitivity,Immune System Diseases,21
"Immunization, Passive",E,E02.095.465.425.400.330,Immunization,Immunotherapy,21
"Immunization, Passive",E,E05.478.550.520,Immunization,Immunologic Techniques,21
"Infant, Premature, Diseases",C,C16.614.521,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",21
Injury Severity Score,E,E05.318.308.940.968.875.500,Trauma Severity Indices,Medical Records,21
Injury Severity Score,E,E05.944.600,Trauma Severity Indices,Investigative Techniques,21
Injury Severity Score,N,N05.715.360.300.715.500.800.400,Trauma Severity Indices,Medical Records,21
Injury Severity Score,N,N04.452.859.564.800.500,Trauma Severity Indices,Medical Records,21
Intercellular Adhesion Molecule-1,D,D12.776.543.550.200.450,Cell Adhesion Molecules,Membrane Glycoproteins,21
Intercellular Adhesion Molecule-1,D,D23.050.301.350.450,Cell Adhesion Molecules,"Antigens, Surface",21
Intercellular Adhesion Molecule-1,D,D12.776.395.550.200.450,Cell Adhesion Molecules,Membrane Glycoproteins,21
Intergenerational Relations,F,F01.829.263.370.110,Family Relations,Family,21
Intergenerational Relations,F,F01.829.401.190,Interpersonal Relations,"Psychology, Social",21
Interleukin-17,D,D12.644.276.374.465.517,Interleukins,Cytokines,21
Interleukin-17,D,D12.776.467.374.465.517,Interleukins,Cytokines,21
Interleukin-17,D,D23.529.374.465.517,Interleukins,Cytokines,21
Islands,N,N06.230.295,Environment,Environment and Public Health,21
Islands,G,G16.500.275.505,Environment,Ecological and Environmental Phenomena,21
Islands,Z,Z01.639,Geographic Locations,NULL,21
Jordan,Z,Z01.252.245.500.400,Middle East,"Asia, Western",21
Kangaroo-Mother Care Method,N,N02.421.585.700.500,Patient Positioning,Patient Care,21
Kangaroo-Mother Care Method,N,N02.421.088.120.140,Infant Care,Child Care,21
Kangaroo-Mother Care Method,E,E02.760.670.500,Patient Positioning,Patient Care,21
Learning Disabilities,F,F03.625.562,Neurodevelopmental Disorders,Mental Disorders,21
Learning Disabilities,C,C10.597.606.150.550,Communication Disorders,Neurobehavioral Manifestations,21
Learning Disabilities,C,C23.888.592.604.150.550,Communication Disorders,Neurobehavioral Manifestations,21
Leishmania mexicana,B,B01.268.475.868.488.410,Leishmania,Trypanosomatina,21
L-Lactate Dehydrogenase,D,D08.811.682.047.551.400,Lactate Dehydrogenases,Alcohol Oxidoreductases,21
L-Lactate Dehydrogenase,D,D08.811.682.047.820.493,NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases,Alcohol Oxidoreductases,21
Masks,E,E07.325.877.500,Surgical Attire,"Equipment and Supplies, Hospital",21
Masks,E,E07.700.500,Protective Devices,Equipment and Supplies,21
Masks,E,E07.858.594.750,Surgical Attire,Surgical Equipment,21
Masks,J,J01.637.708.560.782,Personal Protective Equipment,Protective Devices,21
Maternal Behavior,F,F01.829.263.370.215,Family Relations,Family,21
Mentoring,I,I02.358.859,"Education, Professional",Education,21
Mentoring,I,I02.588,Education,NULL,21
Metabolomics,H,H01.158.273.180.599,Computational Biology,Biology,21
Metabolomics,H,H01.158.201.586,Biochemistry,Biological Science Disciplines,21
Metabolomics,H,H01.181.122.638,Biochemistry,Chemistry,21
"Microscopy, Electron, Transmission",E,E05.595.402.580,"Microscopy, Electron",Microscopy,21
"Microscopy, Electron, Transmission",E,E01.370.350.515.402.580,"Microscopy, Electron",Microscopy,21
"Neoplasms, Second Primary",C,C04.692,Neoplasms,NULL,21
Neurodevelopmental Disorders,F,F03.625,Mental Disorders,NULL,21
Neurons,A,A08.675,Nervous System,NULL,21
Neurons,A,A11.671,Cells,NULL,21
Nicotine,D,D03.132.760.570,Solanaceous Alkaloids,Alkaloids,21
Nicotine,D,D03.383.725.518,Pyridines,"Heterocyclic Compounds, 1-Ring",21
Operations Research,H,H01.770.644.333,Research,Science,21
Operations Research,L,L01.906.394,Systems Analysis,Information Science,21
Ophthalmic Solutions,D,D27.720.752.608,Pharmaceutical Solutions,Specialty Uses of Chemicals,21
Ophthalmic Solutions,D,D26.776.708.645,Pharmaceutical Solutions,Solutions,21
Ophthalmic Solutions,D,D27.505.954.578.645,Pharmaceutical Solutions,Therapeutic Uses,21
Orthomyxoviridae,B,B04.820.480.968,Negative-Sense RNA Viruses,RNA Viruses,21
Oxygen Consumption,G,G03.680,Metabolism,NULL,21
Penicillin Resistance,G,G07.690.773.984.269.347.500.600,beta-Lactam Resistance,"Drug Resistance, Bacterial",21
Penicillin Resistance,G,G06.099.225.500.600,beta-Lactam Resistance,"Drug Resistance, Bacterial",21
Penicillin Resistance,G,G06.225.347.500.600,beta-Lactam Resistance,"Drug Resistance, Bacterial",21
Pheromones,D,D23.641,Biological Factors,NULL,21
Phosphates,D,D01.029.260.700.675.374,Phosphoric Acids,Phosphorus Acids,21
Phosphates,D,D01.695.625.675.650,Phosphoric Acids,Phosphorus Acids,21
Phosphates,D,D01.248.497.158.730,Anions,Ions,21
Physical Therapy Modalities,E,E02.779,Therapeutics,NULL,21
Physical Therapy Modalities,E,E02.831.535,Rehabilitation,Therapeutics,21
Plague,C,C01.150.252.400.310.980.390,Yersinia Infections,Enterobacteriaceae Infections,21
Plague,C,C01.920.906,Vector Borne Diseases,Infections,21
Protein Precursors,D,D12.776.811,Proteins,"Amino Acids, Peptides, and Proteins",21
Psychological Theory,F,F02.739,Psychological Phenomena,NULL,21
"Receptor, erbB-2",D,D12.776.624.664.700.642,Proto-Oncogene Proteins,Oncogene Proteins,21
"Receptor, ErbB-2",D,D12.776.543.750.750.400.074.400,ErbB Receptors,"Receptors, Growth Factor",21
"Receptor, ErbB-2",D,D12.776.543.750.630.009.400,ErbB Receptors,Receptor Protein-Tyrosine Kinases,21
"Receptor, erbB-2",D,D23.050.301.500.600.700,Minor Histocompatibility Antigens,Histocompatibility Antigens,21
"Receptor, ErbB-2",D,D23.050.705.552.600.550,Minor Histocompatibility Antigens,Histocompatibility Antigens,21
"Receptor, ErbB-2",D,D23.101.140.642,"Biomarkers, Tumor",Biomarkers,21
"Receptor, erbB-2",D,D08.811.913.696.620.682.725.400.009.400,ErbB Receptors,Receptor Protein-Tyrosine Kinases,21
Rectal Neoplasms,C,C04.588.274.476.411.307.790,Colorectal Neoplasms,Intestinal Neoplasms,21
Rectal Neoplasms,C,C06.405.249.411.307.790,Colorectal Neoplasms,Intestinal Neoplasms,21
Rectal Neoplasms,C,C06.301.371.411.307.790,Colorectal Neoplasms,Intestinal Neoplasms,21
Rectal Neoplasms,C,C06.405.469.491.307.790,Colorectal Neoplasms,Intestinal Neoplasms,21
Rectal Neoplasms,C,C06.405.469.860.180.500,Colorectal Neoplasms,Rectal Diseases,21
Respiratory System,A,A04,NULL,NULL,21
Retreatment,E,E02.887,Therapeutics,NULL,21
Reward,F,F02.463.425.770.836,"Reinforcement, Psychology",Learning,21
Rheumatic Heart Disease,C,C01.150.252.410.890.731.649,Rheumatic Fever,Streptococcal Infections,21
Rheumatic Heart Disease,C,C14.280.874,Heart Diseases,Cardiovascular Diseases,21
Salivary Glands,A,A03.556.500.760,Mouth,Gastrointestinal Tract,21
Salivary Glands,A,A10.336.779,Exocrine Glands,Tissues,21
Salivary Glands,A,A14.549.760,Mouth,Stomatognathic System,21
Semen,A,A12.200.732,Bodily Secretions,Fluids and Secretions,21
Subtilisins,D,D08.811.277.656.959.350.787,Serine Endopeptidases,Serine Proteases,21
Subtilisins,D,D08.811.277.656.300.760.787,Serine Endopeptidases,Endopeptidases,21
Sulfur Dioxide,D,D01.362.810,Gases,Inorganic Chemicals,21
Sulfur Dioxide,D,D01.650.550.850.925,Sulfur Oxides,Oxides,21
Sulfur Dioxide,D,D01.875.825.925,Sulfur Oxides,Sulfur Compounds,21
Systems Integration,L,L01.906.787,Systems Analysis,Information Science,21
Systems Integration,H,H01.770.787,Science,Natural Science Disciplines,21
Thiazolidinediones,D,D03.383.129.708.933,Thiazoles,Azoles,21
Thiazolidinediones,D,D02.886.675.933,Thiazoles,Sulfur Compounds,21
Thromboembolism,C,C14.907.355.590,Embolism and Thrombosis,Vascular Diseases,21
Trace Elements,D,D01.268.811,Elements,Inorganic Chemicals,21
Trace Elements,D,D27.505.696.494.555,Micronutrients,Physiological Effects of Drugs,21
Trace Elements,J,J02.500.681.500.555,Micronutrients,Nutrients,21
Trace Elements,G,G07.203.300.681.500.555,Micronutrients,Nutrients,21
"Tuberculosis, Pleural",C,C08.730.912,Respiratory Tract Infections,Respiratory Tract Diseases,21
"Tuberculosis, Pleural",C,C08.528.928,Pleural Diseases,Respiratory Tract Diseases,21
"Tuberculosis, Pleural",C,C01.150.252.410.040.552.846.877,Tuberculosis,Mycobacterium Infections,21
"Tuberculosis, Pleural",C,C01.748.912,Respiratory Tract Infections,Infections,21
"Twins, Dizygotic",M,M01.438.873.920,Twins,Multiple Birth Offspring,21
"Vaginal Creams, Foams, and Jellies",E,E07.357.750,Feminine Hygiene Products,Equipment and Supplies,21
"Vaginal Creams, Foams, and Jellies",D,D26.255.955,Dosage Forms,Pharmaceutical Preparations,21
Academic Medical Centers,N,N02.278.020,Health Facilities,"Health Care Facilities, Manpower, and Services",20
Achievement,F,F01.658.059,Motivation,Behavior and Behavior Mechanisms,20
Achievement,F,F02.784.629.054,"Psychology, Educational","Psychology, Applied",20
Agglutination Tests,E,E05.478.594.760.050,Serologic Tests,Immunologic Tests,20
Agglutination Tests,E,E05.200.812.735.050,Serologic Tests,Immunologic Tests,20
Agglutination Tests,E,E01.370.225.812.735.050,Serologic Tests,Immunologic Tests,20
Apolipoproteins,D,D12.776.521.120,Lipoproteins,Proteins,20
Apolipoproteins,D,D10.532.091,Lipoproteins,Lipids,20
Apolipoproteins,D,D12.776.070.400,Apoproteins,Proteins,20
Ascaris,B,B01.050.500.500.294.400.500.100.108,Ascaridoidea,Ascaridida,20
Breeding,E,E05.820.150,Reproductive Techniques,Investigative Techniques,20
Breeding,G,G05.090,Genetic Phenomena,NULL,20
"Cardiomyopathy, Dilated",C,C14.280.195.160,Cardiomegaly,Heart Diseases,20
"Cardiomyopathy, Dilated",C,C14.280.238.070,Cardiomyopathies,Heart Diseases,20
"Cardiomyopathy, Dilated",C,C16.320.488.750,Laminopathies,"Genetic Diseases, Inborn",20
Carotid Arteries,A,A07.015.114.186,Arteries,Blood Vessels,20
Catalytic Domain,G,G02.111.570.820.709.275.750.188,Protein Domains,Protein Structural Elements,20
Catalytic Domain,G,G02.111.570.120.704,Binding Sites,Molecular Structure,20
Cerebral Cortex,A,A08.186.211.200.885.287.500,Cerebrum,Telencephalon,20
CHO Cells,A,A11.436.155,Epithelial Cells,Cells,20
CHO Cells,A,A11.251.210.200,Cell Line,"Cells, Cultured",20
Chromatin,A,A11.284.430.106.279.345.190.160.180,Chromosome Structures,Chromosomes,20
Chromatin,D,D12.776.664.224,Nucleoproteins,Proteins,20
Chromatin,G,G05.360.160.180,Chromosome Structures,Genetic Structures,20
"Clinical Trials, Phase II as Topic",E,E05.318.372.250.250.210,Clinical Trials as Topic,Clinical Studies as Topic,20
"Clinical Trials, Phase II as Topic",N,N05.715.360.330.250.250.210,Clinical Trials as Topic,Clinical Studies as Topic,20
"Clinical Trials, Phase II as Topic",N,N06.850.520.450.250.250.210,Clinical Trials as Topic,Clinical Studies as Topic,20
"Communicable Diseases, Imported",C,C01.221.625,Communicable Diseases,Infections,20
"Communicable Diseases, Imported",C,C23.550.291.531.875,Communicable Diseases,Disease Attributes,20
Dermatologic Agents,D,D27.505.954.444,Therapeutic Uses,Pharmacologic Actions,20
Deuterium,D,D01.268.406.500,Hydrogen,Elements,20
Deuterium,D,D01.362.340.500,Hydrogen,Gases,20
Deuterium,D,D01.496.289,Isotopes,Inorganic Chemicals,20
"DNA, Ribosomal Spacer",D,D13.444.308.324.230,"DNA, Intergenic",DNA,20
"DNA, Ribosomal Spacer",D,D13.444.308.475.230,"DNA, Ribosomal",DNA,20
Dracunculiasis,C,C01.610.335.508.700.750.299,Spirurida Infections,Secernentea Infections,20
Drinking,G,G10.261.330.249,Eating,Digestive System Physiological Phenomena,20
Drinking,G,G07.203.650.283.249,Eating,Nutritional Physiological Phenomena,20
"Economics, Pharmaceutical",N,N03.219.390,Economics,Health Care Economics and Organizations,20
Estradiol,D,D06.472.334.851.437.500,Estradiol Congeners,Gonadal Steroid Hormones,20
Estradiol,D,D04.210.500.365.415.248,Estrenes,Estranes,20
Expert Testimony,N,N03.706.535.253,Jurisprudence,"Social Control, Formal",20
Expert Testimony,I,I01.880.604.583.232,Jurisprudence,"Social Control, Formal",20
Extreme Heat,G,G16.500.750.775.271,Weather,Meteorological Concepts,20
Extreme Heat,N,N06.230.300.100.725.710.380.500,Hot Temperature,Temperature,20
Extreme Heat,N,N06.230.300.100.725.232.500,Hot Temperature,Weather,20
Eyelashes,A,A09.371.337.338,Eyelids,Eye,20
Eyelashes,A,A01.456.505.420.504.421,Eyelids,Eye,20
Eyelashes,A,A17.360.421,Hair,Integumentary System,20
Foster Home Care,E,E02.760.352,Patient Care,Therapeutics,20
Foster Home Care,N,N02.421.143.452,Community Health Services,Health Services,20
Foster Home Care,N,N02.421.585.352,Patient Care,Health Services,20
Foster Home Care,I,I01.880.787.416,Social Welfare,Sociology,20
Frailty,C,C23.550.359,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",20
Genetic Techniques,E,E05.393,Investigative Techniques,NULL,20
Glycoconjugates,D,D09.400,Carbohydrates,NULL,20
Habits,F,F01.145.466,Behavior,Behavior and Behavior Mechanisms,20
Hand,A,A01.378.800.667,Upper Extremity,Extremities,20
Heart Valve Prosthesis,E,E07.695.310,Prostheses and Implants,Equipment and Supplies,20
Herbicides,D,D27.888.723.366,Pesticides,Toxic Actions,20
Herbicides,D,D27.720.031.700.366,Pesticides,Agrochemicals,20
Hip Prosthesis,E,E07.695.400.400,Joint Prosthesis,Prostheses and Implants,20
"Home Care Services, Hospital-Based",N,N02.421.143.524.403,Home Care Services,Community Health Services,20
"Hospitals, Psychiatric",N,N02.278.421.556.508,"Hospitals, Special",Hospitals,20
Immunodominant Epitopes,D,D23.050.550.500,Epitopes,Antigens,20
Immunoglobulin Isotypes,D,D12.776.124.486.485.114.619,Antibodies,Immunoglobulins,20
Immunoglobulin Isotypes,D,D12.776.124.790.651.114.619,Antibodies,Immunoglobulins,20
Immunoglobulin Isotypes,D,D12.776.377.715.548.114.619,Antibodies,Immunoglobulins,20
Intelligence Tests,F,F04.711.141.493,Aptitude Tests,Psychological Tests,20
Ischemia,C,C23.550.513,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",20
Liposomes,D,D25.479.517,"Membranes, Artificial",Biomedical and Dental Materials,20
Liposomes,D,D26.255.260.517,Drug Carriers,Dosage Forms,20
Liposomes,J,J01.637.087.500.517,"Membranes, Artificial",Biomimetic Materials,20
Liposomes,J,J01.637.051.479.517,"Membranes, Artificial",Biomedical and Dental Materials,20
Listeria monocytogenes,B,B03.353.500.500.500,Listeria,Bacillales,20
Listeria monocytogenes,B,B03.510.100.500.500,Listeria,Bacillales,20
Listeria monocytogenes,B,B03.510.460.400.410.485.500,Listeria,"Gram-Positive Asporogenous Rods, Regular",20
Maternal-Child Health Centers,N,N02.278.035.310,Ambulatory Care Facilities,Health Facilities,20
Medication Errors,N,N02.421.450.500,Medical Errors,Health Services,20
Medication Errors,E,E02.319.529,Drug Therapy,Therapeutics,20
Menorrhagia,C,C23.550.568.875,Menstruation Disturbances,Pathologic Processes,20
Menorrhagia,C,C23.550.414.993.350,Uterine Hemorrhage,Hemorrhage,20
Menorrhagia,C,C13.351.500.852.691.449,Uterine Hemorrhage,Uterine Diseases,20
Metagenome,G,G05.360.340.550,Genome,Genetic Structures,20
"Mice, Inbred Strains",B,B01.050.150.900.649.313.992.635.505.500.400,Mice,Murinae,20
"Mice, Inbred Strains",B,B01.050.050.199.520.520,"Animals, Inbred Strains","Animals, Laboratory",20
Muscles,A,A02.633,Musculoskeletal System,NULL,20
Muscles,A,A10.690,Tissues,NULL,20
Mycobacterium smegmatis,B,B03.510.460.400.410.552.552.720.662,Nontuberculous Mycobacteria,Mycobacterium,20
Mycobacterium smegmatis,B,B03.510.024.962.500.720.662,Nontuberculous Mycobacteria,Mycobacterium,20
Naphthoquinones,D,D04.615.638.721,Naphthalenes,Polycyclic Aromatic Hydrocarbons,20
Naphthoquinones,D,D02.806.550,Quinones,Organic Chemicals,20
Naphthoquinones,D,D02.455.426.559.847.638.721,Naphthalenes,Polycyclic Aromatic Hydrocarbons,20
NF-kappa B,D,D05.500.672,Multiprotein Complexes,Macromolecular Substances,20
NF-kappa B,D,D12.776.260.600,DNA-Binding Proteins,Proteins,20
NF-kappa B,D,D12.776.660.600,Nuclear Proteins,Proteins,20
NF-kappa B,D,D12.776.930.600,Transcription Factors,Proteins,20
Occupational Medicine,H,H02.403.720.750.510,Preventive Medicine,Public Health,20
Operon,G,G05.360.340.358.207.500,"Genome, Bacterial","Genome, Microbial",20
Operon,G,G05.360.340.024.686,Genome Components,Genome,20
Orthomyxoviridae Infections,C,C01.925.782.620,RNA Virus Infections,Virus Diseases,20
Osteoblasts,A,A11.329.629,Connective Tissue Cells,Cells,20
Oviposition,G,G08.686.784.480,Reproduction,Reproductive Physiological Phenomena,20
Physical Abuse,I,I01.198.240.856.688,Violence,Crime,20
Physical Abuse,I,I01.880.735.900.744,Violence,Social Problems,20
Phytotherapy,E,E02.190.755,Complementary Therapies,Therapeutics,20
Placenta Diseases,C,C13.703.590,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,20
Plant Diseases,G,G15.610,Plant Physiological Phenomena,NULL,20
Plasmodium ovale,B,B01.043.075.380.611.700,Plasmodium,Haemosporida,20
Platelet Glycoprotein GPIIb-IIIa Complex,D,D12.776.543.550.625.785,Platelet Membrane Glycoproteins,Membrane Glycoproteins,20
Platelet Glycoprotein GPIIb-IIIa Complex,D,D12.776.543.750.705.675.784,Platelet Membrane Glycoproteins,"Receptors, Immunologic",20
Platelet Glycoprotein GPIIb-IIIa Complex,D,D12.776.543.750.705.408.460.700,"Receptors, Cytoadhesin",Integrins,20
Platelet Glycoprotein GPIIb-IIIa Complex,D,D12.776.395.550.625.785,Platelet Membrane Glycoproteins,Membrane Glycoproteins,20
"pol Gene Products, Human Immunodeficiency Virus",D,D12.776.964.900.750.500.545,"Gene Products, pol",Viral Replicase Complex Proteins,20
"pol Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.562.764,Human Immunodeficiency Virus Proteins,Retroviridae Proteins,20
"pol Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.375.545,"Gene Products, pol",Retroviridae Proteins,20
"pol Gene Products, Human Immunodeficiency Virus",D,D12.776.775.360.650,"Gene Products, pol",Polyproteins,20
"pol Gene Products, Human Immunodeficiency Virus",D,D12.776.964.970.600.850.375.545,"Gene Products, pol",Viral Core Proteins,20
Protein-Energy Malnutrition,C,C18.654.521.500.708.626,Protein Deficiency,Deficiency Diseases,20
Protozoan Infections,C,C01.610.752,Parasitic Diseases,Infections,20
Radiotherapy Dosage,E,E02.815.639,Radiotherapy,Therapeutics,20
"Receptors, Antigen, T-Cell, alpha-beta",D,D12.776.543.750.705.816.824.825,"Receptors, Antigen, T-Cell","Receptors, Antigen",20
Recommended Dietary Allowances,G,G07.203.650.620.500,Nutritional Requirements,Nutritional Physiological Phenomena,20
Recommended Dietary Allowances,I,I01.655.500.608.400.650.500,Nutrition Policy,Health Policy,20
Recommended Dietary Allowances,I,I01.880.604.825.608.400.650.500,Nutrition Policy,Health Policy,20
Recommended Dietary Allowances,N,N03.623.500.608.428.650.500,Nutrition Policy,Health Policy,20
Retinoblastoma,C,C04.557.580.625.600.725,"Neoplasms, Neuroepithelial",Neuroectodermal Tumors,20
Retinoblastoma,C,C04.557.470.670.725,"Neoplasms, Neuroepithelial","Neoplasms, Glandular and Epithelial",20
Retinoblastoma,C,C04.557.465.625.600.725,"Neoplasms, Neuroepithelial",Neuroectodermal Tumors,20
Retinoblastoma,C,C04.588.364.818.760,Retinal Neoplasms,Eye Neoplasms,20
Retinoblastoma,C,C11.768.717.760,Retinal Neoplasms,Retinal Diseases,20
Retinoblastoma,C,C11.319.475.760,Retinal Neoplasms,Eye Neoplasms,20
Retinoblastoma,C,C11.270.862,"Eye Diseases, Hereditary",Eye Diseases,20
"Salmonella Infections, Animal",C,C22.812,Animal Diseases,NULL,20
"Salmonella Infections, Animal",C,C01.150.252.400.310.821.706,Salmonella Infections,Enterobacteriaceae Infections,20
Serine Endopeptidases,D,D08.811.277.656.300.760,Endopeptidases,Peptide Hydrolases,20
Serine Endopeptidases,D,D08.811.277.656.959.350,Serine Proteases,Peptide Hydrolases,20
Social Discrimination,F,F01.145.813.629,Social Behavior,Behavior,20
Stereoisomerism,G,G02.607.445.682,Isomerism,Organic Chemistry Phenomena,20
Television,J,J01.897.280.500.898,Audiovisual Aids,Educational Technology,20
Television,L,L01.178.590.875,Mass Media,Communications Media,20
Television,L,L01.178.847.823,Telecommunications,Communications Media,20
Television,L,L01.178.820.090.898,Audiovisual Aids,Teaching Materials,20
Thiophenes,D,D02.886.778,Sulfur Compounds,Organic Chemicals,20
Thiophenes,D,D03.383.903,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,20
Timor-Leste,Z,Z01.252.145.900,"Asia, Southeastern",Asia,20
Toll-Like Receptor 2,D,D12.776.543.750.705.910.500.200,Toll-Like Receptors,"Receptors, Pattern Recognition",20
Trans-Activators,D,D12.776.964.925.984,Viral Regulatory and Accessory Proteins,Viral Proteins,20
Trans-Activators,D,D12.776.930.900,Transcription Factors,Proteins,20
Trans-Activators,D,D12.776.260.755,DNA-Binding Proteins,Proteins,20
Twins,M,M01.438.873,Multiple Birth Offspring,Persons,20
Uterine Neoplasms,C,C04.588.945.418.948,"Genital Neoplasms, Female",Urogenital Neoplasms,20
Uterine Neoplasms,C,C13.351.500.852.762,Uterine Diseases,"Genital Diseases, Female",20
Uterine Neoplasms,C,C13.351.937.418.875,"Genital Neoplasms, Female",Urogenital Neoplasms,20
Ventilation,N,N06.230.150.520,"Environment, Controlled",Environment,20
Wound Healing,G,G16.762.891,Regeneration,Biological Phenomena,20
"Abnormalities, Drug-Induced",C,C16.131.042,Congenital Abnormalities,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",19
"Abortifacient Agents, Nonsteroidal",D,D27.505.954.705.131.100,Abortifacient Agents,Reproductive Control Agents,19
"Abortifacient Agents, Nonsteroidal",D,D27.505.696.875.131.100,Abortifacient Agents,Reproductive Control Agents,19
"Abortifacient Agents, Steroidal",D,D27.505.696.875.131.200,Abortifacient Agents,Reproductive Control Agents,19
"Abortifacient Agents, Steroidal",D,D27.505.954.705.131.200,Abortifacient Agents,Reproductive Control Agents,19
"Accidents, Occupational",N,N06.850.135.240,Accidents,Public Health,19
Adenosine Triphosphatases,D,D08.811.277.040.025,Acid Anhydride Hydrolases,Hydrolases,19
Adolescent Development,F,F01.525.049,Human Development,Behavior and Behavior Mechanisms,19
Adolescent Development,G,G07.345.374.500,Human Development,Growth and Development,19
Albumins,D,D12.776.034,Proteins,"Amino Acids, Peptides, and Proteins",19
Alcoholic Intoxication,C,C25.775.100.175,Alcohol-Related Disorders,Substance-Related Disorders,19
Alcoholic Intoxication,F,F03.900.100.300,Alcohol-Related Disorders,Substance-Related Disorders,19
Antimicrobial Cationic Peptides,D,D12.644.050,Peptides,"Amino Acids, Peptides, and Proteins",19
Antimicrobial Cationic Peptides,D,D12.776.543.695.054,Pore Forming Cytotoxic Proteins,Membrane Proteins,19
Antinematodal Agents,D,D27.505.954.122.250.075.080,Anthelmintics,Antiparasitic Agents,19
Aorta,A,A07.015.114.056,Arteries,Blood Vessels,19
Arboviruses,B,B04.080,Viruses,NULL,19
Arginase,D,D08.811.277.913.292,Ureohydrolases,Hydrolases,19
"Arthritis, Juvenile",C,C05.550.114.122,Arthritis,Joint Diseases,19
"Arthritis, Juvenile",C,C05.799.056,Rheumatic Diseases,Musculoskeletal Diseases,19
"Arthritis, Juvenile",C,C20.111.198,Autoimmune Diseases,Immune System Diseases,19
"Arthritis, Juvenile",C,C17.300.775.049,Rheumatic Diseases,Connective Tissue Diseases,19
Attitude to Death,F,F01.100.125,Attitude,Behavior and Behavior Mechanisms,19
Attitude to Death,N,N05.300.125,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",19
Automobiles,J,J01.937.500.100,Motor Vehicles,Transportation,19
Brucellosis,C,C01.150.252.400.167,Gram-Negative Bacterial Infections,Bacterial Infections,19
"Calcium, Dietary",D,D01.146.395,Calcium Compounds,Inorganic Chemicals,19
"Centers for Disease Control and Prevention, U.S.",I,I01.409.418.750.600.650.200,United States Public Health Service,United States Dept. of Health and Human Services,19
"Centers for Disease Control and Prevention, U.S.",N,N03.540.348.500.500.600.650.225,United States Public Health Service,United States Dept. of Health and Human Services,19
Child Care,N,N02.421.088,Health Services,"Health Care Facilities, Manpower, and Services",19
Child Care,I,I01.880.787.293.360,Child Welfare,Social Welfare,19
Clinical Trials Data Monitoring Committees,N,N05.700.685.149,Professional Staff Committees,"Quality Assurance, Health Care",19
Clofazimine,D,D03.633.300.704.353,Phenazines,"Heterocyclic Compounds, 3-Ring",19
Complement C3,D,D12.776.124.050.140,Acute-Phase Proteins,Blood Proteins,19
Complement C3,D,D12.776.124.486.274.250,Complement System Proteins,Immunoproteins,19
Consumer Product Safety,N,N06.850.210,Public Health,Environment and Public Health,19
Continuous Positive Airway Pressure,E,E02.880.820.790.259,Positive-Pressure Respiration,"Respiration, Artificial",19
Continuous Positive Airway Pressure,E,E02.041.625.790.259,Positive-Pressure Respiration,"Respiration, Artificial",19
Coronary Thrombosis,C,C14.907.355.830.220,Thrombosis,Embolism and Thrombosis,19
Coronary Thrombosis,C,C14.907.585.250.290,Coronary Disease,Myocardial Ischemia,19
Coronary Thrombosis,C,C14.280.647.250.290,Coronary Disease,Myocardial Ischemia,19
COS Cells,A,A11.329.228.220,Fibroblasts,Connective Tissue Cells,19
COS Cells,A,A11.251.210.172.500,"Cell Line, Transformed",Cell Line,19
Cyclic GMP,D,D13.695.462.275,"Nucleotides, Cyclic",Nucleotides,19
Cyclic GMP,D,D13.695.667.454.160,Guanine Nucleotides,Purine Nucleotides,19
Cyclic GMP,D,D13.695.827.426.160,Guanine Nucleotides,Ribonucleotides,19
Cyclic GMP,D,D03.633.100.759.646.454.160,Guanine Nucleotides,Purine Nucleotides,19
Diabetic Nephropathies,C,C13.351.968.419.192,Kidney Diseases,Urologic Diseases,19
Diabetic Nephropathies,C,C12.777.419.192,Kidney Diseases,Urologic Diseases,19
Diabetic Nephropathies,C,C19.246.099.875,Diabetes Complications,Diabetes Mellitus,19
"Diet, Sodium-Restricted",E,E02.642.249.290,Diet Therapy,Nutrition Therapy,19
"Diet, Sodium-Restricted",G,G07.203.650.240.290,Diet,Nutritional Physiological Phenomena,19
Drug Carriers,E,E02.319.300.380,Drug Delivery Systems,Drug Therapy,19
Drug Carriers,D,D26.255.260,Dosage Forms,Pharmaceutical Preparations,19
Drug Overdose,E,E02.319.306.500.500,Prescription Drug Misuse,Drug Misuse,19
Drug Overdose,C,C25.775.383,Substance-Related Disorders,Chemically-Induced Disorders,19
"Effect Modifier, Epidemiologic",N,N06.850.490.734,Epidemiologic Factors,Public Health,19
"Effect Modifier, Epidemiologic",N,N05.715.350.350,Epidemiologic Factors,Quality of Health Care,19
"Electrophoresis, Agar Gel",E,E05.301.300.100,Electrophoresis,Electrochemical Techniques,19
"Electrophoresis, Agar Gel",E,E05.196.401.153,Electrophoresis,"Chemistry Techniques, Analytical",19
Eplerenone,D,D02.540.383,Lactones,Organic Chemicals,19
Eplerenone,D,D04.210.500.745.745.329,Pregnenes,Pregnanes,19
Equipment Failure,E,E05.325,Investigative Techniques,NULL,19
Erythropoietin,D,D12.776.395.240.150,Colony-Stimulating Factors,Glycoproteins,19
Erythropoietin,D,D12.644.276.374.410.240.150,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,19
Erythropoietin,D,D23.529.374.410.240.150,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,19
Erythropoietin,D,D12.776.467.374.410.240.150,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,19
Fertilization in Vitro,E,E05.820.800.750,"Reproductive Techniques, Assisted",Reproductive Techniques,19
Fertilization in Vitro,E,E02.875.800.750,"Reproductive Techniques, Assisted",Reproductive Techniques,19
Filariasis,C,C01.610.335.508.700.750.361,Spirurida Infections,Secernentea Infections,19
Fisheries,J,J01.040.168.300,Aquaculture,Agriculture,19
Fisheries,J,J03.540.280,Manufacturing and Industrial Facilities,Non-Medical Public and Private Facilities,19
Gene Silencing,G,G05.308.203.374,"Epigenesis, Genetic",Gene Expression Regulation,19
Genetic Heterogeneity,G,G05.365.331,Genetic Variation,Genetic Phenomena,19
Giardia lamblia,B,B01.237.385.400,Giardia,Diplomonadida,19
Golgi Apparatus,A,A11.284.430.214.190.875.336,Organelles,Cytoplasmic Structures,19
Gynecology,H,H02.403.810.310,"Specialties, Surgical",Medicine,19
Gynecology,H,H02.403.763.750,Reproductive Medicine,Medicine,19
Hair,A,A17.360,Integumentary System,NULL,19
Heart Arrest,C,C14.280.383,Heart Diseases,Cardiovascular Diseases,19
Hematologic Diseases,C,C15.378,Hemic and Lymphatic Diseases,NULL,19
Heroin Dependence,C,C25.775.643.500.400,Opioid-Related Disorders,Narcotic-Related Disorders,19
Heroin Dependence,F,F03.900.647.500.300,Opioid-Related Disorders,Narcotic-Related Disorders,19
HIV Antigens,D,D23.050.327.520,"Antigens, Viral",Antigens,19
Hormone Replacement Therapy,E,E02.319.452,Drug Therapy,Therapeutics,19
Hormones,D,D27.505.696.399.472,"Hormones, Hormone Substitutes, and Hormone Antagonists",Physiological Effects of Drugs,19
Hormones,D,D06.472,"Hormones, Hormone Substitutes, and Hormone Antagonists",NULL,19
Human Migration,I,I01.240.600.525,Population Dynamics,Demography,19
Human Migration,N,N06.850.505.400.700.525,Population Dynamics,Demography,19
Human Migration,N,N01.224.625.525,Population Dynamics,Demography,19
Hypolipidemic Agents,D,D27.505.519.186.071,Antimetabolites,Molecular Mechanisms of Pharmacological Action,19
Hypolipidemic Agents,D,D27.505.954.557.500,Lipid Regulating Agents,Therapeutic Uses,19
"Imaging, Three-Dimensional",E,E01.370.350.400,Diagnostic Imaging,Diagnostic Techniques and Procedures,19
"Imaging, Three-Dimensional",L,L01.224.308.410,"Image Processing, Computer-Assisted",Computing Methodologies,19
Information Systems,L,L01.313.500.750.300,Medical Informatics Applications,Medical Informatics,19
Inhalation Exposure,N,N06.850.460.350.112,Environmental Exposure,Environmental Pollution,19
Interleukin-18,D,D23.529.374.465.518,Interleukins,Cytokines,19
Interleukin-18,D,D12.776.467.374.465.518,Interleukins,Cytokines,19
Interleukin-18,D,D12.644.276.374.465.518,Interleukins,Cytokines,19
Intestinal Diseases,C,C06.405.469,Gastrointestinal Diseases,Digestive System Diseases,19
Korea,Z,Z01.252.474.557,Far East,Asia,19
Korea,Z,Z01.586.407,Historical Geographic Locations,Geographic Locations,19
Laparotomy,E,E04.406,"Surgical Procedures, Operative",NULL,19
Latent Class Analysis,E,E05.318.740.250.338,Cluster Analysis,Statistics as Topic,19
Latent Class Analysis,N,N05.715.360.750.200.375,Cluster Analysis,Statistics as Topic,19
Latent Class Analysis,L,L01.224.050.687,Algorithms,Computing Methodologies,19
Latent Class Analysis,G,G17.035.625,Algorithms,Mathematical Concepts,19
Latent Class Analysis,N,N06.850.520.830.250.338,Cluster Analysis,Statistics as Topic,19
"Leukemia, Myeloid, Acute",C,C04.557.337.539.275,"Leukemia, Myeloid",Leukemia,19
Lysosomes,A,A11.284.430.214.190.875.190.550,Cytoplasmic Vesicles,Organelles,19
Macaca fascicularis,B,B01.050.150.900.649.313.988.400.112.199.120.510.520,Macaca,Cercopithecinae,19
Madagascar,Z,Z01.639.520.500,Indian Ocean Islands,Islands,19
Marburgvirus,B,B04.820.480.937.300.650,Filoviridae,Mononegavirales,19
Metabolome,G,G03.500,Metabolism,NULL,19
Metallurgy,J,J01.576.655.875.400,Extraction and Processing Industry,Manufacturing Industry,19
Methylenetetrahydrofolate Reductase (NADPH2),D,D12.776.331.775,Flavoproteins,Proteins,19
Methylenetetrahydrofolate Reductase (NADPH2),D,D08.811.682.662.290,Oxidoreductases Acting on CH-NH Group Donors,Oxidoreductases,19
Movement,G,G11.427.410,Musculoskeletal Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,19
Movement,G,G07.568,Physiological Phenomena,NULL,19
"Neisseria meningitidis, Serogroup B",B,B03.660.075.525.520.500.710,Neisseria meningitidis,Neisseria,19
"Neisseria meningitidis, Serogroup B",B,B03.440.400.425.550.550.641.710,Neisseria meningitidis,Neisseria,19
Neural Tube Defects,C,C16.131.666.680,Nervous System Malformations,Congenital Abnormalities,19
Neural Tube Defects,C,C10.500.680,Nervous System Malformations,Nervous System Diseases,19
Nontuberculous Mycobacteria,B,B03.510.024.962.500.720,Mycobacterium,Mycobacteriaceae,19
Nontuberculous Mycobacteria,B,B03.510.460.400.410.552.552.720,Mycobacterium,Mycobacteriaceae,19
"Obstetrics and Gynecology Department, Hospital",N,N04.452.442.452.422.495,Hospital Departments,Hospital Administration,19
"Obstetrics and Gynecology Department, Hospital",N,N02.278.216.500.968.495,Hospital Departments,Hospital Administration,19
Ophthalmoscopy,E,E01.370.380.560,"Diagnostic Techniques, Ophthalmological",Diagnostic Techniques and Procedures,19
Organometallic Compounds,D,D02.691,Organic Chemicals,NULL,19
Organothiophosphorus Compounds,D,D02.705.539,Organophosphorus Compounds,Organic Chemicals,19
Organothiophosphorus Compounds,D,D02.886.300,Sulfur Compounds,Organic Chemicals,19
Orosomucoid,D,D12.776.377.715.085.640,Alpha-Globulins,Serum Globulins,19
Orosomucoid,D,D12.776.395.560.742,Mucoproteins,Glycoproteins,19
Orosomucoid,D,D12.776.124.790.106.640,Alpha-Globulins,Serum Globulins,19
Orosomucoid,D,D12.776.124.050.600,Acute-Phase Proteins,Blood Proteins,19
Oxazines,D,D03.383.533,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,19
Personal Protective Equipment,J,J01.637.708.560,Protective Devices,Manufactured Materials,19
Personal Protective Equipment,E,E07.700.560,Protective Devices,Equipment and Supplies,19
Personality,F,F01.752,Behavior and Behavior Mechanisms,NULL,19
"Pharmacy Service, Hospital",N,N02.278.216.500.968.603,Hospital Departments,Hospital Administration,19
"Pharmacy Service, Hospital",N,N02.421.668.556,Pharmaceutical Services,Health Services,19
"Pharmacy Service, Hospital",N,N04.452.442.452.422.603,Hospital Departments,Hospital Administration,19
Plasmodium chabaudi,B,B01.043.075.380.611.490,Plasmodium,Haemosporida,19
Postoperative Hemorrhage,C,C23.550.767.850,Postoperative Complications,Pathologic Processes,19
Postoperative Hemorrhage,C,C23.550.414.941,Hemorrhage,Pathologic Processes,19
Protein Biosynthesis,G,G03.734.871,Peptide Biosynthesis,Metabolism,19
Protein Biosynthesis,G,G02.111.660.871,Peptide Biosynthesis,Biochemical Phenomena,19
Protein Biosynthesis,G,G05.297.670,Gene Expression,Genetic Phenomena,19
Pseudogenes,G,G05.360.340.024.340.700,Genes,Genome Components,19
Puerperal Disorders,C,C13.703.844,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,19
Radiation Injuries,C,C26.733,Wounds and Injuries,NULL,19
Radiation Injuries,G,G01.750.748.500,Radiation Exposure,Radiation,19
Radiation Injuries,N,N06.850.460.350.850.500,Radiation Exposure,Environmental Exposure,19
Radiation Injuries,N,N06.850.810.300.360,Radiation Effects,Radiologic Health,19
Reactive Oxygen Species,D,D01.339.431,Free Radicals,Inorganic Chemicals,19
Reactive Oxygen Species,D,D01.650.775,Oxygen Compounds,Inorganic Chemicals,19
Reading,L,L01.559.423.557,Language Arts,Language,19
Rhodnius,B,B01.050.500.131.617.412.420.700.850.700,Triatominae,Reduviidae,19
Role,F,F01.829.316.616,Group Processes,"Psychology, Social",19
Schistosoma japonicum,B,B01.050.500.500.736.715.770.680.570,Schistosoma,Schistosomatidae,19
Self-Assessment,F,F01.752.747.792.537,Self Concept,Personality Development,19
Sleep Wake Disorders,F,F03.870,Mental Disorders,NULL,19
Sleep Wake Disorders,C,C23.888.592.796,Neurologic Manifestations,Signs and Symptoms,19
Sleep Wake Disorders,C,C10.886,Nervous System Diseases,NULL,19
Snacks,G,G07.203.300.590.780,Meals,Food,19
Snacks,J,J02.500.590.780,Meals,Food,19
"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E,E05.196.566.755,Mass Spectrometry,"Chemistry Techniques, Analytical",19
"Spondylitis, Ankylosing",C,C05.550.114.865.800.850,Spondylarthropathies,Spondylarthritis,19
"Spondylitis, Ankylosing",C,C05.116.900.853.625.800.850,Spondylarthropathies,Spondylarthritis,19
"Spondylitis, Ankylosing",C,C05.550.069.680,Ankylosis,Joint Diseases,19
Ticagrelor,D,D03.633.100.759.590.138.806,Adenosine,Purine Nucleosides,19
Ticagrelor,D,D13.570.800.096.815,Adenosine,Ribonucleosides,19
Ticagrelor,D,D13.570.583.138.806,Adenosine,Purine Nucleosides,19
"Transplantation, Homologous",E,E04.936.864,Transplantation,"Surgical Procedures, Operative",19
Trichomonas Infections,C,C01.610.752.890,Protozoan Infections,Parasitic Diseases,19
Urethritis,C,C12.777.767.851,Urethral Diseases,Urologic Diseases,19
Urethritis,C,C13.351.968.767.851,Urethral Diseases,Urologic Diseases,19
Vaccination Refusal,F,F01.100.150.750.750.500,Treatment Refusal,Treatment Adherence and Compliance,19
Vaccination Refusal,F,F01.145.488.887.750.500,Treatment Refusal,Treatment Adherence and Compliance,19
Vaccination Refusal,I,I01.880.604.473.650.968.500,Treatment Refusal,Patient Rights,19
Vaccination Refusal,N,N03.706.437.650.875.500,Treatment Refusal,Patient Rights,19
Vaccination Refusal,N,N05.300.150.800.750.500,Treatment Refusal,Treatment Adherence and Compliance,19
Vaginal Discharge,C,C13.351.500.894.700,Vaginal Diseases,"Genital Diseases, Female",19
Viral Hepatitis Vaccines,D,D20.215.894.899.955,Viral Vaccines,Vaccines,19
Accelerometry,E,E05.003,Investigative Techniques,NULL,18
Acetaminophen,D,D02.065.199.092.040,Acetanilides,Anilides,18
Acetaminophen,D,D02.092.146.113.092.040,Acetanilides,Anilides,18
Amyotrophic Lateral Sclerosis,C,C18.452.845.800.050,TDP-43 Proteinopathies,Proteostasis Deficiencies,18
Amyotrophic Lateral Sclerosis,C,C10.574.950.050,TDP-43 Proteinopathies,Neurodegenerative Diseases,18
Amyotrophic Lateral Sclerosis,C,C10.574.562.250,Motor Neuron Disease,Neurodegenerative Diseases,18
Amyotrophic Lateral Sclerosis,C,C10.668.467.250,Motor Neuron Disease,Neuromuscular Diseases,18
Amyotrophic Lateral Sclerosis,C,C10.228.854.139,Spinal Cord Diseases,Central Nervous System Diseases,18
Analgesics,D,D27.505.954.427.040,Central Nervous System Agents,Therapeutic Uses,18
Analgesics,D,D27.505.696.663.850.014,Sensory System Agents,Peripheral Nervous System Agents,18
Angiogenesis Inhibitors,D,D27.505.954.248.025,Antineoplastic Agents,Therapeutic Uses,18
Angiogenesis Inhibitors,D,D27.505.696.377.077.099,Angiogenesis Modulating Agents,Growth Substances,18
Angiogenesis Inhibitors,D,D27.505.696.377.450.100,Growth Inhibitors,Growth Substances,18
Arbovirus Infections,C,C01.925.081,Virus Diseases,Infections,18
Arbovirus Infections,C,C01.920.500,Vector Borne Diseases,Infections,18
"Asia, Central",Z,Z01.252.100,Asia,Geographic Locations,18
beta Carotene,D,D02.455.426.392.368.367.379.249.050,Carotenoids,Cyclohexenes,18
beta Carotene,D,D02.455.326.271.665.202.123,Carotenoids,Polyenes,18
beta Carotene,D,D23.767.261.050,Carotenoids,"Pigments, Biological",18
beta Carotene,D,D02.455.849.131.123,Carotenoids,Terpenes,18
Binomial Distribution,N,N06.850.520.830.994.250,Statistical Distributions,Statistics as Topic,18
Binomial Distribution,E,E05.318.740.994.250,Statistical Distributions,Statistics as Topic,18
Binomial Distribution,N,N05.715.360.750.750.150,Statistical Distributions,Statistics as Topic,18
Binomial Distribution,G,G17.820.250,Statistical Distributions,Mathematical Concepts,18
Birth Certificates,N,N06.850.520.308.940.250,Records,Data Collection,18
Birth Certificates,N,N05.715.360.300.715.175,Records,Data Collection,18
Birth Certificates,N,N04.452.859.132,Records,Organization and Administration,18
Birth Certificates,L,L01.399.250.900.250,Records,Data Collection,18
Birth Certificates,E,E05.318.308.940.250,Records,Data Collection,18
"Blotting, Northern",E,E05.301.300.074,Electrophoresis,Electrochemical Techniques,18
"Blotting, Northern",E,E05.196.401.095,Electrophoresis,"Chemistry Techniques, Analytical",18
"Blotting, Northern",E,E05.601.100,Molecular Probe Techniques,Investigative Techniques,18
"Brain Injuries, Traumatic",C,C26.915.300.200.194,Brain Injuries,Craniocerebral Trauma,18
"Brain Injuries, Traumatic",C,C10.228.140.199.444,Brain Injuries,Brain Diseases,18
"Brain Injuries, Traumatic",C,C10.900.300.087.235,Brain Injuries,Craniocerebral Trauma,18
Bronchiectasis,C,C08.127.384,Bronchial Diseases,Respiratory Tract Diseases,18
Bronchiolitis,C,C08.127.446.135,Bronchitis,Bronchial Diseases,18
Bronchiolitis,C,C08.381.495.146.135,Bronchitis,"Lung Diseases, Obstructive",18
Bronchiolitis,C,C08.730.099.135,Bronchitis,Respiratory Tract Infections,18
Bronchiolitis,C,C01.748.099.135,Bronchitis,Respiratory Tract Infections,18
Burundi,Z,Z01.058.290.120.180,"Africa, Eastern",Africa South of the Sahara,18
Caenorhabditis elegans,B,B01.050.500.500.294.400.875.660.250.250,Caenorhabditis,Rhabditoidea,18
Calcium-Binding Proteins,D,D12.776.157.125,Carrier Proteins,Proteins,18
Cancer Survivors,M,M01.860.350,Survivors,Persons,18
Capital Financing,N,N03.219.463.085,Financial Management,Economics,18
"Carcinoma, Ductal, Breast",C,C04.557.470.615.132.500,"Carcinoma, Ductal","Neoplasms, Ductal, Lobular, and Medullary",18
"Carcinoma, Ductal, Breast",C,C04.557.470.200.025.232.500,"Carcinoma, Ductal",Adenocarcinoma,18
"Carcinoma, Ductal, Breast",C,C04.588.180.390,Breast Neoplasms,Neoplasms by Site,18
"Carcinoma, Ductal, Breast",C,C17.800.090.500.390,Breast Neoplasms,Breast Diseases,18
Cell Adhesion Molecules,D,D12.776.395.550.200,Membrane Glycoproteins,Glycoproteins,18
Cell Adhesion Molecules,D,D23.050.301.350,"Antigens, Surface",Antigens,18
Cell Adhesion Molecules,D,D12.776.543.550.200,Membrane Glycoproteins,Membrane Proteins,18
Cell Cycle,G,G04.144,Cell Physiological Phenomena,NULL,18
Central America,Z,Z01.107.169,Americas,Geographic Locations,18
Chemokine CCL2,D,D12.776.467.374.200.110.990.600,Monocyte Chemoattractant Proteins,"Chemokines, CC",18
Chemokine CCL2,D,D23.529.374.200.110.990.500,Monocyte Chemoattractant Proteins,"Chemokines, CC",18
Chemokine CCL2,D,D23.469.200.110.990.600,Monocyte Chemoattractant Proteins,"Chemokines, CC",18
Chemokine CCL2,D,D23.125.300.110.990.600,Monocyte Chemoattractant Proteins,"Chemokines, CC",18
Chemokine CCL2,D,D12.644.276.374.200.110.990.600,Monocyte Chemoattractant Proteins,"Chemokines, CC",18
Child Day Care Centers,N,N02.421.143.098,Community Health Services,Health Services,18
Child Day Care Centers,J,J03.160,Non-Medical Public and Private Facilities,NULL,18
Chlamydia,B,B03.440.190.190.190,Chlamydiaceae,Chlamydiales,18
Colon,A,A03.556.249.249.356,"Intestine, Large",Lower Gastrointestinal Tract,18
Colon,A,A03.556.124.526.356,"Intestine, Large",Intestines,18
"Contraceptives, Oral, Combined",D,D26.310.360,Drug Combinations,Pharmaceutical Preparations,18
"Contraceptives, Oral, Combined",D,D27.505.696.875.360.276.210.100,"Contraceptives, Oral","Contraceptive Agents, Female",18
"Contraceptives, Oral, Combined",D,D27.505.954.705.360.276.210.100,"Contraceptives, Oral","Contraceptive Agents, Female",18
Cost Sharing,N,N03.219.521.576.090,Insurance,"Financing, Organized",18
Cost Sharing,N,N03.219.151.170,Costs and Cost Analysis,Economics,18
Cotinine,D,D03.383.773.812.180,Pyrrolidinones,Pyrrolidines,18
Cytoskeletal Proteins,D,D12.776.220,Proteins,"Amino Acids, Peptides, and Proteins",18
"Databases, Protein",L,L01.470.750.750.300.750,"Databases, Chemical","Databases, Factual",18
"Databases, Protein",L,L01.470.750.750.325.710,"Databases, Genetic","Databases, Factual",18
"Databases, Protein",L,L01.313.500.750.300.188.400.325.710,"Databases, Genetic","Databases, Factual",18
"Databases, Protein",L,L01.313.500.750.300.188.400.300.750,"Databases, Chemical","Databases, Factual",18
DEET,D,D02.455.426.559.389.127.085.230,Benzamides,Benzoates,18
DEET,D,D02.241.223.100.100.230,Benzamides,Benzoates,18
DEET,D,D02.065.277.194,Benzamides,Amides,18
DNA Replication,G,G05.226,Genetic Phenomena,NULL,18
DNA Replication,G,G02.111.225,Biochemical Phenomena,Chemical Phenomena,18
DNA Restriction Enzymes,D,D08.811.277.352.335.350.300,Endodeoxyribonucleases,Deoxyribonucleases,18
DNA Restriction Enzymes,D,D08.811.277.352.355.325.300,Endodeoxyribonucleases,Endonucleases,18
DNA Restriction Enzymes,D,D08.811.150.280,DNA Restriction-Modification Enzymes,Enzymes,18
"Drugs, Generic",D,D26.360,Pharmaceutical Preparations,NULL,18
Edema,C,C23.888.277,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",18
Electronics,H,H01.671.293,Physics,Natural Science Disciplines,18
Enterovirus Infections,C,C01.925.782.687.359,Picornaviridae Infections,RNA Virus Infections,18
Estrogen Replacement Therapy,E,E02.319.452.150,Hormone Replacement Therapy,Drug Therapy,18
Estrogens,D,D27.505.696.399.472.277,Hormones,"Hormones, Hormone Substitutes, and Hormone Antagonists",18
Ferrous Compounds,D,D01.490.200,Iron Compounds,Inorganic Chemicals,18
Fetal Hemoglobin,D,D12.776.422.316.762.320,Hemoglobins,Globins,18
Fetal Hemoglobin,D,D12.776.124.400.303,Hemoglobins,Blood Proteins,18
Fluorouracil,D,D03.383.742.698.875.404,Uracil,Pyrimidinones,18
Gametogenesis,G,G04.152.650,Cell Differentiation,Cell Physiological Phenomena,18
Gametogenesis,G,G08.686.784.310,Reproduction,Reproductive Physiological Phenomena,18
Genetic Complementation Test,E,E05.393.281.526,"Crosses, Genetic",Genetic Techniques,18
Gray Matter,A,A08.186.854.348,Spinal Cord,Central Nervous System,18
Gray Matter,A,A08.186.211.168,Brain,Central Nervous System,18
Greenhouse Gases,D,D01.362.311,Gases,Inorganic Chemicals,18
Greenhouse Gases,D,D27.888.284.101.696,Air Pollutants,Environmental Pollutants,18
Heating,N,N06.230.150.300,"Environment, Controlled",Environment,18
HLA-B Antigens,D,D23.050.301.500.450.380,HLA Antigens,Histocompatibility Antigens,18
HLA-B Antigens,D,D23.050.705.552.100.500,Histocompatibility Antigens Class I,Histocompatibility Antigens,18
HLA-B Antigens,D,D23.050.705.552.450.380,HLA Antigens,Histocompatibility Antigens,18
HLA-B Antigens,D,D12.776.543.550.439.500,Histocompatibility Antigens Class I,Membrane Glycoproteins,18
HLA-B Antigens,D,D23.050.301.500.100.500,Histocompatibility Antigens Class I,Histocompatibility Antigens,18
HLA-B Antigens,D,D12.776.395.550.489.500,Histocompatibility Antigens Class I,Membrane Glycoproteins,18
Human T-lymphotropic virus 1,B,B04.613.807.200.725.400,Primate T-lymphotropic virus 1,Deltaretrovirus,18
Human T-lymphotropic virus 1,B,B04.820.650.200.725.400,Primate T-lymphotropic virus 1,Deltaretrovirus,18
"Hybridization, Genetic",E,E05.820.150.390,Breeding,Reproductive Techniques,18
"Hybridization, Genetic",G,G05.090.390,Breeding,Genetic Phenomena,18
Hydrocarbons,D,D02.455,Organic Chemicals,NULL,18
Hydrogen Peroxide,D,D02.389.338.253,Peroxides,Free Radicals,18
Hydrogen Peroxide,D,D01.339.431.374.424,Peroxides,Reactive Oxygen Species,18
Hydrogen Peroxide,D,D01.248.497.158.685.750.424,Peroxides,Oxides,18
Hydrogen Peroxide,D,D01.650.550.750.400,Peroxides,Oxides,18
Hypotension,C,C14.907.514,Vascular Diseases,Cardiovascular Diseases,18
"Insurance, Health, Reimbursement",N,N03.219.521.710,"Financing, Organized",Economics,18
"Insurance, Health, Reimbursement",N,N03.219.521.576.343.480,"Insurance, Health",Insurance,18
Interleukin-5,D,D12.644.276.374.465.202,Interleukins,Cytokines,18
Interleukin-5,D,D12.776.467.374.465.186,Interleukins,Cytokines,18
Interleukin-5,D,D23.529.374.465.202,Interleukins,Cytokines,18
Iodine,D,D01.268.380.400,Halogens,Elements,18
"Labor Stage, Third",G,G08.686.784.769.326.500.110,Labor Onset,"Labor, Obstetric",18
Limit of Detection,E,E05.318.740.872.374,Sensitivity and Specificity,Statistics as Topic,18
Limit of Detection,N,N05.715.360.750.725.500,Sensitivity and Specificity,Statistics as Topic,18
Limit of Detection,N,N06.850.520.830.872.500,Sensitivity and Specificity,Statistics as Topic,18
"Macrophages, Peritoneal",A,A11.329.372.630,Macrophages,Connective Tissue Cells,18
"Macrophages, Peritoneal",A,A11.627.482.630,Macrophages,Myeloid Cells,18
"Macrophages, Peritoneal",A,A11.733.397.630,Macrophages,Phagocytes,18
"Macrophages, Peritoneal",A,A15.382.680.397.630,Macrophages,Phagocytes,18
"Macrophages, Peritoneal",A,A15.382.670.522.630,Macrophages,Mononuclear Phagocyte System,18
"Mastitis, Bovine",C,C22.196.581,Cattle Diseases,Animal Diseases,18
Memory Disorders,C,C23.888.592.604.529,Neurobehavioral Manifestations,Neurologic Manifestations,18
Memory Disorders,C,C10.597.606.525,Neurobehavioral Manifestations,Neurologic Manifestations,18
Memory Disorders,F,F01.700.625,Neurobehavioral Manifestations,Behavior and Behavior Mechanisms,18
Microcirculation,G,G09.330.100.645,Blood Circulation,Cardiovascular Physiological Phenomena,18
Mobility Limitation,C,C23.888.550,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",18
Morocco,Z,Z01.058.266.629,"Africa, Northern",Africa,18
Motor Skills,F,F02.808.260,Psychomotor Performance,Psychological Phenomena,18
Multiple Myeloma,C,C20.683.780.650,Paraproteinemias,Immunoproliferative Disorders,18
Multiple Myeloma,C,C20.683.515.845,Lymphoproliferative Disorders,Immunoproliferative Disorders,18
Multiple Myeloma,C,C14.907.454.460,Hemostatic Disorders,Vascular Diseases,18
Multiple Myeloma,C,C15.378.463.515.460,Hemostatic Disorders,Hemorrhagic Disorders,18
Multiple Myeloma,C,C15.378.147.780.650,Paraproteinemias,Blood Protein Disorders,18
Multiple Myeloma,C,C04.557.595.500,"Neoplasms, Plasma Cell",Neoplasms by Histologic Type,18
Mycobacterium marinum,B,B03.510.460.400.410.552.552.720.500,Nontuberculous Mycobacteria,Mycobacterium,18
Mycobacterium marinum,B,B03.510.024.962.500.720.500,Nontuberculous Mycobacteria,Mycobacterium,18
Namibia,Z,Z01.058.290.175.580,"Africa, Southern",Africa South of the Sahara,18
"Neisseria meningitidis, Serogroup C",B,B03.440.400.425.550.550.641.720,Neisseria meningitidis,Neisseria,18
"Neisseria meningitidis, Serogroup C",B,B03.660.075.525.520.500.720,Neisseria meningitidis,Neisseria,18
Nematoda,B,B01.050.500.500.294,Helminths,Invertebrates,18
Nursing Staff,N,N02.360.680,Health Personnel,"Health Care Facilities, Manpower, and Services",18
Nursing Staff,M,M01.526.485.680,Health Personnel,Occupational Groups,18
Nutritional Sciences,H,H02.533,Health Occupations,NULL,18
Optic Nerve Diseases,C,C11.640,Eye Diseases,NULL,18
Optic Nerve Diseases,C,C10.292.700,Cranial Nerve Diseases,Nervous System Diseases,18
Oseltamivir,D,D02.065.064.525,Acetamides,Amides,18
Oseltamivir,D,D02.455.426.392.368.367.379.500,Cyclohexenes,Cyclohexanes,18
"Osteoarthritis, Knee",C,C05.550.114.606.500,Osteoarthritis,Arthritis,18
"Osteoarthritis, Knee",C,C05.799.613.500,Osteoarthritis,Rheumatic Diseases,18
Ovum,A,A16.690,Embryonic Structures,NULL,18
Ovum,A,A11.497.497,Germ Cells,Cells,18
Ovum,A,A05.360.490.690,Germ Cells,Genitalia,18
Postal Service,I,I01.451.617,Government Programs,Social Sciences,18
Prions,D,D12.776.785,Proteins,"Amino Acids, Peptides, and Proteins",18
Protein Domains,G,G02.111.570.820.709.610.500,"Protein Structure, Tertiary",Protein Conformation,18
Protein Domains,G,G02.111.570.820.709.275.750,Protein Structural Elements,Protein Conformation,18
Public Facilities,J,J03.720,Non-Medical Public and Private Facilities,NULL,18
Pyrazoles,D,D03.383.129.539,Azoles,"Heterocyclic Compounds, 1-Ring",18
Quinolones,D,D03.633.100.810.835,Quinolines,"Heterocyclic Compounds, 2-Ring",18
"Receptors, CCR5",D,D12.776.543.750.695.160.150.500,"Receptors, CCR","Receptors, Chemokine",18
"Receptors, CCR5",D,D12.776.543.750.705.852.125.150.500,"Receptors, CCR","Receptors, Chemokine",18
"Receptors, CCR5",D,D12.776.543.750.830.700.605,"Receptors, HIV","Receptors, Virus",18
"Receptors, Chemokine",D,D12.776.543.750.705.852.125,"Receptors, Cytokine","Receptors, Immunologic",18
"Receptors, Chemokine",D,D12.776.543.750.695.160,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",18
"Receptors, KIR",D,D12.776.543.750.705.895.500,"Receptors, Natural Killer Cell","Receptors, Immunologic",18
"Respiratory Distress Syndrome, Newborn",C,C08.618.840.500,Respiratory Distress Syndrome,Respiration Disorders,18
"Respiratory Distress Syndrome, Newborn",C,C08.381.840.500,Respiratory Distress Syndrome,Lung Diseases,18
"Respiratory Distress Syndrome, Newborn",C,C16.614.521.563,"Infant, Premature, Diseases","Infant, Newborn, Diseases",18
Rodent Diseases,C,C22.795,Animal Diseases,NULL,18
Roma,M,M01.686.754.283,Ethnic Groups,Population Groups,18
Security Measures,N,N04.452.910,Organization and Administration,Health Services Administration,18
Simplexvirus,B,B04.280.382.100.750,Alphaherpesvirinae,Herpesviridae,18
Sirolimus,D,D02.540.505.760,Macrolides,Lactones,18
Smallpox,C,C01.925.256.743.826,Poxviridae Infections,DNA Virus Infections,18
Starvation,C,C18.654.521.750,Malnutrition,Nutrition Disorders,18
Stavudine,D,D03.383.742.680.705.875,Thymidine,Pyrimidine Nucleosides,18
Stavudine,D,D13.570.230.855.875,Thymidine,Deoxyribonucleosides,18
Stavudine,D,D13.570.230.500.850,Dideoxynucleosides,Deoxyribonucleosides,18
Stavudine,D,D13.570.685.705.875,Thymidine,Pyrimidine Nucleosides,18
Sudden Infant Death,C,C23.550.260.322.625,"Death, Sudden",Death,18
Sudden Infant Death,C,C23.550.260.657.500,Infant Death,Death,18
Survival,I,I03.784,Human Activities,NULL,18
Tajikistan,Z,Z01.252.100.900,"Asia, Central",Asia,18
Tobacco Use,F,F01.145.958,Behavior,Behavior and Behavior Mechanisms,18
Triazoles,D,D03.383.129.799,Azoles,"Heterocyclic Compounds, 1-Ring",18
United States Food and Drug Administration,I,I01.409.418.750.600.650.760,United States Public Health Service,United States Dept. of Health and Human Services,18
United States Food and Drug Administration,N,N03.540.348.500.500.600.650.760,United States Public Health Service,United States Dept. of Health and Human Services,18
"Variant Surface Glycoproteins, Trypanosoma",D,D12.776.395.550.990,Membrane Glycoproteins,Glycoproteins,18
"Variant Surface Glycoproteins, Trypanosoma",D,D23.050.293.900,"Antigens, Protozoan",Antigens,18
"Variant Surface Glycoproteins, Trypanosoma",D,D12.776.543.550.990,Membrane Glycoproteins,Membrane Proteins,18
"Variant Surface Glycoproteins, Trypanosoma",D,D23.050.301.900,"Antigens, Surface",Antigens,18
Wood,A,A18.450.500.500,Xylem,Plant Vascular Bundle,18
Wood,J,J01.637.241.900,Construction Materials,Manufactured Materials,18
Amoxicillin-Potassium Clavulanate Combination,D,D02.065.589.099.750.750.050.050.060,Amoxicillin,Ampicillin,17
Amoxicillin-Potassium Clavulanate Combination,D,D02.065.589.099.374.160.060,Clavulanic Acid,Clavulanic Acids,17
Amoxicillin-Potassium Clavulanate Combination,D,D26.310.102,Drug Combinations,Pharmaceutical Preparations,17
Amoxicillin-Potassium Clavulanate Combination,D,D02.886.108.750.750.050.050.060,Amoxicillin,Ampicillin,17
Amoxicillin-Potassium Clavulanate Combination,D,D03.633.100.300.750.750.050.050.500,Amoxicillin,Ampicillin,17
Amoxicillin-Potassium Clavulanate Combination,D,D03.633.100.300.374.160.060,Clavulanic Acid,Clavulanic Acids,17
Animal Distribution,G,G16.049,Biological Phenomena,NULL,17
Animal Distribution,F,F01.145.113.069,"Behavior, Animal",Behavior,17
Anti-Arrhythmia Agents,D,D27.505.954.411.097,Cardiovascular Agents,Therapeutic Uses,17
Arteries,A,A07.015.114,Blood Vessels,Cardiovascular System,17
Bites and Stings,C,C26.176,Wounds and Injuries,NULL,17
Bites and Stings,C,C25.723.127,Poisoning,Chemically-Induced Disorders,17
Bronchial Hyperreactivity,C,C08.127.210,Bronchial Diseases,Respiratory Tract Diseases,17
Carbohydrates,D,D09,NULL,NULL,17
Cardiotonic Agents,D,D27.505.954.411.222,Cardiovascular Agents,Therapeutic Uses,17
Cardiotonic Agents,D,D27.720.799.080,Protective Agents,Specialty Uses of Chemicals,17
CD3 Complex,D,D23.101.100.894.095,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",17
CD3 Complex,D,D23.050.301.264.894.095,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",17
Ceftazidime,D,D03.633.100.300.249.210.150,Cephaloridine,Cephalosporins,17
Ceftazidime,D,D02.886.665.074.210.150,Cephaloridine,Cephalosporins,17
Ceftazidime,D,D02.065.589.099.249.210.150,Cephaloridine,Cephalosporins,17
Celiac Disease,C,C18.452.603.250,Malabsorption Syndromes,Metabolic Diseases,17
Celiac Disease,C,C06.405.469.637.250,Malabsorption Syndromes,Intestinal Diseases,17
Cell Wall,A,A11.284.183,Cellular Structures,Cells,17
Child of Impaired Parents,M,M01.106,Persons,NULL,17
"Child, Orphaned",M,M01.108,Persons,NULL,17
"Chromosomes, Human, Pair 6",G,G05.360.162.520.300.325.330,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",17
"Chromosomes, Human, Pair 6",A,A11.284.187.520.300.325.330,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",17
Chronic Pain,C,C23.888.592.612.274,Pain,Neurologic Manifestations,17
Classification,L,L01.453.245.275,Documentation,Information Services,17
Classification,L,L01.100,Information Science,NULL,17
Cleft Lip,C,C16.131.850.525.164,Mouth Abnormalities,Stomatognathic System Abnormalities,17
Cleft Lip,C,C07.650.525.164,Mouth Abnormalities,Stomatognathic System Abnormalities,17
Cleft Lip,C,C07.465.409.225,Lip Diseases,Mouth Diseases,17
Cleft Lip,C,C07.465.525.164,Mouth Abnormalities,Mouth Diseases,17
Cleft Palate,C,C07.465.525.185,Mouth Abnormalities,Mouth Diseases,17
Cleft Palate,C,C07.320.440.185,Jaw Abnormalities,Jaw Diseases,17
Cleft Palate,C,C07.650.525.185,Mouth Abnormalities,Stomatognathic System Abnormalities,17
Cleft Palate,C,C07.650.500.460.185,Jaw Abnormalities,Maxillofacial Abnormalities,17
Cleft Palate,C,C05.660.207.540.460.185,Jaw Abnormalities,Maxillofacial Abnormalities,17
Cleft Palate,C,C05.500.460.185,Jaw Abnormalities,Jaw Diseases,17
Cleft Palate,C,C16.131.850.525.185,Mouth Abnormalities,Stomatognathic System Abnormalities,17
Cleft Palate,C,C16.131.621.207.540.460.185,Jaw Abnormalities,Maxillofacial Abnormalities,17
Cleft Palate,C,C16.131.850.500.460.185,Jaw Abnormalities,Maxillofacial Abnormalities,17
Clinical Medicine,H,H02.403.200,Medicine,Health Occupations,17
Coffee,J,J02.200.325,Beverages,Food and Beverages,17
Coffee,G,G07.203.100.325,Beverages,"Diet, Food, and Nutrition",17
Coffee,D,D20.215.784.249,Plant Preparations,Biological Products,17
Computers,L,L01.224.230.260,Computer Systems,Computing Methodologies,17
Consultants,M,M01.120,Persons,NULL,17
Cryopreservation,E,E05.760.156,"Preservation, Biological",Investigative Techniques,17
Cryopreservation,E,E05.200.750.600.760.160,Tissue Preservation,Histocytological Preparation Techniques,17
Cryopreservation,E,E05.200.500.620.760.160,Tissue Preservation,Histocytological Preparation Techniques,17
Cryopreservation,E,E02.792.156,"Preservation, Biological",Therapeutics,17
Cryopreservation,E,E01.370.225.750.600.760.160,Tissue Preservation,Histocytological Preparation Techniques,17
Cryopreservation,E,E01.370.225.500.620.760.160,Tissue Preservation,Histocytological Preparation Techniques,17
Cysteine,D,D02.886.489.155,Sulfhydryl Compounds,Sulfur Compounds,17
Cysteine,D,D02.886.030.230,"Amino Acids, Sulfur",Sulfur Compounds,17
Cysteine,D,D12.125.166.230,"Amino Acids, Sulfur",Amino Acids,17
Cysteine,D,D12.125.154.299,"Amino Acids, Neutral",Amino Acids,17
Cytosol,A,A11.284.430.429.200,Intracellular Fluid,Intracellular Space,17
Cytosol,A,A11.284.835.450.200,Intracellular Fluid,Subcellular Fractions,17
Cytosol,A,A11.284.430.214.200,Cytoplasm,Intracellular Space,17
Diagnostic Imaging,E,E01.370.350,Diagnostic Techniques and Procedures,Diagnosis,17
Diffusion Magnetic Resonance Imaging,E,E01.370.350.825.500.150,Magnetic Resonance Imaging,Tomography,17
Disease Resistance,C,C23.550.291.671,Disease Attributes,Pathologic Processes,17
Disease Resistance,G,G15.630.250,Plant Immunity,Plant Physiological Phenomena,17
Disease Resistance,G,G12.450.564.250,"Immunity, Innate",Immunity,17
Disease Resistance,G,G12.450.800.250,Plant Immunity,Immunity,17
Dissent and Disputes,F,F01.829.401.094,Interpersonal Relations,"Psychology, Social",17
Dissent and Disputes,F,F02.463.785.373.476,Decision Making,Thinking,17
Drug Eruptions,C,C20.543.206.380,Drug Hypersensitivity,Hypersensitivity,17
Drug Eruptions,C,C25.100.468.380,Drug Hypersensitivity,Drug-Related Side Effects and Adverse Reactions,17
Drug Eruptions,C,C17.800.174.600,Dermatitis,Skin Diseases,17
Drug Hypersensitivity,C,C25.100.468,Drug-Related Side Effects and Adverse Reactions,Chemically-Induced Disorders,17
Drug Hypersensitivity,C,C20.543.206,Hypersensitivity,Immune System Diseases,17
Drug Stability,E,E05.916.330,"Technology, Pharmaceutical",Investigative Techniques,17
Electric Impedance,G,G01.358.500.249.277.350,Electric Conductivity,Electricity,17
Electronic Mail,L,L01.178.847.249,Telecommunications,Communications Media,17
Electronic Mail,L,L01.559.423.906.377.333,Correspondence as Topic,Writing,17
Endometrial Neoplasms,C,C13.351.937.418.875.200,Uterine Neoplasms,"Genital Neoplasms, Female",17
Endometrial Neoplasms,C,C13.351.500.852.762.200,Uterine Neoplasms,Uterine Diseases,17
Endometrial Neoplasms,C,C04.588.945.418.948.585,Uterine Neoplasms,"Genital Neoplasms, Female",17
Endovascular Procedures,E,E04.100.814.529,Vascular Surgical Procedures,Cardiovascular Surgical Procedures,17
Endovascular Procedures,E,E04.502.382,Minimally Invasive Surgical Procedures,"Surgical Procedures, Operative",17
Enzymes,D,D08.811,Enzymes and Coenzymes,NULL,17
"Epistasis, Genetic",G,G05.308.207,Gene Expression Regulation,Genetic Phenomena,17
Epitope Mapping,E,E05.601.690.300,Protein Interaction Mapping,Molecular Probe Techniques,17
Epitope Mapping,E,E05.478.274,Immunologic Techniques,Investigative Techniques,17
Ethnic Groups,M,M01.686.754,Population Groups,Persons,17
Ethnic Groups,N,N01.224.317,Demography,Population Characteristics,17
Eyelid Diseases,C,C11.338,Eye Diseases,NULL,17
Fertilization,G,G08.686.784.277,Reproduction,Reproductive Physiological Phenomena,17
Fires,N,N06.230.216,Environment,Environment and Public Health,17
"Fluorescent Antibody Technique, Indirect",E,E05.478.583.375.310,Fluorescent Antibody Technique,Immunohistochemistry,17
"Fluorescent Antibody Technique, Indirect",E,E05.200.750.551.512.240.310,Fluorescent Antibody Technique,Immunohistochemistry,17
"Fluorescent Antibody Technique, Indirect",E,E05.200.500.607.512.240.310,Fluorescent Antibody Technique,Immunohistochemistry,17
"Fluorescent Antibody Technique, Indirect",E,E01.370.225.500.607.512.240.310,Fluorescent Antibody Technique,Immunohistochemistry,17
"Fluorescent Antibody Technique, Indirect",E,E01.370.225.750.551.512.240.310,Fluorescent Antibody Technique,Immunohistochemistry,17
Food Analysis,E,E05.362,Investigative Techniques,NULL,17
Food Analysis,J,J01.576.423.850.100,Food Technology,Food Industry,17
Foot-and-Mouth Disease,C,C22.380,Animal Diseases,NULL,17
Foot-and-Mouth Disease,C,C01.925.782.687.484,Picornaviridae Infections,RNA Virus Infections,17
Fossil Fuels,D,D20.345,Complex Mixtures,NULL,17
Fossil Fuels,N,N06.230.132.258,Energy-Generating Resources,Environment,17
"Genetics, Medical",H,H02.403.350,Medicine,Health Occupations,17
"Genetics, Medical",H,H01.158.273.343.385.500,Human Genetics,Genetics,17
Geriatrics,H,H02.403.355,Medicine,Health Occupations,17
Gonioscopy,E,E01.370.380.300,"Diagnostic Techniques, Ophthalmological",Diagnostic Techniques and Procedures,17
Hematuria,C,C23.550.414.849,Hemorrhage,Pathologic Processes,17
Hematuria,C,C12.777.934.442,Urination Disorders,Urologic Diseases,17
Hematuria,C,C13.351.968.934.442,Urination Disorders,Urologic Diseases,17
Heroin,D,D04.615.723.795.576.445,Morphine Derivatives,Morphinans,17
Heroin,D,D03.132.577.249.562.445,Morphine Derivatives,Morphinans,17
Heroin,D,D03.633.400.686.607.490,Morphine Derivatives,Morphinans,17
Heroin,D,D03.605.497.607.490,Morphine Derivatives,Morphinans,17
HIV Long-Term Survivors,M,M01.860.400,Survivors,Persons,17
"Hospitals, Maternity",N,N02.278.421.556.366,"Hospitals, Special",Hospitals,17
HSP70 Heat-Shock Proteins,D,D12.776.580.216.375,Heat-Shock Proteins,Molecular Chaperones,17
Hyperlipoproteinemia Type II,C,C18.452.584.500.500.644.475,Hyperlipoproteinemias,Hyperlipidemias,17
Hyperlipoproteinemia Type II,C,C16.320.565.398.481,"Lipid Metabolism, Inborn Errors","Metabolism, Inborn Errors",17
Hyperlipoproteinemia Type II,C,C18.452.648.398.481,"Lipid Metabolism, Inborn Errors","Metabolism, Inborn Errors",17
"Hypothermia, Induced",E,E02.258.750,Cryotherapy,Therapeutics,17
"Indians, South American",M,M01.686.508.150.625,American Native Continental Ancestry Group,Continental Population Groups,17
Insulin-Like Growth Factor Binding Protein 3,D,D12.776.157.420.270,Insulin-Like Growth Factor Binding Proteins,Carrier Proteins,17
"Intensive Care, Neonatal",E,E02.760.190.405,Critical Care,Patient Care,17
"Intensive Care, Neonatal",N,N02.421.585.190.500,Critical Care,Patient Care,17
Internal-External Control,F,F01.829.379,"Psychology, Social",Behavior and Behavior Mechanisms,17
Intraoperative Complications,C,C23.550.505,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",17
"Ischemic Attack, Transient",C,C14.907.253.092.836,Brain Ischemia,Cerebrovascular Disorders,17
"Ischemic Attack, Transient",C,C10.228.140.300.150.836,Brain Ischemia,Cerebrovascular Disorders,17
Karyotyping,E,E01.370.225.500.385.315,Cytogenetic Analysis,Cytological Techniques,17
Karyotyping,E,E05.393.285.475,Cytogenetic Analysis,Genetic Techniques,17
Karyotyping,E,E05.200.500.385.315,Cytogenetic Analysis,Cytological Techniques,17
Karyotyping,E,E05.242.385.315,Cytogenetic Analysis,Cytological Techniques,17
"Leukemia, Radiation-Induced",G,G01.750.748.500.345,Radiation Injuries,Radiation Exposure,17
"Leukemia, Radiation-Induced",C,C26.733.345,Radiation Injuries,Wounds and Injuries,17
"Leukemia, Radiation-Induced",C,C04.557.337.650,Leukemia,Neoplasms by Histologic Type,17
"Leukemia, Radiation-Induced",C,C04.682.512,"Neoplasms, Radiation-Induced",Neoplasms,17
Liver Function Tests,E,E01.370.372.460,"Diagnostic Techniques, Digestive System",Diagnostic Techniques and Procedures,17
Lod Score,G,G05.348.750,Genetic Linkage,Genetic Phenomena,17
Lymphocyte Subsets,A,A11.118.637.555.567.550,Lymphocytes,"Leukocytes, Mononuclear",17
Lymphocyte Subsets,A,A15.145.229.637.555.567.550,Lymphocytes,"Leukocytes, Mononuclear",17
Lymphocyte Subsets,A,A15.382.490.555.567.550,Lymphocytes,"Leukocytes, Mononuclear",17
Macular Edema,C,C11.768.585.439.245,Macular Degeneration,Retinal Degeneration,17
Magnesium,D,D01.268.552.437,"Metals, Alkaline Earth",Elements,17
Magnesium,D,D01.268.557.500,"Metals, Light",Elements,17
Magnesium,D,D01.552.547.500,"Metals, Light",Metals,17
Metals,D,D01.552,Inorganic Chemicals,NULL,17
"Microscopy, Electron, Scanning",E,E01.370.350.515.402.541,"Microscopy, Electron",Microscopy,17
"Microscopy, Electron, Scanning",E,E05.595.402.541,"Microscopy, Electron",Microscopy,17
Middle East Respiratory Syndrome Coronavirus,B,B04.820.578.500.540.150.113.750,Betacoronavirus,Coronavirus,17
"Models, Animal",E,E05.598,Investigative Techniques,NULL,17
"Models, Chemical",E,E05.599.495,"Models, Theoretical",Investigative Techniques,17
Nasal Mucosa,A,A10.615.550.760.600,Respiratory Mucosa,Mucous Membrane,17
Nasal Mucosa,A,A04.760.600,Respiratory Mucosa,Respiratory System,17
Nasal Mucosa,A,A04.531.520,Nose,Respiratory System,17
Nebulizers and Vaporizers,E,E07.605,Equipment and Supplies,NULL,17
Nonprescription Drugs,D,D26.530,Pharmaceutical Preparations,NULL,17
Non-Randomized Controlled Trials as Topic,E,E05.318.372.250.250.365.250,Controlled Clinical Trials as Topic,Clinical Trials as Topic,17
Non-Randomized Controlled Trials as Topic,N,N05.715.360.330.250.250.365.250,Controlled Clinical Trials as Topic,Clinical Trials as Topic,17
Non-Randomized Controlled Trials as Topic,N,N06.850.520.450.250.250.365.250,Controlled Clinical Trials as Topic,Clinical Trials as Topic,17
Nucleocapsid Proteins,D,D12.776.964.970.600,Viral Structural Proteins,Viral Proteins,17
Nucleoproteins,D,D12.776.664,Proteins,"Amino Acids, Peptides, and Proteins",17
Occupational Health Services,N,N02.421.143.740,Community Health Services,Health Services,17
Oligopeptides,D,D12.644.456,Peptides,"Amino Acids, Peptides, and Proteins",17
Opium,D,D20.215.784.500.534,Plant Extracts,Plant Preparations,17
Orthopedics,H,H02.403.810.494,"Specialties, Surgical",Medicine,17
Out-of-Hospital Cardiac Arrest,C,C14.280.383.610,Heart Arrest,Heart Diseases,17
Oxazoles,D,D03.383.129.462,Azoles,"Heterocyclic Compounds, 1-Ring",17
Periodicity,G,G07.180.562,Chronobiology Phenomena,Physiological Phenomena,17
Periodicity,G,G01.910.645,Time,Physical Phenomena,17
Physical Exertion,G,G11.427.683,Musculoskeletal Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,17
Platelet Transfusion,E,E02.095.135.140.650,Blood Component Transfusion,Blood Transfusion,17
Pleural Effusion,C,C08.528.652,Pleural Diseases,Respiratory Tract Diseases,17
Poisoning,C,C25.723,Chemically-Induced Disorders,NULL,17
Polylysine,D,D12.644.760,Peptides,"Amino Acids, Peptides, and Proteins",17
Polylysine,D,D12.125.095.647.750,Lysine,"Amino Acids, Diamino",17
Polylysine,D,D12.125.068.555.750,Lysine,"Amino Acids, Basic",17
"Pregnancy, Multiple",G,G08.686.784.769.545,Pregnancy,Reproduction,17
Privacy,I,I01.880.604.473.352.500,Civil Rights,Human Rights,17
Privacy,N,N03.706.437.352.500,Civil Rights,Human Rights,17
Privacy,N,N03.706.615.862,Legislation as Topic,"Social Control, Formal",17
Professional Autonomy,N,N04.452.758.752,Professional Practice,Organization and Administration,17
Proton Pump Inhibitors,D,D27.505.519.389.848,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,17
Psychosocial Deprivation,I,I01.880.853.100.806,Culture,Sociological Factors,17
Psychosocial Deprivation,F,F01.829.628,"Psychology, Social",Behavior and Behavior Mechanisms,17
Purines,D,D03.633.100.759,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",17
Racism,F,F01.829.595.500,Prejudice,"Psychology, Social",17
Racism,F,F01.145.813.550.500,Prejudice,Social Behavior,17
Racism,F,F01.145.813.629.625,Social Discrimination,Social Behavior,17
Racism,I,I01.880.735.820.500.500,Race Relations,Social Segregation,17
Rape,I,I01.880.735.900.772,Violence,Social Problems,17
Rape,I,I01.198.240.856.744,Violence,Crime,17
Rape,I,I01.198.240.748.640,Sex Offenses,Crime,17
"Receptors, Antigen, T-Cell, gamma-delta",D,D12.776.543.750.705.816.824.830,"Receptors, Antigen, T-Cell","Receptors, Antigen",17
Recreation,I,I03.450.642,Leisure Activities,Human Activities,17
Respiration,G,G09.772.705,Respiratory Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,17
Rift Valley Fever,C,C22.467.435.812,"Hepatitis, Viral, Animal","Hepatitis, Animal",17
Rift Valley Fever,C,C01.436.430.812,"Hepatitis, Viral, Animal","Hepatitis, Animal",17
Rift Valley Fever,C,C06.552.380.315.430.812,"Hepatitis, Viral, Animal","Hepatitis, Animal",17
Rift Valley Fever,C,C01.925.782.147.810,Bunyaviridae Infections,RNA Virus Infections,17
Rift Valley Fever,C,C01.925.407.810,"Hepatitis, Viral, Animal",Virus Diseases,17
Rift Valley Fever,C,C01.925.782.417.762,"Hemorrhagic Fevers, Viral",RNA Virus Infections,17
Rift Valley Fever,C,C01.925.081.810,Arbovirus Infections,Virus Diseases,17
Rift Valley Fever,C,C01.920.500.770,Arbovirus Infections,Vector Borne Diseases,17
Schistosomicides,D,D27.505.954.122.250.075.100.750,Antiplatyhelmintic Agents,Anthelmintics,17
School Teachers,M,M01.526.702.500,Educational Personnel,Occupational Groups,17
Simvastatin,D,D02.455.426.559.847.638.400.900,Lovastatin,Naphthalenes,17
Simvastatin,D,D04.615.638.400.900,Lovastatin,Naphthalenes,17
South Sudan,Z,Z01.058.290.120.745,"Africa, Eastern",Africa South of the Sahara,17
Tetracycline Resistance,G,G07.690.773.984.269.347.937,"Drug Resistance, Bacterial","Drug Resistance, Microbial",17
Tetracycline Resistance,G,G06.225.347.937,"Drug Resistance, Bacterial","Drug Resistance, Microbial",17
Tetracycline Resistance,G,G06.099.225.937,"Drug Resistance, Bacterial",Bacterial Physiological Phenomena,17
Thyrotropin,D,D06.472.699.631.525.883,"Pituitary Hormones, Anterior",Pituitary Hormones,17
Thyrotropin,D,D12.644.548.691.525.883,"Pituitary Hormones, Anterior",Pituitary Hormones,17
"T-Lymphocytes, Helper-Inducer",A,A11.118.637.555.567.550.500.400,T-Lymphocyte Subsets,Lymphocyte Subsets,17
"T-Lymphocytes, Helper-Inducer",A,A11.118.637.555.567.569.500.400,T-Lymphocyte Subsets,T-Lymphocytes,17
"T-Lymphocytes, Helper-Inducer",A,A11.118.637.555.567.569.200.400,CD4-Positive T-Lymphocytes,T-Lymphocytes,17
"T-Lymphocytes, Helper-Inducer",A,A15.382.490.555.567.550.500.400,T-Lymphocyte Subsets,Lymphocyte Subsets,17
"T-Lymphocytes, Helper-Inducer",A,A15.382.490.555.567.569.200.400,CD4-Positive T-Lymphocytes,T-Lymphocytes,17
"T-Lymphocytes, Helper-Inducer",A,A15.145.229.637.555.567.569.500.400,T-Lymphocyte Subsets,T-Lymphocytes,17
"T-Lymphocytes, Helper-Inducer",A,A15.145.229.637.555.567.569.200.400,CD4-Positive T-Lymphocytes,T-Lymphocytes,17
"T-Lymphocytes, Helper-Inducer",A,A15.145.229.637.555.567.550.500.400,T-Lymphocyte Subsets,Lymphocyte Subsets,17
"T-Lymphocytes, Helper-Inducer",A,A15.382.490.555.567.569.500.400,T-Lymphocyte Subsets,T-Lymphocytes,17
Trimethoprim,D,D03.383.742.906,Pyrimidines,"Heterocyclic Compounds, 1-Ring",17
Tumor Suppressor Proteins,D,D12.776.624.776,Neoplasm Proteins,Proteins,17
Voluntary Programs,N,N04.452.977,Organization and Administration,Health Services Administration,17
Water Pollution,N,N06.850.460.790,Environmental Pollution,Public Health,17
Abstracting and Indexing,L,L01.453.245.100,Documentation,Information Services,16
Accident Prevention,N,N06.850.135.060,Accidents,Public Health,16
"Adhesins, Bacterial",D,D23.050.161.050,"Antigens, Bacterial",Antigens,16
"Adhesins, Bacterial",D,D12.776.543.100.050,Bacterial Outer Membrane Proteins,Membrane Proteins,16
"Adhesins, Bacterial",D,D12.776.097.120.050,Bacterial Outer Membrane Proteins,Bacterial Proteins,16
African Swine Fever Virus,B,B04.280.049.035,Asfarviridae,DNA Viruses,16
After-Hours Care,N,N05.300.049,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",16
After-Hours Care,N,N04.590.374.034,Delivery of Health Care,Patient Care Management,16
alpha-Tocopherol,D,D03.383.663.283.909.750.249,Tocopherols,Vitamin E,16
alpha-Tocopherol,D,D03.633.100.150.909.750.249,Tocopherols,Vitamin E,16
Ampicillin,D,D03.633.100.300.750.750.050,Penicillin G,Penicillins,16
Ampicillin,D,D02.886.108.750.750.050,Penicillin G,Penicillins,16
Ampicillin,D,D02.065.589.099.750.750.050,Penicillin G,Penicillins,16
"Analgesics, Non-Narcotic",D,D27.505.954.427.040.100,Analgesics,Central Nervous System Agents,16
"Analgesics, Non-Narcotic",D,D27.505.696.663.850.014.040,Analgesics,Sensory System Agents,16
Antigen-Antibody Complex,D,D23.050.101,Antigens,Biological Factors,16
Antigen-Antibody Complex,D,D12.776.124.486.485.114.257,Antibodies,Immunoglobulins,16
Antigen-Antibody Complex,D,D12.776.124.790.651.114.257,Antibodies,Immunoglobulins,16
Antigen-Antibody Complex,D,D12.776.377.715.548.114.257,Antibodies,Immunoglobulins,16
Armadillos,B,B01.050.150.900.649.313.999.200,Cingulata,Eutheria,16
Armenia,Z,Z01.586.950.099,USSR,Historical Geographic Locations,16
Armenia,Z,Z01.586.035.150,Ancient Lands,Historical Geographic Locations,16
Armenia,Z,Z01.542.931.099,USSR,Europe,16
Armenia,Z,Z01.542.900.099,Transcaucasia,Europe,16
Arthritis,C,C05.550.114,Joint Diseases,Musculoskeletal Diseases,16
Aspartate Aminotransferases,D,D08.811.913.477.700.225,Transaminases,Nitrogenous Group Transferases,16
Atovaquone,D,D02.806.550.312,Naphthoquinones,Quinones,16
Atovaquone,D,D04.615.638.721.186,Naphthoquinones,Naphthalenes,16
Attention,F,F02.830.104.214,Arousal,Psychophysiology,16
Autism Spectrum Disorder,F,F03.625.164.113,"Child Development Disorders, Pervasive",Neurodevelopmental Disorders,16
Autoradiography,E,E05.799.256,Radiometry,Investigative Techniques,16
Autoradiography,E,E05.200.750.132,Histological Techniques,Clinical Laboratory Techniques,16
Autoradiography,E,E01.370.225.750.132,Histological Techniques,Clinical Laboratory Techniques,16
Bed Occupancy,N,N02.278.050,Health Facilities,"Health Care Facilities, Manpower, and Services",16
"Biopsy, Needle",E,E05.200.998.054.119,Biopsy,Specimen Handling,16
"Biopsy, Needle",E,E05.242.384.100.119,Biopsy,Cytodiagnosis,16
"Biopsy, Needle",E,E05.200.500.384.100.119,Biopsy,Cytodiagnosis,16
"Biopsy, Needle",E,E04.665.100,Punctures,"Surgical Procedures, Operative",16
"Biopsy, Needle",E,E04.074.119,Biopsy,"Surgical Procedures, Operative",16
"Biopsy, Needle",E,E01.370.225.500.384.100.119,Biopsy,Cytodiagnosis,16
"Biopsy, Needle",E,E01.370.225.998.054.119,Biopsy,Specimen Handling,16
"Biopsy, Needle",E,E01.370.388.100.100,Biopsy,"Diagnostic Techniques, Surgical",16
Blastocystis Infections,C,C06.405.469.452.250,"Intestinal Diseases, Parasitic",Intestinal Diseases,16
Blastocystis Infections,C,C01.610.752.049.250,Amebiasis,Protozoan Infections,16
Blastocystis Infections,C,C01.610.432.250,"Intestinal Diseases, Parasitic",Parasitic Diseases,16
Body Fluids,A,A12.207,Fluids and Secretions,NULL,16
Bottle Feeding,E,E02.421.150,Feeding Methods,Therapeutics,16
Bottle Feeding,F,F01.145.407.099,Feeding Behavior,Behavior,16
Bottle Feeding,G,G07.203.650.220.500.250,Infant Nutritional Physiological Phenomena,Child Nutritional Physiological Phenomena,16
Bottle Feeding,G,G07.203.650.353.099,Feeding Behavior,Nutritional Physiological Phenomena,16
Bronchiolitis Obliterans,C,C08.127.446.135.140,Bronchiolitis,Bronchitis,16
Bronchiolitis Obliterans,C,C08.381.495.146.135.140,Bronchiolitis,Bronchitis,16
"Burnout, Professional",C,C24.580.500,Occupational Stress,Occupational Diseases,16
"Burnout, Professional",F,F02.830.900.333.500,"Burnout, Psychological","Stress, Psychological",16
"Burnout, Professional",F,F01.145.126.990.367.500,"Burnout, Psychological","Stress, Psychological",16
Burns,C,C26.200,Wounds and Injuries,NULL,16
"Carcinoma, Basal Cell",C,C04.557.470.200.165,Carcinoma,"Neoplasms, Glandular and Epithelial",16
"Carcinoma, Basal Cell",C,C04.557.470.565.165,"Neoplasms, Basal Cell","Neoplasms, Glandular and Epithelial",16
Cardiovascular System,A,A07,NULL,NULL,16
Cell Communication,G,G04.085,Cell Physiological Phenomena,NULL,16
Certification,N,N05.700.200.190,Credentialing,"Quality Assurance, Health Care",16
Certification,N,N03.706.110.120,Credentialing,"Social Control, Formal",16
Chad,Z,Z01.058.290.100.130,"Africa, Central",Africa South of the Sahara,16
Chemical and Drug Induced Liver Injury,C,C06.552.100,Liver Diseases,Digestive System Diseases,16
Chemical and Drug Induced Liver Injury,C,C25.100.562,Drug-Related Side Effects and Adverse Reactions,Chemically-Induced Disorders,16
Chemical and Drug Induced Liver Injury,C,C25.723.260,Poisoning,Chemically-Induced Disorders,16
Cholera Vaccines,D,D20.215.894.135.225,Bacterial Vaccines,Vaccines,16
"Chromatography, Gas",E,E05.196.181.349,Chromatography,"Chemistry Techniques, Analytical",16
Coma,C,C23.888.592.604.359.800.200,Unconsciousness,Consciousness Disorders,16
Coma,C,C10.597.606.358.800.200,Unconsciousness,Consciousness Disorders,16
Consensus Sequence,G,G02.111.570.580.175,Conserved Sequence,Molecular Structure,16
Consumer Advocacy,N,N03.706.437.368,Human Rights,"Social Control, Formal",16
Consumer Advocacy,I,I01.880.604.473.368,Human Rights,"Social Control, Formal",16
Control Groups,E,E05.318.370.074,Epidemiologic Research Design,Epidemiologic Methods,16
Control Groups,E,E05.581.500.149,Research Design,Methods,16
Cyclophosphamide,D,D02.705.672.500.243,Phosphoramide Mustards,Phosphoramides,16
Cyclophosphamide,D,D02.455.526.728.650.730.243,Phosphoramide Mustards,Nitrogen Mustard Compounds,16
Cytoplasm,A,A11.284.430.214,Intracellular Space,Cellular Structures,16
"Diagnosis, Computer-Assisted",E,E01.158,Diagnosis,NULL,16
"Diagnosis, Computer-Assisted",L,L01.313.500.750.100.158,"Decision Making, Computer-Assisted",Medical Informatics Applications,16
Diphtheria Toxoid,D,D20.215.894.691.263,Toxoids,Vaccines,16
"DNA, Recombinant",D,D13.444.308.460,DNA,Nucleic Acids,16
Dominican Republic,Z,Z01.107.084.900.300,West Indies,Caribbean Region,16
Dominican Republic,Z,Z01.639.880.300,West Indies,Islands,16
Dopamine,D,D02.455.426.559.389.657.166.175.342,Catecholamines,Catechols,16
Dopamine,D,D02.092.311.342,Catecholamines,Amines,16
Dopamine,D,D02.092.211.215.406,Biogenic Monoamines,Biogenic Amines,16
Drug Utilization Review,N,N04.452.706.477.400,Drug Utilization,Pharmacy Administration,16
Drug Utilization Review,N,N05.700.900.300,Utilization Review,"Quality Assurance, Health Care",16
Drug Utilization Review,N,N04.761.879.300,Utilization Review,Quality of Health Care,16
Electroencephalography,E,E01.370.376.300,"Diagnostic Techniques, Neurological",Diagnostic Techniques and Procedures,16
Electroencephalography,E,E01.370.405.245,Electrodiagnosis,Diagnostic Techniques and Procedures,16
Electronic Data Processing,L,L01.224.085,Computing Methodologies,Information Science,16
Elephantiasis,C,C15.604.496.320,Lymphedema,Lymphatic Diseases,16
Emtricitabine,D,D13.570.685.245.500.600,Deoxycytidine,Cytidine,16
Emtricitabine,D,D13.570.230.329.525,Deoxycytidine,Deoxyribonucleosides,16
Emtricitabine,D,D03.383.742.680.245.500.600,Deoxycytidine,Cytidine,16
Erythrocyte Membrane,A,A11.284.149.356,Cell Membrane,Cellular Structures,16
Erythrocyte Membrane,A,A11.118.290.270,Erythrocytes,Blood Cells,16
Erythrocyte Membrane,A,A15.145.229.334.270,Erythrocytes,Blood Cells,16
Exercise Tolerance,G,G11.427.680.270,Physical Endurance,Musculoskeletal Physiological Phenomena,16
Farms,J,J03.540.150,Manufacturing and Industrial Facilities,Non-Medical Public and Private Facilities,16
Farms,J,J01.040.372,Agriculture,"Technology, Industry, and Agriculture",16
Fish Diseases,C,C22.362,Animal Diseases,NULL,16
Flagellin,D,D12.776.097.380,Bacterial Proteins,Proteins,16
Fluorescent Dyes,D,D27.720.470.410.505.500,Luminescent Agents,Indicators and Reagents,16
Fluorescent Dyes,D,D27.720.233.348,Coloring Agents,Specialty Uses of Chemicals,16
Folic Acid Antagonists,D,D27.505.519.389.350,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,16
Food Labeling,J,J01.576.423.850.600.400,Food Packaging,Food Technology,16
Food Labeling,J,J01.576.761.400.450,Food Packaging,Product Packaging,16
Forkhead Transcription Factors,D,D12.776.930.977.249,Winged-Helix Transcription Factors,Transcription Factors,16
Forkhead Transcription Factors,D,D12.776.260.950.249,Winged-Helix Transcription Factors,DNA-Binding Proteins,16
gamma-Glutamyltransferase,D,D08.811.913.050.200.500,Aminoacyltransferases,Acyltransferases,16
Gene Order,G,G05.340,Genetic Phenomena,NULL,16
"Genes, pol",G,G05.360.340.358.840.500.667,"Genes, Viral","Genome, Viral",16
"Genes, pol",G,G05.360.340.358.024.875.667,"Genes, Viral","Genes, Microbial",16
"Genes, pol",G,G05.360.340.024.340.364.875.667,"Genes, Viral","Genes, Microbial",16
"Genetic Diseases, Inborn",C,C16.320,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",NULL,16
Genetic Therapy,E,E02.095.301,Biological Therapy,Therapeutics,16
Genetic Therapy,E,E05.393.420.301,Genetic Engineering,Genetic Techniques,16
Hemeproteins,D,D12.776.422,Proteins,"Amino Acids, Peptides, and Proteins",16
Hemophilia A,C,C16.320.099.500,"Blood Coagulation Disorders, Inherited","Genetic Diseases, Inborn",16
Hemophilia A,C,C15.378.463.500,Hemorrhagic Disorders,Hematologic Diseases,16
Hemophilia A,C,C15.378.100.100.500,"Blood Coagulation Disorders, Inherited",Blood Coagulation Disorders,16
Hemophilia A,C,C15.378.100.141.500,Coagulation Protein Disorders,Blood Coagulation Disorders,16
"Hemorrhagic Fevers, Viral",C,C01.925.782.417,RNA Virus Infections,Virus Diseases,16
Hemostasis,G,G09.188.390,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,16
Herpes Zoster Vaccine,D,D20.215.894.899.290.130.400,Chickenpox Vaccine,Herpesvirus Vaccines,16
HLA-DQ beta-Chains,D,D12.776.543.550.440.400.430.750,HLA-DQ Antigens,HLA-D Antigens,16
HLA-DQ beta-Chains,D,D23.050.705.552.450.400.430.750,HLA-DQ Antigens,HLA-D Antigens,16
HLA-DQ beta-Chains,D,D23.050.301.500.450.400.430.750,HLA-DQ Antigens,HLA-D Antigens,16
HLA-DQ beta-Chains,D,D23.050.301.500.400.400.430.750,HLA-DQ Antigens,HLA-D Antigens,16
HLA-DQ beta-Chains,D,D23.050.705.552.410.400.430.750,HLA-DQ Antigens,HLA-D Antigens,16
HLA-DQ beta-Chains,D,D12.776.395.550.509.400.430.750,HLA-DQ Antigens,HLA-D Antigens,16
Hospital Bed Capacity,N,N02.278.306.472,Health Facility Size,Health Facilities,16
Hospital Records,L,L01.399.250.900.425,Records,Data Collection,16
Hospital Records,N,N05.715.360.300.715.380,Records,Data Collection,16
Hospital Records,N,N04.452.859.380,Records,Organization and Administration,16
Hospital Records,N,N06.850.520.308.940.425,Records,Data Collection,16
Hospital Records,E,E05.318.308.940.425,Records,Data Collection,16
"In Situ Hybridization, Fluorescence",E,E05.200.750.600.670.325.350,In Situ Hybridization,Staining and Labeling,16
"In Situ Hybridization, Fluorescence",E,E05.200.500.620.670.325.350,In Situ Hybridization,Staining and Labeling,16
"In Situ Hybridization, Fluorescence",E,E05.393.285.350,Cytogenetic Analysis,Genetic Techniques,16
"In Situ Hybridization, Fluorescence",E,E05.393.661.475.350,In Situ Hybridization,Nucleic Acid Hybridization,16
"In Situ Hybridization, Fluorescence",E,E01.370.225.500.620.670.325.350,In Situ Hybridization,Staining and Labeling,16
"In Situ Hybridization, Fluorescence",E,E01.370.225.750.600.670.325.350,In Situ Hybridization,Staining and Labeling,16
Infectious Disease Medicine,H,H02.403.429.480,Internal Medicine,Medicine,16
Information Seeking Behavior,L,L01.143.458,Communication,Information Science,16
Information Seeking Behavior,F,F01.145.209.372,Communication,Behavior,16
Information Seeking Behavior,F,F01.145.535,Behavior,Behavior and Behavior Mechanisms,16
Institutionalization,N,N02.421.585.415,Patient Care,Health Services,16
Institutionalization,E,E02.760.415,Patient Care,Therapeutics,16
Interleukin-1,D,D23.529.374.465.131,Interleukins,Cytokines,16
Interleukin-1,D,D23.529.374.500.400,Monokines,Cytokines,16
Interleukin-1,D,D12.776.467.374.465.010,Interleukins,Cytokines,16
Interleukin-1,D,D12.776.467.374.500.400,Monokines,Cytokines,16
Interleukin-1,D,D12.644.276.374.500.400,Monokines,Cytokines,16
Interleukin-1,D,D12.644.276.374.465.010,Interleukins,Cytokines,16
Interleukin-1beta,D,D12.644.276.374.465.010.600,Interleukin-1,Interleukins,16
Interleukin-1beta,D,D12.644.276.374.500.400.600,Interleukin-1,Monokines,16
Interleukin-1beta,D,D12.776.467.374.500.400.600,Interleukin-1,Monokines,16
Interleukin-1beta,D,D12.776.467.374.465.010.600,Interleukin-1,Interleukins,16
Interleukin-1beta,D,D23.529.374.500.400.600,Interleukin-1,Monokines,16
Interleukin-1beta,D,D23.529.374.465.131.600,Interleukin-1,Interleukins,16
Jews,M,M01.686.754.600,Ethnic Groups,Population Groups,16
KB Cells,A,A11.251.210.190.400.500,HeLa Cells,"Cell Line, Tumor",16
KB Cells,A,A11.251.860.180.400.500,HeLa Cells,"Cell Line, Tumor",16
KB Cells,A,A11.436.340.500,HeLa Cells,Epithelial Cells,16
Low Back Pain,C,C23.888.592.612.107.400,Back Pain,Pain,16
Mammaplasty,E,E02.218.565,Cosmetic Techniques,Therapeutics,16
Mammaplasty,E,E04.680.500,Reconstructive Surgical Procedures,"Surgical Procedures, Operative",16
"Mammary Glands, Human",A,A10.336.532,Exocrine Glands,Tissues,16
"Mammary Glands, Human",A,A01.236.249,Breast,Body Regions,16
Medroxyprogesterone Acetate,D,D04.210.500.745.745.654.829.395.700.500,Medroxyprogesterone,Hydroxyprogesterones,16
"Memory, Short-Term",F,F02.463.425.540.407,Memory,Learning,16
Men's Health,N,N01.400.425,Health,Population Characteristics,16
Methionine,D,D02.886.030.676,"Amino Acids, Sulfur",Sulfur Compounds,16
Methionine,D,D12.125.154.549,"Amino Acids, Neutral",Amino Acids,16
Methionine,D,D12.125.142.557,"Amino Acids, Essential",Amino Acids,16
Methionine,D,D12.125.166.676,"Amino Acids, Sulfur",Amino Acids,16
Mitosis,G,G04.144.220.220.781,Cell Nucleus Division,Cell Division,16
Mitosis,G,G05.113.220.781,Cell Nucleus Division,Cell Division,16
Mood Disorders,F,F03.600,Mental Disorders,NULL,16
Mouth,A,A01.456.505.631,Face,Head,16
Mouth,A,A03.556.500,Gastrointestinal Tract,Digestive System,16
Mouth,A,A14.549,Stomatognathic System,NULL,16
Moxifloxacin,D,D03.633.100.810.835.322.327,Fluoroquinolones,Quinolones,16
Mucous Membrane,A,A10.615.550,Membranes,Tissues,16
Neurologic Examination,E,E01.370.600.550,Physical Examination,Diagnostic Techniques and Procedures,16
Neurologic Examination,E,E01.370.376.550,"Diagnostic Techniques, Neurological",Diagnostic Techniques and Procedures,16
New York,Z,Z01.107.567.875.075.437,Appalachian Region,United States,16
New York,Z,Z01.107.567.875.350.530,Great Lakes Region,United States,16
New York,Z,Z01.107.567.875.500.530,Mid-Atlantic Region,United States,16
New York City,Z,Z01.107.567.875.500.530.530,New York,Mid-Atlantic Region,16
New York City,Z,Z01.107.567.875.350.530.530,New York,Great Lakes Region,16
New York City,Z,Z01.433.741,Cities,Geographic Locations,16
Non-ST Elevated Myocardial Infarction,C,C23.550.513.355.750.469,Myocardial Infarction,Infarction,16
Non-ST Elevated Myocardial Infarction,C,C23.550.717.489.750.469,Myocardial Infarction,Infarction,16
Non-ST Elevated Myocardial Infarction,C,C14.280.647.500.469,Myocardial Infarction,Myocardial Ischemia,16
Non-ST Elevated Myocardial Infarction,C,C14.907.585.500.656,Myocardial Infarction,Myocardial Ischemia,16
Osteoarthritis,C,C05.550.114.606,Arthritis,Joint Diseases,16
Osteoarthritis,C,C05.799.613,Rheumatic Diseases,Musculoskeletal Diseases,16
Ovariectomy,E,E04.270.282.685,Castration,Endocrine Surgical Procedures,16
Ovariectomy,E,E04.950.165.685,Castration,Urogenital Surgical Procedures,16
Ovariectomy,E,E04.950.300.680,Gynecologic Surgical Procedures,Urogenital Surgical Procedures,16
Paratyphoid Fever,C,C01.150.252.400.310.821.438,Salmonella Infections,Enterobacteriaceae Infections,16
"Pattern Recognition, Automated",L,L01.399.750,Information Management,Information Science,16
Perindopril,D,D03.633.100.473.766,Indoles,"Heterocyclic Compounds, 2-Ring",16
Perineum,A,A01.719,Body Regions,NULL,16
Photosensitizing Agents,D,D27.505.954.600.710,Radiation-Sensitizing Agents,Therapeutic Uses,16
Photosensitizing Agents,D,D27.505.954.444.600,Dermatologic Agents,Therapeutic Uses,16
Polypharmacy,E,E02.319.698,Drug Therapy,Therapeutics,16
Power Plants,J,J03.540.680,Manufacturing and Industrial Facilities,Non-Medical Public and Private Facilities,16
Power Plants,J,J01.780,"Technology, Industry, and Agriculture",NULL,16
Pregnancy Trimesters,G,G08.686.707,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,16
Probiotics,G,G07.203.300.456.500,Dietary Supplements,Food,16
Probiotics,J,J02.500.456.500,Dietary Supplements,Food,16
Professional-Family Relations,F,F01.829.401.550,Interpersonal Relations,"Psychology, Social",16
Protein Folding,G,G02.111.688,Biochemical Phenomena,Chemical Phenomena,16
Protein Folding,G,G01.154.651,Biophysical Phenomena,Physical Phenomena,16
Pseudomonas Infections,C,C01.150.252.400.739,Gram-Negative Bacterial Infections,Bacterial Infections,16
"Psychotherapy, Group",F,F04.754.864.581,Socioenvironmental Therapy,Psychotherapy,16
Public Health Informatics,L,L01.313.750,Informatics,Information Science,16
Puerperal Infection,C,C01.674.715,"Pregnancy Complications, Infectious",Infections,16
Puerperal Infection,C,C13.703.700.715,"Pregnancy Complications, Infectious",Pregnancy Complications,16
Puerperal Infection,C,C13.703.844.757,Puerperal Disorders,Pregnancy Complications,16
Regional Blood Flow,G,G09.330.100.780,Blood Circulation,Cardiovascular Physiological Phenomena,16
Regional Medical Programs,N,N03.349.650.400,Regional Health Planning,Health Planning,16
Rehabilitation,N,N02.421.784,Health Services,"Health Care Facilities, Manpower, and Services",16
Rehabilitation,H,H02.403.680.600,Physical and Rehabilitation Medicine,Medicine,16
Rehabilitation,E,E02.831,Therapeutics,NULL,16
Rehabilitation,E,E02.760.169.063.500,Aftercare,Continuity of Patient Care,16
Reinfection,C,C23.550.291.937.250,Recurrence,Disease Attributes,16
"Remission, Spontaneous",C,C23.550.291.656.700,Disease Progression,Disease Attributes,16
"Remission, Spontaneous",G,G16.767,Biological Phenomena,NULL,16
Respiratory Distress Syndrome,C,C08.381.840,Lung Diseases,Respiratory Tract Diseases,16
Respiratory Distress Syndrome,C,C08.618.840,Respiration Disorders,Respiratory Tract Diseases,16
Sarcoma,C,C04.557.450.795,"Neoplasms, Connective and Soft Tissue",Neoplasms by Histologic Type,16
Schistosomiasis japonica,C,C01.920.922.521,Schistosomiasis,Vector Borne Diseases,16
Schistosomiasis japonica,C,C01.610.335.865.859.521,Schistosomiasis,Trematode Infections,16
Schizonts,B,B05.775.740.800,"Spores, Protozoan",Spores,16
Schizonts,B,B05.500.800,Life Cycle Stages,Organism Forms,16
Schizonts,A,A11.870.740.800,"Spores, Protozoan",Spores,16
Schizonts,G,G07.345.500.550.500.800,Life Cycle Stages,"Metamorphosis, Biological",16
Scrub Typhus,C,C01.150.252.400.789.850,Rickettsiaceae Infections,Gram-Negative Bacterial Infections,16
Scrub Typhus,C,C01.920.914.850,Rickettsiaceae Infections,Vector Borne Diseases,16
SEER Program,E,E05.318.308.970.725,Registries,Data Collection,16
SEER Program,N,N06.850.520.308.970.725,Registries,Data Collection,16
SEER Program,N,N05.715.360.300.715.700.725,Registries,Records,16
SEER Program,N,N04.452.859.819.725,Registries,Records,16
Sex Hormone-Binding Globulin,D,D12.776.377.715.182.800,Beta-Globulins,Serum Globulins,16
Sex Hormone-Binding Globulin,D,D12.776.157.762,Carrier Proteins,Proteins,16
Sex Hormone-Binding Globulin,D,D12.776.124.790.223.800,Beta-Globulins,Serum Globulins,16
Sexual Abstinence,F,F01.145.802.900,Sexual Behavior,Behavior,16
Sleep Initiation and Maintenance Disorders,F,F03.870.400.800.800,"Sleep Disorders, Intrinsic",Dyssomnias,16
Sleep Initiation and Maintenance Disorders,C,C10.886.425.800.800,"Sleep Disorders, Intrinsic",Dyssomnias,16
Snails,B,B01.050.500.644.400.750,Gastropoda,Mollusca,16
Snake Bites,C,C25.723.127.442,Bites and Stings,Poisoning,16
Snake Bites,C,C26.176.724,Bites and Stings,Wounds and Injuries,16
Soccer,I,I03.450.642.845.800,Sports,Recreation,16
"Social Control, Formal",I,I01.880.604,Sociology,Social Sciences,16
"Social Control, Formal",N,N03.706,Health Care Economics and Organizations,NULL,16
Social Identification,F,F01.145.813.708,Social Behavior,Behavior,16
Social Security,N,N03.219.521.346.506.849,Public Assistance,"Financing, Government",16
Social Security,N,N03.219.521.576.823,Insurance,"Financing, Organized",16
Somatoform Disorders,F,F03.875,Mental Disorders,NULL,16
Syringes,E,E07.877,Equipment and Supplies,NULL,16
Tamoxifen,D,D02.455.426.559.389.150.700.900,Stilbenes,Benzylidene Compounds,16
Thyroid Neoplasms,C,C19.344.894,Endocrine Gland Neoplasms,Endocrine System Diseases,16
Thyroid Neoplasms,C,C19.874.788,Thyroid Diseases,Endocrine System Diseases,16
Thyroid Neoplasms,C,C04.588.322.894,Endocrine Gland Neoplasms,Neoplasms by Site,16
Thyroid Neoplasms,C,C04.588.443.915,Head and Neck Neoplasms,Neoplasms by Site,16
Tobacco Smoking,F,F01.145.805.375,Smoking,Behavior,16
Tobacco Smoking,F,F01.145.958.875,Tobacco Use,Behavior,16
Tritium,D,D01.496.749.925,Radioisotopes,Isotopes,16
Tritium,D,D01.362.340.875,Hydrogen,Gases,16
Tritium,D,D01.268.406.875,Hydrogen,Elements,16
Troponin,D,D12.776.210.500.910,Muscle Proteins,Contractile Proteins,16
Troponin,D,D12.776.220.525.825,Microfilament Proteins,Cytoskeletal Proteins,16
Troponin,D,D05.500.945,Multiprotein Complexes,Macromolecular Substances,16
Troponin,D,D05.750.078.730.825,Microfilament Proteins,Biopolymers,16
Urinary Incontinence,C,C23.888.942.343.800,Lower Urinary Tract Symptoms,Urological Manifestations,16
Urinary Incontinence,C,C12.777.934.852,Urination Disorders,Urologic Diseases,16
Urinary Incontinence,C,C13.351.968.934.814,Urination Disorders,Urologic Diseases,16
"Urinary Incontinence, Stress",C,C13.351.968.934.814.500,Urinary Incontinence,Urination Disorders,16
"Urinary Incontinence, Stress",C,C12.777.934.852.249,Urinary Incontinence,Urination Disorders,16
"Urinary Incontinence, Stress",C,C23.888.942.343.800.500,Urinary Incontinence,Lower Urinary Tract Symptoms,16
Utilization Review,N,N05.700.900,"Quality Assurance, Health Care","Health Care Quality, Access, and Evaluation",16
Utilization Review,N,N04.761.879,Quality of Health Care,Health Services Administration,16
Vascular Stiffness,G,G09.330.940,Cardiovascular Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,16
Venereology,H,H02.403.909,Medicine,Health Occupations,16
Vitamin B 12 Deficiency,C,C18.654.521.500.133.699.923,Vitamin B Deficiency,Avitaminosis,16
Vitamin B Complex,D,D27.505.696.494.600.708,Vitamins,Micronutrients,16
Vitamin E,D,D03.633.100.150.909,Benzopyrans,"Heterocyclic Compounds, 2-Ring",16
Vitamin E,D,D03.383.663.283.909,Benzopyrans,Pyrans,16
"Wounds, Gunshot",C,C26.986.900,"Wounds, Penetrating",Wounds and Injuries,16
Abdominal Pain,C,C23.888.592.612.054,Pain,Neurologic Manifestations,15
Abdominal Pain,C,C23.888.821.030,"Signs and Symptoms, Digestive",Signs and Symptoms,15
Acetylcholinesterase,D,D08.811.277.352.100.170.176,Cholinesterases,Carboxylic Ester Hydrolases,15
Acinetobacter Infections,C,C01.150.252.400.560.022,Moraxellaceae Infections,Gram-Negative Bacterial Infections,15
Acyltransferases,D,D08.811.913.050,Transferases,Enzymes,15
Air Travel,I,I03.883.209,Travel,Human Activities,15
alpha-Thalassemia,C,C15.378.071.141.150.875.100,Thalassemia,"Anemia, Hemolytic, Congenital",15
alpha-Thalassemia,C,C15.378.420.826.100,Thalassemia,Hemoglobinopathies,15
alpha-Thalassemia,C,C16.320.070.875.100,Thalassemia,"Anemia, Hemolytic, Congenital",15
alpha-Thalassemia,C,C16.320.365.826.100,Thalassemia,Hemoglobinopathies,15
Anesthesiology,H,H02.403.066,Medicine,Health Occupations,15
Angiotensin II Type 1 Receptor Blockers,D,D27.505.519.162.500,Angiotensin Receptor Antagonists,Molecular Mechanisms of Pharmacological Action,15
Antigen Presentation,G,G12.450.050.400.070,"Immunity, Cellular",Adaptive Immunity,15
Antigen Presentation,G,G12.119,Immune System Phenomena,NULL,15
"Antigens, Differentiation, T-Lymphocyte",D,D23.101.100.894,"Antigens, Differentiation",Biomarkers,15
"Antigens, Differentiation, T-Lymphocyte",D,D23.050.301.264.894,"Antigens, Differentiation","Antigens, Surface",15
Anus Neoplasms,C,C06.405.469.860.180.500.040,Rectal Neoplasms,Colorectal Neoplasms,15
Anus Neoplasms,C,C06.405.469.860.101.163,Anus Diseases,Rectal Diseases,15
Anus Neoplasms,C,C06.405.469.491.307.790.040,Rectal Neoplasms,Colorectal Neoplasms,15
Anus Neoplasms,C,C06.405.249.411.307.790.040,Rectal Neoplasms,Colorectal Neoplasms,15
Anus Neoplasms,C,C06.301.371.411.307.790.040,Rectal Neoplasms,Colorectal Neoplasms,15
Anus Neoplasms,C,C04.588.274.476.411.307.790.040,Rectal Neoplasms,Colorectal Neoplasms,15
Arteriosclerosis,C,C14.907.137.126,Arterial Occlusive Diseases,Vascular Diseases,15
Austria,Z,Z01.542.088,Europe,Geographic Locations,15
Aza Compounds,D,D02.145,Organic Chemicals,NULL,15
Benzodiazepines,D,D03.633.100.079.080,Benzazepines,"Heterocyclic Compounds, 2-Ring",15
Bereavement,F,F01.470.142,Emotions,Behavior and Behavior Mechanisms,15
Bevacizumab,D,D12.776.377.715.548.114.224.200.438,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",15
Bevacizumab,D,D12.776.124.486.485.114.224.060.375,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",15
Bevacizumab,D,D12.776.124.790.651.114.224.060.438,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",15
Bilirubin,D,D03.633.400.909.249.184,Bile Pigments,Tetrapyrroles,15
Bilirubin,D,D03.383.129.578.840.249.184,Bile Pigments,Tetrapyrroles,15
Bilirubin,D,D04.345.783.249.184,Bile Pigments,Tetrapyrroles,15
Bilirubin,D,D23.767.193.184,Bile Pigments,"Pigments, Biological",15
"Binding, Competitive",G,G02.111.084,Biochemical Phenomena,Chemical Phenomena,15
"Binding, Competitive",G,G02.111.570.120.309,Binding Sites,Molecular Structure,15
"Binding, Competitive",E,E05.196.080,"Chemistry Techniques, Analytical",Investigative Techniques,15
Bone Neoplasms,C,C04.588.149,Neoplasms by Site,Neoplasms,15
Bone Neoplasms,C,C05.116.231,Bone Diseases,Musculoskeletal Diseases,15
Brain Mapping,E,E01.370.376.537.625.500,Functional Neuroimaging,Neuroimaging,15
Brain Mapping,E,E01.370.350.578.875.500,Functional Neuroimaging,Neuroimaging,15
Brain Mapping,E,E05.629.875.500,Functional Neuroimaging,Neuroimaging,15
Breath Tests,E,E01.370.100,Diagnostic Techniques and Procedures,Diagnosis,15
"Calorimetry, Indirect",E,E05.196.131.655,Calorimetry,"Chemistry Techniques, Analytical",15
Cancer Care Facilities,N,N02.278.421.556.070,"Hospitals, Special",Hospitals,15
Carbamates,D,D02.241.081.251,"Acids, Acyclic",Carboxylic Acids,15
Carbohydrate Metabolism,G,G03.191,Metabolism,NULL,15
Carbohydrate Metabolism,G,G02.111.158,Biochemical Phenomena,Chemical Phenomena,15
Carcinoma in Situ,C,C04.557.470.200.240,Carcinoma,"Neoplasms, Glandular and Epithelial",15
Career Mobility,N,N01.824.547.330,Occupations,Socioeconomic Factors,15
Career Mobility,N,N01.824.245.175,Employment,Socioeconomic Factors,15
Cation Transport Proteins,D,D12.776.543.585.450.250,Ion Pumps,Membrane Transport Proteins,15
Cation Transport Proteins,D,D12.776.157.530.450.250,Ion Pumps,Membrane Transport Proteins,15
Central African Republic,Z,Z01.058.290.100.120,"Africa, Central",Africa South of the Sahara,15
Cephalosporins,D,D02.886.665.074,Thiazines,Sulfur Compounds,15
Cephalosporins,D,D03.633.100.300.249,beta-Lactams,"Heterocyclic Compounds, 2-Ring",15
Cephalosporins,D,D02.065.589.099.249,beta-Lactams,Lactams,15
Chromosome Aberrations,C,C23.550.210,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",15
Chromosome Aberrations,G,G05.365.590.175,Mutation,Genetic Variation,15
Clinical Governance,N,N04.452.115,Organization and Administration,Health Services Administration,15
Clothing,J,J01.637.215,Manufactured Materials,"Technology, Industry, and Agriculture",15
Computer Security,L,L01.224.134,Computing Methodologies,Information Science,15
Computer Security,N,N04.452.910.200,Security Measures,Organization and Administration,15
Computer-Assisted Instruction,I,I02.903.771.500.208,Programmed Instructions as Topic,Self-Directed Learning as Topic,15
"Computers, Handheld",L,L01.224.230.260.550.500,Microcomputers,Computers,15
Congo,Z,Z01.058.290.100.140,"Africa, Central",Africa South of the Sahara,15
"Contraceptive Devices, Female",E,E07.190.250,Contraceptive Devices,Equipment and Supplies,15
Coronary Stenosis,C,C14.280.647.250.285,Coronary Disease,Myocardial Ischemia,15
Coronary Stenosis,C,C14.907.585.250.285,Coronary Disease,Myocardial Ischemia,15
Cross Protection,G,G12.450.275,Immunity,Immune System Phenomena,15
Crystallization,E,E05.196.300,"Chemistry Techniques, Analytical",Investigative Techniques,15
Crystallization,G,G02.171,Chemical Phenomena,NULL,15
Cysteine Endopeptidases,D,D08.811.277.656.262.500,Cysteine Proteases,Peptide Hydrolases,15
Cysteine Endopeptidases,D,D08.811.277.656.300.200,Endopeptidases,Peptide Hydrolases,15
Cytochromes b,D,D08.244.187.249,Cytochrome b Group,Cytochromes,15
Cytochromes b,D,D12.776.422.220.187.249,Cytochrome b Group,Cytochromes,15
"Defibrillators, Implantable",E,E07.305.250.159.175,Defibrillators,Electrodes,15
"Defibrillators, Implantable",E,E07.305.250.319.175,"Electrodes, Implanted",Electrodes,15
"Defibrillators, Implantable",E,E07.695.202.175,"Electrodes, Implanted",Prostheses and Implants,15
Dental Enamel,A,A14.549.167.900.255,Tooth Components,Dentition,15
Diagnostic Services,N,N02.421.726.233,Preventive Health Services,Health Services,15
"Diet, Mediterranean",G,G07.203.650.240.270,Diet,Nutritional Physiological Phenomena,15
"Diet, Mediterranean",E,E02.642.249.270,Diet Therapy,Nutrition Therapy,15
"Diet, Vegetarian",E,E02.642.249.300,Diet Therapy,Nutrition Therapy,15
"Diet, Vegetarian",G,G07.203.650.240.300,Diet,Nutritional Physiological Phenomena,15
Dimerization,G,G02.206,Chemical Phenomena,NULL,15
Dimerization,G,G03.230,Metabolism,NULL,15
"Dose-Response Relationship, Radiation",G,G01.750.740.500,Radiation Dosage,Radiation,15
"Dose-Response Relationship, Radiation",G,G07.225,Physiological Phenomena,NULL,15
"Dose-Response Relationship, Radiation",G,G07.738.500,Radiation Tolerance,Physiological Phenomena,15
"Dose-Response Relationship, Radiation",G,G04.712.500,Radiation Tolerance,Cell Physiological Phenomena,15
"Dose-Response Relationship, Radiation",E,E05.799.513.500,Radiation Dosage,Radiometry,15
"Dose-Response Relationship, Radiation",N,N06.850.810.250.180,Radiation Dosage,Radiologic Health,15
Earthquakes,G,G01.311.250,Geological Phenomena,Physical Phenomena,15
Earthquakes,N,N06.230.100.230.200,Natural Disasters,Disasters,15
Eclampsia,C,C13.703.395.124,"Hypertension, Pregnancy-Induced",Pregnancy Complications,15
"Education, Graduate",I,I02.358.337,"Education, Professional",Education,15
"Fatty Acids, Unsaturated",D,D10.251.355,Fatty Acids,Lipids,15
Gene Amplification,G,G05.308.250,Gene Expression Regulation,Genetic Phenomena,15
Gene Amplification,G,G05.365.590.310,Mutation,Genetic Variation,15
Gene Amplification,G,G05.558.315,Mutagenesis,Genetic Phenomena,15
Gene Transfer Techniques,E,E05.393.350,Genetic Techniques,Investigative Techniques,15
"Genes, rRNA",G,G05.360.340.024.340.645.750,Multigene Family,Genes,15
Genetic Speciation,G,G05.045.350,Biological Evolution,Genetic Phenomena,15
Genetic Speciation,G,G16.075.350,Biological Evolution,Biological Phenomena,15
Gram-Positive Bacteria,B,B03.510,Bacteria,NULL,15
Half-Life,G,G01.910.405,Time,Physical Phenomena,15
"Heart Defects, Congenital",C,C14.240.400,Cardiovascular Abnormalities,Cardiovascular Diseases,15
"Heart Defects, Congenital",C,C14.280.400,Heart Diseases,Cardiovascular Diseases,15
"Heart Defects, Congenital",C,C16.131.240.400,Cardiovascular Abnormalities,Congenital Abnormalities,15
Help-Seeking Behavior,F,F01.145.813.217,Social Behavior,Behavior,15
Hirudins,D,D12.644.861.060.875,Antithrombin Proteins,Serpins,15
Hirudins,D,D12.776.872.060.875,Antithrombin Proteins,Serpins,15
Histocompatibility Antigens Class II,D,D23.050.301.500.400,Histocompatibility Antigens,"Antigens, Surface",15
Histocompatibility Antigens Class II,D,D12.776.543.550.440,Membrane Glycoproteins,Membrane Proteins,15
Histocompatibility Antigens Class II,D,D23.050.705.552.410,Histocompatibility Antigens,Isoantigens,15
Histocompatibility Antigens Class II,D,D12.776.395.550.509,Membrane Glycoproteins,Glycoproteins,15
"History, 16th Century",K,K01.400.475.750,"History, Early Modern 1451-1600",History,15
HIV Core Protein p24,D,D23.050.327.520.300,HIV Antigens,"Antigens, Viral",15
HIV Core Protein p24,D,D12.776.964.970.600.850.350.362.500,"gag Gene Products, Human Immunodeficiency Virus","Gene Products, gag",15
HIV Core Protein p24,D,D12.776.964.775.350.362.500,"gag Gene Products, Human Immunodeficiency Virus","Gene Products, gag",15
HIV Core Protein p24,D,D12.776.964.775.562.750.500,"gag Gene Products, Human Immunodeficiency Virus",Human Immunodeficiency Virus Proteins,15
HLA-C Antigens,D,D23.050.301.500.100.600,Histocompatibility Antigens Class I,Histocompatibility Antigens,15
HLA-C Antigens,D,D12.776.543.550.439.600,Histocompatibility Antigens Class I,Membrane Glycoproteins,15
HLA-C Antigens,D,D23.050.301.500.450.390,HLA Antigens,Histocompatibility Antigens,15
HLA-C Antigens,D,D23.050.705.552.100.600,Histocompatibility Antigens Class I,Histocompatibility Antigens,15
HLA-C Antigens,D,D23.050.705.552.450.390,HLA Antigens,Histocompatibility Antigens,15
HLA-C Antigens,D,D12.776.395.550.489.600,Histocompatibility Antigens Class I,Membrane Glycoproteins,15
Homeodomain Proteins,D,D12.776.260.400,DNA-Binding Proteins,Proteins,15
Hospital Units,N,N02.278.388,Health Facilities,"Health Care Facilities, Manpower, and Services",15
"Hospitals, Urban",N,N02.278.421.660,Hospitals,Health Facilities,15
Hunger,G,G10.261.390,Digestive System Physiological Phenomena,Digestive System and Oral Physiological Phenomena,15
Hunger,F,F01.658.293.391,Drive,Motivation,15
Hunger,G,G07.203.650.390,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",15
Hydrophobic and Hydrophilic Interactions,G,G02.409,Chemical Phenomena,NULL,15
"Hypertrophy, Left Ventricular",C,C14.280.195.400,Cardiomegaly,Heart Diseases,15
"Hypertrophy, Left Ventricular",C,C23.300.775.250.400,Cardiomegaly,Hypertrophy,15
In Situ Hybridization,E,E01.370.225.750.600.670.325,Staining and Labeling,Histocytological Preparation Techniques,15
In Situ Hybridization,E,E01.370.225.500.620.670.325,Staining and Labeling,Histocytological Preparation Techniques,15
In Situ Hybridization,E,E05.393.661.475,Nucleic Acid Hybridization,Genetic Techniques,15
In Situ Hybridization,E,E05.200.500.620.670.325,Staining and Labeling,Histocytological Preparation Techniques,15
In Situ Hybridization,E,E05.200.750.600.670.325,Staining and Labeling,Histocytological Preparation Techniques,15
Incisor,A,A14.549.167.860.425,Tooth,Dentition,15
Influenza B virus,B,B04.820.480.968.407.410,Influenzavirus B,Orthomyxoviridae,15
"Injections, Subcutaneous",E,E02.319.267.530.620,Injections,Drug Administration Routes,15
Interspersed Repetitive Sequences,G,G02.111.570.080.708.330,"Repetitive Sequences, Nucleic Acid",Base Sequence,15
Interspersed Repetitive Sequences,G,G05.360.080.708.330,"Repetitive Sequences, Nucleic Acid",Base Sequence,15
Interspersed Repetitive Sequences,G,G05.360.340.024.425,Genome Components,Genome,15
Intracellular Signaling Peptides and Proteins,D,D12.776.476,Proteins,"Amino Acids, Peptides, and Proteins",15
Intracellular Signaling Peptides and Proteins,D,D12.644.360,Peptides,"Amino Acids, Peptides, and Proteins",15
Judgment,F,F02.463.785.626,Thinking,Mental Processes,15
"Leishmaniasis, Mucocutaneous",C,C01.610.752.300.500.400.385,"Leishmaniasis, Cutaneous",Leishmaniasis,15
"Leishmaniasis, Mucocutaneous",C,C01.610.858.560.400.385,"Leishmaniasis, Cutaneous",Leishmaniasis,15
"Leishmaniasis, Mucocutaneous",C,C01.920.813.400.385,"Leishmaniasis, Cutaneous",Leishmaniasis,15
"Leishmaniasis, Mucocutaneous",C,C17.800.838.775.560.400.385,"Leishmaniasis, Cutaneous",Leishmaniasis,15
"Leprosy, Borderline",C,C01.150.252.410.040.552.475.371.850.249,"Leprosy, Paucibacillary",Leprosy,15
"Leukemia, Lymphoid",C,C04.557.337.428,Leukemia,Neoplasms by Histologic Type,15
"Leukemia, Lymphoid",C,C15.604.515.560,Lymphoproliferative Disorders,Lymphatic Diseases,15
"Leukemia, Lymphoid",C,C20.683.515.528,Lymphoproliferative Disorders,Immunoproliferative Disorders,15
"Lung Diseases, Obstructive",C,C08.381.495,Lung Diseases,Respiratory Tract Diseases,15
Methyltransferases,D,D08.811.913.555.500,One-Carbon Group Transferases,Transferases,15
Microfilament Proteins,D,D12.776.220.525,Cytoskeletal Proteins,Proteins,15
Microfilament Proteins,D,D05.750.078.730,Biopolymers,Polymers,15
Molecular Conformation,G,G02.111.570.820,Molecular Structure,Biochemical Phenomena,15
Monkeypox virus,B,B04.280.650.160.650.500,Orthopoxvirus,Chordopoxvirinae,15
Neuraminidase,D,D08.811.277.450.692,Glycoside Hydrolases,Hydrolases,15
Neurodegenerative Diseases,C,C10.574,Nervous System Diseases,NULL,15
Neutropenia,C,C15.378.553.546.184.564,Agranulocytosis,Leukopenia,15
Nifurtimox,D,D03.383.855.400,Thiazines,"Heterocyclic Compounds, 1-Ring",15
Nifurtimox,D,D03.383.312.649.480,Nitrofurans,Furans,15
Nifurtimox,D,D02.886.665.400,Thiazines,Sulfur Compounds,15
Nifurtimox,D,D02.640.600.480,Nitrofurans,Nitro Compounds,15
Nutritional Support,E,E02.642.500,Nutrition Therapy,Therapeutics,15
Oocytes,A,A11.497.497.600,Ovum,Germ Cells,15
Oocytes,A,A05.360.490.690.680,Ovum,Germ Cells,15
Ophthalmologic Surgical Procedures,E,E04.540,"Surgical Procedures, Operative",NULL,15
Opsonin Proteins,D,D12.776.377.715.548.114.767,Antibodies,Immunoglobulins,15
Opsonin Proteins,D,D12.776.124.486.657,Immunoproteins,Blood Proteins,15
Opsonin Proteins,D,D12.776.124.486.485.114.767,Antibodies,Immunoglobulins,15
Opsonin Proteins,D,D12.776.124.790.651.114.767,Antibodies,Immunoglobulins,15
Organ Transplantation,E,E04.936.450,Transplantation,"Surgical Procedures, Operative",15
Orthopedic Procedures,E,E04.555,"Surgical Procedures, Operative",NULL,15
Orthopedic Procedures,E,E02.718,Therapeutics,NULL,15
"Pain, Postoperative",C,C23.888.592.612.832,Pain,Neurologic Manifestations,15
"Pain, Postoperative",C,C23.550.767.700,Postoperative Complications,Pathologic Processes,15
Pamphlets,L,L01.178.682.707,Publications,Communications Media,15
Paromomycin,D,D09.408.051.706,Aminoglycosides,Glycosides,15
Patient Simulation,I,I02.903.847.500,Simulation Training,Teaching,15
Personality Disorders,F,F03.675,Mental Disorders,NULL,15
Personality Inventory,F,F04.711.647.513,Personality Tests,Psychological Tests,15
Personnel Turnover,N,N04.452.677.680,Personnel Management,Organization and Administration,15
Pharmaceutical Services,N,N02.421.668,Health Services,"Health Care Facilities, Manpower, and Services",15
Pharmacovigilance,N,N06.850.505.636,Epidemiologic Measurements,Public Health,15
Pharmacovigilance,E,E05.337.800.600,"Product Surveillance, Postmarketing",Evaluation Studies as Topic,15
Phospholipids,D,D10.570.755,Membrane Lipids,Lipids,15
Presbyopia,C,C11.744.786,Refractive Errors,Eye Diseases,15
Progranulins,D,D12.644.276.917,Intercellular Signaling Peptides and Proteins,Peptides,15
Progranulins,D,D06.472.699.682,Peptide Hormones,Hormones,15
Progranulins,D,D23.529.917,Intercellular Signaling Peptides and Proteins,Biological Factors,15
Progranulins,D,D12.776.467.917,Intercellular Signaling Peptides and Proteins,Proteins,15
Progranulins,D,D12.776.811.703,Protein Precursors,Proteins,15
Proline,D,D12.125.072.401.623,Imino Acids,"Amino Acids, Cyclic",15
Protein Array Analysis,E,E05.601.680,Molecular Probe Techniques,Investigative Techniques,15
Protein Array Analysis,E,E05.588.570.700,Microarray Analysis,Microchip Analytical Procedures,15
Protein Multimerization,G,G02.111.694,Biochemical Phenomena,Chemical Phenomena,15
Proteolysis,G,G02.111.720,Biochemical Phenomena,Chemical Phenomena,15
Proteolysis,G,G03.812,Metabolism,NULL,15
Pseudomonas,B,B03.440.400.425.625.625,Pseudomonadaceae,Gram-Negative Aerobic Rods and Cocci,15
Pseudomonas,B,B03.660.250.580.590,Pseudomonadaceae,Gammaproteobacteria,15
Purinergic P2Y Receptor Antagonists,D,D27.505.519.625.725.400.200.200,Purinergic P2 Receptor Antagonists,Purinergic Antagonists,15
Purinergic P2Y Receptor Antagonists,D,D27.505.696.577.725.400.200.200,Purinergic P2 Receptor Antagonists,Purinergic Antagonists,15
Pyridones,D,D03.383.725.791,Pyridines,"Heterocyclic Compounds, 1-Ring",15
Pyrroles,D,D03.383.129.578,Azoles,"Heterocyclic Compounds, 1-Ring",15
Qatar,Z,Z01.252.245.500.690,Middle East,"Asia, Western",15
Rabies Vaccines,D,D20.215.894.899.700,Viral Vaccines,Vaccines,15
Reassortant Viruses,B,B04.800,Viruses,NULL,15
"Receptors, Tumor Necrosis Factor",D,D12.776.543.750.705.852.760,"Receptors, Cytokine","Receptors, Immunologic",15
Reticulocytes,A,A15.145.229.334.760,Erythrocytes,Blood Cells,15
Reticulocytes,A,A15.378.316.790,Bone Marrow Cells,Hematopoietic System,15
Reticulocytes,A,A11.443.240.665,Erythrocytes,Erythroid Cells,15
Reticulocytes,A,A11.118.290.760,Erythrocytes,Blood Cells,15
Reticulocytes,A,A11.148.790,Bone Marrow Cells,Cells,15
Retinal Neoplasms,C,C04.588.364.818,Eye Neoplasms,Neoplasms by Site,15
Retinal Neoplasms,C,C11.768.717,Retinal Diseases,Eye Diseases,15
Retinal Neoplasms,C,C11.319.475,Eye Neoplasms,Eye Diseases,15
Rituximab,D,D12.776.124.790.651.114.224.075.785,"Antibodies, Monoclonal, Murine-Derived","Antibodies, Monoclonal",15
Rituximab,D,D12.776.124.486.485.114.224.075.785,"Antibodies, Monoclonal, Murine-Derived","Antibodies, Monoclonal",15
Rituximab,D,D12.776.377.715.548.114.224.284.785,"Antibodies, Monoclonal, Murine-Derived","Antibodies, Monoclonal",15
Saccharomyces cerevisiae,B,B01.300.107.795.785.800,Saccharomyces,Saccharomycetales,15
Saccharomyces cerevisiae,B,B01.300.930.705.655,Saccharomyces,Yeasts,15
Scandinavian and Nordic Countries,Z,Z01.542.816,Europe,Geographic Locations,15
"Sequence Analysis, Protein",E,E05.393.760.705,Sequence Analysis,Genetic Techniques,15
Serum,A,A15.145.846,Blood,Hemic and Immune Systems,15
Serum,A,A12.207.152.846,Blood,Body Fluids,15
Sick Leave,N,N04.452.677.800.662,Salaries and Fringe Benefits,Personnel Management,15
Sick Leave,N,N01.824.417.700.662,Salaries and Fringe Benefits,Income,15
Soft Tissue Infections,C,C01.820,Infections,NULL,15
"Spores, Bacterial",B,B05.775.700,Spores,Organism Forms,15
"Spores, Bacterial",A,A11.870.700,Spores,Cells,15
Stem Cell Transplantation,E,E02.095.147.500.500,Cell Transplantation,Cell- and Tissue-Based Therapy,15
Stem Cell Transplantation,E,E04.936.225.687,Cell Transplantation,Transplantation,15
Substance Abuse Treatment Centers,N,N02.278.035.128.800,Community Health Centers,Ambulatory Care Facilities,15
Substance Abuse Treatment Centers,N,N02.278.808.930,Rehabilitation Centers,Health Facilities,15
Taste,G,G11.561.790.724,Sensation,Nervous System Physiological Phenomena,15
Taste,F,F02.830.816.724,Sensation,Psychophysiology,15
Tea,G,G07.203.100.831,Beverages,"Diet, Food, and Nutrition",15
Tea,J,J02.200.831,Beverages,Food and Beverages,15
Tea,D,D20.215.784.844,Plant Preparations,Biological Products,15
Term Birth,G,G08.686.784.769.490.500,Parturition,Pregnancy,15
Therapeutics,E,E02,NULL,NULL,15
Tissue and Organ Procurement,N,N02.421.911,Health Services,"Health Care Facilities, Manpower, and Services",15
"Tonometry, Ocular",E,E01.370.380.750,"Diagnostic Techniques, Ophthalmological",Diagnostic Techniques and Procedures,15
Transcriptional Activation,G,G05.308.800,Gene Expression Regulation,Genetic Phenomena,15
Translating,L,L01.559.423.796,Language Arts,Language,15
Tubulin,D,D12.776.631.920,Nerve Tissue Proteins,Proteins,15
Tubulin,D,D12.776.220.600.800,Microtubule Proteins,Cytoskeletal Proteins,15
Tubulin,D,D05.750.078.734.800,Microtubule Proteins,Biopolymers,15
Umbilical Cord,A,A16.378.693,Fetus,Embryonic Structures,15
Uric Acid,D,D03.132.960.877,Xanthines,Alkaloids,15
Uric Acid,D,D03.633.100.759.758.824.877,Xanthines,Purinones,15
Uterus,A,A05.360.319.679,"Genitalia, Female",Genitalia,15
Volatile Organic Compounds,D,D02.974,Organic Chemicals,NULL,15
Work Schedule Tolerance,N,N04.452.677.650.375,Personnel Staffing and Scheduling,Personnel Management,15
Work Schedule Tolerance,I,I03.946.225.375,Personnel Staffing and Scheduling,Work,15
Workflow,L,L01.906.893,Systems Analysis,Information Science,15
Writing,L,L01.559.423.906,Language Arts,Language,15
Yugoslavia,Z,Z01.586.980,Historical Geographic Locations,Geographic Locations,15
Zea mays,B,B01.650.940.800.575.912.250.822.966,Poaceae,Magnoliopsida,15
"Adenoviruses, Human",B,B04.280.030.500.350,Mastadenovirus,Adenoviridae,14
Aluminum,D,D01.268.557.050,"Metals, Light",Elements,14
Aluminum,D,D01.552.547.050,"Metals, Light",Metals,14
Amidohydrolases,D,D08.811.277.087,Hydrolases,Enzymes,14
Anterior Chamber,A,A09.371.060.067,Anterior Eye Segment,Eye,14
Arachnid Vectors,N,N06.850.520.203.375.100.100,Arthropod Vectors,Disease Vectors,14
Arachnid Vectors,N,N06.850.335.188.100.100,Arthropod Vectors,Disease Vectors,14
"Arthritis, Psoriatic",C,C05.116.900.853.625.800.424,Spondylarthropathies,Spondylarthritis,14
"Arthritis, Psoriatic",C,C05.550.114.145,Arthritis,Joint Diseases,14
"Arthritis, Psoriatic",C,C05.550.114.865.800.424,Spondylarthropathies,Spondylarthritis,14
"Arthritis, Psoriatic",C,C17.800.859.675.175,Psoriasis,"Skin Diseases, Papulosquamous",14
Base Composition,G,G02.111.080,Biochemical Phenomena,Chemical Phenomena,14
Bhutan,Z,Z01.252.245.162,"Asia, Western",Asia,14
Blood-Brain Barrier,A,A08.186.211.035,Brain,Central Nervous System,14
Blood-Brain Barrier,A,A07.035,Cardiovascular System,NULL,14
Buffaloes,B,B01.050.150.900.649.313.500.380.135,Ruminants,Artiodactyla,14
Built Environment,N,N06.230.145.500,Environment Design,Environment,14
"Carcinoma, Small Cell",C,C04.557.470.200.380,Carcinoma,"Neoplasms, Glandular and Epithelial",14
Catheter Ablation,E,E02.808.750.500,Radiofrequency Ablation,Radiofrequency Therapy,14
Catheter Ablation,E,E04.014.760.500,Radiofrequency Ablation,Ablation Techniques,14
Central Nervous System,A,A08.186,Nervous System,NULL,14
Ceratopogonidae,B,B01.050.500.131.617.720.500.500.750.712.500.500,Culicomorpha,Nematocera,14
"Chromosomes, Human",A,A11.284.187.520.300,"Chromosomes, Mammalian",Chromosomes,14
"Chromosomes, Human",G,G05.360.162.520.300,"Chromosomes, Mammalian",Chromosomes,14
Clarithromycin,D,D02.540.576.500.992.100,Erythromycin,Macrolides,14
Clostridium,B,B03.300.390.400.200,Gram-Positive Endospore-Forming Rods,Gram-Positive Endospore-Forming Bacteria,14
Clostridium,B,B03.353.625.375.500,Clostridiaceae,Clostridiales,14
Clostridium,B,B03.510.415.400.200,Gram-Positive Endospore-Forming Rods,Gram-Positive Endospore-Forming Bacteria,14
Colorimetry,E,E05.196.922.250,Titrimetry,"Chemistry Techniques, Analytical",14
Commonwealth of Independent States,I,I01.615.500.188,International Cooperation,Internationality,14
Commonwealth of Independent States,Z,Z01.586.200,Historical Geographic Locations,Geographic Locations,14
Computer Graphics,L,L01.224.108,Computing Methodologies,Information Science,14
Computer Graphics,L,L01.296.110,Data Display,Information Science,14
"Conjugation, Genetic",G,G05.728.200,"Recombination, Genetic",Genetic Phenomena,14
Containment of Biohazards,E,E05.235,Investigative Techniques,NULL,14
Containment of Biohazards,N,N06.850.135.060.075.249,Safety,Accident Prevention,14
Criminal Law,I,I01.880.604.583.100,Jurisprudence,"Social Control, Formal",14
Criminal Law,I,I01.198.290,Criminology,Social Sciences,14
Cytochrome P-450 Enzyme System,D,D08.811.682.690.708.170,Mixed Function Oxygenases,Oxygenases,14
Cytochrome P-450 Enzyme System,D,D08.244.453,Cytochromes,Enzymes and Coenzymes,14
Cytochrome P-450 Enzyme System,D,D12.776.422.220.453,Cytochromes,Hemeproteins,14
Data Mining,L,L01.313.500.750.280.199,Information Storage and Retrieval,Medical Informatics Applications,14
Data Mining,L,L01.470.625,Information Storage and Retrieval,Information Science,14
Dietary Fiber,J,J02.500.400,Food,Food and Beverages,14
Dietary Fiber,G,G07.203.300.400,Food,"Diet, Food, and Nutrition",14
Dietary Fiber,D,D09.301.416,Dietary Carbohydrates,Carbohydrates,14
"DNA, Helminth",D,D13.444.308.315,DNA,Nucleic Acids,14
Docetaxel,D,D02.455.849.291.850.389,Taxoids,Diterpenes,14
Docetaxel,D,D02.455.426.392.368.242.888.389,Taxoids,Cyclodecanes,14
Droughts,G,G16.500.175.781,Climatic Processes,Ecological and Environmental Phenomena,14
Droughts,G,G16.500.750.775.154,Weather,Meteorological Concepts,14
Droughts,N,N06.230.100.230.150,Natural Disasters,Disasters,14
Drug Compounding,E,E05.916.270,"Technology, Pharmaceutical",Investigative Techniques,14
Drug Contamination,N,N06.850.360,Public Health,Environment and Public Health,14
Drug Substitution,N,N02.421.668.778.500.312,Drug Prescriptions,Prescriptions,14
Drug Substitution,E,E02.319.307.312,Drug Prescriptions,Drug Therapy,14
"Education, Special",I,I02.233.213,"Education, Nonprofessional",Education,14
Eicosapentaenoic Acid,D,D10.627.430.450.390,"Fatty Acids, Omega-3",Fish Oils,14
Eicosapentaenoic Acid,D,D10.251.355.255.200,Eicosanoids,"Fatty Acids, Unsaturated",14
Eicosapentaenoic Acid,D,D10.212.302.380.410.385,"Fatty Acids, Omega-3","Dietary Fats, Unsaturated",14
Eicosapentaenoic Acid,D,D10.251.355.337.290,"Fatty Acids, Omega-3","Fatty Acids, Unsaturated",14
"Encephalitis, Japanese",C,C10.228.140.430.520.750.300.400,"Encephalitis, Arbovirus","Encephalitis, Viral",14
"Encephalitis, Japanese",C,C10.228.228.399.750.300.400,"Encephalitis, Arbovirus","Encephalitis, Viral",14
"Encephalitis, Japanese",C,C10.228.228.245.340.300.400,"Encephalitis, Arbovirus","Encephalitis, Viral",14
"Encephalitis, Japanese",C,C01.920.500.343.345,"Encephalitis, Arbovirus",Arbovirus Infections,14
"Encephalitis, Japanese",C,C01.925.081.343.345,"Encephalitis, Arbovirus",Arbovirus Infections,14
"Encephalitis, Japanese",C,C01.925.182.525.300.250,"Encephalitis, Arbovirus","Encephalitis, Viral",14
"Encephalitis, Japanese",C,C01.925.782.350.250.300,Flavivirus Infections,Flaviviridae Infections,14
"Encephalitis, Japanese",C,C01.925.782.310.345,"Encephalitis, Arbovirus",RNA Virus Infections,14
"Encephalitis, Japanese",C,C01.207.245.340.300.400,"Encephalitis, Arbovirus","Encephalitis, Viral",14
"Encephalitis, Japanese",C,C01.207.399.750.300.400,"Encephalitis, Arbovirus","Encephalitis, Viral",14
Endoscopy,E,E01.370.388.250,"Diagnostic Techniques, Surgical",Diagnostic Techniques and Procedures,14
Endoscopy,E,E04.502.250,Minimally Invasive Surgical Procedures,"Surgical Procedures, Operative",14
Enterovirus,B,B04.820.578.750.284,Picornaviridae,Positive-Strand RNA Viruses,14
Epidemiologic Factors,N,N06.850.490,Public Health,Environment and Public Health,14
Epidemiologic Factors,N,N05.715.350,Quality of Health Care,"Health Care Quality, Access, and Evaluation",14
Erythrocyte Count,G,G09.188.105.330,Blood Cell Count,Blood Physiological Phenomena,14
Erythrocyte Count,E,E05.242.195.107.330,Blood Cell Count,Cell Count,14
Erythrocyte Count,E,E05.200.625.107.330,Blood Cell Count,Hematologic Tests,14
Erythrocyte Count,E,E05.200.500.195.107.330,Blood Cell Count,Cell Count,14
Erythrocyte Count,G,G04.140.107.330,Blood Cell Count,Cell Count,14
Erythrocyte Count,E,E01.370.225.625.107.330,Blood Cell Count,Hematologic Tests,14
Erythrocyte Count,E,E01.370.225.500.195.107.330,Blood Cell Count,Cell Count,14
Esophagectomy,E,E04.210.346,Digestive System Surgical Procedures,"Surgical Procedures, Operative",14
Exocytosis,G,G04.468,Cell Physiological Phenomena,NULL,14
Factor VII,D,D23.119.325,Blood Coagulation Factors,Biological Factors,14
Factor VII,D,D12.776.811.243.432,Enzyme Precursors,Protein Precursors,14
Factor VII,D,D12.776.124.125.325,Blood Coagulation Factors,Blood Proteins,14
Factor VII,D,D08.622.432,Enzyme Precursors,Enzymes and Coenzymes,14
"Fees, Medical",N,N03.219.300.426,"Economics, Medical",Economics,14
"Fees, Medical",N,N03.219.442.426,Fees and Charges,Economics,14
"Fimbriae, Bacterial",A,A20.843,Bacterial Structures,NULL,14
"Fimbriae, Bacterial",A,A11.284.180.285,Cell Surface Extensions,Cellular Structures,14
Forms and Records Control,N,N04.452.758.708.200.400,Office Management,Practice Management,14
Foundations,N,N03.219.483.311,Financial Support,Economics,14
Foundations,N,N03.540.630.180,"Organizations, Nonprofit",Organizations,14
Fraud,I,I01.198.240.300,Crime,Criminology,14
Gardnerella vaginalis,B,B03.510.024.400.800,Gardnerella,Actinobacteria,14
"Gene Products, env",D,D12.776.775.320,Polyproteins,Proteins,14
"Gene Products, env",D,D12.776.964.775.325,Retroviridae Proteins,Viral Proteins,14
"Gene Products, env",D,D12.776.964.970.880.325,Viral Envelope Proteins,Viral Structural Proteins,14
"Genes, gag",G,G05.360.340.358.024.875.258,"Genes, Viral","Genes, Microbial",14
"Genes, gag",G,G05.360.340.358.840.500.258,"Genes, Viral","Genome, Viral",14
"Genes, gag",G,G05.360.340.024.340.364.875.258,"Genes, Viral","Genes, Microbial",14
Genetic Engineering,E,E05.393.420,Genetic Techniques,Investigative Techniques,14
Giardia,B,B01.237.385,Diplomonadida,Eukaryota,14
Glioma,C,C04.557.470.670.380,"Neoplasms, Neuroepithelial","Neoplasms, Glandular and Epithelial",14
Glioma,C,C04.557.580.625.600.380,"Neoplasms, Neuroepithelial",Neuroectodermal Tumors,14
Glioma,C,C04.557.465.625.600.380,"Neoplasms, Neuroepithelial",Neuroectodermal Tumors,14
Global Warming,G,G16.500.175.374.500,Climate Change,Climatic Processes,14
Glutathione,D,D12.644.456.448,Oligopeptides,Peptides,14
Glycolipids,D,D10.390,Lipids,NULL,14
Glycolipids,D,D09.400.410,Glycoconjugates,Carbohydrates,14
Granulocytes,A,A15.378.316.340,Bone Marrow Cells,Hematopoietic System,14
Granulocytes,A,A15.382.490.315,Leukocytes,Immune System,14
Granulocytes,A,A15.145.229.637.415,Leukocytes,Blood Cells,14
Granulocytes,A,A11.148.350,Bone Marrow Cells,Cells,14
Granulocytes,A,A11.118.637.415,Leukocytes,Blood Cells,14
Granulocytes,A,A11.627.340,Myeloid Cells,Cells,14
Groundwater,G,G01.311.355,Geological Phenomena,Physical Phenomena,14
Healthy Lifestyle,F,F01.829.458.205,Life Style,"Psychology, Social",14
Hepatitis E,C,C01.925.782.455,RNA Virus Infections,Virus Diseases,14
Hepatitis E,C,C01.925.440.470,"Hepatitis, Viral, Human",Virus Diseases,14
Hepatitis E,C,C06.552.380.705.470,"Hepatitis, Viral, Human",Hepatitis,14
Histocytochemistry,E,E01.370.225.750.551,Histological Techniques,Clinical Laboratory Techniques,14
Histocytochemistry,E,E01.370.225.500.607,Cytological Techniques,Clinical Laboratory Techniques,14
Histocytochemistry,E,E05.200.500.607,Cytological Techniques,Clinical Laboratory Techniques,14
Histocytochemistry,E,E05.200.750.551,Histological Techniques,Clinical Laboratory Techniques,14
Histocytochemistry,H,H01.158.100.656.234,Histology,Anatomy,14
Histocytochemistry,H,H01.158.201.344,Biochemistry,Biological Science Disciplines,14
Histocytochemistry,H,H01.181.122.573,Biochemistry,Chemistry,14
HIV Protease,D,D12.776.964.775.375.545.750,"pol Gene Products, Human Immunodeficiency Virus","Gene Products, pol",14
HIV Protease,D,D12.776.964.900.500.625,Viral Proteases,Viral Nonstructural Proteins,14
HIV Protease,D,D08.811.277.656.979.500,Viral Proteases,Peptide Hydrolases,14
HIV Protease,D,D08.811.277.656.074.500.340,Aspartic Acid Endopeptidases,Aspartic Acid Proteases,14
HIV Protease,D,D08.811.277.656.300.048.340,Aspartic Acid Endopeptidases,Endopeptidases,14
Hospice Care,N,N02.421.585.905.400,Terminal Care,Patient Care,14
Hospice Care,E,E02.760.905.400,Terminal Care,Patient Care,14
"Hydrocarbons, Chlorinated",D,D02.455.526.439,"Hydrocarbons, Halogenated",Hydrocarbons,14
Immunologic Techniques,E,E05.478,Investigative Techniques,NULL,14
Independent Living,N,N01.224.791.550,Residence Characteristics,Demography,14
Independent Living,N,N06.850.505.400.800.550,Residence Characteristics,Demography,14
Independent Living,I,I03.050.500,Activities of Daily Living,Human Activities,14
Kidney Calculi,C,C12.777.967.249.500,Nephrolithiasis,Urolithiasis,14
Kidney Calculi,C,C12.777.967.500.503,Urinary Calculi,Urolithiasis,14
Kidney Calculi,C,C12.777.419.600.500,Nephrolithiasis,Kidney Diseases,14
Kidney Calculi,C,C13.351.968.967.500.503,Urinary Calculi,Urolithiasis,14
Kidney Calculi,C,C13.351.968.967.249.500,Nephrolithiasis,Urolithiasis,14
Kidney Calculi,C,C13.351.968.419.600.500,Nephrolithiasis,Kidney Diseases,14
Kidney Calculi,C,C23.300.175.850.550,Urinary Calculi,Calculi,14
Lactic Acid,D,D02.241.511.459.450,Lactates,Hydroxy Acids,14
Laryngeal Neoplasms,C,C08.360.369,Laryngeal Diseases,Respiratory Tract Diseases,14
Laryngeal Neoplasms,C,C08.785.481,Respiratory Tract Neoplasms,Respiratory Tract Diseases,14
Laryngeal Neoplasms,C,C09.647.481,Otorhinolaryngologic Neoplasms,Otorhinolaryngologic Diseases,14
Laryngeal Neoplasms,C,C09.400.369,Laryngeal Diseases,Otorhinolaryngologic Diseases,14
Laryngeal Neoplasms,C,C04.588.443.665.481,Otorhinolaryngologic Neoplasms,Head and Neck Neoplasms,14
Latex Fixation Tests,E,E01.370.225.812.735.050.450,Agglutination Tests,Serologic Tests,14
Latex Fixation Tests,E,E05.478.594.760.050.450,Agglutination Tests,Serologic Tests,14
Latex Fixation Tests,E,E05.200.812.735.050.450,Agglutination Tests,Serologic Tests,14
Law Enforcement,I,I01.880.604.594,"Social Control, Formal",Sociology,14
Lepidoptera,B,B01.050.500.131.617.720.500.500.937,Holometabola,Neoptera,14
"Leukemia, Lymphocytic, Chronic, B-Cell",C,C04.557.337.428.080.125,"Leukemia, B-Cell","Leukemia, Lymphoid",14
"Leukemia, Lymphocytic, Chronic, B-Cell",C,C15.604.515.560.080.125,"Leukemia, B-Cell","Leukemia, Lymphoid",14
"Leukemia, Lymphocytic, Chronic, B-Cell",C,C20.683.515.528.080.125,"Leukemia, B-Cell","Leukemia, Lymphoid",14
Levofloxacin,D,D03.633.100.810.835.322.500.500,Ofloxacin,Fluoroquinolones,14
"Lipoproteins, LDL",D,D10.532.515,Lipoproteins,Lipids,14
"Lipoproteins, LDL",D,D12.776.521.550,Lipoproteins,Proteins,14
"Magnetic Resonance Imaging, Cine",E,E01.370.350.825.500.510,Magnetic Resonance Imaging,Tomography,14
Mebendazole,D,D03.633.100.103.600,Benzimidazoles,"Heterocyclic Compounds, 2-Ring",14
Mebendazole,D,D02.241.081.251.415,Carbamates,"Acids, Acyclic",14
Mesocricetus,B,B01.050.150.900.649.313.992.635.075.250.500,Cricetinae,Arvicolinae,14
Meteorological Concepts,G,G16.500.750,Ecological and Environmental Phenomena,Biological Phenomena,14
Meteorological Concepts,N,N06.230.300,Environment,Environment and Public Health,14
Methamphetamine,D,D02.092.471.683.152.619,Amphetamines,Phenethylamines,14
Molecular Docking Simulation,L,L01.224.160.249,Computer Simulation,Computing Methodologies,14
Molecular Docking Simulation,E,E05.599.595.249,"Models, Molecular","Models, Theoretical",14
Morphogenesis,G,G07.345.500,Growth and Development,Physiological Phenomena,14
Motivational Interviewing,F,F02.784.176.279.500,Directive Counseling,Counseling,14
Motivational Interviewing,F,F04.408.413.349.500,Directive Counseling,Counseling,14
Motivational Interviewing,N,N02.421.461.363.349.500,Directive Counseling,Counseling,14
Mutation Rate,G,G16.075.250.750,"Evolution, Molecular",Biological Evolution,14
Mutation Rate,G,G05.365.590.612,Mutation,Genetic Variation,14
Mutation Rate,G,G05.045.250.750,"Evolution, Molecular",Biological Evolution,14
Myopia,C,C11.744.636,Refractive Errors,Eye Diseases,14
Narcotics,D,D27.505.696.663.850.014.760,Analgesics,Sensory System Agents,14
Narcotics,D,D27.505.954.427.040.550,Analgesics,Central Nervous System Agents,14
Narcotics,D,D27.505.954.427.210.600,Central Nervous System Depressants,Central Nervous System Agents,14
Narcotics,D,D27.505.696.277.600,Central Nervous System Depressants,Physiological Effects of Drugs,14
Newspapers as Topic,L,L01.178.682.829.481,Serial Publications,Publications,14
Nitric Oxide Synthase,D,D08.811.682.664.500.772,Amino Acid Oxidoreductases,Oxidoreductases Acting on CH-NH2 Group Donors,14
Oligonucleotides,D,D13.695.578.424,Polynucleotides,Nucleotides,14
Optic Disk,A,A09.371.729.690,Retina,Eye,14
Optic Disk,A,A08.800.800.120.680.660,Optic Nerve,Cranial Nerves,14
Optometry,H,H02.553,Health Occupations,NULL,14
Organic Chemicals,D,D02,NULL,NULL,14
Patient Acuity,N,N05.715.360.300.800.438.375.364,Health Status Indicators,Health Surveys,14
Patient Acuity,N,N06.850.520.308.980.438.475.364,Health Status Indicators,Health Surveys,14
Patient Acuity,E,E05.318.308.980.438.475.456,Health Status Indicators,Health Surveys,14
"Pemphigoid, Bullous",C,C20.111.730,Autoimmune Diseases,Immune System Diseases,14
"Pemphigoid, Bullous",C,C17.800.865.690,"Skin Diseases, Vesiculobullous",Skin Diseases,14
Peripheral Arterial Disease,C,C14.907.617.671,Peripheral Vascular Diseases,Vascular Diseases,14
Peripheral Arterial Disease,C,C14.907.137.126.307.500,Atherosclerosis,Arteriosclerosis,14
Peritoneal Dialysis,E,E02.870.300.650,Renal Dialysis,Renal Replacement Therapy,14
Peritoneal Dialysis,E,E02.912.800.650,Renal Dialysis,Sorption Detoxification,14
Pest Control,N,N06.850.780.200.650,Communicable Disease Control,Public Health Practice,14
Phagocytes,A,A11.733,Cells,NULL,14
Phagocytes,A,A15.382.680,Immune System,Hemic and Immune Systems,14
Picornaviridae Infections,C,C01.925.782.687,RNA Virus Infections,Virus Diseases,14
Platelet Count,E,E01.370.225.625.625.625,Platelet Function Tests,Hematologic Tests,14
Platelet Count,E,E01.370.225.625.107.700,Blood Cell Count,Hematologic Tests,14
Platelet Count,E,E01.370.225.500.195.107.740,Blood Cell Count,Cell Count,14
Platelet Count,E,E05.200.625.625.625,Platelet Function Tests,Hematologic Tests,14
Platelet Count,E,E05.200.625.107.700,Blood Cell Count,Hematologic Tests,14
Platelet Count,E,E05.242.195.107.740,Blood Cell Count,Cell Count,14
Platelet Count,E,E05.200.500.195.107.740,Blood Cell Count,Cell Count,14
Platelet Count,G,G04.140.107.740,Blood Cell Count,Cell Count,14
Platelet Count,G,G09.188.105.700,Blood Cell Count,Blood Physiological Phenomena,14
"Practice Management, Medical",N,N04.452.758.708.450,Practice Management,Professional Practice,14
Protein Sorting Signals,G,G02.111.570.060.670,Amino Acid Sequence,Molecular Structure,14
Protein Sorting Signals,D,D12.644.770,Peptides,"Amino Acids, Peptides, and Proteins",14
Proteoglycans,D,D09.698.735,Polysaccharides,Carbohydrates,14
Proteoglycans,D,D12.776.395.650,Glycoproteins,Proteins,14
Pruritus,C,C17.800.685,Skin Diseases,Skin and Connective Tissue Diseases,14
Pruritus,C,C23.888.885.625,Skin Manifestations,Signs and Symptoms,14
"Psychology, Adolescent",F,F04.096.628.065,Psychology,Behavioral Sciences,14
Psychotropic Drugs,D,D27.505.954.427.700,Central Nervous System Agents,Therapeutic Uses,14
Queensland,Z,Z01.639.100.937,Australia,Islands,14
Queensland,Z,Z01.678.100.373.937,Australia,Australasia,14
Radiation Dosage,N,N06.850.810.250,Radiologic Health,Public Health,14
Radiation Dosage,G,G01.750.740,Radiation,Physical Phenomena,14
Radiation Dosage,E,E05.799.513,Radiometry,Investigative Techniques,14
"Radiographic Image Interpretation, Computer-Assisted",L,L01.313.500.750.100.158.600.680,"Image Interpretation, Computer-Assisted","Diagnosis, Computer-Assisted",14
"Radiographic Image Interpretation, Computer-Assisted",E,E01.158.600.680,"Image Interpretation, Computer-Assisted","Diagnosis, Computer-Assisted",14
"Radiographic Image Interpretation, Computer-Assisted",E,E01.370.350.700.705,Radiography,Diagnostic Imaging,14
"Radiographic Image Interpretation, Computer-Assisted",E,E01.370.350.350.700,"Image Interpretation, Computer-Assisted",Diagnostic Imaging,14
"Radiotherapy, Adjuvant",E,E02.186.775,Combined Modality Therapy,Therapeutics,14
"Radiotherapy, Adjuvant",E,E02.815.600,Radiotherapy,Therapeutics,14
"Rats, Inbred Strains",B,B01.050.150.900.649.313.992.635.505.700.400,Rats,Murinae,14
"Rats, Inbred Strains",B,B01.050.050.199.520.760,"Animals, Inbred Strains","Animals, Laboratory",14
Reaction Time,E,E05.796.817,Psychological Techniques,Investigative Techniques,14
Reaction Time,F,F04.669.817,Psychological Techniques,Behavioral Disciplines and Activities,14
Reaction Time,F,F02.830.650,Psychophysiology,Psychological Phenomena,14
Reaction Time,G,G11.561.677,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,14
"Receptors, Interleukin",D,D12.776.543.750.705.852.420,"Receptors, Cytokine","Receptors, Immunologic",14
"Receptors, Virus",D,D12.776.543.750.830,"Receptors, Cell Surface",Membrane Proteins,14
Regulon,G,G05.360.340.024.742,Genome Components,Genome,14
Reproductive Tract Infections,C,C01.730,Infections,NULL,14
Reproductive Tract Infections,C,C12.294.604,"Genital Diseases, Male",Male Urogenital Diseases,14
Reproductive Tract Infections,C,C13.351.500.630,"Genital Diseases, Female",Female Urogenital Diseases,14
Retention in Care,E,E02.760.169.671,Continuity of Patient Care,Patient Care,14
Retention in Care,N,N02.421.585.169.671,Continuity of Patient Care,Patient Care,14
Rheumatology,H,H02.403.429.730,Internal Medicine,Medicine,14
Rhinovirus,B,B04.820.578.750.775,Picornaviridae,Positive-Strand RNA Viruses,14
Rift Valley fever virus,B,B04.820.480.750.710.700,Phlebovirus,Bunyaviridae,14
RNA Viruses,B,B04.820,Viruses,NULL,14
RNA-Binding Proteins,D,D12.776.664.962,Nucleoproteins,Proteins,14
RNA-Binding Proteins,D,D12.776.157.725,Carrier Proteins,Proteins,14
Rosiglitazone,D,D02.886.675.933.500,Thiazolidinediones,Thiazoles,14
Rosiglitazone,D,D03.383.129.708.933.500,Thiazolidinediones,Thiazoles,14
Rubella virus,B,B04.820.578.875.700.700,Rubivirus,Togaviridae,14
Self-Help Devices,E,E07.796,Equipment and Supplies,NULL,14
Skin Ulcer,C,C17.800.893,Skin Diseases,Skin and Connective Tissue Diseases,14
Smell,F,F02.830.816.643,Sensation,Psychophysiology,14
Smell,G,G11.561.790.643,Sensation,Nervous System Physiological Phenomena,14
Social Participation,I,I03.050.750,Activities of Daily Living,Human Activities,14
Societies,N,N03.540.828,Organizations,Health Care Economics and Organizations,14
Streptomycin,D,D09.408.051.885,Aminoglycosides,Glycosides,14
Superinfection,C,C01.610.684.880,Opportunistic Infections,Parasitic Diseases,14
Superinfection,C,C01.597.880,Opportunistic Infections,Infections,14
Superinfection,C,C01.925.597.880,Opportunistic Infections,Virus Diseases,14
Sus scrofa,B,B01.050.150.900.649.313.500.880.399,Swine,Artiodactyla,14
Tacrolimus,D,D02.540.505.810,Macrolides,Lactones,14
"Tuberculosis, Lymph Node",C,C01.150.252.410.040.552.846.719,Tuberculosis,Mycobacterium Infections,14
Ubiquitin-Protein Ligases,D,D08.811.464.938.750,Ubiquitin-Protein Ligase Complexes,Ligases,14
Uzbekistan,Z,Z01.542.931.975,USSR,Europe,14
Uzbekistan,Z,Z01.252.100.975,"Asia, Central",Asia,14
Uzbekistan,Z,Z01.586.950.975,USSR,Historical Geographic Locations,14
Validation Studies as Topic,N,N05.715.360.335.500,Evaluation Studies as Topic,Health Care Evaluation Mechanisms,14
Validation Studies as Topic,E,E05.337.925,Evaluation Studies as Topic,Investigative Techniques,14
Varicose Veins,C,C14.907.927,Vascular Diseases,Cardiovascular Diseases,14
Viral Plaque Assay,E,E01.370.225.875.970.790,Virus Cultivation,Microbiological Techniques,14
Viral Plaque Assay,E,E05.200.875.970.790,Virus Cultivation,Microbiological Techniques,14
Waste Management,N,N06.850.860.510.900,Sanitary Engineering,Sanitation,14
Waste Management,N,N06.850.780.200.800.800.900,Sanitary Engineering,Sanitation,14
Abattoirs,J,J01.576.423.200.700.100,Meat-Packing Industry,Food Handling,13
Abattoirs,J,J03.540.020,Manufacturing and Industrial Facilities,Non-Medical Public and Private Facilities,13
Abortifacient Agents,D,D27.505.954.705.131,Reproductive Control Agents,Therapeutic Uses,13
Abortifacient Agents,D,D27.505.696.875.131,Reproductive Control Agents,Physiological Effects of Drugs,13
Abscess,C,C23.550.470.756.100,Suppuration,Inflammation,13
Abscess,C,C01.830.025,Suppuration,Infections,13
Accreditation,N,N03.706.110.070,Credentialing,"Social Control, Formal",13
Accreditation,N,N05.700.200.100,Credentialing,"Quality Assurance, Health Care",13
African Horse Sickness,C,C01.925.782.791.142,Reoviridae Infections,RNA Virus Infections,13
African Horse Sickness,C,C01.920.500.030,Arbovirus Infections,Vector Borne Diseases,13
African Horse Sickness,C,C01.925.081.030,Arbovirus Infections,Virus Diseases,13
African Horse Sickness,C,C22.488.088,Horse Diseases,Animal Diseases,13
Air Microbiology,N,N06.850.425.110,Environmental Microbiology,Public Health,13
Air Microbiology,H,H01.158.273.540.274.110,Environmental Microbiology,Microbiology,13
Albania,Z,Z01.542.248.020,"Europe, Eastern",Europe,13
Alcohols,D,D02.033,Organic Chemicals,NULL,13
Androgen Antagonists,D,D27.505.696.399.450.065,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",13
Androgen Antagonists,D,D06.347.065,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",13
APACHE,N,N06.850.520.308.980.438.475.364.500.250,Severity of Illness Index,Patient Acuity,13
APACHE,N,N05.715.360.300.800.438.375.364.500.250,Severity of Illness Index,Patient Acuity,13
APACHE,E,E05.318.308.980.438.475.365,Health Status Indicators,Health Surveys,13
APACHE,E,E05.318.308.980.438.475.456.500.250,Severity of Illness Index,Patient Acuity,13
Autoimmunity,G,G12.450.192,Immunity,Immune System Phenomena,13
Beds,E,E07.325.220,"Equipment and Supplies, Hospital",Equipment and Supplies,13
Benzamides,D,D02.065.277,Amides,Organic Chemicals,13
Benzamides,D,D02.241.223.100.100,Benzoates,"Acids, Carbocyclic",13
Benzamides,D,D02.455.426.559.389.127.085,Benzoates,Benzene Derivatives,13
beta-Lactams,D,D02.065.589.099,Lactams,Amides,13
beta-Lactams,D,D02.886.108,Sulfur Compounds,Organic Chemicals,13
beta-Lactams,D,D03.633.100.300,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",13
Binge Drinking,C,C25.775.100.437,Alcohol-Related Disorders,Substance-Related Disorders,13
Binge Drinking,F,F01.145.317.269.500,Alcohol Drinking,Drinking Behavior,13
Binge Drinking,F,F03.900.100.550,Alcohol-Related Disorders,Substance-Related Disorders,13
Blood Culture,E,E05.200.875.185,Microbiological Techniques,Clinical Laboratory Techniques,13
Blood Culture,E,E01.370.225.875.185,Microbiological Techniques,Clinical Laboratory Techniques,13
Body Fat Distribution,E,E01.370.600.115.100.062,Body Weights and Measures,Body Constitution,13
Body Fat Distribution,G,G02.111.130.134,Body Composition,Biochemical Phenomena,13
Body Fat Distribution,G,G03.180.134,Body Composition,Metabolism,13
Body Fat Distribution,G,G07.100.049.134,Body Composition,Body Constitution,13
Bone Density Conservation Agents,D,D27.505.696.242,Physiological Effects of Drugs,Pharmacologic Actions,13
Boston,Z,Z01.433.210,Cities,Geographic Locations,13
Boston,Z,Z01.107.567.875.550.510.210,Massachusetts,New England,13
Bronchi,A,A04.411.125,Lung,Respiratory System,13
Burkholderia,B,B03.660.075.090.688.100,Burkholderiaceae,Burkholderiales,13
Cadmium,D,D01.552.544.137,"Metals, Heavy",Metals,13
Cadmium,D,D01.268.956.061,Transition Elements,Elements,13
Cadmium,D,D01.268.556.137,"Metals, Heavy",Elements,13
Cardiomyopathies,C,C14.280.238,Heart Diseases,Cardiovascular Diseases,13
Carotenoids,D,D02.455.426.392.368.367.379.249,Cyclohexenes,Cyclohexanes,13
Carotenoids,D,D02.455.326.271.665.202,Polyenes,Alkenes,13
Carotenoids,D,D23.767.261,"Pigments, Biological",Biological Factors,13
Carotenoids,D,D02.455.849.131,Terpenes,Hydrocarbons,13
Catheterization,E,E02.148,Therapeutics,NULL,13
Catheterization,E,E05.157,Investigative Techniques,NULL,13
CD36 Antigens,D,D12.776.543.750.710.450.750.625.249,"Scavenger Receptors, Class B","Receptors, Scavenger",13
CD36 Antigens,D,D12.776.543.750.705.675.136,Platelet Membrane Glycoproteins,"Receptors, Immunologic",13
CD36 Antigens,D,D12.776.543.750.705.940.625.249,"Scavenger Receptors, Class B","Receptors, Scavenger",13
CD36 Antigens,D,D12.776.543.550.625.136,Platelet Membrane Glycoproteins,Membrane Glycoproteins,13
CD36 Antigens,D,D12.776.543.585.300.500,Fatty Acid Transport Proteins,Membrane Transport Proteins,13
CD36 Antigens,D,D12.776.543.750.011,"Receptors, Cell Surface",Membrane Proteins,13
CD36 Antigens,D,D12.776.395.550.625.136,Platelet Membrane Glycoproteins,Membrane Glycoproteins,13
CD36 Antigens,D,D12.776.157.530.300.500,Fatty Acid Transport Proteins,Membrane Transport Proteins,13
CD8 Antigens,D,D23.050.301.264.894.108,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",13
CD8 Antigens,D,D23.101.100.894.108,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",13
Cell Death,G,G04.146,Cell Physiological Phenomena,NULL,13
Cerebrovascular Circulation,G,G09.330.100.159,Blood Circulation,Cardiovascular Physiological Phenomena,13
Charities,I,I01.880.787.190,Social Welfare,Sociology,13
Charities,N,N03.540.125,Organizations,Health Care Economics and Organizations,13
Chlorhexidine,D,D02.078.370.141.100,Biguanides,Guanidines,13
Clinical Audit,N,N05.700.175,"Quality Assurance, Health Care","Health Care Quality, Access, and Evaluation",13
Clinical Audit,N,N04.761.700.250,"Quality Assurance, Health Care",Quality of Health Care,13
Clinical Coding,N,N04.452.758.708.200.400.500,Forms and Records Control,Office Management,13
Clinical Coding,N,N04.452.859.564.274,Medical Records,Records,13
Clinical Coding,N,N05.715.360.300.715.500.249,Medical Records,Records,13
Clinical Coding,N,N06.850.520.308.940.968.249,Medical Records,Records,13
Cocaine-Related Disorders,F,F03.900.300,Substance-Related Disorders,Mental Disorders,13
Cocaine-Related Disorders,C,C25.775.300,Substance-Related Disorders,Chemically-Induced Disorders,13
Common Cold,C,C08.730.162,Respiratory Tract Infections,Respiratory Tract Diseases,13
Common Cold,C,C01.748.162,Respiratory Tract Infections,Infections,13
Common Cold,C,C01.925.782.687.207,Picornaviridae Infections,RNA Virus Infections,13
Community Medicine,H,H02.403.220,Medicine,Health Occupations,13
Complement C4,D,D12.776.124.486.274.350,Complement System Proteins,Immunoproteins,13
Complement Factor H,D,D12.776.124.486.274.920.325.200,Complement C3b Inactivator Proteins,Complement Inactivator Proteins,13
Complement Factor H,D,D12.776.124.790.223.200,Beta-Globulins,Serum Globulins,13
Complement Factor H,D,D12.776.377.715.182.200,Beta-Globulins,Serum Globulins,13
Computer Systems,L,L01.224.230,Computing Methodologies,Information Science,13
"Contraception, Postcoital",E,E02.875.194.540,Contraception,Reproductive Techniques,13
Contracts,I,I01.880.604.583.090,Jurisprudence,"Social Control, Formal",13
Contracts,N,N03.706.535.241,Jurisprudence,"Social Control, Formal",13
Corneal Opacity,C,C11.204.299,Corneal Diseases,Eye Diseases,13
Coronary Circulation,G,G09.330.100.324,Blood Circulation,Cardiovascular Physiological Phenomena,13
CRISPR-Cas Systems,G,G05.308.203.374.394,Gene Silencing,"Epigenesis, Genetic",13
Croatia,Z,Z01.542.248.295,"Europe, Eastern",Europe,13
Culturally Competent Care,N,N05.300.206,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",13
Culturally Competent Care,N,N04.590.374.052,Delivery of Health Care,Patient Care Management,13
Dideoxynucleosides,D,D13.570.230.500,Deoxyribonucleosides,Nucleosides,13
Diethylcarbamazine,D,D03.383.606.380,Piperazines,"Heterocyclic Compounds, 1-Ring",13
Diethylcarbamazine,D,D02.241.081.251.240,Carbamates,"Acids, Acyclic",13
Digestive System,A,A03,NULL,NULL,13
Dipeptidyl-Peptidase IV Inhibitors,D,D27.505.696.422.500,Hypoglycemic Agents,Physiological Effects of Drugs,13
Dipeptidyl-Peptidase IV Inhibitors,D,D27.505.519.389.745.335,Protease Inhibitors,Enzyme Inhibitors,13
Diphosphonates,D,D02.705.429.500,Organophosphonates,Organophosphorus Compounds,13
Disinfectants,D,D27.505.954.122.425,Anti-Infective Agents,Therapeutic Uses,13
Disinfectants,D,D27.720.274,Specialty Uses of Chemicals,Chemical Actions and Uses,13
Doxorubicin,D,D02.455.426.559.847.562.050.200.175,Daunorubicin,Anthracyclines,13
Doxorubicin,D,D04.615.562.050.200.175,Daunorubicin,Anthracyclines,13
Doxorubicin,D,D09.408.051.059.200.175,Daunorubicin,Anthracyclines,13
Drosophila melanogaster,B,B01.050.500.131.617.720.500.500.750.310.250.500,Drosophila,Drosophilidae,13
Drug Dosage Calculations,E,E02.319.305,Drug Therapy,Therapeutics,13
Drug Packaging,J,J01.576.655.750.321,Drug Industry,Manufacturing Industry,13
Drug Packaging,J,J01.576.761.300,Product Packaging,Industry,13
Drug Packaging,E,E05.916.320,"Technology, Pharmaceutical",Investigative Techniques,13
"Economics, Hospital",N,N03.219.262,Economics,Health Care Economics and Organizations,13
Electrophoresis,E,E05.196.401,"Chemistry Techniques, Analytical",Investigative Techniques,13
Electrophoresis,E,E05.301.300,Electrochemical Techniques,Investigative Techniques,13
Empowerment,F,F01.145.813.195,Social Behavior,Behavior,13
Empowerment,F,F01.658.780.500,"Power, Psychological",Motivation,13
Endosomes,A,A11.284.430.214.190.875.190.880.337,Transport Vesicles,Cytoplasmic Vesicles,13
Enteral Nutrition,E,E02.642.500.360,Nutritional Support,Nutrition Therapy,13
Enteral Nutrition,E,E02.421.360,Feeding Methods,Therapeutics,13
Environmental Policy,N,N03.623.500.608.180,Public Policy,Social Control Policies,13
Environmental Policy,N,N06.230.204,Environment,Environment and Public Health,13
Environmental Policy,I,I01.880.604.825.608.180,Public Policy,Social Control Policies,13
Environmental Policy,I,I01.655.500.608.180,Public Policy,Social Control Policies,13
Episiotomy,E,E04.520.252.750,"Delivery, Obstetric",Obstetric Surgical Procedures,13
Extramarital Relations,F,F01.145.802.295,Sexual Behavior,Behavior,13
Fabaceae,B,B01.650.940.800.575.912.250.401,Magnoliopsida,Tracheophyta,13
Face,A,A01.456.505,Head,Body Regions,13
Fibrinolysis,G,G09.188.390.150.390,Blood Coagulation,Hemostasis,13
Fimbriae Proteins,D,D12.776.543.100.300,Bacterial Outer Membrane Proteins,Membrane Proteins,13
Fimbriae Proteins,D,D12.776.097.120.425,Bacterial Outer Membrane Proteins,Bacterial Proteins,13
Fluorescence,G,G01.590.540.665.500,Luminescence,Light,13
Fluorescence,G,G01.358.500.505.650.665.500,Luminescence,Light,13
Foreign Medical Graduates,N,N02.360.810.390,Physicians,Health Personnel,13
Foreign Medical Graduates,M,M01.526.485.810.390,Physicians,Health Personnel,13
Foreign Medical Graduates,M,M01.526.407.435,Foreign Professional Personnel,Occupational Groups,13
Functional Laterality,G,G11.561.225.425,"Dominance, Cerebral",Nervous System Physiological Phenomena,13
Functional Laterality,F,F02.830.297.425,"Dominance, Cerebral",Psychophysiology,13
Gastroesophageal Reflux,C,C06.405.117.119.500.484,Esophageal Motility Disorders,Deglutition Disorders,13
Giant Cell Arteritis,C,C20.111.258.962.800,"Vasculitis, Central Nervous System",Autoimmune Diseases of the Nervous System,13
Giant Cell Arteritis,C,C10.228.140.300.850.500,"Vasculitis, Central Nervous System",Cerebrovascular Disorders,13
Giant Cell Arteritis,C,C10.114.875.700,"Vasculitis, Central Nervous System",Autoimmune Diseases of the Nervous System,13
Giant Cell Arteritis,C,C14.907.940.090.530,Arteritis,Vasculitis,13
Giant Cell Arteritis,C,C14.907.940.907.700,"Vasculitis, Central Nervous System",Vasculitis,13
Giant Cell Arteritis,C,C14.907.253.946.700,"Vasculitis, Central Nervous System",Cerebrovascular Disorders,13
Giant Cell Arteritis,C,C17.800.862.252,"Skin Diseases, Vascular",Skin Diseases,13
Goat Diseases,C,C22.405,Animal Diseases,NULL,13
Gynecologic Surgical Procedures,E,E04.950.300,Urogenital Surgical Procedures,"Surgical Procedures, Operative",13
Haplorhini,B,B01.050.150.900.649.313.988.400,Primates,Eutheria,13
Health Facility Administration,N,N02.278.216,Health Facilities,"Health Care Facilities, Manpower, and Services",13
Health Facility Administration,N,N04.452.442,Organization and Administration,Health Services Administration,13
Health Risk Behaviors,F,F01.145.488.250,Health Behavior,Behavior,13
Hearing,F,F02.830.816.263,Sensation,Psychophysiology,13
Hearing,G,G07.888.500,Vestibulocochlear Physiological Phenomena,Physiological Phenomena,13
Hearing,G,G11.561.790.263,Sensation,Nervous System Physiological Phenomena,13
Heat-Shock Response,G,G07.775.500,"Stress, Physiological",Physiological Phenomena,13
"Hip Dislocation, Congenital",C,C05.660.297.500,Developmental Dysplasia of the Hip,Musculoskeletal Abnormalities,13
"Hip Dislocation, Congenital",C,C16.131.621.297.500,Developmental Dysplasia of the Hip,Musculoskeletal Abnormalities,13
"Hip Dislocation, Congenital",C,C16.131.621.449,Musculoskeletal Abnormalities,Congenital Abnormalities,13
Historiography,K,K01.400.441,History,Humanities,13
"History, Medieval",K,K01.400.500,History,Humanities,13
"Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18",D,D20.215.894.815.455,"Vaccines, Combined",Vaccines,13
"Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18",D,D20.215.894.899.498.500,Papillomavirus Vaccines,Viral Vaccines,13
Hyperkalemia,C,C18.452.950.396,Water-Electrolyte Imbalance,Metabolic Diseases,13
Hyperlipidemias,C,C18.452.584.500.500,Dyslipidemias,Lipid Metabolism Disorders,13
Indapamide,D,D02.065.884.540,Sulfonamides,Amides,13
Indapamide,D,D02.886.590.700.540,Sulfonamides,Sulfones,13
Indapamide,D,D03.633.100.473.391,Indoles,"Heterocyclic Compounds, 2-Ring",13
Indian Ocean Islands,Z,Z01.639.520,Islands,Geographic Locations,13
Indicators and Reagents,D,D27.720.470.410,Laboratory Chemicals,Specialty Uses of Chemicals,13
"Infant, Very Low Birth Weight",M,M01.060.703.520.460.600,"Infant, Low Birth Weight","Infant, Newborn",13
"Infertility, Male",C,C12.294.365.700,Infertility,"Genital Diseases, Male",13
"Injections, Intradermal",E,E02.319.267.530.620.410,"Injections, Subcutaneous",Injections,13
Intercellular Signaling Peptides and Proteins,D,D23.529,Biological Factors,NULL,13
Intercellular Signaling Peptides and Proteins,D,D12.776.467,Proteins,"Amino Acids, Peptides, and Proteins",13
Intercellular Signaling Peptides and Proteins,D,D12.644.276,Peptides,"Amino Acids, Peptides, and Proteins",13
Introns,G,G05.360.340.024.220.400,"DNA, Intergenic",Genome Components,13
Introns,G,G05.360.340.024.340.137.515,Gene Components,Genes,13
Latvia,Z,Z01.542.248.136.560,Baltic States,"Europe, Eastern",13
Laundering,J,J01.576.549,Industry,"Technology, Industry, and Agriculture",13
"Leprosy, Tuberculoid",C,C01.150.252.410.040.552.475.371.850.500,"Leprosy, Paucibacillary",Leprosy,13
Loneliness,I,I01.880.853.748.435,Social Isolation,Sociological Factors,13
Loneliness,F,F01.470.713,Emotions,Behavior and Behavior Mechanisms,13
Malathion,D,D02.886.300.692.500,Organothiophosphates,Organothiophosphorus Compounds,13
Malathion,D,D02.705.400.625.500,Organothiophosphates,Organophosphates,13
Malathion,D,D02.705.539.345.500,Organothiophosphates,Organothiophosphorus Compounds,13
Mastitis,C,C17.800.090.968,Breast Diseases,Skin Diseases,13
Mastitis,C,C13.703.844.603,Puerperal Disorders,Pregnancy Complications,13
Mathematical Concepts,G,G17,NULL,NULL,13
Methylprednisolone,D,D04.210.500.745.432.769.795.539,Prednisolone,Pregnadienetriols,13
"Mice, Inbred C3H",B,B01.050.050.199.520.520.388,"Mice, Inbred Strains","Animals, Inbred Strains",13
"Mice, Inbred C3H",B,B01.050.150.900.649.313.992.635.505.500.400.388,"Mice, Inbred Strains",Mice,13
Microphthalmos,C,C16.131.384.666,Eye Abnormalities,Congenital Abnormalities,13
Microphthalmos,C,C11.250.566,Eye Abnormalities,Eye Diseases,13
Mites,B,B01.050.500.131.166.132.419,Acari,Arachnida,13
Mitogen-Activated Protein Kinases,D,D12.644.360.450,Intracellular Signaling Peptides and Proteins,Peptides,13
Mitogen-Activated Protein Kinases,D,D08.811.913.696.620.682.700.567,Protein-Serine-Threonine Kinases,Protein Kinases,13
Mitogen-Activated Protein Kinases,D,D12.776.476.450,Intracellular Signaling Peptides and Proteins,Proteins,13
Molecular Targeted Therapy,E,E02.319.574,Drug Therapy,Therapeutics,13
Mouth Neoplasms,C,C04.588.443.591,Head and Neck Neoplasms,Neoplasms by Site,13
Mouth Neoplasms,C,C07.465.530,Mouth Diseases,Stomatognathic Diseases,13
"NADH, NADPH Oxidoreductases",D,D08.811.682.608,Oxidoreductases,Enzymes,13
Necrosis,C,C23.550.717,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",13
Neoadjuvant Therapy,E,E02.186.450,Combined Modality Therapy,Therapeutics,13
"Neoplasms, Germ Cell and Embryonal",C,C04.557.465,Neoplasms by Histologic Type,Neoplasms,13
"Neoplasms, Multiple Primary",C,C04.651,Neoplasms,NULL,13
Neopterin,D,D08.211.090.500,Biopterin,Coenzymes,13
Neopterin,D,D03.633.100.733.631.202.500,Biopterin,Pterins,13
Nitrates,D,D02.583,Organic Chemicals,NULL,13
Nitrates,D,D01.248.497.158.606,Anions,Ions,13
Nitrates,D,D01.625.525.550,Nitric Acid,Nitrogen Compounds,13
Nurse Practitioners,M,M01.526.485.650.640,Nurses,Health Personnel,13
Nurse Practitioners,N,N02.360.650.640,Nurses,Health Personnel,13
Nutrients,J,J02.500.681,Food,Food and Beverages,13
Nutrients,G,G07.203.300.681,Food,"Diet, Food, and Nutrition",13
Orientia tsutsugamushi,B,B03.660.050.783.875.650.450.500,Orientia,Rickettsieae,13
Ovary,A,A05.360.319.114.630,Adnexa Uteri,"Genitalia, Female",13
Ovary,A,A05.360.576.497,Gonads,Genitalia,13
Ovary,A,A06.300.312.497,Gonads,Endocrine Glands,13
Oxytocin,D,D06.472.699.631.692.433,"Pituitary Hormones, Posterior",Pituitary Hormones,13
Oxytocin,D,D12.644.548.691.692.433,"Pituitary Hormones, Posterior",Pituitary Hormones,13
Parathyroid Hormone,D,D12.644.548.587,Peptide Hormones,Peptides,13
Parathyroid Hormone,D,D06.472.699.590,Peptide Hormones,Hormones,13
Peptidyl-Dipeptidase A,D,D08.811.277.656.350.350.687,Dipeptidyl-Peptidases and Tripeptidyl-Peptidases,Exopeptidases,13
Perioperative Care,E,E04.604,"Surgical Procedures, Operative",NULL,13
Perioperative Care,E,E02.760.731,Patient Care,Therapeutics,13
Perioperative Care,N,N02.421.585.722,Patient Care,Health Services,13
Photochemotherapy,E,E02.774.722,Phototherapy,Therapeutics,13
Photochemotherapy,E,E02.186.500,Combined Modality Therapy,Therapeutics,13
Photochemotherapy,E,E02.319.685,Drug Therapy,Therapeutics,13
Polychlorinated Biphenyls,D,D02.455.526.439.773,"Hydrocarbons, Chlorinated","Hydrocarbons, Halogenated",13
Polychlorinated Biphenyls,D,D02.309.750,Dioxins and Dioxin-like Compounds,Organic Chemicals,13
Polychlorinated Biphenyls,D,D02.455.426.559.389.185.698,Biphenyl Compounds,Benzene Derivatives,13
Prophages,B,B04.123.655,Bacteriophages,Viruses,13
Protozoan Vaccines,D,D20.215.894.582,Vaccines,Biological Products,13
Psychological Distress,F,F01.470.315,Emotions,Behavior and Behavior Mechanisms,13
Rabies,C,C01.925.782.580.830.750,Rhabdoviridae Infections,Mononegavirales Infections,13
Refuse Disposal,N,N06.850.780.200.800.800.700,Sanitary Engineering,Sanitation,13
Refuse Disposal,N,N06.850.860.510.900.600,Waste Management,Sanitary Engineering,13
Religion and Medicine,K,K01.844.619,Religion,Humanities,13
Reproductive Rights,I,I01.880.604.473.675,Human Rights,"Social Control, Formal",13
Reproductive Rights,N,N03.706.437.675,Human Rights,"Social Control, Formal",13
"Reproductive Techniques, Assisted",E,E02.875.800,Reproductive Techniques,Therapeutics,13
"Reproductive Techniques, Assisted",E,E05.820.800,Reproductive Techniques,Investigative Techniques,13
Respiratory Rate,G,G09.772.705.730,Respiration,Respiratory Physiological Phenomena,13
Respiratory Rate,E,E01.370.600.875.875,Vital Signs,Physical Examination,13
Riboflavin,D,D23.767.405.650,Flavins,"Pigments, Biological",13
Riboflavin,D,D03.633.100.733.315.650,Flavins,Pteridines,13
Riboflavin,D,D03.633.300.507.650,Flavins,"Heterocyclic Compounds, 3-Ring",13
Riboflavin,D,D08.211.474.650,Flavins,Coenzymes,13
Ribotyping,E,E01.370.225.875.150.125.765,Bacterial Typing Techniques,Bacteriological Techniques,13
Ribotyping,E,E05.393.290.765,DNA Fingerprinting,Genetic Techniques,13
Ribotyping,E,E05.200.875.150.125.765,Bacterial Typing Techniques,Bacteriological Techniques,13
Rosette Formation,E,E05.200.812.706,Immunologic Tests,Clinical Laboratory Techniques,13
Rosette Formation,E,E05.478.594.730,Immunologic Tests,Immunologic Techniques,13
Rosette Formation,E,E01.370.225.812.706,Immunologic Tests,Clinical Laboratory Techniques,13
Salmonella enteritidis,B,B03.660.250.150.710.160.160,Salmonella enterica,Salmonella,13
Salmonella enteritidis,B,B03.440.450.425.800.200.300,Salmonella enterica,Salmonella,13
"Sexual Dysfunction, Physiological",C,C12.294.644,"Genital Diseases, Male",Male Urogenital Diseases,13
"Sexual Dysfunction, Physiological",C,C13.351.500.665,"Genital Diseases, Female",Female Urogenital Diseases,13
Sick Role,F,F01.829.316.616.751,Role,Group Processes,13
Single Person,F,F01.829.263.315.500.725,Marital Status,Family Characteristics,13
Single Person,I,I01.240.361.500.725,Marital Status,Family Characteristics,13
Single Person,I,I01.880.853.150.423.500.725,Marital Status,Family Characteristics,13
Single Person,N,N01.824.308.500.725,Marital Status,Family Characteristics,13
Single Person,N,N01.224.361.500.725,Marital Status,Family Characteristics,13
Single Person,M,M01.785,Persons,NULL,13
Spinal Cord Injuries,C,C10.900.850,"Trauma, Nervous System",Nervous System Diseases,13
Spinal Cord Injuries,C,C10.228.854.763,Spinal Cord Diseases,Central Nervous System Diseases,13
Spinal Cord Injuries,C,C26.819,Wounds and Injuries,NULL,13
Staff Development,N,N04.452.677.822,Personnel Management,Organization and Administration,13
Staff Development,I,I02.574.700,Inservice Training,Education,13
Subarachnoid Hemorrhage,C,C23.550.414.913.850,Intracranial Hemorrhages,Hemorrhage,13
Subarachnoid Hemorrhage,C,C10.228.140.300.535.800,Intracranial Hemorrhages,Cerebrovascular Disorders,13
Subarachnoid Hemorrhage,C,C14.907.253.573.800,Intracranial Hemorrhages,Cerebrovascular Disorders,13
Sulfones,D,D02.886.590,Sulfur Compounds,Organic Chemicals,13
Tandem Repeat Sequences,G,G02.111.570.080.708.800,"Repetitive Sequences, Nucleic Acid",Base Sequence,13
Tandem Repeat Sequences,G,G05.360.340.024.850,Genome Components,Genome,13
Tandem Repeat Sequences,G,G05.360.080.708.800,"Repetitive Sequences, Nucleic Acid",Base Sequence,13
Time and Motion Studies,F,F02.784.692.746.707,Task Performance and Analysis,"Psychology, Industrial",13
Time and Motion Studies,F,F02.784.412.846.707,Task Performance and Analysis,Ergonomics,13
"Tobacco, Smokeless",J,J01.637.767.844.500,Tobacco Products,Smoking Devices,13
"Translocation, Genetic",G,G05.365.590.175.870,Chromosome Aberrations,Mutation,13
"Translocation, Genetic",G,G05.558.860,Mutagenesis,Genetic Phenomena,13
"Translocation, Genetic",C,C23.550.210.870,Chromosome Aberrations,Pathologic Processes,13
Transportation of Patients,E,E02.365.839,Emergency Treatment,Therapeutics,13
Transportation of Patients,N,N02.421.297.879,Emergency Medical Services,Health Services,13
Triazines,D,D03.383.931,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,13
Vaginitis,C,C13.351.500.894.906,Vaginal Diseases,"Genital Diseases, Female",13
Vascular Resistance,G,G09.330.380.921,Hemodynamics,Cardiovascular Physiological Phenomena,13
Vector Borne Diseases,C,C01.920,Infections,NULL,13
Venous Thrombosis,C,C14.907.355.830.925,Thrombosis,Embolism and Thrombosis,13
Vincristine,D,D03.633.100.473.402.681.827.817,Vinca Alkaloids,Secologanin Tryptamine Alkaloids,13
Vincristine,D,D03.633.100.496.500.500.681.827.817,Vinca Alkaloids,Secologanin Tryptamine Alkaloids,13
Vincristine,D,D03.132.436.681.827.817,Vinca Alkaloids,Secologanin Tryptamine Alkaloids,13
Viral Matrix Proteins,D,D12.776.964.970.880.940,Viral Envelope Proteins,Viral Structural Proteins,13
Virus Activation,G,G06.920.925.940,Virus Replication,Virus Physiological Phenomena,13
Voluntary Health Agencies,N,N03.540.630.780,"Organizations, Nonprofit",Organizations,13
Welding,J,J01.576.655.875.400.900,Metallurgy,Extraction and Processing Industry,13
Yoga,K,K01.844.799.867,Religious Philosophies,Religion,13
Yoga,E,E02.779.474.937,Exercise Movement Techniques,Physical Therapy Modalities,13
Yoga,E,E02.190.525.937,Mind-Body Therapies,Complementary Therapies,13
Yoga,E,E02.190.901.984,Spiritual Therapies,Complementary Therapies,13
"Abortion, Criminal",I,I01.198.240.089,Crime,Criminology,12
"Abortion, Therapeutic",E,E04.520.050.060,"Abortion, Induced",Obstetric Surgical Procedures,12
Acclimatization,G,G07.025.133,"Adaptation, Physiological",Physiological Phenomena,12
Acclimatization,G,G16.012.500.133,"Adaptation, Physiological","Adaptation, Biological",12
Actinobacillus pleuropneumoniae,B,B03.660.250.550.050.580,Actinobacillus,Pasteurellaceae,12
Actinobacillus pleuropneumoniae,B,B03.440.450.009.580,Actinobacillus,Gram-Negative Facultatively Anaerobic Rods,12
Actuarial Analysis,N,N05.715.360.750.100,Statistics as Topic,Health Care Evaluation Mechanisms,12
Actuarial Analysis,E,E05.318.740.100,Statistics as Topic,Epidemiologic Methods,12
Actuarial Analysis,N,N06.850.520.830.100,Statistics as Topic,Epidemiologic Methods,12
Adamantane,D,D02.455.426.100.050,Bridged-Ring Compounds,"Hydrocarbons, Cyclic",12
Adamantane,D,D02.455.426.392.368.075,Cycloparaffins,"Hydrocarbons, Alicyclic",12
Adenoma,C,C04.557.470.035,"Neoplasms, Glandular and Epithelial",Neoplasms by Histologic Type,12
"Adenoviruses, Simian",B,B04.280.030.500.700,Mastadenovirus,Adenoviridae,12
Adenylyl Cyclases,D,D12.776.476.050,Intracellular Signaling Peptides and Proteins,Proteins,12
Adenylyl Cyclases,D,D08.811.520.650.200,Phosphorus-Oxygen Lyases,Lyases,12
Adenylyl Cyclases,D,D12.644.360.050,Intracellular Signaling Peptides and Proteins,Peptides,12
Affect,F,F01.470.047,Emotions,Behavior and Behavior Mechanisms,12
Aflatoxins,D,D03.633.100.150.119,Benzopyrans,"Heterocyclic Compounds, 2-Ring",12
Aflatoxins,D,D03.383.663.283.119,Benzopyrans,Pyrans,12
Aflatoxins,D,D23.946.587.142,Mycotoxins,"Toxins, Biological",12
Ambulances,N,N02.421.297.879.100,Transportation of Patients,Emergency Medical Services,12
Ambulances,J,J01.937.500.050,Motor Vehicles,Transportation,12
Ambulatory Surgical Procedures,E,E04.030,"Surgical Procedures, Operative",NULL,12
Amides,D,D02.065,Organic Chemicals,NULL,12
Anaerobiosis,G,G03.078,Metabolism,NULL,12
Anaerobiosis,G,G02.111.062,Biochemical Phenomena,Chemical Phenomena,12
Androstadienes,D,D04.210.500.054.079.129,Androstenes,Androstanes,12
"Antibodies, Anti-Idiotypic",D,D12.776.124.486.485.114.071,Antibodies,Immunoglobulins,12
"Antibodies, Anti-Idiotypic",D,D12.776.124.790.651.114.071,Antibodies,Immunoglobulins,12
"Antibodies, Anti-Idiotypic",D,D12.776.377.715.548.114.071,Antibodies,Immunoglobulins,12
Apolipoproteins B,D,D12.776.070.400.300,Apolipoproteins,Apoproteins,12
Apolipoproteins B,D,D10.532.091.300,Apolipoproteins,Lipoproteins,12
Apolipoproteins B,D,D12.776.521.120.300,Apolipoproteins,Lipoproteins,12
Appetite,F,F02.830.071,Psychophysiology,Psychological Phenomena,12
Appetite,G,G07.203.650.390.070,Hunger,Nutritional Physiological Phenomena,12
Appetite,G,G10.261.390.070,Hunger,Digestive System Physiological Phenomena,12
Arthralgia,G,G11.561.790.444.350,Pain,Sensation,12
Arthralgia,F,F02.830.816.444.350,Pain,Sensation,12
Arthralgia,C,C23.888.592.612.094,Pain,Neurologic Manifestations,12
Arthralgia,C,C05.550.091,Joint Diseases,Musculoskeletal Diseases,12
"Audiometry, Pure-Tone",E,E01.370.382.375.060.055,Audiometry,Hearing Tests,12
Audiovisual Aids,L,L01.178.820.090,Teaching Materials,Communications Media,12
Audiovisual Aids,J,J01.897.280.500,Educational Technology,Technology,12
Azathioprine,D,D13.570.900.111,Thionucleosides,Nucleosides,12
Azathioprine,D,D03.633.100.759.570.090,Mercaptopurine,Purines,12
Azathioprine,D,D02.886.759.111,Thionucleosides,Sulfur Compounds,12
Baltic States,Z,Z01.542.248.136,"Europe, Eastern",Europe,12
Bariatric Surgery,E,E04.062,"Surgical Procedures, Operative",NULL,12
Bariatric Surgery,E,E02.650.500.062,Bariatrics,Obesity Management,12
Biological Products,D,D20.215,Complex Mixtures,NULL,12
Blood Cells,A,A15.145.229,Blood,Hemic and Immune Systems,12
Blood Cells,A,A11.118,Cells,NULL,12
"Breast Neoplasms, Male",C,C04.588.180.260,Breast Neoplasms,Neoplasms by Site,12
"Breast Neoplasms, Male",C,C17.800.090.500.260,Breast Neoplasms,Breast Diseases,12
Bronchoscopy,E,E01.370.386.105,"Diagnostic Techniques, Respiratory System",Diagnostic Techniques and Procedures,12
Bronchoscopy,E,E01.370.388.250.100,Endoscopy,"Diagnostic Techniques, Surgical",12
Bronchoscopy,E,E04.502.250.100,Endoscopy,Minimally Invasive Surgical Procedures,12
Bronchoscopy,E,E04.928.600.080,Pulmonary Surgical Procedures,Thoracic Surgical Procedures,12
Buruli Ulcer,C,C17.800.893.295,Skin Ulcer,Skin Diseases,12
Buruli Ulcer,C,C01.150.252.410.040.552.475.247,"Mycobacterium Infections, Nontuberculous",Mycobacterium Infections,12
Carbapenem-Resistant Enterobacteriaceae,B,B03.660.250.150.097,Enterobacteriaceae,Gammaproteobacteria,12
Carbapenem-Resistant Enterobacteriaceae,B,B03.440.450.425.189,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,12
Carotid Artery Diseases,C,C14.907.253.123,Cerebrovascular Disorders,Vascular Diseases,12
Carotid Artery Diseases,C,C10.228.140.300.200,Cerebrovascular Disorders,Brain Diseases,12
"Catheterization, Swan-Ganz",E,E02.148.442.165,Cardiac Catheterization,Catheterization,12
"Catheterization, Swan-Ganz",E,E02.148.224.165,"Catheterization, Peripheral",Catheterization,12
"Catheterization, Swan-Ganz",E,E01.370.370.380.140.210,Cardiac Catheterization,Heart Function Tests,12
"Catheterization, Swan-Ganz",E,E04.502.382.937.165,"Catheterization, Peripheral",Endovascular Procedures,12
"Catheterization, Swan-Ganz",E,E04.100.814.529.937.165,"Catheterization, Peripheral",Endovascular Procedures,12
"Catheterization, Swan-Ganz",E,E05.157.250.165,Cardiac Catheterization,Catheterization,12
"Catheterization, Swan-Ganz",E,E05.157.375.165,"Catheterization, Peripheral",Catheterization,12
CD56 Antigen,D,D23.101.100.894.156,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",12
CD56 Antigen,D,D23.050.301.264.894.156,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",12
CD56 Antigen,D,D23.050.301.350.250.520.156,Neural Cell Adhesion Molecules,"Cell Adhesion Molecules, Neuronal",12
CD56 Antigen,D,D12.776.543.550.200.250.520.156,Neural Cell Adhesion Molecules,"Cell Adhesion Molecules, Neuronal",12
CD56 Antigen,D,D12.776.395.550.200.250.520.156,Neural Cell Adhesion Molecules,"Cell Adhesion Molecules, Neuronal",12
Cell Lineage,G,G08.686.155,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,12
Cell Lineage,G,G08.686.784.170.104.249,Embryonic Development,Embryonic and Fetal Development,12
Cell Lineage,G,G07.345.500.325.180.500,Embryonic Development,Embryonic and Fetal Development,12
Cell Lineage,G,G04.172,Cell Physiological Phenomena,NULL,12
Central Nervous System Neoplasms,C,C10.551.240,Nervous System Neoplasms,Nervous System Diseases,12
Central Nervous System Neoplasms,C,C04.588.614.250,Nervous System Neoplasms,Neoplasms by Site,12
Chemokine CCL4,D,D12.644.276.374.200.110.200,"Chemokines, CC",Chemokines,12
Chemokine CCL4,D,D12.644.276.374.200.600.200,Macrophage Inflammatory Proteins,Chemokines,12
Chemokine CCL4,D,D12.776.467.374.200.600.200,Macrophage Inflammatory Proteins,Chemokines,12
Chemokine CCL4,D,D12.776.467.374.200.110.200,"Chemokines, CC",Chemokines,12
Chemokine CCL4,D,D23.125.300.110.200,"Chemokines, CC",Chemokines,12
Chemokine CCL4,D,D23.125.300.600.750,Macrophage Inflammatory Proteins,Chemokines,12
Chemokine CCL4,D,D23.469.200.110.200,"Chemokines, CC",Chemokines,12
Chemokine CCL4,D,D23.529.374.200.110.200,"Chemokines, CC",Chemokines,12
Chemokine CCL4,D,D23.529.374.200.600.200,Macrophage Inflammatory Proteins,Chemokines,12
Chemokine CCL5,D,D23.529.374.200.110.250,"Chemokines, CC",Chemokines,12
Chemokine CCL5,D,D23.469.200.110.250,"Chemokines, CC",Chemokines,12
Chemokine CCL5,D,D23.125.300.110.250,"Chemokines, CC",Chemokines,12
Chemokine CCL5,D,D12.776.467.374.200.110.250,"Chemokines, CC",Chemokines,12
Chemokine CCL5,D,D12.644.276.374.200.110.250,"Chemokines, CC",Chemokines,12
Chemotaxis,G,G04.198.424,Cell Movement,Cell Physiological Phenomena,12
Chemotaxis,G,G07.568.500.590.500,Taxis Response,Locomotion,12
Chemotaxis,F,F01.145.875.439.500.500,Taxis Response,"Orientation, Spatial",12
Chemotaxis,F,F01.145.113.780.500,Taxis Response,"Behavior, Animal",12
Chemotaxis,G,G11.427.410.568.850.500,Taxis Response,Locomotion,12
"Chromosomes, Human, Pair 2",G,G05.360.162.520.300.235.245,"Chromosomes, Human, 1-3","Chromosomes, Human",12
"Chromosomes, Human, Pair 2",A,A11.284.187.520.300.235.245,"Chromosomes, Human, 1-3","Chromosomes, Human",12
Cigarette Smoking,F,F01.145.958.875.750,Tobacco Smoking,Tobacco Use,12
Cigarette Smoking,F,F01.145.805.375.750,Tobacco Smoking,Smoking,12
Colonialism,I,I01.696.116,Political Systems,Social Sciences,12
Coloring Agents,D,D27.720.233,Specialty Uses of Chemicals,Chemical Actions and Uses,12
"Condoms, Female",E,E07.190.250.260,"Contraceptive Devices, Female",Contraceptive Devices,12
Consensus Development Conferences as Topic,L,L01.178.682.759.150,Review Literature as Topic,Publications,12
Consensus Development Conferences as Topic,N,N03.540.199.205,Congresses as Topic,Organizations,12
Contraceptive Devices,E,E07.190,Equipment and Supplies,NULL,12
"Contraceptives, Postcoital",D,D27.505.954.705.360.276.310,"Contraceptive Agents, Female",Contraceptive Agents,12
"Contraceptives, Postcoital",D,D27.505.696.875.360.276.310,"Contraceptive Agents, Female",Contraceptive Agents,12
Contrast Sensitivity,E,E01.370.380.850.950.500,Visual Acuity,Vision Tests,12
Contrast Sensitivity,F,F02.463.593.932.901.500,Visual Acuity,Visual Perception,12
Contrast Sensitivity,F,F02.463.593.932.281,Visual Perception,Perception,12
Contrast Sensitivity,F,F02.463.593.778.435.110,Form Perception,Space Perception,12
Contrast Sensitivity,G,G14.940.500,Visual Acuity,Ocular Physiological Phenomena,12
COVID-19 Nucleic Acid Testing,E,E05.200.312.500,COVID-19 Testing,Clinical Laboratory Techniques,12
COVID-19 Nucleic Acid Testing,E,E01.370.225.312.500,COVID-19 Testing,Clinical Laboratory Techniques,12
Crack Cocaine,D,D26.878.250,Illicit Drugs,Pharmaceutical Preparations,12
Crack Cocaine,D,D03.132.889.354.250,Cocaine,Tropanes,12
Crack Cocaine,D,D03.605.869.388.250,Cocaine,Tropanes,12
Crack Cocaine,D,D03.605.084.500.722.388.250,Cocaine,Tropanes,12
Crack Cocaine,D,D02.145.074.722.388.250,Cocaine,Tropanes,12
Cuba,Z,Z01.107.084.900.225,West Indies,Caribbean Region,12
Cuba,Z,Z01.639.880.225,West Indies,Islands,12
Czech Republic,Z,Z01.542.248.395,"Europe, Eastern",Europe,12
Dairy Products,G,G07.203.300.350,Food,"Diet, Food, and Nutrition",12
Dairy Products,J,J02.500.350,Food,Food and Beverages,12
Data Management,L,L01.470.563,Information Storage and Retrieval,Information Science,12
Data Management,L,L01.399.375,Information Management,Information Science,12
Data Management,L,L01.453.233,Information Services,Information Science,12
Database Management Systems,N,N04.452.515.110,Management Information Systems,Organization and Administration,12
Database Management Systems,L,L01.224.068,Computing Methodologies,Information Science,12
Database Management Systems,L,L01.224.900.280,Software,Computing Methodologies,12
Deficiency Diseases,C,C18.654.521.500,Malnutrition,Nutrition Disorders,12
Delirium,C,C23.888.592.604.339.500,Confusion,Neurobehavioral Manifestations,12
Delirium,C,C10.597.606.337.500,Confusion,Neurobehavioral Manifestations,12
Delirium,F,F03.615.350,Neurocognitive Disorders,Mental Disorders,12
Delirium,F,F01.700.250.500,Confusion,Neurobehavioral Manifestations,12
Diastole,G,G09.330.580.295,Myocardial Contraction,Cardiovascular Physiological Phenomena,12
Diastole,G,G11.427.494.570.295,Myocardial Contraction,Muscle Contraction,12
Diastole,G,G11.427.494.554.250,Muscle Relaxation,Muscle Contraction,12
Didanosine,D,D03.633.100.759.590.616.130,Inosine,Purine Nucleosides,12
Didanosine,D,D13.570.800.573.130,Inosine,Ribonucleosides,12
Didanosine,D,D13.570.583.616.130,Inosine,Purine Nucleosides,12
Didanosine,D,D13.570.230.500.090,Dideoxynucleosides,Deoxyribonucleosides,12
"Discrimination, Psychological",F,F02.463.593.257,Perception,Mental Processes,12
DNA Gyrase,D,D08.811.399.403.741.149,"DNA Topoisomerases, Type II",DNA Topoisomerases,12
DNA Gyrase,D,D12.776.097.237,Bacterial Proteins,Proteins,12
Drainage,E,E02.309,Therapeutics,NULL,12
Drainage,E,E04.237,"Surgical Procedures, Operative",NULL,12
"Dysentery, Amebic",C,C06.405.205.331.312,Dysentery,Gastroenteritis,12
"Dysentery, Amebic",C,C06.405.469.452.396,"Intestinal Diseases, Parasitic",Intestinal Diseases,12
"Dysentery, Amebic",C,C06.405.469.300.312,Dysentery,Intestinal Diseases,12
"Dysentery, Amebic",C,C01.610.432.396,"Intestinal Diseases, Parasitic",Parasitic Diseases,12
"Dysentery, Amebic",C,C01.610.752.049.328,Amebiasis,Protozoan Infections,12
"Echocardiography, Doppler",E,E01.370.370.380.220.220,Echocardiography,Heart Function Tests,12
"Echocardiography, Doppler",E,E01.370.350.850.220.220,Echocardiography,Ultrasonography,12
"Echocardiography, Doppler",E,E01.370.350.850.850.220,"Ultrasonography, Doppler",Ultrasonography,12
"Echocardiography, Doppler",E,E01.370.350.130.750.220,Echocardiography,Cardiac Imaging Techniques,12
"Education, Nursing, Continuing",I,I02.358.212.450,"Education, Continuing","Education, Professional",12
"Education, Nursing, Continuing",I,I02.358.462.399,"Education, Nursing","Education, Professional",12
"Education, Public Health Professional",I,I02.358.556,"Education, Professional",Education,12
"Electrophoresis, Gel, Two-Dimensional",E,E05.196.401.250,Electrophoresis,"Chemistry Techniques, Analytical",12
"Electrophoresis, Gel, Two-Dimensional",E,E05.301.300.230,Electrophoresis,Electrochemical Techniques,12
Eligibility Determination,N,N04.452.264,Organization and Administration,Health Services Administration,12
Emergency Medicine,H,H02.403.250,Medicine,Health Occupations,12
Endometrium,A,A05.360.319.679.490,Uterus,"Genitalia, Female",12
Enterococcus faecium,B,B03.353.750.250.250.300,Enterococcus,Enterococcaceae,12
Enterococcus faecium,B,B03.510.550.250.250.300,Enterococcus,Enterococcaceae,12
Enteropathogenic Escherichia coli,B,B03.660.250.150.180.100.330,Escherichia coli,Escherichia,12
Enteropathogenic Escherichia coli,B,B03.440.450.425.325.300.330,Escherichia coli,Escherichia,12
Epithelium,A,A10.272,Tissues,NULL,12
Estrogen Receptor alpha,D,D12.776.826.750.350.174,"Receptors, Estrogen","Receptors, Steroid",12
"Evoked Potentials, Visual",G,G11.561.200.500.425,Evoked Potentials,Cortical Excitability,12
"Evoked Potentials, Visual",G,G14.330,Ocular Physiological Phenomena,NULL,12
"Evoked Potentials, Visual",G,G07.265.216.500.425,Evoked Potentials,Cortical Excitability,12
Executive Function,F,F02.463.217,Mental Processes,Psychological Phenomena,12
Eyelids,A,A09.371.337,Eye,Sense Organs,12
Eyelids,A,A01.456.505.420.504,Eye,Face,12
Fibroblast Growth Factors,D,D12.776.467.624,Intercellular Signaling Peptides and Proteins,Proteins,12
Fibroblast Growth Factors,D,D23.529.624,Intercellular Signaling Peptides and Proteins,Biological Factors,12
Fibroblast Growth Factors,D,D12.644.276.624,Intercellular Signaling Peptides and Proteins,Peptides,12
Firearms,J,J01.637.870.350,Weapons,Manufactured Materials,12
Flavonoids,D,D03.633.100.150.266.450,Chromones,Benzopyrans,12
Flavonoids,D,D03.383.663.283.266.450,Chromones,Benzopyrans,12
Folic Acid Deficiency,C,C18.654.521.500.133.699.308,Vitamin B Deficiency,Avitaminosis,12
Food Safety,J,J01.576.423.850.730.500,Food Quality,Food Technology,12
Food Safety,N,N06.850.601.500,Food Quality,Public Health,12
Gastric Mucosa,A,A03.556.875.875.440,Stomach,Upper Gastrointestinal Tract,12
Gastric Mucosa,A,A10.615.550.291,Mucous Membrane,Membranes,12
Gender-Based Violence,I,I01.198.240.856.463,Violence,Crime,12
"Genes, Dominant",G,G05.420.320,Inheritance Patterns,Genetic Phenomena,12
"Genes, Dominant",G,G05.360.340.024.340.240,Genes,Genome Components,12
"Genome, Insect",G,G05.360.340.357,Genome,Genetic Structures,12
Genomic Imprinting,G,G05.308.203.500,"Epigenesis, Genetic",Gene Expression Regulation,12
Glutathione Transferase,D,D08.811.913.225.500,Alkyl and Aryl Transferases,Transferases,12
Gonadal Steroid Hormones,D,D06.472.334.851,Gonadal Hormones,Hormones,12
GPI-Linked Proteins,D,D12.776.395.550.448,Membrane Glycoproteins,Glycoproteins,12
GPI-Linked Proteins,D,D12.776.543.550.418,Membrane Glycoproteins,Membrane Proteins,12
GPI-Linked Proteins,D,D12.776.543.484.500,Lipid-Linked Proteins,Membrane Proteins,12
Growth and Development,G,G07.345,Physiological Phenomena,NULL,12
Headache,C,C23.888.592.612.441,Pain,Neurologic Manifestations,12
Health Occupations,H,H02,NULL,NULL,12
Health Planning Organizations,N,N03.540.452,Organizations,Health Care Economics and Organizations,12
Healthy Aging,F,F01.829.458.205.250,Healthy Lifestyle,Life Style,12
"Heart Failure, Systolic",C,C14.280.434.676,Heart Failure,Heart Diseases,12
Hematinics,D,D27.505.954.502.543,Hematologic Agents,Therapeutic Uses,12
Heme,D,D23.767.727.640.587,Metalloporphyrins,Porphyrins,12
Heme,D,D04.345.783.500.640.587,Metalloporphyrins,Porphyrins,12
Heme,D,D03.633.400.909.500.640.587,Metalloporphyrins,Porphyrins,12
Heme,D,D03.383.129.578.840.500.640.587,Metalloporphyrins,Porphyrins,12
Hepatitis B Core Antigens,D,D23.050.327.495.500.450,Hepatitis B Antigens,Hepatitis Antigens,12
Hepatitis B e Antigens,D,D23.050.327.495.500.469,Hepatitis B Antigens,Hepatitis Antigens,12
"Hernia, Inguinal",C,C23.300.707.374.875,"Hernia, Abdominal",Hernia,12
"Herpesvirus 6, Human",B,B04.280.382.150.750.400,Roseolovirus,Betaherpesvirinae,12
"History, Modern 1601-",K,K01.400.504,History,Humanities,12
HLA-A Antigens,D,D23.050.301.500.450.370,HLA Antigens,Histocompatibility Antigens,12
HLA-A Antigens,D,D23.050.705.552.450.370,HLA Antigens,Histocompatibility Antigens,12
HLA-A Antigens,D,D23.050.705.552.100.400,Histocompatibility Antigens Class I,Histocompatibility Antigens,12
HLA-A Antigens,D,D12.776.543.550.439.400,Histocompatibility Antigens Class I,Membrane Glycoproteins,12
HLA-A Antigens,D,D23.050.301.500.100.400,Histocompatibility Antigens Class I,Histocompatibility Antigens,12
HLA-A Antigens,D,D12.776.395.550.489.400,Histocompatibility Antigens Class I,Membrane Glycoproteins,12
Human Activities,I,I03,NULL,NULL,12
Immunoelectrophoresis,E,E05.301.300.568,Electrophoresis,Electrochemical Techniques,12
Immunoelectrophoresis,E,E05.200.812.735.645.350.350,Immunodiffusion,Precipitin Tests,12
Immunoelectrophoresis,E,E05.196.401.568,Electrophoresis,"Chemistry Techniques, Analytical",12
Immunoelectrophoresis,E,E05.478.605.492.350.350,Immunodiffusion,Precipitin Tests,12
Immunoelectrophoresis,E,E05.478.594.760.645.350.350,Immunodiffusion,Precipitin Tests,12
Immunoelectrophoresis,E,E01.370.225.812.735.645.350.350,Immunodiffusion,Precipitin Tests,12
"Immunoglobulins, Intravenous",D,D12.776.377.715.548.114.632,Antibodies,Immunoglobulins,12
"Immunoglobulins, Intravenous",D,D12.776.124.486.485.114.632,Antibodies,Immunoglobulins,12
"Immunoglobulins, Intravenous",D,D12.776.124.486.485.114.619.393.536,Immunoglobulin G,Immunoglobulin Isotypes,12
"Immunoglobulins, Intravenous",D,D12.776.124.790.651.114.632,Antibodies,Immunoglobulins,12
Immunologic Deficiency Syndromes,C,C20.673,Immune System Diseases,NULL,12
INDEL Mutation,G,G05.558.370,Mutagenesis,Genetic Phenomena,12
INDEL Mutation,G,G05.365.590.500,Mutation,Genetic Variation,12
Indigenous Peoples,M,M01.686.754.254,Ethnic Groups,Population Groups,12
Infectious Mononucleosis,C,C20.683.515.515,Lymphoproliferative Disorders,Immunoproliferative Disorders,12
Infectious Mononucleosis,C,C15.378.553.381,Leukocyte Disorders,Hematologic Diseases,12
Infectious Mononucleosis,C,C15.604.515.516,Lymphoproliferative Disorders,Lymphatic Diseases,12
Infectious Mononucleosis,C,C01.925.256.466.313.400,Epstein-Barr Virus Infections,Herpesviridae Infections,12
Infliximab,D,D12.776.124.790.651.114.224.537,"Antibodies, Monoclonal",Antibodies,12
Infliximab,D,D12.776.124.486.485.114.224.608,"Antibodies, Monoclonal",Antibodies,12
Infliximab,D,D12.776.377.715.548.114.224.642,"Antibodies, Monoclonal",Antibodies,12
Intestinal Absorption,G,G10.261.353.500,Gastrointestinal Absorption,Digestive System Physiological Phenomena,12
Intestinal Absorption,G,G07.690.725.015.500.374.500,Gastrointestinal Absorption,"Absorption, Physiological",12
Intestinal Absorption,G,G07.203.650.372.500,Gastrointestinal Absorption,Nutritional Physiological Phenomena,12
Intestinal Absorption,G,G03.015.500.374.500,Gastrointestinal Absorption,"Absorption, Physiological",12
Intestinal Absorption,G,G03.787.024.500.374.500,Gastrointestinal Absorption,"Absorption, Physiological",12
"Intestine, Small",A,A03.556.124.684,Intestines,Gastrointestinal Tract,12
Intracellular Membranes,A,A11.284.149.450,Cell Membrane,Cellular Structures,12
Intracellular Membranes,A,A11.284.835.514,Subcellular Fractions,Cellular Structures,12
Intussusception,C,C06.405.469.531.577,Intestinal Obstruction,Intestinal Diseases,12
Legionnaires' Disease,C,C01.748.382.380,Legionellosis,Respiratory Tract Infections,12
Legionnaires' Disease,C,C01.150.252.400.500.501,Legionellosis,Gram-Negative Bacterial Infections,12
Legionnaires' Disease,C,C08.730.382.380,Legionellosis,Respiratory Tract Infections,12
Lesotho,Z,Z01.058.290.175.400,"Africa, Southern",Africa South of the Sahara,12
Leukocyte Common Antigens,D,D12.644.360.587.100.500,"Receptor-Like Protein Tyrosine Phosphatases, Class 1",Receptor-Like Protein Tyrosine Phosphatases,12
Leukocyte Common Antigens,D,D08.811.277.352.650.775.400.100.500,"Receptor-Like Protein Tyrosine Phosphatases, Class 1",Receptor-Like Protein Tyrosine Phosphatases,12
Leukocyte Common Antigens,D,D12.776.476.592.100.500,"Receptor-Like Protein Tyrosine Phosphatases, Class 1",Receptor-Like Protein Tyrosine Phosphatases,12
Leukocyte Common Antigens,D,D12.776.543.733.937.500,"Receptor-Like Protein Tyrosine Phosphatases, Class 1",Receptor-Like Protein Tyrosine Phosphatases,12
Literacy,F,F01.145.209.429,Communication,Behavior,12
Literacy,N,N01.824.196.500,Educational Status,Socioeconomic Factors,12
Macromolecular Substances,D,D05,NULL,NULL,12
Macula Lutea,A,A09.371.729.522,Retina,Eye,12
Mandatory Reporting,N,N03.706.657.249,Mandatory Programs,"Social Control, Formal",12
Mandatory Reporting,N,N03.706.535.615,Jurisprudence,"Social Control, Formal",12
Mandatory Reporting,I,I01.880.604.583.080.134.300,Disclosure,Confidentiality,12
Mandatory Reporting,I,I01.880.604.622.249,Mandatory Programs,"Social Control, Formal",12
Mandatory Reporting,I,I01.880.604.583.527,Jurisprudence,"Social Control, Formal",12
Matched-Pair Analysis,N,N05.715.360.750.500,Statistics as Topic,Health Care Evaluation Mechanisms,12
Matched-Pair Analysis,N,N05.715.360.325.500,Epidemiologic Research Design,Health Care Evaluation Mechanisms,12
Matched-Pair Analysis,E,E05.318.740.475,Statistics as Topic,Epidemiologic Methods,12
Matched-Pair Analysis,E,E05.318.370.485,Epidemiologic Research Design,Epidemiologic Methods,12
Matched-Pair Analysis,N,N06.850.520.830.475,Statistics as Topic,Epidemiologic Methods,12
Matched-Pair Analysis,N,N06.850.520.445.485,Epidemiologic Research Design,Epidemiologic Methods,12
Matrix Metalloproteinase 9,D,D08.811.277.656.675.374.205.360,Collagenases,Metalloendopeptidases,12
Matrix Metalloproteinase 9,D,D08.811.277.656.675.374.252.445,Gelatinases,Metalloendopeptidases,12
Matrix Metalloproteinase 9,D,D08.811.277.656.675.374.525.700.350,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,12
Matrix Metalloproteinase 9,D,D08.811.277.656.300.480.525.700.350,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,12
Matrix Metalloproteinase 9,D,D08.811.277.656.300.480.205.360,Collagenases,Metalloendopeptidases,12
Matrix Metalloproteinase 9,D,D08.811.277.656.300.480.252.445,Gelatinases,Metalloendopeptidases,12
Matrix Metalloproteinase 9,D,D12.644.276.848.350,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,12
Matrix Metalloproteinase 9,D,D12.776.467.836.350,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,12
Methylation,G,G03.059.538,Alkylation,Metabolism,12
Methylation,G,G02.607.094.538,Alkylation,Organic Chemistry Phenomena,12
Methylation,G,G02.111.035.538,Alkylation,Biochemical Phenomena,12
"Mice, Inbred DBA",B,B01.050.150.900.649.313.992.635.505.500.400.500,"Mice, Inbred Strains",Mice,12
"Mice, Inbred DBA",B,B01.050.050.199.520.520.500,"Mice, Inbred Strains","Animals, Inbred Strains",12
Microspheres,E,E07.565,Equipment and Supplies,NULL,12
Molecular Chaperones,D,D12.776.580,Proteins,"Amino Acids, Peptides, and Proteins",12
Mutant Proteins,D,D12.776.602,Proteins,"Amino Acids, Peptides, and Proteins",12
Mycobacterium ulcerans,B,B03.510.024.962.500.720.700,Nontuberculous Mycobacteria,Mycobacterium,12
Mycobacterium ulcerans,B,B03.510.460.400.410.552.552.720.700,Nontuberculous Mycobacteria,Mycobacterium,12
Myocarditis,C,C14.280.238.625,Cardiomyopathies,Heart Diseases,12
Necator americanus,B,B01.050.500.500.294.400.968.100.550.100,Necator,Ancylostomatoidea,12
Needles,E,E07.612,Equipment and Supplies,NULL,12
"Nerve Fibers, Myelinated",A,A08.675.542.512,Nerve Fibers,Neurons,12
"Nerve Fibers, Myelinated",A,A11.671.514,Neurons,Cells,12
"Nerve Fibers, Myelinated",A,A11.671.501.512,Nerve Fibers,Neurons,12
Neuralgia,C,C10.668.829.600,Peripheral Nervous System Diseases,Neuromuscular Diseases,12
Neuralgia,C,C23.888.592.612.664,Pain,Neurologic Manifestations,12
Neurofilament Proteins,D,D12.776.631.630,Nerve Tissue Proteins,Proteins,12
Neurofilament Proteins,D,D12.776.220.475.630,Intermediate Filament Proteins,Cytoskeletal Proteins,12
Neurofilament Proteins,D,D05.750.078.593.630,Intermediate Filament Proteins,Biopolymers,12
Normal Distribution,E,E05.318.740.994.500,Statistical Distributions,Statistics as Topic,12
Normal Distribution,N,N05.715.360.750.750.565,Statistical Distributions,Statistics as Topic,12
Normal Distribution,G,G17.820.500,Statistical Distributions,Mathematical Concepts,12
Normal Distribution,N,N06.850.520.830.994.500,Statistical Distributions,Statistics as Topic,12
"Nuclear Magnetic Resonance, Biomolecular",E,E05.196.867.519.550,Magnetic Resonance Spectroscopy,Spectrum Analysis,12
Nursing Care,N,N02.421.533,Health Services,"Health Care Facilities, Manpower, and Services",12
Nursing Care,E,E02.760.611,Patient Care,Therapeutics,12
Nutrition Therapy,E,E02.642,Therapeutics,NULL,12
Oligonucleotide Probes,D,D27.720.470.530.600.650,Nucleic Acid Probes,Molecular Probes,12
Oligonucleotide Probes,D,D27.505.259.750.600.650,Nucleic Acid Probes,Molecular Probes,12
Oligonucleotide Probes,D,D13.444.600.601,Nucleic Acid Probes,Nucleic Acids,12
Opossums,B,B01.050.150.900.649.573.575,Marsupialia,Mammals,12
"Osteoarthritis, Hip",C,C05.550.114.606.400,Osteoarthritis,Arthritis,12
"Osteoarthritis, Hip",C,C05.799.613.400,Osteoarthritis,Rheumatic Diseases,12
Paper,J,J01.637.650,Manufactured Materials,"Technology, Industry, and Agriculture",12
Patient Care Management,N,N04.590,Health Services Administration,NULL,12
Penetrance,G,G05.420.655,Inheritance Patterns,Genetic Phenomena,12
Penetrance,G,G05.695.650,Phenotype,Genetic Phenomena,12
Pentamidine,D,D02.078.100.700,Benzamidines,Amidines,12
Pesticide Residues,D,D27.720.031.700.672,Pesticides,Agrochemicals,12
Pesticide Residues,D,D27.888.723.697,Pesticides,Toxic Actions,12
Pesticide Residues,N,N06.850.460.200.700,Body Burden,Environmental Pollution,12
Pharmacogenetics,H,H02.628.479,Pharmacology,Health Occupations,12
Pharmacogenetics,H,H01.158.273.343.750,Genetics,Biology,12
Pharmacogenetics,H,H01.158.703.052,Pharmacology,Biological Science Disciplines,12
Pharmacy,H,H02.646,Health Occupations,NULL,12
Phenols,D,D02.455.426.559.389.657,Benzene Derivatives,"Hydrocarbons, Aromatic",12
Photic Stimulation,E,E05.723.729,Physical Stimulation,Investigative Techniques,12
Placebo Effect,N,N06.850.490.734.875,"Effect Modifier, Epidemiologic",Epidemiologic Factors,12
Placebo Effect,N,N05.715.350.350.625,"Effect Modifier, Epidemiologic",Epidemiologic Factors,12
Platelet Aggregation,G,G09.188.370.687,Hemorheology,Blood Physiological Phenomena,12
Platelet Aggregation,G,G09.188.390.600.640,Platelet Activation,Hemostasis,12
Pneumonectomy,E,E04.928.600.600,Pulmonary Surgical Procedures,Thoracic Surgical Procedures,12
Pneumonectomy,E,E04.620,"Surgical Procedures, Operative",NULL,12
Pollen,A,A18.024.249.500.249.500,"Germ Cells, Plant",Flowers,12
Porins,D,D12.776.543.550.450.730,Ion Channels,Membrane Glycoproteins,12
Porins,D,D12.776.543.585.400.730,Ion Channels,Membrane Transport Proteins,12
Porins,D,D12.776.157.530.400.500,Ion Channels,Membrane Transport Proteins,12
Premedication,E,E02.319.703,Drug Therapy,Therapeutics,12
Product Packaging,J,J01.576.761,Industry,"Technology, Industry, and Agriculture",12
Programmed Cell Death 1 Receptor,D,D23.101.100.894.790,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",12
Programmed Cell Death 1 Receptor,D,D12.776.543.750.705.222.875,Costimulatory and Inhibitory T-Cell Receptors,"Receptors, Immunologic",12
Programmed Cell Death 1 Receptor,D,D12.776.465.844,Immune Checkpoint Proteins,Proteins,12
Programmed Cell Death 1 Receptor,D,D23.050.301.264.894.790,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",12
Proto-Oncogene Proteins,D,D12.776.624.664.700,Oncogene Proteins,Neoplasm Proteins,12
Proxy,M,M01.380.600,Legal Guardians,Persons,12
Psychological Tests,F,F04.711,Behavioral Disciplines and Activities,NULL,12
Pulmonary Artery,A,A07.015.114.715,Arteries,Blood Vessels,12
Pulmonary Medicine,H,H02.403.429.675,Internal Medicine,Medicine,12
Pulse Wave Analysis,E,E01.370.370.680,"Diagnostic Techniques, Cardiovascular",Diagnostic Techniques and Procedures,12
Radionuclide Imaging,E,E01.370.350.710,Diagnostic Imaging,Diagnostic Techniques and Procedures,12
Radionuclide Imaging,E,E01.370.384.730,"Diagnostic Techniques, Radioisotope",Diagnostic Techniques and Procedures,12
"Receptors, CXCR4",D,D12.776.543.750.705.852.125.500.400,"Receptors, CXCR","Receptors, Chemokine",12
"Receptors, CXCR4",D,D12.776.543.750.830.700.650,"Receptors, HIV","Receptors, Virus",12
"Receptors, CXCR4",D,D12.776.543.750.695.160.500.400,"Receptors, CXCR","Receptors, Chemokine",12
"Receptors, Dopamine D2",D,D12.776.543.750.695.150.400.500,"Receptors, Dopamine","Receptors, Catecholamine",12
"Receptors, Dopamine D2",D,D12.776.543.750.670.300.400.500,"Receptors, Dopamine","Receptors, Catecholamine",12
"Receptors, Dopamine D2",D,D12.776.543.750.720.330.400.500,"Receptors, Dopamine","Receptors, Catecholamine",12
Records,L,L01.399.250.900,Data Collection,Information Management,12
Records,N,N04.452.859,Organization and Administration,Health Services Administration,12
Records,N,N06.850.520.308.940,Data Collection,Epidemiologic Methods,12
Records,N,N05.715.360.300.715,Data Collection,Health Care Evaluation Mechanisms,12
Records,E,E05.318.308.940,Data Collection,Epidemiologic Methods,12
Rehydration Solutions,D,D26.776.741,Solutions,Pharmaceutical Preparations,12
Respiratory Burst,G,G03.197.620,Cell Respiration,Metabolism,12
Respiratory Burst,G,G04.270.620,Cell Respiration,Cell Physiological Phenomena,12
Respiratory Syncytial Virus Vaccines,D,D20.215.894.899.730,Viral Vaccines,Vaccines,12
RNA-Dependent RNA Polymerase,D,D08.811.913.696.445.735.780,RNA Nucleotidyltransferases,Nucleotidyltransferases,12
"Schools, Public Health",I,I02.783.495.765,"Schools, Health Occupations",Schools,12
Shock,C,C23.550.835,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",12
Sinusitis,C,C08.730.749,Respiratory Tract Infections,Respiratory Tract Diseases,12
Sinusitis,C,C09.603.692.752,Paranasal Sinus Diseases,Nose Diseases,12
Sinusitis,C,C08.460.692.752,Paranasal Sinus Diseases,Nose Diseases,12
Sinusitis,C,C01.748.749,Respiratory Tract Infections,Infections,12
Skin Pigmentation,E,E01.370.600.620.750,Pigmentation,Physical Examination,12
Skin Pigmentation,E,E01.370.600.115.450.500,"Physical Appearance, Body",Body Constitution,12
Skin Pigmentation,G,G16.690.890,Pigmentation,Biological Phenomena,12
Skin Pigmentation,G,G13.750.837,Skin Physiological Phenomena,Integumentary System Physiological Phenomena,12
Skin Pigmentation,G,G07.100.175.500,"Physical Appearance, Body",Body Constitution,12
Slovenia,Z,Z01.542.248.820,"Europe, Eastern",Europe,12
Social Adjustment,F,F01.145.813.621,Social Behavior,Behavior,12
Soil Pollutants,D,D27.888.284.756,Environmental Pollutants,Toxic Actions,12
Solvents,D,D27.720.844,Specialty Uses of Chemicals,Chemical Actions and Uses,12
"Specialties, Surgical",H,H02.403.810,Medicine,Health Occupations,12
Stem Cells,A,A11.872,Cells,NULL,12
Strongylida Infections,C,C01.610.335.508.700.775,Secernentea Infections,Nematode Infections,12
Surgeons,M,M01.526.485.810.910,Physicians,Health Personnel,12
Surgeons,N,N02.360.810.910,Physicians,Health Personnel,12
Swimming,G,G11.427.410.568.800,Locomotion,Movement,12
Swimming,G,G11.427.410.698.277.875,Exercise,Motor Activity,12
Swimming,I,I03.450.642.845.945.500,Water Sports,Sports,12
Swimming,I,I03.350.875,Exercise,Human Activities,12
Task Performance and Analysis,F,F02.784.412.846,Ergonomics,"Psychology, Applied",12
Task Performance and Analysis,F,F02.808.600,Psychomotor Performance,Psychological Phenomena,12
Task Performance and Analysis,F,F02.784.692.746,"Psychology, Industrial","Psychology, Applied",12
Tears,A,A12.200.882,Bodily Secretions,Fluids and Secretions,12
Thyroxine,D,D12.125.072.050.767,"Amino Acids, Aromatic","Amino Acids, Cyclic",12
Thyroxine,D,D06.472.931.812,Thyroid Hormones,Hormones,12
Tibia,A,A02.835.232.043.650.883,Leg Bones,Bones of Lower Extremity,12
Tonsillectomy,E,E04.580.848,Otorhinolaryngologic Surgical Procedures,"Surgical Procedures, Operative",12
Transcatheter Aortic Valve Replacement,E,E04.650.410.500,Heart Valve Prosthesis Implantation,Prosthesis Implantation,12
Transcatheter Aortic Valve Replacement,E,E04.928.220.410.500,Heart Valve Prosthesis Implantation,Cardiac Surgical Procedures,12
Transcatheter Aortic Valve Replacement,E,E04.100.376.485.500,Heart Valve Prosthesis Implantation,Cardiac Surgical Procedures,12
"Transduction, Genetic",E,E05.393.350.800,Gene Transfer Techniques,Genetic Techniques,12
"Transduction, Genetic",G,G05.728.850,"Recombination, Genetic",Genetic Phenomena,12
Treatment Adherence and Compliance,F,F01.145.488.887,Health Behavior,Behavior,12
Treatment Adherence and Compliance,F,F01.100.150.750,Attitude to Health,Attitude,12
Treatment Adherence and Compliance,N,N05.300.150.800,Attitude to Health,Delivery of Health Care,12
Urea,D,D02.065.950,Amides,Organic Chemicals,12
Uterine Hemorrhage,C,C23.550.414.993,Hemorrhage,Pathologic Processes,12
Uterine Hemorrhage,C,C13.351.500.852.691,Uterine Diseases,"Genital Diseases, Female",12
Vaccine-Preventable Diseases,C,C01.918,Infections,NULL,12
Vascular Surgical Procedures,E,E04.100.814,Cardiovascular Surgical Procedures,"Surgical Procedures, Operative",12
Vasoconstrictor Agents,D,D27.505.954.411.793,Cardiovascular Agents,Therapeutic Uses,12
Veterinary Medicine,H,H02.956,Health Occupations,NULL,12
Videotape Recording,J,J01.897.280.500.898.840,Television,Audiovisual Aids,12
Videotape Recording,J,J01.897.280.500.846.734,Tape Recording,Audiovisual Aids,12
Videotape Recording,L,L01.280.940.840,Tape Recording,Copying Processes,12
Videotape Recording,L,L01.280.960.880,Video Recording,Copying Processes,12
Videotape Recording,L,L01.178.820.090.898.840,Television,Audiovisual Aids,12
Videotape Recording,L,L01.178.820.090.846.734,Tape Recording,Audiovisual Aids,12
Videotape Recording,L,L01.178.590.875.840,Television,Mass Media,12
Vitrectomy,E,E04.540.960,Ophthalmologic Surgical Procedures,"Surgical Procedures, Operative",12
Washington,Z,Z01.107.567.875.560.900,Northwestern United States,United States,12
Washington,Z,Z01.107.567.875.580.900,Pacific States,United States,12
Watchful Waiting,N,N04.761.559.590.900,"Outcome Assessment, Health Care","Outcome and Process Assessment, Health Care",12
West Virginia,Z,Z01.107.567.875.750.900,Southeastern United States,United States,12
West Virginia,Z,Z01.107.567.875.075.900,Appalachian Region,United States,12
Acculturation,I,I01.880.853.100.079,Culture,Sociological Factors,11
Acculturation,I,I01.076.201.450.050,Culture,"Anthropology, Cultural",11
Actin Cytoskeleton,A,A11.284.430.214.190.750.050,Cytoskeleton,Cytoplasmic Structures,11
"Administration, Rectal",E,E02.319.267.120.655.750,"Administration, Mucosal","Administration, Topical",11
Aeromonas,B,B03.440.450.019.025,Aeromonadaceae,Gram-Negative Facultatively Anaerobic Rods,11
African Swine Fever,C,C01.925.081.078,Arbovirus Infections,Virus Diseases,11
African Swine Fever,C,C01.920.930.125,Tick-Borne Diseases,Vector Borne Diseases,11
African Swine Fever,C,C01.925.256.142,DNA Virus Infections,Virus Diseases,11
African Swine Fever,C,C22.905.072,Swine Diseases,Animal Diseases,11
Alphavirus Infections,C,C01.920.500.078,Arbovirus Infections,Vector Borne Diseases,11
Alphavirus Infections,C,C01.925.782.930.100,Togaviridae Infections,RNA Virus Infections,11
Amyloid,D,D05.500.049,Multiprotein Complexes,Macromolecular Substances,11
Amyloid,D,D12.776.049,Proteins,"Amino Acids, Peptides, and Proteins",11
"Anesthesia, Local",E,E03.155.086.231,"Anesthesia, Conduction",Anesthesia,11
"Angina, Stable",C,C23.888.592.612.233.500.575,Angina Pectoris,Chest Pain,11
"Angina, Stable",C,C14.280.647.187.362,Angina Pectoris,Myocardial Ischemia,11
"Angina, Stable",C,C14.907.585.187.362,Angina Pectoris,Myocardial Ischemia,11
Angioplasty,E,E02.148.050,Catheterization,Therapeutics,11
Angioplasty,E,E04.100.814.529.124,Endovascular Procedures,Vascular Surgical Procedures,11
Angioplasty,E,E04.502.382.124,Endovascular Procedures,Minimally Invasive Surgical Procedures,11
Angioplasty,E,E05.157.016,Catheterization,Investigative Techniques,11
Antigen-Presenting Cells,A,A15.382.066,Immune System,Hemic and Immune Systems,11
Antigen-Presenting Cells,A,A11.066,Cells,NULL,11
Antivenins,D,D20.215.401.601.163,Antitoxins,Immune Sera,11
Antivenins,D,D12.776.124.486.485.114.573.601.138,Antitoxins,Immune Sera,11
Antivenins,D,D12.776.124.790.651.114.573.601.138,Antitoxins,Immune Sera,11
Antivenins,D,D12.776.377.715.548.114.573.601.138,Antitoxins,Immune Sera,11
Apolipoprotein E4,D,D12.776.070.400.500.750,Apolipoproteins E,Apolipoproteins,11
Apolipoprotein E4,D,D10.532.091.500.750,Apolipoproteins E,Apolipoproteins,11
Apolipoprotein E4,D,D12.776.521.120.500.750,Apolipoproteins E,Apolipoproteins,11
Audiometry,E,E01.370.382.375.060,Hearing Tests,"Diagnostic Techniques, Otological",11
Benzothiazoles,D,D03.383.129.708.089,Thiazoles,Azoles,11
Benzothiazoles,D,D03.633.100.185,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",11
Bioethics,K,K01.752.566.479.045,Ethics,Morals,11
Bioethics,N,N05.350.200,Ethics,"Health Care Quality, Access, and Evaluation",11
Biotechnology,J,J01.897.120,Technology,"Technology, Industry, and Agriculture",11
Biotechnology,H,H01.158.550,Biological Science Disciplines,Natural Science Disciplines,11
Blood Coagulation Factors,D,D12.776.124.125,Blood Proteins,Proteins,11
Blood Coagulation Factors,D,D23.119,Biological Factors,NULL,11
Blood-Borne Pathogens,B,B05.155,Organism Forms,NULL,11
Body Temperature Regulation,G,G16.012.500.535,"Adaptation, Physiological","Adaptation, Biological",11
Body Temperature Regulation,G,G07.110.232,Body Temperature,Physiological Phenomena,11
Body Temperature Regulation,G,G07.410.421,Homeostasis,Physiological Phenomena,11
Camelus,B,B01.050.150.900.649.313.500.190.180,Camelidae,Artiodactyla,11
"Carcinogens, Environmental",D,D27.888.569.100.125,Carcinogens,Noxae,11
"Carcinoma, Renal Cell",C,C04.557.470.200.025.390,Adenocarcinoma,Carcinoma,11
"Carcinoma, Renal Cell",C,C04.588.945.947.535.160,Kidney Neoplasms,Urologic Neoplasms,11
"Carcinoma, Renal Cell",C,C13.351.937.820.535.160,Kidney Neoplasms,Urologic Neoplasms,11
"Carcinoma, Renal Cell",C,C13.351.968.419.473.160,Kidney Neoplasms,Kidney Diseases,11
"Carcinoma, Renal Cell",C,C12.758.820.750.160,Kidney Neoplasms,Urologic Neoplasms,11
"Carcinoma, Renal Cell",C,C12.777.419.473.160,Kidney Neoplasms,Kidney Diseases,11
"Cardiomyopathy, Hypertrophic",C,C14.280.484.048.750.070.160,"Aortic Stenosis, Subvalvular",Aortic Valve Stenosis,11
"Cardiomyopathy, Hypertrophic",C,C14.280.238.100,Cardiomyopathies,Heart Diseases,11
Catastrophic Illness,C,C23.550.291.250,Disease Attributes,Pathologic Processes,11
Catheter-Related Infections,C,C01.195,Infections,NULL,11
Cefixime,D,D02.065.589.099.249.190.190.115,Cefotaxime,Cephacetrile,11
Cefixime,D,D03.633.100.300.249.190.190.115,Cefotaxime,Cephacetrile,11
Cefixime,D,D02.886.665.074.190.190.115,Cefotaxime,Cephacetrile,11
"Centrifugation, Density Gradient",E,E05.181.724.336,Ultracentrifugation,Centrifugation,11
"Centrifugation, Density Gradient",E,E05.196.941.336,Ultracentrifugation,"Chemistry Techniques, Analytical",11
Centromere,G,G05.360.160.165,Chromosome Structures,Genetic Structures,11
Centromere,A,A11.284.430.106.279.345.190.160.165,Chromosome Structures,Chromosomes,11
Chemical Phenomena,G,G02,NULL,NULL,11
Chlorine,D,D01.268.380.150,Halogens,Elements,11
Chlorine,D,D01.362.225,Gases,Inorganic Chemicals,11
"Circumcision, Female",E,E02.218.085.165,"Body Modification, Non-Therapeutic",Cosmetic Techniques,11
"Circumcision, Female",E,E04.950.300.200,Gynecologic Surgical Procedures,Urogenital Surgical Procedures,11
"Circumcision, Female",E,E04.085.165,"Body Modification, Non-Therapeutic","Surgical Procedures, Operative",11
"Circumcision, Female",I,I01.076.201.450.199,Culture,"Anthropology, Cultural",11
"Clinical Trials, Phase I as Topic",N,N05.715.360.330.250.250.200,Clinical Trials as Topic,Clinical Studies as Topic,11
"Clinical Trials, Phase I as Topic",E,E05.318.372.250.250.200,Clinical Trials as Topic,Clinical Studies as Topic,11
"Clinical Trials, Phase I as Topic",N,N06.850.520.450.250.250.200,Clinical Trials as Topic,Clinical Studies as Topic,11
Colistin,D,D12.776.543.695.054.600.110,Polymyxins,Antimicrobial Cationic Peptides,11
Colistin,D,D04.345.566.780.110,Polymyxins,"Peptides, Cyclic",11
Colistin,D,D10.477.750.110,Polymyxins,Lipopeptides,11
Colistin,D,D12.644.050.600.110,Polymyxins,Antimicrobial Cationic Peptides,11
Colistin,D,D12.644.641.780.110,Polymyxins,"Peptides, Cyclic",11
Color,G,G01.590.540.199,Light,Optical Phenomena,11
Coronary Care Units,N,N02.278.388.493.211,Intensive Care Units,Hospital Units,11
Counterfeit Drugs,D,D26.894.500,Substandard Drugs,Pharmaceutical Preparations,11
COVID-19 Serological Testing,E,E01.370.225.312.250,COVID-19 Testing,Clinical Laboratory Techniques,11
COVID-19 Serological Testing,E,E01.370.225.812.735.258,Serologic Tests,Immunologic Tests,11
COVID-19 Serological Testing,E,E05.478.594.760.258,Serologic Tests,Immunologic Tests,11
COVID-19 Serological Testing,E,E05.200.312.250,COVID-19 Testing,Clinical Laboratory Techniques,11
COVID-19 Serological Testing,E,E05.200.812.735.258,Serologic Tests,Immunologic Tests,11
Cues,F,F02.463.425.234,Learning,Mental Processes,11
Cystic Fibrosis Transmembrane Conductance Regulator,D,D12.776.543.585.400.175.125,Chloride Channels,Ion Channels,11
Cystic Fibrosis Transmembrane Conductance Regulator,D,D12.776.543.585.450.074.500.500.500.500,Multidrug Resistance-Associated Proteins,"Organic Anion Transporters, ATP-Dependent",11
Cystic Fibrosis Transmembrane Conductance Regulator,D,D12.776.543.550.450.175.125,Chloride Channels,Ion Channels,11
Cystic Fibrosis Transmembrane Conductance Regulator,D,D12.776.543.585.100.304.500,Multidrug Resistance-Associated Proteins,ATP-Binding Cassette Transporters,11
Cystic Fibrosis Transmembrane Conductance Regulator,D,D12.776.157.530.400.175.125,Chloride Channels,Ion Channels,11
Cystic Fibrosis Transmembrane Conductance Regulator,D,D12.776.157.530.100.304.500,Multidrug Resistance-Associated Proteins,ATP-Binding Cassette Transporters,11
Cystic Fibrosis Transmembrane Conductance Regulator,D,D12.776.157.530.450.074.500.500.500.500,Multidrug Resistance-Associated Proteins,"Organic Anion Transporters, ATP-Dependent",11
"Day Care, Medical",E,E02.760.246,Patient Care,Therapeutics,11
"Day Care, Medical",N,N02.421.585.246,Patient Care,Health Services,11
Deafness,C,C23.888.592.763.393.341.186,Hearing Loss,Hearing Disorders,11
Deafness,C,C10.597.751.418.341.186,Hearing Loss,Hearing Disorders,11
Deafness,C,C09.218.458.341.186,Hearing Loss,Hearing Disorders,11
Deception,F,F01.145.813.157,Social Behavior,Behavior,11
Democracy,I,I01.696.374,Political Systems,Social Sciences,11
Dentin,A,A14.549.167.900.280,Tooth Components,Dentition,11
"Deoxyribonucleases, Type II Site-Specific",D,D08.811.150.280.260,DNA Restriction Enzymes,DNA Restriction-Modification Enzymes,11
"Deoxyribonucleases, Type II Site-Specific",D,D08.811.277.352.355.325.300.260,DNA Restriction Enzymes,Endodeoxyribonucleases,11
"Deoxyribonucleases, Type II Site-Specific",D,D08.811.277.352.335.350.300.260,DNA Restriction Enzymes,Endodeoxyribonucleases,11
Dermoscopy,E,E01.370.350.515.277.250,Intravital Microscopy,Microscopy,11
Dermoscopy,E,E05.595.185.250,Intravital Microscopy,Microscopy,11
Dextrans,D,D05.750.078.562.272,Glucans,Biopolymers,11
Dextrans,D,D09.698.365.272,Glucans,Polysaccharides,11
Diagnosis,E,E01,NULL,NULL,11
Diffusion Tensor Imaging,E,E01.370.350.578.750,Neuroimaging,Diagnostic Imaging,11
Diffusion Tensor Imaging,E,E01.370.350.825.500.150.500,Diffusion Magnetic Resonance Imaging,Magnetic Resonance Imaging,11
Diffusion Tensor Imaging,E,E01.370.376.537.500,Neuroimaging,"Diagnostic Techniques, Neurological",11
Diffusion Tensor Imaging,E,E05.629.750,Neuroimaging,Investigative Techniques,11
"DNA Barcoding, Taxonomic",E,E05.393.760.700.149,"Sequence Analysis, DNA",Sequence Analysis,11
"DNA Barcoding, Taxonomic",E,E05.393.542.249,Molecular Typing,Genetic Techniques,11
"DNA, Intergenic",G,G05.360.340.024.220,Genome Components,Genome,11
"DNA, Intergenic",D,D13.444.308.324,DNA,Nucleic Acids,11
Drosophila,B,B01.050.500.131.617.720.500.500.750.310.250,Drosophilidae,Diptera,11
Drowning,C,C26.304,Wounds and Injuries,NULL,11
Drowning,C,C23.550.260.393,Death,Pathologic Processes,11
Drowning,N,N06.850.135.696,Accidents,Public Health,11
"Drug Resistance, Multiple, Viral",G,G07.690.773.984.269.420.500,"Drug Resistance, Viral","Drug Resistance, Microbial",11
"Drug Resistance, Multiple, Viral",G,G07.690.773.984.300.750,"Drug Resistance, Multiple",Drug Resistance,11
"Drug Resistance, Multiple, Viral",G,G06.225.420.500,"Drug Resistance, Viral","Drug Resistance, Microbial",11
"Drug Resistance, Multiple, Viral",G,G06.920.225.500,"Drug Resistance, Viral",Virus Physiological Phenomena,11
Echinococcosis,C,C01.610.335.190.396,Cestode Infections,Helminthiasis,11
Economic Status,N,N01.824.098,Socioeconomic Factors,Population Characteristics,11
Economic Status,I,I01.880.853.996.268,Socioeconomic Factors,Sociological Factors,11
Electrolytes,D,D01.248,Inorganic Chemicals,NULL,11
Electrophysiology,H,H01.158.344.528,Biophysics,Biological Science Disciplines,11
Electrophysiology,H,H01.158.782.236,Physiology,Biological Science Disciplines,11
Endopeptidases,D,D08.811.277.656.300,Peptide Hydrolases,Hydrolases,11
"Enhancer Elements, Genetic",G,G05.360.080.689.330,"Regulatory Sequences, Nucleic Acid",Base Sequence,11
"Enhancer Elements, Genetic",G,G05.360.340.024.340.137.750.249,"Regulatory Elements, Transcriptional",Gene Components,11
"Enhancer Elements, Genetic",G,G02.111.570.080.689.330,"Regulatory Sequences, Nucleic Acid",Base Sequence,11
Enteritis,C,C06.405.469.326,Intestinal Diseases,Gastrointestinal Diseases,11
Enteritis,C,C06.405.205.462,Gastroenteritis,Gastrointestinal Diseases,11
Enterotoxigenic Escherichia coli,B,B03.660.250.150.180.100.340,Escherichia coli,Escherichia,11
Enterotoxigenic Escherichia coli,B,B03.440.450.425.325.300.340,Escherichia coli,Escherichia,11
Episode of Care,E,E02.760.300,Patient Care,Therapeutics,11
Episode of Care,N,N02.421.585.300,Patient Care,Health Services,11
"Epitopes, B-Lymphocyte",D,D23.050.550.395,Epitopes,Antigens,11
Equivalence Trials as Topic,N,N05.715.360.330.250.250.365.500.250,Randomized Controlled Trials as Topic,Controlled Clinical Trials as Topic,11
Equivalence Trials as Topic,E,E05.318.372.250.250.365.500.250,Randomized Controlled Trials as Topic,Controlled Clinical Trials as Topic,11
Equivalence Trials as Topic,N,N06.850.520.450.250.250.365.500.250,Randomized Controlled Trials as Topic,Controlled Clinical Trials as Topic,11
Etanercept,D,D12.776.543.750.705.852.760.232,"Receptors, Tumor Necrosis Factor","Receptors, Cytokine",11
Etanercept,D,D12.644.541.500.697.624,Immunoglobulin Fc Fragments,Immunoglobulin Fragments,11
Etanercept,D,D12.776.124.790.651.538.500.624,Immunoglobulin Fc Fragments,Immunoglobulin Constant Regions,11
Etanercept,D,D12.776.124.790.651.680.660.624,Immunoglobulin Fc Fragments,Immunoglobulin Fragments,11
Etanercept,D,D12.776.124.486.485.538.500.624,Immunoglobulin Fc Fragments,Immunoglobulin Constant Regions,11
Etanercept,D,D12.776.124.486.485.680.697.624,Immunoglobulin Fc Fragments,Immunoglobulin Fragments,11
Etanercept,D,D12.776.377.715.548.538.500.624,Immunoglobulin Fc Fragments,Immunoglobulin Constant Regions,11
Etanercept,D,D12.776.377.715.548.680.660.624,Immunoglobulin Fc Fragments,Immunoglobulin Fragments,11
Eye Injuries,C,C26.915.300.425.250,Facial Injuries,Craniocerebral Trauma,11
Eye Injuries,C,C10.900.300.284.250,Facial Injuries,Craniocerebral Trauma,11
Eye Injuries,C,C11.297,Eye Diseases,NULL,11
Eye Neoplasms,C,C11.319,Eye Diseases,NULL,11
Eye Neoplasms,C,C04.588.364,Neoplasms by Site,Neoplasms,11
Fee-for-Service Plans,N,N04.452.758.745.225,Private Practice,Professional Practice,11
Fee-for-Service Plans,N,N03.219.521.710.305.090,Reimbursement Mechanisms,"Insurance, Health, Reimbursement",11
Fee-for-Service Plans,N,N03.219.442.195,Fees and Charges,Economics,11
Female Urogenital Diseases,C,C13.351,Female Urogenital Diseases and Pregnancy Complications,NULL,11
Femoral Neck Fractures,C,C26.531.750.500,Hip Fractures,Hip Injuries,11
Femoral Neck Fractures,C,C26.558.276.425.500,Hip Fractures,Femoral Fractures,11
Femoral Neck Fractures,C,C26.404.061.425.500,Hip Fractures,Femoral Fractures,11
Flavivirus,B,B04.820.578.344.350,Flaviviridae,Positive-Strand RNA Viruses,11
Flavivirus Infections,C,C01.925.782.350.250,Flaviviridae Infections,RNA Virus Infections,11
Flour,J,J02.500.484,Food,Food and Beverages,11
Flour,G,G07.203.300.484,Food,"Diet, Food, and Nutrition",11
Fluorobenzenes,D,D02.455.426.559.389.358,Benzene Derivatives,"Hydrocarbons, Aromatic",11
Fluorobenzenes,D,D02.455.526.510.432,"Hydrocarbons, Fluorinated","Hydrocarbons, Halogenated",11
Gadolinium,D,D01.552.550.399.484,Lanthanoid Series Elements,"Metals, Rare Earth",11
Gadolinium,D,D01.268.558.362.484,Lanthanoid Series Elements,"Metals, Rare Earth",11
Gene Targeting,E,E05.393.335,Genetic Techniques,Investigative Techniques,11
"Genes, MHC Class II",G,G05.360.340.024.380.500.600,Major Histocompatibility Complex,Genetic Loci,11
"Genes, MHC Class II",G,G05.360.340.024.340.610.600,Major Histocompatibility Complex,Genes,11
"Genes, MHC Class II",G,G12.500.500.600,Major Histocompatibility Complex,Immunogenetic Phenomena,11
"Genes, Recessive",G,G05.360.340.024.340.415,Genes,Genome Components,11
"Genes, Recessive",G,G05.420.325,Inheritance Patterns,Genetic Phenomena,11
Grounded Theory,H,H01.770.644.241.424,Empirical Research,Research,11
GTP-Binding Proteins,D,D08.811.277.040.330.300,GTP Phosphohydrolases,Acid Anhydride Hydrolases,11
GTP-Binding Proteins,D,D12.776.157.325,Carrier Proteins,Proteins,11
Hair Diseases,C,C17.800.329,Skin Diseases,Skin and Connective Tissue Diseases,11
Hair Removal,E,E02.218.372,Cosmetic Techniques,Therapeutics,11
Happiness,F,F01.470.516,Emotions,Behavior and Behavior Mechanisms,11
Health Services Misuse,N,N02.421.380,Health Services,"Health Care Facilities, Manpower, and Services",11
Health Services Misuse,N,N05.300.150.395,Attitude to Health,Delivery of Health Care,11
Hearing Aids,E,E07.814.458,Sensory Aids,Equipment and Supplies,11
Hearing Aids,E,E07.305.906.500,Wearable Electronic Devices,Electrical Equipment and Supplies,11
Hepatitis Antibodies,D,D12.776.124.790.651.114.254.450,"Antibodies, Viral",Antibodies,11
Hepatitis Antibodies,D,D12.776.124.486.485.114.254.450,"Antibodies, Viral",Antibodies,11
Hepatitis Antibodies,D,D12.776.377.715.548.114.254.450,"Antibodies, Viral",Antibodies,11
"Heterocyclic Compounds, 3-Ring",D,D03.633.300,"Heterocyclic Compounds, Fused-Ring",Heterocyclic Compounds,11
Hope,F,F01.470.572,Emotions,Behavior and Behavior Mechanisms,11
Hotlines,N,N02.421.297.448,Emergency Medical Services,Health Services,11
"Hypertension, Pregnancy-Induced",C,C13.703.395,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,11
"Hypertension, Pregnancy-Induced",C,C14.907.489.480,Hypertension,Vascular Diseases,11
Image-Guided Biopsy,E,E01.370.388.100.370,Biopsy,"Diagnostic Techniques, Surgical",11
Image-Guided Biopsy,E,E01.370.225.998.054.370,Biopsy,Specimen Handling,11
Image-Guided Biopsy,E,E01.370.225.500.384.100.370,Biopsy,Cytodiagnosis,11
Image-Guided Biopsy,E,E05.200.998.054.370,Biopsy,Specimen Handling,11
Image-Guided Biopsy,E,E05.242.384.100.370,Biopsy,Cytodiagnosis,11
Image-Guided Biopsy,E,E05.200.500.384.100.370,Biopsy,Cytodiagnosis,11
Image-Guided Biopsy,E,E04.074.370,Biopsy,"Surgical Procedures, Operative",11
"Immunity, Active",G,G12.450.050.370,Adaptive Immunity,Immunity,11
Immunocompetence,G,G12.460,Immune System Phenomena,NULL,11
Inheritance Patterns,G,G05.420,Genetic Phenomena,NULL,11
Insurance Benefits,N,N03.219.521.576.130,Insurance,"Financing, Organized",11
Inventions,J,J01.897.400,Technology,"Technology, Industry, and Agriculture",11
Ixodes,B,B01.050.500.131.166.132.832.400.425,Ixodidae,Ticks,11
Lactobacillus,B,B03.510.460.400.410.475.475,Lactobacillaceae,"Gram-Positive Asporogenous Rods, Regular",11
Lactobacillus,B,B03.353.750.450.475,Lactobacillaceae,Lactobacillales,11
Lactobacillus,B,B03.510.550.450.475,Lactobacillaceae,Lactobacillales,11
Laser Coagulation,E,E02.520.745.410,Light Coagulation,Hemostatic Techniques,11
Laser Coagulation,E,E02.594.530,Laser Therapy,Therapeutics,11
Laser Coagulation,E,E04.014.520.530,Laser Therapy,Ablation Techniques,11
Laser Coagulation,E,E04.540.630.410,Light Coagulation,Ophthalmologic Surgical Procedures,11
Laser Coagulation,E,E04.350.750.410,Light Coagulation,"Hemostasis, Surgical",11
Lipopolysaccharide Receptors,D,D23.101.100.900.045,"Antigens, Differentiation, Myelomonocytic","Antigens, Differentiation",11
Lipopolysaccharide Receptors,D,D12.776.543.750.705.045,"Receptors, Immunologic","Receptors, Cell Surface",11
Lipopolysaccharide Receptors,D,D12.776.543.550.418.100,GPI-Linked Proteins,Membrane Glycoproteins,11
Lipopolysaccharide Receptors,D,D12.776.543.484.500.100,GPI-Linked Proteins,Lipid-Linked Proteins,11
Lipopolysaccharide Receptors,D,D23.050.301.264.900.045,"Antigens, Differentiation, Myelomonocytic","Antigens, Differentiation",11
Lipopolysaccharide Receptors,D,D12.776.395.550.448.100,GPI-Linked Proteins,Membrane Glycoproteins,11
Long-Acting Reversible Contraception,E,E02.875.194.589,Contraception,Reproductive Techniques,11
Lumbar Vertebrae,A,A02.835.232.834.519,Spine,Bone and Bones,11
Lymphedema,C,C15.604.496,Lymphatic Diseases,Hemic and Lymphatic Diseases,11
"Lymphoma, Large B-Cell, Diffuse",C,C15.604.515.569.480.150.585,"Lymphoma, B-Cell","Lymphoma, Non-Hodgkin",11
"Lymphoma, Large B-Cell, Diffuse",C,C20.683.515.761.480.150.585,"Lymphoma, B-Cell","Lymphoma, Non-Hodgkin",11
"Lymphoma, Large B-Cell, Diffuse",C,C04.557.386.480.150.585,"Lymphoma, B-Cell","Lymphoma, Non-Hodgkin",11
Major Histocompatibility Complex,G,G05.360.340.024.380.500,Genetic Loci,Genome Components,11
Major Histocompatibility Complex,G,G05.360.340.024.340.610,Genes,Genome Components,11
Major Histocompatibility Complex,G,G12.500.500,Immunogenetic Phenomena,Immune System Phenomena,11
Male Urogenital Diseases,C,C12,NULL,NULL,11
Malpractice,I,I01.880.604.583.524,Jurisprudence,"Social Control, Formal",11
Malpractice,N,N03.706.535.606,Jurisprudence,"Social Control, Formal",11
Mandatory Programs,N,N03.706.657,"Social Control, Formal",Health Care Economics and Organizations,11
Mandatory Programs,N,N04.452.521,Organization and Administration,Health Services Administration,11
Mandatory Programs,I,I01.880.604.622,"Social Control, Formal",Sociology,11
Marijuana Abuse,F,F03.900.635,Substance-Related Disorders,Mental Disorders,11
Marijuana Abuse,C,C25.775.635,Substance-Related Disorders,Chemically-Induced Disorders,11
Massachusetts,Z,Z01.107.567.875.550.510,New England,United States,11
Meals,G,G07.203.300.590,Food,"Diet, Food, and Nutrition",11
Meals,J,J02.500.590,Food,Food and Beverages,11
Medicare,N,N03.706.615.696,Legislation as Topic,"Social Control, Formal",11
Medicare,N,N03.219.521.346.506.564.663,Medical Assistance,Public Assistance,11
Medicare,N,N03.219.521.576.343.840,"Insurance, Health",Insurance,11
MEDLINE,L,L01.470.750.500.650.500,PubMed,"Databases, Bibliographic",11
MEDLINE,L,L01.313.500.750.280.710.500,MEDLARS,Information Storage and Retrieval,11
MEDLINE,L,L01.313.500.750.280.750.500,PubMed,Information Storage and Retrieval,11
MEDLINE,L,L01.313.500.750.300.188.300.650.500,PubMed,"Databases, Bibliographic",11
MEDLINE,L,L01.313.500.750.300.742.650.500,PubMed,Online Systems,11
MEDLINE,L,L01.313.500.750.300.710.500,MEDLARS,Information Systems,11
Mercury,D,D01.268.556.504,"Metals, Heavy",Elements,11
Mercury,D,D01.268.956.437,Transition Elements,Elements,11
Mercury,D,D01.552.544.504,"Metals, Heavy",Metals,11
Military Medicine,H,H02.403.500,Medicine,Health Occupations,11
Mitochondrial Proteins,D,D12.776.575,Proteins,"Amino Acids, Peptides, and Proteins",11
Moral Obligations,K,K01.752.566.869.500,Social Responsibility,Morals,11
Moral Obligations,F,F01.829.500.760.500,Social Responsibility,Morals,11
Mucins,D,D12.776.395.560.631,Mucoproteins,Glycoproteins,11
Music,K,K01.602,Humanities,NULL,11
Necatoriasis,C,C01.610.335.508.700.775.455.683,Hookworm Infections,Strongylida Infections,11
"Neisseria meningitidis, Serogroup W-135",B,B03.660.075.525.520.500.800,Neisseria meningitidis,Neisseria,11
"Neisseria meningitidis, Serogroup W-135",B,B03.440.400.425.550.550.641.800,Neisseria meningitidis,Neisseria,11
Nephrotic Syndrome,C,C12.777.419.630.643,Nephrosis,Kidney Diseases,11
Nephrotic Syndrome,C,C13.351.968.419.630.643,Nephrosis,Kidney Diseases,11
Nitroglycerin,D,D02.640.636,Nitro Compounds,Organic Chemicals,11
Norethindrone,D,D04.210.500.668.651.693.651,Norpregnenes,Norpregnanes,11
Nurse Clinicians,M,M01.526.485.650.648.525,Nurse Specialists,Nurses,11
Nurse Clinicians,N,N02.360.650.648.525,Nurse Specialists,Nurses,11
Nursing Methodology Research,N,N04.590.233.508.613.634,Nursing Research,Nursing Process,11
Nursing Methodology Research,H,H01.770.644.145.390.634,Nursing Research,Biomedical Research,11
Nursing Methodology Research,H,H02.478.395.634,Nursing Research,Nursing,11
Oligodeoxyribonucleotides,D,D13.695.578.424.450,Oligonucleotides,Polynucleotides,11
Oral Health,N,N01.400.535,Health,Population Characteristics,11
Oropharynx,A,A14.724.603,Pharynx,Stomatognathic System,11
Oropharynx,A,A04.623.603,Pharynx,Respiratory System,11
Osteocalcin,D,D12.776.157.125.700,Calcium-Binding Proteins,Carrier Proteins,11
Osteoporotic Fractures,C,C26.404.545,"Fractures, Bone",Wounds and Injuries,11
Oxygen Isotopes,D,D01.362.670.300,Oxygen,Gases,11
Oxygen Isotopes,D,D01.496.625,Isotopes,Inorganic Chemicals,11
Oxygen Isotopes,D,D01.268.185.550.500,Oxygen,Chalcogens,11
p38 Mitogen-Activated Protein Kinases,D,D12.644.360.450.835,Mitogen-Activated Protein Kinases,Intracellular Signaling Peptides and Proteins,11
p38 Mitogen-Activated Protein Kinases,D,D08.811.913.696.620.682.700.567.843,Mitogen-Activated Protein Kinases,Protein-Serine-Threonine Kinases,11
p38 Mitogen-Activated Protein Kinases,D,D12.776.476.450.835,Mitogen-Activated Protein Kinases,Intracellular Signaling Peptides and Proteins,11
Patch Tests,E,E01.370.225.812.871.610,Skin Tests,Immunologic Tests,11
Patch Tests,E,E05.200.812.871.610,Skin Tests,Immunologic Tests,11
Patch Tests,E,E05.478.594.890.610,Skin Tests,Immunologic Tests,11
Paternal Exposure,N,N06.850.460.350.700,Environmental Exposure,Environmental Pollution,11
Patient Care Bundles,E,E02.765,Therapeutics,NULL,11
Personality Assessment,F,F04.513,Behavioral Disciplines and Activities,NULL,11
Personnel Management,N,N04.452.677,Organization and Administration,Health Services Administration,11
"Philosophy, Medical",K,K01.752.667,Philosophy,Humanities,11
Piperidines,D,D03.383.621,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,11
Plasma Substitutes,D,D27.505.954.502.140.500,Blood Substitutes,Hematologic Agents,11
Polychlorinated Dibenzodioxins,D,D03.633.300.786,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",11
Polychlorinated Dibenzodioxins,D,D02.309.500.450,Dioxins,Dioxins and Dioxin-like Compounds,11
"Polycystic Kidney, Autosomal Dominant",C,C13.351.968.419.403.875.500,Polycystic Kidney Diseases,"Kidney Diseases, Cystic",11
"Polycystic Kidney, Autosomal Dominant",C,C16.131.077.717.500,Polycystic Kidney Diseases,"Abnormalities, Multiple",11
"Polycystic Kidney, Autosomal Dominant",C,C16.320.184.625.500,Polycystic Kidney Diseases,Ciliopathies,11
"Polycystic Kidney, Autosomal Dominant",C,C12.777.419.403.875.500,Polycystic Kidney Diseases,"Kidney Diseases, Cystic",11
Polymyalgia Rheumatica,C,C17.300.775.720,Rheumatic Diseases,Connective Tissue Diseases,11
Polymyalgia Rheumatica,C,C05.799.720,Rheumatic Diseases,Musculoskeletal Diseases,11
Polymyalgia Rheumatica,C,C05.651.742,Muscular Diseases,Musculoskeletal Diseases,11
Polynesia,Z,Z01.639.760.815,Pacific Islands,Islands,11
Polysorbates,J,J01.637.051.720.741.700,Polyethylene Glycols,Polymers,11
Polysorbates,D,D02.033.455.250.700.690,Polyethylene Glycols,Ethylene Glycols,11
Polysorbates,D,D05.750.741.700,Polyethylene Glycols,Polymers,11
Polysorbates,D,D25.720.741.700,Polyethylene Glycols,Polymers,11
Pragmatic Clinical Trials as Topic,N,N05.715.360.330.250.250.365.500.750,Randomized Controlled Trials as Topic,Controlled Clinical Trials as Topic,11
Pragmatic Clinical Trials as Topic,E,E05.318.372.250.250.365.500.750,Randomized Controlled Trials as Topic,Controlled Clinical Trials as Topic,11
Pragmatic Clinical Trials as Topic,N,N06.850.520.450.250.250.365.500.750,Randomized Controlled Trials as Topic,Controlled Clinical Trials as Topic,11
Primate Diseases,C,C22.735,Animal Diseases,NULL,11
Prodromal Symptoms,C,C23.888.672,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",11
Prodromal Symptoms,E,E01.599,Diagnosis,NULL,11
Progestins,D,D27.505.696.399.472.858,Hormones,"Hormones, Hormone Substitutes, and Hormone Antagonists",11
Proof of Concept Study,H,H01.770.644.578,Research,Science,11
Protein Subunits,D,D12.776.813,Proteins,"Amino Acids, Peptides, and Proteins",11
Psychological Distance,F,F01.145.813.630,Social Behavior,Behavior,11
Psychological Distance,F,F01.829.316.777,Group Processes,"Psychology, Social",11
Punishment,F,F02.463.425.770.571,"Reinforcement, Psychology",Learning,11
Punishment,I,I01.880.630.716,"Social Control, Informal",Sociology,11
Raltegravir Potassium,D,D03.383.773.812.752,Pyrrolidinones,Pyrrolidines,11
"Receptor, Interferon alpha-beta",D,D12.776.543.750.705.852.400.500,"Receptors, Interferon","Receptors, Cytokine",11
Residential Facilities,J,J03.775,Non-Medical Public and Private Facilities,NULL,11
Residential Facilities,N,N02.278.825,Health Facilities,"Health Care Facilities, Manpower, and Services",11
Respect,F,F01.100.907,Attitude,Behavior and Behavior Mechanisms,11
Respiratory Hypersensitivity,C,C20.543.480.680,"Hypersensitivity, Immediate",Hypersensitivity,11
Respiratory Hypersensitivity,C,C08.674,Respiratory Tract Diseases,NULL,11
Scientific Misconduct,N,N05.350.979.500,Professional Misconduct,Ethics,11
Scientific Misconduct,K,K01.752.566.479.915.500,Professional Misconduct,Ethics,11
Seawater,G,G16.500.275.725.500,Saline Waters,Environment,11
Silicon Dioxide,D,D01.578.750,Minerals,Inorganic Chemicals,11
Silicon Dioxide,D,D01.650.550.825,Oxides,Oxygen Compounds,11
Silicon Dioxide,D,D01.837.725,Silicon Compounds,Inorganic Chemicals,11
Simian Acquired Immunodeficiency Syndrome,C,C22.735.500.850,Monkey Diseases,Primate Diseases,11
Simian Acquired Immunodeficiency Syndrome,C,C01.925.839.850,Slow Virus Diseases,Virus Diseases,11
Simian Acquired Immunodeficiency Syndrome,C,C01.925.782.815.616.850,Lentivirus Infections,Retroviridae Infections,11
"Skin Diseases, Bacterial",C,C01.800.720,"Skin Diseases, Infectious",Infections,11
"Skin Diseases, Bacterial",C,C01.150.252.819,Bacterial Infections,Bacterial Infections and Mycoses,11
"Skin Diseases, Bacterial",C,C17.800.838.765,"Skin Diseases, Infectious",Skin Diseases,11
"Sleep Apnea, Obstructive",C,C08.618.085.852.850,Sleep Apnea Syndromes,Apnea,11
"Sleep Apnea, Obstructive",C,C10.886.425.800.750.850,Sleep Apnea Syndromes,"Sleep Disorders, Intrinsic",11
Social Capital,I,I01.880.853.375,Sociological Factors,Sociology,11
Social Medicine,H,H02.403.800,Medicine,Health Occupations,11
Social Mobility,I,I01.880.853.996.755.673,Social Class,Socioeconomic Factors,11
Social Mobility,N,N01.824.782.673,Social Class,Socioeconomic Factors,11
Spectinomycin,D,D03.383.188.712,Dioxanes,"Heterocyclic Compounds, 1-Ring",11
Spectinomycin,D,D03.633.300.835,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",11
Spectinomycin,D,D09.408.051.836,Aminoglycosides,Glycosides,11
Spinal Puncture,E,E01.370.225.998.054.790,Biopsy,Specimen Handling,11
Spinal Puncture,E,E01.370.376.700,"Diagnostic Techniques, Neurological",Diagnostic Techniques and Procedures,11
Spinal Puncture,E,E02.800.779,Punctures,Therapeutics,11
Spinal Puncture,E,E04.074.790,Biopsy,"Surgical Procedures, Operative",11
Spinal Puncture,E,E04.665.700,Punctures,"Surgical Procedures, Operative",11
Spinal Puncture,E,E05.200.998.054.790,Biopsy,Specimen Handling,11
Sustained Virologic Response,N,N04.761.559.590.800.665,Treatment Outcome,"Outcome Assessment, Health Care",11
Sustained Virologic Response,N,N05.715.360.575.575.800.665,Treatment Outcome,"Outcome Assessment, Health Care",11
Sustained Virologic Response,E,E01.789.800.570,Treatment Outcome,Prognosis,11
Sympathectomy,E,E04.525.210.105.800,Autonomic Denervation,Denervation,11
Synteny,G,G02.111.810.550.830,"Sequence Homology, Nucleic Acid",Sequence Homology,11
Synteny,G,G05.810.550.830,"Sequence Homology, Nucleic Acid",Sequence Homology,11
Systems Biology,H,H01.158.273.180.800,Computational Biology,Biology,11
Telecommunications,L,L01.178.847,Communications Media,Information Science,11
Terrorism,I,I01.880.735.900.800,Violence,Social Problems,11
Terrorism,I,I01.198.240.856.800,Violence,Crime,11
Thyroid Gland,A,A06.300.900,Endocrine Glands,Endocrine System,11
Tissue Plasminogen Activator,D,D23.119.970,Blood Coagulation Factors,Biological Factors,11
Tissue Plasminogen Activator,D,D12.776.124.125.662.768,Plasminogen Activators,Blood Coagulation Factors,11
Tissue Plasminogen Activator,D,D08.811.277.656.300.760.875,Serine Endopeptidases,Endopeptidases,11
Tissue Plasminogen Activator,D,D08.811.277.656.959.350.875,Serine Endopeptidases,Serine Proteases,11
Triticum,B,B01.650.940.800.575.912.250.822.918,Poaceae,Magnoliopsida,11
Tunica Intima,A,A07.015.700,Blood Vessels,Cardiovascular System,11
U937 Cells,A,A11.251.860.180.880,"Cell Line, Tumor","Tumor Cells, Cultured",11
U937 Cells,A,A11.251.210.190.880,"Cell Line, Tumor",Cell Line,11
U937 Cells,A,A11.627.482.665.500,Monocyte-Macrophage Precursor Cells,Macrophages,11
U937 Cells,A,A11.627.624.249.500,Monocyte-Macrophage Precursor Cells,Monocytes,11
U937 Cells,A,A11.627.635.675.750.500,Monocyte-Macrophage Precursor Cells,Granulocyte-Macrophage Progenitor Cells,11
United Arab Emirates,Z,Z01.252.245.500.900,Middle East,"Asia, Western",11
Unnecessary Procedures,N,N05.300.150.395.450.500,Medical Overuse,Health Services Misuse,11
Unnecessary Procedures,N,N02.421.380.450.500,Medical Overuse,Health Services Misuse,11
Uveitis,C,C11.941.879,Uveal Diseases,Eye Diseases,11
Vaginal Douching,E,E05.927.852,Therapeutic Irrigation,Investigative Techniques,11
Vaping,F,F01.145.805.500,Smoking,Behavior,11
Virus Cultivation,E,E05.200.875.970,Microbiological Techniques,Clinical Laboratory Techniques,11
Virus Cultivation,E,E01.370.225.875.970,Microbiological Techniques,Clinical Laboratory Techniques,11
von Willebrand Factor,D,D23.119.985,Blood Coagulation Factors,Biological Factors,11
von Willebrand Factor,D,D12.776.124.125.920,Blood Coagulation Factors,Blood Proteins,11
Wet Macular Degeneration,C,C11.768.585.439.622,Macular Degeneration,Retinal Degeneration,11
"Women, Working",M,M01.975.825,Women,Persons,11
Wound Infection,C,C01.947,Infections,NULL,11
Xenopus laevis,B,B01.050.150.900.090.180.610.500.562,Xenopus,Pipidae,11
Xerophthalmia,C,C11.496.260.892,Dry Eye Syndromes,Lacrimal Apparatus Diseases,11
Xerophthalmia,C,C11.187.810,Conjunctival Diseases,Eye Diseases,11
Yellow fever virus,B,B04.820.578.344.350.990,Flavivirus,Flaviviridae,11
5' Untranslated Regions,D,D13.444.735.790.878.885,Untranslated Regions,"RNA, Untranslated",10
5' Untranslated Regions,D,D13.444.735.544.875.885,Untranslated Regions,"RNA, Messenger",10
5' Untranslated Regions,G,G05.360.340.024.220.880.885,Untranslated Regions,"DNA, Intergenic",10
5' Untranslated Regions,G,G05.360.340.024.340.137.910.885,Untranslated Regions,Gene Components,10
ABO Blood-Group System,D,D23.050.301.290.031,Blood Group Antigens,"Antigens, Surface",10
ABO Blood-Group System,D,D23.050.705.230.031,Blood Group Antigens,Isoantigens,10
Acoustic Impedance Tests,E,E01.370.382.375.050,Hearing Tests,"Diagnostic Techniques, Otological",10
Acoustic Stimulation,E,E02.037,Therapeutics,NULL,10
Acoustic Stimulation,E,E02.190.888.030,Sensory Art Therapies,Complementary Therapies,10
Acoustic Stimulation,E,E05.723.136,Physical Stimulation,Investigative Techniques,10
Actinobacillus Infections,C,C01.150.252.400.700.030,Pasteurellaceae Infections,Gram-Negative Bacterial Infections,10
Adenosine,D,D13.570.583.138,Purine Nucleosides,Nucleosides,10
Adenosine,D,D13.570.800.096,Ribonucleosides,Nucleosides,10
Adenosine,D,D03.633.100.759.590.138,Purine Nucleosides,Purines,10
Alkaloids,D,D03.132,Heterocyclic Compounds,NULL,10
alpha-Fetoproteins,D,D12.776.124.790.106.092,Alpha-Globulins,Serum Globulins,10
alpha-Fetoproteins,D,D12.776.377.228.500,Fetal Globulins,Globulins,10
alpha-Fetoproteins,D,D12.776.377.715.085.092,Alpha-Globulins,Serum Globulins,10
alpha-Fetoproteins,D,D12.776.320.525.500,Fetal Globulins,Fetal Proteins,10
alpha-Fetoproteins,D,D23.101.140.050,"Biomarkers, Tumor",Biomarkers,10
Amenorrhea,C,C23.550.568.500,Menstruation Disturbances,Pathologic Processes,10
Amines,D,D02.092,Organic Chemicals,NULL,10
Amphetamine-Related Disorders,C,C25.775.225,Substance-Related Disorders,Chemically-Induced Disorders,10
Amphetamine-Related Disorders,F,F03.900.225,Substance-Related Disorders,Mental Disorders,10
Anesthesia,E,E03.155,Anesthesia and Analgesia,NULL,10
Animal Diseases,C,C22,NULL,NULL,10
Anisotropy,G,G02.050,Chemical Phenomena,NULL,10
Anisotropy,G,G01.590.040,Optical Phenomena,Physical Phenomena,10
Antigen-Antibody Reactions,G,G12.122,Immune System Phenomena,NULL,10
"Antigens, Dermatophagoides",D,D23.050.181,Antigens,Biological Factors,10
Aortic Aneurysm,C,C14.907.055.239,Aneurysm,Vascular Diseases,10
Aortic Aneurysm,C,C14.907.109.139,Aortic Diseases,Vascular Diseases,10
Aortic Rupture,C,C14.907.109.139.175,Aortic Aneurysm,Aortic Diseases,10
Aortic Rupture,C,C14.907.055.185.125,"Aneurysm, Ruptured",Aneurysm,10
Aortic Rupture,C,C14.907.055.239.175,Aortic Aneurysm,Aneurysm,10
Aortic Rupture,C,C26.761.125,Rupture,Wounds and Injuries,10
Apicomplexa,B,B01.043.075,Alveolata,Eukaryota,10
Apolipoprotein A-I,D,D12.776.521.120.200.100,Apolipoproteins A,Apolipoproteins,10
Apolipoprotein A-I,D,D12.776.070.400.200.100,Apolipoproteins A,Apolipoproteins,10
Apolipoprotein A-I,D,D10.532.091.200.100,Apolipoproteins A,Apolipoproteins,10
Appendicitis,C,C01.463.099,Intraabdominal Infections,Infections,10
Appendicitis,C,C06.405.205.099,Gastroenteritis,Gastrointestinal Diseases,10
Appendicitis,C,C06.405.469.110.207,Cecal Diseases,Intestinal Diseases,10
"Arthritis, Infectious",C,C05.550.114.099,Arthritis,Joint Diseases,10
"Arthritis, Infectious",C,C01.100,Infections,NULL,10
Atorvastatin,D,D10.251.450.200,Heptanoic Acids,Fatty Acids,10
Atorvastatin,D,D03.383.129.578.075,Pyrroles,Azoles,10
Auditory Perception,F,F02.463.593.071,Perception,Mental Processes,10
Auditory Perception,G,G07.888.125,Vestibulocochlear Physiological Phenomena,Physiological Phenomena,10
Australasia,Z,Z01.678.100,Oceania,Geographic Locations,10
Azerbaijan,Z,Z01.542.900.120,Transcaucasia,Europe,10
Basic Helix-Loop-Helix Transcription Factors,D,D12.776.260.103,DNA-Binding Proteins,Proteins,10
Basic Helix-Loop-Helix Transcription Factors,D,D12.776.930.125,Transcription Factors,Proteins,10
Beijing,Z,Z01.252.474.164.225,China,Far East,10
Beijing,Z,Z01.433.114,Cities,Geographic Locations,10
beta-Thalassemia,C,C15.378.420.826.150,Thalassemia,Hemoglobinopathies,10
beta-Thalassemia,C,C15.378.071.141.150.875.150,Thalassemia,"Anemia, Hemolytic, Congenital",10
beta-Thalassemia,C,C16.320.365.826.150,Thalassemia,Hemoglobinopathies,10
beta-Thalassemia,C,C16.320.070.875.150,Thalassemia,"Anemia, Hemolytic, Congenital",10
Big Data,L,L01.313.500.750.300.092,Information Systems,Medical Informatics Applications,10
Biology,H,H01.158.273,Biological Science Disciplines,Natural Science Disciplines,10
Biomechanical Phenomena,G,G01.374.089,Mechanical Phenomena,Physical Phenomena,10
Biomechanical Phenomena,G,G01.154.090,Biophysical Phenomena,Physical Phenomena,10
Blood Volume,G,G09.188.130,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,10
Blood Volume,G,G09.330.380.092,Hemodynamics,Cardiovascular Physiological Phenomena,10
Body Water,A,A12.207.200,Body Fluids,Fluids and Secretions,10
Brachytherapy,E,E02.815.150,Radiotherapy,Therapeutics,10
Bronchial Provocation Tests,E,E01.370.386.700.125,Respiratory Function Tests,"Diagnostic Techniques, Respiratory System",10
Calcitriol,D,D10.570.938.146.478.387.300,Dihydroxycholecalciferols,Hydroxycholecalciferols,10
Calcitriol,D,D04.210.500.812.768.196.478.387.300,Dihydroxycholecalciferols,Hydroxycholecalciferols,10
Calcitriol,D,D04.210.500.247.222.159.478.387.300,Dihydroxycholecalciferols,Hydroxycholecalciferols,10
Calcitriol,D,D04.210.500.247.808.146.478.387.300,Dihydroxycholecalciferols,Hydroxycholecalciferols,10
Candidiasis,C,C01.150.703.160,Mycoses,Bacterial Infections and Mycoses,10
Cardiopulmonary Bypass,E,E04.292.413,Extracorporeal Circulation,"Surgical Procedures, Operative",10
"Catheters, Indwelling",E,E07.132.500,Catheters,Equipment and Supplies,10
CD4-CD8 Ratio,E,E05.200.625.107.595.500.150.160,CD4 Lymphocyte Count,Lymphocyte Count,10
CD4-CD8 Ratio,E,E05.242.195.107.595.500.150.160,CD4 Lymphocyte Count,Lymphocyte Count,10
CD4-CD8 Ratio,E,E05.200.500.195.107.595.500.150.160,CD4 Lymphocyte Count,Lymphocyte Count,10
CD4-CD8 Ratio,G,G04.140.107.595.500.150.160,CD4 Lymphocyte Count,Lymphocyte Count,10
CD4-CD8 Ratio,G,G09.188.105.595.500.150.160,CD4 Lymphocyte Count,Lymphocyte Count,10
CD4-CD8 Ratio,G,G12.248,Immune System Phenomena,NULL,10
CD4-CD8 Ratio,E,E01.370.225.625.107.595.500.150.160,CD4 Lymphocyte Count,Lymphocyte Count,10
CD4-CD8 Ratio,E,E01.370.225.500.195.107.595.500.150.160,CD4 Lymphocyte Count,Lymphocyte Count,10
Cell Membrane Permeability,G,G04.175,Cell Physiological Phenomena,NULL,10
Cell Membrane Permeability,G,G03.143.335,Biological Transport,Metabolism,10
Central Nervous System Diseases,C,C10.228,Nervous System Diseases,NULL,10
Cephalosporin Resistance,G,G07.690.773.984.269.347.500.175,beta-Lactam Resistance,"Drug Resistance, Bacterial",10
Cephalosporin Resistance,G,G06.225.347.500.175,beta-Lactam Resistance,"Drug Resistance, Bacterial",10
Cephalosporin Resistance,G,G06.099.225.500.175,beta-Lactam Resistance,"Drug Resistance, Bacterial",10
Checkpoint Kinase 2,D,D08.811.913.696.620.682.700.145,Protein-Serine-Threonine Kinases,Protein Kinases,10
"Child Development Disorders, Pervasive",F,F03.625.164,Neurodevelopmental Disorders,Mental Disorders,10
Child Nutrition Sciences,H,H02.533.252,Nutritional Sciences,Health Occupations,10
Cholecalciferol,D,D10.570.938.146,Sterols,Membrane Lipids,10
Cholecalciferol,D,D04.210.500.247.808.146,Sterols,Cholestanes,10
Cholecalciferol,D,D04.210.500.247.222.159,Cholestenes,Cholestanes,10
Cholecalciferol,D,D04.210.500.812.768.196,Vitamin D,Secosteroids,10
Cholecystectomy,E,E04.210.120.172,Biliary Tract Surgical Procedures,Digestive System Surgical Procedures,10
Christianity,K,K01.844.188,Religion,Humanities,10
"Chromosomal Proteins, Non-Histone",D,D12.776.664.235,Nucleoproteins,Proteins,10
"Chromosomal Proteins, Non-Histone",D,D12.776.660.235,Nuclear Proteins,Proteins,10
Chromosome Inversion,C,C23.550.210.190,Chromosome Aberrations,Pathologic Processes,10
Chromosome Inversion,G,G05.558.805.500,Sequence Inversion,Mutagenesis,10
Chromosome Inversion,G,G05.365.590.175.190,Chromosome Aberrations,Mutation,10
Chromosome Inversion,G,G05.365.590.770.500,Sequence Inversion,Mutation,10
Circular Dichroism,E,E05.196.867.151,Spectrum Analysis,"Chemistry Techniques, Analytical",10
Civil Rights,I,I01.880.604.473.352,Human Rights,"Social Control, Formal",10
Civil Rights,N,N03.706.437.352,Human Rights,"Social Control, Formal",10
Clindamycin,D,D03.383.773.532.500.125,Lincomycin,Lincosamides,10
Clindamycin,D,D09.408.471.500.125,Lincomycin,Lincosamides,10
Clubfoot,C,C16.131.621.585.512.500.681.063,Talipes,"Foot Deformities, Congenital",10
Clubfoot,C,C05.330.495.681.063,Talipes,"Foot Deformities, Congenital",10
Clubfoot,C,C05.330.488.655.063,Talipes,"Foot Deformities, Acquired",10
Clubfoot,C,C05.660.585.512.380.813.063,Talipes,"Foot Deformities, Congenital",10
Collagen Type I,D,D05.750.078.280.300.100,Fibrillar Collagens,Collagen,10
Collagen Type I,D,D12.776.860.300.250.300.100,Fibrillar Collagens,Collagen,10
Colonoscopy,E,E01.370.372.250.250.200,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",10
Colonoscopy,E,E01.370.388.250.250.250.160,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",10
Colonoscopy,E,E04.210.240.250.160,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",10
Colonoscopy,E,E04.502.250.250.250.160,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",10
"Conjunctivitis, Inclusion",C,C01.375.354.220.250,"Conjunctivitis, Bacterial","Eye Infections, Bacterial",10
"Conjunctivitis, Inclusion",C,C01.150.252.289.225.250,"Conjunctivitis, Bacterial","Eye Infections, Bacterial",10
"Conjunctivitis, Inclusion",C,C01.150.252.400.210.125.245,Chlamydia Infections,Chlamydiaceae Infections,10
"Conjunctivitis, Inclusion",C,C11.187.183.220.250,"Conjunctivitis, Bacterial",Conjunctivitis,10
"Conjunctivitis, Inclusion",C,C11.294.354.220.250,"Conjunctivitis, Bacterial","Eye Infections, Bacterial",10
Consanguinity,G,G05.090.403.180,Inbreeding,Breeding,10
Consanguinity,G,G05.180,Genetic Phenomena,NULL,10
Coronary Restenosis,C,C14.280.647.250.285.200,Coronary Stenosis,Coronary Disease,10
Coronary Restenosis,C,C14.907.585.250.285.200,Coronary Stenosis,Coronary Disease,10
Counselors,M,M01.526.225,Occupational Groups,Persons,10
"Crosses, Genetic",E,E05.393.281,Genetic Techniques,Investigative Techniques,10
Crown-Rump Length,E,E05.041.124.160.500.500,Body Height,Body Size,10
Crown-Rump Length,G,G07.100.100.250,Body Weights and Measures,Body Constitution,10
Crown-Rump Length,G,G07.100.100.160.100.500,Body Height,Body Size,10
Crown-Rump Length,N,N06.850.505.200.100.400,Anthropometry,Biometry,10
Crown-Rump Length,E,E01.370.600.115.100.160.100.500,Body Height,Body Size,10
Cryptosporidium parvum,B,B01.043.075.189.250.150.160.170,Cryptosporidium,Cryptosporidiidae,10
Cystatin C,D,D12.776.215.300,Cystatins,Proteins,10
Cytological Techniques,E,E01.370.225.500,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,10
Cytological Techniques,E,E05.200.500,Clinical Laboratory Techniques,Investigative Techniques,10
Cytological Techniques,E,E05.242,Investigative Techniques,NULL,10
"Cytotoxicity Tests, Immunologic",E,E05.200.812.160,Immunologic Tests,Clinical Laboratory Techniques,10
"Cytotoxicity Tests, Immunologic",E,E05.478.594.160,Immunologic Tests,Immunologic Techniques,10
"Cytotoxicity Tests, Immunologic",E,E05.940.245,Toxicity Tests,Investigative Techniques,10
"Cytotoxicity Tests, Immunologic",E,E01.370.225.812.160,Immunologic Tests,Clinical Laboratory Techniques,10
Deferoxamine,D,D02.092.570.394.265,Hydroxamic Acids,Hydroxylamines,10
Deferoxamine,D,D02.241.511.372.265,Hydroxamic Acids,Hydroxy Acids,10
Deinstitutionalization,E,E02.760.415.280,Institutionalization,Patient Care,10
Deinstitutionalization,N,N02.421.585.415.280,Institutionalization,Patient Care,10
Delivery Rooms,N,N02.278.388.150,Hospital Units,Health Facilities,10
Deltaretrovirus,B,B04.820.650.200,Retroviridae,RNA Viruses,10
Deltaretrovirus,B,B04.613.807.200,Retroviridae,Oncogenic Viruses,10
Demyelinating Diseases,C,C10.314,Nervous System Diseases,NULL,10
Dentists,M,M01.526.485.330,Health Personnel,Occupational Groups,10
Dentists,N,N02.360.330,Health Personnel,"Health Care Facilities, Manpower, and Services",10
Deoxycytidine,D,D13.570.685.245.500,Cytidine,Pyrimidine Nucleosides,10
Deoxycytidine,D,D13.570.230.329,Deoxyribonucleosides,Nucleosides,10
Deoxycytidine,D,D03.383.742.680.245.500,Cytidine,Pyrimidine Nucleosides,10
"Dermatitis, Occupational",C,C17.800.174.255.700,"Dermatitis, Contact",Dermatitis,10
"Dermatitis, Occupational",C,C17.800.815.255.700,"Dermatitis, Contact","Skin Diseases, Eczematous",10
"Dermatitis, Occupational",C,C24.270,Occupational Diseases,NULL,10
Desiccation,E,E05.196.335,"Chemistry Techniques, Analytical",Investigative Techniques,10
Desiccation,G,G02.176,Chemical Phenomena,NULL,10
Dichlorodiphenyl Dichloroethylene,D,D02.455.526.439.292,"Hydrocarbons, Chlorinated","Hydrocarbons, Halogenated",10
Dictyostelium,B,B01.046.550.200.300,Dictyosteliida,Mycetozoa,10
"Diet, Reducing",E,E02.642.249.285,Diet Therapy,Nutrition Therapy,10
"Diet, Reducing",G,G07.203.650.240.285,Diet,Nutritional Physiological Phenomena,10
Dioxins,D,D03.383.231,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,10
Dioxins,D,D02.309.500,Dioxins and Dioxin-like Compounds,Organic Chemicals,10
Discriminant Analysis,E,E05.318.740.350,Statistics as Topic,Epidemiologic Methods,10
Discriminant Analysis,N,N05.715.360.750.325,Statistics as Topic,Health Care Evaluation Mechanisms,10
Discriminant Analysis,N,N06.850.520.830.350,Statistics as Topic,Epidemiologic Methods,10
DNA Repair Enzymes,D,D08.811.074,Enzymes,Enzymes and Coenzymes,10
"DNA, Neoplasm",D,D13.444.308.425,DNA,Nucleic Acids,10
Drug Repositioning,E,E05.290.875,Drug Development,Investigative Techniques,10
Eflornithine,D,D12.125.068.665.340,Ornithine,"Amino Acids, Basic",10
Eflornithine,D,D12.125.095.765.340,Ornithine,"Amino Acids, Diamino",10
Electric Power Supplies,E,E07.305.124,Electrical Equipment and Supplies,Equipment and Supplies,10
"Embolization, Therapeutic",E,E02.926.500,Therapeutic Occlusion,Therapeutics,10
"Embolization, Therapeutic",E,E02.520.360,Hemostatic Techniques,Therapeutics,10
"Embryo, Nonmammalian",A,A16.331,Embryonic Structures,NULL,10
"Embryo, Nonmammalian",A,A13.350,Animal Structures,NULL,10
Encephalitis,C,C10.228.140.430,Brain Diseases,Central Nervous System Diseases,10
"Encephalitis, Tick-Borne",C,C10.228.140.430.520.750.300.775,"Encephalitis, Arbovirus","Encephalitis, Viral",10
"Encephalitis, Tick-Borne",C,C10.228.228.245.340.300.775,"Encephalitis, Arbovirus","Encephalitis, Viral",10
"Encephalitis, Tick-Borne",C,C10.228.228.399.750.300.775,"Encephalitis, Arbovirus","Encephalitis, Viral",10
"Encephalitis, Tick-Borne",C,C01.207.245.340.300.775,"Encephalitis, Arbovirus","Encephalitis, Viral",10
"Encephalitis, Tick-Borne",C,C01.207.399.750.300.775,"Encephalitis, Arbovirus","Encephalitis, Viral",10
"Encephalitis, Tick-Borne",C,C01.925.782.310.360,"Encephalitis, Arbovirus",RNA Virus Infections,10
"Encephalitis, Tick-Borne",C,C01.925.782.350.250.500,Flavivirus Infections,Flaviviridae Infections,10
"Encephalitis, Tick-Borne",C,C01.920.500.343.360,"Encephalitis, Arbovirus",Arbovirus Infections,10
"Encephalitis, Tick-Borne",C,C01.920.930.400,Tick-Borne Diseases,Vector Borne Diseases,10
"Encephalitis, Tick-Borne",C,C01.925.182.525.300.350,"Encephalitis, Arbovirus","Encephalitis, Viral",10
"Encephalitis, Tick-Borne",C,C01.925.081.343.360,"Encephalitis, Arbovirus",Arbovirus Infections,10
Endotoxins,D,D23.946.123.329,Bacterial Toxins,"Toxins, Biological",10
Erythropoiesis,G,G04.152.825.414,Hematopoiesis,Cell Differentiation,10
Erythropoiesis,G,G09.188.343.414,Hematopoiesis,Blood Physiological Phenomena,10
Ethics,K,K01.752.566.479,Morals,Philosophy,10
Ethics,N,N05.350,"Health Care Quality, Access, and Evaluation",NULL,10
Exome,G,G05.360.340.011,Genome,Genetic Structures,10
Exotoxins,D,D23.946.350,"Toxins, Biological",Biological Factors,10
Expressed Sequence Tags,G,G05.360.340.024.340.137.275,Gene Components,Genes,10
Eye Abnormalities,C,C11.250,Eye Diseases,NULL,10
Eye Abnormalities,C,C16.131.384,Congenital Abnormalities,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",10
Factor VIII,D,D23.119.350,Blood Coagulation Factors,Biological Factors,10
Factor VIII,D,D12.776.811.286,Protein Precursors,Proteins,10
Factor VIII,D,D12.776.124.125.350,Blood Coagulation Factors,Blood Proteins,10
Famous Persons,M,M01.228,Persons,NULL,10
Famous Persons,K,K01.517.211.506,Biographies as Topic,Literature,10
Fecal Incontinence,C,C06.405.469.860.300,Rectal Diseases,Intestinal Diseases,10
Fellowships and Scholarships,N,N03.219.483.838.276,Training Support,Financial Support,10
Ferric Compounds,D,D01.490.100,Iron Compounds,Inorganic Chemicals,10
"Flight, Animal",G,G11.427.410.568.304,Locomotion,Movement,10
"Flight, Animal",G,G11.427.410.698.416,Motor Activity,Movement,10
Food Insecurity,J,J01.576.423.750.688,Food Supply,Food Industry,10
Food Quality,J,J01.576.423.850.730,Food Technology,Food Industry,10
Food Quality,N,N06.850.601,Public Health,Environment and Public Health,10
Gases,D,D01.362,Inorganic Chemicals,NULL,10
Gastroenterology,H,H02.403.429.405,Internal Medicine,Medicine,10
Gastrointestinal Neoplasms,C,C06.405.249,Gastrointestinal Diseases,Digestive System Diseases,10
Gastrointestinal Neoplasms,C,C06.301.371,Digestive System Neoplasms,Digestive System Diseases,10
Gastrointestinal Neoplasms,C,C04.588.274.476,Digestive System Neoplasms,Neoplasms by Site,10
Gene Duplication,G,G05.365.590.320,Mutation,Genetic Variation,10
Gene Duplication,G,G05.558.320,Mutagenesis,Genetic Phenomena,10
Gene Ontology,H,H01.770.644.145.350.124,Genetic Research,Biomedical Research,10
Gene Ontology,H,H01.158.273.343.249.099,Genetic Research,Genetics,10
Gene Ontology,L,L01.313.500.750.300.550.500.500,Biological Ontologies,Knowledge Bases,10
Gene Ontology,L,L01.224.050.375.480.500.500,Biological Ontologies,Knowledge Bases,10
Gene Ontology,L,L01.453.245.945.079.500,Biological Ontologies,"Vocabulary, Controlled",10
"Genes, MHC Class I",G,G12.500.500.595,Major Histocompatibility Complex,Immunogenetic Phenomena,10
"Genes, MHC Class I",G,G05.360.340.024.340.610.595,Major Histocompatibility Complex,Genes,10
"Genes, MHC Class I",G,G05.360.340.024.380.500.595,Major Histocompatibility Complex,Genetic Loci,10
Genetic Carrier Screening,E,E05.200.562.250,Genetic Testing,Clinical Laboratory Techniques,10
Genetic Carrier Screening,E,E05.393.435.250,Genetic Testing,Genetic Techniques,10
Genetic Carrier Screening,N,N02.421.726.233.221.250,Genetic Testing,Diagnostic Services,10
Genetic Carrier Screening,N,N02.421.308.200,Genetic Services,Health Services,10
Genetic Carrier Screening,E,E01.370.225.562.250,Genetic Testing,Clinical Laboratory Techniques,10
Genetic Counseling,N,N02.421.308.400,Genetic Services,Health Services,10
Genetic Counseling,H,H01.158.273.343.385.500.384,"Genetics, Medical",Human Genetics,10
Genetic Research,H,H01.770.644.145.350,Biomedical Research,Research,10
Genetic Research,H,H01.158.273.343.249,Genetics,Biology,10
"Genital Neoplasms, Female",C,C04.588.945.418,Urogenital Neoplasms,Neoplasms by Site,10
"Genital Neoplasms, Female",C,C13.351.937.418,Urogenital Neoplasms,Female Urogenital Diseases,10
Genitalia,A,A05.360,Urogenital System,NULL,10
"Genome, Mitochondrial",G,G05.360.340.360,Genome,Genetic Structures,10
Geologic Sediments,G,G01.311.330,Geological Phenomena,Physical Phenomena,10
Geologic Sediments,G,G16.500.320,Ecological and Environmental Phenomena,Biological Phenomena,10
Glutathione Peroxidase,D,D08.811.682.732.500,Peroxidases,Oxidoreductases,10
Granulocyte-Macrophage Colony-Stimulating Factor,D,D12.776.395.240.300,Colony-Stimulating Factors,Glycoproteins,10
Granulocyte-Macrophage Colony-Stimulating Factor,D,D12.644.276.374.410.240.375,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,10
Granulocyte-Macrophage Colony-Stimulating Factor,D,D23.529.374.410.240.375,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,10
Granulocyte-Macrophage Colony-Stimulating Factor,D,D12.776.467.374.410.240.375,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,10
Guanylate Cyclase,D,D12.776.476.350,Intracellular Signaling Peptides and Proteins,Proteins,10
Guanylate Cyclase,D,D12.644.360.350,Intracellular Signaling Peptides and Proteins,Peptides,10
Guanylate Cyclase,D,D08.811.520.650.600,Phosphorus-Oxygen Lyases,Lyases,10
Haemophilus,B,B03.440.450.600.450,Pasteurellaceae,Gram-Negative Facultatively Anaerobic Rods,10
Haemophilus,B,B03.660.250.550.290,Pasteurellaceae,Gammaproteobacteria,10
"Hand, Foot and Mouth Disease",C,C01.925.782.687.359.213.331,Coxsackievirus Infections,Enterovirus Infections,10
Health Planning Councils,N,N03.540.452.210,Health Planning Organizations,Organizations,10
Hematopoietic Stem Cell Transplantation,E,E04.936.225.687.500,Stem Cell Transplantation,Cell Transplantation,10
Hematopoietic Stem Cell Transplantation,E,E02.095.147.500.500.500,Stem Cell Transplantation,Cell Transplantation,10
Heme Oxygenase-1,D,D08.811.682.690.708.410.500,Heme Oxygenase (Decyclizing),Mixed Function Oxygenases,10
Hep G2 Cells,A,A11.436.348.500,Hepatocytes,Epithelial Cells,10
Hep G2 Cells,A,A11.251.860.180.432,"Cell Line, Tumor","Tumor Cells, Cultured",10
Hepatitis E virus,B,B04.450.412,Hepatitis Viruses,Viruses,10
Hepatitis E virus,B,B04.820.578.407.400,Hepevirus,Positive-Strand RNA Viruses,10
Herniorrhaphy,E,E04.680.325,Reconstructive Surgical Procedures,"Surgical Procedures, Operative",10
HIV Envelope Protein gp41,D,D23.050.327.520.330,HIV Antigens,"Antigens, Viral",10
HIV Envelope Protein gp41,D,D12.776.543.512.500.330,Viral Fusion Proteins,Membrane Fusion Proteins,10
HIV Envelope Protein gp41,D,D12.776.964.775.562.500.200,"env Gene Products, Human Immunodeficiency Virus",Human Immunodeficiency Virus Proteins,10
HIV Envelope Protein gp41,D,D12.776.964.775.325.164.200,"env Gene Products, Human Immunodeficiency Virus","Gene Products, env",10
HIV Envelope Protein gp41,D,D12.776.964.970.880.910.330,Viral Fusion Proteins,Viral Envelope Proteins,10
HIV Envelope Protein gp41,D,D12.776.964.970.880.325.164.200,"env Gene Products, Human Immunodeficiency Virus","Gene Products, env",10
Human Growth Hormone,D,D06.472.699.631.525.425.875,Growth Hormone,"Pituitary Hormones, Anterior",10
Human Growth Hormone,D,D12.644.548.691.525.425.875,Growth Hormone,"Pituitary Hormones, Anterior",10
Hydrolysis,G,G02.380,Chemical Phenomena,NULL,10
Hyperphagia,C,C23.888.821.645,"Signs and Symptoms, Digestive",Signs and Symptoms,10
Hypnotics and Sedatives,D,D27.505.696.277.350,Central Nervous System Depressants,Physiological Effects of Drugs,10
Hypnotics and Sedatives,D,D27.505.954.427.210.350,Central Nervous System Depressants,Central Nervous System Agents,10
Hypothermia,C,C23.888.119.565,Body Temperature Changes,Signs and Symptoms,10
Hypothyroidism,C,C19.874.482,Thyroid Diseases,Endocrine System Diseases,10
"Hypoxia-Ischemia, Brain",C,C23.888.852.079.797.500,"Hypoxia, Brain",Hypoxia,10
"Hypoxia-Ischemia, Brain",C,C14.907.253.092.716,Brain Ischemia,Cerebrovascular Disorders,10
"Hypoxia-Ischemia, Brain",C,C10.228.140.624.500,"Hypoxia, Brain",Brain Diseases,10
"Hypoxia-Ischemia, Brain",C,C10.228.140.300.150.716,Brain Ischemia,Cerebrovascular Disorders,10
Immunomodulation,E,E02.095.465,Biological Therapy,Therapeutics,10
Immunomodulation,G,G12.535,Immune System Phenomena,NULL,10
Impetigo,C,C17.800.838.765.770.360,Staphylococcal Skin Infections,"Skin Diseases, Bacterial",10
Impetigo,C,C01.150.252.819.770.360,Staphylococcal Skin Infections,"Skin Diseases, Bacterial",10
Impetigo,C,C01.150.252.410.890.587,Streptococcal Infections,Gram-Positive Bacterial Infections,10
Impetigo,C,C01.150.252.410.868.951.360,Staphylococcal Skin Infections,Staphylococcal Infections,10
Impetigo,C,C01.800.720.770.360,Staphylococcal Skin Infections,"Skin Diseases, Bacterial",10
Infectious Disease Incubation Period,N,N06.850.335.250,"Disease Transmission, Infectious",Public Health,10
"Infusions, Parenteral",E,E02.319.267.510,Drug Administration Routes,Drug Therapy,10
Insulin-Secreting Cells,A,A11.436.294.092,Enteroendocrine Cells,Epithelial Cells,10
Insulin-Secreting Cells,A,A11.382.625.092,Enteroendocrine Cells,Endocrine Cells,10
Insulin-Secreting Cells,A,A03.734.414.131,Islets of Langerhans,Pancreas,10
Insulin-Secreting Cells,A,A06.390.131,Enteroendocrine Cells,Endocrine System,10
Insulin-Secreting Cells,A,A06.300.414.087,Islets of Langerhans,Endocrine Glands,10
Interferon-beta,D,D23.529.374.440.890.275,Interferon Type I,Interferons,10
Interferon-beta,D,D12.776.467.374.440.890.275,Interferon Type I,Interferons,10
Interferon-beta,D,D12.644.276.374.440.890.275,Interferon Type I,Interferons,10
Islets of Langerhans,A,A06.300.414,Endocrine Glands,Endocrine System,10
Islets of Langerhans,A,A03.734.414,Pancreas,Digestive System,10
Joint Diseases,C,C05.550,Musculoskeletal Diseases,NULL,10
"Journalism, Medical",L,L01.737.498.550,Journalism,Publishing,10
Jurisprudence,N,N03.706.535,"Social Control, Formal",Health Care Economics and Organizations,10
Jurisprudence,I,I01.880.604.583,"Social Control, Formal",Sociology,10
Klebsiella,B,B03.660.250.150.400,Enterobacteriaceae,Gammaproteobacteria,10
Klebsiella,B,B03.440.450.425.425,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,10
Legislation as Topic,N,N03.706.615,"Social Control, Formal",Health Care Economics and Organizations,10
"Legislation, Food",N,N03.706.615.412,Legislation as Topic,"Social Control, Formal",10
Lice Infestations,C,C01.610.858.211.465,Ectoparasitic Infestations,"Skin Diseases, Parasitic",10
Lice Infestations,C,C17.800.838.775.580,"Skin Diseases, Parasitic","Skin Diseases, Infectious",10
Light,G,G01.358.500.505.650,Electromagnetic Radiation,Electromagnetic Phenomena,10
Light,G,G01.590.540,Optical Phenomena,Physical Phenomena,10
Light,G,G01.750.250.650,Electromagnetic Radiation,Radiation,10
Light,G,G01.750.770.578,"Radiation, Nonionizing",Radiation,10
Listeriosis,C,C01.150.252.410.514,Gram-Positive Bacterial Infections,Bacterial Infections,10
Lithuania,Z,Z01.542.248.136.580,Baltic States,"Europe, Eastern",10
Living Donors,M,M01.898.656,Tissue Donors,Persons,10
Lymphatic Diseases,C,C15.604,Hemic and Lymphatic Diseases,NULL,10
Magnetic Resonance Angiography,E,E01.370.350.825.500.500,Magnetic Resonance Imaging,Tomography,10
Magnetic Resonance Angiography,E,E01.370.370.050.500,Angiography,"Diagnostic Techniques, Cardiovascular",10
Manganese,D,D01.552.544.484,"Metals, Heavy",Metals,10
Manganese,D,D01.268.956.374,Transition Elements,Elements,10
Manganese,D,D01.268.556.484,"Metals, Heavy",Elements,10
Matrix Metalloproteinase 1,D,D12.776.467.836.100,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,10
Matrix Metalloproteinase 1,D,D12.644.276.848.100,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,10
Matrix Metalloproteinase 1,D,D08.811.277.656.300.480.525.700.100,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,10
Matrix Metalloproteinase 1,D,D08.811.277.656.675.374.525.700.100,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,10
Matrix Metalloproteinase 1,D,D08.811.277.656.675.374.205.351,Collagenases,Metalloendopeptidases,10
Matrix Metalloproteinase 1,D,D08.811.277.656.300.480.205.351,Collagenases,Metalloendopeptidases,10
Menstrual Cycle,G,G08.686.605,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,10
Menstrual Hygiene Products,E,E07.357.500,Feminine Hygiene Products,Equipment and Supplies,10
Mental Status Schedule,F,F04.711.513.653.574,Psychiatric Status Rating Scales,Neuropsychological Tests,10
Mental Status Schedule,F,F04.711.513.603.500,Mental Status and Dementia Tests,Neuropsychological Tests,10
Microsatellite Instability,G,G05.365.590.335.590,Genomic Instability,Mutation,10
Microsatellite Instability,G,G05.370.590,Genomic Instability,Genetic Phenomena,10
Microsatellite Instability,C,C23.550.362.590,Genomic Instability,Pathologic Processes,10
"Microscopy, Immunoelectron",E,E01.370.350.515.402.625,"Microscopy, Electron",Microscopy,10
"Microscopy, Immunoelectron",E,E05.595.402.625,"Microscopy, Electron",Microscopy,10
Middle Ear Ventilation,E,E04.580.450.472,Otologic Surgical Procedures,Otorhinolaryngologic Surgical Procedures,10
Middle Ear Ventilation,E,E04.579.592,Ostomy,"Surgical Procedures, Operative",10
Mitral Valve,A,A07.541.510.507,Heart Valves,Heart,10
"Models, Cardiovascular",E,E05.599.395.161,"Models, Biological","Models, Theoretical",10
Molecular Biology,H,H01.158.273.343.595,Genetics,Biology,10
Molecular Biology,H,H01.181.122.650,Biochemistry,Chemistry,10
Molecular Biology,H,H01.158.201.636,Biochemistry,Biological Science Disciplines,10
Molecular Mimicry,G,G16.012.750.500,Biological Mimicry,"Adaptation, Biological",10
Molecular Mimicry,G,G05.545,Genetic Phenomena,NULL,10
Molecular Mimicry,G,G02.111.560,Biochemical Phenomena,Chemical Phenomena,10
Motion Pictures,L,L01.178.590.500,Mass Media,Communications Media,10
Motion Pictures,L,L01.178.820.090.598,Audiovisual Aids,Teaching Materials,10
Motion Pictures,K,K01.093.545,Art,Humanities,10
Motion Pictures,J,J01.897.280.500.598,Audiovisual Aids,Educational Technology,10
Multimedia,J,J01.897.280.500.633,Audiovisual Aids,Educational Technology,10
Multimedia,L,L01.178.820.090.633,Audiovisual Aids,Teaching Materials,10
Multiple Organ Failure,C,C23.550.835.525,Shock,Pathologic Processes,10
Mycoplasma,B,B03.440.860.580.553.553,Mycoplasmataceae,Mycoplasmatales,10
Names,L,L01.559.598.400.556,Terminology as Topic,Linguistics,10
Nanoparticles,J,J01.637.512.600,Nanostructures,Manufactured Materials,10
Nasal Cavity,A,A04.531.449,Nose,Respiratory System,10
Nausea,C,C23.888.821.712,"Signs and Symptoms, Digestive",Signs and Symptoms,10
"Neisseria meningitidis, Serogroup A",B,B03.440.400.425.550.550.641.700,Neisseria meningitidis,Neisseria,10
"Neisseria meningitidis, Serogroup A",B,B03.660.075.525.520.500.700,Neisseria meningitidis,Neisseria,10
"Neural Networks, Computer",L,L01.224.050.375.605,Artificial Intelligence,Algorithms,10
"Neural Networks, Computer",G,G17.485,Mathematical Concepts,NULL,10
Nickel,D,D01.268.556.607,"Metals, Heavy",Elements,10
Nickel,D,D01.268.956.625,Transition Elements,Elements,10
Nickel,D,D01.552.544.607,"Metals, Heavy",Metals,10
Nitric Oxide Synthase Type II,D,D12.776.660.720.575,Poly-ADP-Ribose Binding Proteins,Nuclear Proteins,10
Nitric Oxide Synthase Type II,D,D08.811.682.664.500.772.500,Nitric Oxide Synthase,Amino Acid Oxidoreductases,10
Nitric Oxide Synthase Type II,D,D12.776.157.687.575,Poly-ADP-Ribose Binding Proteins,Carrier Proteins,10
Nitroreductases,D,D08.811.682.655,Oxidoreductases,Enzymes,10
Nursing Evaluation Research,H,H01.770.644.145.390.432,Nursing Research,Biomedical Research,10
Nursing Evaluation Research,H,H02.478.395.432,Nursing Research,Nursing,10
Nursing Evaluation Research,N,N04.590.233.508.613.432,Nursing Research,Nursing Process,10
"Obesity, Morbid",G,G07.100.100.160.120.699.500.500,Obesity,Overweight,10
"Obesity, Morbid",E,E01.370.600.115.100.160.120.699.500.500,Obesity,Overweight,10
"Obesity, Morbid",C,C23.888.144.699.500.500,Obesity,Overweight,10
"Obesity, Morbid",C,C18.654.726.500.700,Obesity,Overnutrition,10
Occupational Stress,C,C24.580,Occupational Diseases,NULL,10
Occupational Stress,F,F02.830.900.666,"Stress, Psychological",Psychophysiology,10
Occupational Stress,F,F01.145.126.990.734,"Stress, Psychological",Behavioral Symptoms,10
Ohio,Z,Z01.107.567.875.510.540,Midwestern United States,United States,10
Ohio,Z,Z01.107.567.875.075.512,Appalachian Region,United States,10
Ohio,Z,Z01.107.567.875.350.540,Great Lakes Region,United States,10
Oligosaccharides,D,D09.698.629,Polysaccharides,Carbohydrates,10
Online Systems,L,L01.313.500.750.300.742,Information Systems,Medical Informatics Applications,10
Optic Atrophy,C,C10.292.700.225,Optic Nerve Diseases,Cranial Nerve Diseases,10
Optic Atrophy,C,C11.640.451,Optic Nerve Diseases,Eye Diseases,10
Orchiectomy,E,E04.270.282.679,Castration,Endocrine Surgical Procedures,10
Orchiectomy,E,E04.950.774.860.618,"Urologic Surgical Procedures, Male",Urologic Surgical Procedures,10
Orchiectomy,E,E04.950.165.679,Castration,Urogenital Surgical Procedures,10
"Organizations, Nonprofit",N,N03.540.630,Organizations,Health Care Economics and Organizations,10
Organophosphates,D,D02.705.400,Organophosphorus Compounds,Organic Chemicals,10
Ovulation Induction,E,E02.875.800.984,"Reproductive Techniques, Assisted",Reproductive Techniques,10
Ovulation Induction,E,E05.820.800.984,"Reproductive Techniques, Assisted",Reproductive Techniques,10
Oxidoreductases,D,D08.811.682,Enzymes,Enzymes and Coenzymes,10
Panama,Z,Z01.107.169.772,Central America,Americas,10
Penicillin G Benzathine,D,D02.886.108.750.750.685,Penicillin G,Penicillins,10
Penicillin G Benzathine,D,D03.633.100.300.750.750.685,Penicillin G,Penicillins,10
Penicillin G Benzathine,D,D02.065.589.099.750.750.685,Penicillin G,Penicillins,10
Perforin,D,D12.776.543.695.875,Pore Forming Cytotoxic Proteins,Membrane Proteins,10
Peripheral Vascular Diseases,C,C14.907.617,Vascular Diseases,Cardiovascular Diseases,10
Permeability,G,G02.723,Chemical Phenomena,NULL,10
Pertussis Toxin,D,D23.946.896.980.690,"Virulence Factors, Bordetella",Virulence Factors,10
Pertussis Toxin,D,D23.946.123.946.690,"Virulence Factors, Bordetella",Bacterial Toxins,10
Pertussis Toxin,D,D08.811.913.400.725.115.680,ADP Ribose Transferases,Pentosyltransferases,10
Physician Incentive Plans,N,N04.452.677.740,Personnel Management,Organization and Administration,10
Platelet Activation,G,G09.188.390.600,Hemostasis,Blood Physiological Phenomena,10
Play and Playthings,I,I03.450.642.693,Recreation,Leisure Activities,10
Pneumothorax,C,C08.528.778,Pleural Diseases,Respiratory Tract Diseases,10
Positron Emission Tomography Computed Tomography,E,E01.370.384.730.800.399.500,Positron-Emission Tomography,"Tomography, Emission-Computed",10
Positron Emission Tomography Computed Tomography,E,E01.370.350.567.500,Multimodal Imaging,Diagnostic Imaging,10
Positron Emission Tomography Computed Tomography,E,E01.370.350.600.350.700.810.490,"Tomography, X-Ray Computed",Radiographic Image Enhancement,10
Positron Emission Tomography Computed Tomography,E,E01.370.350.700.700.810.645,"Tomography, X-Ray Computed",Radiographic Image Enhancement,10
Positron Emission Tomography Computed Tomography,E,E01.370.350.700.810.810.723,"Tomography, X-Ray Computed","Tomography, X-Ray",10
Positron Emission Tomography Computed Tomography,E,E01.370.350.600.350.800.399.500,Positron-Emission Tomography,"Tomography, Emission-Computed",10
Positron Emission Tomography Computed Tomography,E,E01.370.350.350.810.645,"Tomography, X-Ray Computed","Image Interpretation, Computer-Assisted",10
Positron Emission Tomography Computed Tomography,E,E01.370.350.350.800.700.500,Positron-Emission Tomography,"Tomography, Emission-Computed",10
Positron Emission Tomography Computed Tomography,E,E01.370.350.710.800.399.500,Positron-Emission Tomography,"Tomography, Emission-Computed",10
Positron Emission Tomography Computed Tomography,E,E01.370.350.825.800.399.500,Positron-Emission Tomography,"Tomography, Emission-Computed",10
Positron Emission Tomography Computed Tomography,E,E01.370.350.825.810.810.700,"Tomography, X-Ray Computed","Tomography, X-Ray",10
Precancerous Conditions,C,C04.834,Neoplasms,NULL,10
"Pregnancy Complications, Cardiovascular",C,C14.583,Cardiovascular Diseases,NULL,10
"Pregnancy Complications, Cardiovascular",C,C13.703.634,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,10
Problem-Based Learning,I,I02.158.660,Curriculum,Education,10
Problem-Based Learning,I,I02.903.565,Teaching,Education,10
Problem-Based Learning,F,F02.463.425.720,Learning,Mental Processes,10
Prodrugs,D,D26.675,Pharmaceutical Preparations,NULL,10
"Programming, Linear",L,L01.906.394.748,Operations Research,Systems Analysis,10
Progression-Free Survival,N,N04.761.559.590.800.474,Treatment Outcome,"Outcome Assessment, Health Care",10
Progression-Free Survival,N,N05.715.360.575.575.800.474,Treatment Outcome,"Outcome Assessment, Health Care",10
Progression-Free Survival,N,N05.715.360.750.795.738,Survival Analysis,Statistics as Topic,10
Progression-Free Survival,E,E05.318.740.998.738,Survival Analysis,Statistics as Topic,10
Progression-Free Survival,N,N06.850.520.830.998.825,Survival Analysis,Statistics as Topic,10
Progression-Free Survival,E,E01.789.800.285,Treatment Outcome,Prognosis,10
Proto-Oncogene Proteins B-raf,D,D12.776.476.400.842.437,raf Kinases,MAP Kinase Kinase Kinases,10
Proto-Oncogene Proteins B-raf,D,D12.776.624.664.700.204.200,raf Kinases,Proto-Oncogene Proteins,10
Proto-Oncogene Proteins B-raf,D,D08.811.913.696.620.682.700.559.842.374,raf Kinases,MAP Kinase Kinase Kinases,10
Proto-Oncogene Proteins B-raf,D,D12.644.360.400.842.374,raf Kinases,MAP Kinase Kinase Kinases,10
Proviruses,B,B04.725,Viruses,NULL,10
Psychomotor Disorders,C,C10.597.606.881,Neurobehavioral Manifestations,Neurologic Manifestations,10
Psychomotor Disorders,C,C23.888.592.604.882,Neurobehavioral Manifestations,Neurologic Manifestations,10
Psychomotor Disorders,F,F01.700.875,Neurobehavioral Manifestations,Behavior and Behavior Mechanisms,10
Psychosocial Support Systems,I,I01.880.853.500.600.500,Social Support,Social Environment,10
Pyroglyphidae,B,B01.050.500.131.166.132.419.600,Mites,Acari,10
Radiographic Image Enhancement,E,E01.370.350.700.700,Radiography,Diagnostic Imaging,10
Radiographic Image Enhancement,E,E01.370.350.600.350.700,Image Enhancement,Photography,10
Radiographic Image Enhancement,L,L01.224.308.380.600,Image Enhancement,"Image Processing, Computer-Assisted",10
Radiopharmaceuticals,D,D27.505.259.843,Diagnostic Uses of Chemicals,Pharmacologic Actions,10
Radiopharmaceuticals,D,D27.505.519.871,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,10
Radiopharmaceuticals,D,D27.720.470.410.650,Indicators and Reagents,Laboratory Chemicals,10
Radon,D,D01.362.641.745,Noble Gases,Gases,10
Radon,D,D01.496.749.305.800,"Elements, Radioactive",Radioisotopes,10
Radon,D,D01.268.613.700,Noble Gases,Elements,10
Radon,D,D01.268.271.800,"Elements, Radioactive",Elements,10
"Receptor, Melanocortin, Type 1",D,D12.776.543.750.695.430.500,"Receptors, Melanocortin","Receptors, G-Protein-Coupled",10
"Receptor, Melanocortin, Type 1",D,D12.776.543.750.720.600.285.500.500,"Receptors, Melanocortin","Receptors, Corticotropin",10
"Receptor, Melanocortin, Type 1",D,D12.776.543.750.750.555.285.500.500,"Receptors, Melanocortin","Receptors, Corticotropin",10
"Receptor, Melanocortin, Type 1",D,D12.776.543.750.750.660.285.500.500,"Receptors, Melanocortin","Receptors, Corticotropin",10
"Recognition, Psychology",F,F02.463.425.540.706,Memory,Learning,10
Refusal to Participate,F,F02.463.785.373.476.850,Dissent and Disputes,Decision Making,10
Regeneration,G,G16.762,Biological Phenomena,NULL,10
Religion and Psychology,K,K01.844.664,Religion,Humanities,10
Religion and Psychology,F,F02.880,Psychological Phenomena,NULL,10
Renin,D,D08.811.277.656.837.750,Proprotein Convertases,Peptide Hydrolases,10
Renin,D,D08.811.277.656.300.048.780,Aspartic Acid Endopeptidases,Endopeptidases,10
Renin,D,D08.811.277.656.074.500.780,Aspartic Acid Endopeptidases,Aspartic Acid Proteases,10
Researcher-Subject Relations,F,F01.829.401.650.837,Professional-Patient Relations,Interpersonal Relations,10
"Rhinitis, Allergic",C,C20.543.480.680.443,Respiratory Hypersensitivity,"Hypersensitivity, Immediate",10
"Rhinitis, Allergic",C,C08.460.799.315,Rhinitis,Nose Diseases,10
"Rhinitis, Allergic",C,C08.674.453,Respiratory Hypersensitivity,Respiratory Tract Diseases,10
"Rhinitis, Allergic",C,C09.603.799.315,Rhinitis,Nose Diseases,10
RNA Probes,D,D13.444.600.723,Nucleic Acid Probes,Nucleic Acids,10
RNA Probes,D,D27.505.259.750.600.825,Nucleic Acid Probes,Molecular Probes,10
RNA Probes,D,D27.720.470.530.600.825,Nucleic Acid Probes,Molecular Probes,10
"RNA, Small Interfering",D,D13.444.735.150.700,"RNA, Antisense",RNA,10
"RNA, Small Interfering",D,D13.444.735.790.552.875,"RNA, Small Untranslated","RNA, Untranslated",10
"RNA, Small Interfering",D,D13.150.650.700,"RNA, Antisense",Antisense Elements (Genetics),10
Ruminants,B,B01.050.150.900.649.313.500.380,Artiodactyla,Eutheria,10
Satellite Communications,L,L01.178.847.550,Telecommunications,Communications Media,10
Scalp Dermatoses,C,C17.800.738,Skin Diseases,Skin and Connective Tissue Diseases,10
Self-Examination,E,E01.370.600.750,Physical Examination,Diagnostic Techniques and Procedures,10
Self-Examination,F,F01.145.488.700,Health Behavior,Behavior,10
Semantics,L,L01.559.598.745,Linguistics,Language,10
Serbia,Z,Z01.542.248.786,"Europe, Eastern",Europe,10
Sex,G,G08.686.810,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,10
Simulation Training,I,I02.903.847,Teaching,Education,10
"Societies, Scientific",N,N03.540.828.838,Societies,Organizations,10
Sociological Factors,I,I01.880.853,Sociology,Social Sciences,10
Sociology,I,I01.880,Social Sciences,NULL,10
Sociology,F,F04.096.879.757,Social Sciences,Behavioral Sciences,10
Software Design,L,L01.224.900.820,Software,Computing Methodologies,10
Specific Pathogen-Free Organisms,G,G06.320.676,Germ-Free Life,Microbiological Phenomena,10
Sperm Motility,G,G04.198.750,Cell Movement,Cell Physiological Phenomena,10
Sperm Motility,E,E05.200.992.812,Semen Analysis,Clinical Laboratory Techniques,10
Sperm Motility,E,E01.370.225.992.812,Semen Analysis,Clinical Laboratory Techniques,10
Spiro Compounds,D,D04.711,Polycyclic Compounds,NULL,10
Spiro Compounds,D,D02.455.426.779,"Hydrocarbons, Cyclic",Hydrocarbons,10
Staphylococcus,B,B03.510.100.750.750,Staphylococcaceae,Bacillales,10
Staphylococcus,B,B03.510.400.790.750,Staphylococcaceae,Gram-Positive Cocci,10
Staphylococcus,B,B03.300.390.400.800.750,Staphylococcaceae,Gram-Positive Endospore-Forming Rods,10
Staphylococcus,B,B03.353.500.750.750,Staphylococcaceae,Bacillales,10
Static Electricity,G,G01.358.500.249.820,Electricity,Electromagnetic Phenomena,10
"Sterilization, Tubal",E,E04.950.300.766,Gynecologic Surgical Procedures,Urogenital Surgical Procedures,10
"Sterilization, Tubal",E,E04.950.599.683,"Sterilization, Reproductive",Urogenital Surgical Procedures,10
Streptolysins,D,D23.946.123.868,Bacterial Toxins,"Toxins, Biological",10
Streptolysins,D,D23.946.350.750,Exotoxins,"Toxins, Biological",10
Streptolysins,D,D12.776.543.695.937,Pore Forming Cytotoxic Proteins,Membrane Proteins,10
Sugar-Sweetened Beverages,G,G07.203.100.772,Beverages,"Diet, Food, and Nutrition",10
Sugar-Sweetened Beverages,J,J02.200.772,Beverages,Food and Beverages,10
Sulfamethoxazole,D,D02.886.590.700.725.867,Sulfanilamides,Sulfonamides,10
Sulfamethoxazole,D,D02.065.884.725.867,Sulfanilamides,Sulfonamides,10
Sulfamethoxazole,D,D02.092.146.807.867,Sulfanilamides,Aniline Compounds,10
Suramin,D,D02.886.645.600.080.050.650.750,Naphthalenesulfonates,Arylsulfonates,10
Suramin,D,D02.455.426.559.847.638.555.750,Naphthalenesulfonates,Naphthalenes,10
Suramin,D,D04.615.638.555.750,Naphthalenesulfonates,Naphthalenes,10
Temporal Lobe,A,A08.186.211.200.885.287.500.863,Cerebral Cortex,Cerebrum,10
Textile Industry,J,J01.576.655.937,Manufacturing Industry,Industry,10
Textiles,J,J01.637.836,Manufactured Materials,"Technology, Industry, and Agriculture",10
"Therapy, Computer-Assisted",L,L01.313.500.750.100.710,"Decision Making, Computer-Assisted",Medical Informatics Applications,10
"Therapy, Computer-Assisted",E,E02.950,Therapeutics,NULL,10
Thermodynamics,G,G01.906,Physical Phenomena,NULL,10
Tooth,A,A14.549.167.860,Dentition,Mouth,10
Toxoplasmosis,C,C01.610.752.250.800,Coccidiosis,Protozoan Infections,10
"Transformation, Genetic",G,G05.728.865,"Recombination, Genetic",Genetic Phenomena,10
Urinary Catheterization,E,E05.157.500,Catheterization,Investigative Techniques,10
Urinary Catheterization,E,E02.148.947,Catheterization,Therapeutics,10
Urinary Catheterization,E,E01.370.390.820,"Diagnostic Techniques, Urological",Diagnostic Techniques and Procedures,10
Urination Disorders,C,C13.351.968.934,Urologic Diseases,Female Urogenital Diseases,10
Urination Disorders,C,C12.777.934,Urologic Diseases,Male Urogenital Diseases,10
Vancomycin,D,D12.644.233.925,Glycopeptides,Peptides,10
Vancomycin,D,D09.400.420.925,Glycopeptides,Glycoconjugates,10
Vanuatu,Z,Z01.639.760.590.736,Melanesia,Pacific Islands,10
Vasopressins,D,D12.644.548.691.692.781,"Pituitary Hormones, Posterior",Pituitary Hormones,10
Vasopressins,D,D12.644.456.925,Oligopeptides,Peptides,10
Vasopressins,D,D12.644.400.900,Neuropeptides,Peptides,10
Vasopressins,D,D06.472.699.631.692.781,"Pituitary Hormones, Posterior",Pituitary Hormones,10
Vasopressins,D,D12.776.631.650.937,Neuropeptides,Nerve Tissue Proteins,10
Ventricular Remodeling,C,C23.300.985,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",10
Ventricular Remodeling,G,G09.330.955.975,Ventricular Function,Cardiovascular Physiological Phenomena,10
Vesicular stomatitis Indiana virus,B,B04.820.480.937.750.900.900,Vesiculovirus,Rhabdoviridae,10
Virus Latency,G,G06.920.900,Virus Physiological Phenomena,Microbiological Phenomena,10
Wearable Electronic Devices,E,E07.305.906,Electrical Equipment and Supplies,Equipment and Supplies,10
"Wounds, Nonpenetrating",C,C26.974,Wounds and Injuries,NULL,10
"Wounds, Penetrating",C,C26.986,Wounds and Injuries,NULL,10
X-Ray Diffraction,E,E05.196.309.742,Crystallography,"Chemistry Techniques, Analytical",10
X-Ray Diffraction,E,E05.196.822.950,"Scattering, Radiation","Chemistry Techniques, Analytical",10
X-Ray Diffraction,G,G01.867.950,"Scattering, Radiation",Physical Phenomena,10
X-Ray Diffraction,G,G02.965,Chemical Phenomena,NULL,10
Yersinia,B,B03.660.250.150.950,Enterobacteriaceae,Gammaproteobacteria,10
Yersinia,B,B03.440.450.425.900,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,10
Zebrafish Proteins,D,D12.776.325.500,Fish Proteins,Proteins,10
3' Untranslated Regions,D,D13.444.735.544.875.880,Untranslated Regions,"RNA, Messenger",9
3' Untranslated Regions,D,D13.444.735.790.878.880,Untranslated Regions,"RNA, Untranslated",9
3' Untranslated Regions,G,G05.360.340.024.220.880.880,Untranslated Regions,"DNA, Intergenic",9
3' Untranslated Regions,G,G05.360.340.024.340.137.910.880,Untranslated Regions,Gene Components,9
Acupuncture Therapy,E,E02.190.044,Complementary Therapies,Therapeutics,9
Acute-Phase Reaction,C,C23.550.470.099,Inflammation,Pathologic Processes,9
Adipocytes,A,A11.329.114,Connective Tissue Cells,Cells,9
Adiponectin,D,D23.529.024.249,Adipokines,Intercellular Signaling Peptides and Proteins,9
Adiponectin,D,D12.776.467.024.249,Adipokines,Intercellular Signaling Peptides and Proteins,9
Adiponectin,D,D12.644.548.011.249,Adipokines,Peptide Hormones,9
Adiponectin,D,D12.644.276.024.249,Adipokines,Intercellular Signaling Peptides and Proteins,9
Adiponectin,D,D06.472.699.042.249,Adipokines,Peptide Hormones,9
"Administration, Intranasal",E,E02.319.267.120.655.500,"Administration, Mucosal","Administration, Topical",9
Adolescent Nutritional Physiological Phenomena,G,G07.203.650.220.060,Child Nutritional Physiological Phenomena,Nutritional Physiological Phenomena,9
AIDS Dementia Complex,F,F03.615.400.050,Dementia,Neurocognitive Disorders,9
AIDS Dementia Complex,C,C01.778.640.400.070,HIV Infections,"Sexually Transmitted Diseases, Viral",9
AIDS Dementia Complex,C,C01.221.250.875.049,HIV Infections,Blood-Borne Infections,9
AIDS Dementia Complex,C,C01.221.812.640.400.070,HIV Infections,"Sexually Transmitted Diseases, Viral",9
AIDS Dementia Complex,C,C01.925.782.815.616.400.049,HIV Infections,Lentivirus Infections,9
AIDS Dementia Complex,C,C01.925.813.400.070,HIV Infections,"Sexually Transmitted Diseases, Viral",9
AIDS Dementia Complex,C,C20.673.480.070,HIV Infections,Immunologic Deficiency Syndromes,9
AIDS Dementia Complex,C,C10.228.140.380.070,Dementia,Brain Diseases,9
Airway Obstruction,C,C08.618.846.185,Respiratory Insufficiency,Respiration Disorders,9
Alcohol Dehydrogenase,D,D08.811.682.047.820.250,NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases,Alcohol Oxidoreductases,9
Alpha-Ketoglutarate-Dependent Dioxygenase FTO,D,D08.811.682.662.582.242,"Oxidoreductases, N-Demethylating",Oxidoreductases Acting on CH-NH Group Donors,9
Alpha-Ketoglutarate-Dependent Dioxygenase FTO,D,D08.811.682.690.416.139.992,AlkB Enzymes,Dioxygenases,9
Alpha-Ketoglutarate-Dependent Dioxygenase FTO,D,D08.811.074.062.968,AlkB Enzymes,DNA Repair Enzymes,9
Amblyopia,C,C10.228.140.055,Brain Diseases,Central Nervous System Diseases,9
Amblyopia,C,C11.966.073,Vision Disorders,Eye Diseases,9
Amblyopia,C,C10.597.751.941.073,Vision Disorders,Sensation Disorders,9
Amblyopia,C,C23.888.592.763.941.073,Vision Disorders,Sensation Disorders,9
Ameloblasts,A,A11.436.107,Epithelial Cells,Cells,9
Anecdotes as Topic,K,K01.517.067,Literature,Humanities,9
"Anesthesia, General",E,E03.155.197,Anesthesia,Anesthesia and Analgesia,9
Angiotensin-Converting Enzyme 2,D,D08.811.277.656.350.245.042,Carboxypeptidases,Exopeptidases,9
"Animals, Zoo",B,B01.050.050.448,Animal Population Groups,Animals,9
Anonymous Testing,E,E01.370.500.174,Mass Screening,Diagnostic Techniques and Procedures,9
Anonymous Testing,E,E05.318.308.980.438.580.174,Mass Screening,Health Surveys,9
Anonymous Testing,N,N02.421.726.233.443.221,Mass Screening,Diagnostic Services,9
Anonymous Testing,N,N05.715.360.300.800.438.500.174,Mass Screening,Health Surveys,9
Anonymous Testing,N,N06.850.520.308.980.438.580.174,Mass Screening,Health Surveys,9
Anonymous Testing,N,N06.850.780.500.162,Mass Screening,Public Health Practice,9
"Antibodies, Antineutrophil Cytoplasmic",D,D23.101.050,Biomarkers,Biological Factors,9
"Antibodies, Antineutrophil Cytoplasmic",D,D12.776.377.715.548.114.323.190,Autoantibodies,Antibodies,9
"Antibodies, Antineutrophil Cytoplasmic",D,D12.776.124.486.485.114.323.190,Autoantibodies,Antibodies,9
"Antibodies, Antineutrophil Cytoplasmic",D,D12.776.124.790.651.114.323.190,Autoantibodies,Antibodies,9
"Antibodies, Blocking",D,D12.776.124.790.651.114.143,Antibodies,Immunoglobulins,9
"Antibodies, Blocking",D,D12.776.124.486.485.114.143,Antibodies,Immunoglobulins,9
"Antibodies, Blocking",D,D12.776.377.715.548.114.143,Antibodies,Immunoglobulins,9
"Antidepressive Agents, Tricyclic",D,D27.505.954.427.700.122.055,Antidepressive Agents,Psychotropic Drugs,9
Apgar Score,E,E01.370.600.050,Physical Examination,Diagnostic Techniques and Procedures,9
Aprotinin,D,D12.776.083,Proteins,"Amino Acids, Peptides, and Proteins",9
Aquaculture,J,J01.040.168,Agriculture,"Technology, Industry, and Agriculture",9
Arsenic Poisoning,C,C25.723.098,Poisoning,Chemically-Induced Disorders,9
Arsenic Poisoning,C,C10.720.475.150,"Heavy Metal Poisoning, Nervous System",Neurotoxicity Syndromes,9
Artifacts,E,E05.047,Investigative Techniques,NULL,9
Asbestosis,C,C08.381.520.702.125,Pneumoconiosis,Lung Injury,9
Asbestosis,C,C08.381.483.581.125,Pneumoconiosis,"Lung Diseases, Interstitial",9
Asbestosis,C,C24.800.127,Pneumoconiosis,Occupational Diseases,9
Aspartic Acid Endopeptidases,D,D08.811.277.656.074.500,Aspartic Acid Proteases,Peptide Hydrolases,9
Aspartic Acid Endopeptidases,D,D08.811.277.656.300.048,Endopeptidases,Peptide Hydrolases,9
Astigmatism,C,C11.744.212,Refractive Errors,Eye Diseases,9
Athletic Injuries,C,C26.115,Wounds and Injuries,NULL,9
Attitude to Computers,F,F01.100.100,Attitude,Behavior and Behavior Mechanisms,9
Aviadenovirus,B,B04.280.030.100,Adenoviridae,DNA Viruses,9
Axons,A,A11.671.137,Neurons,Cells,9
Axons,A,A11.671.501.145,Nerve Fibers,Neurons,9
Axons,A,A11.284.180.075,Cell Surface Extensions,Cellular Structures,9
Axons,A,A08.675.542.145,Nerve Fibers,Neurons,9
Bacterial Physiological Phenomena,G,G06.099,Microbiological Phenomena,NULL,9
Behavior Control,F,F04.047,Behavioral Disciplines and Activities,NULL,9
Behavior Control,I,I01.880.630.099,"Social Control, Informal",Sociology,9
Behavior Control,E,E02.085,Therapeutics,NULL,9
beta-Defensins,D,D12.776.543.695.054.200.075,Defensins,Antimicrobial Cationic Peptides,9
beta-Defensins,D,D12.644.050.200.075,Defensins,Antimicrobial Cationic Peptides,9
Bioprosthesis,E,E07.695.100,Prostheses and Implants,Equipment and Supplies,9
Birthing Centers,N,N02.278.080,Health Facilities,"Health Care Facilities, Manpower, and Services",9
Blood Glucose Self-Monitoring,E,E05.200.124.100.105,Blood Chemical Analysis,Clinical Chemistry Tests,9
Blood Glucose Self-Monitoring,E,E02.900.950.500,Self-Testing,Self Care,9
Blood Glucose Self-Monitoring,E,E01.370.520.100,"Monitoring, Physiologic",Diagnostic Techniques and Procedures,9
Blood Glucose Self-Monitoring,E,E01.370.374.100,"Diagnostic Techniques, Endocrine",Diagnostic Techniques and Procedures,9
Blood Glucose Self-Monitoring,E,E01.370.225.124.100.105,Blood Chemical Analysis,Clinical Chemistry Tests,9
B-Lymphocyte Subsets,A,A11.063.438.450,B-Lymphocytes,Antibody-Producing Cells,9
B-Lymphocyte Subsets,A,A11.118.637.555.567.562.200,B-Lymphocytes,Lymphocytes,9
B-Lymphocyte Subsets,A,A11.118.637.555.567.550.450,Lymphocyte Subsets,Lymphocytes,9
B-Lymphocyte Subsets,A,A15.145.229.637.555.567.562.200,B-Lymphocytes,Lymphocytes,9
B-Lymphocyte Subsets,A,A15.145.229.637.555.567.550.450,Lymphocyte Subsets,Lymphocytes,9
B-Lymphocyte Subsets,A,A15.382.490.555.567.550.300,Lymphocyte Subsets,Lymphocytes,9
B-Lymphocyte Subsets,A,A15.382.490.555.567.562.450,B-Lymphocytes,Lymphocytes,9
B-Lymphocyte Subsets,A,A15.382.032.438.450,B-Lymphocytes,Antibody-Producing Cells,9
Bone Marrow Cells,A,A15.378.316,Hematopoietic System,Hemic and Immune Systems,9
Bone Marrow Cells,A,A11.148,Cells,NULL,9
Bone Remodeling,G,G11.427.213,Musculoskeletal Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,9
Bone Remodeling,G,G16.762.150,Regeneration,Biological Phenomena,9
Borneo,Z,Z01.252.145.103,"Asia, Southeastern",Asia,9
Borneo,Z,Z01.639.160,Islands,Geographic Locations,9
Brucella,B,B03.440.400.425.215.500,Brucellaceae,Gram-Negative Aerobic Rods and Cocci,9
Brucella,B,B03.660.050.070.100,Brucellaceae,Alphaproteobacteria,9
Burkholderia mallei,B,B03.660.075.090.688.100.477,Burkholderia,Burkholderiaceae,9
Cabo Verde,Z,Z01.639.040.543,Atlantic Islands,Islands,9
Cabo Verde,Z,Z01.058.290.190.258,"Africa, Western",Africa South of the Sahara,9
Cadherins,D,D12.776.543.550.200.200,Cell Adhesion Molecules,Membrane Glycoproteins,9
Cadherins,D,D23.050.301.350.200,Cell Adhesion Molecules,"Antigens, Surface",9
Cadherins,D,D12.776.395.550.200.200,Cell Adhesion Molecules,Membrane Glycoproteins,9
Calcium Signaling,G,G03.143.500.100,Ion Transport,Biological Transport,9
Calcium Signaling,G,G02.111.820.800.100,Second Messenger Systems,Signal Transduction,9
Calcium Signaling,G,G04.835.800.100,Second Messenger Systems,Signal Transduction,9
Capitation Fee,N,N03.219.442.090,Fees and Charges,Economics,9
Capsules,D,D26.255.150,Dosage Forms,Pharmaceutical Preparations,9
"Carcinoma, Intraductal, Noninfiltrating",C,C04.557.470.200.240.187.250,Breast Carcinoma In Situ,Carcinoma in Situ,9
"Carcinoma, Intraductal, Noninfiltrating",C,C04.557.470.200.025.275,Adenocarcinoma,Carcinoma,9
"Carcinoma, Intraductal, Noninfiltrating",C,C04.557.470.615.275,"Neoplasms, Ductal, Lobular, and Medullary","Neoplasms, Glandular and Epithelial",9
"Carcinoma, Lobular",C,C04.557.470.615.305,"Neoplasms, Ductal, Lobular, and Medullary","Neoplasms, Glandular and Epithelial",9
"Carcinoma, Lobular",C,C04.557.470.200.025.305,Adenocarcinoma,Carcinoma,9
"Carcinoma, Lobular",C,C04.588.180.437,Breast Neoplasms,Neoplasms by Site,9
"Carcinoma, Lobular",C,C17.800.090.500.437,Breast Neoplasms,Breast Diseases,9
Cardiac Output,E,E01.370.370.380.150,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",9
Cardiac Output,G,G09.330.380.124,Hemodynamics,Cardiovascular Physiological Phenomena,9
Cardiac Rehabilitation,H,H02.403.680.600.250,Rehabilitation,Physical and Rehabilitation Medicine,9
Cardiac Rehabilitation,N,N02.421.784.244,Rehabilitation,Health Services,9
Cardiac Rehabilitation,E,E02.831.185,Rehabilitation,Therapeutics,9
Cardiac Rehabilitation,E,E02.760.169.063.500.185,Rehabilitation,Aftercare,9
"Cardiology Service, Hospital",N,N02.278.216.500.968.215,Hospital Departments,Hospital Administration,9
"Cardiology Service, Hospital",N,N04.452.442.452.422.215,Hospital Departments,Hospital Administration,9
Cecum,A,A03.556.249.249.209,"Intestine, Large",Lower Gastrointestinal Tract,9
Cecum,A,A03.556.124.526.209,"Intestine, Large",Intestines,9
Cerebral Ventricles,A,A08.186.211.140,Brain,Central Nervous System,9
Chagas Cardiomyopathy,C,C01.920.625.190,Chagas Disease,Vector Borne Diseases,9
Chagas Cardiomyopathy,C,C01.610.752.300.900.200.190,Chagas Disease,Trypanosomiasis,9
Chagas Cardiomyopathy,C,C14.280.238.190,Cardiomyopathies,Heart Diseases,9
Chlorophenols,D,D02.455.426.559.389.261.190,Chlorobenzenes,Benzene Derivatives,9
Chlorophenols,D,D02.455.426.559.389.657.190,Phenols,Benzene Derivatives,9
Choroidal Neovascularization,C,C23.550.589.500.145,"Neovascularization, Pathologic",Metaplasia,9
Choroidal Neovascularization,C,C11.941.160.244,Choroid Diseases,Uveal Diseases,9
Chromatography,E,E05.196.181,"Chemistry Techniques, Analytical",Investigative Techniques,9
"Chromatography, Gel",E,E05.196.181.400.250,"Chromatography, Liquid",Chromatography,9
"Chromosomes, Human, Pair 11",G,G05.360.162.520.300.325.355,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",9
"Chromosomes, Human, Pair 11",A,A11.284.187.520.300.325.355,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",9
"Chromosomes, Human, Pair 17",A,A11.284.187.520.300.415.425,"Chromosomes, Human, 16-18","Chromosomes, Human",9
"Chromosomes, Human, Pair 17",G,G05.360.162.520.300.415.425,"Chromosomes, Human, 16-18","Chromosomes, Human",9
"Chromosomes, Human, Pair 3",G,G05.360.162.520.300.235.250,"Chromosomes, Human, 1-3","Chromosomes, Human",9
"Chromosomes, Human, Pair 3",A,A11.284.187.520.300.235.250,"Chromosomes, Human, 1-3","Chromosomes, Human",9
"Chromosomes, Human, Pair 9",A,A11.284.187.520.300.325.345,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",9
"Chromosomes, Human, Pair 9",G,G05.360.162.520.300.325.345,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",9
Cocaine,D,D02.145.074.722.388,Tropanes,Azabicyclo Compounds,9
Cocaine,D,D03.132.889.354,Tropanes,Alkaloids,9
Cocaine,D,D03.605.084.500.722.388,Tropanes,Azabicyclo Compounds,9
Cocaine,D,D03.605.869.388,Tropanes,"Heterocyclic Compounds, Bridged-Ring",9
Coccidiosis,C,C01.610.752.250,Protozoan Infections,Parasitic Diseases,9
Coloboma,C,C11.270.147,"Eye Diseases, Hereditary",Eye Diseases,9
Coloboma,C,C11.250.110,Eye Abnormalities,Eye Diseases,9
Coloboma,C,C16.131.384.282,Eye Abnormalities,Congenital Abnormalities,9
Comprehensive Health Care,N,N04.590.233,Patient Care Management,Health Services Administration,9
Computer Communication Networks,L,L01.224.230.110,Computer Systems,Computing Methodologies,9
Conservation of Energy Resources,N,N06.230.080.078,Conservation of Natural Resources,Environment,9
Constipation,C,C23.888.821.150,"Signs and Symptoms, Digestive",Signs and Symptoms,9
Construction Materials,J,J01.637.241,Manufactured Materials,"Technology, Industry, and Agriculture",9
Controlled Before-After Studies,N,N05.715.360.330.500.812,Epidemiologic Studies,Epidemiologic Study Characteristics,9
Controlled Before-After Studies,E,E05.318.372.500.812,Epidemiologic Studies,Epidemiologic Study Characteristics,9
Controlled Before-After Studies,N,N06.850.520.450.500.812,Epidemiologic Studies,Epidemiologic Study Characteristics,9
Costa Rica,Z,Z01.107.169.238,Central America,Americas,9
Cresols,D,D02.455.426.559.389.657.239,Phenols,Benzene Derivatives,9
Cryotherapy,E,E02.258,Therapeutics,NULL,9
Cysticercosis,C,C01.610.335.190.902.185,Taeniasis,Cestode Infections,9
Cytochrome P-450 CYP3A,D,D12.776.422.220.453.860.500,Cytochrome P450 Family 3,Cytochrome P-450 Enzyme System,9
Cytochrome P-450 CYP3A,D,D08.811.682.690.708.170.495.500,Cytochrome P450 Family 3,Cytochrome P-450 Enzyme System,9
Cytochrome P-450 CYP3A,D,D08.811.682.662.582.353,"Oxidoreductases, N-Demethylating",Oxidoreductases Acting on CH-NH Group Donors,9
Cytochrome P-450 CYP3A,D,D08.244.453.860.500,Cytochrome P450 Family 3,Cytochrome P-450 Enzyme System,9
"Decision Making, Computer-Assisted",L,L01.313.500.750.100,Medical Informatics Applications,Medical Informatics,9
Decontamination,N,N06.850.780.325,Public Health Practice,Public Health,9
Dental Caries,C,C07.793.720.210,Tooth Demineralization,Tooth Diseases,9
Diabetic Neuropathies,C,C10.668.829.300,Peripheral Nervous System Diseases,Neuromuscular Diseases,9
Diabetic Neuropathies,C,C19.246.099.937,Diabetes Complications,Diabetes Mellitus,9
Dieldrin,D,D02.455.526.439.371,"Hydrocarbons, Chlorinated","Hydrocarbons, Halogenated",9
Dietary Sucrose,D,D09.301.831.250,Dietary Sugars,Dietary Carbohydrates,9
Dietary Sucrose,D,D09.698.629.305.770.200,Sucrose,Disaccharides,9
Dietary Sucrose,D,D09.947.500.250,Dietary Sugars,Sugars,9
Dietary Sucrose,D,D09.947.750.770.200,Sucrose,Disaccharides,9
Dietary Sucrose,D,D27.720.372.300.353.609.750.250,Nutritive Sweeteners,Sweetening Agents,9
Dietary Sucrose,J,J02.500.514.500.400.700.750.250,Nutritive Sweeteners,Sweetening Agents,9
Dietary Sucrose,J,J02.500.362.831.250,Dietary Sugars,Dietary Carbohydrates,9
Dietary Sucrose,G,G07.203.300.514.500.400.700.750.250,Nutritive Sweeteners,Sweetening Agents,9
Dietary Sucrose,G,G07.203.300.362.831.250,Dietary Sugars,Dietary Carbohydrates,9
Digestive System Surgical Procedures,E,E04.210,"Surgical Procedures, Operative",NULL,9
"DNA, Kinetoplast",D,D13.444.308.442.200,"DNA, Protozoan",DNA,9
"DNA, Kinetoplast",D,D13.444.308.283.225.200,"DNA, Mitochondrial","DNA, Circular",9
Dual Anti-Platelet Therapy,E,E02.319.310.537,"Drug Therapy, Combination",Drug Therapy,9
Ectoparasitic Infestations,C,C01.610.858.211,"Skin Diseases, Parasitic",Parasitic Diseases,9
"Education, Distance",I,I02.195,Education,NULL,9
Ehrlichia ruminantium,B,B03.660.050.783.500.287.700,Ehrlichia,Anaplasmataceae,9
Ehrlichia ruminantium,B,B03.440.664.750.287.700,Ehrlichia,Anaplasmataceae,9
Electron Transport Complex IV,D,D12.776.543.277.687,Electron Transport Chain Complex Proteins,Membrane Proteins,9
Electron Transport Complex IV,D,D12.776.543.585.450.250.875.484,Proton Pumps,Cation Transport Proteins,9
Electron Transport Complex IV,D,D12.776.157.530.450.250.875.304,Proton Pumps,Cation Transport Proteins,9
Electron Transport Complex IV,D,D05.500.562.374,Multienzyme Complexes,Multiprotein Complexes,9
Electron Transport Complex IV,D,D08.811.682.285,Oxidoreductases,Enzymes,9
Electron Transport Complex IV,D,D08.811.600.250.687,Electron Transport Chain Complex Proteins,Multienzyme Complexes,9
"Encephalitis Viruses, Tick-Borne",B,B04.820.578.344.350.350,Flavivirus,Flaviviridae,9
"Encephalitis Viruses, Tick-Borne",B,B04.820.230.511,Encephalitis Viruses,RNA Viruses,9
Enterococcus faecalis,B,B03.510.550.250.250.280,Enterococcus,Enterococcaceae,9
Enterococcus faecalis,B,B03.353.750.250.250.280,Enterococcus,Enterococcaceae,9
Entrepreneurship,J,J01.219.375,Commerce,"Technology, Industry, and Agriculture",9
Entrepreneurship,N,N04.452.610.250,Organizational Innovation,Organization and Administration,9
Epinephrine,D,D02.455.426.559.389.657.166.175.461,Catecholamines,Catechols,9
Epinephrine,D,D02.092.211.215.454,Biogenic Monoamines,Biogenic Amines,9
Epinephrine,D,D02.092.311.461,Catecholamines,Amines,9
Epinephrine,D,D02.092.063.291.310,Ethanolamines,Amino Alcohols,9
Epinephrine,D,D02.033.100.291.310,Ethanolamines,Amino Alcohols,9
Escherichia coli O157,B,B03.440.450.425.325.300.800.250.500,Enterohemorrhagic Escherichia coli,Shiga-Toxigenic Escherichia coli,9
Escherichia coli O157,B,B03.660.250.150.180.100.800.250.500,Enterohemorrhagic Escherichia coli,Shiga-Toxigenic Escherichia coli,9
Ethical Review,N,N05.350.250,Ethics,"Health Care Quality, Access, and Evaluation",9
Ethical Review,K,K01.752.566.479.117,Ethics,Morals,9
Ethical Theory,K,K01.752.566.479.118,Ethics,Morals,9
Ethical Theory,N,N05.350.256,Ethics,"Health Care Quality, Access, and Evaluation",9
Exanthema,C,C17.800.257,Skin Diseases,Skin and Connective Tissue Diseases,9
Extremities,A,A01.378,Body Regions,NULL,9
Facial Dermatoses,C,C17.800.271,Skin Diseases,Skin and Connective Tissue Diseases,9
"Fatty Acids, Essential",D,D10.251.355.310,"Fatty Acids, Unsaturated",Fatty Acids,9
"Fetal Membranes, Premature Rupture",C,C13.703.420.339,Obstetric Labor Complications,Pregnancy Complications,9
Fetal Monitoring,E,E01.370.520.230,"Monitoring, Physiologic",Diagnostic Techniques and Procedures,9
Fetal Monitoring,E,E01.370.378.230,"Diagnostic Techniques, Obstetrical and Gynecological",Diagnostic Techniques and Procedures,9
Fish Oils,D,D10.627.430,Oils,Lipids,9
Fluorodeoxyglucose F18,D,D09.254.229.500,Deoxyglucose,Deoxy Sugars,9
Fluticasone,D,D04.210.500.054.079.129.114,Androstadienes,Androstenes,9
Follicle Stimulating Hormone,D,D06.472.699.631.525.343.288,"Gonadotropins, Pituitary","Pituitary Hormones, Anterior",9
Follicle Stimulating Hormone,D,D06.472.699.322.576.288,"Gonadotropins, Pituitary",Gonadotropins,9
Follicle Stimulating Hormone,D,D12.644.548.691.525.343.288,"Gonadotropins, Pituitary","Pituitary Hormones, Anterior",9
Food Chain,N,N06.230.124.250,Ecosystem,Environment,9
Food Chain,G,G16.500.275.157.250,Ecosystem,Environment,9
Foot,A,A01.378.610.250,Lower Extremity,Extremities,9
Frontotemporal Lobar Degeneration,C,C10.574.950.300,TDP-43 Proteinopathies,Neurodegenerative Diseases,9
Frontotemporal Lobar Degeneration,C,C10.228.140.380.266,Dementia,Brain Diseases,9
Frontotemporal Lobar Degeneration,C,C18.452.845.800.300,TDP-43 Proteinopathies,Proteostasis Deficiencies,9
Frontotemporal Lobar Degeneration,F,F03.615.400.380,Dementia,Neurocognitive Disorders,9
Gadolinium DTPA,D,D02.092.782.590.401,Pentetic Acid,Polyamines,9
Gadolinium DTPA,D,D02.241.081.018.639.400,Pentetic Acid,Acetates,9
Gadolinium DTPA,D,D02.257.141,Coordination Complexes,Organic Chemicals,9
gamma-Globulins,D,D12.776.124.790.651.397,Immunoglobulins,Serum Globulins,9
gamma-Globulins,D,D12.776.124.486.485.397,Immunoglobulins,Immunoproteins,9
gamma-Globulins,D,D12.776.377.715.548.397,Immunoglobulins,Serum Globulins,9
Gels,D,D26.255.165.320,Colloids,Dosage Forms,9
Gels,D,D20.280.320,Colloids,Complex Mixtures,9
Geographic Atrophy,C,C11.768.585.439.122,Macular Degeneration,Retinal Degeneration,9
Giant Cells,A,A11.500,Cells,NULL,9
Gift Giving,F,F01.145.813.208,Social Behavior,Behavior,9
Glomerulonephritis,C,C12.777.419.570.363,Nephritis,Kidney Diseases,9
Glomerulonephritis,C,C13.351.968.419.570.363,Nephritis,Kidney Diseases,9
Glutamic Acid,D,D12.125.427.300,Excitatory Amino Acids,Amino Acids,9
Glutamic Acid,D,D12.125.119.409.349,Glutamates,"Amino Acids, Dicarboxylic",9
Glutamic Acid,D,D12.125.067.625.349,Glutamates,"Amino Acids, Acidic",9
Glycosylphosphatidylinositols,D,D10.570.755.375.760.400.942.250,Phosphatidylinositols,Glycerophospholipids,9
Glycosylphosphatidylinositols,D,D10.390.475,Glycolipids,Lipids,9
Glycosylphosphatidylinositols,D,D09.400.410.475,Glycolipids,Glycoconjugates,9
"Graft Occlusion, Vascular",C,C23.550.767.400,Postoperative Complications,Pathologic Processes,9
Grandparents,F,F01.829.263.403,Family,"Psychology, Social",9
Grandparents,I,I01.880.853.150.452,Family,Sociological Factors,9
Grandparents,M,M01.264,Persons,NULL,9
H-2 Antigens,D,D23.050.301.500.400.199,Histocompatibility Antigens Class II,Histocompatibility Antigens,9
H-2 Antigens,D,D23.050.301.500.100.350,Histocompatibility Antigens Class I,Histocompatibility Antigens,9
H-2 Antigens,D,D23.050.705.552.100.350,Histocompatibility Antigens Class I,Histocompatibility Antigens,9
H-2 Antigens,D,D23.050.705.552.410.199,Histocompatibility Antigens Class II,Histocompatibility Antigens,9
Health Systems Plans,N,N03.349.650.270,Regional Health Planning,Health Planning,9
Hearing Tests,E,E01.370.382.375,"Diagnostic Techniques, Otological",Diagnostic Techniques and Procedures,9
Heartwater Disease,C,C22.434,Animal Diseases,NULL,9
Heartwater Disease,C,C01.150.252.400.285.500,Ehrlichiosis,Gram-Negative Bacterial Infections,9
Heartwater Disease,C,C01.150.252.400.054.750.500,Ehrlichiosis,Anaplasmataceae Infections,9
Heartwater Disease,C,C01.920.930.300.500,Ehrlichiosis,Tick-Borne Diseases,9
Hemoglobin A,D,D12.776.422.316.762.380,Hemoglobins,Globins,9
Hemoglobin A,D,D12.776.124.400.405,Hemoglobins,Blood Proteins,9
Hemorrhagic Fever with Renal Syndrome,C,C01.925.782.147.420.400,Hantavirus Infections,Bunyaviridae Infections,9
Hemorrhagic Fever with Renal Syndrome,C,C01.925.782.417.300,"Hemorrhagic Fevers, Viral",RNA Virus Infections,9
Hemostatics,D,D27.505.954.502.270.463,Coagulants,Hematologic Agents,9
Hepatitis A Vaccines,D,D20.215.894.899.955.395,Viral Hepatitis Vaccines,Viral Vaccines,9
Hip Joint,A,A02.835.583.411,Joints,Skeleton,9
Histone Deacetylases,D,D08.811.277.087.520,Amidohydrolases,Hydrolases,9
"History, 15th Century",K,K01.400.475.500,"History, Early Modern 1451-1600",History,9
Hospital Departments,N,N02.278.216.500.968,Hospital Administration,Health Facility Administration,9
Hospital Departments,N,N04.452.442.452.422,Hospital Administration,Health Facility Administration,9
Hospital Information Systems,N,N04.452.442.452.452,Hospital Administration,Health Facility Administration,9
Hospital Information Systems,N,N04.452.515.360,Management Information Systems,Organization and Administration,9
Host Microbial Interactions,G,G16.527,Biological Phenomena,NULL,9
Host Microbial Interactions,G,G06.373,Microbiological Phenomena,NULL,9
"Housing, Animal",J,J03.340.250,Housing,Non-Medical Public and Private Facilities,9
"Housing, Animal",N,N06.230.150.360.250,Housing,"Environment, Controlled",9
HTLV-I Antibodies,D,D12.776.124.486.485.114.254.150.500,Deltaretrovirus Antibodies,"Antibodies, Viral",9
HTLV-I Antibodies,D,D12.776.124.790.651.114.254.150.500,Deltaretrovirus Antibodies,"Antibodies, Viral",9
HTLV-I Antibodies,D,D12.776.377.715.548.114.254.150.500,Deltaretrovirus Antibodies,"Antibodies, Viral",9
Hydrazines,D,D02.442,Organic Chemicals,NULL,9
Hydrazones,D,D02.442.288,Hydrazines,Organic Chemicals,9
Hydrocephalus,C,C10.228.140.602,Brain Diseases,Central Nervous System Diseases,9
Hydroxamic Acids,D,D02.241.511.372,Hydroxy Acids,Carboxylic Acids,9
Hydroxamic Acids,D,D02.092.570.394,Hydroxylamines,Amines,9
Hypokalemia,C,C18.452.950.565,Water-Electrolyte Imbalance,Metabolic Diseases,9
"Immunoglobulin A, Secretory",D,D12.776.377.715.548.114.619.026.030,Immunoglobulin A,Immunoglobulin Isotypes,9
"Immunoglobulin A, Secretory",D,D12.776.124.790.651.114.619.026.030,Immunoglobulin A,Immunoglobulin Isotypes,9
"Immunoglobulin A, Secretory",D,D12.776.124.486.485.114.619.026.030,Immunoglobulin A,Immunoglobulin Isotypes,9
Immunoglobulin Fab Fragments,D,D12.776.124.486.485.680.650,Immunoglobulin Fragments,Immunoglobulins,9
Immunoglobulin Fab Fragments,D,D12.776.124.790.651.680.650,Immunoglobulin Fragments,Immunoglobulins,9
Immunoglobulin Fab Fragments,D,D12.776.377.715.548.680.650,Immunoglobulin Fragments,Immunoglobulins,9
Immunoglobulin Fab Fragments,D,D12.644.541.500.650,Immunoglobulin Fragments,Peptide Fragments,9
"Infectious Disease Transmission, Professional-to-Patient",N,N06.850.335.750,"Disease Transmission, Infectious",Public Health,9
Information Management,L,L01.399,Information Science,NULL,9
Insulin-Like Growth Factor II,D,D12.644.276.937.420,Somatomedins,Intercellular Signaling Peptides and Proteins,9
Insulin-Like Growth Factor II,D,D12.776.124.862.425,Somatomedins,Blood Proteins,9
Insulin-Like Growth Factor II,D,D12.776.467.937.420,Somatomedins,Intercellular Signaling Peptides and Proteins,9
Insulin-Like Growth Factor II,D,D23.529.937.420,Somatomedins,Intercellular Signaling Peptides and Proteins,9
Interleukin-12 Subunit p40,D,D23.529.374.465.512.500,Interleukin-12,Interleukins,9
Interleukin-12 Subunit p40,D,D23.529.374.465.550.249,Interleukin-23,Interleukins,9
Interleukin-12 Subunit p40,D,D12.776.467.374.465.512.500,Interleukin-12,Interleukins,9
Interleukin-12 Subunit p40,D,D12.776.467.374.465.759.249,Interleukin-23,Interleukins,9
Interleukin-12 Subunit p40,D,D12.644.276.374.465.512.500,Interleukin-12,Interleukins,9
Interleukin-12 Subunit p40,D,D12.644.276.374.465.759.249,Interleukin-23,Interleukins,9
Interleukin-7,D,D12.644.276.374.465.246,Interleukins,Cytokines,9
Interleukin-7,D,D12.776.467.374.465.224,Interleukins,Cytokines,9
Interleukin-7,D,D23.529.374.465.246,Interleukins,Cytokines,9
Intestinal Neoplasms,C,C04.588.274.476.411,Gastrointestinal Neoplasms,Digestive System Neoplasms,9
Intestinal Neoplasms,C,C06.301.371.411,Gastrointestinal Neoplasms,Digestive System Neoplasms,9
Intestinal Neoplasms,C,C06.405.249.411,Gastrointestinal Neoplasms,Gastrointestinal Diseases,9
Intestinal Neoplasms,C,C06.405.469.491,Intestinal Diseases,Gastrointestinal Diseases,9
Intracranial Hemorrhages,C,C23.550.414.913,Hemorrhage,Pathologic Processes,9
Intracranial Hemorrhages,C,C10.228.140.300.535,Cerebrovascular Disorders,Brain Diseases,9
Intracranial Hemorrhages,C,C14.907.253.573,Cerebrovascular Disorders,Vascular Diseases,9
Irritable Bowel Syndrome,C,C06.405.469.158.272.608,"Colonic Diseases, Functional",Colonic Diseases,9
Ixodidae,B,B01.050.500.131.166.132.832.400,Ticks,Acari,9
Job Description,N,N04.452.677.410,Personnel Management,Organization and Administration,9
Lactoferrin,D,D12.776.556.579.750.249,Transferrins,Iron-Binding Proteins,9
Lactoferrin,D,D12.776.157.427.750.249,Transferrins,Iron-Binding Proteins,9
Lactoferrin,D,D12.776.377.457.507,Lactoglobulins,Globulins,9
Lactoferrin,D,D12.776.395.507,Glycoproteins,Proteins,9
Lactoferrin,D,D12.776.256.159.750.816.500.507,Lactoglobulins,Whey Proteins,9
Lactoferrin,D,D08.811.277.656.300.760.471,Serine Endopeptidases,Endopeptidases,9
Lactoferrin,D,D08.811.277.656.959.350.471,Serine Endopeptidases,Serine Proteases,9
"Legislation, Medical",N,N03.706.615.473,Legislation as Topic,"Social Control, Formal",9
Leiomyoma,C,C04.557.450.590.450,"Neoplasms, Muscle Tissue","Neoplasms, Connective and Soft Tissue",9
Leishmania tropica,B,B01.268.475.868.488.680,Leishmania,Trypanosomatina,9
"Leprosy, Multibacillary",C,C01.150.252.410.040.552.475.371.775,Leprosy,"Mycobacterium Infections, Nontuberculous",9
Levonorgestrel,D,D04.210.500.668.651.693.762.450,Norgestrel,Norpregnenes,9
Lower Extremity,A,A01.378.610,Extremities,Body Regions,9
Lymph Node Excision,E,E04.446,"Surgical Procedures, Operative",NULL,9
Lymphocyte Depletion,E,E05.478.610.570,Immunosuppression,Immunologic Techniques,9
Lymphocyte Depletion,E,E02.095.465.425.450.521,Immunosuppression,Immunotherapy,9
Lymphoid Tissue,A,A10.549,Tissues,NULL,9
Lymphoid Tissue,A,A15.382.520.604,Lymphatic System,Immune System,9
"Lymphoma, AIDS-Related",C,C04.557.386.480.150.450,"Lymphoma, B-Cell","Lymphoma, Non-Hodgkin",9
"Lymphoma, AIDS-Related",C,C15.604.515.569.480.150.450,"Lymphoma, B-Cell","Lymphoma, Non-Hodgkin",9
"Lymphoma, AIDS-Related",C,C20.683.515.761.480.150.450,"Lymphoma, B-Cell","Lymphoma, Non-Hodgkin",9
Management Audit,N,N04.452.500,Organization and Administration,Health Services Administration,9
Mannitol,D,D02.033.800.609,Sugar Alcohols,Alcohols,9
Mannitol,D,D09.853.609,Sugar Alcohols,Carbohydrates,9
MAP Kinase Signaling System,G,G04.835.560,Signal Transduction,Cell Physiological Phenomena,9
MAP Kinase Signaling System,G,G02.111.820.560,Signal Transduction,Biochemical Phenomena,9
MAP Kinase Signaling System,G,G03.493.560,Metabolic Networks and Pathways,Metabolism,9
Maps as Topic,L,L01.178.820.090.426,Audiovisual Aids,Teaching Materials,9
Maps as Topic,J,J01.897.280.500.426,Audiovisual Aids,Educational Technology,9
Mass Chest X-Ray,N,N06.850.520.308.980.438.580.510,Mass Screening,Health Surveys,9
Mass Chest X-Ray,N,N05.715.360.300.800.438.500.500,Mass Screening,Health Surveys,9
Mass Chest X-Ray,N,N02.421.726.233.443.443,Mass Screening,Diagnostic Services,9
Mass Chest X-Ray,E,E05.318.308.980.438.580.510,Mass Screening,Health Surveys,9
Mass Chest X-Ray,N,N06.850.780.500.500,Mass Screening,Public Health Practice,9
Mass Chest X-Ray,E,E01.370.386.500,"Diagnostic Techniques, Respiratory System",Diagnostic Techniques and Procedures,9
Mass Chest X-Ray,E,E01.370.500.500,Mass Screening,Diagnostic Techniques and Procedures,9
Mass Chest X-Ray,E,E01.370.350.700.730.500,"Radiography, Thoracic",Radiography,9
Mast Cells,A,A15.382.652,Immune System,Hemic and Immune Systems,9
Mast Cells,A,A11.329.427,Connective Tissue Cells,Cells,9
"Mastectomy, Segmental",E,E04.466.701,Mastectomy,"Surgical Procedures, Operative",9
Mathematical Computing,L,L01.224.680,Computing Methodologies,Information Science,9
Meat Products,J,J02.500.600.500,Meat,Food,9
Meat Products,G,G07.203.300.600.500,Meat,Food,9
Melarsoprol,D,D02.129.500,Arsenicals,Organic Chemicals,9
Meningeal Neoplasms,C,C10.551.240.500,Central Nervous System Neoplasms,Nervous System Neoplasms,9
Meningeal Neoplasms,C,C04.588.614.250.580,Central Nervous System Neoplasms,Nervous System Neoplasms,9
"Metals, Heavy",D,D01.268.556,Elements,Inorganic Chemicals,9
"Metals, Heavy",D,D01.552.544,Metals,Inorganic Chemicals,9
Methylene Blue,D,D02.886.369.517,Phenothiazines,Sulfur Compounds,9
Methylene Blue,D,D03.633.300.783.517,Phenothiazines,"Heterocyclic Compounds, 3-Ring",9
"Mice, Nude",B,B01.050.150.900.649.313.992.635.505.500.550.500,"Mice, Mutant Strains",Mice,9
Microbial Interactions,G,G06.550,Microbiological Phenomena,NULL,9
Minimally Invasive Surgical Procedures,E,E04.502,"Surgical Procedures, Operative",NULL,9
Minority Health,N,N01.400.512,Health,Population Characteristics,9
Mitogens,D,D27.505.519.593.624,Mitosis Modulators,Molecular Mechanisms of Pharmacological Action,9
Motor Neuron Disease,C,C10.574.562,Neurodegenerative Diseases,Nervous System Diseases,9
Motor Neuron Disease,C,C10.668.467,Neuromuscular Diseases,Nervous System Diseases,9
Mouth Mucosa,A,A14.549.512,Mouth,Stomatognathic System,9
Mouth Mucosa,A,A10.615.550.599,Mucous Membrane,Membranes,9
Multiprotein Complexes,D,D05.500,Macromolecular Substances,NULL,9
Muscle Strength,E,E01.370.600.425,Physical Examination,Diagnostic Techniques and Procedures,9
Muscle Strength,G,G11.427.560,Musculoskeletal Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,9
Mycobacterium kansasii,B,B03.510.024.962.500.720.400,Nontuberculous Mycobacteria,Mycobacterium,9
Mycobacterium kansasii,B,B03.510.460.400.410.552.552.720.400,Nontuberculous Mycobacteria,Mycobacterium,9
Myeloid Cells,A,A11.627,Cells,NULL,9
Myocardial Reperfusion,E,E04.100.700.600,Reperfusion,Cardiovascular Surgical Procedures,9
Myocardial Reperfusion,E,E05.680.730.600,Reperfusion,Perfusion,9
N-Acetylneuraminic Acid,D,D02.241.081.844.562.668.050,Sialic Acids,Neuraminic Acids,9
N-Acetylneuraminic Acid,D,D02.241.511.902.562.668.050,Sialic Acids,Neuraminic Acids,9
N-Acetylneuraminic Acid,D,D09.811.589.668.030,Sialic Acids,Neuraminic Acids,9
N-Acetylneuraminic Acid,D,D09.067.687.668.030,Sialic Acids,Neuraminic Acids,9
Naphthyridines,D,D03.633.100.612,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",9
National Institutes of Health (U.S.),I,I01.409.418.750.600.650.496,United States Public Health Service,United States Dept. of Health and Human Services,9
National Institutes of Health (U.S.),N,N03.540.052.750,Academies and Institutes,Organizations,9
National Institutes of Health (U.S.),N,N03.540.348.500.500.600.650.496,United States Public Health Service,United States Dept. of Health and Human Services,9
"Neovascularization, Pathologic",C,C23.550.589.500,Metaplasia,Pathologic Processes,9
Neurotic Disorders,F,F03.650,Mental Disorders,NULL,9
Neurotic Disorders,F,F03.080.550,Anxiety Disorders,Mental Disorders,9
Nitro Compounds,D,D02.640,Organic Chemicals,NULL,9
Northern Territory,Z,Z01.639.100.875,Australia,Islands,9
Northern Territory,Z,Z01.678.100.373.875,Australia,Australasia,9
Nuclear Reactors,E,E07.710.600,Radiation Equipment and Supplies,Equipment and Supplies,9
Nuclear Warfare,I,I01.880.735.950.500.600,Warfare,Warfare and Armed Conflicts,9
Nursing Assessment,N,N04.590.233.508.480,Nursing Process,Comprehensive Health Care,9
Oceania,Z,Z01.678,Geographic Locations,NULL,9
Ocular Hypertension,C,C11.525,Eye Diseases,NULL,9
Ointments,D,D26.255.640,Dosage Forms,Pharmaceutical Preparations,9
"Oncogene Proteins, Viral",D,D12.776.624.664.520,Oncogene Proteins,Neoplasm Proteins,9
"Oncogene Proteins, Viral",D,D12.776.964.700,Viral Proteins,Proteins,9
Operating Rooms,N,N02.278.388.700,Hospital Units,Health Facilities,9
"Organisms, Genetically Modified",B,B05.620,Organism Forms,NULL,9
Organization and Administration,N,N04.452,Health Services Administration,NULL,9
Osmolar Concentration,G,G02.640,Chemical Phenomena,NULL,9
Oxaliplatin,D,D02.257.750,Coordination Complexes,Organic Chemicals,9
Parenteral Nutrition,E,E02.642.500.505,Nutritional Support,Nutrition Therapy,9
Parenteral Nutrition,E,E02.421.505,Feeding Methods,Therapeutics,9
"Parks, Recreational",J,J03.925.680,Sports and Recreational Facilities,Non-Medical Public and Private Facilities,9
Patient Health Questionnaire,N,N05.715.360.300.800.485,Surveys and Questionnaires,Data Collection,9
Patient Health Questionnaire,N,N06.850.520.308.980.485,Surveys and Questionnaires,Data Collection,9
Patient Health Questionnaire,F,F04.711.580,Psychological Tests,Behavioral Disciplines and Activities,9
Patient Health Questionnaire,E,E05.318.308.980.493,Surveys and Questionnaires,Data Collection,9
Pediculus,B,B01.050.500.131.617.690.060.716,Anoplura,Phthiraptera,9
Penile Neoplasms,C,C04.588.945.440.715,"Genital Neoplasms, Male",Urogenital Neoplasms,9
Penile Neoplasms,C,C12.294.260.500,"Genital Neoplasms, Male","Genital Diseases, Male",9
Penile Neoplasms,C,C12.294.494.591,Penile Diseases,"Genital Diseases, Male",9
Penile Neoplasms,C,C12.758.409.500,"Genital Neoplasms, Male",Urogenital Neoplasms,9
Periodontitis,C,C07.465.714.533,Periodontal Diseases,Mouth Diseases,9
Peripheral Nerves,A,A08.800.800,Peripheral Nervous System,Nervous System,9
Persuasive Communication,L,L01.143.762,Communication,Information Science,9
Pharyngitis,C,C07.550.781,Pharyngeal Diseases,Stomatognathic Diseases,9
Pharyngitis,C,C01.748.561,Respiratory Tract Infections,Infections,9
Pharyngitis,C,C08.730.561,Respiratory Tract Infections,Respiratory Tract Diseases,9
Pharyngitis,C,C09.775.649,Pharyngeal Diseases,Otorhinolaryngologic Diseases,9
Phosphorus Isotopes,D,D01.496.669,Isotopes,Inorganic Chemicals,9
Phosphorus Isotopes,D,D01.268.666.500,Phosphorus,Elements,9
Phytohemagglutinins,D,D12.776.765.678.750,Plant Lectins,Plant Proteins,9
Phytohemagglutinins,D,D12.776.503.499.750,Plant Lectins,Lectins,9
Phytohemagglutinins,D,D12.776.395.560.825,Mucoproteins,Glycoproteins,9
Plant Oils,D,D10.627.700,Oils,Lipids,9
Plant Oils,D,D20.215.784.750,Plant Preparations,Biological Products,9
Pneumocystis carinii,B,B01.300.107.730.650,Pneumocystis,Ascomycota,9
"Pneumonia, Ventilator-Associated",C,C01.748.610.300.500,Healthcare-Associated Pneumonia,Pneumonia,9
"Pneumonia, Ventilator-Associated",C,C01.248.250.500,Healthcare-Associated Pneumonia,Cross Infection,9
"Pneumonia, Ventilator-Associated",C,C23.550.291.875.500.500.500,Healthcare-Associated Pneumonia,Cross Infection,9
"Pneumonia, Ventilator-Associated",C,C08.730.610.300.500,Healthcare-Associated Pneumonia,Pneumonia,9
"Pneumonia, Ventilator-Associated",C,C08.381.677.300.500,Healthcare-Associated Pneumonia,Pneumonia,9
Political Systems,I,I01.696,Social Sciences,NULL,9
Population Characteristics,N,N01,NULL,NULL,9
Precipitin Tests,E,E05.478.605.492,Immunoprecipitation,Immunologic Techniques,9
Precipitin Tests,E,E05.478.594.760.645,Serologic Tests,Immunologic Tests,9
Precipitin Tests,E,E05.196.150.639.500,Immunoprecipitation,Chemical Precipitation,9
Precipitin Tests,E,E05.200.812.735.645,Serologic Tests,Immunologic Tests,9
Precipitin Tests,E,E01.370.225.812.735.645,Serologic Tests,Immunologic Tests,9
Predatory Behavior,F,F01.145.113.252.520,Consummatory Behavior,"Behavior, Animal",9
Predatory Behavior,F,F01.145.113.111.600,Appetitive Behavior,"Behavior, Animal",9
"Pregnancy, Ectopic",C,C13.703.733,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,9
"Pregnancy, High-Risk",G,G08.686.784.769.500,Pregnancy,Reproduction,9
Product Labeling,J,J01.576.761.700,Product Packaging,Industry,9
Programming Languages,L,L01.224.900.780,Software,Computing Methodologies,9
Protein Interaction Mapping,E,E05.601.690,Molecular Probe Techniques,Investigative Techniques,9
Psychosocial Intervention,F,F04.754.715,Psychotherapy,Behavioral Disciplines and Activities,9
Pupa,G,G07.345.500.550.500.700,Life Cycle Stages,"Metamorphosis, Biological",9
Pupa,B,B05.500.700,Life Cycle Stages,Organism Forms,9
Radiation Oncology,H,H02.403.429.515.500,Medical Oncology,Internal Medicine,9
Radiation Oncology,H,H02.403.740.650,Radiology,Medicine,9
"Radiation, Ionizing",G,G01.750.750,Radiation,Physical Phenomena,9
Radioimmunoassay,E,E05.601.470.639,Immunoassay,Molecular Probe Techniques,9
Radioimmunoassay,E,E05.478.566.639,Immunoassay,Immunologic Techniques,9
Radioimmunoassay,E,E01.370.384.700,"Diagnostic Techniques, Radioisotope",Diagnostic Techniques and Procedures,9
"Receptors, Cytokine",D,D12.776.543.750.705.852,"Receptors, Immunologic","Receptors, Cell Surface",9
"Receptors, Nicotinic",D,D12.776.543.750.720.360.550,"Receptors, Cholinergic","Receptors, Neurotransmitter",9
"Receptors, Nicotinic",D,D12.776.543.585.400.500.100.500,Cysteine Loop Ligand-Gated Ion Channel Receptors,Ligand-Gated Ion Channels,9
"Receptors, Nicotinic",D,D12.776.543.550.450.500.100.500,Cysteine Loop Ligand-Gated Ion Channel Receptors,Ligand-Gated Ion Channels,9
"Receptors, Nicotinic",D,D12.776.543.750.130.687,Cysteine Loop Ligand-Gated Ion Channel Receptors,"Receptors, Cell Surface",9
"Receptors, Nicotinic",D,D12.776.157.530.400.400.100.500,Cysteine Loop Ligand-Gated Ion Channel Receptors,Ligand-Gated Ion Channels,9
"Regulatory Sequences, Nucleic Acid",G,G02.111.570.080.689,Base Sequence,Molecular Structure,9
"Regulatory Sequences, Nucleic Acid",G,G05.360.080.689,Base Sequence,Genetic Structures,9
Remuneration,N,N01.824.417.605,Income,Socioeconomic Factors,9
Retinal Vessels,A,A07.015.611,Blood Vessels,Cardiovascular System,9
Rickettsia,B,B03.660.050.783.875.650.650,Rickettsieae,Rickettsiaceae,9
"RNA, Long Noncoding",D,D13.444.735.790.375,"RNA, Untranslated",RNA,9
"RNA, Transfer",D,D13.444.735.757,RNA,Nucleic Acids,9
"RNA, Untranslated",D,D13.444.735.790,RNA,Nucleic Acids,9
Saccharomyces cerevisiae Proteins,D,D12.776.354.750,Fungal Proteins,Proteins,9
Sanitary Engineering,H,H02.229.656,Environmental Health,Health Occupations,9
Sanitary Engineering,J,J01.293.821,Engineering,"Technology, Industry, and Agriculture",9
Sanitary Engineering,N,N06.850.780.200.800.800,Sanitation,Communicable Disease Control,9
Sanitary Engineering,N,N06.850.860.510,Sanitation,Public Health,9
"Sexual Behavior, Animal",F,F01.145.113.252.748,Consummatory Behavior,"Behavior, Animal",9
Sexual Harassment,F,F01.145.813.606,Social Behavior,Behavior,9
Sexual Harassment,F,F01.145.802.950,Sexual Behavior,Behavior,9
Skull,A,A02.835.232.781,Bone and Bones,Skeleton,9
Slovakia,Z,Z01.542.248.797,"Europe, Eastern",Europe,9
"Sperm Injections, Intracytoplasmic",E,E05.820.800.750.700,Fertilization in Vitro,"Reproductive Techniques, Assisted",9
"Sperm Injections, Intracytoplasmic",E,E02.875.800.750.700,Fertilization in Vitro,"Reproductive Techniques, Assisted",9
Spermatozoa,A,A05.360.490.890,Germ Cells,Genitalia,9
Spermatozoa,A,A11.497.760,Germ Cells,Cells,9
Squalene,D,D02.455.326.271.665.806,Polyenes,Alkenes,9
Squalene,D,D02.455.849.919.681,Triterpenes,Terpenes,9
"Sterilization, Reproductive",E,E02.875.194.910,Contraception,Reproductive Techniques,9
"Sterilization, Reproductive",E,E04.950.599,Urogenital Surgical Procedures,"Surgical Procedures, Operative",9
Synovial Fluid,A,A12.207.270.847,Extracellular Fluid,Body Fluids,9
Synovial Fluid,A,A02.835.583.443.800.800,Synovial Membrane,Joint Capsule,9
Systemic Inflammatory Response Syndrome,C,C23.550.470.790,Inflammation,Pathologic Processes,9
Systemic Inflammatory Response Syndrome,C,C23.550.835.900,Shock,Pathologic Processes,9
Tape Recording,L,L01.280.940,Copying Processes,Information Science,9
Tape Recording,L,L01.178.820.090.846,Audiovisual Aids,Teaching Materials,9
Tape Recording,J,J01.897.280.500.846,Audiovisual Aids,Educational Technology,9
Taxoids,D,D02.455.426.392.368.242.888,Cyclodecanes,Cycloparaffins,9
Taxoids,D,D02.455.849.291.850,Diterpenes,Terpenes,9
Technology Transfer,J,J01.897.900,Technology,"Technology, Industry, and Agriculture",9
Technology Transfer,L,L01.143.320.800,Diffusion of Innovation,Communication,9
Theophylline,D,D03.132.960.751,Xanthines,Alkaloids,9
Theophylline,D,D03.633.100.759.758.824.751,Xanthines,Purinones,9
Therapeutic Equivalency,G,G07.690.725.898,Pharmacokinetics,Pharmacological and Toxicological Phenomena,9
Therapeutic Equivalency,G,G03.787.559,Pharmacokinetics,Metabolism,9
Thinking,F,F02.463.785,Mental Processes,Psychological Phenomena,9
Third-Party Consent,I,I01.880.604.583.427.635,Informed Consent,Jurisprudence,9
Third-Party Consent,N,N03.706.535.489.635,Informed Consent,Jurisprudence,9
Toxicity Tests,E,E05.940,Investigative Techniques,NULL,9
Transcription Initiation Site,G,G05.360.340.024.340.137.750.840,"Regulatory Elements, Transcriptional",Gene Components,9
Transgenes,G,G05.360.340.024.340.825,Genes,Genome Components,9
"Tuberculosis, Miliary",C,C01.150.252.410.040.552.846.764,Tuberculosis,Mycobacterium Infections,9
Tumor Suppressor Protein p53,D,D12.776.260.820,DNA-Binding Proteins,Proteins,9
Tumor Suppressor Protein p53,D,D12.776.157.687.650,Poly-ADP-Ribose Binding Proteins,Carrier Proteins,9
Tumor Suppressor Protein p53,D,D12.776.744.845,Phosphoproteins,Proteins,9
Tumor Suppressor Protein p53,D,D12.776.660.720.650,Poly-ADP-Ribose Binding Proteins,Nuclear Proteins,9
Tumor Suppressor Protein p53,D,D12.776.624.776.775,Tumor Suppressor Proteins,Neoplasm Proteins,9
Underage Drinking,F,F01.145.317.269.875,Alcohol Drinking,Drinking Behavior,9
Underage Drinking,F,F01.145.022.750,Adolescent Behavior,Behavior,9
Underage Drinking,I,I01.880.735.878,Social Problems,Sociology,9
Urodynamics,G,G08.852.898,Urinary Tract Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,9
Urologic Diseases,C,C13.351.968,Female Urogenital Diseases,Female Urogenital Diseases and Pregnancy Complications,9
Urologic Diseases,C,C12.777,Male Urogenital Diseases,NULL,9
Uruguay,Z,Z01.107.757.904,South America,Americas,9
Uterine Cervical Diseases,C,C13.351.500.852.593,Uterine Diseases,"Genital Diseases, Female",9
Vascular Calcification,C,C18.452.174.130.780,Calcinosis,Calcium Metabolism Disorders,9
Viral Fusion Proteins,D,D12.776.964.970.880.910,Viral Envelope Proteins,Viral Structural Proteins,9
Viral Fusion Proteins,D,D12.776.543.512.500,Membrane Fusion Proteins,Membrane Proteins,9
Visual Field Tests,E,E01.370.380.850.962,Vision Tests,"Diagnostic Techniques, Ophthalmological",9
Visual Perception,F,F02.463.593.932,Perception,Mental Processes,9
Vitreous Body,A,A09.371.714.500,Posterior Eye Segment,Eye,9
Waist-Height Ratio,E,E01.370.600.115.100.160.780,Body Size,Body Weights and Measures,9
Waist-Height Ratio,E,E05.041.124.160.937,Body Size,Body Weights and Measures,9
Whole Body Imaging,E,E05.979,Investigative Techniques,NULL,9
Whole Body Imaging,E,E01.370.350.925,Diagnostic Imaging,Diagnostic Techniques and Procedures,9
"Wings, Animal",A,A13.395.823,Forelimb,Animal Structures,9
Yersinia Infections,C,C01.150.252.400.310.980,Enterobacteriaceae Infections,Gram-Negative Bacterial Infections,9
3T3 Cells,A,A11.329.228.100,Fibroblasts,Connective Tissue Cells,8
3T3 Cells,A,A11.251.210.100,Cell Line,"Cells, Cultured",8
Academic Success,I,I02.399.136.500,Academic Performance,Educational Measurement,8
"Acidosis, Lactic",C,C18.452.076.176.180,Acidosis,Acid-Base Imbalance,8
Acne Vulgaris,C,C17.800.794.111,Sebaceous Gland Diseases,Skin Diseases,8
Acne Vulgaris,C,C17.800.030.150,Acneiform Eruptions,Skin Diseases,8
Adenoidectomy,E,E04.580.068,Otorhinolaryngologic Surgical Procedures,"Surgical Procedures, Operative",8
Adult Children,F,F01.829.263.065,Family,"Psychology, Social",8
Adult Children,I,I01.880.853.150.281,Family,Sociological Factors,8
Adult Children,M,M01.055,Persons,NULL,8
Adverse Childhood Experiences,I,I01.880.853.050,Sociological Factors,Sociology,8
Adverse Childhood Experiences,I,I01.880.735.035,Social Problems,Sociology,8
Aeromonas salmonicida,B,B03.440.450.019.025.690,Aeromonas,Aeromonadaceae,8
Amphibians,B,B01.050.150.900.090,Vertebrates,Chordata,8
Anaphylaxis,C,C20.543.480.099,"Hypersensitivity, Immediate",Hypersensitivity,8
Ancylostoma,B,B01.050.500.500.294.400.968.100.100,Ancylostomatoidea,Strongylida,8
Androstenes,D,D04.210.500.054.079,Androstanes,Steroids,8
Animal Feed,J,J02.500.300.100,"Crops, Agricultural",Food,8
Animal Feed,G,G07.203.300.300.100,"Crops, Agricultural",Food,8
Anorexia Nervosa,F,F03.400.125,Feeding and Eating Disorders,Mental Disorders,8
Anthrax,C,C01.150.252.410.090.072,Bacillaceae Infections,Gram-Positive Bacterial Infections,8
"Antibodies, Antinuclear",D,D12.776.377.715.548.114.323.204,Autoantibodies,Antibodies,8
"Antibodies, Antinuclear",D,D12.776.124.790.651.114.323.204,Autoantibodies,Antibodies,8
"Antibodies, Antinuclear",D,D12.776.124.486.485.114.323.204,Autoantibodies,Antibodies,8
"Antigens, Differentiation",D,D23.101.100,Biomarkers,Biological Factors,8
"Antigens, Differentiation",D,D23.050.301.264,"Antigens, Surface",Antigens,8
Antithrombins,D,D27.505.519.389.745.800.449,Serine Proteinase Inhibitors,Protease Inhibitors,8
Antithrombins,D,D27.505.954.502.119.500,Anticoagulants,Hematologic Agents,8
Appetite Depressants,D,D27.505.954.203.155,Anti-Obesity Agents,Therapeutic Uses,8
Arterial Occlusive Diseases,C,C14.907.137,Vascular Diseases,Cardiovascular Diseases,8
Aspergillus fumigatus,B,B01.300.381.081.295,Aspergillus,Mitosporic Fungi,8
Atenolol,D,D02.092.063.624.698.070,Phenoxypropanolamines,Propanolamines,8
Atenolol,D,D02.033.755.624.698.070,Phenoxypropanolamines,Propanolamines,8
Atenolol,D,D02.033.100.624.698.070,Phenoxypropanolamines,Propanolamines,8
Back Pain,C,C23.888.592.612.107,Pain,Neurologic Manifestations,8
Beer,G,G07.203.200.250,Fermented Foods and Beverages,"Diet, Food, and Nutrition",8
Beer,G,G07.203.100.100.200,Alcoholic Beverages,Beverages,8
Beer,J,J02.350.250,Fermented Foods and Beverages,Food and Beverages,8
Beer,J,J02.200.100.200,Alcoholic Beverages,Beverages,8
Behavioral Research,H,H01.770.644.108,Research,Science,8
Behavioral Research,F,F04.096.144,Behavioral Sciences,Behavioral Disciplines and Activities,8
Benzoates,D,D02.241.223.100,"Acids, Carbocyclic",Carboxylic Acids,8
Benzoates,D,D02.455.426.559.389.127,Benzene Derivatives,"Hydrocarbons, Aromatic",8
beta-Galactosidase,D,D08.811.277.450.410.100,Galactosidases,Glycoside Hydrolases,8
Biopterin,D,D08.211.090,Coenzymes,Enzymes and Coenzymes,8
Biopterin,D,D03.633.100.733.631.202,Pterins,Pteridines,8
Blood Flow Velocity,E,E01.370.370.130,"Diagnostic Techniques, Cardiovascular",Diagnostic Techniques and Procedures,8
Blood Flow Velocity,G,G09.330.380.630.080,Hemorheology,Hemodynamics,8
Blood Preservation,E,E02.792.833.230,Tissue Preservation,"Preservation, Biological",8
Blood Preservation,E,E05.760.833.230,Tissue Preservation,"Preservation, Biological",8
Body Burden,E,E05.799.638.231,Radiation Monitoring,Radiometry,8
Body Burden,N,N06.850.460.200,Environmental Pollution,Public Health,8
Body Image,F,F01.752.747.792.110,Self Concept,Personality Development,8
Body Image,F,F02.463.593.112,Perception,Mental Processes,8
Bone Matrix,A,A10.165.265.166,Bone and Bones,Connective Tissue,8
Boron Compounds,D,D02.203,Organic Chemicals,NULL,8
Boron Compounds,D,D01.132,Inorganic Chemicals,NULL,8
Bosnia and Herzegovina,Z,Z01.542.248.160,"Europe, Eastern",Europe,8
Brain Concussion,C,C26.974.382.200,"Head Injuries, Closed","Wounds, Nonpenetrating",8
Brain Concussion,C,C26.915.300.450.500,"Head Injuries, Closed",Craniocerebral Trauma,8
Brain Concussion,C,C26.915.300.200.194.250,"Brain Injuries, Traumatic",Brain Injuries,8
Brain Concussion,C,C10.900.300.087.235.250,"Brain Injuries, Traumatic",Brain Injuries,8
Brain Concussion,C,C10.900.300.350.300,"Head Injuries, Closed",Craniocerebral Trauma,8
Brain Concussion,C,C10.228.140.199.444.250,"Brain Injuries, Traumatic",Brain Injuries,8
Burkholderia Infections,C,C01.150.252.400.170,Gram-Negative Bacterial Infections,Bacterial Infections,8
Caloric Restriction,E,E02.642.249.200,Diet Therapy,Nutrition Therapy,8
Caloric Restriction,G,G07.203.650.240.340.150,Energy Intake,Diet,8
Cannabis,B,B01.650.940.800.575.912.250.859.937.055.500,Cannabaceae,Rosales,8
Carbon Footprint,N,N06.230.063,Environment,Environment and Public Health,8
Carbon Footprint,G,G16.500.275.066,Environment,Ecological and Environmental Phenomena,8
Cartilage,A,A10.165.382,Connective Tissue,Tissues,8
Cartilage,A,A02.165,Musculoskeletal System,NULL,8
Cat Diseases,C,C22.180,Animal Diseases,NULL,8
Catalase,D,D08.811.682.732.332,Peroxidases,Oxidoreductases,8
Catalysis,G,G02.130,Chemical Phenomena,NULL,8
"Catheterization, Central Venous",E,E04.100.814.529.875,Endovascular Procedures,Vascular Surgical Procedures,8
"Catheterization, Central Venous",E,E04.502.382.875,Endovascular Procedures,Minimally Invasive Surgical Procedures,8
"Catheterization, Central Venous",E,E05.157.313,Catheterization,Investigative Techniques,8
"Catheterization, Central Venous",E,E02.148.167,Catheterization,Therapeutics,8
Cell Shape,G,G04.320,Cell Physiological Phenomena,NULL,8
Central Nervous System Stimulants,D,D27.505.954.427.220,Central Nervous System Agents,Therapeutic Uses,8
Central Nervous System Stimulants,D,D27.505.696.282,Physiological Effects of Drugs,Pharmacologic Actions,8
Chromatin Immunoprecipitation,E,E05.478.605.160,Immunoprecipitation,Immunologic Techniques,8
Chromatin Immunoprecipitation,E,E05.393.170,Genetic Techniques,Investigative Techniques,8
Chromosome Disorders,C,C16.131.260,Congenital Abnormalities,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",8
Chromosome Disorders,C,C16.320.180,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",8
"Chromosomes, Human, Pair 8",A,A11.284.187.520.300.325.340,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",8
"Chromosomes, Human, Pair 8",G,G05.360.162.520.300.325.340,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",8
Clavulanic Acids,D,D02.065.589.099.374,beta-Lactams,Lactams,8
Clavulanic Acids,D,D03.633.100.300.374,beta-Lactams,"Heterocyclic Compounds, 2-Ring",8
Clinical Deterioration,C,C23.550.291.656.350,Disease Progression,Disease Attributes,8
Clostridium perfringens,B,B03.353.625.375.500.575,Clostridium,Clostridiaceae,8
Clostridium perfringens,B,B03.300.390.400.200.575,Clostridium,Gram-Positive Endospore-Forming Rods,8
Clostridium perfringens,B,B03.510.415.400.200.575,Clostridium,Gram-Positive Endospore-Forming Rods,8
"Colitis, Ulcerative",C,C06.405.469.158.188.231,Colitis,Colonic Diseases,8
"Colitis, Ulcerative",C,C06.405.469.432.249,Inflammatory Bowel Diseases,Intestinal Diseases,8
"Colitis, Ulcerative",C,C06.405.205.731.249,Inflammatory Bowel Diseases,Gastroenteritis,8
"Colitis, Ulcerative",C,C06.405.205.265.231,Colitis,Gastroenteritis,8
Complement C1q,D,D12.776.124.486.274.050.270,Complement C1,Complement System Proteins,8
Confusion,C,C23.888.592.604.339,Neurobehavioral Manifestations,Neurologic Manifestations,8
Confusion,C,C10.597.606.337,Neurobehavioral Manifestations,Neurologic Manifestations,8
Confusion,F,F01.700.250,Neurobehavioral Manifestations,Behavior and Behavior Mechanisms,8
"Conjunctivitis, Bacterial",C,C11.187.183.220,Conjunctivitis,Conjunctival Diseases,8
"Conjunctivitis, Bacterial",C,C11.294.354.220,"Eye Infections, Bacterial",Eye Infections,8
"Conjunctivitis, Bacterial",C,C01.150.252.289.225,"Eye Infections, Bacterial",Bacterial Infections,8
"Conjunctivitis, Bacterial",C,C01.375.354.220,"Eye Infections, Bacterial",Eye Infections,8
"Contraceptive Devices, Male",E,E07.190.270,Contraceptive Devices,Equipment and Supplies,8
Cricetulus,B,B01.050.150.900.649.313.992.635.075.250.250,Cricetinae,Arvicolinae,8
Cryoelectron Microscopy,E,E01.370.350.515.402.150,"Microscopy, Electron",Microscopy,8
Cryoelectron Microscopy,E,E05.595.402.150,"Microscopy, Electron",Microscopy,8
Cyprus,Z,Z01.542.580.500.300,Mediterranean Islands,Mediterranean Region,8
Cyprus,Z,Z01.639.640.300,Mediterranean Islands,Islands,8
Cytodiagnosis,E,E05.200.500.384,Cytological Techniques,Clinical Laboratory Techniques,8
Cytodiagnosis,E,E05.242.384,Cytological Techniques,Investigative Techniques,8
Cytodiagnosis,E,E01.370.225.500.384,Cytological Techniques,Clinical Laboratory Techniques,8
"Denial, Psychological",F,F01.393.200,Defense Mechanisms,Behavior and Behavior Mechanisms,8
Deoxycholic Acid,D,D04.210.500.105.225.272,Cholic Acids,Bile Acids and Salts,8
Deoxycholic Acid,D,D04.210.500.221.430.342,Cholic Acids,Cholanes,8
Dermatitis,C,C17.800.174,Skin Diseases,Skin and Connective Tissue Diseases,8
"Dermatitis, Allergic Contact",C,C17.800.174.255.100,"Dermatitis, Contact",Dermatitis,8
"Dermatitis, Allergic Contact",C,C17.800.815.255.100,"Dermatitis, Contact","Skin Diseases, Eczematous",8
"Dermatitis, Allergic Contact",C,C20.543.418.150,"Hypersensitivity, Delayed",Hypersensitivity,8
Device Removal,E,E04.199,"Surgical Procedures, Operative",NULL,8
Dientamoeba,B,B01.630.800.180,Trichomonadida,Parabasalidea,8
Dietary Sugars,D,D09.947.500,Sugars,Carbohydrates,8
Dietary Sugars,D,D09.301.831,Dietary Carbohydrates,Carbohydrates,8
Dietary Sugars,G,G07.203.300.362.831,Dietary Carbohydrates,Food,8
Dietary Sugars,J,J02.500.362.831,Dietary Carbohydrates,Food,8
Dipyridamole,D,D03.383.742.175,Pyrimidines,"Heterocyclic Compounds, 1-Ring",8
Disulfides,D,D02.886.520.150,Sulfides,Sulfur Compounds,8
Disulfides,D,D01.875.350.850.150,Sulfides,Hydrogen Sulfide,8
Disulfides,D,D01.248.497.158.874.390,Sulfides,Anions,8
Diterpenes,D,D02.455.849.291,Terpenes,Hydrocarbons,8
Divorce,I,I01.880.735.255,Social Problems,Sociology,8
Divorce,I,I01.880.853.150.423.500.300,Marital Status,Family Characteristics,8
Divorce,I,I01.240.361.500.300,Marital Status,Family Characteristics,8
Divorce,N,N01.824.308.500.300,Marital Status,Family Characteristics,8
Divorce,N,N01.224.361.500.300,Marital Status,Family Characteristics,8
Divorce,F,F01.829.263.315.500.300,Marital Status,Family Characteristics,8
Djibouti,Z,Z01.058.290.120.275,"Africa, Eastern",Africa South of the Sahara,8
"DNA, Circular",G,G02.111.570.820.486.212,Nucleic Acid Conformation,Molecular Conformation,8
"DNA, Circular",G,G05.360.580.156,Nucleic Acid Conformation,Genetic Structures,8
"DNA, Circular",D,D13.444.308.283,DNA,Nucleic Acids,8
"DNA, Fungal",D,D13.444.308.300,DNA,Nucleic Acids,8
Donor Selection,E,E04.936.537.500,Tissue and Organ Harvesting,Transplantation,8
Donor Selection,N,N02.421.911.600,Tissue and Organ Procurement,Health Services,8
"Drugs, Investigational",D,D26.371,Pharmaceutical Preparations,NULL,8
"Early Intervention, Educational",N,N02.421.726.320,Preventive Health Services,Health Services,8
"Early Intervention, Educational",N,N02.421.143.130.320,Child Health Services,Community Health Services,8
"Education, Pharmacy",I,I02.358.525,"Education, Professional",Education,8
"Education, Professional",I,I02.358,Education,NULL,8
Eggs,J,J02.500.470,Food,Food and Beverages,8
Eggs,G,G07.203.300.470,Food,"Diet, Food, and Nutrition",8
El Nino-Southern Oscillation,G,G16.500.275.071.387,Climate,Environment,8
Electromagnetic Phenomena,G,G01.358.500,Magnetic Phenomena,Physical Phenomena,8
"Electrophoresis, Starch Gel",E,E05.301.300.402,Electrophoresis,Electrochemical Techniques,8
"Electrophoresis, Starch Gel",E,E05.196.401.485,Electrophoresis,"Chemistry Techniques, Analytical",8
Electrophoretic Mobility Shift Assay,E,E05.196.401.500,Electrophoresis,"Chemistry Techniques, Analytical",8
"Encephalitis Virus, Japanese",B,B04.820.230.475.227,"Encephalitis Viruses, Japanese",Encephalitis Viruses,8
"Encephalitis Virus, Japanese",B,B04.820.578.344.350.300.227,"Encephalitis Viruses, Japanese",Flavivirus,8
Endarterectomy,E,E04.100.814.456,Vascular Surgical Procedures,Cardiovascular Surgical Procedures,8
Endometriosis,C,C13.351.500.163,"Genital Diseases, Female",Female Urogenital Diseases,8
Enterococcus,B,B03.510.550.250.250,Enterococcaceae,Lactobacillales,8
Enterococcus,B,B03.353.750.250.250,Enterococcaceae,Lactobacillales,8
Erythema,C,C17.800.229,Skin Diseases,Skin and Connective Tissue Diseases,8
Erythema,C,C23.888.885.328,Skin Manifestations,Signs and Symptoms,8
Ethics Committees,K,K01.752.566.479.147,Ethics,Morals,8
Ethics Committees,N,N04.452.758.788.300,Professional Staff Committees,Professional Practice,8
Ethics Committees,N,N05.350.268,Ethics,"Health Care Quality, Access, and Evaluation",8
Ethics Committees,N,N05.700.685.300,Professional Staff Committees,"Quality Assurance, Health Care",8
Factor V,D,D23.119.300,Blood Coagulation Factors,Biological Factors,8
Factor V,D,D12.776.811.272,Protein Precursors,Proteins,8
Factor V,D,D12.776.124.125.300,Blood Coagulation Factors,Blood Proteins,8
"Faculty, Medical",N,N02.360.375,Health Personnel,"Health Care Facilities, Manpower, and Services",8
"Faculty, Medical",M,M01.526.485.375,Health Personnel,Occupational Groups,8
"Faculty, Medical",M,M01.526.702.250.373,Faculty,Educational Personnel,8
Family Planning Policy,N,N03.623.500.608.214,Public Policy,Social Control Policies,8
Family Planning Policy,I,I01.880.604.825.608.200,Public Policy,Social Control Policies,8
Family Planning Policy,I,I01.655.500.608.200,Public Policy,Social Control Policies,8
Family Therapy,F,F04.754.864.581.273,"Psychotherapy, Group",Socioenvironmental Therapy,8
Fermentation,G,G02.111.158.249,Carbohydrate Metabolism,Biochemical Phenomena,8
Fermentation,G,G03.191.249,Carbohydrate Metabolism,Metabolism,8
Fetal Mortality,E,E05.318.308.985.550.362,Mortality,Vital Statistics,8
Fetal Mortality,N,N06.850.520.308.985.550.362,Mortality,Vital Statistics,8
Fetal Mortality,N,N06.850.505.400.975.550.362,Mortality,Vital Statistics,8
Fetal Mortality,N,N01.224.935.698.300,Mortality,Vital Statistics,8
Fibrin,D,D12.776.124.270,Blood Proteins,Proteins,8
Fibrin Fibrinogen Degradation Products,D,D12.776.124.270.300,Fibrin,Blood Proteins,8
Fibrin Fibrinogen Degradation Products,D,D12.776.811.300.290,Fibrinogen,Protein Precursors,8
Floors and Floorcoverings,J,J01.086.339.140,Facility Design and Construction,Architecture,8
Fluorescein Angiography,E,E01.370.370.050.350,Angiography,"Diagnostic Techniques, Cardiovascular",8
Fluorescein Angiography,E,E01.370.380.250,"Diagnostic Techniques, Ophthalmological",Diagnostic Techniques and Procedures,8
Fluorescence Resonance Energy Transfer,E,E05.196.712.516.600.676.500,"Spectrometry, Fluorescence",Fluorometry,8
Fluorescence Resonance Energy Transfer,G,G02.111.255.280,Energy Transfer,Biochemical Phenomena,8
Fluorescence Resonance Energy Transfer,G,G01.154.240.280,Energy Transfer,Biophysical Phenomena,8
Food Hypersensitivity,C,C20.543.480.370,"Hypersensitivity, Immediate",Hypersensitivity,8
Foot Rot,C,C22.394,Animal Diseases,NULL,8
Foot Rot,C,C01.150.252.400.369,Gram-Negative Bacterial Infections,Bacterial Infections,8
Furosemide,D,D02.065.884.725.300,Sulfanilamides,Sulfonamides,8
Furosemide,D,D02.092.146.807.300,Sulfanilamides,Aniline Compounds,8
Furosemide,D,D02.886.590.700.725.300,Sulfanilamides,Sulfonamides,8
Gatifloxacin,D,D03.633.100.810.835.322.316,Fluoroquinolones,Quinolones,8
Genetic Pleiotropy,G,G05.695.550,Phenotype,Genetic Phenomena,8
Genetic Pleiotropy,G,G05.420.556,Inheritance Patterns,Genetic Phenomena,8
Glanders,C,C22.488.409,Horse Diseases,Animal Diseases,8
Glanders,C,C01.150.252.400.170.400,Burkholderia Infections,Gram-Negative Bacterial Infections,8
Glasgow Outcome Scale,E,E05.318.308.940.968.875.260,Trauma Severity Indices,Medical Records,8
Glasgow Outcome Scale,E,E05.944.510,Trauma Severity Indices,Investigative Techniques,8
Glasgow Outcome Scale,N,N05.715.360.300.715.500.800.335,Trauma Severity Indices,Medical Records,8
Glasgow Outcome Scale,N,N04.452.859.564.800.260,Trauma Severity Indices,Medical Records,8
Glutamine,D,D12.125.068.330,"Amino Acids, Basic",Amino Acids,8
Glutamine,D,D12.125.154.424,"Amino Acids, Neutral",Amino Acids,8
Glutamine,D,D12.125.095.461,"Amino Acids, Diamino",Amino Acids,8
Glycemic Index,J,J01.576.423.850.730.750.500,Nutritive Value,Food Quality,8
Glycemic Index,G,G07.203.650.660.500,Nutritive Value,Nutritional Physiological Phenomena,8
Glycemic Index,N,N06.850.601.750.500,Nutritive Value,Food Quality,8
Glycerol,D,D09.853.875.500,Triose Sugar Alcohols,Sugar Alcohols,8
Glycerol,D,D02.033.800.875.500,Triose Sugar Alcohols,Sugar Alcohols,8
Glycolysis,G,G02.111.158.750,Carbohydrate Metabolism,Biochemical Phenomena,8
Glycolysis,G,G03.191.750,Carbohydrate Metabolism,Metabolism,8
Glycolysis,G,G03.493.360,Metabolic Networks and Pathways,Metabolism,8
Glycolysis,G,G03.295.436,Energy Metabolism,Metabolism,8
Glycophorins,D,D12.644.233.800.350,Sialoglycoproteins,Glycopeptides,8
Glycophorins,D,D12.776.395.700.350,Sialoglycoproteins,Glycoproteins,8
Gonadotropin-Releasing Hormone,D,D12.644.456.460,Oligopeptides,Peptides,8
Gonadotropin-Releasing Hormone,D,D12.644.400.400.740.320,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,8
Gonadotropin-Releasing Hormone,D,D12.644.548.365.740.320,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,8
Gonadotropin-Releasing Hormone,D,D06.472.699.327.740.320,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,8
Gonadotropin-Releasing Hormone,D,D12.776.631.650.405.740.320,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,8
Guanidines,D,D02.078.370,Amidines,Organic Chemicals,8
Halogenation,G,G03.360,Metabolism,NULL,8
Halogenation,G,G02.111.323,Biochemical Phenomena,Chemical Phenomena,8
Hepatitis,C,C06.552.380,Liver Diseases,Digestive System Diseases,8
Hepatomegaly,C,C06.552.416,Liver Diseases,Digestive System Diseases,8
Hepatomegaly,C,C23.300.775.525,Hypertrophy,"Pathological Conditions, Anatomical",8
Histidine,D,D12.125.072.329,"Amino Acids, Cyclic",Amino Acids,8
Histidine,D,D12.125.142.308,"Amino Acids, Essential",Amino Acids,8
History of Pharmacy,K,K01.400.456,History,Humanities,8
HLA-A2 Antigen,D,D12.776.395.550.489.400.020,HLA-A Antigens,Histocompatibility Antigens Class I,8
HLA-A2 Antigen,D,D23.050.301.500.100.400.020,HLA-A Antigens,Histocompatibility Antigens Class I,8
HLA-A2 Antigen,D,D12.776.543.550.439.400.020,HLA-A Antigens,Histocompatibility Antigens Class I,8
HLA-A2 Antigen,D,D23.050.705.552.100.400.020,HLA-A Antigens,Histocompatibility Antigens Class I,8
HLA-A2 Antigen,D,D23.050.705.552.450.370.374,HLA-A Antigens,HLA Antigens,8
HLA-A2 Antigen,D,D23.050.301.500.450.370.020,HLA-A Antigens,HLA Antigens,8
Homeless Youth,M,M01.325.400,Homeless Persons,Persons,8
Horse Diseases,C,C22.488,Animal Diseases,NULL,8
"Hospitals, County",N,N02.278.421.510.100,"Hospitals, Public",Hospitals,8
Human Rights Abuses,I,I01.880.735.384,Social Problems,Sociology,8
Hyaluronan Receptors,D,D12.776.543.550.200.625.144,"Receptors, Lymphocyte Homing",Cell Adhesion Molecules,8
Hyaluronan Receptors,D,D12.776.543.750.705.877.144,"Receptors, Lymphocyte Homing","Receptors, Immunologic",8
Hyaluronan Receptors,D,D23.050.301.350.625.144,"Receptors, Lymphocyte Homing",Cell Adhesion Molecules,8
Hyaluronan Receptors,D,D12.776.395.650.750.281,Chondroitin Sulfate Proteoglycans,Proteoglycans,8
Hyaluronan Receptors,D,D12.776.395.550.200.625.144,"Receptors, Lymphocyte Homing",Cell Adhesion Molecules,8
Hyaluronan Receptors,D,D09.698.735.200.625,Chondroitin Sulfate Proteoglycans,Proteoglycans,8
Hydroxyurea,D,D02.065.950.395,Urea,Amides,8
Hypothalamo-Hypophyseal System,A,A06.688.357,Neurosecretory Systems,Endocrine System,8
Hypothalamo-Hypophyseal System,A,A08.713.357,Neurosecretory Systems,Nervous System,8
Hypothalamo-Hypophyseal System,A,A08.186.211.180.497.352.435,"Hypothalamus, Middle",Hypothalamus,8
Hypothalamo-Hypophyseal System,A,A08.186.211.200.317.357.352.435,"Hypothalamus, Middle",Hypothalamus,8
Image Enhancement,E,E01.370.350.600.350,Photography,Diagnostic Imaging,8
Image Enhancement,L,L01.224.308.380,"Image Processing, Computer-Assisted",Computing Methodologies,8
Immunodiffusion,E,E05.478.605.492.350,Precipitin Tests,Immunoprecipitation,8
Immunodiffusion,E,E05.478.594.760.645.350,Precipitin Tests,Serologic Tests,8
Immunodiffusion,E,E05.200.812.735.645.350,Precipitin Tests,Serologic Tests,8
Immunodiffusion,E,E01.370.225.812.735.645.350,Precipitin Tests,Serologic Tests,8
"Indians, North American",M,M01.686.508.150.600,American Native Continental Ancestry Group,Continental Population Groups,8
Insect Viruses,B,B04.525,Viruses,NULL,8
Intellectual Property,N,N03.706.535.518,Jurisprudence,"Social Control, Formal",8
Intellectual Property,I,I01.880.604.583.458,Jurisprudence,"Social Control, Formal",8
Interferon alpha-2,D,D23.529.374.440.890.250.500,Interferon-alpha,Interferon Type I,8
Interferon alpha-2,D,D12.776.467.374.440.890.250.500,Interferon-alpha,Interferon Type I,8
Interferon alpha-2,D,D12.644.276.374.440.890.250.500,Interferon-alpha,Interferon Type I,8
Interleukin-2 Receptor alpha Subunit,D,D12.776.543.750.705.852.420.320.500,"Receptors, Interleukin-2","Receptors, Interleukin",8
Intermediate Filament Proteins,D,D12.776.220.475,Cytoskeletal Proteins,Proteins,8
Intermediate Filament Proteins,D,D05.750.078.593,Biopolymers,Polymers,8
International Educational Exchange,I,I02.581,Education,NULL,8
International Educational Exchange,I,I01.615.500.650,International Cooperation,Internationality,8
Intracranial Pressure,G,G11.561.170.505,Cerebrospinal Fluid Pressure,Nervous System Physiological Phenomena,8
Iodine Radioisotopes,D,D01.268.380.400.500.496,Iodine Isotopes,Iodine,8
Iodine Radioisotopes,D,D01.496.448.496,Iodine Isotopes,Isotopes,8
Iodine Radioisotopes,D,D01.496.749.474,Radioisotopes,Isotopes,8
Kanamycin,D,D09.408.051.476,Aminoglycosides,Glycosides,8
Kuwait,Z,Z01.252.245.500.425,Middle East,"Asia, Western",8
Language Development,F,F01.525.200.310,Child Development,Human Development,8
Leukocytosis,C,C23.550.526,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",8
Leukocytosis,C,C15.378.553.475,Leukocyte Disorders,Hematologic Diseases,8
Lipid A,D,D09.698.718.450.500,Lipopolysaccharides,"Polysaccharides, Bacterial",8
Lipid A,D,D10.494.500,Lipopolysaccharides,Lipids,8
Lipid A,D,D23.050.161.616.525.500,Lipopolysaccharides,"Polysaccharides, Bacterial",8
Lipid A,D,D23.946.123.329.500.500,Lipopolysaccharides,Endotoxins,8
Lithotripsy,E,E02.600,Therapeutics,NULL,8
Lithotripsy,E,E04.943.500,Ultrasonic Surgical Procedures,"Surgical Procedures, Operative",8
"Liver Cirrhosis, Biliary",C,C23.550.355.412.400,Liver Cirrhosis,Fibrosis,8
"Liver Cirrhosis, Biliary",C,C06.552.630.400,Liver Cirrhosis,Liver Diseases,8
"Liver Cirrhosis, Biliary",C,C06.552.150.250,"Cholestasis, Intrahepatic",Liver Diseases,8
"Liver Cirrhosis, Biliary",C,C06.130.120.135.250.250,"Cholestasis, Intrahepatic",Cholestasis,8
"Liver Diseases, Alcoholic",C,C06.552.645,Liver Diseases,Digestive System Diseases,8
"Liver Diseases, Alcoholic",C,C25.775.100.087.645,Alcohol-Induced Disorders,Alcohol-Related Disorders,8
Logic,K,K01.752.448,Philosophy,Humanities,8
Loiasis,C,C01.610.335.508.700.750.361.518,Filariasis,Spirurida Infections,8
Lot Quality Assurance Sampling,N,N05.715.360.330.875.500,Sampling Studies,Epidemiologic Study Characteristics,8
Lot Quality Assurance Sampling,N,N06.850.520.308.461,Data Collection,Epidemiologic Methods,8
Lot Quality Assurance Sampling,E,E05.318.308.461,Data Collection,Epidemiologic Methods,8
Luteinizing Hormone,D,D12.644.548.691.525.343.463,"Gonadotropins, Pituitary","Pituitary Hormones, Anterior",8
Luteinizing Hormone,D,D06.472.699.322.576.463,"Gonadotropins, Pituitary",Gonadotropins,8
Luteinizing Hormone,D,D06.472.699.631.525.343.463,"Gonadotropins, Pituitary","Pituitary Hormones, Anterior",8
Lyme Disease,C,C01.150.252.400.536,Gram-Negative Bacterial Infections,Bacterial Infections,8
Lyme Disease,C,C01.150.252.400.794.352.250,Borrelia Infections,Spirochaetales Infections,8
Lyme Disease,C,C01.920.930.513,Tick-Borne Diseases,Vector Borne Diseases,8
Lymphopenia,C,C20.673.627,Immunologic Deficiency Syndromes,Immune System Diseases,8
Lymphopenia,C,C15.378.553.546.605,Leukopenia,Leukocyte Disorders,8
Lysosomal-Associated Membrane Protein 1,D,D12.776.395.550.550.500,Lysosome-Associated Membrane Glycoproteins,Membrane Glycoproteins,8
Lysosomal-Associated Membrane Protein 1,D,D12.776.395.550.625.449,Platelet Membrane Glycoproteins,Membrane Glycoproteins,8
Lysosomal-Associated Membrane Protein 1,D,D12.776.543.750.705.675.554,Platelet Membrane Glycoproteins,"Receptors, Immunologic",8
Lysosomal-Associated Membrane Protein 1,D,D12.776.543.550.527.500,Lysosome-Associated Membrane Glycoproteins,Membrane Glycoproteins,8
Lysosomal-Associated Membrane Protein 1,D,D12.776.543.550.625.449,Platelet Membrane Glycoproteins,Membrane Glycoproteins,8
"Macrophages, Alveolar",A,A11.329.372.600,Macrophages,Connective Tissue Cells,8
"Macrophages, Alveolar",A,A11.627.482.600,Macrophages,Myeloid Cells,8
"Macrophages, Alveolar",A,A11.733.397.600,Macrophages,Phagocytes,8
"Macrophages, Alveolar",A,A15.382.670.522.600,Macrophages,Mononuclear Phagocyte System,8
"Macrophages, Alveolar",A,A15.382.680.397.600,Macrophages,Phagocytes,8
Mansonella,B,B01.050.500.500.294.400.937.463.438,Filarioidea,Spirurida,8
Medical Staff,M,M01.526.485.630,Health Personnel,Occupational Groups,8
Medical Staff,N,N02.360.630,Health Personnel,"Health Care Facilities, Manpower, and Services",8
Meningioma,C,C04.557.645.520,"Neoplasms, Vascular Tissue",Neoplasms by Histologic Type,8
Meningioma,C,C04.557.580.520,"Neoplasms, Nerve Tissue",Neoplasms by Histologic Type,8
Meningioma,C,C04.588.614.250.580.500,Meningeal Neoplasms,Central Nervous System Neoplasms,8
Meningioma,C,C10.551.240.500.500,Meningeal Neoplasms,Central Nervous System Neoplasms,8
"Meningitis, Viral",C,C10.228.614.400,Meningitis,Central Nervous System Diseases,8
"Meningitis, Viral",C,C10.228.228.245.500,Central Nervous System Viral Diseases,Central Nervous System Infections,8
"Meningitis, Viral",C,C01.925.182.550,Central Nervous System Viral Diseases,Virus Diseases,8
"Meningitis, Viral",C,C01.207.245.500,Central Nervous System Viral Diseases,Central Nervous System Infections,8
Menstruation Disturbances,C,C23.550.568,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",8
Mental Competency,N,N03.706.535.625,Jurisprudence,"Social Control, Formal",8
Mental Competency,I,I01.880.604.583.530,Jurisprudence,"Social Control, Formal",8
Mental Competency,F,F01.590,Behavior and Behavior Mechanisms,NULL,8
Mental Competency,F,F02.410,Psychological Phenomena,NULL,8
Meropenem,D,D02.065.589.099.124.300.750,Thienamycins,Carbapenems,8
Meropenem,D,D03.633.100.300.124.300.750,Thienamycins,Carbapenems,8
"Mesothelioma, Malignant",C,C08.381.540.144,Lung Neoplasms,Lung Diseases,8
"Mesothelioma, Malignant",C,C08.785.520.124,Lung Neoplasms,Respiratory Tract Neoplasms,8
"Mesothelioma, Malignant",C,C08.785.640.350,Pleural Neoplasms,Respiratory Tract Neoplasms,8
"Mesothelioma, Malignant",C,C04.557.470.660.510.757,Mesothelioma,"Neoplasms, Mesothelial",8
"Mesothelioma, Malignant",C,C04.557.470.035.510.757,Mesothelioma,Adenoma,8
"Mesothelioma, Malignant",C,C04.588.894.797.520.173,Lung Neoplasms,Respiratory Tract Neoplasms,8
"Mesothelioma, Malignant",C,C04.588.894.797.640.350,Pleural Neoplasms,Respiratory Tract Neoplasms,8
Metalloendopeptidases,D,D08.811.277.656.675.374,Metalloproteases,Peptide Hydrolases,8
Metalloendopeptidases,D,D08.811.277.656.300.480,Endopeptidases,Peptide Hydrolases,8
Metronidazole,D,D03.383.129.308.658.500,Nitroimidazoles,Imidazoles,8
Metronidazole,D,D02.640.672.500,Nitroimidazoles,Nitro Compounds,8
Microcomputers,L,L01.224.230.260.550,Computers,Computer Systems,8
Microtubules,A,A11.284.430.214.190.750.602,Cytoskeleton,Cytoplasmic Structures,8
Minnesota,Z,Z01.107.567.875.510.510,Midwestern United States,United States,8
Minnesota,Z,Z01.107.567.875.350.510,Great Lakes Region,United States,8
Mononegavirales,B,B04.820.480.937,Negative-Sense RNA Viruses,RNA Viruses,8
Moscow,Z,Z01.433.653,Cities,Geographic Locations,8
Moscow,Z,Z01.542.248.775.510,Russia,"Europe, Eastern",8
Motor Skills Disorders,F,F03.625.813,Neurodevelopmental Disorders,Mental Disorders,8
Mumps virus,B,B04.820.480.937.600.650.750.550,Rubulavirus,Paramyxovirinae,8
Mycobacterium avium,B,B03.510.460.400.410.552.552.300,Mycobacterium,Mycobacteriaceae,8
Mycobacterium avium,B,B03.510.024.962.500.300,Mycobacterium,Mycobacteriaceae,8
Nairovirus,B,B04.820.480.750.565,Bunyaviridae,Negative-Sense RNA Viruses,8
Nanotechnology,J,J01.897.520.600,Miniaturization,Technology,8
Nanotechnology,H,H01.603,Natural Science Disciplines,NULL,8
Naphthalenesulfonates,D,D02.455.426.559.847.638.555,Naphthalenes,Polycyclic Aromatic Hydrocarbons,8
Naphthalenesulfonates,D,D02.886.645.600.080.050.650,Arylsulfonates,Arylsulfonic Acids,8
Naphthalenesulfonates,D,D04.615.638.555,Naphthalenes,Polycyclic Aromatic Hydrocarbons,8
"Near Miss, Healthcare",E,E02.319.529.750,Medication Errors,Drug Therapy,8
"Near Miss, Healthcare",N,N05.700.513,"Quality Assurance, Health Care","Health Care Quality, Access, and Evaluation",8
"Near Miss, Healthcare",N,N04.761.700.594,"Quality Assurance, Health Care",Quality of Health Care,8
"Near Miss, Healthcare",N,N02.421.450.500.750,Medication Errors,Medical Errors,8
"Near Miss, Healthcare",N,N02.421.450.550,Medical Errors,Health Services,8
Neisseria,B,B03.660.075.525.520,Neisseriaceae,Betaproteobacteria,8
Neisseria,B,B03.440.400.425.550.550,Neisseriaceae,Gram-Negative Aerobic Rods and Cocci,8
"Neoplasms, Hormone-Dependent",C,C04.626,Neoplasms,NULL,8
Nephrology,H,H02.403.429.580,Internal Medicine,Medicine,8
Nerve Fibers,A,A11.671.501,Neurons,Cells,8
Nerve Fibers,A,A08.675.542,Neurons,Nervous System,8
Nerve Net,A,A08.511,Nervous System,NULL,8
Nervous System,A,A08,NULL,NULL,8
Neuritis,C,C10.668.829.650,Peripheral Nervous System Diseases,Neuromuscular Diseases,8
Neurosurgical Procedures,E,E04.525,"Surgical Procedures, Operative",NULL,8
Neurosyphilis,C,C10.228.228.180.600,Central Nervous System Bacterial Infections,Central Nervous System Infections,8
Neurosyphilis,C,C01.150.252.223.600,Central Nervous System Bacterial Infections,Bacterial Infections,8
Neurosyphilis,C,C01.207.180.600,Central Nervous System Bacterial Infections,Central Nervous System Infections,8
Neurosyphilis,C,C01.150.252.400.794.840.500.750,Syphilis,Treponemal Infections,8
Neurosyphilis,C,C01.150.252.400.840.500.750,Syphilis,Treponemal Infections,8
Nevus,C,C04.557.665.560,Nevi and Melanomas,Neoplasms by Histologic Type,8
"Nevus, Pigmented",C,C04.557.665.560.615,Nevus,Nevi and Melanomas,8
Nitrogen Oxides,D,D01.650.550.587,Oxides,Oxygen Compounds,8
Nitrogen Oxides,D,D01.625.550,Nitrogen Compounds,Inorganic Chemicals,8
Nitrogen Oxides,D,D01.362.635,Gases,Inorganic Chemicals,8
Norepinephrine,D,D02.033.100.291.502,Ethanolamines,Amino Alcohols,8
Norepinephrine,D,D02.092.063.480,Amino Alcohols,Amines,8
Norepinephrine,D,D02.092.311.830,Catecholamines,Amines,8
Norepinephrine,D,D02.092.211.215.746,Biogenic Monoamines,Biogenic Amines,8
Norepinephrine,D,D02.455.426.559.389.657.166.175.830,Catecholamines,Catechols,8
Nose,A,A09.531,Sense Organs,NULL,8
Nose,A,A04.531,Respiratory System,NULL,8
Nose,A,A01.456.505.733,Face,Head,8
Nucleic Acids,D,D13.444,"Nucleic Acids, Nucleotides, and Nucleosides",NULL,8
Nucleopolyhedroviruses,B,B04.525.100.500,Baculoviridae,Insect Viruses,8
Nucleopolyhedroviruses,B,B04.280.065.500,Baculoviridae,DNA Viruses,8
Nursing Research,H,H01.770.644.145.390,Biomedical Research,Research,8
Nursing Research,H,H02.478.395,Nursing,Health Occupations,8
Nursing Research,N,N04.590.233.508.613,Nursing Process,Comprehensive Health Care,8
Occupational Injuries,C,C26.716,Wounds and Injuries,NULL,8
Oceans and Seas,G,G16.500.275.725.500.650,Seawater,Saline Waters,8
Oceans and Seas,G,G01.311.625,Geological Phenomena,Physical Phenomena,8
Oceans and Seas,Z,Z01.756,Geographic Locations,NULL,8
Osteogenesis,G,G07.345.500.325.377.625.050.500.729,Bone Development,Biomineralization,8
Osteogenesis,G,G11.427.578.050.500.729,Bone Development,Biomineralization,8
Ovulation,G,G08.686.784.690,Reproduction,Reproductive Physiological Phenomena,8
Panstrongylus,B,B01.050.500.131.617.412.420.700.850.600,Triatominae,Reduviidae,8
Papanicolaou Test,E,E01.370.225.500.384.100.422,Biopsy,Cytodiagnosis,8
Papanicolaou Test,E,E01.370.225.998.054.422,Biopsy,Specimen Handling,8
Papanicolaou Test,E,E04.074.422,Biopsy,"Surgical Procedures, Operative",8
Papanicolaou Test,E,E05.242.384.100.422,Biopsy,Cytodiagnosis,8
Papanicolaou Test,E,E05.200.998.054.422,Biopsy,Specimen Handling,8
Papanicolaou Test,E,E05.200.500.384.100.422,Biopsy,Cytodiagnosis,8
Paramyxoviridae Infections,C,C01.925.782.580.600,Mononegavirales Infections,RNA Virus Infections,8
"Parasitic Diseases, Animal",C,C01.610.701,Parasitic Diseases,Infections,8
"Parasitic Diseases, Animal",C,C22.674,Animal Diseases,NULL,8
Parental Consent,I,I01.880.604.583.427.635.500,Third-Party Consent,Informed Consent,8
Parental Consent,N,N03.706.535.489.635.500,Third-Party Consent,Informed Consent,8
Parvoviridae Infections,C,C01.925.256.700,DNA Virus Infections,Virus Diseases,8
"Parvovirus B19, Human",B,B04.280.580.650.200.650,Erythrovirus,Parvovirinae,8
Paternal Age,G,G08.686.700,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,8
"Pathology, Molecular",H,H01.158.201.636.475.750,Molecular Medicine,Molecular Biology,8
"Pathology, Molecular",H,H01.181.122.650.475.680,Molecular Medicine,Molecular Biology,8
"Pathology, Molecular",H,H01.158.273.343.595.475.750,Molecular Medicine,Molecular Biology,8
"Pathology, Molecular",H,H02.403.650.505,Pathology,Medicine,8
Patients' Rooms,N,N02.278.220.640,Health Facility Environment,Health Facilities,8
"Pattern Recognition, Visual",F,F02.463.593.932.622,Visual Perception,Perception,8
"Pattern Recognition, Visual",F,F02.463.593.524.500,"Pattern Recognition, Physiological",Perception,8
Penicillin G Procaine,D,D02.455.426.559.389.127.020.937.906.666,Procaine,para-Aminobenzoates,8
Penicillin G Procaine,D,D02.241.223.100.050.500.906.666,Procaine,para-Aminobenzoates,8
Penicillin G Procaine,D,D02.065.589.099.750.750.695,Penicillin G,Penicillins,8
Penicillin G Procaine,D,D02.886.108.750.750.695,Penicillin G,Penicillins,8
Penicillin G Procaine,D,D03.633.100.300.750.750.695,Penicillin G,Penicillins,8
Penicillinase,D,D08.811.277.087.180.697,beta-Lactamases,Amidohydrolases,8
Peptic Ulcer,C,C06.405.748.586,Stomach Diseases,Gastrointestinal Diseases,8
Peptic Ulcer,C,C06.405.469.275.800,Duodenal Diseases,Intestinal Diseases,8
Pericarditis,C,C14.280.720,Heart Diseases,Cardiovascular Diseases,8
Pesticide Synergists,D,D27.888.723.748,Pesticides,Toxic Actions,8
Pesticide Synergists,D,D27.720.031.700.748,Pesticides,Agrochemicals,8
Pets,B,B01.050.050.116.600,"Animals, Domestic",Animal Population Groups,8
Phosphatidylinositol 3-Kinases,D,D08.811.913.696.620.500,Phosphotransferases (Alcohol Group Acceptor),Phosphotransferases,8
Phosphoric Monoester Hydrolases,D,D08.811.277.352.650,Esterases,Hydrolases,8
Physical Chromosome Mapping,E,E05.393.183.620,Chromosome Mapping,Genetic Techniques,8
Planning Techniques,N,N04.452.718,Organization and Administration,Health Services Administration,8
Plant Preparations,D,D20.215.784,Biological Products,Complex Mixtures,8
Plant Proteins,D,D12.776.765,Proteins,"Amino Acids, Peptides, and Proteins",8
Plastics,D,D25.720.716,Polymers,Biomedical and Dental Materials,8
Plastics,D,D05.750.716,Polymers,Macromolecular Substances,8
Plastics,J,J01.637.051.720.716,Polymers,Biomedical and Dental Materials,8
Platelet Function Tests,E,E05.200.625.625,Hematologic Tests,Clinical Laboratory Techniques,8
Platelet Function Tests,E,E01.370.225.625.625,Hematologic Tests,Clinical Laboratory Techniques,8
Poaceae,B,B01.650.940.800.575.912.250.822,Magnoliopsida,Tracheophyta,8
Polyamines,D,D02.092.782,Amines,Organic Chemicals,8
Polyethyleneimine,D,D02.455.326.271.665.550.600,Polyethylenes,Polyenes,8
Polyethyleneimine,D,D25.720.716.507.600,Polyethylenes,Plastics,8
Polyethyleneimine,D,D05.750.716.507.600,Polyethylenes,Plastics,8
Polyethyleneimine,D,D02.491.650,Imines,Organic Chemicals,8
Polyethyleneimine,J,J01.637.051.720.716.507.600,Polyethylenes,Plastics,8
"Polymorphism, Single-Stranded Conformational",G,G05.365.795.600,"Polymorphism, Genetic",Genetic Variation,8
Porphyrins,D,D03.383.129.578.840.500,Tetrapyrroles,Pyrroles,8
Porphyrins,D,D03.633.400.909.500,Tetrapyrroles,"Heterocyclic Compounds, 4 or More Rings",8
Porphyrins,D,D04.345.783.500,Tetrapyrroles,Macrocyclic Compounds,8
Porphyrins,D,D23.767.727,"Pigments, Biological",Biological Factors,8
Posture,G,G11.427.695,Musculoskeletal Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,8
Powders,D,D26.255.779,Dosage Forms,Pharmaceutical Preparations,8
Prehypertension,C,C14.907.653,Vascular Diseases,Cardiovascular Diseases,8
Presenilin-1,D,D12.776.543.696.500,Presenilins,Membrane Proteins,8
Pressure,G,G01.374.715,Mechanical Phenomena,Physical Phenomena,8
Private Facilities,J,J03.700,Non-Medical Public and Private Facilities,NULL,8
Progesterone,D,D04.210.500.745.745.654.829,Pregnenediones,Pregnenes,8
Progesterone,D,D06.472.334.734.623,Corpus Luteum Hormones,Gonadal Hormones,8
Progesterone,D,D06.472.334.851.687.750,Progesterone Congeners,Gonadal Steroid Hormones,8
Propaganda,L,L01.143.790,Communication,Information Science,8
Protein Interaction Maps,G,G03.493.750,Metabolic Networks and Pathways,Metabolism,8
Protein Phosphatase 1,D,D08.811.277.352.650.625.687,Phosphoprotein Phosphatases,Phosphoric Monoester Hydrolases,8
Public Housing,J,J03.340.650,Housing,Non-Medical Public and Private Facilities,8
Public Housing,N,N06.230.150.360.650,Housing,"Environment, Controlled",8
Public Housing,N,N01.224.791.400.650,Housing,Residence Characteristics,8
Random Amplified Polymorphic DNA Technique,E,E05.393.620.500.687,Polymerase Chain Reaction,Nucleic Acid Amplification Techniques,8
Random Amplified Polymorphic DNA Technique,E,E05.601.700,Molecular Probe Techniques,Investigative Techniques,8
"Range of Motion, Articular",G,G11.427.760,Musculoskeletal Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,8
"Range of Motion, Articular",E,E01.370.600.700,Physical Examination,Diagnostic Techniques and Procedures,8
"Receptors, Fc",D,D12.776.543.750.705.871,"Receptors, Immunologic","Receptors, Cell Surface",8
"Receptors, Glucocorticoid",D,D12.776.826.750.430,"Receptors, Steroid","Receptors, Cytoplasmic and Nuclear",8
"Receptors, Interleukin-2",D,D12.776.543.750.705.852.420.320,"Receptors, Interleukin","Receptors, Cytokine",8
Reflex,E,E01.370.600.550.650,Neurologic Examination,Physical Examination,8
Reflex,E,E01.370.376.550.650,Neurologic Examination,"Diagnostic Techniques, Neurological",8
Reflex,G,G11.561.731,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,8
Reflex,F,F02.830.702,Psychophysiology,Psychological Phenomena,8
Remote Sensing Technology,E,E05.925.500,Telemetry,Investigative Techniques,8
Remote Sensing Technology,L,L01.178.847.675.500,Telemetry,Telecommunications,8
Remote Sensing Technology,E,E01.370.520.750.500,Telemetry,"Monitoring, Physiologic",8
Respiratory Tract Neoplasms,C,C08.785,Respiratory Tract Diseases,NULL,8
Respiratory Tract Neoplasms,C,C04.588.894.797,Thoracic Neoplasms,Neoplasms by Site,8
Rest,I,I03.450.769.647,Relaxation,Leisure Activities,8
Reverse Genetics,E,E05.393.731,Genetic Techniques,Investigative Techniques,8
Ribonucleases,D,D08.811.277.352.700,Esterases,Hydrolases,8
Risperidone,D,D03.383.742.698.685,Pyrimidinones,Pyrimidines,8
Robotic Surgical Procedures,E,E04.749.500,"Surgery, Computer-Assisted","Surgical Procedures, Operative",8
Robotic Surgical Procedures,J,J01.897.104.834.500,Robotics,Automation,8
Rome,Z,Z01.542.489.569,Italy,Europe,8
Rome,Z,Z01.433.850,Cities,Geographic Locations,8
Salivary Proteins and Peptides,D,D12.644.848,Peptides,"Amino Acids, Peptides, and Proteins",8
Salivary Proteins and Peptides,D,D12.776.850,Proteins,"Amino Acids, Peptides, and Proteins",8
Salmeterol Xinafoate,D,D02.092.471.683.061.750,Albuterol,Phenethylamines,8
Salmeterol Xinafoate,D,D02.092.063.291.057.750,Albuterol,Ethanolamines,8
Salmeterol Xinafoate,D,D02.033.100.291.057.750,Albuterol,Ethanolamines,8
Seafood,J,J02.500.600.875,Meat,Food,8
Seafood,G,G07.203.300.600.875,Meat,Food,8
Semantic Web,L,L01.224.740,Computing Methodologies,Information Science,8
Serine,D,D12.125.154.800,"Amino Acids, Neutral",Amino Acids,8
Serine Proteases,D,D08.811.277.656.959,Peptide Hydrolases,Hydrolases,8
Sex Preselection,E,E05.393.420.890,Genetic Engineering,Genetic Techniques,8
"Sexual Dysfunctions, Psychological",F,F03.835,Mental Disorders,NULL,8
Shiga-Toxigenic Escherichia coli,B,B03.660.250.150.180.100.800,Escherichia coli,Escherichia,8
Shiga-Toxigenic Escherichia coli,B,B03.440.450.425.325.300.800,Escherichia coli,Escherichia,8
Shoes,J,J01.637.215.800,Clothing,Manufactured Materials,8
Single Parent,I,I01.880.853.150.423.500.725.700,Single Person,Marital Status,8
Single Parent,I,I01.880.853.150.500.340.785,Parents,Nuclear Family,8
Single Parent,I,I01.240.361.500.725.700,Single Person,Marital Status,8
Single Parent,N,N01.224.361.500.725.700,Single Person,Marital Status,8
Single Parent,M,M01.620.785,Parents,Persons,8
Single Parent,N,N01.824.308.500.725.700,Single Person,Marital Status,8
Single Parent,F,F01.829.263.500.320.785,Parents,Nuclear Family,8
Single Parent,F,F01.829.263.315.500.725.700,Single Person,Marital Status,8
Smallpox Vaccine,D,D20.215.894.899.859,Viral Vaccines,Vaccines,8
Smoke-Free Policy,I,I01.655.249,Policy,Social Sciences,8
Smokers,M,M01.808,Persons,NULL,8
Snakes,B,B01.050.150.900.833.672,Reptiles,Vertebrates,8
Social Theory,F,F02.970,Psychological Phenomena,NULL,8
Soft Tissue Neoplasms,C,C04.588.839,Neoplasms by Site,Neoplasms,8
Somatomedins,D,D12.776.467.937,Intercellular Signaling Peptides and Proteins,Proteins,8
Somatomedins,D,D23.529.937,Intercellular Signaling Peptides and Proteins,Biological Factors,8
Somatomedins,D,D12.644.276.937,Intercellular Signaling Peptides and Proteins,Peptides,8
Somatomedins,D,D12.776.124.862,Blood Proteins,Proteins,8
"Spectrometry, Mass, Electrospray Ionization",E,E05.196.566.600,Mass Spectrometry,"Chemistry Techniques, Analytical",8
"Spectroscopy, Near-Infrared",E,E05.196.867.851,Spectrum Analysis,"Chemistry Techniques, Analytical",8
"Spectroscopy, Near-Infrared",E,E01.370.350.750,Diagnostic Imaging,Diagnostic Techniques and Procedures,8
Spirituality,F,F02.880.705,Religion and Psychology,Psychological Phenomena,8
Spirituality,K,K01.844.664.500,Religion and Psychology,Religion,8
Statistical Distributions,G,G17.820,Mathematical Concepts,NULL,8
Statistical Distributions,N,N05.715.360.750.750,Statistics as Topic,Health Care Evaluation Mechanisms,8
Statistical Distributions,E,E05.318.740.994,Statistics as Topic,Epidemiologic Methods,8
Statistical Distributions,N,N06.850.520.830.994,Statistics as Topic,Epidemiologic Methods,8
Strabismus,C,C10.292.562.887,Ocular Motility Disorders,Cranial Nerve Diseases,8
Strabismus,C,C11.590.810,Ocular Motility Disorders,Eye Diseases,8
"Stress, Mechanical",G,G01.374.835,Mechanical Phenomena,Physical Phenomena,8
Student Dropouts,F,F02.784.629.796,"Psychology, Educational","Psychology, Applied",8
Student Dropouts,M,M01.848.602,Students,Persons,8
Substance Withdrawal Syndrome,F,F03.900.825,Substance-Related Disorders,Mental Disorders,8
Substance Withdrawal Syndrome,C,C25.775.835,Substance-Related Disorders,Chemically-Induced Disorders,8
Sucrose,D,D09.698.629.305.770,Disaccharides,Oligosaccharides,8
Sucrose,D,D09.947.750.770,Disaccharides,Sugars,8
Systems Theory,H,H01.770.808,Science,Natural Science Disciplines,8
Tasmania,Z,Z01.639.100.984,Australia,Islands,8
Tasmania,Z,Z01.678.100.373.984,Australia,Australasia,8
"Technology, Pharmaceutical",J,J01.897.836,Technology,"Technology, Industry, and Agriculture",8
"Technology, Pharmaceutical",E,E05.916,Investigative Techniques,NULL,8
"Thoracic Surgery, Video-Assisted",E,E04.928.752.830,Thoracoscopy,Thoracic Surgical Procedures,8
"Thoracic Surgery, Video-Assisted",E,E04.502.250.840.830,Thoracoscopy,Endoscopy,8
"Thoracic Surgery, Video-Assisted",E,E04.502.250.950.830,Video-Assisted Surgery,Endoscopy,8
"Thoracic Surgery, Video-Assisted",E,E01.370.388.250.840.830,Thoracoscopy,Endoscopy,8
"Thoracic Surgery, Video-Assisted",E,E01.370.388.250.950.830,Video-Assisted Surgery,Endoscopy,8
Thorax,A,A01.923.761,Torso,Body Regions,8
Thyroid Diseases,C,C19.874,Endocrine System Diseases,NULL,8
TOR Serine-Threonine Kinases,D,D12.776.476.925,Intracellular Signaling Peptides and Proteins,Proteins,8
TOR Serine-Threonine Kinases,D,D08.811.913.696.620.682.700.931,Protein-Serine-Threonine Kinases,Protein Kinases,8
Total Quality Management,N,N04.452.955,Organization and Administration,Health Services Administration,8
Total Quality Management,N,N04.761.700.675,"Quality Assurance, Health Care",Quality of Health Care,8
Total Quality Management,N,N05.700.792,"Quality Assurance, Health Care","Health Care Quality, Access, and Evaluation",8
Trans Fatty Acids,D,D10.251.355.920,"Fatty Acids, Unsaturated",Fatty Acids,8
Transition to Adult Care,E,E02.760.169.718,Continuity of Patient Care,Patient Care,8
Transition to Adult Care,N,N04.590.233.727.210.718,Continuity of Patient Care,Primary Health Care,8
Transition to Adult Care,N,N02.421.585.169.718,Continuity of Patient Care,Patient Care,8
Translations,L,L01.178.682.920,Publications,Communications Media,8
"Transplantation, Autologous",E,E04.936.664,Transplantation,"Surgical Procedures, Operative",8
Transsexualism,F,F01.145.802.975.750,Sexuality,Sexual Behavior,8
Trauma Severity Indices,E,E05.944,Investigative Techniques,NULL,8
Trauma Severity Indices,E,E05.318.308.940.968.875,Medical Records,Records,8
Trauma Severity Indices,N,N04.452.859.564.800,Medical Records,Records,8
Trauma Severity Indices,N,N05.715.360.300.715.500.800,Medical Records,Records,8
Trauma Severity Indices,N,N06.850.520.308.940.968.875,Medical Records,Records,8
Tumor Burden,E,E05.041.124.892,Body Weights and Measures,Anthropometry,8
Turkeys,B,B01.050.150.900.248.350.800,Galliformes,Birds,8
Turkeys,B,B01.050.150.900.248.690.800,Poultry,Birds,8
Urethra,A,A05.810.876,Urinary Tract,Urogenital System,8
Urethra,A,A05.360.444.492.726,Penis,"Genitalia, Male",8
Valine,D,D12.125.142.930,"Amino Acids, Essential",Amino Acids,8
Valine,D,D12.125.070.950,"Amino Acids, Branched-Chain",Amino Acids,8
Vancomycin-Resistant Enterococci,B,B03.353.750.250.250.650,Enterococcus,Enterococcaceae,8
Vancomycin-Resistant Enterococci,B,B03.510.550.250.250.650,Enterococcus,Enterococcaceae,8
Vasculitis,C,C14.907.940,Vascular Diseases,Cardiovascular Diseases,8
Vasodilation,G,G09.330.380.928,Hemodynamics,Cardiovascular Physiological Phenomena,8
Veins,A,A07.015.908,Blood Vessels,Cardiovascular System,8
Vesicular Transport Proteins,D,D12.776.543.990,Membrane Proteins,Proteins,8
Veterinarians,N,N02.360.905,Health Personnel,"Health Care Facilities, Manpower, and Services",8
Veterinarians,M,M01.526.485.905,Health Personnel,Occupational Groups,8
"Vision, Binocular",F,F02.463.593.932.885,Visual Perception,Perception,8
Vitamin B 6,D,D03.383.725.676.925,Picolines,Pyridines,8
"Vocabulary, Controlled",L,L01.453.245.945,Documentation,Information Services,8
Water Pollutants,D,D27.888.284.903,Environmental Pollutants,Toxic Actions,8
West Nile Fever,C,C01.207.245.340.300.887,"Encephalitis, Arbovirus","Encephalitis, Viral",8
West Nile Fever,C,C01.207.399.750.300.887,"Encephalitis, Arbovirus","Encephalitis, Viral",8
West Nile Fever,C,C01.925.182.525.300.850,"Encephalitis, Arbovirus","Encephalitis, Viral",8
West Nile Fever,C,C01.925.081.343.950,"Encephalitis, Arbovirus",Arbovirus Infections,8
West Nile Fever,C,C01.920.500.343.950,"Encephalitis, Arbovirus",Arbovirus Infections,8
West Nile Fever,C,C01.925.782.310.950,"Encephalitis, Arbovirus",RNA Virus Infections,8
West Nile Fever,C,C01.925.782.350.250.900,Flavivirus Infections,Flaviviridae Infections,8
West Nile Fever,C,C10.228.228.245.340.300.887,"Encephalitis, Arbovirus","Encephalitis, Viral",8
West Nile Fever,C,C10.228.228.399.750.300.887,"Encephalitis, Arbovirus","Encephalitis, Viral",8
West Nile Fever,C,C10.228.140.430.520.750.300.887,"Encephalitis, Arbovirus","Encephalitis, Viral",8
Wine,J,J02.200.100.900,Alcoholic Beverages,Beverages,8
Wine,J,J02.350.887,Fermented Foods and Beverages,Food and Beverages,8
Wine,G,G07.203.200.887,Fermented Foods and Beverages,"Diet, Food, and Nutrition",8
Wine,G,G07.203.100.100.900,Alcoholic Beverages,Beverages,8
Workers' Compensation,N,N03.219.521.346.866,"Financing, Government","Financing, Organized",8
Workers' Compensation,N,N03.219.521.576.300.900,"Insurance, Disability",Insurance,8
Workplace Violence,I,I01.880.735.900.912,Violence,Social Problems,8
Workplace Violence,I,I01.198.240.856.912,Violence,Crime,8
Xenopus,B,B01.050.150.900.090.180.610.500,Pipidae,Anura,8
A549 Cells,A,A11.436.054,Epithelial Cells,Cells,7
A549 Cells,A,A11.251.860.180.080,"Cell Line, Tumor","Tumor Cells, Cultured",7
A549 Cells,A,A11.251.210.190.080,"Cell Line, Tumor",Cell Line,7
"Abnormalities, Multiple",C,C16.131.077,Congenital Abnormalities,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",7
Acetic Acid,D,D02.241.081.018.165,Acetates,"Acids, Acyclic",7
Acetic Acid,D,D10.251.400.045.500,Acetates,"Fatty Acids, Volatile",7
Acetylation,G,G02.111.012.052,Acylation,Biochemical Phenomena,7
Acetylation,G,G03.040.052,Acylation,Metabolism,7
Acetylation,G,G02.607.063.052,Acylation,Organic Chemistry Phenomena,7
Acetylcholine,D,D02.092.211.111,Biogenic Amines,Amines,7
Actinomycetales,B,B03.510.024.049,Actinobacteria,Gram-Positive Bacteria,7
Adalimumab,D,D12.776.124.790.651.114.224.060.250,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",7
Adalimumab,D,D12.776.124.486.485.114.224.060.250,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",7
Adalimumab,D,D12.776.377.715.548.114.224.200.250,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",7
ADP Ribose Transferases,D,D08.811.913.400.725.115,Pentosyltransferases,Glycosyltransferases,7
Aerobiosis,G,G03.049,Metabolism,NULL,7
Aerobiosis,G,G02.111.017,Biochemical Phenomena,Chemical Phenomena,7
Affective Symptoms,F,F01.145.126.100,Behavioral Symptoms,Behavior,7
Agar,D,D09.698.360.041,Galactans,Polysaccharides,7
Alanine,D,D12.125.042,Amino Acids,"Amino Acids, Peptides, and Proteins",7
Aldosterone,D,D06.472.040.585.353.118,11-Hydroxycorticosteroids,Hydroxycorticosteroids,7
Aldosterone,D,D04.210.500.745.745.654.062,Pregnenediones,Pregnenes,7
Allergy and Immunology,H,H02.403.044,Medicine,Health Occupations,7
Allostasis,G,G16.012.500.274,"Adaptation, Physiological","Adaptation, Biological",7
alpha 1-Antitrypsin,D,D12.776.377.715.085.085,Alpha-Globulins,Serum Globulins,7
alpha 1-Antitrypsin,D,D12.776.395.068,Glycoproteins,Proteins,7
alpha 1-Antitrypsin,D,D12.776.124.790.106.085,Alpha-Globulins,Serum Globulins,7
alpha 1-Antitrypsin,D,D12.644.861.035,Serpins,Peptides,7
alpha 1-Antitrypsin,D,D12.776.124.050.070,Acute-Phase Proteins,Blood Proteins,7
alpha 1-Antitrypsin,D,D12.776.872.035,Serpins,Proteins,7
Alveolar Process,A,A14.521.125,Jaw,Stomatognathic System,7
Alveolar Process,A,A14.549.167.646.094,Periodontium,Dentition,7
Alveolar Process,A,A02.835.232.781.324.502.125,Jaw,Facial Bones,7
Amebiasis,C,C01.610.752.049,Protozoan Infections,Parasitic Diseases,7
Amelogenesis,G,G07.345.500.325.377.750.190,Odontogenesis,Organogenesis,7
Amikacin,D,D09.408.051.476.060,Kanamycin,Aminoglycosides,7
Aminoglycosides,D,D09.408.051,Glycosides,Carbohydrates,7
Amlodipine,D,D03.383.725.203.065,Dihydropyridines,Pyridines,7
Amyloidosis,C,C18.452.845.500,Proteostasis Deficiencies,Metabolic Diseases,7
"Anemia, Hemolytic",C,C15.378.071.141,Anemia,Hematologic Diseases,7
"Aneurysm, Ruptured",C,C14.907.055.185,Aneurysm,Vascular Diseases,7
Animal Migration,F,F01.145.113.069.500,Animal Distribution,"Behavior, Animal",7
Anophthalmos,C,C16.131.384.159,Eye Abnormalities,Congenital Abnormalities,7
Anophthalmos,C,C11.250.080,Eye Abnormalities,Eye Diseases,7
Anterior Eye Segment,A,A09.371.060,Eye,Sense Organs,7
Anthropology,F,F04.096.879.201,Social Sciences,Behavioral Sciences,7
Anthropology,I,I01.076,Social Sciences,NULL,7
"Antibodies, Monoclonal, Murine-Derived",D,D12.776.124.486.485.114.224.075,"Antibodies, Monoclonal",Antibodies,7
"Antibodies, Monoclonal, Murine-Derived",D,D12.776.124.790.651.114.224.075,"Antibodies, Monoclonal",Antibodies,7
"Antibodies, Monoclonal, Murine-Derived",D,D12.776.377.715.548.114.224.284,"Antibodies, Monoclonal",Antibodies,7
"Antigens, Neoplasm",D,D23.050.285,Antigens,Biological Factors,7
Antitoxins,D,D20.215.401.601,Immune Sera,Biological Products,7
Antitoxins,D,D12.776.377.715.548.114.573.601,Immune Sera,Antibodies,7
Antitoxins,D,D12.776.124.790.651.114.573.601,Immune Sera,Antibodies,7
Antitoxins,D,D12.776.124.486.485.114.573.601,Immune Sera,Antibodies,7
"Aphakia, Postcataract",C,C11.510.103.110,Aphakia,Lens Diseases,7
Aphids,B,B01.050.500.131.617.412.165,Hemiptera,Insecta,7
Apoptosis Regulatory Proteins,D,D12.644.360.075,Intracellular Signaling Peptides and Proteins,Peptides,7
Apoptosis Regulatory Proteins,D,D12.776.476.075,Intracellular Signaling Peptides and Proteins,Proteins,7
Aromatase Inhibitors,D,D27.505.696.399.450.327.149,Estrogen Antagonists,Hormone Antagonists,7
Aromatase Inhibitors,D,D27.505.696.399.450.855.300,Steroid Synthesis Inhibitors,Hormone Antagonists,7
Aromatase Inhibitors,D,D27.505.519.389.870.300,Steroid Synthesis Inhibitors,Enzyme Inhibitors,7
Arterial Pressure,G,G09.330.380.076.347,Blood Pressure,Hemodynamics,7
Arthropod Vectors,N,N06.850.520.203.375.100,Disease Vectors,Chain of Infection,7
Arthropod Vectors,N,N06.850.335.188.100,Disease Vectors,"Disease Transmission, Infectious",7
Aryl Hydrocarbon Hydroxylases,D,D12.776.422.220.453.010,Cytochrome P-450 Enzyme System,Cytochromes,7
Aryl Hydrocarbon Hydroxylases,D,D08.244.453.005,Cytochrome P-450 Enzyme System,Cytochromes,7
Aryl Hydrocarbon Hydroxylases,D,D08.811.682.690.708.170.010,Cytochrome P-450 Enzyme System,Mixed Function Oxygenases,7
Ascorbic Acid Deficiency,C,C18.654.521.500.133.115,Avitaminosis,Deficiency Diseases,7
Aspartic Acid,D,D12.125.119.170,"Amino Acids, Dicarboxylic",Amino Acids,7
Aspartic Acid,D,D12.125.427.040,Excitatory Amino Acids,Amino Acids,7
Aspartic Acid,D,D12.125.067.500,"Amino Acids, Acidic",Amino Acids,7
Autoantigens,D,D23.050.422,Antigens,Biological Factors,7
Autonomic Nervous System,A,A08.800.050,Peripheral Nervous System,Nervous System,7
Autonomic Nervous System Diseases,C,C10.177,Nervous System Diseases,NULL,7
Aviation,J,J01.937.285,Transportation,"Technology, Industry, and Agriculture",7
Avoidance Learning,F,F02.463.785.373.173,Decision Making,Thinking,7
Avoidance Learning,F,F02.463.425.097,Learning,Mental Processes,7
Babesiosis,C,C22.674.710.122,"Protozoan Infections, Animal","Parasitic Diseases, Animal",7
Babesiosis,C,C01.610.752.075,Protozoan Infections,Parasitic Diseases,7
Babesiosis,C,C01.610.701.688.122,"Protozoan Infections, Animal","Parasitic Diseases, Animal",7
Babesiosis,C,C01.610.752.625.122,"Protozoan Infections, Animal",Protozoan Infections,7
Babesiosis,C,C01.920.930.182,Tick-Borne Diseases,Vector Borne Diseases,7
Bacillus subtilis,B,B03.510.100.100.218.725,Bacillus,Bacillaceae,7
Bacillus subtilis,B,B03.510.460.410.158.218.725,Bacillus,Bacillaceae,7
Bacillus subtilis,B,B03.510.415.400.158.218.725,Bacillus,Bacillaceae,7
Bacillus subtilis,B,B03.300.390.400.158.218.725,Bacillus,Bacillaceae,7
Bacillus subtilis,B,B03.353.500.100.218.725,Bacillus,Bacillaceae,7
Bacteriuria,C,C01.915.219,Urinary Tract Infections,Infections,7
Bacteriuria,C,C12.777.892.219,Urinary Tract Infections,Urologic Diseases,7
Bacteriuria,C,C13.351.968.892.219,Urinary Tract Infections,Urologic Diseases,7
Barbados,Z,Z01.639.880.140,West Indies,Islands,7
Barbados,Z,Z01.107.084.900.140,West Indies,Caribbean Region,7
Barrett Esophagus,C,C04.834.154,Precancerous Conditions,Neoplasms,7
Barrett Esophagus,C,C06.405.117.102,Esophageal Diseases,Gastrointestinal Diseases,7
Behavioral Risk Factor Surveillance System,E,E05.318.308.980.438.149,Health Surveys,Surveys and Questionnaires,7
Behavioral Risk Factor Surveillance System,N,N06.850.520.308.980.438.149,Health Surveys,Surveys and Questionnaires,7
Behavioral Risk Factor Surveillance System,N,N05.715.360.300.800.438.149,Health Surveys,Surveys and Questionnaires,7
beta 2-Microglobulin,D,D23.050.705.552.100.175,Histocompatibility Antigens Class I,Histocompatibility Antigens,7
beta 2-Microglobulin,D,D12.776.543.550.439.100,Histocompatibility Antigens Class I,Membrane Glycoproteins,7
beta 2-Microglobulin,D,D23.050.301.500.100.175,Histocompatibility Antigens Class I,Histocompatibility Antigens,7
beta 2-Microglobulin,D,D12.776.124.790.223.100,Beta-Globulins,Serum Globulins,7
beta 2-Microglobulin,D,D12.776.377.715.182.100,Beta-Globulins,Serum Globulins,7
beta 2-Microglobulin,D,D12.776.395.550.489.100,Histocompatibility Antigens Class I,Membrane Glycoproteins,7
Biofuels,D,D20.147,Complex Mixtures,NULL,7
Biofuels,N,N06.230.132.644.124,Renewable Energy,Energy-Generating Resources,7
Biomphalaria,B,B01.050.500.644.400.750.185,Snails,Gastropoda,7
Bird Diseases,C,C22.131,Animal Diseases,NULL,7
Blood Coagulation Disorders,C,C15.378.100,Hematologic Diseases,Hemic and Lymphatic Diseases,7
Blood Sedimentation,E,E01.370.225.625.125,Hematologic Tests,Clinical Laboratory Techniques,7
Blood Sedimentation,E,E05.200.625.125,Hematologic Tests,Clinical Laboratory Techniques,7
Blood Vessels,A,A07.015,Cardiovascular System,NULL,7
Bone Development,G,G07.345.500.325.377.625.050.500,Biomineralization,Musculoskeletal Development,7
Bone Development,G,G11.427.578.050.500,Biomineralization,Musculoskeletal Development,7
Bone Marrow Transplantation,E,E04.936.580.040,Tissue Transplantation,Transplantation,7
Bone Marrow Transplantation,E,E02.095.147.725.040,Tissue Transplantation,Cell- and Tissue-Based Therapy,7
Botulinum Toxins,D,D23.946.123.179,Bacterial Toxins,"Toxins, Biological",7
Botulinum Toxins,D,D12.776.097.156,Bacterial Proteins,Proteins,7
Botulinum Toxins,D,D08.811.277.656.300.480.153,Metalloendopeptidases,Endopeptidases,7
Botulinum Toxins,D,D08.811.277.656.675.374.153,Metalloendopeptidases,Metalloproteases,7
Brain Death,C,C10.597.606.358.800.200.100,Coma,Unconsciousness,7
Brain Death,C,C10.228.140.151,Brain Diseases,Central Nervous System Diseases,7
Brain Death,C,C23.550.260.159,Death,Pathologic Processes,7
Brain Edema,C,C10.228.140.187,Brain Diseases,Central Nervous System Diseases,7
Brefeldin A,D,D02.540.576.500.875,Macrolides,Polyketides,7
Bronchoalveolar Lavage,E,E05.927.100,Therapeutic Irrigation,Investigative Techniques,7
Bronchopulmonary Dysplasia,C,C08.381.520.750.500,Ventilator-Induced Lung Injury,Lung Injury,7
Bronchopulmonary Dysplasia,C,C16.614.521.125,"Infant, Premature, Diseases","Infant, Newborn, Diseases",7
Buprenorphine,D,D03.132.577.249.150,Morphinans,Opiate Alkaloids,7
Buprenorphine,D,D03.605.497.150,Morphinans,"Heterocyclic Compounds, Bridged-Ring",7
Buprenorphine,D,D03.633.400.686.150,Morphinans,"Heterocyclic Compounds, 4 or More Rings",7
Buprenorphine,D,D04.615.723.795.150,Morphinans,Phenanthrenes,7
Cadaver,C,C23.550.260.224,Death,Pathologic Processes,7
Calcitonin,D,D06.472.931.052,Thyroid Hormones,Hormones,7
Calcitonin,D,D06.472.699.150,Peptide Hormones,Hormones,7
Calcitonin,D,D12.644.548.150,Peptide Hormones,Peptides,7
Calcitonin,D,D12.644.400.095,Neuropeptides,Peptides,7
Calcitonin,D,D12.776.631.650.095,Neuropeptides,Nerve Tissue Proteins,7
Candida albicans,B,B01.300.381.147.326,Candida,Mitosporic Fungi,7
Candida albicans,B,B01.300.107.795.095.326,Candida,Saccharomycetales,7
Candida albicans,B,B01.300.930.176.326,Candida,Yeasts,7
Capillary Permeability,G,G03.143.330,Biological Transport,Metabolism,7
Capillary Permeability,G,G09.330.165,Cardiovascular Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,7
Carbohydrate Sequence,L,L01.453.245.667.160,Molecular Sequence Data,Documentation,7
Carbohydrate Sequence,G,G02.111.570.160,Molecular Structure,Biochemical Phenomena,7
"Cardiac Output, Low",C,C23.888.192,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",7
"Cardiac Output, Low",C,C14.280.148,Heart Diseases,Cardiovascular Diseases,7
Caspase 8,D,D12.776.476.075.405.550.800,"Caspases, Initiator",Caspases,7
Caspase 8,D,D12.776.476.075.421.037,Death Domain Receptor Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,7
Caspase 8,D,D12.776.476.024.320.025,Death Domain Receptor Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",7
Caspase 8,D,D12.644.360.075.405.550.800,"Caspases, Initiator",Caspases,7
Caspase 8,D,D12.644.360.075.421.037,Death Domain Receptor Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,7
Caspase 8,D,D12.644.360.024.285.037,Death Domain Receptor Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",7
Caspase 8,D,D12.776.157.057.018.037,Death Domain Receptor Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",7
Caspase 8,D,D08.811.277.656.300.200.126.550.800,"Caspases, Initiator",Caspases,7
Caspase 8,D,D08.811.277.656.262.500.126.550.800,"Caspases, Initiator",Caspases,7
Catholicism,K,K01.844.188.250,Christianity,Religion,7
Caudate Nucleus,A,A08.186.211.200.885.287.249.487.550.184,Neostriatum,Corpus Striatum,7
CD40 Antigens,D,D12.776.465.750,Immune Checkpoint Proteins,Proteins,7
CD40 Antigens,D,D12.776.543.750.705.852.760.097,"Receptors, Tumor Necrosis Factor","Receptors, Cytokine",7
CD40 Antigens,D,D23.050.301.264.051.140,"Antigens, Differentiation, B-Lymphocyte","Antigens, Differentiation",7
CD40 Antigens,D,D23.101.100.150.140,"Antigens, Differentiation, B-Lymphocyte","Antigens, Differentiation",7
"Cell Line, Transformed",A,A11.251.210.172,Cell Line,"Cells, Cultured",7
Ceramics,J,J01.637.153,Manufactured Materials,"Technology, Industry, and Agriculture",7
"Chemokines, CC",D,D23.125.300.110,Chemokines,Chemotactic Factors,7
"Chemokines, CC",D,D23.469.200.110,Chemokines,Inflammation Mediators,7
"Chemokines, CC",D,D23.529.374.200.110,Chemokines,Cytokines,7
"Chemokines, CC",D,D12.776.467.374.200.110,Chemokines,Cytokines,7
"Chemokines, CC",D,D12.644.276.374.200.110,Chemokines,Cytokines,7
"Chemotaxis, Leukocyte",G,G04.198.424.233,Chemotaxis,Cell Movement,7
Child Advocacy,I,I01.880.787.293.350,Child Welfare,Social Welfare,7
Child Advocacy,I,I01.880.604.473.300,Human Rights,"Social Control, Formal",7
Child Advocacy,N,N03.706.437.300,Human Rights,"Social Control, Formal",7
Chloramphenicol Resistance,G,G07.690.773.984.269.347.750,"Drug Resistance, Bacterial","Drug Resistance, Microbial",7
Chloramphenicol Resistance,G,G06.225.347.750,"Drug Resistance, Bacterial","Drug Resistance, Microbial",7
Chloramphenicol Resistance,G,G06.099.225.750,"Drug Resistance, Bacterial",Bacterial Physiological Phenomena,7
Choline,D,D02.675.276.232,Quaternary Ammonium Compounds,Onium Compounds,7
Choline,D,D02.092.877.883.333,Trimethyl Ammonium Compounds,Quaternary Ammonium Compounds,7
Choline,D,D02.092.063.291.211,Ethanolamines,Amino Alcohols,7
Choline,D,D02.033.100.291.211,Ethanolamines,Amino Alcohols,7
"Chromatography, Thin Layer",E,E05.196.181.400.537,"Chromatography, Liquid",Chromatography,7
Chromosome Deletion,G,G05.365.590.762.180,Sequence Deletion,Mutation,7
Chromosome Deletion,G,G05.365.590.175.050.500.500,Monosomy,Aneuploidy,7
Chromosome Deletion,G,G05.365.590.029.530.175,Loss of Heterozygosity,Allelic Imbalance,7
Chromosome Deletion,G,G05.558.800.180,Sequence Deletion,Mutagenesis,7
Chromosome Deletion,G,G05.700.131.500.500,Monosomy,Aneuploidy,7
Chromosome Deletion,C,C23.550.210.050.500.500,Monosomy,Aneuploidy,7
"Chromosomes, Human, Pair 5",A,A11.284.187.520.300.280.290,"Chromosomes, Human, 4-5","Chromosomes, Human",7
"Chromosomes, Human, Pair 5",G,G05.360.162.520.300.280.290,"Chromosomes, Human, 4-5","Chromosomes, Human",7
"Chromosomes, Human, X",G,G05.360.162.520.300.325.680,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",7
"Chromosomes, Human, X",G,G05.360.162.865.982.500,X Chromosome,Sex Chromosomes,7
"Chromosomes, Human, X",A,A11.284.187.520.300.325.680,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",7
"Chromosomes, Human, X",A,A11.284.187.865.982.500,X Chromosome,Sex Chromosomes,7
Civil Disorders,I,I01.880.735.140,Social Problems,Sociology,7
Clathrin,D,D12.776.543.990.200,Vesicular Transport Proteins,Membrane Proteins,7
Clozapine,D,D03.633.300.240.220,Dibenzazepines,"Heterocyclic Compounds, 3-Ring",7
Coagulants,D,D27.505.954.502.270,Hematologic Agents,Therapeutic Uses,7
"Codon, Nonsense",D,D13.444.735.544.355.250.235,"Codon, Terminator",Codon,7
"Codon, Nonsense",G,G05.360.335.355.250.235,"Codon, Terminator",Codon,7
"Codon, Nonsense",G,G05.365.590.195,Mutation,Genetic Variation,7
Communism,I,I01.696.232,Political Systems,Social Sciences,7
Comoros,Z,Z01.639.520.200,Indian Ocean Islands,Islands,7
Comparative Genomic Hybridization,E,E05.393.520.500,Molecular Diagnostic Techniques,Genetic Techniques,7
Comparative Genomic Hybridization,E,E05.393.285.240,Cytogenetic Analysis,Genetic Techniques,7
Comparative Genomic Hybridization,E,E05.393.661.187,Nucleic Acid Hybridization,Genetic Techniques,7
Competitive Behavior,F,F01.145.813.105,Social Behavior,Behavior,7
Conduct Disorder,F,F03.625.094.300,Attention Deficit and Disruptive Behavior Disorders,Neurodevelopmental Disorders,7
Convalescence,C,C23.550.291.562,Disease Attributes,Pathologic Processes,7
Corpus Striatum,A,A08.186.211.200.885.287.249.487,Basal Ganglia,Cerebrum,7
Corticosterone,D,D06.472.040.585.353.237,11-Hydroxycorticosteroids,Hydroxycorticosteroids,7
Corticosterone,D,D04.210.500.745.745.654.237,Pregnenediones,Pregnenes,7
Corynebacterium diphtheriae,B,B03.510.460.400.400.200.150,Corynebacterium,"Gram-Positive Asporogenous Rods, Irregular",7
Corynebacterium diphtheriae,B,B03.510.024.250.150,Corynebacterium,Actinobacteria,7
C-Peptide,D,D06.472.699.587.200.500.250,Proinsulin,Insulins,7
C-Peptide,D,D12.644.548.586.200.500.250,Proinsulin,Insulins,7
Cyclic AMP-Dependent Protein Kinases,D,D12.644.360.200.125,Cyclic Nucleotide-Regulated Protein Kinases,Intracellular Signaling Peptides and Proteins,7
Cyclic AMP-Dependent Protein Kinases,D,D08.811.913.696.620.682.700.150.125,Cyclic Nucleotide-Regulated Protein Kinases,Protein-Serine-Threonine Kinases,7
Cyclic AMP-Dependent Protein Kinases,D,D12.776.476.200.125,Cyclic Nucleotide-Regulated Protein Kinases,Intracellular Signaling Peptides and Proteins,7
Cyclobutanes,D,D02.455.426.392.368.201,Cycloparaffins,"Hydrocarbons, Alicyclic",7
Cysts,C,C23.300.306,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",7
Cysts,C,C04.182,Neoplasms,NULL,7
Cytochrome P-450 CYP2D6,D,D12.776.422.220.453.010.600,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,7
Cytochrome P-450 CYP2D6,D,D12.776.422.220.453.491.368,Cytochrome P450 Family 2,Cytochrome P-450 Enzyme System,7
Cytochrome P-450 CYP2D6,D,D08.244.453.005.600,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,7
Cytochrome P-450 CYP2D6,D,D08.244.453.491.372,Cytochrome P450 Family 2,Cytochrome P-450 Enzyme System,7
Cytochrome P-450 CYP2D6,D,D08.811.682.690.708.170.010.600,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,7
Cytochrome P-450 CYP2D6,D,D08.811.682.690.708.170.450.368,Cytochrome P450 Family 2,Cytochrome P-450 Enzyme System,7
"Databases, Nucleic Acid",L,L01.313.500.750.300.188.400.300.500,"Databases, Chemical","Databases, Factual",7
"Databases, Nucleic Acid",L,L01.313.500.750.300.188.400.325.630,"Databases, Genetic","Databases, Factual",7
"Databases, Nucleic Acid",L,L01.470.750.750.300.500,"Databases, Chemical","Databases, Factual",7
"Databases, Nucleic Acid",L,L01.470.750.750.325.630,"Databases, Genetic","Databases, Factual",7
Deer,B,B01.050.150.900.649.313.500.380.373,Ruminants,Artiodactyla,7
Defective Viruses,B,B04.265,Viruses,NULL,7
Dental Care,N,N02.421.240.190,Dental Health Services,Health Services,7
Dental Care,E,E06.170,Dentistry,NULL,7
"Dermatitis, Contact",C,C17.800.174.255,Dermatitis,Skin Diseases,7
"Dermatitis, Contact",C,C17.800.815.255,"Skin Diseases, Eczematous",Skin Diseases,7
Detergents,D,D27.720.877.265,Surface-Active Agents,Specialty Uses of Chemicals,7
Detergents,J,J01.516.381,Household Products,"Technology, Industry, and Agriculture",7
Diabetic Ketoacidosis,C,C18.452.076.176.652.500,Ketosis,Acidosis,7
Diabetic Ketoacidosis,C,C18.452.394.750.535,Diabetes Mellitus,Glucose Metabolism Disorders,7
Diabetic Ketoacidosis,C,C19.246.099.812,Diabetes Complications,Diabetes Mellitus,7
Digestive System Neoplasms,C,C04.588.274,Neoplasms by Site,Neoplasms,7
Digestive System Neoplasms,C,C06.301,Digestive System Diseases,NULL,7
Digital Technology,J,J01.897.160,Technology,"Technology, Industry, and Agriculture",7
Digital Technology,H,H01.671.293.239,Electronics,Physics,7
Disseminated Intravascular Coagulation,C,C15.378.100.220,Blood Coagulation Disorders,Hematologic Diseases,7
Disseminated Intravascular Coagulation,C,C15.378.925.220,Thrombophilia,Hematologic Diseases,7
Disseminated Intravascular Coagulation,C,C15.378.463.250,Hemorrhagic Disorders,Hematologic Diseases,7
DNA Helicases,D,D08.811.399.340,Isomerases,Enzymes,7
DNA Helicases,D,D08.811.277.040.025.159,Adenosine Triphosphatases,Acid Anhydride Hydrolases,7
DNA Viruses,B,B04.280,Viruses,NULL,7
Drug Implants,D,D26.255.210.315,Delayed-Action Preparations,Dosage Forms,7
Drug Labeling,J,J01.576.761.300.400,Drug Packaging,Product Packaging,7
Drug Labeling,J,J01.576.655.750.321.400,Drug Packaging,Drug Industry,7
Drug Labeling,E,E05.916.310,"Technology, Pharmaceutical",Investigative Techniques,7
Dry Eye Syndromes,C,C11.496.260,Lacrimal Apparatus Diseases,Eye Diseases,7
Dysbiosis,C,C23.550.308,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",7
Ear Diseases,C,C09.218,Otorhinolaryngologic Diseases,NULL,7
Edetic Acid,D,D02.092.782.258.368.250,Ethylenediamines,Diamines,7
Edetic Acid,D,D02.241.081.018.253,Acetates,"Acids, Acyclic",7
Electroporation,E,E05.200.500.454,Cytological Techniques,Clinical Laboratory Techniques,7
Electroporation,E,E05.301.500,Electrochemical Techniques,Investigative Techniques,7
Electroporation,E,E05.242.448,Cytological Techniques,Investigative Techniques,7
Employee Discipline,N,N04.452.677.358,Personnel Management,Organization and Administration,7
Enamel Organ,A,A14.549.167.900.720.265,Tooth Germ,Tooth Components,7
Endangered Species,B,B01.050.050.565,Animal Population Groups,Animals,7
Endangered Species,N,N06.230.124.049.250,Biodiversity,Ecosystem,7
Endangered Species,N,N06.230.080.200,Conservation of Natural Resources,Environment,7
Endangered Species,G,G16.500.275.157.049.250,Biodiversity,Ecosystem,7
Endocrine Disruptors,D,D27.505.696.353,Physiological Effects of Drugs,Pharmacologic Actions,7
Endocrine Disruptors,D,D27.888.141,Toxic Actions,Chemical Actions and Uses,7
Endophthalmitis,C,C01.375.265,Eye Infections,Infections,7
Endophthalmitis,C,C11.294.265,Eye Infections,Eye Diseases,7
Enoxaparin,D,D09.698.373.400.300.200,"Heparin, Low-Molecular-Weight",Heparin,7
Epidermal Growth Factor,D,D12.644.276.382.500,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,7
Epidermal Growth Factor,D,D06.472.317.350,Gastrointestinal Hormones,Hormones,7
Epidermal Growth Factor,D,D23.529.382.500,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,7
Epidermal Growth Factor,D,D12.776.467.382.500,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,7
ErbB Receptors,D,D12.776.543.750.750.400.074,"Receptors, Growth Factor","Receptors, Peptide",7
ErbB Receptors,D,D12.776.543.750.630.009,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",7
ErbB Receptors,D,D08.811.913.696.620.682.725.400.009,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,7
Erythroblasts,A,A15.378.316.378.590.837.250.200,Erythroid Precursor Cells,Megakaryocyte-Erythroid Progenitor Cells,7
Erythroblasts,A,A11.148.378.590.837.250.200,Erythroid Precursor Cells,Megakaryocyte-Erythroid Progenitor Cells,7
Erythroblasts,A,A11.443.240.497.200,Erythroid Precursor Cells,Erythrocytes,7
Esophagoscopy,E,E01.370.372.250.250.275,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",7
Esophagoscopy,E,E01.370.388.250.250.250.260,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",7
Esophagoscopy,E,E04.502.250.250.250.260,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",7
Esophagoscopy,E,E04.210.240.250.260,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",7
Extraction and Processing Industry,J,J01.576.655.875,Manufacturing Industry,Industry,7
"Eye Infections, Viral",C,C01.375.725,Eye Infections,Infections,7
"Eye Infections, Viral",C,C01.925.325,Virus Diseases,Infections,7
"Eye Infections, Viral",C,C11.294.800,Eye Infections,Eye Diseases,7
Father-Child Relations,F,F01.829.263.370.290.110,Parent-Child Relations,Family Relations,7
Fibronectins,D,D12.776.543.550.350,Membrane Glycoproteins,Membrane Proteins,7
Fibronectins,D,D12.776.860.300.450,Extracellular Matrix Proteins,Scleroproteins,7
Fibronectins,D,D12.776.395.550.350,Membrane Glycoproteins,Glycoproteins,7
Fibronectins,D,D12.776.377.715.390,Serum Globulins,Globulins,7
Food Security,J,J01.576.423.750.875,Food Supply,Food Industry,7
"Food, Formulated",J,J02.500.525.350,"Foods, Specialized",Food,7
"Food, Formulated",G,G07.203.300.525.350,"Foods, Specialized",Food,7
Forearm,A,A01.378.800.585,Upper Extremity,Extremities,7
Freedom,I,I01.880.604.473.380,Human Rights,"Social Control, Formal",7
Freedom,N,N03.706.437.380,Human Rights,"Social Control, Formal",7
Frontal Lobe,A,A08.186.211.200.885.287.500.270,Cerebral Cortex,Cerebrum,7
Fund Raising,N,N03.219.463.360,Financial Management,Economics,7
Fungal Proteins,D,D12.776.354,Proteins,"Amino Acids, Peptides, and Proteins",7
Fusarium,B,B01.300.381.366,Mitosporic Fungi,Fungi,7
Galactose,D,D09.947.875.359.377,Hexoses,Monosaccharides,7
Ganciclovir,D,D03.633.100.759.758.399.454.250.300,Acyclovir,Guanine,7
Gastrectomy,E,E04.210.419,Digestive System Surgical Procedures,"Surgical Procedures, Operative",7
Gene Editing,E,E05.393.420.270,Genetic Engineering,Genetic Techniques,7
Gene Rearrangement,G,G05.344,Genetic Phenomena,NULL,7
"General Practice, Dental",H,H02.163.342,Dentistry,Health Occupations,7
"Genes, Essential",G,G05.360.340.024.340.270,Genes,Genome Components,7
"Genes, Helminth",G,G05.360.340.024.340.310,Genes,Genome Components,7
"Genes, Helminth",G,G05.360.340.337.500,"Genome, Helminth",Genome,7
Genetic Drift,G,G05.330.320,Gene Frequency,Genetic Phenomena,7
Genetic Drift,G,G05.045.300,Biological Evolution,Genetic Phenomena,7
"Genetics, Microbial",H,H01.158.273.540.367,Microbiology,Biology,7
"Genetics, Microbial",H,H01.158.273.343.330,Genetics,Biology,7
Genocide,I,I01.198.240.903.149,War Crimes,Crime,7
Genocide,I,I01.880.735.950.500.903.149,War Crimes,Warfare,7
Genomic Instability,G,G05.365.590.335,Mutation,Genetic Variation,7
Genomic Instability,G,G05.370,Genetic Phenomena,NULL,7
Genomic Instability,C,C23.550.362,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",7
Gestational Weight Gain,C,C23.888.144.243.926.500,Weight Gain,Body Weight Changes,7
Gestational Weight Gain,G,G07.345.249.314.120.200.926.500,Weight Gain,Body Weight Changes,7
Gestational Weight Gain,G,G08.686.330,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,7
Glutathione Reductase,D,D08.811.682.667.092,Oxidoreductases Acting on Sulfur Group Donors,Oxidoreductases,7
Glycine,D,D12.125.481,Amino Acids,"Amino Acids, Peptides, and Proteins",7
Glycopeptides,D,D12.644.233,Peptides,"Amino Acids, Peptides, and Proteins",7
Glycopeptides,D,D09.400.420,Glycoconjugates,Carbohydrates,7
Glycosyltransferases,D,D08.811.913.400,Transferases,Enzymes,7
Governing Board,N,N04.452.394,Organization and Administration,Health Services Administration,7
Graves Disease,C,C19.874.283.605,Goiter,Thyroid Diseases,7
Graves Disease,C,C19.874.397.370,Hyperthyroidism,Thyroid Diseases,7
Graves Disease,C,C20.111.555,Autoimmune Diseases,Immune System Diseases,7
Graves Disease,C,C11.675.349.500,Exophthalmos,Orbital Diseases,7
"Greece, Ancient",Z,Z01.586.035.519,Ancient Lands,Historical Geographic Locations,7
Grief,F,F01.470.142.110,Bereavement,Emotions,7
Gyrus Cinguli,A,A08.186.211.200.885.287.500.382.500,Limbic Lobe,Cerebral Cortex,7
Gyrus Cinguli,A,A08.186.211.180.590.500,Limbic Lobe,Limbic System,7
Haemophilus parasuis,B,B03.440.450.600.450.700,Haemophilus,Pasteurellaceae,7
Haemophilus parasuis,B,B03.660.250.550.290.700,Haemophilus,Pasteurellaceae,7
Health Facility Size,N,N05.300.430.410,Health Services Accessibility,Delivery of Health Care,7
Health Facility Size,N,N02.278.306,Health Facilities,"Health Care Facilities, Manpower, and Services",7
Health Maintenance Organizations,N,N03.219.521.576.343.800.400,Managed Care Programs,"Insurance, Health",7
Health Maintenance Organizations,N,N03.219.521.576.343.925.400,Prepaid Health Plans,"Insurance, Health",7
Health Maintenance Organizations,N,N04.590.374.410.400,Managed Care Programs,Delivery of Health Care,7
Health Maintenance Organizations,N,N04.452.758.244.425,Group Practice,Professional Practice,7
Hearing Disorders,C,C10.597.751.418,Sensation Disorders,Neurologic Manifestations,7
Hearing Disorders,C,C09.218.458,Ear Diseases,Otorhinolaryngologic Diseases,7
Hearing Disorders,C,C23.888.592.763.393,Sensation Disorders,Neurologic Manifestations,7
Heart Valve Diseases,C,C14.280.484,Heart Diseases,Cardiovascular Diseases,7
Helping Behavior,F,F01.145.813.225,Social Behavior,Behavior,7
Hemagglutinins,D,D27.505.696.477.136.377,Agglutinins,Immunologic Factors,7
Hematopoietic Stem Cells,A,A15.378.316.378,Bone Marrow Cells,Hematopoietic System,7
Hematopoietic Stem Cells,A,A11.872.378,Stem Cells,Cells,7
Hematopoietic Stem Cells,A,A11.148.378,Bone Marrow Cells,Cells,7
Hemin,D,D23.767.727.640.587.462,Heme,Metalloporphyrins,7
Hemin,D,D04.345.783.500.640.587.462,Heme,Metalloporphyrins,7
Hemin,D,D03.633.400.909.500.640.587.462,Heme,Metalloporphyrins,7
Hemin,D,D03.383.129.578.840.500.640.587.462,Heme,Metalloporphyrins,7
Hemoglobin C,D,D12.776.124.400.463.338,"Hemoglobins, Abnormal",Hemoglobins,7
Hemoglobin C,D,D12.776.422.316.762.426.338,"Hemoglobins, Abnormal",Hemoglobins,7
Hemoglobinopathies,C,C15.378.420,Hematologic Diseases,Hemic and Lymphatic Diseases,7
Hemoglobinopathies,C,C16.320.365,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",7
Hepatitis A Antibodies,D,D12.776.124.486.485.114.254.450.251,Hepatitis Antibodies,"Antibodies, Viral",7
Hepatitis A Antibodies,D,D12.776.124.790.651.114.254.450.251,Hepatitis Antibodies,"Antibodies, Viral",7
Hepatitis A Antibodies,D,D12.776.377.715.548.114.254.450.251,Hepatitis Antibodies,"Antibodies, Viral",7
Herpesviridae,B,B04.280.382,DNA Viruses,Viruses,7
Heterochromatin,A,A11.284.430.106.279.345.190.160.180.383,Chromatin,Chromosome Structures,7
Heterochromatin,D,D12.776.664.224.466,Chromatin,Nucleoproteins,7
Heterochromatin,G,G05.360.160.180.383,Chromatin,Chromosome Structures,7
Hexokinase,D,D08.811.913.696.620.300,Phosphotransferases (Alcohol Group Acceptor),Phosphotransferases,7
Hexosyltransferases,D,D08.811.913.400.450,Glycosyltransferases,Transferases,7
HIV Integrase Inhibitors,D,D27.505.954.122.388.077.088.314,Anti-HIV Agents,Anti-Retroviral Agents,7
HIV Integrase Inhibitors,D,D27.505.519.389.375.400,Integrase Inhibitors,Enzyme Inhibitors,7
HLA-B27 Antigen,D,D23.050.705.552.100.500.270,HLA-B Antigens,Histocompatibility Antigens Class I,7
HLA-B27 Antigen,D,D23.050.705.552.450.380.270,HLA-B Antigens,HLA Antigens,7
HLA-B27 Antigen,D,D23.050.301.500.450.380.270,HLA-B Antigens,HLA Antigens,7
HLA-B27 Antigen,D,D23.050.301.500.100.500.270,HLA-B Antigens,Histocompatibility Antigens Class I,7
HLA-B27 Antigen,D,D12.776.543.550.439.500.270,HLA-B Antigens,Histocompatibility Antigens Class I,7
HLA-B27 Antigen,D,D12.776.395.550.489.500.270,HLA-B Antigens,Histocompatibility Antigens Class I,7
HLA-D Antigens,D,D12.776.395.550.509.400,Histocompatibility Antigens Class II,Membrane Glycoproteins,7
HLA-D Antigens,D,D12.776.543.550.440.400,Histocompatibility Antigens Class II,Membrane Glycoproteins,7
HLA-D Antigens,D,D23.050.301.500.400.400,Histocompatibility Antigens Class II,Histocompatibility Antigens,7
HLA-D Antigens,D,D23.050.301.500.450.400,HLA Antigens,Histocompatibility Antigens,7
HLA-D Antigens,D,D23.050.705.552.450.400,HLA Antigens,Histocompatibility Antigens,7
HLA-D Antigens,D,D23.050.705.552.410.400,Histocompatibility Antigens Class II,Histocompatibility Antigens,7
Hospital Charges,N,N03.219.262.300,"Economics, Hospital",Economics,7
Hospital Charges,N,N03.219.442.613,Fees and Charges,Economics,7
Hospital Design and Construction,N,N02.278.200.403,Facility Design and Construction,Health Facilities,7
Hospital Design and Construction,J,J01.086.339.250,Facility Design and Construction,Architecture,7
"Hospitals, Community",N,N02.278.421.306,Hospitals,Health Facilities,7
"Hospitals, High-Volume",N,N02.278.421.414,Hospitals,Health Facilities,7
Hyperthyroidism,C,C19.874.397,Thyroid Diseases,Endocrine System Diseases,7
Iceland,Z,Z01.639.490,Islands,Geographic Locations,7
Iceland,Z,Z01.542.816.249,Scandinavian and Nordic Countries,Europe,7
"Immunity, Heterologous",G,G12.450.418,Immunity,Immune System Phenomena,7
Immunoglobulin Class Switching,G,G12.500.274.501.450,"Gene Rearrangement, B-Lymphocyte, Heavy Chain","Gene Rearrangement, B-Lymphocyte",7
Immunoglobulin Class Switching,G,G05.344.401.501.450,"Gene Rearrangement, B-Lymphocyte, Heavy Chain","Gene Rearrangement, B-Lymphocyte",7
"Immunotherapy, Adoptive",E,E05.478.550.520.050.400,Adoptive Transfer,"Immunization, Passive",7
"Immunotherapy, Adoptive",E,E02.095.465.425.400.330.050.400,Adoptive Transfer,"Immunization, Passive",7
"Inclusion Bodies, Viral",A,A11.284.420.390,Inclusion Bodies,Cellular Structures,7
"Inclusion Bodies, Viral",G,G06.920.400,Virus Physiological Phenomena,Microbiological Phenomena,7
Interleukin 1 Receptor Antagonist Protein,D,D23.529.374.460,Cytokines,Intercellular Signaling Peptides and Proteins,7
Interleukin 1 Receptor Antagonist Protein,D,D12.776.467.374.460,Cytokines,Intercellular Signaling Peptides and Proteins,7
Interleukin 1 Receptor Antagonist Protein,D,D12.644.276.374.460,Cytokines,Intercellular Signaling Peptides and Proteins,7
"Ischemic Preconditioning, Myocardial",E,E02.592.325,Ischemic Preconditioning,Therapeutics,7
"Ischemic Preconditioning, Myocardial",E,E05.516.325,Ischemic Preconditioning,Investigative Techniques,7
Isoproterenol,D,D02.092.311.649,Catecholamines,Amines,7
Isoproterenol,D,D02.092.063.291.439,Ethanolamines,Amino Alcohols,7
Isoproterenol,D,D02.455.426.559.389.657.166.175.649,Catecholamines,Catechols,7
Isoproterenol,D,D02.033.100.291.439,Ethanolamines,Amino Alcohols,7
Journal Impact Factor,L,L01.178.682.099.325.500,Bibliometrics,Bibliographies as Topic,7
Journal Impact Factor,L,L01.453.183.291.500,Bibliometrics,Bibliographies as Topic,7
"Labor, Induced",E,E04.520.252.968,"Delivery, Obstetric",Obstetric Surgical Procedures,7
Lactates,D,D02.241.511.459,Hydroxy Acids,Carboxylic Acids,7
Language Development Disorders,C,C23.888.592.604.150.500.550,Language Disorders,Communication Disorders,7
Language Development Disorders,C,C10.597.606.150.500.550,Language Disorders,Communication Disorders,7
Leishmaniasis Vaccines,D,D20.215.894.582.480,Protozoan Vaccines,Vaccines,7
Lethal Dose 50,E,E05.940.402,Toxicity Tests,Investigative Techniques,7
Lethal Dose 50,G,G07.225.500,"Dose-Response Relationship, Radiation",Physiological Phenomena,7
Lethal Dose 50,G,G07.690.936.500.750,"Dose-Response Relationship, Drug",Toxicological Phenomena,7
Lethal Dose 50,G,G07.690.773.875.750,"Dose-Response Relationship, Drug",Pharmacological Phenomena,7
Leucine,D,D12.125.142.441,"Amino Acids, Essential",Amino Acids,7
Leucine,D,D12.125.070.637,"Amino Acids, Branched-Chain",Amino Acids,7
"Liability, Legal",N,N03.706.535.547,Jurisprudence,"Social Control, Formal",7
"Liability, Legal",I,I01.880.604.583.490,Jurisprudence,"Social Control, Formal",7
Lighting,N,N06.230.150.410,"Environment, Controlled",Environment,7
Lipoprotein(a),D,D10.532.350,Lipoproteins,Lipids,7
Lipoprotein(a),D,D12.776.521.400,Lipoproteins,Proteins,7
Lymphocytosis,C,C15.378.553.475.604,Leukocytosis,Leukocyte Disorders,7
Managed Care Programs,N,N04.590.374.410,Delivery of Health Care,Patient Care Management,7
Managed Care Programs,N,N03.219.521.576.343.800,"Insurance, Health",Insurance,7
Mannose-Binding Lectins,D,D12.776.503.311,Lectins,Proteins,7
Marijuana Smoking,F,F01.145.805.250.500,"Smoking, Non-Tobacco Products",Smoking,7
Marijuana Smoking,F,F01.145.610.875,Marijuana Use,Behavior,7
Matrix Metalloproteinases,D,D08.811.277.656.300.480.525,Metalloendopeptidases,Endopeptidases,7
Matrix Metalloproteinases,D,D08.811.277.656.675.374.525,Metalloendopeptidases,Metalloproteases,7
Mediation Analysis,E,E05.318.740.400.500,"Factor Analysis, Statistical",Statistics as Topic,7
Mediation Analysis,N,N05.715.360.750.350.500,"Factor Analysis, Statistical",Statistics as Topic,7
Mediation Analysis,N,N06.850.520.830.400.500,"Factor Analysis, Statistical",Statistics as Topic,7
Medicaid,N,N03.706.615.693,Legislation as Topic,"Social Control, Formal",7
Medicaid,N,N03.219.521.346.506.564.655,Medical Assistance,Public Assistance,7
Medical Overuse,N,N02.421.380.450,Health Services Misuse,Health Services,7
Medical Overuse,N,N05.300.150.395.450,Health Services Misuse,Attitude to Health,7
Melatonin,D,D06.472.506,Hormones,"Hormones, Hormone Substitutes, and Hormone Antagonists",7
Melatonin,D,D03.633.100.473.914.481,Tryptamines,Indoles,7
Membrane Microdomains,A,A11.284.149.165.570,Cell Membrane Structures,Cell Membrane,7
Mental Status and Dementia Tests,F,F04.711.513.603,Neuropsychological Tests,Psychological Tests,7
Metalloproteases,D,D08.811.277.656.675,Peptide Hydrolases,Hydrolases,7
Methane,D,D02.455.326.146.571,Alkanes,"Hydrocarbons, Acyclic",7
"Mice, Mutant Strains",B,B01.050.150.900.649.313.992.635.505.500.550,Mice,Murinae,7
Micronesia,Z,Z01.639.760.680,Pacific Islands,Islands,7
Microtubule-Associated Proteins,D,D12.776.220.600.450,Microtubule Proteins,Cytoskeletal Proteins,7
Microtubule-Associated Proteins,D,D12.776.631.560,Nerve Tissue Proteins,Proteins,7
Miners,M,M01.526.693,Occupational Groups,Persons,7
Minor Histocompatibility Antigens,D,D23.050.705.552.600,Histocompatibility Antigens,Isoantigens,7
Minor Histocompatibility Antigens,D,D23.050.301.500.600,Histocompatibility Antigens,"Antigens, Surface",7
Mitral Valve Insufficiency,C,C14.280.484.461,Heart Valve Diseases,Heart Diseases,7
Moraxella catarrhalis,B,B03.440.400.425.537.525.200,Moraxella,Moraxellaceae,7
Moraxella catarrhalis,B,B03.660.250.530.525.200,Moraxella,Moraxellaceae,7
Morpholines,D,D03.383.533.640,Oxazines,"Heterocyclic Compounds, 1-Ring",7
Multilingualism,L,L01.559.423.452,Language Arts,Language,7
Multimodal Imaging,E,E01.370.350.567,Diagnostic Imaging,Diagnostic Techniques and Procedures,7
Muramidase,D,D08.811.277.450.642,Glycoside Hydrolases,Hydrolases,7
Muscidae,B,B01.050.500.131.617.720.500.500.750.642,Diptera,Holometabola,7
Muscular Diseases,C,C05.651,Musculoskeletal Diseases,NULL,7
Muscular Diseases,C,C10.668.491,Neuromuscular Diseases,Nervous System Diseases,7
"Muscular Dystrophy, Facioscapulohumeral",C,C10.668.491.175.500.400,Muscular Dystrophies,"Muscular Disorders, Atrophic",7
"Muscular Dystrophy, Facioscapulohumeral",C,C16.320.577.400,Muscular Dystrophies,"Genetic Diseases, Inborn",7
"Muscular Dystrophy, Facioscapulohumeral",C,C05.651.534.500.400,Muscular Dystrophies,"Muscular Disorders, Atrophic",7
Music Therapy,E,E02.760.169.063.500.440,Rehabilitation,Aftercare,7
Music Therapy,E,E02.190.888.500,Sensory Art Therapies,Complementary Therapies,7
Music Therapy,F,F04.754.549,Psychotherapy,Behavioral Disciplines and Activities,7
Music Therapy,E,E02.831.440,Rehabilitation,Therapeutics,7
Mutagens,D,D27.888.569.468,Noxae,Toxic Actions,7
Mycobacteriophages,B,B04.123.502,Bacteriophages,Viruses,7
Mycobacterium avium subsp. paratuberculosis,B,B03.510.024.962.500.300.600,Mycobacterium avium,Mycobacterium,7
Mycobacterium avium subsp. paratuberculosis,B,B03.510.460.400.410.552.552.300.600,Mycobacterium avium,Mycobacterium,7
Myelodysplastic Syndromes,C,C15.378.190.625,Bone Marrow Diseases,Hematologic Diseases,7
Myocardial Reperfusion Injury,C,C14.907.725.600,Reperfusion Injury,Vascular Diseases,7
Myocardial Reperfusion Injury,C,C14.280.647.625,Myocardial Ischemia,Heart Diseases,7
Myocardial Reperfusion Injury,C,C14.907.585.625,Myocardial Ischemia,Vascular Diseases,7
Myocardial Reperfusion Injury,C,C14.280.238.615,Cardiomyopathies,Heart Diseases,7
Myocardial Reperfusion Injury,C,C23.550.767.877.500,Reperfusion Injury,Postoperative Complications,7
Myosins,D,D08.811.277.040.025.193.750,Molecular Motor Proteins,Adenosine Triphosphatases,7
Myosins,D,D05.750.078.730.475,Microfilament Proteins,Biopolymers,7
Myosins,D,D12.776.220.525.475,Microfilament Proteins,Cytoskeletal Proteins,7
Myosins,D,D12.776.210.500.600,Muscle Proteins,Contractile Proteins,7
Naegleria,B,B01.046.500.700.710,Schizopyrenida,Lobosea,7
Nanopores,J,J01.637.512.650,Nanostructures,Manufactured Materials,7
Narcolepsy,F,F03.870.400.800.200.750,Disorders of Excessive Somnolence,"Sleep Disorders, Intrinsic",7
Narcolepsy,C,C10.886.425.800.200.750,Disorders of Excessive Somnolence,"Sleep Disorders, Intrinsic",7
Needlestick Injuries,C,C26.986.950.500,"Wounds, Stab","Wounds, Penetrating",7
Neonatology,H,H02.403.670.400,Pediatrics,Medicine,7
Neonicotinoids,D,D03.383.464,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,7
Neural Conduction,G,G11.561.601,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,7
Neural Conduction,G,G07.265.753,Electrophysiological Phenomena,Physiological Phenomena,7
Neural Pathways,A,A08.612,Nervous System,NULL,7
Niacinamide,D,D03.383.725.547.530,Nicotinic Acids,Pyridines,7
Niacinamide,D,D03.066.515.530,Nicotinic Acids,"Acids, Heterocyclic",7
Nicotinic Agonists,D,D27.505.519.625.120.140.700,Cholinergic Agonists,Cholinergic Agents,7
Nicotinic Agonists,D,D27.505.696.577.120.140.700,Cholinergic Agonists,Cholinergic Agents,7
Nitrites,D,D02.633,Organic Chemicals,NULL,7
Nitrites,D,D01.248.497.158.635,Anions,Ions,7
Nitrites,D,D01.625.600.600,Nitrous Acid,Nitrogen Compounds,7
Nitrogen,D,D01.362.625,Gases,Inorganic Chemicals,7
Nitrogen,D,D01.268.604,Elements,Inorganic Chemicals,7
North Carolina,Z,Z01.107.567.875.075.475,Appalachian Region,United States,7
North Carolina,Z,Z01.107.567.875.750.530,Southeastern United States,United States,7
Olanzapine,D,D03.633.100.079.080.738,Benzodiazepines,Benzazepines,7
Ophthalmologists,M,M01.526.485.810.705,Physicians,Health Personnel,7
Ophthalmologists,N,N02.360.810.705,Physicians,Health Personnel,7
Optic Nerve,A,A08.800.800.120.680,Cranial Nerves,Peripheral Nerves,7
Orbivirus,B,B04.820.223.719.550,Reoviridae,Double Stranded RNA Viruses,7
Organoplatinum Compounds,D,D02.691.788,Organometallic Compounds,Organic Chemicals,7
Osteoclasts,A,A11.627.482.700,Macrophages,Myeloid Cells,7
Osteoclasts,A,A11.329.372.700,Macrophages,Connective Tissue Cells,7
Osteomyelitis,C,C01.160.495,"Bone Diseases, Infectious",Infections,7
Osteomyelitis,C,C05.116.165.495,"Bone Diseases, Infectious",Bone Diseases,7
Otolaryngology,H,H02.403.810.526,"Specialties, Surgical",Medicine,7
Oxidoreductases Acting on CH-CH Group Donors,D,D08.811.682.660,Oxidoreductases,Enzymes,7
Palatine Tonsil,A,A10.549.580,Lymphoid Tissue,Tissues,7
Palatine Tonsil,A,A04.623.603.925,Oropharynx,Pharynx,7
Palatine Tonsil,A,A15.382.520.604.580,Lymphoid Tissue,Lymphatic System,7
Palatine Tonsil,A,A14.724.603.925,Oropharynx,Pharynx,7
Paraguay,Z,Z01.107.757.656,South America,Americas,7
Paralysis,C,C23.888.592.636,Neurologic Manifestations,Signs and Symptoms,7
Paralysis,C,C10.597.622,Neurologic Manifestations,Nervous System Diseases,7
Patents as Topic,I,I01.880.604.583.458.650,Intellectual Property,Jurisprudence,7
Patents as Topic,N,N03.706.535.518.650,Intellectual Property,Jurisprudence,7
Pelvis,A,A01.923.600,Torso,Body Regions,7
Pemphigus,C,C17.800.865.716,"Skin Diseases, Vesiculobullous",Skin Diseases,7
Pemphigus,C,C20.111.736,Autoimmune Diseases,Immune System Diseases,7
Penicillin G,D,D02.065.589.099.750.750,Penicillins,beta-Lactams,7
Penicillin G,D,D02.886.108.750.750,Penicillins,beta-Lactams,7
Penicillin G,D,D03.633.100.300.750.750,Penicillins,beta-Lactams,7
Pensions,N,N01.824.417.510,Income,Socioeconomic Factors,7
"Peptides, Cyclic",D,D04.345.566,Macrocyclic Compounds,Polycyclic Compounds,7
"Peptides, Cyclic",D,D12.644.641,Peptides,"Amino Acids, Peptides, and Proteins",7
Perches,B,B01.050.150.900.493.602.600,Perciformes,Fishes,7
Peripartum Period,G,G08.686.701,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,7
Phagosomes,A,A11.284.430.214.190.875.190.700,Cytoplasmic Vesicles,Organelles,7
Pharmacopoeias as Topic,L,L01.178.682.192.836.749,Reference Books,Books,7
Phototherapy,E,E02.774,Therapeutics,NULL,7
Plasma Cells,A,A11.063.438.725,B-Lymphocytes,Antibody-Producing Cells,7
Plasma Cells,A,A11.118.637.555.567.562.725,B-Lymphocytes,Lymphocytes,7
Plasma Cells,A,A15.145.229.637.555.567.562.725,B-Lymphocytes,Lymphocytes,7
Plasma Cells,A,A15.382.490.555.567.562.725,B-Lymphocytes,Lymphocytes,7
Plasma Cells,A,A15.382.032.438.725,B-Lymphocytes,Antibody-Producing Cells,7
Plasminogen Activator Inhibitor 1,D,D12.644.861.695.500,Plasminogen Inactivators,Serpins,7
Plasminogen Activator Inhibitor 1,D,D12.776.124.125.640,Blood Coagulation Factors,Blood Proteins,7
Plasminogen Activator Inhibitor 1,D,D23.119.832.500,Plasminogen Inactivators,Blood Coagulation Factors,7
Plasminogen Activator Inhibitor 1,D,D12.776.872.695.500,Plasminogen Inactivators,Serpins,7
Pleasure,F,F02.830.816.492,Sensation,Psychophysiology,7
Pleasure,F,F01.470.867,Emotions,Behavior and Behavior Mechanisms,7
Polycyclic Aromatic Hydrocarbons,D,D04.615,Polycyclic Compounds,NULL,7
Polycyclic Aromatic Hydrocarbons,D,D02.455.426.559.847,"Hydrocarbons, Aromatic","Hydrocarbons, Cyclic",7
Polycythemia,C,C15.378.738,Hematologic Diseases,Hemic and Lymphatic Diseases,7
Population Control,I,I01.240.600.650,Population Dynamics,Demography,7
Population Control,N,N01.224.625.650,Population Dynamics,Demography,7
Population Control,N,N06.850.505.400.700.650,Population Dynamics,Demography,7
Portion Size,G,G07.203.650.240.835,Diet,Nutritional Physiological Phenomena,7
Primary Cell Culture,E,E05.242.223.500,Cell Culture Techniques,Cytological Techniques,7
Primary Cell Culture,E,E05.200.500.265.500,Cell Culture Techniques,Cytological Techniques,7
Primary Cell Culture,E,E05.481.500.249.500,Cell Culture Techniques,Culture Techniques,7
Primary Cell Culture,E,E01.370.225.500.223.500,Cell Culture Techniques,Cytological Techniques,7
Prolactin,D,D06.472.699.631.525.525,"Pituitary Hormones, Anterior",Pituitary Hormones,7
Prolactin,D,D06.472.699.322.576.773,"Gonadotropins, Pituitary",Gonadotropins,7
Prolactin,D,D12.644.548.691.525.525,"Pituitary Hormones, Anterior",Pituitary Hormones,7
"Protein Structure, Quaternary",G,G02.111.570.820.709.550,Protein Conformation,Molecular Conformation,7
Prothrombin,D,D12.776.124.125.800,Blood Coagulation Factors,Blood Proteins,7
Prothrombin,D,D08.622.709,Enzyme Precursors,Enzymes and Coenzymes,7
Prothrombin,D,D23.119.945,Blood Coagulation Factors,Biological Factors,7
Prothrombin,D,D12.776.811.243.709,Enzyme Precursors,Protein Precursors,7
"Psychotherapy, Brief",F,F04.754.738,Psychotherapy,Behavioral Disciplines and Activities,7
Public Relations,N,N04.452.822,Organization and Administration,Health Services Administration,7
Pulmonary Edema,C,C08.381.742,Lung Diseases,Respiratory Tract Diseases,7
Pulmonary Fibrosis,C,C08.381.765,Lung Diseases,Respiratory Tract Diseases,7
"Purpura, Thrombocytopenic, Idiopathic",C,C15.378.463.740,Hemorrhagic Disorders,Hematologic Diseases,7
"Purpura, Thrombocytopenic, Idiopathic",C,C15.378.100.802.687.600,"Purpura, Thrombocytopenic",Purpura,7
"Purpura, Thrombocytopenic, Idiopathic",C,C15.378.140.855.925.750.600,"Purpura, Thrombocytopenic",Thrombotic Microangiopathies,7
"Purpura, Thrombocytopenic, Idiopathic",C,C20.111.759,Autoimmune Diseases,Immune System Diseases,7
"Purpura, Thrombocytopenic, Idiopathic",C,C23.550.414.950.687.600,"Purpura, Thrombocytopenic",Purpura,7
"Purpura, Thrombocytopenic, Idiopathic",C,C20.841.600,"Purpura, Thrombocytopenic",Immune System Diseases,7
"Purpura, Thrombocytopenic, Idiopathic",C,C23.888.885.687.687.600,"Purpura, Thrombocytopenic",Purpura,7
Pyelonephritis,C,C13.351.968.419.570.643.790,"Nephritis, Interstitial",Nephritis,7
Pyelonephritis,C,C13.351.968.419.570.821.717,Pyelitis,Nephritis,7
Pyelonephritis,C,C12.777.419.570.643.790,"Nephritis, Interstitial",Nephritis,7
Pyelonephritis,C,C12.777.419.570.821.717,Pyelitis,Nephritis,7
Q Fever,C,C01.150.252.400.755,Gram-Negative Bacterial Infections,Bacterial Infections,7
Quantitative Structure-Activity Relationship,G,G02.111.830.500,Structure-Activity Relationship,Biochemical Phenomena,7
Quantitative Structure-Activity Relationship,G,G07.690.773.997.500,Structure-Activity Relationship,Pharmacological Phenomena,7
Quinazolines,D,D03.633.100.786,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",7
Radiology,H,H02.403.740,Medicine,Health Occupations,7
Ranibizumab,D,D12.776.124.486.485.114.224.060.868,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",7
Ranibizumab,D,D12.776.124.790.651.114.224.060.868,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",7
Ranibizumab,D,D12.776.377.715.548.114.224.200.868,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",7
"Receptors, Calcitriol",D,D12.776.826.535,"Receptors, Cytoplasmic and Nuclear",Proteins,7
"Receptors, G-Protein-Coupled",D,D12.776.543.750.695,"Receptors, Cell Surface",Membrane Proteins,7
"Receptors, Natural Killer Cell",D,D12.776.543.750.705.895,"Receptors, Immunologic","Receptors, Cell Surface",7
"Receptors, Thyrotropin",D,D12.776.543.750.720.600.850,"Receptors, Neuropeptide","Receptors, Neurotransmitter",7
"Receptors, Thyrotropin",D,D12.776.543.750.750.660.825,"Receptors, Pituitary Hormone","Receptors, Peptide",7
"Receptors, Thyrotropin",D,D12.776.543.750.750.555.850,"Receptors, Neuropeptide","Receptors, Peptide",7
Recombinases,D,D08.811.739,Enzymes,Enzymes and Coenzymes,7
Refrigeration,E,E05.760.643,"Preservation, Biological",Investigative Techniques,7
Refrigeration,E,E02.792.643,"Preservation, Biological",Therapeutics,7
Rehabilitation Centers,N,N02.278.808,Health Facilities,"Health Care Facilities, Manpower, and Services",7
"Reinforcement, Psychology",F,F02.463.425.770,Learning,Mental Processes,7
Retinal Detachment,C,C11.768.648,Retinal Diseases,Eye Diseases,7
Retinyl Esters,D,D02.455.426.392.368.367.379.249.700.775,Retinoids,Carotenoids,7
Retinyl Esters,D,D02.455.326.271.665.202.495.754,Retinoids,Carotenoids,7
Retinyl Esters,D,D02.241.400.500,Esters,Carboxylic Acids,7
Retinyl Esters,D,D02.455.849.131.495.754,Retinoids,Carotenoids,7
Retinyl Esters,D,D23.767.261.700.735,Retinoids,Carotenoids,7
Rheumatic Fever,C,C01.150.252.410.890.731,Streptococcal Infections,Gram-Positive Bacterial Infections,7
Rheumatic Fever,C,C05.799.825,Rheumatic Diseases,Musculoskeletal Diseases,7
Rheumatic Fever,C,C05.550.114.843,Arthritis,Joint Diseases,7
Rickettsia Infections,C,C01.920.914.725,Rickettsiaceae Infections,Vector Borne Diseases,7
Rickettsia Infections,C,C01.150.252.400.789.725,Rickettsiaceae Infections,Gram-Negative Bacterial Infections,7
Right to Health,N,N03.706.437.688,Human Rights,"Social Control, Formal",7
Right to Health,N,N04.590.374.350.750,Health Services Accessibility,Delivery of Health Care,7
Right to Health,I,I01.880.604.473.688,Human Rights,"Social Control, Formal",7
"RNA Processing, Post-Transcriptional",G,G02.111.760,Biochemical Phenomena,Chemical Phenomena,7
"RNA Processing, Post-Transcriptional",G,G03.839,Metabolism,NULL,7
"RNA Processing, Post-Transcriptional",G,G05.308.700,Gene Expression Regulation,Genetic Phenomena,7
RNA Splicing,G,G05.308.700.700,"RNA Processing, Post-Transcriptional",Gene Expression Regulation,7
RNA Splicing,G,G03.839.700,"RNA Processing, Post-Transcriptional",Metabolism,7
RNA Splicing,G,G02.111.760.700,"RNA Processing, Post-Transcriptional",Biochemical Phenomena,7
Routinely Collected Health Data,N,N05.425.210.750,Health Care Surveys,Health Services Research,7
Routinely Collected Health Data,N,N03.349.380.210.875,Health Care Surveys,Health Services Research,7
Salmonella Food Poisoning,C,C01.150.252.400.310.821.606,Salmonella Infections,Enterobacteriaceae Infections,7
Salmonella Food Poisoning,C,C25.723.415.738,Foodborne Diseases,Poisoning,7
Salmonella Vaccines,D,D20.215.894.135.685,Bacterial Vaccines,Vaccines,7
San Francisco,Z,Z01.107.567.875.760.200.700,California,Southwestern United States,7
San Francisco,Z,Z01.107.567.875.580.200.700,California,Pacific States,7
San Francisco,Z,Z01.433.875,Cities,Geographic Locations,7
Sarcopenia,C,C23.888.592.608.612.500,Muscular Atrophy,Neuromuscular Manifestations,7
Sarcopenia,C,C23.300.070.500.500,Muscular Atrophy,Atrophy,7
Sarcopenia,C,C10.597.613.612.500,Muscular Atrophy,Neuromuscular Manifestations,7
Sclera,A,A09.371.784,Eye,Sense Organs,7
"Seizures, Febrile",C,C10.597.742.571,Seizures,Neurologic Manifestations,7
"Seizures, Febrile",C,C23.888.592.742.571,Seizures,Neurologic Manifestations,7
Serotonin Plasma Membrane Transport Proteins,D,D12.776.543.585.562.374.875,Plasma Membrane Neurotransmitter Transport Proteins,Neurotransmitter Transport Proteins,7
Serotonin Plasma Membrane Transport Proteins,D,D12.776.543.585.937.747,Solute Carrier Proteins,Membrane Transport Proteins,7
Serotonin Plasma Membrane Transport Proteins,D,D12.776.543.585.450.625.374,Symporters,Ion Pumps,7
Serotonin Plasma Membrane Transport Proteins,D,D12.776.157.530.450.625.311,Symporters,Ion Pumps,7
Serotonin Plasma Membrane Transport Proteins,D,D12.776.157.530.562.374.875,Plasma Membrane Neurotransmitter Transport Proteins,Neurotransmitter Transport Proteins,7
Serotonin Plasma Membrane Transport Proteins,D,D12.776.157.530.937.624,Solute Carrier Proteins,Membrane Transport Proteins,7
Sexual Maturation,G,G07.345.750.750,Sexual Development,Growth and Development,7
Sexual Maturation,G,G08.686.841.750,Sexual Development,Reproductive Physiological Phenomena,7
"Shock, Hemorrhagic",C,C23.550.835.650,Shock,Pathologic Processes,7
"Shock, Hemorrhagic",C,C23.550.414.980,Hemorrhage,Pathologic Processes,7
Sigma Factor,D,D12.776.930.800,Transcription Factors,Proteins,7
Sildenafil Citrate,D,D02.886.590.700.675,Sulfonamides,Sulfones,7
Sildenafil Citrate,D,D03.633.100.759.824,Purines,"Heterocyclic Compounds, 2-Ring",7
Sildenafil Citrate,D,D03.383.606.854,Piperazines,"Heterocyclic Compounds, 1-Ring",7
Sildenafil Citrate,D,D02.065.884.675,Sulfonamides,Amides,7
Skin Absorption,G,G07.690.725.015.500.750,"Absorption, Physiological",Absorption,7
Skin Absorption,G,G03.787.024.500.750,"Absorption, Physiological",Absorption,7
Skin Absorption,G,G03.015.500.750,"Absorption, Physiological",Absorption,7
Skin Absorption,G,G13.750.778,Skin Physiological Phenomena,Integumentary System Physiological Phenomena,7
"Skin Diseases, Infectious",C,C17.800.838,Skin Diseases,Skin and Connective Tissue Diseases,7
"Skin Diseases, Infectious",C,C01.800,Infections,NULL,7
Small Molecule Libraries,D,D27.720.470.765,Laboratory Chemicals,Specialty Uses of Chemicals,7
Social Behavior Disorders,I,I01.880.735.784,Social Problems,Sociology,7
Social Marginalization,I,I01.880.853.872,Sociological Factors,Sociology,7
Social Marginalization,F,F01.145.813.817,Social Behavior,Behavior,7
"Spectrometry, Fluorescence",E,E05.196.867.726,Spectrum Analysis,"Chemistry Techniques, Analytical",7
"Spectrometry, Fluorescence",E,E05.196.712.516.600.676,Fluorometry,Luminescent Measurements,7
"Spectrophotometry, Ultraviolet",E,E05.196.712.726.802,Spectrophotometry,Photometry,7
"Spectrophotometry, Ultraviolet",E,E05.196.867.826.802,Spectrophotometry,Spectrum Analysis,7
"Spectrum Analysis, Raman",E,E05.196.867.890,Spectrum Analysis,"Chemistry Techniques, Analytical",7
"Spectrum Analysis, Raman",E,E05.196.822.860,"Scattering, Radiation","Chemistry Techniques, Analytical",7
Splenectomy,E,E04.726,"Surgical Procedures, Operative",NULL,7
State Government,I,I01.409.775,Government,Social Sciences,7
State Government,N,N03.540.348.875,Government,Organizations,7
Sterilization,N,N06.850.780.200.450.850,Infection Control,Communicable Disease Control,7
"Students, Nursing",M,M01.848.769.685,"Students, Health Occupations",Students,7
Subcellular Fractions,A,A11.284.835,Cellular Structures,Cells,7
Subtraction Technique,E,E01.370.350.760,Diagnostic Imaging,Diagnostic Techniques and Procedures,7
Surface Plasmon Resonance,E,E05.196.890,"Chemistry Techniques, Analytical",Investigative Techniques,7
Surface Plasmon Resonance,E,E05.601.043.700,Biosensing Techniques,Molecular Probe Techniques,7
Surgical Mesh,E,E07.858.708,Surgical Equipment,Equipment and Supplies,7
Swimming Pools,J,J03.925.830,Sports and Recreational Facilities,Non-Medical Public and Private Facilities,7
Synapses,A,A11.284.149.165.420.780,Intercellular Junctions,Cell Membrane Structures,7
Synapses,A,A08.850,Nervous System,NULL,7
T-Box Domain Proteins,D,D12.776.930.850,Transcription Factors,Proteins,7
T-Box Domain Proteins,D,D12.776.260.725,DNA-Binding Proteins,Proteins,7
Telemetry,E,E01.370.520.750,"Monitoring, Physiologic",Diagnostic Techniques and Procedures,7
Telemetry,L,L01.178.847.675,Telecommunications,Communications Media,7
Telemetry,E,E05.925,Investigative Techniques,NULL,7
"Templates, Genetic",G,G05.360.840,Genetic Structures,Genetic Phenomena,7
Terpenes,D,D02.455.849,Hydrocarbons,Organic Chemicals,7
Testis,A,A06.300.312.782,Gonads,Endocrine Glands,7
Testis,A,A05.360.444.849,"Genitalia, Male",Genitalia,7
Testis,A,A05.360.576.782,Gonads,Genitalia,7
Tetradecanoylphorbol Acetate,D,D02.455.849.291.500.510.850,Phorbol Esters,Phorbols,7
Thalassemia,C,C16.320.365.826,Hemoglobinopathies,"Genetic Diseases, Inborn",7
Thalassemia,C,C16.320.070.875,"Anemia, Hemolytic, Congenital","Genetic Diseases, Inborn",7
Thalassemia,C,C15.378.071.141.150.875,"Anemia, Hemolytic, Congenital","Anemia, Hemolytic",7
Thalassemia,C,C15.378.420.826,Hemoglobinopathies,Hematologic Diseases,7
Thalidomide,D,D02.241.223.805.810.800,Phthalimides,Phthalic Acids,7
Thalidomide,D,D03.383.621.808.800,Piperidones,Piperidines,7
Thalidomide,D,D03.633.100.513.750.750,Phthalimides,Isoindoles,7
Therapeutic Human Experimentation,E,E05.445.875,Human Experimentation,Investigative Techniques,7
Therapeutic Human Experimentation,H,H01.770.644.145.365.875,Human Experimentation,Biomedical Research,7
Therapeutic Irrigation,E,E05.927,Investigative Techniques,NULL,7
Therapeutic Irrigation,E,E02.779.492.500,Hydrotherapy,Physical Therapy Modalities,7
Therapeutic Irrigation,E,E02.831.535.492.500,Hydrotherapy,Physical Therapy Modalities,7
Thogotovirus,B,B04.820.480.968.850,Orthomyxoviridae,Negative-Sense RNA Viruses,7
Thyroid Hormones,D,D06.472.931,Hormones,"Hormones, Hormone Substitutes, and Hormone Antagonists",7
Tobacco Use Cessation,F,F01.145.488.750,Health Behavior,Behavior,7
Tobacco Use Cessation Devices,E,E02.980,Therapeutics,NULL,7
Tonga,Z,Z01.639.760.815.890,Polynesia,Pacific Islands,7
Transaminases,D,D08.811.913.477.700,Nitrogenous Group Transferases,Transferases,7
"Transformation, Bacterial",E,E05.393.350.810.500,Transfection,Gene Transfer Techniques,7
"Transformation, Bacterial",G,G05.728.865.820,"Transformation, Genetic","Recombination, Genetic",7
"Transformation, Bacterial",G,G05.728.860.500,Transfection,"Recombination, Genetic",7
"Transformation, Bacterial",G,G06.099.850,Bacterial Physiological Phenomena,Microbiological Phenomena,7
Tripartite Motif Proteins,D,D12.776.934,Proteins,"Amino Acids, Peptides, and Proteins",7
Trophozoites,B,B05.775.740.900,"Spores, Protozoan",Spores,7
Trophozoites,B,B05.500.950,Life Cycle Stages,Organism Forms,7
Trophozoites,A,A11.870.740.900,"Spores, Protozoan",Spores,7
Trophozoites,G,G07.345.500.550.500.950,Life Cycle Stages,"Metamorphosis, Biological",7
Tryptophan,D,D12.125.072.050.850,"Amino Acids, Aromatic","Amino Acids, Cyclic",7
Tryptophan,D,D12.125.142.875,"Amino Acids, Essential",Amino Acids,7
Tunica Media,A,A07.015.733,Blood Vessels,Cardiovascular System,7
Type VI Secretion Systems,D,D05.500.890.500.984,Bacterial Secretion Systems,Protein Translocation Systems,7
Tyrosine,D,D12.125.072.050.875,"Amino Acids, Aromatic","Amino Acids, Cyclic",7
Ubiquitination,G,G05.308.670.600.831,"Protein Processing, Post-Translational","Protein Modification, Translational",7
Ubiquitination,G,G03.734.871.790.600.831,"Protein Processing, Post-Translational","Protein Modification, Translational",7
Ubiquitination,G,G02.111.691.600.775,"Protein Processing, Post-Translational","Protein Modification, Translational",7
Ubiquitination,G,G02.111.660.871.790.600.925,"Protein Processing, Post-Translational","Protein Modification, Translational",7
"Ultrasound, High-Intensity Focused, Transrectal",E,E04.014.380.500,High-Intensity Focused Ultrasound Ablation,Ablation Techniques,7
"Ultrasound, High-Intensity Focused, Transrectal",E,E04.950.774.860.625.875,Prostatectomy,"Urologic Surgical Procedures, Male",7
"Ultrasound, High-Intensity Focused, Transrectal",E,E02.565.280.945.399.500,High-Intensity Focused Ultrasound Ablation,Ultrasonic Therapy,7
Undocumented Immigrants,M,M01.189.500,Emigrants and Immigrants,Persons,7
United States Department of Veterans Affairs,N,N03.540.348.500.500.700,United States Government Agencies,Federal Government,7
United States Department of Veterans Affairs,I,I01.409.418.750.700,United States Government Agencies,Government Agencies,7
Urethral Diseases,C,C13.351.968.767,Urologic Diseases,Female Urogenital Diseases,7
Urethral Diseases,C,C12.777.767,Urologic Diseases,Male Urogenital Diseases,7
Urologic Surgical Procedures,E,E04.950.774,Urogenital Surgical Procedures,"Surgical Procedures, Operative",7
Vaccine Potency,G,G12.300.500,"Dose-Response Relationship, Immunologic",Immune System Phenomena,7
"Vaccines, Acellular",D,D20.215.894.860.900,"Vaccines, Subunit",Vaccines,7
Vaginal Fistula,C,C13.351.500.894.767,Vaginal Diseases,"Genital Diseases, Female",7
Vaginal Fistula,C,C23.300.575.925,Fistula,"Pathological Conditions, Anatomical",7
Vancomycin Resistance,G,G07.690.773.984.269.347.984,"Drug Resistance, Bacterial","Drug Resistance, Microbial",7
Vancomycin Resistance,G,G06.099.225.984,"Drug Resistance, Bacterial",Bacterial Physiological Phenomena,7
Vancomycin Resistance,G,G06.225.347.984,"Drug Resistance, Bacterial","Drug Resistance, Microbial",7
Vascular Cell Adhesion Molecule-1,D,D23.050.301.350.920,Cell Adhesion Molecules,"Antigens, Surface",7
Vascular Cell Adhesion Molecule-1,D,D12.776.543.550.200.920,Cell Adhesion Molecules,Membrane Glycoproteins,7
Vascular Cell Adhesion Molecule-1,D,D12.776.395.550.200.920,Cell Adhesion Molecules,Membrane Glycoproteins,7
Verteporfin,D,D04.345.783.500.940,Porphyrins,Tetrapyrroles,7
Verteporfin,D,D03.633.400.909.500.940,Porphyrins,Tetrapyrroles,7
Verteporfin,D,D03.383.129.578.840.500.940,Porphyrins,Tetrapyrroles,7
Vibrio cholerae O1,B,B03.440.450.900.859.225.151,Vibrio cholerae,Vibrio,7
Vibrio cholerae O1,B,B03.660.250.830.830.100.151,Vibrio cholerae,Vibrio,7
Videoconferencing,L,L01.178.847.900,Telecommunications,Communications Media,7
Vinblastine,D,D03.132.436.681.827.650,Vinca Alkaloids,Secologanin Tryptamine Alkaloids,7
Vinblastine,D,D03.633.100.496.500.500.681.827.650,Vinca Alkaloids,Secologanin Tryptamine Alkaloids,7
Vinblastine,D,D03.633.100.473.402.681.827.650,Vinca Alkaloids,Secologanin Tryptamine Alkaloids,7
Viral Regulatory and Accessory Proteins,D,D12.776.964.925,Viral Proteins,Proteins,7
Virus Release,G,G06.920.913,Virus Physiological Phenomena,Microbiological Phenomena,7
Vital Signs,E,E01.370.600.875,Physical Examination,Diagnostic Techniques and Procedures,7
"Water Pollution, Chemical",N,N06.850.460.790.410,Water Pollution,Environmental Pollution,7
Water-Electrolyte Balance,G,G07.410.810.500,Osmoregulation,Homeostasis,7
Water-Electrolyte Balance,G,G02.111.635.500,Osmoregulation,Biochemical Phenomena,7
Water-Electrolyte Balance,G,G03.615.500,Osmoregulation,Metabolism,7
West Nile virus,B,B04.820.578.344.350.300.950,"Encephalitis Viruses, Japanese",Flavivirus,7
West Nile virus,B,B04.820.230.475.950,"Encephalitis Viruses, Japanese",Encephalitis Viruses,7
Wildfires,G,G01.311.988,Geological Phenomena,Physical Phenomena,7
Wildfires,N,N06.230.216.875,Fires,Environment,7
Wildfires,N,N06.230.100.230.925,Natural Disasters,Disasters,7
Xanthophylls,D,D02.455.326.271.665.202.868,Carotenoids,Polyenes,7
Xanthophylls,D,D02.455.426.392.368.367.379.249.887,Carotenoids,Cyclohexenes,7
Xanthophylls,D,D23.767.261.887,Carotenoids,"Pigments, Biological",7
Xanthophylls,D,D02.455.849.131.868,Carotenoids,Terpenes,7
X-Ray Microtomography,E,E01.370.350.825.810.810.900,"Tomography, X-Ray Computed","Tomography, X-Ray",7
X-Ray Microtomography,E,E01.370.350.700.810.810.900,"Tomography, X-Ray Computed","Tomography, X-Ray",7
"2,4,5-Trichlorophenoxyacetic Acid",D,D02.241.511.316.682.800,Phenoxyacetates,Glycolates,6
"2,4,5-Trichlorophenoxyacetic Acid",D,D02.241.081.018.386.682.800,Phenoxyacetates,Glycolates,6
Abatacept,D,D12.776.377.715.548.114.580.225,Immunoconjugates,Antibodies,6
Abatacept,D,D12.776.124.790.651.114.580.225,Immunoconjugates,Antibodies,6
Abruptio Placentae,C,C13.703.420.078,Obstetric Labor Complications,Pregnancy Complications,6
Abruptio Placentae,C,C13.703.590.132,Placenta Diseases,Pregnancy Complications,6
Absorption,G,G01.015,Physical Phenomena,NULL,6
Absorption,G,G02.010,Chemical Phenomena,NULL,6
Absorption,G,G03.787.024,Pharmacokinetics,Metabolism,6
Absorption,G,G03.015,Metabolism,NULL,6
Absorption,G,G07.690.725.015,Pharmacokinetics,Pharmacological and Toxicological Phenomena,6
Acanthamoeba Keratitis,C,C11.294.725.125,"Eye Infections, Parasitic",Eye Infections,6
Acanthamoeba Keratitis,C,C11.204.564.112,Keratitis,Corneal Diseases,6
Acanthamoeba Keratitis,C,C01.610.300.125,"Eye Infections, Parasitic",Parasitic Diseases,6
Acanthamoeba Keratitis,C,C01.610.752.049.203,Amebiasis,Protozoan Infections,6
Acetabulum,A,A02.835.232.043.825.108,Pelvic Bones,Bones of Lower Extremity,6
Acetylcysteine,D,D12.125.166.230.259,Cysteine,"Amino Acids, Sulfur",6
Acetylcysteine,D,D02.886.030.230.259,Cysteine,"Amino Acids, Sulfur",6
Acidosis,C,C18.452.076.176,Acid-Base Imbalance,Metabolic Diseases,6
"Adjuvants, Pharmaceutic",D,D27.720.744.064,Pharmaceutic Aids,Specialty Uses of Chemicals,6
"Adjuvants, Pharmaceutic",D,D26.650.064,Pharmaceutic Aids,Pharmaceutical Preparations,6
Adrenocorticotropic Hormone,D,D12.776.631.650.405.935.531.500,Melanocortins,Pro-Opiomelanocortin,6
Adrenocorticotropic Hormone,D,D06.472.699.631.525.600.531.500,Melanocortins,Pro-Opiomelanocortin,6
Adrenocorticotropic Hormone,D,D06.472.699.327.935.531.500,Melanocortins,Pro-Opiomelanocortin,6
Adrenocorticotropic Hormone,D,D12.644.548.365.935.531.500,Melanocortins,Pro-Opiomelanocortin,6
Adrenocorticotropic Hormone,D,D12.644.548.691.525.690.531.500,Melanocortins,Pro-Opiomelanocortin,6
Adrenocorticotropic Hormone,D,D12.644.400.400.935.531.500,Melanocortins,Pro-Opiomelanocortin,6
Adult Survivors of Child Abuse,M,M01.135.500,Crime Victims,Persons,6
Adult Survivors of Child Abuse,M,M01.860.300.500,Adult Survivors of Child Adverse Events,Survivors,6
Aerospace Medicine,H,H02.403.029,Medicine,Health Occupations,6
Alcohol Abstinence,F,F01.145.317.134,Drinking Behavior,Behavior,6
Aluminum Silicates,D,D01.650.550.050.075,Aluminum Oxide,Oxides,6
Aluminum Silicates,D,D01.837.725.700.760.050,Silicates,Silicic Acid,6
Aluminum Silicates,D,D01.578.725.025,Silicates,Minerals,6
Aluminum Silicates,D,D01.056.050.075,Aluminum Oxide,Aluminum Compounds,6
American Heart Association,N,N03.540.630.780.110,Voluntary Health Agencies,"Organizations, Nonprofit",6
Aminophenols,D,D02.092.146.100,Aniline Compounds,Amines,6
Aminophenols,D,D02.455.426.559.389.657.050,Phenols,Benzene Derivatives,6
Amiodarone,D,D03.633.100.127.075,Benzofurans,"Heterocyclic Compounds, 2-Ring",6
Amniocentesis,E,E01.370.225.500.384.050,Cytodiagnosis,Cytological Techniques,6
Amniocentesis,E,E01.370.225.998.329.309,Paracentesis,Specimen Handling,6
Amniocentesis,E,E01.370.378.630.050,Prenatal Diagnosis,"Diagnostic Techniques, Obstetrical and Gynecological",6
Amniocentesis,E,E05.200.500.384.050,Cytodiagnosis,Cytological Techniques,6
Amniocentesis,E,E05.200.998.329.309,Paracentesis,Specimen Handling,6
Amniocentesis,E,E05.242.384.050,Cytodiagnosis,Cytological Techniques,6
Amniocentesis,E,E04.665.600.309,Paracentesis,Punctures,6
Amyloid beta-Protein Precursor,D,D12.776.645.468.500,Protease Nexins,"Proteinase Inhibitory Proteins, Secretory",6
Amyloid beta-Protein Precursor,D,D12.776.811.050,Protein Precursors,Proteins,6
Amyloid beta-Protein Precursor,D,D12.776.543.039,Membrane Proteins,Proteins,6
Amyloid beta-Protein Precursor,D,D12.776.049.407.249,Amyloidogenic Proteins,Amyloid,6
Aneurysm,C,C14.907.055,Vascular Diseases,Cardiovascular Diseases,6
Animal Experimentation,E,E05.017,Investigative Techniques,NULL,6
Animal Experimentation,H,H01.770.644.053,Research,Science,6
Animal Welfare,I,I01.880.604.100,"Social Control, Formal",Sociology,6
Antelopes,B,B01.050.150.900.649.313.500.380.100,Ruminants,Artiodactyla,6
Antibody-Dependent Cell Cytotoxicity,G,G12.287.070,"Cytotoxicity, Immunologic",Immune System Phenomena,6
Antimony,D,D01.552.544.050,"Metals, Heavy",Metals,6
Antimony,D,D01.268.513.124,Metalloids,Elements,6
Antimony,D,D01.268.556.050,"Metals, Heavy",Elements,6
Antisickling Agents,D,D27.505.954.502.135,Hematologic Agents,Therapeutic Uses,6
"Aorta, Abdominal",A,A07.015.114.056.205,Aorta,Arteries,6
Aortic Diseases,C,C14.907.109,Vascular Diseases,Cardiovascular Diseases,6
"Aphasia, Primary Progressive",C,C10.597.606.150.500.800.100.155,Aphasia,Speech Disorders,6
"Aphasia, Primary Progressive",C,C10.228.140.380.132,Dementia,Brain Diseases,6
"Aphasia, Primary Progressive",C,C23.888.592.604.150.500.800.100.155,Aphasia,Speech Disorders,6
"Aphasia, Primary Progressive",F,F03.615.400.125,Dementia,Neurocognitive Disorders,6
Appendectomy,E,E04.210.078,Digestive System Surgical Procedures,"Surgical Procedures, Operative",6
Arachidonic Acid,D,D10.251.355.310.166.100,Arachidonic Acids,"Fatty Acids, Essential",6
Arachidonic Acid,D,D10.251.355.255.100.100,Arachidonic Acids,Eicosanoids,6
Archaeology,I,I01.076.201.208,"Anthropology, Cultural",Anthropology,6
Art Therapy,E,E02.831.100,Rehabilitation,Therapeutics,6
Art Therapy,F,F04.754.070,Psychotherapy,Behavioral Disciplines and Activities,6
Art Therapy,E,E02.760.169.063.500.100,Rehabilitation,Aftercare,6
Art Therapy,E,E02.190.888.124,Sensory Art Therapies,Complementary Therapies,6
Aryldialkylphosphatase,D,D08.811.277.352.660.500,Phosphoric Triester Hydrolases,Esterases,6
"Asbestos, Amphibole",D,D01.578.725.050.050,Asbestos,Silicates,6
"Asbestos, Amphibole",D,D01.837.725.700.760.070.050,Asbestos,Silicates,6
Aspergillosis,C,C01.150.703.080,Mycoses,Bacterial Infections and Mycoses,6
Aspergillus,B,B01.300.381.081,Mitosporic Fungi,Fungi,6
Ataxia Telangiectasia Mutated Proteins,D,D08.811.913.696.620.682.700.097,Protein-Serine-Threonine Kinases,Protein Kinases,6
Ataxia Telangiectasia Mutated Proteins,D,D12.776.157.687.125,Poly-ADP-Ribose Binding Proteins,Carrier Proteins,6
Ataxia Telangiectasia Mutated Proteins,D,D12.776.660.720.125,Poly-ADP-Ribose Binding Proteins,Nuclear Proteins,6
"ATP Binding Cassette Transporter, Subfamily B, Member 1",D,D12.776.543.550.192.400.153,"ATP Binding Cassette Transporter, Subfamily B",ATP-Binding Cassette Transporters,6
"ATP Binding Cassette Transporter, Subfamily B, Member 1",D,D12.776.543.585.450.074.500.500.250.125,"ATP Binding Cassette Transporter, Subfamily B","Organic Anion Transporters, ATP-Dependent",6
"ATP Binding Cassette Transporter, Subfamily B, Member 1",D,D12.776.543.585.100.200.125,"ATP Binding Cassette Transporter, Subfamily B",ATP-Binding Cassette Transporters,6
"ATP Binding Cassette Transporter, Subfamily B, Member 1",D,D12.776.395.550.020.400.153,"ATP Binding Cassette Transporter, Subfamily B",ATP-Binding Cassette Transporters,6
"ATP Binding Cassette Transporter, Subfamily B, Member 1",D,D12.776.157.530.100.075.063,"ATP Binding Cassette Transporter, Subfamily B",ATP-Binding Cassette Transporters,6
"ATP Binding Cassette Transporter, Subfamily B, Member 1",D,D12.776.157.530.450.074.500.500.250.125,"ATP Binding Cassette Transporter, Subfamily B","Organic Anion Transporters, ATP-Dependent",6
Bacillus thuringiensis,B,B03.353.500.100.218.800,Bacillus,Bacillaceae,6
Bacillus thuringiensis,B,B03.300.390.400.158.218.800,Bacillus,Bacillaceae,6
Bacillus thuringiensis,B,B03.510.100.100.218.800,Bacillus,Bacillaceae,6
Bacillus thuringiensis,B,B03.510.460.410.158.218.800,Bacillus,Bacillaceae,6
Bacillus thuringiensis,B,B03.510.415.400.158.218.800,Bacillus,Bacillaceae,6
Bacterial Translocation,G,G06.099.114,Bacterial Physiological Phenomena,Microbiological Phenomena,6
Bioethical Issues,K,K01.752.566.479.023,Ethics,Morals,6
Bioethical Issues,N,N05.350.100,Ethics,"Health Care Quality, Access, and Evaluation",6
Biological Factors,D,D23,NULL,NULL,6
"Biomarkers, Pharmacological",D,D23.101.137,Biomarkers,Biological Factors,6
Biosensing Techniques,E,E05.601.043,Molecular Probe Techniques,Investigative Techniques,6
Blood Coagulation Tests,E,E05.200.625.115,Hematologic Tests,Clinical Laboratory Techniques,6
Blood Coagulation Tests,E,E01.370.225.625.115,Hematologic Tests,Clinical Laboratory Techniques,6
"Bone Diseases, Metabolic",C,C05.116.198,Bone Diseases,Musculoskeletal Diseases,6
"Bone Diseases, Metabolic",C,C18.452.104,Metabolic Diseases,Nutritional and Metabolic Diseases,6
Books,L,L01.178.682.192,Publications,Communications Media,6
Botulism,C,C10.668.758.200,Neuromuscular Junction Diseases,Neuromuscular Diseases,6
Botulism,C,C10.720.150,Neurotoxicity Syndromes,Nervous System Diseases,6
Botulism,C,C25.723.415.151,Foodborne Diseases,Poisoning,6
Botulism,C,C01.150.252.410.222.151,Clostridium Infections,Gram-Positive Bacterial Infections,6
Bread,J,J02.500.100,Food,Food and Beverages,6
Bread,G,G07.203.300.100,Food,"Diet, Food, and Nutrition",6
Bronchial Neoplasms,C,C04.588.894.797.520.109,Lung Neoplasms,Respiratory Tract Neoplasms,6
Bronchial Neoplasms,C,C08.127.265,Bronchial Diseases,Respiratory Tract Diseases,6
Bronchial Neoplasms,C,C08.785.520.100,Lung Neoplasms,Respiratory Tract Neoplasms,6
"Bronchitis, Chronic",C,C08.730.099.567,Bronchitis,Respiratory Tract Infections,6
"Bronchitis, Chronic",C,C08.127.446.567,Bronchitis,Bronchial Diseases,6
"Bronchitis, Chronic",C,C08.381.495.146.567,Bronchitis,"Lung Diseases, Obstructive",6
"Bronchitis, Chronic",C,C08.381.495.389.500,"Pulmonary Disease, Chronic Obstructive","Lung Diseases, Obstructive",6
"Bronchitis, Chronic",C,C01.748.099.567,Bronchitis,Respiratory Tract Infections,6
Bundle-Branch Block,C,C14.280.067.558.323,Heart Block,"Arrhythmias, Cardiac",6
Bundle-Branch Block,C,C14.280.123.500.323,Heart Block,Cardiac Conduction System Disease,6
Bundle-Branch Block,C,C23.550.073.425.100,Heart Block,"Arrhythmias, Cardiac",6
Butterflies,B,B01.050.500.131.617.720.500.500.937.200,Lepidoptera,Holometabola,6
Cachexia,C,C23.888.144.243.963.500.500,Emaciation,Weight Loss,6
Calcifediol,D,D10.570.938.146.478.250,Hydroxycholecalciferols,Cholecalciferol,6
Calcifediol,D,D04.210.500.812.768.196.478.250,Hydroxycholecalciferols,Cholecalciferol,6
Calcifediol,D,D04.210.500.247.222.159.478.250,Hydroxycholecalciferols,Cholecalciferol,6
Calcifediol,D,D04.210.500.247.808.146.478.250,Hydroxycholecalciferols,Cholecalciferol,6
Campylobacter coli,B,B03.440.180.200,Campylobacter,Gram-Negative Bacteria,6
Campylobacter coli,B,B03.660.150.235.250.500.100,Campylobacter,Campylobacteraceae,6
"Candidiasis, Vulvovaginal",C,C01.150.703.160.190,Candidiasis,Mycoses,6
"Candidiasis, Vulvovaginal",C,C13.351.500.894.906.820.500,Vulvovaginitis,Vaginitis,6
"Candidiasis, Vulvovaginal",C,C13.351.500.944.902.737.500,Vulvovaginitis,Vulvitis,6
Capillaries,A,A07.015.461.165,Microvessels,Blood Vessels,6
Carbon Isotopes,D,D01.496.123,Isotopes,Inorganic Chemicals,6
Carbon Isotopes,D,D01.268.150.075,Carbon,Elements,6
Carboplatin,D,D02.257.125,Coordination Complexes,Organic Chemicals,6
"Carcinoma, Papillary",C,C04.557.470.700.360,"Neoplasms, Squamous Cell","Neoplasms, Glandular and Epithelial",6
"Carcinoma, Papillary",C,C04.557.470.200.360,Carcinoma,"Neoplasms, Glandular and Epithelial",6
"Carotid Artery, Common",A,A07.015.114.186.200,Carotid Arteries,Arteries,6
"Cartilage, Articular",A,A02.835.583.192,Joints,Skeleton,6
"Cartilage, Articular",A,A02.165.407.150,Hyaline Cartilage,Cartilage,6
Caspases,D,D08.811.277.656.262.500.126,Cysteine Endopeptidases,Cysteine Proteases,6
Caspases,D,D08.811.277.656.300.200.126,Cysteine Endopeptidases,Endopeptidases,6
Caspases,D,D12.644.360.075.405,Apoptosis Regulatory Proteins,Intracellular Signaling Peptides and Proteins,6
Caspases,D,D12.776.476.075.405,Apoptosis Regulatory Proteins,Intracellular Signaling Peptides and Proteins,6
"Casts, Surgical",E,E07.858.690.725.430.500,External Fixators,Orthopedic Fixation Devices,6
"Casts, Surgical",E,E07.858.442.660.430.500,External Fixators,Orthopedic Fixation Devices,6
Cathepsin D,D,D08.811.277.656.300.048.180,Aspartic Acid Endopeptidases,Endopeptidases,6
Cathepsin D,D,D08.811.277.656.224.187,Cathepsins,Peptide Hydrolases,6
Cathepsin D,D,D08.811.277.656.074.500.180,Aspartic Acid Endopeptidases,Aspartic Acid Proteases,6
Central Venous Catheters,E,E07.132.750.500,Vascular Access Devices,Catheters,6
Cerebral Infarction,C,C23.550.513.355.250.200,Brain Infarction,Infarction,6
Cerebral Infarction,C,C23.550.717.489.250.200,Brain Infarction,Infarction,6
Cerebral Infarction,C,C14.907.253.092.477.200,Brain Infarction,Brain Ischemia,6
Cerebral Infarction,C,C14.907.253.855.200.200,Brain Infarction,Stroke,6
Cerebral Infarction,C,C10.228.140.300.775.200.200,Brain Infarction,Stroke,6
Cerebral Infarction,C,C10.228.140.300.150.477.200,Brain Infarction,Brain Ischemia,6
Cervical Vertebrae,A,A02.835.232.834.151,Spine,Bone and Bones,6
Chelating Agents,D,D27.720.832.500,Sequestering Agents,Specialty Uses of Chemicals,6
Chelating Agents,D,D27.505.519.914.500,Sequestering Agents,Molecular Mechanisms of Pharmacological Action,6
Chemical Warfare Agents,D,D27.720.777.300,Poisons,Specialty Uses of Chemicals,6
Chemical Warfare Agents,D,D27.888.569.612.150,Poisons,Noxae,6
Chemical Warfare Agents,J,J01.637.870.900.200,Weapons of Mass Destruction,Weapons,6
Chemistry,H,H01.181,Natural Science Disciplines,NULL,6
"Chemistry Techniques, Analytical",E,E05.196,Investigative Techniques,NULL,6
Chlorides,D,D01.248.497.158.215,Anions,Ions,6
Chlorides,D,D01.210.450.150,Hydrochloric Acid,Chlorine Compounds,6
Cholelithiasis,C,C06.130.409,Biliary Tract Diseases,Digestive System Diseases,6
Cholera Toxin,D,D23.946.123.194,Bacterial Toxins,"Toxins, Biological",6
Cholera Toxin,D,D23.946.330.150,Enterotoxins,"Toxins, Biological",6
Cholera Toxin,D,D08.811.913.400.725.115.180,ADP Ribose Transferases,Pentosyltransferases,6
Cholinesterase Inhibitors,D,D27.505.519.625.120.300,Cholinergic Agents,Neurotransmitter Agents,6
Cholinesterase Inhibitors,D,D27.505.519.389.275,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,6
Cholinesterase Inhibitors,D,D27.505.696.577.120.300,Cholinergic Agents,Neurotransmitter Agents,6
Chondrocytes,A,A11.329.171,Connective Tissue Cells,Cells,6
Chromium,D,D01.268.556.175,"Metals, Heavy",Elements,6
Chromium,D,D01.268.956.124,Transition Elements,Elements,6
Chromium,D,D01.552.544.175,"Metals, Heavy",Metals,6
"Chromosomes, Human, Pair 12",A,A11.284.187.520.300.325.360,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",6
"Chromosomes, Human, Pair 12",G,G05.360.162.520.300.325.360,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",6
"Chromosomes, Human, Pair 19",G,G05.360.162.520.300.460.465,"Chromosomes, Human, 19-20","Chromosomes, Human",6
"Chromosomes, Human, Pair 19",A,A11.284.187.520.300.460.465,"Chromosomes, Human, 19-20","Chromosomes, Human",6
"Chromosomes, Human, Pair 7",A,A11.284.187.520.300.325.335,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",6
"Chromosomes, Human, Pair 7",G,G05.360.162.520.300.325.335,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",6
Clinical Laboratory Services,N,N02.421.726.233.110,Diagnostic Services,Preventive Health Services,6
Colloids,D,D26.255.165,Dosage Forms,Pharmaceutical Preparations,6
Colloids,D,D20.280,Complex Mixtures,NULL,6
Colostrum,A,A12.200.194,Bodily Secretions,Fluids and Secretions,6
Commitment of Mentally Ill,N,N03.706.535.351.200,Forensic Psychiatry,Jurisprudence,6
Commitment of Mentally Ill,F,F04.096.544.335.200,Forensic Psychiatry,Psychiatry,6
Consent Forms,N,N03.706.535.489.134,Informed Consent,Jurisprudence,6
Consent Forms,N,N04.452.859.198,Records,Organization and Administration,6
Consent Forms,N,N05.715.360.300.715.245,Records,Data Collection,6
Consent Forms,I,I01.880.604.583.427.134,Informed Consent,Jurisprudence,6
Construction Industry,J,J01.576.655.125,Manufacturing Industry,Industry,6
Consumer Health Information,I,I02.233.332.186,Health Education,"Education, Nonprofessional",6
Consumer Health Information,N,N02.421.726.407.229,Health Education,Preventive Health Services,6
"Coronary Artery Bypass, Off-Pump",E,E04.100.814.868.750.199,Coronary Artery Bypass,Vascular Grafting,6
"Coronary Artery Bypass, Off-Pump",E,E04.100.376.719.332.199,Coronary Artery Bypass,Myocardial Revascularization,6
"Coronary Artery Bypass, Off-Pump",E,E04.928.220.520.220.189,Coronary Artery Bypass,Myocardial Revascularization,6
Cosmids,G,G05.360.600.250,Plasmids,Genetic Structures,6
Cosmids,G,G05.360.337.500,Genetic Vectors,Genetic Structures,6
Crying,F,F01.525.200.310.300,Language Development,Child Development,6
Crying,F,F01.145.209.530.258,Nonverbal Communication,Communication,6
Cryptorchidism,C,C19.391.829.258,Testicular Diseases,Gonadal Disorders,6
Cryptorchidism,C,C12.706.258,Urogenital Abnormalities,Male Urogenital Diseases,6
Cryptorchidism,C,C12.294.829.258,Testicular Diseases,"Genital Diseases, Male",6
Cryptorchidism,C,C16.131.939.258,Urogenital Abnormalities,Congenital Abnormalities,6
Cultural Evolution,I,I01.076.201.450.370,Culture,"Anthropology, Cultural",6
Cytochrome P-450 CYP2C19,D,D12.776.422.220.453.491.500.700,Limonene Hydroxylases,Cytochrome P450 Family 2,6
Cytochrome P-450 CYP2C19,D,D08.811.682.690.708.170.450.500.700,Limonene Hydroxylases,Cytochrome P450 Family 2,6
Cytochrome P-450 CYP2C19,D,D08.244.453.491.500.700,Limonene Hydroxylases,Cytochrome P450 Family 2,6
Cytokinesis,G,G04.144.220.250,Cell Division,Cell Cycle,6
Dangerous Behavior,F,F01.145.263,Behavior,Behavior and Behavior Mechanisms,6
Dangerous Behavior,I,I01.880.735.223,Social Problems,Sociology,6
"Death, Sudden",C,C23.550.260.322,Death,Pathologic Processes,6
Deep Learning,L,L01.224.050.375.605.500,"Neural Networks, Computer",Artificial Intelligence,6
Deep Learning,L,L01.224.050.375.530.250,Machine Learning,Artificial Intelligence,6
Deep Learning,G,G17.485.500,"Neural Networks, Computer",Mathematical Concepts,6
Deep Learning,G,G17.035.250.500.250,Machine Learning,Artificial Intelligence,6
Denervation,E,E04.525.210,Neurosurgical Procedures,"Surgical Procedures, Operative",6
Deoxyribonuclease I,D,D08.811.277.352.335.350.250,Endodeoxyribonucleases,Deoxyribonucleases,6
Device Approval,E,E05.337.275,Evaluation Studies as Topic,Investigative Techniques,6
Device Approval,N,N06.850.210.275,Consumer Product Safety,Public Health,6
Diabetic Foot,C,C19.246.099.937.250,Diabetic Neuropathies,Diabetes Complications,6
Diabetic Foot,C,C19.246.099.500.191,Diabetic Angiopathies,Diabetes Complications,6
Diabetic Foot,C,C17.800.893.592.450.200,Foot Ulcer,Leg Ulcer,6
Diabetic Foot,C,C14.907.320.191,Diabetic Angiopathies,Vascular Diseases,6
Digestive System Diseases,C,C06,NULL,NULL,6
Dipeptides,D,D12.644.456.345,Oligopeptides,Peptides,6
Direct Service Costs,N,N05.300.375.250,Health Care Costs,Delivery of Health Care,6
Direct Service Costs,N,N03.219.151.400.325,Health Care Costs,Costs and Cost Analysis,6
Disk Diffusion Antimicrobial Tests,E,E05.200.875.595.399,Microbial Sensitivity Tests,Microbiological Techniques,6
Disk Diffusion Antimicrobial Tests,E,E01.370.225.875.595.399,Microbial Sensitivity Tests,Microbiological Techniques,6
DMF Index,E,E05.318.308.980.438.300.350,Dental Health Surveys,Health Surveys,6
DMF Index,E,E06.208.266,Dental Health Surveys,Dentistry,6
DMF Index,N,N06.850.520.308.980.438.300.350,Dental Health Surveys,Health Surveys,6
DMF Index,N,N05.715.360.300.800.438.300.340,Dental Health Surveys,Health Surveys,6
DMF Index,N,N06.890.160.100,Dental Health Surveys,Public Health Dentistry,6
"DNA, Single-Stranded",G,G05.360.580.437,Nucleic Acid Conformation,Genetic Structures,6
"DNA, Single-Stranded",G,G02.111.570.820.486.437,Nucleic Acid Conformation,Molecular Conformation,6
"DNA, Single-Stranded",D,D13.444.308.497,DNA,Nucleic Acids,6
Dracunculus Nematode,B,B01.050.500.500.294.400.937.225.250.250,Dracunculoidea,Camallanina,6
Drosophila Proteins,D,D12.776.093.500.462,Insect Proteins,Arthropod Proteins,6
Duffy Blood-Group System,D,D23.050.301.290.301,Blood Group Antigens,"Antigens, Surface",6
Duffy Blood-Group System,D,D23.050.705.230.301,Blood Group Antigens,Isoantigens,6
Durapatite,D,D01.146.360.050.300.200,Hydroxyapatites,Apatites,6
Durapatite,D,D01.029.260.700.675.374.075.025.300.150,Hydroxyapatites,Apatites,6
Durapatite,D,D01.578.122.477.300,Hydroxyapatites,Apatites,6
Durapatite,D,D01.695.625.675.650.075.025.300.150,Hydroxyapatites,Apatites,6
Dyspepsia,C,C23.888.821.236,"Signs and Symptoms, Digestive",Signs and Symptoms,6
Elder Abuse,I,I01.198.240.856.350.390,Domestic Violence,Violence,6
Elder Abuse,I,I01.880.735.900.350.390,Domestic Violence,Violence,6
Electric Countershock,E,E02.331.350,Electric Stimulation Therapy,Therapeutics,6
"Electrocardiography, Ambulatory",E,E01.370.520.500.230,"Monitoring, Ambulatory","Monitoring, Physiologic",6
"Electrocardiography, Ambulatory",E,E01.370.405.240.230,Electrocardiography,Electrodiagnosis,6
"Electrocardiography, Ambulatory",E,E01.370.370.380.240.230,Electrocardiography,Heart Function Tests,6
"Electrophoresis, Cellulose Acetate",E,E05.301.300.200,Electrophoresis,Electrochemical Techniques,6
"Electrophoresis, Cellulose Acetate",E,E05.196.401.200,Electrophoresis,"Chemistry Techniques, Analytical",6
Electroretinography,E,E01.370.405.270,Electrodiagnosis,Diagnostic Techniques and Procedures,6
Electroretinography,E,E01.370.380.225,"Diagnostic Techniques, Ophthalmological",Diagnostic Techniques and Procedures,6
Embryo Transfer,E,E02.875.800.500,"Reproductive Techniques, Assisted",Reproductive Techniques,6
Embryo Transfer,E,E05.820.800.500,"Reproductive Techniques, Assisted",Reproductive Techniques,6
"Embryo, Mammalian",A,A16.254,Embryonic Structures,NULL,6
Emollients,D,D27.505.954.444.200,Dermatologic Agents,Therapeutic Uses,6
Employee Performance Appraisal,N,N04.452.677.370,Personnel Management,Organization and Administration,6
End Stage Liver Disease,C,C06.552.308.500.177,Liver Failure,Hepatic Insufficiency,6
Endometrial Ablation Techniques,E,E04.014.240,Ablation Techniques,"Surgical Procedures, Operative",6
Endometrial Ablation Techniques,E,E04.950.300.320,Gynecologic Surgical Procedures,Urogenital Surgical Procedures,6
Endometritis,C,C13.351.500.852.299,Uterine Diseases,"Genital Diseases, Female",6
Endometritis,C,C13.351.500.056.750.249,Pelvic Inflammatory Disease,Adnexal Diseases,6
Environmental Illness,C,C20.543.312,Hypersensitivity,Immune System Diseases,6
Environmental Illness,C,C21.223,Disorders of Environmental Origin,NULL,6
Epidemiologic Measurements,N,N06.850.505,Public Health,Environment and Public Health,6
"Equipment and Supplies, Hospital",E,E07.325,Equipment and Supplies,NULL,6
Equipment Failure Analysis,E,E05.325.192,Equipment Failure,Investigative Techniques,6
Erectile Dysfunction,F,F03.835.400,"Sexual Dysfunctions, Psychological",Mental Disorders,6
Erectile Dysfunction,C,C12.294.644.486,"Sexual Dysfunction, Physiological","Genital Diseases, Male",6
Ergonovine,D,D03.633.400.439.262,Ergolines,"Heterocyclic Compounds, 4 or More Rings",6
Ergonovine,D,D03.132.327.287.262,Ergolines,Ergot Alkaloids,6
Esthetics,F,F02.463.785.477,Thinking,Mental Processes,6
Esthetics,K,K01.752.210,Philosophy,Humanities,6
"Ethics, Clinical",K,K01.752.566.479.045.500,Bioethics,Ethics,6
"Ethics, Clinical",K,K01.752.566.479.171.132,"Ethics, Professional",Ethics,6
"Ethics, Clinical",N,N05.350.200.500,Bioethics,Ethics,6
"Ethics, Clinical",N,N05.350.340.162,"Ethics, Professional",Ethics,6
Everolimus,D,D02.540.505.760.500,Sirolimus,Macrolides,6
Extracellular Signal-Regulated MAP Kinases,D,D12.644.360.450.169,Mitogen-Activated Protein Kinases,Intracellular Signaling Peptides and Proteins,6
Extracellular Signal-Regulated MAP Kinases,D,D08.811.913.696.620.682.700.567.249,Mitogen-Activated Protein Kinases,Protein-Serine-Threonine Kinases,6
Extracellular Signal-Regulated MAP Kinases,D,D12.776.476.450.169,Mitogen-Activated Protein Kinases,Intracellular Signaling Peptides and Proteins,6
Exudates and Transudates,A,A12.383,Fluids and Secretions,NULL,6
Facial Expression,E,E01.370.600.225,Physical Examination,Diagnostic Techniques and Procedures,6
Facial Expression,F,F01.145.209.530.385,Nonverbal Communication,Communication,6
Facility Regulation and Control,N,N05.700.300,"Quality Assurance, Health Care","Health Care Quality, Access, and Evaluation",6
Facility Regulation and Control,N,N03.706.280,"Social Control, Formal",Health Care Economics and Organizations,6
Failure to Thrive,C,C23.888.338,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",6
Fas Ligand Protein,D,D23.529.374.750.249,Tumor Necrosis Factors,Cytokines,6
Fas Ligand Protein,D,D12.776.543.550.312,Membrane Glycoproteins,Membrane Proteins,6
Fas Ligand Protein,D,D12.776.467.374.750.249,Tumor Necrosis Factors,Cytokines,6
Fas Ligand Protein,D,D12.644.276.374.750.249,Tumor Necrosis Factors,Cytokines,6
Fas Ligand Protein,D,D12.776.395.550.312,Membrane Glycoproteins,Glycoproteins,6
"Fatty Acids, Monounsaturated",D,D10.251.355.325,"Fatty Acids, Unsaturated",Fatty Acids,6
Fatty Liver,C,C06.552.241,Liver Diseases,Digestive System Diseases,6
Femoral Artery,A,A07.015.114.351,Arteries,Blood Vessels,6
Filoviridae,B,B04.820.480.937.300,Mononegavirales,Negative-Sense RNA Viruses,6
Fluoxetine,D,D02.092.831.280,Propylamines,Amines,6
Food Deprivation,F,F01.658.433,Motivation,Behavior and Behavior Mechanisms,6
Food Technology,J,J01.576.423.850,Food Industry,Industry,6
"Food, Organic",J,J02.500.519,Food,Food and Beverages,6
"Food, Organic",G,G07.203.300.519,Food,"Diet, Food, and Nutrition",6
Foot-and-Mouth Disease Virus,B,B04.820.578.750.070.250,Aphthovirus,Picornaviridae,6
Forced Expiratory Flow Rates,E,E01.370.386.700.660.225,Pulmonary Ventilation,Respiratory Function Tests,6
Forced Expiratory Flow Rates,G,G09.772.650.300,Pulmonary Ventilation,Respiratory Physiological Phenomena,6
Forestry,J,J01.576.430,Industry,"Technology, Industry, and Agriculture",6
Founder Effect,G,G05.285,Genetic Phenomena,NULL,6
"Fractional Flow Reserve, Myocardial",G,G09.330.100.324.500,Coronary Circulation,Blood Circulation,6
"Fracture Fixation, Internal",E,E04.555.300.300,Fracture Fixation,Orthopedic Procedures,6
Frameshift Mutation,G,G05.365.590.265,Mutation,Genetic Variation,6
Francisella tularensis,B,B03.660.250.200.750,Francisella,Gammaproteobacteria,6
Francisella tularensis,B,B03.440.400.425.340.590,Francisella,Gram-Negative Aerobic Rods and Cocci,6
Free Radicals,D,D02.389,Organic Chemicals,NULL,6
Free Radicals,D,D01.339,Inorganic Chemicals,NULL,6
Furans,D,D03.383.312,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,6
Gabapentin,D,D12.125.190.350.225,gamma-Aminobutyric Acid,Aminobutyrates,6
Gabapentin,D,D02.241.223.268.469,Cyclohexanecarboxylic Acids,"Acids, Carbocyclic",6
Gabapentin,D,D02.455.426.392.368.367.218.500,Cyclohexanecarboxylic Acids,Cyclohexanes,6
Gabapentin,D,D02.092.521,Amines,Organic Chemicals,6
Gabapentin,D,D02.241.081.114.500.350.300,gamma-Aminobutyric Acid,Aminobutyrates,6
Gamma Rays,G,G01.358.500.505.300,Electromagnetic Radiation,Electromagnetic Phenomena,6
Gamma Rays,G,G01.750.250.300,Electromagnetic Radiation,Radiation,6
Gamma Rays,G,G01.750.750.400,"Radiation, Ionizing",Radiation,6
Gender Equity,F,F01.145.813.550.312,Prejudice,Social Behavior,6
Gender Equity,I,I01.880.302,Sociology,Social Sciences,6
"Genes, Regulator",G,G05.360.340.024.340.425,Genes,Genome Components,6
Genomic Library,G,G05.360.340.425,Genome,Genetic Structures,6
Genomic Library,G,G05.360.325.425,Gene Library,Genetic Structures,6
"Germany, East",Z,Z01.586.338,Historical Geographic Locations,Geographic Locations,6
"Germany, West",Z,Z01.586.350,Historical Geographic Locations,Geographic Locations,6
Glass,J,J01.637.437,Manufactured Materials,"Technology, Industry, and Agriculture",6
Glucose-6-Phosphate Isomerase,D,D08.811.399.475.200.350,Aldose-Ketose Isomerases,Intramolecular Oxidoreductases,6
Glycemic Control,E,E02.491,Therapeutics,NULL,6
Glyceraldehyde-3-Phosphate Dehydrogenases,D,D08.811.682.657.163.750,Aldehyde Oxidoreductases,Oxidoreductases Acting on Aldehyde or Oxo Group Donors,6
Granzymes,D,D08.811.277.656.959.350.397,Serine Endopeptidases,Serine Proteases,6
Granzymes,D,D08.811.277.656.300.760.397,Serine Endopeptidases,Endopeptidases,6
Group Purchasing,N,N04.452.442.452.422.679.375,"Purchasing, Hospital",Hospital Departments,6
Group Purchasing,N,N03.219.463.430,Financial Management,Economics,6
Group Purchasing,N,N02.278.216.500.968.679.375,"Purchasing, Hospital",Hospital Departments,6
GTP Phosphohydrolases,D,D08.811.277.040.330,Acid Anhydride Hydrolases,Hydrolases,6
Guanosine Triphosphate,D,D03.633.100.759.646.454.504,Guanine Nucleotides,Purine Nucleotides,6
Guanosine Triphosphate,D,D13.695.827.426.504,Guanine Nucleotides,Ribonucleotides,6
Guanosine Triphosphate,D,D13.695.667.454.504,Guanine Nucleotides,Purine Nucleotides,6
Guilt,F,F01.470.483,Emotions,Behavior and Behavior Mechanisms,6
Hair Color,G,G16.690.490,Pigmentation,Biological Phenomena,6
Hair Color,G,G13.500,Integumentary System Physiological Phenomena,NULL,6
Hantavirus Infections,C,C01.925.782.147.420,Bunyaviridae Infections,RNA Virus Infections,6
Health Facility Closure,N,N02.278.218,Health Facilities,"Health Care Facilities, Manpower, and Services",6
Health Facility Closure,N,N05.300.430.390,Health Services Accessibility,Delivery of Health Care,6
Healthy Worker Effect,N,N05.715.350.350.375,"Effect Modifier, Epidemiologic",Epidemiologic Factors,6
Healthy Worker Effect,N,N06.850.490.734.750,"Effect Modifier, Epidemiologic",Epidemiologic Factors,6
Heart Conduction System,A,A07.541.409,Heart,Cardiovascular System,6
Heart-Assist Devices,E,E07.858.082.374.300,"Heart, Artificial",Artificial Organs,6
Heart-Assist Devices,E,E07.695.300.300,"Heart, Artificial",Prostheses and Implants,6
Heart-Assist Devices,E,E04.050.430,Assisted Circulation,"Surgical Procedures, Operative",6
Heat Stroke,C,C26.522.500,Heat Stress Disorders,Wounds and Injuries,6
Hematopoiesis,G,G04.152.825,Cell Differentiation,Cell Physiological Phenomena,6
Hematopoiesis,G,G09.188.343,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,6
Hemoglobin C Disease,C,C15.378.420.463,Hemoglobinopathies,Hematologic Diseases,6
Hemoglobin C Disease,C,C15.378.071.141.150.490,"Anemia, Hemolytic, Congenital","Anemia, Hemolytic",6
Hemoglobin C Disease,C,C16.320.070.490,"Anemia, Hemolytic, Congenital","Genetic Diseases, Inborn",6
Hemoglobin C Disease,C,C16.320.365.463,Hemoglobinopathies,"Genetic Diseases, Inborn",6
Hemoglobin SC Disease,C,C16.320.365.155.440,"Anemia, Sickle Cell",Hemoglobinopathies,6
Hemoglobin SC Disease,C,C16.320.070.150.440,"Anemia, Sickle Cell","Anemia, Hemolytic, Congenital",6
Hemoglobin SC Disease,C,C15.378.071.141.150.150.440,"Anemia, Sickle Cell","Anemia, Hemolytic, Congenital",6
Hemoglobin SC Disease,C,C15.378.420.155.440,"Anemia, Sickle Cell",Hemoglobinopathies,6
Hemolytic-Uremic Syndrome,C,C15.378.071.141.610,"Anemia, Hemolytic",Anemia,6
Hemolytic-Uremic Syndrome,C,C15.378.140.855.925.500,Thrombotic Microangiopathies,Thrombocytopenia,6
Hemolytic-Uremic Syndrome,C,C13.351.968.419.936.463,Uremia,Kidney Diseases,6
Hemolytic-Uremic Syndrome,C,C12.777.419.936.463,Uremia,Kidney Diseases,6
"Heparin, Low-Molecular-Weight",D,D09.698.373.400.300,Heparin,Glycosaminoglycans,6
"Hepatitis, Chronic",C,C06.552.380.350,Hepatitis,Liver Diseases,6
Hepatocyte Nuclear Factor 4,D,D12.776.260.262.968,Hepatocyte Nuclear Factors,DNA-Binding Proteins,6
Hepatocyte Nuclear Factor 4,D,D12.776.660.352.968,Hepatocyte Nuclear Factors,Nuclear Proteins,6
Hepatocyte Nuclear Factor 4,D,D12.776.826.119,"Receptors, Cytoplasmic and Nuclear",Proteins,6
Hepatocyte Nuclear Factor 4,D,D12.776.930.318.968,Hepatocyte Nuclear Factors,Transcription Factors,6
Herbal Medicine,H,H01.158.273.118.598.500,Pharmacognosy,Botany,6
Herbal Medicine,H,H02.628.190,Pharmacology,Health Occupations,6
Herbal Medicine,H,H01.158.703.060.500,Pharmacognosy,Pharmacology,6
Heteroduplex Analysis,E,E05.393.661.250,Nucleic Acid Hybridization,Genetic Techniques,6
Homeopathy,E,E02.190.388,Complementary Therapies,Therapeutics,6
"Homosexuality, Female",F,F01.145.802.975.500.400,Homosexuality,Sexuality,6
"Homosexuality, Female",G,G08.686.867.500.400,Homosexuality,Sexuality,6
Hordeum,B,B01.650.940.800.575.912.250.822.481,Poaceae,Magnoliopsida,6
Hospital Administrators,M,M01.526.070.490.490,Health Facility Administrators,Administrative Personnel,6
Hospital Administrators,M,M01.526.485.430.490,Health Facility Administrators,Health Personnel,6
Hospital Administrators,M,M01.526.485.740.380,"Personnel, Hospital",Health Personnel,6
Hospital Administrators,N,N02.360.430.490,Health Facility Administrators,Health Personnel,6
Hospital Administrators,N,N02.360.740.380,"Personnel, Hospital",Health Personnel,6
Hot Flashes,C,C23.888.475,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",6
HTLV-II Infections,C,C20.673.483.480,Deltaretrovirus Infections,Immunologic Deficiency Syndromes,6
HTLV-II Infections,C,C01.925.782.815.200.480,Deltaretrovirus Infections,Retroviridae Infections,6
Human Development,G,G07.345.374,Growth and Development,Physiological Phenomena,6
Human Development,F,F01.525,Behavior and Behavior Mechanisms,NULL,6
Human Immunodeficiency Virus Proteins,D,D12.776.964.775.562,Retroviridae Proteins,Viral Proteins,6
Human papillomavirus 6,B,B04.280.210.655.050.606,Alphapapillomavirus,Papillomaviridae,6
Human papillomavirus 6,B,B04.613.204.655.050.606,Alphapapillomavirus,Papillomaviridae,6
Hydrochlorothiazide,D,D03.633.100.174.261.476,Chlorothiazide,Benzothiadiazines,6
Hydrochlorothiazide,D,D02.886.590.700.135.261.476,Chlorothiazide,Benzothiadiazines,6
Hydrochlorothiazide,D,D02.886.655.500.261.476,Chlorothiazide,Benzothiadiazines,6
Hypertriglyceridemia,C,C18.452.584.500.500.851,Hyperlipidemias,Dyslipidemias,6
Hypertrophy,C,C23.300.775,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",6
Immunoconjugates,D,D12.776.377.715.548.114.580,Antibodies,Immunoglobulins,6
Immunoconjugates,D,D12.776.124.790.651.114.580,Antibodies,Immunoglobulins,6
Immunoconjugates,D,D27.888.569.257,Noxae,Toxic Actions,6
Incidental Findings,E,E01.410,Diagnosis,NULL,6
Induction Chemotherapy,E,E02.319.499,Drug Therapy,Therapeutics,6
Induction Chemotherapy,E,E02.860.500,Remission Induction,Therapeutics,6
Industrial Waste,N,N06.850.460.710.420,Waste Products,Environmental Pollution,6
Industrial Waste,D,D20.944.420,Waste Products,Complex Mixtures,6
Inflammasomes,D,D05.500.224,Multiprotein Complexes,Macromolecular Substances,6
"Injections, Spinal",E,E02.319.267.530.580,Injections,Drug Administration Routes,6
Inositol,D,D09.853.519,Sugar Alcohols,Carbohydrates,6
Inositol,D,D02.033.800.519,Sugar Alcohols,Alcohols,6
Interior Design and Furnishings,J,J01.086.339.290,Facility Design and Construction,Architecture,6
Interleukin-15,D,D12.644.276.374.465.515,Interleukins,Cytokines,6
Interleukin-15,D,D23.529.374.465.515,Interleukins,Cytokines,6
Interleukin-15,D,D12.776.467.374.465.515,Interleukins,Cytokines,6
Internal Medicine,H,H02.403.429,Medicine,Health Occupations,6
Intestinal Obstruction,C,C06.405.469.531,Intestinal Diseases,Gastrointestinal Diseases,6
Intracranial Hypertension,C,C10.228.140.631,Brain Diseases,Central Nervous System Diseases,6
"Intrauterine Devices, Medicated",E,E07.190.250.510.520,Intrauterine Devices,"Contraceptive Devices, Female",6
Invertebrates,B,B01.050.500,Animals,Eukaryota,6
Iris,A,A09.371.894.513,Uvea,Eye,6
Iris,A,A09.371.060.450,Anterior Eye Segment,Eye,6
Isoelectric Focusing,E,E05.196.401.663,Electrophoresis,"Chemistry Techniques, Analytical",6
Isoelectric Focusing,E,E05.301.300.663,Electrophoresis,Electrochemical Techniques,6
Jaundice,C,C23.550.429.500,Hyperbilirubinemia,Pathologic Processes,6
Jaundice,C,C23.888.885.375,Skin Manifestations,Signs and Symptoms,6
Kidney Glomerulus,A,A05.810.453.324.359,Kidney Cortex,Kidney,6
Kidney Glomerulus,A,A05.810.453.736.520,Nephrons,Kidney,6
Knee Joint,A,A02.835.583.475,Joints,Skeleton,6
Kruppel-Like Transcription Factors,D,D12.776.930.375,Transcription Factors,Proteins,6
Kruppel-Like Transcription Factors,D,D12.776.260.522,DNA-Binding Proteins,Proteins,6
Kwashiorkor,C,C18.654.521.719.500,Severe Acute Malnutrition,Malnutrition,6
Labor Unions,N,N03.540.571,Organizations,Health Care Economics and Organizations,6
"Laboratories, Hospital",N,N02.278.487.410,Laboratories,Health Facilities,6
"Laboratories, Hospital",N,N02.278.216.500.968.420,Hospital Departments,Hospital Administration,6
"Laboratories, Hospital",N,N04.452.442.452.422.420,Hospital Departments,Hospital Administration,6
Laboratory Infection,C,C24.506,Occupational Diseases,NULL,6
Laboratory Infection,C,C01.503,Infections,NULL,6
Laboratory Personnel,M,M01.526.502,Occupational Groups,Persons,6
Laboratory Proficiency Testing,N,N04.761.700.512,"Quality Assurance, Health Care",Quality of Health Care,6
Laboratory Proficiency Testing,J,J01.897.608.500,Quality Control,Technology,6
Lacerations,C,C26.540,Wounds and Injuries,NULL,6
Leg Ulcer,C,C17.800.893.592,Skin Ulcer,Skin Diseases,6
"Lens Capsule, Crystalline",A,A09.371.060.500.155,"Lens, Crystalline",Anterior Eye Segment,6
"Lens, Crystalline",A,A09.371.060.500,Anterior Eye Segment,Eye,6
Life Support Care,E,E02.760.440,Patient Care,Therapeutics,6
Life Support Care,N,N02.421.585.440,Patient Care,Health Services,6
Lipocalin-2,D,D12.776.624.664.700.123,Proto-Oncogene Proteins,Oncogene Proteins,6
Lipocalin-2,D,D12.776.157.469.325,Lipocalins,Carrier Proteins,6
Lipocalin-2,D,D12.776.124.050.475,Acute-Phase Proteins,Blood Proteins,6
Listeria,B,B03.353.500.500,Bacillales,Firmicutes,6
Listeria,B,B03.510.460.400.410.485,"Gram-Positive Asporogenous Rods, Regular",Gram-Positive Asporogenous Rods,6
Listeria,B,B03.510.100.500,Bacillales,Gram-Positive Bacteria,6
Liver Abscess,C,C01.830.025.020.455,Abdominal Abscess,Abscess,6
Liver Abscess,C,C06.552.597,Liver Diseases,Digestive System Diseases,6
"Liver Cirrhosis, Alcoholic",C,C06.552.645.590,"Liver Diseases, Alcoholic",Liver Diseases,6
"Liver Cirrhosis, Alcoholic",C,C06.552.630.380,Liver Cirrhosis,Liver Diseases,6
"Liver Cirrhosis, Alcoholic",C,C25.775.100.087.645.550,"Liver Diseases, Alcoholic",Alcohol-Induced Disorders,6
"Liver Cirrhosis, Alcoholic",C,C23.550.355.412.380,Liver Cirrhosis,Fibrosis,6
Luminescence,G,G01.750.250.650.665,Light,Electromagnetic Radiation,6
Luminescence,G,G01.750.770.578.665,Light,"Radiation, Nonionizing",6
Luminescence,G,G01.590.540.665,Light,Optical Phenomena,6
Luminescence,G,G01.358.500.505.650.665,Light,Electromagnetic Radiation,6
"Lung Diseases, Fungal",C,C08.381.472,Lung Diseases,Respiratory Tract Diseases,6
"Lung Diseases, Fungal",C,C08.730.435,Respiratory Tract Infections,Respiratory Tract Diseases,6
"Lung Diseases, Fungal",C,C01.748.435,Respiratory Tract Infections,Infections,6
"Lung Diseases, Fungal",C,C01.150.703.534,Mycoses,Bacterial Infections and Mycoses,6
"Lung Diseases, Interstitial",C,C08.381.483,Lung Diseases,Respiratory Tract Diseases,6
Lysine,D,D12.125.142.497,"Amino Acids, Essential",Amino Acids,6
Lysine,D,D12.125.095.647,"Amino Acids, Diamino",Amino Acids,6
Lysine,D,D12.125.068.555,"Amino Acids, Basic",Amino Acids,6
Magnetics,H,H01.671.493,Physics,Natural Science Disciplines,6
Maltose,D,D09.947.750.523,Disaccharides,Sugars,6
Maltose,D,D09.698.365.450,Glucans,Polysaccharides,6
Maltose,D,D09.698.629.305.523,Disaccharides,Oligosaccharides,6
"Mammary Glands, Animal",A,A13.589,Animal Structures,NULL,6
"Mammary Glands, Animal",A,A10.336.482,Exocrine Glands,Tissues,6
Management Information Systems,N,N04.452.515,Organization and Administration,Health Services Administration,6
Mannose-Binding Lectin,D,D12.776.503.311.500,Mannose-Binding Lectins,Lectins,6
Mannose-Binding Lectin,D,D12.776.503.280.249.500,Collectins,"Lectins, C-Type",6
Materials Testing,E,E05.570,Investigative Techniques,NULL,6
Matrix Metalloproteinase 2,D,D12.776.467.836.150,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,6
Matrix Metalloproteinase 2,D,D12.644.276.848.150,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,6
Matrix Metalloproteinase 2,D,D08.811.277.656.300.480.525.700.150,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,6
Matrix Metalloproteinase 2,D,D08.811.277.656.300.480.252.420,Gelatinases,Metalloendopeptidases,6
Matrix Metalloproteinase 2,D,D08.811.277.656.675.374.205.352,Collagenases,Metalloendopeptidases,6
Matrix Metalloproteinase 2,D,D08.811.277.656.675.374.525.700.150,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,6
Matrix Metalloproteinase 2,D,D08.811.277.656.675.374.252.420,Gelatinases,Metalloendopeptidases,6
Matrix Metalloproteinase 2,D,D08.811.277.656.300.480.205.352,Collagenases,Metalloendopeptidases,6
MCF-7 Cells,A,A11.251.210.190.630,"Cell Line, Tumor",Cell Line,6
Meat-Packing Industry,J,J01.576.423.200.700,Food Handling,Food Industry,6
"Medicine, Ayurvedic",I,I01.076.201.450.654.515,"Medicine, Traditional",Culture,6
"Medicine, Ayurvedic",E,E02.190.488.515,"Medicine, Traditional",Complementary Therapies,6
Meglumine,D,D09.067.342.600,Hexosamines,Amino Sugars,6
Meglumine,D,D09.853.813.550,Sorbitol,Sugar Alcohols,6
Meglumine,D,D02.033.800.813.550,Sorbitol,Sugar Alcohols,6
Meglumine Antimoniate,D,D02.033.800.813.550.800,Meglumine,Sorbitol,6
Meglumine Antimoniate,D,D09.853.813.550.800,Meglumine,Sorbitol,6
Meglumine Antimoniate,D,D09.067.342.600.800,Meglumine,Hexosamines,6
Meiosis,G,G04.144.220.220.687,Cell Nucleus Division,Cell Division,6
Meiosis,G,G05.113.220.687,Cell Nucleus Division,Cell Division,6
Membrane Potentials,G,G04.580,Cell Physiological Phenomena,NULL,6
Membrane Potentials,G,G07.265.675,Electrophysiological Phenomena,Physiological Phenomena,6
Membrane Potentials,G,G01.154.535,Biophysical Phenomena,Physical Phenomena,6
Membrane Potentials,G,G11.561.570,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,6
"Memory, Episodic",F,F02.463.425.540.254,Memory,Learning,6
Meningoencephalitis,C,C10.228.140.430.550,Encephalitis,Brain Diseases,6
Meningoencephalitis,C,C10.228.228.570,Central Nervous System Infections,Central Nervous System Diseases,6
Meningoencephalitis,C,C10.228.614.500,Meningitis,Central Nervous System Diseases,6
Meningoencephalitis,C,C10.228.228.245.550,Central Nervous System Viral Diseases,Central Nervous System Infections,6
Meningoencephalitis,C,C01.207.570,Central Nervous System Infections,Infections,6
Meningoencephalitis,C,C01.207.245.550,Central Nervous System Viral Diseases,Central Nervous System Infections,6
Mesenchymal Stem Cells,A,A11.872.590.500,Multipotent Stem Cells,Stem Cells,6
Mesenchymal Stem Cells,A,A11.329.830.500,Stromal Cells,Connective Tissue Cells,6
Metapneumovirus,B,B04.820.480.937.600.670.500,Pneumovirinae,Paramyxoviridae,6
"Mice, Inbred NOD",B,B01.050.150.900.649.313.992.635.505.500.400.565,"Mice, Inbred Strains",Mice,6
"Mice, Inbred NOD",B,B01.050.050.199.520.520.565,"Mice, Inbred Strains","Animals, Inbred Strains",6
Microfluidic Analytical Techniques,E,E05.588.465,Microchip Analytical Procedures,Investigative Techniques,6
"Microscopy, Video",E,E05.595.690,Microscopy,Investigative Techniques,6
"Microscopy, Video",J,J01.897.280.500.898.475,Television,Audiovisual Aids,6
"Microscopy, Video",L,L01.178.847.823.475,Television,Telecommunications,6
"Microscopy, Video",L,L01.178.820.090.898.475,Television,Audiovisual Aids,6
"Microscopy, Video",E,E01.370.350.515.690,Microscopy,Diagnostic Imaging,6
Microvessels,A,A07.015.461,Blood Vessels,Cardiovascular System,6
Minocycline,D,D04.615.562.900.550,Tetracyclines,Naphthacenes,6
Minocycline,D,D02.455.426.559.847.562.900.550,Tetracyclines,Naphthacenes,6
Mitral Valve Stenosis,C,C14.280.484.517,Heart Valve Diseases,Heart Diseases,6
"Models, Structural",L,L01.178.820.090.545,Audiovisual Aids,Teaching Materials,6
"Models, Structural",J,J01.897.280.500.545,Audiovisual Aids,Educational Technology,6
"Monitoring, Ambulatory",E,E01.370.520.500,"Monitoring, Physiologic",Diagnostic Techniques and Procedures,6
Monomeric GTP-Binding Proteins,D,D12.776.476.525,Intracellular Signaling Peptides and Proteins,Proteins,6
Monomeric GTP-Binding Proteins,D,D08.811.277.040.330.300.400,GTP-Binding Proteins,GTP Phosphohydrolases,6
Monomeric GTP-Binding Proteins,D,D12.644.360.525,Intracellular Signaling Peptides and Proteins,Peptides,6
Monomeric GTP-Binding Proteins,D,D12.776.157.325.515,GTP-Binding Proteins,Carrier Proteins,6
Multidetector Computed Tomography,E,E01.370.350.600.350.700.810.800.500,"Tomography, Spiral Computed","Tomography, X-Ray Computed",6
Multidetector Computed Tomography,E,E01.370.350.700.810.810.800.249,"Tomography, Spiral Computed","Tomography, X-Ray Computed",6
Multidetector Computed Tomography,E,E01.370.350.700.700.810.800.500,"Tomography, Spiral Computed","Tomography, X-Ray Computed",6
Multidetector Computed Tomography,E,E01.370.350.350.810.800.500,"Tomography, Spiral Computed","Tomography, X-Ray Computed",6
Multidetector Computed Tomography,E,E01.370.350.825.810.810.800.249,"Tomography, Spiral Computed","Tomography, X-Ray Computed",6
Multienzyme Complexes,D,D05.500.562,Multiprotein Complexes,Macromolecular Substances,6
Multienzyme Complexes,D,D08.811.600,Enzymes,Enzymes and Coenzymes,6
Multiple Trauma,C,C26.640,Wounds and Injuries,NULL,6
Muscarinic Antagonists,D,D27.505.696.577.120.200.500,Cholinergic Antagonists,Cholinergic Agents,6
Muscarinic Antagonists,D,D27.505.519.625.120.200.500,Cholinergic Antagonists,Cholinergic Agents,6
"Muscle, Smooth, Vascular",A,A07.015.733.500,Tunica Media,Blood Vessels,6
"Muscle, Smooth, Vascular",A,A02.633.570.491,"Muscle, Smooth",Muscles,6
"Muscle, Smooth, Vascular",A,A10.690.467.491,"Muscle, Smooth",Muscles,6
Mycobacterium avium Complex,B,B03.510.024.962.500.720.100,Nontuberculous Mycobacteria,Mycobacterium,6
Mycobacterium avium Complex,B,B03.510.460.400.410.552.552.720.100,Nontuberculous Mycobacteria,Mycobacterium,6
Mydriatics,D,D27.505.696.663.050.500,Autonomic Agents,Peripheral Nervous System Agents,6
Myeloid Differentiation Factor 88,D,D12.776.476.024.390,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,6
Myeloid Differentiation Factor 88,D,D12.776.157.057.074,"Adaptor Proteins, Signal Transducing",Carrier Proteins,6
Myeloid Differentiation Factor 88,D,D12.644.360.024.311,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,6
Myocardial Contraction,G,G11.427.494.570,Muscle Contraction,Musculoskeletal Physiological Phenomena,6
Myocardial Contraction,G,G09.330.580,Cardiovascular Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,6
NADPH Oxidases,D,D12.776.331.894,Flavoproteins,Proteins,6
NADPH Oxidases,D,D08.811.682.608.575,"NADH, NADPH Oxidoreductases",Oxidoreductases,6
NADPH Oxidases,D,D12.776.543.653,Membrane Proteins,Proteins,6
Narcotic Antagonists,D,D27.505.696.663.850.512,Sensory System Agents,Peripheral Nervous System Agents,6
Narcotic Antagonists,D,D27.505.954.427.550,Central Nervous System Agents,Therapeutic Uses,6
Narcotic Antagonists,D,D27.505.696.543,Physiological Effects of Drugs,Pharmacologic Actions,6
Nasopharyngeal Neoplasms,C,C07.550.350.650,Nasopharyngeal Diseases,Pharyngeal Diseases,6
Nasopharyngeal Neoplasms,C,C07.550.745.650,Pharyngeal Neoplasms,Pharyngeal Diseases,6
Nasopharyngeal Neoplasms,C,C04.588.443.665.710.650,Pharyngeal Neoplasms,Otorhinolaryngologic Neoplasms,6
Nasopharyngeal Neoplasms,C,C09.775.350.650,Nasopharyngeal Diseases,Pharyngeal Diseases,6
Nasopharyngeal Neoplasms,C,C09.775.549.650,Pharyngeal Neoplasms,Pharyngeal Diseases,6
Nasopharyngeal Neoplasms,C,C09.647.710.650,Pharyngeal Neoplasms,Otorhinolaryngologic Neoplasms,6
Natamycin,D,D02.540.505.550,Macrolides,Lactones,6
"Neoplasms, Squamous Cell",C,C04.557.470.700,"Neoplasms, Glandular and Epithelial",Neoplasms by Histologic Type,6
Nephrectomy,E,E04.950.774.435,Urologic Surgical Procedures,Urogenital Surgical Procedures,6
Nerve Block,E,E03.155.086.711,"Anesthesia, Conduction",Anesthesia,6
Nerve Block,E,E04.525.210.550,Denervation,Neurosurgical Procedures,6
"Neuralgia, Postherpetic",C,C10.668.829.600.550,Neuralgia,Peripheral Nervous System Diseases,6
"Neuralgia, Postherpetic",C,C23.888.592.612.664.550,Neuralgia,Pain,6
Neuroendocrine Tumors,C,C04.557.580.625.650,Neuroectodermal Tumors,"Neoplasms, Nerve Tissue",6
Neuroendocrine Tumors,C,C04.557.465.625.650,Neuroectodermal Tumors,"Neoplasms, Germ Cell and Embryonal",6
Neutrophil Activation,G,G12.604,Immune System Phenomena,NULL,6
Nifedipine,D,D03.383.725.203.540,Dihydropyridines,Pyridines,6
NIH 3T3 Cells,A,A11.251.210.100.550,3T3 Cells,Cell Line,6
NIH 3T3 Cells,A,A11.329.228.100.550,3T3 Cells,Fibroblasts,6
Nippostrongylus,B,B01.050.500.500.294.400.968.400.575,Heligmosomatoidea,Strongylida,6
Nitric Oxide Synthase Type III,D,D08.811.682.664.500.772.750,Nitric Oxide Synthase,Amino Acid Oxidoreductases,6
NK Cell Lectin-Like Receptor Subfamily C,D,D12.776.543.750.705.895.800.810,"Receptors, NK Cell Lectin-Like","Receptors, Natural Killer Cell",6
Noise,G,G16.500.275.600,Environment,Ecological and Environmental Phenomena,6
Noise,N,N06.850.460.610,Environmental Pollution,Public Health,6
Noise,N,N06.230.400,Environment,Environment and Public Health,6
Noise,G,G01.750.770.776.567,Sound,"Radiation, Nonionizing",6
Norfloxacin,D,D03.633.100.810.835.322.374,Fluoroquinolones,Quinolones,6
Nucleotides,D,D09.408.620,Glycosides,Carbohydrates,6
Nucleotides,D,D13.695,"Nucleic Acids, Nucleotides, and Nucleosides",NULL,6
Nursing,N,N04.452.758.377,Professional Practice,Organization and Administration,6
Nursing,H,H02.478,Health Occupations,NULL,6
Occult Blood,E,E05.200.925,Clinical Laboratory Techniques,Investigative Techniques,6
Occult Blood,E,E01.370.225.925,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,6
Odontoblasts,A,A11.329.522,Connective Tissue Cells,Cells,6
Organ Dysfunction Scores,E,E05.318.308.980.438.475.456.500.625,Severity of Illness Index,Patient Acuity,6
Organ Dysfunction Scores,N,N06.850.520.308.980.438.475.364.500.625,Severity of Illness Index,Patient Acuity,6
Organ Dysfunction Scores,N,N05.715.360.300.800.438.375.364.500.625,Severity of Illness Index,Patient Acuity,6
Orphan Drug Production,J,J01.576.655.750.600,Drug Industry,Manufacturing Industry,6
Osteotomy,E,E04.555.580,Orthopedic Procedures,"Surgical Procedures, Operative",6
Otoscopy,E,E01.370.382.637,"Diagnostic Techniques, Otological",Diagnostic Techniques and Procedures,6
Oxazolidinones,D,D03.383.129.462.600,Oxazoles,Azoles,6
"Pacemaker, Artificial",E,E07.305.250.750,Electrodes,Electrical Equipment and Supplies,6
Paranasal Sinus Neoplasms,C,C04.588.443.665.650.693,Nose Neoplasms,Otorhinolaryngologic Neoplasms,6
Paranasal Sinus Neoplasms,C,C09.647.685.693,Nose Neoplasms,Otorhinolaryngologic Neoplasms,6
Paranasal Sinus Neoplasms,C,C09.603.692.503,Paranasal Sinus Diseases,Nose Diseases,6
Paranasal Sinus Neoplasms,C,C09.603.669.693,Nose Neoplasms,Nose Diseases,6
Paranasal Sinus Neoplasms,C,C08.785.600.693,Nose Neoplasms,Respiratory Tract Neoplasms,6
Paranasal Sinus Neoplasms,C,C08.460.692.503,Paranasal Sinus Diseases,Nose Diseases,6
Paranasal Sinus Neoplasms,C,C08.460.669.693,Nose Neoplasms,Nose Diseases,6
Paris,Z,Z01.542.286.588,France,Europe,6
Paris,Z,Z01.433.800,Cities,Geographic Locations,6
Patient Identification Systems,N,N04.452.653,Organization and Administration,Health Services Administration,6
Peer Influence,F,F01.829.316.483.750,Peer Group,Group Processes,6
Peptide Mapping,E,E05.393.760.705.685,"Sequence Analysis, Protein",Sequence Analysis,6
Peptide Mapping,E,E05.196.181.400.454.720,"Chromatography, Paper","Chromatography, Liquid",6
Peptide Mapping,E,E05.196.401.319.720,"Electrophoresis, Paper",Electrophoresis,6
Peptide Mapping,E,E05.196.700,"Chemistry Techniques, Analytical",Investigative Techniques,6
Periplasmic Proteins,D,D12.776.097.577,Bacterial Proteins,Proteins,6
Periplasmic Proteins,D,D12.776.090.650,Archaeal Proteins,Proteins,6
Periplasmic Proteins,D,D12.776.765.537,Plant Proteins,Proteins,6
Phenytoin,D,D03.383.129.308.432.555.730,Hydantoins,Imidazolidines,6
Philosophy,K,K01.752,Humanities,NULL,6
Phosphoprotein Phosphatases,D,D08.811.277.352.650.625,Phosphoric Monoester Hydrolases,Esterases,6
Phosphorus,D,D01.268.666,Elements,Inorganic Chemicals,6
Photoperiod,G,G01.910.675,Time,Physical Phenomena,6
Physical Stimulation,E,E05.723,Investigative Techniques,NULL,6
Phytoestrogens,D,D27.505.696.399.472.277.540.500,"Estrogens, Non-Steroidal",Estrogens,6
Pigmentation,E,E01.370.600.620,Physical Examination,Diagnostic Techniques and Procedures,6
Pigmentation,G,G16.690,Biological Phenomena,NULL,6
Pituitary-Adrenal System,A,A06.300.691,Endocrine Glands,Endocrine System,6
Placenta Growth Factor,D,D12.776.780.551,Pregnancy Proteins,Proteins,6
Placenta Growth Factor,D,D12.644.276.100.800.100,Vascular Endothelial Growth Factors,Angiogenic Proteins,6
Placenta Previa,C,C13.703.590.734,Placenta Diseases,Pregnancy Complications,6
Placenta Previa,C,C13.703.420.714,Obstetric Labor Complications,Pregnancy Complications,6
Platelet Membrane Glycoproteins,D,D12.776.395.550.625,Membrane Glycoproteins,Glycoproteins,6
Platelet Membrane Glycoproteins,D,D12.776.543.750.705.675,"Receptors, Immunologic","Receptors, Cell Surface",6
Platelet Membrane Glycoproteins,D,D12.776.543.550.625,Membrane Glycoproteins,Membrane Proteins,6
Pneumoconiosis,C,C08.381.483.581,"Lung Diseases, Interstitial",Lung Diseases,6
Pneumoconiosis,C,C08.381.520.702,Lung Injury,Lung Diseases,6
Pneumoconiosis,C,C24.800,Occupational Diseases,NULL,6
Polycystic Ovary Syndrome,C,C19.391.630.580.765,Ovarian Cysts,Ovarian Diseases,6
Polycystic Ovary Syndrome,C,C13.351.500.056.630.580.765,Ovarian Cysts,Ovarian Diseases,6
Polycystic Ovary Syndrome,C,C04.182.612.765,Ovarian Cysts,Cysts,6
Polyomavirus Infections,C,C01.925.256.721,DNA Virus Infections,Virus Diseases,6
Pore Forming Cytotoxic Proteins,D,D12.776.543.695,Membrane Proteins,Proteins,6
Posterior Eye Segment,A,A09.371.714,Eye,Sense Organs,6
Poultry Products,J,J02.500.600.750.500,Poultry,Meat,6
Poultry Products,G,G07.203.300.600.750.500,Poultry,Meat,6
"Practice Patterns, Nurses'",N,N04.590.374.553,Delivery of Health Care,Patient Care Management,6
"Practice Patterns, Nurses'",N,N05.300.581,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",6
Pregnancy in Diabetics,C,C13.703.726,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,6
Pregnancy Proteins,D,D12.776.780,Proteins,"Amino Acids, Peptides, and Proteins",6
Preoperative Period,N,N02.421.585.753.937,Perioperative Period,Patient Care,6
Preoperative Period,E,E04.614.937,Perioperative Period,"Surgical Procedures, Operative",6
"Preservatives, Pharmaceutical",D,D27.720.744.771,Pharmaceutic Aids,Specialty Uses of Chemicals,6
"Preservatives, Pharmaceutical",D,D26.650.702,Pharmaceutic Aids,Pharmaceutical Preparations,6
Primary Progressive Nonfluent Aphasia,C,C10.597.606.150.500.800.100.155.600,"Aphasia, Primary Progressive",Aphasia,6
Primary Progressive Nonfluent Aphasia,C,C10.574.950.300.600,Frontotemporal Lobar Degeneration,TDP-43 Proteinopathies,6
Primary Progressive Nonfluent Aphasia,C,C10.228.140.380.132.600,"Aphasia, Primary Progressive",Dementia,6
Primary Progressive Nonfluent Aphasia,C,C10.228.140.380.266.600,Frontotemporal Lobar Degeneration,Dementia,6
Primary Progressive Nonfluent Aphasia,C,C18.452.845.800.300.600,Frontotemporal Lobar Degeneration,TDP-43 Proteinopathies,6
Primary Progressive Nonfluent Aphasia,C,C23.888.592.604.150.500.800.100.155.600,"Aphasia, Primary Progressive",Aphasia,6
Primary Progressive Nonfluent Aphasia,F,F03.615.400.380.600,Frontotemporal Lobar Degeneration,Dementia,6
Primary Progressive Nonfluent Aphasia,F,F03.615.400.125.600,"Aphasia, Primary Progressive",Dementia,6
Prion Proteins,D,D12.776.785.340,Prions,Proteins,6
Prion Proteins,D,D12.776.543.550.418.600,GPI-Linked Proteins,Membrane Glycoproteins,6
Prion Proteins,D,D12.776.543.484.500.625,GPI-Linked Proteins,Lipid-Linked Proteins,6
Prion Proteins,D,D12.776.395.550.448.600,GPI-Linked Proteins,Membrane Glycoproteins,6
Proctitis,C,C06.405.469.860.622,Rectal Diseases,Intestinal Diseases,6
Proctitis,C,C06.405.205.865,Gastroenteritis,Gastrointestinal Diseases,6
Professional Practice Gaps,N,N05.300.643,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",6
Professional Practice Gaps,N,N04.590.374.650,Delivery of Health Care,Patient Care Management,6
Propranolol,D,D02.033.755.624.698.711,Phenoxypropanolamines,Propanolamines,6
Propranolol,D,D02.033.100.624.698.711,Phenoxypropanolamines,Propanolamines,6
Propranolol,D,D02.092.063.624.698.711,Phenoxypropanolamines,Propanolamines,6
Propranolol,D,D04.615.638.945,Naphthalenes,Polycyclic Aromatic Hydrocarbons,6
Propranolol,D,D02.455.426.559.847.638.945,Naphthalenes,Polycyclic Aromatic Hydrocarbons,6
Proprotein Convertase 9,D,D08.811.277.656.300.760.718,Serine Endopeptidases,Endopeptidases,6
Proprotein Convertase 9,D,D08.811.277.656.837.688,Proprotein Convertases,Peptide Hydrolases,6
Proprotein Convertase 9,D,D08.811.277.656.959.350.718,Serine Endopeptidases,Serine Proteases,6
Prostheses and Implants,E,E07.695,Equipment and Supplies,NULL,6
Prosthesis Implantation,E,E04.650,"Surgical Procedures, Operative",NULL,6
Proteasome Endopeptidase Complex,D,D08.811.277.656.918,Peptide Hydrolases,Hydrolases,6
Proteasome Endopeptidase Complex,D,D08.811.600.730,Multienzyme Complexes,Enzymes,6
Proteasome Endopeptidase Complex,D,D05.500.562.500,Multienzyme Complexes,Multiprotein Complexes,6
Protein Interaction Domains and Motifs,G,G02.111.570.820.709.275.750.500,Protein Domains,Protein Structural Elements,6
Protein-Tyrosine Kinases,D,D08.811.913.696.620.682.725,Protein Kinases,Phosphotransferases (Alcohol Group Acceptor),6
Proto-Oncogene Proteins p21(ras),D,D12.644.360.525.500.600,ras Proteins,Monomeric GTP-Binding Proteins,6
Proto-Oncogene Proteins p21(ras),D,D12.776.157.325.515.500.600,ras Proteins,Monomeric GTP-Binding Proteins,6
Proto-Oncogene Proteins p21(ras),D,D08.811.277.040.330.300.400.500.600,ras Proteins,Monomeric GTP-Binding Proteins,6
Proto-Oncogene Proteins p21(ras),D,D12.776.476.525.500.600,ras Proteins,Monomeric GTP-Binding Proteins,6
Proto-Oncogene Proteins p21(ras),D,D12.776.624.664.700.200,Proto-Oncogene Proteins,Oncogene Proteins,6
Puerto Rico,Z,Z01.107.084.900.750,West Indies,Caribbean Region,6
Puerto Rico,Z,Z01.639.880.750,West Indies,Islands,6
Pyoderma Gangrenosum,C,C17.800.893.675,Skin Ulcer,Skin Diseases,6
Pyoderma Gangrenosum,C,C17.800.862.675,"Skin Diseases, Vascular",Skin Diseases,6
Pyoderma Gangrenosum,C,C17.800.695.675,Pyoderma,Skin Diseases,6
R Factors,G,G05.360.600.600,Plasmids,Genetic Structures,6
rab GTP-Binding Proteins,D,D12.776.476.525.400,Monomeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,6
rab GTP-Binding Proteins,D,D08.811.277.040.330.300.400.400,Monomeric GTP-Binding Proteins,GTP-Binding Proteins,6
rab GTP-Binding Proteins,D,D12.776.157.325.515.400,Monomeric GTP-Binding Proteins,GTP-Binding Proteins,6
rab GTP-Binding Proteins,D,D12.644.360.525.400,Monomeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,6
Radiation Effects,G,G01.750.745,Radiation,Physical Phenomena,6
Radiation Effects,N,N06.850.810.300,Radiologic Health,Public Health,6
Radio Waves,G,G01.750.250.810,Electromagnetic Radiation,Radiation,6
Radio Waves,G,G01.750.770.721,"Radiation, Nonionizing",Radiation,6
Radio Waves,G,G01.358.500.505.810,Electromagnetic Radiation,Electromagnetic Phenomena,6
"Radiotherapy, Intensity-Modulated",E,E02.815.635.700.700,"Radiotherapy, Conformal","Radiotherapy, Computer-Assisted",6
"Radiotherapy, Intensity-Modulated",L,L01.313.500.750.100.710.600.550.700,"Radiotherapy, Conformal","Radiotherapy, Computer-Assisted",6
Reagins,D,D12.776.124.790.651.114.890,Antibodies,Immunoglobulins,6
Reagins,D,D12.776.124.486.485.114.890,Antibodies,Immunoglobulins,6
Reagins,D,D12.776.377.715.548.114.890,Antibodies,Immunoglobulins,6
"Receptors, Cytoplasmic and Nuclear",D,D12.776.826,Proteins,"Amino Acids, Peptides, and Proteins",6
"Receptors, Interferon",D,D12.776.543.750.705.852.400,"Receptors, Cytokine","Receptors, Immunologic",6
"Receptors, Interleukin-1",D,D12.776.543.750.705.852.420.300,"Receptors, Interleukin","Receptors, Cytokine",6
"Receptors, LDL",D,D12.776.543.750.710.450,"Receptors, Lipoprotein","Receptors, Cell Surface",6
Rectal Diseases,C,C06.405.469.860,Intestinal Diseases,Gastrointestinal Diseases,6
Reperfusion Injury,C,C14.907.725,Vascular Diseases,Cardiovascular Diseases,6
Reperfusion Injury,C,C23.550.767.877,Postoperative Complications,Pathologic Processes,6
Respiratory Mechanics,G,G09.772.705.700,Respiration,Respiratory Physiological Phenomena,6
Retinal Ganglion Cells,A,A09.371.729.831.875,Retinal Neurons,Retina,6
Retinal Ganglion Cells,A,A08.675.650.850.875,Retinal Neurons,"Neurons, Afferent",6
Retinal Ganglion Cells,A,A11.671.650.850.875,Retinal Neurons,"Neurons, Afferent",6
Retroviridae,B,B04.613.807,Oncogenic Viruses,Viruses,6
Retroviridae,B,B04.820.650,RNA Viruses,Viruses,6
Rhabdoviridae,B,B04.820.480.937.750,Mononegavirales,Negative-Sense RNA Viruses,6
RNA Nucleotidyltransferases,D,D08.811.913.696.445.735,Nucleotidyltransferases,Phosphotransferases,6
Roseolovirus Infections,C,C01.925.256.466.850,Herpesviridae Infections,DNA Virus Infections,6
"Rupture, Spontaneous",C,C23.300.909,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",6
S100 Proteins,D,D12.776.157.125.750,Calcium-Binding Proteins,Carrier Proteins,6
S100 Proteins,D,D12.776.631.655,Nerve Tissue Proteins,Proteins,6
"Saline Solution, Hypertonic",D,D26.776.314.890,Hypertonic Solutions,Solutions,6
Salmonella Phages,B,B04.123.706,Bacteriophages,Viruses,6
Satellite Imagery,L,L01.178.847.550.500,Satellite Communications,Telecommunications,6
Satellite Imagery,L,L01.178.847.675.500.500,Remote Sensing Technology,Telemetry,6
Satellite Imagery,E,E05.925.500.500,Remote Sensing Technology,Telemetry,6
Seminoma,C,C04.557.465.330.800,Germinoma,"Neoplasms, Germ Cell and Embryonal",6
Sensation Disorders,C,C23.888.592.763,Neurologic Manifestations,Signs and Symptoms,6
Sensation Disorders,C,C10.597.751,Neurologic Manifestations,Nervous System Diseases,6
Seoul virus,B,B04.820.480.750.440.690,Hantavirus,Bunyaviridae,6
Serum Amyloid P-Component,D,D12.776.395.690,Glycoproteins,Proteins,6
Serum Amyloid P-Component,D,D12.776.049.407.875,Amyloidogenic Proteins,Amyloid,6
Serum Amyloid P-Component,D,D12.776.124.050.730,Acute-Phase Proteins,Blood Proteins,6
Serum Bactericidal Test,E,E01.370.225.875.595.800,Microbial Sensitivity Tests,Microbiological Techniques,6
Serum Bactericidal Test,E,E05.337.550.400.800,Microbial Sensitivity Tests,"Drug Evaluation, Preclinical",6
Serum Bactericidal Test,E,E05.200.875.595.800,Microbial Sensitivity Tests,Microbiological Techniques,6
Sex Chromosomes,G,G05.360.162.865,Chromosomes,Genetic Structures,6
Sex Chromosomes,A,A11.284.187.865,Chromosomes,Cellular Structures,6
"Sheep, Domestic",B,B01.050.150.900.649.313.500.380.791.150,Sheep,Ruminants,6
Sialic Acids,D,D02.241.081.844.562.668,Neuraminic Acids,Sugar Acids,6
Sialic Acids,D,D02.241.511.902.562.668,Neuraminic Acids,Sugar Acids,6
Sialic Acids,D,D09.067.687.668,Neuraminic Acids,Amino Sugars,6
Sialic Acids,D,D09.811.589.668,Neuraminic Acids,Sugar Acids,6
"Signal Processing, Computer-Assisted",L,L01.224.800,Computing Methodologies,Information Science,6
Sleep Apnea Syndromes,C,C10.886.425.800.750,"Sleep Disorders, Intrinsic",Dyssomnias,6
Sleep Apnea Syndromes,C,C08.618.085.852,Apnea,Respiration Disorders,6
Social Planning,I,I01.880.709,Sociology,Social Sciences,6
Sofosbuvir,D,D03.383.742.686.850.877.500,Uridine Monophosphate,Uracil Nucleotides,6
Sofosbuvir,D,D13.695.827.919.877.500,Uridine Monophosphate,Uracil Nucleotides,6
Sofosbuvir,D,D13.695.740.850.877.500,Uridine Monophosphate,Uracil Nucleotides,6
Solutions,D,D26.776,Pharmaceutical Preparations,NULL,6
Space Perception,F,F02.463.593.778,Perception,Mental Processes,6
"Spectrophotometry, Atomic",E,E05.196.712.726.551,Spectrophotometry,Photometry,6
"Spectrophotometry, Atomic",E,E05.196.867.826.551,Spectrophotometry,Spectrum Analysis,6
"Spectrophotometry, Infrared",E,E05.196.867.826.676,Spectrophotometry,Spectrum Analysis,6
"Spectrophotometry, Infrared",E,E05.196.712.726.676,Spectrophotometry,Photometry,6
Spectrum Analysis,E,E05.196.867,"Chemistry Techniques, Analytical",Investigative Techniques,6
Speech Disorders,C,C10.597.606.150.500.800,Language Disorders,Communication Disorders,6
Speech Disorders,C,C23.888.592.604.150.500.800,Language Disorders,Communication Disorders,6
Sperm Count,E,E01.370.225.500.195.870,Cell Count,Cytological Techniques,6
Sperm Count,E,E01.370.225.992.624,Semen Analysis,Clinical Laboratory Techniques,6
Sperm Count,E,E05.200.500.195.870,Cell Count,Cytological Techniques,6
Sperm Count,E,E05.200.992.624,Semen Analysis,Clinical Laboratory Techniques,6
Sperm Count,E,E05.242.195.870,Cell Count,Cytological Techniques,6
Sperm Count,G,G04.140.870,Cell Count,Cell Physiological Phenomena,6
Spinal Cord Diseases,C,C10.228.854,Central Nervous System Diseases,Nervous System Diseases,6
Staphylococcal Skin Infections,C,C17.800.838.765.770,"Skin Diseases, Bacterial","Skin Diseases, Infectious",6
Staphylococcal Skin Infections,C,C01.150.252.410.868.951,Staphylococcal Infections,Gram-Positive Bacterial Infections,6
Staphylococcal Skin Infections,C,C01.150.252.819.770,"Skin Diseases, Bacterial",Bacterial Infections,6
Staphylococcal Skin Infections,C,C01.800.720.770,"Skin Diseases, Bacterial","Skin Diseases, Infectious",6
Sterols,D,D04.210.500.247.808,Cholestanes,Steroids,6
Sterols,D,D10.570.938,Membrane Lipids,Lipids,6
Streptococcus suis,B,B03.510.550.737.872.750,Streptococcus,Streptococcaceae,6
Streptococcus suis,B,B03.353.750.737.872.750,Streptococcus,Streptococcaceae,6
Streptococcus suis,B,B03.510.400.800.872.750,Streptococcus,Streptococcaceae,6
"Strikes, Employee",N,N04.452.677.842,Personnel Management,Organization and Administration,6
"Strikes, Employee",N,N03.540.571.608,Labor Unions,Organizations,6
Stromal Cells,A,A11.329.830,Connective Tissue Cells,Cells,6
Sulfonic Acids,D,D01.029.260.877.740,Sulfur Acids,"Acids, Noncarboxylic",6
Sulfonic Acids,D,D01.875.800.740,Sulfur Acids,Sulfur Compounds,6
Sulfonic Acids,D,D02.886.645.600,Sulfur Acids,Sulfur Compounds,6
Superoxides,D,D01.650.550.750.800,Peroxides,Oxides,6
Superoxides,D,D01.339.431.374.850,Peroxides,Reactive Oxygen Species,6
Superoxides,D,D01.248.497.158.685.750.850,Peroxides,Oxides,6
Superoxides,D,D02.389.338.732,Peroxides,Free Radicals,6
Surface Properties,G,G02.860,Chemical Phenomena,NULL,6
Surface-Active Agents,D,D27.720.877,Specialty Uses of Chemicals,Chemical Actions and Uses,6
"Surgery Department, Hospital",N,N02.278.216.500.968.750,Hospital Departments,Hospital Administration,6
"Surgery Department, Hospital",N,N04.452.442.452.422.750,Hospital Departments,Hospital Administration,6
Suriname,Z,Z01.107.757.833,South America,Americas,6
Sweetening Agents,J,J02.500.514.500.400.700,Flavoring Agents,Food Additives,6
Sweetening Agents,G,G07.203.300.514.500.400.700,Flavoring Agents,Food Additives,6
Sweetening Agents,D,D27.720.372.300.353.609,Flavoring Agents,Food Additives,6
Sympatry,G,G05.910,Genetic Phenomena,NULL,6
Symptom Flare Up,C,C23.550.291.937.500,Recurrence,Disease Attributes,6
Taboo,I,I01.076.201.450.948,Culture,"Anthropology, Cultural",6
Tachycardia,C,C23.550.073.845,"Arrhythmias, Cardiac",Pathologic Processes,6
Tachycardia,C,C14.280.067.845,"Arrhythmias, Cardiac",Heart Diseases,6
Tachycardia,C,C14.280.123.875,Cardiac Conduction System Disease,Heart Diseases,6
Teaching Materials,L,L01.178.820,Communications Media,Information Science,6
Temperance,F,F01.914,Behavior and Behavior Mechanisms,NULL,6
Terminally Ill,M,M01.873,Persons,NULL,6
Tertiary Healthcare,N,N04.452.758.849.887,Referral and Consultation,Professional Practice,6
Tertiary Healthcare,N,N05.300.787,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",6
Tetanus Toxin,D,D23.946.123.893,Bacterial Toxins,"Toxins, Biological",6
Tetanus Toxin,D,D12.776.097.872,Bacterial Proteins,Proteins,6
Th17 Cells,A,A11.118.637.555.567.569.500.400.915,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,6
Th17 Cells,A,A11.118.637.555.567.569.200.400.915,"T-Lymphocytes, Helper-Inducer",CD4-Positive T-Lymphocytes,6
Th17 Cells,A,A11.118.637.555.567.550.500.400.915,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,6
Th17 Cells,A,A15.382.490.555.567.569.500.400.915,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,6
Th17 Cells,A,A15.382.490.555.567.550.500.400.915,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,6
Th17 Cells,A,A15.382.490.555.567.569.200.400.915,"T-Lymphocytes, Helper-Inducer",CD4-Positive T-Lymphocytes,6
Th17 Cells,A,A15.145.229.637.555.567.569.200.400.770,"T-Lymphocytes, Helper-Inducer",CD4-Positive T-Lymphocytes,6
Th17 Cells,A,A15.145.229.637.555.567.569.500.400.770,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,6
Th17 Cells,A,A15.145.229.637.555.567.550.500.400.770,"T-Lymphocytes, Helper-Inducer",T-Lymphocyte Subsets,6
Theileriasis,C,C01.610.752.750,Protozoan Infections,Parasitic Diseases,6
Theileriasis,C,C01.610.752.625.735,"Protozoan Infections, Animal",Protozoan Infections,6
Theileriasis,C,C01.610.701.688.735,"Protozoan Infections, Animal","Parasitic Diseases, Animal",6
Theileriasis,C,C01.920.930.915,Tick-Borne Diseases,Vector Borne Diseases,6
Theileriasis,C,C22.196.831,Cattle Diseases,Animal Diseases,6
Theileriasis,C,C22.674.710.735,"Protozoan Infections, Animal","Parasitic Diseases, Animal",6
Thioacetazone,D,D02.886.803.702,Thiosemicarbazones,Sulfur Compounds,6
Thioacetazone,D,D02.845.746.703.702,Thiosemicarbazones,Semicarbazones,6
Thoracic Surgery,H,H02.403.810.803,"Specialties, Surgical",Medicine,6
Threonine,D,D12.125.142.815,"Amino Acids, Essential",Amino Acids,6
Threonine,D,D12.125.154.900,"Amino Acids, Neutral",Amino Acids,6
Tick Infestations,C,C01.610.858.211.857,Ectoparasitic Infestations,"Skin Diseases, Parasitic",6
Tissue Adhesions,C,C23.550.355.274.840,Cicatrix,Fibrosis,6
Tissue Culture Techniques,E,E05.481.500.617,Culture Techniques,In Vitro Techniques,6
Togo,Z,Z01.058.290.190.800,"Africa, Western",Africa South of the Sahara,6
Tooth Calcification,G,G07.345.155.500.710,"Calcification, Physiologic",Biomineralization,6
Tooth Calcification,G,G10.549.800,Dental Physiological Phenomena,Digestive System and Oral Physiological Phenomena,6
Tooth Loss,C,C07.793.870,Tooth Diseases,Stomatognathic Diseases,6
Tooth Loss,C,C07.465.714.804,Periodontal Diseases,Mouth Diseases,6
Torpedo,B,B01.050.150.900.493.378.722,Electric Fish,Fishes,6
Torpedo,B,B01.050.150.900.493.370.935,Elasmobranchii,Fishes,6
Toxocara canis,B,B01.050.500.500.294.400.500.100.780.225,Toxocara,Ascaridoidea,6
Toxocariasis,C,C01.610.701.377.868,"Helminthiasis, Animal","Parasitic Diseases, Animal",6
Toxocariasis,C,C01.610.335.508.700.100.868,Ascaridida Infections,Secernentea Infections,6
Toxocariasis,C,C01.610.335.349.868,"Helminthiasis, Animal",Helminthiasis,6
Toxocariasis,C,C22.674.377.868,"Helminthiasis, Animal","Parasitic Diseases, Animal",6
Trabecular Meshwork,A,A09.371.060.932,Anterior Eye Segment,Eye,6
Training Support,N,N03.219.483.838,Financial Support,Economics,6
Transforming Growth Factor beta1,D,D12.644.276.954.775.100,Transforming Growth Factor beta,TGF-beta Superfamily Proteins,6
Transforming Growth Factor beta1,D,D12.644.276.374.687.100,Transforming Growth Factor beta,Cytokines,6
Transforming Growth Factor beta1,D,D23.529.942.775.100,Transforming Growth Factor beta,TGF-beta Superfamily Proteins,6
Transforming Growth Factor beta1,D,D23.529.374.687.100,Transforming Growth Factor beta,Cytokines,6
Transforming Growth Factor beta1,D,D12.776.467.942.775.100,Transforming Growth Factor beta,TGF-beta Superfamily Proteins,6
Transforming Growth Factor beta1,D,D12.776.467.374.687.100,Transforming Growth Factor beta,Cytokines,6
Transplant Recipients,M,M01.925,Persons,NULL,6
Transport Vesicles,A,A11.284.430.214.190.875.190.880,Cytoplasmic Vesicles,Organelles,6
Trypanosoma congolense,B,B01.268.475.868.887.128,Trypanosoma,Trypanosomatina,6
Trypanosomatina,B,B01.268.475.868,Kinetoplastida,Euglenozoa,6
Two-Hybrid System Techniques,E,E05.601.870,Molecular Probe Techniques,Investigative Techniques,6
Two-Hybrid System Techniques,E,E05.601.690.650,Protein Interaction Mapping,Molecular Probe Techniques,6
Two-Hybrid System Techniques,E,E05.393.220.870,"Cloning, Molecular",Genetic Techniques,6
Tympanic Membrane,A,A09.246.272.702,"Ear, External",Ear,6
Type C Phospholipases,D,D08.811.277.352.640.700.700,Phospholipases,Phosphoric Diester Hydrolases,6
Uncompensated Care,N,N05.300.830,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",6
Uncompensated Care,N,N04.590.374.900,Delivery of Health Care,Patient Care Management,6
Upper Extremity,A,A01.378.800,Extremities,Body Regions,6
Uracil Nucleotides,D,D03.383.742.686.850,Pyrimidine Nucleotides,Pyrimidines,6
Uracil Nucleotides,D,D13.695.740.850,Pyrimidine Nucleotides,Nucleotides,6
Uracil Nucleotides,D,D13.695.827.919,Ribonucleotides,Nucleotides,6
Uremia,C,C12.777.419.936,Kidney Diseases,Urologic Diseases,6
Uremia,C,C13.351.968.419.936,Kidney Diseases,Urologic Diseases,6
Urinary Tract,A,A05.810,Urogenital System,NULL,6
Urogenital System,A,A05,NULL,NULL,6
Vascular Endothelial Growth Factor Receptor-1,D,D12.776.543.750.750.400.910.100,"Receptors, Vascular Endothelial Growth Factor","Receptors, Growth Factor",6
Vascular Endothelial Growth Factor Receptor-1,D,D12.776.543.750.630.750.100,"Receptors, Vascular Endothelial Growth Factor",Receptor Protein-Tyrosine Kinases,6
Vascular Endothelial Growth Factor Receptor-1,D,D08.811.913.696.620.682.725.400.950.100,"Receptors, Vascular Endothelial Growth Factor",Receptor Protein-Tyrosine Kinases,6
Verbal Behavior,F,F01.145.209.908,Communication,Behavior,6
Vertebrates,B,B01.050.150.900,Chordata,Animals,6
Vibrio Infections,C,C01.150.252.400.959,Gram-Negative Bacterial Infections,Bacterial Infections,6
Viral Tropism,G,G06.099.925,Bacterial Physiological Phenomena,Microbiological Phenomena,6
Viral Tropism,G,G06.920.863,Virus Physiological Phenomena,Microbiological Phenomena,6
Volatilization,G,G02.734.933,Phase Transition,Chemical Phenomena,6
Volatilization,G,G01.645.750,Phase Transition,Physical Phenomena,6
Voriconazole,D,D03.383.129.799.950,Triazoles,Azoles,6
Warts,C,C01.925.256.650.810,Papillomavirus Infections,DNA Virus Infections,6
Warts,C,C01.925.928.914,Tumor Virus Infections,Virus Diseases,6
Warts,C,C01.925.825.810,"Skin Diseases, Viral",Virus Diseases,6
Warts,C,C17.800.838.790.810,"Skin Diseases, Viral","Skin Diseases, Infectious",6
"Waste Disposal, Fluid",N,N06.850.780.200.800.800.890,Sanitary Engineering,Sanitation,6
"Waste Disposal, Fluid",N,N06.850.860.510.900.600.900,Refuse Disposal,Waste Management,6
Web Browser,L,L01.470.937,Information Storage and Retrieval,Information Science,6
Web Browser,L,L01.224.900.940,Software,Computing Methodologies,6
Western Australia,Z,Z01.678.100.373.996,Australia,Australasia,6
Western Australia,Z,Z01.639.100.996,Australia,Islands,6
Western World,I,I01.076.201.450.226.800,Civilization,Culture,6
Wetlands,G,G16.500.275.157.812,Ecosystem,Environment,6
Wetlands,N,N06.230.124.625,Ecosystem,Environment,6
Widowhood,N,N01.224.361.500.862,Marital Status,Family Characteristics,6
Widowhood,N,N01.824.308.500.862,Marital Status,Family Characteristics,6
Widowhood,I,I01.240.361.500.862,Marital Status,Family Characteristics,6
Widowhood,I,I01.880.853.150.423.500.862,Marital Status,Family Characteristics,6
Widowhood,F,F01.829.263.315.500.862,Marital Status,Family Characteristics,6
X-Rays,G,G01.358.500.505.970,Electromagnetic Radiation,Electromagnetic Phenomena,6
X-Rays,G,G01.750.750.918,"Radiation, Ionizing",Radiation,6
X-Rays,G,G01.750.250.970,Electromagnetic Radiation,Radiation,6
Yersinia pseudotuberculosis Infections,C,C01.150.252.400.310.980.780,Yersinia Infections,Enterobacteriaceae Infections,6
Zeaxanthins,D,D02.455.326.271.665.202.868.750,Xanthophylls,Carotenoids,6
Zeaxanthins,D,D02.455.426.392.368.367.379.249.887.750,Xanthophylls,Carotenoids,6
Zeaxanthins,D,D02.455.849.131.868.750,Xanthophylls,Carotenoids,6
Zeaxanthins,D,D23.767.261.887.750,Xanthophylls,Carotenoids,6
3-Hydroxybutyric Acid,D,D02.522.585.087,Ketone Bodies,Ketones,5
3-Hydroxybutyric Acid,D,D10.251.400.143.781.500,Hydroxybutyrates,Butyrates,5
3-Hydroxybutyric Acid,D,D02.241.511.429.349,Hydroxybutyrates,Hydroxy Acids,5
3-Hydroxybutyric Acid,D,D02.241.081.114.937.349,Hydroxybutyrates,Butyrates,5
4-Butyrolactone,D,D02.540.150,Lactones,Organic Chemicals,5
4-Butyrolactone,D,D03.383.312.150,Furans,"Heterocyclic Compounds, 1-Ring",5
Abdominal Fat,A,A10.165.114.830.500,"Adipose Tissue, White",Adipose Tissue,5
Abortion Applicants,M,M01.050,Persons,NULL,5
"Abortion, Eugenic",E,E04.520.050.050,"Abortion, Induced",Obstetric Surgical Procedures,5
"Abortion, Incomplete",C,C13.703.039.093,"Abortion, Spontaneous",Pregnancy Complications,5
"Accidents, Home",N,N06.850.135.217,Accidents,Public Health,5
Acid Phosphatase,D,D08.811.277.352.650.025,Phosphoric Monoester Hydrolases,Esterases,5
Acids,D,D01.029,Inorganic Chemicals,NULL,5
Actigraphy,E,E01.370.520.049,"Monitoring, Physiologic",Diagnostic Techniques and Procedures,5
Actigraphy,E,E05.003.500,Accelerometry,Investigative Techniques,5
Action Potentials,G,G07.265.675.100,Membrane Potentials,Electrophysiological Phenomena,5
Action Potentials,G,G04.580.100,Membrane Potentials,Cell Physiological Phenomena,5
Action Potentials,G,G11.561.570.100,Membrane Potentials,Nervous System Physiological Phenomena,5
Adenosine Deaminase,D,D08.811.277.151.486.075,Nucleoside Deaminases,Aminohydrolases,5
Adenosine Monophosphate,D,D03.633.100.759.646.138.180,Adenine Nucleotides,Purine Nucleotides,5
Adenosine Monophosphate,D,D13.695.667.138.180,Adenine Nucleotides,Purine Nucleotides,5
Adenosine Monophosphate,D,D13.695.827.068.180,Adenine Nucleotides,Ribonucleotides,5
Advance Care Planning,N,N04.590.233.624.124,Patient Care Planning,Comprehensive Health Care,5
Aflatoxin B1,D,D23.946.587.142.075,Aflatoxins,Mycotoxins,5
Aflatoxin B1,D,D03.383.663.283.119.075,Aflatoxins,Benzopyrans,5
Aflatoxin B1,D,D03.633.100.150.119.075,Aflatoxins,Benzopyrans,5
"Aging, Premature",C,C23.888.069,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",5
Alendronate,D,D02.705.429.500.100,Diphosphonates,Organophosphonates,5
Algeria,Z,Z01.058.266.104,"Africa, Northern",Africa,5
Allografts,A,A01.941.500,Transplants,Body Regions,5
Amiloride,D,D03.383.679.149,Pyrazines,"Heterocyclic Compounds, 1-Ring",5
Aminoacyltransferases,D,D08.811.913.050.200,Acyltransferases,Transferases,5
Aminocaproic Acid,D,D12.125.213.075,Aminocaproates,Amino Acids,5
Aminocaproic Acid,D,D02.241.081.193.150.075,Aminocaproates,Caproates,5
Aminopeptidases,D,D08.811.277.656.350.100,Exopeptidases,Peptide Hydrolases,5
Aminosalicylic Acid,D,D02.241.223.100.300.595.100.060,Aminosalicylic Acids,Salicylates,5
Aminosalicylic Acid,D,D02.241.223.100.050.500.642,para-Aminobenzoates,Aminobenzoates,5
Aminosalicylic Acid,D,D02.241.511.390.595.100.060,Aminosalicylic Acids,Salicylates,5
Aminosalicylic Acid,D,D02.455.426.559.389.127.020.937.642,para-Aminobenzoates,Aminobenzoates,5
Aminosalicylic Acid,D,D02.455.426.559.389.127.281.595.100.060,Aminosalicylic Acids,Salicylates,5
Aminosalicylic Acid,D,D02.455.426.559.389.657.410.595.100.060,Aminosalicylic Acids,Salicylates,5
Amniotic Fluid,A,A12.098,Fluids and Secretions,NULL,5
Amniotic Fluid,A,A16.378.149,Fetus,Embryonic Structures,5
Amoeba,B,B01.046.500.100.700.089,Tubulina,Amoebida,5
Ancylostomiasis,C,C01.610.335.508.700.775.455.154,Hookworm Infections,Strongylida Infections,5
"Anesthetics, Local",D,D27.505.954.427.210.100.200,Anesthetics,Central Nervous System Depressants,5
"Anesthetics, Local",D,D27.505.696.663.850.025,Sensory System Agents,Peripheral Nervous System Agents,5
"Anesthetics, Local",D,D27.505.696.277.100.200,Anesthetics,Central Nervous System Depressants,5
Anger,F,F01.470.093,Emotions,Behavior and Behavior Mechanisms,5
Angiography,E,E01.370.350.700.060,Radiography,Diagnostic Imaging,5
Angiography,E,E01.370.370.050,"Diagnostic Techniques, Cardiovascular",Diagnostic Techniques and Procedures,5
Angiostrongylus cantonensis,B,B01.050.500.500.294.400.968.588.080.225,Angiostrongylus,Metastrongyloidea,5
Animal Structures,A,A13,NULL,NULL,5
Ankle Brachial Index,E,E01.370.370.140.049,Blood Pressure Determination,"Diagnostic Techniques, Cardiovascular",5
"Anthropology, Physical",I,I01.076.368,Anthropology,Social Sciences,5
Antiemetics,D,D27.505.696.663.050.030,Autonomic Agents,Peripheral Nervous System Agents,5
Antiemetics,D,D27.505.954.427.095,Central Nervous System Agents,Therapeutic Uses,5
Antiemetics,D,D27.505.954.483.200,Gastrointestinal Agents,Therapeutic Uses,5
Anti-Obesity Agents,D,D27.505.954.203,Therapeutic Uses,Pharmacologic Actions,5
Antiparkinson Agents,D,D27.505.954.427.090.050,Anti-Dyskinesia Agents,Central Nervous System Agents,5
Aphakia,C,C11.510.103,Lens Diseases,Eye Diseases,5
Apolipoproteins A,D,D12.776.521.120.200,Apolipoproteins,Lipoproteins,5
Apolipoproteins A,D,D10.532.091.200,Apolipoproteins,Lipoproteins,5
Apolipoproteins A,D,D12.776.070.400.200,Apolipoproteins,Apoproteins,5
"Aptamers, Nucleotide",D,D13.695.578.424.224,Oligonucleotides,Polynucleotides,5
Aqueous Humor,A,A12.207.270.040,Extracellular Fluid,Body Fluids,5
Aqueous Humor,A,A09.371.060.067.070,Anterior Chamber,Anterior Eye Segment,5
Arachis,B,B01.650.940.800.575.912.250.401.077,Fabaceae,Magnoliopsida,5
Arenaviridae Infections,C,C01.925.782.082,RNA Virus Infections,Virus Diseases,5
Arousal,G,G11.561.035,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,5
Arousal,F,F02.830.104,Psychophysiology,Psychological Phenomena,5
Arthropods,B,B01.050.500.131,Invertebrates,Animals,5
Arylamine N-Acetyltransferase,D,D08.811.913.050.134.138,Acetyltransferases,Acyltransferases,5
"Asbestos, Serpentine",D,D01.524.500.050,Magnesium Silicates,Magnesium Compounds,5
"Asbestos, Serpentine",D,D01.578.725.050.075,Asbestos,Silicates,5
"Asbestos, Serpentine",D,D01.578.725.500.050,Magnesium Silicates,Silicates,5
"Asbestos, Serpentine",D,D01.837.725.700.760.070.110,Asbestos,Silicates,5
"Asbestos, Serpentine",D,D01.837.725.700.760.535.400,Magnesium Silicates,Silicates,5
Asphyxia,C,C26.103,Wounds and Injuries,NULL,5
Asphyxia,C,C23.550.260.095,Death,Pathologic Processes,5
Athletes,M,M01.072,Persons,NULL,5
Atlases as Topic,L,L01.178.682.192.836.147,Reference Books,Books,5
Atmosphere,G,G16.500.275.063,Environment,Ecological and Environmental Phenomena,5
Atmosphere,N,N06.230.300.100,Meteorological Concepts,Environment,5
"ATP Binding Cassette Transporter, Subfamily B",D,D12.776.157.530.450.074.500.500.250,"Organic Anion Transporters, ATP-Dependent",Organic Anion Transporters,5
"ATP Binding Cassette Transporter, Subfamily B",D,D12.776.157.530.100.075,ATP-Binding Cassette Transporters,Membrane Transport Proteins,5
"ATP Binding Cassette Transporter, Subfamily B",D,D12.776.395.550.020.400,ATP-Binding Cassette Transporters,Membrane Glycoproteins,5
"ATP Binding Cassette Transporter, Subfamily B",D,D12.776.543.550.192.400,ATP-Binding Cassette Transporters,Membrane Glycoproteins,5
"ATP Binding Cassette Transporter, Subfamily B",D,D12.776.543.585.100.200,ATP-Binding Cassette Transporters,Membrane Transport Proteins,5
"ATP Binding Cassette Transporter, Subfamily B",D,D12.776.543.585.450.074.500.500.250,"Organic Anion Transporters, ATP-Dependent",Organic Anion Transporters,5
ATP Synthetase Complexes,D,D08.811.913.696.650.150,Phosphotransferases (Phosphate Group Acceptor),Phosphotransferases,5
"Automation, Laboratory",J,J01.897.104.416,Automation,Technology,5
"Automation, Laboratory",E,E05.064,Investigative Techniques,NULL,5
B7-H1 Antigen,D,D12.776.543.095.300,B7 Antigens,Membrane Proteins,5
B7-H1 Antigen,D,D12.776.465.625,Immune Checkpoint Proteins,Proteins,5
B7-H1 Antigen,D,D12.776.467.150.300,B7 Antigens,Intercellular Signaling Peptides and Proteins,5
B7-H1 Antigen,D,D23.050.301.285.400,B7 Antigens,"Antigens, Surface",5
B7-H1 Antigen,D,D23.529.168.300,B7 Antigens,Intercellular Signaling Peptides and Proteins,5
Babesia,B,B01.043.075.600.580.070,Piroplasmida,Piroplasmia,5
Bacteriology,H,H01.158.273.540.177,Microbiology,Biology,5
Bacteriophage Typing,E,E05.200.875.150.125.150,Bacterial Typing Techniques,Bacteriological Techniques,5
Bacteriophage Typing,E,E01.370.225.875.150.125.150,Bacterial Typing Techniques,Bacteriological Techniques,5
Basophils,A,A15.145.229.637.415.120,Granulocytes,Leukocytes,5
Basophils,A,A15.382.490.315.120,Granulocytes,Leukocytes,5
Basophils,A,A11.627.340.120,Granulocytes,Myeloid Cells,5
Basophils,A,A11.118.637.415.120,Granulocytes,Leukocytes,5
Bedbugs,B,B01.050.500.131.617.412.420.150.100,Cimicidae,Heteroptera,5
Benzene,D,D02.455.426.559.389.023,Benzene Derivatives,"Hydrocarbons, Aromatic",5
Bifidobacterium,B,B03.510.460.400.400.049.100,Actinobacteria,"Gram-Positive Asporogenous Rods, Irregular",5
Bifidobacterium,B,B03.510.024.100,Actinobacteria,Gram-Positive Bacteria,5
Bile Duct Neoplasms,C,C04.588.274.120.250,Biliary Tract Neoplasms,Digestive System Neoplasms,5
Bile Duct Neoplasms,C,C06.130.320.120,Biliary Tract Neoplasms,Biliary Tract Diseases,5
Bile Duct Neoplasms,C,C06.130.120.120,Bile Duct Diseases,Biliary Tract Diseases,5
Bile Duct Neoplasms,C,C06.301.120.250,Biliary Tract Neoplasms,Digestive System Neoplasms,5
Biocatalysis,G,G02.111.086,Biochemical Phenomena,Chemical Phenomena,5
Biocatalysis,G,G03.105,Metabolism,NULL,5
Biocatalysis,G,G02.130.500,Catalysis,Chemical Phenomena,5
Biocompatible Materials,J,J01.637.051.130,Biomedical and Dental Materials,Manufactured Materials,5
Biocompatible Materials,D,D25.130,Biomedical and Dental Materials,NULL,5
Biocompatible Materials,D,D27.720.102.130,Biomedical and Dental Materials,Specialty Uses of Chemicals,5
Biological Control Agents,D,D20.215.113,Biological Products,Complex Mixtures,5
"Biological Transport, Active",G,G03.143.310,Biological Transport,Metabolism,5
Biosynthetic Pathways,G,G03.493.100,Metabolic Networks and Pathways,Metabolism,5
Biosynthetic Pathways,G,G02.111.098,Biochemical Phenomena,Chemical Phenomena,5
Birth Injuries,C,C26.141,Wounds and Injuries,NULL,5
Birth Injuries,C,C16.614.131,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",5
Blood Banks,N,N02.278.065.200,Biological Specimen Banks,Health Facilities,5
Blood Group Antigens,D,D23.050.301.290,"Antigens, Surface",Antigens,5
Blood Group Antigens,D,D23.050.705.230,Isoantigens,Antigens,5
Blood Viscosity,G,G09.188.370.124,Hemorheology,Blood Physiological Phenomena,5
Blood Viscosity,G,G09.330.380.630.110,Hemorheology,Hemodynamics,5
Bone Cements,J,J01.637.051.720.716.822.300,"Resins, Synthetic",Plastics,5
Bone Cements,D,D25.720.716.822.300,"Resins, Synthetic",Plastics,5
Bone Cements,D,D27.720.102.158,Biomedical and Dental Materials,Specialty Uses of Chemicals,5
Bone Cements,D,D05.750.716.822.300,"Resins, Synthetic",Plastics,5
Brain-Derived Neurotrophic Factor,D,D12.644.276.860.100,Nerve Growth Factors,Intercellular Signaling Peptides and Proteins,5
Brain-Derived Neurotrophic Factor,D,D23.529.850.100,Nerve Growth Factors,Intercellular Signaling Peptides and Proteins,5
Brain-Derived Neurotrophic Factor,D,D12.776.631.600.100,Nerve Growth Factors,Nerve Tissue Proteins,5
Brain-Derived Neurotrophic Factor,D,D12.776.467.860.100,Nerve Growth Factors,Intercellular Signaling Peptides and Proteins,5
Brucella melitensis,B,B03.660.050.070.100.500,Brucella,Brucellaceae,5
Brucella melitensis,B,B03.440.400.425.215.500.500,Brucella,Brucellaceae,5
Bulimia Nervosa,F,F03.400.250,Feeding and Eating Disorders,Mental Disorders,5
Caffeine,D,D03.633.100.759.758.824.175,Xanthines,Purinones,5
Caffeine,D,D03.132.960.175,Xanthines,Alkaloids,5
Calcitonin Gene-Related Peptide,D,D12.644.400.097,Neuropeptides,Peptides,5
Calcitonin Gene-Related Peptide,D,D12.776.631.650.097,Neuropeptides,Nerve Tissue Proteins,5
Calcium Carbonate,D,D01.146.275,Calcium Compounds,Inorganic Chemicals,5
Calcium Carbonate,D,D01.200.275.150.150,Carbonates,Carbonic Acid,5
Calcium Carbonate,D,D01.578.200,Minerals,Inorganic Chemicals,5
Cancer Vaccines,D,D20.215.894.200,Vaccines,Biological Products,5
Candida,B,B01.300.381.147,Mitosporic Fungi,Fungi,5
Candida,B,B01.300.107.795.095,Saccharomycetales,Ascomycota,5
Candida,B,B01.300.930.176,Yeasts,Fungi,5
Capecitabine,D,D13.570.230.329.313,Deoxycytidine,Deoxyribonucleosides,5
Capecitabine,D,D13.570.685.245.500.425,Deoxycytidine,Cytidine,5
Capecitabine,D,D03.383.742.698.875.404.425,Fluorouracil,Uracil,5
Capecitabine,D,D03.383.742.680.245.500.425,Deoxycytidine,Cytidine,5
Carbohydrate Conformation,G,G02.111.570.820.235,Molecular Conformation,Molecular Structure,5
Carbon Monoxide Poisoning,C,C25.723.455.245,Gas Poisoning,Poisoning,5
Carboxyhemoglobin,D,D12.776.124.400.141,Hemoglobins,Blood Proteins,5
Carboxyhemoglobin,D,D12.776.422.316.762.149,Hemoglobins,Globins,5
"Carcinoma, Ovarian Epithelial",C,C19.391.630.705.350,Ovarian Neoplasms,Ovarian Diseases,5
"Carcinoma, Ovarian Epithelial",C,C19.344.410.199,Ovarian Neoplasms,Endocrine Gland Neoplasms,5
"Carcinoma, Ovarian Epithelial",C,C13.351.937.418.685.350,Ovarian Neoplasms,"Genital Neoplasms, Female",5
"Carcinoma, Ovarian Epithelial",C,C13.351.500.056.630.705.350,Ovarian Neoplasms,Ovarian Diseases,5
"Carcinoma, Ovarian Epithelial",C,C04.588.322.455.199,Ovarian Neoplasms,Endocrine Gland Neoplasms,5
"Carcinoma, Ovarian Epithelial",C,C04.557.470.200.295,Carcinoma,"Neoplasms, Glandular and Epithelial",5
Cardiomegaly,C,C14.280.195,Heart Diseases,Cardiovascular Diseases,5
Cardiomegaly,C,C23.300.775.250,Hypertrophy,"Pathological Conditions, Anatomical",5
Cardiometabolic Risk Factors,E,E05.318.740.600.800.725.500.500,Heart Disease Risk Factors,Risk Factors,5
Cardiometabolic Risk Factors,N,N05.715.360.750.625.700.700.500.500,Heart Disease Risk Factors,Risk Factors,5
Cardiometabolic Risk Factors,N,N06.850.490.625.750.500.500,Heart Disease Risk Factors,Risk Factors,5
Cardiometabolic Risk Factors,N,N05.715.350.200.700.500.500,Heart Disease Risk Factors,Risk Factors,5
Cardiometabolic Risk Factors,N,N06.850.520.830.600.800.725.500.500,Heart Disease Risk Factors,Risk Factors,5
Caspase 3,D,D12.776.476.075.405.350.300,"Caspases, Effector",Caspases,5
Caspase 3,D,D12.644.360.075.405.350.300,"Caspases, Effector",Caspases,5
Caspase 3,D,D08.811.277.656.300.200.126.350.300,"Caspases, Effector",Caspases,5
Caspase 3,D,D08.811.277.656.262.500.126.350.300,"Caspases, Effector",Caspases,5
Cathartics,D,D27.505.954.483.396,Gastrointestinal Agents,Therapeutic Uses,5
CD28 Antigens,D,D23.101.100.894.128,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",5
CD28 Antigens,D,D12.776.543.750.705.222.500,Costimulatory and Inhibitory T-Cell Receptors,"Receptors, Immunologic",5
CD28 Antigens,D,D23.050.301.264.894.128,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",5
CD40 Ligand,D,D12.776.467.374.750.124,Tumor Necrosis Factors,Cytokines,5
CD40 Ligand,D,D12.776.543.550.198,Membrane Glycoproteins,Membrane Proteins,5
CD40 Ligand,D,D23.529.374.750.124,Tumor Necrosis Factors,Cytokines,5
CD40 Ligand,D,D12.644.276.374.750.124,Tumor Necrosis Factors,Cytokines,5
CD40 Ligand,D,D12.776.395.550.185,Membrane Glycoproteins,Glycoproteins,5
CD59 Antigens,D,D12.776.395.550.448.140,GPI-Linked Proteins,Membrane Glycoproteins,5
CD59 Antigens,D,D12.776.543.550.418.140,GPI-Linked Proteins,Membrane Glycoproteins,5
CD59 Antigens,D,D12.776.543.484.500.140,GPI-Linked Proteins,Lipid-Linked Proteins,5
Cell Aggregation,G,G04.198.251,Cell Movement,Cell Physiological Phenomena,5
Cell Compartmentation,G,G04.128,Cell Physiological Phenomena,NULL,5
Cell-Free System,A,A11.284.835.168,Subcellular Fractions,Cellular Structures,5
Central Nervous System Infections,C,C01.207,Infections,NULL,5
Central Nervous System Infections,C,C10.228.228,Central Nervous System Diseases,Nervous System Diseases,5
Cercaria,B,B05.500.500.150,Larva,Life Cycle Stages,5
Cercaria,G,G07.345.500.550.500.500.150,Larva,Life Cycle Stages,5
Cerebellum,A,A08.186.211.132.810.428.200,Metencephalon,Rhombencephalon,5
"Cesarean Section, Repeat",E,E04.520.252.500.150,Cesarean Section,"Delivery, Obstetric",5
Chaperonins,D,D12.776.580.216.210,Heat-Shock Proteins,Molecular Chaperones,5
Chaperonins,D,D08.811.277.040.025.142,Adenosine Triphosphatases,Acid Anhydride Hydrolases,5
Chemokine CCL3,D,D12.644.276.374.200.600.150,Macrophage Inflammatory Proteins,Chemokines,5
Chemokine CCL3,D,D12.644.276.374.200.110.150,"Chemokines, CC",Chemokines,5
Chemokine CCL3,D,D12.776.467.374.200.110.150,"Chemokines, CC",Chemokines,5
Chemokine CCL3,D,D12.776.467.374.200.600.150,Macrophage Inflammatory Proteins,Chemokines,5
Chemokine CCL3,D,D23.469.200.600.150,Macrophage Inflammatory Proteins,Chemokines,5
Chemokine CCL3,D,D23.529.374.200.110.150,"Chemokines, CC",Chemokines,5
Chemokine CCL3,D,D23.529.374.200.600.150,Macrophage Inflammatory Proteins,Chemokines,5
Chemokine CCL3,D,D23.125.300.110.150,"Chemokines, CC",Chemokines,5
Chemokine CCL3,D,D23.469.200.110.150,"Chemokines, CC",Chemokines,5
Chemokine CCL3,D,D23.125.300.600.500,Macrophage Inflammatory Proteins,Chemokines,5
Chest Tubes,E,E07.858.150,Surgical Equipment,Equipment and Supplies,5
Chicago,Z,Z01.107.567.875.350.350.200,Illinois,Great Lakes Region,5
Chicago,Z,Z01.107.567.875.510.350.200,Illinois,Midwestern United States,5
Chicago,Z,Z01.433.305,Cities,Geographic Locations,5
"Child, Abandoned",M,M01.097,Persons,NULL,5
Chitinases,D,D08.811.277.450.207,Glycoside Hydrolases,Hydrolases,5
Chitosan,D,D05.750.078.139.500,Chitin,Biopolymers,5
Chitosan,D,D09.698.211.500,Chitin,Polysaccharides,5
Chlorambucil,D,D02.455.526.728.650.156,Nitrogen Mustard Compounds,Mustard Compounds,5
Chondroitin Sulfates,D,D09.698.373.200.300,Chondroitin,Glycosaminoglycans,5
Chorionic Gonadotropin,D,D12.644.548.726.367,Placental Hormones,Peptide Hormones,5
Chorionic Gonadotropin,D,D06.472.699.649.367,Placental Hormones,Peptide Hormones,5
Chorionic Gonadotropin,D,D06.472.699.322.326,Gonadotropins,Peptide Hormones,5
Chorionic Gonadotropin,D,D12.776.780.400,Pregnancy Proteins,Proteins,5
"Chromatography, Ion Exchange",E,E05.196.181.400.383,"Chromatography, Liquid",Chromatography,5
"Chromosomes, Human, Pair 18",G,G05.360.162.520.300.415.430,"Chromosomes, Human, 16-18","Chromosomes, Human",5
"Chromosomes, Human, Pair 18",A,A11.284.187.520.300.415.430,"Chromosomes, Human, 16-18","Chromosomes, Human",5
"Chromosomes, Human, Pair 4",A,A11.284.187.520.300.280.285,"Chromosomes, Human, 4-5","Chromosomes, Human",5
"Chromosomes, Human, Pair 4",G,G05.360.162.520.300.280.285,"Chromosomes, Human, 4-5","Chromosomes, Human",5
"Chromosomes, Human, Y",G,G05.360.162.520.300.505.757,"Chromosomes, Human, 21-22 and Y","Chromosomes, Human",5
"Chromosomes, Human, Y",G,G05.360.162.865.983.500,Y Chromosome,Sex Chromosomes,5
"Chromosomes, Human, Y",A,A11.284.187.520.300.505.757,"Chromosomes, Human, 21-22 and Y","Chromosomes, Human",5
"Chromosomes, Human, Y",A,A11.284.187.865.983.500,Y Chromosome,Sex Chromosomes,5
Chytridiomycota,B,B01.300.283,Fungi,Eukaryota,5
Cisplatin,D,D01.210.375,Chlorine Compounds,Inorganic Chemicals,5
Cisplatin,D,D01.625.125,Nitrogen Compounds,Inorganic Chemicals,5
Cisplatin,D,D01.710.100,Platinum Compounds,Inorganic Chemicals,5
Clavulanic Acid,D,D02.065.589.099.374.160,Clavulanic Acids,beta-Lactams,5
Clavulanic Acid,D,D03.633.100.300.374.160,Clavulanic Acids,beta-Lactams,5
Clinical Studies as Topic,E,E05.318.372.250,Epidemiologic Study Characteristics,Epidemiologic Methods,5
Clinical Studies as Topic,N,N05.715.360.330.250,Epidemiologic Study Characteristics,Health Care Evaluation Mechanisms,5
Clinical Studies as Topic,N,N06.850.520.450.250,Epidemiologic Study Characteristics,Epidemiologic Methods,5
Coal,N,N06.230.132.258.108,Fossil Fuels,Energy-Generating Resources,5
Coal,D,D20.345.108,Fossil Fuels,Complex Mixtures,5
Cobalt,D,D01.552.544.185,"Metals, Heavy",Metals,5
Cobalt,D,D01.268.556.185,"Metals, Heavy",Elements,5
Cobalt,D,D01.268.956.155,Transition Elements,Elements,5
Cockroaches,B,B01.050.500.131.617.140,Insecta,Arthropods,5
Codes of Ethics,N,N05.700.350.324,Guidelines as Topic,"Quality Assurance, Health Care",5
Codes of Ethics,N,N05.350.213,Ethics,"Health Care Quality, Access, and Evaluation",5
Codes of Ethics,N,N05.350.340.080,"Ethics, Professional",Ethics,5
Codes of Ethics,N,N04.761.700.350.324,Guidelines as Topic,"Quality Assurance, Health Care",5
Codes of Ethics,K,K01.752.566.479.068,Ethics,Morals,5
Codes of Ethics,K,K01.752.566.479.171.066,"Ethics, Professional",Ethics,5
Colitis,C,C06.405.469.158.188,Colonic Diseases,Intestinal Diseases,5
Colitis,C,C06.405.205.265,Gastroenteritis,Gastrointestinal Diseases,5
Compassionate Use Trials,E,E05.337.300.199,Drug Approval,Evaluation Studies as Topic,5
Compassionate Use Trials,E,E05.290.250.199,Drug Approval,Drug Development,5
Compassionate Use Trials,E,E02.931.500,"Therapies, Investigational",Therapeutics,5
Competency-Based Education,I,I02.158.210,Curriculum,Education,5
Complement Activation,G,G12.274,Immune System Phenomena,NULL,5
Coombs Test,E,E05.200.812.735.050.375.150,Hemagglutination Tests,Agglutination Tests,5
Coombs Test,E,E05.478.594.760.050.375.150,Hemagglutination Tests,Agglutination Tests,5
Coombs Test,E,E01.370.225.812.735.050.375.150,Hemagglutination Tests,Agglutination Tests,5
Coronary Occlusion,C,C14.280.647.250.272,Coronary Disease,Myocardial Ischemia,5
Coronary Occlusion,C,C14.907.585.250.272,Coronary Disease,Myocardial Ischemia,5
Corpus Callosum,A,A08.186.211.200.885.800.750,Telencephalic Commissures,Telencephalon,5
Correlation of Data,H,H01.548.832.500,Statistics as Topic,Mathematics,5
Creatine,D,D02.078.370.280,Guanidines,Amidines,5
Creatine,D,D12.125.373,Amino Acids,"Amino Acids, Peptides, and Proteins",5
"Creatine Kinase, MB Form",D,D08.811.913.696.640.150.625,Creatine Kinase,Phosphotransferases (Nitrogenous Group Acceptor),5
Criminals,M,M01.142,Persons,NULL,5
Crisis Intervention,F,F04.754.252,Psychotherapy,Behavioral Disciplines and Activities,5
Cross-Linking Reagents,D,D27.720.470.410.210,Indicators and Reagents,Laboratory Chemicals,5
CTLA-4 Antigen,D,D23.101.100.894.158,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",5
CTLA-4 Antigen,D,D23.050.301.264.894.158,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",5
CTLA-4 Antigen,D,D12.776.465.782,Immune Checkpoint Proteins,Proteins,5
CTLA-4 Antigen,D,D12.776.543.750.705.222.750,Costimulatory and Inhibitory T-Cell Receptors,"Receptors, Immunologic",5
Cyclin-Dependent Kinase Inhibitor p16,D,D12.776.476.225.200,Cyclin-Dependent Kinase Inhibitor Proteins,Intracellular Signaling Peptides and Proteins,5
Cyclin-Dependent Kinase Inhibitor p16,D,D12.776.624.776.355.200,Cyclin-Dependent Kinase Inhibitor Proteins,Tumor Suppressor Proteins,5
Cyclin-Dependent Kinase Inhibitor p16,D,D12.644.360.225.200,Cyclin-Dependent Kinase Inhibitor Proteins,Intracellular Signaling Peptides and Proteins,5
Cyclin-Dependent Kinase Inhibitor p16,D,D12.776.167.187.200,Cyclin-Dependent Kinase Inhibitor Proteins,Cell Cycle Proteins,5
Cyclosporins,D,D12.644.641.235,"Peptides, Cyclic",Peptides,5
Cyclosporins,D,D04.345.566.235,"Peptides, Cyclic",Macrocyclic Compounds,5
Cytogenetic Analysis,E,E01.370.225.500.385,Cytological Techniques,Clinical Laboratory Techniques,5
Cytogenetic Analysis,E,E05.393.285,Genetic Techniques,Investigative Techniques,5
Cytogenetic Analysis,E,E05.242.385,Cytological Techniques,Investigative Techniques,5
Cytogenetic Analysis,E,E05.200.500.385,Cytological Techniques,Clinical Laboratory Techniques,5
Cytomegalovirus Retinitis,C,C11.768.773.360,Retinitis,Retinal Diseases,5
Cytomegalovirus Retinitis,C,C11.294.800.270,"Eye Infections, Viral",Eye Infections,5
Cytomegalovirus Retinitis,C,C01.925.325.270,"Eye Infections, Viral",Virus Diseases,5
Cytomegalovirus Retinitis,C,C01.925.256.466.245.150,Cytomegalovirus Infections,Herpesviridae Infections,5
Cytomegalovirus Retinitis,C,C01.375.725.270,"Eye Infections, Viral",Eye Infections,5
Data Display,F,F02.784.412.221,Ergonomics,"Psychology, Applied",5
Data Display,L,L01.296,Information Science,NULL,5
Debridement,E,E04.176,"Surgical Procedures, Operative",NULL,5
Decision Theory,G,G17.162,Mathematical Concepts,NULL,5
Deductibles and Coinsurance,N,N03.219.521.576.090.300,Cost Sharing,Insurance,5
Deductibles and Coinsurance,N,N03.219.151.170.300,Cost Sharing,Costs and Cost Analysis,5
Deglutition,G,G10.261.178,Digestive System Physiological Phenomena,Digestive System and Oral Physiological Phenomena,5
Deglutition Disorders,C,C06.405.117.119,Esophageal Diseases,Gastrointestinal Diseases,5
Deglutition Disorders,C,C09.775.174,Pharyngeal Diseases,Otorhinolaryngologic Diseases,5
Dehydroepiandrosterone Sulfate,D,D04.210.500.578.502.400.300,Dehydroepiandrosterone,17-Ketosteroids,5
Dehydroepiandrosterone Sulfate,D,D04.210.500.054.079.429.625.300,Dehydroepiandrosterone,Androstenols,5
Dehydroepiandrosterone Sulfate,D,D06.472.334.851.968.952.300,Dehydroepiandrosterone,Testosterone Congeners,5
Dehydroepiandrosterone Sulfate,D,D06.472.040.502.400.300,Dehydroepiandrosterone,17-Ketosteroids,5
"Dementia, Vascular",C,C10.228.140.695.500,Leukoencephalopathies,Brain Diseases,5
"Dementia, Vascular",C,C10.228.140.380.230,Dementia,Brain Diseases,5
"Dementia, Vascular",C,C10.228.140.300.510.800.500,Intracranial Arteriosclerosis,Intracranial Arterial Diseases,5
"Dementia, Vascular",C,C10.228.140.300.400,Cerebrovascular Disorders,Brain Diseases,5
"Dementia, Vascular",C,C14.907.253.560.350.500,Intracranial Arteriosclerosis,Intracranial Arterial Diseases,5
"Dementia, Vascular",C,C14.907.137.126.372.500,Intracranial Arteriosclerosis,Arteriosclerosis,5
"Dementia, Vascular",F,F03.615.400.350,Dementia,Neurocognitive Disorders,5
Densitometry,E,E05.196.712.224,Photometry,"Chemistry Techniques, Analytical",5
Dentist-Patient Relations,F,F01.829.401.650.410,Professional-Patient Relations,Interpersonal Relations,5
Dentist-Patient Relations,N,N05.300.660.325,Professional-Patient Relations,Delivery of Health Care,5
Dermatoglyphics,N,N04.452.910.099.500,Biometric Identification,Security Measures,5
Dermatoglyphics,I,I01.198.780.937.343,Forensic Medicine,Forensic Sciences,5
Dermatoglyphics,E,E05.318.740.225.500.375,Biometric Identification,Biometry,5
Dermatomyositis,C,C17.800.185,Skin Diseases,Skin and Connective Tissue Diseases,5
Dermatomyositis,C,C17.300.250,Connective Tissue Diseases,Skin and Connective Tissue Diseases,5
Dermatomyositis,C,C10.668.491.562.575.500,Polymyositis,Myositis,5
Dermatomyositis,C,C05.651.594.819.500,Polymyositis,Myositis,5
"Diabetes Mellitus, Experimental",C,C18.452.394.750.074,Diabetes Mellitus,Glucose Metabolism Disorders,5
"Diabetes Mellitus, Experimental",C,C19.246.240,Diabetes Mellitus,Endocrine System Diseases,5
"Diabetes Mellitus, Experimental",E,E05.598.500.374,"Disease Models, Animal","Models, Animal",5
"Diagnostic Techniques, Respiratory System",E,E01.370.386,Diagnostic Techniques and Procedures,Diagnosis,5
Diamines,D,D02.092.782.258,Polyamines,Amines,5
Diet Therapy,E,E02.642.249,Nutrition Therapy,Therapeutics,5
"Diet, Diabetic",E,E02.642.249.240,Diet Therapy,Nutrition Therapy,5
"Diet, Diabetic",G,G07.203.650.240.240,Diet,Nutritional Physiological Phenomena,5
"Diet, Fat-Restricted",G,G07.203.650.240.260,Diet,Nutritional Physiological Phenomena,5
"Diet, Fat-Restricted",E,E02.642.249.260,Diet Therapy,Nutrition Therapy,5
"Diet, Protein-Restricted",E,E02.642.249.280,Diet Therapy,Nutrition Therapy,5
"Diet, Protein-Restricted",G,G07.203.650.240.280,Diet,Nutritional Physiological Phenomena,5
"Dietary Fats, Unsaturated",G,G07.203.300.375.400,Dietary Fats,Food,5
"Dietary Fats, Unsaturated",J,J02.500.375.400,Dietary Fats,Food,5
"Dietary Fats, Unsaturated",D,D10.212.302.380,Dietary Fats,Fats,5
Diphtheria-Tetanus Vaccine,D,D20.215.894.691.263.310,Diphtheria Toxoid,Toxoids,5
Diphtheria-Tetanus Vaccine,D,D20.215.894.691.824.310,Tetanus Toxoid,Toxoids,5
Diphtheria-Tetanus Vaccine,D,D20.215.894.815.320,"Vaccines, Combined",Vaccines,5
Diphtheria-Tetanus Vaccine,D,D20.215.894.135.310,Bacterial Vaccines,Vaccines,5
Disposable Equipment,E,E07.252,Equipment and Supplies,NULL,5
DNA Adducts,G,G05.200.104,DNA Damage,Genetic Phenomena,5
DNA Adducts,D,D13.444.308.135,DNA,Nucleic Acids,5
DNA Glycosylases,D,D08.811.074.249,DNA Repair Enzymes,Enzymes,5
DNA Glycosylases,D,D08.811.277.450.430.099,N-Glycosyl Hydrolases,Glycoside Hydrolases,5
DNA Mismatch Repair,G,G05.219.220,DNA Repair,Genetic Phenomena,5
DNA Mismatch Repair,G,G02.111.222.220,DNA Repair,Biochemical Phenomena,5
DNA-Directed DNA Polymerase,D,D08.811.913.696.445.308.300,DNA Nucleotidyltransferases,Nucleotidyltransferases,5
Dosage Forms,D,D26.255,Pharmaceutical Preparations,NULL,5
Dosage Forms,E,E05.916.250,"Technology, Pharmaceutical",Investigative Techniques,5
"Dose Fractionation, Radiation",E,E02.815.639.200,Radiotherapy Dosage,Radiotherapy,5
Drug Liberation,G,G02.211,Chemical Phenomena,NULL,5
Drug Liberation,G,G03.787.321,Pharmacokinetics,Metabolism,5
Drug Liberation,G,G07.690.725.321,Pharmacokinetics,Pharmacological and Toxicological Phenomena,5
"Drugs, Chinese Herbal",D,D26.335,Pharmaceutical Preparations,NULL,5
"Drugs, Chinese Herbal",D,D20.215.784.500.350,Plant Extracts,Plant Preparations,5
Dyslexia,C,C23.888.592.604.150.500.300,Language Disorders,Communication Disorders,5
Dyslexia,C,C23.888.592.604.150.550.200,Learning Disabilities,Communication Disorders,5
Dyslexia,C,C10.597.606.150.500.300,Language Disorders,Communication Disorders,5
Dyslexia,C,C10.597.606.150.550.200,Learning Disabilities,Communication Disorders,5
Dyslexia,F,F03.625.562.400,Learning Disabilities,Neurodevelopmental Disorders,5
Early Termination of Clinical Trials,E,E05.581.500.400,Research Design,Methods,5
Early Termination of Clinical Trials,N,N04.761.559.590.800.379,Treatment Outcome,"Outcome Assessment, Health Care",5
Early Termination of Clinical Trials,N,N05.715.360.575.575.800.379,Treatment Outcome,"Outcome Assessment, Health Care",5
Early Termination of Clinical Trials,E,E01.789.800.238,Treatment Outcome,Prognosis,5
"Earth, Planet",G,G01.060.075.730.700.200,Planets,Solar System,5
"Economics, Behavioral",F,F04.096.628.286,Psychology,Behavioral Sciences,5
"Economics, Behavioral",N,N03.219.215,Economics,Health Care Economics and Organizations,5
Egg Proteins,D,D12.776.290,Proteins,"Amino Acids, Peptides, and Proteins",5
Egg Shell,A,A13.316,Animal Structures,NULL,5
Elasticity,G,G01.374.590,Mechanical Phenomena,Physical Phenomena,5
Electric Organ,A,A13.332,Animal Structures,NULL,5
Embryonic Development,G,G07.345.500.325.180,Embryonic and Fetal Development,Morphogenesis,5
Embryonic Development,G,G08.686.784.170.104,Embryonic and Fetal Development,Reproduction,5
"Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",D,D03.633.100.759.138.881.750,Tenofovir,Adenine,5
"Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",D,D03.383.742.680.245.500.600.750,Emtricitabine,Deoxycytidine,5
"Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",D,D02.705.429.906.750,Tenofovir,Organophosphonates,5
"Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",D,D26.310.423,Drug Combinations,Pharmaceutical Preparations,5
"Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",D,D13.570.685.245.500.600.500,Emtricitabine,Deoxycytidine,5
"Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",D,D13.570.230.329.525.500,Emtricitabine,Deoxycytidine,5
Emulsions,D,D20.280.260,Colloids,Complex Mixtures,5
Emulsions,D,D26.255.165.260,Colloids,Dosage Forms,5
Endocarditis,C,C14.280.282,Heart Diseases,Cardiovascular Diseases,5
"Endocarditis, Bacterial",C,C14.280.282.407,Endocarditis,Heart Diseases,5
"Endocarditis, Bacterial",C,C14.260.249,Cardiovascular Infections,Cardiovascular Diseases,5
"Endocarditis, Bacterial",C,C01.190.249,Cardiovascular Infections,Infections,5
"Endocarditis, Bacterial",C,C01.150.252.245,Bacterial Infections,Bacterial Infections and Mycoses,5
Endocrine System Diseases,C,C19,NULL,NULL,5
Endosonography,E,E01.370.350.850.280,Ultrasonography,Diagnostic Imaging,5
Endothelium,A,A10.272.491,Epithelium,Tissues,5
"Enterovirus A, Human",B,B04.820.578.750.284.180,Enterovirus,Picornaviridae,5
"Enterovirus B, Human",B,B04.820.578.750.284.182,Enterovirus,Picornaviridae,5
Entropion,C,C11.338.443,Eyelid Diseases,Eye Diseases,5
"Epilepsies, Partial",C,C10.228.140.490.360,Epilepsy,Brain Diseases,5
Epstein-Barr Virus Nuclear Antigens,D,D23.050.327.300,"Antigens, Viral",Antigens,5
Epstein-Barr Virus Nuclear Antigens,D,D23.050.290.249,"Antigens, Nuclear",Antigens,5
Equipment Reuse,E,E05.328,Investigative Techniques,NULL,5
Equipment Reuse,N,N06.850.585,Public Health,Environment and Public Health,5
Erotica,K,K01.517.414,Literature,Humanities,5
Erotica,L,L01.178.682.441,Publications,Communications Media,5
Esophageal and Gastric Varices,C,C06.405.117.240,Esophageal Diseases,Gastrointestinal Diseases,5
Esophageal and Gastric Varices,C,C06.552.494.414,"Hypertension, Portal",Liver Diseases,5
Esophagus,A,A03.556.875.500,Upper Gastrointestinal Tract,Gastrointestinal Tract,5
Esterases,D,D08.811.277.352,Hydrolases,Enzymes,5
Estrone,D,D06.472.040.502.497,17-Ketosteroids,Adrenal Cortex Hormones,5
Estrone,D,D06.472.334.851.437.996,Estradiol Congeners,Gonadal Steroid Hormones,5
Estrone,D,D04.210.500.578.502.497,17-Ketosteroids,Ketosteroids,5
Estrone,D,D04.210.500.365.415.414,Estrenes,Estranes,5
"Ethics, Professional",K,K01.752.566.479.171,Ethics,Morals,5
"Ethics, Professional",N,N05.350.340,Ethics,"Health Care Quality, Access, and Evaluation",5
Ethionamide,D,D03.066.349.220,Isonicotinic Acids,"Acids, Heterocyclic",5
Ethionamide,D,D03.383.725.394.220,Isonicotinic Acids,Pyridines,5
Etoposide,D,D02.455.426.559.847.638.960.675.250,Podophyllotoxin,Tetrahydronaphthalenes,5
Etoposide,D,D04.615.638.960.675.250,Podophyllotoxin,Tetrahydronaphthalenes,5
Etoposide,D,D09.408.348.275,Glucosides,Glycosides,5
Eukaryotic Cells,A,A11.450,Cells,NULL,5
"Extinction, Biological",G,G16.510,Biological Phenomena,NULL,5
"Extraversion, Psychological",F,F02.739.794.253,Psychoanalytic Theory,Psychological Theory,5
"Extraversion, Psychological",F,F01.752.747.246,Personality Development,Personality,5
Extreme Cold Weather,G,G16.500.750.775.291.250,Extreme Weather,Weather,5
Extreme Cold Weather,N,N06.230.300.100.725.154.500,Cold Temperature,Weather,5
Extreme Cold Weather,N,N06.230.300.100.725.710.300.500,Cold Temperature,Temperature,5
Eye Color,G,G16.690.360,Pigmentation,Biological Phenomena,5
Eye Color,G,G14.340,Ocular Physiological Phenomena,NULL,5
Eye Enucleation,E,E04.540.429,Ophthalmologic Surgical Procedures,"Surgical Procedures, Operative",5
Fabry Disease,C,C10.228.140.300.275.374,Cerebral Small Vessel Diseases,Cerebrovascular Disorders,5
Fabry Disease,C,C10.228.140.163.100.435.825.200,Sphingolipidoses,"Lysosomal Storage Diseases, Nervous System",5
Fabry Disease,C,C14.907.253.329.374,Cerebral Small Vessel Diseases,Cerebrovascular Disorders,5
Fabry Disease,C,C18.452.132.100.435.825.200,Sphingolipidoses,"Lysosomal Storage Diseases, Nervous System",5
Fabry Disease,C,C18.452.584.687.803.300,Sphingolipidoses,Lipidoses,5
Fabry Disease,C,C18.452.648.189.435.825.200,Sphingolipidoses,"Lysosomal Storage Diseases, Nervous System",5
Fabry Disease,C,C16.320.565.595.554.825.200,Sphingolipidoses,"Lysosomal Storage Diseases, Nervous System",5
Fabry Disease,C,C16.320.565.398.641.803.300,Sphingolipidoses,Lipidoses,5
Fabry Disease,C,C16.320.565.189.435.825.200,Sphingolipidoses,"Lysosomal Storage Diseases, Nervous System",5
Fabry Disease,C,C16.320.322.124,"Genetic Diseases, X-Linked","Genetic Diseases, Inborn",5
Fabry Disease,C,C18.452.648.398.641.803.300,Sphingolipidoses,Lipidoses,5
Fabry Disease,C,C18.452.648.595.554.825.200,Sphingolipidoses,"Lysosomal Storage Diseases, Nervous System",5
Factor VIIa,D,D12.776.124.125.325.300,Factor VII,Blood Coagulation Factors,5
Factor VIIa,D,D08.811.277.656.300.760.300,Serine Endopeptidases,Endopeptidases,5
Factor VIIa,D,D08.811.277.656.959.350.300,Serine Endopeptidases,Serine Proteases,5
Factor VIIa,D,D23.119.325.300,Factor VII,Blood Coagulation Factors,5
Fallopian Tubes,A,A13.706.500,Oviducts,Animal Structures,5
Fallopian Tubes,A,A05.360.319.114.373,Adnexa Uteri,"Genitalia, Female",5
Familial Hypophosphatemic Rickets,C,C05.116.198.816.875.500,"Rickets, Hypophosphatemic",Rickets,5
Familial Hypophosphatemic Rickets,C,C18.452.648.618.544.500,"Hypophosphatemia, Familial","Metal Metabolism, Inborn Errors",5
Familial Hypophosphatemic Rickets,C,C18.452.750.400.500.500,"Hypophosphatemia, Familial",Hypophosphatemia,5
Familial Hypophosphatemic Rickets,C,C18.452.750.400.750.500,"Rickets, Hypophosphatemic",Hypophosphatemia,5
Familial Hypophosphatemic Rickets,C,C18.654.521.500.133.770.734.875.500,"Rickets, Hypophosphatemic",Rickets,5
Familial Hypophosphatemic Rickets,C,C16.320.565.618.544.500,"Hypophosphatemia, Familial","Metal Metabolism, Inborn Errors",5
Familial Hypophosphatemic Rickets,C,C16.320.831.647.500,"Hypophosphatemia, Familial","Renal Tubular Transport, Inborn Errors",5
Familial Hypophosphatemic Rickets,C,C18.452.104.816.875.500,"Rickets, Hypophosphatemic",Rickets,5
Familial Hypophosphatemic Rickets,C,C18.452.174.845.875.500,"Rickets, Hypophosphatemic",Rickets,5
Familial Hypophosphatemic Rickets,C,C13.351.968.419.815.647.500,"Hypophosphatemia, Familial","Renal Tubular Transport, Inborn Errors",5
Familial Hypophosphatemic Rickets,C,C12.777.419.815.647.500,"Hypophosphatemia, Familial","Renal Tubular Transport, Inborn Errors",5
"Fatty Acids, Omega-6",D,D10.251.355.343,"Fatty Acids, Unsaturated",Fatty Acids,5
Feeding Methods,E,E02.421,Therapeutics,NULL,5
Femur Neck,A,A02.835.232.043.150.510,Femur,Bones of Lower Extremity,5
"Fertility Agents, Female",D,D27.505.954.705.552.344,Fertility Agents,Reproductive Control Agents,5
"Fertility Agents, Female",D,D27.505.696.875.552.344,Fertility Agents,Reproductive Control Agents,5
Fetal Macrosomia,C,C13.703.170.500,"Diabetes, Gestational",Pregnancy Complications,5
Fetal Macrosomia,C,C13.703.277.570,Fetal Diseases,Pregnancy Complications,5
Fetal Macrosomia,C,C13.703.726.570,Pregnancy in Diabetics,Pregnancy Complications,5
Fetal Macrosomia,C,C16.300.570,Fetal Diseases,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",5
Fetal Macrosomia,C,C19.246.099.968,Diabetes Complications,Diabetes Mellitus,5
Fetal Macrosomia,C,C23.888.144.186.500,Birth Weight,Body Weight,5
Fetal Weight,C,C23.888.144.300,Body Weight,Signs and Symptoms,5
Fetal Weight,E,E01.370.600.115.100.160.120.300,Body Weight,Body Size,5
Fetal Weight,E,E05.041.124.160.750.300,Body Weight,Body Size,5
Fetal Weight,G,G08.686.280,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,5
Fetal Weight,G,G07.345.249.314.120.300,Body Weight,Body Size,5
Fetal Weight,G,G07.345.500.325.235.937,Fetal Development,Embryonic and Fetal Development,5
Fetal Weight,G,G07.100.100.160.120.300,Body Weight,Body Size,5
Fingers,A,A01.378.800.667.430,Hand,Upper Extremity,5
Firefighters,M,M01.526.373.400,Emergency Responders,Occupational Groups,5
Fluorescein-5-isothiocyanate,D,D04.711.347.400,Fluoresceins,Spiro Compounds,5
Fluorescein-5-isothiocyanate,D,D02.455.426.779.347.400,Fluoresceins,Spiro Compounds,5
Fluorescein-5-isothiocyanate,D,D02.500.375.250,Isothiocyanates,Isocyanates,5
Fluorescein-5-isothiocyanate,D,D02.886.250.250,Isothiocyanates,Sulfur Compounds,5
Fluorescein-5-isothiocyanate,D,D03.633.300.953.275.400,Fluoresceins,Xanthenes,5
Fluorine Radioisotopes,D,D01.496.749.340,Radioisotopes,Isotopes,5
Fluticasone-Salmeterol Drug Combination,D,D02.033.100.291.057.750.500,Salmeterol Xinafoate,Albuterol,5
Fluticasone-Salmeterol Drug Combination,D,D02.092.471.683.061.750.500,Salmeterol Xinafoate,Albuterol,5
Fluticasone-Salmeterol Drug Combination,D,D02.092.063.291.057.750.500,Salmeterol Xinafoate,Albuterol,5
Fluticasone-Salmeterol Drug Combination,D,D04.210.500.054.079.129.114.500,Fluticasone,Androstadienes,5
Fluticasone-Salmeterol Drug Combination,D,D26.310.438,Drug Combinations,Pharmaceutical Preparations,5
Fomites,N,N06.850.520.203.250.500,Disease Reservoirs,Chain of Infection,5
Formaldehyde,D,D02.047.407,Aldehydes,Organic Chemicals,5
Formative Feedback,F,F02.784.629.529.223,Learning,"Psychology, Educational",5
Fourier Analysis,E,E05.377,Investigative Techniques,NULL,5
Fourier Analysis,G,G17.226,Mathematical Concepts,NULL,5
Fourier Analysis,L,L01.224.800.625,"Signal Processing, Computer-Assisted",Computing Methodologies,5
Fracture Fixation,E,E04.555.300,Orthopedic Procedures,"Surgical Procedures, Operative",5
Fukushima Nuclear Accident,K,K01.400.504.984.186,"History, 21st Century","History, Modern 1601-",5
Fukushima Nuclear Accident,N,N06.850.135.848.750,Radioactive Hazard Release,Accidents,5
Fumigation,N,N06.850.780.200.300,Communicable Disease Control,Public Health Practice,5
Fundus Oculi,A,A09.371.729.313,Retina,Eye,5
Funeral Rites,I,I01.076.201.450.550,Culture,"Anthropology, Cultural",5
Gallbladder,A,A03.159.439,Biliary Tract,Digestive System,5
Gallbladder Neoplasms,C,C06.301.120.401,Biliary Tract Neoplasms,Digestive System Neoplasms,5
Gallbladder Neoplasms,C,C06.130.320.401,Biliary Tract Neoplasms,Biliary Tract Diseases,5
Gallbladder Neoplasms,C,C06.130.564.401,Gallbladder Diseases,Biliary Tract Diseases,5
Gallbladder Neoplasms,C,C04.588.274.120.401,Biliary Tract Neoplasms,Digestive System Neoplasms,5
Gallstones,C,C06.130.564.332.500,Cholecystolithiasis,Gallbladder Diseases,5
Gallstones,C,C06.130.409.633,Cholelithiasis,Biliary Tract Diseases,5
Gallstones,C,C23.300.175.525,Calculi,"Pathological Conditions, Anatomical",5
gamma-Aminobutyric Acid,D,D02.241.081.114.500.350,Aminobutyrates,Butyrates,5
gamma-Aminobutyric Acid,D,D12.125.190.350,Aminobutyrates,Amino Acids,5
Gammaproteobacteria,B,B03.660.250,Proteobacteria,Bacteria,5
Gatekeeping,N,N04.452.758.849.350,Referral and Consultation,Professional Practice,5
Gelatin,D,D12.776.860.476,Scleroproteins,Proteins,5
Gene Conversion,G,G05.728.615.475,Homologous Recombination,"Recombination, Genetic",5
"Genes, p53",G,G05.360.340.024.340.375.249.385,"Genes, Tumor Suppressor","Genes, Neoplasm",5
"Genes, p53",G,G05.360.340.024.340.415.400.385,"Genes, Tumor Suppressor","Genes, Recessive",5
"Genitalia, Male",A,A05.360.444,Genitalia,Urogenital System,5
Geriatricians,M,M01.526.485.810.533,Physicians,Health Personnel,5
Geriatricians,N,N02.360.810.533,Physicians,Health Personnel,5
"Gloves, Protective",J,J01.637.215.600.400,Protective Clothing,Clothing,5
"Gloves, Protective",J,J01.637.708.560.875.400,Protective Clothing,Personal Protective Equipment,5
"Gloves, Protective",E,E07.700.600.400,Protective Clothing,Protective Devices,5
Glucose-6-Phosphatase,D,D08.811.277.352.650.225,Phosphoric Monoester Hydrolases,Esterases,5
Glucuronidase,D,D08.811.277.450.426,Glycoside Hydrolases,Hydrolases,5
Glutens,D,D12.776.765.433.500.500,Prolamins,Grain Proteins,5
Glutens,D,D12.776.765.725.500.500,Prolamins,Seed Storage Proteins,5
Glyburide,D,D02.886.590.795.575,Sulfonylurea Compounds,Sulfones,5
Glyburide,D,D02.065.950.828.575,Sulfonylurea Compounds,Urea,5
Glycosphingolipids,D,D10.390.470,Glycolipids,Lipids,5
Glycosphingolipids,D,D10.570.877.360,Sphingolipids,Membrane Lipids,5
Glycosphingolipids,D,D09.400.410.420,Glycolipids,Glycoconjugates,5
Graft vs Host Disease,C,C20.452,Immune System Diseases,NULL,5
Granulocyte Colony-Stimulating Factor,D,D12.644.276.374.410.240.350,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,5
Granulocyte Colony-Stimulating Factor,D,D12.776.395.240.200,Colony-Stimulating Factors,Glycoproteins,5
Granulocyte Colony-Stimulating Factor,D,D12.776.467.374.410.240.350,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,5
Granulocyte Colony-Stimulating Factor,D,D23.529.374.410.240.350,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,5
Granulomatosis with Polyangiitis,C,C20.111.193.875,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Autoimmune Diseases,5
Granulomatosis with Polyangiitis,C,C14.907.940.897.249.750,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Systemic Vasculitis,5
Granulomatosis with Polyangiitis,C,C08.381.483.950,"Lung Diseases, Interstitial",Lung Diseases,5
Growth Inhibitors,D,D27.505.696.377.450,Growth Substances,Physiological Effects of Drugs,5
Guanine Nucleotide Exchange Factors,D,D12.776.476.325.300,GTP-Binding Protein Regulators,Intracellular Signaling Peptides and Proteins,5
Guanine Nucleotide Exchange Factors,D,D12.644.360.325.300,GTP-Binding Protein Regulators,Intracellular Signaling Peptides and Proteins,5
Hallucinations,C,C10.597.606.762.300,Perceptual Disorders,Neurobehavioral Manifestations,5
Hallucinations,C,C23.888.592.604.764.300,Perceptual Disorders,Neurobehavioral Manifestations,5
Hallucinations,F,F01.700.750.300,Perceptual Disorders,Neurobehavioral Manifestations,5
Halogenated Diphenyl Ethers,D,D02.455.426.559.389.657.654.601,Phenyl Ethers,Phenols,5
Halogenated Diphenyl Ethers,D,D02.355.726.601,Phenyl Ethers,Ethers,5
Haloperidol,D,D02.522.352.506,Butyrophenones,Ketones,5
"Health Facilities, Proprietary",N,N02.278.215,Health Facilities,"Health Care Facilities, Manpower, and Services",5
Health Facility Administrators,M,M01.526.485.430,Health Personnel,Occupational Groups,5
Health Facility Administrators,M,M01.526.070.490,Administrative Personnel,Occupational Groups,5
Health Facility Administrators,N,N02.360.430,Health Personnel,"Health Care Facilities, Manpower, and Services",5
"Hearing Loss, Sensorineural",C,C23.888.592.763.393.341.887,Hearing Loss,Hearing Disorders,5
"Hearing Loss, Sensorineural",C,C10.597.751.418.341.887,Hearing Loss,Hearing Disorders,5
"Hearing Loss, Sensorineural",C,C09.218.458.341.887,Hearing Loss,Hearing Disorders,5
Heart Function Tests,E,E01.370.370.380,"Diagnostic Techniques, Cardiovascular",Diagnostic Techniques and Procedures,5
Hedgehog Proteins,D,D23.529.671,Intercellular Signaling Peptides and Proteins,Biological Factors,5
Hedgehog Proteins,D,D12.776.467.671,Intercellular Signaling Peptides and Proteins,Proteins,5
Hedgehog Proteins,D,D12.644.276.671,Intercellular Signaling Peptides and Proteins,Peptides,5
"Helminthiasis, Animal",C,C22.674.377,"Parasitic Diseases, Animal",Animal Diseases,5
"Helminthiasis, Animal",C,C01.610.335.349,Helminthiasis,Parasitic Diseases,5
"Helminthiasis, Animal",C,C01.610.701.377,"Parasitic Diseases, Animal",Parasitic Diseases,5
Hematology,H,H02.403.429.445,Internal Medicine,Medicine,5
Hemoglobin A2,D,D12.776.124.400.405.450,Hemoglobin A,Hemoglobins,5
Hemoglobin A2,D,D12.776.422.316.762.380.450,Hemoglobin A,Hemoglobins,5
Hemolysin Proteins,D,D12.776.543.695.444,Pore Forming Cytotoxic Proteins,Membrane Proteins,5
Hepatectomy,E,E04.210.556,Digestive System Surgical Procedures,"Surgical Procedures, Operative",5
Hepatitis A virus,B,B04.450.420.410,Hepatovirus,Hepatitis Viruses,5
Hepatitis A virus,B,B04.820.578.750.400.410,Hepatovirus,Picornaviridae,5
Hexachlorocyclohexane,D,D02.455.526.439.600,"Hydrocarbons, Chlorinated","Hydrocarbons, Halogenated",5
Histoplasmosis,C,C01.150.703.450,Mycoses,Bacterial Infections and Mycoses,5
History of Medicine,K,K01.400.552,History,Humanities,5
HLA-DQ alpha-Chains,D,D12.776.395.550.509.400.430.500,HLA-DQ Antigens,HLA-D Antigens,5
HLA-DQ alpha-Chains,D,D12.776.543.550.440.400.430.500,HLA-DQ Antigens,HLA-D Antigens,5
HLA-DQ alpha-Chains,D,D23.050.301.500.400.400.430.500,HLA-DQ Antigens,HLA-D Antigens,5
HLA-DQ alpha-Chains,D,D23.050.301.500.450.400.430.500,HLA-DQ Antigens,HLA-D Antigens,5
HLA-DQ alpha-Chains,D,D23.050.705.552.410.400.430.500,HLA-DQ Antigens,HLA-D Antigens,5
HLA-DQ alpha-Chains,D,D23.050.705.552.450.400.430.500,HLA-DQ Antigens,HLA-D Antigens,5
Holistic Health,E,E02.190.321,Complementary Therapies,Therapeutics,5
Holistic Health,K,K01.752.667.710,"Philosophy, Medical",Philosophy,5
Holistic Health,N,N01.400.350,Health,Population Characteristics,5
Homophobia,F,F01.145.813.550.374,Prejudice,Social Behavior,5
Homophobia,F,F01.145.813.629.562,Social Discrimination,Social Behavior,5
Homophobia,F,F01.829.595.374,Prejudice,"Psychology, Social",5
Honduras,Z,Z01.107.169.534,Central America,Americas,5
Hoof and Claw,A,A13.491,Animal Structures,NULL,5
Hostility,F,F01.470.596,Emotions,Behavior and Behavior Mechanisms,5
HSP90 Heat-Shock Proteins,D,D12.776.580.216.380,Heat-Shock Proteins,Molecular Chaperones,5
Human papillomavirus 11,B,B04.613.204.655.050.606.611,Human papillomavirus 6,Alphapapillomavirus,5
Human papillomavirus 11,B,B04.280.210.655.050.606.611,Human papillomavirus 6,Alphapapillomavirus,5
Hydroxyethyl Starch Derivatives,D,D09.301.915.500,Starch,Dietary Carbohydrates,5
Hydroxyethyl Starch Derivatives,D,D09.698.365.855.500,Starch,Glucans,5
Hydroxymethylglutaryl CoA Reductases,D,D08.811.682.047.820.150.415,3-Hydroxyacyl CoA Dehydrogenases,NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases,5
Hyperinsulinism,C,C18.452.394.968,Glucose Metabolism Disorders,Metabolic Diseases,5
Hyperplasia,C,C23.550.444,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",5
Hyponatremia,C,C18.452.950.620,Water-Electrolyte Imbalance,Metabolic Diseases,5
Hypospadias,C,C16.131.939.516,Urogenital Abnormalities,Congenital Abnormalities,5
Hypospadias,C,C13.351.875.466,Urogenital Abnormalities,Female Urogenital Diseases,5
Hypospadias,C,C12.706.516,Urogenital Abnormalities,Male Urogenital Diseases,5
Hypospadias,C,C12.294.494.400,Penile Diseases,"Genital Diseases, Male",5
Hypovolemia,C,C23.550.455,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",5
I-kappa B Proteins,D,D12.644.360.365,Intracellular Signaling Peptides and Proteins,Peptides,5
I-kappa B Proteins,D,D12.776.260.420,DNA-Binding Proteins,Proteins,5
I-kappa B Proteins,D,D12.776.930.326,Transcription Factors,Proteins,5
I-kappa B Proteins,D,D12.776.476.381,Intracellular Signaling Peptides and Proteins,Proteins,5
Immunogenetics,H,H01.158.273.343.420,Genetics,Biology,5
Immunoglobulin D,D,D12.776.377.715.548.114.619.251,Immunoglobulin Isotypes,Antibodies,5
Immunoglobulin D,D,D12.776.124.486.485.114.619.251,Immunoglobulin Isotypes,Antibodies,5
Immunoglobulin D,D,D12.776.124.790.651.114.619.251,Immunoglobulin Isotypes,Antibodies,5
Indicator Dilution Techniques,E,E05.484,Investigative Techniques,NULL,5
Infant Death,C,C23.550.260.657,Death,Pathologic Processes,5
Infarction,C,C23.550.513.355,Ischemia,Pathologic Processes,5
Infarction,C,C23.550.717.489,Necrosis,Pathologic Processes,5
Infrared Rays,G,G01.750.250.650.552,Light,Electromagnetic Radiation,5
Infrared Rays,G,G01.590.540.552,Light,Optical Phenomena,5
Infrared Rays,G,G01.358.500.505.650.552,Light,Electromagnetic Radiation,5
Infrared Rays,G,G01.750.770.578.552,Light,"Radiation, Nonionizing",5
Infrared Rays,G,G16.500.750.775.525.400,Sunlight,Weather,5
Infrared Rays,G,G16.500.275.063.725.525.400,Sunlight,Weather,5
Infrared Rays,N,N06.230.300.100.725.525.400,Sunlight,Weather,5
"Injections, Intraperitoneal",E,E02.319.267.530.490,Injections,Drug Administration Routes,5
Integrin-Binding Sialoprotein,D,D12.776.860.300.562,Extracellular Matrix Proteins,Scleroproteins,5
Integrin-Binding Sialoprotein,D,D12.776.744.527,Phosphoproteins,Proteins,5
Integrin-Binding Sialoprotein,D,D12.776.395.700.675,Sialoglycoproteins,Glycoproteins,5
Interferon Regulatory Factors,D,D12.776.260.504,DNA-Binding Proteins,Proteins,5
Interferon Regulatory Factors,D,D12.776.157.057.050,"Adaptor Proteins, Signal Transducing",Carrier Proteins,5
Interferon Regulatory Factors,D,D12.644.360.024.302,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,5
Interferon Regulatory Factors,D,D12.776.930.332,Transcription Factors,Proteins,5
Interferon Regulatory Factors,D,D12.776.476.024.385,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,5
International Normalized Ratio,E,E01.370.225.625.115.320,Blood Coagulation Tests,Hematologic Tests,5
International Normalized Ratio,E,E05.200.625.115.320,Blood Coagulation Tests,Hematologic Tests,5
Intestinal Perforation,C,C06.405.469.557,Intestinal Diseases,Gastrointestinal Diseases,5
"Intestine, Large",A,A03.556.249.249,Lower Gastrointestinal Tract,Gastrointestinal Tract,5
"Intestine, Large",A,A03.556.124.526,Intestines,Gastrointestinal Tract,5
Intracellular Space,A,A10.082.750,Body Fluid Compartments,Tissues,5
Intracellular Space,A,A11.284.430,Cellular Structures,Cells,5
"Intracranial Hemorrhage, Traumatic",C,C26.915.300.490,Craniocerebral Trauma,"Trauma, Nervous System",5
"Intracranial Hemorrhage, Traumatic",C,C10.900.300.837,Craniocerebral Trauma,"Trauma, Nervous System",5
"Intracranial Hemorrhage, Traumatic",C,C10.228.140.300.535.450,Intracranial Hemorrhages,Cerebrovascular Disorders,5
"Intracranial Hemorrhage, Traumatic",C,C14.907.253.573.400,Intracranial Hemorrhages,Cerebrovascular Disorders,5
"Iraq War, 2003-2011",K,K01.400.504.984.249,"History, 21st Century","History, Modern 1601-",5
"Iraq War, 2003-2011",I,I01.880.735.950.250.782,Armed Conflicts,Warfare and Armed Conflicts,5
Iron Chelating Agents,D,D27.720.832.500.410,Chelating Agents,Sequestering Agents,5
Iron Chelating Agents,D,D27.505.519.914.500.410,Chelating Agents,Sequestering Agents,5
Iron Isotopes,D,D01.496.473,Isotopes,Inorganic Chemicals,5
Iron Isotopes,D,D01.552.544.412.500,Iron,"Metals, Heavy",5
Iron Isotopes,D,D01.268.956.287.500,Iron,Transition Elements,5
Iron Isotopes,D,D01.268.556.412.500,Iron,"Metals, Heavy",5
Iron-Binding Proteins,D,D12.776.556.579,Metalloproteins,Proteins,5
Iron-Binding Proteins,D,D12.776.157.427,Carrier Proteins,Proteins,5
Ischemic Stroke,C,C14.907.253.855.400,Stroke,Cerebrovascular Disorders,5
Ischemic Stroke,C,C10.228.140.300.775.400,Stroke,Cerebrovascular Disorders,5
Isoantibodies,D,D12.776.124.790.651.114.664,Antibodies,Immunoglobulins,5
Isoantibodies,D,D12.776.124.486.485.114.664,Antibodies,Immunoglobulins,5
Isoantibodies,D,D12.776.377.715.548.114.664,Antibodies,Immunoglobulins,5
Isoflavones,D,D03.633.100.150.266.450.400,Flavonoids,Chromones,5
Isoflavones,D,D03.383.663.283.266.450.400,Flavonoids,Chromones,5
Isotope Labeling,E,E05.522,Investigative Techniques,NULL,5
Japanese Encephalitis Vaccines,D,D20.215.894.899.320,Viral Vaccines,Vaccines,5
Jealousy,F,F01.470.653,Emotions,Behavior and Behavior Mechanisms,5
Jurkat Cells,A,A11.251.860.180.495,"Cell Line, Tumor","Tumor Cells, Cultured",5
Jurkat Cells,A,A11.251.210.190.495,"Cell Line, Tumor",Cell Line,5
Jurkat Cells,A,A15.382.490.555.567.569.440,T-Lymphocytes,Lymphocytes,5
Kallikreins,D,D23.119.597,Blood Coagulation Factors,Biological Factors,5
Kallikreins,D,D08.811.277.656.959.350.442,Serine Endopeptidases,Serine Proteases,5
Kallikreins,D,D08.811.277.656.300.760.442,Serine Endopeptidases,Endopeptidases,5
Kallikreins,D,D12.776.124.125.597,Blood Coagulation Factors,Blood Proteins,5
Keratoconus,C,C11.204.627,Corneal Diseases,Eye Diseases,5
Ketoconazole,D,D03.383.606.560,Piperazines,"Heterocyclic Compounds, 1-Ring",5
Kidney Tubules,A,A05.810.453.736.560,Nephrons,Kidney,5
"Kidney Tubules, Proximal",A,A05.810.453.736.560.570,Kidney Tubules,Nephrons,5
Kuru,C,C01.207.800.435,Prion Diseases,Central Nervous System Infections,5
Kuru,C,C10.574.843.625,Prion Diseases,Neurodegenerative Diseases,5
Kuru,C,C10.228.228.800.435,Prion Diseases,Central Nervous System Infections,5
Larva Migrans,C,C17.800.838.775.424,"Skin Diseases, Parasitic","Skin Diseases, Infectious",5
Larva Migrans,C,C01.610.335.508.523,Nematode Infections,Helminthiasis,5
Larva Migrans,C,C01.610.858.424,"Skin Diseases, Parasitic",Parasitic Diseases,5
Lasers,E,E07.710.520,Radiation Equipment and Supplies,Equipment and Supplies,5
Lasers,E,E07.632.490,Optical Devices,Equipment and Supplies,5
Lead Poisoning,C,C25.723.522.750,Heavy Metal Poisoning,Poisoning,5
Legal Guardians,M,M01.380,Persons,NULL,5
Legionella pneumophila,B,B03.660.250.460.460.580,Legionella,Legionellaceae,5
Legionella pneumophila,B,B03.440.400.425.450.450.500,Legionella,Legionellaceae,5
"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C,C04.557.337.539.250,"Leukemia, Myeloid",Leukemia,5
"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C,C15.378.190.636.370,Myeloproliferative Disorders,Bone Marrow Diseases,5
Leukocidins,D,D12.776.543.695.750,Pore Forming Cytotoxic Proteins,Membrane Proteins,5
Leukopenia,C,C15.378.553.546,Leukocyte Disorders,Hematologic Diseases,5
Leukotriene Antagonists,D,D27.505.696.399.450.565,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",5
Leukotriene Antagonists,D,D06.347.565,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",5
Libido,F,F02.739.794.511,Psychoanalytic Theory,Psychological Theory,5
Libya,Z,Z01.058.266.513,"Africa, Northern",Africa,5
Ligases,D,D08.811.464,Enzymes,Enzymes and Coenzymes,5
Limb Salvage,E,E04.555.400,Orthopedic Procedures,"Surgical Procedures, Operative",5
Limb Salvage,E,E04.680.350,Reconstructive Surgical Procedures,"Surgical Procedures, Operative",5
Limb Salvage,E,E04.100.814.603,Vascular Surgical Procedures,Cardiovascular Surgical Procedures,5
Lipolysis,G,G02.111.534,Biochemical Phenomena,Chemical Phenomena,5
Lipolysis,G,G03.458.500,Lipid Metabolism,Metabolism,5
Liraglutide,D,D06.472.317.680.500.500.500,Glucagon-Like Peptide 1,Glucagon-Like Peptides,5
"Liver Abscess, Amebic",C,C06.552.597.517,Liver Abscess,Liver Diseases,5
"Liver Abscess, Amebic",C,C06.552.664.642,"Liver Diseases, Parasitic",Liver Diseases,5
"Liver Abscess, Amebic",C,C01.830.025.020.455.460,Liver Abscess,Abdominal Abscess,5
"Liver Abscess, Amebic",C,C01.610.518.600,"Liver Diseases, Parasitic",Parasitic Diseases,5
"Liver Abscess, Amebic",C,C01.610.752.049.703,Amebiasis,Protozoan Infections,5
"Liver Diseases, Parasitic",C,C01.610.518,Parasitic Diseases,Infections,5
"Liver Diseases, Parasitic",C,C06.552.664,Liver Diseases,Digestive System Diseases,5
"Liver Failure, Acute",C,C06.552.308.500.750,Liver Failure,Hepatic Insufficiency,5
Long QT Syndrome,C,C14.280.067.565,"Arrhythmias, Cardiac",Heart Diseases,5
Long QT Syndrome,C,C14.280.123.625,Cardiac Conduction System Disease,Heart Diseases,5
Long QT Syndrome,C,C16.131.240.400.715,"Heart Defects, Congenital",Cardiovascular Abnormalities,5
Long QT Syndrome,C,C23.550.073.547,"Arrhythmias, Cardiac",Pathologic Processes,5
Lutein,D,D02.455.326.271.665.202.868.500,Xanthophylls,Carotenoids,5
Lutein,D,D02.455.426.392.368.367.379.249.887.500,Xanthophylls,Carotenoids,5
Lutein,D,D02.455.849.131.868.500,Xanthophylls,Carotenoids,5
Lutein,D,D23.767.261.887.500,Xanthophylls,Carotenoids,5
Lymphadenitis,C,C15.604.315,Lymphatic Diseases,Hemic and Lymphatic Diseases,5
"Lymphocytes, Tumor-Infiltrating",A,A15.145.229.637.555.567.650,Lymphocytes,"Leukocytes, Mononuclear",5
"Lymphocytes, Tumor-Infiltrating",A,A15.382.490.555.567.650,Lymphocytes,"Leukocytes, Mononuclear",5
"Lymphocytes, Tumor-Infiltrating",A,A11.118.637.555.567.650,Lymphocytes,"Leukocytes, Mononuclear",5
"Lymphoma, Follicular",C,C04.557.386.480.350,"Lymphoma, Non-Hodgkin",Lymphoma,5
"Lymphoma, Follicular",C,C15.604.515.569.480.350,"Lymphoma, Non-Hodgkin",Lymphoma,5
"Lymphoma, Follicular",C,C20.683.515.761.480.350,"Lymphoma, Non-Hodgkin",Lymphoma,5
Lymphotoxin-alpha,D,D23.529.374.750.500,Tumor Necrosis Factors,Cytokines,5
Lymphotoxin-alpha,D,D23.529.374.480.438,Lymphokines,Cytokines,5
Lymphotoxin-alpha,D,D12.776.467.374.750.500,Tumor Necrosis Factors,Cytokines,5
Lymphotoxin-alpha,D,D12.776.467.374.480.438,Lymphokines,Cytokines,5
Lymphotoxin-alpha,D,D12.644.276.374.750.500,Tumor Necrosis Factors,Cytokines,5
Lymphotoxin-alpha,D,D12.644.276.374.480.438,Lymphokines,Cytokines,5
Magnesium Sulfate,D,D01.524.550,Magnesium Compounds,Inorganic Chemicals,5
Magnesium Sulfate,D,D01.875.800.800.850.500,Sulfates,Sulfuric Acids,5
Manihot,B,B01.650.940.800.575.912.250.859.797.438.535,Euphorbiaceae,Malpighiales,5
Mansonelliasis,C,C01.610.335.508.700.750.361.588,Filariasis,Spirurida Infections,5
Martinique,Z,Z01.107.084.900.600,West Indies,Caribbean Region,5
Martinique,Z,Z01.639.880.600,West Indies,Islands,5
Maryland,Z,Z01.107.567.875.500.500,Mid-Atlantic Region,United States,5
Maryland,Z,Z01.107.567.875.075.418,Appalachian Region,United States,5
Mass Casualty Incidents,N,N06.230.100.160,Disasters,Environment,5
Mass Casualty Incidents,I,I01.880.735.900.800.575,Terrorism,Violence,5
Mass Casualty Incidents,I,I01.198.240.856.800.537,Terrorism,Violence,5
Maternal Deprivation,F,F01.829.263.370.240,Family Relations,Family,5
Matrix Metalloproteinase 8,D,D12.644.276.848.300,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,5
Matrix Metalloproteinase 8,D,D08.811.277.656.300.480.525.700.300,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,5
Matrix Metalloproteinase 8,D,D08.811.277.656.675.374.525.700.300,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,5
Matrix Metalloproteinase 8,D,D08.811.277.656.675.374.205.358,Collagenases,Metalloendopeptidases,5
Matrix Metalloproteinase 8,D,D08.811.277.656.300.480.205.358,Collagenases,Metalloendopeptidases,5
Matrix Metalloproteinase 8,D,D12.776.467.836.300,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,5
Mauritania,Z,Z01.058.290.190.520,"Africa, Western",Africa South of the Sahara,5
Medical Laboratory Personnel,M,M01.526.485.510,Health Personnel,Occupational Groups,5
Medical Laboratory Personnel,M,M01.526.502.500,Laboratory Personnel,Occupational Groups,5
Medical Laboratory Personnel,N,N02.360.510,Health Personnel,"Health Care Facilities, Manpower, and Services",5
Medical Laboratory Science,H,H02.010.450,Allied Health Occupations,Health Occupations,5
Medical Laboratory Science,J,J01.897.480,Technology,"Technology, Industry, and Agriculture",5
Medical Waste Disposal,N,N06.850.460.710.460.300,Medical Waste,Waste Products,5
Medical Waste Disposal,N,N06.850.860.510.900.600.600,Refuse Disposal,Waste Management,5
Medical Waste Disposal,D,D20.944.460.300,Medical Waste,Waste Products,5
Medication Therapy Management,N,N04.590.661,Patient Care Management,Health Services Administration,5
Medication Therapy Management,N,N02.421.668.438,Pharmaceutical Services,Health Services,5
Medication Therapy Management,N,N03.219.521.576.343.575.500.500,Medicare Part D,"Insurance, Pharmaceutical Services",5
Medication Therapy Management,N,N03.219.521.576.343.840.938.500,Medicare Part D,Medicare,5
Melanins,D,D23.767.620,"Pigments, Biological",Biological Factors,5
Melanins,D,D12.125.072.050.875.379,Tyrosine,"Amino Acids, Aromatic",5
Mercaptopurine,D,D02.886.489.534,Sulfhydryl Compounds,Sulfur Compounds,5
Mercaptopurine,D,D03.633.100.759.570,Purines,"Heterocyclic Compounds, 2-Ring",5
Metabolism,G,G03,NULL,NULL,5
Metoprolol,D,D02.033.100.624.698.573,Phenoxypropanolamines,Propanolamines,5
Metoprolol,D,D02.033.755.624.698.573,Phenoxypropanolamines,Propanolamines,5
Metoprolol,D,D02.092.063.624.698.573,Phenoxypropanolamines,Propanolamines,5
Mexican Americans,M,M01.686.754.441.500,Hispanic Americans,Ethnic Groups,5
Microbiology,H,H01.158.273.540,Biology,Biological Science Disciplines,5
Micronucleus Tests,E,E05.393.560.598,Mutagenicity Tests,Genetic Techniques,5
Milk Proteins,G,G07.203.300.428.159.812,"Animal Proteins, Dietary",Dietary Proteins,5
Milk Proteins,J,J02.500.350.525.520,Milk,Dairy Products,5
Milk Proteins,J,J02.500.428.159.750,"Animal Proteins, Dietary",Dietary Proteins,5
Milk Proteins,A,A12.790.520,Milk,Fluids and Secretions,5
Milk Proteins,D,D12.776.256.159.750,"Animal Proteins, Dietary",Dietary Proteins,5
Mitochondrial Diseases,C,C18.452.660,Metabolic Diseases,Nutritional and Metabolic Diseases,5
Molecular Dynamics Simulation,L,L01.224.160.500,Computer Simulation,Computing Methodologies,5
Molecular Dynamics Simulation,G,G02.111.570.895,Molecular Structure,Biochemical Phenomena,5
Molecular Dynamics Simulation,E,E05.599.595.500,"Models, Molecular","Models, Theoretical",5
Morphine,D,D03.633.400.686.607.587,Morphine Derivatives,Morphinans,5
Morphine,D,D03.605.497.607.587,Morphine Derivatives,Morphinans,5
Morphine,D,D03.132.577.249.562.571,Morphine Derivatives,Morphinans,5
Morphine,D,D04.615.723.795.576.571,Morphine Derivatives,Morphinans,5
Mosaicism,G,G05.365.590.175.595,Chromosome Aberrations,Mutation,5
Motor Neurons,A,A11.671.655.500,"Neurons, Efferent",Neurons,5
Motor Neurons,A,A08.675.655.500,"Neurons, Efferent",Neurons,5
Mouth Diseases,C,C07.465,Stomatognathic Diseases,NULL,5
Muscle Contraction,G,G11.427.494,Musculoskeletal Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,5
Muscle Weakness,C,C05.651.515,Muscular Diseases,Musculoskeletal Diseases,5
Muscle Weakness,C,C23.550.695,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",5
Muscle Weakness,C,C23.888.592.608.593,Neuromuscular Manifestations,Neurologic Manifestations,5
Muscle Weakness,C,C10.597.613.593,Neuromuscular Manifestations,Neurologic Manifestations,5
Myelin Sheath,A,A08.675.542.512.560,"Nerve Fibers, Myelinated",Nerve Fibers,5
Myelin Sheath,A,A08.800.800.690.500,Schwann Cells,Peripheral Nerves,5
Myelin Sheath,A,A08.637.800.500,Schwann Cells,Neuroglia,5
Myelin Sheath,A,A08.637.600.500,Oligodendroglia,Neuroglia,5
Myelin Sheath,A,A11.671.501.512.560,"Nerve Fibers, Myelinated",Nerve Fibers,5
Myelin Sheath,A,A11.671.514.553,"Nerve Fibers, Myelinated",Neurons,5
Myelin Sheath,A,A11.650.600.500,Oligodendroglia,Neuroglia,5
Myelin Sheath,A,A11.650.800.500,Schwann Cells,Neuroglia,5
Myelin Sheath,A,A10.755.503,Nerve Tissue,Tissues,5
Myelin Sheath,A,A11.284.149.165.600,Cell Membrane Structures,Cell Membrane,5
Nasal Lavage Fluid,E,E05.927.573.500,Nasal Lavage,Therapeutic Irrigation,5
Nasal Polyps,C,C09.603.557,Nose Diseases,Otorhinolaryngologic Diseases,5
Nasal Polyps,C,C08.460.572,Nose Diseases,Respiratory Tract Diseases,5
Nasal Polyps,C,C23.300.825.557,Polyps,"Pathological Conditions, Anatomical",5
"National Heart, Lung, and Blood Institute (U.S.)",I,I01.409.418.750.600.650.496.300,National Institutes of Health (U.S.),United States Public Health Service,5
"National Heart, Lung, and Blood Institute (U.S.)",N,N03.540.348.500.500.600.650.496.300,National Institutes of Health (U.S.),United States Public Health Service,5
"National Heart, Lung, and Blood Institute (U.S.)",N,N03.540.052.750.300,National Institutes of Health (U.S.),Academies and Institutes,5
Naval Medicine,H,H02.403.560,Medicine,Health Occupations,5
"Nephrostomy, Percutaneous",E,E04.579.642,Ostomy,"Surgical Procedures, Operative",5
"Nephrostomy, Percutaneous",E,E04.950.774.739.500,Nephrotomy,Urologic Surgical Procedures,5
"Nephrostomy, Percutaneous",E,E04.950.774.852.642,Urinary Diversion,Urologic Surgical Procedures,5
"Nephrostomy, Percutaneous",E,E01.370.390.550,"Diagnostic Techniques, Urological",Diagnostic Techniques and Procedures,5
Neuroblastoma,C,C04.557.465.625.600.590.650.550,"Neuroectodermal Tumors, Primitive, Peripheral","Neuroectodermal Tumors, Primitive",5
Neuroblastoma,C,C04.557.470.670.590.650.550,"Neuroectodermal Tumors, Primitive, Peripheral","Neuroectodermal Tumors, Primitive",5
Neuroblastoma,C,C04.557.580.625.600.590.650.550,"Neuroectodermal Tumors, Primitive, Peripheral","Neuroectodermal Tumors, Primitive",5
Neurocognitive Disorders,F,F03.615,Mental Disorders,NULL,5
Neurology,H,H02.403.600,Medicine,Health Occupations,5
Neuromuscular Diseases,C,C10.668,Nervous System Diseases,NULL,5
New Guinea,Z,Z01.586.650,Historical Geographic Locations,Geographic Locations,5
Night Blindness,C,C11.966.671,Vision Disorders,Eye Diseases,5
Nitrous Oxide,D,D01.625.550.550,Nitrogen Oxides,Nitrogen Compounds,5
Nitrous Oxide,D,D01.650.550.587.650,Nitrogen Oxides,Oxides,5
Nitrous Oxide,D,D01.362.635.625,Nitrogen Oxides,Gases,5
Nod2 Signaling Adaptor Protein,D,D12.776.476.024.139.500,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",5
Nod2 Signaling Adaptor Protein,D,D12.776.476.024.391.500,Nod Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",5
Nod2 Signaling Adaptor Protein,D,D12.776.476.075.358.500,CARD Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,5
Nod2 Signaling Adaptor Protein,D,D12.776.157.057.006.500,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",5
Nod2 Signaling Adaptor Protein,D,D12.776.157.057.078.500,Nod Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",5
Nod2 Signaling Adaptor Protein,D,D12.644.360.024.131.500,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",5
Nod2 Signaling Adaptor Protein,D,D12.644.360.539.500.500,Nod Signaling Adaptor Proteins,NLR Proteins,5
Nod2 Signaling Adaptor Protein,D,D12.644.360.075.358.500,CARD Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,5
Nod2 Signaling Adaptor Protein,D,D12.644.360.024.313.500,Nod Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",5
Nomograms,E,E01.789.650,Prognosis,Diagnosis,5
Nomograms,N,N06.850.520.830.500.625,"Models, Statistical",Statistics as Topic,5
Nomograms,G,G17.582,Mathematical Concepts,NULL,5
Nomograms,N,N05.715.360.750.530.530,"Models, Statistical",Statistics as Topic,5
Nomograms,E,E05.599.835.895,"Models, Statistical","Models, Theoretical",5
Nomograms,E,E05.318.740.500.625,"Models, Statistical",Statistics as Topic,5
Non-Fibrillar Collagens,D,D12.776.860.300.250.400,Collagen,Extracellular Matrix Proteins,5
Nurse Administrators,N,N02.360.650.580,Nurses,Health Personnel,5
Nurse Administrators,M,M01.526.485.650.580,Nurses,Health Personnel,5
Nurse Administrators,M,M01.526.070.670,Administrative Personnel,Occupational Groups,5
Nymph,G,G07.345.500.550.500.650,Life Cycle Stages,"Metamorphosis, Biological",5
Nymph,B,B05.500.650,Life Cycle Stages,Organism Forms,5
Object Attachment,F,F02.739.794.624,Psychoanalytic Theory,Psychological Theory,5
Odontogenesis,G,G07.345.500.325.377.750,Organogenesis,Embryonic and Fetal Development,5
Off-Label Use,E,E02.319.307.500,Drug Prescriptions,Drug Therapy,5
Oils,D,D10.627,Lipids,NULL,5
Oligoribonucleotides,D,D13.695.578.424.500,Oligonucleotides,Polynucleotides,5
Oman,Z,Z01.252.245.500.600,Middle East,"Asia, Western",5
"Oncogene Proteins, Fusion",D,D12.776.602.500.500,Mutant Chimeric Proteins,Mutant Proteins,5
"Oncogene Proteins, Fusion",D,D12.776.624.664.500,Oncogene Proteins,Neoplasm Proteins,5
"Oncology Service, Hospital",N,N02.278.216.500.968.513,Hospital Departments,Hospital Administration,5
"Oncology Service, Hospital",N,N04.452.442.452.422.513,Hospital Departments,Hospital Administration,5
Optical Imaging,E,E05.642,Investigative Techniques,NULL,5
Optical Imaging,E,E01.370.350.589,Diagnostic Imaging,Diagnostic Techniques and Procedures,5
Organ Preservation,E,E05.760.833.660,Tissue Preservation,"Preservation, Biological",5
Organ Preservation,E,E02.792.833.660,Tissue Preservation,"Preservation, Biological",5
Oropharyngeal Neoplasms,C,C04.588.443.665.710.684,Pharyngeal Neoplasms,Otorhinolaryngologic Neoplasms,5
Oropharyngeal Neoplasms,C,C07.550.745.671,Pharyngeal Neoplasms,Pharyngeal Diseases,5
Oropharyngeal Neoplasms,C,C09.775.549.685,Pharyngeal Neoplasms,Pharyngeal Diseases,5
Oropharyngeal Neoplasms,C,C09.647.710.685,Pharyngeal Neoplasms,Otorhinolaryngologic Neoplasms,5
Osteosarcoma,C,C04.557.450.565.575.650,"Neoplasms, Bone Tissue","Neoplasms, Connective Tissue",5
Osteosarcoma,C,C04.557.450.795.620,Sarcoma,"Neoplasms, Connective and Soft Tissue",5
Outsourced Services,N,N03.219.463.100.600,Contract Services,Financial Management,5
Ovalbumin,D,D12.776.872.557,Serpins,Proteins,5
Ovalbumin,D,D12.776.034.614,Albumins,Proteins,5
Ovalbumin,D,D12.644.861.557,Serpins,Peptides,5
Ovalbumin,D,D12.776.256.159.157.663,"Egg Proteins, Dietary","Animal Proteins, Dietary",5
Ovalbumin,D,D12.776.290.663,Egg Proteins,Proteins,5
Paclitaxel,D,D02.455.849.291.850.777,Taxoids,Diterpenes,5
Paclitaxel,D,D02.455.426.392.368.242.888.777,Taxoids,Cyclodecanes,5
Pallor,C,C23.888.885.500,Skin Manifestations,Signs and Symptoms,5
"Paraparesis, Tropical Spastic",C,C10.228.228.618.500,Myelitis,Central Nervous System Infections,5
"Paraparesis, Tropical Spastic",C,C10.228.854.525.700,Myelitis,Spinal Cord Diseases,5
"Paraparesis, Tropical Spastic",C,C01.925.782.815.200.470.710,HTLV-I Infections,Deltaretrovirus Infections,5
"Paraparesis, Tropical Spastic",C,C01.207.618.500,Myelitis,Central Nervous System Infections,5
Paratuberculosis,C,C01.150.252.410.040.552.475.747,"Mycobacterium Infections, Nontuberculous",Mycobacterium Infections,5
Paratuberculosis,C,C22.688,Animal Diseases,NULL,5
Paternal Deprivation,F,F01.829.263.370.380,Family Relations,Family,5
Pediatricians,N,N02.360.810.758,Physicians,Health Personnel,5
Pediatricians,M,M01.526.485.810.758,Physicians,Health Personnel,5
"Pericarditis, Tuberculous",C,C14.260.750.595,"Tuberculosis, Cardiovascular",Cardiovascular Infections,5
"Pericarditis, Tuberculous",C,C14.280.720.801,Pericarditis,Heart Diseases,5
"Pericarditis, Tuberculous",C,C01.150.252.410.040.552.846.554.595,"Tuberculosis, Cardiovascular",Tuberculosis,5
"Pericarditis, Tuberculous",C,C01.190.750.595,"Tuberculosis, Cardiovascular",Cardiovascular Infections,5
Peroxides,D,D02.389.338,Free Radicals,Organic Chemicals,5
Peroxides,D,D01.339.431.374,Reactive Oxygen Species,Free Radicals,5
Peroxides,D,D01.248.497.158.685.750,Oxides,Anions,5
Peroxides,D,D01.650.550.750,Oxides,Oxygen Compounds,5
Personhood,N,N05.350.917,Ethics,"Health Care Quality, Access, and Evaluation",5
Personhood,K,K01.752.566.479.660,Ethics,Morals,5
Phage Therapy,E,E02.095.841,Biological Therapy,Therapeutics,5
Phlebotomy,E,E01.370.225.998.110.625,Blood Specimen Collection,Specimen Handling,5
Phlebotomy,E,E02.800.558,Punctures,Therapeutics,5
Phlebotomy,E,E04.665.150.625,Blood Specimen Collection,Punctures,5
Phlebotomy,E,E05.200.998.110.625,Blood Specimen Collection,Specimen Handling,5
Phosphatidylcholines,D,D10.570.755.375.760.400.800,Glycerophospholipids,Phosphatidic Acids,5
Phosphatidylinositols,D,D10.570.755.375.760.400.942,Glycerophospholipids,Phosphatidic Acids,5
Phosphoglucomutase,D,D08.811.399.520.750.625,Phosphotransferases (Phosphomutases),Intramolecular Transferases,5
Phosphotransferases (Alcohol Group Acceptor),D,D08.811.913.696.620,Phosphotransferases,Transferases,5
Phytic Acid,D,D09.853.519.400.700,Inositol Phosphates,Inositol,5
Phytic Acid,D,D09.894.480.700,Inositol Phosphates,Sugar Phosphates,5
Phytic Acid,D,D02.033.800.519.400.700,Inositol Phosphates,Inositol,5
Pica,C,C23.888.821.825,"Signs and Symptoms, Digestive",Signs and Symptoms,5
Pica,F,F03.400.875,Feeding and Eating Disorders,Mental Disorders,5
Pigmentation Disorders,C,C23.550.755,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",5
Pigmentation Disorders,C,C17.800.621,Skin Diseases,Skin and Connective Tissue Diseases,5
Placental Insufficiency,C,C13.703.590.800,Placenta Diseases,Pregnancy Complications,5
Plant Leaves,A,A18.024.812,"Plant Components, Aerial",Plant Structures,5
"Plants, Toxic",B,B01.650.660,Plants,Eukaryota,5
Plasmodium cynomolgi,B,B01.043.075.380.611.505,Plasmodium,Haemosporida,5
Plasmodium gallinaceum,B,B01.043.075.380.611.576,Plasmodium,Haemosporida,5
Platinum,D,D01.268.956.734,Transition Elements,Elements,5
Platinum,D,D01.268.556.690,"Metals, Heavy",Elements,5
Platinum,D,D01.552.544.690,"Metals, Heavy",Metals,5
"Pleural Effusion, Malignant",C,C08.785.640.700,Pleural Neoplasms,Respiratory Tract Neoplasms,5
"Pleural Effusion, Malignant",C,C08.528.652.700,Pleural Effusion,Pleural Diseases,5
"Pleural Effusion, Malignant",C,C08.528.694.700,Pleural Neoplasms,Pleural Diseases,5
"Pleural Effusion, Malignant",C,C04.588.894.797.640.700,Pleural Neoplasms,Respiratory Tract Neoplasms,5
Ploidies,G,G05.700,Genetic Phenomena,NULL,5
Polymethyl Methacrylate,J,J01.637.051.720.716.822.111.650.605.500,Methylmethacrylates,Polymethacrylic Acids,5
Polymethyl Methacrylate,D,D02.241.081.069.800.550.500,Methylmethacrylates,Polymethacrylic Acids,5
Polymethyl Methacrylate,D,D05.750.716.822.111.650.605.500,Methylmethacrylates,Polymethacrylic Acids,5
Polymethyl Methacrylate,D,D25.720.716.822.111.650.605.500,Methylmethacrylates,Polymethacrylic Acids,5
Polysomnography,E,E01.370.520.625,"Monitoring, Physiologic",Diagnostic Techniques and Procedures,5
Pravastatin,D,D04.615.638.930,Naphthalenes,Polycyclic Aromatic Hydrocarbons,5
Pravastatin,D,D02.455.426.559.847.638.930,Naphthalenes,Polycyclic Aromatic Hydrocarbons,5
"Pregnancy, Animal",G,G08.686.784.769.498,Pregnancy,Reproduction,5
"Pregnancy, Twin",G,G08.686.784.769.545.253,"Pregnancy, Multiple",Pregnancy,5
Pregnanediol,D,D04.210.500.745.495,Pregnanes,Steroids,5
Pregnanediol,D,D06.472.334.851.687.750.739,Progesterone,Progesterone Congeners,5
Pressure Ulcer,C,C17.800.893.665,Skin Ulcer,Skin Diseases,5
Primary Nursing,N,N02.421.533.760,Nursing Care,Health Services,5
"Printing, Three-Dimensional",J,J01.897.564,Technology,"Technology, Industry, and Agriculture",5
"Printing, Three-Dimensional",L,L01.224.108.150.500,Computer-Aided Design,Computer Graphics,5
"Printing, Three-Dimensional",L,L01.296.110.150.500,Computer-Aided Design,Computer Graphics,5
Prion Diseases,C,C10.228.228.800,Central Nervous System Infections,Central Nervous System Diseases,5
Prion Diseases,C,C10.574.843,Neurodegenerative Diseases,Nervous System Diseases,5
Prion Diseases,C,C01.207.800,Central Nervous System Infections,Infections,5
Procarbazine,D,D02.241.223.100.100.655,Benzamides,Benzoates,5
Procarbazine,D,D02.455.426.559.389.127.085.655,Benzamides,Benzoates,5
Procarbazine,D,D02.065.277.727,Benzamides,Amides,5
Professional Practice Location,N,N04.452.758.772,Professional Practice,Organization and Administration,5
Professionalism,N,N05.350.340.581,"Ethics, Professional",Ethics,5
Professionalism,K,K01.752.566.479.171.566,"Ethics, Professional",Ethics,5
Prophylactic Surgical Procedures,E,E04.625,"Surgical Procedures, Operative",NULL,5
Propionibacterium acnes,B,B03.510.024.990.600.600,Propionibacterium,Propionibacteriaceae,5
Propionibacterium acnes,B,B03.510.460.400.400.600.600.600,Propionibacterium,Propionibacteriaceae,5
Propofol,D,D02.455.426.559.389.657.773,Phenols,Benzene Derivatives,5
Protein C,D,D08.622.705,Enzyme Precursors,Enzymes and Coenzymes,5
Protein C,D,D12.776.395.635,Glycoproteins,Proteins,5
Protein C,D,D12.776.124.650,Blood Proteins,Proteins,5
Protein C,D,D23.113.700,Blood Coagulation Factor Inhibitors,Biological Factors,5
Protein C,D,D12.776.811.243.705,Enzyme Precursors,Protein Precursors,5
Protein Kinase C,D,D08.811.913.696.620.682.700.725,Protein-Serine-Threonine Kinases,Protein Kinases,5
Protein Stability,G,G02.111.700,Biochemical Phenomena,Chemical Phenomena,5
Proteus Infections,C,C01.150.252.400.310.708,Enterobacteriaceae Infections,Gram-Negative Bacterial Infections,5
Proteus mirabilis,B,B03.660.250.150.590.500,Proteus,Enterobacteriaceae,5
Proteus mirabilis,B,B03.440.450.425.600.501,Proteus,Enterobacteriaceae,5
Proto-Oncogene Proteins c-bcl-2,D,D12.644.360.075.718,Apoptosis Regulatory Proteins,Intracellular Signaling Peptides and Proteins,5
Proto-Oncogene Proteins c-bcl-2,D,D12.776.624.664.700.169,Proto-Oncogene Proteins,Oncogene Proteins,5
Proto-Oncogene Proteins c-bcl-2,D,D12.776.476.075.718,Apoptosis Regulatory Proteins,Intracellular Signaling Peptides and Proteins,5
"Protozoan Infections, Animal",C,C01.610.701.688,"Parasitic Diseases, Animal",Parasitic Diseases,5
"Protozoan Infections, Animal",C,C01.610.752.625,Protozoan Infections,Parasitic Diseases,5
"Protozoan Infections, Animal",C,C22.674.710,"Parasitic Diseases, Animal",Animal Diseases,5
PrPSc Proteins,D,D12.776.785.340.750,Prion Proteins,Prions,5
P-Selectin,D,D23.050.301.350.700.775,Selectins,Cell Adhesion Molecules,5
P-Selectin,D,D12.776.503.843.775,Selectins,Lectins,5
P-Selectin,D,D12.776.543.550.200.700.775,Selectins,Cell Adhesion Molecules,5
P-Selectin,D,D12.776.543.550.625.905,Platelet Membrane Glycoproteins,Membrane Glycoproteins,5
P-Selectin,D,D12.776.395.550.625.905,Platelet Membrane Glycoproteins,Membrane Glycoproteins,5
P-Selectin,D,D12.776.395.550.200.700.775,Selectins,Cell Adhesion Molecules,5
Pseudophakia,C,C23.888.681,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",5
Psychiatric Nursing,H,H02.478.676.710,"Specialties, Nursing",Nursing,5
Psychiatric Nursing,N,N02.421.533.778,Nursing Care,Health Services,5
Public Health Nursing,H,H02.478.676.755,"Specialties, Nursing",Nursing,5
Purinergic P2 Receptor Antagonists,D,D27.505.519.625.725.400.200,Purinergic Antagonists,Purinergic Agents,5
Purinergic P2 Receptor Antagonists,D,D27.505.696.577.725.400.200,Purinergic Antagonists,Purinergic Agents,5
Pyramidal Tracts,A,A08.612.380.730,Efferent Pathways,Neural Pathways,5
Pyramidal Tracts,A,A08.186.854.300,Spinal Cord,Central Nervous System,5
Pyridazines,D,D03.383.710,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,5
Pyridoxine,D,D03.383.725.676.925.875,Vitamin B 6,Picolines,5
Pyrrolidinones,D,D03.383.773.812,Pyrrolidines,"Heterocyclic Compounds, 1-Ring",5
Quaternary Ammonium Compounds,D,D02.675.276,Onium Compounds,Organic Chemicals,5
Quaternary Ammonium Compounds,D,D02.092.877,Amines,Organic Chemicals,5
Quaternary Ammonium Compounds,D,D01.625.062.500,Ammonium Compounds,Nitrogen Compounds,5
Quetiapine Fumarate,D,D02.886.680.702.500.500,Dibenzothiazepines,Thiazepines,5
Quetiapine Fumarate,D,D03.633.300.276.500,Dibenzothiazepines,"Heterocyclic Compounds, 3-Ring",5
Rabies virus,B,B04.820.480.937.750.500.700,Lyssavirus,Rhabdoviridae,5
Radiation Monitoring,E,E05.799.638,Radiometry,Investigative Techniques,5
Radiation Monitoring,N,N06.850.810.370,Radiologic Health,Public Health,5
Radiation Monitoring,N,N06.850.780.375.700,Environmental Monitoring,Public Health Practice,5
Radio,J,J01.897.280.500.739,Audiovisual Aids,Educational Technology,5
Radio,L,L01.178.590.700,Mass Media,Communications Media,5
Radio,L,L01.178.847.514,Telecommunications,Communications Media,5
Radio,L,L01.178.820.090.739,Audiovisual Aids,Teaching Materials,5
Radiometry,E,E05.799,Investigative Techniques,NULL,5
Rainforest,G,G16.500.275.157.437.500,Forests,Ecosystem,5
Rainforest,N,N06.230.124.343.500,Forests,Ecosystem,5
Ramipril,D,D03.633.100.893,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",5
"Rats, Inbred F344",B,B01.050.150.900.649.313.992.635.505.700.400.200,"Rats, Inbred Strains",Rats,5
"Rats, Inbred F344",B,B01.050.050.199.520.760.200,"Rats, Inbred Strains","Animals, Inbred Strains",5
"Rats, Inbred Lew",B,B01.050.050.199.520.760.280,"Rats, Inbred Strains","Animals, Inbred Strains",5
"Rats, Inbred Lew",B,B01.050.150.900.649.313.992.635.505.700.400.280,"Rats, Inbred Strains",Rats,5
"Receptors, CCR2",D,D12.776.543.750.695.160.150.200,"Receptors, CCR","Receptors, Chemokine",5
"Receptors, CCR2",D,D12.776.543.750.705.852.125.150.200,"Receptors, CCR","Receptors, Chemokine",5
"Receptors, Interleukin-10",D,D12.776.543.750.705.852.420.550,"Receptors, Interleukin","Receptors, Cytokine",5
"Receptors, Interleukin-6",D,D12.776.543.750.705.852.420.400,"Receptors, Interleukin","Receptors, Cytokine",5
"Receptors, Leptin",D,D12.776.543.750.650.500,"Receptors, Adipokine","Receptors, Cell Surface",5
"Receptors, N-Methyl-D-Aspartate",D,D12.776.543.550.450.500.200.500,"Receptors, Ionotropic Glutamate",Ligand-Gated Ion Channels,5
"Receptors, N-Methyl-D-Aspartate",D,D12.776.543.585.400.500.200.500,"Receptors, Ionotropic Glutamate",Ligand-Gated Ion Channels,5
"Receptors, N-Methyl-D-Aspartate",D,D12.776.543.750.720.200.450.400.500,"Receptors, Ionotropic Glutamate","Receptors, Glutamate",5
"Receptors, N-Methyl-D-Aspartate",D,D12.776.157.530.400.400.500.500,"Receptors, Ionotropic Glutamate",Ligand-Gated Ion Channels,5
"Repetitive Sequences, Amino Acid",G,G02.111.570.820.709.275.875,Protein Structural Elements,Protein Conformation,5
"Repetitive Sequences, Amino Acid",G,G02.111.570.060.720,Amino Acid Sequence,Molecular Structure,5
Replicon,G,G05.360.340.024.745,Genome Components,Genome,5
Respiratory Mucosa,A,A04.760,Respiratory System,NULL,5
Respiratory Mucosa,A,A10.615.550.760,Mucous Membrane,Membranes,5
Respirovirus Infections,C,C01.925.782.580.600.600,Paramyxoviridae Infections,Mononegavirales Infections,5
"Restraint, Physical",E,E02.085.700,Behavior Control,Therapeutics,5
"Restraint, Physical",E,E05.472.760,Immobilization,Investigative Techniques,5
Resuscitation Orders,E,E02.760.905.700,Terminal Care,Patient Care,5
Resuscitation Orders,N,N03.706.535.704,Jurisprudence,"Social Control, Formal",5
Resuscitation Orders,N,N02.421.585.905.700,Terminal Care,Patient Care,5
Resuscitation Orders,I,I01.880.604.583.789,Jurisprudence,"Social Control, Formal",5
Resuscitation Orders,E,E02.365.647.740,Resuscitation,Emergency Treatment,5
Retinal Neovascularization,C,C23.550.589.500.725,"Neovascularization, Pathologic",Metaplasia,5
Retinal Neovascularization,C,C11.768.725,Retinal Diseases,Eye Diseases,5
Rheumatic Diseases,C,C17.300.775,Connective Tissue Diseases,Skin and Connective Tissue Diseases,5
Rheumatic Diseases,C,C05.799,Musculoskeletal Diseases,NULL,5
Rheumatoid Factor,D,D12.776.124.790.651.114.323.732,Autoantibodies,Antibodies,5
Rheumatoid Factor,D,D12.776.124.486.485.114.323.732,Autoantibodies,Antibodies,5
Rheumatoid Factor,D,D12.776.377.715.548.114.323.732,Autoantibodies,Antibodies,5
Ribosomal Proteins,D,D12.776.835,Proteins,"Amino Acids, Peptides, and Proteins",5
RNA Caps,D,D13.695.667.454.700,Guanine Nucleotides,Purine Nucleotides,5
RNA Caps,D,D13.695.827.426.700,Guanine Nucleotides,Ribonucleotides,5
RNA Caps,D,D13.444.735.544.500,"RNA, Messenger",RNA,5
RNA Caps,D,D03.633.100.759.646.454.700,Guanine Nucleotides,Purine Nucleotides,5
RNA Helicases,D,D08.811.913.696.445.735.720,RNA Nucleotidyltransferases,Nucleotidyltransferases,5
RNA Stability,G,G02.111.780,Biochemical Phenomena,Chemical Phenomena,5
Rupture,C,C26.761,Wounds and Injuries,NULL,5
Saccharum,B,B01.650.940.800.575.912.250.822.835,Poaceae,Magnoliopsida,5
Salinity,G,G02.640.500,Osmolar Concentration,Chemical Phenomena,5
Salpingectomy,E,E04.950.300.715,Gynecologic Surgical Procedures,Urogenital Surgical Procedures,5
Salts,D,D01.786,Inorganic Chemicals,NULL,5
"Sarcoidosis, Pulmonary",C,C15.604.515.827.725,Sarcoidosis,Lymphoproliferative Disorders,5
"Sarcoidosis, Pulmonary",C,C08.381.483.725,"Lung Diseases, Interstitial",Lung Diseases,5
Satiation,F,F02.830.749,Psychophysiology,Psychological Phenomena,5
School Admission Criteria,I,I02.399.750,Educational Measurement,Education,5
Search Engine,L,L01.470.875,Information Storage and Retrieval,Information Science,5
Self-Sustained Sequence Replication,E,E05.393.620.700,Nucleic Acid Amplification Techniques,Genetic Techniques,5
Serratia,B,B03.440.450.425.814,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,5
Serratia,B,B03.660.250.150.720,Enterobacteriaceae,Gammaproteobacteria,5
Sex Counseling,F,F02.784.176.700,Counseling,"Psychology, Applied",5
Sex Counseling,F,F04.096.837.249,Sexology,Behavioral Sciences,5
Sex Counseling,F,F04.408.413.700,Counseling,Mental Health Services,5
Sex Counseling,N,N02.421.461.363.700,Counseling,Mental Health Services,5
Sex Counseling,N,N02.421.143.303.700,Counseling,Community Health Services,5
Shame,F,F01.470.483.666,Guilt,Emotions,5
Siberia,Z,Z01.252.122.500.500,Russia,"Asia, Northern",5
Silver,D,D01.552.544.812,"Metals, Heavy",Metals,5
Silver,D,D01.268.556.812,"Metals, Heavy",Elements,5
Silver,D,D01.268.956.843,Transition Elements,Elements,5
Single-Cell Analysis,E,E05.242.900,Cytological Techniques,Investigative Techniques,5
Siphonaptera,B,B01.050.500.131.617.720.500.500.968,Holometabola,Neoptera,5
"Skin Diseases, Parasitic",C,C01.610.858,Parasitic Diseases,Infections,5
"Skin Diseases, Parasitic",C,C17.800.838.775,"Skin Diseases, Infectious",Skin Diseases,5
Snake Venoms,D,D20.888.850,Venoms,Complex Mixtures,5
Snake Venoms,D,D23.946.833.850,Venoms,"Toxins, Biological",5
Social Conformity,F,F01.145.813.625,Social Behavior,Behavior,5
Social Control Policies,N,N03.623.500,Policy,Health Care Economics and Organizations,5
Social Control Policies,I,I01.880.604.825,"Social Control, Formal",Sociology,5
Social Control Policies,I,I01.655.500,Policy,Social Sciences,5
"Social Control, Informal",I,I01.880.630,Sociology,Social Sciences,5
Social Facilitation,F,F01.145.813.655,Social Behavior,Behavior,5
Social Skills,F,F01.145.813.828,Social Behavior,Behavior,5
Social Skills,F,F01.829.401.737,Interpersonal Relations,"Psychology, Social",5
Sodium Bicarbonate,D,D01.857.625,Sodium Compounds,Inorganic Chemicals,5
Sodium Bicarbonate,D,D01.200.275.150.100.800,Bicarbonates,Carbonates,5
Sodium Fluoride,D,D01.857.725,Sodium Compounds,Inorganic Chemicals,5
Sodium Fluoride,D,D01.303.350.300.875,Fluorides,Hydrofluoric Acid,5
Sodium Fluoride,D,D25.223.716,Cariostatic Agents,Biomedical and Dental Materials,5
Sodium Fluoride,J,J01.637.051.223.716,Cariostatic Agents,Biomedical and Dental Materials,5
Soot,D,D20.633.937.339,Smoke,Particulate Matter,5
Spatial Regression,N,N05.715.360.750.695.825,Regression Analysis,Statistics as Topic,5
Spatial Regression,N,N05.715.360.750.746.375,Spatial Analysis,Statistics as Topic,5
Spatial Regression,E,E05.318.740.750.862,Regression Analysis,Statistics as Topic,5
Spatial Regression,E,E05.318.740.933.375,Spatial Analysis,Statistics as Topic,5
Spatial Regression,N,N06.850.520.830.933.375,Spatial Analysis,Statistics as Topic,5
Spatial Regression,N,N06.850.520.830.750.862,Regression Analysis,Statistics as Topic,5
Spectrophotometry,E,E05.196.712.726,Photometry,"Chemistry Techniques, Analytical",5
Spectrophotometry,E,E05.196.867.826,Spectrum Analysis,"Chemistry Techniques, Analytical",5
"Spectroscopy, Fourier Transform Infrared",E,E05.196.712.726.676.700,"Spectrophotometry, Infrared",Spectrophotometry,5
"Spectroscopy, Fourier Transform Infrared",E,E05.196.867.826.676.700,"Spectrophotometry, Infrared",Spectrophotometry,5
Speech Therapy,E,E02.831.727.552,Rehabilitation of Speech and Language Disorders,Rehabilitation,5
Speech Therapy,E,E02.760.169.063.500.727.552,Rehabilitation of Speech and Language Disorders,Rehabilitation,5
Spermidine,D,D02.092.782.677,Polyamines,Amines,5
Spermidine,D,D02.092.211.415.701.801,Putrescine,Biogenic Polyamines,5
Spinal Dysraphism,C,C16.131.666.680.800,Neural Tube Defects,Nervous System Malformations,5
Spinal Dysraphism,C,C10.500.680.800,Neural Tube Defects,Nervous System Malformations,5
"Spores, Protozoan",B,B05.775.740,Spores,Organism Forms,5
"Spores, Protozoan",A,A11.870.740,Spores,Cells,5
src-Family Kinases,D,D08.811.913.696.620.682.725.800,Protein-Tyrosine Kinases,Protein Kinases,5
State Dentistry,N,N03.787,Health Care Economics and Organizations,NULL,5
Steel,J,J01.637.051.058.807,Alloys,Biomedical and Dental Materials,5
Steel,D,D25.058.807,Alloys,Biomedical and Dental Materials,5
Steel,D,D01.552.033.847,Alloys,Metals,5
Steel,D,D01.490.800,Iron Compounds,Inorganic Chemicals,5
Steroid 17-alpha-Hydroxylase,D,D12.776.422.220.453.915.748,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,5
Steroid 17-alpha-Hydroxylase,D,D12.776.422.220.453.487.500,Cytochrome P450 Family 17,Cytochrome P-450 Enzyme System,5
Steroid 17-alpha-Hydroxylase,D,D08.244.453.487.500,Cytochrome P450 Family 17,Cytochrome P-450 Enzyme System,5
Steroid 17-alpha-Hydroxylase,D,D08.244.453.915.748,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,5
Steroid 17-alpha-Hydroxylase,D,D08.811.682.690.708.170.444.500,Cytochrome P450 Family 17,Cytochrome P-450 Enzyme System,5
Steroid 17-alpha-Hydroxylase,D,D08.811.682.690.708.170.915.748,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,5
Stevens-Johnson Syndrome,C,C25.100.468.380.900,Drug Eruptions,Drug Hypersensitivity,5
Stevens-Johnson Syndrome,C,C20.543.206.380.900,Drug Eruptions,Drug Hypersensitivity,5
Stevens-Johnson Syndrome,C,C17.800.865.475.683,Erythema Multiforme,"Skin Diseases, Vesiculobullous",5
Stevens-Johnson Syndrome,C,C17.800.229.400.683,Erythema Multiforme,Erythema,5
Stevens-Johnson Syndrome,C,C17.800.174.600.900,Drug Eruptions,Dermatitis,5
Stevens-Johnson Syndrome,C,C07.465.864.500,Stomatitis,Mouth Diseases,5
Subtilisin,D,D08.811.277.656.959.350.787.805,Subtilisins,Serine Endopeptidases,5
Subtilisin,D,D08.811.277.656.300.760.787.805,Subtilisins,Serine Endopeptidases,5
Surge Capacity,N,N05.300.450.760,Health Services Needs and Demand,Delivery of Health Care,5
Surgical Flaps,E,E07.862.710,Surgically-Created Structures,Equipment and Supplies,5
Surgical Flaps,A,A10.850.710,Surgically-Created Structures,Tissues,5
Suture Techniques,E,E04.987.775,Wound Closure Techniques,"Surgical Procedures, Operative",5
Taenia solium,B,B01.050.500.500.736.215.895.775,Taenia,Cestoda,5
"tat Gene Products, Human Immunodeficiency Virus",D,D12.776.260.755.199.500,"Gene Products, tat",Trans-Activators,5
"tat Gene Products, Human Immunodeficiency Virus",D,D12.776.964.925.984.400.500,"Gene Products, tat",Trans-Activators,5
"tat Gene Products, Human Immunodeficiency Virus",D,D12.776.930.900.199.500,"Gene Products, tat",Trans-Activators,5
"tat Gene Products, Human Immunodeficiency Virus",D,D12.776.964.900.750.750.500,"Gene Products, tat",Viral Replicase Complex Proteins,5
"tat Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.562.773,Human Immunodeficiency Virus Proteins,Retroviridae Proteins,5
Telomerase,D,D12.776.664.962.500.921,Ribonucleoproteins,RNA-Binding Proteins,5
Telomerase,D,D12.776.660.720.613,Poly-ADP-Ribose Binding Proteins,Nuclear Proteins,5
Telomerase,D,D12.776.157.687.613,Poly-ADP-Ribose Binding Proteins,Carrier Proteins,5
Telomerase,D,D12.776.157.725.500.921,Ribonucleoproteins,RNA-Binding Proteins,5
Telomerase,D,D08.811.913.696.445.308.300.750.750,RNA-Directed DNA Polymerase,DNA-Directed DNA Polymerase,5
Temporal Arteries,A,A07.015.114.228.868,Cerebral Arteries,Arteries,5
Teratoma,C,C04.557.465.910,"Neoplasms, Germ Cell and Embryonal",Neoplasms by Histologic Type,5
Theileria parva,B,B01.043.075.600.580.700.500,Theileria,Piroplasmida,5
Thoracic Injuries,C,C26.891,Wounds and Injuries,NULL,5
THP-1 Cells,A,A11.251.860.180.815,"Cell Line, Tumor","Tumor Cells, Cultured",5
THP-1 Cells,A,A11.251.210.190.815,"Cell Line, Tumor",Cell Line,5
"Thyroiditis, Autoimmune",C,C20.111.809,Autoimmune Diseases,Immune System Diseases,5
"Thyroiditis, Autoimmune",C,C19.874.871.102,Thyroiditis,Thyroid Diseases,5
Tibet,Z,Z01.252.474.164.900,China,Far East,5
Tonsillitis,C,C08.730.561.750,Pharyngitis,Respiratory Tract Infections,5
Tonsillitis,C,C09.775.649.750,Pharyngitis,Pharyngeal Diseases,5
Tonsillitis,C,C07.550.781.750,Pharyngitis,Pharyngeal Diseases,5
Tonsillitis,C,C01.748.561.750,Pharyngitis,Respiratory Tract Infections,5
"Tooth, Deciduous",A,A14.549.167.860.700,Tooth,Dentition,5
Torture,I,I01.880.735.900.825,Violence,Social Problems,5
Torture,I,I01.198.240.856.825,Violence,Crime,5
Touch,G,G11.561.790.850,Sensation,Nervous System Physiological Phenomena,5
Touch,F,F02.830.816.850,Sensation,Psychophysiology,5
"Toxoplasmosis, Animal",C,C01.610.752.625.817,"Protozoan Infections, Animal",Protozoan Infections,5
"Toxoplasmosis, Animal",C,C01.610.701.688.817,"Protozoan Infections, Animal","Parasitic Diseases, Animal",5
"Toxoplasmosis, Animal",C,C01.610.752.250.800.110,Toxoplasmosis,Coccidiosis,5
"Toxoplasmosis, Animal",C,C22.674.710.817,"Protozoan Infections, Animal","Parasitic Diseases, Animal",5
Transglutaminases,D,D08.811.913.050.200.800,Aminoacyltransferases,Acyltransferases,5
Transition Temperature,G,G01.906.595.850,Temperature,Thermodynamics,5
Trastuzumab,D,D12.776.377.715.548.114.224.200.875,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",5
Trastuzumab,D,D12.776.124.486.485.114.224.060.875,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",5
Trastuzumab,D,D12.776.124.790.651.114.224.060.875,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",5
Treponemal Infections,C,C01.150.252.400.794.840,Spirochaetales Infections,Gram-Negative Bacterial Infections,5
Treponemal Infections,C,C01.150.252.400.840,Gram-Negative Bacterial Infections,Bacterial Infections,5
Trichinella spiralis,B,B01.050.500.500.294.100.275.780.608.700,Trichinella,Trichuroidea,5
Triple Negative Breast Neoplasms,C,C04.588.180.788,Breast Neoplasms,Neoplasms by Site,5
Triple Negative Breast Neoplasms,C,C17.800.090.500.788,Breast Neoplasms,Breast Diseases,5
"Trypanosomiasis, Bovine",C,C22.674.710.896,"Protozoan Infections, Animal","Parasitic Diseases, Animal",5
"Trypanosomiasis, Bovine",C,C22.196.888,Cattle Diseases,Animal Diseases,5
"Trypanosomiasis, Bovine",C,C01.610.701.688.896,"Protozoan Infections, Animal","Parasitic Diseases, Animal",5
"Trypanosomiasis, Bovine",C,C01.610.752.625.896,"Protozoan Infections, Animal",Protozoan Infections,5
"Trypanosomiasis, Bovine",C,C01.610.752.300.900.802,Trypanosomiasis,Euglenozoa Infections,5
Trypsin,D,D08.811.277.656.959.350.895,Serine Endopeptidases,Serine Proteases,5
Trypsin,D,D08.811.277.656.300.760.895,Serine Endopeptidases,Endopeptidases,5
Tunisia,Z,Z01.058.266.887,"Africa, Northern",Africa,5
Turkmenistan,Z,Z01.586.200.940,Commonwealth of Independent States,Historical Geographic Locations,5
Turkmenistan,Z,Z01.252.100.940,"Asia, Central",Asia,5
Twin Studies as Topic,N,N06.850.520.450.900,Epidemiologic Study Characteristics,Epidemiologic Methods,5
Twin Studies as Topic,E,E05.318.372.900,Epidemiologic Study Characteristics,Epidemiologic Methods,5
Twin Studies as Topic,N,N05.715.360.330.900,Epidemiologic Study Characteristics,Health Care Evaluation Mechanisms,5
Type III Secretion Systems,D,D05.500.890.500.875,Bacterial Secretion Systems,Protein Translocation Systems,5
Universal Health Care,N,N04.590.374.350.875,Health Services Accessibility,Delivery of Health Care,5
Universal Health Care,N,N04.940,Health Services Administration,NULL,5
Universal Health Care,N,N03.706.871,"Social Control, Formal",Health Care Economics and Organizations,5
Uridine,D,D03.383.742.680.852,Pyrimidine Nucleosides,Pyrimidines,5
Uridine,D,D13.570.685.852,Pyrimidine Nucleosides,Nucleosides,5
Uridine,D,D13.570.800.892,Ribonucleosides,Nucleosides,5
Urinary Bladder,A,A05.810.890,Urinary Tract,Urogenital System,5
Urinary Retention,C,C13.351.968.934.880,Urination Disorders,Urologic Diseases,5
Urinary Retention,C,C12.777.934.880,Urination Disorders,Urologic Diseases,5
Urination,G,G08.852.880,Urinary Tract Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,5
Urology,H,H02.403.810.860,"Specialties, Surgical",Medicine,5
Uterine Cervicitis,C,C13.351.500.852.593.150,Uterine Cervical Diseases,Uterine Diseases,5
Uterine Rupture,C,C13.351.500.852.904,Uterine Diseases,"Genital Diseases, Female",5
Uterine Rupture,C,C13.703.420.904,Obstetric Labor Complications,Pregnancy Complications,5
Uterine Rupture,C,C26.761.853,Rupture,Wounds and Injuries,5
"Vaccines, Virus-Like Particle",D,D20.215.894.865.955,"Vaccines, Synthetic",Vaccines,5
"Vaccines, Virus-Like Particle",D,D12.776.828.868.955,"Vaccines, Synthetic",Recombinant Proteins,5
"Vaccines, Virus-Like Particle",D,D23.050.865.955,"Vaccines, Synthetic",Antigens,5
Vaccinia,C,C01.925.256.743.929,Poxviridae Infections,DNA Virus Infections,5
Vacuum Curettage,E,E04.950.300.299.970,Dilatation and Curettage,Gynecologic Surgical Procedures,5
Vacuum Curettage,E,E04.157.310.970,Dilatation and Curettage,Curettage,5
Vaginal Diseases,C,C13.351.500.894,"Genital Diseases, Female",Female Urogenital Diseases,5
Vesicovaginal Fistula,C,C13.351.968.829.548.733,Urinary Bladder Fistula,Urinary Bladder Diseases,5
Vesicovaginal Fistula,C,C13.351.875.881.312.733,Urinary Bladder Fistula,Urinary Fistula,5
Vesicovaginal Fistula,C,C13.351.500.894.767.500,Vaginal Fistula,Vaginal Diseases,5
Vesicovaginal Fistula,C,C23.300.575.825.250.775,Urinary Bladder Fistula,Urinary Fistula,5
Vesicovaginal Fistula,C,C23.300.575.925.816,Vaginal Fistula,Fistula,5
Vesiculovirus,B,B04.820.480.937.750.900,Rhabdoviridae,Mononegavirales,5
Veterans Health,N,N01.400.850,Health,Population Characteristics,5
Vibrio vulnificus,B,B03.660.250.830.830.900,Vibrio,Vibrionaceae,5
Vibrio vulnificus,B,B03.440.450.900.859.900,Vibrio,Vibrionaceae,5
Video Games,I,I03.450.642.693.930,Play and Playthings,Recreation,5
Video Games,L,L01.224.900.930,Software,Computing Methodologies,5
"Virulence Factors, Bordetella",D,D23.946.896.980,Virulence Factors,"Toxins, Biological",5
"Virulence Factors, Bordetella",D,D23.946.123.946,Bacterial Toxins,"Toxins, Biological",5
Virus Attachment,G,G06.920.868,Virus Physiological Phenomena,Microbiological Phenomena,5
Virus Integration,G,G06.920.877,Virus Physiological Phenomena,Microbiological Phenomena,5
Virus Integration,G,G05.935,Genetic Phenomena,NULL,5
Vitamin K,D,D02.455.426.559.847.638.721.374,Naphthoquinones,Naphthalenes,5
Vitamin K,D,D02.455.849.291.523.500,Phytol,Diterpenes,5
Vitamin K,D,D04.615.638.721.374,Naphthoquinones,Naphthalenes,5
Volcanic Eruptions,G,G01.311.955,Geological Phenomena,Physical Phenomena,5
Voltage-Gated Sodium Channels,D,D12.776.157.530.400.875.750,Sodium Channels,Ion Channels,5
Voltage-Gated Sodium Channels,D,D12.776.631.960,Nerve Tissue Proteins,Proteins,5
Voltage-Gated Sodium Channels,D,D12.776.543.585.400.875.750,Sodium Channels,Ion Channels,5
Voltage-Gated Sodium Channels,D,D12.776.543.550.450.875.750,Sodium Channels,Ion Channels,5
Walk Test,E,E01.370.370.380.250.500,Exercise Test,Heart Function Tests,5
War Exposure,I,I01.880.735.950.500.951,Warfare,Warfare and Armed Conflicts,5
War Exposure,N,N06.850.460.350.600.903,Occupational Exposure,Environmental Exposure,5
Water-Electrolyte Imbalance,C,C18.452.950,Metabolic Diseases,Nutritional and Metabolic Diseases,5
Wind,N,N06.230.300.100.725.780,Weather,Atmosphere,5
Wind,N,N06.230.132.644.875,Renewable Energy,Energy-Generating Resources,5
Wind,N,N06.230.300.100.150.185.200,Air Movements,Air,5
Wind,G,G16.500.175.249.200,Air Movements,Climatic Processes,5
Wind,G,G16.500.275.063.725.154.200,Air Movements,Weather,5
Wind,G,G16.500.750.775.780,Weather,Meteorological Concepts,5
World War I,I,I01.880.735.950.250.968,Armed Conflicts,Warfare and Armed Conflicts,5
World War I,K,K01.400.504.968.900,"History, 20th Century","History, Modern 1601-",5
World War II,K,K01.400.504.968.901,"History, 20th Century","History, Modern 1601-",5
World War II,I,I01.880.735.950.250.984,Armed Conflicts,Warfare and Armed Conflicts,5
X Chromosome,G,G05.360.162.865.982,Sex Chromosomes,Chromosomes,5
X Chromosome,A,A11.284.187.865.982,Sex Chromosomes,Chromosomes,5
Zygote,A,A11.497.497.950,Ovum,Germ Cells,5
Zygote,A,A05.360.490.690.970,Ovum,Germ Cells,5
Zygote,A,A16.950,Embryonic Structures,NULL,5
11-beta-Hydroxysteroid Dehydrogenases,D,D08.811.682.047.820.100,NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases,Alcohol Oxidoreductases,4
11-beta-Hydroxysteroid Dehydrogenases,D,D08.811.682.047.436.174,Hydroxysteroid Dehydrogenases,Alcohol Oxidoreductases,4
2-Pyridinylmethylsulfinylbenzimidazoles,D,D02.886.640.074,Sulfoxides,Sulfur Compounds,4
2-Pyridinylmethylsulfinylbenzimidazoles,D,D03.633.100.103.034,Benzimidazoles,"Heterocyclic Compounds, 2-Ring",4
2-Pyridinylmethylsulfinylbenzimidazoles,D,D03.383.725.024,Pyridines,"Heterocyclic Compounds, 1-Ring",4
Abiraterone Acetate,D,D04.210.500.054.079.065,Androstenes,Androstanes,4
Ablation Techniques,E,E04.014,"Surgical Procedures, Operative",NULL,4
Absorbable Implants,E,E07.695.025,Prostheses and Implants,Equipment and Supplies,4
Academic Performance,I,I02.399.136,Educational Measurement,Education,4
Acanthamoeba,B,B01.046.500.100.075.080,Acanthopodina,Amoebida,4
Accountable Care Organizations,N,N05.300.380.500,Health Care Reform,Delivery of Health Care,4
Acetamides,D,D02.065.064,Amides,Organic Chemicals,4
Acetamides,D,D02.241.081.018.110,Acetates,"Acids, Acyclic",4
Acetyltransferases,D,D08.811.913.050.134,Acyltransferases,Transferases,4
Acid Anhydride Hydrolases,D,D08.811.277.040,Hydrolases,Enzymes,4
Actinobacteria,B,B03.510.024,Gram-Positive Bacteria,Bacteria,4
Actinobacteria,B,B03.510.460.400.400.049,"Gram-Positive Asporogenous Rods, Irregular",Gram-Positive Asporogenous Rods,4
"Active Transport, Cell Nucleus",G,G03.143.310.100,"Biological Transport, Active",Biological Transport,4
"Active Transport, Cell Nucleus",G,G03.143.700.100,Protein Transport,Biological Transport,4
Acute Pain,C,C23.888.592.612.081,Pain,Neurologic Manifestations,4
Adenosine Diphosphate,D,D03.633.100.759.646.138.124,Adenine Nucleotides,Purine Nucleotides,4
Adenosine Diphosphate,D,D13.695.827.068.124,Adenine Nucleotides,Ribonucleotides,4
Adenosine Diphosphate,D,D13.695.667.138.124,Adenine Nucleotides,Purine Nucleotides,4
"Adenovirus Infections, Human",C,C01.925.256.076.045,Adenoviridae Infections,DNA Virus Infections,4
Adhesives,D,D27.720.013,Specialty Uses of Chemicals,Chemical Actions and Uses,4
Adhesives,J,J01.637.016,Manufactured Materials,"Technology, Industry, and Agriculture",4
"Administration, Buccal",E,E02.319.267.120.040,"Administration, Topical",Drug Administration Routes,4
"Administration, Buccal",E,E02.319.267.100.028,"Administration, Oral",Drug Administration Routes,4
Adoptive Transfer,E,E02.095.465.425.400.330.050,"Immunization, Passive",Immunization,4
Adoptive Transfer,E,E05.478.550.520.050,"Immunization, Passive",Immunization,4
ADP-Ribosylation Factor 1,D,D12.776.543.990.300.150,Coat Protein Complex I,Vesicular Transport Proteins,4
ADP-Ribosylation Factor 1,D,D12.776.476.525.100.100,ADP-Ribosylation Factors,Monomeric GTP-Binding Proteins,4
ADP-Ribosylation Factor 1,D,D08.811.277.040.330.300.400.100.100,ADP-Ribosylation Factors,Monomeric GTP-Binding Proteins,4
ADP-Ribosylation Factor 1,D,D12.776.157.325.515.100.100,ADP-Ribosylation Factors,Monomeric GTP-Binding Proteins,4
ADP-Ribosylation Factor 1,D,D12.644.360.525.100.100,ADP-Ribosylation Factors,Monomeric GTP-Binding Proteins,4
Adrenergic alpha-Antagonists,D,D27.505.519.625.050.200.100,Adrenergic Antagonists,Adrenergic Agents,4
Adrenergic alpha-Antagonists,D,D27.505.696.577.050.200.100,Adrenergic Antagonists,Adrenergic Agents,4
Adsorption,G,G01.030,Physical Phenomena,NULL,4
Adsorption,G,G02.020,Chemical Phenomena,NULL,4
Advanced Trauma Life Support Care,N,N02.421.297.028,Emergency Medical Services,Health Services,4
Advanced Trauma Life Support Care,N,N02.421.585.440.040,Life Support Care,Patient Care,4
Advanced Trauma Life Support Care,E,E02.760.440.040,Life Support Care,Patient Care,4
Advanced Trauma Life Support Care,E,E02.365.152,Emergency Treatment,Therapeutics,4
Agglutination,G,G12.122.100,Antigen-Antibody Reactions,Immune System Phenomena,4
Agglutination,G,G02.111.026,Biochemical Phenomena,Chemical Phenomena,4
Agrochemicals,D,D27.720.031,Specialty Uses of Chemicals,Chemical Actions and Uses,4
AIDS-Associated Nephropathy,C,C01.925.782.815.616.400.050,HIV Infections,Lentivirus Infections,4
AIDS-Associated Nephropathy,C,C01.925.813.400.072,HIV Infections,"Sexually Transmitted Diseases, Viral",4
AIDS-Associated Nephropathy,C,C01.778.640.400.072,HIV Infections,"Sexually Transmitted Diseases, Viral",4
AIDS-Associated Nephropathy,C,C01.221.812.640.400.072,HIV Infections,"Sexually Transmitted Diseases, Viral",4
AIDS-Associated Nephropathy,C,C01.221.250.875.050,HIV Infections,Blood-Borne Infections,4
AIDS-Associated Nephropathy,C,C20.673.480.050,HIV Infections,Immunologic Deficiency Syndromes,4
AIDS-Associated Nephropathy,C,C13.351.968.419.050,Kidney Diseases,Urologic Diseases,4
AIDS-Associated Nephropathy,C,C12.777.419.050,Kidney Diseases,Urologic Diseases,4
Air Conditioning,N,N06.230.150.050,"Environment, Controlled",Environment,4
Airports,J,J03.970.100,Transportation Facilities,Non-Medical Public and Private Facilities,4
Alcohol-Induced Disorders,C,C25.775.100.087,Alcohol-Related Disorders,Substance-Related Disorders,4
Alkyl and Aryl Transferases,D,D08.811.913.225,Transferases,Enzymes,4
Alkylation,G,G02.111.035,Biochemical Phenomena,Chemical Phenomena,4
Alkylation,G,G03.059,Metabolism,NULL,4
Alkylation,G,G02.607.094,Organic Chemistry Phenomena,Chemical Phenomena,4
alpha-2-HS-Glycoprotein,D,D12.776.157.125.283.500,Fetuins,Calcium-Binding Proteins,4
alpha-2-HS-Glycoprotein,D,D12.776.124.790.106.304.500,Fetuins,Alpha-Globulins,4
alpha-2-HS-Glycoprotein,D,D12.776.377.715.085.304.500,Fetuins,Alpha-Globulins,4
alpha-2-HS-Glycoprotein,D,D12.776.395.086,Glycoproteins,Proteins,4
alpha-2-HS-Glycoprotein,D,D12.776.215.625.500,Fetuins,Cystatins,4
Amantadine,D,D02.455.426.100.050.035,Adamantane,Bridged-Ring Compounds,4
Amebicides,D,D27.505.954.122.250.100.055,Antiprotozoal Agents,Antiparasitic Agents,4
American Medical Association,N,N03.540.828.589.274,"Societies, Medical",Societies,4
Ampulla of Vater,A,A03.556.875.249.160,Duodenum,Upper Gastrointestinal Tract,4
Ampulla of Vater,A,A03.734.667.500,Pancreatic Ducts,Pancreas,4
Ampulla of Vater,A,A03.556.124.684.124.236,Duodenum,"Intestine, Small",4
Ampulla of Vater,A,A03.159.183.079.300.950,Common Bile Duct,"Bile Ducts, Extrahepatic",4
Amygdala,A,A08.186.211.180.090,Limbic System,Brain,4
Amygdala,A,A08.186.211.200.885.287.249.152,Basal Ganglia,Cerebrum,4
Anastomotic Leak,C,C23.550.767.071,Postoperative Complications,Pathologic Processes,4
Androstenols,D,D04.210.500.054.079.429,Androstenes,Androstanes,4
"Anemia, Pernicious",C,C18.654.521.500.133.699.923.280,Vitamin B 12 Deficiency,Vitamin B Deficiency,4
"Anemia, Pernicious",C,C15.378.071.252.196.500,"Anemia, Megaloblastic","Anemia, Macrocytic",4
"Anesthesia, Obstetrical",E,E03.155.364,Anesthesia,Anesthesia and Analgesia,4
Angiopoietin-1,D,D12.644.276.100.100.100,Angiopoietins,Angiogenic Proteins,4
Angiopoietin-1,D,D23.529.100.100.100,Angiopoietins,Angiogenic Proteins,4
Angiopoietin-1,D,D12.776.467.100.100.100,Angiopoietins,Angiogenic Proteins,4
Angiopoietin-2,D,D12.776.467.100.100.200,Angiopoietins,Angiogenic Proteins,4
Angiopoietin-2,D,D23.529.100.100.200,Angiopoietins,Angiogenic Proteins,4
Angiopoietin-2,D,D12.644.276.100.100.200,Angiopoietins,Angiogenic Proteins,4
Aniline Compounds,D,D02.092.146,Amines,Organic Chemicals,4
Annual Reports as Topic,N,N04.452.070,Organization and Administration,Health Services Administration,4
Antacids,D,D27.505.954.483.080,Gastrointestinal Agents,Therapeutic Uses,4
Antacids,D,D27.505.519.170,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,4
Anthracyclines,D,D09.408.051.059,Aminoglycosides,Glycosides,4
Anthracyclines,D,D04.615.562.050,Naphthacenes,Polycyclic Aromatic Hydrocarbons,4
Anthracyclines,D,D02.455.426.559.847.562.050,Naphthacenes,Polycyclic Aromatic Hydrocarbons,4
"Antidepressive Agents, Second-Generation",D,D27.505.954.427.700.122.050,Antidepressive Agents,Psychotropic Drugs,4
"Antineoplastic Agents, Immunological",D,D27.505.954.248.384,Antineoplastic Agents,Therapeutic Uses,4
"Antineoplastic Agents, Phytogenic",D,D27.505.954.248.179,Antineoplastic Agents,Therapeutic Uses,4
"Aorta, Thoracic",A,A07.015.114.056.372,Aorta,Arteries,4
"Aortic Aneurysm, Thoracic",C,C14.907.055.239.125,Aortic Aneurysm,Aneurysm,4
"Aortic Aneurysm, Thoracic",C,C14.907.109.139.125,Aortic Aneurysm,Aortic Diseases,4
Aortic Valve Insufficiency,C,C14.280.484.048.500,Aortic Valve Disease,Heart Valve Diseases,4
Aphasia,C,C10.597.606.150.500.800.100,Speech Disorders,Language Disorders,4
Aphasia,C,C23.888.592.604.150.500.800.100,Speech Disorders,Language Disorders,4
Apolipoprotein L1,D,D12.776.521.120.750.500,Apolipoproteins L,Apolipoproteins,4
Apolipoprotein L1,D,D10.532.091.750.500,Apolipoproteins L,Apolipoproteins,4
Apolipoprotein L1,D,D12.776.070.400.750.500,Apolipoproteins L,Apolipoproteins,4
Appetitive Behavior,F,F01.145.113.111,"Behavior, Animal",Behavior,4
Arabinose,D,D09.947.875.627.166,Pentoses,Monosaccharides,4
Archaea,B,B02,NULL,NULL,4
Architectural Accessibility,J,J01.086.339.070,Facility Design and Construction,Architecture,4
Archives,K,K01.400.152,History,Humanities,4
Archives,J,J03.400.208,Information Centers,Non-Medical Public and Private Facilities,4
Archives,L,L01.346.208,Information Centers,Information Science,4
Arenaviridae,B,B04.820.480.500,Negative-Sense RNA Viruses,RNA Viruses,4
Aromatase,D,D08.244.453.915.099,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,4
Aromatase,D,D08.244.453.489.500,Cytochrome P450 Family 19,Cytochrome P-450 Enzyme System,4
Aromatase,D,D08.811.682.690.708.170.915.099,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,4
Aromatase,D,D08.811.682.690.708.170.447.500,Cytochrome P450 Family 19,Cytochrome P-450 Enzyme System,4
Aromatase,D,D12.776.422.220.453.489.500,Cytochrome P450 Family 19,Cytochrome P-450 Enzyme System,4
Aromatase,D,D12.776.422.220.453.915.099,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,4
Arsenicals,D,D01.075,Inorganic Chemicals,NULL,4
Arsenicals,D,D02.129,Organic Chemicals,NULL,4
Art,K,K01.093,Humanities,NULL,4
"Arthritis, Reactive",C,C01.100.500,"Arthritis, Infectious",Infections,4
"Arthritis, Reactive",C,C05.550.114.865.800.637,Spondylarthropathies,Spondylarthritis,4
"Arthritis, Reactive",C,C05.550.114.099.500,"Arthritis, Infectious",Arthritis,4
"Arthritis, Reactive",C,C05.116.900.853.625.800.637,Spondylarthropathies,Spondylarthritis,4
Astrocytoma,C,C04.557.465.625.600.380.080,Glioma,"Neoplasms, Neuroepithelial",4
Astrocytoma,C,C04.557.580.625.600.380.080,Glioma,"Neoplasms, Neuroepithelial",4
Astrocytoma,C,C04.557.470.670.380.080,Glioma,"Neoplasms, Neuroepithelial",4
Axilla,A,A01.378.800.090,Upper Extremity,Extremities,4
B7-2 Antigen,D,D12.776.465.500,Immune Checkpoint Proteins,Proteins,4
B7-2 Antigen,D,D12.776.467.150.200,B7 Antigens,Intercellular Signaling Peptides and Proteins,4
B7-2 Antigen,D,D12.776.543.095.200,B7 Antigens,Membrane Proteins,4
B7-2 Antigen,D,D23.050.301.285.200,B7 Antigens,"Antigens, Surface",4
B7-2 Antigen,D,D23.529.168.200,B7 Antigens,Intercellular Signaling Peptides and Proteins,4
Bacillus,B,B03.353.500.100.218,Bacillaceae,Bacillales,4
Bacillus,B,B03.300.390.400.158.218,Bacillaceae,Gram-Positive Endospore-Forming Rods,4
Bacillus,B,B03.510.460.410.158.218,Bacillaceae,Gram-Positive Endospore-Forming Rods,4
Bacillus,B,B03.510.415.400.158.218,Bacillaceae,Gram-Positive Endospore-Forming Rods,4
Bacillus,B,B03.510.100.100.218,Bacillaceae,Bacillales,4
Bacterial Secretion Systems,D,D05.500.890.500,Protein Translocation Systems,Multiprotein Complexes,4
Bahamas,Z,Z01.107.084.900.100,West Indies,Caribbean Region,4
Bahamas,Z,Z01.639.880.100,West Indies,Islands,4
Baltimore,Z,Z01.107.567.875.500.500.100,Maryland,Mid-Atlantic Region,4
Baltimore,Z,Z01.433.100,Cities,Geographic Locations,4
Bandages,E,E07.101,Equipment and Supplies,NULL,4
Basal Bodies,A,A11.284.430.214.190.750.585.079,Microtubule-Organizing Center,Cytoskeleton,4
Basement Membrane,A,A10.615.179,Membranes,Tissues,4
Basement Membrane,A,A10.272.220,Epithelium,Tissues,4
Basigin,D,D12.776.395.550.045,Membrane Glycoproteins,Glycoproteins,4
Basigin,D,D23.050.285.040,"Antigens, Neoplasm",Antigens,4
Basigin,D,D12.776.543.550.187,Membrane Glycoproteins,Membrane Proteins,4
Baths,E,E02.056.110,Balneology,Therapeutics,4
Bees,B,B01.050.500.131.617.720.500.500.875.387,Hymenoptera,Holometabola,4
Behavioral Sciences,F,F04.096,Behavioral Disciplines and Activities,NULL,4
Bell Palsy,C,C01.925.256.466.087,Herpesviridae Infections,DNA Virus Infections,4
Bell Palsy,C,C07.465.094,Mouth Diseases,Stomatognathic Diseases,4
Bell Palsy,C,C07.465.299.250,Facial Nerve Diseases,Mouth Diseases,4
Bell Palsy,C,C10.292.319.250,Facial Nerve Diseases,Cranial Nerve Diseases,4
Benzazepines,D,D03.633.100.079,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",4
Berlin,Z,Z01.433.128,Cities,Geographic Locations,4
Berlin,Z,Z01.542.315.182,Germany,Europe,4
Beta Particles,G,G01.750.750.125,"Radiation, Ionizing",Radiation,4
Bile Acids and Salts,D,D04.210.500.105,Steroids,Fused-Ring Compounds,4
Biliary Tract Neoplasms,C,C06.301.120,Digestive System Neoplasms,Digestive System Diseases,4
Biliary Tract Neoplasms,C,C06.130.320,Biliary Tract Diseases,Digestive System Diseases,4
Biliary Tract Neoplasms,C,C04.588.274.120,Digestive System Neoplasms,Neoplasms by Site,4
Biofortification,J,J01.040.227.250,Crop Production,Agriculture,4
"Biological Variation, Population",G,G16.117,Biological Phenomena,NULL,4
Biological Warfare,I,I01.880.735.950.500.226,Warfare,Warfare and Armed Conflicts,4
"Biopsy, Fine-Needle",E,E04.074.119.500,"Biopsy, Needle",Biopsy,4
"Biopsy, Fine-Needle",E,E04.665.100.500,"Biopsy, Needle",Punctures,4
"Biopsy, Fine-Needle",E,E05.200.500.384.100.119.500,"Biopsy, Needle",Biopsy,4
"Biopsy, Fine-Needle",E,E05.242.384.100.119.500,"Biopsy, Needle",Biopsy,4
"Biopsy, Fine-Needle",E,E05.200.998.054.119.500,"Biopsy, Needle",Biopsy,4
"Biopsy, Fine-Needle",E,E01.370.388.100.100.500,"Biopsy, Needle",Biopsy,4
"Biopsy, Fine-Needle",E,E01.370.225.998.054.119.500,"Biopsy, Needle",Biopsy,4
"Biopsy, Fine-Needle",E,E01.370.225.500.384.100.119.500,"Biopsy, Needle",Biopsy,4
Biotin,D,D08.211.096,Coenzymes,Enzymes and Coenzymes,4
Biotin,D,D03.383.129.308.080,Imidazoles,Azoles,4
Bisoprolol,D,D02.092.063.624.698.085,Phenoxypropanolamines,Propanolamines,4
Bisoprolol,D,D02.033.755.624.698.085,Phenoxypropanolamines,Propanolamines,4
Bisoprolol,D,D02.033.100.624.698.085,Phenoxypropanolamines,Propanolamines,4
BK Virus,B,B04.613.204.670.615.100,Polyomavirus,Polyomaviridae,4
BK Virus,B,B04.280.210.700.615.100,Polyomavirus,Polyomaviridae,4
Blastocystis hominis,B,B01.046.500.100.200.200.375,Blastocystis,Blastocystina,4
Bleomycin,D,D09.400.420.110,Glycopeptides,Glycoconjugates,4
Bleomycin,D,D12.644.233.110,Glycopeptides,Peptides,4
Blood Gas Analysis,E,E01.370.225.124.100.100,Blood Chemical Analysis,Clinical Chemistry Tests,4
Blood Gas Analysis,E,E01.370.386.700.100,Respiratory Function Tests,"Diagnostic Techniques, Respiratory System",4
Blood Gas Analysis,E,E05.200.124.100.100,Blood Chemical Analysis,Clinical Chemistry Tests,4
Blood Grouping and Crossmatching,E,E05.200.625.120,Hematologic Tests,Clinical Laboratory Techniques,4
Blood Grouping and Crossmatching,E,E05.200.812.385.120,Histocompatibility Testing,Immunologic Tests,4
Blood Grouping and Crossmatching,E,E05.478.594.385.120,Histocompatibility Testing,Immunologic Tests,4
Blood Grouping and Crossmatching,E,E01.370.225.625.120,Hematologic Tests,Clinical Laboratory Techniques,4
Blood Grouping and Crossmatching,E,E01.370.225.812.385.120,Histocompatibility Testing,Immunologic Tests,4
Blood Safety,E,E05.760.833.230.500,Blood Preservation,Tissue Preservation,4
Blood Safety,E,E02.792.833.230.500,Blood Preservation,Tissue Preservation,4
Blood Safety,N,N06.850.780.200.450.325,Infection Control,Communicable Disease Control,4
Blood Vessel Prosthesis Implantation,E,E04.100.814.868.500,Vascular Grafting,Vascular Surgical Procedures,4
Blood Vessel Prosthesis Implantation,E,E04.650.200,Prosthesis Implantation,"Surgical Procedures, Operative",4
Bodily Secretions,A,A12.200,Fluids and Secretions,NULL,4
Bone Diseases,C,C05.116,Musculoskeletal Diseases,NULL,4
"Botulinum Toxins, Type A",D,D23.946.123.179.050,Botulinum Toxins,Bacterial Toxins,4
"Botulinum Toxins, Type A",D,D12.776.097.156.100,Botulinum Toxins,Bacterial Proteins,4
"Botulinum Toxins, Type A",D,D08.811.277.656.675.374.153.100,Botulinum Toxins,Metalloendopeptidases,4
"Botulinum Toxins, Type A",D,D08.811.277.656.300.480.153.100,Botulinum Toxins,Metalloendopeptidases,4
Bovine Virus Diarrhea-Mucosal Disease,C,C01.925.782.350.675.106,Pestivirus Infections,Flaviviridae Infections,4
Bovine Virus Diarrhea-Mucosal Disease,C,C22.196.106,Cattle Diseases,Animal Diseases,4
Brachial Artery,A,A07.015.114.139,Arteries,Blood Vessels,4
"Bridged Bicyclo Compounds, Heterocyclic",D,D03.605.084,"Heterocyclic Compounds, Bridged-Ring",Heterocyclic Compounds,4
Brief Psychiatric Rating Scale,F,F04.711.513.653.083,Psychiatric Status Rating Scales,Neuropsychological Tests,4
Budesonide,D,D04.210.500.745.745.654.105,Pregnenediones,Pregnenes,4
Burkholderia cepacia complex,B,B03.660.075.090.688.100.110,Burkholderia,Burkholderiaceae,4
Calcineurin Inhibitors,D,D27.505.519.389.174,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,4
Candidemia,C,C01.150.703.492.500.500,"Candidiasis, Invasive",Invasive Fungal Infections,4
Candidemia,C,C01.150.703.160.175.500,"Candidiasis, Invasive",Candidiasis,4
Candidemia,C,C01.757.360.150,Fungemia,Sepsis,4
Candidemia,C,C23.550.470.790.500.360.150,Fungemia,Sepsis,4
"Candidiasis, Invasive",C,C01.150.703.160.175,Candidiasis,Mycoses,4
"Candidiasis, Invasive",C,C01.150.703.492.500,Invasive Fungal Infections,Mycoses,4
"Candidiasis, Oral",C,C01.150.703.160.180,Candidiasis,Mycoses,4
"Candidiasis, Oral",C,C07.465.130,Mouth Diseases,Stomatognathic Diseases,4
Carbazoles,D,D03.633.100.473.144,Indoles,"Heterocyclic Compounds, 2-Ring",4
Carbazoles,D,D03.633.300.148,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",4
Carboxylic Acids,D,D02.241,Organic Chemicals,NULL,4
Carcinoembryonic Antigen,D,D12.776.395.550.200.210,Cell Adhesion Molecules,Membrane Glycoproteins,4
Carcinoembryonic Antigen,D,D23.101.140.300,"Biomarkers, Tumor",Biomarkers,4
Carcinoembryonic Antigen,D,D12.776.543.550.200.210,Cell Adhesion Molecules,Membrane Glycoproteins,4
Carcinoembryonic Antigen,D,D23.050.285.329,"Antigens, Neoplasm",Antigens,4
Carcinoembryonic Antigen,D,D23.050.301.350.210,Cell Adhesion Molecules,"Antigens, Surface",4
CARD Signaling Adaptor Proteins,D,D12.776.476.075.358,Apoptosis Regulatory Proteins,Intracellular Signaling Peptides and Proteins,4
CARD Signaling Adaptor Proteins,D,D12.776.476.024.139,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,4
CARD Signaling Adaptor Proteins,D,D12.776.157.057.006,"Adaptor Proteins, Signal Transducing",Carrier Proteins,4
CARD Signaling Adaptor Proteins,D,D12.644.360.024.131,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,4
CARD Signaling Adaptor Proteins,D,D12.644.360.075.358,Apoptosis Regulatory Proteins,Intracellular Signaling Peptides and Proteins,4
Cardiac Care Facilities,N,N02.278.421.556.110,"Hospitals, Special",Hospitals,4
Cardiolipins,D,D10.570.755.375.760.400.885.185,Phosphatidylglycerols,Glycerophospholipids,4
Cardiolipins,D,D23.050.550.480.330,Haptens,Epitopes,4
Caspase 1,D,D12.776.476.075.405.550.100,"Caspases, Initiator",Caspases,4
Caspase 1,D,D12.644.360.075.405.550.100,"Caspases, Initiator",Caspases,4
Caspase 1,D,D08.811.277.656.300.200.126.550.100,"Caspases, Initiator",Caspases,4
Caspase 1,D,D08.811.277.656.262.500.126.550.100,"Caspases, Initiator",Caspases,4
Catha,B,B01.650.940.800.575.912.250.859.500.750.155,Celastraceae,Celastrales,4
Cathepsins,D,D08.811.277.656.224,Peptide Hydrolases,Hydrolases,4
CD5 Antigens,D,D23.050.301.264.894.101,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",4
CD5 Antigens,D,D23.050.301.264.051.101,"Antigens, Differentiation, B-Lymphocyte","Antigens, Differentiation",4
CD5 Antigens,D,D23.101.100.150.101,"Antigens, Differentiation, B-Lymphocyte","Antigens, Differentiation",4
CD5 Antigens,D,D23.101.100.894.101,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",4
Cell Degranulation,G,G04.468.160,Exocytosis,Cell Physiological Phenomena,4
Cell Polarity,G,G04.250,Cell Physiological Phenomena,NULL,4
Cell Size,G,G04.325,Cell Physiological Phenomena,NULL,4
Cells,A,A11,NULL,NULL,4
Cellular Senescence,G,G04.043,Cell Physiological Phenomena,NULL,4
Centralized Hospital Services,N,N02.278.216.500.750,Hospital Administration,Health Facility Administration,4
Centralized Hospital Services,N,N04.452.442.452.110,Hospital Administration,Health Facility Administration,4
Centrifugation,E,E05.181,Investigative Techniques,NULL,4
Cerebral Angiography,E,E05.629.937.180,Neuroradiography,Neuroimaging,4
Cerebral Angiography,E,E01.370.350.578.937.180,Neuroradiography,Neuroimaging,4
Cerebral Angiography,E,E01.370.350.700.560.180,Neuroradiography,Radiography,4
Cerebral Angiography,E,E01.370.350.700.060.180,Angiography,Radiography,4
Cerebral Angiography,E,E01.370.376.537.750.180,Neuroradiography,Neuroimaging,4
Cerebral Angiography,E,E01.370.370.050.180,Angiography,"Diagnostic Techniques, Cardiovascular",4
Cerebral Arteries,A,A07.015.114.228,Arteries,Blood Vessels,4
Cerebrospinal Fluid Shunts,E,E04.525.170,Neurosurgical Procedures,"Surgical Procedures, Operative",4
Cerebrospinal Fluid Shunts,E,E04.035.188,"Anastomosis, Surgical","Surgical Procedures, Operative",4
Cervical Cord,A,A08.186.854.126,Spinal Cord,Central Nervous System,4
Chancre,C,C01.150.252.400.840.500.500,Syphilis,Treponemal Infections,4
Chancre,C,C01.150.252.400.794.840.500.500,Syphilis,Treponemal Infections,4
Character,F,F01.752.190,Personality,Behavior and Behavior Mechanisms,4
Charcoal,D,D01.268.150.150,Carbon,Elements,4
"Chemistry, Clinical",H,H01.181.341,Chemistry,Natural Science Disciplines,4
Chemokine CCL11,D,D23.125.300.110.550,"Chemokines, CC",Chemokines,4
Chemokine CCL11,D,D23.469.200.110.550,"Chemokines, CC",Chemokines,4
Chemokine CCL11,D,D23.529.374.200.110.550,"Chemokines, CC",Chemokines,4
Chemokine CCL11,D,D12.776.467.374.200.110.550,"Chemokines, CC",Chemokines,4
Chemokine CCL11,D,D12.644.276.374.200.110.550,"Chemokines, CC",Chemokines,4
Chemokine CXCL11,D,D12.644.276.374.200.120.550,"Chemokines, CXC",Chemokines,4
Chemokine CXCL11,D,D12.776.467.374.200.120.550,"Chemokines, CXC",Chemokines,4
Chemokine CXCL11,D,D23.529.374.200.120.550,"Chemokines, CXC",Chemokines,4
Chemokine CXCL11,D,D23.469.200.120.550,"Chemokines, CXC",Chemokines,4
Chemokine CXCL11,D,D23.125.300.120.550,"Chemokines, CXC",Chemokines,4
Chemokine CXCL9,D,D23.125.300.120.450,"Chemokines, CXC",Chemokines,4
Chemokine CXCL9,D,D23.469.200.120.450,"Chemokines, CXC",Chemokines,4
Chemokine CXCL9,D,D23.529.374.200.120.450,"Chemokines, CXC",Chemokines,4
Chemokine CXCL9,D,D12.776.467.374.200.120.450,"Chemokines, CXC",Chemokines,4
Chemokine CXCL9,D,D12.644.276.374.200.120.450,"Chemokines, CXC",Chemokines,4
"Chemokines, CXC",D,D12.644.276.374.200.120,Chemokines,Cytokines,4
"Chemokines, CXC",D,D12.776.467.374.200.120,Chemokines,Cytokines,4
"Chemokines, CXC",D,D23.529.374.200.120,Chemokines,Cytokines,4
"Chemokines, CXC",D,D23.469.200.120,Chemokines,Inflammation Mediators,4
"Chemokines, CXC",D,D23.125.300.120,Chemokines,Chemotactic Factors,4
Child Rearing,F,F01.318,Behavior and Behavior Mechanisms,NULL,4
Chlamydophila Infections,C,C01.150.252.400.210.250,Chlamydiaceae Infections,Gram-Negative Bacterial Infections,4
Chlamydophila psittaci,B,B03.440.190.190.230.500,Chlamydophila,Chlamydiaceae,4
Chlorpromazine,D,D03.633.300.783.198,Phenothiazines,"Heterocyclic Compounds, 3-Ring",4
Chlorpromazine,D,D02.886.369.198,Phenothiazines,Sulfur Compounds,4
Chlorpyrifos,D,D02.886.300.692.100,Organothiophosphates,Organothiophosphorus Compounds,4
Chlorpyrifos,D,D02.705.539.345.100,Organothiophosphates,Organothiophosphorus Compounds,4
Chlorpyrifos,D,D02.705.400.625.100,Organothiophosphates,Organophosphates,4
"Cholestasis, Intrahepatic",C,C06.552.150,Liver Diseases,Digestive System Diseases,4
"Cholestasis, Intrahepatic",C,C06.130.120.135.250,Cholestasis,Bile Duct Diseases,4
Chorioretinitis,C,C11.768.773.348,Retinitis,Retinal Diseases,4
Chorioretinitis,C,C11.941.160.478.400,Choroiditis,Choroid Diseases,4
Chorioretinitis,C,C11.941.879.780.900.300.318,Choroiditis,"Uveitis, Posterior",4
Chromosomal Instability,C,C23.550.210.110,Chromosome Aberrations,Pathologic Processes,4
Chromosomal Instability,C,C23.550.362.180,Genomic Instability,Pathologic Processes,4
Chromosomal Instability,G,G05.370.180,Genomic Instability,Genetic Phenomena,4
Chromosomal Instability,G,G05.365.590.175.165,Chromosome Aberrations,Mutation,4
"Chromosomes, Human, Pair 10",G,G05.360.162.520.300.325.350,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",4
"Chromosomes, Human, Pair 10",A,A11.284.187.520.300.325.350,"Chromosomes, Human, 6-12 and X","Chromosomes, Human",4
"Chromosomes, Human, Pair 13",A,A11.284.187.520.300.370.375,"Chromosomes, Human, 13-15","Chromosomes, Human",4
"Chromosomes, Human, Pair 13",G,G05.360.162.520.300.370.375,"Chromosomes, Human, 13-15","Chromosomes, Human",4
"Chromosomes, Human, Pair 20",G,G05.360.162.520.300.460.470,"Chromosomes, Human, 19-20","Chromosomes, Human",4
"Chromosomes, Human, Pair 20",A,A11.284.187.520.300.460.470,"Chromosomes, Human, 19-20","Chromosomes, Human",4
"Chromosomes, Human, Pair 21",A,A11.284.187.520.300.505.510,"Chromosomes, Human, 21-22 and Y","Chromosomes, Human",4
"Chromosomes, Human, Pair 21",G,G05.360.162.520.300.505.510,"Chromosomes, Human, 21-22 and Y","Chromosomes, Human",4
"Chromosomes, Insect",G,G05.360.162.440,Chromosomes,Genetic Structures,4
"Chromosomes, Insect",A,A11.284.187.440,Chromosomes,Cellular Structures,4
Citric Acid,D,D02.241.081.901.434.249,Citrates,Tricarboxylic Acids,4
Citrobacter rodentium,B,B03.440.450.425.200.737,Citrobacter,Enterobacteriaceae,4
Citrobacter rodentium,B,B03.660.250.150.100.737,Citrobacter,Enterobacteriaceae,4
Clinical Enzyme Tests,E,E01.370.225.124.200,Clinical Chemistry Tests,Clinical Laboratory Techniques,4
Clinical Enzyme Tests,E,E05.196.427.200,Enzyme Assays,"Chemistry Techniques, Analytical",4
Clinical Enzyme Tests,E,E05.200.124.200,Clinical Chemistry Tests,Clinical Laboratory Techniques,4
Clostridium sordellii,B,B03.510.415.400.200.700,Clostridium,Gram-Positive Endospore-Forming Rods,4
Clostridium sordellii,B,B03.300.390.400.200.700,Clostridium,Gram-Positive Endospore-Forming Rods,4
Clostridium sordellii,B,B03.353.625.375.500.700,Clostridium,Clostridiaceae,4
Clotrimazole,D,D03.383.129.308.175,Imidazoles,Azoles,4
Coagulase,D,D08.811.277.656.300.174,Endopeptidases,Peptide Hydrolases,4
Coagulase,D,D12.776.097.181,Bacterial Proteins,Proteins,4
"Coated Materials, Biocompatible",D,D25.130.420,Biocompatible Materials,Biomedical and Dental Materials,4
"Coated Materials, Biocompatible",J,J01.637.051.130.420,Biocompatible Materials,Biomedical and Dental Materials,4
"Codon, Initiator",G,G05.360.335.355.225,Codon,Genetic Code,4
"Codon, Initiator",G,G05.360.340.024.340.137.190.225,Codon,Gene Components,4
"Codon, Initiator",D,D13.444.735.544.355.225,Codon,"RNA, Messenger",4
"Codon, Terminator",D,D13.444.735.544.355.250,Codon,"RNA, Messenger",4
"Codon, Terminator",G,G05.360.340.024.340.137.190.250,Codon,Gene Components,4
"Codon, Terminator",G,G05.360.335.355.250,Codon,Genetic Code,4
Cognitive Reserve,F,F02.463.188.331,Cognition,Mental Processes,4
Colonic Polyps,C,C23.300.825.411.235,Intestinal Polyps,Polyps,4
Combat Disorders,F,F03.950.750.249,"Stress Disorders, Traumatic",Trauma and Stressor Related Disorders,4
Community Mental Health Centers,N,N02.278.035.158,Ambulatory Care Facilities,Health Facilities,4
Complement C3b,D,D12.776.124.486.274.250.260,Complement C3,Complement System Proteins,4
Conjunctival Diseases,C,C11.187,Eye Diseases,NULL,4
Connective Tissue,A,A10.165,Tissues,NULL,4
"Constriction, Pathologic",C,C23.300.287,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",4
COP-Coated Vesicles,A,A11.284.430.214.190.875.190.880.180.180,Coated Vesicles,Transport Vesicles,4
Core Binding Factor Alpha 2 Subunit,D,D12.776.930.155.200.200,Core Binding Factor alpha Subunits,Core Binding Factors,4
Core Binding Factor Alpha 3 Subunit,D,D12.776.930.155.200.300,Core Binding Factor alpha Subunits,Core Binding Factors,4
Coroners and Medical Examiners,M,M01.526.485.230,Health Personnel,Occupational Groups,4
Coroners and Medical Examiners,N,N02.360.230,Health Personnel,"Health Care Facilities, Manpower, and Services",4
Correspondence as Topic,L,L01.559.423.906.377,Writing,Language Arts,4
Corynebacterium,B,B03.510.460.400.400.200,"Gram-Positive Asporogenous Rods, Irregular",Gram-Positive Asporogenous Rods,4
Corynebacterium,B,B03.510.024.250,Actinobacteria,Gram-Positive Bacteria,4
Coxiella burnetii,B,B03.440.400.425.297.150.100,Coxiella,Coxiellaceae,4
Coxiella burnetii,B,B03.660.250.132.150.100,Coxiella,Coxiellaceae,4
Cranial Nerve Diseases,C,C10.292,Nervous System Diseases,NULL,4
Creatine Kinase,D,D08.811.913.696.640.150,Phosphotransferases (Nitrogenous Group Acceptor),Phosphotransferases,4
Crystallography,H,H01.181.529.240,"Chemistry, Physical",Chemistry,4
Crystallography,E,E05.196.309,"Chemistry Techniques, Analytical",Investigative Techniques,4
Crystalloid Solutions,D,D26.776.498.500,Isotonic Solutions,Solutions,4
Cultural Deprivation,I,I01.880.853.100.400,Culture,Sociological Factors,4
Cyanosis,C,C23.888.248,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",4
Cyclic AMP Receptor Protein,D,D12.776.930.165,Transcription Factors,Proteins,4
Cyclin D1,D,D12.776.624.664.700.100,Proto-Oncogene Proteins,Oncogene Proteins,4
Cyclin D1,D,D12.776.476.262.150.100,Cyclin D,Cyclins,4
Cyclin D1,D,D12.644.360.262.150.100,Cyclin D,Cyclins,4
Cyclin D1,D,D12.776.167.218.150.100,Cyclin D,Cyclins,4
Cyclin-Dependent Kinase 2,D,D12.776.167.200.323,Cyclin-Dependent Kinases,Cell Cycle Proteins,4
Cyclin-Dependent Kinase 2,D,D12.644.360.250.323,Cyclin-Dependent Kinases,Intracellular Signaling Peptides and Proteins,4
Cyclin-Dependent Kinase 2,D,D08.811.913.696.620.682.700.646.500.750,Cyclin-Dependent Kinases,Proline-Directed Protein Kinases,4
Cyclin-Dependent Kinase 2,D,D12.776.476.250.323,Cyclin-Dependent Kinases,Intracellular Signaling Peptides and Proteins,4
Cyclin-Dependent Kinases,D,D12.776.476.250,Intracellular Signaling Peptides and Proteins,Proteins,4
Cyclin-Dependent Kinases,D,D08.811.913.696.620.682.700.646.500,Proline-Directed Protein Kinases,Protein-Serine-Threonine Kinases,4
Cyclin-Dependent Kinases,D,D12.644.360.250,Intracellular Signaling Peptides and Proteins,Peptides,4
Cyclin-Dependent Kinases,D,D12.776.167.200,Cell Cycle Proteins,Proteins,4
Cycloheximide,D,D03.383.621.808.240,Piperidones,Piperidines,4
Cyclooxygenase 2 Inhibitors,D,D27.505.519.389.310.500,Cyclooxygenase Inhibitors,Enzyme Inhibitors,4
Cyclooxygenase 2 Inhibitors,D,D27.505.954.158.030.500.500,Cyclooxygenase Inhibitors,"Anti-Inflammatory Agents, Non-Steroidal",4
Cyclooxygenase 2 Inhibitors,D,D27.505.954.329.030.500.500,Cyclooxygenase Inhibitors,"Anti-Inflammatory Agents, Non-Steroidal",4
Cyclooxygenase 2 Inhibitors,D,D27.505.696.663.850.014.040.500.500.500,Cyclooxygenase Inhibitors,"Anti-Inflammatory Agents, Non-Steroidal",4
Cycloserine,D,D03.383.129.385.162,Isoxazoles,Azoles,4
Cycloserine,D,D03.383.129.462.600.162,Oxazolidinones,Oxazoles,4
Cycloserine,D,D12.125.154.800.750,Serine,"Amino Acids, Neutral",4
Cystectomy,E,E04.950.774.150,Urologic Surgical Procedures,Urogenital Surgical Procedures,4
Cysteine Proteases,D,D08.811.277.656.262,Peptide Hydrolases,Hydrolases,4
Cytidine,D,D03.383.742.680.245,Pyrimidine Nucleosides,Pyrimidines,4
Cytidine,D,D13.570.800.286,Ribonucleosides,Nucleosides,4
Cytidine,D,D13.570.685.245,Pyrimidine Nucleosides,Nucleosides,4
Cytochrome P-450 Enzyme Inhibitors,D,D27.505.519.389.335,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,4
Cytochrome P-450 Enzyme Inhibitors,D,D27.505.389.500,Metabolic Side Effects of Drugs and Substances,Pharmacologic Actions,4
Cytochromes c,D,D12.776.422.220.286.100,Cytochrome c Group,Cytochromes,4
Cytochromes c,D,D08.244.286.100,Cytochrome c Group,Cytochromes,4
Cytoplasmic Granules,A,A11.284.430.214.190.875.190.190,Cytoplasmic Vesicles,Organelles,4
Cytoplasmic Granules,A,A11.284.430.214.190.500,Cytoplasmic Structures,Cytoplasm,4
DEAD-box RNA Helicases,D,D08.811.913.696.445.735.720.249,RNA Helicases,RNA Nucleotidyltransferases,4
Deamino Arginine Vasopressin,D,D12.644.548.691.692.781.100.250,Arginine Vasopressin,Vasopressins,4
Deamino Arginine Vasopressin,D,D12.644.400.900.100.250,Arginine Vasopressin,Vasopressins,4
Deamino Arginine Vasopressin,D,D12.644.456.925.100.250,Arginine Vasopressin,Vasopressins,4
Deamino Arginine Vasopressin,D,D06.472.699.631.692.781.100.250,Arginine Vasopressin,Vasopressins,4
Deamino Arginine Vasopressin,D,D12.776.631.650.937.100.250,Arginine Vasopressin,Vasopressins,4
Democratic People's Republic of Korea,Z,Z01.252.474.557.500,Korea,Far East,4
Dental Cementum,A,A14.549.167.900.250,Tooth Components,Dentition,4
Dental Cementum,A,A14.549.167.646.267,Periodontium,Dentition,4
Dental Enamel Proteins,D,D12.776.231,Proteins,"Amino Acids, Peptides, and Proteins",4
Dental Plaque,C,C07.793.208.377,Dental Deposits,Tooth Diseases,4
Dental Pulp,A,A14.549.167.900.260,Tooth Components,Dentition,4
"Dental Restoration, Permanent",E,E06.323.428,"Dentistry, Operative",Dentistry,4
"Dental Restoration, Permanent",E,E06.780.346.737,Dental Prosthesis,Prosthodontics,4
"Dental Restoration, Permanent",E,E07.695.190.190,Dental Prosthesis,Prostheses and Implants,4
Diaries as Topic,K,K01.517.211.361,Biographies as Topic,Literature,4
Dibenzothiazepines,D,D03.633.300.276,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",4
Dibenzothiazepines,D,D02.886.680.702.500,Thiazepines,Thiepins,4
Dichelobacter nodosus,B,B03.440.450.342.550,Cardiobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,4
Dichelobacter nodosus,B,B03.440.425.410.400,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",Gram-Negative Anaerobic Bacteria,4
Dichelobacter nodosus,B,B03.660.250.080.550,Cardiobacteriaceae,Gammaproteobacteria,4
Digoxin,D,D04.210.500.155.580.130.500.436,Digitalis Glycosides,Cardenolides,4
Digoxin,D,D04.210.500.155.580.130.688,Cardenolides,Cardiac Glycosides,4
Digoxin,D,D09.408.180.261.436,Digitalis Glycosides,Cardiac Glycosides,4
Dinoprostone,D,D10.251.355.255.550.250.200,Prostaglandins E,Prostaglandins,4
Dinoprostone,D,D23.469.050.175.725.250.200,Prostaglandins E,Prostaglandins,4
Diphtheria Antitoxin,D,D20.215.401.601.388,Antitoxins,Immune Sera,4
Diphtheria Antitoxin,D,D12.776.377.715.548.114.573.601.438,Antitoxins,Immune Sera,4
Diphtheria Antitoxin,D,D12.776.124.486.485.114.573.601.438,Antitoxins,Immune Sera,4
Diphtheria Antitoxin,D,D12.776.124.790.651.114.573.601.438,Antitoxins,Immune Sera,4
Directories as Topic,L,L01.178.682.192.836.339,Reference Books,Books,4
Disaster Medicine,H,H02.403.230,Medicine,Health Occupations,4
Disorders of Excessive Somnolence,F,F03.870.400.800.200,"Sleep Disorders, Intrinsic",Dyssomnias,4
Disorders of Excessive Somnolence,C,C10.886.425.800.200,"Sleep Disorders, Intrinsic",Dyssomnias,4
Distemper,C,C22.268.265,Dog Diseases,Animal Diseases,4
Distemper,C,C01.925.782.580.600.500.285,Morbillivirus Infections,Paramyxoviridae Infections,4
"Distemper Virus, Canine",B,B04.820.480.937.600.650.500.280,Morbillivirus,Paramyxovirinae,4
DNA Topoisomerase IV,D,D12.776.097.256,Bacterial Proteins,Proteins,4
DNA Topoisomerase IV,D,D08.811.399.403.741.224,"DNA Topoisomerases, Type II",DNA Topoisomerases,4
Dronabinol,D,D02.455.849.090.810,Cannabinoids,Terpenes,4
Drug Antagonism,G,G07.690.773.968.310,Drug Interactions,Pharmacological Phenomena,4
Drug Misuse,E,E02.319.306,Drug Therapy,Therapeutics,4
"Drug Screening Assays, Antitumor",E,E01.370.225.500.388,Cytological Techniques,Clinical Laboratory Techniques,4
"Drug Screening Assays, Antitumor",E,E05.337.550.200,"Drug Evaluation, Preclinical",Evaluation Studies as Topic,4
"Drug Screening Assays, Antitumor",E,E05.200.500.388,Cytological Techniques,Clinical Laboratory Techniques,4
"Drug Screening Assays, Antitumor",E,E05.242.417,Cytological Techniques,Investigative Techniques,4
Drug Tolerance,G,G07.690.773.992,Pharmacological Phenomena,Pharmacological and Toxicological Phenomena,4
Ducks,B,B01.050.150.900.248.050.200,Anseriformes,Birds,4
Ducks,B,B01.050.150.900.248.690.345,Poultry,Birds,4
Duration of Therapy,E,E02.760.287,Patient Care,Therapeutics,4
Duration of Therapy,N,N02.421.585.287,Patient Care,Health Services,4
Dystocia,C,C13.703.420.288,Obstetric Labor Complications,Pregnancy Complications,4
"Education, Continuing",I,I02.358.212,"Education, Professional",Education,4
"Education, Nonprofessional",I,I02.233,Education,NULL,4
Eimeria tenella,B,B01.043.075.189.250.250.250.250,Eimeria,Eimeriidae,4
Elasticity Imaging Techniques,E,E01.370.350.850.270,Ultrasonography,Diagnostic Imaging,4
Electric Stimulation,E,E05.723.402,Physical Stimulation,Investigative Techniques,4
Electrochemistry,H,H01.181.529.307,"Chemistry, Physical",Chemistry,4
Embryo Implantation,G,G08.686.784.170.104.500,Embryonic Development,Embryonic and Fetal Development,4
Endocrine Gland Neoplasms,C,C04.588.322,Neoplasms by Site,Neoplasms,4
Endocrine Gland Neoplasms,C,C19.344,Endocrine System Diseases,NULL,4
Endoribonucleases,D,D08.811.277.352.355.350,Endonucleases,Esterases,4
Endoribonucleases,D,D08.811.277.352.700.350,Ribonucleases,Esterases,4
Energy-Generating Resources,N,N06.230.132,Environment,Environment and Public Health,4
Enterobacter,B,B03.660.250.150.170,Enterobacteriaceae,Gammaproteobacteria,4
Enterobacter,B,B03.440.450.425.275,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,4
"Enterocolitis, Necrotizing",C,C06.405.469.363.700,Enterocolitis,Intestinal Diseases,4
"Enterocolitis, Necrotizing",C,C06.405.205.596.700,Enterocolitis,Gastroenteritis,4
Entropy,G,G01.906.345,Thermodynamics,Physical Phenomena,4
Epididymitis,C,C12.294.199,"Genital Diseases, Male",Male Urogenital Diseases,4
"Epithelium, Corneal",A,A10.272.510,Epithelium,Tissues,4
"Epithelium, Corneal",A,A09.371.060.217.325,Cornea,Anterior Eye Segment,4
Eptifibatide,D,D12.644.641.366,"Peptides, Cyclic",Peptides,4
Erythema Infectiosum,C,C01.925.825.260,"Skin Diseases, Viral",Virus Diseases,4
Erythema Infectiosum,C,C01.925.256.700.300,Parvoviridae Infections,DNA Virus Infections,4
Erythema Infectiosum,C,C17.800.229.335,Erythema,Skin Diseases,4
Erythema Infectiosum,C,C17.800.838.790.260,"Skin Diseases, Viral","Skin Diseases, Infectious",4
E-Selectin,D,D12.776.395.550.200.700.300,Selectins,Cell Adhesion Molecules,4
E-Selectin,D,D23.050.301.350.700.300,Selectins,Cell Adhesion Molecules,4
E-Selectin,D,D12.776.503.843.300,Selectins,Lectins,4
E-Selectin,D,D12.776.543.550.200.700.300,Selectins,Cell Adhesion Molecules,4
"Ethics, Institutional",N,N05.350.325,Ethics,"Health Care Quality, Access, and Evaluation",4
"Ethics, Institutional",K,K01.752.566.479.168,Ethics,Morals,4
Ethylenediamines,D,D02.092.782.258.368,Diamines,Polyamines,4
Ethylnitrosourea,D,D02.065.950.594.310,Nitrosourea Compounds,Urea,4
Ethylnitrosourea,D,D02.654.692.300,Nitrosourea Compounds,Nitroso Compounds,4
Eugenics,K,K01.400.307,History,Humanities,4
Exfoliation Syndrome,C,C11.941.375.285,Iris Diseases,Uveal Diseases,4
Exhalation,G,G09.772.705.700.275,Respiratory Mechanics,Respiration,4
Exposure to Violence,I,I01.880.735.900.869,Violence,Social Problems,4
Extracellular Space,A,A10.082.500,Body Fluid Compartments,Tissues,4
Extracellular Space,A,A11.284.295,Cellular Structures,Cells,4
"Extraction, Obstetrical",E,E04.520.252.875,"Delivery, Obstetric",Obstetric Surgical Procedures,4
Eye Infections,C,C01.375,Infections,NULL,4
Eye Infections,C,C11.294,Eye Diseases,NULL,4
"Eye Infections, Parasitic",C,C11.294.725,Eye Infections,Eye Diseases,4
"Eye Infections, Parasitic",C,C01.610.300,Parasitic Diseases,Infections,4
Facility Design and Construction,J,J01.086.339,Architecture,"Technology, Industry, and Agriculture",4
Facility Design and Construction,N,N02.278.200,Health Facilities,"Health Care Facilities, Manpower, and Services",4
Factor Xa Inhibitors,D,D27.505.519.389.745.800.449.500,Antithrombins,Serine Proteinase Inhibitors,4
Factor Xa Inhibitors,D,D27.505.954.502.119.500.500,Antithrombins,Anticoagulants,4
Faith Healing,E,E02.190.901.155,Spiritual Therapies,Complementary Therapies,4
Family Conflict,F,F01.829.401.142,Interpersonal Relations,"Psychology, Social",4
Family Conflict,F,F01.829.263.370.054,Family Relations,Family,4
fas Receptor,D,D12.776.543.750.705.852.760.195,"Receptors, Tumor Necrosis Factor","Receptors, Cytokine",4
fas Receptor,D,D12.776.543.750.690.500,"Receptors, Death Domain","Receptors, Cell Surface",4
"Fasciitis, Necrotizing",C,C05.321.550,Fasciitis,Musculoskeletal Diseases,4
Fats,D,D10.212,Lipids,NULL,4
Feminine Hygiene Products,E,E07.357,Equipment and Supplies,NULL,4
Fenfluramine,D,D02.092.471.683.467,Phenethylamines,Ethylamines,4
Fentanyl,D,D03.383.621.265,Piperidines,"Heterocyclic Compounds, 1-Ring",4
Fetal Alcohol Spectrum Disorders,C,C25.775.100.087.323,Alcohol-Induced Disorders,Alcohol-Related Disorders,4
Fetal Alcohol Spectrum Disorders,C,C16.300.070,Fetal Diseases,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",4
Fetal Alcohol Spectrum Disorders,C,C13.703.277.220,Fetal Diseases,Pregnancy Complications,4
Fetal Distress,C,C23.888.380,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",4
Fibromyalgia,C,C10.668.491.425,Muscular Diseases,Neuromuscular Diseases,4
Fibromyalgia,C,C05.651.324,Muscular Diseases,Musculoskeletal Diseases,4
Fibromyalgia,C,C05.799.321,Rheumatic Diseases,Musculoskeletal Diseases,4
Financial Stress,F,F01.145.126.990.643,"Stress, Psychological",Behavioral Symptoms,4
Finite Element Analysis,E,E05.355,Investigative Techniques,NULL,4
Fitness Centers,N,N02.278.207,Health Facilities,"Health Care Facilities, Manpower, and Services",4
Fitness Centers,J,J03.925.380,Sports and Recreational Facilities,Non-Medical Public and Private Facilities,4
Flame Retardants,D,D27.720.361,Specialty Uses of Chemicals,Chemical Actions and Uses,4
Flavoring Agents,D,D27.720.372.300.353,Food Additives,Food Ingredients,4
Flavoring Agents,D,D26.650.294,Pharmaceutic Aids,Pharmaceutical Preparations,4
Flavoring Agents,D,D27.720.744.294,Pharmaceutic Aids,Specialty Uses of Chemicals,4
Flavoring Agents,J,J02.500.514.500.400,Food Additives,Food Ingredients,4
Flavoring Agents,G,G07.203.300.514.500.400,Food Additives,Food Ingredients,4
"Fluorescent Antibody Technique, Direct",E,E05.478.583.375.300,Fluorescent Antibody Technique,Immunohistochemistry,4
"Fluorescent Antibody Technique, Direct",E,E05.200.750.551.512.240.300,Fluorescent Antibody Technique,Immunohistochemistry,4
"Fluorescent Antibody Technique, Direct",E,E05.200.500.607.512.240.300,Fluorescent Antibody Technique,Immunohistochemistry,4
"Fluorescent Antibody Technique, Direct",E,E01.370.225.500.607.512.240.300,Fluorescent Antibody Technique,Immunohistochemistry,4
"Fluorescent Antibody Technique, Direct",E,E01.370.225.750.551.512.240.300,Fluorescent Antibody Technique,Immunohistochemistry,4
Fluoridation,E,E06.761.382,Preventive Dentistry,Dentistry,4
Fluoridation,N,N06.890.235,Public Health Dentistry,Environment and Public Health,4
Focal Adhesions,A,A11.284.149.165.165.285,Cell-Matrix Junctions,Cell Membrane Structures,4
Food-Drug Interactions,G,G07.690.773.968.511,Drug Interactions,Pharmacological Phenomena,4
Food-Processing Industry,J,J01.576.423.200.400,Food Handling,Food Industry,4
Foot Diseases,C,C05.360,Musculoskeletal Diseases,NULL,4
Foot Diseases,C,C17.800.321,Skin Diseases,Skin and Connective Tissue Diseases,4
Fosfomycin,D,D02.705.429.625,Organophosphonates,Organophosphorus Compounds,4
Fracture Healing,G,G16.762.891.500,Wound Healing,Regeneration,4
Free Radical Scavengers,D,D27.505.519.217.500,Antioxidants,Molecular Mechanisms of Pharmacological Action,4
Freeze Drying,E,E01.370.225.500.620.760.160.260,Cryopreservation,Tissue Preservation,4
Freeze Drying,E,E01.370.225.750.600.760.160.260,Cryopreservation,Tissue Preservation,4
Freeze Drying,E,E05.760.156.260,Cryopreservation,"Preservation, Biological",4
Freeze Drying,E,E05.200.750.600.760.160.260,Cryopreservation,Tissue Preservation,4
Freeze Drying,E,E05.200.500.620.760.160.260,Cryopreservation,Tissue Preservation,4
Freeze Drying,E,E02.792.156.260,Cryopreservation,"Preservation, Biological",4
"Fungicides, Industrial",D,D27.888.723.288,Pesticides,Toxic Actions,4
"Fungicides, Industrial",D,D27.720.031.700.288,Pesticides,Agrochemicals,4
Galactosyltransferases,D,D08.811.913.400.450.400,Hexosyltransferases,Glycosyltransferases,4
"Gene Products, tat",D,D12.776.260.755.199,Trans-Activators,DNA-Binding Proteins,4
"Gene Products, tat",D,D12.776.964.925.984.400,Trans-Activators,Viral Regulatory and Accessory Proteins,4
"Gene Products, tat",D,D12.776.964.900.750.750,Viral Replicase Complex Proteins,Viral Nonstructural Proteins,4
"Gene Products, tat",D,D12.776.930.900.199,Trans-Activators,Transcription Factors,4
"Genes, MDR",G,G05.360.340.024.340.361,Genes,Genome Components,4
"Genes, MDR",G,G05.360.340.024.340.645.500,Multigene Family,Genes,4
"Genes, X-Linked",G,G05.360.340.024.340.500,Genes,Genome Components,4
"Genes, X-Linked",G,G05.420.457,Inheritance Patterns,Genetic Phenomena,4
Genetic Code,G,G05.360.335,Genetic Structures,Genetic Phenomena,4
Genetic Services,N,N02.421.308,Health Services,"Health Care Facilities, Manpower, and Services",4
Genetics,H,H01.158.273.343,Biology,Biological Science Disciplines,4
"Genome, Microbial",G,G05.360.340.358,Genome,Genetic Structures,4
Geriatric Psychiatry,F,F04.096.544.380,Psychiatry,Behavioral Sciences,4
Geriatric Psychiatry,H,H02.403.690.260,Psychiatry,Medicine,4
Ghrelin,D,D12.644.548.322,Peptide Hormones,Peptides,4
Ghrelin,D,D06.472.699.301,Peptide Hormones,Hormones,4
Glial Fibrillary Acidic Protein,D,D05.750.078.593.400,Intermediate Filament Proteins,Biopolymers,4
Glial Fibrillary Acidic Protein,D,D12.776.220.475.400,Intermediate Filament Proteins,Cytoskeletal Proteins,4
Globins,D,D12.776.422.316,Hemeproteins,Proteins,4
Glycerophosphates,D,D09.894.299,Sugar Phosphates,Carbohydrates,4
Glycerophosphates,D,D09.853.875.750,Triose Sugar Alcohols,Sugar Alcohols,4
Glycerophosphates,D,D10.570.755.375,Phospholipids,Membrane Lipids,4
Glycerophosphates,D,D02.033.800.875.750,Triose Sugar Alcohols,Sugar Alcohols,4
Glycerophospholipids,D,D10.570.755.375.760.400,Phosphatidic Acids,Glycerophosphates,4
Glycogen,D,D09.698.365.388,Glucans,Polysaccharides,4
Glycogen,D,D05.750.078.562.388,Glucans,Biopolymers,4
Gold Colloid,D,D01.379.400,Gold Compounds,Inorganic Chemicals,4
Government Employees,M,M01.526.446,Occupational Groups,Persons,4
G-Quadruplexes,G,G02.111.570.820.486.550,Nucleic Acid Conformation,Molecular Conformation,4
G-Quadruplexes,G,G05.360.580.550,Nucleic Acid Conformation,Genetic Structures,4
Groin,A,A01.923.047.365,Abdomen,Torso,4
GTP Cyclohydrolase,D,D08.811.277.151.300,Aminohydrolases,Hydrolases,4
Guyana,Z,Z01.107.757.488,South America,Americas,4
Hazardous Substances,D,D27.888.426,Toxic Actions,Chemical Actions and Uses,4
Hazardous Waste,D,D27.888.426.500,Hazardous Substances,Toxic Actions,4
Hazardous Waste,D,D20.944.380,Waste Products,Complex Mixtures,4
Hazardous Waste,N,N06.850.460.710.380,Waste Products,Environmental Pollution,4
Health Care Coalitions,N,N03.540.452.188,Health Planning Organizations,Organizations,4
Health Facility Merger,N,N02.278.235,Health Facilities,"Health Care Facilities, Manpower, and Services",4
Health Information Management,L,L01.399.500,Information Management,Information Science,4
Helicobacter,B,B03.440.500,Gram-Negative Bacteria,Bacteria,4
Helicobacter,B,B03.660.150.235.500.250,Helicobacteraceae,Campylobacterales,4
Helsinki Declaration,N,N05.350.340.080.249,Codes of Ethics,"Ethics, Professional",4
Helsinki Declaration,N,N05.350.670.500,"Ethics, Research",Ethics,4
Helsinki Declaration,N,N05.350.213.249,Codes of Ethics,Ethics,4
Helsinki Declaration,K,K01.752.566.479.068.249,Codes of Ethics,Ethics,4
Helsinki Declaration,K,K01.752.566.479.173.400,"Ethics, Research",Ethics,4
Helsinki Declaration,K,K01.752.566.479.171.066.249,Codes of Ethics,"Ethics, Professional",4
Hemagglutination,G,G12.122.100.200,Agglutination,Antigen-Antibody Reactions,4
Hemagglutination,G,G02.111.026.500,Agglutination,Biochemical Phenomena,4
Hemophilia B,C,C16.320.099.510,"Blood Coagulation Disorders, Inherited","Genetic Diseases, Inborn",4
Hemophilia B,C,C16.320.322.235,"Genetic Diseases, X-Linked","Genetic Diseases, Inborn",4
Hemophilia B,C,C15.378.100.141.510,Coagulation Protein Disorders,Blood Coagulation Disorders,4
Hemophilia B,C,C15.378.100.100.510,"Blood Coagulation Disorders, Inherited",Blood Coagulation Disorders,4
Hemophilia B,C,C15.378.463.510,Hemorrhagic Disorders,Hematologic Diseases,4
"Hemorrhagic Disease Virus, Epizootic",B,B04.820.223.719.550.400,Orbivirus,Reoviridae,4
Heparan Sulfate Proteoglycans,D,D09.698.373.425.500,Heparitin Sulfate,Glycosaminoglycans,4
Heparan Sulfate Proteoglycans,D,D09.698.735.400,Proteoglycans,Polysaccharides,4
Heparan Sulfate Proteoglycans,D,D12.776.395.650.350,Proteoglycans,Glycoproteins,4
Hepatitis B Antigens,D,D23.050.327.495.500,Hepatitis Antigens,"Antigens, Viral",4
Hepatitis D,C,C06.552.380.705.450,"Hepatitis, Viral, Human",Hepatitis,4
Hepatitis D,C,C01.925.782.450,RNA Virus Infections,Virus Diseases,4
Hepatitis D,C,C01.925.440.450,"Hepatitis, Viral, Human",Virus Diseases,4
Hepatocyte Nuclear Factor 3-alpha,D,D12.776.930.977.249.500,Forkhead Transcription Factors,Winged-Helix Transcription Factors,4
Hepatocyte Nuclear Factor 3-alpha,D,D12.776.930.318.750,Hepatocyte Nuclear Factors,Transcription Factors,4
Hepatocyte Nuclear Factor 3-alpha,D,D12.776.660.352.750,Hepatocyte Nuclear Factors,Nuclear Proteins,4
Hepatocyte Nuclear Factor 3-alpha,D,D12.776.260.950.249.500,Forkhead Transcription Factors,Winged-Helix Transcription Factors,4
Hepatocyte Nuclear Factor 3-alpha,D,D12.776.260.262.750,Hepatocyte Nuclear Factors,DNA-Binding Proteins,4
Heptanoic Acids,D,D10.251.450,Fatty Acids,Lipids,4
Heredity,G,G05.390,Genetic Phenomena,NULL,4
Hernia,C,C23.300.707,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",4
Herpesvirus Vaccines,D,D20.215.894.899.290,Viral Vaccines,Vaccines,4
Histocompatibility,G,G12.875.519,Transplantation Immunology,Immune System Phenomena,4
Histone Deacetylase Inhibitors,D,D27.505.519.389.360,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,4
Histone-Lysine N-Methyltransferase,D,D08.811.913.555.500.800.200.500,Histone Methyltransferases,Protein Methyltransferases,4
HL-60 Cells,A,A11.251.860.180.465,"Cell Line, Tumor","Tumor Cells, Cultured",4
HL-60 Cells,A,A11.251.210.190.465,"Cell Line, Tumor",Cell Line,4
HL-60 Cells,A,A11.627.340.360.500,Granulocyte Precursor Cells,Granulocytes,4
HLA-B35 Antigen,D,D12.776.395.550.489.500.350,HLA-B Antigens,Histocompatibility Antigens Class I,4
HLA-B35 Antigen,D,D23.050.301.500.450.380.350,HLA-B Antigens,HLA Antigens,4
HLA-B35 Antigen,D,D23.050.705.552.100.500.350,HLA-B Antigens,Histocompatibility Antigens Class I,4
HLA-B35 Antigen,D,D23.050.705.552.450.380.350,HLA-B Antigens,HLA Antigens,4
HLA-B35 Antigen,D,D23.050.301.500.100.500.350,HLA-B Antigens,Histocompatibility Antigens Class I,4
HLA-B35 Antigen,D,D12.776.543.550.439.500.350,HLA-B Antigens,Histocompatibility Antigens Class I,4
Homing Behavior,F,F01.145.113.646,"Behavior, Animal",Behavior,4
Hominidae,B,B01.050.150.900.649.313.988.400.112.400,Catarrhini,Haplorhini,4
Hospice and Palliative Care Nursing,H,H02.478.676.350,"Specialties, Nursing",Nursing,4
Hospice and Palliative Care Nursing,N,N02.421.533.390,Nursing Care,Health Services,4
"Hospitals, Voluntary",N,N02.278.421.481.800,"Hospitals, Private",Hospitals,4
Housing for the Elderly,N,N01.224.791.400.410,Housing,Residence Characteristics,4
Housing for the Elderly,N,N06.230.150.360.260,Housing,"Environment, Controlled",4
Housing for the Elderly,J,J03.340.260,Housing,Non-Medical Public and Private Facilities,4
Human Genome Project,H,H01.770.644.145.350.500,Genetic Research,Biomedical Research,4
Human Genome Project,H,H01.158.273.343.385.875,Human Genetics,Genetics,4
Human Genome Project,H,H01.158.273.343.350.174,Genomics,Genetics,4
Human Genome Project,H,H01.158.273.343.249.400,Genetic Research,Genetics,4
Human Genome Project,H,H01.158.273.180.350.174,Genomics,Computational Biology,4
Human Genome Project,L,L01.453.450,Information Services,Information Science,4
Human Papillomavirus DNA Tests,E,E05.393.520.750,Molecular Diagnostic Techniques,Genetic Techniques,4
Human Papillomavirus DNA Tests,E,E05.200.880.500,Molecular Diagnostic Techniques,Clinical Laboratory Techniques,4
Human Papillomavirus DNA Tests,E,E01.370.225.880.500,Molecular Diagnostic Techniques,Clinical Laboratory Techniques,4
Huntingtin Protein,D,D12.776.441,Proteins,"Amino Acids, Peptides, and Proteins",4
Hyaluronic Acid,D,D09.698.373.475,Glycosaminoglycans,Polysaccharides,4
Hydrogen Bonding,G,G02.282,Chemical Phenomena,NULL,4
Hydrolases,D,D08.811.277,Enzymes,Enzymes and Coenzymes,4
Hydroxychloroquine,D,D03.633.100.810.050.180.350,Chloroquine,Aminoquinolines,4
Hydroxysteroid Dehydrogenases,D,D08.811.682.047.436,Alcohol Oxidoreductases,Oxidoreductases,4
Hygiene Hypothesis,K,K01.752.667.875,"Philosophy, Medical",Philosophy,4
Hypercalcemia,C,C18.452.950.340,Water-Electrolyte Imbalance,Metabolic Diseases,4
Hypercalcemia,C,C18.452.174.451,Calcium Metabolism Disorders,Metabolic Diseases,4
Hypergammaglobulinemia,C,C15.378.147.542,Blood Protein Disorders,Hematologic Diseases,4
Hypergammaglobulinemia,C,C20.683.460,Immunoproliferative Disorders,Immune System Diseases,4
Hypergammaglobulinemia,C,C23.888.512,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",4
Hyperopia,C,C11.744.479,Refractive Errors,Eye Diseases,4
"Hypophosphatemia, Familial",C,C12.777.419.815.647,"Renal Tubular Transport, Inborn Errors",Kidney Diseases,4
"Hypophosphatemia, Familial",C,C13.351.968.419.815.647,"Renal Tubular Transport, Inborn Errors",Kidney Diseases,4
"Hypophosphatemia, Familial",C,C16.320.831.647,"Renal Tubular Transport, Inborn Errors","Genetic Diseases, Inborn",4
"Hypophosphatemia, Familial",C,C16.320.565.618.544,"Metal Metabolism, Inborn Errors","Metabolism, Inborn Errors",4
"Hypophosphatemia, Familial",C,C18.452.750.400.500,Hypophosphatemia,Phosphorus Metabolism Disorders,4
"Hypophosphatemia, Familial",C,C18.452.648.618.544,"Metal Metabolism, Inborn Errors","Metabolism, Inborn Errors",4
"Hypoxia-Inducible Factor 1, alpha Subunit",D,D12.776.260.103.625.750,Hypoxia-Inducible Factor 1,Basic Helix-Loop-Helix Transcription Factors,4
"Hypoxia-Inducible Factor 1, alpha Subunit",D,D12.776.930.125.625.750,Hypoxia-Inducible Factor 1,Basic Helix-Loop-Helix Transcription Factors,4
Idiopathic Pulmonary Fibrosis,C,C08.381.765.500,Pulmonary Fibrosis,Lung Diseases,4
Ileum,A,A03.556.124.684.249,"Intestine, Small",Intestines,4
Ileum,A,A03.556.249.124,Lower Gastrointestinal Tract,Gastrointestinal Tract,4
Illness Behavior,F,F01.145.499,Behavior,Behavior and Behavior Mechanisms,4
Immediate-Early Proteins,D,D12.776.964.925.968,Viral Regulatory and Accessory Proteins,Viral Proteins,4
Immediate-Early Proteins,D,D12.776.460,Proteins,"Amino Acids, Peptides, and Proteins",4
"Immunodeficiency Virus, Feline",B,B04.820.650.589.530.400,"Lentiviruses, Feline",Lentivirus,4
Immunoglobulin Variable Region,D,D12.776.377.715.548.680.650.500,Immunoglobulin Fab Fragments,Immunoglobulin Fragments,4
Immunoglobulin Variable Region,D,D12.776.377.715.548.797,Immunoglobulins,Serum Globulins,4
Immunoglobulin Variable Region,D,D12.776.124.486.485.680.650.500,Immunoglobulin Fab Fragments,Immunoglobulin Fragments,4
Immunoglobulin Variable Region,D,D12.776.124.486.485.797,Immunoglobulins,Immunoproteins,4
Immunoglobulin Variable Region,D,D12.776.124.790.651.797,Immunoglobulins,Serum Globulins,4
Immunoglobulin Variable Region,D,D12.776.124.790.651.680.650.500,Immunoglobulin Fab Fragments,Immunoglobulin Fragments,4
Immunoglobulin Variable Region,D,D12.644.541.500.650.500,Immunoglobulin Fab Fragments,Immunoglobulin Fragments,4
Immunoglobulin Variable Region,G,G02.111.570.060.425,Amino Acid Sequence,Molecular Structure,4
Immunoprecipitation,E,E05.478.605,Immunologic Techniques,Investigative Techniques,4
Immunoprecipitation,E,E05.196.150.639,Chemical Precipitation,"Chemistry Techniques, Analytical",4
Indans,D,D04.615.486.487,Indenes,Polycyclic Aromatic Hydrocarbons,4
Indans,D,D02.455.426.559.847.486.487,Indenes,Polycyclic Aromatic Hydrocarbons,4
Individuality,F,F01.752.488,Personality,Behavior and Behavior Mechanisms,4
Induced Pluripotent Stem Cells,A,A11.872.700.500,Pluripotent Stem Cells,Stem Cells,4
Induced Pluripotent Stem Cells,A,A11.872.040.500,Adult Stem Cells,Stem Cells,4
"Influenza A Virus, H7N9 Subtype",B,B04.820.480.968.405.400.800,Influenza A virus,Influenzavirus A,4
Integrases,D,D08.811.739.500,Recombinases,Enzymes,4
Integrins,D,D12.776.543.750.705.408,"Receptors, Immunologic","Receptors, Cell Surface",4
Integrons,G,G02.111.570.080.708.330.200.500,DNA Transposable Elements,Interspersed Repetitive Sequences,4
Interdisciplinary Studies,I,I02.158.405,Curriculum,Education,4
Interferon beta-1a,D,D12.776.467.374.440.890.275.500,Interferon-beta,Interferon Type I,4
Interferon beta-1a,D,D23.529.374.440.890.275.500,Interferon-beta,Interferon Type I,4
Interferon beta-1a,D,D12.644.276.374.440.890.275.500,Interferon-beta,Interferon Type I,4
Interleukin-1 Receptor-Like 1 Protein,D,D12.776.543.750.705.852.420.300.375,"Receptors, Interleukin-1","Receptors, Interleukin",4
Interleukin-23,D,D12.776.467.374.465.759,Interleukins,Cytokines,4
Interleukin-23,D,D23.529.374.465.550,Interleukins,Cytokines,4
Interleukin-23,D,D12.644.276.374.465.759,Interleukins,Cytokines,4
Interleukin-3,D,D12.644.276.374.410.240.400,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,4
Interleukin-3,D,D12.644.276.374.465.032,Interleukins,Cytokines,4
Interleukin-3,D,D12.776.395.240.400,Colony-Stimulating Factors,Glycoproteins,4
Interleukin-3,D,D23.529.374.465.169,Interleukins,Cytokines,4
Interleukin-3,D,D23.529.374.410.240.400,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,4
Interleukin-3,D,D12.776.467.374.410.240.400,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,4
Interleukin-3,D,D12.776.467.374.465.032,Interleukins,Cytokines,4
Interleukin-9,D,D12.776.467.374.465.312,Interleukins,Cytokines,4
Interleukin-9,D,D23.529.374.465.377,Interleukins,Cytokines,4
Interleukin-9,D,D12.644.276.374.465.377,Interleukins,Cytokines,4
Intermittent Claudication,C,C14.907.137.126.669,Arteriosclerosis,Arterial Occlusive Diseases,4
Intermittent Claudication,C,C23.888.531,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",4
International Health Regulations,I,I01.655.500.608.400.468,Health Policy,Public Policy,4
International Health Regulations,N,N03.706.615.473.250,"Legislation, Medical",Legislation as Topic,4
Internet-Based Intervention,L,L01.224.230.110.500.688,Internet,Computer Communication Networks,4
Interphase,G,G04.144.500,Cell Cycle,Cell Physiological Phenomena,4
Intracellular Fluid,A,A12.207.515,Body Fluids,Fluids and Secretions,4
Intracellular Fluid,A,A11.284.835.450,Subcellular Fractions,Cellular Structures,4
Intracellular Fluid,A,A11.284.430.429,Intracellular Space,Cellular Structures,4
Intracranial Aneurysm,C,C14.907.055.635,Aneurysm,Vascular Diseases,4
Intracranial Aneurysm,C,C14.907.253.560.300,Intracranial Arterial Diseases,Cerebrovascular Disorders,4
Intracranial Aneurysm,C,C10.228.140.300.510.600,Intracranial Arterial Diseases,Cerebrovascular Disorders,4
Intraoperative Period,E,E04.614.374,Perioperative Period,"Surgical Procedures, Operative",4
Intraoperative Period,N,N02.421.585.753.374,Perioperative Period,Patient Care,4
Intravitreal Injections,E,E02.319.267.530.475.500,"Injections, Intraocular",Injections,4
"Intubation, Intratracheal",E,E02.585.578,Intubation,Therapeutics,4
"Intubation, Intratracheal",E,E02.041.500,Airway Management,Therapeutics,4
"Intubation, Intratracheal",E,E05.497.578,Intubation,Investigative Techniques,4
Iridectomy,E,E04.540.480,Ophthalmologic Surgical Procedures,"Surgical Procedures, Operative",4
Iron Compounds,D,D01.490,Inorganic Chemicals,NULL,4
Ischemic Preconditioning,E,E02.592,Therapeutics,NULL,4
Ischemic Preconditioning,E,E05.516,Investigative Techniques,NULL,4
Isoelectric Point,E,E05.301.300.663.500,Isoelectric Focusing,Electrophoresis,4
Isoelectric Point,G,G02.300.500,Hydrogen-Ion Concentration,Chemical Phenomena,4
Isotonic Solutions,D,D26.776.498,Solutions,Pharmaceutical Preparations,4
"Jaundice, Neonatal",C,C23.550.429.249.500,"Hyperbilirubinemia, Neonatal",Hyperbilirubinemia,4
"Jaundice, Neonatal",C,C16.614.451.500,"Hyperbilirubinemia, Neonatal","Infant, Newborn, Diseases",4
Juvenile Delinquency,I,I01.880.735.479,Social Problems,Sociology,4
Kainic Acid,D,D03.383.773.400,Pyrrolidines,"Heterocyclic Compounds, 1-Ring",4
Keratinocytes,A,A11.409.500,Epidermal Cells,Cells,4
Keratinocytes,A,A11.436.397,Epithelial Cells,Cells,4
"Keratoplasty, Penetrating",E,E02.095.147.725.225.350,Corneal Transplantation,Tissue Transplantation,4
"Keratoplasty, Penetrating",E,E04.540.825.374.350,Corneal Transplantation,Refractive Surgical Procedures,4
"Keratoplasty, Penetrating",E,E04.936.580.225.350,Corneal Transplantation,Tissue Transplantation,4
Ketamine,D,D02.455.426.392.368.367.652,Cyclohexanes,Cycloparaffins,4
Ki-67 Antigen,D,D23.101.140.400,"Biomarkers, Tumor",Biomarkers,4
Ki-67 Antigen,D,D23.050.290.500,"Antigens, Nuclear",Antigens,4
Ki-67 Antigen,D,D12.776.660.625.500,"Antigens, Nuclear",Nuclear Proteins,4
Knowledge Bases,L,L01.224.050.375.480,Artificial Intelligence,Algorithms,4
Knowledge Bases,L,L01.313.500.750.300.550,Information Systems,Medical Informatics Applications,4
"Lactams, Macrocyclic",D,D04.345.295,Macrocyclic Compounds,Polycyclic Compounds,4
"Lactams, Macrocyclic",D,D02.065.589.327,Lactams,Amides,4
Lactose,D,D09.698.629.305.340,Disaccharides,Oligosaccharides,4
Lactose,D,D09.947.750.340,Disaccharides,Sugars,4
Lactose Intolerance,C,C18.452.648.202.589,"Carbohydrate Metabolism, Inborn Errors","Metabolism, Inborn Errors",4
Lactose Intolerance,C,C16.320.565.202.589,"Carbohydrate Metabolism, Inborn Errors","Metabolism, Inborn Errors",4
Lactose Intolerance,C,C18.452.603.506,Malabsorption Syndromes,Metabolic Diseases,4
Lactose Intolerance,C,C06.405.469.637.506,Malabsorption Syndromes,Intestinal Diseases,4
Lapatinib,D,D03.633.100.786.516,Quinazolines,"Heterocyclic Compounds, 2-Ring",4
Laser-Doppler Flowmetry,E,E01.370.370.475,"Diagnostic Techniques, Cardiovascular",Diagnostic Techniques and Procedures,4
Laser-Doppler Flowmetry,E,E05.830.500,Rheology,Investigative Techniques,4
"Leukemia, Myeloid",C,C04.557.337.539,Leukemia,Neoplasms by Histologic Type,4
Leukocyte L1 Antigen Complex,D,D23.050.301.562,"Antigens, Surface",Antigens,4
Leukocyte L1 Antigen Complex,D,D12.776.631.655.500,S100 Proteins,Nerve Tissue Proteins,4
Leukocyte L1 Antigen Complex,D,D12.776.157.125.750.500,S100 Proteins,Calcium-Binding Proteins,4
Levamisole,D,D02.886.675.346,Thiazoles,Sulfur Compounds,4
Levamisole,D,D03.383.129.308.480,Imidazoles,Azoles,4
Levamisole,D,D03.383.129.708.346,Thiazoles,Azoles,4
"Libraries, Medical",J,J03.400.596.831.937,"Libraries, Special",Libraries,4
"Libraries, Medical",L,L01.346.596.719.875,"Libraries, Special",Libraries,4
Life History Traits,G,G16.575,Biological Phenomena,NULL,4
Life History Traits,G,G05.045.513,Biological Evolution,Genetic Phenomena,4
Ligation,E,E04.426,"Surgical Procedures, Operative",NULL,4
Limbus Corneae,A,A09.371.060.217.659,Cornea,Anterior Eye Segment,4
Lipocalins,D,D12.776.157.469,Carrier Proteins,Proteins,4
Lipoprotein Lipase,D,D08.811.277.352.100.430,Carboxylic Ester Hydrolases,Esterases,4
"Lipoproteins, VLDL",D,D10.532.599,Lipoproteins,Lipids,4
"Lipoproteins, VLDL",D,D12.776.521.622,Lipoproteins,Proteins,4
Lisinopril,D,D12.644.456.345.600,Dipeptides,Oligopeptides,4
Loa,B,B01.050.500.500.294.400.937.463.410,Filarioidea,Spirurida,4
Long Interspersed Nucleotide Elements,G,G05.360.080.708.330.800.400,Retroelements,Interspersed Repetitive Sequences,4
Long Interspersed Nucleotide Elements,G,G05.360.340.024.425.800.400,Retroelements,Interspersed Repetitive Sequences,4
Long Interspersed Nucleotide Elements,G,G02.111.570.080.708.330.800.400,Retroelements,Interspersed Repetitive Sequences,4
Long Term Adverse Effects,C,C23.550.543,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",4
Loss of Heterozygosity,G,G05.365.590.029.530,Allelic Imbalance,Mutation,4
Love,F,F01.470.734,Emotions,Behavior and Behavior Mechanisms,4
Lung Volume Measurements,E,E01.370.386.700.485,Respiratory Function Tests,"Diagnostic Techniques, Respiratory System",4
"Lupus Erythematosus, Discoid",C,C17.800.480.479,"Lupus Erythematosus, Cutaneous",Skin Diseases,4
"Lupus Erythematosus, Discoid",C,C17.300.475.479,"Lupus Erythematosus, Cutaneous",Connective Tissue Diseases,4
Luteal Phase,G,G08.686.605.410,Menstrual Cycle,Reproductive Physiological Phenomena,4
Lymphoproliferative Disorders,C,C15.604.515,Lymphatic Diseases,Hemic and Lymphatic Diseases,4
Lymphoproliferative Disorders,C,C20.683.515,Immunoproliferative Disorders,Immune System Diseases,4
Macaca nemestrina,B,B01.050.150.900.649.313.988.400.112.199.120.510.560,Macaca,Cercopithecinae,4
Macrocyclic Compounds,D,D04.345,Polycyclic Compounds,NULL,4
Magnesium Deficiency,C,C18.654.521.500.439,Deficiency Diseases,Malnutrition,4
"Magnetic Resonance Imaging, Interventional",E,E04.502.515,Minimally Invasive Surgical Procedures,"Surgical Procedures, Operative",4
Malta,Z,Z01.542.580.500.650,Mediterranean Islands,Mediterranean Region,4
Malta,Z,Z01.639.640.650,Mediterranean Islands,Islands,4
Mammary Arteries,A,A07.015.114.891.525,Thoracic Arteries,Arteries,4
Mandibular Advancement,E,E04.545.500,Oral Surgical Procedures,"Surgical Procedures, Operative",4
Mandibular Advancement,E,E06.645.500,Oral Surgical Procedures,Dentistry,4
Mandibular Advancement,E,E06.658.280,Orthodontics,Dentistry,4
Manikins,L,L01.178.820.090.545.129.400,"Models, Anatomic","Models, Structural",4
Manikins,J,J01.897.280.500.545.129.400,"Models, Anatomic","Models, Structural",4
Mannich Bases,D,D02.092.650,Amines,Organic Chemicals,4
Mannich Bases,D,D02.522.650,Ketones,Organic Chemicals,4
Mannose,D,D09.947.875.359.588,Hexoses,Monosaccharides,4
Manufacturing Industry,J,J01.576.655,Industry,"Technology, Industry, and Agriculture",4
Mass Behavior,F,F01.145.813.527,Social Behavior,Behavior,4
"Mastectomy, Radical",E,E04.466.678,Mastectomy,"Surgical Procedures, Operative",4
Masturbation,F,F01.145.802.526,Sexual Behavior,Behavior,4
Maternal Inheritance,G,G05.420.275.750,Extrachromosomal Inheritance,Inheritance Patterns,4
"Mating Preference, Animal",F,F01.145.113.252.748.300,"Sexual Behavior, Animal",Consummatory Behavior,4
Maximum Allowable Concentration,N,N06.850.460.350.210,Environmental Exposure,Environmental Pollution,4
Maximum Allowable Concentration,N,N06.850.460.350.600.615,Occupational Exposure,Environmental Exposure,4
Mechanistic Target of Rapamycin Complex 1,D,D08.811.913.696.620.682.700.931.500,TOR Serine-Threonine Kinases,Protein-Serine-Threonine Kinases,4
Mechanistic Target of Rapamycin Complex 1,D,D05.500.337,Multiprotein Complexes,Macromolecular Substances,4
Mechanistic Target of Rapamycin Complex 1,D,D12.776.476.925.500,TOR Serine-Threonine Kinases,Intracellular Signaling Peptides and Proteins,4
Mechlorethamine,D,D02.455.526.728.650.529,Nitrogen Mustard Compounds,Mustard Compounds,4
Medical Futility,E,E01.789.600,Prognosis,Diagnosis,4
Medical Informatics Applications,L,L01.313.500.750,Medical Informatics,Informatics,4
Medicine in Literature,K,K01.517.584,Literature,Humanities,4
Meditation,F,F04.754.137.750.500,Relaxation Therapy,Behavior Therapy,4
Meditation,E,E02.190.901.455,Spiritual Therapies,Complementary Therapies,4
Meditation,E,E02.190.525.374,Mind-Body Therapies,Complementary Therapies,4
Megakaryocytes,A,A11.148.479,Bone Marrow Cells,Cells,4
Megakaryocytes,A,A15.378.316.479,Bone Marrow Cells,Hematopoietic System,4
Memantine,D,D02.455.426.100.050.035.500,Amantadine,Adamantane,4
"Membranes, Artificial",D,D25.479,Biomedical and Dental Materials,NULL,4
"Membranes, Artificial",J,J01.637.051.479,Biomedical and Dental Materials,Manufactured Materials,4
"Membranes, Artificial",J,J01.637.087.500,Biomimetic Materials,Manufactured Materials,4
"Meningitis, Aseptic",C,C10.228.614.220,Meningitis,Central Nervous System Diseases,4
Mental Health Recovery,N,N02.421.784.444,Rehabilitation,Health Services,4
Mesentery,A,A01.923.047.025.600.451,Peritoneum,Abdominal Cavity,4
Metallothionein,D,D12.776.556.670,Metalloproteins,Proteins,4
Metaphor,K,K01.400.899.500,Symbolism,History,4
Metaphor,K,K01.752.798.500,Symbolism,Philosophy,4
Methanol,D,D02.033.623,Alcohols,Organic Chemicals,4
Methicillin,D,D02.065.589.099.750.500,Penicillins,beta-Lactams,4
Methicillin,D,D02.886.108.750.500,Penicillins,beta-Lactams,4
Methicillin,D,D03.633.100.300.750.500,Penicillins,beta-Lactams,4
Microbial Consortia,G,G16.500.275.157.049.100.500.750,Microbiota,Biota,4
Microbial Consortia,N,N06.230.124.049.100.500.500,Microbiota,Biota,4
Microbial Consortia,G,G06.591.750,Microbiota,Microbiological Phenomena,4
Microfluidics,E,E05.830.666,Rheology,Investigative Techniques,4
Microfluidics,H,H01.671.808.500,Rheology,Physics,4
Microfluidics,J,J01.897.520.500.500,Microtechnology,Miniaturization,4
"Micronuclei, Chromosome-Defective",G,G05.365.590.175.570,Chromosome Aberrations,Mutation,4
"Micronuclei, Chromosome-Defective",C,C23.550.210.570,Chromosome Aberrations,Pathologic Processes,4
"Micronuclei, Chromosome-Defective",A,A11.284.430.106.570,Cell Nucleus,Intracellular Space,4
"Micronuclei, Chromosome-Defective",A,A11.284.430.214.190.875.117.570,Cell Nucleus,Organelles,4
"Microsomes, Liver",A,A11.284.835.540.541,Microsomes,Subcellular Fractions,4
Microsurgery,E,E05.591.580,Micromanipulation,Investigative Techniques,4
Microsurgery,E,E04.494,"Surgical Procedures, Operative",NULL,4
Microvascular Angina,C,C14.907.585.187.575,Angina Pectoris,Myocardial Ischemia,4
Microvascular Angina,C,C14.280.647.187.575,Angina Pectoris,Myocardial Ischemia,4
Microwaves,G,G01.358.500.505.810.500,Radio Waves,Electromagnetic Radiation,4
Microwaves,G,G01.750.770.721.500,Radio Waves,"Radiation, Nonionizing",4
Microwaves,G,G01.750.250.810.500,Radio Waves,Electromagnetic Radiation,4
Midazolam,D,D03.633.100.079.080.575,Benzodiazepines,Benzazepines,4
Migraine Disorders,C,C10.228.140.546.399.750,"Headache Disorders, Primary",Headache Disorders,4
Minors,M,M01.416,Persons,NULL,4
Mitochondrial Dynamics,G,G04.599.750,Mitochondrial Turnover,Cell Physiological Phenomena,4
Mixed Function Oxygenases,D,D08.811.682.690.708,Oxygenases,Oxidoreductases,4
"Models, Educational",E,E05.599.545,"Models, Theoretical",Investigative Techniques,4
"Models, Educational",I,I02.903.302,Teaching,Education,4
Monosaccharide Transport Proteins,D,D12.776.157.530.500,Membrane Transport Proteins,Carrier Proteins,4
Monosaccharide Transport Proteins,D,D12.776.543.585.500,Membrane Transport Proteins,Membrane Proteins,4
Moraxellaceae Infections,C,C01.150.252.400.560,Gram-Negative Bacterial Infections,Bacterial Infections,4
Mosaic Viruses,B,B04.715.464,Plant Viruses,Viruses,4
Movement Disorders,C,C10.228.662,Central Nervous System Diseases,Nervous System Diseases,4
Multiple Chronic Conditions,C,C23.550.291.500.500,Chronic Disease,Disease Attributes,4
Mupirocin,D,D02.355.291.411.658,Epoxy Compounds,"Ethers, Cyclic",4
Mupirocin,D,D10.251.536,Fatty Acids,Lipids,4
Mupirocin,D,D03.383.663.555,Pyrans,"Heterocyclic Compounds, 1-Ring",4
Murinae,B,B01.050.150.900.649.313.992.635.505,Muridae,Rodentia,4
Muscle Hypotonia,C,C23.888.592.608.575,Neuromuscular Manifestations,Neurologic Manifestations,4
Muscle Hypotonia,C,C10.597.613.575,Neuromuscular Manifestations,Neurologic Manifestations,4
Muscle Proteins,D,D12.776.210.500,Contractile Proteins,Proteins,4
"Muscle, Smooth",A,A10.690.467,Muscles,Tissues,4
"Muscle, Smooth",A,A02.633.570,Muscles,Musculoskeletal System,4
Mustelidae,B,B01.050.150.900.649.313.750.250.575,Caniformia,Carnivora,4
Myasthenia Gravis,C,C04.730.856.490,"Paraneoplastic Syndromes, Nervous System",Paraneoplastic Syndromes,4
Myasthenia Gravis,C,C04.588.614.550.500,"Paraneoplastic Syndromes, Nervous System",Nervous System Neoplasms,4
Myasthenia Gravis,C,C10.668.758.725,Neuromuscular Junction Diseases,Neuromuscular Diseases,4
Myasthenia Gravis,C,C10.574.781.588,"Paraneoplastic Syndromes, Nervous System",Neurodegenerative Diseases,4
Myasthenia Gravis,C,C10.114.656,Autoimmune Diseases of the Nervous System,Nervous System Diseases,4
Myasthenia Gravis,C,C20.111.258.500,Autoimmune Diseases of the Nervous System,Autoimmune Diseases,4
Mycetoma,C,C17.800.838.765.557,"Skin Diseases, Bacterial","Skin Diseases, Infectious",4
Mycetoma,C,C17.800.838.208.557,Dermatomycoses,"Skin Diseases, Infectious",4
Mycetoma,C,C01.150.252.410.040.692.500,Nocardia Infections,Actinomycetales Infections,4
Mycetoma,C,C01.150.252.819.557,"Skin Diseases, Bacterial",Bacterial Infections,4
Mycetoma,C,C01.150.703.302.500,Dermatomycoses,Mycoses,4
Mycetoma,C,C01.800.720.557,"Skin Diseases, Bacterial","Skin Diseases, Infectious",4
Mycetoma,C,C01.800.200.500,Dermatomycoses,"Skin Diseases, Infectious",4
Mycobacterium avium-intracellulare Infection,C,C01.150.252.410.040.552.475.495,"Mycobacterium Infections, Nontuberculous",Mycobacterium Infections,4
Myelitis,C,C01.207.618,Central Nervous System Infections,Infections,4
Myelitis,C,C10.228.228.618,Central Nervous System Infections,Central Nervous System Diseases,4
Myelitis,C,C10.228.854.525,Spinal Cord Diseases,Central Nervous System Diseases,4
"Myelitis, Transverse",C,C10.228.854.525.553,Myelitis,Spinal Cord Diseases,4
"Myelitis, Transverse",C,C10.314.350.600,"Demyelinating Autoimmune Diseases, CNS",Demyelinating Diseases,4
"Myelitis, Transverse",C,C10.228.228.618.250,Myelitis,Central Nervous System Infections,4
"Myelitis, Transverse",C,C10.114.375.600,"Demyelinating Autoimmune Diseases, CNS",Autoimmune Diseases of the Nervous System,4
"Myelitis, Transverse",C,C10.574.781.625,"Paraneoplastic Syndromes, Nervous System",Neurodegenerative Diseases,4
"Myelitis, Transverse",C,C20.111.258.250.550,"Demyelinating Autoimmune Diseases, CNS",Autoimmune Diseases of the Nervous System,4
"Myelitis, Transverse",C,C01.207.618.250,Myelitis,Central Nervous System Infections,4
"Myelitis, Transverse",C,C04.588.614.550.550,"Paraneoplastic Syndromes, Nervous System",Nervous System Neoplasms,4
"Myelitis, Transverse",C,C04.730.856.543,"Paraneoplastic Syndromes, Nervous System",Paraneoplastic Syndromes,4
Myiasis,C,C01.610.858.211.503,Ectoparasitic Infestations,"Skin Diseases, Parasitic",4
Myocardial Perfusion Imaging,E,E01.370.384.730.354.500,Perfusion Imaging,Radionuclide Imaging,4
Myocardial Perfusion Imaging,E,E01.370.370.380.500,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",4
Myocardial Perfusion Imaging,E,E01.370.350.710.600.500,Perfusion Imaging,Radionuclide Imaging,4
Myocardial Perfusion Imaging,E,E01.370.350.130.875,Cardiac Imaging Techniques,Diagnostic Imaging,4
"Myocytes, Cardiac",A,A07.541.704.570,Myocardium,Heart,4
"Myocytes, Cardiac",A,A10.690.552.750.570,Myocardium,"Muscle, Striated",4
"Myocytes, Cardiac",A,A11.620.500,Muscle Cells,Cells,4
"Myocytes, Smooth Muscle",A,A11.620.520,Muscle Cells,Cells,4
Myositis,C,C05.651.594,Muscular Diseases,Musculoskeletal Diseases,4
Myositis,C,C10.668.491.562,Muscular Diseases,Neuromuscular Diseases,4
Myxovirus Resistance Proteins,D,D12.776.157.325.636,GTP-Binding Proteins,Carrier Proteins,4
Myxovirus Resistance Proteins,D,D08.811.277.040.330.300.550,GTP-Binding Proteins,GTP Phosphohydrolases,4
Naloxone,D,D04.615.723.795.706,Morphinans,Phenanthrenes,4
Naloxone,D,D03.605.497.750,Morphinans,"Heterocyclic Compounds, Bridged-Ring",4
Naloxone,D,D03.633.400.686.750,Morphinans,"Heterocyclic Compounds, 4 or More Rings",4
Naloxone,D,D03.132.577.249.706,Morphinans,Opiate Alkaloids,4
Nasopharyngeal Diseases,C,C09.775.350,Pharyngeal Diseases,Otorhinolaryngologic Diseases,4
Nasopharyngeal Diseases,C,C07.550.350,Pharyngeal Diseases,Stomatognathic Diseases,4
Natural Disasters,N,N06.230.100.230,Disasters,Environment,4
Natural Gas,N,N06.230.132.258.369,Fossil Fuels,Energy-Generating Resources,4
Natural Gas,D,D20.345.369,Fossil Fuels,Complex Mixtures,4
Necator,B,B01.050.500.500.294.400.968.100.550,Ancylostomatoidea,Strongylida,4
"nef Gene Products, Human Immunodeficiency Virus",D,D12.776.964.925.500.500,"Gene Products, nef",Viral Regulatory and Accessory Proteins,4
"nef Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.362.500,"Gene Products, nef",Retroviridae Proteins,4
"nef Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.562.760,Human Immunodeficiency Virus Proteins,Retroviridae Proteins,4
Neisseria lactamica,B,B03.440.400.425.550.550.600,Neisseria,Neisseriaceae,4
Neisseria lactamica,B,B03.660.075.525.520.475,Neisseria,Neisseriaceae,4
Nematospiroides dubius,B,B01.050.500.500.294.400.968.400.550.275,Nematospiroides,Heligmosomatoidea,4
Neonatal Nursing,N,N02.421.533.460.600,Maternal-Child Nursing,Nursing Care,4
Neonatal Nursing,N,N02.421.533.691.600,Pediatric Nursing,Nursing Care,4
Neonatal Nursing,H,H02.478.676.390.600,Maternal-Child Nursing,"Specialties, Nursing",4
Neonatal Nursing,H,H02.478.676.631.600,Pediatric Nursing,"Specialties, Nursing",4
Neoplasm Transplantation,E,E05.624,Investigative Techniques,NULL,4
"Neoplasms, Glandular and Epithelial",C,C04.557.470,Neoplasms by Histologic Type,Neoplasms,4
"Neoplastic Syndromes, Hereditary",C,C04.700,Neoplasms,NULL,4
"Neoplastic Syndromes, Hereditary",C,C16.320.700,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",4
"Neovascularization, Physiologic",G,G09.330.630,Cardiovascular Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,4
"Nephritis, Interstitial",C,C13.351.968.419.570.643,Nephritis,Kidney Diseases,4
"Nephritis, Interstitial",C,C12.777.419.570.643,Nephritis,Kidney Diseases,4
Neprilysin,D,D23.050.285.550,"Antigens, Neoplasm",Antigens,4
Neprilysin,D,D23.101.140.500,"Biomarkers, Tumor",Biomarkers,4
Neprilysin,D,D08.811.277.656.300.480.600,Metalloendopeptidases,Endopeptidases,4
Neprilysin,D,D08.811.277.656.675.374.600,Metalloendopeptidases,Metalloproteases,4
Nerve Degeneration,C,C23.550.737,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",4
Nervous System Malformations,C,C10.500,Nervous System Diseases,NULL,4
Nervous System Malformations,C,C16.131.666,Congenital Abnormalities,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",4
Neuropeptides,D,D12.644.400,Peptides,"Amino Acids, Peptides, and Proteins",4
Neuropeptides,D,D12.776.631.650,Nerve Tissue Proteins,Proteins,4
Neurosciences,H,H01.158.610,Biological Science Disciplines,Natural Science Disciplines,4
Neutral Red,D,D03.633.300.704.600,Phenazines,"Heterocyclic Compounds, 3-Ring",4
New Jersey,Z,Z01.107.567.875.500.525,Mid-Atlantic Region,United States,4
NF-E2-Related Factor 2,D,D12.776.260.108.737,Basic-Leucine Zipper Transcription Factors,DNA-Binding Proteins,4
NF-E2-Related Factor 2,D,D12.776.930.127.737,Basic-Leucine Zipper Transcription Factors,Transcription Factors,4
Night Care,E,E02.760.564,Patient Care,Therapeutics,4
Night Care,N,N02.421.585.564,Patient Care,Health Services,4
Nitrobenzenes,D,D02.640.529,Nitro Compounds,Organic Chemicals,4
Nitrobenzenes,D,D02.455.426.559.389.565,Benzene Derivatives,"Hydrocarbons, Aromatic",4
Nitroprusside,D,D01.625.400.100.325.550,Ferricyanides,Cyanides,4
Nitroprusside,D,D01.490.100.300.550,Ferricyanides,Ferric Compounds,4
Nitroprusside,D,D01.248.497.158.291.350.550,Ferricyanides,Cyanides,4
NK Cell Lectin-Like Receptor Subfamily K,D,D12.776.543.750.705.895.800.910,"Receptors, NK Cell Lectin-Like","Receptors, Natural Killer Cell",4
Non-alcoholic Fatty Liver Disease,C,C06.552.241.519,Fatty Liver,Liver Diseases,4
Nuclear Pore Complex Proteins,D,D12.776.543.585.750.625,Nucleocytoplasmic Transport Proteins,Membrane Transport Proteins,4
Nuclear Pore Complex Proteins,D,D12.776.157.530.750.625,Nucleocytoplasmic Transport Proteins,Membrane Transport Proteins,4
Nucleic Acid Denaturation,E,E05.393.640,Genetic Techniques,Investigative Techniques,4
Nucleic Acid Denaturation,G,G05.627,Genetic Phenomena,NULL,4
Nucleic Acid Denaturation,G,G02.111.603,Biochemical Phenomena,Chemical Phenomena,4
Nucleoplasmins,D,D12.776.580.219.500,Histone Chaperones,Molecular Chaperones,4
Nucleotide Motifs,G,G02.111.570.820.486.662,Nucleic Acid Conformation,Molecular Conformation,4
Nucleotide Motifs,G,G02.111.570.080.611,Base Sequence,Molecular Structure,4
Nucleotide Motifs,G,G05.360.580.662,Nucleic Acid Conformation,Genetic Structures,4
Nucleotide Motifs,G,G05.360.080.611,Base Sequence,Genetic Structures,4
Nucleotidyltransferases,D,D08.811.913.696.445,Phosphotransferases,Transferases,4
"Nurseries, Hospital",N,N02.278.388.557,Hospital Units,Health Facilities,4
Nursing Theory,H,H02.478.408,Nursing,Health Occupations,4
Occlusive Dressings,E,E07.101.650,Bandages,Equipment and Supplies,4
Octanols,D,D10.289.600,Fatty Alcohols,Lipids,4
Octanols,D,D02.033.415.600,Fatty Alcohols,Alcohols,4
Ocular Motility Disorders,C,C10.228.758,Central Nervous System Diseases,Nervous System Diseases,4
Ocular Motility Disorders,C,C10.292.562,Cranial Nerve Diseases,Nervous System Diseases,4
Ocular Motility Disorders,C,C11.590,Eye Diseases,NULL,4
Oncogene Proteins,D,D12.776.624.664,Neoplasm Proteins,Proteins,4
Oncology Nursing,H,H02.478.676.605,"Specialties, Nursing",Nursing,4
Oncology Nursing,N,N02.421.533.600,Nursing Care,Health Services,4
Oncorhynchus mykiss,B,B01.050.150.900.493.817.750.825.580.600,Oncorhynchus,Trout,4
Oral Hygiene,E,E02.547.600,Hygiene,Therapeutics,4
Oral Hygiene,E,E06.761.726,Preventive Dentistry,Dentistry,4
Organ Culture Techniques,E,E05.481.500.484,Culture Techniques,In Vitro Techniques,4
Organogenesis,G,G08.686.784.170.450,Embryonic and Fetal Development,Reproduction,4
Organogenesis,G,G07.345.500.325.377,Embryonic and Fetal Development,Morphogenesis,4
Organophosphorus Compounds,D,D02.705,Organic Chemicals,NULL,4
Orgasm,G,G08.686.784.460,Reproduction,Reproductive Physiological Phenomena,4
Orlistat,D,D02.540.529,Lactones,Organic Chemicals,4
Osmotic Pressure,G,G01.374.715.578,Pressure,Mechanical Phenomena,4
Osmotic Pressure,G,G02.723.661,Permeability,Chemical Phenomena,4
Osmotic Pressure,G,G02.640.249,Osmolar Concentration,Chemical Phenomena,4
"Osteoporosis, Postmenopausal",C,C05.116.198.579.610,Osteoporosis,"Bone Diseases, Metabolic",4
"Osteoporosis, Postmenopausal",C,C18.452.104.579.610,Osteoporosis,"Bone Diseases, Metabolic",4
Osteoprotegerin,D,D12.776.543.750.705.852.760.949.249,Tumor Necrosis Factor Decoy Receptors,"Receptors, Tumor Necrosis Factor",4
Ostreidae,B,B01.050.500.644.080.643,Bivalvia,Mollusca,4
Overnutrition,C,C18.654.726,Nutrition Disorders,Nutritional and Metabolic Diseases,4
Oxacillin,D,D02.065.589.099.750.625,Penicillins,beta-Lactams,4
Oxacillin,D,D02.886.108.750.625,Penicillins,beta-Lactams,4
Oxacillin,D,D03.633.100.300.750.625,Penicillins,beta-Lactams,4
Oxadiazoles,D,D03.383.129.462.580,Oxazoles,Azoles,4
Oxidative Phosphorylation,G,G03.295.631,Energy Metabolism,Metabolism,4
Oxidative Phosphorylation,G,G03.796.550,Phosphorylation,Metabolism,4
Oxidative Phosphorylation,G,G02.111.665.550,Phosphorylation,Biochemical Phenomena,4
Paint,J,J01.637.597,Manufactured Materials,"Technology, Industry, and Agriculture",4
Palm Oil,D,D10.627.700.798,Plant Oils,Oils,4
Palm Oil,D,D20.215.784.750.728,Plant Oils,Plant Preparations,4
Palmitic Acid,D,D10.251.694.750,Palmitic Acids,Fatty Acids,4
Pancreas,A,A03.734,Digestive System,NULL,4
Paramyxoviridae,B,B04.820.480.937.600,Mononegavirales,Negative-Sense RNA Viruses,4
Paraproteinemias,C,C20.683.780,Immunoproliferative Disorders,Immune System Diseases,4
Paraproteinemias,C,C15.378.147.780,Blood Protein Disorders,Hematologic Diseases,4
Parechovirus,B,B04.820.578.750.700,Picornaviridae,Positive-Strand RNA Viruses,4
Parental Leave,N,N01.824.417.700.162.500,Family Leave,Salaries and Fringe Benefits,4
Parental Leave,N,N04.452.677.800.162.500,Family Leave,Salaries and Fringe Benefits,4
Patient Handoff,N,N04.590.233.727.210.249,Continuity of Patient Care,Primary Health Care,4
Patient Handoff,N,N05.715.840.500,Standard of Care,Quality of Health Care,4
Patient Handoff,N,N02.421.585.169.249,Continuity of Patient Care,Patient Care,4
Patient Handoff,N,N02.421.585.400.615,Hospitalization,Patient Care,4
Patient Handoff,E,E02.760.400.615,Hospitalization,Patient Care,4
Patient Handoff,E,E02.760.169.249,Continuity of Patient Care,Patient Care,4
Patient Protection and Affordable Care Act,N,N03.219.521.576.343.918,"Insurance, Health",Insurance,4
Patient Protection and Affordable Care Act,N,N03.706.615.806,Legislation as Topic,"Social Control, Formal",4
Pectobacterium carotovorum,B,B03.660.250.150.542.120,Pectobacterium,Enterobacteriaceae,4
Pectobacterium carotovorum,B,B03.440.450.425.585.120,Pectobacterium,Enterobacteriaceae,4
Pelvic Organ Prolapse,C,C23.300.842.624,Prolapse,"Pathological Conditions, Anatomical",4
Penile Diseases,C,C12.294.494,"Genital Diseases, Male",Male Urogenital Diseases,4
Penis,A,A05.360.444.492,"Genitalia, Male",Genitalia,4
Pentosyltransferases,D,D08.811.913.400.725,Glycosyltransferases,Transferases,4
Peptidoglycan,D,D09.698.718.594,"Polysaccharides, Bacterial",Polysaccharides,4
Peptidoglycan,D,D09.400.420.700,Glycopeptides,Glycoconjugates,4
Peptidoglycan,D,D12.644.233.594,Glycopeptides,Peptides,4
Peptidoglycan,D,D12.776.395.560.800,Mucoproteins,Glycoproteins,4
Peptidoglycan,D,D23.050.161.616.594,"Polysaccharides, Bacterial","Antigens, Bacterial",4
Perceptual Disorders,C,C10.597.606.762,Neurobehavioral Manifestations,Neurologic Manifestations,4
Perceptual Disorders,C,C23.888.592.604.764,Neurobehavioral Manifestations,Neurologic Manifestations,4
Perceptual Disorders,F,F01.700.750,Neurobehavioral Manifestations,Behavior and Behavior Mechanisms,4
Pericardium,A,A07.541.795,Heart,Cardiovascular System,4
Pericardium,A,A10.615.789.470,Serous Membrane,Membranes,4
Periodontics,E,E06.721,Dentistry,NULL,4
Periodontics,H,H02.163.876.623,"Specialties, Dental",Dentistry,4
Periplasm,A,A11.284.295.680,Extracellular Space,Cellular Structures,4
"Peritoneal Dialysis, Continuous Ambulatory",E,E02.760.106.500,Ambulatory Care,Patient Care,4
"Peritoneal Dialysis, Continuous Ambulatory",N,N02.421.585.106.500,Ambulatory Care,Patient Care,4
"Peritoneal Dialysis, Continuous Ambulatory",E,E02.870.300.650.500,Peritoneal Dialysis,Renal Dialysis,4
"Peritoneal Dialysis, Continuous Ambulatory",E,E02.912.800.650.500,Peritoneal Dialysis,Renal Dialysis,4
Peritoneal Neoplasms,C,C04.588.274.780,Digestive System Neoplasms,Neoplasms by Site,4
Peritoneal Neoplasms,C,C06.844.620,Peritoneal Diseases,Digestive System Diseases,4
Peritoneal Neoplasms,C,C06.301.780,Digestive System Neoplasms,Digestive System Diseases,4
Peritoneal Neoplasms,C,C04.588.033.513,Abdominal Neoplasms,Neoplasms by Site,4
Peritonitis,C,C06.844.640,Peritoneal Diseases,Digestive System Diseases,4
Peritonitis,C,C01.463.600,Intraabdominal Infections,Infections,4
Persian Gulf Syndrome,C,C24.653,Occupational Diseases,NULL,4
Personal Narratives as Topic,K,K01.517.211.753,Biographies as Topic,Literature,4
"Personnel Administration, Hospital",N,N02.278.216.500.968.565,Hospital Departments,Hospital Administration,4
"Personnel Administration, Hospital",N,N04.452.442.452.422.565,Hospital Departments,Hospital Administration,4
"Personnel Administration, Hospital",N,N04.452.677.440,Personnel Management,Organization and Administration,4
Personnel Loyalty,N,N04.452.677.460,Personnel Management,Organization and Administration,4
Persons with Mental Disabilities,M,M01.150.600,Disabled Persons,Persons,4
Pharyngeal Neoplasms,C,C09.775.549,Pharyngeal Diseases,Otorhinolaryngologic Diseases,4
Pharyngeal Neoplasms,C,C09.647.710,Otorhinolaryngologic Neoplasms,Otorhinolaryngologic Diseases,4
Pharyngeal Neoplasms,C,C07.550.745,Pharyngeal Diseases,Stomatognathic Diseases,4
Pharyngeal Neoplasms,C,C04.588.443.665.710,Otorhinolaryngologic Neoplasms,Head and Neck Neoplasms,4
Phenomics,H,H01.158.273.343.775,Genetics,Biology,4
Phenomics,H,H01.158.273.180.700,Computational Biology,Biology,4
Phenylurea Compounds,D,D02.455.426.559.389.703,Benzene Derivatives,"Hydrocarbons, Aromatic",4
Phenylurea Compounds,D,D02.065.950.681,Urea,Amides,4
PHEX Phosphate Regulating Neutral Endopeptidase,D,D12.776.543.550.607,Membrane Glycoproteins,Membrane Proteins,4
PHEX Phosphate Regulating Neutral Endopeptidase,D,D12.776.395.550.611,Membrane Glycoproteins,Glycoproteins,4
PHEX Phosphate Regulating Neutral Endopeptidase,D,D08.811.277.656.675.374.616,Metalloendopeptidases,Metalloproteases,4
PHEX Phosphate Regulating Neutral Endopeptidase,D,D08.811.277.656.300.480.616,Metalloendopeptidases,Endopeptidases,4
Phobic Disorders,F,F03.080.725,Anxiety Disorders,Mental Disorders,4
Phosphatidylserines,D,D10.570.755.375.760.400.971,Glycerophospholipids,Phosphatidic Acids,4
Phosphoric Acids,D,D01.695.625.675,Phosphorus Acids,Phosphorus Compounds,4
Phosphoric Acids,D,D01.029.260.700.675,Phosphorus Acids,"Acids, Noncarboxylic",4
Phosphoserine,D,D12.125.740.700,Phosphoamino Acids,Amino Acids,4
Phosphoserine,D,D12.125.154.800.968,Serine,"Amino Acids, Neutral",4
Phthalazines,D,D03.383.710.605,Pyridazines,"Heterocyclic Compounds, 1-Ring",4
Physical Therapy Specialty,H,H02.010.625,Allied Health Occupations,Health Occupations,4
Physician Assistants,M,M01.526.485.067.740,Allied Health Personnel,Health Personnel,4
Physician Assistants,N,N02.360.067.740,Allied Health Personnel,Health Personnel,4
Physician Executives,N,N02.360.800,Health Personnel,"Health Care Facilities, Manpower, and Services",4
Physician Executives,M,M01.526.070.700,Administrative Personnel,Occupational Groups,4
Physician Executives,M,M01.526.485.800,Health Personnel,Occupational Groups,4
Physician Impairment,N,N03.706.535.606.528.500,Professional Impairment,Malpractice,4
Physician Impairment,I,I01.880.604.583.524.528.500,Professional Impairment,Malpractice,4
"Physicians, Women",M,M01.526.485.810.820,Physicians,Health Personnel,4
"Physicians, Women",M,M01.975.790,Women,Persons,4
"Physicians, Women",N,N02.360.810.820,Physicians,Health Personnel,4
Pioglitazone,D,D03.383.129.708.933.250,Thiazolidinediones,Thiazoles,4
Pioglitazone,D,D02.886.675.933.250,Thiazolidinediones,Thiazoles,4
Pituitary Gland,A,A08.186.211.180.497.352.435.500,Hypothalamo-Hypophyseal System,"Hypothalamus, Middle",4
Pituitary Gland,A,A08.186.211.200.317.357.352.435.500,Hypothalamo-Hypophyseal System,"Hypothalamus, Middle",4
Pituitary Gland,A,A08.713.357.750,Hypothalamo-Hypophyseal System,Neurosecretory Systems,4
Pituitary Gland,A,A06.300.747,Endocrine Glands,Endocrine System,4
Pituitary Gland,A,A06.688.357.750,Hypothalamo-Hypophyseal System,Neurosecretory Systems,4
Placental Circulation,G,G09.330.100.749,Blood Circulation,Cardiovascular Physiological Phenomena,4
Placentation,G,G08.686.784.769.491,Pregnancy,Reproduction,4
Plant Roots,A,A18.400,Plant Structures,NULL,4
Plant Viruses,B,B04.715,Viruses,NULL,4
Plethysmography,E,E01.370.370.610,"Diagnostic Techniques, Cardiovascular",Diagnostic Techniques and Procedures,4
Pleura,A,A04.716,Respiratory System,NULL,4
Pleura,A,A10.615.789.736,Serous Membrane,Membranes,4
Pleurodesis,E,E02.319.694,Drug Therapy,Therapeutics,4
Poecilia,B,B01.050.150.900.493.850.280.680,Cyprinodontiformes,Smegmamorpha,4
Polycyclic Compounds,D,D04,NULL,NULL,4
Polyesters,D,D05.750.728,Polymers,Macromolecular Substances,4
Polyesters,D,D25.720.728,Polymers,Biomedical and Dental Materials,4
Polyesters,J,J01.637.051.720.728,Polymers,Biomedical and Dental Materials,4
Porcine Reproductive and Respiratory Syndrome,C,C01.925.782.600.100.700,Arterivirus Infections,Nidovirales Infections,4
Porcine Reproductive and Respiratory Syndrome,C,C22.905.700,Swine Diseases,Animal Diseases,4
Positive-Pressure Respiration,E,E02.041.625.790,"Respiration, Artificial",Airway Management,4
Positive-Pressure Respiration,E,E02.880.820.790,"Respiration, Artificial",Respiratory Therapy,4
Postural Balance,G,G07.888.750.500,Proprioception,Vestibulocochlear Physiological Phenomena,4
Postural Balance,F,F02.830.816.541.752,Proprioception,Sensation,4
Postural Balance,G,G11.561.790.541.595,Proprioception,Sensation,4
Postural Balance,G,G11.427.690,Musculoskeletal Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,4
Potassium Channels,D,D12.776.543.550.450.750,Ion Channels,Membrane Glycoproteins,4
Potassium Channels,D,D12.776.543.585.400.750,Ion Channels,Membrane Transport Proteins,4
Potassium Channels,D,D12.776.157.530.400.600,Ion Channels,Membrane Transport Proteins,4
Potyvirus,B,B04.715.464.600,Mosaic Viruses,Plant Viruses,4
Potyvirus,B,B04.715.635.600,Potyviridae,Plant Viruses,4
Potyvirus,B,B04.820.578.782.600,Potyviridae,Positive-Strand RNA Viruses,4
Povidone-Iodine,D,D01.475.557.500,Iodophors,Iodine Compounds,4
Povidone-Iodine,D,D02.455.326.271.884.533.710,Polyvinyls,Vinyl Compounds,4
Povidone-Iodine,D,D05.750.716.721.838.745,Povidone,Polyvinyls,4
Povidone-Iodine,D,D03.383.773.812.615.630,Povidone,Pyrrolidinones,4
Povidone-Iodine,D,D25.720.716.721.838.745,Povidone,Polyvinyls,4
Povidone-Iodine,J,J01.637.051.720.716.721.838.745,Povidone,Polyvinyls,4
Poxviridae Infections,C,C01.925.256.743,DNA Virus Infections,Virus Diseases,4
Practice Management,N,N04.452.758.708,Professional Practice,Organization and Administration,4
"Pregnancy Complications, Neoplastic",C,C04.850,Neoplasms,NULL,4
"Pregnancy Complications, Neoplastic",C,C13.703.720,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,4
Preimplantation Diagnosis,E,E01.370.378.625,"Diagnostic Techniques, Obstetrical and Gynecological",Diagnostic Techniques and Procedures,4
Prepaid Health Plans,N,N03.219.521.576.343.925,"Insurance, Health",Insurance,4
Printing,L,L01.737.787,Publishing,Information Science,4
Procedures and Techniques Utilization,N,N05.715.360.750.660,Statistics as Topic,Health Care Evaluation Mechanisms,4
Procedures and Techniques Utilization,H,H01.548.832.750,Statistics as Topic,Mathematics,4
Procedures and Techniques Utilization,E,E05.318.740.675,Statistics as Topic,Epidemiologic Methods,4
Procedures and Techniques Utilization,N,N06.850.520.830.675,Statistics as Topic,Epidemiologic Methods,4
Procollagen,D,D12.776.860.300.250.600,Collagen,Extracellular Matrix Proteins,4
Procollagen,D,D12.776.811.690,Protein Precursors,Proteins,4
Professional Corporations,N,N04.452.758.760,Professional Practice,Organization and Administration,4
Proinsulin,D,D12.776.811.706,Protein Precursors,Proteins,4
Proinsulin,D,D06.472.699.587.200.500,Insulins,Pancreatic Hormones,4
Proinsulin,D,D12.644.548.586.200.500,Insulins,Pancreatic Hormones,4
Propanolamines,D,D02.092.063.624,Amino Alcohols,Amines,4
Propanolamines,D,D02.033.100.624,Amino Alcohols,Alcohols,4
Propanolamines,D,D02.033.755.624,Propanols,Alcohols,4
Prostatic Diseases,C,C12.294.565,"Genital Diseases, Male",Male Urogenital Diseases,4
Prostatism,C,C23.888.942.343.600,Lower Urinary Tract Symptoms,Urological Manifestations,4
Prosthesis-Related Infections,C,C23.550.767.868,Postoperative Complications,Pathologic Processes,4
Prosthesis-Related Infections,C,C01.685,Infections,NULL,4
Protamines,D,D12.776.660.750,Nuclear Proteins,Proteins,4
Protamines,D,D12.776.664.750,Nucleoproteins,Proteins,4
Proteasome Inhibitors,D,D27.505.519.389.745.705,Protease Inhibitors,Enzyme Inhibitors,4
Protective Agents,D,D27.505.696.706,Physiological Effects of Drugs,Pharmacologic Actions,4
Protective Agents,D,D27.720.799,Specialty Uses of Chemicals,Chemical Actions and Uses,4
Proton Magnetic Resonance Spectroscopy,E,E05.196.867.519.775,Magnetic Resonance Spectroscopy,Spectrum Analysis,4
Protons,G,G01.249.660.500,Nucleons,Elementary Particles,4
Protons,D,D01.362.340.750,Hydrogen,Gases,4
Protons,D,D01.248.497.300.459.700,"Cations, Monovalent",Cations,4
Protons,D,D01.268.406.750,Hydrogen,Elements,4
Proto-Oncogene Proteins c-akt,D,D12.776.624.664.700.168,Proto-Oncogene Proteins,Oncogene Proteins,4
Proto-Oncogene Proteins c-akt,D,D12.776.476.565,Intracellular Signaling Peptides and Proteins,Proteins,4
Proto-Oncogene Proteins c-akt,D,D08.811.913.696.620.682.700.755,Protein-Serine-Threonine Kinases,Protein Kinases,4
Proto-Oncogene Proteins c-met,D,D08.811.913.696.620.682.725.400.075,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,4
Proto-Oncogene Proteins c-met,D,D12.776.543.750.630.186,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",4
Proto-Oncogene Proteins c-met,D,D12.776.543.750.750.400.100,"Receptors, Growth Factor","Receptors, Peptide",4
Proto-Oncogene Proteins c-met,D,D12.776.624.664.700.186,Proto-Oncogene Proteins,Oncogene Proteins,4
Protoporphyrins,D,D23.767.727.725,Porphyrins,"Pigments, Biological",4
Protoporphyrins,D,D04.345.783.500.725,Porphyrins,Tetrapyrroles,4
Protoporphyrins,D,D03.633.400.909.500.725,Porphyrins,Tetrapyrroles,4
Protoporphyrins,D,D03.383.129.578.840.500.725,Porphyrins,Tetrapyrroles,4
"Psychology, Social",F,F04.096.628.829,Psychology,Behavioral Sciences,4
"Psychology, Social",F,F01.829,Behavior and Behavior Mechanisms,NULL,4
Pterygium,C,C11.187.781,Conjunctival Diseases,Eye Diseases,4
"Puberty, Precocious",C,C19.391.693,Gonadal Disorders,Endocrine System Diseases,4
PubMed,L,L01.470.750.500.650,"Databases, Bibliographic",Databases as Topic,4
PubMed,L,L01.313.500.750.280.750,Information Storage and Retrieval,Medical Informatics Applications,4
PubMed,L,L01.313.500.750.300.742.650,Online Systems,Information Systems,4
PubMed,L,L01.313.500.750.300.188.300.650,"Databases, Bibliographic",Databases as Topic,4
Pulmonary Emphysema,C,C08.381.495.389.750,"Pulmonary Disease, Chronic Obstructive","Lung Diseases, Obstructive",4
Pulsatile Flow,G,G09.330.380.630.555,Hemorheology,Hemodynamics,4
Pulsatile Flow,G,G01.482.620,Motion,Physical Phenomena,4
Pulse,G,G09.330.380.750,Hemodynamics,Cardiovascular Physiological Phenomena,4
Pulse,E,E01.370.370.380.650,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",4
Pupil,A,A09.371.060.450.780,Iris,Anterior Eye Segment,4
Pupil,A,A09.371.894.513.780,Iris,Uvea,4
"Purchasing, Hospital",N,N02.278.216.500.968.679,Hospital Departments,Hospital Administration,4
"Purchasing, Hospital",N,N04.452.442.452.422.679,Hospital Departments,Hospital Administration,4
Pyrazines,D,D03.383.679,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,4
Quorum Sensing,G,G06.550.700,Microbial Interactions,Microbiological Phenomena,4
Quorum Sensing,G,G04.085.700,Cell Communication,Cell Physiological Phenomena,4
"Radiography, Abdominal",E,E01.370.350.700.715,Radiography,Diagnostic Imaging,4
Radiology Information Systems,N,N04.452.515.825,Management Information Systems,Organization and Administration,4
Railroads,J,J01.937.690,Transportation,"Technology, Industry, and Agriculture",4
Rec A Recombinases,D,D08.811.739.650,Recombinases,Enzymes,4
Rec A Recombinases,D,D08.811.913.696.445.692,Nucleotidyltransferases,Phosphotransferases,4
"Receptor, Angiotensin, Type 2",D,D12.776.543.750.750.130.875,"Receptors, Angiotensin","Receptors, Peptide",4
"Receptor, Angiotensin, Type 2",D,D12.776.543.750.695.047.687,"Receptors, Angiotensin","Receptors, G-Protein-Coupled",4
"Receptor, Fibroblast Growth Factor, Type 2",D,D12.776.543.750.630.441,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",4
"Receptor, Fibroblast Growth Factor, Type 2",D,D12.776.543.750.750.400.370.750,"Receptors, Fibroblast Growth Factor","Receptors, Growth Factor",4
"Receptor, Fibroblast Growth Factor, Type 2",D,D08.811.913.696.620.682.725.400.178,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,4
"Receptors, CXCR3",D,D12.776.543.750.705.852.125.500.300,"Receptors, CXCR","Receptors, Chemokine",4
"Receptors, CXCR3",D,D12.776.543.750.695.160.500.300,"Receptors, CXCR","Receptors, Chemokine",4
"Receptors, Erythropoietin",D,D12.776.543.750.705.852.150.200,"Receptors, Colony-Stimulating Factor","Receptors, Cytokine",4
"Receptors, Erythropoietin",D,D12.776.543.750.750.400.200.340,"Receptors, Colony-Stimulating Factor","Receptors, Growth Factor",4
"Receptors, IgE",D,D12.776.543.750.705.871.280,"Receptors, Fc","Receptors, Immunologic",4
"Receptors, Interleukin-7",D,D12.776.543.750.705.852.420.420,"Receptors, Interleukin","Receptors, Cytokine",4
"Receptors, Pattern Recognition",D,D12.776.543.750.705.910,"Receptors, Immunologic","Receptors, Cell Surface",4
"Receptors, Transforming Growth Factor beta",D,D12.776.543.750.705.852.720,"Receptors, Cytokine","Receptors, Immunologic",4
"Receptors, Transforming Growth Factor beta",D,D12.776.543.750.750.400.820,"Receptors, Growth Factor","Receptors, Peptide",4
"Receptors, Tumor Necrosis Factor, Type II",D,D12.776.543.750.705.852.760.798,"Receptors, Tumor Necrosis Factor","Receptors, Cytokine",4
Red Meat,J,J02.500.600.813,Meat,Food,4
Red Meat,G,G07.203.300.600.813,Meat,Food,4
Refusal to Treat,N,N04.590.233.727.605,Primary Health Care,Comprehensive Health Care,4
Refusal to Treat,N,N05.300.100.675,Attitude of Health Personnel,Delivery of Health Care,4
Religious Missions,N,N03.540.297.500,Faith-Based Organizations,Organizations,4
Religious Missions,K,K01.844.777,Religion,Humanities,4
Renal Artery,A,A07.015.114.745,Arteries,Blood Vessels,4
Reoviridae Infections,C,C01.925.782.791,RNA Virus Infections,Virus Diseases,4
Respiratory System Agents,D,D27.505.954.796,Therapeutic Uses,Pharmacologic Actions,4
Retinal Perforations,C,C11.768.740,Retinal Diseases,Eye Diseases,4
Retinal Pigments,D,D23.767.930,"Pigments, Biological",Biological Factors,4
Retinal Vein Occlusion,C,C11.768.760,Retinal Diseases,Eye Diseases,4
Retinal Vein Occlusion,C,C14.907.760,Vascular Diseases,Cardiovascular Diseases,4
Retinal Vein Occlusion,C,C14.907.355.830.925.650,Venous Thrombosis,Thrombosis,4
Retinol-Binding Proteins,D,D12.776.157.700,Carrier Proteins,Proteins,4
Return to Work,I,I03.946.449,Work,Human Activities,4
Return to Work,N,N01.824.245.725,Employment,Socioeconomic Factors,4
Ribonucleoproteins,D,D12.776.157.725.500,RNA-Binding Proteins,Carrier Proteins,4
Ribonucleoproteins,D,D12.776.664.962.500,RNA-Binding Proteins,Nucleoproteins,4
Ribosomes,A,A11.284.430.214.190.875.811,Organelles,Cytoplasmic Structures,4
Rimantadine,D,D02.455.426.100.050.750,Adamantane,Bridged-Ring Compounds,4
Rimantadine,D,D02.455.426.392.368.075.750,Adamantane,Cycloparaffins,4
Rivaroxaban,D,D03.383.533.640.713,Morpholines,Oxazines,4
Rivaroxaban,D,D03.383.903.727,Thiophenes,"Heterocyclic Compounds, 1-Ring",4
Rivaroxaban,D,D02.886.778.727,Thiophenes,Sulfur Compounds,4
RNA Precursors,D,D13.400.730,Nucleic Acid Precursors,"Nucleic Acids, Nucleotides, and Nucleosides",4
RNA Precursors,D,D13.444.735.640,RNA,Nucleic Acids,4
"RNA, Ribosomal, 23S",D,D13.444.735.686.680,"RNA, Ribosomal",RNA,4
"RNA, Transfer, Met",D,D13.444.735.757.700.525,"RNA, Transfer, Amino Acid-Specific","RNA, Transfer",4
RNA-Seq,E,E05.393.332.250,Gene Expression Profiling,Genetic Techniques,4
RNA-Seq,E,E05.393.760.319.500,High-Throughput Nucleotide Sequencing,Sequence Analysis,4
RNA-Seq,E,E05.393.760.710.500,"Sequence Analysis, RNA",Sequence Analysis,4
Rosuvastatin Calcium,D,D02.886.590.700.650,Sulfonamides,Sulfones,4
Rosuvastatin Calcium,D,D02.455.526.510.432.500,Fluorobenzenes,"Hydrocarbons, Fluorinated",4
Rosuvastatin Calcium,D,D03.383.742.775,Pyrimidines,"Heterocyclic Compounds, 1-Ring",4
Rosuvastatin Calcium,D,D02.065.884.650,Sulfonamides,Amides,4
S-Adenosylmethionine,D,D03.633.100.759.590.138.264,Adenosine,Purine Nucleosides,4
S-Adenosylmethionine,D,D02.886.030.676.180,Methionine,"Amino Acids, Sulfur",4
S-Adenosylmethionine,D,D12.125.166.676.180,Methionine,"Amino Acids, Sulfur",4
S-Adenosylmethionine,D,D13.570.800.096.264,Adenosine,Ribonucleosides,4
S-Adenosylmethionine,D,D13.570.583.138.264,Adenosine,Purine Nucleosides,4
SAIDS Vaccines,D,D20.215.894.899.790,Viral Vaccines,Vaccines,4
Salpingitis,C,C13.351.500.056.390.890,Fallopian Tube Diseases,Adnexal Diseases,4
Salpingitis,C,C13.351.500.056.750.875,Pelvic Inflammatory Disease,Adnexal Diseases,4
Salvage Therapy,E,E02.895,Therapeutics,NULL,4
Samoa,Z,Z01.639.760.815.800,Polynesia,Pacific Islands,4
Saponins,D,D09.408.782,Glycosides,Carbohydrates,4
Saskatchewan,Z,Z01.107.567.176.858,Canada,North America,4
Schizosaccharomyces,B,B01.300.107.797,Ascomycota,Fungi,4
Schizosaccharomyces,B,B01.300.930.720,Yeasts,Fungi,4
"Schools, Nursery",I,I02.783.660,Schools,Education,4
"Schools, Nursery",J,J03.832.660,Schools,Non-Medical Public and Private Facilities,4
Scrapie,C,C01.207.800.717,Prion Diseases,Central Nervous System Infections,4
Scrapie,C,C10.574.843.850,Prion Diseases,Neurodegenerative Diseases,4
Scrapie,C,C10.228.228.800.717,Prion Diseases,Central Nervous System Infections,4
Scrapie,C,C22.836.799,Sheep Diseases,Animal Diseases,4
Second Messenger Systems,G,G04.835.800,Signal Transduction,Cell Physiological Phenomena,4
Second Messenger Systems,G,G02.111.820.800,Signal Transduction,Biochemical Phenomena,4
Secondary Care Centers,N,N02.278.421.745,Hospitals,Health Facilities,4
Seeds,J,J02.500.775,Food,Food and Beverages,4
Seeds,G,G07.203.300.775,Food,"Diet, Food, and Nutrition",4
Seeds,A,A18.024.500.750,Fruit,"Plant Components, Aerial",4
Sensation,F,F02.830.816,Psychophysiology,Psychological Phenomena,4
Sensation,G,G11.561.790,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,4
Sensory Thresholds,F,F02.463.593.710,Perception,Mental Processes,4
Sentinel Lymph Node Biopsy,E,E04.074.580,Biopsy,"Surgical Procedures, Operative",4
Sentinel Lymph Node Biopsy,E,E04.446.819,Lymph Node Excision,"Surgical Procedures, Operative",4
Sentinel Lymph Node Biopsy,E,E05.200.500.384.100.580,Biopsy,Cytodiagnosis,4
Sentinel Lymph Node Biopsy,E,E05.242.384.100.580,Biopsy,Cytodiagnosis,4
Sentinel Lymph Node Biopsy,E,E05.200.998.054.580,Biopsy,Specimen Handling,4
Sentinel Lymph Node Biopsy,E,E01.370.225.998.054.580,Biopsy,Specimen Handling,4
Sentinel Lymph Node Biopsy,E,E01.370.225.500.384.100.580,Biopsy,Cytodiagnosis,4
Sentinel Lymph Node Biopsy,E,E01.370.388.100.580,Biopsy,"Diagnostic Techniques, Surgical",4
Serine Proteinase Inhibitors,D,D27.505.519.389.745.800,Protease Inhibitors,Enzyme Inhibitors,4
Serotonin,D,D23.469.050.650,Autacoids,Inflammation Mediators,4
Serotonin,D,D03.633.100.473.914.814,Tryptamines,Indoles,4
Serotonin,D,D02.092.211.215.801.852,Tryptamines,Biogenic Monoamines,4
Serratia marcescens,B,B03.440.450.425.814.664,Serratia,Enterobacteriaceae,4
Serratia marcescens,B,B03.660.250.150.720.500,Serratia,Enterobacteriaceae,4
Sf9 Cells,A,A11.251.210.891,Cell Line,"Cells, Cultured",4
Shigella dysenteriae,B,B03.440.450.425.850.350,Shigella,Enterobacteriaceae,4
Shigella dysenteriae,B,B03.660.250.150.730.125,Shigella,Enterobacteriaceae,4
"Shock, Cardiogenic",C,C23.550.835.550,Shock,Pathologic Processes,4
"Shock, Cardiogenic",C,C23.550.717.489.750.750,Myocardial Infarction,Infarction,4
"Shock, Cardiogenic",C,C23.550.513.355.750.750,Myocardial Infarction,Infarction,4
"Shock, Cardiogenic",C,C14.907.585.500.750,Myocardial Infarction,Myocardial Ischemia,4
"Shock, Cardiogenic",C,C14.280.647.500.750,Myocardial Infarction,Myocardial Ischemia,4
Sibling Relations,F,F01.829.263.370.450,Family Relations,Family,4
Siderophores,D,D27.505.519.914.500.410.750,Iron Chelating Agents,Chelating Agents,4
Siderophores,D,D27.720.832.500.410.750,Iron Chelating Agents,Chelating Agents,4
Silicic Acid,D,D01.029.260.863,"Acids, Noncarboxylic",Acids,4
Silicic Acid,D,D01.837.725.700,Silicon Dioxide,Silicon Compounds,4
Silver Nitrate,D,D01.625.525.550.850,Nitrates,Nitric Acid,4
Silver Nitrate,D,D01.847.900,Silver Compounds,Inorganic Chemicals,4
Sjogren's Syndrome,C,C20.111.199.774,"Arthritis, Rheumatoid",Autoimmune Diseases,4
Sjogren's Syndrome,C,C17.300.775.099.774,"Arthritis, Rheumatoid",Rheumatic Diseases,4
Sjogren's Syndrome,C,C11.496.260.719,Dry Eye Syndromes,Lacrimal Apparatus Diseases,4
Sjogren's Syndrome,C,C05.550.114.154.774,"Arthritis, Rheumatoid",Arthritis,4
Sjogren's Syndrome,C,C05.799.114.774,"Arthritis, Rheumatoid",Rheumatic Diseases,4
Sjogren's Syndrome,C,C07.465.815.929.669,Xerostomia,Salivary Gland Diseases,4
Skin Care,E,E02.547.800,Hygiene,Therapeutics,4
Smoke Inhalation Injury,C,C26.200.322.800,"Burns, Inhalation",Burns,4
Social Desirability,F,F01.145.813.628,Social Behavior,Behavior,4
Social Interaction,F,F01.829.401.716,Interpersonal Relations,"Psychology, Social",4
Sodium Channels,D,D12.776.543.585.400.875,Ion Channels,Membrane Transport Proteins,4
Sodium Channels,D,D12.776.543.550.450.875,Ion Channels,Membrane Glycoproteins,4
Sodium Channels,D,D12.776.157.530.400.875,Ion Channels,Membrane Transport Proteins,4
Sodium Chloride Symporter Inhibitors,D,D27.505.519.562.812,Membrane Transport Modulators,Molecular Mechanisms of Pharmacological Action,4
Sodium Chloride Symporter Inhibitors,D,D27.505.696.560.500.863,Diuretics,Natriuretic Agents,4
Sodium Dodecyl Sulfate,D,D10.289.220.720,Dodecanol,Fatty Alcohols,4
Sodium Dodecyl Sulfate,D,D02.886.645.600.055.050.632,Alkanesulfonates,Alkanesulfonic Acids,4
Sodium Dodecyl Sulfate,D,D02.033.415.220.720,Dodecanol,Fatty Alcohols,4
Sodium Hypochlorite,D,D01.857.750,Sodium Compounds,Inorganic Chemicals,4
Sodium Hypochlorite,D,D01.650.550.400.800,Hypochlorous Acid,Oxides,4
Sodium Hypochlorite,D,D01.210.465.800,Hypochlorous Acid,Chlorine Compounds,4
Sodium-Coupled Vitamin C Transporters,D,D12.776.157.530.450.074.500.687.500,"Organic Anion Transporters, Sodium-Dependent",Organic Anion Transporters,4
Sodium-Coupled Vitamin C Transporters,D,D12.776.157.530.450.625.405,Symporters,Ion Pumps,4
Sodium-Coupled Vitamin C Transporters,D,D12.776.157.530.937.688,Solute Carrier Proteins,Membrane Transport Proteins,4
Sodium-Coupled Vitamin C Transporters,D,D12.776.543.585.450.074.500.812.500,"Organic Anion Transporters, Sodium-Dependent",Organic Anion Transporters,4
Sodium-Coupled Vitamin C Transporters,D,D12.776.543.585.450.625.531,Symporters,Ion Pumps,4
Sodium-Coupled Vitamin C Transporters,D,D12.776.543.585.937.813,Solute Carrier Proteins,Membrane Transport Proteins,4
Solid Phase Extraction,E,E05.196.155.800,Chemical Fractionation,"Chemistry Techniques, Analytical",4
Sorafenib,D,D03.066.515.530.750,Niacinamide,Nicotinic Acids,4
Sorafenib,D,D03.383.725.547.530.750,Niacinamide,Nicotinic Acids,4
Sorafenib,D,D02.065.950.681.757,Phenylurea Compounds,Urea,4
Sorafenib,D,D02.455.426.559.389.703.757,Phenylurea Compounds,Benzene Derivatives,4
Soybeans,B,B01.650.940.800.575.912.250.401.750,Fabaceae,Magnoliopsida,4
Speech Intelligibility,F,F01.145.209.908.677.610,Speech,Verbal Behavior,4
Speech Intelligibility,G,G11.561.812.686,Speech,Nervous System Physiological Phenomena,4
Spermatocidal Agents,D,D27.505.696.138.569,Antispermatogenic Agents,Physiological Effects of Drugs,4
Spermatocidal Agents,D,D27.505.954.705.360.276.827,"Contraceptive Agents, Female",Contraceptive Agents,4
Spermatocidal Agents,D,D27.505.696.875.360.276.827,"Contraceptive Agents, Female",Contraceptive Agents,4
Spermatocidal Agents,D,D27.888.569.071.569,Antispermatogenic Agents,Noxae,4
Spine,A,A02.835.232.834,Bone and Bones,Skeleton,4
"Spores, Fungal",A,A11.870.710,Spores,Cells,4
"Spores, Fungal",A,A19.374.500,"Fruiting Bodies, Fungal",Fungal Structures,4
"Spores, Fungal",B,B05.775.710,Spores,Organism Forms,4
STAT3 Transcription Factor,D,D12.776.476.024.430.300,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",4
STAT3 Transcription Factor,D,D12.776.930.840.300,STAT Transcription Factors,Transcription Factors,4
STAT3 Transcription Factor,D,D12.776.157.057.186.300,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",4
STAT3 Transcription Factor,D,D12.644.360.024.342.300,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",4
Status Epilepticus,C,C23.888.592.742.785,Seizures,Neurologic Manifestations,4
Status Epilepticus,C,C10.597.742.785,Seizures,Neurologic Manifestations,4
"Stimulation, Chemical",G,G07.690.773.996,Pharmacological Phenomena,Pharmacological and Toxicological Phenomena,4
"Stockings, Compression",E,E07.101.400.500,Compression Bandages,Bandages,4
Stomach,A,A03.556.875.875,Upper Gastrointestinal Tract,Gastrointestinal Tract,4
Strategic Planning,N,N04.452.718.500,Planning Techniques,Organization and Administration,4
Streptokinase,D,D12.776.124.125.662.537,Plasminogen Activators,Blood Coagulation Factors,4
Streptokinase,D,D08.811.277.656.300.775,Endopeptidases,Peptide Hydrolases,4
"Structural Homology, Protein",G,G05.820,Genetic Phenomena,NULL,4
"Structural Homology, Protein",G,G02.111.810.200.820,"Sequence Homology, Amino Acid",Sequence Homology,4
"Structural Homology, Protein",G,G02.111.570.820.709.805,Protein Conformation,Molecular Conformation,4
Suburethral Slings,E,E07.695.752,Prostheses and Implants,Equipment and Supplies,4
Suction,E,E04.237.890,Drainage,"Surgical Procedures, Operative",4
Sulfates,D,D01.875.800.800.850,Sulfuric Acids,Sulfur Acids,4
Sulfates,D,D01.248.497.158.845,Anions,Ions,4
Sulfides,D,D01.248.497.158.874,Anions,Ions,4
Sulfides,D,D01.875.350.850,Hydrogen Sulfide,Sulfur Compounds,4
Sulfides,D,D02.886.520,Sulfur Compounds,Organic Chemicals,4
Sunitinib,D,D03.383.129.578.823,Pyrroles,Azoles,4
Sunitinib,D,D03.633.100.473.877,Indoles,"Heterocyclic Compounds, 2-Ring",4
Superstitions,I,I01.076.201.450.897,Culture,"Anthropology, Cultural",4
Suppositories,D,D26.255.785,Dosage Forms,Pharmaceutical Preparations,4
Surgical Oncology,H,H02.403.429.515.750,Medical Oncology,Internal Medicine,4
Surgical Oncology,H,H02.403.810.796,"Specialties, Surgical",Medicine,4
Surgicenters,N,N02.278.421.556.868,"Hospitals, Special",Hospitals,4
Surgicenters,N,N02.278.035.652,Ambulatory Care Facilities,Health Facilities,4
Sutures,E,E07.858.690.820,Surgical Fixation Devices,Surgical Equipment,4
Sweating,G,G07.410.421.693,Body Temperature Regulation,Homeostasis,4
Sweating,G,G07.110.232.693,Body Temperature Regulation,Body Temperature,4
Sweating,G,G13.750.860,Skin Physiological Phenomena,Integumentary System Physiological Phenomena,4
Sweating,G,G16.012.500.535.693,Body Temperature Regulation,"Adaptation, Physiological",4
Symporters,D,D12.776.543.585.450.625,Ion Pumps,Membrane Transport Proteins,4
Symporters,D,D12.776.157.530.450.625,Ion Pumps,Membrane Transport Proteins,4
Synaptic Transmission,G,G11.561.830,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,4
Synaptic Transmission,G,G07.265.880,Electrophysiological Phenomena,Physiological Phenomena,4
Synaptic Transmission,G,G04.835.850,Signal Transduction,Cell Physiological Phenomena,4
Synaptic Transmission,G,G02.111.820.850,Signal Transduction,Biochemical Phenomena,4
Synaptosomes,A,A11.284.835.859,Subcellular Fractions,Cellular Structures,4
Syndemic,N,N06.850.490.937,Epidemiologic Factors,Public Health,4
Tachypnea,C,C23.888.852.944,"Signs and Symptoms, Respiratory",Signs and Symptoms,4
Tachypnea,C,C08.618.961,Respiration Disorders,Respiratory Tract Diseases,4
Telomere Shortening,G,G02.111.225.940,DNA Replication,Biochemical Phenomena,4
Telomere Shortening,G,G05.226.940,DNA Replication,Genetic Phenomena,4
Telomere Shortening,G,G04.043.630,Cellular Senescence,Cell Physiological Phenomena,4
Tertiary Prevention,E,E02.919,Therapeutics,NULL,4
Tertiary Prevention,N,N02.421.726.860,Preventive Health Services,Health Services,4
Tertiary Prevention,N,N06.850.780.800,Public Health Practice,Public Health,4
Testicular Hydrocele,C,C12.294.882,"Genital Diseases, Male",Male Urogenital Diseases,4
Tetraoxanes,D,D01.650.550.750.950,Peroxides,Oxides,4
Tetraoxanes,D,D01.248.497.158.685.750.962,Peroxides,Oxides,4
Tetraoxanes,D,D01.339.431.374.962,Peroxides,Reactive Oxygen Species,4
Tetraoxanes,D,D02.389.338.912,Peroxides,Free Radicals,4
Theft,I,I01.198.240.810,Crime,Criminology,4
Theft,I,I01.880.735.191.410,Crime,Social Problems,4
Therapeutic Equipoise,K,K01.752.566.479.171.132.750.775,"Ethics, Medical","Ethics, Clinical",4
Therapeutic Equipoise,K,K01.752.566.479.173.700,"Ethics, Research",Ethics,4
Therapeutic Equipoise,N,N05.350.670.750,"Ethics, Research",Ethics,4
Therapeutic Equipoise,N,N05.350.340.162.500.750,"Ethics, Medical","Ethics, Clinical",4
Thiamine,D,D03.383.742.795,Pyrimidines,"Heterocyclic Compounds, 1-Ring",4
Thiamine,D,D03.383.129.708.900,Thiazoles,Azoles,4
Thiamine,D,D02.886.675.900,Thiazoles,Sulfur Compounds,4
Thiamphenicol,D,D02.640.529.175.850,Chloramphenicol,Nitrobenzenes,4
Thiamphenicol,D,D02.455.426.559.389.565.175.850,Chloramphenicol,Nitrobenzenes,4
Thiamphenicol,D,D02.033.455.706.300.850,Chloramphenicol,Propylene Glycols,4
Thoracostomy,E,E04.579.918,Ostomy,"Surgical Procedures, Operative",4
Thoracostomy,E,E04.928.755,Thoracic Surgical Procedures,"Surgical Procedures, Operative",4
Thrombelastography,E,E05.200.625.115.830,Blood Coagulation Tests,Hematologic Tests,4
Thrombelastography,E,E01.370.225.625.115.830,Blood Coagulation Tests,Hematologic Tests,4
Thrombopoietin,D,D23.529.374.410.240.750,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,4
Thrombopoietin,D,D12.776.467.374.410.240.750,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,4
Thrombopoietin,D,D12.776.395.240.750,Colony-Stimulating Factors,Glycoproteins,4
Thrombopoietin,D,D12.644.276.374.410.240.750,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,4
Thrombospondin 1,D,D12.776.395.550.895.800,Thrombospondins,Membrane Glycoproteins,4
Thrombospondin 1,D,D12.776.543.550.895.800,Thrombospondins,Membrane Glycoproteins,4
Thymidine,D,D13.570.230.855,Deoxyribonucleosides,Nucleosides,4
Thymidine,D,D13.570.685.705,Pyrimidine Nucleosides,Nucleosides,4
Thymidine,D,D03.383.742.680.705,Pyrimidine Nucleosides,Pyrimidines,4
Thymidylate Synthase,D,D08.811.913.555.500.862,Methyltransferases,One-Carbon Group Transferases,4
Thyroid Function Tests,E,E01.370.374.750,"Diagnostic Techniques, Endocrine",Diagnostic Techniques and Procedures,4
Thyrotropin-Releasing Hormone,D,D12.776.631.650.810,Neuropeptides,Nerve Tissue Proteins,4
Thyrotropin-Releasing Hormone,D,D12.776.631.650.405.740.880,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,4
Thyrotropin-Releasing Hormone,D,D12.644.548.365.740.880,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,4
Thyrotropin-Releasing Hormone,D,D12.644.400.400.740.880,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,4
Thyrotropin-Releasing Hormone,D,D12.644.456.837,Oligopeptides,Peptides,4
Thyrotropin-Releasing Hormone,D,D06.472.699.327.740.880,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,4
Tick Bites,C,C26.176.793,Bites and Stings,Wounds and Injuries,4
Tick Bites,C,C25.723.127.789,Bites and Stings,Poisoning,4
Tick-Borne Diseases,C,C01.920.930,Vector Borne Diseases,Infections,4
Time Management,F,F02.784.692.816,"Psychology, Industrial","Psychology, Applied",4
Time Management,F,F02.784.412.923,Ergonomics,"Psychology, Applied",4
Time Management,F,F04.096.628.779.900,"Psychology, Industrial",Psychology,4
Time Management,N,N04.452.932,Organization and Administration,Health Services Administration,4
Time-Lapse Imaging,L,L01.280.960.399,Video Recording,Copying Processes,4
Time-Lapse Imaging,E,E05.712.657,Photography,Investigative Techniques,4
Time-Lapse Imaging,E,E01.370.350.600.817,Photography,Diagnostic Imaging,4
Tissue and Organ Harvesting,E,E04.936.537,Transplantation,"Surgical Procedures, Operative",4
Tissue Banks,N,N02.278.065.900,Biological Specimen Banks,Health Facilities,4
Tissue Engineering,J,J01.293.069.249.500,Cell Engineering,Bioengineering,4
Tissue Engineering,E,E05.481.500.311.500,Cell Engineering,Culture Techniques,4
Titanium,D,D01.268.956.878,Transition Elements,Elements,4
Titanium,D,D01.268.557.800,"Metals, Light",Elements,4
Titanium,D,D01.552.547.800,"Metals, Light",Metals,4
Toll-Like Receptor 1,D,D12.776.543.750.705.910.500.100,Toll-Like Receptors,"Receptors, Pattern Recognition",4
Toll-Like Receptor 9,D,D12.776.543.750.705.910.500.900,Toll-Like Receptors,"Receptors, Pattern Recognition",4
Toll-Like Receptor 9,D,D12.776.260.750,DNA-Binding Proteins,Proteins,4
"Tomography, Emission-Computed, Single-Photon",E,E01.370.350.600.350.800.800,"Tomography, Emission-Computed",Image Enhancement,4
"Tomography, Emission-Computed, Single-Photon",E,E01.370.350.350.800.800,"Tomography, Emission-Computed","Image Interpretation, Computer-Assisted",4
"Tomography, Emission-Computed, Single-Photon",E,E01.370.350.710.800.800,"Tomography, Emission-Computed",Radionuclide Imaging,4
"Tomography, Emission-Computed, Single-Photon",E,E01.370.350.825.800.800,"Tomography, Emission-Computed",Tomography,4
"Tomography, Emission-Computed, Single-Photon",E,E01.370.384.730.800.800,"Tomography, Emission-Computed",Radionuclide Imaging,4
Tongue,A,A03.556.500.885,Mouth,Gastrointestinal Tract,4
Tongue,A,A14.549.885,Mouth,Stomatognathic System,4
Tooth Extraction,E,E06.645.700,Oral Surgical Procedures,Dentistry,4
Tooth Extraction,E,E04.545.700,Oral Surgical Procedures,"Surgical Procedures, Operative",4
Tooth Germ,A,A14.549.167.900.720,Tooth Components,Dentition,4
Toxocara,B,B01.050.500.500.294.400.500.100.780,Ascaridoidea,Ascaridida,4
Trachea,A,A04.889,Respiratory System,NULL,4
Translational Medical Research,H,H01.770.644.145.675,Biomedical Research,Research,4
Transplantation Immunology,G,G12.875,Immune System Phenomena,NULL,4
"Transplantation, Heterologous",E,E04.936.764,Transplantation,"Surgical Procedures, Operative",4
Transurethral Resection of Prostate,E,E04.950.774.860.625.750,Prostatectomy,"Urologic Surgical Procedures, Male",4
Tremor,C,C23.888.592.350.850,Dyskinesias,Neurologic Manifestations,4
Tremor,C,C10.597.350.850,Dyskinesias,Neurologic Manifestations,4
Trichinellosis,C,C01.610.335.508.100.275.882,Enoplida Infections,Adenophorea Infections,4
"Tuberculosis, Cutaneous",C,C01.800.720.820,"Skin Diseases, Bacterial","Skin Diseases, Infectious",4
"Tuberculosis, Cutaneous",C,C01.150.252.819.820,"Skin Diseases, Bacterial",Bacterial Infections,4
"Tuberculosis, Cutaneous",C,C01.150.252.410.040.552.846.588,Tuberculosis,Mycobacterium Infections,4
"Tuberculosis, Cutaneous",C,C17.800.838.765.820,"Skin Diseases, Bacterial","Skin Diseases, Infectious",4
"Typhus, Endemic Flea-Borne",C,C01.150.252.400.789.725.800,Rickettsia Infections,Rickettsiaceae Infections,4
"Typhus, Endemic Flea-Borne",C,C01.920.914.725.800,Rickettsia Infections,Rickettsiaceae Infections,4
Ultrafiltration,E,E05.196.454.807,Filtration,"Chemistry Techniques, Analytical",4
Ultrafiltration,E,E04.292.975,Extracorporeal Circulation,"Surgical Procedures, Operative",4
Ultrafiltration,G,G01.280.807,Filtration,Physical Phenomena,4
Ultrafiltration,G,G02.263.807,Filtration,Chemical Phenomena,4
Ultrasonics,H,H01.671.031.849,Acoustics,Physics,4
"Ultrasonography, Doppler, Transcranial",E,E05.629.937.260.850,Echoencephalography,Neuroradiography,4
"Ultrasonography, Doppler, Transcranial",E,E01.370.350.850.260.850,Echoencephalography,Ultrasonography,4
"Ultrasonography, Doppler, Transcranial",E,E01.370.350.850.850.870,"Ultrasonography, Doppler",Ultrasonography,4
"Ultrasonography, Doppler, Transcranial",E,E01.370.376.537.750.260.850,Echoencephalography,Neuroradiography,4
"Ultrasonography, Doppler, Transcranial",E,E01.370.350.700.560.260.850,Echoencephalography,Neuroradiography,4
"Ultrasonography, Doppler, Transcranial",E,E01.370.350.578.937.260.850,Echoencephalography,Neuroradiography,4
Umbilical Arteries,A,A07.015.114.929,Arteries,Blood Vessels,4
Umbilical Arteries,A,A16.378.693.641,Umbilical Cord,Fetus,4
Umbilical Veins,A,A16.378.693.807,Umbilical Cord,Fetus,4
Umbilical Veins,A,A07.015.908.670.874,Portal System,Veins,4
Unconsciousness,C,C10.597.606.358.800,Consciousness Disorders,Neurobehavioral Manifestations,4
Unconsciousness,C,C23.888.592.604.359.800,Consciousness Disorders,Neurobehavioral Manifestations,4
Ureaplasma,B,B03.440.860.580.553.900,Mycoplasmataceae,Mycoplasmatales,4
Urease,D,D08.811.277.087.902,Amidohydrolases,Hydrolases,4
Urinary Catheters,E,E07.132.625,Catheters,Equipment and Supplies,4
Urologic Neoplasms,C,C04.588.945.947,Urogenital Neoplasms,Neoplasms by Site,4
Urologic Neoplasms,C,C12.758.820,Urogenital Neoplasms,Male Urogenital Diseases,4
Urologic Neoplasms,C,C13.351.937.820,Urogenital Neoplasms,Female Urogenital Diseases,4
Vascular Endothelial Growth Factor Receptor-2,D,D08.811.913.696.620.682.725.400.950.200,"Receptors, Vascular Endothelial Growth Factor",Receptor Protein-Tyrosine Kinases,4
Vascular Endothelial Growth Factor Receptor-2,D,D12.776.543.750.750.400.910.200,"Receptors, Vascular Endothelial Growth Factor","Receptors, Growth Factor",4
Vascular Endothelial Growth Factor Receptor-2,D,D12.776.543.750.630.750.200,"Receptors, Vascular Endothelial Growth Factor",Receptor Protein-Tyrosine Kinases,4
Vasoconstriction,G,G09.330.380.925,Hemodynamics,Cardiovascular Physiological Phenomena,4
Vasomotor System,A,A08.800.050.800.900,Sympathetic Nervous System,Autonomic Nervous System,4
"Ventricular Dysfunction, Right",C,C14.280.945.910,Ventricular Dysfunction,Heart Diseases,4
Ventricular Fibrillation,C,C14.280.067.922,"Arrhythmias, Cardiac",Heart Diseases,4
Ventricular Fibrillation,C,C23.550.073.922,"Arrhythmias, Cardiac",Pathologic Processes,4
"Ventricular Function, Right",G,G09.330.955.900,Ventricular Function,Cardiovascular Physiological Phenomena,4
Vibrio cholerae O139,B,B03.440.450.900.859.225.200,Vibrio cholerae,Vibrio,4
Vibrio cholerae O139,B,B03.660.250.830.830.100.200,Vibrio cholerae,Vibrio,4
Visual Cortex,A,A08.186.211.200.885.287.500.571.735,Occipital Lobe,Cerebral Cortex,4
Visual Cortex,A,A08.186.211.200.885.287.500.814.953,Sensorimotor Cortex,Cerebral Cortex,4
Vitamin D-Binding Protein,D,D12.776.157.920,Carrier Proteins,Proteins,4
Walking Speed,E,E01.370.600.250.500,Gait,Physical Examination,4
Walking Speed,G,G11.427.410.568.900.750.500,Gait,Walking,4
Water Movements,G,G16.500.971,Ecological and Environmental Phenomena,Biological Phenomena,4
Water Movements,N,N06.230.850,Environment,Environment and Public Health,4
Water Movements,N,N06.230.132.644.750,Renewable Energy,Energy-Generating Resources,4
Wilms Tumor,C,C04.588.945.947.535.585,Kidney Neoplasms,Urologic Neoplasms,4
Wilms Tumor,C,C04.700.900,"Neoplastic Syndromes, Hereditary",Neoplasms,4
Wilms Tumor,C,C04.557.435.595,"Neoplasms, Complex and Mixed",Neoplasms by Histologic Type,4
Wilms Tumor,C,C13.351.968.419.473.585,Kidney Neoplasms,Kidney Diseases,4
Wilms Tumor,C,C13.351.937.820.535.585,Kidney Neoplasms,Urologic Neoplasms,4
Wilms Tumor,C,C16.320.700.900,"Neoplastic Syndromes, Hereditary","Genetic Diseases, Inborn",4
Wilms Tumor,C,C12.758.820.750.585,Kidney Neoplasms,Urologic Neoplasms,4
Wilms Tumor,C,C12.777.419.473.585,Kidney Neoplasms,Kidney Diseases,4
Witchcraft,E,E02.190.901.968,Spiritual Therapies,Complementary Therapies,4
Witchcraft,I,I01.076.201.450.897.439.925,Magic,Superstitions,4
"Wounds, Stab",C,C26.986.950,"Wounds, Penetrating",Wounds and Injuries,4
Xanthenes,D,D03.633.300.953,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",4
Xanthine Oxidase,D,D08.811.682.047.928,Alcohol Oxidoreductases,Oxidoreductases,4
Xanthines,D,D03.633.100.759.758.824,Purinones,Purines,4
Xanthines,D,D03.132.960,Alkaloids,Heterocyclic Compounds,4
Xenobiotics,D,D26.969,Pharmaceutical Preparations,NULL,4
Xenograft Model Antitumor Assays,E,E05.624.850,Neoplasm Transplantation,Investigative Techniques,4
Xenograft Model Antitumor Assays,E,E05.337.550.200.900,"Drug Screening Assays, Antitumor","Drug Evaluation, Preclinical",4
X-ray Repair Cross Complementing Protein 1,D,D12.776.660.720.813,Poly-ADP-Ribose Binding Proteins,Nuclear Proteins,4
X-ray Repair Cross Complementing Protein 1,D,D12.776.157.687.813,Poly-ADP-Ribose Binding Proteins,Carrier Proteins,4
X-ray Repair Cross Complementing Protein 1,D,D12.776.260.963,DNA-Binding Proteins,Proteins,4
Yeasts,B,B01.300.930,Fungi,Eukaryota,4
Zinc Fingers,G,G02.111.570.820.709.275.500.985,Amino Acid Motifs,Protein Structural Elements,4
Zoology,H,H01.158.273.943,Biology,Biological Science Disciplines,4
11-beta-Hydroxysteroid Dehydrogenase Type 2,D,D08.811.682.047.436.174.600,11-beta-Hydroxysteroid Dehydrogenases,Hydroxysteroid Dehydrogenases,3
11-beta-Hydroxysteroid Dehydrogenase Type 2,D,D08.811.682.047.820.100.600,11-beta-Hydroxysteroid Dehydrogenases,NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases,3
2-Naphthylamine,D,D04.615.638.850,Naphthalenes,Polycyclic Aromatic Hydrocarbons,3
2-Naphthylamine,D,D02.455.426.559.847.638.850,Naphthalenes,Polycyclic Aromatic Hydrocarbons,3
2-Naphthylamine,D,D02.092.710,Amines,Organic Chemicals,3
A Kinase Anchor Proteins,D,D12.776.157.057.003,"Adaptor Proteins, Signal Transducing",Carrier Proteins,3
A Kinase Anchor Proteins,D,D12.644.360.024.065,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,3
A Kinase Anchor Proteins,D,D12.776.476.024.069,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,3
Abbreviated Injury Scale,N,N05.715.360.300.715.500.800.100,Trauma Severity Indices,Medical Records,3
Abbreviated Injury Scale,N,N04.452.859.564.800.125,Trauma Severity Indices,Medical Records,3
Abbreviated Injury Scale,E,E05.944.250,Trauma Severity Indices,Investigative Techniques,3
Abbreviated Injury Scale,E,E05.318.308.940.968.875.125,Trauma Severity Indices,Medical Records,3
Abbreviations as Topic,L,L01.559.598.400.556.131,Names,Terminology as Topic,3
Abciximab,D,D12.644.541.500.650.125,Immunoglobulin Fab Fragments,Immunoglobulin Fragments,3
Abciximab,D,D12.776.124.790.651.680.650.125,Immunoglobulin Fab Fragments,Immunoglobulin Fragments,3
Abciximab,D,D12.776.124.790.651.114.224.060.125,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",3
Abciximab,D,D12.776.124.486.485.680.650.125,Immunoglobulin Fab Fragments,Immunoglobulin Fragments,3
Abciximab,D,D12.776.124.486.485.114.224.060.125,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",3
Abciximab,D,D12.776.377.715.548.680.650.125,Immunoglobulin Fab Fragments,Immunoglobulin Fragments,3
Abciximab,D,D12.776.377.715.548.114.224.200.125,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",3
"Accidents, Aviation",N,N06.850.135.185,Accidents,Public Health,3
"Accommodation, Ocular",G,G14.010,Ocular Physiological Phenomena,NULL,3
Acetates,D,D10.251.400.045,"Fatty Acids, Volatile",Fatty Acids,3
Acetates,D,D02.241.081.018,"Acids, Acyclic",Carboxylic Acids,3
Acetazolamide,D,D03.383.129.708.867.060,Thiadiazoles,Thiazoles,3
Acetazolamide,D,D02.886.675.867.060,Thiadiazoles,Thiazoles,3
Acetylgalactosamine,D,D09.067.342.356.050,Galactosamine,Hexosamines,3
Acridines,D,D03.633.300.046,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",3
Acrylates,D,D02.241.081.069,"Acids, Acyclic",Carboxylic Acids,3
Actinomycetales Infections,C,C01.150.252.410.040,Gram-Positive Bacterial Infections,Bacterial Infections,3
Actomyosin,D,D12.776.210.500.154,Muscle Proteins,Contractile Proteins,3
Acute Chest Syndrome,C,C08.381.074,Lung Diseases,Respiratory Tract Diseases,3
Acute Chest Syndrome,C,C08.618.009,Respiration Disorders,Respiratory Tract Diseases,3
Acute Chest Syndrome,C,C16.320.365.155.219,"Anemia, Sickle Cell",Hemoglobinopathies,3
Acute Chest Syndrome,C,C16.320.070.150.219,"Anemia, Sickle Cell","Anemia, Hemolytic, Congenital",3
Acute Chest Syndrome,C,C15.378.071.141.150.150.219,"Anemia, Sickle Cell","Anemia, Hemolytic, Congenital",3
Acute Chest Syndrome,C,C15.378.420.155.219,"Anemia, Sickle Cell",Hemoglobinopathies,3
Addison Disease,C,C20.111.163,Autoimmune Diseases,Immune System Diseases,3
Addison Disease,C,C19.053.500.263,Adrenal Insufficiency,Adrenal Gland Diseases,3
"Adenocarcinoma, Follicular",C,C04.557.470.200.025.060,Adenocarcinoma,Carcinoma,3
Adoption,I,I01.880.853.150.140,Family,Sociological Factors,3
ADP-ribosyl Cyclase 1,D,D08.811.277.450.430.400.060.500,ADP-ribosyl Cyclase,NAD+ Nucleosidase,3
ADP-ribosyl Cyclase 1,D,D12.776.543.550.045,Membrane Glycoproteins,Membrane Proteins,3
Adrenal Glands,A,A06.300.071,Endocrine Glands,Endocrine System,3
Adrenarche,G,G08.686.760.204,Puberty,Reproductive Physiological Phenomena,3
Adrenarche,G,G08.686.841.374.204,Puberty,Sexual Development,3
Adrenergic beta-2 Receptor Agonists,D,D27.505.519.625.050.100.200.200,Adrenergic beta-Agonists,Adrenergic Agonists,3
Adrenergic beta-2 Receptor Agonists,D,D27.505.696.577.050.100.200.200,Adrenergic beta-Agonists,Adrenergic Agonists,3
Adrenergic beta-2 Receptor Antagonists,D,D27.505.696.577.050.200.200.200,Adrenergic beta-Antagonists,Adrenergic Antagonists,3
Adrenergic beta-2 Receptor Antagonists,D,D27.505.519.625.050.200.200.200,Adrenergic beta-Antagonists,Adrenergic Antagonists,3
Afghan Campaign 2001-,I,I01.880.735.950.250.094,Armed Conflicts,Warfare and Armed Conflicts,3
Afghan Campaign 2001-,K,K01.400.504.984.124,"History, 21st Century","History, Modern 1601-",3
African Continental Ancestry Group,M,M01.686.508.100,Continental Population Groups,Population Groups,3
Age Determination by Skeleton,E,E01.370.350.700.050,Radiography,Diagnostic Imaging,3
Age Determination by Skeleton,E,E01.370.049,Diagnostic Techniques and Procedures,Diagnosis,3
Ageism,F,F01.829.595.249,Prejudice,"Psychology, Social",3
Ageism,F,F01.145.813.629.500,Social Discrimination,Social Behavior,3
Ageism,F,F01.145.813.550.249,Prejudice,Social Behavior,3
Agranulocytosis,C,C15.378.553.546.184,Leukopenia,Leukocyte Disorders,3
AIDS-Related Complex,C,C20.673.480.080,HIV Infections,Immunologic Deficiency Syndromes,3
AIDS-Related Complex,C,C01.925.813.400.080,HIV Infections,"Sexually Transmitted Diseases, Viral",3
AIDS-Related Complex,C,C01.925.839.080,Slow Virus Diseases,Virus Diseases,3
AIDS-Related Complex,C,C01.925.782.815.616.400.080,HIV Infections,Lentivirus Infections,3
AIDS-Related Complex,C,C01.221.812.640.400.080,HIV Infections,"Sexually Transmitted Diseases, Viral",3
AIDS-Related Complex,C,C01.221.250.875.080,HIV Infections,Blood-Borne Infections,3
AIDS-Related Complex,C,C01.778.640.400.080,HIV Infections,"Sexually Transmitted Diseases, Viral",3
"Air Pollutants, Radioactive",D,D27.888.284.101.393,Air Pollutants,Environmental Pollutants,3
"Air Pollutants, Radioactive",D,D20.693.101,Radioactive Pollutants,Complex Mixtures,3
Alaska,Z,Z01.107.567.875.580.100,Pacific States,United States,3
Alberta,Z,Z01.107.567.176.064,Canada,North America,3
Alcohol Oxidoreductases,D,D08.811.682.047,Oxidoreductases,Enzymes,3
Aldehydes,D,D02.047,Organic Chemicals,NULL,3
Allied Health Occupations,H,H02.010,Health Occupations,NULL,3
Allosteric Regulation,G,G02.111.044,Biochemical Phenomena,Chemical Phenomena,3
alpha-Linolenic Acid,D,D10.251.355.337.100,"Fatty Acids, Omega-3","Fatty Acids, Unsaturated",3
alpha-Linolenic Acid,D,D10.251.355.310.640.400,Linolenic Acids,"Fatty Acids, Essential",3
alpha-Linolenic Acid,D,D10.212.302.380.410.100,"Fatty Acids, Omega-3","Dietary Fats, Unsaturated",3
alpha-Macroglobulins,D,D12.776.377.715.085.100,Alpha-Globulins,Serum Globulins,3
alpha-Macroglobulins,D,D12.776.377.715.647.100,Macroglobulins,Serum Globulins,3
alpha-Macroglobulins,D,D12.776.124.790.106.100,Alpha-Globulins,Serum Globulins,3
alpha-Macroglobulins,D,D12.776.124.050.080,Acute-Phase Proteins,Blood Proteins,3
alpha-Macroglobulins,D,D12.776.124.790.720.100,Macroglobulins,Serum Globulins,3
Alprostadil,D,D10.251.355.325.050,"Fatty Acids, Monounsaturated","Fatty Acids, Unsaturated",3
Alprostadil,D,D10.251.355.255.550.250.100,Prostaglandins E,Prostaglandins,3
Alprostadil,D,D23.469.050.175.725.250.100,Prostaglandins E,Prostaglandins,3
Altitude Sickness,C,C08.618.020,Respiration Disorders,Respiratory Tract Diseases,3
Aluminum Hydroxide,D,D01.248.497.158.459.075,Hydroxides,Anions,3
Aluminum Hydroxide,D,D01.045.250.050,Hydroxides,Alkalies,3
Aluminum Hydroxide,D,D01.056.037,Aluminum Compounds,Inorganic Chemicals,3
Ambulatory Care Information Systems,N,N04.452.515.360.050,Hospital Information Systems,Management Information Systems,3
Ambulatory Care Information Systems,N,N04.452.442.452.452.250,Hospital Information Systems,Hospital Administration,3
Aminobutyrates,D,D02.241.081.114.500,Butyrates,"Acids, Acyclic",3
Aminobutyrates,D,D12.125.190,Amino Acids,"Amino Acids, Peptides, and Proteins",3
Amitriptyline,D,D04.615.181.384.100,Dibenzocycloheptenes,Benzocycloheptenes,3
Amitriptyline,D,D02.455.426.559.847.181.384.100,Dibenzocycloheptenes,Benzocycloheptenes,3
Amphetamines,D,D02.092.471.683.152,Phenethylamines,Ethylamines,3
"Analgesia, Obstetrical",E,E03.091.110,Analgesia,Anesthesia and Analgesia,3
Anaplasmosis,C,C22.085,Animal Diseases,NULL,3
Anaplasmosis,C,C01.150.252.400.054.500,Anaplasmataceae Infections,Gram-Negative Bacterial Infections,3
Anaplasmosis,C,C01.150.252.400.082,Gram-Negative Bacterial Infections,Bacterial Infections,3
Anaplasmosis,C,C01.920.930.163,Tick-Borne Diseases,Vector Borne Diseases,3
"Anastomosis, Surgical",E,E04.035,"Surgical Procedures, Operative",NULL,3
Anastrozole,D,D03.383.129.799.275,Triazoles,Azoles,3
Anastrozole,D,D02.626.218,Nitriles,Organic Chemicals,3
Androgens,D,D27.505.696.399.472.161,Hormones,"Hormones, Hormone Substitutes, and Hormone Antagonists",3
"Anemia, Aplastic",C,C15.378.190.223.250,Bone Marrow Failure Disorders,Bone Marrow Diseases,3
"Anemia, Aplastic",C,C15.378.071.085,Anemia,Hematologic Diseases,3
"Anemia, Hypochromic",C,C15.378.071.196,Anemia,Hematologic Diseases,3
Anencephaly,C,C16.131.666.680.196,Neural Tube Defects,Nervous System Malformations,3
Anencephaly,C,C16.131.085.197,"Abnormalities, Severe Teratoid",Congenital Abnormalities,3
Anencephaly,C,C10.500.680.196,Neural Tube Defects,Nervous System Malformations,3
"Anesthetics, Inhalation",D,D27.505.696.277.100.035.060,"Anesthetics, General",Anesthetics,3
"Anesthetics, Inhalation",D,D27.505.954.427.210.100.035.060,"Anesthetics, General",Anesthetics,3
"Anesthetics, Intravenous",D,D27.505.954.427.210.100.035.075,"Anesthetics, General",Anesthetics,3
"Anesthetics, Intravenous",D,D27.505.696.277.100.035.075,"Anesthetics, General",Anesthetics,3
Aneuploidy,C,C23.550.210.050,Chromosome Aberrations,Pathologic Processes,3
Aneuploidy,G,G05.700.131,Ploidies,Genetic Phenomena,3
Aneuploidy,G,G05.365.590.175.050,Chromosome Aberrations,Mutation,3
"Aneurysm, False",C,C14.907.055.090,Aneurysm,Vascular Diseases,3
"Angioplasty, Balloon",E,E02.148.050.060,Angioplasty,Catheterization,3
"Angioplasty, Balloon",E,E04.100.814.529.124.060,Angioplasty,Endovascular Procedures,3
"Angioplasty, Balloon",E,E04.502.382.124.060,Angioplasty,Endovascular Procedures,3
"Angioplasty, Balloon",E,E05.157.016.060,Angioplasty,Catheterization,3
Anistreplase,D,D08.811.277.656.959.350.635.075,Plasminogen Activators,Serine Endopeptidases,3
Anistreplase,D,D08.811.277.656.300.775.075,Streptokinase,Endopeptidases,3
Anistreplase,D,D08.811.277.656.300.760.635.075,Plasminogen Activators,Serine Endopeptidases,3
Anistreplase,D,D12.776.124.125.662.537.075,Streptokinase,Plasminogen Activators,3
Ankle Fractures,C,C26.404.014,"Fractures, Bone",Wounds and Injuries,3
Ankle Joint,A,A02.835.583.378.062,Foot Joints,Joints,3
Anorexia,C,C23.888.821.108,"Signs and Symptoms, Digestive",Signs and Symptoms,3
Antibiosis,G,G06.550.050,Microbial Interactions,Microbiological Phenomena,3
Antibiosis,G,G16.062,Biological Phenomena,NULL,3
"Antibodies, Antiphospholipid",D,D12.776.124.486.485.114.323.210,Autoantibodies,Antibodies,3
"Antibodies, Antiphospholipid",D,D12.776.124.790.651.114.323.210,Autoantibodies,Antibodies,3
"Antibodies, Antiphospholipid",D,D12.776.377.715.548.114.323.210,Autoantibodies,Antibodies,3
"Antibodies, Fungal",D,D12.776.377.715.548.114.179,Antibodies,Immunoglobulins,3
"Antibodies, Fungal",D,D12.776.124.790.651.114.179,Antibodies,Immunoglobulins,3
"Antibodies, Fungal",D,D12.776.124.486.485.114.179,Antibodies,Immunoglobulins,3
Antidiarrheals,D,D27.505.954.483.161,Gastrointestinal Agents,Therapeutic Uses,3
"Antigens, CD1",D,D23.101.100.894.080,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",3
"Antigens, CD1",D,D23.101.100.110.100,"Antigens, CD","Antigens, Differentiation",3
"Antigens, CD1",D,D23.050.301.264.035.100,"Antigens, CD","Antigens, Differentiation",3
"Antigens, CD1",D,D23.050.301.264.894.080,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",3
"Antigens, CD20",D,D23.050.301.264.051.120,"Antigens, Differentiation, B-Lymphocyte","Antigens, Differentiation",3
"Antigens, CD20",D,D23.050.301.264.035.120,"Antigens, CD","Antigens, Differentiation",3
"Antigens, CD20",D,D23.101.100.110.120,"Antigens, CD","Antigens, Differentiation",3
"Antigens, CD20",D,D23.101.100.150.120,"Antigens, Differentiation, B-Lymphocyte","Antigens, Differentiation",3
"Antigens, Differentiation, Myelomonocytic",D,D23.101.100.900,"Antigens, Differentiation",Biomarkers,3
"Antigens, Differentiation, Myelomonocytic",D,D23.050.301.264.900,"Antigens, Differentiation","Antigens, Surface",3
"Antigens, Ly",D,D23.050.301.264.920,"Antigens, Differentiation","Antigens, Surface",3
"Antigens, Ly",D,D23.101.100.920,"Antigens, Differentiation",Biomarkers,3
"Antigens, Plant",D,D23.050.291,Antigens,Biological Factors,3
"Antigens, Viral, Tumor",D,D23.050.285.062,"Antigens, Neoplasm",Antigens,3
"Antigens, Viral, Tumor",D,D23.050.327.062,"Antigens, Viral",Antigens,3
"Anti-Infective Agents, Urinary",D,D27.505.954.613.056,Renal Agents,Therapeutic Uses,3
"Anti-Infective Agents, Urinary",D,D27.505.954.122.237,Anti-Infective Agents,Therapeutic Uses,3
"Antimetabolites, Antineoplastic",D,D27.505.954.248.144,Antineoplastic Agents,Therapeutic Uses,3
"Antimetabolites, Antineoplastic",D,D27.505.519.186.144,Antimetabolites,Molecular Mechanisms of Pharmacological Action,3
"Antimetabolites, Antineoplastic",D,D27.888.569.042.030,Antimetabolites,Noxae,3
Antiplatyhelmintic Agents,D,D27.505.954.122.250.075.100,Anthelmintics,Antiparasitic Agents,3
Antisepsis,N,N06.850.780.200.450.150,Infection Control,Communicable Disease Control,3
Antithrombin III,D,D23.113.025,Blood Coagulation Factor Inhibitors,Biological Factors,3
Antithrombin III,D,D12.776.872.060.500,Antithrombin Proteins,Serpins,3
Antithrombin III,D,D12.776.124.790.106.125,Alpha-Globulins,Serum Globulins,3
Antithrombin III,D,D12.644.861.060.500,Antithrombin Proteins,Serpins,3
Antithrombin III,D,D12.776.377.715.085.125,Alpha-Globulins,Serum Globulins,3
Anura,B,B01.050.150.900.090.180,Amphibians,Vertebrates,3
Anus Diseases,C,C06.405.469.860.101,Rectal Diseases,Intestinal Diseases,3
Apatites,D,D01.146.360.050,Calcium Phosphates,Calcium Compounds,3
Apatites,D,D01.029.260.700.675.374.075.025,Calcium Phosphates,Phosphates,3
Apatites,D,D01.695.625.675.650.075.025,Calcium Phosphates,Phosphates,3
Apatites,D,D01.578.122,Minerals,Inorganic Chemicals,3
Apnea,C,C23.888.852.130,"Signs and Symptoms, Respiratory",Signs and Symptoms,3
Apnea,C,C08.618.085,Respiration Disorders,Respiratory Tract Diseases,3
Apolipoprotein A-V,D,D12.776.070.400.200.575,Apolipoproteins A,Apolipoproteins,3
Apolipoprotein A-V,D,D10.532.091.200.575,Apolipoproteins A,Apolipoproteins,3
Apolipoprotein A-V,D,D12.776.521.120.200.575,Apolipoproteins A,Apolipoproteins,3
Appetite Regulation,G,G10.261.390.070.290,Appetite,Hunger,3
Appetite Regulation,G,G07.203.650.170,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",3
Appetite Regulation,G,G07.203.650.390.070.290,Appetite,Hunger,3
Arsphenamine,D,D02.129.050,Arsenicals,Organic Chemicals,3
Artemisia annua,B,B01.650.940.800.575.912.250.100.100.144,Artemisia,Asteraceae,3
"Arthroplasty, Replacement",E,E04.555.110.110,Arthroplasty,Orthopedic Procedures,3
"Arthroplasty, Replacement",E,E04.650.110,Prosthesis Implantation,"Surgical Procedures, Operative",3
"Arthroplasty, Replacement",E,E04.680.101.110,Arthroplasty,Reconstructive Surgical Procedures,3
"Asbestos, Amosite",D,D01.578.725.050.050.050,"Asbestos, Amphibole",Asbestos,3
"Asbestos, Amosite",D,D01.524.500.040,Magnesium Silicates,Magnesium Compounds,3
"Asbestos, Amosite",D,D01.578.725.500.040,Magnesium Silicates,Silicates,3
"Asbestos, Amosite",D,D01.837.725.700.760.535.040,Magnesium Silicates,Silicates,3
"Asbestos, Amosite",D,D01.837.725.700.760.070.050.060,"Asbestos, Amphibole",Asbestos,3
Ascaris suum,B,B01.050.500.500.294.400.500.100.108.700,Ascaris,Ascaridoidea,3
Ascites,C,C23.550.081,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",3
Asparaginase,D,D08.811.277.087.116,Amidohydrolases,Hydrolases,3
Asperger Syndrome,F,F03.625.164.113.250,Autism Spectrum Disorder,"Child Development Disorders, Pervasive",3
"Aspirations, Psychological",F,F02.784.629.155,"Psychology, Educational","Psychology, Applied",3
"Aspirations, Psychological",F,F01.658.100,Motivation,Behavior and Behavior Mechanisms,3
Ataxia,C,C23.888.592.350.090,Dyskinesias,Neurologic Manifestations,3
Ataxia,C,C10.597.350.090,Dyskinesias,Neurologic Manifestations,3
"ATP Binding Cassette Transporter, Subfamily B, Member 11",D,D12.776.157.530.450.074.500.500.250.438,"ATP Binding Cassette Transporter, Subfamily B","Organic Anion Transporters, ATP-Dependent",3
"ATP Binding Cassette Transporter, Subfamily B, Member 11",D,D12.776.157.530.100.075.125,"ATP Binding Cassette Transporter, Subfamily B",ATP-Binding Cassette Transporters,3
"ATP Binding Cassette Transporter, Subfamily B, Member 11",D,D12.776.395.550.020.400.534,"ATP Binding Cassette Transporter, Subfamily B",ATP-Binding Cassette Transporters,3
"ATP Binding Cassette Transporter, Subfamily B, Member 11",D,D12.776.543.550.192.400.534,"ATP Binding Cassette Transporter, Subfamily B",ATP-Binding Cassette Transporters,3
"ATP Binding Cassette Transporter, Subfamily B, Member 11",D,D12.776.543.585.100.200.438,"ATP Binding Cassette Transporter, Subfamily B",ATP-Binding Cassette Transporters,3
"ATP Binding Cassette Transporter, Subfamily B, Member 11",D,D12.776.543.585.450.074.500.500.250.438,"ATP Binding Cassette Transporter, Subfamily B","Organic Anion Transporters, ATP-Dependent",3
Atrial Flutter,C,C14.280.067.248,"Arrhythmias, Cardiac",Heart Diseases,3
Atrial Flutter,C,C23.550.073.248,"Arrhythmias, Cardiac",Pathologic Processes,3
Attention Deficit and Disruptive Behavior Disorders,F,F03.625.094,Neurodevelopmental Disorders,Mental Disorders,3
Audiology,H,H02.010.150,Allied Health Occupations,Health Occupations,3
Auditory Threshold,F,F02.463.593.710.190,Sensory Thresholds,Perception,3
Auditory Threshold,F,F02.463.593.071.173,Auditory Perception,Perception,3
Auditory Threshold,G,G07.888.125.173,Auditory Perception,Vestibulocochlear Physiological Phenomena,3
Aurora Kinases,D,D12.776.167.049,Cell Cycle Proteins,Proteins,3
Aurora Kinases,D,D08.811.913.696.620.682.700.103,Protein-Serine-Threonine Kinases,Protein Kinases,3
Authoritarianism,F,F01.752.098,Personality,Behavior and Behavior Mechanisms,3
Autophagy-Related Proteins,D,D12.776.094,Proteins,"Amino Acids, Peptides, and Proteins",3
Awards and Prizes,K,K01.150,Humanities,NULL,3
Azabicyclo Compounds,D,D03.605.084.500,"Bridged Bicyclo Compounds, Heterocyclic","Heterocyclic Compounds, Bridged-Ring",3
Azabicyclo Compounds,D,D02.145.074,Aza Compounds,Organic Chemicals,3
Azetidines,D,D03.383.082.301,Azetines,"Heterocyclic Compounds, 1-Ring",3
Azoles,D,D03.383.129,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,3
Bacillus anthracis,B,B03.300.390.400.158.218.151,Bacillus,Bacillaceae,3
Bacillus anthracis,B,B03.353.500.100.218.151,Bacillus,Bacillaceae,3
Bacillus anthracis,B,B03.510.100.100.218.151,Bacillus,Bacillaceae,3
Bacillus anthracis,B,B03.510.460.410.158.218.151,Bacillus,Bacillaceae,3
Bacillus anthracis,B,B03.510.415.400.158.218.151,Bacillus,Bacillaceae,3
"Bacteria, Anaerobic",B,B03.130,Bacteria,NULL,3
Bacteriophage lambda,B,B04.123.150.800.230,Siphoviridae,Caudovirales,3
Bacteriophage lambda,B,B04.123.205.230,Coliphages,Bacteriophages,3
Bacteriophage lambda,B,B04.280.090.800.230,Siphoviridae,Caudovirales,3
Barbiturates,D,D03.383.742.698.253,Pyrimidinones,Pyrimidines,3
Bartonella bacilliformis,B,B03.660.050.030.040.080,Bartonella,Bartonellaceae,3
Bartonella bacilliformis,B,B03.440.090.100.080,Bartonella,Bartonellaceae,3
Bartonella Infections,C,C01.150.252.400.126.100,Bartonellaceae Infections,Gram-Negative Bacterial Infections,3
Base Pairing,G,G02.111.611.500,Nucleic Acid Hybridization,Biochemical Phenomena,3
Base Pairing,G,G02.111.570.820.486.100,Nucleic Acid Conformation,Molecular Conformation,3
Base Pairing,G,G05.360.580.100,Nucleic Acid Conformation,Genetic Structures,3
Bathroom Equipment,E,E07.108,Equipment and Supplies,NULL,3
Beauveria,B,B01.300.381.103,Mitosporic Fungi,Fungi,3
Beauveria,B,B01.300.107.501.100,Hypocreales,Ascomycota,3
Beclomethasone,D,D04.210.500.883.154,"Steroids, Chlorinated",Steroids,3
Beclomethasone,D,D04.210.500.745.432.769.125,Pregnadienetriols,Pregnadienes,3
Behavioral Symptoms,F,F01.145.126,Behavior,Behavior and Behavior Mechanisms,3
Belize,Z,Z01.107.169.133,Central America,Americas,3
Benzenesulfonates,D,D02.886.645.600.080.050.100,Arylsulfonates,Arylsulfonic Acids,3
Benzenesulfonates,D,D02.455.426.559.389.097,Benzene Derivatives,"Hydrocarbons, Aromatic",3
Benzodioxoles,D,D03.633.100.115,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",3
Benzodioxoles,D,D03.383.246.118,Dioxoles,"Heterocyclic Compounds, 1-Ring",3
Benzofurans,D,D03.633.100.127,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",3
Benzoquinones,D,D02.806.250,Quinones,Organic Chemicals,3
beta-Cyclodextrins,D,D04.345.103.333,Cyclodextrins,Macrocyclic Compounds,3
beta-Cyclodextrins,D,D09.301.915.400.375.333,Cyclodextrins,Dextrins,3
beta-Cyclodextrins,D,D09.698.365.855.400.375.333,Cyclodextrins,Dextrins,3
Betaproteobacteria,B,B03.660.075,Proteobacteria,Bacteria,3
Biological Clocks,G,G07.180.562.094,Periodicity,Chronobiology Phenomena,3
Biological Science Disciplines,H,H01.158,Natural Science Disciplines,NULL,3
Biological Therapy,E,E02.095,Therapeutics,NULL,3
Blood Component Transfusion,E,E02.095.135.140,Blood Transfusion,Biological Therapy,3
"Blood Transfusion, Autologous",E,E02.095.135.164,Blood Transfusion,Biological Therapy,3
Blood Urea Nitrogen,E,E01.370.390.400.100,Kidney Function Tests,"Diagnostic Techniques, Urological",3
Blood Urea Nitrogen,E,E01.370.225.124.100.115,Blood Chemical Analysis,Clinical Chemistry Tests,3
Blood Urea Nitrogen,E,E05.200.124.100.115,Blood Chemical Analysis,Clinical Chemistry Tests,3
Blood Vessel Prosthesis,E,E07.695.110,Prostheses and Implants,Equipment and Supplies,3
Body Piercing,E,E04.085.090,"Body Modification, Non-Therapeutic","Surgical Procedures, Operative",3
Body Piercing,E,E02.218.085.090,"Body Modification, Non-Therapeutic",Cosmetic Techniques,3
Body Surface Area,E,E01.370.600.115.100.231,Body Weights and Measures,Body Constitution,3
Body Surface Area,E,E05.041.124.231,Body Weights and Measures,Anthropometry,3
Body Surface Area,G,G07.100.100.231,Body Weights and Measures,Body Constitution,3
Borderline Personality Disorder,F,F03.675.100,Personality Disorders,Mental Disorders,3
Bordetella,B,B03.660.075.090.344.425,Alcaligenaceae,Burkholderiales,3
Bordetella,B,B03.440.400.425.115.425,Alcaligenaceae,Gram-Negative Aerobic Rods and Cocci,3
Brain Infarction,C,C23.550.513.355.250,Infarction,Ischemia,3
Brain Infarction,C,C23.550.717.489.250,Infarction,Necrosis,3
Brain Infarction,C,C14.907.253.092.477,Brain Ischemia,Cerebrovascular Disorders,3
Brain Infarction,C,C14.907.253.855.200,Stroke,Cerebrovascular Disorders,3
Brain Infarction,C,C10.228.140.300.150.477,Brain Ischemia,Cerebrovascular Disorders,3
Brain Infarction,C,C10.228.140.300.775.200,Stroke,Cerebrovascular Disorders,3
Brassica,B,B01.650.940.800.575.912.250.157.200,Brassicaceae,Magnoliopsida,3
Breast Implants,E,E07.695.140,Prostheses and Implants,Equipment and Supplies,3
Breech Presentation,G,G08.686.520.150,Labor Presentation,Reproductive Physiological Phenomena,3
Breech Presentation,G,G08.686.784.769.326.520.150,Labor Presentation,"Labor, Obstetric",3
Breech Presentation,C,C13.703.420.183,Obstetric Labor Complications,Pregnancy Complications,3
Buffers,D,D27.720.470.280,Laboratory Chemicals,Specialty Uses of Chemicals,3
Bunyaviridae Infections,C,C01.925.782.147,RNA Virus Infections,Virus Diseases,3
Burial,I,I01.076.201.450.550.150,Funeral Rites,Culture,3
Burkholderia cenocepacia,B,B03.660.075.090.688.100.110.490,Burkholderia cepacia complex,Burkholderia,3
"Burns, Chemical",C,C26.200.156,Burns,Wounds and Injuries,3
Butadienes,D,D02.455.326.271.665.146.240,Alkadienes,Polyenes,3
Butanols,D,D02.033.415.110,Fatty Alcohols,Alcohols,3
Butanols,D,D10.289.110,Fatty Alcohols,Lipids,3
Calcimycin,D,D03.633.100.221.173,Benzoxazoles,"Heterocyclic Compounds, 2-Ring",3
Calcium Channels,D,D12.776.157.530.400.150,Ion Channels,Membrane Transport Proteins,3
Calcium Channels,D,D12.776.543.585.400.150,Ion Channels,Membrane Transport Proteins,3
Calcium Channels,D,D12.776.543.550.450.150,Ion Channels,Membrane Glycoproteins,3
"Calcium Channels, L-Type",D,D12.776.543.550.450.150.400,Calcium Channels,Ion Channels,3
"Calcium Channels, L-Type",D,D12.776.543.585.400.150.400,Calcium Channels,Ion Channels,3
"Calcium Channels, L-Type",D,D12.776.157.530.400.150.400,Calcium Channels,Ion Channels,3
Calmodulin,D,D12.776.157.125.412.249,Intracellular Calcium-Sensing Proteins,Calcium-Binding Proteins,3
Calmodulin,D,D12.644.360.372.249,Intracellular Calcium-Sensing Proteins,Intracellular Signaling Peptides and Proteins,3
Calmodulin,D,D12.776.476.387.249,Intracellular Calcium-Sensing Proteins,Intracellular Signaling Peptides and Proteins,3
Cannabidiol,D,D02.455.849.090.100,Cannabinoids,Terpenes,3
Cannula,E,E07.132.125,Catheters,Equipment and Supplies,3
Capitalism,I,I01.261.100,Economics,Social Sciences,3
Capitalism,I,I01.696.100,Political Systems,Social Sciences,3
Carbonates,D,D01.045.125,Alkalies,Inorganic Chemicals,3
Carbonates,D,D01.248.497.158.165,Anions,Ions,3
Carbonates,D,D01.200.275.150,Carbonic Acid,"Carbon Compounds, Inorganic",3
Carboxylic Ester Hydrolases,D,D08.811.277.352.100,Esterases,Hydrolases,3
Carcinoid Tumor,C,C04.557.470.200.025.200,Adenocarcinoma,Carcinoma,3
Carcinoid Tumor,C,C04.557.465.625.650.200,Neuroendocrine Tumors,Neuroectodermal Tumors,3
Carcinoid Tumor,C,C04.557.580.625.650.200,Neuroendocrine Tumors,Neuroectodermal Tumors,3
"Carcinoma, Pancreatic Ductal",C,C04.588.274.761.750,Pancreatic Neoplasms,Digestive System Neoplasms,3
"Carcinoma, Pancreatic Ductal",C,C04.557.470.615.132.750,"Carcinoma, Ductal","Neoplasms, Ductal, Lobular, and Medullary",3
"Carcinoma, Pancreatic Ductal",C,C04.557.470.200.025.232.750,"Carcinoma, Ductal",Adenocarcinoma,3
"Carcinoma, Pancreatic Ductal",C,C06.301.761.750,Pancreatic Neoplasms,Digestive System Neoplasms,3
"Carcinoma, Pancreatic Ductal",C,C06.689.667.625,Pancreatic Neoplasms,Pancreatic Diseases,3
"Carcinoma, Pancreatic Ductal",C,C04.588.322.475.750,Pancreatic Neoplasms,Endocrine Gland Neoplasms,3
"Carcinoma, Pancreatic Ductal",C,C19.344.421.750,Pancreatic Neoplasms,Endocrine Gland Neoplasms,3
"Carcinoma, Transitional Cell",C,C04.557.470.200.430,Carcinoma,"Neoplasms, Glandular and Epithelial",3
Cardiac Imaging Techniques,E,E01.370.350.130,Diagnostic Imaging,Diagnostic Techniques and Procedures,3
Cardiotoxicity,C,C23.550.161,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",3
Cardiotoxicity,C,C26.733.266,Radiation Injuries,Wounds and Injuries,3
Cardiotoxicity,C,C25.100.389,Drug-Related Side Effects and Adverse Reactions,Chemically-Induced Disorders,3
Cardiotoxicity,C,C14.280.260,Heart Diseases,Cardiovascular Diseases,3
Cardiotoxicity,G,G01.750.748.500.266,Radiation Injuries,Radiation Exposure,3
Carmustine,D,D02.065.950.594.247,Nitrosourea Compounds,Urea,3
Carmustine,D,D02.654.692.247,Nitrosourea Compounds,Nitroso Compounds,3
Carnitine O-Palmitoyltransferase,D,D08.811.913.050.350.200,Carnitine Acyltransferases,Acyltransferases,3
Carnivora,B,B01.050.150.900.649.313.750,Eutheria,Mammals,3
"Carotid Artery, Internal",A,A07.015.114.186.200.230,"Carotid Artery, Common",Carotid Arteries,3
Carpal Tunnel Syndrome,C,C26.844.150.206,Cumulative Trauma Disorders,Sprains and Strains,3
Carpal Tunnel Syndrome,C,C10.668.829.500.500.200,Median Neuropathy,Mononeuropathies,3
Carpal Tunnel Syndrome,C,C10.668.829.550.200,Nerve Compression Syndromes,Peripheral Nervous System Diseases,3
Carps,B,B01.050.150.900.493.200.244.248,Cyprinidae,Cypriniformes,3
Caseins,D,D12.776.256.159.750.207,Milk Proteins,"Animal Proteins, Dietary",3
Caseins,D,D12.776.744.150,Phosphoproteins,Proteins,3
Catechin,D,D03.633.100.150.240.190,Chromans,Benzopyrans,3
Catechin,D,D03.633.100.150.266.450.206,Flavonoids,Chromones,3
Catechin,D,D03.383.663.283.240.190,Chromans,Benzopyrans,3
Catechin,D,D03.383.663.283.266.450.206,Flavonoids,Chromones,3
Cathepsin H,D,D08.811.277.656.262.500.153,Cysteine Endopeptidases,Cysteine Proteases,3
Cathepsin H,D,D08.811.277.656.224.400,Cathepsins,Peptide Hydrolases,3
Cathepsin H,D,D08.811.277.656.300.200.153,Cysteine Endopeptidases,Endopeptidases,3
Cathepsin H,D,D23.050.705.552.600.300,Minor Histocompatibility Antigens,Histocompatibility Antigens,3
Cathepsin H,D,D23.050.301.500.600.300,Minor Histocompatibility Antigens,Histocompatibility Antigens,3
"Catheterization, Peripheral",E,E02.148.224,Catheterization,Therapeutics,3
"Catheterization, Peripheral",E,E05.157.375,Catheterization,Investigative Techniques,3
"Catheterization, Peripheral",E,E04.100.814.529.937,Endovascular Procedures,Vascular Surgical Procedures,3
"Catheterization, Peripheral",E,E04.502.382.937,Endovascular Procedures,Minimally Invasive Surgical Procedures,3
Cations,D,D01.248.497.300,Ions,Electrolytes,3
CD11b Antigen,D,D23.050.301.350.074.049,CD11 Antigens,Cell Adhesion Molecules,3
CD11b Antigen,D,D12.776.543.550.200.093.750,CD11 Antigens,Cell Adhesion Molecules,3
CD11b Antigen,D,D12.776.543.750.705.833.062,"Receptors, Complement","Receptors, Immunologic",3
CD11b Antigen,D,D12.776.543.750.705.408.100.150,Integrin alpha Chains,Integrins,3
CD11b Antigen,D,D12.776.395.550.200.074.750,CD11 Antigens,Cell Adhesion Molecules,3
CD57 Antigens,D,D23.050.301.264.894.157,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",3
CD57 Antigens,D,D23.101.100.894.157,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",3
CDC2 Protein Kinase,D,D12.776.744.360,Phosphoproteins,Proteins,3
CDC2 Protein Kinase,D,D12.776.476.250.067.249,CDC2-CDC28 Kinases,Cyclin-Dependent Kinases,3
CDC2 Protein Kinase,D,D12.776.476.250.580.500,Maturation-Promoting Factor,Cyclin-Dependent Kinases,3
CDC2 Protein Kinase,D,D12.776.167.200.067.249,CDC2-CDC28 Kinases,Cyclin-Dependent Kinases,3
CDC2 Protein Kinase,D,D12.776.167.200.580.500,Maturation-Promoting Factor,Cyclin-Dependent Kinases,3
CDC2 Protein Kinase,D,D12.644.360.250.580.500,Maturation-Promoting Factor,Cyclin-Dependent Kinases,3
CDC2 Protein Kinase,D,D12.644.360.250.067.249,CDC2-CDC28 Kinases,Cyclin-Dependent Kinases,3
CDC2 Protein Kinase,D,D08.811.913.696.620.682.700.646.500.500.250,CDC2-CDC28 Kinases,Cyclin-Dependent Kinases,3
CDC2 Protein Kinase,D,D08.811.913.696.620.682.700.646.500.984.500,Maturation-Promoting Factor,Cyclin-Dependent Kinases,3
cdc42 GTP-Binding Protein,D,D12.644.360.525.700.050,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,3
cdc42 GTP-Binding Protein,D,D12.776.157.325.515.700.050,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,3
cdc42 GTP-Binding Protein,D,D08.811.277.040.330.300.400.700.050,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,3
cdc42 GTP-Binding Protein,D,D12.776.476.525.700.050,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,3
CD-ROM,J,J01.897.280.500.898.800.250.200,Compact Disks,Videodisc Recording,3
CD-ROM,L,L01.280.960.800.250.200,Compact Disks,Videodisc Recording,3
CD-ROM,L,L01.224.230.260.115.475.600.325.750,Compact Disks,Optical Storage Devices,3
CD-ROM,L,L01.178.590.875.800.250.200,Compact Disks,Videodisc Recording,3
CD-ROM,L,L01.178.820.090.668.800.250.200,Compact Disks,Videodisc Recording,3
CD-ROM,L,L01.178.820.090.898.800.250.200,Compact Disks,Videodisc Recording,3
CD-ROM,J,J01.897.280.500.668.800.250.200,Compact Disks,Videodisc Recording,3
Cefuroxime,D,D03.633.100.300.249.188,Cephalosporins,beta-Lactams,3
Cefuroxime,D,D02.886.665.074.188,Cephalosporins,Thiazines,3
Cefuroxime,D,D02.065.589.099.249.188,Cephalosporins,beta-Lactams,3
Cell Cycle Checkpoints,G,G04.144.109,Cell Cycle,Cell Physiological Phenomena,3
Cell Migration Inhibition,G,G04.198.337,Cell Movement,Cell Physiological Phenomena,3
Cell Tracking,E,E05.200.500.373,Cytological Techniques,Clinical Laboratory Techniques,3
Cell Tracking,E,E05.242.373,Cytological Techniques,Investigative Techniques,3
Cell Tracking,E,E01.370.350.557.500,Molecular Imaging,Diagnostic Imaging,3
Cell Tracking,E,E01.370.225.500.373,Cytological Techniques,Clinical Laboratory Techniques,3
"Cell Transformation, Neoplastic",C,C23.550.727.098.500,Carcinogenesis,Neoplastic Processes,3
"Cell Transformation, Neoplastic",C,C04.697.098.500,Carcinogenesis,Neoplastic Processes,3
Cellulitis,C,C01.830.200,Suppuration,Infections,3
Cellulitis,C,C01.800.130,"Skin Diseases, Infectious",Infections,3
Cellulitis,C,C23.550.470.756.200,Suppuration,Inflammation,3
Cellulitis,C,C17.300.185,Connective Tissue Diseases,Skin and Connective Tissue Diseases,3
Central Nervous System Agents,D,D27.505.954.427,Therapeutic Uses,Pharmacologic Actions,3
Central Nervous System Viral Diseases,C,C10.228.228.245,Central Nervous System Infections,Central Nervous System Diseases,3
Central Nervous System Viral Diseases,C,C01.207.245,Central Nervous System Infections,Infections,3
Central Nervous System Viral Diseases,C,C01.925.182,Virus Diseases,Infections,3
Cerebellar Cortex,A,A08.186.211.132.810.428.200.212,Cerebellum,Metencephalon,3
Cerebral Amyloid Angiopathy,C,C10.228.140.300.510.200.200,Cerebral Arterial Diseases,Intracranial Arterial Diseases,3
Cerebral Amyloid Angiopathy,C,C14.907.253.560.200.200,Cerebral Arterial Diseases,Intracranial Arterial Diseases,3
Cerebral Amyloid Angiopathy,C,C18.452.845.500.100,Amyloidosis,Proteostasis Deficiencies,3
Cerebral Small Vessel Diseases,C,C14.907.253.329,Cerebrovascular Disorders,Vascular Diseases,3
Cerebral Small Vessel Diseases,C,C10.228.140.300.275,Cerebrovascular Disorders,Brain Diseases,3
Ceremonial Behavior,F,F01.145.813.097,Social Behavior,Behavior,3
Ceremonial Behavior,I,I01.076.201.450.170,Culture,"Anthropology, Cultural",3
Cervical Ripening,G,G08.686.784.769.326.100,"Labor, Obstetric",Pregnancy,3
Chalcone,D,D02.522.818.222.500,Chalcones,Propiophenones,3
Chalcone,D,D03.633.100.150.266.450.221.500,Chalcones,Flavonoids,3
Cheek,A,A01.456.505.173,Face,Head,3
Cheek,A,A14.194,Stomatognathic System,NULL,3
Cheese,G,G07.203.200.500.444,Cultured Milk Products,Fermented Foods and Beverages,3
Cheese,G,G07.203.300.350.300.444,Cultured Milk Products,Dairy Products,3
Cheese,J,J02.500.350.300.444,Cultured Milk Products,Dairy Products,3
Cheese,J,J02.350.500.444,Cultured Milk Products,Fermented Foods and Beverages,3
Chemical Fractionation,E,E05.196.155,"Chemistry Techniques, Analytical",Investigative Techniques,3
Chemical Warfare,I,I01.880.735.950.500.340,Warfare,Warfare and Armed Conflicts,3
"Chemistry, Physical",H,H01.181.529,Chemistry,Natural Science Disciplines,3
Child Protective Services,I,I01.409.418.500,Government Agencies,Government,3
Child Protective Services,N,N03.540.400.500,Government Agencies,Organizations,3
Chimera,B,B05.200,Organism Forms,NULL,3
Chlamydiaceae Infections,C,C01.150.252.400.210,Gram-Negative Bacterial Infections,Bacterial Infections,3
Chlorophyll,D,D03.633.400.909.374,Tetrapyrroles,"Heterocyclic Compounds, 4 or More Rings",3
Chlorophyll,D,D03.383.129.578.840.374,Tetrapyrroles,Pyrroles,3
Chlorophyll,D,D04.345.783.374,Tetrapyrroles,Macrocyclic Compounds,3
Chlorophyll A,D,D04.345.783.374.140,Chlorophyll,Tetrapyrroles,3
Chlorophyll A,D,D03.383.129.578.840.374.140,Chlorophyll,Tetrapyrroles,3
Chlorophyll A,D,D03.633.400.909.374.140,Chlorophyll,Tetrapyrroles,3
Cholangiocarcinoma,C,C04.557.470.200.025.450,Adenocarcinoma,Carcinoma,3
Cholesterol Ester Transfer Proteins,D,D12.776.157.165,Carrier Proteins,Proteins,3
Cholesterol Ester Transfer Proteins,D,D12.776.124.197,Blood Proteins,Proteins,3
Cholesterol Ester Transfer Proteins,D,D12.776.395.199,Glycoproteins,Proteins,3
Cholesterol Ester Transfer Proteins,D,D09.400.430.750,Glycoproteins,Glycoconjugates,3
Cholinergic Antagonists,D,D27.505.696.577.120.200,Cholinergic Agents,Neurotransmitter Agents,3
Cholinergic Antagonists,D,D27.505.519.625.120.200,Cholinergic Agents,Neurotransmitter Agents,3
Chorioamnionitis,C,C13.703.420.339.260,"Fetal Membranes, Premature Rupture",Obstetric Labor Complications,3
Chorioamnionitis,C,C13.703.590.268,Placenta Diseases,Pregnancy Complications,3
Chorioamnionitis,C,C13.703.277.030,Fetal Diseases,Pregnancy Complications,3
Chorioamnionitis,C,C16.300.030,Fetal Diseases,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",3
"Chorionic Gonadotropin, beta Subunit, Human",D,D23.101.175,Biomarkers,Biological Factors,3
"Chorionic Gonadotropin, beta Subunit, Human",D,D23.101.140.325,"Biomarkers, Tumor",Biomarkers,3
"Chorionic Gonadotropin, beta Subunit, Human",D,D12.776.780.400.125,Chorionic Gonadotropin,Pregnancy Proteins,3
"Chorionic Gonadotropin, beta Subunit, Human",D,D12.644.548.726.367.125,Chorionic Gonadotropin,Placental Hormones,3
"Chorionic Gonadotropin, beta Subunit, Human",D,D06.472.699.322.326.125,Chorionic Gonadotropin,Gonadotropins,3
"Chorionic Gonadotropin, beta Subunit, Human",D,D06.472.699.649.367.125,Chorionic Gonadotropin,Placental Hormones,3
"Chromatography, Agarose",E,E05.196.181.400.250.200,"Chromatography, Gel","Chromatography, Liquid",3
Chromoblastomycosis,C,C17.800.838.208.241,Dermatomycoses,"Skin Diseases, Infectious",3
Chromoblastomycosis,C,C01.150.703.302.110,Dermatomycoses,Mycoses,3
Chromoblastomycosis,C,C01.800.200.110,Dermatomycoses,"Skin Diseases, Infectious",3
"Chromosomes, Artificial, Yeast",A,A19.311.800,"Chromosomes, Fungal",Fungal Structures,3
"Chromosomes, Artificial, Yeast",A,A11.284.187.178.200,"Chromosomes, Artificial",Chromosomes,3
"Chromosomes, Artificial, Yeast",A,A11.284.187.360.800,"Chromosomes, Fungal",Chromosomes,3
"Chromosomes, Artificial, Yeast",G,G05.360.337.249.200,"Chromosomes, Artificial",Genetic Vectors,3
"Chromosomes, Artificial, Yeast",G,G05.360.162.360.800,"Chromosomes, Fungal",Chromosomes,3
"Chromosomes, Artificial, Yeast",G,G05.360.162.178.200,"Chromosomes, Artificial",Chromosomes,3
"Chromosomes, Human, Pair 1",G,G05.360.162.520.300.235.240,"Chromosomes, Human, 1-3","Chromosomes, Human",3
"Chromosomes, Human, Pair 1",A,A11.284.187.520.300.235.240,"Chromosomes, Human, 1-3","Chromosomes, Human",3
"Chromosomes, Human, Pair 15",A,A11.284.187.520.300.370.385,"Chromosomes, Human, 13-15","Chromosomes, Human",3
"Chromosomes, Human, Pair 15",G,G05.360.162.520.300.370.385,"Chromosomes, Human, 13-15","Chromosomes, Human",3
"Chromosomes, Human, Pair 22",G,G05.360.162.520.300.505.515,"Chromosomes, Human, 21-22 and Y","Chromosomes, Human",3
"Chromosomes, Human, Pair 22",A,A11.284.187.520.300.505.515,"Chromosomes, Human, 21-22 and Y","Chromosomes, Human",3
Ciliary Body,A,A09.371.894.280,Uvea,Eye,3
Ciliary Body,A,A09.371.060.160,Anterior Eye Segment,Eye,3
Cinacalcet,D,D04.615.638.183,Naphthalenes,Polycyclic Aromatic Hydrocarbons,3
Cinacalcet,D,D02.455.426.559.847.638.183,Naphthalenes,Polycyclic Aromatic Hydrocarbons,3
Citizen Science,N,N03.540.245.360.150,Community Participation,Consumer Organizations,3
Citizen Science,H,H01.770.644.193.500,Community-Based Participatory Research,Research,3
Civilization,I,I01.076.201.450.226,Culture,"Anthropology, Cultural",3
Clay,G,G16.500.275.815.250,Soil,Environment,3
Clay,N,N06.230.600.250,Soil,Environment,3
Clay,G,G01.311.820.250,Soil,Geological Phenomena,3
Clay,D,D20.721.250,Soil,Complex Mixtures,3
Clinical Clerkship,I,I02.358.105,"Education, Professional",Education,3
Clinical Decision Rules,L,L01.313.500.750.190.190,Decision Support Techniques,Medical Informatics Applications,3
Clinical Decision Rules,E,E05.245.190,Decision Support Techniques,Investigative Techniques,3
Clinical Nursing Research,H,H02.478.395.234,Nursing Research,Nursing,3
Clinical Nursing Research,H,H01.770.644.145.390.234,Nursing Research,Biomedical Research,3
Clinical Nursing Research,N,N04.590.233.508.613.234,Nursing Research,Nursing Process,3
Clomiphene,D,D02.455.426.559.389.150.700.125,Stilbenes,Benzylidene Compounds,3
Clostridium botulinum,B,B03.300.390.400.200.160,Clostridium,Gram-Positive Endospore-Forming Rods,3
Clostridium botulinum,B,B03.353.625.375.500.160,Clostridium,Clostridiaceae,3
Clostridium botulinum,B,B03.510.415.400.200.160,Clostridium,Gram-Positive Endospore-Forming Rods,3
Clostridium tetani,B,B03.510.415.400.200.725,Clostridium,Gram-Positive Endospore-Forming Rods,3
Clostridium tetani,B,B03.353.625.375.500.725,Clostridium,Clostridiaceae,3
Clostridium tetani,B,B03.300.390.400.200.725,Clostridium,Gram-Positive Endospore-Forming Rods,3
Coal Tar,D,D20.749.354,Tars,Complex Mixtures,3
Cognitive Aging,G,G07.345.124.260,Aging,Growth and Development,3
Colchicine,D,D03.132.225,Alkaloids,Heterocyclic Compounds,3
Colectomy,E,E04.210.219,Digestive System Surgical Procedures,"Surgical Procedures, Operative",3
Coleoptera,B,B01.050.500.131.617.720.500.500.375,Holometabola,Neoptera,3
Collagen Diseases,C,C17.300.200,Connective Tissue Diseases,Skin and Connective Tissue Diseases,3
Collateral Circulation,G,G09.330.100.248,Blood Circulation,Cardiovascular Physiological Phenomena,3
Color Vision,G,G11.561.790.964.124,"Vision, Ocular",Sensation,3
Color Vision,G,G14.935.124,"Vision, Ocular",Ocular Physiological Phenomena,3
Color Vision,F,F02.830.816.964.124,"Vision, Ocular",Sensation,3
Comet Assay,E,E05.301.300.100.150,"Electrophoresis, Agar Gel",Electrophoresis,3
Comet Assay,E,E05.196.401.153.150,"Electrophoresis, Agar Gel",Electrophoresis,3
Comet Assay,E,E05.940.560.150,Mutagenicity Tests,Toxicity Tests,3
Comet Assay,E,E05.393.560.150,Mutagenicity Tests,Genetic Techniques,3
Committee Membership,N,N04.452.122,Organization and Administration,Health Services Administration,3
Common Bile Duct Neoplasms,C,C04.588.274.120.250.250,Bile Duct Neoplasms,Biliary Tract Neoplasms,3
Common Bile Duct Neoplasms,C,C06.130.120.250.280,Common Bile Duct Diseases,Bile Duct Diseases,3
Common Bile Duct Neoplasms,C,C06.130.320.120.280,Bile Duct Neoplasms,Biliary Tract Neoplasms,3
Common Bile Duct Neoplasms,C,C06.130.120.120.280,Bile Duct Neoplasms,Bile Duct Diseases,3
Common Bile Duct Neoplasms,C,C06.301.120.250.250,Bile Duct Neoplasms,Biliary Tract Neoplasms,3
Communications Media,L,L01.178,Information Science,NULL,3
Complement C2,D,D12.776.124.486.274.150,Complement System Proteins,Immunoproteins,3
Complement Fixation Tests,E,E01.370.225.812.735.150,Serologic Tests,Immunologic Tests,3
Complement Fixation Tests,E,E05.478.594.760.150,Serologic Tests,Immunologic Tests,3
Complement Fixation Tests,E,E05.200.812.735.150,Serologic Tests,Immunologic Tests,3
"Complement Pathway, Classical",G,G12.274.698,Complement Activation,Immune System Phenomena,3
Complementarity Determining Regions,G,G02.111.570.060.425.160,Immunoglobulin Variable Region,Amino Acid Sequence,3
Complementarity Determining Regions,D,D12.776.543.750.705.816.824.300,"Receptors, Antigen, T-Cell","Receptors, Antigen",3
Complementarity Determining Regions,D,D12.776.124.486.485.797.180,Immunoglobulin Variable Region,Immunoglobulins,3
Complementarity Determining Regions,D,D12.776.124.486.485.680.650.500.180,Immunoglobulin Variable Region,Immunoglobulin Fab Fragments,3
Complementarity Determining Regions,D,D12.776.124.790.651.680.650.500.180,Immunoglobulin Variable Region,Immunoglobulin Fab Fragments,3
Complementarity Determining Regions,D,D12.776.124.790.651.797.180,Immunoglobulin Variable Region,Immunoglobulins,3
Complementarity Determining Regions,D,D12.776.377.715.548.797.180,Immunoglobulin Variable Region,Immunoglobulins,3
Complementarity Determining Regions,D,D12.776.377.715.548.680.650.500.180,Immunoglobulin Variable Region,Immunoglobulin Fab Fragments,3
Complementarity Determining Regions,D,D12.644.541.500.650.500.180,Immunoglobulin Variable Region,Immunoglobulin Fab Fragments,3
Computer User Training,I,I02.903.080,Teaching,Education,3
Concanavalin A,D,D12.776.503.499.500,Plant Lectins,Lectins,3
Concanavalin A,D,D12.776.765.678.500,Plant Lectins,Plant Proteins,3
"Conjunctivitis, Viral",C,C01.925.325.250,"Eye Infections, Viral",Virus Diseases,3
"Conjunctivitis, Viral",C,C01.375.725.250,"Eye Infections, Viral",Eye Infections,3
"Conjunctivitis, Viral",C,C11.187.183.240,Conjunctivitis,Conjunctival Diseases,3
"Conjunctivitis, Viral",C,C11.294.800.250,"Eye Infections, Viral",Eye Infections,3
Conservative Treatment,E,E02.197,Therapeutics,NULL,3
Constitution and Bylaws,N,N04.452.150,Organization and Administration,Health Services Administration,3
Constriction,E,E05.225,Investigative Techniques,NULL,3
Consumer Organizations,N,N03.540.245,Organizations,Health Care Economics and Organizations,3
"Contraceptives, Oral, Synthetic",D,D27.505.696.875.360.276.210.443,"Contraceptives, Oral","Contraceptive Agents, Female",3
"Contraceptives, Oral, Synthetic",D,D27.505.954.705.360.276.210.443,"Contraceptives, Oral","Contraceptive Agents, Female",3
Cooking and Eating Utensils,J,J01.637.370,Manufactured Materials,"Technology, Industry, and Agriculture",3
Cooking and Eating Utensils,J,J01.494.300,Household Articles,"Technology, Industry, and Agriculture",3
Cooking and Eating Utensils,J,J01.576.423.200.300,Food Handling,Food Industry,3
Coronary Aneurysm,C,C14.280.647.250.250,Coronary Disease,Myocardial Ischemia,3
Coronary Aneurysm,C,C14.907.055.395,Aneurysm,Vascular Diseases,3
Coronary Aneurysm,C,C14.907.585.250.250,Coronary Disease,Myocardial Ischemia,3
Coronavirus Nucleocapsid Proteins,D,D12.776.964.970.600.700,Nucleocapsid Proteins,Viral Structural Proteins,3
"Coronavirus OC43, Human",B,B04.820.578.500.540.150.113.500.500,Betacoronavirus 1,Betacoronavirus,3
Corynebacterium Infections,C,C01.150.252.410.040.246,Actinomycetales Infections,Gram-Positive Bacterial Infections,3
Cost Allocation,N,N03.219.151.080,Costs and Cost Analysis,Economics,3
Counterimmunoelectrophoresis,E,E05.301.300.568.250,Immunoelectrophoresis,Electrophoresis,3
Counterimmunoelectrophoresis,E,E05.200.812.735.645.350.350.150,Immunoelectrophoresis,Immunodiffusion,3
Counterimmunoelectrophoresis,E,E05.196.401.568.250,Immunoelectrophoresis,Electrophoresis,3
Counterimmunoelectrophoresis,E,E05.478.605.492.350.350.150,Immunoelectrophoresis,Immunodiffusion,3
Counterimmunoelectrophoresis,E,E05.478.594.760.645.350.350.150,Immunoelectrophoresis,Immunodiffusion,3
Counterimmunoelectrophoresis,E,E01.370.225.812.735.645.350.350.150,Immunoelectrophoresis,Immunodiffusion,3
"Culture Media, Conditioned",D,D27.720.470.305.250,Culture Media,Laboratory Chemicals,3
"Culture Media, Conditioned",E,E07.206.250,Culture Media,Equipment and Supplies,3
Cyclohexanecarboxylic Acids,D,D02.455.426.392.368.367.218,Cyclohexanes,Cycloparaffins,3
Cyclohexanecarboxylic Acids,D,D02.241.223.268,"Acids, Carbocyclic",Carboxylic Acids,3
Cyclonic Storms,N,N06.230.100.230.100,Natural Disasters,Disasters,3
Cyclonic Storms,G,G16.500.175.500,Climatic Processes,Ecological and Environmental Phenomena,3
Cyclooxygenase Inhibitors,D,D27.505.696.663.850.014.040.500.500,"Anti-Inflammatory Agents, Non-Steroidal","Analgesics, Non-Narcotic",3
Cyclooxygenase Inhibitors,D,D27.505.954.329.030.500,"Anti-Inflammatory Agents, Non-Steroidal",Antirheumatic Agents,3
Cyclooxygenase Inhibitors,D,D27.505.954.158.030.500,"Anti-Inflammatory Agents, Non-Steroidal",Anti-Inflammatory Agents,3
Cyclooxygenase Inhibitors,D,D27.505.519.389.310,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,3
Cytochrome b Group,D,D12.776.422.220.187,Cytochromes,Hemeproteins,3
Cytochrome b Group,D,D08.244.187,Cytochromes,Enzymes and Coenzymes,3
"Cytopathogenic Effect, Viral",E,E01.370.225.500.384.235,Cytodiagnosis,Cytological Techniques,3
"Cytopathogenic Effect, Viral",E,E05.200.500.384.235,Cytodiagnosis,Cytological Techniques,3
"Cytopathogenic Effect, Viral",E,E05.242.384.235,Cytodiagnosis,Cytological Techniques,3
"Cytopathogenic Effect, Viral",G,G06.920.190,Virus Physiological Phenomena,Microbiological Phenomena,3
Czechoslovakia,Z,Z01.586.250,Historical Geographic Locations,Geographic Locations,3
Dark Adaptation,G,G14.020.371,"Adaptation, Ocular",Ocular Physiological Phenomena,3
Darunavir,D,D02.886.590.700.400,Sulfonamides,Sulfones,3
Darunavir,D,D03.383.312.303,Furans,"Heterocyclic Compounds, 1-Ring",3
Darunavir,D,D02.241.081.251.222,Carbamates,"Acids, Acyclic",3
Darunavir,D,D02.065.884.438,Sulfonamides,Amides,3
Data Anonymization,H,H01.770.644.205,Research,Science,3
Data Anonymization,L,L01.224.134.500,Computer Security,Computing Methodologies,3
Data Anonymization,N,N03.706.437.650.124.160,Confidentiality,Patient Rights,3
Data Anonymization,N,N04.452.910.200.500,Computer Security,Security Measures,3
Data Curation,L,L01.453.245.332,Documentation,Information Services,3
Data Curation,L,L01.313.500.875.500,Medical Informatics Computing,Medical Informatics,3
Daunorubicin,D,D02.455.426.559.847.562.050.200,Anthracyclines,Naphthacenes,3
Daunorubicin,D,D04.615.562.050.200,Anthracyclines,Naphthacenes,3
Daunorubicin,D,D09.408.051.059.200,Anthracyclines,Aminoglycosides,3
Deaf-Blind Disorders,C,C23.888.592.763.393.341.186.500,Deafness,Hearing Loss,3
Deaf-Blind Disorders,C,C23.888.592.763.941.162.625,Blindness,Vision Disorders,3
Deaf-Blind Disorders,C,C16.131.077.299,"Abnormalities, Multiple",Congenital Abnormalities,3
Deaf-Blind Disorders,C,C10.597.751.418.341.186.500,Deafness,Hearing Loss,3
Deaf-Blind Disorders,C,C10.597.751.941.162.625,Blindness,Vision Disorders,3
Deaf-Blind Disorders,C,C11.966.075.375,Blindness,Vision Disorders,3
Deaf-Blind Disorders,C,C09.218.458.341.186.500,Deafness,Hearing Loss,3
"Decision Making, Shared",I,I03.743.500,Stakeholder Participation,Human Activities,3
"Decision Making, Shared",F,F02.463.785.810.250,Problem Solving,Thinking,3
"Delegation, Professional",N,N04.590.374.070,Delivery of Health Care,Patient Care Management,3
Dental Care for Children,N,N02.421.240.190.215,Dental Care,Dental Health Services,3
Dental Care for Children,E,E06.170.152,Dental Care,Dentistry,3
Dental Health Surveys,E,E06.208,Dentistry,NULL,3
Dental Health Surveys,E,E05.318.308.980.438.300,Health Surveys,Surveys and Questionnaires,3
Dental Health Surveys,N,N05.715.360.300.800.438.300,Health Surveys,Surveys and Questionnaires,3
Dental Health Surveys,N,N06.850.520.308.980.438.300,Health Surveys,Surveys and Questionnaires,3
Dental Health Surveys,N,N06.890.160,Public Health Dentistry,Environment and Public Health,3
Dental Plaque Index,N,N06.890.160.090,Dental Health Surveys,Public Health Dentistry,3
Dental Plaque Index,N,N06.850.520.308.980.438.300.300,Dental Health Surveys,Health Surveys,3
Dental Plaque Index,N,N05.715.360.300.800.438.300.325,Dental Health Surveys,Health Surveys,3
Dental Plaque Index,E,E05.318.308.980.438.300.300,Dental Health Surveys,Health Surveys,3
Dental Plaque Index,E,E06.208.250,Dental Health Surveys,Dentistry,3
Dentistry,E,E06,NULL,NULL,3
Dentistry,H,H02.163,Health Occupations,NULL,3
"Dependency, Psychological",F,F01.752.330,Personality,Behavior and Behavior Mechanisms,3
Depsipeptides,D,D12.644.641.297,"Peptides, Cyclic",Peptides,3
Depsipeptides,D,D04.345.566.297,"Peptides, Cyclic",Macrocyclic Compounds,3
Dermatophagoides farinae,B,B01.050.500.131.166.132.419.600.200,Pyroglyphidae,Mites,3
"Desensitization, Immunologic",E,E02.095.465.425.450.310,Immunosuppression,Immunotherapy,3
"Desensitization, Immunologic",E,E05.478.610.310,Immunosuppression,Immunologic Techniques,3
Deuterium Oxide,D,D01.248.497.158.459.650.200,Water,Hydroxides,3
Deuterium Oxide,D,D01.045.250.875.200,Water,Hydroxides,3
Deuterium Oxide,D,D01.268.406.500.250,Deuterium,Hydrogen,3
Deuterium Oxide,D,D01.362.340.500.250,Deuterium,Hydrogen,3
Diabetic Cardiomyopathies,C,C19.246.099.625,Diabetes Complications,Diabetes Mellitus,3
Diabetic Cardiomyopathies,C,C14.280.238.235,Cardiomyopathies,Heart Diseases,3
Diazepam,D,D03.633.100.079.080.070.216,Benzodiazepinones,Benzodiazepines,3
Dichlorodiphenyldichloroethane,D,D02.455.526.439.294,"Hydrocarbons, Chlorinated","Hydrocarbons, Halogenated",3
Didelphis,B,B01.050.150.900.649.573.575.150,Opossums,Marsupialia,3
Dientamoebiasis,C,C01.610.752.275,Protozoan Infections,Parasitic Diseases,3
Dientamoebiasis,C,C01.610.432.275,"Intestinal Diseases, Parasitic",Parasitic Diseases,3
Dientamoebiasis,C,C06.405.469.452.275,"Intestinal Diseases, Parasitic",Intestinal Diseases,3
"Diet, High-Fat",G,G07.203.650.240.267,Diet,Nutritional Physiological Phenomena,3
Dietetics,H,H02.533.290,Nutritional Sciences,Health Occupations,3
"Diffusion Chambers, Culture",E,E07.241,Equipment and Supplies,NULL,3
Dihydrotestosterone,D,D04.210.500.054.040.248,Androstanols,Androstanes,3
Dihydrotestosterone,D,D06.472.334.851.968.964,Testosterone Congeners,Gonadal Steroid Hormones,3
"Dilatation, Pathologic",C,C23.300.325,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",3
Dimethyl Sulfoxide,D,D02.886.640.150,Sulfoxides,Sulfur Compounds,3
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases,D,D08.811.277.656.350.350,Exopeptidases,Peptide Hydrolases,3
Diphosphates,D,D01.029.260.700.675.374.775.150,Polyphosphates,Phosphates,3
Diphosphates,D,D01.248.497.158.730.650.200,Polyphosphates,Phosphates,3
Diphosphates,D,D01.695.625.675.650.775.150,Polyphosphates,Phosphates,3
Diplomacy,F,F01.829.316.171,Group Processes,"Psychology, Social",3
Diplomacy,F,F02.463.785.373.520.500,Negotiating,Decision Making,3
Diplomacy,I,I01.738.305,Politics,Social Sciences,3
Disaccharides,D,D09.698.629.305,Oligosaccharides,Polysaccharides,3
Disaccharides,D,D09.947.750,Sugars,Carbohydrates,3
Dissociative Disorders,F,F03.300,Mental Disorders,NULL,3
Diverticular Diseases,C,C06.405.205.282,Gastroenteritis,Gastrointestinal Diseases,3
"DNA Breaks, Double-Stranded",G,G05.200.210.220,DNA Breaks,DNA Damage,3
DNA Contamination,E,E05.393.760.700.224,"Sequence Analysis, DNA",Sequence Analysis,3
DNA Contamination,E,E05.393.290.573,DNA Fingerprinting,Genetic Techniques,3
DNA Contamination,E,E05.200.998.293,Specimen Handling,Clinical Laboratory Techniques,3
DNA Contamination,I,I01.198.780.937.375.500,DNA Fingerprinting,Forensic Medicine,3
DNA Contamination,E,E01.370.225.998.293,Specimen Handling,Clinical Laboratory Techniques,3
DNA Modification Methylases,D,D08.811.913.555.500.350,Methyltransferases,One-Carbon Group Transferases,3
DNA Modification Methylases,D,D08.811.150.240,DNA Restriction-Modification Enzymes,Enzymes,3
"DNA Topoisomerases, Type II",D,D08.811.399.403.741,DNA Topoisomerases,Isomerases,3
DNA Virus Infections,C,C01.925.256,Virus Diseases,Infections,3
Donepezil,D,D04.615.486.487.280,Indans,Indenes,3
Donepezil,D,D02.455.426.559.847.486.487.280,Indans,Indenes,3
Donepezil,D,D03.383.621.238,Piperidines,"Heterocyclic Compounds, 1-Ring",3
Dopamine Agents,D,D27.505.519.625.150,Neurotransmitter Agents,Molecular Mechanisms of Pharmacological Action,3
Dopamine Agents,D,D27.505.696.577.150,Neurotransmitter Agents,Physiological Effects of Drugs,3
"Drainage, Sanitary",N,N06.850.780.200.800.800.350,Sanitary Engineering,Sanitation,3
Drug Administration Routes,E,E02.319.267,Drug Therapy,Therapeutics,3
"Drug Resistance, Fungal",G,G06.225.383,"Drug Resistance, Microbial",Microbiological Phenomena,3
"Drug Resistance, Fungal",G,G07.690.773.984.269.383,"Drug Resistance, Microbial",Drug Resistance,3
Drug Tapering,E,E02.319.309,Drug Therapy,Therapeutics,3
Dwarfism,C,C05.116.099.343,"Bone Diseases, Developmental",Bone Diseases,3
Dwarfism,C,C19.297,Endocrine System Diseases,NULL,3
Dwarfism,C,C16.320.240,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",3
Dysgerminoma,C,C04.557.465.330.300,Germinoma,"Neoplasms, Germ Cell and Embryonal",3
Dysmenorrhea,C,C23.888.592.612.944.500,Pelvic Pain,Pain,3
Dysmenorrhea,C,C23.550.568.750,Menstruation Disturbances,Pathologic Processes,3
Dyspareunia,C,C12.294.644.242,"Sexual Dysfunction, Physiological","Genital Diseases, Male",3
Dyspareunia,C,C13.351.500.665.313,"Sexual Dysfunction, Physiological","Genital Diseases, Female",3
Dyspareunia,F,F03.835.199,"Sexual Dysfunctions, Psychological",Mental Disorders,3
"Echocardiography, Stress",E,E01.370.350.130.750.228,Echocardiography,Cardiac Imaging Techniques,3
"Echocardiography, Stress",E,E01.370.370.380.220.228,Echocardiography,Heart Function Tests,3
"Echocardiography, Stress",E,E01.370.350.850.220.228,Echocardiography,Ultrasonography,3
Echoencephalography,E,E01.370.350.850.260,Ultrasonography,Diagnostic Imaging,3
Echoencephalography,E,E01.370.376.537.750.260,Neuroradiography,Neuroimaging,3
Echoencephalography,E,E01.370.350.578.937.260,Neuroradiography,Neuroimaging,3
Echoencephalography,E,E01.370.350.700.560.260,Neuroradiography,Radiography,3
Echoencephalography,E,E05.629.937.260,Neuroradiography,Neuroimaging,3
Eels,B,B01.050.150.900.493.338,Fishes,Vertebrates,3
"Egypt, Ancient",Z,Z01.586.035.325,Ancient Lands,Historical Geographic Locations,3
Eimeria,B,B01.043.075.189.250.250.250,Eimeriidae,Eimeriida,3
Eisenmenger Complex,C,C16.131.240.400.450,"Heart Defects, Congenital",Cardiovascular Abnormalities,3
Eisenmenger Complex,C,C14.280.400.450,"Heart Defects, Congenital",Heart Diseases,3
Eisenmenger Complex,C,C14.240.400.450,"Heart Defects, Congenital",Cardiovascular Abnormalities,3
Elapid Venoms,D,D23.946.833.850.325,Snake Venoms,Venoms,3
Elapid Venoms,D,D20.888.850.325,Snake Venoms,Venoms,3
Elapidae,B,B01.050.150.900.833.672.125.875,Alethinophidia,Snakes,3
Electric Conductivity,G,G01.358.500.249.277,Electricity,Electromagnetic Phenomena,3
Electrocoagulation,E,E04.014.170.402,Cautery,Ablation Techniques,3
Electrocoagulation,E,E02.154.402,Cautery,Therapeutics,3
Electrodes,E,E07.305.250,Electrical Equipment and Supplies,Equipment and Supplies,3
Electromyography,E,E01.370.405.255,Electrodiagnosis,Diagnostic Techniques and Procedures,3
Electromyography,E,E01.370.530.255,Myography,Diagnostic Techniques and Procedures,3
Electron Probe Microanalysis,E,E01.370.350.515.402.250,"Microscopy, Electron",Microscopy,3
Electron Probe Microanalysis,E,E05.799.830.360,"Spectrometry, X-Ray Emission",Radiometry,3
Electron Probe Microanalysis,E,E05.595.402.250,"Microscopy, Electron",Microscopy,3
Electron Probe Microanalysis,E,E05.196.867.800.360,"Spectrometry, X-Ray Emission",Spectrum Analysis,3
"Electrophoresis, Capillary",E,E05.196.401.190,Electrophoresis,"Chemistry Techniques, Analytical",3
"Electrophoresis, Capillary",E,E05.301.300.190,Electrophoresis,Electrochemical Techniques,3
Electrophysiological Phenomena,G,G07.265,Physiological Phenomena,NULL,3
"Elliptocytosis, Hereditary",C,C15.378.071.141.150.365,"Anemia, Hemolytic, Congenital","Anemia, Hemolytic",3
"Elliptocytosis, Hereditary",C,C16.320.070.365,"Anemia, Hemolytic, Congenital","Genetic Diseases, Inborn",3
Embolic Protection Devices,E,E07.695.207,Prostheses and Implants,Equipment and Supplies,3
Emergency Medical Technicians,N,N02.360.067.150,Allied Health Personnel,Health Personnel,3
Emergency Medical Technicians,M,M01.526.485.067.150,Allied Health Personnel,Health Personnel,3
Emergency Medical Technicians,M,M01.526.373.250,Emergency Responders,Occupational Groups,3
Emergency Nursing,N,N02.421.533.200,Nursing Care,Health Services,3
Emergency Nursing,H,H02.478.676.200,"Specialties, Nursing",Nursing,3
Enalapril,D,D12.644.456.345.360,Dipeptides,Oligopeptides,3
"Encephalitis Virus, Venezuelan Equine",B,B04.820.230.369,Encephalitis Viruses,RNA Viruses,3
"Encephalitis Virus, Venezuelan Equine",B,B04.820.578.875.054.340,Alphavirus,Togaviridae,3
"Encephalitis Viruses, Japanese",B,B04.820.230.475,Encephalitis Viruses,RNA Viruses,3
"Encephalitis Viruses, Japanese",B,B04.820.578.344.350.300,Flavivirus,Flaviviridae,3
"Encephalitis, Arbovirus",C,C01.207.245.340.300,"Encephalitis, Viral",Central Nervous System Viral Diseases,3
"Encephalitis, Arbovirus",C,C01.207.399.750.300,"Encephalitis, Viral",Infectious Encephalitis,3
"Encephalitis, Arbovirus",C,C01.925.182.525.300,"Encephalitis, Viral",Central Nervous System Viral Diseases,3
"Encephalitis, Arbovirus",C,C01.925.081.343,Arbovirus Infections,Virus Diseases,3
"Encephalitis, Arbovirus",C,C01.920.500.343,Arbovirus Infections,Vector Borne Diseases,3
"Encephalitis, Arbovirus",C,C01.925.782.310,RNA Virus Infections,Virus Diseases,3
"Encephalitis, Arbovirus",C,C10.228.140.430.520.750.300,"Encephalitis, Viral",Infectious Encephalitis,3
"Encephalitis, Arbovirus",C,C10.228.228.399.750.300,"Encephalitis, Viral",Infectious Encephalitis,3
"Encephalitis, Arbovirus",C,C10.228.228.245.340.300,"Encephalitis, Viral",Central Nervous System Viral Diseases,3
"Encephalomyelitis, Autoimmune, Experimental",C,C10.314.350.250,"Demyelinating Autoimmune Diseases, CNS",Demyelinating Diseases,3
"Encephalomyelitis, Autoimmune, Experimental",C,C10.228.140.695.562.250,"Demyelinating Autoimmune Diseases, CNS",Leukoencephalopathies,3
"Encephalomyelitis, Autoimmune, Experimental",C,C10.114.703.300,"Nervous System Autoimmune Disease, Experimental",Autoimmune Diseases of the Nervous System,3
"Encephalomyelitis, Autoimmune, Experimental",C,C20.111.258.625.300,"Nervous System Autoimmune Disease, Experimental",Autoimmune Diseases of the Nervous System,3
"Encephalomyelitis, Autoimmune, Experimental",E,E05.598.500.500.500,"Nervous System Autoimmune Disease, Experimental","Disease Models, Animal",3
Endodontics,E,E06.397,Dentistry,NULL,3
Endodontics,H,H02.163.876.213,"Specialties, Dental",Dentistry,3
Endomyocardial Fibrosis,C,C14.280.238.406,Cardiomyopathies,Heart Diseases,3
Endophenotypes,G,G05.695.224,Phenotype,Genetic Phenomena,3
Endothelial Protein C Receptor,D,D12.776.395.550.294,Membrane Glycoproteins,Glycoproteins,3
Endothelial Protein C Receptor,D,D12.776.543.550.294,Membrane Glycoproteins,Membrane Proteins,3
Endothelial Protein C Receptor,D,D12.776.543.750.045,"Receptors, Cell Surface",Membrane Proteins,3
Endothelin Receptor Antagonists,D,D27.505.519.364,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,3
Endothelin-1,D,D23.529.400.225,Endothelins,Intercellular Signaling Peptides and Proteins,3
Endothelin-1,D,D12.776.467.400.225,Endothelins,Intercellular Signaling Peptides and Proteins,3
Endothelin-1,D,D12.644.276.400.225,Endothelins,Intercellular Signaling Peptides and Proteins,3
"Endothelium, Corneal",A,A09.371.060.217.318,Cornea,Anterior Eye Segment,3
"Endothelium, Corneal",A,A09.371.060.067.318,Anterior Chamber,Anterior Eye Segment,3
"Endothelium, Corneal",A,A10.272.491.318,Endothelium,Epithelium,3
Endotoxemia,C,C01.861.375,Toxemia,Infections,3
Endotoxemia,C,C01.757.100.275,Bacteremia,Sepsis,3
Endotoxemia,C,C23.550.470.790.500.100.275,Bacteremia,Sepsis,3
Enterocolitis,C,C06.405.205.596,Gastroenteritis,Gastrointestinal Diseases,3
Enterocolitis,C,C06.405.469.363,Intestinal Diseases,Gastrointestinal Diseases,3
"Enterovirus D, Human",B,B04.820.578.750.284.188,Enterovirus,Picornaviridae,3
"Environment, Controlled",N,N06.230.150,Environment,Environment and Public Health,3
Enzyme Induction,G,G05.308.320.200,"Gene Expression Regulation, Enzymologic",Gene Expression Regulation,3
Enzyme Replacement Therapy,E,E02.319.353.500,Enzyme Therapy,Drug Therapy,3
Epidemiologists,N,N02.360.345,Health Personnel,"Health Care Facilities, Manpower, and Services",3
Epidemiologists,M,M01.526.485.353,Health Personnel,Occupational Groups,3
Epidermolysis Bullosa,C,C16.320.850.275,"Skin Diseases, Genetic","Genetic Diseases, Inborn",3
Epidermolysis Bullosa,C,C16.131.831.493,Skin Abnormalities,Congenital Abnormalities,3
Epidermolysis Bullosa,C,C17.800.827.275,"Skin Diseases, Genetic",Skin Diseases,3
Epidermolysis Bullosa,C,C17.800.804.493,Skin Abnormalities,Skin Diseases,3
Epidermolysis Bullosa,C,C17.800.865.410,"Skin Diseases, Vesiculobullous",Skin Diseases,3
Epiretinal Membrane,C,C11.768.328,Retinal Diseases,Eye Diseases,3
Epoetin Alfa,D,D23.529.374.410.240.150.750,Erythropoietin,Colony-Stimulating Factors,3
Epoetin Alfa,D,D12.776.467.374.410.240.150.500,Erythropoietin,Colony-Stimulating Factors,3
Epoetin Alfa,D,D12.644.276.374.410.240.150.500,Erythropoietin,Colony-Stimulating Factors,3
Epoetin Alfa,D,D12.776.395.240.150.750,Erythropoietin,Colony-Stimulating Factors,3
ERG1 Potassium Channel,D,D12.776.157.530.400.600.900.249.500,Ether-A-Go-Go Potassium Channels,"Potassium Channels, Voltage-Gated",3
ERG1 Potassium Channel,D,D12.776.543.550.450.750.900.249.500,Ether-A-Go-Go Potassium Channels,"Potassium Channels, Voltage-Gated",3
ERG1 Potassium Channel,D,D12.776.543.585.400.750.900.249.500,Ether-A-Go-Go Potassium Channels,"Potassium Channels, Voltage-Gated",3
Ergosterol,D,D04.210.500.247.222.537,Cholestenes,Cholestanes,3
Erythrocyte Aging,G,G09.188.230,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,3
Erythrocyte Aging,G,G04.043.260,Cellular Senescence,Cell Physiological Phenomena,3
Esters,D,D02.241.400,Carboxylic Acids,Organic Chemicals,3
Estriol,D,D04.210.500.365.415.331,Estrenes,Estranes,3
Estriol,D,D06.472.334.851.437.750,Estradiol Congeners,Gonadal Steroid Hormones,3
Estrogen Antagonists,D,D06.347.295,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",3
Estrogen Antagonists,D,D27.505.696.399.450.327,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",3
"Estrogens, Non-Steroidal",D,D27.505.696.399.472.277.540,Estrogens,Hormones,3
Ethical Analysis,K,K01.752.566.479.113,Ethics,Morals,3
Ethical Analysis,N,N05.350.244,Ethics,"Health Care Quality, Access, and Evaluation",3
"Ethics, Nursing",N,N05.350.340.162.750,"Ethics, Clinical","Ethics, Professional",3
"Ethics, Nursing",K,K01.752.566.479.171.132.875,"Ethics, Clinical","Ethics, Professional",3
"Ethics, Nursing",K,K01.752.712.416,"Philosophy, Nursing",Philosophy,3
Ethnology,I,I01.076.201.450.457,Culture,"Anthropology, Cultural",3
Exanthema Subitum,C,C17.800.838.790.290,"Skin Diseases, Viral","Skin Diseases, Infectious",3
Exanthema Subitum,C,C17.800.257.335,Exanthema,Skin Diseases,3
Exanthema Subitum,C,C01.925.256.466.850.290,Roseolovirus Infections,Herpesviridae Infections,3
Exanthema Subitum,C,C01.925.825.290,"Skin Diseases, Viral",Virus Diseases,3
Excitatory Amino Acid Antagonists,D,D27.505.519.625.190.300,Excitatory Amino Acid Agents,Neurotransmitter Agents,3
Excitatory Amino Acid Antagonists,D,D27.505.696.577.190.300,Excitatory Amino Acid Agents,Neurotransmitter Agents,3
Exosomes,A,A11.284.295.588.750,Extracellular Vesicles,Extracellular Space,3
Exosomes,A,A11.284.430.214.190.875.190.880.495,Transport Vesicles,Cytoplasmic Vesicles,3
Expert Systems,L,L01.224.050.375.190,Artificial Intelligence,Algorithms,3
Exploratory Behavior,F,F01.658.370,Motivation,Behavior and Behavior Mechanisms,3
Exploratory Behavior,F,F01.145.387,Behavior,Behavior and Behavior Mechanisms,3
Expressed Emotion,F,F01.829.197,"Psychology, Social",Behavior and Behavior Mechanisms,3
Extreme Weather,G,G16.500.275.063.725.232,Weather,Atmosphere,3
Extreme Weather,G,G16.500.750.775.291,Weather,Meteorological Concepts,3
Extreme Weather,N,N06.230.300.100.725.193,Weather,Atmosphere,3
"Eye Diseases, Hereditary",C,C16.320.290,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",3
"Eye Diseases, Hereditary",C,C11.270,Eye Diseases,NULL,3
Eye Movement Measurements,E,E01.370.405.245.787,Electroencephalography,Electrodiagnosis,3
Eye Movement Measurements,E,E01.370.380.230,"Diagnostic Techniques, Ophthalmological",Diagnostic Techniques and Procedures,3
Eye Movements,G,G14.350,Ocular Physiological Phenomena,NULL,3
Eye Movements,G,G11.427.410.140,Movement,Musculoskeletal Physiological Phenomena,3
Facial Paralysis,C,C10.597.622.214,Paralysis,Neurologic Manifestations,3
Facial Paralysis,C,C23.888.592.636.214,Paralysis,Neurologic Manifestations,3
Facial Paralysis,C,C07.465.327,Mouth Diseases,Stomatognathic Diseases,3
Fallopian Tube Diseases,C,C13.351.500.056.390,Adnexal Diseases,"Genital Diseases, Female",3
Familial Primary Pulmonary Hypertension,C,C08.381.423.300,"Hypertension, Pulmonary",Lung Diseases,3
Fanconi Anemia Complementation Group N Protein,D,D12.776.660.323,Nuclear Proteins,Proteins,3
Fanconi Anemia Complementation Group N Protein,D,D12.776.624.776.051,Tumor Suppressor Proteins,Neoplasm Proteins,3
Fanconi Anemia Complementation Group N Protein,D,D12.776.313.953,Fanconi Anemia Complementation Group Proteins,Proteins,3
Fascioliasis,C,C06.552.664.424,"Liver Diseases, Parasitic",Liver Diseases,3
Fascioliasis,C,C01.610.518.424,"Liver Diseases, Parasitic",Parasitic Diseases,3
Fascioliasis,C,C01.610.335.865.354,Trematode Infections,Helminthiasis,3
"Feedback, Physiological",G,G07.410.732,Homeostasis,Physiological Phenomena,3
Feline Acquired Immunodeficiency Syndrome,C,C01.925.839.400,Slow Virus Diseases,Virus Diseases,3
Feline Acquired Immunodeficiency Syndrome,C,C01.925.782.815.616.350,Lentivirus Infections,Retroviridae Infections,3
Feline Acquired Immunodeficiency Syndrome,C,C22.180.350,Cat Diseases,Animal Diseases,3
Femoral Fractures,C,C26.404.061,"Fractures, Bone",Wounds and Injuries,3
Femoral Fractures,C,C26.558.276,Leg Injuries,Wounds and Injuries,3
Femoral Vein,A,A07.015.908.314,Veins,Blood Vessels,3
Femur Head Necrosis,C,C05.116.852.175,Osteonecrosis,Bone Diseases,3
Femur Head Necrosis,C,C23.550.717.732.368,Osteonecrosis,Necrosis,3
Fenofibrate,D,D02.355.726.305.625,Fibric Acids,Phenyl Ethers,3
Fenofibrate,D,D02.455.426.559.389.134.750,Benzophenones,Benzene Derivatives,3
Fenofibrate,D,D02.455.426.559.389.657.654.305.625,Fibric Acids,Phenyl Ethers,3
Fenofibrate,D,D02.241.081.114.968.500.625,Fibric Acids,Isobutyrates,3
Fenofibrate,D,D02.522.223.750,Benzophenones,Ketones,3
Ferredoxin-NADP Reductase,D,D08.811.682.667.076,Oxidoreductases Acting on Sulfur Group Donors,Oxidoreductases,3
Fertilizers,D,D27.720.031.400,Agrochemicals,Specialty Uses of Chemicals,3
Fetal Movement,G,G07.345.500.325.235.374,Fetal Development,Embryonic and Fetal Development,3
Fetal Movement,G,G08.686.784.170.157.374,Fetal Development,Embryonic and Fetal Development,3
Fibrillins,D,D12.776.860.300.400,Extracellular Matrix Proteins,Scleroproteins,3
Fibrillins,D,D12.776.395.341,Glycoproteins,Proteins,3
Fibrillins,D,D09.400.430.875,Glycoproteins,Glycoconjugates,3
Filamins,D,D12.776.210.249,Contractile Proteins,Proteins,3
Filamins,D,D12.776.220.525.315,Microfilament Proteins,Cytoskeletal Proteins,3
Filamins,D,D05.750.078.730.315,Microfilament Proteins,Biopolymers,3
Filamins,A,A11.284.430.214.190.750.050.414,Actin Cytoskeleton,Cytoskeleton,3
Filoviridae Infections,C,C01.925.782.580.250,Mononegavirales Infections,RNA Virus Infections,3
Fish Products,G,G07.203.300.600.875.400,Seafood,Meat,3
Fish Products,J,J02.500.600.875.400,Seafood,Meat,3
Fixatives,D,D27.720.355,Specialty Uses of Chemicals,Chemical Actions and Uses,3
Florida,Z,Z01.107.567.875.750.350,Southeastern United States,United States,3
Fluorescence Recovery After Photobleaching,E,E05.196.712.516.600.393,Fluorometry,Luminescent Measurements,3
Fluorides,D,D01.303.350.300,Hydrofluoric Acid,Fluorine Compounds,3
Fluorides,D,D01.248.497.158.380,Anions,Ions,3
Foot Dermatoses,C,C17.800.321.125,Foot Diseases,Skin Diseases,3
Football,I,I03.450.642.845.300,Sports,Recreation,3
Foreign Professional Personnel,M,M01.526.407,Occupational Groups,Persons,3
Foreign-Body Migration,C,C26.392.500,Foreign Bodies,Wounds and Injuries,3
Foreskin,A,A05.360.444.492.362,Penis,"Genitalia, Male",3
Formoterol Fumarate,D,D02.033.100.291.425,Ethanolamines,Amino Alcohols,3
Formoterol Fumarate,D,D02.092.063.291.425,Ethanolamines,Amino Alcohols,3
"Fractures, Malunited",C,C26.404.249,"Fractures, Bone",Wounds and Injuries,3
Freezing,G,G01.645.500,Phase Transition,Physical Phenomena,3
Freezing,G,G01.906.595.272.437,Cold Temperature,Temperature,3
Freezing,G,G02.734.466,Phase Transition,Chemical Phenomena,3
Friedreich Ataxia,C,C18.452.660.300,Mitochondrial Diseases,Metabolic Diseases,3
Friedreich Ataxia,C,C16.320.400.780.200,Spinocerebellar Degenerations,"Heredodegenerative Disorders, Nervous System",3
Friedreich Ataxia,C,C10.228.140.252.700.150,Spinocerebellar Degenerations,Cerebellar Diseases,3
Friedreich Ataxia,C,C10.228.854.787.200,Spinocerebellar Degenerations,Spinal Cord Diseases,3
Friedreich Ataxia,C,C10.574.500.825.200,Spinocerebellar Degenerations,"Heredodegenerative Disorders, Nervous System",3
Fruit and Vegetable Juices,G,G07.203.100.606,Beverages,"Diet, Food, and Nutrition",3
Fruit and Vegetable Juices,J,J02.200.606,Beverages,Food and Beverages,3
Functional Status,N,N02.421.784.110.500,Activities of Daily Living,Rehabilitation,3
Functional Status,N,N06.850.505.400.425.175,Health Status,Demography,3
Furin,D,D08.811.277.656.837.249,Proprotein Convertases,Peptide Hydrolases,3
Furin,D,D08.811.277.656.959.350.353,Serine Endopeptidases,Serine Proteases,3
Furin,D,D08.811.277.656.300.760.353,Serine Endopeptidases,Endopeptidases,3
Furocoumarins,D,D03.383.663.283.446.794,Coumarins,Benzopyrans,3
Furocoumarins,D,D03.633.300.770,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",3
Furocoumarins,D,D03.633.100.150.446.794,Coumarins,Benzopyrans,3
Fuzzy Logic,K,K01.752.448.250,Logic,Philosophy,3
Fuzzy Logic,L,L01.224.050.375.250,Artificial Intelligence,Algorithms,3
Fuzzy Logic,E,E05.599.250,"Models, Theoretical",Investigative Techniques,3
Gait,G,G11.427.410.568.900.750,Walking,Locomotion,3
Gait,E,E01.370.600.250,Physical Examination,Diagnostic Techniques and Procedures,3
"Gait Disorders, Neurologic",C,C10.597.404,Neurologic Manifestations,Nervous System Diseases,3
"Gait Disorders, Neurologic",C,C23.888.592.413,Neurologic Manifestations,Signs and Symptoms,3
Gasoline,D,D20.345.630.540,Petroleum,Fossil Fuels,3
Gasoline,N,N06.230.132.258.630.540,Petroleum,Fossil Fuels,3
Gastrointestinal Agents,D,D27.505.954.483,Therapeutic Uses,Pharmacologic Actions,3
GATA3 Transcription Factor,D,D12.776.930.216.687,Erythroid-Specific DNA-Binding Factors,Transcription Factors,3
GATA3 Transcription Factor,D,D12.776.930.314.300,GATA Transcription Factors,Transcription Factors,3
GATA3 Transcription Factor,D,D12.776.260.235.687,Erythroid-Specific DNA-Binding Factors,DNA-Binding Proteins,3
GATA3 Transcription Factor,D,D12.776.260.257.300,GATA Transcription Factors,DNA-Binding Proteins,3
"Genes, Tumor Suppressor",G,G05.360.340.024.340.415.400,"Genes, Recessive",Genes,3
"Genes, Tumor Suppressor",G,G05.360.340.024.340.375.249,"Genes, Neoplasm",Genes,3
"Genome, Archaeal",G,G05.360.340.358.050,"Genome, Microbial",Genome,3
Gentian Violet,D,D02.092.146.400,Aniline Compounds,Amines,3
Gerbillinae,B,B01.050.150.900.649.313.992.635.300,Muridae,Rodentia,3
Germinoma,C,C04.557.465.330,"Neoplasms, Germ Cell and Embryonal",Neoplasms by Histologic Type,3
Gills,A,A13.421,Animal Structures,NULL,3
Ginkgo biloba,B,B01.650.940.800.575.912.125,Tracheophyta,Embryophyta,3
Glaucoma Drainage Implants,E,E07.695.250,Prostheses and Implants,Equipment and Supplies,3
Glioblastoma,C,C04.557.465.625.600.380.080.335,Astrocytoma,Glioma,3
Glioblastoma,C,C04.557.470.670.380.080.335,Astrocytoma,Glioma,3
Glioblastoma,C,C04.557.580.625.600.380.080.335,Astrocytoma,Glioma,3
Glomerular Mesangium,A,A05.810.453.736.520.620.500,Mesangial Cells,Kidney Glomerulus,3
Glomerular Mesangium,A,A05.810.453.324.359.620.500,Mesangial Cells,Kidney Glomerulus,3
Glucagon-Like Peptide 1,D,D06.472.317.680.500.500,Glucagon-Like Peptides,Proglucagon,3
Glucokinase,D,D08.811.913.696.620.250,Phosphotransferases (Alcohol Group Acceptor),Phosphotransferases,3
Glucose Metabolism Disorders,C,C18.452.394,Metabolic Diseases,Nutritional and Metabolic Diseases,3
Glutamate Decarboxylase,D,D08.811.520.224.125.250,Carboxy-Lyases,Carbon-Carbon Lyases,3
Glycolates,D,D02.241.081.018.386,Acetates,"Acids, Acyclic",3
Glycolates,D,D02.241.511.316,Hydroxy Acids,Carboxylic Acids,3
Gnathostoma,B,B01.050.500.500.294.400.937.700.722.375,Thelazioidea,Spirurina,3
Granulins,D,D06.472.699.682.500,Progranulins,Peptide Hormones,3
Granulins,D,D12.644.276.917.500,Progranulins,Intercellular Signaling Peptides and Proteins,3
Granulins,D,D12.776.467.917.500,Progranulins,Intercellular Signaling Peptides and Proteins,3
Granulins,D,D23.529.917.500,Progranulins,Intercellular Signaling Peptides and Proteins,3
Greenland,Z,Z01.107.567.403,North America,Americas,3
Greenland,Z,Z01.542.816.124.500,Denmark,Scandinavian and Nordic Countries,3
Greenland,Z,Z01.639.400,Islands,Geographic Locations,3
Growth Substances,D,D27.505.696.377,Physiological Effects of Drugs,Pharmacologic Actions,3
"GTP-Binding Protein alpha Subunits, Gs",D,D12.776.543.325.100.400,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,3
"GTP-Binding Protein alpha Subunits, Gs",D,D12.776.476.375.100.400,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,3
"GTP-Binding Protein alpha Subunits, Gs",D,D12.644.360.360.100.400,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,3
"GTP-Binding Protein alpha Subunits, Gs",D,D12.776.157.325.332.100.400,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,3
"GTP-Binding Protein alpha Subunits, Gs",D,D08.811.277.040.330.300.200.100.400,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,3
Haemonchiasis,C,C01.610.335.508.700.775.825.400,Trichostrongyloidiasis,Strongylida Infections,3
Haemonchus,B,B01.050.500.500.294.400.968.746.410,Trichostrongyloidea,Strongylida,3
Hand Dermatoses,C,C17.800.338,Skin Diseases,Skin and Connective Tissue Diseases,3
Haploidy,G,G05.700.456,Ploidies,Genetic Phenomena,3
HCT116 Cells,A,A11.251.860.180.380,"Cell Line, Tumor","Tumor Cells, Cultured",3
HCT116 Cells,A,A11.251.210.190.380,"Cell Line, Tumor",Cell Line,3
Head Protective Devices,E,E07.700.380,Protective Devices,Equipment and Supplies,3
Head Protective Devices,J,J01.637.708.560.750,Personal Protective Equipment,Protective Devices,3
Health Belief Model,E,E05.599.323,"Models, Theoretical",Investigative Techniques,3
Health Belief Model,E,E05.599.695.275,"Models, Psychological","Models, Theoretical",3
"Health Benefit Plans, Employee",N,N04.452.677.800.325,Salaries and Fringe Benefits,Personnel Management,3
"Health Benefit Plans, Employee",N,N03.219.521.576.343.290,"Insurance, Health",Insurance,3
"Health Benefit Plans, Employee",N,N01.824.417.700.325,Salaries and Fringe Benefits,Income,3
Health Facility Environment,N,N02.278.220,Health Facilities,"Health Care Facilities, Manpower, and Services",3
Health Facility Environment,N,N05.300.430.400,Health Services Accessibility,Delivery of Health Care,3
Health Information Exchange,L,L01.399.500.500,Health Information Management,Information Management,3
Health Information Exchange,L,L01.313.500.500,Medical Informatics,Informatics,3
Health Information Exchange,E,E05.318.308.940.968.625.500.500,Electronic Health Records,"Medical Records Systems, Computerized",3
"Health Records, Personal",E,E05.318.308.940.968.249,Medical Records,Records,3
Health Services for Persons with Disabilities,N,N02.421.314,Health Services,"Health Care Facilities, Manpower, and Services",3
Health Systems Agencies,N,N03.540.452.508.440,State Health Planning and Development Agencies,Health Planning Organizations,3
"Hearing Loss, Conductive",C,C10.597.751.418.341.562,Hearing Loss,Hearing Disorders,3
"Hearing Loss, Conductive",C,C09.218.458.341.562,Hearing Loss,Hearing Disorders,3
"Hearing Loss, Conductive",C,C23.888.592.763.393.341.562,Hearing Loss,Hearing Disorders,3
Heart Atria,A,A07.541.358,Heart,Cardiovascular System,3
Heart Auscultation,E,E01.370.600.060.400,Auscultation,Physical Examination,3
Heart Auscultation,E,E01.370.370.380.400,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",3
Heart Block,C,C23.550.073.425,"Arrhythmias, Cardiac",Pathologic Processes,3
Heart Block,C,C14.280.123.500,Cardiac Conduction System Disease,Heart Diseases,3
Heart Block,C,C14.280.067.558,"Arrhythmias, Cardiac",Heart Diseases,3
"Heart Rate, Fetal",G,G09.330.380.500.430,Heart Rate,Hemodynamics,3
Heme Oxygenase (Decyclizing),D,D08.811.682.690.708.410,Mixed Function Oxygenases,Oxygenases,3
Hemiptera,B,B01.050.500.131.617.412,Insecta,Arthropods,3
"Hemoglobins, Abnormal",D,D12.776.124.400.463,Hemoglobins,Blood Proteins,3
"Hemoglobins, Abnormal",D,D12.776.422.316.762.426,Hemoglobins,Globins,3
Hemoglobinuria,C,C13.351.968.934.734.634,Proteinuria,Urination Disorders,3
Hemoglobinuria,C,C12.777.934.734.634,Proteinuria,Urination Disorders,3
Hemoglobinuria,C,C23.888.942.750.634,Proteinuria,Urological Manifestations,3
Hemolytic Plaque Technique,E,E01.370.225.812.375,Immunologic Tests,Clinical Laboratory Techniques,3
Hemolytic Plaque Technique,E,E05.200.812.375,Immunologic Tests,Clinical Laboratory Techniques,3
Hemolytic Plaque Technique,E,E05.478.594.375,Immunologic Tests,Immunologic Techniques,3
Hemopexin,D,D12.776.124.050.350,Acute-Phase Proteins,Blood Proteins,3
Hemopexin,D,D12.776.124.790.223.338,Beta-Globulins,Serum Globulins,3
Hemopexin,D,D12.776.395.401,Glycoproteins,Proteins,3
Hemopexin,D,D12.776.377.715.182.338,Beta-Globulins,Serum Globulins,3
Hemostatic Techniques,E,E02.520,Therapeutics,NULL,3
Hepatitis Delta Virus,B,B04.820.480.875,Negative-Sense RNA Viruses,RNA Viruses,3
Hepatitis Delta Virus,B,B04.265.270,Defective Viruses,Viruses,3
Hepatitis Delta Virus,B,B04.450.411,Hepatitis Viruses,Viruses,3
Hepatitis Viruses,B,B04.450,Viruses,NULL,3
Hereditary Breast and Ovarian Cancer Syndrome,C,C04.588.322.455.431,Ovarian Neoplasms,Endocrine Gland Neoplasms,3
Hereditary Breast and Ovarian Cancer Syndrome,C,C04.588.180.483,Breast Neoplasms,Neoplasms by Site,3
Hereditary Breast and Ovarian Cancer Syndrome,C,C04.700.517,"Neoplastic Syndromes, Hereditary",Neoplasms,3
Hereditary Breast and Ovarian Cancer Syndrome,C,C19.344.410.431,Ovarian Neoplasms,Endocrine Gland Neoplasms,3
Hereditary Breast and Ovarian Cancer Syndrome,C,C19.391.630.705.431,Ovarian Neoplasms,Ovarian Diseases,3
Hereditary Breast and Ovarian Cancer Syndrome,C,C13.351.500.056.630.705.431,Ovarian Neoplasms,Ovarian Diseases,3
Hereditary Breast and Ovarian Cancer Syndrome,C,C13.351.937.418.685.431,Ovarian Neoplasms,"Genital Neoplasms, Female",3
Hereditary Breast and Ovarian Cancer Syndrome,C,C17.800.090.500.483,Breast Neoplasms,Breast Diseases,3
Hereditary Breast and Ovarian Cancer Syndrome,C,C16.320.700.517,"Neoplastic Syndromes, Hereditary","Genetic Diseases, Inborn",3
"Hernia, Abdominal",C,C23.300.707.374,Hernia,"Pathological Conditions, Anatomical",3
Herpes Simplex Virus Vaccines,D,D20.215.894.899.290.400,Herpesvirus Vaccines,Viral Vaccines,3
"Heterocyclic Compounds, 4 or More Rings",D,D03.633.400,"Heterocyclic Compounds, Fused-Ring",Heterocyclic Compounds,3
Hexosaminidases,D,D08.811.277.450.483,Glycoside Hydrolases,Hydrolases,3
"Hierarchy, Social",I,I01.880.853.200,Sociological Factors,Sociology,3
High Mobility Group Proteins,D,D12.776.660.235.400,"Chromosomal Proteins, Non-Histone",Nuclear Proteins,3
High Mobility Group Proteins,D,D12.776.664.235.400,"Chromosomal Proteins, Non-Histone",Nucleoproteins,3
Hip Dislocation,C,C26.289.384,Joint Dislocations,Wounds and Injuries,3
Hip Dislocation,C,C26.531.500,Hip Injuries,Wounds and Injuries,3
Hip Dislocation,C,C05.550.518.384,Joint Dislocations,Joint Diseases,3
Hippocratic Oath,K,K01.752.566.479.171.132.750.551,"Ethics, Medical","Ethics, Clinical",3
Hippocratic Oath,K,K01.752.566.479.068.400,Codes of Ethics,Ethics,3
Hippocratic Oath,N,N05.350.340.162.500.500,"Ethics, Medical","Ethics, Clinical",3
Hippocratic Oath,N,N05.350.213.400,Codes of Ethics,Ethics,3
Histamine,D,D02.092.471.440,Ethylamines,Amines,3
Histamine,D,D02.092.211.215.501,Biogenic Monoamines,Biogenic Amines,3
Histamine,D,D23.469.050.300,Autacoids,Inflammation Mediators,3
Histamine,D,D03.383.129.308.373,Imidazoles,Azoles,3
Histamine H1 Antagonists,D,D27.505.519.625.375.425.400,Histamine Antagonists,Histamine Agents,3
Histamine H1 Antagonists,D,D27.505.696.577.375.425.400,Histamine Antagonists,Histamine Agents,3
Histamine H2 Antagonists,D,D27.505.696.577.375.425.425,Histamine Antagonists,Histamine Agents,3
Histamine H2 Antagonists,D,D27.505.519.625.375.425.425,Histamine Antagonists,Histamine Agents,3
Histamine Release,G,G12.350,Immune System Phenomena,NULL,3
Histidine Kinase,D,D08.811.913.696.620.682.424,Protein Kinases,Phosphotransferases (Alcohol Group Acceptor),3
Histocompatibility Antigens,D,D23.050.705.552,Isoantigens,Antigens,3
Histocompatibility Antigens,D,D23.050.301.500,"Antigens, Surface",Antigens,3
Histone Acetyltransferases,D,D08.811.913.050.134.415.500,Lysine Acetyltransferases,Acetyltransferases,3
HIV Fusion Inhibitors,D,D27.505.519.957.500,Viral Fusion Protein Inhibitors,Molecular Mechanisms of Pharmacological Action,3
HIV Fusion Inhibitors,D,D27.505.954.122.388.538.500,Viral Fusion Protein Inhibitors,Antiviral Agents,3
HIV Fusion Inhibitors,D,D27.505.954.122.388.077.088.209,Anti-HIV Agents,Anti-Retroviral Agents,3
HIV Serosorting,F,F01.145.699.400,Risk Reduction Behavior,Behavior,3
HIV Serosorting,F,F01.145.802.400,Sexual Behavior,Behavior,3
HIV Wasting Syndrome,C,C18.654.940.520,Wasting Syndrome,Nutrition Disorders,3
HIV Wasting Syndrome,C,C18.452.915.520,Wasting Syndrome,Metabolic Diseases,3
HIV Wasting Syndrome,C,C20.673.480.520,HIV Infections,Immunologic Deficiency Syndromes,3
HIV Wasting Syndrome,C,C01.925.813.400.520,HIV Infections,"Sexually Transmitted Diseases, Viral",3
HIV Wasting Syndrome,C,C01.925.782.815.616.400.520,HIV Infections,Lentivirus Infections,3
HIV Wasting Syndrome,C,C01.778.640.400.520,HIV Infections,"Sexually Transmitted Diseases, Viral",3
HIV Wasting Syndrome,C,C01.221.250.875.520,HIV Infections,Blood-Borne Infections,3
HIV Wasting Syndrome,C,C01.221.812.640.400.520,HIV Infections,"Sexually Transmitted Diseases, Viral",3
HIV-Associated Lipodystrophy Syndrome,C,C01.221.812.640.400.530,HIV Infections,"Sexually Transmitted Diseases, Viral",3
HIV-Associated Lipodystrophy Syndrome,C,C01.221.250.875.550,HIV Infections,Blood-Borne Infections,3
HIV-Associated Lipodystrophy Syndrome,C,C01.778.640.400.530,HIV Infections,"Sexually Transmitted Diseases, Viral",3
HIV-Associated Lipodystrophy Syndrome,C,C01.925.782.815.616.400.550,HIV Infections,Lentivirus Infections,3
HIV-Associated Lipodystrophy Syndrome,C,C01.925.813.400.530,HIV Infections,"Sexually Transmitted Diseases, Viral",3
HIV-Associated Lipodystrophy Syndrome,C,C20.673.480.400,HIV Infections,Immunologic Deficiency Syndromes,3
HIV-Associated Lipodystrophy Syndrome,C,C18.452.880.391.400,Lipodystrophy,"Skin Diseases, Metabolic",3
HIV-Associated Lipodystrophy Syndrome,C,C18.452.584.625.400,Lipodystrophy,Lipid Metabolism Disorders,3
HIV-Associated Lipodystrophy Syndrome,C,C17.800.849.391.400,Lipodystrophy,"Skin Diseases, Metabolic",3
HLA-B8 Antigen,D,D23.050.705.552.100.500.080,HLA-B Antigens,Histocompatibility Antigens Class I,3
HLA-B8 Antigen,D,D23.050.705.552.450.380.080,HLA-B Antigens,HLA Antigens,3
HLA-B8 Antigen,D,D23.050.301.500.450.380.080,HLA-B Antigens,HLA Antigens,3
HLA-B8 Antigen,D,D23.050.301.500.100.500.080,HLA-B Antigens,Histocompatibility Antigens Class I,3
HLA-B8 Antigen,D,D12.776.543.550.439.500.080,HLA-B Antigens,Histocompatibility Antigens Class I,3
HLA-B8 Antigen,D,D12.776.395.550.489.500.080,HLA-B Antigens,Histocompatibility Antigens Class I,3
HLA-DP beta-Chains,D,D12.776.395.550.509.400.420.750,HLA-DP Antigens,HLA-D Antigens,3
HLA-DP beta-Chains,D,D12.776.543.550.440.400.420.750,HLA-DP Antigens,HLA-D Antigens,3
HLA-DP beta-Chains,D,D23.050.301.500.400.400.420.750,HLA-DP Antigens,HLA-D Antigens,3
HLA-DP beta-Chains,D,D23.050.301.500.450.400.420.750,HLA-DP Antigens,HLA-D Antigens,3
HLA-DP beta-Chains,D,D23.050.705.552.410.400.420.750,HLA-DP Antigens,HLA-D Antigens,3
HLA-DP beta-Chains,D,D23.050.705.552.450.400.420.750,HLA-DP Antigens,HLA-D Antigens,3
HMGB1 Protein,D,D12.776.664.235.400.600.300,HMGB Proteins,High Mobility Group Proteins,3
HMGB1 Protein,D,D12.776.660.235.400.600.300,HMGB Proteins,High Mobility Group Proteins,3
HMGB1 Protein,D,D12.776.260.356.300,HMGB Proteins,DNA-Binding Proteins,3
Home Health Aides,N,N02.360.067.350,Allied Health Personnel,Health Personnel,3
Home Health Aides,M,M01.526.485.067.350,Allied Health Personnel,Health Personnel,3
Honey,J,J02.500.581,Food,Food and Beverages,3
Honey,G,G07.203.300.581,Food,"Diet, Food, and Nutrition",3
Hospices,N,N02.278.421.556.185,"Hospitals, Special",Hospitals,3
Hospices,N,N02.421.143.550,Community Health Services,Health Services,3
"Hospital Bed Capacity, 500 and over",N,N02.278.306.472.300,Hospital Bed Capacity,Health Facility Size,3
Hospital Planning,N,N03.349.650.250.200,Health Facility Planning,Regional Health Planning,3
Hospital Rapid Response Team,N,N04.590.715.550,Patient Care Team,Patient Care Management,3
Hospital Restructuring,N,N04.452.442.452.550,Hospital Administration,Health Facility Administration,3
Hospital Restructuring,N,N02.278.216.500.988,Hospital Administration,Health Facility Administration,3
"Hospitals, Chronic Disease",N,N02.278.421.556.200,"Hospitals, Special",Hospitals,3
"Hospitals, Low-Volume",N,N02.278.421.434,Hospitals,Health Facilities,3
"Hospitals, State",N,N02.278.421.510.300,"Hospitals, Public",Hospitals,3
Houseflies,B,B01.050.500.131.617.720.500.500.750.642.470,Muscidae,Diptera,3
"Housekeeping, Hospital",N,N02.278.216.500.968.412,Hospital Departments,Hospital Administration,3
"Housekeeping, Hospital",N,N02.508.472,Housekeeping,"Health Care Facilities, Manpower, and Services",3
"Housekeeping, Hospital",N,N04.452.442.452.422.412,Hospital Departments,Hospital Administration,3
HSP40 Heat-Shock Proteins,D,D12.776.580.216.292,Heat-Shock Proteins,Molecular Chaperones,3
HT29 Cells,A,A11.251.210.190.475,"Cell Line, Tumor",Cell Line,3
HT29 Cells,A,A11.251.860.180.475,"Cell Line, Tumor","Tumor Cells, Cultured",3
HT29 Cells,A,A11.436.365,Epithelial Cells,Cells,3
Human T-lymphotropic virus 2,B,B04.613.807.200.730.399,Primate T-lymphotropic virus 2,Deltaretrovirus,3
Human T-lymphotropic virus 2,B,B04.820.650.200.730.404,Primate T-lymphotropic virus 2,Deltaretrovirus,3
Humeral Fractures,C,C26.404.500,"Fractures, Bone",Wounds and Injuries,3
Humeral Fractures,C,C26.088.390,Arm Injuries,Wounds and Injuries,3
Hydrogen,D,D01.268.406,Elements,Inorganic Chemicals,3
Hydrogen,D,D01.362.340,Gases,Inorganic Chemicals,3
Hydroxides,D,D01.248.497.158.459,Anions,Ions,3
Hydroxides,D,D01.045.250,Alkalies,Inorganic Chemicals,3
Hydroxybutyrates,D,D02.241.081.114.937,Butyrates,"Acids, Acyclic",3
Hydroxybutyrates,D,D02.241.511.429,Hydroxy Acids,Carboxylic Acids,3
Hydroxybutyrates,D,D10.251.400.143.781,Butyrates,"Fatty Acids, Volatile",3
Hyperaldosteronism,C,C19.053.800.604,Adrenocortical Hyperfunction,Adrenal Gland Diseases,3
Hyperemia,C,C14.907.474,Vascular Diseases,Cardiovascular Diseases,3
Hyperhomocysteinemia,C,C18.452.603.378,Malabsorption Syndromes,Metabolic Diseases,3
Hyperhomocysteinemia,C,C18.452.648.100.480,"Amino Acid Metabolism, Inborn Errors","Metabolism, Inborn Errors",3
Hyperhomocysteinemia,C,C16.320.565.100.480,"Amino Acid Metabolism, Inborn Errors","Metabolism, Inborn Errors",3
Hyperhomocysteinemia,C,C18.654.521.500.133.699.418,Vitamin B Deficiency,Avitaminosis,3
Hypernatremia,C,C18.452.950.452,Water-Electrolyte Imbalance,Metabolic Diseases,3
"Hyperparathyroidism, Secondary",C,C19.642.355.480,Hyperparathyroidism,Parathyroid Diseases,3
"Hypertension, Portal",C,C06.552.494,Liver Diseases,Digestive System Diseases,3
"Hyperthermia, Induced",E,E02.565,Therapeutics,NULL,3
Hyperuricemia,C,C23.550.449,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",3
Hypocalcemia,C,C18.452.950.509,Water-Electrolyte Imbalance,Metabolic Diseases,3
Hypocalcemia,C,C18.452.174.509,Calcium Metabolism Disorders,Metabolic Diseases,3
Hypogonadism,C,C19.391.482,Gonadal Disorders,Endocrine System Diseases,3
Hypophosphatasia,C,C18.452.648.618.482,"Metal Metabolism, Inborn Errors","Metabolism, Inborn Errors",3
Hypophosphatasia,C,C16.320.565.618.482,"Metal Metabolism, Inborn Errors","Metabolism, Inborn Errors",3
Hypoxanthine,D,D03.633.100.759.758.399.475,Hypoxanthines,Purinones,3
Illegitimacy,I,I01.880.853.150.465,Family,Sociological Factors,3
Illegitimacy,I,I01.880.735.424,Social Problems,Sociology,3
Imatinib Mesylate,D,D03.383.606.405,Piperazines,"Heterocyclic Compounds, 1-Ring",3
Imatinib Mesylate,D,D03.383.742.349,Pyrimidines,"Heterocyclic Compounds, 1-Ring",3
Imatinib Mesylate,D,D02.455.426.559.389.127.085.465,Benzamides,Benzoates,3
Imatinib Mesylate,D,D02.241.223.100.100.435,Benzamides,Benzoates,3
Imatinib Mesylate,D,D02.065.277.456,Benzamides,Amides,3
Imidazolidines,D,D03.383.129.308.432,Imidazoles,Azoles,3
Imidazolines,D,D03.383.129.308.436,Imidazoles,Azoles,3
Imipenem,D,D03.633.100.300.124.300.500,Thienamycins,Carbapenems,3
Imipenem,D,D02.065.589.099.124.300.500,Thienamycins,Carbapenems,3
Immobilization,E,E05.472,Investigative Techniques,NULL,3
Immune Complex Diseases,C,C20.543.520,Hypersensitivity,Immune System Diseases,3
Immunoglobulin Heavy Chains,D,D12.776.377.715.548.705.500,Immunoglobulin Subunits,Immunoglobulins,3
Immunoglobulin Heavy Chains,D,D12.776.124.486.485.705.500,Immunoglobulin Subunits,Immunoglobulins,3
Immunoglobulin Heavy Chains,D,D12.776.124.790.651.705.500,Immunoglobulin Subunits,Immunoglobulins,3
Immunomagnetic Separation,E,E02.095.437,Biological Therapy,Therapeutics,3
Immunomagnetic Separation,E,E05.242.363.441,Cell Separation,Cytological Techniques,3
Immunomagnetic Separation,E,E05.200.500.363.441,Cell Separation,Cytological Techniques,3
"Immunotherapy, Active",E,E05.478.550.600,Immunization,Immunologic Techniques,3
"Immunotherapy, Active",E,E02.095.465.425.400.530,Immunization,Immunotherapy,3
Incineration,N,N06.850.860.510.900.600.500,Refuse Disposal,Waste Management,3
Inclusion Bodies,A,A11.284.420,Cellular Structures,Cells,3
Income Tax,N,N03.219.900.250,Taxes,Economics,3
Indian Ocean,Z,Z01.756.342,Oceans and Seas,Geographic Locations,3
Indomethacin,D,D03.633.100.473.420,Indoles,"Heterocyclic Compounds, 2-Ring",3
Infection Control Practitioners,N,N02.360.490,Health Personnel,"Health Care Facilities, Manpower, and Services",3
Infection Control Practitioners,M,M01.526.485.490,Health Personnel,Occupational Groups,3
Information Technology,L,L01.479,Information Science,NULL,3
Inhalation,G,G09.772.705.700.390,Respiratory Mechanics,Respiration,3
Inhibitor of Apoptosis Proteins,D,D08.811.464.938.750.210,Ubiquitin-Protein Ligases,Ubiquitin-Protein Ligase Complexes,3
Inhibitor of Apoptosis Proteins,D,D12.644.360.075.437,Apoptosis Regulatory Proteins,Intracellular Signaling Peptides and Proteins,3
Inhibitor of Apoptosis Proteins,D,D12.776.476.075.437,Apoptosis Regulatory Proteins,Intracellular Signaling Peptides and Proteins,3
"Injections, Intralesional",E,E02.319.267.530.430,Injections,Drug Administration Routes,3
Inositol Phosphates,D,D09.894.480,Sugar Phosphates,Carbohydrates,3
Inositol Phosphates,D,D09.853.519.400,Inositol,Sugar Alcohols,3
Inositol Phosphates,D,D02.033.800.519.400,Inositol,Sugar Alcohols,3
Insulin Secretion,G,G07.475,Physiological Phenomena,NULL,3
Insulin Secretion,G,G03.442,Metabolism,NULL,3
"Insulin, Long-Acting",D,D12.644.548.586.200.300,Insulins,Pancreatic Hormones,3
"Insulin, Long-Acting",D,D06.472.699.587.200.300,Insulins,Pancreatic Hormones,3
Insulin-Like Growth Factor Binding Protein 1,D,D12.776.157.420.250,Insulin-Like Growth Factor Binding Proteins,Carrier Proteins,3
Insulin-Like Growth Factor Binding Protein 5,D,D12.776.157.420.290,Insulin-Like Growth Factor Binding Proteins,Carrier Proteins,3
Insulins,D,D12.644.548.586.200,Pancreatic Hormones,Peptide Hormones,3
Insulins,D,D06.472.699.587.200,Pancreatic Hormones,Peptide Hormones,3
Insurance Claim Review,N,N03.219.521.576.215,Insurance,"Financing, Organized",3
"Insurance, Pharmaceutical Services",N,N03.219.521.576.343.575,"Insurance, Health",Insurance,3
Integrin beta1,D,D12.776.543.750.705.408.200.500,Integrin beta Chains,Integrins,3
Integrin beta3,D,D12.776.543.750.705.408.200.750,Integrin beta Chains,Integrins,3
Interdisciplinary Research,H,H01.770.644.287,Research,Science,3
Interferon Regulatory Factor-3,D,D12.776.476.024.385.374,Interferon Regulatory Factors,"Adaptor Proteins, Signal Transducing",3
Interferon Regulatory Factor-3,D,D12.776.744.562,Phosphoproteins,Proteins,3
Interferon Regulatory Factor-3,D,D12.776.930.332.374,Interferon Regulatory Factors,Transcription Factors,3
Interferon Regulatory Factor-3,D,D12.644.360.024.302.374,Interferon Regulatory Factors,"Adaptor Proteins, Signal Transducing",3
Interferon Regulatory Factor-3,D,D12.776.157.057.050.374,Interferon Regulatory Factors,"Adaptor Proteins, Signal Transducing",3
Interferon Regulatory Factor-3,D,D12.776.260.504.374,Interferon Regulatory Factors,DNA-Binding Proteins,3
Interleukin-10 Receptor alpha Subunit,D,D12.776.543.750.705.852.420.550.500,"Receptors, Interleukin-10","Receptors, Interleukin",3
Interleukin-1alpha,D,D12.776.467.374.500.400.300,Interleukin-1,Monokines,3
Interleukin-1alpha,D,D12.776.467.374.465.010.300,Interleukin-1,Interleukins,3
Interleukin-1alpha,D,D23.529.374.465.131.300,Interleukin-1,Interleukins,3
Interleukin-1alpha,D,D23.529.374.500.400.300,Interleukin-1,Monokines,3
Interleukin-1alpha,D,D12.644.276.374.465.010.300,Interleukin-1,Interleukins,3
Interleukin-1alpha,D,D12.644.276.374.500.400.300,Interleukin-1,Monokines,3
Interleukin-7 Receptor alpha Subunit,D,D12.776.543.750.705.852.420.420.450,"Receptors, Interleukin-7","Receptors, Interleukin",3
Intermediate Care Facilities,N,N02.278.825.610.480,Nursing Homes,Residential Facilities,3
Internet Use,L,L01.224.230.110.500.673,Internet,Computer Communication Networks,3
Internet Use,L,L01.143.580,Communication,Information Science,3
Intra-Abdominal Fat,A,A10.165.114.830.500.500,Abdominal Fat,"Adipose Tissue, White",3
Intraabdominal Infections,C,C01.463,Infections,NULL,3
Intra-Aortic Balloon Pumping,E,E04.050.215.400,Counterpulsation,Assisted Circulation,3
Intracranial Arteriovenous Malformations,C,C16.131.666.190.500,Central Nervous System Vascular Malformations,Nervous System Malformations,3
Intracranial Arteriovenous Malformations,C,C16.131.240.850.875.500,Central Nervous System Vascular Malformations,Vascular Malformations,3
Intracranial Arteriovenous Malformations,C,C16.131.240.850.750.295,Arteriovenous Malformations,Vascular Malformations,3
Intracranial Arteriovenous Malformations,C,C14.907.253.560.400,Intracranial Arterial Diseases,Cerebrovascular Disorders,3
Intracranial Arteriovenous Malformations,C,C14.907.150.295,Arteriovenous Malformations,Vascular Diseases,3
Intracranial Arteriovenous Malformations,C,C14.240.850.750.295,Arteriovenous Malformations,Vascular Malformations,3
Intracranial Arteriovenous Malformations,C,C14.240.850.875.500,Central Nervous System Vascular Malformations,Vascular Malformations,3
Intracranial Arteriovenous Malformations,C,C10.500.190.500,Central Nervous System Vascular Malformations,Nervous System Malformations,3
Intracranial Arteriovenous Malformations,C,C10.228.140.300.520,Cerebrovascular Disorders,Brain Diseases,3
Intracranial Embolism,C,C10.228.140.300.525.400,Intracranial Embolism and Thrombosis,Cerebrovascular Disorders,3
Intracranial Embolism,C,C14.907.253.566.300,Intracranial Embolism and Thrombosis,Cerebrovascular Disorders,3
Intracranial Embolism,C,C14.907.355.590.213.300,Intracranial Embolism and Thrombosis,Thromboembolism,3
"Intrauterine Devices, Copper",E,E07.190.250.510.520.300,"Intrauterine Devices, Medicated",Intrauterine Devices,3
Introduced Species,G,G16.500.275.157.049.400,Biodiversity,Ecosystem,3
Introduced Species,N,N06.230.124.049.400,Biodiversity,Ecosystem,3
Introduced Species,B,B01.050.050.580,Animal Population Groups,Animals,3
Ion Channels,D,D12.776.543.550.450,Membrane Glycoproteins,Membrane Proteins,3
Ion Channels,D,D12.776.543.585.400,Membrane Transport Proteins,Membrane Proteins,3
Ion Channels,D,D12.776.157.530.400,Membrane Transport Proteins,Carrier Proteins,3
Ionomycin,D,D10.251.355.391,"Fatty Acids, Unsaturated",Fatty Acids,3
Ions,D,D01.248.497,Electrolytes,Inorganic Chemicals,3
Iron Overload,C,C18.452.565.500,Iron Metabolism Disorders,Metabolic Diseases,3
Irritable Mood,F,F01.470.047.110,Affect,Emotions,3
Isoquinolines,D,D03.633.100.531,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",3
Isotopes,D,D01.496,Inorganic Chemicals,NULL,3
Itraconazole,D,D03.383.606.530,Piperazines,"Heterocyclic Compounds, 1-Ring",3
Itraconazole,D,D03.383.129.799.550,Triazoles,Azoles,3
Jejunal Diseases,C,C06.405.469.600,Intestinal Diseases,Gastrointestinal Diseases,3
Joint Instability,C,C05.550.521,Joint Diseases,Musculoskeletal Diseases,3
Juvenile Hormones,D,D06.472.445.573.666,Insect Hormones,Invertebrate Hormones,3
K562 Cells,A,A11.251.860.180.510,"Cell Line, Tumor","Tumor Cells, Cultured",3
K562 Cells,A,A11.251.210.190.510,"Cell Line, Tumor",Cell Line,3
K562 Cells,A,A11.443.240.497.480,Erythroid Precursor Cells,Erythrocytes,3
Kaposi Varicelliform Eruption,C,C01.925.825.320.410,Herpes Simplex,"Skin Diseases, Viral",3
Kaposi Varicelliform Eruption,C,C01.925.256.466.382.410,Herpes Simplex,Herpesviridae Infections,3
Kaposi Varicelliform Eruption,C,C17.800.838.790.320.410,Herpes Simplex,"Skin Diseases, Viral",3
Kentucky,Z,Z01.107.567.875.075.400,Appalachian Region,United States,3
Kentucky,Z,Z01.107.567.875.510.400,Midwestern United States,United States,3
Keratins,D,D05.750.078.593.450,Intermediate Filament Proteins,Biopolymers,3
Keratins,D,D12.776.220.475.450,Intermediate Filament Proteins,Cytoskeletal Proteins,3
Keratins,D,D12.776.860.607,Scleroproteins,Proteins,3
"Keratitis, Herpetic",C,C11.204.564.425,Keratitis,Corneal Diseases,3
"Keratitis, Herpetic",C,C11.294.800.475,"Eye Infections, Viral",Eye Infections,3
"Keratitis, Herpetic",C,C01.925.256.466.382.465,Herpes Simplex,Herpesviridae Infections,3
"Keratitis, Herpetic",C,C01.925.325.465,"Eye Infections, Viral",Virus Diseases,3
"Keratitis, Herpetic",C,C01.375.725.465,"Eye Infections, Viral",Eye Infections,3
Keratosis,C,C17.800.428,Skin Diseases,Skin and Connective Tissue Diseases,3
Kerosene,D,D20.345.630.600,Petroleum,Fossil Fuels,3
Kerosene,N,N06.230.132.258.630.600,Petroleum,Fossil Fuels,3
Klebsiella oxytoca,B,B03.660.250.150.400.580,Klebsiella,Enterobacteriaceae,3
Klebsiella oxytoca,B,B03.440.450.425.425.580,Klebsiella,Enterobacteriaceae,3
Knee,A,A01.378.610.450,Lower Extremity,Extremities,3
Kupffer Cells,A,A11.627.482.588,Macrophages,Myeloid Cells,3
Kupffer Cells,A,A11.329.372.588,Macrophages,Connective Tissue Cells,3
Kupffer Cells,A,A11.733.397.588,Macrophages,Phagocytes,3
Kupffer Cells,A,A15.382.680.397.588,Macrophages,Phagocytes,3
Kupffer Cells,A,A15.382.670.522.588,Macrophages,Mononuclear Phagocyte System,3
Kynurenine,D,D12.125.608,Amino Acids,"Amino Acids, Peptides, and Proteins",3
"Labor Stage, Second",G,G08.686.784.769.326.500.090,Labor Onset,"Labor, Obstetric",3
Lac Operon,G,G05.360.340.358.207.500.545,Operon,"Genome, Bacterial",3
Lac Operon,G,G05.360.340.024.686.545,Operon,Genome Components,3
Lacrimal Apparatus Diseases,C,C11.496,Eye Diseases,NULL,3
Lactams,D,D02.065.589,Amides,Organic Chemicals,3
Lactams,D,D03.383.411,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,3
Lactulose,D,D09.947.750.423,Disaccharides,Sugars,3
Lactulose,D,D09.698.629.305.423,Disaccharides,Oligosaccharides,3
"Lameness, Animal",C,C22.510,Animal Diseases,NULL,3
Laminin,D,D12.776.395.550.530,Membrane Glycoproteins,Glycoproteins,3
Laminin,D,D12.776.860.300.675,Extracellular Matrix Proteins,Scleroproteins,3
Laminin,D,D12.776.543.550.500,Membrane Glycoproteins,Membrane Proteins,3
Lamotrigine,D,D03.383.931.480,Triazines,"Heterocyclic Compounds, 1-Ring",3
Learning Curve,F,F02.784.629.529.274,Learning,"Psychology, Educational",3
Leg Dermatoses,C,C17.800.446,Skin Diseases,Skin and Connective Tissue Diseases,3
Legionella,B,B03.440.400.425.450.450,Legionellaceae,Gram-Negative Aerobic Rods and Cocci,3
Legionella,B,B03.660.250.460.460,Legionellaceae,Gammaproteobacteria,3
"Legislation, Pharmacy",N,N03.706.615.615,Legislation as Topic,"Social Control, Formal",3
Lentivirus Infections,C,C01.925.782.815.616,Retroviridae Infections,RNA Virus Infections,3
"Leprosy, Paucibacillary",C,C01.150.252.410.040.552.475.371.850,Leprosy,"Mycobacterium Infections, Nontuberculous",3
"Leukemia Virus, Bovine",B,B04.820.650.200.600,Deltaretrovirus,Retroviridae,3
"Leukemia Virus, Bovine",B,B04.613.807.200.600,Deltaretrovirus,Retroviridae,3
"Leukemia Virus, Feline",B,B04.613.807.375.500,Gammaretrovirus,Retroviridae,3
"Leukemia Virus, Feline",B,B04.820.650.375.500,Gammaretrovirus,Retroviridae,3
"Leukemia, Feline",C,C01.925.782.815.622,Retroviridae Infections,RNA Virus Infections,3
"Leukemia, Feline",C,C04.557.337.385,Leukemia,Neoplasms by Histologic Type,3
"Leukemia, Feline",C,C22.180.500,Cat Diseases,Animal Diseases,3
Leukorrhea,C,C13.351.500.894.700.500,Vaginal Discharge,Vaginal Diseases,3
Lewis Blood Group Antigens,D,D23.050.301.290.544,Blood Group Antigens,"Antigens, Surface",3
Lewis Blood Group Antigens,D,D23.050.705.230.544,Blood Group Antigens,Isoantigens,3
"Licensure, Pharmacy",N,N03.706.110.510.560,Licensure,Credentialing,3
"Licensure, Pharmacy",N,N05.700.200.450.625,Licensure,Credentialing,3
Light Coagulation,E,E04.540.630,Ophthalmologic Surgical Procedures,"Surgical Procedures, Operative",3
Light Coagulation,E,E04.350.750,"Hemostasis, Surgical","Surgical Procedures, Operative",3
Light Coagulation,E,E02.520.745,Hemostatic Techniques,Therapeutics,3
Lignans,D,D02.455.426.559.389.140.450,Benzyl Compounds,Benzene Derivatives,3
"Limb Deformities, Congenital",C,C16.131.621.585,Musculoskeletal Abnormalities,Congenital Abnormalities,3
"Limb Deformities, Congenital",C,C05.660.585,Musculoskeletal Abnormalities,Musculoskeletal Diseases,3
Linoleic Acid,D,D10.251.355.343.500.500,Linoleic Acids,"Fatty Acids, Omega-6",3
Linoleic Acid,D,D10.251.355.310.515.500,Linoleic Acids,"Fatty Acids, Essential",3
Lip Neoplasms,C,C04.588.443.591.550,Mouth Neoplasms,Head and Neck Neoplasms,3
Lip Neoplasms,C,C07.465.530.550,Mouth Neoplasms,Mouth Diseases,3
Lip Neoplasms,C,C07.465.409.640,Lip Diseases,Mouth Diseases,3
Lipid Peroxidation,G,G03.295.531.587,Oxidation-Reduction,Energy Metabolism,3
Lipid Peroxidation,G,G02.111.515,Biochemical Phenomena,Chemical Phenomena,3
Lipopeptides,D,D10.477,Lipids,NULL,3
Lipopeptides,D,D12.644.365,Peptides,"Amino Acids, Peptides, and Proteins",3
Literature,K,K01.517,Humanities,NULL,3
Lithium,D,D01.552.547.290,"Metals, Light",Metals,3
Lithium,D,D01.552.528.480,"Metals, Alkali",Metals,3
Lithium,D,D01.268.549.450,"Metals, Alkali",Elements,3
Lithium,D,D01.268.557.290,"Metals, Light",Elements,3
Liver Failure,C,C06.552.308.500,Hepatic Insufficiency,Liver Diseases,3
Lizards,B,B01.050.150.900.833.393,Reptiles,Vertebrates,3
Los Angeles,Z,Z01.107.567.875.580.200.450,California,Pacific States,3
Los Angeles,Z,Z01.107.567.875.760.200.450,California,Southwestern United States,3
Los Angeles,Z,Z01.433.565,Cities,Geographic Locations,3
Loss of Function Mutation,G,G05.365.590.538,Mutation,Genetic Variation,3
L-Selectin,D,D12.776.395.550.200.700.510,Selectins,Cell Adhesion Molecules,3
L-Selectin,D,D12.776.395.550.200.625.903,"Receptors, Lymphocyte Homing",Cell Adhesion Molecules,3
L-Selectin,D,D23.050.301.350.700.510,Selectins,Cell Adhesion Molecules,3
L-Selectin,D,D23.050.301.350.625.903,"Receptors, Lymphocyte Homing",Cell Adhesion Molecules,3
L-Selectin,D,D12.776.543.750.705.877.903,"Receptors, Lymphocyte Homing","Receptors, Immunologic",3
L-Selectin,D,D12.776.543.550.200.700.510,Selectins,Cell Adhesion Molecules,3
L-Selectin,D,D12.776.543.550.200.625.903,"Receptors, Lymphocyte Homing",Cell Adhesion Molecules,3
L-Selectin,D,D12.776.503.843.510,Selectins,Lectins,3
Lung Injury,C,C26.891.554,Thoracic Injuries,Wounds and Injuries,3
Lung Injury,C,C08.381.520,Lung Diseases,Respiratory Tract Diseases,3
Lycopene,D,D02.455.426.392.368.367.379.249.213,Carotenoids,Cyclohexenes,3
Lycopene,D,D02.455.326.271.665.202.216,Carotenoids,Polyenes,3
Lycopene,D,D23.767.261.375,Carotenoids,"Pigments, Biological",3
Lycopene,D,D02.455.849.131.216,Carotenoids,Terpenes,3
Lymphadenopathy,C,C15.604.338,Lymphatic Diseases,Hemic and Lymphatic Diseases,3
Lymphocyte Function-Associated Antigen-1,D,D12.776.395.550.200.625.550,"Receptors, Lymphocyte Homing",Cell Adhesion Molecules,3
Lymphocyte Function-Associated Antigen-1,D,D12.776.395.550.200.074.937,CD11 Antigens,Cell Adhesion Molecules,3
Lymphocyte Function-Associated Antigen-1,D,D12.776.543.550.200.625.550,"Receptors, Lymphocyte Homing",Cell Adhesion Molecules,3
Lymphocyte Function-Associated Antigen-1,D,D12.776.543.550.200.093.937,CD11 Antigens,Cell Adhesion Molecules,3
Lymphocyte Function-Associated Antigen-1,D,D12.776.543.750.705.877.550,"Receptors, Lymphocyte Homing","Receptors, Immunologic",3
Lymphocyte Function-Associated Antigen-1,D,D12.776.543.750.705.408.600.400,"Receptors, Leukocyte-Adhesion",Integrins,3
Lymphocyte Function-Associated Antigen-1,D,D23.050.301.350.625.550,"Receptors, Lymphocyte Homing",Cell Adhesion Molecules,3
Lymphocyte Function-Associated Antigen-1,D,D23.050.301.350.074.400,CD11 Antigens,Cell Adhesion Molecules,3
Lymphocytic choriomeningitis virus,B,B04.820.480.500.070.100.550,"Arenaviruses, Old World",Arenavirus,3
"Lymphoma, B-Cell",C,C04.557.386.480.150,"Lymphoma, Non-Hodgkin",Lymphoma,3
"Lymphoma, B-Cell",C,C15.604.515.569.480.150,"Lymphoma, Non-Hodgkin",Lymphoma,3
"Lymphoma, B-Cell",C,C20.683.515.761.480.150,"Lymphoma, Non-Hodgkin",Lymphoma,3
Lymphopoiesis,G,G04.152.825.597.500,Leukopoiesis,Hematopoiesis,3
Lymphopoiesis,G,G09.188.343.597.500,Leukopoiesis,Hematopoiesis,3
Macrophage Colony-Stimulating Factor,D,D12.776.467.374.410.240.500,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,3
Macrophage Colony-Stimulating Factor,D,D23.529.374.410.240.500,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,3
Macrophage Colony-Stimulating Factor,D,D12.776.395.240.500,Colony-Stimulating Factors,Glycoproteins,3
Macrophage Colony-Stimulating Factor,D,D12.644.276.374.410.240.500,Colony-Stimulating Factors,Hematopoietic Cell Growth Factors,3
Malocclusion,C,C07.793.494,Tooth Diseases,Stomatognathic Diseases,3
Maltose-Binding Proteins,D,D12.776.097.577.500.500,Periplasmic Binding Proteins,Periplasmic Proteins,3
Managed Competition,N,N03.219.521.576.343.820,"Insurance, Health",Insurance,3
Mandatory Testing,N,N03.706.657.500,Mandatory Programs,"Social Control, Formal",3
Mandatory Testing,I,I01.880.604.622.500,Mandatory Programs,"Social Control, Formal",3
Mandatory Testing,N,N06.850.780.200.550,Communicable Disease Control,Public Health Practice,3
Mandatory Testing,N,N06.850.780.500.412,Mass Screening,Public Health Practice,3
Manometry,E,E05.559,Investigative Techniques,NULL,3
Manure,D,D20.601,Complex Mixtures,NULL,3
Marek Disease,C,C01.925.928.489,Tumor Virus Infections,Virus Diseases,3
Marek Disease,C,C01.925.256.466.650,Herpesviridae Infections,DNA Virus Infections,3
Marek Disease,C,C22.131.546,Bird Diseases,Animal Diseases,3
Marek Disease,C,C20.683.515.840,Lymphoproliferative Disorders,Immunoproliferative Disorders,3
Marek Disease,C,C15.604.515.700,Lymphoproliferative Disorders,Lymphatic Diseases,3
Marfan Syndrome,C,C16.131.240.400.720,"Heart Defects, Congenital",Cardiovascular Abnormalities,3
Marfan Syndrome,C,C16.131.077.550,"Abnormalities, Multiple",Congenital Abnormalities,3
Marfan Syndrome,C,C16.320.540,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",3
Marfan Syndrome,C,C17.300.500,Connective Tissue Diseases,Skin and Connective Tissue Diseases,3
Marfan Syndrome,C,C14.240.400.725,"Heart Defects, Congenital",Cardiovascular Abnormalities,3
Marfan Syndrome,C,C14.280.400.725,"Heart Defects, Congenital",Heart Diseases,3
Marfan Syndrome,C,C05.116.099.674,"Bone Diseases, Developmental",Bone Diseases,3
Matrix Metalloproteinase 3,D,D12.776.467.836.200,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,3
Matrix Metalloproteinase 3,D,D12.644.276.848.200,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,3
Matrix Metalloproteinase 3,D,D08.811.277.656.300.480.525.700.200,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,3
Matrix Metalloproteinase 3,D,D08.811.277.656.675.374.525.700.200,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,3
Matrix Metalloproteinase 7,D,D08.811.277.656.675.374.525.700.250,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,3
Matrix Metalloproteinase 7,D,D08.811.277.656.300.480.525.700.250,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,3
Matrix Metalloproteinase 7,D,D12.644.276.848.250,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,3
Matrix Metalloproteinase 7,D,D12.776.467.836.250,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,3
Mauritius,Z,Z01.639.520.520,Indian Ocean Islands,Islands,3
Meconium Aspiration Syndrome,C,C13.703.277.785,Fetal Diseases,Pregnancy Complications,3
Meconium Aspiration Syndrome,C,C16.614.580,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",3
Meconium Aspiration Syndrome,C,C16.300.580,Fetal Diseases,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",3
Meconium Aspiration Syndrome,C,C08.381.520.687,Lung Injury,Lung Diseases,3
Meconium Aspiration Syndrome,C,C08.618.580,Respiration Disorders,Respiratory Tract Diseases,3
Median Nerve,A,A08.800.800.720.050.500,Brachial Plexus,Spinal Nerves,3
Medical Countermeasures,N,N06.850.780.588,Public Health Practice,Public Health,3
Medical Countermeasures,N,N06.230.100.195,Disasters,Environment,3
Medical Illustration,J,J01.897.280.500.480,Audiovisual Aids,Educational Technology,3
Medical Illustration,K,K01.093.410,Art,Humanities,3
Medical Illustration,L,L01.178.820.090.480,Audiovisual Aids,Teaching Materials,3
Medical Illustration,H,H02.385,Health Occupations,NULL,3
Medical Indigency,N,N03.219.780,Economics,Health Care Economics and Organizations,3
Medical Indigency,N,N01.824.460,Socioeconomic Factors,Population Characteristics,3
Medical Missions,I,I01.615.500.750,International Cooperation,Internationality,3
Medical Waste,N,N06.850.460.710.460,Waste Products,Environmental Pollution,3
Medical Waste,D,D20.944.460,Waste Products,Complex Mixtures,3
Medically Unexplained Symptoms,C,C23.888.541,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",3
"Medicine, Chinese Traditional",E,E02.190.488.585.520,"Medicine, East Asian Traditional","Medicine, Traditional",3
"Medicine, Chinese Traditional",I,I01.076.201.450.654.558.520,"Medicine, East Asian Traditional","Medicine, Traditional",3
"Melanoma, Experimental",E,E05.598.500.496.937,"Neoplasms, Experimental","Disease Models, Animal",3
"Melanoma, Experimental",C,C04.619.600,"Neoplasms, Experimental",Neoplasms,3
"Melanoma, Experimental",C,C04.557.465.625.650.510.525,Melanoma,Neuroendocrine Tumors,3
"Melanoma, Experimental",C,C04.557.665.510.525,Melanoma,Nevi and Melanomas,3
"Melanoma, Experimental",C,C04.557.580.625.650.510.525,Melanoma,Neuroendocrine Tumors,3
Melanosis,C,C17.800.621.430.530,Hyperpigmentation,Pigmentation Disorders,3
Membrane Fusion,G,G04.575,Cell Physiological Phenomena,NULL,3
"Membrane Potential, Mitochondrial",G,G04.580.550,Membrane Potentials,Cell Physiological Phenomena,3
"Membrane Potential, Mitochondrial",G,G07.265.675.550,Membrane Potentials,Electrophysiological Phenomena,3
"Membrane Potential, Mitochondrial",G,G03.295.770.500,Proton-Motive Force,Energy Metabolism,3
Memory Consolidation,F,F02.463.425.540.305.500,"Memory, Long-Term",Memory,3
Mentally Ill Persons,M,M01.150.725,Disabled Persons,Persons,3
Mercaptoethanol,D,D02.033.375.534,Ethanol,Alcohols,3
Mercaptoethanol,D,D02.886.489.409,Sulfhydryl Compounds,Sulfur Compounds,3
Mercury Poisoning,C,C25.723.522.875,Heavy Metal Poisoning,Poisoning,3
Mesenchymal Stem Cell Transplantation,E,E02.095.147.500.500.625,Stem Cell Transplantation,Cell Transplantation,3
Mesenchymal Stem Cell Transplantation,E,E04.936.225.687.625,Stem Cell Transplantation,Cell Transplantation,3
Metallocenes,D,D02.691.657,Organometallic Compounds,Organic Chemicals,3
Methacrylates,D,D02.241.081.069.600,Acrylates,"Acids, Acyclic",3
Methyl-Accepting Chemotaxis Proteins,D,D12.644.360.420,Intracellular Signaling Peptides and Proteins,Peptides,3
Methyl-Accepting Chemotaxis Proteins,D,D12.776.097.533,Bacterial Proteins,Proteins,3
Methyl-Accepting Chemotaxis Proteins,D,D12.776.476.420,Intracellular Signaling Peptides and Proteins,Proteins,3
Methyl-Accepting Chemotaxis Proteins,D,D12.776.543.750.054,"Receptors, Cell Surface",Membrane Proteins,3
Methylmercury Compounds,D,D02.691.750.100.738,Alkylmercury Compounds,Organomercury Compounds,3
Microbial Collagenase,D,D08.811.277.656.300.480.205.500,Collagenases,Metalloendopeptidases,3
Microbial Collagenase,D,D08.811.277.656.675.374.205.500,Collagenases,Metalloendopeptidases,3
Microdialysis,E,E05.196.353.500,Dialysis,"Chemistry Techniques, Analytical",3
Microglia,A,A08.637.400,Neuroglia,Nervous System,3
Microglia,A,A11.650.400,Neuroglia,Cells,3
Microinjections,E,E02.319.267.530.690,Injections,Drug Administration Routes,3
Microinjections,E,E05.591.570,Micromanipulation,Investigative Techniques,3
Microvilli,A,A11.284.180.565,Cell Surface Extensions,Cellular Structures,3
Midwestern United States,Z,Z01.107.567.875.510,United States,North America,3
Milk Substitutes,G,G07.203.100.712,Beverages,"Diet, Food, and Nutrition",3
Milk Substitutes,J,J02.200.712,Beverages,Food and Beverages,3
Millets,B,B01.650.940.800.575.912.250.822.587,Poaceae,Magnoliopsida,3
Mindfulness,F,F02.463.551,Mental Processes,Psychological Phenomena,3
Mindfulness,F,F04.754.137.350.500,Cognitive Behavioral Therapy,Behavior Therapy,3
Mineral Fibers,D,D01.578.500,Minerals,Inorganic Chemicals,3
Mitomycin,D,D02.806.400.249.350,Mitomycins,Indolequinones,3
Mitomycin,D,D03.383.097.500.350,Mitomycins,Azirines,3
Mitomycin,D,D03.633.100.473.412.249.350,Mitomycins,Indolequinones,3
"Models, Neurological",E,E05.599.395.642,"Models, Biological","Models, Theoretical",3
"Models, Nursing",E,E05.599.645,"Models, Theoretical",Investigative Techniques,3
Molar,A,A14.549.167.860.525,Tooth,Dentition,3
Molecular Imaging,E,E01.370.350.557,Diagnostic Imaging,Diagnostic Techniques and Procedures,3
Molecular Imaging,E,E05.601.555,Molecular Probe Techniques,Investigative Techniques,3
Molecular Probe Techniques,E,E05.601,Investigative Techniques,NULL,3
"Monitoring, Immunologic",E,E05.478.594.550,Immunologic Tests,Immunologic Techniques,3
"Monitoring, Immunologic",E,E05.200.812.505,Immunologic Tests,Clinical Laboratory Techniques,3
"Monitoring, Immunologic",E,E01.370.225.812.505,Immunologic Tests,Clinical Laboratory Techniques,3
"Monitoring, Immunologic",E,E01.370.520.505,"Monitoring, Physiologic",Diagnostic Techniques and Procedures,3
Monoamine Oxidase,D,D08.811.682.664.750,Oxidoreductases Acting on CH-NH2 Group Donors,Oxidoreductases,3
Montenegro,Z,Z01.542.248.609,"Europe, Eastern",Europe,3
Moringa oleifera,B,B01.650.940.800.575.912.250.752.500,Moringa,Magnoliopsida,3
Mucoproteins,D,D12.776.395.560,Glycoproteins,Proteins,3
Mucus,A,A12.200.503,Bodily Secretions,Fluids and Secretions,3
Multiple Birth Offspring,M,M01.438,Persons,NULL,3
Muromegalovirus,B,B04.280.382.150.500,Betaherpesvirinae,Herpesviridae,3
Muscle Spasticity,C,C05.651.512,Muscular Diseases,Musculoskeletal Diseases,3
Muscle Spasticity,C,C23.888.592.608.550.550,Muscle Hypertonia,Neuromuscular Manifestations,3
Muscle Spasticity,C,C10.597.613.550.550,Muscle Hypertonia,Neuromuscular Manifestations,3
Musculoskeletal Pain,C,C23.888.592.612.547,Pain,Neurologic Manifestations,3
Musculoskeletal Pain,C,C05.651.538,Muscular Diseases,Musculoskeletal Diseases,3
Musculoskeletal Pain,G,G11.561.790.353,Sensation,Nervous System Physiological Phenomena,3
Musculoskeletal Pain,F,F02.830.816.353,Sensation,Psychophysiology,3
Myalgia,F,F02.830.816.353.500,Musculoskeletal Pain,Sensation,3
Myalgia,G,G11.561.790.353.500,Musculoskeletal Pain,Sensation,3
Myalgia,C,C05.651.542,Muscular Diseases,Musculoskeletal Diseases,3
Myalgia,C,C23.888.592.612.547.249,Musculoskeletal Pain,Pain,3
Myalgia,C,C10.668.491.525,Muscular Diseases,Neuromuscular Diseases,3
Mycobacterium abscessus,B,B03.510.460.400.410.552.552.720.050,Nontuberculous Mycobacteria,Mycobacterium,3
Mycobacterium abscessus,B,B03.510.024.962.500.720.050,Nontuberculous Mycobacteria,Mycobacterium,3
Mycobacterium fortuitum,B,B03.510.024.962.500.720.325,Nontuberculous Mycobacteria,Mycobacterium,3
Mycobacterium fortuitum,B,B03.510.460.400.410.552.552.720.325,Nontuberculous Mycobacteria,Mycobacterium,3
Mycoplasma hyopneumoniae,B,B03.440.860.580.553.553.420,Mycoplasma,Mycoplasmataceae,3
Mycoplasma pneumoniae,B,B03.440.860.580.553.553.650,Mycoplasma,Mycoplasmataceae,3
Myeloblastin,D,D08.811.277.656.959.350.530,Serine Endopeptidases,Serine Proteases,3
Myeloblastin,D,D08.811.277.656.300.760.530,Serine Endopeptidases,Endopeptidases,3
Myelodysplastic-Myeloproliferative Diseases,C,C15.378.190.615,Bone Marrow Diseases,Hematologic Diseases,3
Mythology,I,I01.076.201.450.685,Culture,"Anthropology, Cultural",3
Mythology,K,K01.517.647,Literature,Humanities,3
NAD,D,D08.211.589,Coenzymes,Enzymes and Coenzymes,3
NAD,D,D03.633.100.759.646.138.694,Adenine Nucleotides,Purine Nucleotides,3
NAD,D,D13.695.667.138.694,Adenine Nucleotides,Purine Nucleotides,3
NAD,D,D13.695.827.068.694,Adenine Nucleotides,Ribonucleotides,3
NADP Transhydrogenases,D,D08.811.682.608.540,"NADH, NADPH Oxidoreductases",Oxidoreductases,3
Nails,A,A17.600,Integumentary System,NULL,3
Nanostructures,J,J01.637.512,Manufactured Materials,"Technology, Industry, and Agriculture",3
National Cancer Institute (U.S.),I,I01.409.418.750.600.650.496.150,National Institutes of Health (U.S.),United States Public Health Service,3
National Cancer Institute (U.S.),N,N03.540.052.750.150,National Institutes of Health (U.S.),Academies and Institutes,3
National Cancer Institute (U.S.),N,N03.540.348.500.500.600.650.496.150,National Institutes of Health (U.S.),United States Public Health Service,3
Natural Childbirth,G,G08.686.784.769.490.249,Parturition,Pregnancy,3
Natural Family Planning Methods,E,E02.875.194.605,Contraception,Reproductive Techniques,3
Neck Pain,C,C23.888.592.612.553,Pain,Neurologic Manifestations,3
Negative Results,E,E05.318.308.544,Data Collection,Epidemiologic Methods,3
Negative Results,L,L01.399.250.780,Data Collection,Information Management,3
Negative Results,N,N06.850.520.308.544,Data Collection,Epidemiologic Methods,3
Negative Results,N,N05.715.360.300.520,Data Collection,Health Care Evaluation Mechanisms,3
Nelfinavir,D,D03.633.100.531.520,Isoquinolines,"Heterocyclic Compounds, 2-Ring",3
"Neoplasms, Experimental",C,C04.619,Neoplasms,NULL,3
"Neoplasms, Experimental",E,E05.598.500.496,"Disease Models, Animal","Models, Animal",3
Nephelometry and Turbidimetry,E,E05.196.712.650,Photometry,"Chemistry Techniques, Analytical",3
Nephrologists,M,M01.526.485.810.628,Physicians,Health Personnel,3
Nephrologists,N,N02.360.810.628,Physicians,Health Personnel,3
Nerve Endings,A,A08.800.550,Peripheral Nervous System,Nervous System,3
"Neuroma, Acoustic",C,C04.588.614.596.240.015,Cranial Nerve Neoplasms,Peripheral Nervous System Neoplasms,3
"Neuroma, Acoustic",C,C04.588.614.300.015,Cranial Nerve Neoplasms,Nervous System Neoplasms,3
"Neuroma, Acoustic",C,C04.557.580.625.650.595.610,Neurilemmoma,Neuroendocrine Tumors,3
"Neuroma, Acoustic",C,C04.557.580.600.610.595.610,Neurilemmoma,Neuroma,3
"Neuroma, Acoustic",C,C04.557.465.625.650.595.610,Neurilemmoma,Neuroendocrine Tumors,3
"Neuroma, Acoustic",C,C09.218.807.800.675,Vestibulocochlear Nerve Diseases,Retrocochlear Diseases,3
"Neuroma, Acoustic",C,C09.647.675,Otorhinolaryngologic Neoplasms,Otorhinolaryngologic Diseases,3
"Neuroma, Acoustic",C,C10.292.910.600,Vestibulocochlear Nerve Diseases,Cranial Nerve Diseases,3
"Neuroma, Acoustic",C,C10.292.225.750,Cranial Nerve Neoplasms,Cranial Nerve Diseases,3
Neuromuscular Agents,D,D27.505.696.663.700,Peripheral Nervous System Agents,Physiological Effects of Drugs,3
Neurosecretory Systems,A,A08.713,Nervous System,NULL,3
Neurosecretory Systems,A,A06.688,Endocrine System,NULL,3
Neurosurgery,H,H02.403.810.425,"Specialties, Surgical",Medicine,3
N-Formylmethionine Leucyl-Phenylalanine,D,D23.125.685,Chemotactic Factors,Biological Factors,3
N-Formylmethionine Leucyl-Phenylalanine,D,D02.886.030.676.450.440,N-Formylmethionine,Methionine,3
N-Formylmethionine Leucyl-Phenylalanine,D,D12.644.456.400,Oligopeptides,Peptides,3
N-Formylmethionine Leucyl-Phenylalanine,D,D12.125.166.676.450.440,N-Formylmethionine,Methionine,3
N-Formylmethionine Leucyl-Phenylalanine,D,D12.125.142.666.500,Phenylalanine,"Amino Acids, Essential",3
N-Formylmethionine Leucyl-Phenylalanine,D,D12.125.072.050.685.445,Phenylalanine,"Amino Acids, Aromatic",3
Niacin,D,D03.066.515.475,Nicotinic Acids,"Acids, Heterocyclic",3
Niacin,D,D03.383.725.547.475,Nicotinic Acids,Pyridines,3
Nitrofurans,D,D03.383.312.649,Furans,"Heterocyclic Compounds, 1-Ring",3
Nitrofurans,D,D02.640.600,Nitro Compounds,Organic Chemicals,3
"NLR Family, Pyrin Domain-Containing 3 Protein",D,D12.644.360.539.250,NLR Proteins,Intracellular Signaling Peptides and Proteins,3
Nocardia,B,B03.510.024.981.550,Nocardiaceae,Actinobacteria,3
Nodding Syndrome,C,C10.228.140.490.375.525,"Epilepsy, Generalized",Epilepsy,3
"Noise, Transportation",N,N06.850.460.610.680,Noise,Environmental Pollution,3
"Noise, Transportation",N,N06.230.400.550,Noise,Environment,3
Nose Neoplasms,C,C09.647.685,Otorhinolaryngologic Neoplasms,Otorhinolaryngologic Diseases,3
Nose Neoplasms,C,C09.603.669,Nose Diseases,Otorhinolaryngologic Diseases,3
Nose Neoplasms,C,C08.785.600,Respiratory Tract Neoplasms,Respiratory Tract Diseases,3
Nose Neoplasms,C,C08.460.669,Nose Diseases,Respiratory Tract Diseases,3
Nose Neoplasms,C,C04.588.149.721.600,Skull Neoplasms,Bone Neoplasms,3
Nose Neoplasms,C,C04.588.443.665.650,Otorhinolaryngologic Neoplasms,Head and Neck Neoplasms,3
Nose Neoplasms,C,C05.116.231.754.600,Skull Neoplasms,Bone Neoplasms,3
Novobiocin,D,D09.408.554,Glycosides,Carbohydrates,3
Novobiocin,D,D03.383.663.283.446.139.500,Aminocoumarins,Coumarins,3
Novobiocin,D,D03.633.100.150.446.139.500,Aminocoumarins,Coumarins,3
Nuclear Energy,N,N06.230.132.580,Energy-Generating Resources,Environment,3
Nuclear Energy,G,G01.536,Physical Phenomena,NULL,3
"Nuclear Receptor Subfamily 1, Group F, Member 3",D,D12.776.260.643.182,Orphan Nuclear Receptors,DNA-Binding Proteins,3
"Nuclear Receptor Subfamily 1, Group F, Member 3",D,D12.776.826.209.182,Orphan Nuclear Receptors,"Receptors, Cytoplasmic and Nuclear",3
Nucleocapsid,A,A21.249.500,Virion,Viral Structures,3
Nucleosides,D,D13.570,"Nucleic Acids, Nucleotides, and Nucleosides",NULL,3
Nucleosides,D,D09.408.595,Glycosides,Carbohydrates,3
"Nurseries, Infant",N,N02.421.143.098.500,Child Day Care Centers,Community Health Services,3
"Nurseries, Infant",N,N02.278.617,Health Facilities,"Health Care Facilities, Manpower, and Services",3
"Nurseries, Infant",J,J03.160.500,Child Day Care Centers,Non-Medical Public and Private Facilities,3
"Nurses, Community Health",N,N02.360.650.655,Nurses,Health Personnel,3
"Nurses, Community Health",M,M01.526.485.650.655,Nurses,Health Personnel,3
Nursing Administration Research,N,N04.590.233.508.613.385,Nursing Research,Nursing Process,3
Nursing Administration Research,H,H01.770.644.145.390.385,Nursing Research,Biomedical Research,3
Nursing Administration Research,H,H02.478.395.385,Nursing Research,Nursing,3
Nursing Assistants,M,M01.526.485.067.652,Allied Health Personnel,Health Personnel,3
Nursing Assistants,N,N02.360.067.652,Allied Health Personnel,Health Personnel,3
Nursing Education Research,N,N04.590.233.508.613.413,Nursing Research,Nursing Process,3
Nursing Education Research,H,H02.478.395.413,Nursing Research,Nursing,3
Nursing Education Research,H,H01.770.644.145.390.413,Nursing Research,Biomedical Research,3
Nursing Education Research,I,I02.358.462.612,"Education, Nursing","Education, Professional",3
Nuts,J,J02.500.700,Food,Food and Beverages,3
Nuts,G,G07.203.300.700,Food,"Diet, Food, and Nutrition",3
Nuts,A,A18.024.500.500,Fruit,"Plant Components, Aerial",3
"Obesity, Maternal",C,C13.703.417,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,3
"Obesity, Maternal",C,C23.888.144.699.500.125,Obesity,Overweight,3
"Obesity, Maternal",C,C18.654.726.500.633,Obesity,Overnutrition,3
"Obesity, Maternal",E,E01.370.600.115.100.160.120.699.500.312,Obesity,Overweight,3
"Obesity, Maternal",G,G07.100.100.160.120.699.500.312,Obesity,Overweight,3
Obstetric Surgical Procedures,E,E04.520,"Surgical Procedures, Operative",NULL,3
Occludin,D,D12.776.543.940.750,Tight Junction Proteins,Membrane Proteins,3
Occludin,D,D12.776.543.488.500,MARVEL Domain-Containing Proteins,Membrane Proteins,3
Occupational Therapy,E,E02.760.169.063.500.489,Rehabilitation,Aftercare,3
Occupational Therapy,E,E02.831.489,Rehabilitation,Therapeutics,3
Occupational Therapy,H,H02.010.500,Allied Health Occupations,Health Occupations,3
Oceanic Ancestry Group,M,M01.686.508.600,Continental Population Groups,Population Groups,3
Octoxynol,J,J01.637.051.720.741.610,Polyethylene Glycols,Polymers,3
Octoxynol,D,D25.720.741.610,Polyethylene Glycols,Polymers,3
Octoxynol,D,D05.750.741.610,Polyethylene Glycols,Polymers,3
Octoxynol,D,D02.033.455.250.700.660,Polyethylene Glycols,Ethylene Glycols,3
Oil and Gas Industry,J,J01.576.655.875.750,Extraction and Processing Industry,Manufacturing Industry,3
Olfactory Receptor Neurons,A,A04.760.600.640.640,Olfactory Mucosa,Nasal Mucosa,3
Olfactory Receptor Neurons,A,A04.531.520.573.580,Olfactory Mucosa,Nasal Mucosa,3
Olfactory Receptor Neurons,A,A08.675.650.915.500.540,Chemoreceptor Cells,Sensory Receptor Cells,3
Olfactory Receptor Neurons,A,A08.800.950.500.540,Chemoreceptor Cells,Sensory Receptor Cells,3
Olfactory Receptor Neurons,A,A09.531.623.580,Olfactory Mucosa,Nose,3
Olfactory Receptor Neurons,A,A11.671.650.915.500.540,Chemoreceptor Cells,Sensory Receptor Cells,3
Olfactory Receptor Neurons,A,A10.615.550.760.600.640.640,Olfactory Mucosa,Nasal Mucosa,3
"Oligonucleotides, Antisense",D,D27.720.470.530.600.150.640,Antisense Elements (Genetics),Nucleic Acid Probes,3
"Oligonucleotides, Antisense",D,D13.695.578.424.480,Oligonucleotides,Polynucleotides,3
"Oligonucleotides, Antisense",D,D13.150.480,Antisense Elements (Genetics),"Nucleic Acids, Nucleotides, and Nucleosides",3
"Oligonucleotides, Antisense",D,D13.444.600.150.640,Antisense Elements (Genetics),Nucleic Acid Probes,3
Oligospermia,C,C12.294.365.700.508,"Infertility, Male",Infertility,3
omega-N-Methylarginine,D,D12.125.068.050.650,Arginine,"Amino Acids, Basic",3
omega-N-Methylarginine,D,D12.125.095.104.650,Arginine,"Amino Acids, Diamino",3
omega-N-Methylarginine,D,D12.125.142.087.500,Arginine,"Amino Acids, Essential",3
Onychomycosis,C,C17.800.529.550,Nail Diseases,Skin Diseases,3
Onychomycosis,C,C17.800.838.208.883.458,Tinea,Dermatomycoses,3
Onychomycosis,C,C01.150.703.302.720.550,Tinea,Dermatomycoses,3
Onychomycosis,C,C01.800.200.720.550,Tinea,Dermatomycoses,3
Oocyte Retrieval,E,E02.875.800.976,"Reproductive Techniques, Assisted",Reproductive Techniques,3
Oocyte Retrieval,E,E04.936.537.625,Tissue and Organ Harvesting,Transplantation,3
Oocyte Retrieval,E,E05.820.800.976,"Reproductive Techniques, Assisted",Reproductive Techniques,3
Ophthalmoplegia,C,C11.590.472,Ocular Motility Disorders,Eye Diseases,3
Ophthalmoplegia,C,C10.597.622.447,Paralysis,Neurologic Manifestations,3
Ophthalmoplegia,C,C10.292.562.750,Ocular Motility Disorders,Cranial Nerve Diseases,3
Ophthalmoplegia,C,C23.888.592.636.447,Paralysis,Neurologic Manifestations,3
Optics and Photonics,J,J01.293.688,Engineering,"Technology, Industry, and Agriculture",3
Optics and Photonics,H,H01.671.617,Physics,Natural Science Disciplines,3
Optimism,F,F01.100.787,Attitude,Behavior and Behavior Mechanisms,3
Orbital Diseases,C,C11.675,Eye Diseases,NULL,3
Organoids,A,A10.802,Tissues,NULL,3
Orthotic Devices,E,E07.858.442.743,Orthopedic Equipment,Surgical Equipment,3
"Ossification, Heterotopic",C,C23.550.751,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",3
"Otitis Media, Suppurative",C,C09.218.705.663.680,Otitis Media,Otitis,3
"Otitis Media, Suppurative",C,C01.830.694,Suppuration,Infections,3
Otorhinolaryngologic Diseases,C,C09,NULL,NULL,3
Otorhinolaryngologic Surgical Procedures,E,E04.580,"Surgical Procedures, Operative",NULL,3
Palmitic Acids,D,D10.251.694,Fatty Acids,Lipids,3
Pan American Health Organization,N,N03.540.514.718.800.628,World Health Organization,United Nations,3
Pancreatitis,C,C06.689.750,Pancreatic Diseases,Digestive System Diseases,3
Pantoea,B,B03.660.250.150.540,Enterobacteriaceae,Gammaproteobacteria,3
Pantoea,B,B03.440.450.425.580,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,3
Pantothenic Acid,D,D12.125.042.070.500,beta-Alanine,Alanine,3
Pantothenic Acid,D,D02.478.520,Imides,Organic Chemicals,3
Papilledema,C,C10.292.700.900,Optic Nerve Diseases,Cranial Nerve Diseases,3
Papilledema,C,C11.640.710,Optic Nerve Diseases,Eye Diseases,3
Papillomavirus E7 Proteins,D,D12.776.624.664.520.420,"Oncogene Proteins, Viral",Oncogene Proteins,3
Parasympathetic Nervous System,A,A08.800.050.600,Autonomic Nervous System,Peripheral Nervous System,3
Parietal Lobe,A,A08.186.211.200.885.287.500.670,Cerebral Cortex,Cerebrum,3
Parkinsonian Disorders,C,C10.228.662.600,Movement Disorders,Central Nervous System Diseases,3
Parkinsonian Disorders,C,C10.228.140.079.862,Basal Ganglia Diseases,Brain Diseases,3
Partial Pressure,G,G01.374.715.714,Pressure,Mechanical Phenomena,3
Partial Thromboplastin Time,E,E05.200.625.115.600,Blood Coagulation Tests,Hematologic Tests,3
Partial Thromboplastin Time,G,G09.188.660,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,3
Partial Thromboplastin Time,E,E01.370.225.625.115.600,Blood Coagulation Tests,Hematologic Tests,3
Paternalism,F,F01.829.547,"Psychology, Social",Behavior and Behavior Mechanisms,3
"Pathology, Clinical",H,H02.403.650.500,Pathology,Medicine,3
Patient Access to Records,I,I01.880.604.473.352.500.030.500,Access to Information,Privacy,3
Patient Access to Records,I,I01.880.604.473.650.827,Patient Rights,Human Rights,3
Patient Access to Records,N,N03.706.437.650.406,Patient Rights,Human Rights,3
Patient Credit and Collection,N,N03.219.463.030.320,Accounting,Financial Management,3
Patient Harm,N,N06.850.135.060.075.349,Safety,Accident Prevention,3
Patient Harm,N,N06.850.725,Public Health,Environment and Public Health,3
Pelvic Bones,A,A02.835.232.043.825,Bones of Lower Extremity,Bone and Bones,3
Penaeidae,B,B01.050.500.131.365.190.660,Decapoda,Crustacea,3
Penicillin-Binding Proteins,D,D08.811.710,Enzymes,Enzymes and Coenzymes,3
Penicillin-Binding Proteins,D,D12.776.097.545,Bacterial Proteins,Proteins,3
Pentachlorophenol,D,D02.455.426.559.389.657.190.633,Chlorophenols,Phenols,3
Performance-Enhancing Substances,D,D27.505.696.620,Physiological Effects of Drugs,Pharmacologic Actions,3
Pericardial Effusion,C,C14.280.695,Heart Diseases,Cardiovascular Diseases,3
Perinatology,H,H02.403.670.500,Pediatrics,Medicine,3
Periodontal Diseases,C,C07.465.714,Mouth Diseases,Stomatognathic Diseases,3
Periodontal Index,N,N06.850.520.308.980.438.300.725,Dental Health Surveys,Health Surveys,3
Periodontal Index,N,N05.715.360.300.800.438.300.690,Dental Health Surveys,Health Surveys,3
Periodontal Index,E,E05.318.308.980.438.300.725,Dental Health Surveys,Health Surveys,3
Periodontal Index,E,E06.721.658,Periodontics,Dentistry,3
Periodontal Index,E,E06.208.720,Dental Health Surveys,Dentistry,3
Periodontal Index,N,N06.890.160.215,Dental Health Surveys,Public Health Dentistry,3
Periodontal Ligament,A,A14.549.167.646.771,Periodontium,Dentition,3
Peroxidase,D,D08.811.682.732.700,Peroxidases,Oxidoreductases,3
Peroxidases,D,D08.811.682.732,Oxidoreductases,Enzymes,3
Personal Space,F,F01.145.875.596,Spatial Behavior,Behavior,3
Personality Development,F,F01.752.747,Personality,Behavior and Behavior Mechanisms,3
Phenanthrenes,D,D04.615.723,Polycyclic Aromatic Hydrocarbons,Polycyclic Compounds,3
Phenanthrenes,D,D02.455.426.559.847.723,Polycyclic Aromatic Hydrocarbons,"Hydrocarbons, Aromatic",3
Phenylacetates,D,D02.241.223.601,"Acids, Carbocyclic",Carboxylic Acids,3
Phenylalanine,D,D12.125.142.666,"Amino Acids, Essential",Amino Acids,3
Phenylalanine,D,D12.125.072.050.685,"Amino Acids, Aromatic","Amino Acids, Cyclic",3
Philadelphia,Z,Z01.433.820,Cities,Geographic Locations,3
Philadelphia,Z,Z01.107.567.875.500.550.525,Pennsylvania,Mid-Atlantic Region,3
Phosphoinositide Phospholipase C,D,D12.644.360.571,Intracellular Signaling Peptides and Proteins,Peptides,3
Phosphoinositide Phospholipase C,D,D08.811.277.352.640.700.700.562,Type C Phospholipases,Phospholipases,3
Phosphoinositide Phospholipase C,D,D12.776.476.556,Intracellular Signaling Peptides and Proteins,Proteins,3
Phospholipase D,D,D08.811.277.352.640.700.710,Phospholipases,Phosphoric Diester Hydrolases,3
Phospholipases A,D,D08.811.277.352.100.680.750,Phospholipases,Carboxylic Ester Hydrolases,3
Phospholipid Transfer Proteins,D,D12.776.157.674,Carrier Proteins,Proteins,3
Phospholipid Transfer Proteins,D,D12.776.543.693,Membrane Proteins,Proteins,3
Phosphoric Diester Hydrolases,D,D08.811.277.352.640,Esterases,Hydrolases,3
Phosphotransferases,D,D08.811.913.696,Transferases,Enzymes,3
Photometry,E,E05.196.712,"Chemistry Techniques, Analytical",Investigative Techniques,3
Photorhabdus,B,B03.440.450.425.590,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,3
Photorhabdus,B,B03.660.250.150.545,Enterobacteriaceae,Gammaproteobacteria,3
Physical Therapists,N,N02.360.790,Health Personnel,"Health Care Facilities, Manpower, and Services",3
Physical Therapists,M,M01.526.485.790,Health Personnel,Occupational Groups,3
Physician-Nurse Relations,F,F01.829.401.205.500,Interprofessional Relations,Interpersonal Relations,3
Pick Disease of the Brain,F,F03.615.400.380.299.500,Frontotemporal Dementia,Frontotemporal Lobar Degeneration,3
Pick Disease of the Brain,C,C10.228.140.380.266.299.500,Frontotemporal Dementia,Frontotemporal Lobar Degeneration,3
Picornaviridae,B,B04.820.578.750,Positive-Strand RNA Viruses,RNA Viruses,3
Pigment Epithelium of Eye,A,A09.371.670,Eye,Sense Organs,3
Pigment Epithelium of Eye,A,A10.272.640,Epithelium,Tissues,3
Piperazine,D,D03.383.606.768,Piperazines,"Heterocyclic Compounds, 1-Ring",3
Pitch Perception,F,F02.463.593.071.700,Auditory Perception,Perception,3
Pitch Perception,G,G07.888.125.700,Auditory Perception,Vestibulocochlear Physiological Phenomena,3
"Placenta, Retained",C,C13.703.590.767,Placenta Diseases,Pregnancy Complications,3
Planets,G,G01.060.075.680,Astronomical Objects,Astronomical Phenomena,3
Planets,G,G01.060.075.730.700,Solar System,Astronomical Objects,3
Plant Poisoning,C,C25.723.756,Poisoning,Chemically-Induced Disorders,3
"Plants, Genetically Modified",B,B01.650.520,Plants,Eukaryota,3
"Plants, Genetically Modified",B,B05.620.600,"Organisms, Genetically Modified",Organism Forms,3
Plasma Membrane Calcium-Transporting ATPases,D,D08.811.277.040.025.314.250.249,Calcium-Transporting ATPases,P-type ATPases,3
Plasma Membrane Calcium-Transporting ATPases,D,D12.776.157.530.813.250.249,Calcium-Transporting ATPases,P-type ATPases,3
Plasma Membrane Calcium-Transporting ATPases,D,D12.776.157.530.450.250.500.249,Calcium-Transporting ATPases,Cation Transport Proteins,3
Plasma Membrane Calcium-Transporting ATPases,D,D12.776.543.585.813.250.249,Calcium-Transporting ATPases,P-type ATPases,3
Plasma Membrane Calcium-Transporting ATPases,D,D12.776.543.585.450.250.500.249,Calcium-Transporting ATPases,Cation Transport Proteins,3
Plasmapheresis,E,E02.120.770,Blood Component Removal,Therapeutics,3
Plasmapheresis,E,E04.292.869,Extracorporeal Circulation,"Surgical Procedures, Operative",3
Plasmapheresis,E,E02.912.715,Sorption Detoxification,Therapeutics,3
Pleurisy,C,C01.748.582,Respiratory Tract Infections,Infections,3
Pleurisy,C,C08.730.582,Respiratory Tract Infections,Respiratory Tract Diseases,3
Pleurisy,C,C08.528.735,Pleural Diseases,Respiratory Tract Diseases,3
"Pleuropneumonia, Contagious",C,C22.717,Animal Diseases,NULL,3
"Pleuropneumonia, Contagious",C,C01.150.252.400.610.610.717,Mycoplasma Infections,Mycoplasmatales Infections,3
Pneumocystis,B,B01.300.107.730,Ascomycota,Fungi,3
"Pneumonia of Swine, Mycoplasmal",C,C01.150.252.620.330,"Pneumonia, Bacterial",Bacterial Infections,3
"Pneumonia of Swine, Mycoplasmal",C,C01.748.610.540.540,"Pneumonia, Bacterial",Pneumonia,3
"Pneumonia of Swine, Mycoplasmal",C,C22.905.626,Swine Diseases,Animal Diseases,3
"Pneumonia of Swine, Mycoplasmal",C,C08.381.677.540.400,"Pneumonia, Bacterial",Pneumonia,3
"Pneumonia of Swine, Mycoplasmal",C,C08.730.610.540.540,"Pneumonia, Bacterial",Pneumonia,3
"Pneumonia, Mycoplasma",C,C08.730.610.540.545,"Pneumonia, Bacterial",Pneumonia,3
"Pneumonia, Mycoplasma",C,C08.381.677.540.500,"Pneumonia, Bacterial",Pneumonia,3
"Pneumonia, Mycoplasma",C,C01.748.610.540.545,"Pneumonia, Bacterial",Pneumonia,3
"Pneumonia, Mycoplasma",C,C01.150.252.620.500,"Pneumonia, Bacterial",Bacterial Infections,3
"Pneumonia, Mycoplasma",C,C01.150.252.400.610.610.760,Mycoplasma Infections,Mycoplasmatales Infections,3
"Pneumonia, Staphylococcal",C,C01.150.252.620.620,"Pneumonia, Bacterial",Bacterial Infections,3
"Pneumonia, Staphylococcal",C,C01.150.252.410.868.675,Staphylococcal Infections,Gram-Positive Bacterial Infections,3
"Pneumonia, Staphylococcal",C,C01.748.610.540.620,"Pneumonia, Bacterial",Pneumonia,3
"Pneumonia, Staphylococcal",C,C08.381.677.540.620,"Pneumonia, Bacterial",Pneumonia,3
"Pneumonia, Staphylococcal",C,C08.730.610.540.620,"Pneumonia, Bacterial",Pneumonia,3
Poetry as Topic,K,K01.517.781,Literature,Humanities,3
Polymyxin B,D,D12.776.543.695.054.600.750,Polymyxins,Antimicrobial Cationic Peptides,3
Polymyxin B,D,D10.477.750.750,Polymyxins,Lipopeptides,3
Polymyxin B,D,D12.644.641.780.750,Polymyxins,"Peptides, Cyclic",3
Polymyxin B,D,D12.644.050.600.750,Polymyxins,Antimicrobial Cationic Peptides,3
Polymyxin B,D,D04.345.566.780.750,Polymyxins,"Peptides, Cyclic",3
Polyvinyls,D,D05.750.716.721,Plastics,Polymers,3
Polyvinyls,D,D25.720.716.721,Plastics,Polymers,3
Polyvinyls,D,D02.455.326.271.884.533,Vinyl Compounds,Alkenes,3
Polyvinyls,D,D02.455.326.271.665.616,Polyenes,Alkenes,3
Polyvinyls,J,J01.637.051.720.716.721,Plastics,Polymers,3
Ponds,G,G16.500.275.280.625,Fresh Water,Environment,3
Ponds,N,N06.230.232.625,Fresh Water,Environment,3
Ponds,G,G01.311.718,Geological Phenomena,Physical Phenomena,3
Porcine respiratory and reproductive syndrome virus,B,B04.820.578.500.080.500.800,Arterivirus,Arteriviridae,3
Posters as Topic,L,L01.178.820.090.703,Audiovisual Aids,Teaching Materials,3
"Potassium, Dietary",D,D01.745.775,Potassium Compounds,Inorganic Chemicals,3
Potentially Inappropriate Medication List,N,N04.761.700.615,"Quality Assurance, Health Care",Quality of Health Care,3
Potentially Inappropriate Medication List,N,N05.700.594,"Quality Assurance, Health Care","Health Care Quality, Access, and Evaluation",3
Prefrontal Cortex,A,A08.186.211.200.885.287.500.270.700,Frontal Lobe,Cerebral Cortex,3
Pregabalin,D,D02.241.081.114.500.350.500,gamma-Aminobutyric Acid,Aminobutyrates,3
Pregabalin,D,D12.125.190.350.450,gamma-Aminobutyric Acid,Aminobutyrates,3
Prescription Drug Overuse,E,E02.319.306.500.750,Prescription Drug Misuse,Drug Misuse,3
Presynaptic Terminals,A,A08.675.542.145.750,Axons,Nerve Fibers,3
Presynaptic Terminals,A,A08.850.700,Synapses,Nervous System,3
Presynaptic Terminals,A,A11.284.149.165.420.780.700,Synapses,Intercellular Junctions,3
Presynaptic Terminals,A,A11.671.137.750,Axons,Neurons,3
Presynaptic Terminals,A,A11.671.501.145.750,Axons,Nerve Fibers,3
Prevotella,B,B03.440.425.410.194.640,Bacteroidaceae,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",3
Prevotella,B,B03.440.080.094.640,Bacteroidaceae,Bacteroidetes,3
Professional Misconduct,N,N05.350.979,Ethics,"Health Care Quality, Access, and Evaluation",3
Professional Misconduct,K,K01.752.566.479.915,Ethics,Morals,3
Prone Position,G,G11.427.695.525,Posture,Musculoskeletal Physiological Phenomena,3
Prophylactic Mastectomy,E,E04.466.911,Mastectomy,"Surgical Procedures, Operative",3
Prophylactic Mastectomy,E,E04.625.500,Prophylactic Surgical Procedures,"Surgical Procedures, Operative",3
Prostaglandins,D,D23.469.050.175.725,Eicosanoids,Autacoids,3
Prostaglandins,D,D10.251.355.255.550,Eicosanoids,"Fatty Acids, Unsaturated",3
Protein Phosphatase 2,D,D12.644.360.583,Intracellular Signaling Peptides and Proteins,Peptides,3
Protein Phosphatase 2,D,D08.811.277.352.650.625.706,Phosphoprotein Phosphatases,Phosphoric Monoester Hydrolases,3
Protein Phosphatase 2,D,D12.776.476.561,Intracellular Signaling Peptides and Proteins,Proteins,3
Protein Tyrosine Phosphatases,D,D08.811.277.352.650.775,Phosphoric Monoester Hydrolases,Esterases,3
Proto-Oncogene Proteins c-myc,D,D12.776.260.103.813,Basic Helix-Loop-Helix Transcription Factors,DNA-Binding Proteins,3
Proto-Oncogene Proteins c-myc,D,D12.776.624.664.700.189,Proto-Oncogene Proteins,Oncogene Proteins,3
Proto-Oncogene Proteins c-myc,D,D12.776.660.765,Nuclear Proteins,Proteins,3
Proto-Oncogene Proteins c-myc,D,D12.776.930.125.813,Basic Helix-Loop-Helix Transcription Factors,Transcription Factors,3
Pseudomonas fluorescens,B,B03.440.400.425.625.625.325,Pseudomonas,Pseudomonadaceae,3
Pseudomonas fluorescens,B,B03.660.250.580.590.210,Pseudomonas,Pseudomonadaceae,3
Pseudopodia,A,A11.284.180.700,Cell Surface Extensions,Cellular Structures,3
Psittacosis,C,C01.150.252.400.210.250.600,Chlamydophila Infections,Chlamydiaceae Infections,3
"Psychiatric Department, Hospital",N,N04.452.442.452.422.641,Hospital Departments,Hospital Administration,3
"Psychiatric Department, Hospital",N,N02.278.216.500.968.641,Hospital Departments,Hospital Administration,3
Psychological Trauma,F,F03.950.750.375,"Stress Disorders, Traumatic",Trauma and Stressor Related Disorders,3
"Psychology, Child",F,F04.096.628.193,Psychology,Behavioral Sciences,3
Psychopathology,F,F04.096.670,Behavioral Sciences,Behavioral Disciplines and Activities,3
Psychophysics,F,F04.096.753,Behavioral Sciences,Behavioral Disciplines and Activities,3
Psychophysics,E,E01.370.685,Diagnostic Techniques and Procedures,Diagnosis,3
Pulmonary Eosinophilia,C,C08.381.750,Lung Diseases,Respiratory Tract Diseases,3
Pulmonary Eosinophilia,C,C15.378.553.231.549.750,Hypereosinophilic Syndrome,Eosinophilia,3
Pulmonary Surfactants,D,D27.505.954.796.600,Respiratory System Agents,Therapeutic Uses,3
Pulmonary Ventilation,E,E01.370.386.700.660,Respiratory Function Tests,"Diagnostic Techniques, Respiratory System",3
Pulmonary Ventilation,G,G09.772.650,Respiratory Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,3
Pyoderma,C,C17.800.695,Skin Diseases,Skin and Connective Tissue Diseases,3
Pyrimidinones,D,D03.383.742.698,Pyrimidines,"Heterocyclic Compounds, 1-Ring",3
Pyrophosphatases,D,D08.811.277.040.600,Acid Anhydride Hydrolases,Hydrolases,3
Pyroptosis,G,G04.146.954.035.530,Apoptosis,Regulated Cell Death,3
Quinacrine,D,D03.633.300.046.250.760,Aminoacridines,Acridines,3
Quinones,D,D02.806,Organic Chemicals,NULL,3
Quinoxalines,D,D03.633.100.857,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",3
Race Factors,N,N05.715.350.463,Epidemiologic Factors,Quality of Health Care,3
Race Relations,I,I01.880.735.820.500,Social Segregation,Social Problems,3
Radiation Protection,N,N06.850.810.425,Radiologic Health,Public Health,3
Radiologists,M,M01.526.485.810.877,Physicians,Health Personnel,3
Radiologists,N,N02.360.810.877,Physicians,Health Personnel,3
"Radiotherapy, Conformal",L,L01.313.500.750.100.710.600.550,"Radiotherapy, Computer-Assisted","Therapy, Computer-Assisted",3
"Radiotherapy, Conformal",E,E02.815.635.700,"Radiotherapy, Computer-Assisted",Radiotherapy,3
"Radiotherapy, High-Energy",E,E02.815.722,Radiotherapy,Therapeutics,3
Radius,A,A02.835.232.087.090.700,Arm Bones,Bones of Upper Extremity,3
ras Proteins,D,D08.811.277.040.330.300.400.500,Monomeric GTP-Binding Proteins,GTP-Binding Proteins,3
ras Proteins,D,D12.776.157.325.515.500,Monomeric GTP-Binding Proteins,GTP-Binding Proteins,3
ras Proteins,D,D12.644.360.525.500,Monomeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,3
ras Proteins,D,D12.776.476.525.500,Monomeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,3
"Rats, Long-Evans",B,B01.050.150.900.649.313.992.635.505.700.500,Rats,Murinae,3
Receptor Protein-Tyrosine Kinases,D,D12.776.543.750.630,"Receptors, Cell Surface",Membrane Proteins,3
Receptor Protein-Tyrosine Kinases,D,D08.811.913.696.620.682.725.400,Protein-Tyrosine Kinases,Protein Kinases,3
Receptor-Interacting Protein Serine-Threonine Kinase 2,D,D08.811.913.696.620.682.700.801.500,Receptor-Interacting Protein Serine-Threonine Kinases,Protein-Serine-Threonine Kinases,3
Receptor-Interacting Protein Serine-Threonine Kinase 2,D,D12.644.360.024.500.186.500,Receptor-Interacting Protein Serine-Threonine Kinases,Tumor Necrosis Factor Receptor-Associated Peptides and Proteins,3
Receptor-Interacting Protein Serine-Threonine Kinase 2,D,D12.644.360.075.358.750,CARD Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,3
Receptor-Interacting Protein Serine-Threonine Kinase 2,D,D12.644.360.024.131.750,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",3
Receptor-Interacting Protein Serine-Threonine Kinase 2,D,D12.776.157.057.500.186.500,Receptor-Interacting Protein Serine-Threonine Kinases,Tumor Necrosis Factor Receptor-Associated Peptides and Proteins,3
Receptor-Interacting Protein Serine-Threonine Kinase 2,D,D12.776.157.057.006.750,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",3
Receptor-Interacting Protein Serine-Threonine Kinase 2,D,D12.776.476.024.139.750,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",3
Receptor-Interacting Protein Serine-Threonine Kinase 2,D,D12.776.476.075.358.750,CARD Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,3
Receptor-Interacting Protein Serine-Threonine Kinase 2,D,D12.776.476.024.500.186.500,Receptor-Interacting Protein Serine-Threonine Kinases,Tumor Necrosis Factor Receptor-Associated Peptides and Proteins,3
"Receptors, Androgen",D,D12.776.826.750.150,"Receptors, Steroid","Receptors, Cytoplasmic and Nuclear",3
"Receptors, Aryl Hydrocarbon",D,D12.776.826.209.715,Orphan Nuclear Receptors,"Receptors, Cytoplasmic and Nuclear",3
"Receptors, Aryl Hydrocarbon",D,D12.776.930.760,Transcription Factors,Proteins,3
"Receptors, Aryl Hydrocarbon",D,D12.776.260.643.715,Orphan Nuclear Receptors,DNA-Binding Proteins,3
"Receptors, CCR7",D,D12.776.543.750.695.160.150.700,"Receptors, CCR","Receptors, Chemokine",3
"Receptors, CCR7",D,D12.776.543.750.705.852.125.150.700,"Receptors, CCR","Receptors, Chemokine",3
"Receptors, Dopamine D1",D,D12.776.543.750.720.330.400.400,"Receptors, Dopamine","Receptors, Catecholamine",3
"Receptors, Dopamine D1",D,D12.776.543.750.695.150.400.400,"Receptors, Dopamine","Receptors, Catecholamine",3
"Receptors, Dopamine D1",D,D12.776.543.750.670.300.400.400,"Receptors, Dopamine","Receptors, Catecholamine",3
"Receptors, HIV",D,D12.776.543.750.830.700,"Receptors, Virus","Receptors, Cell Surface",3
"Receptors, Metabotropic Glutamate",D,D12.776.543.750.720.200.450.500,"Receptors, Glutamate","Receptors, Amino Acid",3
"Receptors, Metabotropic Glutamate",D,D12.776.543.750.695.450,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",3
"Receptors, Opioid, mu",D,D12.776.543.750.695.620.550,"Receptors, Opioid","Receptors, G-Protein-Coupled",3
"Receptors, Opioid, mu",D,D12.776.543.750.720.600.610.550,"Receptors, Opioid","Receptors, Neuropeptide",3
"Receptors, Opioid, mu",D,D12.776.543.750.750.555.610.550,"Receptors, Opioid","Receptors, Neuropeptide",3
"Receptors, Purinergic P1",D,D12.776.543.750.720.700.700,"Receptors, Purinergic","Receptors, Neurotransmitter",3
"Receptors, Purinergic P1",D,D12.776.543.750.695.700.700,"Receptors, Purinergic","Receptors, G-Protein-Coupled",3
"Receptors, Purinergic P2X7",D,D12.776.543.750.695.700.720.250.700,"Receptors, Purinergic P2X","Receptors, Purinergic P2",3
"Receptors, Purinergic P2X7",D,D12.776.543.585.400.500.600.700,"Receptors, Purinergic P2X",Ligand-Gated Ion Channels,3
"Receptors, Purinergic P2X7",D,D12.776.543.550.450.500.600.700,"Receptors, Purinergic P2X",Ligand-Gated Ion Channels,3
"Receptors, Purinergic P2X7",D,D12.776.543.750.720.700.720.500.700,"Receptors, Purinergic P2X","Receptors, Purinergic P2",3
"Receptors, Purinergic P2X7",D,D12.776.157.530.400.400.750.700,"Receptors, Purinergic P2X",Ligand-Gated Ion Channels,3
"Receptors, Thrombin",D,D12.776.395.550.625.800,Platelet Membrane Glycoproteins,Membrane Glycoproteins,3
"Receptors, Thrombin",D,D12.776.543.750.750.850,"Receptors, Peptide","Receptors, Cell Surface",3
"Receptors, Thrombin",D,D12.776.543.750.792.500,"Receptors, Proteinase-Activated","Receptors, Cell Surface",3
"Receptors, Thrombin",D,D12.776.543.750.705.675.892,Platelet Membrane Glycoproteins,"Receptors, Immunologic",3
"Receptors, Thrombin",D,D12.776.543.550.625.800,Platelet Membrane Glycoproteins,Membrane Glycoproteins,3
"Receptors, Thrombin",D,D12.776.543.750.695.875,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",3
"Receptors, Tumor Necrosis Factor, Type I",D,D12.776.543.750.690.750,"Receptors, Death Domain","Receptors, Cell Surface",3
"Receptors, Tumor Necrosis Factor, Type I",D,D12.776.543.750.705.852.760.597,"Receptors, Tumor Necrosis Factor","Receptors, Cytokine",3
"Receptors, Vascular Endothelial Growth Factor",D,D12.776.543.750.750.400.910,"Receptors, Growth Factor","Receptors, Peptide",3
"Receptors, Vascular Endothelial Growth Factor",D,D12.776.543.750.630.750,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",3
"Receptors, Vascular Endothelial Growth Factor",D,D08.811.913.696.620.682.725.400.950,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,3
"Reflex, Abnormal",E,E01.370.600.550.650.655,Reflex,Neurologic Examination,3
"Reflex, Abnormal",E,E01.370.376.550.650.655,Reflex,Neurologic Examination,3
"Reflex, Abnormal",C,C10.597.704,Neurologic Manifestations,Nervous System Diseases,3
"Reflex, Abnormal",C,C23.888.592.717,Neurologic Manifestations,Signs and Symptoms,3
"Reflex, Abnormal",G,G11.561.731.587,Reflex,Nervous System Physiological Phenomena,3
"Reflex, Pupillary",G,G11.561.731.705,Reflex,Nervous System Physiological Phenomena,3
"Reflex, Pupillary",E,E01.370.376.550.650.690,Reflex,Neurologic Examination,3
"Reflex, Pupillary",E,E01.370.600.550.650.690,Reflex,Neurologic Examination,3
Religion and Sex,K,K01.844.754,Religion,Humanities,3
Renal Elimination,G,G08.852.761,Urinary Tract Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,3
Renal Elimination,G,G07.690.725.297.875,Drug Elimination Routes,Pharmacokinetics,3
Renal Elimination,G,G03.787.297.875,Drug Elimination Routes,Pharmacokinetics,3
Renewable Energy,N,N06.230.132.644,Energy-Generating Resources,Environment,3
Reptiles,B,B01.050.150.900.833,Vertebrates,Chordata,3
Republic of North Macedonia,Z,Z01.542.248.517,"Europe, Eastern",Europe,3
Respiratory Protective Devices,J,J01.637.708.560.937,Personal Protective Equipment,Protective Devices,3
Respiratory Protective Devices,E,E07.700.700,Protective Devices,Equipment and Supplies,3
Respiratory Therapy,E,E02.880,Therapeutics,NULL,3
Retinal Degeneration,C,C11.270.612,"Eye Diseases, Hereditary",Eye Diseases,3
Retinal Degeneration,C,C11.768.585,Retinal Diseases,Eye Diseases,3
Retinal Drusen,C,C11.768.585.585,Retinal Degeneration,Retinal Diseases,3
Retinoblastoma Protein,D,D12.776.744.770,Phosphoproteins,Proteins,3
Retinoblastoma Protein,D,D12.776.660.807,Nuclear Proteins,Proteins,3
Retinoblastoma Protein,D,D12.776.624.776.745,Tumor Suppressor Proteins,Neoplasm Proteins,3
Retinoblastoma Protein,D,D12.776.260.704,DNA-Binding Proteins,Proteins,3
Retroelements,D,D13.444.308.760,DNA,Nucleic Acids,3
Retroelements,G,G02.111.570.080.708.330.800,Interspersed Repetitive Sequences,"Repetitive Sequences, Nucleic Acid",3
Retroelements,G,G05.360.080.708.330.800,Interspersed Repetitive Sequences,"Repetitive Sequences, Nucleic Acid",3
Retroelements,G,G05.360.340.024.425.800,Interspersed Repetitive Sequences,Genome Components,3
Retroviridae Infections,C,C01.925.782.815,RNA Virus Infections,Virus Diseases,3
"rev Gene Products, Human Immunodeficiency Virus",D,D12.776.964.925.984.385.500,"Gene Products, rev",Trans-Activators,3
"rev Gene Products, Human Immunodeficiency Virus",D,D12.776.664.962.186.500,"Gene Products, rev",RNA-Binding Proteins,3
"rev Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.562.770,Human Immunodeficiency Virus Proteins,Retroviridae Proteins,3
"rev Gene Products, Human Immunodeficiency Virus",D,D12.776.157.725.076.500,"Gene Products, rev",RNA-Binding Proteins,3
Rh Isoimmunization,G,G12.122.780,Antigen-Antibody Reactions,Immune System Phenomena,3
Rh Isoimmunization,G,G12.186.750,Blood Group Incompatibility,Immune System Phenomena,3
Rh Isoimmunization,G,G09.188.114.750,Blood Group Incompatibility,Blood Physiological Phenomena,3
Rhabdomyosarcoma,C,C04.557.450.795.550.660,Myosarcoma,Sarcoma,3
Rhabdomyosarcoma,C,C04.557.450.590.550.660,Myosarcoma,"Neoplasms, Muscle Tissue",3
Rheology,H,H01.671.808,Physics,Natural Science Disciplines,3
Rheology,E,E05.830,Investigative Techniques,NULL,3
Ribonuclease III,D,D08.811.277.352.700.350.707,Endoribonucleases,Ribonucleases,3
Rickettsia typhi,B,B03.660.050.783.875.650.650.810,Rickettsia,Rickettsieae,3
Rinderpest,C,C01.925.782.580.600.500.700,Morbillivirus Infections,Paramyxoviridae Infections,3
Rinderpest,C,C22.780,Animal Diseases,NULL,3
Rinderpest virus,B,B04.820.480.937.600.650.500.675,Morbillivirus,Paramyxovirinae,3
Riots,I,I01.880.735.140.652,Civil Disorders,Social Problems,3
Rivastigmine,D,D02.241.081.251.583.899,Phenylcarbamates,Carbamates,3
RNA Polymerase I,D,D08.811.913.696.445.735.270.750,DNA-Directed RNA Polymerases,RNA Nucleotidyltransferases,3
"RNA, Antisense",D,D13.150.650,Antisense Elements (Genetics),"Nucleic Acids, Nucleotides, and Nucleosides",3
"RNA, Antisense",D,D13.444.600.150.760,Antisense Elements (Genetics),Nucleic Acid Probes,3
"RNA, Antisense",D,D13.444.735.150,RNA,Nucleic Acids,3
"RNA, Antisense",D,D27.720.470.530.600.150.760,Antisense Elements (Genetics),Nucleic Acid Probes,3
"RNA, Catalytic",D,D13.444.735.790.199,"RNA, Untranslated",RNA,3
"RNA, Catalytic",D,D08.811.797,Enzymes,Enzymes and Coenzymes,3
"RNA, Small Nuclear",D,D13.444.735.790.552.937,"RNA, Small Untranslated","RNA, Untranslated",3
"RNA, Small Nuclear",D,D13.444.735.628.818,"RNA, Nuclear",RNA,3
"RNA, Transfer, Amino Acyl",D,D13.444.735.757.715,"RNA, Transfer",RNA,3
"RNA, Transfer, Amino Acyl",D,D12.125.780,Amino Acids,"Amino Acids, Peptides, and Proteins",3
Robotics,J,J01.897.104.834,Automation,Technology,3
Robotics,L,L01.224.050.375.630,Artificial Intelligence,Algorithms,3
Robotics,H,H01.671.293.643,Electronics,Physics,3
Ross River virus,B,B04.820.578.875.054.813,Alphavirus,Togaviridae,3
Rotation,G,G01.482.703,Motion,Physical Phenomena,3
R-SNARE Proteins,D,D12.776.543.990.775.750,SNARE Proteins,Vesicular Transport Proteins,3
R-SNARE Proteins,D,D12.776.543.512.249.750,SNARE Proteins,Membrane Fusion Proteins,3
Rubber,D,D25.720.327.840,Elastomers,Polymers,3
Rubber,D,D25.720.099.750,Biopolymers,Polymers,3
Rubber,J,J01.637.412.767,Elastomers,Manufactured Materials,3
Rubber,J,J01.637.051.720.327.840,Elastomers,Polymers,3
Rubber,J,J01.637.051.720.099.750,Biopolymers,Polymers,3
S100 Calcium Binding Protein A7,D,D12.776.157.125.750.563,S100 Proteins,Calcium-Binding Proteins,3
S-Adenosylhomocysteine,D,D12.125.166.498.050,Homocysteine,"Amino Acids, Sulfur",3
S-Adenosylhomocysteine,D,D03.633.100.759.590.138.240,Adenosine,Purine Nucleosides,3
S-Adenosylhomocysteine,D,D02.886.030.498.050,Homocysteine,"Amino Acids, Sulfur",3
S-Adenosylhomocysteine,D,D13.570.583.138.240,Adenosine,Purine Nucleosides,3
S-Adenosylhomocysteine,D,D13.570.800.096.262,Adenosine,Ribonucleosides,3
Saguinus,B,B01.050.150.900.649.313.988.400.600.150.150.710,Callitrichinae,Cebidae,3
Salicylates,D,D02.241.223.100.300.595,Hydroxybenzoates,Benzoates,3
Salicylates,D,D02.241.511.390.595,Hydroxybenzoates,Hydroxy Acids,3
Salicylates,D,D02.455.426.559.389.657.410.595,Hydroxybenzoates,Phenols,3
Salicylates,D,D02.455.426.559.389.127.281.595,Hydroxybenzoates,Benzoates,3
Salicylic Acid,D,D02.455.426.559.389.657.410.595.608,Salicylates,Hydroxybenzoates,3
Salicylic Acid,D,D02.455.426.559.389.127.281.595.608,Salicylates,Hydroxybenzoates,3
Salicylic Acid,D,D02.241.511.390.595.608,Salicylates,Hydroxybenzoates,3
Salicylic Acid,D,D02.241.223.100.300.595.608,Salicylates,Hydroxybenzoates,3
Salmo salar,B,B01.050.150.900.493.817.750.705.790,Salmon,Salmonidae,3
Sarcomeres,A,A10.690.552.875.700,Myofibrils,"Muscle, Striated",3
Sarcomeres,A,A11.284.430.214.190.875.820,Organelles,Cytoplasmic Structures,3
Sarcomeres,A,A11.620.500.500.700,Myofibrils,"Myocytes, Cardiac",3
Sarcomeres,A,A11.620.249.850.700,Myofibrils,"Muscle Fibers, Skeletal",3
"Scavenger Receptors, Class B",D,D12.776.543.750.710.450.750.625,"Receptors, Scavenger","Receptors, LDL",3
"Scavenger Receptors, Class B",D,D12.776.543.750.705.940.625,"Receptors, Scavenger","Receptors, Immunologic",3
Schizosaccharomyces pombe Proteins,D,D12.776.354.875,Fungal Proteins,Proteins,3
School Nursing,H,H02.478.676.824,"Specialties, Nursing",Nursing,3
School Nursing,N,N02.421.726.809.742,School Health Services,Preventive Health Services,3
"Scleroderma, Systemic",C,C17.800.784,Skin Diseases,Skin and Connective Tissue Diseases,3
"Scleroderma, Systemic",C,C17.300.799,Connective Tissue Diseases,Skin and Connective Tissue Diseases,3
Sclerosis,C,C23.550.823,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",3
Scopolamine Derivatives,D,D02.145.074.722.822,Tropanes,Azabicyclo Compounds,3
Scopolamine Derivatives,D,D03.132.889.601,Tropanes,Alkaloids,3
Scopolamine Derivatives,D,D03.605.869.822,Tropanes,"Heterocyclic Compounds, Bridged-Ring",3
Scopolamine Derivatives,D,D03.605.084.500.722.822,Tropanes,Azabicyclo Compounds,3
Secretory Component,D,D12.776.377.715.548.705.875,Immunoglobulin Subunits,Immunoglobulins,3
Secretory Component,D,D12.776.377.715.548.114.619.026.030.500,"Immunoglobulin A, Secretory",Immunoglobulin A,3
Secretory Component,D,D12.776.124.790.651.705.875,Immunoglobulin Subunits,Immunoglobulins,3
Secretory Component,D,D12.776.124.790.651.114.619.026.030.500,"Immunoglobulin A, Secretory",Immunoglobulin A,3
Secretory Component,D,D12.776.124.486.485.705.875,Immunoglobulin Subunits,Immunoglobulins,3
Secretory Component,D,D12.776.124.486.485.114.619.026.030.500,"Immunoglobulin A, Secretory",Immunoglobulin A,3
Secretory Vesicles,A,A11.284.430.214.190.875.190.880.810,Transport Vesicles,Cytoplasmic Vesicles,3
Sensory Aids,E,E07.814,Equipment and Supplies,NULL,3
Serology,H,H02.781,Health Occupations,NULL,3
Serpins,D,D12.644.861,Peptides,"Amino Acids, Peptides, and Proteins",3
Serpins,D,D12.776.872,Proteins,"Amino Acids, Peptides, and Proteins",3
Serpins,D,D27.505.519.389.745.800.675,Serine Proteinase Inhibitors,Protease Inhibitors,3
Serum Bactericidal Antibody Assay,E,E01.370.225.812.735.845,Serologic Tests,Immunologic Tests,3
Serum Bactericidal Antibody Assay,E,E05.478.594.760.845,Serologic Tests,Immunologic Tests,3
Serum Bactericidal Antibody Assay,E,E05.200.812.735.845,Serologic Tests,Immunologic Tests,3
Sexual Development,G,G07.345.750,Growth and Development,Physiological Phenomena,3
Sexual Development,G,G08.686.841,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,3
Shiga Toxin,D,D23.946.330.575.100,Shiga Toxins,Enterotoxins,3
Shiga Toxin,D,D23.946.123.794.095,Shiga Toxins,Bacterial Toxins,3
Shiga Toxin,D,D08.811.277.450.430.700.750.750.100,Shiga Toxins,"Ribosome Inactivating Proteins, Type 2",3
Shiga Toxin 2,D,D08.811.277.450.430.700.750.750.124,Shiga Toxins,"Ribosome Inactivating Proteins, Type 2",3
Shiga Toxin 2,D,D12.776.097.275.879,Escherichia coli Proteins,Bacterial Proteins,3
Shiga Toxin 2,D,D23.946.123.794.124,Shiga Toxins,Bacterial Toxins,3
Shiga Toxin 2,D,D23.946.330.575.124,Shiga Toxins,Enterotoxins,3
Sigmodontinae,B,B01.050.150.900.649.313.992.635.075.500,Arvicolinae,Muridae,3
Signaling Lymphocytic Activation Molecule Family,D,D12.776.543.750.705.970,"Receptors, Immunologic","Receptors, Cell Surface",3
Signaling Lymphocytic Activation Molecule Family,D,D12.776.543.550.746,Membrane Glycoproteins,Membrane Proteins,3
Signaling Lymphocytic Activation Molecule Family,D,D12.776.395.550.736,Membrane Glycoproteins,Glycoproteins,3
Simendan,D,D03.383.710.802,Pyridazines,"Heterocyclic Compounds, 1-Ring",3
Simendan,D,D02.442.288.610,Hydrazones,Hydrazines,3
Siphoviridae,B,B04.100.750,Archaeal Viruses,Viruses,3
Siphoviridae,B,B04.280.090.800,Caudovirales,DNA Viruses,3
Siphoviridae,B,B04.123.150.800,Caudovirales,Bacteriophages,3
Sirtuins,D,D08.811.277.087.520.200.650,Group III Histone Deacetylases,Histone Deacetylases,3
Sirtuins,D,D08.811.913.400.725.115.961,ADP Ribose Transferases,Pentosyltransferases,3
Sirtuins,D,D12.776.476.900,Intracellular Signaling Peptides and Proteins,Proteins,3
Sitting Position,G,G11.427.695.575,Posture,Musculoskeletal Physiological Phenomena,3
Skiing,I,I03.450.642.845.787.500,Snow Sports,Sports,3
Skin Transplantation,E,E04.936.580.700,Tissue Transplantation,Transplantation,3
Skin Transplantation,E,E04.680.275.850,Dermatologic Surgical Procedures,Reconstructive Surgical Procedures,3
Skin Transplantation,E,E02.095.147.725.700,Tissue Transplantation,Cell- and Tissue-Based Therapy,3
Sleep Stages,F,F02.830.855.796,Sleep,Psychophysiology,3
Sleep Stages,G,G11.561.803.754,Sleep,Nervous System Physiological Phenomena,3
Smad7 Protein,D,D12.776.476.024.428.249.700,"Smad Proteins, Inhibitory",Smad Proteins,3
Smad7 Protein,D,D12.776.157.057.170.249.700,"Smad Proteins, Inhibitory",Smad Proteins,3
Smad7 Protein,D,D12.644.360.024.334.200.700,"Smad Proteins, Inhibitory",Smad Proteins,3
Small Cell Lung Carcinoma,C,C04.588.894.797.520.109.220.624,"Carcinoma, Bronchogenic",Bronchial Neoplasms,3
Small Cell Lung Carcinoma,C,C08.381.540.140.750,"Carcinoma, Bronchogenic",Lung Neoplasms,3
Small Cell Lung Carcinoma,C,C08.785.520.100.220.750,"Carcinoma, Bronchogenic",Bronchial Neoplasms,3
Smog,D,D20.633.875,Particulate Matter,Complex Mixtures,3
Snoring,C,C23.888.852.779.850,Respiratory Sounds,"Signs and Symptoms, Respiratory",3
Social Factors,I,I01.880.853.996.877,Socioeconomic Factors,Sociological Factors,3
Social Inclusion,F,F01.145.813.745,Social Behavior,Behavior,3
Social Network Analysis,I,I01.880.866.500,Sociometric Techniques,Sociology,3
Sodium-Hydrogen Exchangers,D,D12.776.543.550.190.775,Antiporters,Membrane Glycoproteins,3
Sodium-Hydrogen Exchangers,D,D12.776.543.585.450.162.775,Antiporters,Ion Pumps,3
Sodium-Hydrogen Exchangers,D,D12.776.543.585.937.828,Solute Carrier Proteins,Membrane Transport Proteins,3
Sodium-Hydrogen Exchangers,D,D12.776.157.530.450.162.775,Antiporters,Ion Pumps,3
Sodium-Hydrogen Exchangers,D,D12.776.157.530.937.703,Solute Carrier Proteins,Membrane Transport Proteins,3
Sodium-Potassium-Exchanging ATPase,D,D12.776.157.530.813.750,P-type ATPases,Membrane Transport Proteins,3
Sodium-Potassium-Exchanging ATPase,D,D12.776.157.530.450.162.780,Antiporters,Ion Pumps,3
Sodium-Potassium-Exchanging ATPase,D,D12.776.157.530.450.250.880,Cation Transport Proteins,Ion Pumps,3
Sodium-Potassium-Exchanging ATPase,D,D08.811.277.040.025.314.750,P-type ATPases,Adenosine Triphosphatases,3
Sodium-Potassium-Exchanging ATPase,D,D12.776.543.585.813.750,P-type ATPases,Membrane Transport Proteins,3
Sodium-Potassium-Exchanging ATPase,D,D12.776.543.585.450.162.800,Antiporters,Ion Pumps,3
Sodium-Potassium-Exchanging ATPase,D,D12.776.543.585.450.250.890,Cation Transport Proteins,Ion Pumps,3
Solid Waste,D,D20.944.730,Waste Products,Complex Mixtures,3
Solid Waste,N,N06.850.460.710.730,Waste Products,Environmental Pollution,3
Sound,G,G01.750.770.776,"Radiation, Nonionizing",Radiation,3
South Carolina,Z,Z01.107.567.875.075.662,Appalachian Region,United States,3
South Carolina,Z,Z01.107.567.875.750.700,Southeastern United States,United States,3
Spacecraft,J,J01.937.285.850.900,Space Flight,Aviation,3
Speech,G,G11.561.812,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,3
Speech,L,L01.559.423.676,Language Arts,Language,3
Speech,F,F01.145.209.908.677,Verbal Behavior,Communication,3
Speech Perception,F,F02.463.593.071.875,Auditory Perception,Perception,3
Speech Perception,G,G07.888.125.875,Auditory Perception,Vestibulocochlear Physiological Phenomena,3
"Spheroids, Cellular",A,A11.251.800,"Cells, Cultured",Cells,3
Spinal Cord Compression,C,C26.819.678,Spinal Cord Injuries,Wounds and Injuries,3
Spinal Cord Compression,C,C10.228.854.761,Spinal Cord Diseases,Central Nervous System Diseases,3
Spirurida Infections,C,C01.610.335.508.700.750,Secernentea Infections,Nematode Infections,3
Splints,E,E07.858.442.660.430.750,External Fixators,Orthopedic Fixation Devices,3
Splints,E,E07.858.690.725.430.750,External Fixators,Orthopedic Fixation Devices,3
Squamous Cell Carcinoma of Head and Neck,C,C04.588.443.177,Head and Neck Neoplasms,Neoplasms by Site,3
Squamous Cell Carcinoma of Head and Neck,C,C04.557.470.200.400.565,"Carcinoma, Squamous Cell",Carcinoma,3
Staphylococcal Protein A,D,D23.050.161.821,"Antigens, Bacterial",Antigens,3
Staphylococcal Protein A,D,D12.776.097.820,Bacterial Proteins,Proteins,3
Staphylococcus epidermidis,B,B03.510.100.750.750.343,Staphylococcus,Staphylococcaceae,3
Staphylococcus epidermidis,B,B03.510.400.790.750.343,Staphylococcus,Staphylococcaceae,3
Staphylococcus epidermidis,B,B03.300.390.400.800.750.343,Staphylococcus,Staphylococcaceae,3
Staphylococcus epidermidis,B,B03.353.500.750.750.343,Staphylococcus,Staphylococcaceae,3
Starch,D,D09.698.365.855,Glucans,Polysaccharides,3
Starch,D,D09.301.915,Dietary Carbohydrates,Carbohydrates,3
Starch,D,D05.750.078.562.855,Glucans,Biopolymers,3
STAT1 Transcription Factor,D,D12.644.360.024.342.100,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",3
STAT1 Transcription Factor,D,D12.644.360.024.303.500.500,"Interferon-Stimulated Gene Factor 3, alpha Subunit",Interferon-Stimulated Gene Factor 3,3
STAT1 Transcription Factor,D,D12.776.157.057.186.100,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",3
STAT1 Transcription Factor,D,D12.776.157.057.061.500.500,"Interferon-Stimulated Gene Factor 3, alpha Subunit",Interferon-Stimulated Gene Factor 3,3
STAT1 Transcription Factor,D,D12.776.260.513.249.500,"Interferon-Stimulated Gene Factor 3, alpha Subunit",Interferon-Stimulated Gene Factor 3,3
STAT1 Transcription Factor,D,D12.776.930.840.100,STAT Transcription Factors,Transcription Factors,3
STAT1 Transcription Factor,D,D12.776.930.354.249.500,"Interferon-Stimulated Gene Factor 3, alpha Subunit",Interferon-Stimulated Gene Factor 3,3
STAT1 Transcription Factor,D,D12.776.476.024.430.100,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",3
STAT1 Transcription Factor,D,D12.776.476.024.386.500.500,"Interferon-Stimulated Gene Factor 3, alpha Subunit",Interferon-Stimulated Gene Factor 3,3
Sterol 14-Demethylase,D,D12.776.422.220.453.915.880,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,3
Sterol 14-Demethylase,D,D12.776.422.220.453.878.500,Cytochrome P450 Family 51,Cytochrome P-450 Enzyme System,3
Sterol 14-Demethylase,D,D08.244.453.878.500,Cytochrome P450 Family 51,Cytochrome P-450 Enzyme System,3
Sterol 14-Demethylase,D,D08.244.453.915.880,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,3
Sterol 14-Demethylase,D,D08.811.682.690.708.170.915.880,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,3
Sterol 14-Demethylase,D,D08.811.682.690.708.170.499.500,Cytochrome P450 Family 51,Cytochrome P-450 Enzyme System,3
Stomach Diseases,C,C06.405.748,Gastrointestinal Diseases,Digestive System Diseases,3
Streptococcus mutans,B,B03.510.550.737.872.875.520,Viridans Streptococci,Streptococcus,3
Streptococcus mutans,B,B03.353.750.737.872.875.520,Viridans Streptococci,Streptococcus,3
Streptococcus mutans,B,B03.510.400.800.872.875.520,Viridans Streptococci,Streptococcus,3
Streptomyces,B,B03.510.415.400.810.768,Streptomycetaceae,Gram-Positive Endospore-Forming Rods,3
Streptomyces,B,B03.510.460.410.810.768,Streptomycetaceae,Gram-Positive Endospore-Forming Rods,3
Streptomyces,B,B03.510.024.997.775,Streptomycetaceae,Actinobacteria,3
Streptomyces,B,B03.300.390.400.810.768,Streptomycetaceae,Gram-Positive Endospore-Forming Rods,3
Streptomyces coelicolor,B,B03.300.390.400.810.768.200,Streptomyces,Streptomycetaceae,3
Streptomyces coelicolor,B,B03.510.024.997.775.200,Streptomyces,Streptomycetaceae,3
Streptomyces coelicolor,B,B03.510.460.410.810.768.200,Streptomyces,Streptomycetaceae,3
Streptomyces coelicolor,B,B03.510.415.400.810.768.200,Streptomyces,Streptomycetaceae,3
Student Health Services,N,N02.421.897,Health Services,"Health Care Facilities, Manpower, and Services",3
Subacute Sclerosing Panencephalitis,C,C01.207.245.340.600,"Encephalitis, Viral",Central Nervous System Viral Diseases,3
Subacute Sclerosing Panencephalitis,C,C01.207.399.750.600,"Encephalitis, Viral",Infectious Encephalitis,3
Subacute Sclerosing Panencephalitis,C,C01.925.839.862,Slow Virus Diseases,Virus Diseases,3
Subacute Sclerosing Panencephalitis,C,C01.925.782.580.600.500.500.800,Measles,Morbillivirus Infections,3
Subacute Sclerosing Panencephalitis,C,C01.925.182.525.600,"Encephalitis, Viral",Central Nervous System Viral Diseases,3
Subacute Sclerosing Panencephalitis,C,C10.228.228.245.340.600,"Encephalitis, Viral",Central Nervous System Viral Diseases,3
Subacute Sclerosing Panencephalitis,C,C10.228.228.399.750.600,"Encephalitis, Viral",Infectious Encephalitis,3
Subacute Sclerosing Panencephalitis,C,C10.228.140.430.520.750.600,"Encephalitis, Viral",Infectious Encephalitis,3
"Suicide, Assisted",N,N02.421.585.905.850,Terminal Care,Patient Care,3
"Suicide, Assisted",I,I01.880.735.856.300,Suicide,Social Problems,3
"Suicide, Assisted",F,F01.145.126.980.875.300,Suicide,Self-Injurious Behavior,3
"Suicide, Assisted",E,E02.760.905.850,Terminal Care,Patient Care,3
Sulfhydryl Compounds,D,D02.886.489,Sulfur Compounds,Organic Chemicals,3
Sunscreening Agents,D,D27.720.799.763.764,Radiation-Protective Agents,Protective Agents,3
Sunscreening Agents,D,D27.720.269.800,Cosmetics,Specialty Uses of Chemicals,3
Sunscreening Agents,D,D27.505.954.444.695,Dermatologic Agents,Therapeutic Uses,3
Sunscreening Agents,D,D27.505.696.706.776.800,Radiation-Protective Agents,Protective Agents,3
Superantigens,D,D23.050.820,Antigens,Biological Factors,3
Support Vector Machine,L,L01.224.050.375.530.500.500,Supervised Machine Learning,Machine Learning,3
Support Vector Machine,G,G17.035.250.500.500.500,Supervised Machine Learning,Machine Learning,3
Suppressor of Cytokine Signaling Proteins,D,D12.776.476.024.437,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,3
Suppressor of Cytokine Signaling Proteins,D,D12.776.157.057.249,"Adaptor Proteins, Signal Transducing",Carrier Proteins,3
Suppressor of Cytokine Signaling Proteins,D,D12.644.360.024.374,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,3
Surgical Instruments,E,E07.858.700,Surgical Equipment,Equipment and Supplies,3
Survivorship,F,F01.058.144.500,Emotional Adjustment,"Adaptation, Psychological",3
Sweat,A,A12.200.849,Bodily Secretions,Fluids and Secretions,3
Synaptic Vesicles,A,A11.284.430.214.190.875.190.880.830,Transport Vesicles,Cytoplasmic Vesicles,3
Synaptic Vesicles,A,A08.850.840,Synapses,Nervous System,3
Taenia,B,B01.050.500.500.736.215.895,Cestoda,Platyhelminths,3
Taeniasis,C,C01.610.335.190.902,Cestode Infections,Helminthiasis,3
Takayasu Arteritis,C,C17.800.862.875,"Skin Diseases, Vascular",Skin Diseases,3
Takayasu Arteritis,C,C14.907.940.090.800,Arteritis,Vasculitis,3
Takayasu Arteritis,C,C14.907.109.239.650,Aortic Arch Syndromes,Aortic Diseases,3
Talin,D,D12.776.220.985,Cytoskeletal Proteins,Proteins,3
Taq Polymerase,D,D08.811.913.696.445.308.300.875,DNA-Directed DNA Polymerase,DNA Nucleotidyltransferases,3
Taste Perception,F,F02.463.593.817,Perception,Mental Processes,3
Tattooing,E,E04.085.840,"Body Modification, Non-Therapeutic","Surgical Procedures, Operative",3
Tattooing,E,E02.218.085.840,"Body Modification, Non-Therapeutic",Cosmetic Techniques,3
T-Cell Antigen Receptor Specificity,G,G12.450.900,Immunity,Immune System Phenomena,3
Telerehabilitation,H,H02.403.680.600.937,Rehabilitation,Physical and Rehabilitation Medicine,3
Telerehabilitation,H,H02.403.840.850,Telemedicine,Medicine,3
Telerehabilitation,L,L01.178.847.652.850,Telemedicine,Telecommunications,3
Telerehabilitation,N,N02.421.784.840,Rehabilitation,Health Services,3
Telerehabilitation,N,N04.590.374.800.850,Telemedicine,Delivery of Health Care,3
Telerehabilitation,E,E02.831.891,Rehabilitation,Therapeutics,3
Telerehabilitation,E,E02.760.169.063.500.891,Rehabilitation,Aftercare,3
Telmisartan,D,D03.633.100.103.791,Benzimidazoles,"Heterocyclic Compounds, 2-Ring",3
Telmisartan,D,D02.455.426.559.389.185.849,Biphenyl Compounds,Benzene Derivatives,3
Telomere Homeostasis,G,G07.345.249.410.750.500.750,Cell Division,Cell Proliferation,3
Telomere Homeostasis,G,G04.144.220.625,Cell Division,Cell Cycle,3
Telomere Homeostasis,G,G04.161.750.500.500,Cell Division,Cell Proliferation,3
Telomere Homeostasis,G,G05.113.610,Cell Division,Genetic Phenomena,3
Tendinopathy,C,C26.874.800,Tendon Injuries,Wounds and Injuries,3
Tendinopathy,C,C05.651.869,Muscular Diseases,Musculoskeletal Diseases,3
Tendons,A,A02.880,Musculoskeletal System,NULL,3
Tensile Strength,G,G01.374.850,Mechanical Phenomena,Physical Phenomena,3
Teratogens,D,D27.888.569.864,Noxae,Toxic Actions,3
Tetanus Antitoxin,D,D20.215.401.601.824,Antitoxins,Immune Sera,3
Tetanus Antitoxin,D,D12.776.377.715.548.114.573.601.849,Antitoxins,Immune Sera,3
Tetanus Antitoxin,D,D12.776.124.790.651.114.573.601.849,Antitoxins,Immune Sera,3
Tetanus Antitoxin,D,D12.776.124.486.485.114.573.601.849,Antitoxins,Immune Sera,3
Tetracyclines,D,D02.455.426.559.847.562.900,Naphthacenes,Polycyclic Aromatic Hydrocarbons,3
Tetracyclines,D,D04.615.562.900,Naphthacenes,Polycyclic Aromatic Hydrocarbons,3
Tetralogy of Fallot,C,C14.240.400.849,"Heart Defects, Congenital",Cardiovascular Abnormalities,3
Tetralogy of Fallot,C,C14.280.400.849,"Heart Defects, Congenital",Heart Diseases,3
Tetralogy of Fallot,C,C16.131.240.400.849,"Heart Defects, Congenital",Cardiovascular Abnormalities,3
Textbooks as Topic,L,L01.178.820.900,Teaching Materials,Communications Media,3
Textbooks as Topic,L,L01.178.682.192.900,Books,Publications,3
Th1-Th2 Balance,G,G12.838,Immune System Phenomena,NULL,3
"Therapies, Investigational",E,E02.931,Therapeutics,NULL,3
Thermosensing,F,F02.830.816.781,Sensation,Psychophysiology,3
Thermosensing,G,G07.850,Physiological Phenomena,NULL,3
Thermosensing,G,G11.561.790.781,Sensation,Nervous System Physiological Phenomena,3
Thiamine Deficiency,C,C18.654.521.500.133.699.827,Vitamin B Deficiency,Avitaminosis,3
Thienamycins,D,D02.065.589.099.124.300,Carbapenems,beta-Lactams,3
Thienamycins,D,D03.633.100.300.124.300,Carbapenems,beta-Lactams,3
Thrombotic Microangiopathies,C,C15.378.140.855.925,Thrombocytopenia,Blood Platelet Disorders,3
Thymocytes,A,A11.900,Cells,NULL,3
Thymocytes,A,A11.872.378.294.750.800,"Precursor Cells, T-Lymphoid",Lymphoid Progenitor Cells,3
Thymocytes,A,A11.148.378.294.750.800,"Precursor Cells, T-Lymphoid",Lymphoid Progenitor Cells,3
Thymocytes,A,A11.118.637.555.567.569.360.800,"Precursor Cells, T-Lymphoid",T-Lymphocytes,3
Tick Control,N,N06.850.780.200.650.850,Pest Control,Communicable Disease Control,3
Tinea Capitis,C,C01.800.200.720.730,Tinea,Dermatomycoses,3
Tinea Capitis,C,C01.150.703.302.720.730,Tinea,Dermatomycoses,3
Tinea Capitis,C,C17.800.838.208.883.558,Tinea,Dermatomycoses,3
Tinea Capitis,C,C17.800.738.708,Scalp Dermatoses,Skin Diseases,3
Tiotropium Bromide,D,D02.145.074.722.822.887,Scopolamine Derivatives,Tropanes,3
Tiotropium Bromide,D,D03.605.084.500.722.822.887,Scopolamine Derivatives,Tropanes,3
Tiotropium Bromide,D,D03.605.869.822.887,Scopolamine Derivatives,Tropanes,3
Tiotropium Bromide,D,D03.132.889.601.887,Scopolamine Derivatives,Tropanes,3
Tocopherols,D,D03.383.663.283.909.750,Vitamin E,Benzopyrans,3
Tocopherols,D,D03.633.100.150.909.750,Vitamin E,Benzopyrans,3
Toll-Like Receptor 3,D,D12.776.543.750.705.910.500.300,Toll-Like Receptors,"Receptors, Pattern Recognition",3
Tomography,E,E01.370.350.825,Diagnostic Imaging,Diagnostic Techniques and Procedures,3
Tooth Diseases,C,C07.793,Stomatognathic Diseases,NULL,3
Tooth Root,A,A14.549.167.900.750,Tooth Components,Dentition,3
Torsades de Pointes,C,C23.550.073.845.940.700,"Tachycardia, Ventricular",Tachycardia,3
Torsades de Pointes,C,C14.280.123.875.940.700,"Tachycardia, Ventricular",Tachycardia,3
Torsades de Pointes,C,C14.280.067.845.940.700,"Tachycardia, Ventricular",Tachycardia,3
Torso,A,A01.923,Body Regions,NULL,3
Transcaucasia,Z,Z01.542.900,Europe,Geographic Locations,3
Transcription Factor 7-Like 2 Protein,D,D12.776.930.875.875,TCF Transcription Factors,Transcription Factors,3
Transcription Factor 7-Like 2 Protein,D,D12.776.664.235.400.800.875,TCF Transcription Factors,High Mobility Group Proteins,3
Transcription Factor 7-Like 2 Protein,D,D12.776.660.235.400.800.875,TCF Transcription Factors,High Mobility Group Proteins,3
Transcription Factor 7-Like 2 Protein,D,D12.776.260.730.875,TCF Transcription Factors,DNA-Binding Proteins,3
Transcription Factor RelA,D,D12.776.260.600.249,NF-kappa B,DNA-Binding Proteins,3
Transcription Factor RelA,D,D12.776.660.600.249,NF-kappa B,Nuclear Proteins,3
Transcription Factor RelA,D,D12.776.930.600.249,NF-kappa B,Transcription Factors,3
Transcultural Nursing,H,H02.478.676.920,"Specialties, Nursing",Nursing,3
Transcutaneous Electric Nerve Stimulation,E,E03.091.823,Analgesia,Anesthesia and Analgesia,3
Transcutaneous Electric Nerve Stimulation,E,E02.831.535.468.800,Electric Stimulation Therapy,Physical Therapy Modalities,3
Transcutaneous Electric Nerve Stimulation,E,E02.779.468.800,Electric Stimulation Therapy,Physical Therapy Modalities,3
Transcutaneous Electric Nerve Stimulation,E,E02.331.800,Electric Stimulation Therapy,Therapeutics,3
Transferases,D,D08.811.913,Enzymes,Enzymes and Coenzymes,3
Transforming Growth Factor beta2,D,D12.644.276.954.775.200,Transforming Growth Factor beta,TGF-beta Superfamily Proteins,3
Transforming Growth Factor beta2,D,D12.644.276.374.687.200,Transforming Growth Factor beta,Cytokines,3
Transforming Growth Factor beta2,D,D23.529.942.775.200,Transforming Growth Factor beta,TGF-beta Superfamily Proteins,3
Transforming Growth Factor beta2,D,D23.529.374.687.200,Transforming Growth Factor beta,Cytokines,3
Transforming Growth Factor beta2,D,D12.776.467.942.775.200,Transforming Growth Factor beta,TGF-beta Superfamily Proteins,3
Transforming Growth Factor beta2,D,D12.776.467.374.687.200,Transforming Growth Factor beta,Cytokines,3
Transplantation,E,E04.936,"Surgical Procedures, Operative",NULL,3
Transplants,A,A01.941,Body Regions,NULL,3
Treponema,B,B03.440.425.410.711.795,Spirochaetaceae,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",3
Treponema,B,B03.851.595.795,Spirochaetaceae,Spirochaetales,3
Triamcinolone,D,D04.210.500.908.891,"Steroids, Fluorinated",Steroids,3
Triamcinolone,D,D04.210.500.745.432.915,Pregnadienes,Pregnanes,3
Trichophyton,B,B01.300.381.928,Mitosporic Fungi,Fungi,3
Triclosan,D,D02.455.426.559.389.657.654.900,Phenyl Ethers,Phenols,3
Triclosan,D,D02.355.726.900,Phenyl Ethers,Ethers,3
Tricuspid Valve Insufficiency,C,C14.280.484.856,Heart Valve Diseases,Heart Diseases,3
Tropomyosin,D,D05.750.078.730.800,Microfilament Proteins,Biopolymers,3
Tropomyosin,D,D12.776.210.500.895,Muscle Proteins,Contractile Proteins,3
Tropomyosin,D,D12.776.220.525.800,Microfilament Proteins,Cytoskeletal Proteins,3
Trypanosoma vivax,B,B01.268.475.868.887.850,Trypanosoma,Trypanosomatina,3
Tryptases,D,D08.811.277.656.959.350.902,Serine Endopeptidases,Serine Proteases,3
Tryptases,D,D08.811.277.656.300.760.902,Serine Endopeptidases,Endopeptidases,3
"Tuberculosis, Osteoarticular",C,C01.160.886,"Bone Diseases, Infectious",Infections,3
"Tuberculosis, Osteoarticular",C,C01.150.252.410.040.552.846.843,Tuberculosis,Mycobacterium Infections,3
"Tuberculosis, Osteoarticular",C,C05.116.165.886,"Bone Diseases, Infectious",Bone Diseases,3
Tularemia,C,C01.920.930.943,Tick-Borne Diseases,Vector Borne Diseases,3
Tularemia,C,C01.150.252.400.900,Gram-Negative Bacterial Infections,Bacterial Infections,3
"Tumor Necrosis Factor Receptor Superfamily, Member 7",D,D12.776.543.750.705.852.760.048,"Receptors, Tumor Necrosis Factor","Receptors, Cytokine",3
"Tumor Necrosis Factor Receptor Superfamily, Member 7",D,D23.050.301.264.894.127,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",3
"Tumor Necrosis Factor Receptor Superfamily, Member 7",D,D23.101.100.894.127,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",3
Type A Personality,F,F01.752.747.880,Personality Development,Personality,3
Ubiquitin Thiolesterase,D,D12.776.637.937,Parkinson Disease Associated Proteins,Proteins,3
Ubiquitin Thiolesterase,D,D08.811.277.352.897.850,Thiolester Hydrolases,Esterases,3
Ubiquitin Thiolesterase,D,D08.811.037.500,Deubiquitinating Enzymes,Enzymes,3
Ulnar Nerve,A,A08.800.800.720.050.850,Brachial Plexus,Spinal Nerves,3
Ultrasonic Therapy,E,E02.565.280.945,Diathermy,"Hyperthermia, Induced",3
"Ultrasonography, Doppler",E,E01.370.350.850.850,Ultrasonography,Diagnostic Imaging,3
Unsupervised Machine Learning,G,G17.035.250.500.750,Machine Learning,Artificial Intelligence,3
Unsupervised Machine Learning,L,L01.224.050.375.530.750,Machine Learning,Artificial Intelligence,3
Uracil,D,D03.383.742.698.875,Pyrimidinones,Pyrimidines,3
Ureteral Neoplasms,C,C04.588.945.947.940,Urologic Neoplasms,Urogenital Neoplasms,3
Ureteral Neoplasms,C,C13.351.968.725.676,Ureteral Diseases,Urologic Diseases,3
Ureteral Neoplasms,C,C13.351.937.820.875,Urologic Neoplasms,Urogenital Neoplasms,3
Ureteral Neoplasms,C,C12.758.820.875,Urologic Neoplasms,Urogenital Neoplasms,3
Ureteral Neoplasms,C,C12.777.725.676,Ureteral Diseases,Urologic Diseases,3
Ureteral Obstruction,C,C12.777.725.776,Ureteral Diseases,Urologic Diseases,3
Ureteral Obstruction,C,C13.351.968.725.776,Ureteral Diseases,Urologic Diseases,3
Urinary Bladder Diseases,C,C13.351.968.829,Urologic Diseases,Female Urogenital Diseases,3
Urinary Bladder Diseases,C,C12.777.829,Urologic Diseases,Male Urogenital Diseases,3
Urogenital Neoplasms,C,C12.758,Male Urogenital Diseases,NULL,3
Urogenital Neoplasms,C,C13.351.937,Female Urogenital Diseases,Female Urogenital Diseases and Pregnancy Complications,3
Urogenital Neoplasms,C,C04.588.945,Neoplasms by Site,Neoplasms,3
Urticaria,C,C17.800.862.945,"Skin Diseases, Vascular",Skin Diseases,3
Urticaria,C,C20.543.480.904,"Hypersensitivity, Immediate",Hypersensitivity,3
Ustekinumab,D,D12.776.377.715.548.114.224.200.937,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",3
Ustekinumab,D,D12.776.124.486.485.114.224.060.937,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",3
Ustekinumab,D,D12.776.124.790.651.114.224.060.937,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",3
Uterine Artery,A,A07.015.114.940,Arteries,Blood Vessels,3
Uterine Artery Embolization,E,E02.520.360.575,"Embolization, Therapeutic",Hemostatic Techniques,3
Uterine Artery Embolization,E,E02.926.500.575,"Embolization, Therapeutic",Therapeutic Occlusion,3
Uterine Artery Embolization,E,E04.950.300.883,Gynecologic Surgical Procedures,Urogenital Surgical Procedures,3
Uterine Diseases,C,C13.351.500.852,"Genital Diseases, Female",Female Urogenital Diseases,3
Uveal Neoplasms,C,C11.941.855,Uveal Diseases,Eye Diseases,3
Uveal Neoplasms,C,C11.319.494,Eye Neoplasms,Eye Diseases,3
Uveal Neoplasms,C,C04.588.364.978,Eye Neoplasms,Neoplasms by Site,3
"Uveitis, Anterior",C,C11.941.879.780.880,Panuveitis,Uveitis,3
"Vacuum Extraction, Obstetrical",E,E04.520.252.875.970,"Extraction, Obstetrical","Delivery, Obstetric",3
Vaginal Neoplasms,C,C13.351.937.418.937,"Genital Neoplasms, Female",Urogenital Neoplasms,3
Vaginal Neoplasms,C,C13.351.500.894.834,Vaginal Diseases,"Genital Diseases, Female",3
Vaginal Neoplasms,C,C04.588.945.418.955,"Genital Neoplasms, Female",Urogenital Neoplasms,3
Valacyclovir,D,D03.633.100.759.758.399.454.250.650,Acyclovir,Guanine,3
Valproic Acid,D,D10.251.400.895.593.900,Pentanoic Acids,Valerates,3
Valproic Acid,D,D02.241.081.944.509.900,Pentanoic Acids,Valerates,3
Varicella Zoster Virus Infection,C,C01.925.256.466.930,Herpesviridae Infections,DNA Virus Infections,3
Verapamil,D,D02.092.471.683.953,Phenethylamines,Ethylamines,3
Veterinary Drugs,D,D26.939,Pharmaceutical Preparations,NULL,3
Vibrio cholerae non-O1,B,B03.660.250.830.830.100.075,Vibrio cholerae,Vibrio,3
Vibrio cholerae non-O1,B,B03.440.450.900.859.225.075,Vibrio cholerae,Vibrio,3
Visual Analog Scale,E,E01.370.928,Diagnostic Techniques and Procedures,Diagnosis,3
Volition,F,F02.463.902,Mental Processes,Psychological Phenomena,3
Vulva,A,A05.360.319.887,"Genitalia, Female",Genitalia,3
Vulvar Neoplasms,C,C04.588.945.418.968,"Genital Neoplasms, Female",Urogenital Neoplasms,3
Vulvar Neoplasms,C,C13.351.500.944.819,Vulvar Diseases,"Genital Diseases, Female",3
Vulvar Neoplasms,C,C13.351.937.418.968,"Genital Neoplasms, Female",Urogenital Neoplasms,3
Water Resources,J,J01.728.500,Natural Resources,"Technology, Industry, and Agriculture",3
Water Resources,G,G16.500.275.553.500,Natural Resources,Environment,3
Water Resources,N,N06.230.350.500,Natural Resources,Environment,3
Water Wells,J,J01.293.821.500.500,Water Supply,Sanitary Engineering,3
Weibel-Palade Bodies,A,A11.284.430.214.190.500.950,Cytoplasmic Granules,Cytoplasmic Structures,3
Weibel-Palade Bodies,A,A11.284.430.214.190.875.190.190.950,Cytoplasmic Granules,Cytoplasmic Vesicles,3
Weights and Measures,E,E05.978,Investigative Techniques,NULL,3
Whistleblowing,F,F01.145.813.963,Social Behavior,Behavior,3
Whistleblowing,I,I01.880.604.583.080.134.900,Disclosure,Confidentiality,3
Whole-Body Counting,E,E05.799.950,Radiometry,Investigative Techniques,3
Wit and Humor as Topic,F,F01.100.960,Attitude,Behavior and Behavior Mechanisms,3
Wit and Humor as Topic,K,K01.517.946,Literature,Humanities,3
Wrist Injuries,C,C26.088.906,Arm Injuries,Wounds and Injuries,3
X Chromosome Inactivation,G,G05.308.203.249.970,"Dosage Compensation, Genetic","Epigenesis, Genetic",3
X-Ray Therapy,E,E02.815.907,Radiotherapy,Therapeutics,3
Zanamivir,D,D02.078.370.926,Guanidines,Amidines,3
Zanamivir,D,D02.241.081.844.562.668.775,Sialic Acids,Neuraminic Acids,3
Zanamivir,D,D02.241.511.902.562.668.775,Sialic Acids,Neuraminic Acids,3
Zanamivir,D,D09.811.589.668.775,Sialic Acids,Neuraminic Acids,3
Zanamivir,D,D09.067.687.668.775,Sialic Acids,Neuraminic Acids,3
Zanamivir,D,D03.383.663.859,Pyrans,"Heterocyclic Compounds, 1-Ring",3
Zoledronic Acid,D,D03.383.129.308.990,Imidazoles,Azoles,3
Zoledronic Acid,D,D02.705.429.500.942,Diphosphonates,Organophosphonates,3
11-beta-Hydroxysteroid Dehydrogenase Type 1,D,D08.811.682.047.436.174.300,11-beta-Hydroxysteroid Dehydrogenases,Hydroxysteroid Dehydrogenases,2
11-beta-Hydroxysteroid Dehydrogenase Type 1,D,D08.811.682.047.820.100.300,11-beta-Hydroxysteroid Dehydrogenases,NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases,2
14-alpha Demethylase Inhibitors,D,D27.505.389.500.059,Cytochrome P-450 Enzyme Inhibitors,Metabolic Side Effects of Drugs and Substances,2
14-alpha Demethylase Inhibitors,D,D27.505.519.389.335.059,Cytochrome P-450 Enzyme Inhibitors,Enzyme Inhibitors,2
14-alpha Demethylase Inhibitors,D,D27.505.519.389.870.100,Steroid Synthesis Inhibitors,Enzyme Inhibitors,2
14-alpha Demethylase Inhibitors,D,D27.505.696.399.450.855.100,Steroid Synthesis Inhibitors,Hormone Antagonists,2
1-Alkyl-2-acetylglycerophosphocholine Esterase,D,D08.811.277.352.100.680.750.937.249,Phospholipases A2,Phospholipases A,2
1-Propanol,D,D02.033.755.600,Propanols,Alcohols,2
"2,4-Dichlorophenoxyacetic Acid",D,D02.241.511.316.682.149,Phenoxyacetates,Glycolates,2
"2,4-Dichlorophenoxyacetic Acid",D,D02.241.081.018.386.682.224,Phenoxyacetates,Glycolates,2
25-Hydroxyvitamin D 2,D,D04.210.500.812.768.462.400,Ergocalciferols,Vitamin D,2
25-Hydroxyvitamin D 2,D,D04.210.500.247.808.412.400,Ergocalciferols,Sterols,2
25-Hydroxyvitamin D 2,D,D04.210.500.247.222.474.400,Ergocalciferols,Cholestenes,2
25-Hydroxyvitamin D 2,D,D10.570.938.439.500,Ergocalciferols,Sterols,2
25-Hydroxyvitamin D3 1-alpha-Hydroxylase,D,D08.244.453.915.400,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,2
25-Hydroxyvitamin D3 1-alpha-Hydroxylase,D,D08.244.453.499.500,Cytochrome P450 Family 27,Cytochrome P-450 Enzyme System,2
25-Hydroxyvitamin D3 1-alpha-Hydroxylase,D,D08.811.682.690.708.170.915.400,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,2
25-Hydroxyvitamin D3 1-alpha-Hydroxylase,D,D08.811.682.690.708.170.493.500,Cytochrome P450 Family 27,Cytochrome P-450 Enzyme System,2
25-Hydroxyvitamin D3 1-alpha-Hydroxylase,D,D12.776.422.220.453.499.500,Cytochrome P450 Family 27,Cytochrome P-450 Enzyme System,2
25-Hydroxyvitamin D3 1-alpha-Hydroxylase,D,D12.776.422.220.453.915.400,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,2
2-Methyl-4-chlorophenoxyacetic Acid,D,D02.241.081.018.386.682.500,Phenoxyacetates,Glycolates,2
2-Methyl-4-chlorophenoxyacetic Acid,D,D02.241.511.316.682.224,Phenoxyacetates,Glycolates,2
4-Quinolones,D,D03.633.100.810.835.830,Quinolones,Quinolines,2
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase,D,D08.811.913.555.500.645,Methyltransferases,One-Carbon Group Transferases,2
"8,11,14-Eicosatrienoic Acid",D,D10.251.355.255.207,Eicosanoids,"Fatty Acids, Unsaturated",2
Abdominal Abscess,C,C01.830.025.020,Abscess,Suppuration,2
Abdominal Injuries,C,C26.017,Wounds and Injuries,NULL,2
Abdominal Neoplasms,C,C04.588.033,Neoplasms by Site,Neoplasms,2
Abietanes,D,D02.455.426.559.847.723.040,Phenanthrenes,Polycyclic Aromatic Hydrocarbons,2
Abietanes,D,D02.455.849.291.040,Diterpenes,Terpenes,2
Abietanes,D,D04.615.723.040,Phenanthrenes,Polycyclic Aromatic Hydrocarbons,2
Acanthamoeba castellanii,B,B01.046.500.100.075.080.150,Acanthamoeba,Acanthopodina,2
Acceleration,G,G01.482.107,Motion,Physical Phenomena,2
Acetobacteraceae,B,B03.440.400.425.100,Gram-Negative Aerobic Rods and Cocci,Gram-Negative Aerobic Bacteria,2
Acetobacteraceae,B,B03.660.050.755.050,Rhodospirillales,Alphaproteobacteria,2
Acetylesterase,D,D08.811.277.352.100.050,Carboxylic Ester Hydrolases,Esterases,2
Achilles Tendon,A,A02.880.176,Tendons,Musculoskeletal System,2
Achondroplasia,C,C05.116.099.708.017,Osteochondrodysplasias,"Bone Diseases, Developmental",2
Achondroplasia,C,C05.116.099.343.110,Dwarfism,"Bone Diseases, Developmental",2
Achondroplasia,C,C16.320.240.500,Dwarfism,"Genetic Diseases, Inborn",2
Acid-Base Equilibrium,G,G02.111.007,Biochemical Phenomena,Chemical Phenomena,2
Acid-Base Equilibrium,G,G03.030,Metabolism,NULL,2
Acid-Base Equilibrium,G,G02.300.176,Hydrogen-Ion Concentration,Chemical Phenomena,2
Acid-Base Equilibrium,G,G09.188.050,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,2
Acid-Base Equilibrium,G,G07.410.110,Homeostasis,Physiological Phenomena,2
Acinetobacter,B,B03.660.250.530.050,Moraxellaceae,Gammaproteobacteria,2
Acinetobacter,B,B03.440.400.425.537.050,Moraxellaceae,Gram-Negative Aerobic Rods and Cocci,2
Acrylamides,D,D02.241.081.069.094,Acrylates,"Acids, Acyclic",2
Acrylamides,D,D02.065.122,Amides,Organic Chemicals,2
Acrylic Resins,D,D05.750.716.822.111,"Resins, Synthetic",Plastics,2
Acrylic Resins,D,D25.720.716.822.111,"Resins, Synthetic",Plastics,2
Acrylic Resins,J,J01.637.051.720.716.822.111,"Resins, Synthetic",Plastics,2
Acrylonitrile,D,D02.626.095,Nitriles,Organic Chemicals,2
Actin-Related Protein 2-3 Complex,D,D05.750.078.730.246,Microfilament Proteins,Biopolymers,2
Actin-Related Protein 2-3 Complex,D,D12.776.220.525.246,Microfilament Proteins,Cytoskeletal Proteins,2
Activity Cycles,G,G07.180.562.797.500,Ultradian Rhythm,Periodicity,2
Acute Lung Injury,C,C08.381.520.500,Lung Injury,Lung Diseases,2
Adaptor Protein Complex 2,D,D12.776.543.990.150.200,"Adaptor Proteins, Vesicular Transport",Vesicular Transport Proteins,2
"Adaptor Proteins, Vesicular Transport",D,D12.776.543.990.150,Vesicular Transport Proteins,Membrane Proteins,2
Addiction Medicine,H,H02.403.007,Medicine,Health Occupations,2
"Adenocarcinoma, Mucinous",C,C04.557.470.590.075,"Neoplasms, Cystic, Mucinous, and Serous","Neoplasms, Glandular and Epithelial",2
"Adenocarcinoma, Mucinous",C,C04.557.470.200.025.075,Adenocarcinoma,Carcinoma,2
Adenoids,A,A15.382.520.604.100,Lymphoid Tissue,Lymphatic System,2
Adenoids,A,A14.724.557.500,Nasopharynx,Pharynx,2
Adenoids,A,A04.623.557.500,Nasopharynx,Pharynx,2
Adenoids,A,A10.549.100,Lymphoid Tissue,Tissues,2
Adenomatous Polyposis Coli Protein,D,D12.776.476.081.249,Axin Signaling Complex,Intracellular Signaling Peptides and Proteins,2
Adenomatous Polyposis Coli Protein,D,D12.776.624.776.010,Tumor Suppressor Proteins,Neoplasm Proteins,2
Adenomatous Polyposis Coli Protein,D,D12.776.220.040,Cytoskeletal Proteins,Proteins,2
Adenomatous Polyposis Coli Protein,D,D05.500.117.249,Axin Signaling Complex,Multiprotein Complexes,2
Adherens Junctions,A,A11.284.149.165.420.020,Intercellular Junctions,Cell Membrane Structures,2
Adhesiveness,G,G02.860.139,Surface Properties,Chemical Phenomena,2
Adipogenesis,G,G04.152.149,Cell Differentiation,Cell Physiological Phenomena,2
"Administration, Ophthalmic",E,E02.319.267.120.805,"Administration, Topical",Drug Administration Routes,2
"Administrative Claims, Healthcare",N,N04.452.859.564.137,Medical Records,Records,2
"Admitting Department, Hospital",N,N04.452.442.452.422.040,Hospital Departments,Hospital Administration,2
"Admitting Department, Hospital",N,N02.278.216.500.968.040,Hospital Departments,Hospital Administration,2
Adrenal Gland Neoplasms,C,C04.588.322.078,Endocrine Gland Neoplasms,Neoplasms by Site,2
Adrenal Gland Neoplasms,C,C19.344.078,Endocrine Gland Neoplasms,Endocrine System Diseases,2
Adrenal Gland Neoplasms,C,C19.053.347,Adrenal Gland Diseases,Endocrine System Diseases,2
Adrenal Insufficiency,C,C19.053.500,Adrenal Gland Diseases,Endocrine System Diseases,2
Adrenalectomy,E,E04.270.115,Endocrine Surgical Procedures,"Surgical Procedures, Operative",2
Adrenergic Agonists,D,D27.505.696.577.050.100,Adrenergic Agents,Neurotransmitter Agents,2
Adrenergic Agonists,D,D27.505.519.625.050.100,Adrenergic Agents,Neurotransmitter Agents,2
Adrenergic beta-1 Receptor Antagonists,D,D27.505.519.625.050.200.200.100,Adrenergic beta-Antagonists,Adrenergic Antagonists,2
Adrenergic beta-1 Receptor Antagonists,D,D27.505.696.577.050.200.200.100,Adrenergic beta-Antagonists,Adrenergic Antagonists,2
"Affective Disorders, Psychotic",F,F03.700.150,Schizophrenia Spectrum and Other Psychotic Disorders,Mental Disorders,2
Agammaglobulinaemia Tyrosine Kinase,D,D08.811.913.696.620.682.725.025,Protein-Tyrosine Kinases,Protein Kinases,2
Agraphia,C,C23.888.592.604.150.500.050,Language Disorders,Communication Disorders,2
Agraphia,C,C10.597.606.150.500.050,Language Disorders,Communication Disorders,2
Air Ambulances,N,N02.421.297.879.100.100,Ambulances,Transportation of Patients,2
Air Ambulances,J,J01.937.285.100.100,Aircraft,Aviation,2
Air Filters,E,E05.196.454.201,Filtration,"Chemistry Techniques, Analytical",2
Air Filters,E,E07.039,Equipment and Supplies,NULL,2
Air Ionization,G,G02.035,Chemical Phenomena,NULL,2
Air Ionization,G,G16.500.050,Ecological and Environmental Phenomena,Biological Phenomena,2
Air Ionization,N,N06.230.300.100.150.100,Air,Atmosphere,2
Air Movements,N,N06.230.300.100.150.185,Air,Atmosphere,2
Air Movements,G,G16.500.175.249,Climatic Processes,Ecological and Environmental Phenomena,2
Air Movements,G,G16.500.275.063.725.154,Weather,Atmosphere,2
Airway Extubation,E,E05.008,Investigative Techniques,NULL,2
Airway Extubation,E,E02.041.249,Airway Management,Therapeutics,2
Alcian Blue,D,D03.633.100.473.050,Indoles,"Heterocyclic Compounds, 2-Ring",2
"Aldehyde Dehydrogenase, Mitochondrial",D,D08.811.682.657.163.249.375,Aldehyde Dehydrogenase,Aldehyde Oxidoreductases,2
"Aldehyde Dehydrogenase, Mitochondrial",D,D12.776.575.093,Mitochondrial Proteins,Proteins,2
Aldehyde Reductase,D,D08.811.682.047.150.700.156.500,Aldo-Keto Reductases,Sugar Alcohol Dehydrogenases,2
Aldehyde Reductase,D,D08.811.682.047.820.284.500,Aldo-Keto Reductases,NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases,2
Alemtuzumab,D,D12.776.377.715.548.114.224.200.375,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Alemtuzumab,D,D12.776.124.790.651.114.224.060.375,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Alemtuzumab,D,D12.776.124.486.485.114.224.060.313,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Allelic Imbalance,G,G05.365.590.029,Mutation,Genetic Variation,2
Alopecia,C,C17.800.329.937.122,Hypotrichosis,Hair Diseases,2
Alopecia,C,C23.300.035,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",2
alpha 1-Antichymotrypsin,D,D12.776.124.790.106.050,Alpha-Globulins,Serum Globulins,2
alpha 1-Antichymotrypsin,D,D12.776.124.050.050,Acute-Phase Proteins,Blood Proteins,2
alpha 1-Antichymotrypsin,D,D12.644.861.030,Serpins,Peptides,2
alpha 1-Antichymotrypsin,D,D12.776.377.715.085.050,Alpha-Globulins,Serum Globulins,2
alpha 1-Antichymotrypsin,D,D12.776.395.045,Glycoproteins,Proteins,2
alpha 1-Antichymotrypsin,D,D12.776.872.030,Serpins,Proteins,2
alpha-Defensins,D,D12.776.543.695.054.200.050,Defensins,Antimicrobial Cationic Peptides,2
alpha-Defensins,D,D12.644.050.200.050,Defensins,Antimicrobial Cationic Peptides,2
alpha-Globins,D,D12.776.124.400.434.320,Hemoglobin Subunits,Hemoglobins,2
alpha-Globins,D,D12.776.422.316.762.403.320,Hemoglobin Subunits,Hemoglobins,2
Alphaproteobacteria,B,B03.660.050,Proteobacteria,Bacteria,2
alpha-Synuclein,D,D12.776.637.500,Parkinson Disease Associated Proteins,Proteins,2
alpha-Synuclein,D,D12.776.631.860.500,Synucleins,Nerve Tissue Proteins,2
Alphavirus,B,B04.820.578.875.054,Togaviridae,Positive-Strand RNA Viruses,2
Alternaria,B,B01.300.381.075,Mitosporic Fungi,Fungi,2
Alum Compounds,D,D01.056.025,Aluminum Compounds,Inorganic Chemicals,2
Alum Compounds,D,D01.875.800.800.850.025,Sulfates,Sulfuric Acids,2
Amidines,D,D02.078,Organic Chemicals,NULL,2
Amino Acid Oxidoreductases,D,D08.811.682.664.500,Oxidoreductases Acting on CH-NH2 Group Donors,Oxidoreductases,2
Aminoisobutyric Acids,D,D12.125.190.055,Aminobutyrates,Amino Acids,2
Aminoisobutyric Acids,D,D12.125.070.075,"Amino Acids, Branched-Chain",Amino Acids,2
Aminoisobutyric Acids,D,D02.241.081.114.968.249,Isobutyrates,Butyrates,2
Aminopyridines,D,D02.092.080,Amines,Organic Chemicals,2
Aminopyridines,D,D03.383.725.050,Pyridines,"Heterocyclic Compounds, 1-Ring",2
Ammonia,D,D01.625.050,Nitrogen Compounds,Inorganic Chemicals,2
Ammonia,D,D01.362.075,Gases,Inorganic Chemicals,2
Amnesia,C,C23.888.592.604.529.100,Memory Disorders,Neurobehavioral Manifestations,2
Amnesia,C,C10.597.606.525.100,Memory Disorders,Neurobehavioral Manifestations,2
Amnesia,F,F03.615.200,Neurocognitive Disorders,Mental Disorders,2
Amnesia,F,F01.700.625.100,Memory Disorders,Neurobehavioral Manifestations,2
Amplified Fragment Length Polymorphism Analysis,E,E05.393.620.500.324,Polymerase Chain Reaction,Nucleic Acid Amplification Techniques,2
Amplified Fragment Length Polymorphism Analysis,E,E05.393.290.382,DNA Fingerprinting,Genetic Techniques,2
Amylases,D,D08.811.277.450.066,Glycoside Hydrolases,Hydrolases,2
Anabolic Agents,D,D27.505.696.399.472.080,Hormones,"Hormones, Hormone Substitutes, and Hormone Antagonists",2
Analgesia,E,E03.091,Anesthesia and Analgesia,NULL,2
"Analgesia, Epidural",E,E03.091.080,Analgesia,Anesthesia and Analgesia,2
"Analgesia, Patient-Controlled",E,E03.091.120,Analgesia,Anesthesia and Analgesia,2
Anaplasma phagocytophilum,B,B03.440.664.750.050.600,Anaplasma,Anaplasmataceae,2
Anaplasma phagocytophilum,B,B03.660.050.783.500.050.600,Anaplasma,Anaplasmataceae,2
Anatomy,H,H01.158.100,Biological Science Disciplines,Natural Science Disciplines,2
"Anesthesia, Cardiac Procedures",E,E03.155.403,Anesthesia,Anesthesia and Analgesia,2
"Anesthesia, Epidural",E,E03.155.086.131,"Anesthesia, Conduction",Anesthesia,2
"Anesthesia, Inhalation",E,E03.155.197.197,"Anesthesia, General",Anesthesia,2
"Anesthesia, Intravenous",E,E03.155.308,Anesthesia,Anesthesia and Analgesia,2
"Anesthesia, Spinal",E,E03.155.086.331,"Anesthesia, Conduction",Anesthesia,2
"Aneurysm, Infected",C,C01.069,Infections,NULL,2
"Aneurysm, Infected",C,C14.907.055.131,Aneurysm,Vascular Diseases,2
Angioedema,C,C14.907.079,Vascular Diseases,Cardiovascular Diseases,2
Angioedema,C,C17.800.862.945.066,Urticaria,"Skin Diseases, Vascular",2
Angioedema,C,C20.543.480.904.066,Urticaria,"Hypersensitivity, Immediate",2
Angiotensin II,D,D23.469.050.050.050,Angiotensins,Autacoids,2
Angiotensin II,D,D12.776.631.650.070.078,Angiotensins,Neuropeptides,2
Angiotensin II,D,D06.472.699.094.078,Angiotensins,Peptide Hormones,2
Angiotensin II,D,D12.644.548.058.078,Angiotensins,Peptide Hormones,2
Angiotensin II,D,D12.644.456.073.041,Angiotensins,Oligopeptides,2
Angiotensin II,D,D12.644.400.070.078,Angiotensins,Neuropeptides,2
Anguilla,B,B01.050.150.900.493.338.282,Eels,Fishes,2
Anhedonia,C,C23.888.592.604.039,Neurobehavioral Manifestations,Neurologic Manifestations,2
Anhedonia,C,C10.597.606.057,Neurobehavioral Manifestations,Neurologic Manifestations,2
Anhedonia,F,F01.700.039,Neurobehavioral Manifestations,Behavior and Behavior Mechanisms,2
Animal Communication,F,F01.145.113.055,"Behavior, Animal",Behavior,2
Animal Nutritional Physiological Phenomena,G,G07.203.650.161,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",2
Animal Population Groups,B,B01.050.050,Animals,Eukaryota,2
Animal Testing Alternatives,E,E05.017.080.100,Animal Use Alternatives,Animal Experimentation,2
"Animals, Laboratory",B,B01.050.050.199,Animal Population Groups,Animals,2
"Animals, Outbred Strains",B,B01.050.050.284,Animal Population Groups,Animals,2
Anions,D,D01.248.497.158,Ions,Electrolytes,2
Ankyrin Repeat,G,G02.111.570.060.720.030,"Repetitive Sequences, Amino Acid",Amino Acid Sequence,2
Ankyrin Repeat,G,G02.111.570.820.709.275.500.030,Amino Acid Motifs,Protein Structural Elements,2
Ankyrin Repeat,G,G02.111.570.820.709.275.750.500.080,Protein Interaction Domains and Motifs,Protein Domains,2
Ankyrin Repeat,G,G02.111.570.820.709.275.875.030,"Repetitive Sequences, Amino Acid",Protein Structural Elements,2
Annexin A2,D,D12.776.157.125.050.060,Annexins,Calcium-Binding Proteins,2
Annexin A5,D,D12.776.157.125.050.100,Annexins,Calcium-Binding Proteins,2
Anomia,C,C23.888.592.604.150.500.090,Language Disorders,Communication Disorders,2
Anomia,C,C10.597.606.150.500.090,Language Disorders,Communication Disorders,2
Anovulation,C,C13.351.500.056.630.050,Ovarian Diseases,Adnexal Diseases,2
Anovulation,C,C19.391.630.050,Ovarian Diseases,Gonadal Disorders,2
Anovulation,G,G08.686.784.690.080,Ovulation,Reproduction,2
Antarctic Regions,Z,Z01.158,Geographic Locations,NULL,2
Anthozoa,B,B01.050.500.308.237,Cnidaria,Invertebrates,2
Anti-Anxiety Agents,D,D27.505.696.277.950.015,Tranquilizing Agents,Central Nervous System Depressants,2
Anti-Anxiety Agents,D,D27.505.954.427.700.872.015,Tranquilizing Agents,Psychotropic Drugs,2
Anti-Anxiety Agents,D,D27.505.954.427.210.950.015,Tranquilizing Agents,Central Nervous System Depressants,2
"Antibiotics, Antineoplastic",D,D27.505.954.248.106,Antineoplastic Agents,Therapeutic Uses,2
"Antibodies, Neoplasm",D,D12.776.124.790.651.114.240,Antibodies,Immunoglobulins,2
"Antibodies, Neoplasm",D,D12.776.124.486.485.114.240,Antibodies,Immunoglobulins,2
"Antibodies, Neoplasm",D,D12.776.377.715.548.114.240,Antibodies,Immunoglobulins,2
Antibody Diversity,G,G05.365.036,Genetic Variation,Genetic Phenomena,2
Antibody Diversity,G,G12.500.199,Immunogenetic Phenomena,Immune System Phenomena,2
Antibody-Producing Cells,A,A15.382.032,Immune System,Hemic and Immune Systems,2
Antibody-Producing Cells,A,A11.063,Cells,NULL,2
Anticarcinogenic Agents,D,D27.505.954.248.125,Antineoplastic Agents,Therapeutic Uses,2
Anticarcinogenic Agents,D,D27.505.696.706.018,Protective Agents,Physiological Effects of Drugs,2
Anticarcinogenic Agents,D,D27.720.799.018,Protective Agents,Specialty Uses of Chemicals,2
"Anticipation, Psychological",F,F02.463.093,Mental Processes,Psychological Phenomena,2
"Antigens, Heterophile",D,D23.050.244,Antigens,Biological Factors,2
Antilymphocyte Serum,D,D20.215.401.203,Immune Sera,Biological Products,2
Antilymphocyte Serum,D,D12.776.377.715.548.114.573.203,Immune Sera,Antibodies,2
Antilymphocyte Serum,D,D12.776.124.486.485.114.573.203,Immune Sera,Antibodies,2
Antilymphocyte Serum,D,D12.776.124.790.651.114.573.203,Immune Sera,Antibodies,2
Antilymphocyte Serum,A,A12.207.152.846.500.203,Immune Sera,Serum,2
Antimanic Agents,D,D27.505.954.427.210.950.025,Tranquilizing Agents,Central Nervous System Depressants,2
Antimanic Agents,D,D27.505.954.427.700.872.025,Tranquilizing Agents,Psychotropic Drugs,2
Antimanic Agents,D,D27.505.696.277.950.025,Tranquilizing Agents,Central Nervous System Depressants,2
Antimetabolites,D,D27.505.519.186,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,2
Antimetabolites,D,D27.888.569.042,Noxae,Toxic Actions,2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,C,C20.111.193,Autoimmune Diseases,Immune System Diseases,2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,C,C14.907.940.897.249,Systemic Vasculitis,Vasculitis,2
Antiporters,D,D12.776.543.550.190,Membrane Glycoproteins,Membrane Proteins,2
Antiporters,D,D12.776.543.585.450.162,Ion Pumps,Membrane Transport Proteins,2
Antiporters,D,D12.776.157.530.450.162,Ion Pumps,Membrane Transport Proteins,2
Antipyretics,D,D27.505.696.068,Physiological Effects of Drugs,Pharmacologic Actions,2
Antipyrine,D,D03.383.129.539.850.088,Pyrazolones,Pyrazoles,2
Antisocial Personality Disorder,F,F03.675.050,Personality Disorders,Mental Disorders,2
Antithyroid Agents,D,D06.347.100,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",2
Antithyroid Agents,D,D27.505.696.399.450.100,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",2
Antitreponemal Agents,D,D27.505.954.122.085.222,Anti-Bacterial Agents,Anti-Infective Agents,2
Anti-Ulcer Agents,D,D27.505.954.483.203,Gastrointestinal Agents,Therapeutic Uses,2
Anti-Vaccination Movement,I,I03.088,Human Activities,NULL,2
Aortography,E,E01.370.370.050.070,Angiography,"Diagnostic Techniques, Cardiovascular",2
Aortography,E,E01.370.350.700.060.070,Angiography,Radiography,2
Aotus trivirgatus,B,B01.050.150.900.649.313.988.400.600.037.092,Aotidae,Platyrrhini,2
Apathy,F,F01.470.137,Emotions,Behavior and Behavior Mechanisms,2
Ape Diseases,C,C22.735.050,Primate Diseases,Animal Diseases,2
Apicoplasts,A,A11.284.430.214.190.875.700.069,Plastids,Organelles,2
Apolipoprotein C-III,D,D12.776.521.120.400.875,Apolipoproteins C,Apolipoproteins,2
Apolipoprotein C-III,D,D12.776.070.400.400.875,Apolipoproteins C,Apolipoproteins,2
Apolipoprotein C-III,D,D10.532.091.400.875,Apolipoproteins C,Apolipoproteins,2
Aptitude Tests,F,F04.711.141,Psychological Tests,Behavioral Disciplines and Activities,2
Aquatic Organisms,G,G16.500.275.725.500.650.075,Oceans and Seas,Seawater,2
Aquatic Organisms,B,B05.080,Organism Forms,NULL,2
Arab World,I,I01.076.201.450.226.200,Civilization,Culture,2
Arachidonic Acids,D,D10.251.355.255.100,Eicosanoids,"Fatty Acids, Unsaturated",2
Arachidonic Acids,D,D10.251.355.310.166,"Fatty Acids, Essential","Fatty Acids, Unsaturated",2
Archamoebae,B,B01.046.060,Amoebozoa,Eukaryota,2
Arctic Regions,Z,Z01.208,Geographic Locations,NULL,2
Areca,B,B01.650.940.800.575.912.250.093.088,Arecaceae,Magnoliopsida,2
Arenavirus,B,B04.820.480.500.070,Arenaviridae,Negative-Sense RNA Viruses,2
Argonaute Proteins,D,D12.776.157.725.500.906.500,RNA-Induced Silencing Complex,Ribonucleoproteins,2
Argonaute Proteins,D,D08.811.277.352.700.350.810.500,RNA-Induced Silencing Complex,Endoribonucleases,2
Argonaute Proteins,D,D08.811.277.352.355.350.810.500,RNA-Induced Silencing Complex,Endoribonucleases,2
Argonaute Proteins,D,D12.776.664.962.500.906.500,RNA-Induced Silencing Complex,Ribonucleoproteins,2
Aripiprazole,D,D03.383.606.170,Piperazines,"Heterocyclic Compounds, 1-Ring",2
Aripiprazole,D,D03.633.100.810.835.122,Quinolones,Quinolines,2
Aristolochic Acids,D,D02.640.139,Nitro Compounds,Organic Chemicals,2
Aristolochic Acids,D,D02.455.426.559.847.723.089,Phenanthrenes,Polycyclic Aromatic Hydrocarbons,2
Aristolochic Acids,D,D04.615.723.089,Phenanthrenes,Polycyclic Aromatic Hydrocarbons,2
Armadillo Domain Proteins,D,D12.776.091,Proteins,"Amino Acids, Peptides, and Proteins",2
ARNTL Transcription Factors,D,D12.776.260.103.249,Basic Helix-Loop-Helix Transcription Factors,DNA-Binding Proteins,2
ARNTL Transcription Factors,D,D12.644.360.138.049,Circadian Rhythm Signaling Peptides and Proteins,Intracellular Signaling Peptides and Proteins,2
ARNTL Transcription Factors,D,D12.776.930.125.249,Basic Helix-Loop-Helix Transcription Factors,Transcription Factors,2
ARNTL Transcription Factors,D,D12.776.476.156.100,Circadian Rhythm Signaling Peptides and Proteins,Intracellular Signaling Peptides and Proteins,2
Artemisia,B,B01.650.940.800.575.912.250.100.100,Asteraceae,Magnoliopsida,2
Arterioles,A,A07.015.114.060,Arteries,Blood Vessels,2
Arterioles,A,A07.015.461.080,Microvessels,Blood Vessels,2
Arthroplasty,E,E04.680.101,Reconstructive Surgical Procedures,"Surgical Procedures, Operative",2
Arthroplasty,E,E04.555.110,Orthopedic Procedures,"Surgical Procedures, Operative",2
Arthropod Antennae,A,A13.093,Animal Structures,NULL,2
Arthropod Proteins,D,D12.776.093,Proteins,"Amino Acids, Peptides, and Proteins",2
Artificial Gene Fusion,E,E05.393.220.250,"Cloning, Molecular",Genetic Techniques,2
Arvicolinae,B,B01.050.150.900.649.313.992.635.075,Muridae,Rodentia,2
Arylalkylamine N-Acetyltransferase,D,D08.811.913.050.134.127,Acetyltransferases,Acyltransferases,2
Ascitic Fluid,A,A12.207.119,Body Fluids,Fluids and Secretions,2
Asialoglycoproteins,D,D12.776.395.140,Glycoproteins,Proteins,2
Asparagine,D,D12.125.095.165,"Amino Acids, Diamino",Amino Acids,2
Asparagine,D,D12.125.154.049,"Amino Acids, Neutral",Amino Acids,2
Asparagine,D,D12.125.068.060,"Amino Acids, Basic",Amino Acids,2
"Asthma, Exercise-Induced",C,C20.543.480.680.095.110,Asthma,Respiratory Hypersensitivity,2
"Asthma, Exercise-Induced",C,C08.127.108.110,Asthma,Bronchial Diseases,2
"Asthma, Exercise-Induced",C,C08.674.095.110,Asthma,Respiratory Hypersensitivity,2
Ataxia Telangiectasia,C,C10.228.140.252.190.530.060,Spinocerebellar Ataxias,Cerebellar Ataxia,2
Ataxia Telangiectasia,C,C10.562.100,Neurocutaneous Syndromes,Nervous System Diseases,2
Ataxia Telangiectasia,C,C10.597.350.090.500.530.060,Spinocerebellar Ataxias,Cerebellar Ataxia,2
Ataxia Telangiectasia,C,C14.907.823.213,Telangiectasis,Vascular Diseases,2
Ataxia Telangiectasia,C,C18.452.284.060,DNA Repair-Deficiency Disorders,Metabolic Diseases,2
Ataxia Telangiectasia,C,C16.320.080,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Ataxia Telangiectasia,C,C16.320.798.250,Primary Immunodeficiency Diseases,"Genetic Diseases, Inborn",2
Ataxia Telangiectasia,C,C20.673.795.250,Primary Immunodeficiency Diseases,Immunologic Deficiency Syndromes,2
Atazanavir Sulfate,D,D12.644.456.157,Oligopeptides,Peptides,2
Atazanavir Sulfate,D,D03.383.725.068,Pyridines,"Heterocyclic Compounds, 1-Ring",2
Atlantic Islands,Z,Z01.639.040,Islands,Geographic Locations,2
ATP Binding Cassette Transporter 1,D,D12.776.395.550.020.381.500,"ATP Binding Cassette Transporter, Subfamily A",ATP-Binding Cassette Transporters,2
ATP Binding Cassette Transporter 1,D,D12.776.157.530.100.050.500,"ATP Binding Cassette Transporter, Subfamily A",ATP-Binding Cassette Transporters,2
ATP Binding Cassette Transporter 1,D,D12.776.543.550.192.381.500,"ATP Binding Cassette Transporter, Subfamily A",ATP-Binding Cassette Transporters,2
ATP Binding Cassette Transporter 1,D,D12.776.543.585.100.190.500,"ATP Binding Cassette Transporter, Subfamily A",ATP-Binding Cassette Transporters,2
ATP Citrate (pro-S)-Lyase,D,D08.811.913.050.331,Acyltransferases,Transferases,2
Atrial Natriuretic Factor,D,D06.472.699.584.500,Natriuretic Peptides,Peptide Hormones,2
Atrial Natriuretic Factor,D,D12.644.548.585.500,Natriuretic Peptides,Peptide Hormones,2
Auditory Perceptual Disorders,C,C23.888.592.604.764.200,Perceptual Disorders,Neurobehavioral Manifestations,2
Auditory Perceptual Disorders,C,C10.597.606.762.200,Perceptual Disorders,Neurobehavioral Manifestations,2
Auditory Perceptual Disorders,C,C10.228.140.068.094,"Auditory Diseases, Central",Brain Diseases,2
Auditory Perceptual Disorders,C,C09.218.807.186.094,"Auditory Diseases, Central",Retrocochlear Diseases,2
Auditory Perceptual Disorders,F,F01.700.750.200,Perceptual Disorders,Neurobehavioral Manifestations,2
Auditory Perceptual Disorders,F,F03.615.250.100,Cognition Disorders,Neurocognitive Disorders,2
Aurora Kinase A,D,D08.811.913.696.620.682.700.103.500,Aurora Kinases,Protein-Serine-Threonine Kinases,2
Aurora Kinase A,D,D12.776.167.049.500,Aurora Kinases,Cell Cycle Proteins,2
Auscultation,E,E01.370.600.060,Physical Examination,Diagnostic Techniques and Procedures,2
Autoreceptors,D,D12.776.543.750.035,"Receptors, Cell Surface",Membrane Proteins,2
Autoreceptors,D,D12.776.543.750.720.670.100,"Receptors, Presynaptic","Receptors, Neurotransmitter",2
Avitaminosis,C,C18.654.521.500.133,Deficiency Diseases,Malnutrition,2
Axoneme,A,A11.284.430.214.190.750.602.309,Microtubules,Cytoskeleton,2
B7-1 Antigen,D,D12.776.543.095.100,B7 Antigens,Membrane Proteins,2
B7-1 Antigen,D,D12.776.467.150.100,B7 Antigens,Intercellular Signaling Peptides and Proteins,2
B7-1 Antigen,D,D23.050.301.285.100,B7 Antigens,"Antigens, Surface",2
B7-1 Antigen,D,D23.529.168.100,B7 Antigens,Intercellular Signaling Peptides and Proteins,2
Babesia bovis,B,B01.043.075.600.580.070.100,Babesia,Piroplasmida,2
Bacterial Proton-Translocating ATPases,D,D12.776.543.585.450.250.875.500.249,Proton-Translocating ATPases,Proton Pumps,2
Bacterial Proton-Translocating ATPases,D,D12.776.157.530.450.250.875.500.249,Proton-Translocating ATPases,Proton Pumps,2
Bacterial Proton-Translocating ATPases,D,D12.776.097.130,Bacterial Proteins,Proteins,2
Bacterial Proton-Translocating ATPases,D,D08.811.913.696.650.150.500.249,Proton-Translocating ATPases,ATP Synthetase Complexes,2
Bacterial Proton-Translocating ATPases,D,D08.811.277.040.025.325.249,Proton-Translocating ATPases,Adenosine Triphosphatases,2
Bacterial Shedding,G,G07.075,Physiological Phenomena,NULL,2
Bacterial Zoonoses,C,C01.150.252.162,Bacterial Infections,Bacterial Infections and Mycoses,2
Bacterial Zoonoses,C,C01.973.250,Zoonoses,Infections,2
Bacterial Zoonoses,C,C22.969.250,Zoonoses,Animal Diseases,2
Bacteriolysis,G,G06.099.115,Bacterial Physiological Phenomena,Microbiological Phenomena,2
Bacteriophage T7,B,B04.123.205.891.230,T-Phages,Coliphages,2
Bacteriophage T7,B,B04.123.150.700.230,Podoviridae,Caudovirales,2
Bacteriophage T7,B,B04.280.090.700.230,Podoviridae,Caudovirales,2
Balantidiasis,C,C01.610.432.146,"Intestinal Diseases, Parasitic",Parasitic Diseases,2
Balantidiasis,C,C01.610.752.200.146,Ciliophora Infections,Protozoan Infections,2
Balantidiasis,C,C06.405.469.452.146,"Intestinal Diseases, Parasitic",Intestinal Diseases,2
Balloon Occlusion,E,E02.148.106,Catheterization,Therapeutics,2
Balloon Occlusion,E,E02.520.392.500,Endotamponade,Hemostatic Techniques,2
Balloon Occlusion,E,E02.926.500.074,"Embolization, Therapeutic",Therapeutic Occlusion,2
Balloon Occlusion,E,E05.157.063,Catheterization,Investigative Techniques,2
"Banking, Personal",N,N03.219.463.030.100,Accounting,Financial Management,2
Basal Ganglia,A,A08.186.211.200.885.287.249,Cerebrum,Telencephalon,2
Basic-Leucine Zipper Transcription Factors,D,D12.776.930.127,Transcription Factors,Proteins,2
Basic-Leucine Zipper Transcription Factors,D,D12.776.260.108,DNA-Binding Proteins,Proteins,2
Basketball,I,I03.450.642.845.117,Sports,Recreation,2
Bathing Beaches,J,J03.925.080,Sports and Recreational Facilities,Non-Medical Public and Private Facilities,2
Behavior Observation Techniques,E,E05.796.112,Psychological Techniques,Investigative Techniques,2
Behavior Observation Techniques,F,F04.669.112,Psychological Techniques,Behavioral Disciplines and Activities,2
Beneficence,K,K01.752.566.479.830.500,Principle-Based Ethics,Ethics,2
Beneficence,N,N05.350.958.500,Principle-Based Ethics,Ethics,2
Benzene Derivatives,D,D02.455.426.559.389,"Hydrocarbons, Aromatic","Hydrocarbons, Cyclic",2
Benzethonium,D,D02.092.877.096.082,Benzylammonium Compounds,Quaternary Ammonium Compounds,2
Benzethonium,D,D02.675.276.090,Quaternary Ammonium Compounds,Onium Compounds,2
Benzo(a)pyrene,D,D02.455.426.559.847.799.306.300,Benzopyrenes,Pyrenes,2
Benzo(a)pyrene,D,D04.615.799.306.300,Benzopyrenes,Pyrenes,2
Benzothiadiazines,D,D02.886.590.700.135,Sulfonamides,Sulfones,2
Benzothiadiazines,D,D02.886.655.500,Thiazides,Sulfur Compounds,2
Benzothiadiazines,D,D03.633.100.174,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",2
beta 2-Glycoprotein I,D,D12.776.395.195,Glycoproteins,Proteins,2
beta 2-Glycoprotein I,D,D12.776.124.117,Blood Proteins,Proteins,2
beta-Globins,D,D12.776.124.400.434.325,Hemoglobin Subunits,Hemoglobins,2
beta-Globins,D,D12.776.422.316.762.403.325,Hemoglobin Subunits,Hemoglobins,2
Betaine,D,D02.675.276.125,Quaternary Ammonium Compounds,Onium Compounds,2
Betaine,D,D02.092.877.883.077,Trimethyl Ammonium Compounds,Quaternary Ammonium Compounds,2
beta-Lactamase Inhibitors,D,D27.505.954.122.085.516,Anti-Bacterial Agents,Anti-Infective Agents,2
beta-Lactamase Inhibitors,D,D27.505.519.389.400,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,2
Betamethasone,D,D04.210.500.745.432.769.199,Pregnadienetriols,Pregnadienes,2
Betamethasone,D,D04.210.500.908.093,"Steroids, Fluorinated",Steroids,2
Betaretrovirus,B,B04.820.650.124,Retroviridae,RNA Viruses,2
Betaretrovirus,B,B04.613.807.124,Retroviridae,Oncogenic Viruses,2
Bezafibrate,D,D02.241.081.114.968.500.249,Fibric Acids,Isobutyrates,2
Bezafibrate,D,D02.241.223.100.100.120,Benzamides,Benzoates,2
Bezafibrate,D,D02.241.223.100.200.249,Chlorobenzoates,Benzoates,2
Bezafibrate,D,D02.455.426.559.389.127.085.101,Benzamides,Benzoates,2
Bezafibrate,D,D02.455.426.559.389.127.250.249,Chlorobenzoates,Benzoates,2
Bezafibrate,D,D02.455.426.559.389.657.654.305.249,Fibric Acids,Phenyl Ethers,2
Bezafibrate,D,D02.355.726.305.249,Fibric Acids,Phenyl Ethers,2
Bezafibrate,D,D02.065.277.067,Benzamides,Amides,2
Bicarbonates,D,D01.200.275.150.100,Carbonates,Carbonic Acid,2
Bicarbonates,D,D01.248.497.158.165.100,Carbonates,Anions,2
Bile,A,A12.200.087,Bodily Secretions,Fluids and Secretions,2
Biliary Tract Diseases,C,C06.130,Digestive System Diseases,NULL,2
"Binding Sites, Antibody",G,G12.122.232,Antigen-Antibody Reactions,Immune System Phenomena,2
"Binding Sites, Antibody",G,G12.125,Immune System Phenomena,NULL,2
"Binding Sites, Antibody",G,G02.111.570.060.425.079,Immunoglobulin Variable Region,Amino Acid Sequence,2
"Binding Sites, Antibody",G,G02.111.570.120.408,Binding Sites,Molecular Structure,2
Biobehavioral Sciences,H,H01.770.644.108.687,Behavioral Research,Research,2
Biochemistry,H,H01.181.122,Chemistry,Natural Science Disciplines,2
Biochemistry,H,H01.158.201,Biological Science Disciplines,Natural Science Disciplines,2
"Biodegradation, Environmental",N,N06.230.080.600.500,Environmental Restoration and Remediation,Conservation of Natural Resources,2
"Biodegradation, Environmental",N,N06.850.460.375.500,Environmental Restoration and Remediation,Environmental Pollution,2
Bioelectric Energy Sources,E,E07.305.124.150,Electric Power Supplies,Electrical Equipment and Supplies,2
Biological Monitoring,N,N06.850.460.350.080.125,Environmental Monitoring,Environmental Exposure,2
Biological Monitoring,N,N06.850.780.375.175,Environmental Monitoring,Public Health Practice,2
Biomedical Engineering,H,H02.070,Health Occupations,NULL,2
Biomedical Engineering,J,J01.293.140,Engineering,"Technology, Industry, and Agriculture",2
Biometric Identification,N,N04.452.910.099,Security Measures,Organization and Administration,2
Biometric Identification,E,E05.318.740.225.500,Biometry,Statistics as Topic,2
Biomimetics,J,J01.897.120.100,Biotechnology,Technology,2
Biomimetics,H,H01.158.550.100,Biotechnology,Biological Science Disciplines,2
Bioreactors,J,J01.897.120.115,Biotechnology,Technology,2
Bioreactors,E,E07.115,Equipment and Supplies,NULL,2
Biosimilar Pharmaceuticals,D,D20.215.261,Biological Products,Complex Mixtures,2
Biota,G,G16.500.275.157.049.100,Biodiversity,Ecosystem,2
Biota,N,N06.230.124.049.100,Biodiversity,Ecosystem,2
Biotransformation,G,G03.171,Metabolism,NULL,2
Biotransformation,G,G03.787.225,Pharmacokinetics,Metabolism,2
Biotransformation,G,G07.690.725.225,Pharmacokinetics,Pharmacological and Toxicological Phenomena,2
Biphasic Insulins,D,D26.310.249,Drug Combinations,Pharmaceutical Preparations,2
Biphasic Insulins,D,D06.472.699.587.200.200,Insulins,Pancreatic Hormones,2
Biphasic Insulins,D,D12.644.548.586.200.200,Insulins,Pancreatic Hormones,2
Birth Setting,G,G08.686.784.769.490.062,Parturition,Pregnancy,2
Bismuth,D,D01.496.749.305.245,"Elements, Radioactive",Radioisotopes,2
Bismuth,D,D01.552.544.100,"Metals, Heavy",Metals,2
Bismuth,D,D01.268.556.100,"Metals, Heavy",Elements,2
Bismuth,D,D01.268.271.245,"Elements, Radioactive",Elements,2
Bleeding Time,E,E01.370.225.625.625.100,Platelet Function Tests,Hematologic Tests,2
Bleeding Time,G,G09.188.087,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,2
Bleeding Time,E,E05.200.625.625.100,Platelet Function Tests,Hematologic Tests,2
Blister,C,C23.300.122,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",2
Blister,C,C17.800.865.187,"Skin Diseases, Vesiculobullous",Skin Diseases,2
Blogging,L,L01.559.423.906.296,Writing,Language Arts,2
Blogging,L,L01.143.140,Communication,Information Science,2
Blogging,L,L01.178.148,Communications Media,Information Science,2
"Blood Coagulation Disorders, Inherited",C,C16.320.099,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
"Blood Coagulation Disorders, Inherited",C,C15.378.100.100,Blood Coagulation Disorders,Hematologic Diseases,2
Blood Physiological Phenomena,G,G09.188,Circulatory and Respiratory Physiological Phenomena,NULL,2
Blood Platelet Disorders,C,C15.378.140,Hematologic Diseases,Hemic and Lymphatic Diseases,2
Blood Pressure Monitors,E,E07.230.740.100,Sphygmomanometers,Diagnostic Equipment,2
Blood Protein Electrophoresis,E,E05.301.300.049,Electrophoresis,Electrochemical Techniques,2
Blood Protein Electrophoresis,E,E05.196.401.076,Electrophoresis,"Chemistry Techniques, Analytical",2
Blood Protein Electrophoresis,E,E05.200.124.100.110,Blood Chemical Analysis,Clinical Chemistry Tests,2
Blood Protein Electrophoresis,E,E01.370.225.124.100.110,Blood Chemical Analysis,Clinical Chemistry Tests,2
"B-Lymphocytes, Regulatory",A,A11.063.438.450.300,B-Lymphocyte Subsets,B-Lymphocytes,2
"B-Lymphocytes, Regulatory",A,A11.118.637.555.567.562.200.300,B-Lymphocyte Subsets,B-Lymphocytes,2
"B-Lymphocytes, Regulatory",A,A11.118.637.555.567.550.450.300,B-Lymphocyte Subsets,Lymphocyte Subsets,2
"B-Lymphocytes, Regulatory",A,A15.382.032.438.450.300,B-Lymphocyte Subsets,B-Lymphocytes,2
"B-Lymphocytes, Regulatory",A,A15.382.490.555.567.562.450.300,B-Lymphocyte Subsets,B-Lymphocytes,2
"B-Lymphocytes, Regulatory",A,A15.145.229.637.555.567.562.200.300,B-Lymphocyte Subsets,B-Lymphocytes,2
"B-Lymphocytes, Regulatory",A,A15.145.229.637.555.567.550.450.300,B-Lymphocyte Subsets,Lymphocyte Subsets,2
Bone Conduction,G,G07.888.500.500,Hearing,Vestibulocochlear Physiological Phenomena,2
Bone Conduction,F,F02.830.816.263.500,Hearing,Sensation,2
Bone Conduction,G,G11.561.790.263.398,Hearing,Sensation,2
"Bone Diseases, Infectious",C,C05.116.165,Bone Diseases,Musculoskeletal Diseases,2
"Bone Diseases, Infectious",C,C01.160,Infections,NULL,2
Bone Marrow Diseases,C,C15.378.190,Hematologic Diseases,Hemic and Lymphatic Diseases,2
Bone Marrow Examination,E,E01.370.225.625.135,Hematologic Tests,Clinical Laboratory Techniques,2
Bone Marrow Examination,E,E05.200.625.135,Hematologic Tests,Clinical Laboratory Techniques,2
Bone Regeneration,G,G11.427.213.140,Bone Remodeling,Musculoskeletal Physiological Phenomena,2
Bone Regeneration,G,G16.762.150.150,Bone Remodeling,Regeneration,2
Bone Resorption,G,G11.427.213.150,Bone Remodeling,Musculoskeletal Physiological Phenomena,2
Bone Resorption,C,C05.116.264,Bone Diseases,Musculoskeletal Diseases,2
Borrelia,B,B03.851.595.193,Spirochaetaceae,Spirochaetales,2
Borrelia,B,B03.440.425.410.711.193,Spirochaetaceae,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",2
Borrelia burgdorferi Group,B,B03.440.425.410.711.193.150,Borrelia,Spirochaetaceae,2
Borrelia burgdorferi Group,B,B03.851.595.193.150,Borrelia,Spirochaetaceae,2
Boutonneuse Fever,C,C01.150.252.400.789.725.400.250,Spotted Fever Group Rickettsiosis,Rickettsia Infections,2
Boutonneuse Fever,C,C01.920.930.887.250,Spotted Fever Group Rickettsiosis,Tick-Borne Diseases,2
Bradycardia,C,C14.280.067.319,"Arrhythmias, Cardiac",Heart Diseases,2
Bradycardia,C,C23.550.073.300,"Arrhythmias, Cardiac",Pathologic Processes,2
Bradykinin B2 Receptor Antagonists,D,D27.505.519.265.500,Bradykinin Receptor Antagonists,Molecular Mechanisms of Pharmacological Action,2
Bradykinin B2 Receptor Antagonists,D,D27.505.696.477.656.500.500,Complement Inactivating Agents,Immunosuppressive Agents,2
Brain Chemistry,G,G03.185,Metabolism,NULL,2
Brain Chemistry,G,G02.111.150,Biochemical Phenomena,Chemical Phenomena,2
"Brain Diseases, Metabolic",C,C18.452.132,Metabolic Diseases,Nutritional and Metabolic Diseases,2
"Brain Diseases, Metabolic",C,C10.228.140.163,Brain Diseases,Central Nervous System Diseases,2
Brain Stem,A,A08.186.211.132,Brain,Central Nervous System,2
Breakfast,G,G07.203.300.590.120,Meals,Food,2
Breakfast,J,J02.500.590.120,Meals,Food,2
Broadly Neutralizing Antibodies,D,D12.776.124.486.485.114.244.500,"Antibodies, Neutralizing",Antibodies,2
Broadly Neutralizing Antibodies,D,D12.776.124.790.651.114.244.500,"Antibodies, Neutralizing",Antibodies,2
Broadly Neutralizing Antibodies,D,D12.776.377.715.548.114.244.500,"Antibodies, Neutralizing",Antibodies,2
Bromocriptine,D,D03.132.327.412.100,Ergotamines,Ergot Alkaloids,2
Bromocriptine,D,D03.633.400.439.131,Ergolines,"Heterocyclic Compounds, 4 or More Rings",2
Bromocriptine,D,D03.633.400.562.100,Ergotamines,"Heterocyclic Compounds, 4 or More Rings",2
Bronchial Spasm,C,C08.127.321,Bronchial Diseases,Respiratory Tract Diseases,2
Bronchoconstriction,G,G09.772.705.700.080,Respiratory Mechanics,Respiration,2
Brucella abortus,B,B03.440.400.425.215.500.100,Brucella,Brucellaceae,2
Brucella abortus,B,B03.660.050.070.100.100,Brucella,Brucellaceae,2
"Brucellosis, Bovine",C,C01.150.252.400.167.322,Brucellosis,Gram-Negative Bacterial Infections,2
"Brucellosis, Bovine",C,C22.021.322,"Abortion, Veterinary",Animal Diseases,2
"Brucellosis, Bovine",C,C22.196.148,Cattle Diseases,Animal Diseases,2
Brugia,B,B01.050.500.500.294.400.937.463.088,Filarioidea,Spirurida,2
Brugia malayi,B,B01.050.500.500.294.400.937.463.088.500,Brugia,Filarioidea,2
Buchnera,B,B03.440.100,Gram-Negative Bacteria,Bacteria,2
Buchnera,B,B03.660.250.150.047,Enterobacteriaceae,Gammaproteobacteria,2
Buddhism,K,K01.844.117,Religion,Humanities,2
Building Codes,N,N02.278.200.100,Facility Design and Construction,Health Facilities,2
Bulimia,C,C23.888.821.645.500,Hyperphagia,"Signs and Symptoms, Digestive",2
Bupivacaine,D,D02.065.199.239,Anilides,Amides,2
Bupivacaine,D,D02.092.146.113.239,Anilides,Aniline Compounds,2
Bupropion,D,D02.522.818.110,Propiophenones,Ketones,2
Burn Units,N,N02.278.388.493.160,Intensive Care Units,Hospital Units,2
"Burnout, Psychological",F,F02.830.900.333,"Stress, Psychological",Psychophysiology,2
"Burnout, Psychological",F,F01.145.126.990.367,"Stress, Psychological",Behavioral Symptoms,2
Butanones,D,D02.522.296,Ketones,Organic Chemicals,2
Butyrates,D,D10.251.400.143,"Fatty Acids, Volatile",Fatty Acids,2
Butyrates,D,D02.241.081.114,"Acids, Acyclic",Carboxylic Acids,2
CA-125 Antigen,D,D12.776.395.560.631.050,Mucins,Mucoproteins,2
CA-125 Antigen,D,D23.101.140.075.225,"Antigens, Tumor-Associated, Carbohydrate","Biomarkers, Tumor",2
CA-125 Antigen,D,D23.050.550.325.225,"Antigens, Tumor-Associated, Carbohydrate",Epitopes,2
CA-125 Antigen,D,D23.050.285.050.225,"Antigens, Tumor-Associated, Carbohydrate","Antigens, Neoplasm",2
Cacao,B,B01.650.940.800.575.912.250.859.821.500.164,Malvaceae,Malvales,2
Caenorhabditis elegans Proteins,D,D12.776.419.500,Helminth Proteins,Proteins,2
Calcimimetic Agents,D,D27.505.696.399.450.230,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",2
Calcimimetic Agents,D,D06.347.230,Hormone Antagonists,"Hormones, Hormone Substitutes, and Hormone Antagonists",2
Calcineurin,D,D08.811.277.352.650.625.150,Phosphoprotein Phosphatases,Phosphoric Monoester Hydrolases,2
Calcineurin,D,D12.644.360.087,Intracellular Signaling Peptides and Proteins,Peptides,2
Calcineurin,D,D12.776.476.087,Intracellular Signaling Peptides and Proteins,Proteins,2
Calcium Compounds,D,D01.146,Inorganic Chemicals,NULL,2
Calcium Phosphates,D,D01.146.360,Calcium Compounds,Inorganic Chemicals,2
Calcium Phosphates,D,D01.029.260.700.675.374.075,Phosphates,Phosphoric Acids,2
Calcium Phosphates,D,D01.695.625.675.650.075,Phosphates,Phosphoric Acids,2
Calcium Radioisotopes,D,D01.268.552.100.500.325,Calcium Isotopes,Calcium,2
Calcium Radioisotopes,D,D01.552.539.288.500.325,Calcium Isotopes,Calcium,2
Calcium Radioisotopes,D,D01.496.749.113,Radioisotopes,Isotopes,2
Calcium Radioisotopes,D,D01.496.098.325,Calcium Isotopes,Isotopes,2
Callithrix,B,B01.050.150.900.649.313.988.400.600.150.150.114,Callitrichinae,Cebidae,2
Camellia sinensis,B,B01.650.940.800.575.912.250.341.998.500.500,Camellia,Theaceae,2
Candy,G,G07.203.300.140,Food,"Diet, Food, and Nutrition",2
Candy,J,J02.500.140,Food,Food and Beverages,2
Cannabinoids,D,D02.455.849.090,Terpenes,Hydrocarbons,2
Capreomycin,D,D04.345.566.142,"Peptides, Cyclic",Macrocyclic Compounds,2
Capreomycin,D,D12.644.641.142,"Peptides, Cyclic",Peptides,2
Capsicum,B,B01.650.940.800.575.912.250.908.500.145,Solanaceae,Solanales,2
Capsulorhexis,E,E04.540.825.249.352,Cataract Extraction,Refractive Surgical Procedures,2
Captopril,D,D12.125.072.401.623.270,Proline,Imino Acids,2
Carbamazepine,D,D03.633.300.240.127,Dibenzazepines,"Heterocyclic Compounds, 3-Ring",2
Carbohydrate Epimerases,D,D08.811.399.894.500,Racemases and Epimerases,Isomerases,2
"Carbon Compounds, Inorganic",D,D01.200,Inorganic Chemicals,NULL,2
Carbon Radioisotopes,D,D01.496.123.328,Carbon Isotopes,Isotopes,2
Carbon Radioisotopes,D,D01.496.749.154,Radioisotopes,Isotopes,2
Carbon Radioisotopes,D,D01.268.150.075.328,Carbon Isotopes,Carbon,2
Carbonic Anhydrase II,D,D08.811.520.241.300.150.200,Carbonic Anhydrases,Hydro-Lyases,2
Carboxy-Lyases,D,D08.811.520.224.125,Carbon-Carbon Lyases,Lyases,2
"Carcinoma, Adenosquamous",C,C04.557.435.250,"Neoplasms, Complex and Mixed",Neoplasms by Histologic Type,2
"Carcinoma, Adenosquamous",C,C04.557.470.200.150,Carcinoma,"Neoplasms, Glandular and Epithelial",2
"Carcinoma, Large Cell",C,C04.557.470.200.260,Carcinoma,"Neoplasms, Glandular and Epithelial",2
"Carcinoma, Skin Appendage",C,C04.557.470.200.025.420,Adenocarcinoma,Carcinoma,2
"Carcinoma, Skin Appendage",C,C04.557.470.550.420,"Neoplasms, Adnexal and Skin Appendage","Neoplasms, Glandular and Epithelial",2
Cardiac Resynchronization Therapy Devices,E,E07.305.250.750.500,"Pacemaker, Artificial",Electrodes,2
"Cardiomegaly, Exercise-Induced",G,G09.330.170,Cardiovascular Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,2
"Cardiomyopathy, Alcoholic",C,C25.775.100.087.250,Alcohol-Induced Disorders,Alcohol-Related Disorders,2
"Cardiomyopathy, Alcoholic",C,C14.280.238.057,Cardiomyopathies,Heart Diseases,2
"Cardiomyopathy, Hypertrophic, Familial",C,C14.280.238.100.500,"Cardiomyopathy, Hypertrophic",Cardiomyopathies,2
"Cardiomyopathy, Hypertrophic, Familial",C,C14.280.484.048.750.070.160.500,"Cardiomyopathy, Hypertrophic","Aortic Stenosis, Subvalvular",2
"Cardiomyopathy, Hypertrophic, Familial",C,C16.320.160,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Cardioplegic Solutions,D,D26.776.708.160,Pharmaceutical Solutions,Solutions,2
Cardioplegic Solutions,D,D27.505.954.411.207,Cardiovascular Agents,Therapeutic Uses,2
Cardioplegic Solutions,D,D27.505.954.578.322,Pharmaceutical Solutions,Therapeutic Uses,2
Cardioplegic Solutions,D,D27.720.752.322,Pharmaceutical Solutions,Specialty Uses of Chemicals,2
Cardiorespiratory Fitness,G,G11.427.685.500,Physical Fitness,Musculoskeletal Physiological Phenomena,2
Cardiorespiratory Fitness,I,I03.450.642.845.054.800.500,Physical Fitness,Athletic Performance,2
Cardiorespiratory Fitness,I,I03.450.642.845.054.300,Athletic Performance,Sports,2
Cardiorespiratory Fitness,N,N01.400.545.500,Physical Fitness,Health,2
Cardiorespiratory Fitness,N,N01.400.150,Health,Population Characteristics,2
Cardiovascular Physiological Phenomena,G,G09.330,Circulatory and Respiratory Physiological Phenomena,NULL,2
Cardiovascular Surgical Procedures,E,E04.100,"Surgical Procedures, Operative",NULL,2
Caregiver Burden,F,F01.145.126.990.551,"Stress, Psychological",Behavioral Symptoms,2
Cartilage Diseases,C,C17.300.182,Connective Tissue Diseases,Skin and Connective Tissue Diseases,2
Cartilage Diseases,C,C05.182,Musculoskeletal Diseases,NULL,2
Carvedilol,D,D02.033.100.624.151,Propanolamines,Amino Alcohols,2
Carvedilol,D,D02.033.755.624.151,Propanolamines,Propanols,2
Carvedilol,D,D02.092.063.624.151,Propanolamines,Amino Alcohols,2
Carvedilol,D,D03.633.300.148.125,Carbazoles,"Heterocyclic Compounds, 3-Ring",2
Carvedilol,D,D03.633.100.473.144.125,Carbazoles,Indoles,2
Case Managers,M,M01.526.485.215,Health Personnel,Occupational Groups,2
Case Managers,M,M01.526.070.245,Administrative Personnel,Occupational Groups,2
Case Managers,N,N02.360.215,Health Personnel,"Health Care Facilities, Manpower, and Services",2
Casein Kinase II,D,D08.811.913.696.620.682.700.140.600,Casein Kinases,Protein-Serine-Threonine Kinases,2
Casein Kinase II,D,D12.776.476.150.600,Casein Kinases,Intracellular Signaling Peptides and Proteins,2
Caspofungin,D,D10.477.250,Lipopeptides,Lipids,2
Caspofungin,D,D12.644.641.311.500,Echinocandins,"Peptides, Cyclic",2
Caspofungin,D,D12.644.365.250,Lipopeptides,Peptides,2
Castration,E,E04.270.282,Endocrine Surgical Procedures,"Surgical Procedures, Operative",2
Castration,E,E04.950.165,Urogenital Surgical Procedures,"Surgical Procedures, Operative",2
Catecholamines,D,D02.092.311,Amines,Organic Chemicals,2
Catecholamines,D,D02.455.426.559.389.657.166.175,Catechols,Phenols,2
Catgut,E,E07.858.690.820.250,Sutures,Surgical Fixation Devices,2
Cathelicidins,D,D12.644.050.099,Antimicrobial Cationic Peptides,Peptides,2
Cathelicidins,D,D12.776.543.695.054.099,Antimicrobial Cationic Peptides,Pore Forming Cytotoxic Proteins,2
Cathepsin B,D,D08.811.277.656.224.125,Cathepsins,Peptide Hydrolases,2
Cathepsin B,D,D08.811.277.656.300.200.133,Cysteine Endopeptidases,Endopeptidases,2
Cathepsin B,D,D08.811.277.656.262.500.133,Cysteine Endopeptidases,Cysteine Proteases,2
Cathepsin K,D,D08.811.277.656.300.200.156,Cysteine Endopeptidases,Endopeptidases,2
Cathepsin K,D,D08.811.277.656.224.405,Cathepsins,Peptide Hydrolases,2
Cathepsin K,D,D08.811.277.656.262.500.156,Cysteine Endopeptidases,Cysteine Proteases,2
Cathepsin L,D,D08.811.277.656.262.500.157,Cysteine Endopeptidases,Cysteine Proteases,2
Cathepsin L,D,D08.811.277.656.224.407,Cathepsins,Peptide Hydrolases,2
Cathepsin L,D,D08.811.277.656.300.200.157,Cysteine Endopeptidases,Endopeptidases,2
Cathepsin Z,D,D08.811.277.656.224.425,Cathepsins,Peptide Hydrolases,2
Cathepsin Z,D,D08.811.277.656.262.249,Cysteine Proteases,Peptide Hydrolases,2
Cathepsin Z,D,D08.811.277.656.350.245.270,Carboxypeptidases,Exopeptidases,2
Catheters,E,E07.132,Equipment and Supplies,NULL,2
Cation Exchange Resins,D,D27.720.470.420.275,Ion Exchange Resins,Laboratory Chemicals,2
"Cations, Divalent",D,D01.248.497.300.333,Cations,Ions,2
CDX2 Transcription Factor,D,D12.776.930.146,Transcription Factors,Proteins,2
CDX2 Transcription Factor,D,D12.776.660.201,Nuclear Proteins,Proteins,2
CDX2 Transcription Factor,D,D12.776.260.400.140,Homeodomain Proteins,DNA-Binding Proteins,2
Cefaclor,D,D03.633.100.300.249.200.155,Cephalexin,Cephalosporins,2
Cefaclor,D,D02.886.665.074.200.155,Cephalexin,Cephalosporins,2
Cefaclor,D,D02.065.589.099.249.200.155,Cephalexin,Cephalosporins,2
Cefotaxime,D,D02.065.589.099.249.190.190,Cephacetrile,Cephalosporins,2
Cefotaxime,D,D02.886.665.074.190.190,Cephacetrile,Cephalosporins,2
Cefotaxime,D,D03.633.100.300.249.190.190,Cephacetrile,Cephalosporins,2
Celecoxib,D,D02.886.590.700.247,Sulfonamides,Sulfones,2
Celecoxib,D,D03.383.129.539.160,Pyrazoles,Azoles,2
Celecoxib,D,D02.065.884.247,Sulfonamides,Amides,2
"Cell Adhesion Molecules, Neuronal",D,D12.776.395.550.200.250,Cell Adhesion Molecules,Membrane Glycoproteins,2
"Cell Adhesion Molecules, Neuronal",D,D23.050.301.350.250,Cell Adhesion Molecules,"Antigens, Surface",2
"Cell Adhesion Molecules, Neuronal",D,D12.776.543.550.200.250,Cell Adhesion Molecules,Membrane Glycoproteins,2
Cell- and Tissue-Based Therapy,E,E02.095.147,Biological Therapy,Therapeutics,2
Cell Biology,H,H01.158.100.433,Anatomy,Biological Science Disciplines,2
Cell Biology,H,H01.158.273.160,Biology,Biological Science Disciplines,2
Cell Extracts,D,D20.777.162,Tissue Extracts,Complex Mixtures,2
Cell Fusion,E,E05.242.307,Cytological Techniques,Investigative Techniques,2
Cell Fusion,G,G04.155,Cell Physiological Phenomena,NULL,2
Cell Hypoxia,G,G04.270.300,Cell Respiration,Cell Physiological Phenomena,2
Cell Hypoxia,G,G03.197.300,Cell Respiration,Metabolism,2
Cell Surface Display Techniques,E,E05.393.220.250.500,Artificial Gene Fusion,"Cloning, Molecular",2
Cell Surface Display Techniques,E,E05.393.420.601.292,Protein Engineering,Genetic Engineering,2
"Cell Transformation, Viral",G,G06.920.143,Virus Physiological Phenomena,Microbiological Phenomena,2
"Cell Transformation, Viral",C,C23.550.727.098.500.160,"Cell Transformation, Neoplastic",Carcinogenesis,2
"Cell Transformation, Viral",C,C04.697.098.500.160,"Cell Transformation, Neoplastic",Carcinogenesis,2
Cell-Derived Microparticles,A,A11.284.295.588.500,Extracellular Vesicles,Extracellular Space,2
Cellulose,D,D25.720.099.500,Biopolymers,Polymers,2
Cellulose,D,D09.698.365.180,Glucans,Polysaccharides,2
Cellulose,D,D05.750.078.562.180,Glucans,Biopolymers,2
Cellulose,J,J01.637.051.720.099.500,Biopolymers,Polymers,2
Cementation,E,E06.095.170,Dental Bonding,Dentistry,2
Cementation,E,E05.170,Investigative Techniques,NULL,2
Cementogenesis,G,G07.345.500.325.377.124,Organogenesis,Embryonic and Fetal Development,2
Central Nervous System Depressants,D,D27.505.954.427.210,Central Nervous System Agents,Therapeutic Uses,2
Central Nervous System Depressants,D,D27.505.696.277,Physiological Effects of Drugs,Pharmacologic Actions,2
Central Nervous System Protozoal Infections,C,C01.207.205.300,Central Nervous System Parasitic Infections,Central Nervous System Infections,2
Central Nervous System Protozoal Infections,C,C01.610.752.100,Protozoan Infections,Parasitic Diseases,2
Central Nervous System Protozoal Infections,C,C01.610.105.300,Central Nervous System Parasitic Infections,Parasitic Diseases,2
Central Nervous System Protozoal Infections,C,C10.228.228.205.300,Central Nervous System Parasitic Infections,Central Nervous System Infections,2
Cephalothin,D,D02.065.589.099.249.190.210,Cephacetrile,Cephalosporins,2
Cephalothin,D,D02.886.665.074.190.210,Cephacetrile,Cephalosporins,2
Cephalothin,D,D03.633.100.300.249.190.210,Cephacetrile,Cephalosporins,2
Cercocebus atys,B,B01.050.150.900.649.313.988.400.112.199.120.120.110,Cercocebus,Cercopithecinae,2
Cerebellar Diseases,C,C10.228.140.252,Brain Diseases,Central Nervous System Diseases,2
"Cerebral Hemorrhage, Traumatic",C,C10.228.140.199.275.300,"Brain Hemorrhage, Traumatic",Brain Injuries,2
"Cerebral Hemorrhage, Traumatic",C,C10.228.140.300.535.200.200,Cerebral Hemorrhage,Intracranial Hemorrhages,2
"Cerebral Hemorrhage, Traumatic",C,C10.228.140.300.535.450.200.750,"Brain Hemorrhage, Traumatic","Intracranial Hemorrhage, Traumatic",2
"Cerebral Hemorrhage, Traumatic",C,C10.900.300.837.150.650,"Brain Hemorrhage, Traumatic","Intracranial Hemorrhage, Traumatic",2
"Cerebral Hemorrhage, Traumatic",C,C10.900.300.087.187.300,"Brain Hemorrhage, Traumatic",Brain Injuries,2
"Cerebral Hemorrhage, Traumatic",C,C14.907.253.573.200.200,Cerebral Hemorrhage,Intracranial Hemorrhages,2
"Cerebral Hemorrhage, Traumatic",C,C14.907.253.573.400.150.300,"Brain Hemorrhage, Traumatic","Intracranial Hemorrhage, Traumatic",2
"Cerebral Hemorrhage, Traumatic",C,C26.915.300.490.150.300,"Brain Hemorrhage, Traumatic","Intracranial Hemorrhage, Traumatic",2
"Cerebral Hemorrhage, Traumatic",C,C26.915.300.200.175.300,"Brain Hemorrhage, Traumatic",Brain Injuries,2
Cerebral Revascularization,E,E04.494.150,Microsurgery,"Surgical Procedures, Operative",2
Cerebral Revascularization,E,E04.100.814.868.625,Vascular Grafting,Vascular Surgical Procedures,2
Cerebrosides,D,D02.065.313.250,Ceramides,Amides,2
Cerebrosides,D,D09.400.410.420.525.200.250,Ceramides,Neutral Glycosphingolipids,2
Cerebrosides,D,D10.390.470.675.200.250,Ceramides,Neutral Glycosphingolipids,2
Cerebrosides,D,D10.570.877.360.612.200.250,Ceramides,Neutral Glycosphingolipids,2
Cerebrospinal Fluid Pressure,G,G11.561.170,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,2
Cesium,D,D01.268.556.165,"Metals, Heavy",Elements,2
Cesium,D,D01.268.549.125,"Metals, Alkali",Elements,2
Cesium,D,D01.552.544.165,"Metals, Heavy",Metals,2
Cesium,D,D01.552.528.160,"Metals, Alkali",Metals,2
Cetuximab,D,D12.776.377.715.548.114.224.200.750,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Cetuximab,D,D12.776.124.790.651.114.224.060.750,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Cetuximab,D,D12.776.124.486.485.114.224.060.750,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Chalcones,D,D03.383.663.283.266.450.221,Flavonoids,Chromones,2
Chalcones,D,D03.633.100.150.266.450.221,Flavonoids,Chromones,2
Chalcones,D,D02.522.818.222,Propiophenones,Ketones,2
Chaperonin 10,D,D12.776.580.216.210.590.500,Group I Chaperonins,Chaperonins,2
Chemical Hazard Release,N,N06.850.135.195,Accidents,Public Health,2
Chemical Precipitation,E,E05.196.150,"Chemistry Techniques, Analytical",Investigative Techniques,2
Chemical Precipitation,G,G02.159,Chemical Phenomena,NULL,2
Chemokine CCL22,D,D12.776.467.374.200.110.900,"Chemokines, CC",Chemokines,2
Chemokine CCL22,D,D23.469.200.110.900,"Chemokines, CC",Chemokines,2
Chemokine CCL22,D,D23.529.374.200.110.900,"Chemokines, CC",Chemokines,2
Chemokine CCL22,D,D23.125.300.110.900,"Chemokines, CC",Chemokines,2
Chemokine CCL22,D,D12.644.276.374.200.110.900,"Chemokines, CC",Chemokines,2
Chemoradiotherapy,E,E02.319.164,Drug Therapy,Therapeutics,2
Chemoradiotherapy,E,E02.186.079,Combined Modality Therapy,Therapeutics,2
Chemoradiotherapy,E,E02.815.160,Radiotherapy,Therapeutics,2
Chemotactic Factors,D,D23.125,Biological Factors,NULL,2
Chlamydiales,B,B03.440.190,Gram-Negative Bacteria,Bacteria,2
Chlamydophila,B,B03.440.190.190.230,Chlamydiaceae,Chlamydiales,2
Chloramphenicol O-Acetyltransferase,D,D08.811.913.050.134.170,Acetyltransferases,Acyltransferases,2
Chlorobi,B,B03.250,Bacteria,NULL,2
Chloroplasts,A,A11.284.430.214.190.875.700.140,Plastids,Organelles,2
Chocolate,G,G07.203.300.195,Food,"Diet, Food, and Nutrition",2
Chocolate,J,J02.500.195,Food,Food and Beverages,2
"Cholangiopancreatography, Endoscopic Retrograde",E,E04.210.240.160,"Endoscopy, Digestive System",Digestive System Surgical Procedures,2
"Cholangiopancreatography, Endoscopic Retrograde",E,E04.502.250.250.160,"Endoscopy, Digestive System",Endoscopy,2
"Cholangiopancreatography, Endoscopic Retrograde",E,E01.370.388.250.250.160,"Endoscopy, Digestive System",Endoscopy,2
"Cholangiopancreatography, Endoscopic Retrograde",E,E01.370.350.700.715.200.200,Cholangiography,"Radiography, Abdominal",2
"Cholangiopancreatography, Endoscopic Retrograde",E,E01.370.372.200.200,Cholangiography,"Diagnostic Techniques, Digestive System",2
"Cholangiopancreatography, Endoscopic Retrograde",E,E01.370.372.250.200,"Endoscopy, Digestive System","Diagnostic Techniques, Digestive System",2
Cholestanetriol 26-Monooxygenase,D,D12.776.422.220.453.499.750,Cytochrome P450 Family 27,Cytochrome P-450 Enzyme System,2
Cholestanetriol 26-Monooxygenase,D,D12.776.422.220.453.915.150,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,2
Cholestanetriol 26-Monooxygenase,D,D08.811.682.690.708.170.915.150,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,2
Cholestanetriol 26-Monooxygenase,D,D08.811.682.690.708.170.493.750,Cytochrome P450 Family 27,Cytochrome P-450 Enzyme System,2
Cholestanetriol 26-Monooxygenase,D,D08.244.453.499.750,Cytochrome P450 Family 27,Cytochrome P-450 Enzyme System,2
Cholestanetriol 26-Monooxygenase,D,D08.244.453.915.149,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,2
"Cholesterol, Dietary",D,D04.210.500.247.808.197.225,Cholesterol,Sterols,2
"Cholesterol, Dietary",D,D10.570.938.208.222,Cholesterol,Sterols,2
"Cholesterol, Dietary",D,D10.212.302.347,Dietary Fats,Fats,2
Choline Deficiency,C,C18.654.521.500.133.699.160,Vitamin B Deficiency,Avitaminosis,2
Chorea,C,C23.888.592.350.250,Dyskinesias,Neurologic Manifestations,2
Chorea,C,C10.597.350.250,Dyskinesias,Neurologic Manifestations,2
Chorea,C,C10.228.662.262.249,Dyskinesias,Movement Disorders,2
Choroid,A,A09.371.894.223,Uvea,Eye,2
Choroid Diseases,C,C11.941.160,Uveal Diseases,Eye Diseases,2
"Chromatography, DEAE-Cellulose",E,E05.196.181.400.383.349,"Chromatography, Ion Exchange","Chromatography, Liquid",2
Chromogranins,D,D12.776.631.199,Nerve Tissue Proteins,Proteins,2
Chromogranins,D,D12.776.811.185,Protein Precursors,Proteins,2
Chromosome Painting,E,E01.370.225.500.620.670.325.350.125,"In Situ Hybridization, Fluorescence",In Situ Hybridization,2
Chromosome Painting,E,E01.370.225.750.600.670.325.350.125,"In Situ Hybridization, Fluorescence",In Situ Hybridization,2
Chromosome Painting,E,E05.200.500.620.670.325.350.125,"In Situ Hybridization, Fluorescence",In Situ Hybridization,2
Chromosome Painting,E,E05.200.750.600.670.325.350.125,"In Situ Hybridization, Fluorescence",In Situ Hybridization,2
Chromosome Painting,E,E05.393.285.350.125,"In Situ Hybridization, Fluorescence",Cytogenetic Analysis,2
Chromosome Painting,E,E05.393.661.475.350.125,"In Situ Hybridization, Fluorescence",In Situ Hybridization,2
Chromosome Segregation,G,G04.144.220.220.625,Cell Nucleus Division,Cell Division,2
Chromosome Segregation,G,G05.113.220.625,Cell Nucleus Division,Cell Division,2
"Chromosomes, Artificial, Bacterial",G,G05.360.337.249.170,"Chromosomes, Artificial",Genetic Vectors,2
"Chromosomes, Artificial, Bacterial",G,G05.360.162.190.170,"Chromosomes, Bacterial",Chromosomes,2
"Chromosomes, Artificial, Bacterial",G,G05.360.162.178.170,"Chromosomes, Artificial",Chromosomes,2
"Chromosomes, Artificial, Bacterial",A,A11.284.187.178.170,"Chromosomes, Artificial",Chromosomes,2
"Chromosomes, Artificial, Bacterial",A,A11.284.187.190.170,"Chromosomes, Bacterial",Chromosomes,2
"Chromosomes, Artificial, Bacterial",A,A20.812.170,"Chromosomes, Bacterial",Bacterial Structures,2
"Chromosomes, Human, Pair 14",A,A11.284.187.520.300.370.380,"Chromosomes, Human, 13-15","Chromosomes, Human",2
"Chromosomes, Human, Pair 14",G,G05.360.162.520.300.370.380,"Chromosomes, Human, 13-15","Chromosomes, Human",2
"Chromosomes, Human, Pair 16",G,G05.360.162.520.300.415.420,"Chromosomes, Human, 16-18","Chromosomes, Human",2
"Chromosomes, Human, Pair 16",A,A11.284.187.520.300.415.420,"Chromosomes, Human, 16-18","Chromosomes, Human",2
Churg-Strauss Syndrome,C,C14.907.940.897.249.249,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Systemic Vasculitis,2
Churg-Strauss Syndrome,C,C15.604.515.292.015,Granuloma,Lymphoproliferative Disorders,2
Churg-Strauss Syndrome,C,C20.111.193.500,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Autoimmune Diseases,2
Chymases,D,D08.811.277.656.959.350.103,Serine Endopeptidases,Serine Proteases,2
Chymases,D,D08.811.277.656.300.760.103,Serine Endopeptidases,Endopeptidases,2
Cilia,A,A11.284.180.165,Cell Surface Extensions,Cellular Structures,2
Cinchona Alkaloids,D,D03.132.206,Alkaloids,Heterocyclic Compounds,2
Circovirus,B,B04.280.120.150,Circoviridae,DNA Viruses,2
Circulating MicroRNA,D,D13.444.735.790.552.500.500,MicroRNAs,"RNA, Small Untranslated",2
Circulating MicroRNA,D,D13.444.735.150.319.500,MicroRNAs,"RNA, Antisense",2
Circulating MicroRNA,D,D13.150.650.319.500,MicroRNAs,"RNA, Antisense",2
Circulating MicroRNA,D,D13.444.154.250,Cell-Free Nucleic Acids,Nucleic Acids,2
"Circulatory Arrest, Deep Hypothermia Induced",E,E04.928.220.360.500,"Heart Arrest, Induced",Cardiac Surgical Procedures,2
"Circulatory Arrest, Deep Hypothermia Induced",E,E04.100.376.374.500,"Heart Arrest, Induced",Cardiac Surgical Procedures,2
Citrates,D,D02.241.081.901.434,Tricarboxylic Acids,"Acids, Acyclic",2
Citrulline,D,D12.125.095.226,"Amino Acids, Diamino",Amino Acids,2
Cladribine,D,D03.633.100.759.590.138.300.200,2-Chloroadenosine,Adenosine,2
Cladribine,D,D03.633.100.759.590.138.325.075,Deoxyadenosines,Adenosine,2
Cladribine,D,D13.570.800.096.300.200,2-Chloroadenosine,Adenosine,2
Cladribine,D,D13.570.583.138.300.200,2-Chloroadenosine,Adenosine,2
Cladribine,D,D13.570.583.138.325.075,Deoxyadenosines,Adenosine,2
Cladribine,D,D13.570.230.229.075,Deoxyadenosines,Deoxyribonucleosides,2
Class I Phosphatidylinositol 3-Kinases,D,D12.776.476.162,Intracellular Signaling Peptides and Proteins,Proteins,2
Class I Phosphatidylinositol 3-Kinases,D,D08.811.913.696.620.500.100.100,Phosphatidylinositol 3-Kinase,Phosphatidylinositol 3-Kinases,2
Class I Phosphatidylinositol 3-Kinases,D,D08.811.913.696.620.500.200.100,Phosphatidylinositol-4-Phosphate 3-Kinase,Phosphatidylinositol 3-Kinases,2
Classical Swine Fever,C,C22.905.170,Swine Diseases,Animal Diseases,2
Classical Swine Fever,C,C01.925.782.350.675.200,Pestivirus Infections,Flaviviridae Infections,2
Clergy,M,M01.526.799.500,Religious Personnel,Occupational Groups,2
Climacteric,G,G08.686.157,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,2
Climacteric,G,G08.686.841.249,Sexual Development,Reproductive Physiological Phenomena,2
Clinical Reasoning,E,E01.055.500,Clinical Decision-Making,Diagnosis,2
"Clinical Trials, Phase IV as Topic",E,E05.337.800.200,"Product Surveillance, Postmarketing",Evaluation Studies as Topic,2
"Clinical Trials, Phase IV as Topic",E,E05.318.372.250.250.230,Clinical Trials as Topic,Clinical Studies as Topic,2
"Clinical Trials, Phase IV as Topic",N,N05.715.360.330.250.250.230,Clinical Trials as Topic,Clinical Studies as Topic,2
"Clinical Trials, Phase IV as Topic",N,N06.850.520.450.250.250.230,Clinical Trials as Topic,Clinical Studies as Topic,2
Clobetasol,D,D04.210.500.908.093.250,Betamethasone,"Steroids, Fluorinated",2
Clonal Anergy,G,G12.535.425.100,Immune Tolerance,Immunomodulation,2
Clonal Evolution,G,G05.158,Genetic Phenomena,NULL,2
Clonal Evolution,G,G04.375,Cell Physiological Phenomena,NULL,2
"Cloning, Organism",E,E05.393.240,Genetic Techniques,Investigative Techniques,2
"Cloning, Organism",E,E05.820.180,Reproductive Techniques,Investigative Techniques,2
Clostridioides,B,B03.353.625.657,Clostridiales,Firmicutes,2
Cloud Computing,L,L01.224.097,Computing Methodologies,Information Science,2
Clustered Regularly Interspaced Short Palindromic Repeats,G,G05.360.080.708.800.325.500,Inverted Repeat Sequences,Tandem Repeat Sequences,2
Clustered Regularly Interspaced Short Palindromic Repeats,G,G05.360.340.024.850.069,Tandem Repeat Sequences,Genome Components,2
Clustered Regularly Interspaced Short Palindromic Repeats,G,G02.111.570.080.708.800.325.500,Inverted Repeat Sequences,Tandem Repeat Sequences,2
Coat Protein Complex I,D,D12.776.543.990.300,Vesicular Transport Proteins,Membrane Proteins,2
Cobalt Radioisotopes,D,D01.552.544.185.500.354,Cobalt Isotopes,Cobalt,2
Cobalt Radioisotopes,D,D01.496.239.354,Cobalt Isotopes,Isotopes,2
Cobalt Radioisotopes,D,D01.496.749.256,Radioisotopes,Isotopes,2
Cobalt Radioisotopes,D,D01.268.556.185.500.354,Cobalt Isotopes,Cobalt,2
Cobalt Radioisotopes,D,D01.268.956.155.500.354,Cobalt Isotopes,Cobalt,2
Coca,B,B01.650.940.800.575.912.250.346.500,Erythroxylaceae,Magnoliopsida,2
Cocarcinogenesis,C,C04.697.098.875,Carcinogenesis,Neoplastic Processes,2
Cocarcinogenesis,C,C23.550.727.098.750,Carcinogenesis,Neoplastic Processes,2
Cod Liver Oil,D,D10.212.507.325,"Fats, Unsaturated",Fats,2
Cod Liver Oil,D,D10.212.302.380.360,"Dietary Fats, Unsaturated",Dietary Fats,2
Cod Liver Oil,D,D10.627.430.354,Fish Oils,Oils,2
Codeine,D,D04.615.723.795.576.149,Morphine Derivatives,Morphinans,2
Codeine,D,D03.633.400.686.607.204,Morphine Derivatives,Morphinans,2
Codeine,D,D03.605.497.607.204,Morphine Derivatives,Morphinans,2
Codeine,D,D03.132.577.249.562.149,Morphine Derivatives,Morphinans,2
Coenzyme A,D,D03.633.100.759.646.138.382,Adenine Nucleotides,Purine Nucleotides,2
Coenzyme A,D,D08.211.211,Coenzymes,Enzymes and Coenzymes,2
Coenzyme A,D,D13.695.827.068.382,Adenine Nucleotides,Ribonucleotides,2
Coenzyme A,D,D13.695.667.138.382,Adenine Nucleotides,Purine Nucleotides,2
Coenzymes,D,D08.211,Enzymes and Coenzymes,NULL,2
Cohort Effect,N,N06.850.490.734.500,"Effect Modifier, Epidemiologic",Epidemiologic Factors,2
Cohort Effect,N,N05.715.350.350.225,"Effect Modifier, Epidemiologic",Epidemiologic Factors,2
Coitus Interruptus,F,F01.145.802.188.300,Coitus,Sexual Behavior,2
Coitus Interruptus,E,E02.875.194.250,Contraception,Reproductive Techniques,2
Cold Climate,N,N06.230.300.100.250.275,Climate,Atmosphere,2
Cold Climate,G,G16.500.275.071.275,Climate,Environment,2
Colforsin,D,D02.455.849.291.300,Diterpenes,Terpenes,2
Coliphages,B,B04.123.205,Bacteriophages,Viruses,2
Collagen Type II,D,D05.750.078.280.300.200,Fibrillar Collagens,Collagen,2
Collagen Type II,D,D12.776.860.300.250.300.200,Fibrillar Collagens,Collagen,2
Collagen Type IV,D,D12.776.860.300.250.400.100,Non-Fibrillar Collagens,Collagen,2
Collagenases,D,D08.811.277.656.675.374.205,Metalloendopeptidases,Metalloproteases,2
Collagenases,D,D08.811.277.656.300.480.205,Metalloendopeptidases,Endopeptidases,2
Collectins,D,D12.776.503.280.249,"Lectins, C-Type",Lectins,2
Collective Bargaining,N,N04.452.677.356,Personnel Management,Organization and Administration,2
Collective Bargaining,N,N03.540.571.356,Labor Unions,Organizations,2
Collodion,J,J01.637.051.720.099.500.439,Cellulose,Biopolymers,2
Collodion,D,D25.720.099.500.439,Cellulose,Biopolymers,2
"Colonography, Computed Tomographic",E,E01.370.372.230,"Diagnostic Techniques, Digestive System",Diagnostic Techniques and Procedures,2
"Colonography, Computed Tomographic",E,E01.370.350.700.700.810.180,"Tomography, X-Ray Computed",Radiographic Image Enhancement,2
"Colonography, Computed Tomographic",E,E01.370.350.700.810.810.180,"Tomography, X-Ray Computed","Tomography, X-Ray",2
"Colonography, Computed Tomographic",E,E01.370.350.600.350.700.810.180,"Tomography, X-Ray Computed",Radiographic Image Enhancement,2
"Colonography, Computed Tomographic",E,E01.370.350.350.810.180,"Tomography, X-Ray Computed","Image Interpretation, Computer-Assisted",2
Color Vision Defects,C,C23.888.592.763.941.256,Vision Disorders,Sensation Disorders,2
Color Vision Defects,C,C11.966.256,Vision Disorders,Eye Diseases,2
Color Vision Defects,C,C10.597.751.941.256,Vision Disorders,Sensation Disorders,2
Color Vision Defects,C,C11.270.151.500,Cone Dystrophy,"Eye Diseases, Hereditary",2
"Colorectal Neoplasms, Hereditary Nonpolyposis",C,C16.320.700.250,"Neoplastic Syndromes, Hereditary","Genetic Diseases, Inborn",2
"Colorectal Neoplasms, Hereditary Nonpolyposis",C,C18.452.284.255,DNA Repair-Deficiency Disorders,Metabolic Diseases,2
"Colorectal Neoplasms, Hereditary Nonpolyposis",C,C04.700.250,"Neoplastic Syndromes, Hereditary",Neoplasms,2
"Colorectal Neoplasms, Hereditary Nonpolyposis",C,C06.405.249.411.307.190,Colorectal Neoplasms,Intestinal Neoplasms,2
"Colorectal Neoplasms, Hereditary Nonpolyposis",C,C06.405.469.158.356.190,Colorectal Neoplasms,Colonic Diseases,2
"Colorectal Neoplasms, Hereditary Nonpolyposis",C,C06.405.469.491.307.190,Colorectal Neoplasms,Intestinal Neoplasms,2
"Colorectal Neoplasms, Hereditary Nonpolyposis",C,C06.301.371.411.307.190,Colorectal Neoplasms,Intestinal Neoplasms,2
"Colorectal Neoplasms, Hereditary Nonpolyposis",C,C04.588.274.476.411.307.190,Colorectal Neoplasms,Intestinal Neoplasms,2
Columbidae,B,B01.050.150.900.248.165.150,Columbiformes,Birds,2
Common Variable Immunodeficiency,C,C20.673.330,Immunologic Deficiency Syndromes,Immune System Diseases,2
Compensation and Redress,I,I01.880.604.583.050,Jurisprudence,"Social Control, Formal",2
Compensation and Redress,N,N03.219.075,Economics,Health Care Economics and Organizations,2
Compensation and Redress,N,N03.706.535.125,Jurisprudence,"Social Control, Formal",2
Complement C1,D,D12.776.124.486.274.050,Complement System Proteins,Immunoproteins,2
Complement C1 Inhibitor Protein,D,D12.776.124.486.274.920.250.500,Complement C1 Inactivator Proteins,Complement Inactivator Proteins,2
Complement C1 Inhibitor Protein,D,D12.644.861.140.500,Complement C1 Inactivator Proteins,Serpins,2
Complement C1 Inhibitor Protein,D,D12.776.395.320,Glycoproteins,Proteins,2
Complement C1 Inhibitor Protein,D,D12.776.872.140.500,Complement C1 Inactivator Proteins,Serpins,2
Complement Membrane Attack Complex,D,D12.776.124.486.274.930,Complement System Proteins,Immunoproteins,2
Composite Resins,D,D05.750.716.822.308,"Resins, Synthetic",Plastics,2
Composite Resins,D,D25.720.716.822.308,"Resins, Synthetic",Plastics,2
Composite Resins,D,D25.339.816.500,"Resins, Synthetic",Dental Materials,2
Composite Resins,J,J01.637.051.339.816.500,"Resins, Synthetic",Dental Materials,2
Composite Resins,J,J01.637.051.720.716.822.308,"Resins, Synthetic",Plastics,2
Compulsive Behavior,F,F01.145.527.100,Impulsive Behavior,Behavior,2
Computer Literacy,L,L01.143.256,Communication,Information Science,2
"Conditioning, Operant",F,F02.463.425.179.509,"Conditioning, Psychological",Learning,2
Connectin,D,D12.776.210.500.246,Muscle Proteins,Contractile Proteins,2
Connectin,D,D08.811.913.696.620.682.324,Protein Kinases,Phosphotransferases (Alcohol Group Acceptor),2
Connective Tissue Diseases,C,C17.300,Skin and Connective Tissue Diseases,NULL,2
Connective Tissue Growth Factor,D,D12.644.276.200.100,CCN Intercellular Signaling Proteins,Intercellular Signaling Peptides and Proteins,2
Connective Tissue Growth Factor,D,D23.529.237.100,CCN Intercellular Signaling Proteins,Intercellular Signaling Peptides and Proteins,2
Connective Tissue Growth Factor,D,D12.776.860.300.200.100,CCN Intercellular Signaling Proteins,Extracellular Matrix Proteins,2
Connective Tissue Growth Factor,D,D12.776.467.200.100,CCN Intercellular Signaling Proteins,Intercellular Signaling Peptides and Proteins,2
Conscious Sedation,E,E03.250,Anesthesia and Analgesia,NULL,2
Consciousness,F,F02.463.188.409,Cognition,Mental Processes,2
Consciousness,F,F02.830.233,Psychophysiology,Psychological Phenomena,2
Contact Lenses,E,E07.632.500.276,Lenses,Optical Devices,2
"Contact Lenses, Hydrophilic",E,E07.632.500.276.360,Contact Lenses,Lenses,2
Contig Mapping,E,E05.393.260,Genetic Techniques,Investigative Techniques,2
Contig Mapping,E,E05.393.183.620.160,Physical Chromosome Mapping,Chromosome Mapping,2
"Contraception, Barrier",E,E02.875.194.285,Contraception,Reproductive Techniques,2
Contractile Proteins,D,D12.776.210,Proteins,"Amino Acids, Peptides, and Proteins",2
"Contraindications, Drug",E,E02.208.200,Contraindications,Therapeutics,2
Contusions,C,C26.974.250,"Wounds, Nonpenetrating",Wounds and Injuries,2
Coordination Complexes,D,D01.234,Inorganic Chemicals,NULL,2
Coordination Complexes,D,D02.257,Organic Chemicals,NULL,2
Cordocentesis,E,E01.370.225.998.329.543,Paracentesis,Specimen Handling,2
Cordocentesis,E,E01.370.225.998.110.150,Blood Specimen Collection,Specimen Handling,2
Cordocentesis,E,E02.800.550.465,Paracentesis,Punctures,2
Cordocentesis,E,E04.665.600.543,Paracentesis,Punctures,2
Cordocentesis,E,E04.665.150.150,Blood Specimen Collection,Punctures,2
Cordocentesis,E,E05.200.998.329.543,Paracentesis,Specimen Handling,2
Cordocentesis,E,E05.200.998.110.150,Blood Specimen Collection,Specimen Handling,2
Corn Oil,G,G07.203.300.375.400.250,"Dietary Fats, Unsaturated",Dietary Fats,2
Corn Oil,J,J02.500.375.400.250,"Dietary Fats, Unsaturated",Dietary Fats,2
Corn Oil,D,D20.215.784.750.240,Plant Oils,Plant Preparations,2
Corn Oil,D,D10.627.700.240,Plant Oils,Oils,2
Corn Oil,D,D10.212.302.380.370,"Dietary Fats, Unsaturated",Dietary Fats,2
Corn Oil,D,D10.212.507.340,"Fats, Unsaturated",Fats,2
Corneal Topography,E,E01.370.380.150,"Diagnostic Techniques, Ophthalmological",Diagnostic Techniques and Procedures,2
Corneal Transplantation,E,E02.095.147.725.225,Tissue Transplantation,Cell- and Tissue-Based Therapy,2
Corneal Transplantation,E,E04.936.580.225,Tissue Transplantation,Transplantation,2
Corneal Transplantation,E,E04.540.825.374,Refractive Surgical Procedures,Ophthalmologic Surgical Procedures,2
Coronary Vessel Anomalies,C,C16.131.240.400.210,"Heart Defects, Congenital",Cardiovascular Abnormalities,2
Coronary Vessel Anomalies,C,C14.280.400.210,"Heart Defects, Congenital",Heart Diseases,2
Coronary Vessel Anomalies,C,C14.240.400.210,"Heart Defects, Congenital",Cardiovascular Abnormalities,2
Correctional Facilities,J,J03.220,Non-Medical Public and Private Facilities,NULL,2
Corticotropin-Releasing Hormone,D,D12.776.631.650.405.740.140,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,2
Corticotropin-Releasing Hormone,D,D12.644.400.400.740.140,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,2
Corticotropin-Releasing Hormone,D,D12.644.548.365.740.140,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,2
Corticotropin-Releasing Hormone,D,D06.472.699.327.740.140,Pituitary Hormone-Releasing Hormones,Hypothalamic Hormones,2
Corynebacterium pseudotuberculosis,B,B03.510.024.250.600,Corynebacterium,Actinobacteria,2
Corynebacterium pseudotuberculosis,B,B03.510.460.400.400.200.600,Corynebacterium,"Gram-Positive Asporogenous Rods, Irregular",2
Coumarins,D,D03.633.100.150.446,Benzopyrans,"Heterocyclic Compounds, 2-Ring",2
Coumarins,D,D03.383.663.283.446,Benzopyrans,Pyrans,2
Coxsackievirus Infections,C,C01.925.782.687.359.213,Enterovirus Infections,Picornaviridae Infections,2
Craniotomy,E,E04.525.190,Neurosurgical Procedures,"Surgical Procedures, Operative",2
Craving,F,F01.658.293.195,Drive,Motivation,2
Credentialing,N,N03.706.110,"Social Control, Formal",Health Care Economics and Organizations,2
Credentialing,N,N05.700.200,"Quality Assurance, Health Care","Health Care Quality, Access, and Evaluation",2
Critical Care Nursing,N,N02.421.533.149,Nursing Care,Health Services,2
Critical Care Nursing,H,H02.478.676.175,"Specialties, Nursing",Nursing,2
"Critical Period, Psychological",F,F02.463.425.209,Learning,Mental Processes,2
Cross-Priming,G,G12.565.150,Lymphocyte Activation,Immune System Phenomena,2
Cross-Priming,G,G12.450.050.400.545.150,Lymphocyte Activation,"Immunity, Cellular",2
Crows,B,B01.050.150.900.248.620.750.150,Songbirds,Passeriformes,2
Cryoglobulins,D,D12.776.377.715.548.900.225,Paraproteins,Immunoglobulins,2
Cryoglobulins,D,D12.776.124.486.485.900.225,Paraproteins,Immunoglobulins,2
Cryoglobulins,D,D12.776.124.790.651.900.225,Paraproteins,Immunoglobulins,2
Cryosurgery,E,E04.014.180,Ablation Techniques,"Surgical Procedures, Operative",2
Cryptoxanthins,D,D02.455.849.131.868.374,Xanthophylls,Carotenoids,2
Cryptoxanthins,D,D23.767.261.887.374,Xanthophylls,Carotenoids,2
Cryptoxanthins,D,D02.455.326.271.665.202.868.374,Xanthophylls,Carotenoids,2
Cryptoxanthins,D,D02.455.426.392.368.367.379.249.887.374,Xanthophylls,Carotenoids,2
Curcumin,D,D02.455.426.559.389.657.166.200,Catechols,Phenols,2
Curcumin,D,D02.455.426.559.694.222,Diarylheptanoids,"Hydrocarbons, Aromatic",2
Curcumin,D,D02.455.326.146.485.222.222,Diarylheptanoids,Heptanes,2
Cyanobacteria,B,B03.440.475.100,Gram-Negative Oxygenic Photosynthetic Bacteria,Gram-Negative Bacteria,2
Cyanobacteria,B,B03.280,Bacteria,NULL,2
Cyberbullying,F,F01.145.813.213.500.500,Bullying,"Harassment, Non-Sexual",2
Cyberbullying,F,F01.145.126.125.550.500,Bullying,Aggression,2
Cyberbullying,I,I01.880.735.070.500,Bullying,Social Problems,2
"Cyclic Nucleotide Phosphodiesterases, Type 4",D,D12.776.476.008.400,"3',5'-Cyclic-AMP Phosphodiesterases",Intracellular Signaling Peptides and Proteins,2
"Cyclic Nucleotide Phosphodiesterases, Type 4",D,D08.811.277.352.640.150.400,"3',5'-Cyclic-AMP Phosphodiesterases",Phosphoric Diester Hydrolases,2
"Cyclic Nucleotide Phosphodiesterases, Type 4",D,D12.644.360.008.400,"3',5'-Cyclic-AMP Phosphodiesterases",Intracellular Signaling Peptides and Proteins,2
Cyclin E,D,D12.644.360.262.180,Cyclins,Intracellular Signaling Peptides and Proteins,2
Cyclin E,D,D12.776.167.218.180,Cyclins,Cell Cycle Proteins,2
Cyclin E,D,D12.776.476.262.180,Cyclins,Intracellular Signaling Peptides and Proteins,2
Cyclin-Dependent Kinase 6,D,D12.776.476.250.515,Cyclin-Dependent Kinases,Intracellular Signaling Peptides and Proteins,2
Cyclin-Dependent Kinase 6,D,D12.776.167.200.515,Cyclin-Dependent Kinases,Cell Cycle Proteins,2
Cyclin-Dependent Kinase 6,D,D12.644.360.250.515,Cyclin-Dependent Kinases,Intracellular Signaling Peptides and Proteins,2
Cyclin-Dependent Kinase 6,D,D08.811.913.696.620.682.700.646.500.937,Cyclin-Dependent Kinases,Proline-Directed Protein Kinases,2
Cyclin-Dependent Kinase Inhibitor p18,D,D12.644.360.225.300,Cyclin-Dependent Kinase Inhibitor Proteins,Intracellular Signaling Peptides and Proteins,2
Cyclin-Dependent Kinase Inhibitor p18,D,D12.776.167.187.300,Cyclin-Dependent Kinase Inhibitor Proteins,Cell Cycle Proteins,2
Cyclin-Dependent Kinase Inhibitor p18,D,D12.776.476.225.300,Cyclin-Dependent Kinase Inhibitor Proteins,Intracellular Signaling Peptides and Proteins,2
Cyclin-Dependent Kinase Inhibitor p18,D,D12.776.624.776.355.300,Cyclin-Dependent Kinase Inhibitor Proteins,Tumor Suppressor Proteins,2
Cyclin-Dependent Kinase Inhibitor p21,D,D12.776.624.776.355.500,Cyclin-Dependent Kinase Inhibitor Proteins,Tumor Suppressor Proteins,2
Cyclin-Dependent Kinase Inhibitor p21,D,D12.776.660.720.250,Poly-ADP-Ribose Binding Proteins,Nuclear Proteins,2
Cyclin-Dependent Kinase Inhibitor p21,D,D12.776.476.225.500,Cyclin-Dependent Kinase Inhibitor Proteins,Intracellular Signaling Peptides and Proteins,2
Cyclin-Dependent Kinase Inhibitor p21,D,D12.776.167.187.500,Cyclin-Dependent Kinase Inhibitor Proteins,Cell Cycle Proteins,2
Cyclin-Dependent Kinase Inhibitor p21,D,D12.776.157.687.250,Poly-ADP-Ribose Binding Proteins,Carrier Proteins,2
Cyclin-Dependent Kinase Inhibitor p21,D,D12.644.360.225.500,Cyclin-Dependent Kinase Inhibitor Proteins,Intracellular Signaling Peptides and Proteins,2
Cyclins,D,D12.644.360.262,Intracellular Signaling Peptides and Proteins,Peptides,2
Cyclins,D,D12.776.167.218,Cell Cycle Proteins,Proteins,2
Cyclins,D,D12.776.476.262,Intracellular Signaling Peptides and Proteins,Proteins,2
Cyclization,G,G03.208,Metabolism,NULL,2
Cyclization,G,G02.607.133,Organic Chemistry Phenomena,Chemical Phenomena,2
Cyclization,G,G02.111.180,Biochemical Phenomena,Chemical Phenomena,2
Cyclooxygenase 2,D,D08.811.600.720.750,Prostaglandin-Endoperoxide Synthases,Multienzyme Complexes,2
Cyclophilin A,D,D08.811.399.325.500.400.300.500,Cyclophilins,Immunophilins,2
Cyclophilins,D,D08.811.399.325.500.400.300,Immunophilins,Peptidylprolyl Isomerase,2
Cyclophilins,D,D12.776.543.750.705.400.300,Immunophilins,"Receptors, Immunologic",2
Cyclophilins,D,D12.776.827.275.300,Immunophilins,"Receptors, Drug",2
Cynodon,B,B01.650.940.800.575.912.250.822.288,Poaceae,Magnoliopsida,2
Cyprinidae,B,B01.050.150.900.493.200.244,Cypriniformes,Fishes,2
"Cystadenocarcinoma, Serous",C,C04.557.470.590.480.240,Cystadenocarcinoma,"Neoplasms, Cystic, Mucinous, and Serous",2
"Cystadenocarcinoma, Serous",C,C04.557.470.200.025.480.240,Cystadenocarcinoma,Adenocarcinoma,2
Cysteine Proteinase Inhibitors,D,D27.505.519.389.745.325,Protease Inhibitors,Enzyme Inhibitors,2
Cystoscopy,E,E01.370.390.175,"Diagnostic Techniques, Urological",Diagnostic Techniques and Procedures,2
Cystoscopy,E,E01.370.388.250.180,Endoscopy,"Diagnostic Techniques, Surgical",2
Cystoscopy,E,E04.502.250.180,Endoscopy,Minimally Invasive Surgical Procedures,2
Cystoscopy,E,E04.950.774.155,Urologic Surgical Procedures,Urogenital Surgical Procedures,2
Cytarabine,D,D13.570.065.300,Arabinonucleosides,Nucleosides,2
Cytarabine,D,D13.570.685.245.453,Cytidine,Pyrimidine Nucleosides,2
Cytarabine,D,D03.383.742.680.245.453,Cytidine,Pyrimidine Nucleosides,2
Cytochalasin D,D,D03.633.100.473.231.450,Cytochalasins,Indoles,2
Cytochalasin D,D,D23.946.587.370.450,Cytochalasins,Mycotoxins,2
Cytochrome P-450 CYP1A1,D,D12.776.422.220.453.100.500,Cytochrome P450 Family 1,Cytochrome P-450 Enzyme System,2
Cytochrome P-450 CYP1A1,D,D12.776.422.220.453.010.332,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,2
Cytochrome P-450 CYP1A1,D,D08.811.682.690.708.170.020.500,Cytochrome P450 Family 1,Cytochrome P-450 Enzyme System,2
Cytochrome P-450 CYP1A1,D,D08.811.682.690.708.170.010.277,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,2
Cytochrome P-450 CYP1A1,D,D08.244.453.005.332,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,2
Cytochrome P-450 CYP1A1,D,D08.244.453.100.500,Cytochrome P450 Family 1,Cytochrome P-450 Enzyme System,2
Cytochrome P450 Family 2,D,D08.244.453.491,Cytochrome P-450 Enzyme System,Cytochromes,2
Cytochrome P450 Family 2,D,D08.811.682.690.708.170.450,Cytochrome P-450 Enzyme System,Mixed Function Oxygenases,2
Cytochrome P450 Family 2,D,D12.776.422.220.453.491,Cytochrome P-450 Enzyme System,Cytochromes,2
Cytogenetics,H,H01.158.273.343.180,Genetics,Biology,2
Cytokine Receptor Common beta Subunit,D,D12.776.543.750.705.852.150.310.500,"Receptors, Granulocyte-Macrophage Colony-Stimulating Factor","Receptors, Colony-Stimulating Factor",2
Cytokine Receptor Common beta Subunit,D,D12.776.543.750.705.852.420.380.500,"Receptors, Interleukin-5","Receptors, Interleukin",2
Cytokine Receptor Common beta Subunit,D,D12.776.543.750.705.852.420.340.350,"Receptors, Interleukin-3","Receptors, Interleukin",2
Cytokine Receptor Common beta Subunit,D,D12.776.543.750.750.400.200.420.500,"Receptors, Granulocyte-Macrophage Colony-Stimulating Factor","Receptors, Colony-Stimulating Factor",2
Cytoplasmic Structures,A,A11.284.430.214.190,Cytoplasm,Intracellular Space,2
Cytosine,D,D03.383.742.698.421,Pyrimidinones,Pyrimidines,2
Cytotoxins,D,D27.888.569.213,Noxae,Toxic Actions,2
Dacryocystorhinostomy,E,E04.540.255,Ophthalmologic Surgical Procedures,"Surgical Procedures, Operative",2
Dacryocystorhinostomy,E,E04.579.255,Ostomy,"Surgical Procedures, Operative",2
Darkness,G,G01.590.540.233,Light,Optical Phenomena,2
Data Science,L,L01.305,Information Science,NULL,2
"Databases, Pharmaceutical",L,L01.313.500.750.300.188.400.400,"Databases, Factual",Databases as Topic,2
"Databases, Pharmaceutical",L,L01.470.750.750.400,"Databases, Factual",Databases as Topic,2
DEAD Box Protein 58,D,D08.811.913.696.445.735.720.249.750,DEAD-box RNA Helicases,RNA Helicases,2
"Decompression, Surgical",E,E04.188,"Surgical Procedures, Operative",NULL,2
Defibrillators,E,E07.305.250.159,Electrodes,Electrical Equipment and Supplies,2
Delay Discounting,F,F02.463.785.373.346.700,Choice Behavior,Decision Making,2
Deltaretrovirus Infections,C,C01.925.782.815.200,Retroviridae Infections,RNA Virus Infections,2
Deltaretrovirus Infections,C,C20.673.483,Immunologic Deficiency Syndromes,Immune System Diseases,2
Dental Alloys,D,D25.339.208,Dental Materials,Biomedical and Dental Materials,2
Dental Alloys,J,J01.637.051.339.208,Dental Materials,Biomedical and Dental Materials,2
Dental Care for Aged,N,N02.421.240.190.210,Dental Care,Dental Health Services,2
Dental Care for Aged,E,E06.170.100,Dental Care,Dentistry,2
Dental Clinics,N,N02.278.192.250,Dental Facilities,Health Facilities,2
"Dental Devices, Home Care",E,E06.186.250,Dental Equipment,Dentistry,2
"Dental Devices, Home Care",E,E06.761.726.292,Oral Hygiene,Preventive Dentistry,2
"Dental Devices, Home Care",E,E07.222.250,Dental Equipment,Equipment and Supplies,2
Dental Health Services,N,N02.421.240,Health Services,"Health Care Facilities, Manpower, and Services",2
Dental Implants,J,J01.637.051.339.312,Dental Materials,Biomedical and Dental Materials,2
Dental Implants,E,E07.695.185,Prostheses and Implants,Equipment and Supplies,2
Dental Implants,E,E06.780.346.593,Dental Prosthesis,Prosthodontics,2
Dental Implants,D,D25.339.312,Dental Materials,Biomedical and Dental Materials,2
Dental Research,H,H01.770.644.145.124,Biomedical Research,Research,2
Dental Research,H,H02.163.090,Dentistry,Health Occupations,2
Dental Scaling,E,E06.721.189.350,Dental Prophylaxis,Periodontics,2
Dental Scaling,E,E06.761.227.350,Dental Prophylaxis,Preventive Dentistry,2
"Dental Service, Hospital",N,N02.421.240.200,Dental Health Services,Health Services,2
"Dental Service, Hospital",N,N02.278.216.500.968.298,Hospital Departments,Hospital Administration,2
"Dental Service, Hospital",N,N04.452.442.452.422.298,Hospital Departments,Hospital Administration,2
Dentinogenesis,G,G07.345.500.325.377.186,Organogenesis,Embryonic and Fetal Development,2
"Dentists, Women",M,M01.975.310,Women,Persons,2
"Dentists, Women",M,M01.526.485.330.310,Dentists,Health Personnel,2
"Dentists, Women",N,N02.360.330.310,Dentists,Health Personnel,2
Deoxyribonucleases,D,D08.811.277.352.335,Esterases,Hydrolases,2
Depersonalization,F,F01.145.126.300,Behavioral Symptoms,Behavior,2
"Dermatitis, Photoallergic",C,C20.543.418.150.600,"Dermatitis, Allergic Contact","Hypersensitivity, Delayed",2
"Dermatitis, Photoallergic",C,C17.800.174.255.100.600,"Dermatitis, Allergic Contact","Dermatitis, Contact",2
"Dermatitis, Photoallergic",C,C17.800.600.325,Photosensitivity Disorders,Skin Diseases,2
"Dermatitis, Photoallergic",C,C17.800.815.255.100.600,"Dermatitis, Allergic Contact","Dermatitis, Contact",2
"Dermatitis, Seborrheic",C,C17.800.815.580,"Skin Diseases, Eczematous",Skin Diseases,2
"Dermatitis, Seborrheic",C,C17.800.794.230,Sebaceous Gland Diseases,Skin Diseases,2
"Dermatitis, Seborrheic",C,C17.800.174.580,Dermatitis,Skin Diseases,2
"Dermatitis, Seborrheic",C,C17.800.859.350,"Skin Diseases, Papulosquamous",Skin Diseases,2
Dermatophagoides pteronyssinus,B,B01.050.500.131.166.132.419.600.215,Pyroglyphidae,Mites,2
Dermis,A,A17.815.180,Skin,Integumentary System,2
Designer Drugs,D,D26.909.500,Synthetic Drugs,Pharmaceutical Preparations,2
Desogestrel,D,D04.210.500.668.651.693.175,Norpregnenes,Norpregnanes,2
Dextran Sulfate,D,D09.698.365.272.300,Dextrans,Glucans,2
Diagnostic Screening Programs,N,N02.421.726.233.138,Diagnostic Services,Preventive Health Services,2
"Diagnostic Techniques, Cardiovascular",E,E01.370.370,Diagnostic Techniques and Procedures,Diagnosis,2
"Diagnostic Techniques, Endocrine",E,E01.370.374,Diagnostic Techniques and Procedures,Diagnosis,2
"Diagnostic Techniques, Neurological",E,E01.370.376,Diagnostic Techniques and Procedures,Diagnosis,2
Dialysis,E,E05.196.353,"Chemistry Techniques, Analytical",Investigative Techniques,2
Dialysis,G,G02.186,Chemical Phenomena,NULL,2
"Diapers, Infant",E,E07.325.068.249,Absorbent Pads,"Equipment and Supplies, Hospital",2
Diaphragm,A,A02.633.567.900.300,Respiratory Muscles,"Muscle, Skeletal",2
Dicarboxylic Acids,D,D02.241.081.337,"Acids, Acyclic",Carboxylic Acids,2
Dicyclomine,D,D02.241.223.268.300,Cyclohexanecarboxylic Acids,"Acids, Carbocyclic",2
Dicyclomine,D,D02.455.426.392.368.367.440,Cyclohexanes,Cycloparaffins,2
"Diet, Carbohydrate-Restricted",E,E02.642.249.245,Diet Therapy,Nutrition Therapy,2
"Diet, Carbohydrate-Restricted",G,G07.203.650.240.245,Diet,Nutritional Physiological Phenomena,2
Dietary Approaches To Stop Hypertension,G,G07.203.650.240.325,Diet,Nutritional Physiological Phenomena,2
Dietary Approaches To Stop Hypertension,E,E02.642.249.475,Diet Therapy,Nutrition Therapy,2
Dietary Services,N,N02.421.242,Health Services,"Health Care Facilities, Manpower, and Services",2
Diethylhexyl Phthalate,D,D02.241.223.805.250,Phthalic Acids,"Acids, Carbocyclic",2
Diffusion,G,G02.196,Chemical Phenomena,NULL,2
Diffusion,G,G01.202,Physical Phenomena,NULL,2
Digestion,G,G07.203.650.250,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",2
Digestion,G,G10.261.190,Digestive System Physiological Phenomena,Digestive System and Oral Physiological Phenomena,2
Diketopiperazines,D,D03.383.606.385,Piperazines,"Heterocyclic Compounds, 1-Ring",2
Dimethylpolysiloxanes,D,D02.756.650.700.150,Silicones,Siloxanes,2
Dimethylpolysiloxanes,D,D05.750.900.850.150,Silicones,Siloxanes,2
Dimethylpolysiloxanes,D,D25.720.900.850.150,Silicones,Siloxanes,2
Dimethylpolysiloxanes,J,J01.637.051.720.900.850.150,Silicones,Siloxanes,2
Dinoprost,D,D23.469.050.175.725.400.200,Prostaglandins F,Prostaglandins,2
Dinoprost,D,D10.251.355.255.550.400.200,Prostaglandins F,Prostaglandins,2
Diphenhydramine,D,D02.455.426.559.389.115.250,Benzhydryl Compounds,Benzene Derivatives,2
Diphenhydramine,D,D02.092.471.320,Ethylamines,Amines,2
Diphtheria Toxin,D,D08.811.913.400.725.115.220,ADP Ribose Transferases,Pentosyltransferases,2
Diphtheria Toxin,D,D23.946.123.305,Bacterial Toxins,"Toxins, Biological",2
Diploidy,G,G05.700.264,Ploidies,Genetic Phenomena,2
Diplopia,C,C23.888.592.763.941.339,Vision Disorders,Sensation Disorders,2
Diplopia,C,C10.597.751.941.339,Vision Disorders,Sensation Disorders,2
Diplopia,C,C11.966.339,Vision Disorders,Eye Diseases,2
Dipyrone,D,D03.383.129.539.850.077.150,Aminopyrine,Pyrazolones,2
Disease Hotspot,N,N06.850.290.100,Disease Outbreaks,Public Health,2
Dithiothreitol,D,D02.886.740.224,Thioglycosides,Sulfur Compounds,2
Dithiothreitol,D,D09.853.196,Sugar Alcohols,Carbohydrates,2
Dithiothreitol,D,D02.033.800.196,Sugar Alcohols,Alcohols,2
"Diuretics, Osmotic",D,D27.505.696.560.500.453,Diuretics,Natriuretic Agents,2
Diverticulum,C,C23.300.415,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",2
Diverticulum,C,C06.405.205.282.750,Diverticular Diseases,Gastroenteritis,2
"Diverticulum, Colon",C,C06.405.205.282.750.500,Diverticulum,Diverticular Diseases,2
"Diverticulum, Colon",C,C23.300.415.500,Diverticulum,"Pathological Conditions, Anatomical",2
Dizziness,C,C23.888.592.763.237,Sensation Disorders,Neurologic Manifestations,2
DNA (Cytosine-5-)-Methyltransferases,D,D08.811.913.555.500.350.100.500,DNA-Cytosine Methylases,DNA Modification Methylases,2
DNA Breaks,G,G05.200.210,DNA Damage,Genetic Phenomena,2
DNA Fragmentation,G,G05.200.230,DNA Damage,Genetic Phenomena,2
DNA Ligase ATP,D,D08.811.464.754.600.500,DNA Ligases,Polynucleotide Ligases,2
DNA Ligase ATP,D,D08.811.074.500.500,DNA Ligases,DNA Repair Enzymes,2
DNA Ligases,D,D08.811.074.500,DNA Repair Enzymes,Enzymes,2
DNA Ligases,D,D08.811.464.754.600,Polynucleotide Ligases,Ligases,2
DNA Nucleotidylexotransferase,D,D08.811.913.696.445.308.325,DNA Nucleotidyltransferases,Nucleotidyltransferases,2
DNA Nucleotidyltransferases,D,D08.811.913.696.445.308,Nucleotidyltransferases,Phosphotransferases,2
DNA Polymerase gamma,D,D08.811.913.696.445.308.300.169,DNA-Directed DNA Polymerase,DNA Nucleotidyltransferases,2
DNA Polymerase gamma,D,D12.776.575.280,Mitochondrial Proteins,Proteins,2
"DNA Probes, HPV",D,D13.444.600.223.555,DNA Probes,Nucleic Acid Probes,2
"DNA Probes, HPV",D,D27.505.259.750.600.223.620,DNA Probes,Nucleic Acid Probes,2
"DNA Probes, HPV",D,D27.720.470.530.600.223.620,DNA Probes,Nucleic Acid Probes,2
"DNA, Ancient",D,D13.444.308.065,DNA,Nucleic Acids,2
"DNA, Antisense",D,D13.444.308.150,DNA,Nucleic Acids,2
"DNA, Antisense",D,D13.150.200,Antisense Elements (Genetics),"Nucleic Acids, Nucleotides, and Nucleosides",2
"DNA, Antisense",D,D13.444.600.150.200,Antisense Elements (Genetics),Nucleic Acid Probes,2
"DNA, Antisense",D,D27.720.470.530.600.150.200,Antisense Elements (Genetics),Nucleic Acid Probes,2
"DNA, Satellite",D,D13.444.308.480,DNA,Nucleic Acids,2
"DNA, Satellite",G,G05.360.080.708.800.150,Tandem Repeat Sequences,"Repetitive Sequences, Nucleic Acid",2
"DNA, Satellite",G,G05.360.340.024.220.150,"DNA, Intergenic",Genome Components,2
"DNA, Satellite",G,G05.360.340.024.850.150,Tandem Repeat Sequences,Genome Components,2
"DNA, Satellite",G,G02.111.570.080.708.800.150,Tandem Repeat Sequences,"Repetitive Sequences, Nucleic Acid",2
Dobutamine,D,D02.092.471.683.410,Phenethylamines,Ethylamines,2
Dobutamine,D,D02.092.311.220,Catecholamines,Amines,2
Dobutamine,D,D02.455.426.559.389.657.166.175.220,Catecholamines,Catechols,2
Dopamine beta-Hydroxylase,D,D08.811.682.690.708.292,Mixed Function Oxygenases,Oxygenases,2
Dopamine Uptake Inhibitors,D,D27.505.519.625.600.220,Neurotransmitter Uptake Inhibitors,Neurotransmitter Agents,2
Dopamine Uptake Inhibitors,D,D27.505.519.625.150.800,Dopamine Agents,Neurotransmitter Agents,2
Dopamine Uptake Inhibitors,D,D27.505.519.562.437.220,Neurotransmitter Uptake Inhibitors,Membrane Transport Modulators,2
Dopamine Uptake Inhibitors,D,D27.505.696.577.600.220,Neurotransmitter Uptake Inhibitors,Neurotransmitter Agents,2
Dopamine Uptake Inhibitors,D,D27.505.696.577.150.800,Dopamine Agents,Neurotransmitter Agents,2
Doxylamine,D,D03.383.725.259,Pyridines,"Heterocyclic Compounds, 1-Ring",2
Drama,K,K01.517.333,Literature,Humanities,2
Drinking Behavior,F,F01.145.317,Behavior,Behavior and Behavior Mechanisms,2
"Drug Resistance, Neoplasm",G,G07.690.773.984.395,Drug Resistance,Pharmacological Phenomena,2
Drug-Seeking Behavior,F,F01.145.342,Behavior,Behavior and Behavior Mechanisms,2
E2F1 Transcription Factor,D,D12.644.360.024.328.049,Retinoblastoma Binding Proteins,"Adaptor Proteins, Signal Transducing",2
E2F1 Transcription Factor,D,D12.776.157.057.158.049,Retinoblastoma Binding Proteins,"Adaptor Proteins, Signal Transducing",2
E2F1 Transcription Factor,D,D12.776.660.769.049,Retinoblastoma Binding Proteins,Nuclear Proteins,2
E2F1 Transcription Factor,D,D12.776.930.211.500,E2F Transcription Factors,Transcription Factors,2
E2F1 Transcription Factor,D,D12.776.476.024.420.049,Retinoblastoma Binding Proteins,"Adaptor Proteins, Signal Transducing",2
"Ear, Middle",A,A09.246.397,Ear,Sense Organs,2
Echinocandins,D,D12.644.641.311,"Peptides, Cyclic",Peptides,2
Echinococcus granulosus,B,B01.050.500.500.736.215.327.400,Echinococcus,Cestoda,2
Echovirus Infections,C,C01.925.782.687.359.347,Enterovirus Infections,Picornaviridae Infections,2
Ecological and Environmental Phenomena,G,G16.500,Biological Phenomena,NULL,2
Ectropion,C,C11.338.362,Eyelid Diseases,Eye Diseases,2
Education of Visually Disabled,I,I02.233.213.500,"Education, Special","Education, Nonprofessional",2
Egg Hypersensitivity,C,C20.543.480.370.150,Food Hypersensitivity,"Hypersensitivity, Immediate",2
Ehlers-Danlos Syndrome,C,C17.300.200.310,Collagen Diseases,Connective Tissue Diseases,2
Ehlers-Danlos Syndrome,C,C17.800.804.428,Skin Abnormalities,Skin Diseases,2
Ehlers-Danlos Syndrome,C,C17.800.827.260,"Skin Diseases, Genetic",Skin Diseases,2
Ehlers-Danlos Syndrome,C,C16.131.831.428,Skin Abnormalities,Congenital Abnormalities,2
Ehlers-Danlos Syndrome,C,C16.320.850.260,"Skin Diseases, Genetic","Genetic Diseases, Inborn",2
Ehlers-Danlos Syndrome,C,C15.378.463.515.240,Hemostatic Disorders,Hemorrhagic Disorders,2
Ehlers-Danlos Syndrome,C,C14.907.454.240,Hemostatic Disorders,Vascular Diseases,2
Eicosanoic Acids,D,D10.251.220,Fatty Acids,Lipids,2
eIF-2 Kinase,D,D08.811.913.696.620.682.700.300,Protein-Serine-Threonine Kinases,Protein Kinases,2
eIF-2 Kinase,D,D12.644.360.275,Intracellular Signaling Peptides and Proteins,Peptides,2
eIF-2 Kinase,D,D12.776.476.275,Intracellular Signaling Peptides and Proteins,Proteins,2
El Salvador,Z,Z01.107.169.339,Central America,Americas,2
Elafin,D,D12.776.645.437,"Proteinase Inhibitory Proteins, Secretory",Proteins,2
Elafin,D,D12.644.822.437,"Proteinase Inhibitory Proteins, Secretory",Peptides,2
Elbow Joint,A,A02.835.583.290,Joints,Skeleton,2
Electric Wiring,E,E07.305.245,Electrical Equipment and Supplies,Equipment and Supplies,2
Electrochemical Techniques,E,E05.301,Investigative Techniques,NULL,2
Electron Transport,G,G03.295.531.403,Oxidation-Reduction,Energy Metabolism,2
Electron Transport,G,G03.493.350,Metabolic Networks and Pathways,Metabolism,2
Electron Transport,G,G02.111.248,Biochemical Phenomena,Chemical Phenomena,2
Electron Transport Chain Complex Proteins,D,D08.811.600.250,Multienzyme Complexes,Enzymes,2
Electron Transport Chain Complex Proteins,D,D12.776.543.277,Membrane Proteins,Proteins,2
"Electrophoresis, Disc",E,E05.301.300.319.403,"Electrophoresis, Polyacrylamide Gel",Electrophoresis,2
"Electrophoresis, Disc",E,E05.196.401.402.236,"Electrophoresis, Polyacrylamide Gel",Electrophoresis,2
Elements,D,D01.268,Inorganic Chemicals,NULL,2
Embolism,C,C14.907.355.350,Embolism and Thrombosis,Vascular Diseases,2
Emergency Responders,M,M01.526.373,Occupational Groups,Persons,2
Emphysema,C,C23.550.325,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",2
Empyema,C,C23.550.470.756.305,Suppuration,Inflammation,2
Empyema,C,C01.830.305,Suppuration,Infections,2
"Encephalitis, Viral",C,C01.207.245.340,Central Nervous System Viral Diseases,Central Nervous System Infections,2
"Encephalitis, Viral",C,C01.207.399.750,Infectious Encephalitis,Central Nervous System Infections,2
"Encephalitis, Viral",C,C01.925.182.525,Central Nervous System Viral Diseases,Virus Diseases,2
"Encephalitis, Viral",C,C10.228.228.245.340,Central Nervous System Viral Diseases,Central Nervous System Infections,2
"Encephalitis, Viral",C,C10.228.228.399.750,Infectious Encephalitis,Central Nervous System Infections,2
"Encephalitis, Viral",C,C10.228.140.430.520.750,Infectious Encephalitis,Encephalitis,2
Encephalomyelitis,C,C10.228.228.291,Central Nervous System Infections,Central Nervous System Diseases,2
Encephalomyelitis,C,C10.228.440,Central Nervous System Diseases,Nervous System Diseases,2
Encephalomyelitis,C,C01.207.291,Central Nervous System Infections,Infections,2
Endocardium,A,A07.541.207,Heart,Cardiovascular System,2
Endolimax,B,B01.046.500.100.700.325,Tubulina,Amoebida,2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E01.370.225.500.384.100.119.500.500,"Biopsy, Fine-Needle","Biopsy, Needle",2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E01.370.225.500.384.100.370.500,Image-Guided Biopsy,Biopsy,2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E01.370.350.850.855.500,"Ultrasonography, Interventional",Ultrasonography,2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E01.370.225.998.054.119.500.500,"Biopsy, Fine-Needle","Biopsy, Needle",2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E01.370.225.998.054.370.500,Image-Guided Biopsy,Biopsy,2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E01.370.388.100.100.500.500,"Biopsy, Fine-Needle","Biopsy, Needle",2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E01.370.388.100.370.500,Image-Guided Biopsy,Biopsy,2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E05.200.500.384.100.370.500,Image-Guided Biopsy,Biopsy,2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E05.200.500.384.100.119.500.500,"Biopsy, Fine-Needle","Biopsy, Needle",2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E05.242.384.100.119.500.500,"Biopsy, Fine-Needle","Biopsy, Needle",2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E05.242.384.100.370.500,Image-Guided Biopsy,Biopsy,2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E05.200.998.054.370.500,Image-Guided Biopsy,Biopsy,2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E05.200.998.054.119.500.500,"Biopsy, Fine-Needle","Biopsy, Needle",2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E04.074.370.500,Image-Guided Biopsy,Biopsy,2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E04.074.119.500.500,"Biopsy, Fine-Needle","Biopsy, Needle",2
Endoscopic Ultrasound-Guided Fine Needle Aspiration,E,E04.502.890.500,"Ultrasonography, Interventional",Minimally Invasive Surgical Procedures,2
"Endoscopy, Digestive System",E,E04.502.250.250,Endoscopy,Minimally Invasive Surgical Procedures,2
"Endoscopy, Digestive System",E,E04.210.240,Digestive System Surgical Procedures,"Surgical Procedures, Operative",2
"Endoscopy, Digestive System",E,E01.370.388.250.250,Endoscopy,"Diagnostic Techniques, Surgical",2
"Endoscopy, Digestive System",E,E01.370.372.250,"Diagnostic Techniques, Digestive System",Diagnostic Techniques and Procedures,2
Endosomal Sorting Complexes Required for Transport,D,D12.776.543.990.493,Vesicular Transport Proteins,Membrane Proteins,2
Endosomal Sorting Complexes Required for Transport,D,D05.500.199,Multiprotein Complexes,Macromolecular Substances,2
Engineering,J,J01.293,"Technology, Industry, and Agriculture",NULL,2
Enslavement,I,I01.880.735.384.350,Human Rights Abuses,Social Problems,2
Enterobacter cloacae,B,B03.440.450.425.275.200,Enterobacter,Enterobacteriaceae,2
Enterobacter cloacae,B,B03.660.250.150.170.100,Enterobacter,Enterobacteriaceae,2
Enterobiasis,C,C01.610.335.508.700.550.550.375,Oxyuriasis,Oxyurida Infections,2
Enterobius,B,B01.050.500.500.294.400.750.500.308,Oxyuroidea,Oxyurida,2
Enterohemorrhagic Escherichia coli,B,B03.440.450.425.325.300.800.250,Shiga-Toxigenic Escherichia coli,Escherichia coli,2
Enterohemorrhagic Escherichia coli,B,B03.660.250.150.180.100.800.250,Shiga-Toxigenic Escherichia coli,Escherichia coli,2
"Enterovirus C, Human",B,B04.820.578.750.284.184,Enterovirus,Picornaviridae,2
Environmental Biomarkers,D,D23.101.258,Biomarkers,Biological Factors,2
Environmental Biomarkers,G,G16.505,Biological Phenomena,NULL,2
Environmental Biomarkers,N,N06.850.460.350.080.250,Environmental Monitoring,Environmental Exposure,2
Enzyme Assays,E,E05.196.427,"Chemistry Techniques, Analytical",Investigative Techniques,2
Epidermis,A,A17.815.250,Skin,Integumentary System,2
Epidermis,A,A10.272.497,Epithelium,Tissues,2
Epididymis,A,A05.360.444.371,"Genitalia, Male",Genitalia,2
"Epilepsy, Tonic-Clonic",C,C10.228.140.490.375.290,"Epilepsy, Generalized",Epilepsy,2
Epirubicin,D,D04.615.562.050.200.175.200,Doxorubicin,Daunorubicin,2
Epirubicin,D,D02.455.426.559.847.562.050.200.175.200,Doxorubicin,Daunorubicin,2
Epirubicin,D,D09.408.051.059.200.175.200,Doxorubicin,Daunorubicin,2
Epistaxis,C,C08.460.261,Nose Diseases,Respiratory Tract Diseases,2
Epistaxis,C,C09.603.261,Nose Diseases,Otorhinolaryngologic Diseases,2
Epistaxis,C,C23.550.414.712,Hemorrhage,Pathologic Processes,2
Epistaxis,C,C23.888.852.040,"Signs and Symptoms, Respiratory",Signs and Symptoms,2
Epoprostenol,D,D10.251.355.255.550.550.500,Prostaglandins I,Prostaglandins,2
Epoprostenol,D,D23.469.050.175.725.550.500,Prostaglandins I,Prostaglandins,2
Epsilonproteobacteria,B,B03.660.150,Proteobacteria,Bacteria,2
Ergonomics,F,F02.784.412,"Psychology, Applied",Psychological Phenomena,2
Ergonomics,J,J01.293.556,Engineering,"Technology, Industry, and Agriculture",2
Erythrocyte Aggregation,G,G09.188.370.187,Hemorheology,Blood Physiological Phenomena,2
Erythrocyte Aggregation,E,E05.200.625.225,Hematologic Tests,Clinical Laboratory Techniques,2
Erythrocyte Aggregation,E,E01.370.225.625.225,Hematologic Tests,Clinical Laboratory Techniques,2
Erythrocyte Deformability,G,G09.188.370.249,Hemorheology,Blood Physiological Phenomena,2
Escape Reaction,G,G11.427.410.568.850.688,Taxis Response,Locomotion,2
Escape Reaction,F,F01.145.367,Behavior,Behavior and Behavior Mechanisms,2
Escape Reaction,F,F01.145.113.780.688,Taxis Response,"Behavior, Animal",2
Escape Reaction,F,F01.145.875.439.500.688,Taxis Response,"Orientation, Spatial",2
Escape Reaction,G,G07.568.500.590.688,Taxis Response,Locomotion,2
Escherichia coli Vaccines,D,D20.215.894.135.390,Bacterial Vaccines,Vaccines,2
Esomeprazole,D,D02.886.640.074.500.500,Omeprazole,2-Pyridinylmethylsulfinylbenzimidazoles,2
Esomeprazole,D,D03.383.725.024.500.500,Omeprazole,2-Pyridinylmethylsulfinylbenzimidazoles,2
Esomeprazole,D,D03.633.100.103.034.500.500,Omeprazole,2-Pyridinylmethylsulfinylbenzimidazoles,2
Esophageal Squamous Cell Carcinoma,C,C04.557.470.200.400.330,"Carcinoma, Squamous Cell",Carcinoma,2
Esophageal Squamous Cell Carcinoma,C,C04.557.470.700.400.565,"Carcinoma, Squamous Cell","Neoplasms, Squamous Cell",2
Esophageal Squamous Cell Carcinoma,C,C04.588.274.476.205.500,Esophageal Neoplasms,Gastrointestinal Neoplasms,2
Esophageal Squamous Cell Carcinoma,C,C06.405.117.430.500,Esophageal Neoplasms,Esophageal Diseases,2
Esophageal Squamous Cell Carcinoma,C,C06.405.249.205.500,Esophageal Neoplasms,Gastrointestinal Neoplasms,2
Esophageal Squamous Cell Carcinoma,C,C04.588.443.353.500,Esophageal Neoplasms,Head and Neck Neoplasms,2
Esophageal Squamous Cell Carcinoma,C,C06.301.371.205.500,Esophageal Neoplasms,Gastrointestinal Neoplasms,2
Esophagitis,C,C06.405.205.663,Gastroenteritis,Gastrointestinal Diseases,2
Esophagitis,C,C06.405.117.620,Esophageal Diseases,Gastrointestinal Diseases,2
Essential Hypertension,C,C14.907.489.165,Hypertension,Vascular Diseases,2
Estradiol Congeners,D,D06.472.334.851.437,Gonadal Steroid Hormones,Gonadal Hormones,2
Ethamsylate,D,D02.886.645.600.080.050.100.300,Benzenesulfonates,Arylsulfonates,2
Ethamsylate,D,D02.455.426.559.389.097.250,Benzenesulfonates,Benzene Derivatives,2
Ethicists,K,K01.752.566.479.119,Ethics,Morals,2
Ethicists,N,N05.350.262,Ethics,"Health Care Quality, Access, and Evaluation",2
Ethicists,M,M01.526.276,Occupational Groups,Persons,2
"Ethics, Business",N,N05.350.297,Ethics,"Health Care Quality, Access, and Evaluation",2
"Ethics, Business",K,K01.752.566.479.161,Ethics,Morals,2
Ethnic Violence,I,I01.880.735.900.575,Violence,Social Problems,2
Ethnopsychology,F,F04.096.628.317,Psychology,Behavioral Sciences,2
Ethnopsychology,F,F04.096.544.275,Psychiatry,Behavioral Sciences,2
Ethylamines,D,D02.092.471,Amines,Organic Chemicals,2
Ethylene Glycols,D,D02.033.455.250,Glycols,Alcohols,2
Ethylmaleimide,D,D02.241.081.337.502.524.418,Maleimides,Maleates,2
Ethylmaleimide,D,D03.383.129.578.399.418,Maleimides,Pyrroles,2
Ethylmaleimide,D,D02.478.440.418,Maleimides,Imides,2
Etidronic Acid,D,D02.705.429.500.830,Diphosphonates,Organophosphonates,2
Euthanasia,E,E02.760.905.199,Terminal Care,Patient Care,2
Euthanasia,I,I01.880.735.344.500,Homicide,Social Problems,2
Euthanasia,N,N02.421.585.905.199,Terminal Care,Patient Care,2
Evoked Potentials,G,G11.561.200.500,Cortical Excitability,Nervous System Physiological Phenomena,2
Evoked Potentials,G,G07.265.216.500,Cortical Excitability,Electrophysiological Phenomena,2
"Evoked Potentials, Auditory",G,G07.265.216.500.370,Evoked Potentials,Cortical Excitability,2
"Evoked Potentials, Auditory",G,G07.888.250,Vestibulocochlear Physiological Phenomena,Physiological Phenomena,2
"Evoked Potentials, Auditory",G,G11.561.200.500.370,Evoked Potentials,Cortical Excitability,2
"Exchange Transfusion, Whole Blood",E,E02.095.135.469,Blood Transfusion,Biological Therapy,2
Excipients,D,D27.720.744.770.419,Pharmaceutical Vehicles,Pharmaceutic Aids,2
Excipients,D,D26.650.700.419,Pharmaceutical Vehicles,Pharmaceutic Aids,2
Exhibitions as Topic,J,J01.897.280.500.269,Audiovisual Aids,Educational Technology,2
Exhibitions as Topic,L,L01.178.820.090.269,Audiovisual Aids,Teaching Materials,2
Exocrine Pancreatic Insufficiency,C,C06.689.276,Pancreatic Diseases,Digestive System Diseases,2
Exodeoxyribonucleases,D,D08.811.277.352.335.375,Deoxyribonucleases,Esterases,2
Exodeoxyribonucleases,D,D08.811.277.352.365.290,Exonucleases,Esterases,2
Expeditions,I,I03.883.532,Travel,Human Activities,2
Exsanguination,C,C23.550.414.734,Hemorrhage,Pathologic Processes,2
"Extinction, Psychological",F,F02.463.425.770.232,"Reinforcement, Psychology",Learning,2
Extracellular Vesicles,A,A11.284.295.588,Extracellular Space,Cellular Structures,2
Eye Foreign Bodies,C,C26.915.300.425.250.260,Eye Injuries,Facial Injuries,2
Eye Foreign Bodies,C,C26.392.421,Foreign Bodies,Wounds and Injuries,2
Eye Foreign Bodies,C,C10.900.300.284.250.260,Eye Injuries,Facial Injuries,2
Eye Hemorrhage,C,C11.290,Eye Diseases,NULL,2
Eye Hemorrhage,C,C23.888.307.500,Eye Manifestations,Signs and Symptoms,2
Eye Hemorrhage,C,C23.550.414.756,Hemorrhage,Pathologic Processes,2
"Eye Injuries, Penetrating",C,C26.915.300.425.250.270,Eye Injuries,Facial Injuries,2
"Eye Injuries, Penetrating",C,C26.986.450,"Wounds, Penetrating",Wounds and Injuries,2
"Eye Injuries, Penetrating",C,C10.900.300.284.250.270,Eye Injuries,Facial Injuries,2
Eye-Tracking Technology,E,E01.370.405.245.787.642,Eye Movement Measurements,Electroencephalography,2
Eye-Tracking Technology,E,E01.370.380.230.642,Eye Movement Measurements,"Diagnostic Techniques, Ophthalmological",2
Facial Muscles,A,A02.633.567.400,"Muscle, Skeletal",Muscles,2
Facial Muscles,A,A14.363,Stomatognathic System,NULL,2
Facial Recognition,F,F02.463.593.524.250.500,Identity Recognition,"Pattern Recognition, Physiological",2
Facial Recognition,F,F02.463.593.524.500.500,"Pattern Recognition, Visual","Pattern Recognition, Physiological",2
Facial Recognition,F,F02.463.593.932.622.500,"Pattern Recognition, Visual",Visual Perception,2
Factor IX,D,D23.119.375,Blood Coagulation Factors,Biological Factors,2
Factor IX,D,D12.776.811.243.355,Enzyme Precursors,Protein Precursors,2
Factor IX,D,D08.622.355,Enzyme Precursors,Enzymes and Coenzymes,2
Factor IX,D,D12.776.124.125.375,Blood Coagulation Factors,Blood Proteins,2
Factor X,D,D12.776.124.125.400,Blood Coagulation Factors,Blood Proteins,2
Factor X,D,D08.622.471,Enzyme Precursors,Enzymes and Coenzymes,2
Factor X,D,D12.776.811.243.471,Enzyme Precursors,Protein Precursors,2
Factor X,D,D23.119.400,Blood Coagulation Factors,Biological Factors,2
"Faculty, Nursing",N,N02.360.390,Health Personnel,"Health Care Facilities, Manpower, and Services",2
"Faculty, Nursing",M,M01.526.485.390,Health Personnel,Occupational Groups,2
"Faculty, Nursing",M,M01.526.702.250.473,Faculty,Educational Personnel,2
Faith-Based Organizations,N,N03.540.297,Organizations,Health Care Economics and Organizations,2
Falconiformes,B,B01.050.150.900.248.815.350,Raptors,Birds,2
Familial Mediterranean Fever,C,C16.320.382.625,Hereditary Autoinflammatory Diseases,"Genetic Diseases, Inborn",2
Family Nursing,H,H02.478.676.218,"Specialties, Nursing",Nursing,2
Farnesyltranstransferase,D,D08.811.913.225.437,Alkyl and Aryl Transferases,Transferases,2
Fatty Acid Desaturases,D,D08.811.682.690.708.392,Mixed Function Oxygenases,Oxygenases,2
Fatty Acid-Binding Proteins,D,D12.776.157.170,Carrier Proteins,Proteins,2
"Fatty Acids, Nonesterified",D,D10.251.310,Fatty Acids,Lipids,2
Fatty Alcohols,D,D10.289,Lipids,NULL,2
Fatty Alcohols,D,D02.033.415,Alcohols,Organic Chemicals,2
"Feedback, Psychological",F,F04.754.308,Psychotherapy,Behavioral Disciplines and Activities,2
"Feedback, Psychological",F,F01.058.288,"Adaptation, Psychological",Behavior and Behavior Mechanisms,2
Feeding and Eating Disorders of Childhood,F,F03.400.500,Feeding and Eating Disorders,Mental Disorders,2
Femininity,F,F01.393.446.250.500,Gender Identity,"Identification, Psychological",2
Femininity,F,F01.752.747.385.200.500,Gender Identity,"Identification, Psychological",2
Femininity,F,F01.145.813.199,Social Behavior,Behavior,2
Feminism,I,I01.880.604.473.374,Human Rights,"Social Control, Formal",2
Feminism,K,K01.752.566.479.174.700,Humanism,Ethics,2
Fetal Hypoxia,C,C23.888.852.079.594,Hypoxia,"Signs and Symptoms, Respiratory",2
Fetal Hypoxia,C,C16.300.420,Fetal Diseases,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Fetal Hypoxia,C,C13.703.277.390,Fetal Diseases,Pregnancy Complications,2
Fetal Nutrition Disorders,C,C13.703.277.677,Fetal Diseases,Pregnancy Complications,2
Fetal Nutrition Disorders,C,C18.654.521.625,Malnutrition,Nutrition Disorders,2
Fiber Optic Technology,H,H01.671.617.249,Optics and Photonics,Physics,2
Fibrillin-2,D,D09.400.430.875.750,Fibrillins,Glycoproteins,2
Fibrillin-2,D,D12.776.395.341.750,Fibrillins,Glycoproteins,2
Fibrillin-2,D,D12.776.860.300.400.750,Fibrillins,Extracellular Matrix Proteins,2
Fibroblast Growth Factor 2,D,D12.776.467.624.120,Fibroblast Growth Factors,Intercellular Signaling Peptides and Proteins,2
Fibroblast Growth Factor 2,D,D23.529.624.120,Fibroblast Growth Factors,Intercellular Signaling Peptides and Proteins,2
Fibroblast Growth Factor 2,D,D12.644.276.624.120,Fibroblast Growth Factors,Intercellular Signaling Peptides and Proteins,2
Filtering Surgery,E,E04.540.450,Ophthalmologic Surgical Procedures,"Surgical Procedures, Operative",2
First Aid,E,E02.365.305,Emergency Treatment,Therapeutics,2
Fiscal Policy,I,I01.655.125,Policy,Social Sciences,2
Fistula,C,C23.300.575,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",2
Flavin Mononucleotide,D,D23.767.405.650.500,Riboflavin,Flavins,2
Flavin Mononucleotide,D,D13.695.827.349,Ribonucleotides,Nucleotides,2
Flavin Mononucleotide,D,D08.211.474.650.500,Riboflavin,Flavins,2
Flavin Mononucleotide,D,D03.633.100.733.315.650.500,Riboflavin,Flavins,2
Flavin Mononucleotide,D,D03.633.300.507.650.500,Riboflavin,Flavins,2
Flavins,D,D03.633.300.507,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",2
Flavins,D,D03.633.100.733.315,Pteridines,"Heterocyclic Compounds, 2-Ring",2
Flavins,D,D08.211.474,Coenzymes,Enzymes and Coenzymes,2
Flavins,D,D23.767.405,"Pigments, Biological",Biological Factors,2
Flaviviridae,B,B04.820.578.344,Positive-Strand RNA Viruses,RNA Viruses,2
Flaviviridae Infections,C,C01.925.782.350,RNA Virus Infections,Virus Diseases,2
Flavobacteriaceae,B,B03.440.080.190,Bacteroidetes,Gram-Negative Bacteria,2
Flavobacteriaceae,B,B03.440.400.425.310,Gram-Negative Aerobic Rods and Cocci,Gram-Negative Aerobic Bacteria,2
Flavobacteriaceae Infections,C,C01.150.252.400.349,Gram-Negative Bacterial Infections,Bacterial Infections,2
Fluoresceins,D,D04.711.347,Spiro Compounds,Polycyclic Compounds,2
Fluoresceins,D,D03.633.300.953.275,Xanthenes,"Heterocyclic Compounds, 3-Ring",2
Fluoresceins,D,D02.455.426.779.347,Spiro Compounds,"Hydrocarbons, Cyclic",2
Fluorescent Treponemal Antibody-Absorption Test,E,E01.370.225.812.735.850.200,Syphilis Serodiagnosis,Serologic Tests,2
Fluorescent Treponemal Antibody-Absorption Test,E,E05.200.812.735.850.200,Syphilis Serodiagnosis,Serologic Tests,2
Fluorescent Treponemal Antibody-Absorption Test,E,E05.478.594.760.850.200,Syphilis Serodiagnosis,Serologic Tests,2
Fluoroimmunoassay,E,E05.478.583.375.655,Fluorescent Antibody Technique,Immunohistochemistry,2
Fluoroimmunoassay,E,E05.478.566.159,Immunoassay,Immunologic Techniques,2
Fluoroimmunoassay,E,E05.200.750.551.512.240.655,Fluorescent Antibody Technique,Immunohistochemistry,2
Fluoroimmunoassay,E,E05.200.500.607.512.240.655,Fluorescent Antibody Technique,Immunohistochemistry,2
Fluoroimmunoassay,E,E01.370.225.750.551.512.240.655,Fluorescent Antibody Technique,Immunohistochemistry,2
Fluoroimmunoassay,E,E01.370.225.500.607.512.240.655,Fluorescent Antibody Technique,Immunohistochemistry,2
Fluorometry,E,E05.196.712.516.600,Luminescent Measurements,Photometry,2
"Fluorosis, Dental",C,C07.793.330,Tooth Diseases,Stomatognathic Diseases,2
Folklore,I,I01.076.201.450.515,Culture,"Anthropology, Cultural",2
Folklore,K,K01.517.455,Literature,Humanities,2
Follicular Phase,G,G08.686.605.310,Menstrual Cycle,Reproductive Physiological Phenomena,2
Folliculitis,C,C17.800.329.500,Hair Diseases,Skin Diseases,2
Food Additives,D,D27.720.372.300,Food Ingredients,Specialty Uses of Chemicals,2
Food Additives,G,G07.203.300.514.500,Food Ingredients,Food,2
Food Additives,J,J02.500.514.500,Food Ingredients,Food,2
Food Parasitology,J,J01.576.423.850.730.500.249.650,Food Contamination,Food Safety,2
Food Parasitology,H,H01.158.273.688.500,Parasitology,Biology,2
Food Parasitology,N,N06.850.460.400.650,Food Contamination,Environmental Pollution,2
Food Parasitology,N,N06.850.601.500.249.650,Food Contamination,Food Safety,2
Food Storage,J,J01.576.423.200.387,Food Handling,Food Industry,2
"Food, Genetically Modified",J,J02.500.518,Food,Food and Beverages,2
"Food, Genetically Modified",G,G07.203.300.518,Food,"Diet, Food, and Nutrition",2
"Food, Preserved",G,G07.203.300.521,Food,"Diet, Food, and Nutrition",2
"Food, Preserved",J,J02.500.521,Food,Food and Beverages,2
"Foods, Specialized",J,J02.500.525,Food,Food and Beverages,2
"Foods, Specialized",G,G07.203.300.525,Food,"Diet, Food, and Nutrition",2
Foreign-Body Reaction,C,C23.550.470.251,Inflammation,Pathologic Processes,2
Foreign-Body Reaction,C,C26.392.560,Foreign Bodies,Wounds and Injuries,2
Forensic Medicine,H,H02.403.330,Medicine,Health Occupations,2
Forensic Medicine,I,I01.198.780.937,Forensic Sciences,Criminology,2
Formates,D,D02.241.081.420,"Acids, Acyclic",Carboxylic Acids,2
Formularies as Topic,L,L01.178.682.192.836.535,Reference Books,Books,2
"Formularies, Hospital as Topic",L,L01.178.682.192.836.535.561,Formularies as Topic,Reference Books,2
Foscarnet,D,D02.241.081.018.677.250,Phosphonoacetic Acid,Acetates,2
Foscarnet,D,D02.705.429.875.500,Phosphonoacetic Acid,Organophosphonates,2
Fovea Centralis,A,A09.371.729.522.436,Macula Lutea,Retina,2
Freeze Fracturing,E,E01.370.225.500.620.620.260,Replica Techniques,Histocytological Preparation Techniques,2
Freeze Fracturing,E,E01.370.225.750.600.620.260,Replica Techniques,Histocytological Preparation Techniques,2
Freeze Fracturing,E,E05.200.500.620.620.260,Replica Techniques,Histocytological Preparation Techniques,2
Freeze Fracturing,E,E05.200.750.600.620.260,Replica Techniques,Histocytological Preparation Techniques,2
Freund's Adjuvant,D,D20.475,Complex Mixtures,NULL,2
Frustration,F,F01.470.405,Emotions,Behavior and Behavior Mechanisms,2
Fucose,D,D09.254.488,Deoxy Sugars,Carbohydrates,2
Fucosyltransferases,D,D08.811.913.400.450.300,Hexosyltransferases,Glycosyltransferases,2
Fumarates,D,D02.241.081.337.302,Dicarboxylic Acids,"Acids, Acyclic",2
Functional Food,G,G07.203.300.572,Food,"Diet, Food, and Nutrition",2
Functional Food,J,J02.500.572,Food,Food and Beverages,2
Functional Neuroimaging,E,E05.629.875,Neuroimaging,Investigative Techniques,2
Functional Neuroimaging,E,E01.370.376.537.625,Neuroimaging,"Diagnostic Techniques, Neurological",2
Functional Neuroimaging,E,E01.370.350.578.875,Neuroimaging,Diagnostic Imaging,2
"Fusion Proteins, bcr-abl",D,D12.776.624.664.500.100,"Oncogene Proteins, Fusion",Oncogene Proteins,2
"Fusion Proteins, bcr-abl",D,D12.776.602.500.500.100,"Oncogene Proteins, Fusion",Mutant Chimeric Proteins,2
"Fusion Proteins, bcr-abl",D,D12.776.624.664.700.171.500,Proto-Oncogene Proteins c-bcr,Proto-Oncogene Proteins,2
"Fusion Proteins, bcr-abl",D,D08.811.913.696.620.682.725.500.500,Proto-Oncogene Proteins c-abl,Protein-Tyrosine Kinases,2
"Fusion Proteins, gag-pol",D,D12.776.775.330.300,"Gene Products, gag",Polyproteins,2
"Fusion Proteins, gag-pol",D,D12.776.775.360.300,"Gene Products, pol",Polyproteins,2
"Fusion Proteins, gag-pol",D,D12.776.964.900.750.500.325,"Gene Products, pol",Viral Replicase Complex Proteins,2
"Fusion Proteins, gag-pol",D,D12.776.964.775.375.325,"Gene Products, pol",Retroviridae Proteins,2
"Fusion Proteins, gag-pol",D,D12.776.964.775.350.325,"Gene Products, gag",Retroviridae Proteins,2
"Fusion Proteins, gag-pol",D,D12.776.964.970.600.850.350.325,"Gene Products, gag",Viral Core Proteins,2
"Fusion Proteins, gag-pol",D,D12.776.964.970.600.850.375.325,"Gene Products, pol",Viral Core Proteins,2
G(M1) Ganglioside,D,D09.400.410.420.025.475.390,Gangliosides,Acidic Glycosphingolipids,2
G(M1) Ganglioside,D,D10.390.470.025.475.390,Gangliosides,Acidic Glycosphingolipids,2
G(M1) Ganglioside,D,D10.570.877.360.025.475.390,Gangliosides,Acidic Glycosphingolipids,2
Galantamine,D,D03.132.052.500,Amaryllidaceae Alkaloids,Alkaloids,2
Galantamine,D,D03.633.100.079.525,Benzazepines,"Heterocyclic Compounds, 2-Ring",2
Galectin 2,D,D12.776.503.307.200,Galectins,Lectins,2
Galectin 3,D,D12.776.503.307.300,Galectins,Lectins,2
Gallbladder Diseases,C,C06.130.564,Biliary Tract Diseases,Digestive System Diseases,2
Galliformes,B,B01.050.150.900.248.350,Birds,Vertebrates,2
Game Theory,G,G17.388,Mathematical Concepts,NULL,2
Ganglionic Stimulants,D,D27.505.696.663.050.400,Autonomic Agents,Peripheral Nervous System Agents,2
Gastric Acid,A,A12.200.307.603,Gastric Juice,Bodily Secretions,2
Gastric Acidity Determination,E,E01.370.372.300,"Diagnostic Techniques, Digestive System",Diagnostic Techniques and Procedures,2
Gastric Acidity Determination,E,E01.370.225.124.300,Clinical Chemistry Tests,Clinical Laboratory Techniques,2
Gastric Acidity Determination,E,E05.200.124.300,Clinical Chemistry Tests,Clinical Laboratory Techniques,2
Gastric Bypass,E,E04.210.457.430,Gastroenterostomy,Digestive System Surgical Procedures,2
Gastric Bypass,E,E04.035.398.385,Gastroenterostomy,"Anastomosis, Surgical",2
Gastric Bypass,E,E04.062.249,Bariatric Surgery,"Surgical Procedures, Operative",2
Gastric Bypass,E,E02.650.500.062.249,Bariatric Surgery,Bariatrics,2
Gastritis,C,C06.405.748.398,Stomach Diseases,Gastrointestinal Diseases,2
Gastritis,C,C06.405.205.697,Gastroenteritis,Gastrointestinal Diseases,2
Gastrointestinal Motility,G,G10.261.360,Digestive System Physiological Phenomena,Digestive System and Oral Physiological Phenomena,2
Gastroschisis,C,C05.660.417,Musculoskeletal Abnormalities,Musculoskeletal Diseases,2
Gastroschisis,C,C23.300.707.374.500,"Hernia, Abdominal",Hernia,2
Gastroschisis,C,C16.131.621.417,Musculoskeletal Abnormalities,Congenital Abnormalities,2
Gastrostomy,E,E04.210.496,Digestive System Surgical Procedures,"Surgical Procedures, Operative",2
Gastrostomy,E,E04.579.408,Ostomy,"Surgical Procedures, Operative",2
Gender Role,F,F01.393.446.250.625,Gender Identity,"Identification, Psychological",2
Gender Role,F,F01.752.747.385.200.625,Gender Identity,"Identification, Psychological",2
Gender Role,F,F01.829.750.500,Social Norms,"Psychology, Social",2
Gene Drive Technology,E,E05.393.420.175.500,Directed Molecular Evolution,Genetic Engineering,2
"Gene Products, pol",D,D12.776.964.970.600.850.375,Viral Core Proteins,Nucleocapsid Proteins,2
"Gene Products, pol",D,D12.776.964.775.375,Retroviridae Proteins,Viral Proteins,2
"Gene Products, pol",D,D12.776.964.900.750.500,Viral Replicase Complex Proteins,Viral Nonstructural Proteins,2
"Gene Products, pol",D,D12.776.775.360,Polyproteins,Proteins,2
"Gene Products, rev",D,D12.776.664.962.186,RNA-Binding Proteins,Nucleoproteins,2
"Gene Products, rev",D,D12.776.964.925.984.385,Trans-Activators,Viral Regulatory and Accessory Proteins,2
"Gene Products, rev",D,D12.776.157.725.076,RNA-Binding Proteins,Carrier Proteins,2
"Gene Products, vif",D,D12.776.964.925.875,Viral Regulatory and Accessory Proteins,Viral Proteins,2
"Gene Products, vif",D,D12.776.964.775.468,Retroviridae Proteins,Viral Proteins,2
"Gene Rearrangement, beta-Chain T-Cell Antigen Receptor",G,G05.344.801.211,"Gene Rearrangement, T-Lymphocyte",Gene Rearrangement,2
"Gene Rearrangement, beta-Chain T-Cell Antigen Receptor",G,G12.500.287.211,"Gene Rearrangement, T-Lymphocyte",Immunogenetic Phenomena,2
"Gene Rearrangement, B-Lymphocyte",G,G12.500.274,Immunogenetic Phenomena,Immune System Phenomena,2
"Gene Rearrangement, B-Lymphocyte",G,G05.344.401,Gene Rearrangement,Genetic Phenomena,2
"Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor",G,G05.344.801.311,"Gene Rearrangement, T-Lymphocyte",Gene Rearrangement,2
"Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor",G,G12.500.287.311,"Gene Rearrangement, T-Lymphocyte",Immunogenetic Phenomena,2
"Gene Rearrangement, T-Lymphocyte",G,G12.500.287,Immunogenetic Phenomena,Immune System Phenomena,2
"Gene Rearrangement, T-Lymphocyte",G,G05.344.801,Gene Rearrangement,Genetic Phenomena,2
"Genes, Duplicate",G,G05.360.340.024.340.250,Genes,Genome Components,2
"Genes, Fungal",G,G05.360.340.024.340.364.500,"Genes, Microbial",Genes,2
"Genes, Fungal",G,G05.360.340.358.365.500,"Genome, Fungal","Genome, Microbial",2
"Genes, Fungal",G,G05.360.340.358.024.500,"Genes, Microbial","Genome, Microbial",2
"Genes, Immunoglobulin Heavy Chain",G,G05.360.340.024.340.335.300,"Genes, Immunoglobulin",Genes,2
"Genes, Lethal",G,G05.360.340.024.340.350,Genes,Genome Components,2
"Genes, Mitochondrial",G,G05.360.340.024.340.365,Genes,Genome Components,2
"Genes, Mitochondrial",G,G05.420.275.500,Extrachromosomal Inheritance,Inheritance Patterns,2
"Genes, Modifier",G,G05.360.340.024.340.370,Genes,Genome Components,2
"Genes, ras",G,G05.360.340.024.340.375.500.791.550,Proto-Oncogenes,Oncogenes,2
"Genetic Diseases, X-Linked",C,C16.320.322,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Genistein,D,D03.383.663.283.266.450.400.375,Isoflavones,Flavonoids,2
Genistein,D,D03.633.100.150.266.450.400.375,Isoflavones,Flavonoids,2
Genome Size,G,G05.360.340.037,Genome,Genetic Structures,2
"Genome, Fungal",G,G05.360.340.358.365,"Genome, Microbial",Genome,2
"Genome, Helminth",G,G05.360.340.337,Genome,Genetic Structures,2
Genomic Structural Variation,G,G05.365.795.297,"Polymorphism, Genetic",Genetic Variation,2
Germ Theory of Disease,K,K01.752.667.555,"Philosophy, Medical",Philosophy,2
Germ-Free Life,G,G06.320,Microbiological Phenomena,NULL,2
Gingivitis,C,C07.465.714.258.480,Gingival Diseases,Periodontal Diseases,2
Gingivitis,C,C01.408,Infections,NULL,2
Gliadin,D,D12.776.765.725.500.500.400,Glutens,Prolamins,2
Gliadin,D,D12.776.765.433.500.500.400,Glutens,Prolamins,2
Gliclazide,D,D02.886.590.795.475,Sulfonylurea Compounds,Sulfones,2
Gliclazide,D,D02.065.950.828.475,Sulfonylurea Compounds,Urea,2
"Glomerulonephritis, Membranoproliferative",C,C20.425,Immune System Diseases,NULL,2
"Glomerulonephritis, Membranoproliferative",C,C13.351.968.419.570.363.615,Glomerulonephritis,Nephritis,2
"Glomerulonephritis, Membranoproliferative",C,C12.777.419.570.363.615,Glomerulonephritis,Nephritis,2
"Glomerulosclerosis, Focal Segmental",C,C12.777.419.570.363.660,Glomerulonephritis,Nephritis,2
"Glomerulosclerosis, Focal Segmental",C,C13.351.968.419.570.363.640,Glomerulonephritis,Nephritis,2
Glucagon-Like Peptide-1 Receptor,D,D12.776.543.750.750.360.100.500,Glucagon-Like Peptide Receptors,"Receptors, Gastrointestinal Hormone",2
Glucagon-Like Peptide-1 Receptor,D,D12.776.543.750.695.021.500,Glucagon-Like Peptide Receptors,"Receptors, G-Protein-Coupled",2
Glucans,D,D05.750.078.562,Biopolymers,Polymers,2
Glucans,D,D09.698.365,Polysaccharides,Carbohydrates,2
Glucose Oxidase,D,D08.811.682.047.239,Alcohol Oxidoreductases,Oxidoreductases,2
Glucose Transporter Type 4,D,D12.776.157.530.937.563.937,"Glucose Transport Proteins, Facilitative",Solute Carrier Proteins,2
Glucose Transporter Type 4,D,D12.776.157.530.500.500.937,"Glucose Transport Proteins, Facilitative",Monosaccharide Transport Proteins,2
Glucose Transporter Type 4,D,D12.776.543.585.937.625.937,"Glucose Transport Proteins, Facilitative",Solute Carrier Proteins,2
Glucose Transporter Type 4,D,D12.776.543.585.500.500.937,"Glucose Transport Proteins, Facilitative",Monosaccharide Transport Proteins,2
Glucosyltransferases,D,D08.811.913.400.450.460,Hexosyltransferases,Glycosyltransferases,2
Glucuronic Acid,D,D09.811.922.162.500,Glucuronates,Uronic Acids,2
Glucuronic Acid,D,D02.241.081.844.915.162.249,Glucuronates,Uronic Acids,2
Glucuronic Acid,D,D02.241.152.811.162.500,Glucuronates,Uronic Acids,2
Glucuronic Acid,D,D02.241.511.902.915.162.500,Glucuronates,Uronic Acids,2
Glucuronides,D,D02.241.511.902.915.162.750,Glucuronates,Uronic Acids,2
Glucuronides,D,D02.241.152.811.162.750,Glucuronates,Uronic Acids,2
Glucuronides,D,D02.241.081.844.915.162.500,Glucuronates,Uronic Acids,2
Glucuronides,D,D09.811.922.162.750,Glucuronates,Uronic Acids,2
Glucuronosyltransferase,D,D08.811.913.400.450.480,Hexosyltransferases,Glycosyltransferases,2
Glutamate Dehydrogenase,D,D08.811.682.664.500.398,Amino Acid Oxidoreductases,Oxidoreductases Acting on CH-NH2 Group Donors,2
Glutamates,D,D12.125.067.625,"Amino Acids, Acidic",Amino Acids,2
Glutamates,D,D12.125.119.409,"Amino Acids, Dicarboxylic",Amino Acids,2
Glycemic Load,G,G07.203.650.660.750,Nutritive Value,Nutritional Physiological Phenomena,2
Glycemic Load,J,J01.576.423.850.730.750.750,Nutritive Value,Food Quality,2
Glycemic Load,N,N06.850.601.750.750,Nutritive Value,Food Quality,2
Glycogen Storage Disease Type I,C,C18.452.648.202.449.448,Glycogen Storage Disease,"Carbohydrate Metabolism, Inborn Errors",2
Glycogen Storage Disease Type I,C,C16.320.565.202.449.448,Glycogen Storage Disease,"Carbohydrate Metabolism, Inborn Errors",2
Glycomics,H,H01.158.273.343.350.086,Genomics,Genetics,2
Glycomics,H,H01.158.273.180.350.150,Genomics,Computational Biology,2
Glycomics,H,H01.158.201.085.320,Carbohydrate Biochemistry,Biochemistry,2
Glycomics,H,H01.181.122.508,Biochemistry,Chemistry,2
Glycosaminoglycans,D,D09.698.373,Polysaccharides,Carbohydrates,2
Glycosides,D,D09.408,Carbohydrates,NULL,2
Glycosuria,C,C18.452.394.937,Glucose Metabolism Disorders,Metabolic Diseases,2
Glycosuria,C,C13.351.968.934.363,Urination Disorders,Urologic Diseases,2
Glycosuria,C,C12.777.934.363,Urination Disorders,Urologic Diseases,2
Gordonia Bacterium,B,B03.510.024.700,Actinobacteria,Gram-Positive Bacteria,2
Gorilla gorilla,B,B01.050.150.900.649.313.988.400.112.400.375,Hominidae,Catarrhini,2
Gram-Positive Cocci,B,B03.510.400,Gram-Positive Bacteria,Bacteria,2
Granuloma Inguinale,C,C01.800.720.360,"Skin Diseases, Bacterial","Skin Diseases, Infectious",2
Granuloma Inguinale,C,C01.778.281.451,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,2
Granuloma Inguinale,C,C01.150.252.734.451,"Sexually Transmitted Diseases, Bacterial",Bacterial Infections,2
Granuloma Inguinale,C,C01.221.812.281.451,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,2
Granuloma Inguinale,C,C01.150.252.819.360,"Skin Diseases, Bacterial",Bacterial Infections,2
Granuloma Inguinale,C,C01.150.252.400.310.417,Enterobacteriaceae Infections,Gram-Negative Bacterial Infections,2
Granuloma Inguinale,C,C13.351.500.711.281.451,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,2
Granuloma Inguinale,C,C12.294.668.281.451,"Sexually Transmitted Diseases, Bacterial",Sexually Transmitted Diseases,2
Granuloma Inguinale,C,C17.800.838.765.360,"Skin Diseases, Bacterial","Skin Diseases, Infectious",2
Grassland,G,G16.500.275.157.531,Ecosystem,Environment,2
Grassland,N,N06.230.124.390,Ecosystem,Environment,2
Greek World,I,I01.076.201.450.226.800.250,Western World,Civilization,2
Group Practice,N,N04.452.758.244,Professional Practice,Organization and Administration,2
Growth Differentiation Factor 15,D,D12.644.276.954.300.915,Growth Differentiation Factors,TGF-beta Superfamily Proteins,2
Growth Differentiation Factor 15,D,D12.644.276.374.305,Cytokines,Intercellular Signaling Peptides and Proteins,2
Growth Differentiation Factor 15,D,D12.776.467.942.300.915,Growth Differentiation Factors,TGF-beta Superfamily Proteins,2
Growth Differentiation Factor 15,D,D12.776.467.374.305,Cytokines,Intercellular Signaling Peptides and Proteins,2
Growth Differentiation Factor 15,D,D23.529.942.300.915,Growth Differentiation Factors,TGF-beta Superfamily Proteins,2
Growth Differentiation Factor 15,D,D23.529.374.305,Cytokines,Intercellular Signaling Peptides and Proteins,2
Growth Hormone,D,D12.644.548.691.525.425,"Pituitary Hormones, Anterior",Pituitary Hormones,2
Growth Hormone,D,D06.472.699.631.525.425,"Pituitary Hormones, Anterior",Pituitary Hormones,2
GTPase-Activating Proteins,D,D12.644.360.325.150,GTP-Binding Protein Regulators,Intracellular Signaling Peptides and Proteins,2
GTPase-Activating Proteins,D,D12.776.476.325.150,GTP-Binding Protein Regulators,Intracellular Signaling Peptides and Proteins,2
"GTP-Binding Protein alpha Subunit, Gi2",D,D12.776.476.375.100.200.500,"GTP-Binding Protein alpha Subunits, Gi-Go",GTP-Binding Protein alpha Subunits,2
"GTP-Binding Protein alpha Subunit, Gi2",D,D12.776.543.325.100.200.500,"GTP-Binding Protein alpha Subunits, Gi-Go",GTP-Binding Protein alpha Subunits,2
"GTP-Binding Protein alpha Subunit, Gi2",D,D12.644.360.360.100.200.500,"GTP-Binding Protein alpha Subunits, Gi-Go",GTP-Binding Protein alpha Subunits,2
"GTP-Binding Protein alpha Subunit, Gi2",D,D12.776.157.325.332.100.200.500,"GTP-Binding Protein alpha Subunits, Gi-Go",GTP-Binding Protein alpha Subunits,2
"GTP-Binding Protein alpha Subunit, Gi2",D,D08.811.277.040.330.300.200.100.200.500,"GTP-Binding Protein alpha Subunits, Gi-Go",GTP-Binding Protein alpha Subunits,2
"GTP-Binding Protein alpha Subunits, Gi-Go",D,D08.811.277.040.330.300.200.100.200,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,2
"GTP-Binding Protein alpha Subunits, Gi-Go",D,D12.776.157.325.332.100.200,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,2
"GTP-Binding Protein alpha Subunits, Gi-Go",D,D12.644.360.360.100.200,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,2
"GTP-Binding Protein alpha Subunits, Gi-Go",D,D12.776.543.325.100.200,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,2
"GTP-Binding Protein alpha Subunits, Gi-Go",D,D12.776.476.375.100.200,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,2
Guanosine Diphosphate,D,D13.695.827.426.340,Guanine Nucleotides,Ribonucleotides,2
Guanosine Diphosphate,D,D13.695.667.454.340,Guanine Nucleotides,Purine Nucleotides,2
Guanosine Diphosphate,D,D03.633.100.759.646.454.340,Guanine Nucleotides,Purine Nucleotides,2
Gulf War,I,I01.880.735.950.250.657,Armed Conflicts,Warfare and Armed Conflicts,2
Gulf War,K,K01.400.504.968.400,"History, 20th Century","History, Modern 1601-",2
"Habituation, Psychophysiologic",G,G11.561.312,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,2
"Habituation, Psychophysiologic",F,F02.463.425.393,Learning,Mental Processes,2
"Habituation, Psychophysiologic",F,F02.830.422,Psychophysiology,Psychological Phenomena,2
Hair Follicle,A,A17.815.250.500,Epidermis,Skin,2
Hair Follicle,A,A17.360.710,Hair,Integumentary System,2
Hair Follicle,A,A10.272.497.500,Epidermis,Epithelium,2
Hair Preparations,D,D27.720.269.430,Cosmetics,Specialty Uses of Chemicals,2
Hallucinogens,D,D27.505.954.427.700.372,Psychotropic Drugs,Central Nervous System Agents,2
Hallucinogens,D,D27.505.696.388,Physiological Effects of Drugs,Pharmacologic Actions,2
Hand Sanitizers,D,D27.720.274.650,Disinfectants,Specialty Uses of Chemicals,2
Hand Sanitizers,D,D27.505.954.122.187.500,"Anti-Infective Agents, Local",Anti-Infective Agents,2
Hand Sanitizers,D,D27.505.954.122.425.650,Disinfectants,Anti-Infective Agents,2
Hantaan virus,B,B04.820.480.750.440.400,Hantavirus,Bunyaviridae,2
Hantavirus Pulmonary Syndrome,C,C01.925.782.147.420.380,Hantavirus Infections,Bunyaviridae Infections,2
Hantavirus Pulmonary Syndrome,C,C08.618.846.450,Respiratory Insufficiency,Respiration Disorders,2
"Harassment, Non-Sexual",F,F01.145.813.213,Social Behavior,Behavior,2
Hares,B,B01.050.150.900.649.313.968.400,Lagomorpha,Eutheria,2
Hashimoto Disease,C,C19.874.871.102.500,"Thyroiditis, Autoimmune",Thyroiditis,2
"Head Injuries, Closed",C,C26.974.382,"Wounds, Nonpenetrating",Wounds and Injuries,2
"Head Injuries, Closed",C,C26.915.300.450,Craniocerebral Trauma,"Trauma, Nervous System",2
"Head Injuries, Closed",C,C10.900.300.350,Craniocerebral Trauma,"Trauma, Nervous System",2
Health Facility Planning,N,N03.349.650.250,Regional Health Planning,Health Planning,2
Health Planning Support,N,N03.219.483.408,Financial Support,Economics,2
"Hearing Loss, Bilateral",C,C10.597.751.418.341.374,Hearing Loss,Hearing Disorders,2
"Hearing Loss, Bilateral",C,C09.218.458.341.374,Hearing Loss,Hearing Disorders,2
"Hearing Loss, Bilateral",C,C23.888.592.763.393.341.374,Hearing Loss,Hearing Disorders,2
Heart Aneurysm,C,C14.280.358,Heart Diseases,Cardiovascular Diseases,2
Heart Aneurysm,C,C14.907.055.608,Aneurysm,Vascular Diseases,2
Heart Injuries,C,C26.891.375,Thoracic Injuries,Wounds and Injuries,2
Heart Neoplasms,C,C14.280.459,Heart Diseases,Cardiovascular Diseases,2
Heart Neoplasms,C,C04.588.894.309,Thoracic Neoplasms,Neoplasms by Site,2
"Heart Septal Defects, Atrial",C,C14.280.400.560.375,Heart Septal Defects,"Heart Defects, Congenital",2
"Heart Septal Defects, Atrial",C,C14.240.400.560.375,Heart Septal Defects,"Heart Defects, Congenital",2
"Heart Septal Defects, Atrial",C,C16.131.240.400.560.375,Heart Septal Defects,"Heart Defects, Congenital",2
Heart Septum,A,A07.541.459,Heart,Cardiovascular System,2
Heart Valves,A,A07.541.510,Heart,Cardiovascular System,2
HELLP Syndrome,C,C13.703.395.186,"Hypertension, Pregnancy-Induced",Pregnancy Complications,2
"Hemagglutinin Glycoproteins, Influenza Virus",D,D12.776.964.970.880.345.500,"Hemagglutinins, Viral",Viral Envelope Proteins,2
"Hemagglutinins, Viral",D,D12.776.964.970.880.345,Viral Envelope Proteins,Viral Structural Proteins,2
"Hemagglutinins, Viral",D,D23.050.327.461,"Antigens, Viral",Antigens,2
Hemangioma,C,C04.557.645.375,"Neoplasms, Vascular Tissue",Neoplasms by Histologic Type,2
Hemangiosarcoma,C,C04.557.645.390,"Neoplasms, Vascular Tissue",Neoplasms by Histologic Type,2
Hemangiosarcoma,C,C04.557.450.795.390,Sarcoma,"Neoplasms, Connective and Soft Tissue",2
Hemochromatosis Protein,D,D23.050.705.552.100.375,Histocompatibility Antigens Class I,Histocompatibility Antigens,2
Hemochromatosis Protein,D,D23.050.301.500.100.363,Histocompatibility Antigens Class I,Histocompatibility Antigens,2
Hemochromatosis Protein,D,D12.776.543.550.439.200,Histocompatibility Antigens Class I,Membrane Glycoproteins,2
Hemochromatosis Protein,D,D12.776.395.550.489.200,Histocompatibility Antigens Class I,Membrane Glycoproteins,2
Hemocyanins,D,D12.776.093.375,Arthropod Proteins,Proteins,2
Hemocyanins,D,D12.776.556.462,Metalloproteins,Proteins,2
Hemocyanins,D,D23.767.482,"Pigments, Biological",Biological Factors,2
"Hemodialysis, Home",N,N02.421.143.524.337,Home Care Services,Community Health Services,2
"Hemodialysis, Home",E,E02.912.800.300,Renal Dialysis,Sorption Detoxification,2
"Hemodialysis, Home",E,E02.870.300.300,Renal Dialysis,Renal Replacement Therapy,2
Hemofiltration,E,E02.870.225,Renal Replacement Therapy,Therapeutics,2
Hemofiltration,E,E04.292.471,Extracorporeal Circulation,"Surgical Procedures, Operative",2
Hemoglobinometry,E,E05.200.625.410,Hematologic Tests,Clinical Laboratory Techniques,2
Hemoglobinometry,E,E01.370.225.625.410,Hematologic Tests,Clinical Laboratory Techniques,2
Hemorrhagic Stroke,C,C14.907.253.855.300,Stroke,Cerebrovascular Disorders,2
Hemorrhagic Stroke,C,C10.228.140.300.775.300,Stroke,Cerebrovascular Disorders,2
"Hemostasis, Surgical",E,E02.520.490,Hemostatic Techniques,Therapeutics,2
"Hemostasis, Surgical",E,E04.350,"Surgical Procedures, Operative",NULL,2
Henipavirus Infections,C,C01.925.782.580.600.400,Paramyxoviridae Infections,Mononegavirales Infections,2
Heparitin Sulfate,D,D09.698.373.425,Glycosaminoglycans,Polysaccharides,2
"Hepatitis A Virus, Human",B,B04.820.578.750.400.410.500,Hepatitis A virus,Hepatovirus,2
"Hepatitis A Virus, Human",B,B04.450.420.410.500,Hepatitis A virus,Hepatovirus,2
"Hepatitis, Viral, Animal",C,C01.436.430,"Hepatitis, Animal",Infections,2
"Hepatitis, Viral, Animal",C,C01.925.407,Virus Diseases,Infections,2
"Hepatitis, Viral, Animal",C,C06.552.380.315.430,"Hepatitis, Animal",Hepatitis,2
"Hepatitis, Viral, Animal",C,C22.467.435,"Hepatitis, Animal",Animal Diseases,2
Hepatoblastoma,C,C04.557.435.380,"Neoplasms, Complex and Mixed",Neoplasms by Histologic Type,2
Hepatocyte Nuclear Factor 3-beta,D,D12.776.260.262.875,Hepatocyte Nuclear Factors,DNA-Binding Proteins,2
Hepatocyte Nuclear Factor 3-beta,D,D12.776.260.950.249.750,Forkhead Transcription Factors,Winged-Helix Transcription Factors,2
Hepatocyte Nuclear Factor 3-beta,D,D12.776.660.352.875,Hepatocyte Nuclear Factors,Nuclear Proteins,2
Hepatocyte Nuclear Factor 3-beta,D,D12.776.930.977.249.750,Forkhead Transcription Factors,Winged-Helix Transcription Factors,2
Hepatocyte Nuclear Factor 3-beta,D,D12.776.930.318.875,Hepatocyte Nuclear Factors,Transcription Factors,2
Hepatovirus,B,B04.450.420,Hepatitis Viruses,Viruses,2
Hepatovirus,B,B04.820.578.750.400,Picornaviridae,Positive-Strand RNA Viruses,2
Herpes Zoster Ophthalmicus,C,C01.375.725.450,"Eye Infections, Viral",Eye Infections,2
Herpes Zoster Ophthalmicus,C,C01.925.325.450,"Eye Infections, Viral",Virus Diseases,2
Herpes Zoster Ophthalmicus,C,C01.925.256.466.930.750.466,Herpes Zoster,Varicella Zoster Virus Infection,2
Herpes Zoster Ophthalmicus,C,C11.294.800.450,"Eye Infections, Viral",Eye Infections,2
Herpestidae,B,B01.050.150.900.649.313.750.377.875,Feliformia,Carnivora,2
"Herpesvirus 7, Human",B,B04.280.382.150.750.420,Roseolovirus,Betaherpesvirinae,2
Heterocyclic Compounds,D,D03,NULL,NULL,2
Heterotrimeric GTP-Binding Proteins,D,D08.811.277.040.330.300.200,GTP-Binding Proteins,GTP Phosphohydrolases,2
Heterotrimeric GTP-Binding Proteins,D,D12.776.157.325.332,GTP-Binding Proteins,Carrier Proteins,2
Heterotrimeric GTP-Binding Proteins,D,D12.644.360.360,Intracellular Signaling Peptides and Proteins,Peptides,2
Heterotrimeric GTP-Binding Proteins,D,D12.776.543.325,Membrane Proteins,Proteins,2
Heterotrimeric GTP-Binding Proteins,D,D12.776.476.375,Intracellular Signaling Peptides and Proteins,Proteins,2
Hexachlorobenzene,D,D02.455.526.439.202.400,Chlorobenzenes,"Hydrocarbons, Chlorinated",2
Hexachlorobenzene,D,D02.455.426.559.389.261.400,Chlorobenzenes,Benzene Derivatives,2
High-Frequency Ventilation,E,E02.041.625.508,"Respiration, Artificial",Airway Management,2
High-Frequency Ventilation,E,E02.880.820.508,"Respiration, Artificial",Respiratory Therapy,2
Hip,A,A01.378.610.400,Lower Extremity,Extremities,2
Hispanic Americans,M,M01.686.754.441,Ethnic Groups,Population Groups,2
Histocompatibility Antigen H-2D,D,D23.050.301.500.100.375,Histocompatibility Antigens Class I,Histocompatibility Antigens,2
Histological Techniques,E,E01.370.225.750,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,2
Histological Techniques,E,E05.200.750,Clinical Laboratory Techniques,Investigative Techniques,2
Histology,H,H01.158.100.656,Anatomy,Biological Science Disciplines,2
Histone Code,G,G02.111.570.060.360,Amino Acid Sequence,Molecular Structure,2
Histone Code,G,G05.360.360,Genetic Structures,Genetic Phenomena,2
Histone Deacetylase 1,D,D08.811.600.620.100,Mi-2 Nucleosome Remodeling and Deacetylase Complex,Multienzyme Complexes,2
Histone Deacetylase 1,D,D08.811.600.795.100,Sin3 Histone Deacetylase and Corepressor Complex,Multienzyme Complexes,2
Histone Deacetylase 1,D,D08.811.277.087.520.500.100,Mi-2 Nucleosome Remodeling and Deacetylase Complex,Histone Deacetylases,2
Histone Deacetylase 1,D,D08.811.277.087.520.750.100,Sin3 Histone Deacetylase and Corepressor Complex,Histone Deacetylases,2
Histone Deacetylase 2,D,D08.811.277.087.520.750.200,Sin3 Histone Deacetylase and Corepressor Complex,Histone Deacetylases,2
Histone Deacetylase 2,D,D08.811.277.087.520.500.200,Mi-2 Nucleosome Remodeling and Deacetylase Complex,Histone Deacetylases,2
Histone Deacetylase 2,D,D08.811.600.795.200,Sin3 Histone Deacetylase and Corepressor Complex,Multienzyme Complexes,2
Histone Deacetylase 2,D,D08.811.600.620.200,Mi-2 Nucleosome Remodeling and Deacetylase Complex,Multienzyme Complexes,2
History of Nursing,K,K01.400.608,History,Humanities,2
HIV Envelope Protein gp160,D,D12.776.964.970.880.325.164.374,"env Gene Products, Human Immunodeficiency Virus","Gene Products, env",2
HIV Envelope Protein gp160,D,D12.776.964.775.325.164.374,"env Gene Products, Human Immunodeficiency Virus","Gene Products, env",2
HIV Envelope Protein gp160,D,D12.776.964.775.562.500.750,"env Gene Products, Human Immunodeficiency Virus",Human Immunodeficiency Virus Proteins,2
HIV Integrase,D,D12.776.964.775.562.764.500,"pol Gene Products, Human Immunodeficiency Virus",Human Immunodeficiency Virus Proteins,2
HIV Integrase,D,D12.776.964.900.750.500.545.500,"pol Gene Products, Human Immunodeficiency Virus","Gene Products, pol",2
HIV Integrase,D,D12.776.964.775.375.545.500,"pol Gene Products, Human Immunodeficiency Virus","Gene Products, pol",2
HIV Integrase,D,D12.776.964.970.600.850.375.545.500,"pol Gene Products, Human Immunodeficiency Virus","Gene Products, pol",2
HIV Integrase,D,D08.811.739.500.667.500,Transposases,Integrases,2
HIV Integrase,D,D08.811.913.696.445.825.500,Transposases,Nucleotidyltransferases,2
HLA-DR3 Antigen,D,D12.776.395.550.509.400.440.400.030,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DR3 Antigen,D,D12.776.543.550.440.400.440.400.030,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DR3 Antigen,D,D23.050.705.552.450.400.440.389.875,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DR3 Antigen,D,D23.050.705.552.410.400.440.389.030,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DR3 Antigen,D,D23.050.301.500.450.400.440.389.875,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DR3 Antigen,D,D23.050.301.500.400.400.440.400.030,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DR4 Antigen,D,D23.050.301.500.400.400.440.400.040,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DR4 Antigen,D,D23.050.301.500.450.400.440.389.937,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DR4 Antigen,D,D23.050.705.552.410.400.440.389.040,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DR4 Antigen,D,D23.050.705.552.450.400.440.389.937,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DR4 Antigen,D,D12.776.543.550.440.400.440.400.040,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DR4 Antigen,D,D12.776.395.550.509.400.440.400.040,HLA-DR Serological Subtypes,HLA-DR Antigens,2
HLA-DRB3 Chains,D,D12.776.395.550.509.400.440.200.030,HLA-DR beta-Chains,HLA-DR Antigens,2
HLA-DRB3 Chains,D,D12.776.543.550.440.400.440.200.030,HLA-DR beta-Chains,HLA-DR Antigens,2
HLA-DRB3 Chains,D,D23.050.705.552.450.400.440.333.750,HLA-DR beta-Chains,HLA-DR Antigens,2
HLA-DRB3 Chains,D,D23.050.705.552.410.400.440.200.030,HLA-DR beta-Chains,HLA-DR Antigens,2
HLA-DRB3 Chains,D,D23.050.301.500.450.400.440.333.750,HLA-DR beta-Chains,HLA-DR Antigens,2
HLA-DRB3 Chains,D,D23.050.301.500.400.400.440.200.030,HLA-DR beta-Chains,HLA-DR Antigens,2
HMGA2 Protein,D,D12.776.660.235.400.500.600,HMGA Proteins,High Mobility Group Proteins,2
HMGA2 Protein,D,D12.776.664.235.400.500.600,HMGA Proteins,High Mobility Group Proteins,2
HMGA2 Protein,D,D12.776.260.312.937,HMGA Proteins,DNA-Binding Proteins,2
Hobbies,I,I03.450.642.469,Recreation,Leisure Activities,2
Homocystinuria,C,C10.228.140.163.100.365,"Brain Diseases, Metabolic, Inborn","Brain Diseases, Metabolic",2
Homocystinuria,C,C16.320.565.189.365,"Brain Diseases, Metabolic, Inborn","Metabolism, Inborn Errors",2
Homocystinuria,C,C16.320.565.100.480.500,Hyperhomocysteinemia,"Amino Acid Metabolism, Inborn Errors",2
Homocystinuria,C,C18.452.132.100.365,"Brain Diseases, Metabolic, Inborn","Brain Diseases, Metabolic",2
Homocystinuria,C,C18.452.648.100.480.500,Hyperhomocysteinemia,"Amino Acid Metabolism, Inborn Errors",2
Homocystinuria,C,C18.452.648.189.365,"Brain Diseases, Metabolic, Inborn","Metabolism, Inborn Errors",2
Homocystinuria,C,C17.300.428,Connective Tissue Diseases,Skin and Connective Tissue Diseases,2
Homologous Recombination,G,G05.728.615,"Recombination, Genetic",Genetic Phenomena,2
Homoserine,D,D12.125.526,Amino Acids,"Amino Acids, Peptides, and Proteins",2
Homovanillic Acid,D,D02.241.223.601.521,Phenylacetates,"Acids, Carbocyclic",2
Hospital-Patient Relations,N,N02.278.216.500.992,Hospital Administration,Health Facility Administration,2
Hospital-Patient Relations,N,N04.452.822.370,Public Relations,Organization and Administration,2
Hospital-Physician Joint Ventures,N,N04.452.442.452.550.380,Hospital Restructuring,Hospital Administration,2
Hospital-Physician Joint Ventures,N,N02.278.216.500.988.380,Hospital Restructuring,Hospital Administration,2
Hospital-Physician Relations,N,N02.278.216.500.996,Hospital Administration,Health Facility Administration,2
Hospital-Physician Relations,N,N04.452.442.452.530,Hospital Administration,Health Facility Administration,2
Hospital-Physician Relations,N,N04.452.822.379,Public Relations,Organization and Administration,2
Hospital-Physician Relations,N,N04.452.758.275,Professional Practice,Organization and Administration,2
"Hospitals, Municipal",N,N02.278.421.510.210,"Hospitals, Public",Hospitals,2
"Hospitals, Municipal",N,N02.278.421.660.400,"Hospitals, Urban",Hospitals,2
"Hospitals, Proprietary",N,N02.278.421.481.500,"Hospitals, Private",Hospitals,2
"Hospitals, Proprietary",N,N02.278.215.110,"Health Facilities, Proprietary",Health Facilities,2
"Hospitals, Religious",N,N02.278.421.481.600,"Hospitals, Private",Hospitals,2
Human papillomavirus 31,B,B04.280.210.655.050.616.500,Human papillomavirus 16,Alphapapillomavirus,2
Human papillomavirus 31,B,B04.613.204.655.050.616.500,Human papillomavirus 16,Alphapapillomavirus,2
Human-Animal Bond,F,F01.145.496.500,Human-Animal Interaction,Behavior,2
Humanism,N,N05.350.835,Ethics,"Health Care Quality, Access, and Evaluation",2
Humanism,K,K01.752.566.479.174,Ethics,Morals,2
Humanities,K,K01,NULL,NULL,2
Humerus,A,A02.835.232.087.090.400,Arm Bones,Bones of Upper Extremity,2
Hybridomas,A,A11.251.600.485,Hybrid Cells,"Cells, Cultured",2
Hybridomas,A,A11.251.353.485,Clone Cells,"Cells, Cultured",2
Hydatidiform Mole,C,C04.557.465.955.416.812,Gestational Trophoblastic Disease,Trophoblastic Neoplasms,2
Hydatidiform Mole,C,C04.850.908.416.750,Gestational Trophoblastic Disease,Trophoblastic Neoplasms,2
Hydatidiform Mole,C,C13.703.720.949.416.875,Gestational Trophoblastic Disease,Trophoblastic Neoplasms,2
"Hydrogel, Polyethylene Glycol Dimethacrylate",D,D02.033.455.250.700.485,Polyethylene Glycols,Ethylene Glycols,2
"Hydrogel, Polyethylene Glycol Dimethacrylate",D,D05.750.741.485,Polyethylene Glycols,Polymers,2
"Hydrogel, Polyethylene Glycol Dimethacrylate",D,D05.750.219.500,Nanogels,Polymers,2
"Hydrogel, Polyethylene Glycol Dimethacrylate",D,D20.280.320.609.500,Nanogels,Gels,2
"Hydrogel, Polyethylene Glycol Dimethacrylate",D,D25.720.741.485,Polyethylene Glycols,Polymers,2
"Hydrogel, Polyethylene Glycol Dimethacrylate",D,D25.720.532.500,Nanogels,Polymers,2
"Hydrogel, Polyethylene Glycol Dimethacrylate",D,D26.255.165.320.375.375,Hydrogels,Gels,2
"Hydrogel, Polyethylene Glycol Dimethacrylate",J,J01.637.051.720.741.485,Polyethylene Glycols,Polymers,2
"Hydrogel, Polyethylene Glycol Dimethacrylate",J,J01.637.051.720.584.500,Nanogels,Polymers,2
Hydrogen Sulfide,D,D01.875.350,Sulfur Compounds,Inorganic Chemicals,2
Hydrogen Sulfide,D,D01.362.350,Gases,Inorganic Chemicals,2
Hydrogen Sulfide,D,D01.029.260.340,"Acids, Noncarboxylic",Acids,2
Hydrophthalmos,C,C16.614.438,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Hydrophthalmos,C,C16.131.384.480,Eye Abnormalities,Congenital Abnormalities,2
Hydrophthalmos,C,C11.250.480,Eye Abnormalities,Eye Diseases,2
Hydrophthalmos,C,C11.525.381.407.480,"Glaucoma, Open-Angle",Glaucoma,2
Hydrops Fetalis,C,C16.300.060.480,"Erythroblastosis, Fetal",Fetal Diseases,2
Hydrops Fetalis,C,C16.320.365.826.100.350,alpha-Thalassemia,Thalassemia,2
Hydrops Fetalis,C,C13.703.277.060.480,"Erythroblastosis, Fetal",Fetal Diseases,2
Hydrops Fetalis,C,C15.378.295.480,"Erythroblastosis, Fetal",Hematologic Diseases,2
Hydrops Fetalis,C,C15.378.420.826.100.350,alpha-Thalassemia,Thalassemia,2
Hydrops Fetalis,C,C23.888.277.395,Edema,Signs and Symptoms,2
Hydrops Fetalis,C,C20.306.480,"Erythroblastosis, Fetal",Immune System Diseases,2
Hydroxyindoleacetic Acid,D,D03.066.288.478,Indoleacetic Acids,"Acids, Heterocyclic",2
Hydroxyindoleacetic Acid,D,D03.633.100.473.404.478,Indoleacetic Acids,Indoles,2
Hydroxylamines,D,D02.092.570,Amines,Organic Chemicals,2
Hydroxylation,G,G02.111.385,Biochemical Phenomena,Chemical Phenomena,2
Hydroxylation,G,G03.425,Metabolism,NULL,2
Hydroxylation,G,G02.607.348,Organic Chemistry Phenomena,Chemical Phenomena,2
Hyperbilirubinemia,C,C23.550.429,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",2
"Hyperbilirubinemia, Neonatal",C,C23.550.429.249,Hyperbilirubinemia,Pathologic Processes,2
"Hyperbilirubinemia, Neonatal",C,C16.614.451,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Hyperkinesis,C,C10.597.350.350,Dyskinesias,Neurologic Manifestations,2
Hyperkinesis,C,C23.888.592.350.350,Dyskinesias,Neurologic Manifestations,2
Hyperphosphatemia,C,C18.452.750.199,Phosphorus Metabolism Disorders,Metabolic Diseases,2
"Hypertension, Renal",C,C12.777.419.331,Kidney Diseases,Urologic Diseases,2
"Hypertension, Renal",C,C14.907.489.631,Hypertension,Vascular Diseases,2
"Hypertension, Renal",C,C13.351.968.419.331,Kidney Diseases,Urologic Diseases,2
Hypertonic Solutions,D,D26.776.314,Solutions,Pharmaceutical Preparations,2
Hyphae,A,A19.687.400,Mycelium,Fungal Structures,2
Hypoalbuminemia,C,C15.378.147.607.500,Hypoproteinemia,Blood Protein Disorders,2
Hypochondriasis,F,F03.875.450,Somatoform Disorders,Mental Disorders,2
Hypopharyngeal Neoplasms,C,C09.647.710.485,Pharyngeal Neoplasms,Otorhinolaryngologic Neoplasms,2
Hypopharyngeal Neoplasms,C,C09.775.549.485,Pharyngeal Neoplasms,Pharyngeal Diseases,2
Hypopharyngeal Neoplasms,C,C04.588.443.665.710.485,Pharyngeal Neoplasms,Otorhinolaryngologic Neoplasms,2
Hypopharyngeal Neoplasms,C,C07.550.745.436,Pharyngeal Neoplasms,Pharyngeal Diseases,2
Hypophosphatemia,C,C18.452.750.400,Phosphorus Metabolism Disorders,Metabolic Diseases,2
"Hypotension, Orthostatic",C,C10.177.575.600.450,Orthostatic Intolerance,Primary Dysautonomias,2
"Hypotension, Orthostatic",C,C14.907.514.482,Hypotension,Vascular Diseases,2
Hypothalamus,A,A08.186.211.180.497,Limbic System,Brain,2
Hypothalamus,A,A08.186.211.200.317.357,Diencephalon,Prosencephalon,2
Hypoxanthine Phosphoribosyltransferase,D,D08.811.913.400.725.450,Pentosyltransferases,Glycosyltransferases,2
"Hypoxia, Brain",C,C10.228.140.624,Brain Diseases,Central Nervous System Diseases,2
"Hypoxia, Brain",C,C23.888.852.079.797,Hypoxia,"Signs and Symptoms, Respiratory",2
Hysteria,F,F03.675.400.500,Histrionic Personality Disorder,Personality Disorders,2
Hysteroscopy,E,E04.950.300.539,Gynecologic Surgical Procedures,Urogenital Surgical Procedures,2
Hysteroscopy,E,E04.520.360,Obstetric Surgical Procedures,"Surgical Procedures, Operative",2
Hysteroscopy,E,E04.502.250.360,Endoscopy,Minimally Invasive Surgical Procedures,2
Hysteroscopy,E,E01.370.378.330,"Diagnostic Techniques, Obstetrical and Gynecological",Diagnostic Techniques and Procedures,2
Hysteroscopy,E,E01.370.388.250.360,Endoscopy,"Diagnostic Techniques, Surgical",2
I-kappa B Kinase,D,D12.776.476.378,Intracellular Signaling Peptides and Proteins,Proteins,2
I-kappa B Kinase,D,D12.644.360.361,Intracellular Signaling Peptides and Proteins,Peptides,2
I-kappa B Kinase,D,D08.811.913.696.620.682.700.494,Protein-Serine-Threonine Kinases,Protein Kinases,2
Imiquimod,D,D03.633.100.810.050.545,Aminoquinolines,Quinolines,2
Immune System Diseases,C,C20,NULL,NULL,2
Immunoglobulin Fc Fragments,D,D12.644.541.500.697,Immunoglobulin Fragments,Peptide Fragments,2
Immunoglobulin Fc Fragments,D,D12.776.377.715.548.680.660,Immunoglobulin Fragments,Immunoglobulins,2
Immunoglobulin Fc Fragments,D,D12.776.377.715.548.538.500,Immunoglobulin Constant Regions,Immunoglobulins,2
Immunoglobulin Fc Fragments,D,D12.776.124.790.651.680.660,Immunoglobulin Fragments,Immunoglobulins,2
Immunoglobulin Fc Fragments,D,D12.776.124.790.651.538.500,Immunoglobulin Constant Regions,Immunoglobulins,2
Immunoglobulin Fc Fragments,D,D12.776.124.486.485.680.697,Immunoglobulin Fragments,Immunoglobulins,2
Immunoglobulin Fc Fragments,D,D12.776.124.486.485.538.500,Immunoglobulin Constant Regions,Immunoglobulins,2
Immunoglobulin Fragments,D,D12.776.124.486.485.680,Immunoglobulins,Immunoproteins,2
Immunoglobulin Fragments,D,D12.776.124.790.651.680,Immunoglobulins,Serum Globulins,2
Immunoglobulin Fragments,D,D12.776.377.715.548.680,Immunoglobulins,Serum Globulins,2
Immunoglobulin Fragments,D,D12.644.541.500,Peptide Fragments,Peptides,2
Immunoglobulin Light Chains,D,D12.776.377.715.548.705.750,Immunoglobulin Subunits,Immunoglobulins,2
Immunoglobulin Light Chains,D,D12.776.124.790.651.705.750,Immunoglobulin Subunits,Immunoglobulins,2
Immunoglobulin Light Chains,D,D12.776.124.486.485.705.750,Immunoglobulin Subunits,Immunoglobulins,2
"Immunoglobulins, Thyroid-Stimulating",D,D12.776.124.486.485.114.323.480,Autoantibodies,Antibodies,2
"Immunoglobulins, Thyroid-Stimulating",D,D12.776.124.790.651.114.323.480,Autoantibodies,Antibodies,2
"Immunoglobulins, Thyroid-Stimulating",D,D12.776.377.715.548.114.323.480,Autoantibodies,Antibodies,2
Immunosuppression,E,E02.095.465.425.450,Immunotherapy,Immunomodulation,2
Immunosuppression,E,E05.478.610,Immunologic Techniques,Investigative Techniques,2
Impulsive Behavior,F,F01.145.527,Behavior,Behavior and Behavior Mechanisms,2
In Situ Nick-End Labeling,E,E05.393.475,Genetic Techniques,Investigative Techniques,2
"Inactivation, Metabolic",G,G03.171.450,Biotransformation,Metabolism,2
"Inactivation, Metabolic",G,G03.787.225.450,Biotransformation,Pharmacokinetics,2
"Inactivation, Metabolic",G,G07.690.725.225.450,Biotransformation,Pharmacokinetics,2
Inbreeding,G,G05.090.403,Breeding,Genetic Phenomena,2
Inbreeding,E,E05.820.150.520,Breeding,Reproductive Techniques,2
Indazoles,D,D03.633.100.449,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",2
Indazoles,D,D03.383.129.539.487,Pyrazoles,Azoles,2
Independent Practice Associations,N,N04.590.374.410.450,Managed Care Programs,Delivery of Health Care,2
Independent Practice Associations,N,N04.452.758.745.450,Private Practice,Professional Practice,2
Independent Practice Associations,N,N04.452.758.244.450,Group Practice,Professional Practice,2
Independent Practice Associations,N,N03.219.521.576.343.800.450,Managed Care Programs,"Insurance, Health",2
Indium Radioisotopes,D,D01.496.749.460,Radioisotopes,Isotopes,2
Indole Alkaloids,D,D03.132.436,Alkaloids,Heterocyclic Compounds,2
Indole Alkaloids,D,D03.633.100.473.402,Indoles,"Heterocyclic Compounds, 2-Ring",2
Indole Alkaloids,D,D03.633.100.496.500.500,Indolizidines,Indolizines,2
"Indoleamine-Pyrrole 2,3,-Dioxygenase",D,D08.811.682.690.416.333,Dioxygenases,Oxygenases,2
Indolizines,D,D03.633.100.496,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",2
Inducible T-Cell Co-Stimulator Protein,D,D23.101.100.894.580,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",2
Inducible T-Cell Co-Stimulator Protein,D,D12.776.543.750.705.222.812,Costimulatory and Inhibitory T-Cell Receptors,"Receptors, Immunologic",2
Inducible T-Cell Co-Stimulator Protein,D,D23.050.301.264.894.580,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",2
Infanticide,I,I01.198.240.470.572,Homicide,Crime,2
"Inflation, Economic",N,N03.219.680,Economics,Health Care Economics and Organizations,2
"Influenza A Virus, H3N8 Subtype",B,B04.820.480.968.405.400.350,Influenza A virus,Influenzavirus A,2
"Influenza A Virus, H5N2 Subtype",B,B04.820.480.968.405.400.505,Influenza A virus,Influenzavirus A,2
"Influenza A Virus, H9N2 Subtype",B,B04.820.480.968.405.400.900,Influenza A virus,Influenzavirus A,2
"Influenza Pandemic, 1918-1919",K,K01.400.504.968.450,"History, 20th Century","History, Modern 1601-",2
Influenzavirus C,B,B04.820.480.968.410,Orthomyxoviridae,Negative-Sense RNA Viruses,2
Information Centers,J,J03.400,Non-Medical Public and Private Facilities,NULL,2
Information Centers,L,L01.346,Information Science,NULL,2
Informed Consent By Minors,N,N03.706.437.650.312.500,Informed Consent,Patient Rights,2
Informed Consent By Minors,N,N03.706.535.489.384,Informed Consent,Jurisprudence,2
Informed Consent By Minors,I,I01.880.604.583.427.384,Informed Consent,Jurisprudence,2
Informed Consent By Minors,I,I01.880.604.473.650.718.500,Informed Consent,Patient Rights,2
Infusion Pumps,E,E07.505,Equipment and Supplies,NULL,2
Infusion Pumps,E,E07.858.082.505,Artificial Organs,Surgical Equipment,2
"Infusions, Intraosseous",E,E02.319.267.510.560,"Infusions, Parenteral",Drug Administration Routes,2
"Inhibition, Psychological",F,F01.145.544,Behavior,Behavior and Behavior Mechanisms,2
"Inhibition, Psychological",F,F02.739.794.405,Psychoanalytic Theory,Psychological Theory,2
"Inhibition, Psychological",F,F02.463.425.475,Learning,Mental Processes,2
Inorganic Chemicals,D,D01,NULL,NULL,2
Institutional Management Teams,N,N04.452.460,Organization and Administration,Health Services Administration,2
Insulin Glargine,D,D06.472.699.587.200.300.100,"Insulin, Long-Acting",Insulins,2
Insulin Glargine,D,D12.644.548.586.200.300.100,"Insulin, Long-Acting",Insulins,2
Insulin-Like Growth Factor Binding Protein 2,D,D12.776.157.420.260,Insulin-Like Growth Factor Binding Proteins,Carrier Proteins,2
Insurance,N,N03.219.521.576,"Financing, Organized",Economics,2
Insurance Claim Reporting,N,N03.219.521.576.210,Insurance,"Financing, Organized",2
Insurance Pools,N,N03.219.521.576.570,Insurance,"Financing, Organized",2
"Insurance, Hospitalization",N,N03.219.521.576.343.492,"Insurance, Health",Insurance,2
Intercalating Agents,D,D27.720.470.410.360,Indicators and Reagents,Laboratory Chemicals,2
Interferon Regulatory Factor-1,D,D12.776.930.332.124,Interferon Regulatory Factors,Transcription Factors,2
Interferon Regulatory Factor-1,D,D12.776.930.127.374,Basic-Leucine Zipper Transcription Factors,Transcription Factors,2
Interferon Regulatory Factor-1,D,D12.776.476.024.385.124,Interferon Regulatory Factors,"Adaptor Proteins, Signal Transducing",2
Interferon Regulatory Factor-1,D,D12.776.157.057.050.124,Interferon Regulatory Factors,"Adaptor Proteins, Signal Transducing",2
Interferon Regulatory Factor-1,D,D12.776.260.108.374,Basic-Leucine Zipper Transcription Factors,DNA-Binding Proteins,2
Interferon Regulatory Factor-1,D,D12.776.260.504.124,Interferon Regulatory Factors,DNA-Binding Proteins,2
Interferon Regulatory Factor-1,D,D12.644.360.024.302.124,Interferon Regulatory Factors,"Adaptor Proteins, Signal Transducing",2
Interleukin-18 Receptor alpha Subunit,D,D12.776.543.750.705.852.420.830.500,"Receptors, Interleukin-18","Receptors, Interleukin",2
Interleukin-5 Receptor alpha Subunit,D,D12.776.543.750.705.852.420.380.750,"Receptors, Interleukin-5","Receptors, Interleukin",2
Interneurons,A,A08.675.358,Neurons,Nervous System,2
Interneurons,A,A11.671.358,Neurons,Cells,2
Intradermal Tests,E,E01.370.225.812.871.300,Skin Tests,Immunologic Tests,2
Intradermal Tests,E,E05.478.594.890.300,Skin Tests,Immunologic Tests,2
Intradermal Tests,E,E05.200.812.871.300,Skin Tests,Immunologic Tests,2
Intraoperative Care,E,E04.604.249,Perioperative Care,"Surgical Procedures, Operative",2
Intraoperative Care,E,E02.760.731.400,Perioperative Care,Patient Care,2
Intraoperative Care,N,N02.421.585.722.400,Perioperative Care,Patient Care,2
"Introversion, Psychological",F,F01.752.747.511,Personality Development,Personality,2
"Introversion, Psychological",F,F02.739.794.438,Psychoanalytic Theory,Psychological Theory,2
"Intubation, Gastrointestinal",E,E05.497.412,Intubation,Investigative Techniques,2
"Intubation, Gastrointestinal",E,E02.585.412,Intubation,Therapeutics,2
Intuition,F,F02.463.188.675,Cognition,Mental Processes,2
Invasive Fungal Infections,C,C01.150.703.492,Mycoses,Bacterial Infections and Mycoses,2
Iodides,D,D01.248.497.158.490,Anions,Ions,2
Iodides,D,D01.475.410,Iodine Compounds,Inorganic Chemicals,2
Ionophores,D,D27.720.395,Specialty Uses of Chemicals,Chemical Actions and Uses,2
Ionophores,D,D27.505.519.562.374,Membrane Transport Modulators,Molecular Mechanisms of Pharmacological Action,2
Ipilimumab,D,D12.776.377.715.548.114.224.200.798,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Ipilimumab,D,D12.776.124.790.651.114.224.060.798,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Ipilimumab,D,D12.776.124.486.485.114.224.060.798,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Ipratropium,D,D03.605.869.229.400,Atropine Derivatives,Tropanes,2
Ipratropium,D,D03.605.084.500.722.229.400,Atropine Derivatives,Tropanes,2
Ipratropium,D,D03.132.760.180.572.400,Atropine Derivatives,Belladonna Alkaloids,2
Ipratropium,D,D03.132.889.180.648.400,Atropine Derivatives,Belladonna Alkaloids,2
Ipratropium,D,D02.145.074.722.229.400,Atropine Derivatives,Tropanes,2
Irbesartan,D,D02.455.426.559.389.185.413,Biphenyl Compounds,Benzene Derivatives,2
Irbesartan,D,D03.383.129.617.351,Tetrazoles,Azoles,2
Irbesartan,D,D02.455.426.779.431,Spiro Compounds,"Hydrocarbons, Cyclic",2
Irbesartan,D,D04.711.431,Spiro Compounds,Polycyclic Compounds,2
Iritis,C,C11.941.375.385,Iris Diseases,Uveal Diseases,2
Iritis,C,C11.941.879.780.880.448,"Uveitis, Anterior",Panuveitis,2
Isoantigens,D,D23.050.705,Antigens,Biological Factors,2
Isoleucine,D,D12.125.142.383,"Amino Acids, Essential",Amino Acids,2
Isoleucine,D,D12.125.070.577,"Amino Acids, Branched-Chain",Amino Acids,2
Jails,J,J03.220.250,Correctional Facilities,Non-Medical Public and Private Facilities,2
JC Virus,B,B04.613.204.670.615.400,Polyomavirus,Polyomaviridae,2
JC Virus,B,B04.280.210.700.615.400,Polyomavirus,Polyomaviridae,2
Jejunum,A,A03.556.124.684.500,"Intestine, Small",Intestines,2
Jejunum,A,A03.556.249.750,Lower Gastrointestinal Tract,Gastrointestinal Tract,2
Joint Prosthesis,E,E07.695.400,Prostheses and Implants,Equipment and Supplies,2
Joints,A,A02.835.583,Skeleton,Musculoskeletal System,2
Journalism,L,L01.737.498,Publishing,Information Science,2
Judicial Role,I,I01.880.604.583.474,Jurisprudence,"Social Control, Formal",2
Kanamycin Kinase,D,D08.811.913.696.620.475,Phosphotransferases (Alcohol Group Acceptor),Phosphotransferases,2
Kansas,Z,Z01.107.567.875.510.390,Midwestern United States,United States,2
Karyopherins,D,D12.776.157.530.750.500,Nucleocytoplasmic Transport Proteins,Membrane Transport Proteins,2
Karyopherins,D,D12.776.543.585.750.500,Nucleocytoplasmic Transport Proteins,Membrane Transport Proteins,2
Karyopherins,D,D12.776.660.502,Nuclear Proteins,Proteins,2
KCNQ1 Potassium Channel,D,D12.776.543.550.450.750.900.124.249.500,KCNQ Potassium Channels,Delayed Rectifier Potassium Channels,2
KCNQ1 Potassium Channel,D,D12.776.543.585.400.750.900.124.249.500,KCNQ Potassium Channels,Delayed Rectifier Potassium Channels,2
KCNQ1 Potassium Channel,D,D12.776.157.530.400.600.900.124.249.500,KCNQ Potassium Channels,Delayed Rectifier Potassium Channels,2
Kelch Repeat,G,G02.111.570.820.709.275.875.273,"Repetitive Sequences, Amino Acid",Protein Structural Elements,2
Kelch Repeat,G,G02.111.570.820.709.275.750.500.448,Protein Interaction Domains and Motifs,Protein Domains,2
Kelch Repeat,G,G02.111.570.820.709.275.500.500,Amino Acid Motifs,Protein Structural Elements,2
Kelch Repeat,G,G02.111.570.060.720.273,"Repetitive Sequences, Amino Acid",Amino Acid Sequence,2
"Keratitis, Dendritic",C,C01.375.725.465.450,"Keratitis, Herpetic","Eye Infections, Viral",2
"Keratitis, Dendritic",C,C01.925.256.466.382.465.450,"Keratitis, Herpetic",Herpes Simplex,2
"Keratitis, Dendritic",C,C01.925.325.465.450,"Keratitis, Herpetic","Eye Infections, Viral",2
"Keratitis, Dendritic",C,C11.204.564.425.450,"Keratitis, Herpetic",Keratitis,2
"Keratitis, Dendritic",C,C11.294.800.475.450,"Keratitis, Herpetic","Eye Infections, Viral",2
Keratoconjunctivitis,C,C11.204.564.585,Keratitis,Corneal Diseases,2
Keratoconjunctivitis,C,C11.187.183.394,Conjunctivitis,Conjunctival Diseases,2
Ketones,D,D02.522,Organic Chemicals,NULL,2
Ki-1 Antigen,D,D12.776.543.750.705.852.760.072,"Receptors, Tumor Necrosis Factor","Receptors, Cytokine",2
Ki-1 Antigen,D,D23.050.285.025,"Antigens, Neoplasm",Antigens,2
Ki-1 Antigen,D,D23.101.140.055,"Biomarkers, Tumor",Biomarkers,2
Kinetoplastida,B,B01.268.475,Euglenozoa,Eukaryota,2
Klinefelter Syndrome,C,C12.706.316.795.500,Sex Chromosome Disorders of Sex Development,Disorders of Sex Development,2
Klinefelter Syndrome,C,C13.351.875.253.795.500,Sex Chromosome Disorders of Sex Development,Disorders of Sex Development,2
Klinefelter Syndrome,C,C16.320.180.830.835.500,Sex Chromosome Disorders of Sex Development,Sex Chromosome Disorders,2
Klinefelter Syndrome,C,C16.131.939.316.795.500,Sex Chromosome Disorders of Sex Development,Disorders of Sex Development,2
Klinefelter Syndrome,C,C16.131.260.830.835.500,Sex Chromosome Disorders of Sex Development,Sex Chromosome Disorders,2
Klinefelter Syndrome,C,C19.391.482.629,Hypogonadism,Gonadal Disorders,2
Klinefelter Syndrome,C,C19.391.119.795.500,Sex Chromosome Disorders of Sex Development,Disorders of Sex Development,2
Knee Prosthesis,E,E07.695.400.410,Joint Prosthesis,Prostheses and Implants,2
Lab-On-A-Chip Devices,E,E07.305.343.500,Micro-Electrical-Mechanical Systems,Electrical Equipment and Supplies,2
"Labor Stage, First",G,G08.686.784.769.326.500.080,Labor Onset,"Labor, Obstetric",2
Lacrimal Apparatus,A,A09.371.463,Eye,Sense Organs,2
Lacrimal Apparatus,A,A10.336.422,Exocrine Glands,Tissues,2
Lactobacillus acidophilus,B,B03.353.750.450.475.100,Lactobacillus,Lactobacillaceae,2
Lactobacillus acidophilus,B,B03.510.460.400.410.475.475.100,Lactobacillus,Lactobacillaceae,2
Lactobacillus acidophilus,B,B03.510.550.450.475.100,Lactobacillus,Lactobacillaceae,2
Lactoglobulins,D,D12.776.256.159.750.816.500,Whey Proteins,Milk Proteins,2
Lactoglobulins,D,D12.776.377.457,Globulins,Proteins,2
Lamins,D,D12.776.660.650.875,Nuclear Matrix-Associated Proteins,Nuclear Proteins,2
Language Disorders,C,C23.888.592.604.150.500,Communication Disorders,Neurobehavioral Manifestations,2
Language Disorders,C,C10.597.606.150.500,Communication Disorders,Neurobehavioral Manifestations,2
Lansoprazole,D,D02.886.640.074.249,2-Pyridinylmethylsulfinylbenzimidazoles,Sulfoxides,2
Lansoprazole,D,D03.633.100.103.034.249,2-Pyridinylmethylsulfinylbenzimidazoles,Benzimidazoles,2
Lansoprazole,D,D03.383.725.024.249,2-Pyridinylmethylsulfinylbenzimidazoles,Pyridines,2
Laryngopharyngeal Reflux,C,C08.360.577,Laryngeal Diseases,Respiratory Tract Diseases,2
Laryngopharyngeal Reflux,C,C06.405.117.119.500.484.500,Gastroesophageal Reflux,Esophageal Motility Disorders,2
"Lasers, Semiconductor",E,E07.632.490.480,Lasers,Optical Devices,2
"Lasers, Semiconductor",E,E07.710.520.480,Lasers,Radiation Equipment and Supplies,2
Lateral Ventricles,A,A08.186.211.140.650,Cerebral Ventricles,Brain,2
Latex,D,D05.750.078.625,Biopolymers,Polymers,2
Latex,D,D20.215.721.124,Plant Exudates,Biological Products,2
Latex,D,D25.720.327.840.239,Rubber,Elastomers,2
Latex,D,D25.720.099.625,Biopolymers,Polymers,2
Latex,D,D25.720.099.750.500,Rubber,Biopolymers,2
Latex,J,J01.637.051.720.099.625,Biopolymers,Polymers,2
Latex,J,J01.637.051.720.540,Polymers,Biomedical and Dental Materials,2
Learning Health System,N,N04.590.374.395,Delivery of Health Care,Patient Care Management,2
Learning Health System,N,N05.300.504,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",2
Leg Length Inequality,C,C05.116.099.655,"Bone Diseases, Developmental",Bone Diseases,2
Leg Length Inequality,C,C23.300.808,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",2
"Legislation, Hospital",N,N03.706.615.420,Legislation as Topic,"Social Control, Formal",2
Leishmania guyanensis,B,B01.268.475.868.488.285,Leishmania,Trypanosomatina,2
Lemur,B,B01.050.150.900.649.313.988.700.508.490,Lemuridae,Strepsirhini,2
"Lens Nucleus, Crystalline",A,A09.371.060.500.670,"Lens, Crystalline",Anterior Eye Segment,2
Lenses,E,E07.632.500,Optical Devices,Equipment and Supplies,2
Lentivirus,B,B04.820.650.589,Retroviridae,RNA Viruses,2
Lepromin,D,D23.050.161.386,"Antigens, Bacterial",Antigens,2
Lethargy,C,C23.888.592.604.444,Neurobehavioral Manifestations,Neurologic Manifestations,2
Lethargy,C,C10.597.606.441,Neurobehavioral Manifestations,Neurologic Manifestations,2
Lethargy,F,F01.700.470,Neurobehavioral Manifestations,Behavior and Behavior Mechanisms,2
Leucine Zippers,G,G02.111.570.820.709.275.500.520,Amino Acid Motifs,Protein Structural Elements,2
Leucovorin,D,D08.211.840.300.500,Formyltetrahydrofolates,Tetrahydrofolates,2
Leucovorin,D,D03.633.100.733.631.400.800.350.450,Formyltetrahydrofolates,Tetrahydrofolates,2
"Leukemia Virus, Murine",B,B04.820.650.375.525,Gammaretrovirus,Retroviridae,2
"Leukemia Virus, Murine",B,B04.613.807.375.525,Gammaretrovirus,Retroviridae,2
"Leukemia, Promyelocytic, Acute",C,C04.557.337.539.275.700,"Leukemia, Myeloid, Acute","Leukemia, Myeloid",2
"Leukemia, T-Cell",C,C04.557.337.428.580,"Leukemia, Lymphoid",Leukemia,2
"Leukemia, T-Cell",C,C15.604.515.560.575,"Leukemia, Lymphoid",Lymphoproliferative Disorders,2
"Leukemia, T-Cell",C,C20.683.515.528.582,"Leukemia, Lymphoid",Lymphoproliferative Disorders,2
Leukocyte Disorders,C,C15.378.553,Hematologic Diseases,Hemic and Lymphatic Diseases,2
Leukocyte Transfusion,E,E02.095.135.140.425,Blood Component Transfusion,Blood Transfusion,2
Lewy Body Disease,C,C10.574.928.500,Synucleinopathies,Neurodegenerative Diseases,2
Lewy Body Disease,C,C10.228.140.380.422,Dementia,Brain Diseases,2
Lewy Body Disease,C,C10.228.140.079.862.400,Parkinsonian Disorders,Basal Ganglia Diseases,2
Lewy Body Disease,C,C10.228.662.600.200,Parkinsonian Disorders,Movement Disorders,2
Lewy Body Disease,F,F03.615.400.512,Dementia,Neurocognitive Disorders,2
"Licensure, Medical",N,N03.706.110.510.410,Licensure,Credentialing,2
"Licensure, Medical",N,N05.700.200.450.500,Licensure,Credentialing,2
Lichen Planus,C,C17.800.859.475.560,Lichenoid Eruptions,"Skin Diseases, Papulosquamous",2
Lidocaine,D,D02.092.146.113.092.500,Acetanilides,Anilides,2
Lidocaine,D,D02.065.199.092.500,Acetanilides,Anilides,2
Ligase Chain Reaction,E,E05.393.620.311,Nucleic Acid Amplification Techniques,Genetic Techniques,2
Lincosamides,D,D03.383.773.532,Pyrrolidines,"Heterocyclic Compounds, 1-Ring",2
Lincosamides,D,D09.408.471,Glycosides,Carbohydrates,2
Lipase,D,D08.811.277.352.100.400,Carboxylic Ester Hydrolases,Esterases,2
Lipogenesis,G,G03.458.249,Lipid Metabolism,Metabolism,2
Lipogenesis,G,G02.111.528,Biochemical Phenomena,Chemical Phenomena,2
Liver Circulation,G,G09.330.100.881.552,Splanchnic Circulation,Blood Circulation,2
Liver Glycogen,D,D05.750.078.562.388.518,Glycogen,Glucans,2
Liver Glycogen,D,D09.698.365.388.518,Glycogen,Glucans,2
Lorazepam,D,D03.633.100.079.080.070.450,Benzodiazepinones,Benzodiazepines,2
Losartan,D,D03.383.129.617.467,Tetrazoles,Azoles,2
Losartan,D,D03.383.129.308.507,Imidazoles,Azoles,2
Losartan,D,D02.455.426.559.389.185.475,Biphenyl Compounds,Benzene Derivatives,2
Lovastatin,D,D02.455.426.559.847.638.400,Naphthalenes,Polycyclic Aromatic Hydrocarbons,2
Lovastatin,D,D04.615.638.400,Naphthalenes,Polycyclic Aromatic Hydrocarbons,2
Low-Level Light Therapy,E,E02.594.540,Laser Therapy,Therapeutics,2
Low-Level Light Therapy,E,E02.774.500,Phototherapy,Therapeutics,2
Lubricants,D,D27.720.556,Specialty Uses of Chemicals,Chemical Actions and Uses,2
Lubrication,E,E05.830.583,Rheology,Investigative Techniques,2
"Luciferases, Bacterial",D,D12.776.532.510.249,Luciferases,Luminescent Proteins,2
"Luciferases, Bacterial",D,D08.811.682.517.500,Luciferases,Oxidoreductases,2
"Luciferases, Bacterial",D,D12.776.097.529,Bacterial Proteins,Proteins,2
"Luciferases, Firefly",D,D12.776.093.500.577,Insect Proteins,Arthropod Proteins,2
"Luciferases, Firefly",D,D08.811.682.517.750,Luciferases,Oxidoreductases,2
"Luciferases, Firefly",D,D12.776.532.510.500,Luciferases,Luminescent Proteins,2
Lujo virus,B,B04.820.480.500.070.100.525,"Arenaviruses, Old World",Arenavirus,2
Lumbosacral Region,A,A01.923.176.519,Back,Torso,2
Luminescent Agents,D,D27.720.470.410.505,Indicators and Reagents,Laboratory Chemicals,2
Lunch,G,G07.203.300.590.560,Meals,Food,2
Lunch,J,J02.500.590.560,Meals,Food,2
Lung Abscess,C,C01.830.025.490,Abscess,Suppuration,2
Lung Abscess,C,C01.748.407,Respiratory Tract Infections,Infections,2
Lung Abscess,C,C08.381.450,Lung Diseases,Respiratory Tract Diseases,2
Lung Abscess,C,C08.730.407,Respiratory Tract Infections,Respiratory Tract Diseases,2
"Lung Diseases, Parasitic",C,C08.730.450,Respiratory Tract Infections,Respiratory Tract Diseases,2
"Lung Diseases, Parasitic",C,C08.381.517,Lung Diseases,Respiratory Tract Diseases,2
"Lung Diseases, Parasitic",C,C01.748.450,Respiratory Tract Infections,Infections,2
"Lung Diseases, Parasitic",C,C01.610.582,Parasitic Diseases,Infections,2
"Lupus Erythematosus, Cutaneous",C,C17.300.475,Connective Tissue Diseases,Skin and Connective Tissue Diseases,2
"Lupus Erythematosus, Cutaneous",C,C17.800.480,Skin Diseases,Skin and Connective Tissue Diseases,2
Lupus Nephritis,C,C17.300.480.680,"Lupus Erythematosus, Systemic",Connective Tissue Diseases,2
Lupus Nephritis,C,C13.351.968.419.570.363.680,Glomerulonephritis,Nephritis,2
Lupus Nephritis,C,C12.777.419.570.363.680,Glomerulonephritis,Nephritis,2
Lupus Nephritis,C,C20.111.590.560,"Lupus Erythematosus, Systemic",Autoimmune Diseases,2
Lymphatic Irradiation,E,E02.815.350,Radiotherapy,Therapeutics,2
Lymphocyte Cooperation,G,G04.502,Cell Physiological Phenomena,NULL,2
Lymphocyte Cooperation,G,G12.575,Immune System Phenomena,NULL,2
Lymphocytic Choriomeningitis,C,C10.228.614.400.500,"Meningitis, Viral",Meningitis,2
Lymphocytic Choriomeningitis,C,C10.228.228.245.500.500,"Meningitis, Viral",Central Nervous System Viral Diseases,2
Lymphocytic Choriomeningitis,C,C01.207.245.500.500,"Meningitis, Viral",Central Nervous System Viral Diseases,2
Lymphocytic Choriomeningitis,C,C01.925.782.082.580,Arenaviridae Infections,RNA Virus Infections,2
Lymphocytic Choriomeningitis,C,C01.925.182.550.500,"Meningitis, Viral",Central Nervous System Viral Diseases,2
Lymphokines,D,D23.529.374.480,Cytokines,Intercellular Signaling Peptides and Proteins,2
Lymphokines,D,D12.776.467.374.480,Cytokines,Intercellular Signaling Peptides and Proteins,2
Lymphokines,D,D12.644.276.374.480,Cytokines,Intercellular Signaling Peptides and Proteins,2
Lysine-tRNA Ligase,D,D08.811.464.263.200.550,Amino Acyl-tRNA Synthetases,Carbon-Oxygen Ligases,2
Lysogeny,G,G05.935.500,Virus Integration,Genetic Phenomena,2
Lysogeny,G,G06.920.877.500,Virus Integration,Virus Physiological Phenomena,2
Lysophospholipids,D,D10.570.755.375.760.550,Phosphatidic Acids,Glycerophosphates,2
Lysosomal-Associated Membrane Protein 2,D,D12.776.395.550.550.750,Lysosome-Associated Membrane Glycoproteins,Membrane Glycoproteins,2
Lysosomal-Associated Membrane Protein 2,D,D12.776.543.550.527.750,Lysosome-Associated Membrane Glycoproteins,Membrane Glycoproteins,2
Macrophage Inflammatory Proteins,D,D12.776.467.374.200.600,Chemokines,Cytokines,2
Macrophage Inflammatory Proteins,D,D23.529.374.200.600,Chemokines,Cytokines,2
Macrophage Inflammatory Proteins,D,D23.469.200.600,Chemokines,Inflammation Mediators,2
Macrophage Inflammatory Proteins,D,D23.125.300.600,Chemokines,Chemotactic Factors,2
Macrophage Inflammatory Proteins,D,D12.644.276.374.200.600,Chemokines,Cytokines,2
Macrophage-1 Antigen,D,D12.776.543.750.705.833.500,"Receptors, Complement","Receptors, Immunologic",2
Macrophage-1 Antigen,D,D12.776.543.750.705.408.495.500,"Receptors, Fibrinogen",Integrins,2
Macrophage-1 Antigen,D,D12.776.543.750.705.408.600.500,"Receptors, Leukocyte-Adhesion",Integrins,2
Madin Darby Canine Kidney Cells,A,A11.251.210.827,Cell Line,"Cells, Cultured",2
Madin Darby Canine Kidney Cells,A,A11.436.589,Epithelial Cells,Cells,2
Magic,E,E02.190.901.411,Spiritual Therapies,Complementary Therapies,2
Magic,I,I01.076.201.450.897.439,Superstitions,Culture,2
Magnetite Nanoparticles,J,J01.637.512.600.500.144.500,Magnetic Iron Oxide Nanoparticles,Metal Nanoparticles,2
Maintenance,N,N02.628,"Health Care Facilities, Manpower, and Services",NULL,2
Maintenance Chemotherapy,E,E02.319.509,Drug Therapy,Therapeutics,2
Malate Dehydrogenase,D,D08.811.682.047.820.496,NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases,Alcohol Oxidoreductases,2
Malondialdehyde,D,D02.047.700,Aldehydes,Organic Chemicals,2
Malvaceae,B,B01.650.940.800.575.912.250.859.821.500,Malvales,Rosanae,2
Mannheimia haemolytica,B,B03.440.450.600.500.500,Mannheimia,Pasteurellaceae,2
Mannheimia haemolytica,B,B03.660.250.550.500.500,Mannheimia,Pasteurellaceae,2
Mannose-Binding Protein-Associated Serine Proteases,D,D08.811.277.656.959.350.501,Serine Endopeptidases,Serine Proteases,2
Mannose-Binding Protein-Associated Serine Proteases,D,D08.811.277.656.300.760.501,Serine Endopeptidases,Endopeptidases,2
Mannose-Binding Protein-Associated Serine Proteases,D,D12.776.124.486.274.045.387.875,Complement C3-C5 Convertases,Complement Activating Enzymes,2
Manuals as Topic,L,L01.178.682.192.609,Books,Publications,2
Manuals as Topic,L,L01.178.820.500,Teaching Materials,Communications Media,2
Manuscripts as Topic,L,L01.178.682.608,Publications,Communications Media,2
"Manuscripts, Medical as Topic",L,L01.178.682.608.526,Manuscripts as Topic,Publications,2
MAP Kinase Kinase Kinase 1,D,D12.644.360.400.100,MAP Kinase Kinase Kinases,Intracellular Signaling Peptides and Proteins,2
MAP Kinase Kinase Kinase 1,D,D08.811.913.696.620.682.700.559.100,MAP Kinase Kinase Kinases,Protein-Serine-Threonine Kinases,2
MAP Kinase Kinase Kinase 1,D,D12.776.476.400.100,MAP Kinase Kinase Kinases,Intracellular Signaling Peptides and Proteins,2
MAP Kinase Kinase Kinases,D,D12.776.476.400,Intracellular Signaling Peptides and Proteins,Proteins,2
MAP Kinase Kinase Kinases,D,D08.811.913.696.620.682.700.559,Protein-Serine-Threonine Kinases,Protein Kinases,2
MAP Kinase Kinase Kinases,D,D12.644.360.400,Intracellular Signaling Peptides and Proteins,Peptides,2
Mardivirus,B,B04.280.382.100.562,Alphaherpesvirinae,Herpesviridae,2
Margarine,D,D10.212.302.651,Dietary Fats,Fats,2
Margarine,J,J02.500.375.650,Dietary Fats,Food,2
Margarine,J,J02.500.350.500,Dairy Products,Food,2
Margarine,G,G07.203.300.375.650,Dietary Fats,Food,2
Margarine,G,G07.203.300.350.500,Dairy Products,Food,2
Massage,E,E02.779.867.880.750,"Therapy, Soft Tissue",Musculoskeletal Manipulations,2
Massage,E,E02.831.535.867.880.750,"Therapy, Soft Tissue",Musculoskeletal Manipulations,2
Massage,E,E02.190.599.750.750,"Therapy, Soft Tissue",Musculoskeletal Manipulations,2
Mastocytosis,C,C04.557.450.565.465,"Neoplasms, Connective Tissue","Neoplasms, Connective and Soft Tissue",2
Mastocytosis,C,C20.543.520.350,Immune Complex Diseases,Hypersensitivity,2
Mastocytosis,C,C17.800.508,Skin Diseases,Skin and Connective Tissue Diseases,2
Maternal Serum Screening Tests,E,E01.370.378.630.582,Prenatal Diagnosis,"Diagnostic Techniques, Obstetrical and Gynecological",2
Maternal-Child Nursing,H,H02.478.676.390,"Specialties, Nursing",Nursing,2
Maternal-Child Nursing,N,N02.421.533.460,Nursing Care,Health Services,2
Maxilla,A,A14.521.645,Jaw,Stomatognathic System,2
Maxilla,A,A02.835.232.781.324.502.645,Jaw,Facial Bones,2
Maximum Tolerated Dose,E,E05.940.481,Toxicity Tests,Investigative Techniques,2
Maximum Tolerated Dose,G,G07.690.936.625,Toxicological Phenomena,Pharmacological and Toxicological Phenomena,2
Maze Learning,F,F02.463.425.874.500,Spatial Learning,Learning,2
Mediastinal Emphysema,C,C08.846.187.290,Mediastinal Diseases,Thoracic Diseases,2
Mediastinal Emphysema,C,C23.550.325.250,Emphysema,Pathologic Processes,2
Mediastinitis,C,C08.846.187.790,Mediastinal Diseases,Thoracic Diseases,2
Mediastinum,A,A01.923.761.800.500,Thoracic Cavity,Thorax,2
Mediator Complex,D,D12.776.476.024.388,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,2
Mediator Complex,D,D12.776.660.551,Nuclear Proteins,Proteins,2
Mediator Complex,D,D12.644.360.024.309,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,2
Mediator Complex,D,D12.776.157.057.072,"Adaptor Proteins, Signal Transducing",Carrier Proteins,2
Mediator Complex,D,D05.500.374,Multiprotein Complexes,Macromolecular Substances,2
Medical Order Entry Systems,N,N04.452.442.452.452.500,Hospital Information Systems,Hospital Administration,2
Medical Order Entry Systems,N,N04.452.515.360.500,Hospital Information Systems,Management Information Systems,2
Medical Order Entry Systems,N,N04.452.859.564.650.500,"Medical Records Systems, Computerized",Medical Records,2
Medical Order Entry Systems,L,L01.313.500.750.300.695.600,"Medical Records Systems, Computerized",Information Systems,2
Medical Savings Accounts,N,N03.219.151.170.650,Cost Sharing,Costs and Cost Analysis,2
Medical Savings Accounts,N,N03.219.521.576.090.650,Cost Sharing,Insurance,2
Medical Savings Accounts,N,N03.219.521.576.343.830,"Insurance, Health",Insurance,2
Medical Savings Accounts,N,N03.219.559.500,"Financing, Personal",Economics,2
Medicalization,I,I01.880.853.250,Sociological Factors,Sociology,2
"Medication Systems, Hospital",N,N04.452.528.473,Medication Systems,Organization and Administration,2
"Medication Systems, Hospital",N,N04.452.442.452.675,Hospital Administration,Health Facility Administration,2
Medicine in the Arts,K,K01.093.530,Art,Humanities,2
"Medicine, East Asian Traditional",I,I01.076.201.450.654.558,"Medicine, Traditional",Culture,2
"Medicine, East Asian Traditional",E,E02.190.488.585,"Medicine, Traditional",Complementary Therapies,2
Medroxyprogesterone,D,D04.210.500.745.745.654.829.395.700,Hydroxyprogesterones,Progesterone,2
MEF2 Transcription Factors,D,D12.776.260.103.750.294,Myogenic Regulatory Factors,Basic Helix-Loop-Helix Transcription Factors,2
MEF2 Transcription Factors,D,D12.776.260.400.249.624,MADS Domain Proteins,Homeodomain Proteins,2
MEF2 Transcription Factors,D,D12.776.210.500.570.294,Myogenic Regulatory Factors,Muscle Proteins,2
MEF2 Transcription Factors,D,D12.776.930.125.750.294,Myogenic Regulatory Factors,Basic Helix-Loop-Helix Transcription Factors,2
MEF2 Transcription Factors,D,D12.776.930.397.700,MADS Domain Proteins,Transcription Factors,2
Melanocytes,A,A11.436.613,Epithelial Cells,Cells,2
Melanocytes,A,A11.409.750,Epidermal Cells,Cells,2
Melanocyte-Stimulating Hormones,D,D12.776.631.650.405.935.531.750,Melanocortins,Pro-Opiomelanocortin,2
Melanocyte-Stimulating Hormones,D,D12.776.631.650.460,Neuropeptides,Nerve Tissue Proteins,2
Melanocyte-Stimulating Hormones,D,D12.644.548.365.935.531.750,Melanocortins,Pro-Opiomelanocortin,2
Melanocyte-Stimulating Hormones,D,D12.644.548.691.525.690.531.750,Melanocortins,Pro-Opiomelanocortin,2
Melanocyte-Stimulating Hormones,D,D12.644.400.400.935.531.750,Melanocortins,Pro-Opiomelanocortin,2
Melanocyte-Stimulating Hormones,D,D12.644.400.460,Neuropeptides,Peptides,2
Melanocyte-Stimulating Hormones,D,D06.472.699.631.525.600.531.750,Melanocortins,Pro-Opiomelanocortin,2
Melanocyte-Stimulating Hormones,D,D06.472.699.327.935.531.750,Melanocortins,Pro-Opiomelanocortin,2
Membranes,A,A10.615,Tissues,NULL,2
Memory and Learning Tests,F,F04.711.513.401,Neuropsychological Tests,Psychological Tests,2
"Meningitis, Fungal",C,C01.150.703.181.500,Central Nervous System Fungal Infections,Mycoses,2
"Meningitis, Fungal",C,C01.207.198.500,Central Nervous System Fungal Infections,Central Nervous System Infections,2
"Meningitis, Fungal",C,C10.228.228.198.500,Central Nervous System Fungal Infections,Central Nervous System Infections,2
"Meningitis, Fungal",C,C10.228.614.300,Meningitis,Central Nervous System Diseases,2
Menstruation-Inducing Agents,D,D27.505.954.705.360.276.500,"Contraceptive Agents, Female",Contraceptive Agents,2
Menstruation-Inducing Agents,D,D27.505.954.705.360.360.937,"Contraceptive Agents, Hormonal",Contraceptive Agents,2
Menstruation-Inducing Agents,D,D27.505.954.705.650,Reproductive Control Agents,Therapeutic Uses,2
Menstruation-Inducing Agents,D,D27.505.696.875.360.360.937,"Contraceptive Agents, Hormonal",Contraceptive Agents,2
Menstruation-Inducing Agents,D,D27.505.696.875.360.276.500,"Contraceptive Agents, Female",Contraceptive Agents,2
Menu Planning,J,J01.576.423.500.500,Food Services,Food Industry,2
Menu Planning,N,N02.421.242.472.310,"Food Service, Hospital",Dietary Services,2
Meperidine,D,D03.066.399.450,Isonipecotic Acids,"Acids, Heterocyclic",2
Meperidine,D,D03.383.621.349.450,Isonipecotic Acids,Piperidines,2
Mesalamine,D,D02.455.426.559.389.657.410.595.100.540,Aminosalicylic Acids,Salicylates,2
Mesalamine,D,D02.455.426.559.389.127.020.452.750,meta-Aminobenzoates,Aminobenzoates,2
Mesalamine,D,D02.455.426.559.389.127.281.595.100.540,Aminosalicylic Acids,Salicylates,2
Mesalamine,D,D02.241.511.390.595.100.540,Aminosalicylic Acids,Salicylates,2
Mesalamine,D,D02.241.223.100.050.300.500,meta-Aminobenzoates,Aminobenzoates,2
Mesalamine,D,D02.241.223.100.300.595.100.540,Aminosalicylic Acids,Salicylates,2
Mesenteric Vascular Occlusion,C,C14.907.137.534,Arterial Occlusive Diseases,Vascular Diseases,2
Mesenteric Vascular Occlusion,C,C06.405.469.675,Intestinal Diseases,Gastrointestinal Diseases,2
Mesenteric Vascular Occlusion,C,C06.844.550,Peritoneal Diseases,Digestive System Diseases,2
Mesylates,D,D02.455.326.146.100.050.500,Alkanesulfonates,Alkanesulfonic Acids,2
Mesylates,D,D02.886.645.600.055.050.510,Alkanesulfonates,Alkanesulfonic Acids,2
Metabolic Clearance Rate,E,E01.370.225.843,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,2
Metabolic Clearance Rate,G,G03.490,Metabolism,NULL,2
Metabolic Clearance Rate,G,G07.690.725.513,Pharmacokinetics,Pharmacological and Toxicological Phenomena,2
Metabolic Clearance Rate,G,G07.690.595,Pharmacological and Toxicological Phenomena,Physiological Phenomena,2
Metabolic Clearance Rate,E,E05.200.843,Clinical Laboratory Techniques,Investigative Techniques,2
Metadata,L,L01.399.250.590,Data Collection,Information Management,2
Metal-on-Metal Joint Prostheses,E,E07.695.400.705,Joint Prosthesis,Prostheses and Implants,2
Metaphase,G,G05.113.220.687.625,Meiosis,Cell Nucleus Division,2
Metaphase,G,G05.113.220.781.625,Mitosis,Cell Nucleus Division,2
Metaphase,G,G04.144.220.220.687.625,Meiosis,Cell Nucleus Division,2
Metaphase,G,G04.144.220.220.781.625,Mitosis,Cell Nucleus Division,2
Metaproterenol,D,D02.455.426.559.389.657.166.175.660,Catecholamines,Catechols,2
Metaproterenol,D,D02.092.063.291.465,Ethanolamines,Amino Alcohols,2
Metaproterenol,D,D02.092.311.660,Catecholamines,Amines,2
Metaproterenol,D,D02.033.100.291.465,Ethanolamines,Amino Alcohols,2
Metarhizium,B,B01.300.107.501.490,Hypocreales,Ascomycota,2
Metarhizium,B,B01.300.381.541,Mitosporic Fungi,Fungi,2
Methylphenidate,D,D02.241.223.601.600,Phenylacetates,"Acids, Carbocyclic",2
Methylphenidate,D,D03.383.621.460,Piperidines,"Heterocyclic Compounds, 1-Ring",2
"Mice, Inbred ICR",B,B01.050.150.900.649.313.992.635.505.500.400.510,"Mice, Inbred Strains",Mice,2
"Mice, Inbred ICR",B,B01.050.050.199.520.520.510,"Mice, Inbred Strains","Animals, Inbred Strains",2
Microbodies,A,A11.284.430.214.190.500.585,Cytoplasmic Granules,Cytoplasmic Structures,2
Microbodies,A,A11.284.430.214.190.875.190.190.755,Cytoplasmic Granules,Cytoplasmic Vesicles,2
Micrococcaceae,B,B03.510.400.500,Gram-Positive Cocci,Gram-Positive Bacteria,2
Micrococcaceae,B,B03.510.024.850,Actinobacteria,Gram-Positive Bacteria,2
"Microorganisms, Genetically-Modified",B,B05.620.368,"Organisms, Genetically Modified",Organism Forms,2
Microscopic Polyangiitis,C,C20.111.193.750,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Autoimmune Diseases,2
Microscopic Polyangiitis,C,C14.907.253.329.600,Cerebral Small Vessel Diseases,Cerebrovascular Disorders,2
Microscopic Polyangiitis,C,C14.907.940.897.249.500,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Systemic Vasculitis,2
Microscopic Polyangiitis,C,C10.228.140.300.275.600,Cerebral Small Vessel Diseases,Cerebrovascular Disorders,2
"Microscopy, Phase-Contrast",E,E01.370.350.515.513.569,"Microscopy, Interference",Microscopy,2
"Microscopy, Phase-Contrast",E,E05.490.630.569,"Microscopy, Interference",Interferometry,2
"Microscopy, Phase-Contrast",E,E05.595.513.569,"Microscopy, Interference",Microscopy,2
"Microscopy, Polarization",E,E05.595.624,Microscopy,Investigative Techniques,2
"Microscopy, Polarization",E,E01.370.350.515.624,Microscopy,Diagnostic Imaging,2
Microsporidia,B,B01.300.360,Fungi,Eukaryota,2
Microsporidiosis,C,C01.150.703.617,Mycoses,Bacterial Infections and Mycoses,2
Microtubule-Organizing Center,A,A11.284.430.214.190.750.585,Cytoskeleton,Cytoplasmic Structures,2
Miller Fisher Syndrome,C,C10.228.140.252.500,Cerebellar Diseases,Brain Diseases,2
Miller Fisher Syndrome,C,C10.114.750.100.500,Guillain-Barre Syndrome,Polyradiculoneuropathy,2
Miller Fisher Syndrome,C,C10.292.562.350,Ocular Motility Disorders,Cranial Nerve Diseases,2
Miller Fisher Syndrome,C,C10.314.750.450.500,Guillain-Barre Syndrome,Polyradiculoneuropathy,2
Miller Fisher Syndrome,C,C11.590.312,Ocular Motility Disorders,Eye Diseases,2
Miller Fisher Syndrome,C,C10.668.829.350.500,Guillain-Barre Syndrome,Peripheral Nervous System Diseases,2
Miller Fisher Syndrome,C,C10.668.829.800.750.300.500,Guillain-Barre Syndrome,Polyradiculoneuropathy,2
Miller Fisher Syndrome,C,C20.111.258.750.400.500,Guillain-Barre Syndrome,Polyradiculoneuropathy,2
Minor Surgical Procedures,E,E04.506,"Surgical Procedures, Operative",NULL,2
Missionaries,M,M01.427,Persons,NULL,2
Mite Infestations,C,C01.610.858.211.480,Ectoparasitic Infestations,"Skin Diseases, Parasitic",2
Mitochondrial Proton-Translocating ATPases,D,D12.776.575.750.625,Mitochondrial Membrane Transport Proteins,Mitochondrial Proteins,2
Mitochondrial Proton-Translocating ATPases,D,D12.776.543.585.475.625,Mitochondrial Membrane Transport Proteins,Membrane Transport Proteins,2
Mitochondrial Proton-Translocating ATPases,D,D12.776.543.585.450.250.875.500.750,Proton-Translocating ATPases,Proton Pumps,2
Mitochondrial Proton-Translocating ATPases,D,D08.811.277.040.025.325.750,Proton-Translocating ATPases,Adenosine Triphosphatases,2
Mitochondrial Proton-Translocating ATPases,D,D08.811.913.696.650.150.500.750,Proton-Translocating ATPases,ATP Synthetase Complexes,2
Mitochondrial Proton-Translocating ATPases,D,D12.776.157.530.450.250.875.500.750,Proton-Translocating ATPases,Proton Pumps,2
Mitogen-Activated Protein Kinase 3,D,D08.811.913.696.620.682.700.567.249.750,Extracellular Signal-Regulated MAP Kinases,Mitogen-Activated Protein Kinases,2
Mitogen-Activated Protein Kinase 3,D,D12.644.360.450.169.750,Extracellular Signal-Regulated MAP Kinases,Mitogen-Activated Protein Kinases,2
Mitogen-Activated Protein Kinase 3,D,D12.776.476.450.169.750,Extracellular Signal-Regulated MAP Kinases,Mitogen-Activated Protein Kinases,2
Mitoguazone,D,D02.078.370.600,Guanidines,Amidines,2
Mitoxantrone,D,D02.455.426.559.847.117.159.500,Anthraquinones,Anthracenes,2
Mitoxantrone,D,D04.615.117.159.500,Anthraquinones,Anthracenes,2
Mitoxantrone,D,D02.806.100.500,Anthraquinones,Quinones,2
Mobius Syndrome,C,C10.292.319.825,Facial Nerve Diseases,Cranial Nerve Diseases,2
Mobius Syndrome,C,C16.614.595,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Mobius Syndrome,C,C16.131.077.578,"Abnormalities, Multiple",Congenital Abnormalities,2
Mobius Syndrome,C,C07.465.299.825,Facial Nerve Diseases,Mouth Diseases,2
"Models, Spatial Interaction",E,E05.599.835.893,"Models, Statistical","Models, Theoretical",2
Molecular Probes,D,D27.720.470.530,Laboratory Chemicals,Specialty Uses of Chemicals,2
Molecular Probes,D,D27.505.259.750,Diagnostic Uses of Chemicals,Pharmacologic Actions,2
Moloney murine leukemia virus,B,B04.820.650.375.525.596,"Leukemia Virus, Murine",Gammaretrovirus,2
Moloney murine leukemia virus,B,B04.613.807.375.525.596,"Leukemia Virus, Murine",Gammaretrovirus,2
Monensin,D,D03.383.312.600,Furans,"Heterocyclic Compounds, 1-Ring",2
Monoclonal Gammopathy of Undetermined Significance,C,C15.378.147.542.640,Hypergammaglobulinemia,Blood Protein Disorders,2
Monoclonal Gammopathy of Undetermined Significance,C,C15.378.147.780.570,Paraproteinemias,Blood Protein Disorders,2
Monoclonal Gammopathy of Undetermined Significance,C,C20.683.460.640,Hypergammaglobulinemia,Immunoproliferative Disorders,2
Monoclonal Gammopathy of Undetermined Significance,C,C20.683.780.640,Paraproteinemias,Immunoproliferative Disorders,2
Mononuclear Phagocyte System,A,A15.382.670,Immune System,Hemic and Immune Systems,2
Monophenol Monooxygenase,D,D08.811.682.690.708.125.500,Catechol Oxidase,Mixed Function Oxygenases,2
Montana,Z,Z01.107.567.875.560.500,Northwestern United States,United States,2
Moraxella,B,B03.440.400.425.537.525,Moraxellaceae,Gram-Negative Aerobic Rods and Cocci,2
Moraxella,B,B03.660.250.530.525,Moraxellaceae,Gammaproteobacteria,2
Morbillivirus,B,B04.820.480.937.600.650.500,Paramyxovirinae,Paramyxoviridae,2
Morbillivirus Infections,C,C01.925.782.580.600.500,Paramyxoviridae Infections,Mononegavirales Infections,2
Morphine Dependence,C,C25.775.643.500.600,Opioid-Related Disorders,Narcotic-Related Disorders,2
Morphine Dependence,F,F03.900.647.500.600,Opioid-Related Disorders,Narcotic-Related Disorders,2
Morpholinos,D,D03.383.533.640.562,Morpholines,Oxazines,2
Morpholinos,D,D13.695.578.424.337,Oligonucleotides,Polynucleotides,2
Mortuary Practice,H,H02.438,Health Occupations,NULL,2
Motor Cortex,A,A08.186.211.200.885.287.500.270.548,Frontal Lobe,Cerebral Cortex,2
Motor Cortex,A,A08.186.211.200.885.287.500.814.624,Sensorimotor Cortex,Cerebral Cortex,2
Mucin-1,D,D23.050.285.050.300,"Antigens, Tumor-Associated, Carbohydrate","Antigens, Neoplasm",2
Mucin-1,D,D12.776.543.550.530,Membrane Glycoproteins,Membrane Proteins,2
Mucin-1,D,D23.101.140.075.300,"Antigens, Tumor-Associated, Carbohydrate","Biomarkers, Tumor",2
Mucin-1,D,D23.050.550.325.300,"Antigens, Tumor-Associated, Carbohydrate",Epitopes,2
Mucin-1,D,D12.776.395.550.560,Membrane Glycoproteins,Glycoproteins,2
Mucin-1,D,D12.776.395.560.631.115,Mucins,Mucoproteins,2
Mucin-5B,D,D12.776.395.560.631.207,Mucins,Mucoproteins,2
Mucin-5B,D,D12.644.848.750,Salivary Proteins and Peptides,Peptides,2
Mucin-5B,D,D12.776.850.850,Salivary Proteins and Peptides,Proteins,2
Muridae,B,B01.050.150.900.649.313.992.635,Rodentia,Eutheria,2
Musa,B,B01.650.940.800.575.912.250.618.937.555.500,Musaceae,Zingiberales,2
Muscle Development,G,G11.427.578.590,Musculoskeletal Development,Musculoskeletal Physiological Phenomena,2
Muscle Development,G,G07.345.500.325.377.625.590,Musculoskeletal Development,Organogenesis,2
Musculoskeletal Abnormalities,C,C05.660,Musculoskeletal Diseases,NULL,2
Musculoskeletal Abnormalities,C,C16.131.621,Congenital Abnormalities,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Mustard Compounds,D,D02.455.526.728,"Hydrocarbons, Halogenated",Hydrocarbons,2
Mutagenicity Tests,E,E05.393.560,Genetic Techniques,Investigative Techniques,2
Mutagenicity Tests,E,E05.940.560,Toxicity Tests,Investigative Techniques,2
Mycobacterium scrofulaceum,B,B03.510.024.962.500.720.625,Nontuberculous Mycobacteria,Mycobacterium,2
Mycobacterium scrofulaceum,B,B03.510.460.400.410.552.552.720.625,Nontuberculous Mycobacteria,Mycobacterium,2
Mycological Typing Techniques,E,E01.370.225.875.610,Microbiological Techniques,Clinical Laboratory Techniques,2
Mycological Typing Techniques,E,E05.200.875.610,Microbiological Techniques,Clinical Laboratory Techniques,2
Mycophenolic Acid,D,D10.251.618,Fatty Acids,Lipids,2
Mycophenolic Acid,D,D02.241.081.193.678,Caproates,"Acids, Acyclic",2
Mycoplasma hominis,B,B03.440.860.580.553.553.400,Mycoplasma,Mycoplasmataceae,2
Mycorrhizae,B,B01.300.655,Fungi,Eukaryota,2
Mycorrhizae,A,A19.690,Fungal Structures,NULL,2
Mycorrhizae,A,A18.400.525,Plant Roots,Plant Structures,2
Mycorrhizae,B,B05.550,Organism Forms,NULL,2
Mycosis Fungoides,C,C04.557.386.480.750.800.550,"Lymphoma, T-Cell, Cutaneous","Lymphoma, T-Cell",2
Mycosis Fungoides,C,C20.683.515.761.480.750.800.550,"Lymphoma, T-Cell, Cutaneous","Lymphoma, T-Cell",2
Mycosis Fungoides,C,C15.604.515.569.480.750.800.550,"Lymphoma, T-Cell, Cutaneous","Lymphoma, T-Cell",2
Myelin and Lymphocyte-Associated Proteolipid Proteins,D,D10.570.780.249,Proteolipids,Membrane Lipids,2
Myelin and Lymphocyte-Associated Proteolipid Proteins,D,D12.776.816.249,Proteolipids,Proteins,2
Myelin and Lymphocyte-Associated Proteolipid Proteins,D,D12.776.543.990.681,Vesicular Transport Proteins,Membrane Proteins,2
Myelin and Lymphocyte-Associated Proteolipid Proteins,D,D12.776.631.580.249,Myelin Proteins,Nerve Tissue Proteins,2
Myelin and Lymphocyte-Associated Proteolipid Proteins,D,D12.776.543.620.264,Myelin Proteins,Membrane Proteins,2
Myelin and Lymphocyte-Associated Proteolipid Proteins,D,D12.776.543.488.374,MARVEL Domain-Containing Proteins,Membrane Proteins,2
Myelin Proteins,D,D12.776.543.620,Membrane Proteins,Proteins,2
Myelin Proteins,D,D12.776.631.580,Nerve Tissue Proteins,Proteins,2
Myeloproliferative Disorders,C,C15.378.190.636,Bone Marrow Diseases,Hematologic Diseases,2
Myoblasts,A,A11.872.620,Stem Cells,Cells,2
"Myopia, Degenerative",C,C11.744.636.500,Myopia,Refractive Errors,2
Myosin Light Chains,D,D12.776.157.125.475,Calcium-Binding Proteins,Carrier Proteins,2
Myosin Light Chains,D,D12.776.210.500.600.200,Myosins,Muscle Proteins,2
Myosin Light Chains,D,D12.776.220.525.475.200,Myosins,Microfilament Proteins,2
Myosin Light Chains,D,D05.750.078.730.475.200,Myosins,Microfilament Proteins,2
Myristic Acid,D,D10.251.640.630,Myristic Acids,Fatty Acids,2
Myxedema,C,C17.300.550.590,Mucinoses,Connective Tissue Diseases,2
Myxedema,C,C19.874.482.638,Hypothyroidism,Thyroid Diseases,2
N-Acetylmuramoyl-L-alanine Amidase,D,D08.811.277.087.030,Amidohydrolases,Hydrolases,2
NADH Dehydrogenase,D,D08.811.682.608.504.500,Electron Transport Complex I,"NADH, NADPH Oxidoreductases",2
NADH Dehydrogenase,D,D12.776.331.887,Flavoproteins,Proteins,2
NADH Dehydrogenase,D,D12.776.157.427.374.375.863.500,Electron Transport Complex I,Iron-Sulfur Proteins,2
NADH Dehydrogenase,D,D12.776.556.579.374.375.140.500,Electron Transport Complex I,Iron-Sulfur Proteins,2
NADP,D,D13.695.667.138.749,Adenine Nucleotides,Purine Nucleotides,2
NADP,D,D13.695.827.068.749,Adenine Nucleotides,Ribonucleotides,2
NADP,D,D08.211.625,Coenzymes,Enzymes and Coenzymes,2
NADP,D,D03.633.100.759.646.138.749,Adenine Nucleotides,Purine Nucleotides,2
Naegleria fowleri,B,B01.046.500.700.710.375,Naegleria,Schizopyrenida,2
Nalidixic Acid,D,D03.633.100.810.835.830.500,4-Quinolones,Quinolones,2
Nalidixic Acid,D,D03.633.100.612.500,Naphthyridines,"Heterocyclic Compounds, 2-Ring",2
"Nanotubes, Carbon",D,D01.268.150.250.500,Fullerenes,Carbon,2
"Nanotubes, Carbon",J,J01.637.512.850.500,Nanotubes,Nanostructures,2
Nanowires,J,J01.637.512.925,Nanostructures,Manufactured Materials,2
Naphthalenes,D,D02.455.426.559.847.638,Polycyclic Aromatic Hydrocarbons,"Hydrocarbons, Aromatic",2
Naphthalenes,D,D04.615.638,Polycyclic Aromatic Hydrocarbons,Polycyclic Compounds,2
Nasal Surgical Procedures,E,E04.580.392,Otorhinolaryngologic Surgical Procedures,"Surgical Procedures, Operative",2
Nasolacrimal Duct,A,A09.371.463.640,Lacrimal Apparatus,Eye,2
Natalizumab,D,D12.776.124.790.651.114.224.060.813,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Natalizumab,D,D12.776.124.486.485.114.224.060.813,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Natalizumab,D,D12.776.377.715.548.114.224.200.813,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
National Institute of Allergy and Infectious Diseases (U.S.),I,I01.409.418.750.600.650.496.400,National Institutes of Health (U.S.),United States Public Health Service,2
National Institute of Allergy and Infectious Diseases (U.S.),N,N03.540.052.750.400,National Institutes of Health (U.S.),Academies and Institutes,2
National Institute of Allergy and Infectious Diseases (U.S.),N,N03.540.348.500.500.600.650.496.400,National Institutes of Health (U.S.),United States Public Health Service,2
National Library of Medicine (U.S.),N,N03.540.348.500.500.600.650.496.742,National Institutes of Health (U.S.),United States Public Health Service,2
National Library of Medicine (U.S.),N,N03.540.052.750.490,National Institutes of Health (U.S.),Academies and Institutes,2
National Library of Medicine (U.S.),L,L01.346.596.719.875.500,"Libraries, Medical","Libraries, Special",2
National Library of Medicine (U.S.),I,I01.409.418.750.600.650.496.490,National Institutes of Health (U.S.),United States Public Health Service,2
National Library of Medicine (U.S.),J,J03.400.596.831.937.725,"Libraries, Medical","Libraries, Special",2
National Socialism,I,I01.696.586,Political Systems,Social Sciences,2
Natural Cytotoxicity Triggering Receptor 1,D,D12.776.543.750.705.895.750.100,"Receptors, Natural Cytotoxicity Triggering","Receptors, Natural Killer Cell",2
Natural Killer T-Cells,A,A11.118.637.555.567.569.290,T-Lymphocytes,Lymphocytes,2
Natural Killer T-Cells,A,A15.382.490.555.567.569.470,T-Lymphocytes,Lymphocytes,2
Natural Killer T-Cells,A,A15.145.229.637.555.567.569.360,T-Lymphocytes,Lymphocytes,2
Natural Language Processing,L,L01.224.050.375.580,Artificial Intelligence,Algorithms,2
Neck,A,A01.598,Body Regions,NULL,2
Negativism,F,F01.752.698,Personality,Behavior and Behavior Mechanisms,2
Neisseriaceae,B,B03.440.400.425.550,Gram-Negative Aerobic Rods and Cocci,Gram-Negative Aerobic Bacteria,2
Neisseriaceae,B,B03.660.075.525,Betaproteobacteria,Proteobacteria,2
Neocortex,A,A08.186.211.200.885.287.500.420,Cerebral Cortex,Cerebrum,2
Neospora,B,B01.043.075.189.250.750.550,Sarcocystidae,Eimeriida,2
Neostriatum,A,A08.186.211.200.885.287.249.487.550,Corpus Striatum,Basal Ganglia,2
Nephritis,C,C13.351.968.419.570,Kidney Diseases,Urologic Diseases,2
Nephritis,C,C12.777.419.570,Kidney Diseases,Urologic Diseases,2
"Nephrosis, Lipoid",C,C12.777.419.630.477,Nephrosis,Kidney Diseases,2
"Nephrosis, Lipoid",C,C13.351.968.419.630.477,Nephrosis,Kidney Diseases,2
"Nerve Fibers, Unmyelinated",A,A08.675.542.756,Nerve Fibers,Neurons,2
"Nerve Fibers, Unmyelinated",A,A11.671.501.756,Nerve Fibers,Neurons,2
Neurites,A,A11.671.501.145.500,Axons,Nerve Fibers,2
Neurites,A,A11.671.543,Neurons,Cells,2
Neurites,A,A11.284.180.610,Cell Surface Extensions,Cellular Structures,2
Neurites,A,A08.675.542.145.500,Axons,Nerve Fibers,2
Neurites,A,A08.675.256.500,Dendrites,Neurons,2
Neurocysticercosis,C,C01.610.105.250.550,Central Nervous System Helminthiasis,Central Nervous System Parasitic Infections,2
Neurocysticercosis,C,C01.610.335.190.902.185.550,Cysticercosis,Taeniasis,2
Neurocysticercosis,C,C01.207.205.250.550,Central Nervous System Helminthiasis,Central Nervous System Parasitic Infections,2
Neurocysticercosis,C,C10.228.228.205.250.550,Central Nervous System Helminthiasis,Central Nervous System Parasitic Infections,2
Neuroglia,A,A08.637,Nervous System,NULL,2
Neuroglia,A,A11.650,Cells,NULL,2
Neuronal Plasticity,G,G11.561.638,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,2
Neuropeptide Y,D,D12.776.631.650.500,Neuropeptides,Nerve Tissue Proteins,2
Neuropeptide Y,D,D12.644.400.500,Neuropeptides,Peptides,2
Neuroprotection,G,G11.561.645,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,2
Neuroticism,F,F01.752.723,Personality,Behavior and Behavior Mechanisms,2
Neurotoxicity Syndromes,C,C10.720,Nervous System Diseases,NULL,2
Neurotoxicity Syndromes,C,C25.723.705,Poisoning,Chemically-Induced Disorders,2
Neurotoxins,D,D27.888.569.504,Noxae,Toxic Actions,2
New Hampshire,Z,Z01.107.567.875.550.580,New England,United States,2
New Orleans,Z,Z01.107.567.875.750.480.500,Louisiana,Southeastern United States,2
New Orleans,Z,Z01.433.697,Cities,Geographic Locations,2
NFATC Transcription Factors,D,D12.776.930.608,Transcription Factors,Proteins,2
NF-KappaB Inhibitor alpha,D,D12.776.930.326.500,I-kappa B Proteins,Transcription Factors,2
NF-KappaB Inhibitor alpha,D,D12.776.476.381.500,I-kappa B Proteins,Intracellular Signaling Peptides and Proteins,2
NF-KappaB Inhibitor alpha,D,D12.644.360.365.500,I-kappa B Proteins,Intracellular Signaling Peptides and Proteins,2
NF-KappaB Inhibitor alpha,D,D12.776.260.420.500,I-kappa B Proteins,DNA-Binding Proteins,2
Nicotinic Acids,D,D03.066.515,"Acids, Heterocyclic",Heterocyclic Compounds,2
Nicotinic Acids,D,D03.383.725.547,Pyridines,"Heterocyclic Compounds, 1-Ring",2
Nipples,A,A01.236.500,Breast,Body Regions,2
Nitric Oxide Donors,D,D27.505.519.656,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,2
Nitric Oxide Donors,D,D27.505.954.411.590,Cardiovascular Agents,Therapeutic Uses,2
Nitrogen Mustard Compounds,D,D02.455.526.728.650,Mustard Compounds,"Hydrocarbons, Halogenated",2
Nitrosourea Compounds,D,D02.654.692,Nitroso Compounds,Organic Chemicals,2
Nitrosourea Compounds,D,D02.065.950.594,Urea,Amides,2
Nocardia Infections,C,C01.150.252.410.040.692,Actinomycetales Infections,Gram-Positive Bacterial Infections,2
Nocebo Effect,N,N05.715.350.350.625.500,Placebo Effect,"Effect Modifier, Epidemiologic",2
Nocebo Effect,N,N06.850.490.734.875.500,Placebo Effect,"Effect Modifier, Epidemiologic",2
Nocodazole,D,D03.633.100.103.637,Benzimidazoles,"Heterocyclic Compounds, 2-Ring",2
"Noise, Occupational",N,N06.850.460.610.526,Noise,Environmental Pollution,2
"Noise, Occupational",N,N06.230.400.500,Noise,Environment,2
Noninvasive Ventilation,E,E02.880.820.657,"Respiration, Artificial",Respiratory Therapy,2
Noninvasive Ventilation,E,E02.041.625.591,"Respiration, Artificial",Airway Management,2
Nonverbal Communication,F,F01.145.209.530,Communication,Behavior,2
Nonverbal Communication,L,L01.143.649,Communication,Information Science,2
No-Observed-Adverse-Effect Level,E,E05.940.600,Toxicity Tests,Investigative Techniques,2
No-Observed-Adverse-Effect Level,G,G07.690.936.750,Toxicological Phenomena,Pharmacological and Toxicological Phenomena,2
North Dakota,Z,Z01.107.567.875.510.525,Midwestern United States,United States,2
Nuclear Envelope,A,A11.284.835.514.700,Intracellular Membranes,Subcellular Fractions,2
Nuclear Envelope,A,A11.284.149.165.630,Cell Membrane Structures,Cell Membrane,2
Nuclear Envelope,A,A11.284.149.450.700,Intracellular Membranes,Cell Membrane,2
Nuclear Envelope,A,A11.284.430.106.279.692,Cell Nucleus Structures,Cell Nucleus,2
Nucleic Acid Heteroduplexes,D,D13.444.500,Nucleic Acids,"Nucleic Acids, Nucleotides, and Nucleosides",2
Nucleic Acid Precursors,D,D13.400,"Nucleic Acids, Nucleotides, and Nucleosides",NULL,2
Nucleoside Transport Proteins,D,D12.776.543.585.625.750,"Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins",Membrane Transport Proteins,2
Nucleoside Transport Proteins,D,D12.776.157.530.625.750,"Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins",Membrane Transport Proteins,2
Nucleoside-Diphosphate Kinase,D,D08.811.913.696.650.550,Phosphotransferases (Phosphate Group Acceptor),Phosphotransferases,2
Nucleus Accumbens,A,A08.186.211.200.885.287.249.487.775.500,Ventral Striatum,Corpus Striatum,2
Numbers Needed To Treat,E,E05.581.500.902.500,Sample Size,Research Design,2
"Numerical Analysis, Computer-Assisted",L,L01.224.680.700,Mathematical Computing,Computing Methodologies,2
Nurse Specialists,M,M01.526.485.650.648,Nurses,Health Personnel,2
Nurse Specialists,N,N02.360.650.648,Nurses,Health Personnel,2
Nursing Audit,N,N05.700.175.520,Clinical Audit,"Quality Assurance, Health Care",2
Nursing Audit,N,N04.761.700.250.520,Clinical Audit,"Quality Assurance, Health Care",2
"Nursing, Supervisory",N,N04.452.758.377.750,Nursing,Professional Practice,2
"Nystagmus, Pathologic",C,C11.590.400,Ocular Motility Disorders,Eye Diseases,2
"Nystagmus, Pathologic",C,C10.292.562.675,Ocular Motility Disorders,Cranial Nerve Diseases,2
Obsessive-Compulsive Disorder,F,F03.080.600,Anxiety Disorders,Mental Disorders,2
Occipital Lobe,A,A08.186.211.200.885.287.500.571,Cerebral Cortex,Cerebrum,2
Oculomotor Muscles,A,A02.633.567.700,"Muscle, Skeletal",Muscles,2
Office Nursing,N,N04.452.758.377.875,Nursing,Professional Practice,2
"Oils, Volatile",D,D10.627.675,Oils,Lipids,2
Old Age Assistance,N,N03.219.521.346.506.678,Public Assistance,"Financing, Government",2
Oleic Acid,D,D10.251.355.325.600.525,Oleic Acids,"Fatty Acids, Monounsaturated",2
Oleic Acids,D,D10.251.355.325.600,"Fatty Acids, Monounsaturated","Fatty Acids, Unsaturated",2
Olfactory Perception,F,F02.463.593.485,Perception,Mental Processes,2
Olive Oil,G,G07.203.300.375.400.500,"Dietary Fats, Unsaturated",Dietary Fats,2
Olive Oil,J,J02.500.375.400.500,"Dietary Fats, Unsaturated",Dietary Fats,2
Olive Oil,D,D10.212.507.650,"Fats, Unsaturated",Fats,2
Olive Oil,D,D10.212.302.380.580,"Dietary Fats, Unsaturated",Dietary Fats,2
Olive Oil,D,D10.627.700.728,Plant Oils,Oils,2
Oncogenic Viruses,B,B04.613,Viruses,NULL,2
Oocyte Donation,E,E05.820.800.968,"Reproductive Techniques, Assisted",Reproductive Techniques,2
Oocyte Donation,E,E02.875.800.968,"Reproductive Techniques, Assisted",Reproductive Techniques,2
Oogenesis,G,G08.686.784.310.500,Gametogenesis,Reproduction,2
Oogenesis,G,G04.152.650.249,Gametogenesis,Cell Differentiation,2
Operative Time,E,E04.614.374.500,Intraoperative Period,Perioperative Period,2
Operative Time,N,N02.421.585.753.374.500,Intraoperative Period,Perioperative Period,2
Ophthalmic Assistants,N,N02.360.067.740.690,Physician Assistants,Allied Health Personnel,2
Ophthalmic Assistants,M,M01.526.485.067.740.690,Physician Assistants,Allied Health Personnel,2
Optical Devices,E,E07.632,Equipment and Supplies,NULL,2
Orchitis,C,C12.294.829.493,Testicular Diseases,"Genital Diseases, Male",2
Orchitis,C,C19.391.829.493,Testicular Diseases,Gonadal Disorders,2
Oregon,Z,Z01.107.567.875.560.550,Northwestern United States,United States,2
Oregon,Z,Z01.107.567.875.580.550,Pacific States,United States,2
Organ Sparing Treatments,E,E02.674,Therapeutics,NULL,2
Organic Anion Transporters,D,D12.776.543.585.450.074.500,Anion Transport Proteins,Ion Pumps,2
Organic Anion Transporters,D,D12.776.157.530.450.074.500,Anion Transport Proteins,Ion Pumps,2
Organisation for Economic Co-Operation and Development,N,N03.540.514.481,International Agencies,Organizations,2
Orientation,F,F01.058.577,"Adaptation, Psychological",Behavior and Behavior Mechanisms,2
Orientation,F,F02.830.606,Psychophysiology,Psychological Phenomena,2
Ornithine,D,D12.125.068.665,"Amino Acids, Basic",Amino Acids,2
Ornithine,D,D12.125.095.765,"Amino Acids, Diamino",Amino Acids,2
Orthobunyavirus,B,B04.820.480.750.640,Bunyaviridae,Negative-Sense RNA Viruses,2
Orthodontics,E,E06.658,Dentistry,NULL,2
Orthodontics,H,H02.163.876.439,"Specialties, Dental",Dentistry,2
Orthoptics,H,H02.573,Health Occupations,NULL,2
Orthoptics,E,E02.730,Therapeutics,NULL,2
Oscillometry,E,E05.654,Investigative Techniques,NULL,2
Osteocytes,A,A11.329.629.500,Osteoblasts,Connective Tissue Cells,2
Osteogenesis Imperfecta,C,C05.116.099.708.685,Osteochondrodysplasias,"Bone Diseases, Developmental",2
Osteogenesis Imperfecta,C,C17.300.200.540,Collagen Diseases,Connective Tissue Diseases,2
Osteogenesis Imperfecta,C,C16.320.737,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
"Osteogenesis, Distraction",E,E04.555.120.690,Bone Lengthening,Orthopedic Procedures,2
Osteomalacia,C,C18.452.104.816.640,Rickets,"Bone Diseases, Metabolic",2
Osteomalacia,C,C18.452.174.845.640,Rickets,Calcium Metabolism Disorders,2
Osteomalacia,C,C18.654.521.500.133.770.734.640,Rickets,Vitamin D Deficiency,2
Osteomalacia,C,C05.116.198.816.640,Rickets,"Bone Diseases, Metabolic",2
Ottoman Empire,Z,Z01.586.687,Historical Geographic Locations,Geographic Locations,2
Ouabain,D,D09.408.180.810.600,Strophanthins,Cardiac Glycosides,2
Ouabain,D,D04.210.500.155.580.130.750.600,Strophanthins,Cardenolides,2
Ovarian Follicle,A,A05.360.319.114.630.535,Ovary,Adnexa Uteri,2
Ovarian Follicle,A,A06.300.312.497.535,Ovary,Gonads,2
Oviducts,A,A13.706,Animal Structures,NULL,2
Oxidants,D,D27.888.569.540,Noxae,Toxic Actions,2
Oxidants,D,D27.720.642,Specialty Uses of Chemicals,Chemical Actions and Uses,2
Oxides,D,D01.248.497.158.685,Anions,Ions,2
Oxides,D,D01.650.550,Oxygen Compounds,Inorganic Chemicals,2
Oximes,D,D02.092.570.665,Hydroxylamines,Amines,2
Oxycodone,D,D04.615.723.795.576.149.575,Codeine,Morphine Derivatives,2
Oxycodone,D,D03.605.497.607.204.650,Codeine,Morphine Derivatives,2
Oxycodone,D,D03.633.400.686.607.204.650,Codeine,Morphine Derivatives,2
Oxycodone,D,D03.132.577.249.562.149.575,Codeine,Morphine Derivatives,2
Oxyhemoglobins,D,D12.776.124.400.707,Hemoglobins,Blood Proteins,2
Oxyhemoglobins,D,D12.776.422.316.762.687,Hemoglobins,Globins,2
"Paget Disease, Extramammary",C,C04.557.470.615.660,"Neoplasms, Ductal, Lobular, and Medullary","Neoplasms, Glandular and Epithelial",2
"Paget Disease, Extramammary",C,C04.557.470.200.025.660,Adenocarcinoma,Carcinoma,2
"Pain, Procedural",C,C23.888.592.612.860,Pain,Neurologic Manifestations,2
Paintings,K,K01.093.646,Art,Humanities,2
Paleopathology,I,I01.076.368.584.709,Paleontology,"Anthropology, Physical",2
Palivizumab,D,D12.776.124.486.485.114.224.060.860,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Palivizumab,D,D12.776.124.790.651.114.224.060.860,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Palivizumab,D,D12.776.377.715.548.114.224.200.860,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",2
Pancreatectomy,E,E04.210.752,Digestive System Surgical Procedures,"Surgical Procedures, Operative",2
"Pancreatitis, Chronic",C,C06.689.750.830,Pancreatitis,Pancreatic Diseases,2
Pancytopenia,C,C15.378.700,Hematologic Diseases,Hemic and Lymphatic Diseases,2
Papilloma,C,C04.557.470.700.600,"Neoplasms, Squamous Cell","Neoplasms, Glandular and Epithelial",2
Papio,B,B01.050.150.900.649.313.988.400.112.199.120.610,Cercopithecinae,Cercopithecidae,2
Paranasal Sinuses,A,A04.531.621,Nose,Respiratory System,2
Paranoid Disorders,F,F03.700.450,Schizophrenia Spectrum and Other Psychotic Disorders,Mental Disorders,2
Paraquat,D,D03.383.725.762.621,Pyridinium Compounds,Pyridines,2
Parental Notification,I,I01.880.604.583.080.134.399,Disclosure,Confidentiality,2
"Parenteral Nutrition, Total",E,E02.642.500.505.750,Parenteral Nutrition,Nutritional Support,2
"Parenteral Nutrition, Total",E,E02.421.505.575,Parenteral Nutrition,Feeding Methods,2
Parotitis,C,C07.465.815.470.800,Parotid Diseases,Salivary Gland Diseases,2
Parotitis,C,C07.465.815.793.500,Sialadenitis,Salivary Gland Diseases,2
Partnership Practice,N,N04.452.758.671,Professional Practice,Organization and Administration,2
Parvoviridae,B,B04.280.580,DNA Viruses,Viruses,2
Pasteurella multocida,B,B03.660.250.550.590.500,Pasteurella,Pasteurellaceae,2
Pasteurella multocida,B,B03.440.450.600.600.500,Pasteurella,Pasteurellaceae,2
Pasteurellaceae Infections,C,C01.150.252.400.700,Gram-Negative Bacterial Infections,Bacterial Infections,2
"Pasteurellosis, Pneumonic",C,C01.150.252.400.700.675,Pasteurellaceae Infections,Gram-Negative Bacterial Infections,2
"Pasteurellosis, Pneumonic",C,C01.748.085.600,Bovine Respiratory Disease Complex,Respiratory Tract Infections,2
"Pasteurellosis, Pneumonic",C,C01.925.782.580.600.600.648,Respirovirus Infections,Paramyxoviridae Infections,2
"Pasteurellosis, Pneumonic",C,C08.730.085.600,Bovine Respiratory Disease Complex,Respiratory Tract Infections,2
"Pasteurellosis, Pneumonic",C,C22.196.090.600,Bovine Respiratory Disease Complex,Cattle Diseases,2
Patch-Clamp Techniques,E,E05.200.500.905,Cytological Techniques,Clinical Laboratory Techniques,2
Patch-Clamp Techniques,E,E05.242.800,Cytological Techniques,Investigative Techniques,2
Patella,A,A02.835.232.730.500,Sesamoid Bones,Bone and Bones,2
Patella,A,A02.835.232.043.650.624,Leg Bones,Bones of Lower Extremity,2
Paternal Behavior,F,F01.829.263.370.330,Family Relations,Family,2
Patient-Specific Modeling,E,E05.599.395.821,"Models, Biological","Models, Theoretical",2
Patient-Specific Modeling,L,L01.224.160.750,Computer Simulation,Computing Methodologies,2
"Pattern Recognition, Physiological",F,F02.463.593.524,Perception,Mental Processes,2
Peanut Hypersensitivity,C,C20.543.480.370.572.750,Nut and Peanut Hypersensitivity,Food Hypersensitivity,2
Peas,B,B01.650.940.800.575.912.250.401.630,Fabaceae,Magnoliopsida,2
Pedestrians,M,M01.665,Persons,NULL,2
Pelvic Neoplasms,C,C04.588.699,Neoplasms by Site,Neoplasms,2
Penicillamine,D,D02.886.030.786,"Amino Acids, Sulfur",Sulfur Compounds,2
Penicillamine,D,D12.125.166.786,"Amino Acids, Sulfur",Amino Acids,2
Penicillanic Acid,D,D02.886.108.750.687,Penicillins,beta-Lactams,2
Penicillanic Acid,D,D03.633.100.300.750.687,Penicillins,beta-Lactams,2
Penicillanic Acid,D,D02.065.589.099.750.687,Penicillins,beta-Lactams,2
Penicillin V,D,D02.065.589.099.750.781,Penicillins,beta-Lactams,2
Penicillin V,D,D03.633.100.300.750.781,Penicillins,beta-Lactams,2
Penicillin V,D,D02.886.108.750.781,Penicillins,beta-Lactams,2
Pennsylvania,Z,Z01.107.567.875.500.550,Mid-Atlantic Region,United States,2
Pennsylvania,Z,Z01.107.567.875.350.550,Great Lakes Region,United States,2
Pennsylvania,Z,Z01.107.567.875.075.550,Appalachian Region,United States,2
Pentanols,D,D10.289.640,Fatty Alcohols,Lipids,2
Pentanols,D,D02.033.415.640,Fatty Alcohols,Alcohols,2
"Peptide Chain Initiation, Translational",G,G03.734.871.650,Protein Biosynthesis,Peptide Biosynthesis,2
"Peptide Chain Initiation, Translational",G,G02.111.660.871.650,Protein Biosynthesis,Peptide Biosynthesis,2
Peptide Elongation Factor 1,D,D12.776.157.325.150.101,GTP Phosphohydrolase-Linked Elongation Factors,GTP-Binding Proteins,2
Peptide Elongation Factor 1,D,D08.811.277.040.330.300.100.101,GTP Phosphohydrolase-Linked Elongation Factors,GTP-Binding Proteins,2
Peptide Elongation Factor 1,D,D12.776.835.700.350.101,GTP Phosphohydrolase-Linked Elongation Factors,Peptide Elongation Factors,2
Peptide Synthases,D,D08.811.464.259.850,Carbon-Nitrogen Ligases,Ligases,2
Peptide Termination Factors,D,D12.776.835.862,Ribosomal Proteins,Proteins,2
Peptidyl Transferases,D,D08.811.913.050.200.700,Aminoacyltransferases,Acyltransferases,2
Periaqueductal Gray,A,A08.186.211.132.659.413.875.595,Tegmentum Mesencephali,Cerebral Peduncle,2
Perimenopause,G,G08.686.841.249.500.562,Menopause,Climacteric,2
Perimenopause,G,G08.686.157.500.562,Menopause,Climacteric,2
Perioperative Period,E,E04.614,"Surgical Procedures, Operative",NULL,2
Perioperative Period,N,N02.421.585.753,Patient Care,Health Services,2
Peripheral Nervous System,A,A08.800,Nervous System,NULL,2
Peritoneal Cavity,A,A01.923.047.025.600.678,Peritoneum,Abdominal Cavity,2
Peroxiredoxins,D,D08.811.682.732.850,Peroxidases,Oxidoreductases,2
Peroxynitrous Acid,D,D01.625.600.800,Nitrous Acid,Nitrogen Compounds,2
Peroxynitrous Acid,D,D01.625.700.750,Reactive Nitrogen Species,Nitrogen Compounds,2
Persistent Fetal Circulation Syndrome,C,C08.381.423.694,"Hypertension, Pulmonary",Lung Diseases,2
Persistent Fetal Circulation Syndrome,C,C16.614.694,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Personal Construct Theory,F,F02.739.660,Psychological Theory,Psychological Phenomena,2
Persons With Hearing Impairments,M,M01.150.750,Disabled Persons,Persons,2
Petrolatum,D,D02.455.699,Hydrocarbons,Organic Chemicals,2
Pharmaceutical Research,H,H01.770.644.145.442,Biomedical Research,Research,2
"Pharmaceutical Services, Online",N,N02.421.668.475,Pharmaceutical Services,Health Services,2
Pharmacogenomic Variants,G,G05.365.795.446,"Polymorphism, Genetic",Genetic Variation,2
Pharmacokinetics,G,G07.690.725,Pharmacological and Toxicological Phenomena,Physiological Phenomena,2
Pharmacokinetics,G,G03.787,Metabolism,NULL,2
Phase Transition,G,G02.734,Chemical Phenomena,NULL,2
Phase Transition,G,G01.645,Physical Phenomena,NULL,2
Phenazines,D,D03.633.300.704,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",2
Phenobarbital,D,D03.383.742.698.253.650,Barbiturates,Pyrimidinones,2
Phenylpropionates,D,D02.241.223.701,"Acids, Carbocyclic",Carboxylic Acids,2
"Philosophy, Nursing",K,K01.752.712,Philosophy,Humanities,2
Phosphodiesterase 4 Inhibitors,D,D27.505.519.389.735.374,Phosphodiesterase Inhibitors,Enzyme Inhibitors,2
Phosphodiesterase 5 Inhibitors,D,D27.505.519.389.735.500,Phosphodiesterase Inhibitors,Enzyme Inhibitors,2
Phosphodiesterase Inhibitors,D,D27.505.519.389.735,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,2
Phosphogluconate Dehydrogenase,D,D08.811.682.047.150.600,Carbohydrate Dehydrogenases,Alcohol Oxidoreductases,2
Phosphoinositide-3 Kinase Inhibitors,D,D27.505.519.389.736,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,2
Phospholipase C beta,D,D12.776.476.556.500,Phosphoinositide Phospholipase C,Intracellular Signaling Peptides and Proteins,2
Phospholipase C beta,D,D08.811.277.352.640.700.700.562.500,Phosphoinositide Phospholipase C,Type C Phospholipases,2
Phospholipase C beta,D,D12.644.360.571.500,Phosphoinositide Phospholipase C,Intracellular Signaling Peptides and Proteins,2
Phospholipases A1,D,D08.811.277.352.100.680.750.875,Phospholipases A,Phospholipases,2
Phospholipases A2,D,D08.811.277.352.100.680.750.937,Phospholipases A,Phospholipases,2
Phospholipid Ethers,D,D10.570.755.375.760.400.985,Glycerophospholipids,Phosphatidic Acids,2
Phospholipid Ethers,D,D02.355.460.750,Glyceryl Ethers,Ethers,2
Phospholipid Ethers,D,D02.033.800.875.875.750,Glyceryl Ethers,Triose Sugar Alcohols,2
Phosphothreonine,D,D12.125.740.725,Phosphoamino Acids,Amino Acids,2
Phosphothreonine,D,D12.125.142.815.500,Threonine,"Amino Acids, Essential",2
Phosphothreonine,D,D12.125.154.900.500,Threonine,"Amino Acids, Neutral",2
Phosphotyrosine,D,D12.125.072.050.875.750,Tyrosine,"Amino Acids, Aromatic",2
Phosphotyrosine,D,D12.125.740.740,Phosphoamino Acids,Amino Acids,2
Photobleaching,G,G02.740.680,Photochemical Processes,Chemical Phenomena,2
Phthalic Acids,D,D02.241.223.805,"Acids, Carbocyclic",Carboxylic Acids,2
Physical and Rehabilitation Medicine,H,H02.403.680,Medicine,Health Occupations,2
Physical Education and Training,I,I02.233.543,"Education, Nonprofessional",Education,2
Physical Functional Performance,N,N01.400.545.750,Physical Fitness,Health,2
Physics,H,H01.671,Natural Science Disciplines,NULL,2
Physiological Phenomena,G,G07,NULL,NULL,2
Pilots,M,M01.526.727,Occupational Groups,Persons,2
Pinocytosis,G,G04.417.370,Endocytosis,Cell Physiological Phenomena,2
Plagiarism,L,L01.737.684,Publishing,Information Science,2
Plant Bark,A,A18.024.750.200,Plant Epidermis,"Plant Components, Aerial",2
Plant Lectins,D,D12.776.503.499,Lectins,Proteins,2
Plant Lectins,D,D12.776.765.678,Plant Proteins,Proteins,2
Plant Physiological Phenomena,G,G15,NULL,NULL,2
"Plants, Edible",B,B01.650.510,Plants,Eukaryota,2
Plasma Exchange,E,E02.095.135.750,Blood Transfusion,Biological Therapy,2
Plasma Exchange,E,E02.120.770.500,Plasmapheresis,Blood Component Removal,2
Plasma Exchange,E,E04.292.869.500,Plasmapheresis,Extracorporeal Circulation,2
Plasma Exchange,E,E02.912.715.500,Plasmapheresis,Sorption Detoxification,2
Plasminogen,D,D12.776.811.243.610,Enzyme Precursors,Protein Precursors,2
Plasminogen,D,D12.776.124.790.223.580,Beta-Globulins,Serum Globulins,2
Plasminogen,D,D12.776.377.715.182.580,Beta-Globulins,Serum Globulins,2
Plasminogen,D,D08.622.610,Enzyme Precursors,Enzymes and Coenzymes,2
Platelet Adhesiveness,G,G09.188.390.600.500,Platelet Activation,Hemostasis,2
Platelet Adhesiveness,G,G09.188.670,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,2
Platelet-Rich Plasma,A,A15.145.693.600,Plasma,Blood,2
Platelet-Rich Plasma,A,A12.207.270.695.600,Plasma,Extracellular Fluid,2
Platelet-Rich Plasma,A,A12.207.152.693.600,Plasma,Blood,2
Platyrrhini,B,B01.050.150.900.649.313.988.400.600,Haplorhini,Primates,2
Pleural Diseases,C,C08.528,Respiratory Tract Diseases,NULL,2
Pneumocystis Infections,C,C01.150.703.770,Mycoses,Bacterial Infections and Mycoses,2
Podophyllotoxin,D,D02.455.426.559.389.140.450.777,Lignans,Benzyl Compounds,2
Podophyllotoxin,D,D04.615.638.960.675,Tetrahydronaphthalenes,Naphthalenes,2
Podophyllotoxin,D,D02.455.426.559.847.638.960.675,Tetrahydronaphthalenes,Naphthalenes,2
Poisons,D,D27.720.777,Specialty Uses of Chemicals,Chemical Actions and Uses,2
Poisons,D,D27.888.569.612,Noxae,Toxic Actions,2
Political Activism,I,I01.738.708,Politics,Social Sciences,2
Poly I-C,D,D13.695.578.550.560.600,Poly C,Polyribonucleotides,2
Poly I-C,D,D13.695.578.550.650.600,Poly I,Polyribonucleotides,2
Poly(ADP-ribose) Polymerases,D,D08.811.913.400.725.115.690,ADP Ribose Transferases,Pentosyltransferases,2
Polyadenylation,G,G05.308.700.225.710,RNA 3' End Processing,"RNA Processing, Post-Transcriptional",2
Polyadenylation,G,G03.839.225.710,RNA 3' End Processing,"RNA Processing, Post-Transcriptional",2
Polyadenylation,G,G02.111.760.225.710,RNA 3' End Processing,"RNA Processing, Post-Transcriptional",2
Polycyclic Sesquiterpenes,D,D04.663,Polycyclic Compounds,NULL,2
Polycyclic Sesquiterpenes,D,D02.455.849.765.674,Sesquiterpenes,Terpenes,2
Polyethylene,D,D05.750.716.507.500,Polyethylenes,Plastics,2
Polyethylene,D,D25.720.716.507.500,Polyethylenes,Plastics,2
Polyethylene,D,D02.455.326.271.665.550.500,Polyethylenes,Polyenes,2
Polyethylene,J,J01.637.051.720.716.507.500,Polyethylenes,Plastics,2
Polyglactin 910,J,J01.637.051.720.728.772,Polyesters,Polymers,2
Polyglactin 910,D,D25.720.728.772,Polyesters,Polymers,2
Polyglactin 910,D,D05.750.728.772,Polyesters,Polymers,2
Polyglutamic Acid,D,D12.125.119.409.700,Glutamates,"Amino Acids, Dicarboxylic",2
Polyglutamic Acid,D,D12.644.748,Peptides,"Amino Acids, Peptides, and Proteins",2
Polyglutamic Acid,D,D12.125.067.625.700,Glutamates,"Amino Acids, Acidic",2
Polyketides,D,D04.345.674,Macrocyclic Compounds,Polycyclic Compounds,2
Polyketides,D,D02.540.576,Lactones,Organic Chemicals,2
Polymyxins,D,D04.345.566.780,"Peptides, Cyclic",Macrocyclic Compounds,2
Polymyxins,D,D10.477.750,Lipopeptides,Lipids,2
Polymyxins,D,D12.644.641.780,"Peptides, Cyclic",Peptides,2
Polymyxins,D,D12.644.050.600,Antimicrobial Cationic Peptides,Peptides,2
Polymyxins,D,D12.776.543.695.054.600,Antimicrobial Cationic Peptides,Pore Forming Cytotoxic Proteins,2
Polyomavirus,B,B04.280.210.700.615,Polyomaviridae,DNA Tumor Viruses,2
Polyomavirus,B,B04.613.204.670.615,Polyomaviridae,DNA Tumor Viruses,2
Polyphenols,D,D02.455.426.559.389.657.715,Phenols,Benzene Derivatives,2
Polyphenols,D,D03.633.100.150.266.450.260.777,Flavones,Flavonoids,2
Polyproteins,D,D12.776.775,Proteins,"Amino Acids, Peptides, and Proteins",2
"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",C,C20.111.258.750.800,Polyradiculoneuropathy,Autoimmune Diseases of the Nervous System,2
"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",C,C10.314.750.700,Polyradiculoneuropathy,Demyelinating Diseases,2
"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",C,C10.114.750.175,Polyradiculoneuropathy,Autoimmune Diseases of the Nervous System,2
"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",C,C10.668.829.800.750.600,Polyradiculoneuropathy,Polyneuropathies,2
Polystyrenes,D,D02.455.426.559.389.150.750.800.830,Styrene,Styrenes,2
Polystyrenes,D,D25.720.716.579,Plastics,Polymers,2
Polystyrenes,D,D05.750.716.579,Plastics,Polymers,2
Polystyrenes,J,J01.637.051.720.716.579,Plastics,Polymers,2
Polyurethanes,J,J01.637.051.720.716.650,Plastics,Polymers,2
Polyurethanes,J,J01.637.051.720.327.782,Elastomers,Polymers,2
Polyurethanes,J,J01.637.412.700,Elastomers,Manufactured Materials,2
Polyurethanes,D,D05.750.716.650,Plastics,Polymers,2
Polyurethanes,D,D25.720.716.650,Plastics,Polymers,2
Polyurethanes,D,D25.720.327.782,Elastomers,Polymers,2
Polyurethanes,D,D02.241.081.251.944.750,Urethane,Carbamates,2
Polyvinyl Chloride,D,D02.455.326.271.884.533.565,Polyvinyls,Vinyl Compounds,2
Polyvinyl Chloride,D,D25.720.327.811,Elastomers,Polymers,2
Polyvinyl Chloride,D,D25.720.716.721.812,Polyvinyls,Plastics,2
Polyvinyl Chloride,D,D05.750.716.721.812,Polyvinyls,Plastics,2
Polyvinyl Chloride,J,J01.637.051.720.716.721.812,Polyvinyls,Plastics,2
Population Health Management,N,N05.300.570,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",2
Porcine Postweaning Multisystemic Wasting Syndrome,C,C22.905.690,Swine Diseases,Animal Diseases,2
Porcine Postweaning Multisystemic Wasting Syndrome,C,C01.925.256.200.500,Circoviridae Infections,DNA Virus Infections,2
Postoperative Nausea and Vomiting,C,C23.888.821.937.059,Vomiting,"Signs and Symptoms, Digestive",2
Postoperative Nausea and Vomiting,C,C23.888.821.712.700,Nausea,"Signs and Symptoms, Digestive",2
Postoperative Nausea and Vomiting,C,C23.550.767.859,Postoperative Complications,Pathologic Processes,2
Potassium Chloride,D,D01.210.450.150.750,Chlorides,Hydrochloric Acid,2
Potassium Chloride,D,D01.745.625,Potassium Compounds,Inorganic Chemicals,2
Potassium Compounds,D,D01.745,Inorganic Chemicals,NULL,2
Potassium Iodide,D,D01.745.680,Potassium Compounds,Inorganic Chemicals,2
Potassium Iodide,D,D01.475.410.700,Iodides,Iodine Compounds,2
Povidone,D,D02.455.326.271.884.533.699,Polyvinyls,Vinyl Compounds,2
Povidone,D,D05.750.716.721.838,Polyvinyls,Plastics,2
Povidone,D,D03.383.773.812.615,Pyrrolidinones,Pyrrolidines,2
Povidone,D,D25.720.716.721.838,Polyvinyls,Plastics,2
Povidone,J,J01.637.051.720.716.721.838,Polyvinyls,Plastics,2
PPAR gamma,D,D12.776.826.239.588,Peroxisome Proliferator-Activated Receptors,"Receptors, Cytoplasmic and Nuclear",2
Prealbumin,D,D12.776.124.727.750,Serum Albumin,Blood Proteins,2
Prealbumin,D,D12.776.034.841.450,Serum Albumin,Albumins,2
Prebiotics,D,D09.698.718.622,"Polysaccharides, Bacterial",Polysaccharides,2
Prebiotics,D,D09.301.416.500,Dietary Fiber,Dietary Carbohydrates,2
Prebiotics,J,J02.500.400.500,Dietary Fiber,Food,2
Prebiotics,J,J02.500.456.249,Dietary Supplements,Food,2
Prebiotics,G,G07.203.300.400.500,Dietary Fiber,Food,2
Prebiotics,G,G07.203.300.456.249,Dietary Supplements,Food,2
Preliminary Data,E,E05.318.308.763,Data Collection,Epidemiologic Methods,2
Preliminary Data,N,N05.715.360.300.638,Data Collection,Health Care Evaluation Mechanisms,2
Preliminary Data,N,N06.850.520.308.763,Data Collection,Epidemiologic Methods,2
Prenatal Education,N,N02.421.726.407.680.500,Patient Education as Topic,Health Education,2
Prenatal Education,I,I02.233.332.500.500,Patient Education as Topic,Health Education,2
Prescription Drug Misuse,E,E02.319.306.500,Drug Misuse,Drug Therapy,2
Prescription Fees,N,N03.219.442.551.621,"Fees, Pharmaceutical",Fees and Charges,2
"Preservation, Biological",E,E02.792,Therapeutics,NULL,2
"Preservation, Biological",E,E05.760,Investigative Techniques,NULL,2
Prilocaine,D,D02.092.146.113.750,Anilides,Aniline Compounds,2
Prilocaine,D,D02.065.199.750,Anilides,Amides,2
Primary Care Nursing,E,E02.760.611.735,Nursing Care,Patient Care,2
Prokaryotic Cells,A,A11.760,Cells,NULL,2
Pro-Opiomelanocortin,D,D12.776.811.800,Protein Precursors,Proteins,2
Pro-Opiomelanocortin,D,D12.776.631.650.405.935,Hypothalamic Hormones,Neuropeptides,2
Pro-Opiomelanocortin,D,D12.644.548.365.935,Hypothalamic Hormones,Peptide Hormones,2
Pro-Opiomelanocortin,D,D12.644.548.691.525.690,"Pituitary Hormones, Anterior",Pituitary Hormones,2
Pro-Opiomelanocortin,D,D12.644.400.400.935,Hypothalamic Hormones,Neuropeptides,2
Pro-Opiomelanocortin,D,D06.472.699.327.935,Hypothalamic Hormones,Peptide Hormones,2
Pro-Opiomelanocortin,D,D06.472.699.631.525.600,"Pituitary Hormones, Anterior",Pituitary Hormones,2
Propane,D,D02.455.326.146.800,Alkanes,"Hydrocarbons, Acyclic",2
Propidium,D,D03.633.300.633.700,Phenanthridines,"Heterocyclic Compounds, 3-Ring",2
Propoxur,D,D02.241.081.251.583.788,Phenylcarbamates,Carbamates,2
Prostatitis,C,C12.294.565.750,Prostatic Diseases,"Genital Diseases, Male",2
"Protein Conformation, beta-Strand",G,G02.111.570.820.709.600.750,"Protein Structure, Secondary",Protein Conformation,2
Protein Denaturation,G,G02.111.688.750.500,Protein Unfolding,Protein Folding,2
Protein Denaturation,G,G01.154.651.750.500,Protein Unfolding,Protein Folding,2
Protein Engineering,E,E05.393.420.601,Genetic Engineering,Genetic Techniques,2
Protein Synthesis Inhibitors,D,D27.505.519.389.760,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,2
"Protein Tyrosine Phosphatase, Non-Receptor Type 1",D,D12.776.476.564.100,"Protein Tyrosine Phosphatases, Non-Receptor",Intracellular Signaling Peptides and Proteins,2
"Protein Tyrosine Phosphatase, Non-Receptor Type 1",D,D08.811.277.352.650.775.300.100,"Protein Tyrosine Phosphatases, Non-Receptor",Protein Tyrosine Phosphatases,2
"Protein Tyrosine Phosphatase, Non-Receptor Type 1",D,D12.644.360.585.100,"Protein Tyrosine Phosphatases, Non-Receptor",Intracellular Signaling Peptides and Proteins,2
"Protein Tyrosine Phosphatase, Non-Receptor Type 2",D,D12.644.360.585.200,"Protein Tyrosine Phosphatases, Non-Receptor",Intracellular Signaling Peptides and Proteins,2
"Protein Tyrosine Phosphatase, Non-Receptor Type 2",D,D08.811.277.352.650.775.300.200,"Protein Tyrosine Phosphatases, Non-Receptor",Protein Tyrosine Phosphatases,2
"Protein Tyrosine Phosphatase, Non-Receptor Type 2",D,D12.776.476.564.200,"Protein Tyrosine Phosphatases, Non-Receptor",Intracellular Signaling Peptides and Proteins,2
Protein-Serine-Threonine Kinases,D,D08.811.913.696.620.682.700,Protein Kinases,Phosphotransferases (Alcohol Group Acceptor),2
Proteolipids,D,D10.570.780,Membrane Lipids,Lipids,2
Proteolipids,D,D12.776.816,Proteins,"Amino Acids, Peptides, and Proteins",2
Proteostasis,G,G02.111.730,Biochemical Phenomena,Chemical Phenomena,2
Proteostasis,G,G03.816,Metabolism,NULL,2
Proteus,B,B03.440.450.425.600,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,2
Proteus,B,B03.660.250.150.590,Enterobacteriaceae,Gammaproteobacteria,2
Prothrombin Time,E,E01.370.225.625.115.610,Blood Coagulation Tests,Hematologic Tests,2
Prothrombin Time,E,E05.200.625.115.610,Blood Coagulation Tests,Hematologic Tests,2
Prothrombin Time,G,G09.188.680,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,2
Proton Pumps,D,D12.776.543.585.450.250.875,Cation Transport Proteins,Ion Pumps,2
Proton Pumps,D,D12.776.157.530.450.250.875,Cation Transport Proteins,Ion Pumps,2
Proton-Translocating ATPases,D,D12.776.157.530.450.250.875.500,Proton Pumps,Cation Transport Proteins,2
Proton-Translocating ATPases,D,D08.811.913.696.650.150.500,ATP Synthetase Complexes,Phosphotransferases (Phosphate Group Acceptor),2
Proton-Translocating ATPases,D,D08.811.277.040.025.325,Adenosine Triphosphatases,Acid Anhydride Hydrolases,2
Proton-Translocating ATPases,D,D12.776.543.585.450.250.875.500,Proton Pumps,Cation Transport Proteins,2
Proto-Oncogene Proteins c-ets,D,D12.776.930.720,Transcription Factors,Proteins,2
Proto-Oncogene Proteins c-ets,D,D12.776.624.664.700.175,Proto-Oncogene Proteins,Oncogene Proteins,2
Proto-Oncogene Proteins c-ets,D,D12.776.260.665,DNA-Binding Proteins,Proteins,2
Proto-Oncogene Proteins c-kit,D,D08.811.913.696.620.682.725.400.050,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,2
Proto-Oncogene Proteins c-kit,D,D12.776.624.664.700.183,Proto-Oncogene Proteins,Oncogene Proteins,2
Proto-Oncogene Proteins c-kit,D,D12.776.543.750.630.124,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",2
Proto-Oncogene Proteins c-kit,D,D12.776.543.750.705.852.150.100,"Receptors, Colony-Stimulating Factor","Receptors, Cytokine",2
Proto-Oncogene Proteins c-kit,D,D12.776.543.750.750.400.200.170,"Receptors, Colony-Stimulating Factor","Receptors, Growth Factor",2
Proto-Oncogene Proteins c-myb,D,D12.776.624.664.700.188,Proto-Oncogene Proteins,Oncogene Proteins,2
Proto-Oncogene Proteins c-myb,D,D12.776.930.725,Transcription Factors,Proteins,2
Proto-Oncogene Proteins c-myb,D,D12.776.260.675,DNA-Binding Proteins,Proteins,2
Proto-Oncogenes,G,G05.360.340.024.340.375.500.791,Oncogenes,"Genes, Neoplasm",2
Psychological Techniques,F,F04.669,Behavioral Disciplines and Activities,NULL,2
Psychological Techniques,E,E05.796,Investigative Techniques,NULL,2
Psychomotor Agitation,F,F01.700.875.700,Psychomotor Disorders,Neurobehavioral Manifestations,2
Psychomotor Agitation,C,C10.597.350.600,Dyskinesias,Neurologic Manifestations,2
Psychomotor Agitation,C,C10.597.606.881.700,Psychomotor Disorders,Neurobehavioral Manifestations,2
Psychomotor Agitation,C,C23.888.592.350.600,Dyskinesias,Neurologic Manifestations,2
Psychomotor Agitation,C,C23.888.592.604.882.700,Psychomotor Disorders,Neurobehavioral Manifestations,2
Psychopharmacology,F,F04.096.712,Behavioral Sciences,Behavioral Disciplines and Activities,2
Psychopharmacology,F,F04.570.505,Psychiatric Somatic Therapies,Behavioral Disciplines and Activities,2
Psychopharmacology,H,H02.628.546,Pharmacology,Health Occupations,2
Psychopharmacology,H,H01.158.703.546,Pharmacology,Biological Science Disciplines,2
"Psychoses, Substance-Induced",F,F03.900.746,Substance-Related Disorders,Mental Disorders,2
"Psychoses, Substance-Induced",F,F03.700.675.600,Psychotic Disorders,Schizophrenia Spectrum and Other Psychotic Disorders,2
"Psychoses, Substance-Induced",C,C25.723.809,Poisoning,Chemically-Induced Disorders,2
"Psychoses, Substance-Induced",C,C25.775.746,Substance-Related Disorders,Chemically-Induced Disorders,2
Pubic Symphysis,A,A02.835.583.656,Joints,Skeleton,2
"Pulmonary Adenomatosis, Ovine",C,C01.925.782.815.725,Retroviridae Infections,RNA Virus Infections,2
"Pulmonary Adenomatosis, Ovine",C,C04.557.470.200.025.715,Adenocarcinoma,Carcinoma,2
"Pulmonary Adenomatosis, Ovine",C,C01.925.928.740,Tumor Virus Infections,Virus Diseases,2
"Pulmonary Adenomatosis, Ovine",C,C22.836.715,Sheep Diseases,Animal Diseases,2
Pulmonary Aspergillosis,C,C08.381.472.850,"Lung Diseases, Fungal",Lung Diseases,2
Pulmonary Aspergillosis,C,C01.150.703.534.850,"Lung Diseases, Fungal",Mycoses,2
Pulmonary Aspergillosis,C,C01.150.703.080.768,Aspergillosis,Mycoses,2
Pulmonary Circulation,G,G09.330.100.770,Blood Circulation,Cardiovascular Physiological Phenomena,2
Pulmonary Circulation,G,G09.772.593,Respiratory Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,2
Pulmonary Gas Exchange,G,G09.772.705.760.602,Respiratory Transport,Respiration,2
Pulmonary Gas Exchange,G,G03.143.775.602,Respiratory Transport,Biological Transport,2
Pulmonary Gas Exchange,E,E01.370.386.700.650,Respiratory Function Tests,"Diagnostic Techniques, Respiratory System",2
Pupil Disorders,C,C10.597.690,Neurologic Manifestations,Nervous System Diseases,2
Pupil Disorders,C,C11.710,Eye Diseases,NULL,2
Pupil Disorders,C,C23.888.592.708,Neurologic Manifestations,Signs and Symptoms,2
Purinergic P1 Receptor Agonists,D,D27.505.519.625.725.200.100,Purinergic Agonists,Purinergic Agents,2
Purinergic P1 Receptor Agonists,D,D27.505.696.577.725.200.100,Purinergic Agonists,Purinergic Agents,2
Purinergic P1 Receptor Antagonists,D,D27.505.696.577.725.400.100,Purinergic Antagonists,Purinergic Agents,2
Purinergic P1 Receptor Antagonists,D,D27.505.519.625.725.400.100,Purinergic Antagonists,Purinergic Agents,2
Purpura,C,C23.888.885.687,Skin Manifestations,Signs and Symptoms,2
Purpura,C,C23.550.414.950,Hemorrhage,Pathologic Processes,2
Purpura,C,C15.378.100.802,Blood Coagulation Disorders,Hematologic Diseases,2
Putamen,A,A08.186.211.200.885.287.249.487.550.784,Neostriatum,Corpus Striatum,2
PUVA Therapy,E,E02.774.945.500,Ultraviolet Therapy,Phototherapy,2
Pyrantel,D,D03.383.903.634,Thiophenes,"Heterocyclic Compounds, 1-Ring",2
Pyrantel,D,D03.383.742.634,Pyrimidines,"Heterocyclic Compounds, 1-Ring",2
Pyrantel,D,D02.886.778.634,Thiophenes,Sulfur Compounds,2
Pyridoxal Phosphate,D,D03.383.725.676.925.500.500,Pyridoxal,Vitamin B 6,2
Pyridoxal Phosphate,D,D08.211.740,Coenzymes,Enzymes and Coenzymes,2
Pyruvates,D,D02.241.755.812,Keto Acids,Carboxylic Acids,2
Quinidine,D,D03.605.687.637,Quinuclidines,"Heterocyclic Compounds, Bridged-Ring",2
Quinidine,D,D03.633.100.810.699,Quinolines,"Heterocyclic Compounds, 2-Ring",2
Quinidine,D,D03.132.206.636,Cinchona Alkaloids,Alkaloids,2
Quinuclidines,D,D03.605.687,"Heterocyclic Compounds, Bridged-Ring",Heterocyclic Compounds,2
Rabeprazole,D,D03.633.100.103.034.750,2-Pyridinylmethylsulfinylbenzimidazoles,Benzimidazoles,2
Rabeprazole,D,D03.383.725.024.750,2-Pyridinylmethylsulfinylbenzimidazoles,Pyridines,2
Rabeprazole,D,D02.886.640.074.750,2-Pyridinylmethylsulfinylbenzimidazoles,Sulfoxides,2
rac1 GTP-Binding Protein,D,D08.811.277.040.330.300.400.700.100.500,rac GTP-Binding Proteins,rho GTP-Binding Proteins,2
rac1 GTP-Binding Protein,D,D12.776.157.325.515.700.100.100,rac GTP-Binding Proteins,rho GTP-Binding Proteins,2
rac1 GTP-Binding Protein,D,D12.644.360.525.700.100.100,rac GTP-Binding Proteins,rho GTP-Binding Proteins,2
rac1 GTP-Binding Protein,D,D12.776.476.525.700.100.100,rac GTP-Binding Proteins,rho GTP-Binding Proteins,2
Racemases and Epimerases,D,D08.811.399.894,Isomerases,Enzymes,2
Radiation Dose Hypofractionation,E,E02.815.639.200.500,"Dose Fractionation, Radiation",Radiotherapy Dosage,2
Radiation Exposure,G,G01.750.748,Radiation,Physical Phenomena,2
Radiation Exposure,N,N06.850.460.350.850,Environmental Exposure,Environmental Pollution,2
Radioactive Hazard Release,N,N06.850.135.848,Accidents,Public Health,2
Radioimmunodetection,E,E05.478.805,Immunologic Techniques,Investigative Techniques,2
Radioimmunodetection,E,E01.370.384.730.710,Radionuclide Imaging,"Diagnostic Techniques, Radioisotope",2
Radioimmunodetection,E,E01.370.350.710.710,Radionuclide Imaging,Diagnostic Imaging,2
Radioisotopes,D,D01.496.749,Isotopes,Inorganic Chemicals,2
Radiosurgery,E,E05.873.500,Stereotaxic Techniques,Investigative Techniques,2
Radiosurgery,E,E02.815.530,Radiotherapy,Therapeutics,2
Radiosurgery,E,E04.525.800.650,Stereotaxic Techniques,Neurosurgical Procedures,2
"Radiotherapy Planning, Computer-Assisted",E,E02.950.825,"Therapy, Computer-Assisted",Therapeutics,2
"Radiotherapy Planning, Computer-Assisted",L,L01.313.500.750.100.710.600.608,"Radiotherapy, Computer-Assisted","Therapy, Computer-Assisted",2
Ranavirus,B,B04.280.410.700,Iridoviridae,DNA Viruses,2
Receptor Cross-Talk,G,G04.794,Cell Physiological Phenomena,NULL,2
Receptor for Advanced Glycation End Products,D,D12.776.543.750.615,"Receptors, Cell Surface",Membrane Proteins,2
"Receptor, Fibroblast Growth Factor, Type 4",D,D12.776.543.750.630.443,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",2
"Receptor, Fibroblast Growth Factor, Type 4",D,D12.776.543.750.750.400.370.937,"Receptors, Fibroblast Growth Factor","Receptors, Growth Factor",2
"Receptor, Fibroblast Growth Factor, Type 4",D,D08.811.913.696.620.682.725.400.180,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,2
"Receptor, Insulin",D,D08.811.913.696.620.682.725.400.200,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,2
"Receptor, Insulin",D,D12.776.543.750.750.580.300,"Receptors, Pancreatic Hormone","Receptors, Peptide",2
"Receptor, Insulin",D,D12.776.543.750.630.484,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",2
"Receptor, Melanocortin, Type 4",D,D12.776.543.750.695.430.937,"Receptors, Melanocortin","Receptors, G-Protein-Coupled",2
"Receptor, Melanocortin, Type 4",D,D12.776.543.750.750.660.285.500.937,"Receptors, Melanocortin","Receptors, Corticotropin",2
"Receptor, Melanocortin, Type 4",D,D12.776.543.750.750.555.285.500.937,"Receptors, Melanocortin","Receptors, Corticotropin",2
"Receptor, Melanocortin, Type 4",D,D12.776.543.750.720.600.285.500.937,"Receptors, Melanocortin","Receptors, Corticotropin",2
"Receptor, Transforming Growth Factor-beta Type II",D,D12.776.543.750.750.400.820.875,"Receptors, Transforming Growth Factor beta","Receptors, Growth Factor",2
"Receptor, Transforming Growth Factor-beta Type II",D,D12.776.543.750.705.852.720.750,"Receptors, Transforming Growth Factor beta","Receptors, Cytokine",2
"Receptor, Transforming Growth Factor-beta Type II",D,D08.811.913.696.620.682.700.795,Protein-Serine-Threonine Kinases,Protein Kinases,2
"Receptors, Adrenergic, beta-2",D,D12.776.543.750.720.330.300.340.200,"Receptors, Adrenergic, beta","Receptors, Adrenergic",2
"Receptors, Adrenergic, beta-2",D,D12.776.543.750.670.300.300.340.200,"Receptors, Adrenergic, beta","Receptors, Adrenergic",2
"Receptors, Adrenergic, beta-2",D,D12.776.543.750.695.150.300.340.725,"Receptors, Adrenergic, beta","Receptors, Adrenergic",2
"Receptors, Angiotensin",D,D12.776.543.750.695.047,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",2
"Receptors, Angiotensin",D,D12.776.543.750.750.130,"Receptors, Peptide","Receptors, Cell Surface",2
"Receptors, Antigen",D,D12.776.543.750.705.816,"Receptors, Immunologic","Receptors, Cell Surface",2
"Receptors, Antigen, B-Cell",D,D12.776.543.750.705.816.821,"Receptors, Antigen","Receptors, Immunologic",2
"Receptors, Antigen, B-Cell",D,D12.776.124.790.651.950,Immunoglobulins,Serum Globulins,2
"Receptors, Antigen, B-Cell",D,D12.776.377.715.548.950,Immunoglobulins,Serum Globulins,2
"Receptors, CCR3",D,D12.776.543.750.705.852.125.150.300,"Receptors, CCR","Receptors, Chemokine",2
"Receptors, CCR3",D,D12.776.543.750.695.160.150.300,"Receptors, CCR","Receptors, Chemokine",2
"Receptors, Complement 3b",D,D12.776.543.750.705.833.600,"Receptors, Complement","Receptors, Immunologic",2
"Receptors, Corticotropin-Releasing Hormone",D,D12.776.543.750.720.600.290,"Receptors, Neuropeptide","Receptors, Neurotransmitter",2
"Receptors, Corticotropin-Releasing Hormone",D,D12.776.543.750.750.555.290,"Receptors, Neuropeptide","Receptors, Peptide",2
"Receptors, Corticotropin-Releasing Hormone",D,D12.776.543.750.750.700.150,"Receptors, Pituitary Hormone-Regulating Hormone","Receptors, Peptide",2
"Receptors, Corticotropin-Releasing Hormone",D,D12.776.543.750.695.180,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",2
"Receptors, Dopamine D4",D,D12.776.543.750.695.150.400.500.750,"Receptors, Dopamine D2","Receptors, Dopamine",2
"Receptors, Dopamine D4",D,D12.776.543.750.670.300.400.500.500,"Receptors, Dopamine D2","Receptors, Dopamine",2
"Receptors, Dopamine D4",D,D12.776.543.750.720.330.400.500.500,"Receptors, Dopamine D2","Receptors, Dopamine",2
"Receptors, Fibroblast Growth Factor",D,D12.776.543.750.750.400.370,"Receptors, Growth Factor","Receptors, Peptide",2
"Receptors, Glucagon",D,D12.776.543.750.750.580.350,"Receptors, Pancreatic Hormone","Receptors, Peptide",2
"Receptors, Glucagon",D,D12.776.543.750.695.330,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",2
"Receptors, Growth Factor",D,D12.776.543.750.750.400,"Receptors, Peptide","Receptors, Cell Surface",2
"Receptors, Interleukin-1 Type I",D,D12.776.543.750.705.852.420.300.500,"Receptors, Interleukin-1","Receptors, Interleukin",2
"Receptors, Interleukin-12",D,D12.776.543.750.705.852.420.580,"Receptors, Interleukin","Receptors, Cytokine",2
"Receptors, Interleukin-4",D,D12.776.543.750.705.852.420.360,"Receptors, Interleukin","Receptors, Cytokine",2
"Receptors, Interleukin-8B",D,D12.776.543.750.705.852.125.500.750.750,"Receptors, Interleukin-8","Receptors, CXCR",2
"Receptors, Interleukin-8B",D,D12.776.543.750.705.852.420.421.750,"Receptors, Interleukin-8","Receptors, Interleukin",2
"Receptors, Interleukin-8B",D,D12.776.543.750.695.160.500.750.750,"Receptors, Interleukin-8","Receptors, CXCR",2
"Receptors, KIR2DL4",D,D12.776.543.750.705.895.500.468,"Receptors, KIR","Receptors, Natural Killer Cell",2
"Receptors, KIR3DL1",D,D12.776.543.750.705.895.500.500,"Receptors, KIR","Receptors, Natural Killer Cell",2
"Receptors, Lymphocyte Homing",D,D12.776.543.750.705.877,"Receptors, Immunologic","Receptors, Cell Surface",2
"Receptors, Lymphocyte Homing",D,D12.776.543.550.200.625,Cell Adhesion Molecules,Membrane Glycoproteins,2
"Receptors, Lymphocyte Homing",D,D23.050.301.350.625,Cell Adhesion Molecules,"Antigens, Surface",2
"Receptors, Lymphocyte Homing",D,D12.776.395.550.200.625,Cell Adhesion Molecules,Membrane Glycoproteins,2
"Receptors, Mineralocorticoid",D,D12.776.826.750.530,"Receptors, Steroid","Receptors, Cytoplasmic and Nuclear",2
"Receptors, Oxytocin",D,D12.776.543.750.720.600.630,"Receptors, Neuropeptide","Receptors, Neurotransmitter",2
"Receptors, Oxytocin",D,D12.776.543.750.750.555.630,"Receptors, Neuropeptide","Receptors, Peptide",2
"Receptors, Oxytocin",D,D12.776.543.750.750.660.600,"Receptors, Pituitary Hormone","Receptors, Peptide",2
"Receptors, Oxytocin",D,D12.776.543.750.695.630,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",2
"Receptors, Purinergic P2",D,D12.776.543.750.695.700.720,"Receptors, Purinergic","Receptors, G-Protein-Coupled",2
"Receptors, Purinergic P2",D,D12.776.543.750.720.700.720,"Receptors, Purinergic","Receptors, Neurotransmitter",2
"Receptors, Retinoic Acid",D,D12.776.826.701,"Receptors, Cytoplasmic and Nuclear",Proteins,2
"Receptors, Retinoic Acid",D,D12.776.930.775,Transcription Factors,Proteins,2
"Receptors, Scavenger",D,D12.776.543.750.710.450.750,"Receptors, LDL","Receptors, Lipoprotein",2
"Receptors, Scavenger",D,D12.776.543.750.705.940,"Receptors, Immunologic","Receptors, Cell Surface",2
RecQ Helicases,D,D08.811.399.340.249,DNA Helicases,Isomerases,2
RecQ Helicases,D,D08.811.277.040.025.159.249,DNA Helicases,Adenosine Triphosphatases,2
Recreational Drug Use,F,F01.145.683,Behavior,Behavior and Behavior Mechanisms,2
Rectovaginal Fistula,C,C06.267.550.600.650,Rectal Fistula,Intestinal Fistula,2
Rectovaginal Fistula,C,C06.405.469.860.752.650,Rectal Fistula,Rectal Diseases,2
Rectovaginal Fistula,C,C06.405.469.471.600.650,Rectal Fistula,Intestinal Fistula,2
Rectovaginal Fistula,C,C23.300.575.185.550.600.650,Rectal Fistula,Intestinal Fistula,2
Rectovaginal Fistula,C,C23.300.575.925.558,Vaginal Fistula,Fistula,2
Rectovaginal Fistula,C,C13.351.500.894.767.249,Vaginal Fistula,Vaginal Diseases,2
Rectus Abdominis,A,A02.633.567.050.800,Abdominal Muscles,"Muscle, Skeletal",2
"Regulatory Elements, Transcriptional",G,G05.360.340.024.340.137.750,Gene Components,Genes,2
Rehabilitation Nursing,H,H02.478.676.789,"Specialties, Nursing",Nursing,2
Rehabilitation Nursing,N,N02.421.533.889,Nursing Care,Health Services,2
"Rehabilitation, Vocational",N,N02.421.784.644,Rehabilitation,Health Services,2
"Rehabilitation, Vocational",E,E02.831.782,Rehabilitation,Therapeutics,2
"Rehabilitation, Vocational",E,E02.760.169.063.500.782,Rehabilitation,Aftercare,2
Renal Artery Obstruction,C,C12.777.419.775,Kidney Diseases,Urologic Diseases,2
Renal Artery Obstruction,C,C14.907.137.727,Arterial Occlusive Diseases,Vascular Diseases,2
Renal Artery Obstruction,C,C13.351.968.419.775,Kidney Diseases,Urologic Diseases,2
Renal Circulation,G,G08.852.725,Urinary Tract Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,2
Renal Circulation,G,G09.330.100.812,Blood Circulation,Cardiovascular Physiological Phenomena,2
"Reproduction, Asexual",G,G08.686.784.830,Reproduction,Reproductive Physiological Phenomena,2
Respiratory Physiological Phenomena,G,G09.772,Circulatory and Respiratory Physiological Phenomena,NULL,2
Respite Care,N,N02.421.533.320.610,Home Nursing,Nursing Care,2
Respite Care,N,N02.421.143.524.470.610,Home Nursing,Home Care Services,2
Respite Care,E,E02.760.611.470.610,Home Nursing,Nursing Care,2
Response Elements,G,G05.360.340.024.340.137.750.249.765,"Enhancer Elements, Genetic","Regulatory Elements, Transcriptional",2
Response Elements,G,G05.360.340.024.340.137.750.680.765,"Promoter Regions, Genetic","Regulatory Elements, Transcriptional",2
Response Elements,G,G05.360.080.689.330.700,"Enhancer Elements, Genetic","Regulatory Sequences, Nucleic Acid",2
Response Elements,G,G05.360.080.689.675.700,"Promoter Regions, Genetic","Regulatory Sequences, Nucleic Acid",2
Response Elements,G,G02.111.570.080.689.330.700,"Enhancer Elements, Genetic","Regulatory Sequences, Nucleic Acid",2
Response Elements,G,G02.111.570.080.689.675.700,"Promoter Regions, Genetic","Regulatory Sequences, Nucleic Acid",2
Retinal Hemorrhage,C,C11.768.710,Retinal Diseases,Eye Diseases,2
Retinal Hemorrhage,C,C11.290.807,Eye Hemorrhage,Eye Diseases,2
Retinal Hemorrhage,C,C23.550.414.756.775,Eye Hemorrhage,Hemorrhage,2
Retinitis Pigmentosa,C,C11.270.684,"Eye Diseases, Hereditary",Eye Diseases,2
Retinitis Pigmentosa,C,C11.768.585.658.500,Retinal Dystrophies,Retinal Degeneration,2
Retinitis Pigmentosa,C,C16.320.290.684,"Eye Diseases, Hereditary","Genetic Diseases, Inborn",2
Retinoscopy,E,E01.370.380.560.500,Ophthalmoscopy,"Diagnostic Techniques, Ophthalmological",2
Reverse Transcription,G,G02.111.873.500,"Transcription, Genetic",Biochemical Phenomena,2
Reverse Transcription,G,G05.297.700.500,"Transcription, Genetic",Gene Expression,2
Rhabdomyolysis,C,C05.651.807,Muscular Diseases,Musculoskeletal Diseases,2
Rh-Hr Blood-Group System,D,D23.050.705.230.775,Blood Group Antigens,Isoantigens,2
Rh-Hr Blood-Group System,D,D23.050.301.290.775,Blood Group Antigens,"Antigens, Surface",2
rho GTP-Binding Proteins,D,D12.776.476.525.700,Monomeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,2
rho GTP-Binding Proteins,D,D08.811.277.040.330.300.400.700,Monomeric GTP-Binding Proteins,GTP-Binding Proteins,2
rho GTP-Binding Proteins,D,D12.776.157.325.515.700,Monomeric GTP-Binding Proteins,GTP-Binding Proteins,2
rho GTP-Binding Proteins,D,D12.644.360.525.700,Monomeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,2
Rho Guanine Nucleotide Exchange Factors,D,D12.644.360.325.300.099,Guanine Nucleotide Exchange Factors,GTP-Binding Protein Regulators,2
Rho Guanine Nucleotide Exchange Factors,D,D12.776.476.325.300.099,Guanine Nucleotide Exchange Factors,GTP-Binding Protein Regulators,2
Rho(D) Immune Globulin,D,D12.776.124.790.651.114.619.393.700,Immunoglobulin G,Immunoglobulin Isotypes,2
Rho(D) Immune Globulin,D,D12.776.124.486.485.114.619.393.700,Immunoglobulin G,Immunoglobulin Isotypes,2
Rho(D) Immune Globulin,D,D12.776.377.715.548.114.619.393.700,Immunoglobulin G,Immunoglobulin Isotypes,2
rhoA GTP-Binding Protein,D,D12.776.157.325.515.700.200,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,2
rhoA GTP-Binding Protein,D,D12.644.360.525.700.200,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,2
rhoA GTP-Binding Protein,D,D08.811.277.040.330.300.400.700.200,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,2
rhoA GTP-Binding Protein,D,D12.776.476.525.700.200,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,2
Rhodococcus,B,B03.510.024.981.775,Nocardiaceae,Actinobacteria,2
Rhombencephalon,A,A08.186.211.132.810,Brain Stem,Brain,2
Riboflavin Deficiency,C,C18.654.521.500.133.699.713,Vitamin B Deficiency,Avitaminosis,2
Ribonuclease T1,D,D08.811.277.352.355.350.725,Endoribonucleases,Endonucleases,2
Ribonuclease T1,D,D08.811.277.352.700.350.725,Endoribonucleases,Ribonucleases,2
"Ribonuclease, Pancreatic",D,D08.811.277.352.700.350.715,Endoribonucleases,Ribonucleases,2
"Ribonuclease, Pancreatic",D,D08.811.277.352.355.350.715,Endoribonucleases,Endonucleases,2
"Ribonucleoproteins, Small Nuclear",D,D12.776.157.725.500.875,Ribonucleoproteins,RNA-Binding Proteins,2
"Ribonucleoproteins, Small Nuclear",D,D12.776.664.962.500.875,Ribonucleoproteins,RNA-Binding Proteins,2
Ribonucleotides,D,D13.695.827,Nucleotides,"Nucleic Acids, Nucleotides, and Nucleosides",2
"Ribosome Subunits, Small",A,A11.284.430.214.190.875.811.870.750,Ribosome Subunits,Ribosomes,2
Rickets,C,C05.116.198.816,"Bone Diseases, Metabolic",Bone Diseases,2
Rickets,C,C18.654.521.500.133.770.734,Vitamin D Deficiency,Avitaminosis,2
Rickets,C,C18.452.174.845,Calcium Metabolism Disorders,Metabolic Diseases,2
Rickets,C,C18.452.104.816,"Bone Diseases, Metabolic",Metabolic Diseases,2
Rickettsiaceae Infections,C,C01.920.914,Vector Borne Diseases,Infections,2
Rickettsiaceae Infections,C,C01.150.252.400.789,Gram-Negative Bacterial Infections,Bacterial Infections,2
Rifabutin,D,D04.345.295.750.650,Rifamycins,"Lactams, Macrocyclic",2
Rifabutin,D,D03.633.400.811.650,Rifamycins,"Heterocyclic Compounds, 4 or More Rings",2
Rifamycins,D,D03.633.400.811,"Heterocyclic Compounds, 4 or More Rings","Heterocyclic Compounds, Fused-Ring",2
Rifamycins,D,D04.345.295.750,"Lactams, Macrocyclic",Macrocyclic Compounds,2
Rilpivirine,D,D03.383.742.755,Pyrimidines,"Heterocyclic Compounds, 1-Ring",2
Rilpivirine,D,D02.626.809,Nitriles,Organic Chemicals,2
Risedronic Acid,D,D02.705.429.500.872,Diphosphonates,Organophosphonates,2
Risedronic Acid,D,D03.383.725.836,Pyridines,"Heterocyclic Compounds, 1-Ring",2
"Risk Sharing, Financial",N,N03.219.463.800.800,Risk Management,Financial Management,2
"Risk Sharing, Financial",N,N04.452.871.800,Risk Management,Organization and Administration,2
RNA Editing,G,G05.308.700.250,"RNA Processing, Post-Transcriptional",Gene Expression Regulation,2
RNA Editing,G,G02.111.760.250,"RNA Processing, Post-Transcriptional",Biochemical Phenomena,2
RNA Editing,G,G03.839.250,"RNA Processing, Post-Transcriptional",Metabolism,2
RNA Splice Sites,G,G02.111.570.080.689.687.490,"Regulatory Sequences, Ribonucleic Acid","Regulatory Sequences, Nucleic Acid",2
RNA Splice Sites,G,G05.360.080.689.687.490,"Regulatory Sequences, Ribonucleic Acid","Regulatory Sequences, Nucleic Acid",2
RNA Splice Sites,G,G05.360.340.024.340.137.800,Gene Components,Genes,2
RNA Splice Sites,D,D13.444.735.544.550,"RNA, Messenger",RNA,2
"RNA, Complementary",D,D13.444.600.723.480,RNA Probes,Nucleic Acid Probes,2
"RNA, Complementary",D,D13.444.735.480,RNA,Nucleic Acids,2
"RNA, Complementary",D,D27.720.470.530.600.825.840,RNA Probes,Nucleic Acid Probes,2
"RNA, Neoplasm",D,D13.444.735.615,RNA,Nucleic Acids,2
"RNA, Ribosomal, 28S",D,D13.444.735.686.690,"RNA, Ribosomal",RNA,2
"RNA, Small Untranslated",D,D13.444.735.790.552,"RNA, Untranslated",RNA,2
"RNA, Transfer, Amino Acid-Specific",D,D13.444.735.757.700,"RNA, Transfer",RNA,2
"RNA, Transfer, Lys",D,D13.444.735.757.700.510,"RNA, Transfer, Amino Acid-Specific","RNA, Transfer",2
RNA-Directed DNA Polymerase,D,D12.776.964.970.600.850.375.750,"Gene Products, pol",Viral Core Proteins,2
RNA-Directed DNA Polymerase,D,D12.776.964.900.750.500.750,"Gene Products, pol",Viral Replicase Complex Proteins,2
RNA-Directed DNA Polymerase,D,D12.776.964.775.375.750,"Gene Products, pol",Retroviridae Proteins,2
RNA-Directed DNA Polymerase,D,D08.811.913.696.445.308.300.750,DNA-Directed DNA Polymerase,DNA Nucleotidyltransferases,2
Role Playing,E,E02.190.525.781.653,Psychodrama,Mind-Body Therapies,2
Role Playing,F,F04.754.864.581.679.653,Psychodrama,"Psychotherapy, Group",2
Root Canal Therapy,E,E06.397.778,Endodontics,Dentistry,2
Running,G,G11.427.410.568.610,Locomotion,Movement,2
Running,G,G11.427.410.698.277.750,Exercise,Motor Activity,2
Running,I,I03.350.750,Exercise,Human Activities,2
Running,I,I03.450.642.845.610,Sports,Recreation,2
Rutaceae,B,B01.650.940.800.575.912.250.875,Magnoliopsida,Tracheophyta,2
S100 Calcium Binding Protein beta Subunit,D,D12.776.631.655.750,S100 Proteins,Nerve Tissue Proteins,2
S100 Calcium Binding Protein beta Subunit,D,D12.776.157.125.750.625,S100 Proteins,Calcium-Binding Proteins,2
Safety-Based Drug Withdrawals,I,I01.880.604.605.250.812,Drug and Narcotic Control,"Legislation, Drug",2
Safety-Based Drug Withdrawals,N,N04.452.706.310.750,Drug and Narcotic Control,Pharmacy Administration,2
Safety-Based Drug Withdrawals,N,N06.850.210.637.700,Product Recalls and Withdrawals,Consumer Product Safety,2
Salivary Gland Neoplasms,C,C04.588.443.591.824,Mouth Neoplasms,Head and Neck Neoplasms,2
Salivary Gland Neoplasms,C,C07.465.815.718,Salivary Gland Diseases,Mouth Diseases,2
Salivary Gland Neoplasms,C,C07.465.530.824,Mouth Neoplasms,Mouth Diseases,2
Salpingo-oophorectomy,E,E04.270.282.685.500,Ovariectomy,Castration,2
Salpingo-oophorectomy,E,E04.950.300.680.500,Ovariectomy,Gynecologic Surgical Procedures,2
Salpingo-oophorectomy,E,E04.950.300.715.500,Salpingectomy,Gynecologic Surgical Procedures,2
Salpingo-oophorectomy,E,E04.950.165.685.500,Ovariectomy,Castration,2
Saphenous Vein,A,A07.015.908.819,Veins,Blood Vessels,2
Sarcoidosis,C,C15.604.515.827,Lymphoproliferative Disorders,Lymphatic Diseases,2
"Sarcoma, Ewing",C,C04.557.450.565.575.650.800,Osteosarcoma,"Neoplasms, Bone Tissue",2
"Sarcoma, Ewing",C,C04.557.450.795.620.800,Osteosarcoma,Sarcoma,2
Sarcoptes scabiei,B,B01.050.500.131.166.132.419.750.800,Sarcoptidae,Mites,2
Scalp,A,A01.456.810,Head,Body Regions,2
Scapegoating,F,F01.145.813.572,Social Behavior,Behavior,2
Scapegoating,F,F01.393.693.500,Projection,Defense Mechanisms,2
Scapegoating,F,F01.393.246.500,"Displacement, Psychological",Defense Mechanisms,2
"Scattering, Radiation",G,G01.867,Physical Phenomena,NULL,2
"Scattering, Radiation",E,E05.196.822,"Chemistry Techniques, Analytical",Investigative Techniques,2
"Scattering, Small Angle",E,E05.196.822.830,"Scattering, Radiation","Chemistry Techniques, Analytical",2
"Scattering, Small Angle",G,G01.867.755,"Scattering, Radiation",Physical Phenomena,2
"Schizophrenia, Paranoid",F,F03.700.750.600,Schizophrenia,Schizophrenia Spectrum and Other Psychotic Disorders,2
School Mental Health Services,N,N04.880,Health Services Administration,NULL,2
School Mental Health Services,N,N02.421.726.809.659,School Health Services,Preventive Health Services,2
School Mental Health Services,N,N02.421.461.581,Mental Health Services,Health Services,2
"Schools, Dental",I,I02.783.495.481,"Schools, Health Occupations",Schools,2
"Schools, Nursing",I,I02.783.495.623,"Schools, Health Occupations",Schools,2
Scientific Experimental Error,N,N05.715.360.300.202.500,Data Accuracy,Data Collection,2
Scientific Experimental Error,E,E05.318.370.725.250.500,Data Accuracy,Reproducibility of Results,2
Screw Worm Infection,C,C01.610.858.211.503.744,Myiasis,Ectoparasitic Infestations,2
Sea Bream,B,B01.050.150.900.493.602.750,Perciformes,Fishes,2
Sea Urchins,B,B01.050.500.408.578,Echinodermata,Invertebrates,2
Self-Control,F,F01.145.813.595,Social Behavior,Behavior,2
Semen Analysis,E,E05.200.992,Clinical Laboratory Techniques,Investigative Techniques,2
Semen Analysis,E,E01.370.225.992,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,2
Semen Preservation,E,E02.792.833.890,Tissue Preservation,"Preservation, Biological",2
Semen Preservation,E,E05.760.833.890,Tissue Preservation,"Preservation, Biological",2
Seminal Vesicles,A,A05.360.444.713,"Genitalia, Male",Genitalia,2
Sepharose,D,D09.698.813,Polysaccharides,Carbohydrates,2
Sequestosome-1 Protein,D,D12.644.360.024.329,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,2
Sequestosome-1 Protein,D,D12.776.157.057.160,"Adaptor Proteins, Signal Transducing",Carrier Proteins,2
Sequestosome-1 Protein,D,D12.776.094.750,Autophagy-Related Proteins,Proteins,2
Sequestosome-1 Protein,D,D12.776.476.024.422,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,2
Serial Publications,L,L01.178.682.829,Publications,Communications Media,2
Serratia Infections,C,C01.150.252.400.310.850,Enterobacteriaceae Infections,Gram-Negative Bacterial Infections,2
Sertraline,D,D02.092.705.800,1-Naphthylamine,Amines,2
Sertraline,D,D02.455.426.559.847.638.845.800,1-Naphthylamine,Naphthalenes,2
Sertraline,D,D04.615.638.845.800,1-Naphthylamine,Naphthalenes,2
"Serum Albumin, Bovine",D,D12.776.034.841.540,Serum Albumin,Albumins,2
"Serum Albumin, Bovine",D,D12.776.124.727.875,Serum Albumin,Blood Proteins,2
Serving Size,G,G07.203.650.240.917,Diet,Nutritional Physiological Phenomena,2
Severe Combined Immunodeficiency,C,C20.673.795.750,Primary Immunodeficiency Diseases,Immunologic Deficiency Syndromes,2
Severe Combined Immunodeficiency,C,C16.320.798.750,Primary Immunodeficiency Diseases,"Genetic Diseases, Inborn",2
Severe Combined Immunodeficiency,C,C18.452.284.800,DNA Repair-Deficiency Disorders,Metabolic Diseases,2
Severe Combined Immunodeficiency,C,C16.614.815,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Sex Determination Analysis,E,E01.370.225.996,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,2
Sex Determination Analysis,E,E05.393.285.830,Cytogenetic Analysis,Genetic Techniques,2
Sex Determination Analysis,E,E05.200.996,Clinical Laboratory Techniques,Investigative Techniques,2
Sex Differentiation,G,G08.686.841.500,Sexual Development,Reproductive Physiological Phenomena,2
Sex Differentiation,G,G07.345.500.325.377.843,Organogenesis,Embryonic and Fetal Development,2
Sex Differentiation,G,G07.345.750.500,Sexual Development,Growth and Development,2
Sexology,F,F04.096.837,Behavioral Sciences,Behavioral Disciplines and Activities,2
Shewanella,B,B03.660.250.021.755,Alteromonadaceae,Gammaproteobacteria,2
Shewanella,B,B03.440.450.690,Gram-Negative Facultatively Anaerobic Rods,Gram-Negative Bacteria,2
Shiga Toxins,D,D23.946.123.794,Bacterial Toxins,"Toxins, Biological",2
Shiga Toxins,D,D23.946.330.575,Enterotoxins,"Toxins, Biological",2
Shiga Toxins,D,D08.811.277.450.430.700.750.750,"Ribosome Inactivating Proteins, Type 2",Ribosome Inactivating Proteins,2
Shigella Vaccines,D,D20.215.894.135.720,Bacterial Vaccines,Vaccines,2
Shivering,G,G07.410.421.778.500,Thermogenesis,Body Temperature Regulation,2
Shivering,G,G07.110.232.778.500,Thermogenesis,Body Temperature Regulation,2
Shivering,G,G16.012.500.535.778.500,Thermogenesis,Body Temperature Regulation,2
Short Interspersed Nucleotide Elements,G,G05.360.340.024.425.800.800,Retroelements,Interspersed Repetitive Sequences,2
Short Interspersed Nucleotide Elements,G,G05.360.080.708.330.800.800,Retroelements,Interspersed Repetitive Sequences,2
Short Interspersed Nucleotide Elements,G,G02.111.570.080.708.330.800.800,Retroelements,Interspersed Repetitive Sequences,2
Shoulder,A,A01.378.800.750,Upper Extremity,Extremities,2
Shoulder Joint,A,A02.835.583.748,Joints,Skeleton,2
Shrews,B,B01.050.150.900.649.313.961.751,Insectivora,Eutheria,2
Sigmoidoscopy,E,E01.370.372.250.250.200.700,Colonoscopy,"Endoscopy, Gastrointestinal",2
Sigmoidoscopy,E,E01.370.388.250.250.250.160.800,Colonoscopy,"Endoscopy, Gastrointestinal",2
Sigmoidoscopy,E,E04.210.240.250.160.800,Colonoscopy,"Endoscopy, Gastrointestinal",2
Sigmoidoscopy,E,E04.502.250.250.250.160.800,Colonoscopy,"Endoscopy, Gastrointestinal",2
Signal Recognition Particle,D,D12.776.664.962.500.750.800,"Ribonucleoproteins, Small Cytoplasmic",Ribonucleoproteins,2
Signal Recognition Particle,D,D12.776.157.725.500.750.800,"Ribonucleoproteins, Small Cytoplasmic",Ribonucleoproteins,2
Silanes,D,D01.837.700,Silicon Compounds,Inorganic Chemicals,2
Silicon,D,D01.268.513.937,Metalloids,Elements,2
Silicon Compounds,D,D01.837,Inorganic Chemicals,NULL,2
Silicones,D,D05.750.900.850,Siloxanes,Polymers,2
Silicones,D,D02.756.650.700,Siloxanes,Organosilicon Compounds,2
Silicones,D,D25.720.900.850,Siloxanes,Polymers,2
Silicones,J,J01.637.051.720.900.850,Siloxanes,Polymers,2
Silk,D,D05.750.078.875,Biopolymers,Polymers,2
Silk,D,D12.776.093.750,Arthropod Proteins,Proteins,2
Single-Parent Family,I,I01.880.853.150.750,Family,Sociological Factors,2
Single-Parent Family,F,F01.829.263.750,Family,"Psychology, Social",2
Single-Payer System,N,N03.219.521.576.343.962,"Insurance, Health",Insurance,2
Single-Payer System,N,N03.219.521.855,"Financing, Organized",Economics,2
Single-Payer System,N,N03.349.550.805,National Health Programs,Health Planning,2
Size Perception,F,F02.463.593.725,Perception,Mental Processes,2
Size Perception,F,F02.463.593.778.794,Space Perception,Perception,2
Skilled Nursing Facilities,N,N02.278.825.610.770,Nursing Homes,Residential Facilities,2
Skin Aging,G,G13.750.804,Skin Physiological Phenomena,Integumentary System Physiological Phenomena,2
Skin Physiological Phenomena,G,G13.750,Integumentary System Physiological Phenomena,NULL,2
Skin Temperature,G,G13.750.844,Skin Physiological Phenomena,Integumentary System Physiological Phenomena,2
Skin Temperature,G,G07.110.753,Body Temperature,Physiological Phenomena,2
Skull Fractures,C,C26.404.750,"Fractures, Bone",Wounds and Injuries,2
Skull Fractures,C,C26.915.300.745,Craniocerebral Trauma,"Trauma, Nervous System",2
Skull Fractures,C,C10.900.300.918,Craniocerebral Trauma,"Trauma, Nervous System",2
Sleep Deprivation,C,C10.886.425.175,Dyssomnias,Sleep Wake Disorders,2
Sleep Deprivation,C,C23.888.592.796.772,Sleep Wake Disorders,Neurologic Manifestations,2
Sleep Deprivation,F,F02.830.855.671,Sleep,Psychophysiology,2
Sleep Deprivation,F,F03.870.400.099,Dyssomnias,Sleep Wake Disorders,2
"Sleep Disorders, Circadian Rhythm",F,F03.870.400.200,Dyssomnias,Sleep Wake Disorders,2
"Sleep Disorders, Circadian Rhythm",C,C24.900,Occupational Diseases,NULL,2
"Sleep Disorders, Circadian Rhythm",C,C10.886.425.200,Dyssomnias,Sleep Wake Disorders,2
"Sleep Disorders, Circadian Rhythm",C,C10.281.800,Chronobiology Disorders,Nervous System Diseases,2
Smad3 Protein,D,D12.776.157.057.170.500.300,"Smad Proteins, Receptor-Regulated",Smad Proteins,2
Smad3 Protein,D,D12.776.260.713.500.300,"Smad Proteins, Receptor-Regulated",Smad Proteins,2
Smad3 Protein,D,D12.644.360.024.334.500.300,"Smad Proteins, Receptor-Regulated",Smad Proteins,2
Smad3 Protein,D,D12.776.744.741.875,"Smad Proteins, Receptor-Regulated",Phosphoproteins,2
Smad3 Protein,D,D12.776.930.806.500.300,"Smad Proteins, Receptor-Regulated",Smad Proteins,2
Smad3 Protein,D,D12.776.476.024.428.500.300,"Smad Proteins, Receptor-Regulated",Smad Proteins,2
Small Business,J,J01.219.921,Commerce,"Technology, Industry, and Agriculture",2
Social Cognition,F,F02.463.593.752.500,Social Perception,Perception,2
Social Dominance,F,F01.145.813.650,Social Behavior,Behavior,2
Social Learning,F,F02.784.629.529.663,Learning,"Psychology, Educational",2
Social Workers,M,M01.526.919,Occupational Groups,Persons,2
Sociometric Techniques,I,I01.880.866,Sociology,Social Sciences,2
Sodium Oxybate,D,D02.241.081.114.937.700,Hydroxybutyrates,Butyrates,2
Sodium Oxybate,D,D02.241.511.429.700,Hydroxybutyrates,Hydroxy Acids,2
Sodium Pertechnetate Tc 99m,D,D01.925.800,Technetium Compounds,Inorganic Chemicals,2
Sodium Potassium Chloride Symporter Inhibitors,D,D27.505.519.562.906,Membrane Transport Modulators,Molecular Mechanisms of Pharmacological Action,2
Sodium Potassium Chloride Symporter Inhibitors,D,D27.505.696.560.500.931,Diuretics,Natriuretic Agents,2
Sodium-Phosphate Cotransporter Proteins,D,D12.776.543.585.450.625.625,Symporters,Ion Pumps,2
Sodium-Phosphate Cotransporter Proteins,D,D12.776.543.585.450.074.750.750,Phosphate Transport Proteins,Anion Transport Proteins,2
Sodium-Phosphate Cotransporter Proteins,D,D12.776.157.530.450.625.625,Symporters,Ion Pumps,2
Sodium-Phosphate Cotransporter Proteins,D,D12.776.157.648.500.750,Phosphate Transport Proteins,Phosphate-Binding Proteins,2
Sodium-Phosphate Cotransporter Proteins,D,D12.776.157.530.450.074.750.750,Phosphate Transport Proteins,Anion Transport Proteins,2
"Sodium-Phosphate Cotransporter Proteins, Type III",D,D12.776.157.530.450.074.750.750.875,Sodium-Phosphate Cotransporter Proteins,Phosphate Transport Proteins,2
"Sodium-Phosphate Cotransporter Proteins, Type III",D,D12.776.157.530.937.719,Solute Carrier Proteins,Membrane Transport Proteins,2
"Sodium-Phosphate Cotransporter Proteins, Type III",D,D12.776.157.530.450.625.625.875,Sodium-Phosphate Cotransporter Proteins,Symporters,2
"Sodium-Phosphate Cotransporter Proteins, Type III",D,D12.776.157.648.500.750.875,Sodium-Phosphate Cotransporter Proteins,Phosphate Transport Proteins,2
"Sodium-Phosphate Cotransporter Proteins, Type III",D,D12.776.543.585.450.625.625.875,Sodium-Phosphate Cotransporter Proteins,Symporters,2
"Sodium-Phosphate Cotransporter Proteins, Type III",D,D12.776.543.585.450.074.750.750.875,Sodium-Phosphate Cotransporter Proteins,Phosphate Transport Proteins,2
"Sodium-Phosphate Cotransporter Proteins, Type III",D,D12.776.543.585.937.844,Solute Carrier Proteins,Membrane Transport Proteins,2
Software Validation,L,L01.224.900.868,Software,Computing Methodologies,2
Solanum tuberosum,B,B01.650.940.800.575.912.250.908.500.725.777,Solanum,Solanaceae,2
Solar System,G,G01.060.075.730,Astronomical Objects,Astronomical Phenomena,2
Songbirds,B,B01.050.150.900.248.620.750,Passeriformes,Birds,2
Sonication,E,E05.848,Investigative Techniques,NULL,2
Sorghum,B,B01.650.940.800.575.912.250.822.894,Poaceae,Magnoliopsida,2
South Australia,Z,Z01.639.100.968,Australia,Islands,2
South Australia,Z,Z01.678.100.373.968,Australia,Australasia,2
Soy Foods,G,G07.203.200.775,Fermented Foods and Beverages,"Diet, Food, and Nutrition",2
Soy Foods,G,G07.203.300.850.450.500,Vegetable Products,Vegetables,2
Soy Foods,J,J02.500.850.800.500,Vegetable Products,Vegetables,2
Soy Foods,J,J02.350.775,Fermented Foods and Beverages,Food and Beverages,2
Soybean Proteins,J,J02.500.850.800.500.750,Soy Foods,Vegetable Products,2
Soybean Proteins,J,J02.500.428.920.750,"Plant Proteins, Dietary",Dietary Proteins,2
Soybean Proteins,G,G07.203.300.850.450.500.750,Soy Foods,Vegetable Products,2
Soybean Proteins,G,G07.203.300.428.920.750,"Plant Proteins, Dietary",Dietary Proteins,2
Soybean Proteins,D,D12.776.765.741,Plant Proteins,Proteins,2
"Spasms, Infantile",C,C10.228.140.490.493.875,Epileptic Syndromes,Epilepsy,2
"Spasms, Infantile",C,C10.228.140.490.375.760,"Epilepsy, Generalized",Epilepsy,2
Spatial Processing,F,F01.145.875.830,Spatial Behavior,Behavior,2
Spectrin,D,D12.776.543.850,Membrane Proteins,Proteins,2
Spectrin,D,D12.776.220.980,Cytoskeletal Proteins,Proteins,2
"Spectrometry, X-Ray Emission",E,E05.799.830,Radiometry,Investigative Techniques,2
"Spectrometry, X-Ray Emission",E,E05.196.867.800,Spectrum Analysis,"Chemistry Techniques, Analytical",2
Sphygmomanometers,E,E07.230.740,Diagnostic Equipment,Equipment and Supplies,2
Spin Labels,D,D02.389.678,Free Radicals,Organic Chemicals,2
Spinal Diseases,C,C05.116.900,Bone Diseases,Musculoskeletal Diseases,2
Spinal Fractures,C,C26.404.812,"Fractures, Bone",Wounds and Injuries,2
Spinal Fractures,C,C26.117.500.500,Spinal Injuries,Back Injuries,2
Spiperone,D,D04.711.800,Spiro Compounds,Polycyclic Compounds,2
Spiperone,D,D02.522.352.800,Butyrophenones,Ketones,2
Spiperone,D,D02.455.426.779.800,Spiro Compounds,"Hydrocarbons, Cyclic",2
Spiritual Therapies,E,E02.190.901,Complementary Therapies,Therapeutics,2
Splenic Diseases,C,C15.604.744,Lymphatic Diseases,Hemic and Lymphatic Diseases,2
Spores,B,B05.775,Organism Forms,NULL,2
Spores,A,A11.870,Cells,NULL,2
Sporothrix,B,B01.300.381.820,Mitosporic Fungi,Fungi,2
Sporotrichosis,C,C01.150.703.302.675,Dermatomycoses,Mycoses,2
Sporotrichosis,C,C01.800.200.675,Dermatomycoses,"Skin Diseases, Infectious",2
Sporotrichosis,C,C17.800.838.208.675,Dermatomycoses,"Skin Diseases, Infectious",2
Spotted Fever Group Rickettsiosis,C,C01.150.252.400.789.725.400,Rickettsia Infections,Rickettsiaceae Infections,2
Spotted Fever Group Rickettsiosis,C,C01.920.930.887,Tick-Borne Diseases,Vector Borne Diseases,2
Squamous Intraepithelial Lesions of the Cervix,C,C04.834.818.500,Uterine Cervical Dysplasia,Precancerous Conditions,2
Squamous Intraepithelial Lesions of the Cervix,C,C13.351.500.852.593.074.500,Uterine Cervical Dysplasia,Uterine Cervical Diseases,2
Squamous Intraepithelial Lesions of the Cervix,C,C23.149.688.500,Squamous Intraepithelial Lesions,Morphological and Microscopic Findings,2
src Homology Domains,G,G02.111.570.820.709.275.750.500.750,Protein Interaction Domains and Motifs,Protein Domains,2
Stainless Steel,J,J01.637.051.058.807.681,Steel,Alloys,2
Stainless Steel,D,D01.490.800.900,Steel,Iron Compounds,2
Stainless Steel,D,D01.552.033.847.681,Steel,Alloys,2
Stainless Steel,D,D25.058.807.681,Steel,Alloys,2
STAT4 Transcription Factor,D,D12.776.476.024.430.400,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",2
STAT4 Transcription Factor,D,D12.776.930.840.400,STAT Transcription Factors,Transcription Factors,2
STAT4 Transcription Factor,D,D12.776.157.057.186.400,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",2
STAT4 Transcription Factor,D,D12.644.360.024.342.400,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",2
"Sterilization, Involuntary",I,I01.880.604.528.750,Involuntary Treatment,"Social Control, Formal",2
"Sterilization, Involuntary",E,E04.950.599.450,"Sterilization, Reproductive",Urogenital Surgical Procedures,2
Sternotomy,E,E04.928.710,Thoracic Surgical Procedures,"Surgical Procedures, Operative",2
Stethoscopes,E,E07.230.750,Diagnostic Equipment,Equipment and Supplies,2
Stramenopiles,B,B01.750,Eukaryota,NULL,2
"Stress Disorders, Traumatic",F,F03.950.750,Trauma and Stressor Related Disorders,Mental Disorders,2
Stress Fibers,A,A11.284.430.214.190.750.050.830,Actin Cytoskeleton,Cytoskeleton,2
Strongyloides ratti,B,B01.050.500.500.294.400.875.640.680.600,Strongyloides,Rhabdiasoidea,2
Styrenes,D,D02.455.426.559.389.150.750,Benzylidene Compounds,Benzene Derivatives,2
Subacute Care,E,E02.760.850,Patient Care,Therapeutics,2
Subacute Care,N,N02.421.585.850,Patient Care,Health Services,2
Submandibular Gland,A,A14.549.760.812,Salivary Glands,Mouth,2
Submandibular Gland,A,A10.336.779.812,Salivary Glands,Exocrine Glands,2
Submandibular Gland,A,A03.556.500.760.812,Salivary Glands,Mouth,2
Succinimides,D,D02.478.770,Imides,Organic Chemicals,2
Succinimides,D,D03.383.773.812.852,Pyrrolidinones,Pyrrolidines,2
Sugar Acids,D,D09.811,Carbohydrates,NULL,2
Sugar Acids,D,D02.241.511.902,Hydroxy Acids,Carboxylic Acids,2
Sugar Acids,D,D02.241.081.844,"Acids, Acyclic",Carboxylic Acids,2
Sulfanilamides,D,D02.092.146.807,Aniline Compounds,Amines,2
Sulfanilamides,D,D02.065.884.725,Sulfonamides,Amides,2
Sulfanilamides,D,D02.886.590.700.725,Sulfonamides,Sulfones,2
Sumoylation,G,G02.111.660.871.790.600.925.500,Ubiquitination,"Protein Processing, Post-Translational",2
Sumoylation,G,G02.111.691.600.775.500,Ubiquitination,"Protein Processing, Post-Translational",2
Sumoylation,G,G03.734.871.790.600.831.500,Ubiquitination,"Protein Processing, Post-Translational",2
Sumoylation,G,G05.308.670.600.831.500,Ubiquitination,"Protein Processing, Post-Translational",2
Superoxide Dismutase-1,D,D08.811.682.881.500,Superoxide Dismutase,Oxidoreductases,2
Supervised Machine Learning,G,G17.035.250.500.500,Machine Learning,Artificial Intelligence,2
Supervised Machine Learning,L,L01.224.050.375.530.500,Machine Learning,Artificial Intelligence,2
Supine Position,G,G11.427.695.625,Posture,Musculoskeletal Physiological Phenomena,2
Suprachiasmatic Nucleus,A,A08.186.211.180.497.342.625,"Hypothalamus, Anterior",Hypothalamus,2
Suprachiasmatic Nucleus,A,A08.186.211.200.317.357.342.625,"Hypothalamus, Anterior",Hypothalamus,2
Supreme Court Decisions,I,I01.880.604.583.858,Jurisprudence,"Social Control, Formal",2
"Surgery, Plastic",H,H02.403.810.788,"Specialties, Surgical",Medicine,2
Surgical Drapes,E,E07.325.137.750,Bedding and Linens,"Equipment and Supplies, Hospital",2
Surgical Drapes,E,E07.858.642,Surgical Equipment,Equipment and Supplies,2
Surgical Wound Dehiscence,C,C23.550.767.887,Postoperative Complications,Pathologic Processes,2
Surrogate Mothers,F,F01.829.263.500.320.892,Parents,Nuclear Family,2
Surrogate Mothers,I,I01.880.853.150.500.340.892,Parents,Nuclear Family,2
Surrogate Mothers,M,M01.620.892,Parents,Persons,2
Survivin,D,D12.644.360.075.437.625,Inhibitor of Apoptosis Proteins,Apoptosis Regulatory Proteins,2
Survivin,D,D12.776.220.600.450.495,Microtubule-Associated Proteins,Microtubule Proteins,2
Survivin,D,D12.776.167.576,Cell Cycle Proteins,Proteins,2
Survivin,D,D12.776.476.075.437.625,Inhibitor of Apoptosis Proteins,Apoptosis Regulatory Proteins,2
Suspensions,D,D20.280.810,Colloids,Complex Mixtures,2
Suspensions,D,D26.255.165.810,Colloids,Dosage Forms,2
Sympatholytics,D,D27.505.696.663.050.850,Autonomic Agents,Peripheral Nervous System Agents,2
Synapsins,D,D12.776.744.840,Phosphoproteins,Proteins,2
Synapsins,D,D12.776.631.750,Nerve Tissue Proteins,Proteins,2
Synaptophysin,D,D12.776.631.800,Nerve Tissue Proteins,Proteins,2
Synaptophysin,D,D12.776.543.990.840,Vesicular Transport Proteins,Membrane Proteins,2
Synaptophysin,D,D12.776.543.488.875,MARVEL Domain-Containing Proteins,Membrane Proteins,2
Synaptophysin,D,D23.101.140.800,"Biomarkers, Tumor",Biomarkers,2
Synaptotagmins,D,D12.776.543.990.850,Vesicular Transport Proteins,Membrane Proteins,2
Synaptotagmins,D,D12.776.157.125.825,Calcium-Binding Proteins,Carrier Proteins,2
Syncope,C,C23.888.592.604.359.800.600,Unconsciousness,Consciousness Disorders,2
Syncope,C,C10.597.606.358.800.600,Unconsciousness,Consciousness Disorders,2
Synovial Membrane,A,A02.835.583.443.800,Joint Capsule,Joints,2
Systematized Nomenclature of Medicine,L,L01.453.245.945.720,"Vocabulary, Controlled",Documentation,2
"Tachycardia, Supraventricular",C,C14.280.067.845.880,Tachycardia,"Arrhythmias, Cardiac",2
"Tachycardia, Supraventricular",C,C14.280.123.875.880,Tachycardia,Cardiac Conduction System Disease,2
"Tachycardia, Supraventricular",C,C23.550.073.845.880,Tachycardia,"Arrhythmias, Cardiac",2
Tacrolimus Binding Proteins,D,D08.811.399.325.500.400.700,Immunophilins,Peptidylprolyl Isomerase,2
Tacrolimus Binding Proteins,D,D12.776.827.275.700,Immunophilins,"Receptors, Drug",2
Tacrolimus Binding Proteins,D,D12.776.543.750.705.400.700,Immunophilins,"Receptors, Immunologic",2
Talc,D,D01.837.725.700.760.535.800,Magnesium Silicates,Silicates,2
Talc,D,D01.578.725.500.800,Magnesium Silicates,Silicates,2
Talc,D,D01.524.500.850,Magnesium Silicates,Magnesium Compounds,2
"Tampons, Surgical",E,E07.858.826,Surgical Equipment,Equipment and Supplies,2
Tars,D,D20.749,Complex Mixtures,NULL,2
Taste Threshold,F,F02.463.593.710.790,Sensory Thresholds,Perception,2
Taste Threshold,G,G11.561.790.724.880,Taste,Sensation,2
Taste Threshold,G,G11.561.840,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,2
Taurocholic Acid,D,D04.210.500.105.225.900,Cholic Acids,Bile Acids and Salts,2
Taurocholic Acid,D,D04.210.500.221.430.873,Cholic Acids,Cholanes,2
Taurocholic Acid,D,D02.886.645.600.055.850.800,Taurine,Alkanesulfonic Acids,2
Taurocholic Acid,D,D02.455.326.146.100.850.875,Taurine,Alkanesulfonic Acids,2
TCF Transcription Factors,D,D12.776.260.730,DNA-Binding Proteins,Proteins,2
TCF Transcription Factors,D,D12.776.930.875,Transcription Factors,Proteins,2
TCF Transcription Factors,D,D12.776.660.235.400.800,High Mobility Group Proteins,"Chromosomal Proteins, Non-Histone",2
TCF Transcription Factors,D,D12.776.664.235.400.800,High Mobility Group Proteins,"Chromosomal Proteins, Non-Histone",2
Teaching Rounds,I,I02.358.399.822,"Education, Medical","Education, Professional",2
Tegafur,D,D03.383.742.698.875.404.850,Fluorouracil,Uracil,2
Teicoplanin,D,D12.644.233.352.500,Lipoglycopeptides,Glycopeptides,2
Teicoplanin,D,D09.400.420.405.500,Lipoglycopeptides,Glycopeptides,2
Temefos,D,D02.886.300.692.800,Organothiophosphates,Organothiophosphorus Compounds,2
Temefos,D,D02.705.539.345.800,Organothiophosphates,Organothiophosphorus Compounds,2
Temefos,D,D02.705.400.625.800,Organothiophosphates,Organophosphates,2
Temperament,F,F01.752.898,Personality,Behavior and Behavior Mechanisms,2
Tennessee,Z,Z01.107.567.875.075.775,Appalachian Region,United States,2
Tensins,D,D05.750.078.730.719,Microfilament Proteins,Biopolymers,2
Tensins,D,D12.776.220.525.719,Microfilament Proteins,Cytoskeletal Proteins,2
Terminal Repeat Sequences,G,G02.111.570.080.708.850,"Repetitive Sequences, Nucleic Acid",Base Sequence,2
Terminal Repeat Sequences,G,G05.360.080.708.850,"Repetitive Sequences, Nucleic Acid",Base Sequence,2
Tetraspanins,D,D12.776.543.900,Membrane Proteins,Proteins,2
Tetrazolium Salts,D,D03.383.129.617.700,Tetrazoles,Azoles,2
Thalamus,A,A08.186.211.200.317.826,Diencephalon,Prosencephalon,2
Theileria,B,B01.043.075.600.580.700,Piroplasmida,Piroplasmia,2
Theileria annulata,B,B01.043.075.600.580.700.100,Theileria,Piroplasmida,2
Therapeutic Community,F,F04.754.864.392.701,Milieu Therapy,Socioenvironmental Therapy,2
Therapy with Helminths,E,E02.960,Therapeutics,NULL,2
Thermodilution,E,E05.484.750,Indicator Dilution Techniques,Investigative Techniques,2
Thermography,E,E05.933.500,Thermometry,Investigative Techniques,2
Thermography,E,E01.370.350.800,Diagnostic Imaging,Diagnostic Techniques and Procedures,2
Thermometry,E,E05.933,Investigative Techniques,NULL,2
Thiazolidines,D,D02.886.675.966,Thiazoles,Sulfur Compounds,2
Thimerosal,D,D02.691.750.100.347.850,Ethylmercury Compounds,Alkylmercury Compounds,2
Thiobarbituric Acid Reactive Substances,D,D27.720.470.410.750,Indicators and Reagents,Laboratory Chemicals,2
Thiobarbituric Acid Reactive Substances,D,D02.047.700.700,Malondialdehyde,Aldehydes,2
Thionucleotides,D,D13.695.900,Nucleotides,"Nucleic Acids, Nucleotides, and Nucleosides",2
Thionucleotides,D,D02.886.765,Sulfur Compounds,Organic Chemicals,2
Thiostrepton,D,D04.345.566.825,"Peptides, Cyclic",Macrocyclic Compounds,2
Thiostrepton,D,D12.644.641.825,"Peptides, Cyclic",Peptides,2
Thiourea,D,D02.886.904,Sulfur Compounds,Organic Chemicals,2
Thiourea,D,D02.065.950.898,Urea,Amides,2
Thoracic Surgical Procedures,E,E04.928,"Surgical Procedures, Operative",NULL,2
Thoracic Wall,A,A01.923.761.850,Thorax,Torso,2
Threshold Limit Values,N,N03.706.615.917,Legislation as Topic,"Social Control, Formal",2
Threshold Limit Values,N,N06.850.460.350.600.807,Occupational Exposure,Environmental Exposure,2
Thrombin,D,D08.811.277.656.959.350.855,Serine Endopeptidases,Serine Proteases,2
Thrombin,D,D08.811.277.656.300.760.855,Serine Endopeptidases,Endopeptidases,2
Thrombin,D,D12.776.124.125.890,Blood Coagulation Factors,Blood Proteins,2
Thrombin,D,D23.119.960,Blood Coagulation Factors,Biological Factors,2
Thrombophlebitis,C,C14.907.355.830.925.770,Venous Thrombosis,Thrombosis,2
Thrombophlebitis,C,C14.907.617.718.788,Phlebitis,Peripheral Vascular Diseases,2
Thrombophlebitis,C,C14.907.940.740.910,Phlebitis,Vasculitis,2
Thromboplastin,D,D23.119.965,Blood Coagulation Factors,Biological Factors,2
Thromboplastin,D,D12.776.124.125.900,Blood Coagulation Factors,Blood Proteins,2
"Thyroid Cancer, Papillary",C,C19.874.788.400,Thyroid Neoplasms,Thyroid Diseases,2
"Thyroid Cancer, Papillary",C,C19.344.894.400,Thyroid Neoplasms,Endocrine Gland Neoplasms,2
"Thyroid Cancer, Papillary",C,C04.588.322.894.400,Thyroid Neoplasms,Endocrine Gland Neoplasms,2
"Thyroid Cancer, Papillary",C,C04.588.443.915.400,Thyroid Neoplasms,Head and Neck Neoplasms,2
"Thyroid Cancer, Papillary",C,C04.557.470.200.025.085.612,"Adenocarcinoma, Papillary",Adenocarcinoma,2
Tibial Nerve,A,A08.800.800.720.450.760.820,Sciatic Nerve,Lumbosacral Plexus,2
Tight Junctions,A,A11.284.149.165.420.820,Intercellular Junctions,Cell Membrane Structures,2
Timolol,D,D02.092.063.624.915,Propanolamines,Amino Alcohols,2
Timolol,D,D02.033.755.624.915,Propanolamines,Propanols,2
Timolol,D,D02.033.100.624.915,Propanolamines,Amino Alcohols,2
Timolol,D,D02.886.675.867.768,Thiadiazoles,Thiazoles,2
Timolol,D,D03.383.129.708.867.768,Thiadiazoles,Thiazoles,2
Timolol,D,D03.383.533.640.775,Morpholines,Oxazines,2
Tinea,C,C17.800.838.208.883,Dermatomycoses,"Skin Diseases, Infectious",2
Tinea,C,C01.150.703.302.720,Dermatomycoses,Mycoses,2
Tinea,C,C01.800.200.720,Dermatomycoses,"Skin Diseases, Infectious",2
Tinea Versicolor,C,C01.800.200.860,Dermatomycoses,"Skin Diseases, Infectious",2
Tinea Versicolor,C,C01.150.703.302.860,Dermatomycoses,Mycoses,2
Tinea Versicolor,C,C17.800.838.208.941,Dermatomycoses,"Skin Diseases, Infectious",2
Tissue Array Analysis,E,E05.588.570.850,Microarray Analysis,Microchip Analytical Procedures,2
Tissue Fixation,E,E05.200.500.620.760.720,Tissue Preservation,Histocytological Preparation Techniques,2
Tissue Fixation,E,E05.200.750.600.760.720,Tissue Preservation,Histocytological Preparation Techniques,2
Tissue Fixation,E,E01.370.225.500.620.760.720,Tissue Preservation,Histocytological Preparation Techniques,2
Tissue Fixation,E,E01.370.225.750.600.760.720,Tissue Preservation,Histocytological Preparation Techniques,2
Tissue Scaffolds,E,E07.206.627,Culture Media,Equipment and Supplies,2
Tissue Scaffolds,E,E07.695.825,Prostheses and Implants,Equipment and Supplies,2
Titrimetry,E,E05.196.922,"Chemistry Techniques, Analytical",Investigative Techniques,2
Token Economy,F,F02.463.425.770.836.500,Reward,"Reinforcement, Psychology",2
Toll-Like Receptor 5,D,D12.776.543.750.705.910.500.500,Toll-Like Receptors,"Receptors, Pattern Recognition",2
Toll-Like Receptor 6,D,D12.776.543.750.705.910.500.600,Toll-Like Receptors,"Receptors, Pattern Recognition",2
Toll-Like Receptor 7,D,D12.776.543.750.705.910.500.700,Toll-Like Receptors,"Receptors, Pattern Recognition",2
Toll-Like Receptor 8,D,D12.776.543.750.705.910.500.800,Toll-Like Receptors,"Receptors, Pattern Recognition",2
"Tomography, Emission-Computed",E,E01.370.350.710.800,Radionuclide Imaging,Diagnostic Imaging,2
"Tomography, Emission-Computed",E,E01.370.350.825.800,Tomography,Diagnostic Imaging,2
"Tomography, Emission-Computed",E,E01.370.350.350.800,"Image Interpretation, Computer-Assisted",Diagnostic Imaging,2
"Tomography, Emission-Computed",E,E01.370.350.600.350.800,Image Enhancement,Photography,2
"Tomography, Emission-Computed",E,E01.370.384.730.800,Radionuclide Imaging,"Diagnostic Techniques, Radioisotope",2
Tongue Diseases,C,C07.465.910,Mouth Diseases,Stomatognathic Diseases,2
Tool Use Behavior,F,F01.145.113.840,"Behavior, Animal",Behavior,2
Tooth Abnormalities,C,C07.650.800,Stomatognathic System Abnormalities,Stomatognathic Diseases,2
Tooth Abnormalities,C,C16.131.850.800,Stomatognathic System Abnormalities,Congenital Abnormalities,2
Tooth Abnormalities,C,C07.793.700,Tooth Diseases,Stomatognathic Diseases,2
Tooth Eruption,G,G10.549.810,Dental Physiological Phenomena,Digestive System and Oral Physiological Phenomena,2
Toothache,C,C07.793.929,Tooth Diseases,Stomatognathic Diseases,2
Toothache,C,C23.888.592.612.330.500,Facial Pain,Pain,2
Toothbrushing,E,E06.761.726.794,Oral Hygiene,Preventive Dentistry,2
Topiramate,D,D09.947.875.465.354.500,Fructose,Ketoses,2
Topiramate,D,D09.947.875.359.250.500,Fructose,Hexoses,2
Toxin-Antitoxin Systems,G,G06.773,Microbiological Phenomena,NULL,2
"Toxins, Biological",D,D23.946,Biological Factors,NULL,2
"Toxoplasmosis, Cerebral",C,C10.228.228.090.800,Brain Abscess,Central Nervous System Infections,2
"Toxoplasmosis, Cerebral",C,C10.228.140.116.800,Brain Abscess,Brain Diseases,2
"Toxoplasmosis, Cerebral",C,C10.228.228.205.300.800,Central Nervous System Protozoal Infections,Central Nervous System Parasitic Infections,2
"Toxoplasmosis, Cerebral",C,C01.830.025.160.800,Brain Abscess,Abscess,2
"Toxoplasmosis, Cerebral",C,C01.207.090.800,Brain Abscess,Central Nervous System Infections,2
"Toxoplasmosis, Cerebral",C,C01.207.205.300.800,Central Nervous System Protozoal Infections,Central Nervous System Parasitic Infections,2
"Toxoplasmosis, Cerebral",C,C01.610.105.300.800,Central Nervous System Protozoal Infections,Central Nervous System Parasitic Infections,2
"Toxoplasmosis, Cerebral",C,C01.610.752.250.800.250,Toxoplasmosis,Coccidiosis,2
"Toxoplasmosis, Congenital",C,C01.610.752.250.800.445,Toxoplasmosis,Coccidiosis,2
"Toxoplasmosis, Congenital",C,C01.207.205.300.900,Central Nervous System Protozoal Infections,Central Nervous System Parasitic Infections,2
"Toxoplasmosis, Congenital",C,C10.228.228.205.300.900,Central Nervous System Protozoal Infections,Central Nervous System Parasitic Infections,2
"Toxoplasmosis, Congenital",C,C16.614.909,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Traffic-Related Pollution,N,N06.850.460.685,Environmental Pollution,Public Health,2
Trail Making Test,F,F04.711.513.838,Neuropsychological Tests,Psychological Tests,2
Transcription Factor AP-1,D,D12.776.930.127.875,Basic-Leucine Zipper Transcription Factors,Transcription Factors,2
Transcription Factor AP-1,D,D12.776.260.108.875,Basic-Leucine Zipper Transcription Factors,DNA-Binding Proteins,2
Transcriptional Regulator ERG,D,D12.776.260.755.100,Trans-Activators,DNA-Binding Proteins,2
Transcriptional Regulator ERG,D,D12.776.930.900.625,Trans-Activators,Transcription Factors,2
Transdermal Patch,E,E07.935,Equipment and Supplies,NULL,2
Transforming Growth Factor alpha,D,D12.776.467.382.750,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,2
Transforming Growth Factor alpha,D,D12.776.467.960.360,Transforming Growth Factors,Intercellular Signaling Peptides and Proteins,2
Transforming Growth Factor alpha,D,D23.529.960.360,Transforming Growth Factors,Intercellular Signaling Peptides and Proteins,2
Transforming Growth Factor alpha,D,D23.529.382.750,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,2
Transforming Growth Factor alpha,D,D12.644.276.963.360,Transforming Growth Factors,Intercellular Signaling Peptides and Proteins,2
Transforming Growth Factor alpha,D,D12.644.276.382.750,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,2
Transtheoretical Model,E,E05.599.323.500,Health Belief Model,"Models, Theoretical",2
Transtheoretical Model,E,E05.599.695.275.500,Health Belief Model,"Models, Psychological",2
Transtheoretical Model,E,E05.599.925,"Models, Theoretical",Investigative Techniques,2
Trematode Infections,C,C01.610.335.865,Helminthiasis,Parasitic Diseases,2
Trephining,E,E04.525.190.840,Craniotomy,Neurosurgical Procedures,2
Tretinoin,D,D02.455.326.271.665.202.495.818.500,Vitamin A,Retinoids,2
Tretinoin,D,D02.455.426.392.368.367.379.249.700.860.500,Vitamin A,Retinoids,2
Tretinoin,D,D02.455.849.291.925.500,Vitamin A,Diterpenes,2
Tretinoin,D,D02.455.849.131.495.818.800,Vitamin A,Retinoids,2
Tretinoin,D,D23.767.261.700.780,Retinoids,Carotenoids,2
Trichomonas,B,B01.630.800.808,Trichomonadida,Parabasalidea,2
Trihalomethanes,D,D02.455.526.913,"Hydrocarbons, Halogenated",Hydrocarbons,2
Triiodothyronine,D,D06.472.931.740.385,Thyronines,Thyroid Hormones,2
Triiodothyronine,D,D12.125.072.050.767.741.894,Thyronines,Thyroxine,2
Trinucleotide Repeat Expansion,G,G02.111.570.080.708.800.140.865,DNA Repeat Expansion,Tandem Repeat Sequences,2
Trinucleotide Repeat Expansion,G,G02.111.570.080.708.800.500.850.200,Trinucleotide Repeats,Microsatellite Repeats,2
Trinucleotide Repeat Expansion,G,G05.360.080.708.800.500.850.200,Trinucleotide Repeats,Microsatellite Repeats,2
Trinucleotide Repeat Expansion,G,G05.360.340.024.189.220.865,DNA Repeat Expansion,"DNA Sequence, Unstable",2
Trinucleotide Repeat Expansion,G,G05.360.080.708.800.074.865,DNA Repeat Expansion,Tandem Repeat Sequences,2
Trinucleotide Repeat Expansion,G,G05.360.340.024.850.500.850.200,Trinucleotide Repeats,Microsatellite Repeats,2
Trinucleotide Repeat Expansion,G,G05.365.590.220.865,DNA Repeat Expansion,Mutation,2
Trinucleotide Repeat Expansion,G,G05.558.220.865,DNA Repeat Expansion,Mutagenesis,2
Triterpenes,D,D02.455.849.919,Terpenes,Hydrocarbons,2
tRNA Methyltransferases,D,D08.811.913.555.500.925,Methyltransferases,One-Carbon Group Transferases,2
Trophoblasts,A,A16.710.802,Placenta,Embryonic Structures,2
Trophoblasts,A,A16.254.500.766,Blastocyst,"Embryo, Mammalian",2
Trophoblasts,A,A11.382.992,Endocrine Cells,Cells,2
Tropolone,D,D02.455.426.392.368.284.900,Cycloheptanes,Cycloparaffins,2
Troponin C,D,D12.776.220.525.825.900,Troponin,Microfilament Proteins,2
Troponin C,D,D12.776.210.500.910.900,Troponin,Muscle Proteins,2
Troponin C,D,D12.776.157.125.900,Calcium-Binding Proteins,Carrier Proteins,2
Troponin C,D,D05.750.078.730.825.900,Troponin,Microfilament Proteins,2
Troponin C,D,D05.500.945.900,Troponin,Multiprotein Complexes,2
"Tuberculosis, Central Nervous System",C,C10.228.228.180.850,Central Nervous System Bacterial Infections,Central Nervous System Infections,2
"Tuberculosis, Central Nervous System",C,C01.207.180.850,Central Nervous System Bacterial Infections,Central Nervous System Infections,2
"Tuberculosis, Central Nervous System",C,C01.150.252.410.040.552.846.570,Tuberculosis,Mycobacterium Infections,2
"Tuberculosis, Central Nervous System",C,C01.150.252.223.850,Central Nervous System Bacterial Infections,Bacterial Infections,2
"Tuberculosis, Gastrointestinal",C,C01.150.252.410.040.552.846.628,Tuberculosis,Mycobacterium Infections,2
"Tuberculosis, Gastrointestinal",C,C06.405.874,Gastrointestinal Diseases,Digestive System Diseases,2
Tuberous Sclerosis,C,C04.700.700,"Neoplastic Syndromes, Hereditary",Neoplasms,2
Tuberous Sclerosis,C,C04.651.800,"Neoplasms, Multiple Primary",Neoplasms,2
Tuberous Sclerosis,C,C04.445.810,Hamartoma,Neoplasms,2
Tuberous Sclerosis,C,C10.500.507.400.750,"Malformations of Cortical Development, Group I",Malformations of Cortical Development,2
Tuberous Sclerosis,C,C10.574.500.865,"Heredodegenerative Disorders, Nervous System",Neurodegenerative Diseases,2
Tuberous Sclerosis,C,C10.562.850,Neurocutaneous Syndromes,Nervous System Diseases,2
Tuberous Sclerosis,C,C16.131.666.507.400.750,"Malformations of Cortical Development, Group I",Malformations of Cortical Development,2
Tuberous Sclerosis,C,C16.320.700.700,"Neoplastic Syndromes, Hereditary","Genetic Diseases, Inborn",2
Tuberous Sclerosis,C,C16.320.400.880,"Heredodegenerative Disorders, Nervous System","Genetic Diseases, Inborn",2
Tumor Microenvironment,G,G04.366.500,Cellular Microenvironment,Cell Physiological Phenomena,2
Tumor Necrosis Factor Inhibitors,D,D27.505.954.158.757,Anti-Inflammatory Agents,Therapeutic Uses,2
Turner Syndrome,C,C16.320.180.830.835.750,Sex Chromosome Disorders of Sex Development,Sex Chromosome Disorders,2
Turner Syndrome,C,C16.131.939.316.795.750,Sex Chromosome Disorders of Sex Development,Disorders of Sex Development,2
Turner Syndrome,C,C16.131.939.316.309.872,Gonadal Dysgenesis,Disorders of Sex Development,2
Turner Syndrome,C,C16.131.260.830.835.750,Sex Chromosome Disorders of Sex Development,Sex Chromosome Disorders,2
Turner Syndrome,C,C16.131.240.400.970,"Heart Defects, Congenital",Cardiovascular Abnormalities,2
Turner Syndrome,C,C14.280.400.980,"Heart Defects, Congenital",Heart Diseases,2
Turner Syndrome,C,C14.240.400.980,"Heart Defects, Congenital",Cardiovascular Abnormalities,2
Turner Syndrome,C,C13.351.875.253.795.750,Sex Chromosome Disorders of Sex Development,Disorders of Sex Development,2
Turner Syndrome,C,C13.351.875.253.309.872,Gonadal Dysgenesis,Disorders of Sex Development,2
Turner Syndrome,C,C12.706.316.795.750,Sex Chromosome Disorders of Sex Development,Disorders of Sex Development,2
Turner Syndrome,C,C12.706.316.309.872,Gonadal Dysgenesis,Disorders of Sex Development,2
Turner Syndrome,C,C19.391.119.795.750,Sex Chromosome Disorders of Sex Development,Disorders of Sex Development,2
Turner Syndrome,C,C19.391.119.309.872,Gonadal Dysgenesis,Disorders of Sex Development,2
Turtles,B,B01.050.150.900.833.848,Reptiles,Vertebrates,2
TYK2 Kinase,D,D12.776.476.393.650,Janus Kinases,Intracellular Signaling Peptides and Proteins,2
TYK2 Kinase,D,D08.811.913.696.620.682.725.124.650,Janus Kinases,Protein-Tyrosine Kinases,2
Tympanic Membrane Perforation,C,C26.930,Wounds and Injuries,NULL,2
Tympanic Membrane Perforation,C,C09.218.903,Ear Diseases,Otorhinolaryngologic Diseases,2
Ubiquitins,D,D12.776.947,Proteins,"Amino Acids, Peptides, and Proteins",2
UDPglucose 4-Epimerase,D,D08.811.399.894.500.700,Carbohydrate Epimerases,Racemases and Epimerases,2
Ulna,A,A02.835.232.087.090.850,Arm Bones,Bones of Upper Extremity,2
"Ultrasonography, Interventional",E,E01.370.350.850.855,Ultrasonography,Diagnostic Imaging,2
"Ultrasonography, Interventional",E,E04.502.890,Minimally Invasive Surgical Procedures,"Surgical Procedures, Operative",2
Ultraviolet Therapy,E,E02.774.945,Phototherapy,Therapeutics,2
Unified Medical Language System,L,L01.453.245.945.800,"Vocabulary, Controlled",Documentation,2
United States Agency for Healthcare Research and Quality,N,N03.540.348.500.500.600.650.592,United States Public Health Service,United States Dept. of Health and Human Services,2
United States Agency for Healthcare Research and Quality,I,I01.409.418.750.600.650.592,United States Public Health Service,United States Dept. of Health and Human Services,2
United States Agency for International Development,I,I01.409.418.750.199,United States Government Agencies,Government Agencies,2
United States Agency for International Development,N,N03.540.348.500.500.199,United States Government Agencies,Federal Government,2
United States Dept. of Health and Human Services,N,N03.540.348.500.500.600,United States Government Agencies,Federal Government,2
United States Dept. of Health and Human Services,I,I01.409.418.750.600,United States Government Agencies,Government Agencies,2
United States Public Health Service,I,I01.409.418.750.600.650,United States Dept. of Health and Human Services,United States Government Agencies,2
United States Public Health Service,N,N03.540.348.500.500.600.650,United States Dept. of Health and Human Services,United States Government Agencies,2
Universal Precautions,N,N06.850.780.200.925,Communicable Disease Control,Public Health Practice,2
Ureter,A,A05.810.776,Urinary Tract,Urogenital System,2
Ureteral Calculi,C,C12.777.967.500.851,Urinary Calculi,Urolithiasis,2
Ureteral Calculi,C,C12.777.967.374.500,Ureterolithiasis,Urolithiasis,2
Ureteral Calculi,C,C12.777.725.938.500,Ureterolithiasis,Ureteral Diseases,2
Ureteral Calculi,C,C13.351.968.967.500.851,Urinary Calculi,Urolithiasis,2
Ureteral Calculi,C,C13.351.968.967.374.500,Ureterolithiasis,Urolithiasis,2
Ureteral Calculi,C,C13.351.968.725.938.500,Ureterolithiasis,Ureteral Diseases,2
Ureteral Calculi,C,C23.300.175.850.750,Urinary Calculi,Calculi,2
"Urinary Bladder, Neurogenic",C,C23.888.592.900,Neurologic Manifestations,Signs and Symptoms,2
"Urinary Bladder, Neurogenic",C,C13.351.968.829.760,Urinary Bladder Diseases,Urologic Diseases,2
"Urinary Bladder, Neurogenic",C,C12.777.829.839,Urinary Bladder Diseases,Urologic Diseases,2
"Urinary Bladder, Neurogenic",C,C10.597.900,Neurologic Manifestations,Nervous System Diseases,2
Urinary Calculi,C,C12.777.967.500,Urolithiasis,Urologic Diseases,2
Urinary Calculi,C,C13.351.968.967.500,Urolithiasis,Urologic Diseases,2
Urinary Calculi,C,C23.300.175.850,Calculi,"Pathological Conditions, Anatomical",2
Urine Specimen Collection,E,E01.370.225.998.762,Specimen Handling,Clinical Laboratory Techniques,2
Urine Specimen Collection,E,E05.200.998.762,Specimen Handling,Clinical Laboratory Techniques,2
Urocortins,D,D06.472.699.857,Peptide Hormones,Hormones,2
Urocortins,D,D12.644.548.887,Peptide Hormones,Peptides,2
Urocortins,D,D12.644.400.837,Neuropeptides,Peptides,2
Urogenital Abnormalities,C,C13.351.875,Female Urogenital Diseases,Female Urogenital Diseases and Pregnancy Complications,2
Urogenital Abnormalities,C,C16.131.939,Congenital Abnormalities,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",2
Urogenital Abnormalities,C,C12.706,Male Urogenital Diseases,NULL,2
Uromodulin,D,D12.776.395.550.448.850,GPI-Linked Proteins,Membrane Glycoproteins,2
Uromodulin,D,D12.776.395.560.912,Mucoproteins,Glycoproteins,2
Uromodulin,D,D12.776.543.484.500.850,GPI-Linked Proteins,Lipid-Linked Proteins,2
Uromodulin,D,D12.776.543.550.418.850,GPI-Linked Proteins,Membrane Glycoproteins,2
Ursodeoxycholic Acid,D,D04.210.500.221.430.342.925,Deoxycholic Acid,Cholic Acids,2
Ursodeoxycholic Acid,D,D04.210.500.105.225.272.962,Deoxycholic Acid,Cholic Acids,2
Utah,Z,Z01.107.567.875.760.800,Southwestern United States,United States,2
Uterine Inertia,C,C13.703.420.288.728,Dystocia,Obstetric Labor Complications,2
V(D)J Recombination,G,G05.344.900,Gene Rearrangement,Genetic Phenomena,2
V(D)J Recombination,G,G05.728.932,"Recombination, Genetic",Genetic Phenomena,2
"Vaccines, Virosome",D,D12.776.828.868.940,"Vaccines, Synthetic",Recombinant Proteins,2
"Vaccines, Virosome",D,D20.215.894.865.940,"Vaccines, Synthetic",Vaccines,2
"Vaccines, Virosome",D,D23.050.865.940,"Vaccines, Synthetic",Antigens,2
Vacuolar Proton-Translocating ATPases,D,D12.776.543.585.450.250.875.500.875,Proton-Translocating ATPases,Proton Pumps,2
Vacuolar Proton-Translocating ATPases,D,D08.811.277.040.025.325.875,Proton-Translocating ATPases,Adenosine Triphosphatases,2
Vacuolar Proton-Translocating ATPases,D,D12.776.157.530.450.250.875.500.875,Proton-Translocating ATPases,Proton Pumps,2
Vacuolar Proton-Translocating ATPases,D,D08.811.913.696.650.150.500.875,Proton-Translocating ATPases,ATP Synthetase Complexes,2
Vaginal Birth after Cesarean,E,E04.520.252.992,"Delivery, Obstetric",Obstetric Surgical Procedures,2
Varenicline,D,D03.633.100.079.900,Benzazepines,"Heterocyclic Compounds, 2-Ring",2
Varenicline,D,D03.633.100.857.942,Quinoxalines,"Heterocyclic Compounds, 2-Ring",2
Varicocele,C,C14.907.903,Vascular Diseases,Cardiovascular Diseases,2
Varicocele,C,C12.294.936,"Genital Diseases, Male",Male Urogenital Diseases,2
Vascular Endothelial Growth Factors,D,D12.644.276.100.800,Angiogenic Proteins,Intercellular Signaling Peptides and Proteins,2
Vascular Endothelial Growth Factors,D,D12.776.467.100.800,Angiogenic Proteins,Intercellular Signaling Peptides and Proteins,2
Vascular Endothelial Growth Factors,D,D23.529.100.800,Angiogenic Proteins,Intercellular Signaling Peptides and Proteins,2
"Vasculitis, Leukocytoclastic, Cutaneous",C,C14.907.940.910,Vasculitis,Vascular Diseases,2
"Vasculitis, Leukocytoclastic, Cutaneous",C,C20.543.520.910,Immune Complex Diseases,Hypersensitivity,2
Vault Ribonucleoprotein Particles,A,A11.284.430.214.190.875.930,Organelles,Cytoplasmic Structures,2
Vault Ribonucleoprotein Particles,D,D12.776.664.962.500.937,Ribonucleoproteins,RNA-Binding Proteins,2
Vault Ribonucleoprotein Particles,D,D12.776.157.725.500.937,Ribonucleoproteins,RNA-Binding Proteins,2
"Ventilators, Mechanical",E,E07.950,Equipment and Supplies,NULL,2
Ventricular Dysfunction,C,C14.280.945,Heart Diseases,Cardiovascular Diseases,2
Ventricular Function,G,G09.330.955,Cardiovascular Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,2
Ventricular Pressure,G,G09.330.955.950,Ventricular Function,Cardiovascular Physiological Phenomena,2
Ventricular Pressure,G,G09.330.380.937,Hemodynamics,Cardiovascular Physiological Phenomena,2
Vertigo,C,C10.597.951,Neurologic Manifestations,Nervous System Diseases,2
Vertigo,C,C09.218.568.900.883,Vestibular Diseases,Labyrinth Diseases,2
Vertigo,C,C23.888.592.958,Neurologic Manifestations,Signs and Symptoms,2
Vibration,G,G01.374.930,Mechanical Phenomena,Physical Phenomena,2
Vibrio,B,B03.440.450.900.859,Vibrionaceae,Gram-Negative Facultatively Anaerobic Rods,2
Vibrio,B,B03.660.250.830.830,Vibrionaceae,Gammaproteobacteria,2
Vimentin,D,D12.776.220.475.900,Intermediate Filament Proteins,Cytoskeletal Proteins,2
Vimentin,D,D05.750.078.593.900,Intermediate Filament Proteins,Biopolymers,2
Vinyl Chloride,D,D02.455.526.439.975,"Hydrocarbons, Chlorinated","Hydrocarbons, Halogenated",2
Vinyl Chloride,D,D02.455.326.271.884.750,Vinyl Compounds,Alkenes,2
Viral Fusion Protein Inhibitors,D,D27.505.954.122.388.538,Antiviral Agents,Anti-Infective Agents,2
Viral Fusion Protein Inhibitors,D,D27.505.519.957,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,2
Viral Interference,G,G06.920.800,Virus Physiological Phenomena,Microbiological Phenomena,2
Viral Zoonoses,C,C22.969.500,Zoonoses,Animal Diseases,2
Viral Zoonoses,C,C01.973.500,Zoonoses,Infections,2
Viral Zoonoses,C,C01.925.933,Virus Diseases,Infections,2
Virginia,Z,Z01.107.567.875.750.870,Southeastern United States,United States,2
Virginia,Z,Z01.107.567.875.075.837,Appalachian Region,United States,2
Virtual Reality,L,L01.224.160.875,Computer Simulation,Computing Methodologies,2
Virtual Reality,L,L01.296.555,Data Display,Information Science,2
Virus Inactivation,G,G06.920.872,Virus Physiological Phenomena,Microbiological Phenomena,2
Virus Inactivation,E,E05.200.875.977,Microbiological Techniques,Clinical Laboratory Techniques,2
Virus Inactivation,E,E01.370.225.875.977,Microbiological Techniques,Clinical Laboratory Techniques,2
Virus Physiological Phenomena,G,G06.920,Microbiological Phenomena,NULL,2
"Viruses, Unclassified",B,B04.970,Viruses,NULL,2
Viscosity,G,G02.930,Chemical Phenomena,NULL,2
Visitors to Patients,M,M01.935,Persons,NULL,2
Visual Pathways,A,A08.612.220.860,Afferent Pathways,Neural Pathways,2
Vitamin D3 24-Hydroxylase,D,D12.776.422.220.453.496.500,Cytochrome P450 Family 24,Cytochrome P-450 Enzyme System,2
Vitamin D3 24-Hydroxylase,D,D08.244.453.496.500,Cytochrome P450 Family 24,Cytochrome P-450 Enzyme System,2
Vitamin D3 24-Hydroxylase,D,D08.811.682.690.708.170.469.500,Cytochrome P450 Family 24,Cytochrome P-450 Enzyme System,2
Vitamin K 1,D,D04.615.638.721.374.689,Vitamin K,Naphthoquinones,2
Vitamin K 1,D,D02.455.426.559.847.638.721.374.689,Vitamin K,Naphthoquinones,2
Vitamin K 1,D,D02.455.849.291.523.500.689,Vitamin K,Phytol,2
Vitamin K 1,D,D02.806.550.625,Naphthoquinones,Quinones,2
"Vitreoretinopathy, Proliferative",C,C11.768.890,Retinal Diseases,Eye Diseases,2
Vitronectin,D,D12.776.124.920,Blood Proteins,Proteins,2
Vitronectin,D,D12.776.395.970,Glycoproteins,Proteins,2
Vitronectin,D,D12.776.860.300.920,Extracellular Matrix Proteins,Scleroproteins,2
Voice,G,G09.772.925,Respiratory Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,2
Wakefulness,G,G11.561.035.738,Arousal,Nervous System Physiological Phenomena,2
Wakefulness,F,F02.830.104.821,Arousal,Psychophysiology,2
Wallerian Degeneration,C,C23.550.737.750,Nerve Degeneration,Pathologic Processes,2
War Crimes,I,I01.198.240.903,Crime,Criminology,2
War Crimes,I,I01.880.735.950.500.903,Warfare,Warfare and Armed Conflicts,2
Wastewater-Based Epidemiological Monitoring,E,E05.318.375.500,Epidemiological Monitoring,Epidemiologic Methods,2
Wastewater-Based Epidemiological Monitoring,N,N06.850.520.460.500,Epidemiological Monitoring,Epidemiologic Methods,2
Water Insecurity,G,G07.203.100.418.750,Drinking Water,Beverages,2
Water Insecurity,J,J02.200.418.750,Drinking Water,Beverages,2
"Water Loss, Insensible",G,G07.410.810.500.750,Water-Electrolyte Balance,Osmoregulation,2
"Water Loss, Insensible",G,G03.615.500.750,Water-Electrolyte Balance,Osmoregulation,2
"Water Loss, Insensible",G,G02.111.635.500.750,Water-Electrolyte Balance,Osmoregulation,2
Water Pipe Smoking,F,F01.145.805.063.500,Pipe Smoking,Smoking,2
Water Softening,N,N06.850.860.510.910,Sanitary Engineering,Sanitation,2
Waxes,D,D10.945,Lipids,NULL,2
Weight-Bearing,G,G01.374.965,Mechanical Phenomena,Physical Phenomena,2
Wisconsin,Z,Z01.107.567.875.350.900,Great Lakes Region,United States,2
Wisconsin,Z,Z01.107.567.875.510.900,Midwestern United States,United States,2
Wiskott-Aldrich Syndrome,C,C20.673.627.900,Lymphopenia,Immunologic Deficiency Syndromes,2
Wiskott-Aldrich Syndrome,C,C20.673.795.875,Primary Immunodeficiency Diseases,Immunologic Deficiency Syndromes,2
Wiskott-Aldrich Syndrome,C,C15.378.100.100.970,"Blood Coagulation Disorders, Inherited",Blood Coagulation Disorders,2
Wiskott-Aldrich Syndrome,C,C15.378.553.546.605.900,Lymphopenia,Leukopenia,2
Wiskott-Aldrich Syndrome,C,C15.378.463.960,Hemorrhagic Disorders,Hematologic Diseases,2
Wiskott-Aldrich Syndrome,C,C16.320.099.970,"Blood Coagulation Disorders, Inherited","Genetic Diseases, Inborn",2
Wiskott-Aldrich Syndrome,C,C16.320.322.937,"Genetic Diseases, X-Linked","Genetic Diseases, Inborn",2
Wiskott-Aldrich Syndrome,C,C16.320.798.875,Primary Immunodeficiency Diseases,"Genetic Diseases, Inborn",2
Work Engagement,I,I03.946.562,Work,Human Activities,2
Work Engagement,N,N04.452.677.896,Personnel Management,Organization and Administration,2
Work Performance,I,I03.946.675,Work,Human Activities,2
Work-Life Balance,I,I03.946.225.438,Personnel Staffing and Scheduling,Work,2
Work-Life Balance,I,I01.940,Social Sciences,NULL,2
Work-Life Balance,N,N04.452.677.650.438,Personnel Staffing and Scheduling,Personnel Management,2
Wortmannin,D,D04.210.500.054.079.129.891,Androstadienes,Androstenes,2
Wound Closure Techniques,E,E04.987,"Surgical Procedures, Operative",NULL,2
Xanthine,D,D03.132.960.938,Xanthines,Alkaloids,2
Xanthine,D,D03.633.100.759.758.824.938,Xanthines,Purinones,2
Xanthurenates,D,D03.066.942,"Acids, Heterocyclic",Heterocyclic Compounds,2
Xenophobia,F,F01.145.813.629.875,Social Discrimination,Social Behavior,2
Xenophobia,F,F01.145.813.550.875,Prejudice,Social Behavior,2
Xenophobia,F,F01.829.595.875,Prejudice,"Psychology, Social",2
Xenotropic murine leukemia virus-related virus,B,B04.820.650.375.930,Gammaretrovirus,Retroviridae,2
Xeroderma Pigmentosum Group D Protein,D,D08.811.277.040.025.159.500,DNA Helicases,Adenosine Triphosphatases,2
Xeroderma Pigmentosum Group D Protein,D,D08.811.399.340.500,DNA Helicases,Isomerases,2
Xeroderma Pigmentosum Group D Protein,D,D12.776.260.775.875.875.500,Transcription Factor TFIIH,"Transcription Factors, TFII",2
Xeroderma Pigmentosum Group D Protein,D,D12.776.930.930.875.875.500,Transcription Factor TFIIH,"Transcription Factors, TFII",2
Y Chromosome,A,A11.284.187.865.983,Sex Chromosomes,Chromosomes,2
Y Chromosome,G,G05.360.162.865.983,Sex Chromosomes,Chromosomes,2
Yogurt,G,G07.203.200.500.888,Cultured Milk Products,Fermented Foods and Beverages,2
Yogurt,G,G07.203.300.350.300.888,Cultured Milk Products,Dairy Products,2
Yogurt,J,J02.350.500.888,Cultured Milk Products,Fermented Foods and Beverages,2
Yogurt,J,J02.500.350.300.888,Cultured Milk Products,Dairy Products,2
17-alpha-Hydroxyprogesterone,D,D06.472.334.851.687.750.478.400,Hydroxyprogesterones,Progesterone,1
17-alpha-Hydroxyprogesterone,D,D04.210.500.745.745.654.829.395.400,Hydroxyprogesterones,Progesterone,1
1-Butanol,D,D10.289.110.175,Butanols,Fatty Alcohols,1
1-Butanol,D,D02.033.415.110.175,Butanols,Fatty Alcohols,1
1-Deoxynojirimycin,D,D09.553.500.033,Imino Pyranoses,Imino Sugars,1
1-Deoxynojirimycin,D,D03.132.014,Alkaloids,Heterocyclic Compounds,1
1-Deoxynojirimycin,D,D02.491.567.500.033,Imino Pyranoses,Imino Sugars,1
1-Deoxynojirimycin,D,D03.383.621.300.033,Imino Pyranoses,Piperidines,1
1-Naphthylamine,D,D02.455.426.559.847.638.845,Naphthalenes,Polycyclic Aromatic Hydrocarbons,1
1-Naphthylamine,D,D04.615.638.845,Naphthalenes,Polycyclic Aromatic Hydrocarbons,1
1-Naphthylamine,D,D02.092.705,Amines,Organic Chemicals,1
1-Phosphatidylinositol 4-Kinase,D,D08.811.913.696.620.550,Phosphotransferases (Alcohol Group Acceptor),Phosphotransferases,1
"2,2'-Dipyridyl",D,D03.383.725.220,Pyridines,"Heterocyclic Compounds, 1-Ring",1
"2',5'-Oligoadenylate Synthetase",D,D08.811.913.696.445.625,Nucleotidyltransferases,Phosphotransferases,1
2-Aminopurine,D,D03.633.100.759.138.050,Adenine,Purines,1
2-Hydroxypropyl-beta-cyclodextrin,D,D04.345.103.333.500,beta-Cyclodextrins,Cyclodextrins,1
2-Hydroxypropyl-beta-cyclodextrin,D,D09.698.365.855.400.375.333.500,beta-Cyclodextrins,Cyclodextrins,1
2-Hydroxypropyl-beta-cyclodextrin,D,D09.301.915.400.375.333.500,beta-Cyclodextrins,Cyclodextrins,1
3' Flanking Region,G,G05.360.340.024.220.280,"DNA, Intergenic",Genome Components,1
3' Flanking Region,G,G05.360.340.024.340.137.290,Gene Components,Genes,1
"3,4-Dihydroxyphenylacetic Acid",D,D02.241.223.601.220,Phenylacetates,"Acids, Carbocyclic",1
"3',5'-Cyclic-AMP Phosphodiesterases",D,D12.644.360.008,Intracellular Signaling Peptides and Proteins,Peptides,1
"3',5'-Cyclic-AMP Phosphodiesterases",D,D08.811.277.352.640.150,Phosphoric Diester Hydrolases,Esterases,1
"3',5'-Cyclic-AMP Phosphodiesterases",D,D12.776.476.008,Intracellular Signaling Peptides and Proteins,Proteins,1
"3',5'-Cyclic-GMP Phosphodiesterases",D,D12.776.476.009,Intracellular Signaling Peptides and Proteins,Proteins,1
"3',5'-Cyclic-GMP Phosphodiesterases",D,D08.811.277.352.640.155,Phosphoric Diester Hydrolases,Esterases,1
"3',5'-Cyclic-GMP Phosphodiesterases",D,D12.644.360.009,Intracellular Signaling Peptides and Proteins,Peptides,1
3-Iodobenzylguanidine,D,D02.455.526.581.496.300,Iodobenzenes,"Hydrocarbons, Iodinated",1
3-Iodobenzylguanidine,D,D02.455.426.559.389.454.300,Iodobenzenes,Benzene Derivatives,1
3-Iodobenzylguanidine,D,D02.078.370.510,Guanidines,Amidines,1
3-Oxo-5-alpha-Steroid 4-Dehydrogenase,D,D08.811.682.660.465,Oxidoreductases Acting on CH-CH Group Donors,Oxidoreductases,1
4-Aminopyridine,D,D03.383.725.050.060,Aminopyridines,Pyridines,1
4-Aminopyridine,D,D02.092.080.060,Aminopyridines,Amines,1
4-Hydroxyphenylpyruvate Dioxygenase,D,D08.811.682.690.416.330,Dioxygenases,Oxygenases,1
5-alpha Reductase Inhibitors,D,D27.505.519.389.870.200,Steroid Synthesis Inhibitors,Enzyme Inhibitors,1
5-alpha Reductase Inhibitors,D,D27.505.696.399.450.855.200,Steroid Synthesis Inhibitors,Hormone Antagonists,1
5'-Nucleotidase,D,D08.811.277.352.650.600.600,Nucleotidases,Phosphoric Monoester Hydrolases,1
6-Phytase,D,D08.811.277.352.650.700,Phosphoric Monoester Hydrolases,Esterases,1
8-Hydroxy-2'-Deoxyguanosine,D,D03.633.100.759.590.454.240.500,Deoxyguanosine,Guanosine,1
8-Hydroxy-2'-Deoxyguanosine,D,D13.570.583.454.240.500,Deoxyguanosine,Guanosine,1
8-Hydroxy-2'-Deoxyguanosine,D,D13.570.230.360.500,Deoxyguanosine,Deoxyribonucleosides,1
"Abdomen, Acute",C,C23.888.821.030.249,Abdominal Pain,"Signs and Symptoms, Digestive",1
"Abdomen, Acute",C,C23.888.592.612.054.200,Abdominal Pain,Pain,1
Abdominal Muscles,A,A02.633.567.050,"Muscle, Skeletal",Muscles,1
Abducens Nerve Diseases,C,C10.292.150,Cranial Nerve Diseases,Nervous System Diseases,1
"Abnormalities, Radiation-Induced",C,C16.131.080,Congenital Abnormalities,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",1
"Abnormalities, Radiation-Induced",C,C26.733.031,Radiation Injuries,Wounds and Injuries,1
"Abnormalities, Radiation-Induced",G,G01.750.748.500.031,Radiation Injuries,Radiation Exposure,1
"Abnormalities, Radiation-Induced",N,N06.850.460.350.850.500.031,Radiation Injuries,Radiation Exposure,1
"Abnormalities, Radiation-Induced",N,N06.850.810.300.360.031,Radiation Injuries,Radiation Effects,1
"Abortion, Habitual",C,C13.703.039.089,"Abortion, Spontaneous",Pregnancy Complications,1
"Abortion, Threatened",C,C13.703.090,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,1
"Abortion, Veterinary",C,C13.703.039.422,"Abortion, Spontaneous",Pregnancy Complications,1
"Abortion, Veterinary",C,C22.021,Animal Diseases,NULL,1
Abscisic Acid,D,D02.455.426.392.368.367.379.249.024,Carotenoids,Cyclohexenes,1
Abscisic Acid,D,D02.241.223.268.034,Cyclohexanecarboxylic Acids,"Acids, Carbocyclic",1
Abscisic Acid,D,D02.455.326.271.665.202.061,Carotenoids,Polyenes,1
Abscisic Acid,D,D02.455.849.131.061,Carotenoids,Terpenes,1
Abscisic Acid,D,D02.455.849.765.521.500,Monocyclic Sesquiterpenes,Sesquiterpenes,1
"Absorption, Physiological",G,G03.787.024.500,Absorption,Pharmacokinetics,1
"Absorption, Physiological",G,G03.015.500,Absorption,Metabolism,1
"Absorption, Physiological",G,G07.690.725.015.500,Absorption,Pharmacokinetics,1
Academic Failure,N,N01.824.196.125,Educational Status,Socioeconomic Factors,1
Acanthosis Nigricans,C,C17.800.621.430.530.100,Melanosis,Hyperpigmentation,1
Acarbose,D,D09.698.629.802.100,Trisaccharides,Oligosaccharides,1
Acaricides,D,D27.720.031.700.071,Pesticides,Agrochemicals,1
Acaricides,D,D27.888.723.071,Pesticides,Toxic Actions,1
Acaridae,B,B01.050.500.131.166.132.419.050,Mites,Acari,1
Acceptance and Commitment Therapy,F,F04.754.137.350.249,Cognitive Behavioral Therapy,Behavior Therapy,1
Acellular Dermis,A,A17.815.180.040,Dermis,Skin,1
Acetaldehyde,D,D02.047.064,Aldehydes,Organic Chemicals,1
Acetolactate Synthase,D,D12.776.331.049,Flavoproteins,Proteins,1
Acetolactate Synthase,D,D08.811.913.200.324,Aldehyde-Ketone Transferases,Transferases,1
Acetone,D,D02.522.064,Ketones,Organic Chemicals,1
Acetophenones,D,D02.522.120,Ketones,Organic Chemicals,1
Acetylglucosamine,D,D09.067.342.531.050,Glucosamine,Hexosamines,1
Acetylglucosaminidase,D,D08.811.277.450.483.180.500,beta-N-Acetylhexosaminidases,Hexosaminidases,1
Acetylmuramyl-Alanyl-Isoglutamine,D,D09.067.550.050,Muramic Acids,Amino Sugars,1
Acetylmuramyl-Alanyl-Isoglutamine,D,D09.811.522.050,Muramic Acids,Sugar Acids,1
Acetylmuramyl-Alanyl-Isoglutamine,D,D12.644.233.050,Glycopeptides,Peptides,1
Acetylserotonin O-Methyltransferase,D,D08.811.913.555.500.100,Methyltransferases,One-Carbon Group Transferases,1
Acid-Base Imbalance,C,C18.452.076,Metabolic Diseases,Nutritional and Metabolic Diseases,1
Acoustics,H,H01.671.031,Physics,Natural Science Disciplines,1
Acrosome,A,A05.360.490.890.820.100,Sperm Head,Spermatozoa,1
Acrosome,A,A11.284.430.214.190.875.190.550.040,Lysosomes,Cytoplasmic Vesicles,1
Acrosome,A,A11.497.760.400.100,Sperm Head,Spermatozoa,1
Acrylamide,D,D02.065.122.015,Acrylamides,Amides,1
Acrylamide,D,D02.241.081.069.094.015,Acrylamides,Acrylates,1
Actin Depolymerizing Factors,D,D12.776.220.525.212,Microfilament Proteins,Cytoskeletal Proteins,1
Actin Depolymerizing Factors,D,D05.750.078.730.212,Microfilament Proteins,Biopolymers,1
Actinin,D,D05.750.078.730.248,Microfilament Proteins,Biopolymers,1
Actinin,D,D12.776.220.525.250,Microfilament Proteins,Cytoskeletal Proteins,1
Actinin,D,D12.776.210.500.095,Muscle Proteins,Contractile Proteins,1
Actinomycosis,C,C01.150.252.410.040.137,Actinomycetales Infections,Gram-Positive Bacterial Infections,1
Activated Protein C Resistance,C,C16.320.099.037,"Blood Coagulation Disorders, Inherited","Genetic Diseases, Inborn",1
Activated Protein C Resistance,C,C15.378.925.050,Thrombophilia,Hematologic Diseases,1
Activated Protein C Resistance,C,C15.378.100.141.036,Coagulation Protein Disorders,Blood Coagulation Disorders,1
Activated Protein C Resistance,C,C15.378.100.100.037,"Blood Coagulation Disorders, Inherited",Blood Coagulation Disorders,1
Acupuncture,H,H02.004,Health Occupations,NULL,1
Acupuncture Analgesia,E,E03.091.048,Analgesia,Anesthesia and Analgesia,1
Acupuncture Analgesia,E,E02.190.044.105,Acupuncture Therapy,Complementary Therapies,1
Acute Radiation Syndrome,C,C26.733.188,Radiation Injuries,Wounds and Injuries,1
Acute Radiation Syndrome,G,G01.750.748.500.188,Radiation Injuries,Radiation Exposure,1
Acute Radiation Syndrome,N,N06.850.460.350.850.500.158,Radiation Injuries,Radiation Exposure,1
Acute Radiation Syndrome,N,N06.850.810.300.360.158,Radiation Injuries,Radiation Effects,1
Acute Retroviral Syndrome,C,C20.673.480.044,HIV Infections,Immunologic Deficiency Syndromes,1
Acute Retroviral Syndrome,C,C01.221.812.640.400.044,HIV Infections,"Sexually Transmitted Diseases, Viral",1
Acute Retroviral Syndrome,C,C01.221.250.875.044,HIV Infections,Blood-Borne Infections,1
Acute Retroviral Syndrome,C,C01.778.640.400.044,HIV Infections,"Sexually Transmitted Diseases, Viral",1
Acute Retroviral Syndrome,C,C01.925.813.400.044,HIV Infections,"Sexually Transmitted Diseases, Viral",1
Acute Retroviral Syndrome,C,C01.925.782.815.616.400.044,HIV Infections,Lentivirus Infections,1
Acute-On-Chronic Liver Failure,C,C06.552.308.500.750.249,"Liver Failure, Acute",Liver Failure,1
Acylation,G,G02.111.012,Biochemical Phenomena,Chemical Phenomena,1
Acylation,G,G03.040,Metabolism,NULL,1
Acylation,G,G02.607.063,Organic Chemistry Phenomena,Chemical Phenomena,1
Acyl-Butyrolactones,D,D02.540.232,Lactones,Organic Chemicals,1
ADAMTS Proteins,D,D08.811.277.656.675.374.102.500,ADAM Proteins,Metalloendopeptidases,1
ADAMTS Proteins,D,D12.776.395.033.500,ADAM Proteins,Glycoproteins,1
ADAMTS Proteins,D,D09.400.430.500.500,ADAM Proteins,Glycoproteins,1
ADAMTS Proteins,D,D12.776.860.300.085,Extracellular Matrix Proteins,Scleroproteins,1
Adaptive Clinical Trials as Topic,E,E05.318.372.250.250.100,Clinical Trials as Topic,Clinical Studies as Topic,1
Adaptive Clinical Trials as Topic,N,N05.715.360.330.250.250.100,Clinical Trials as Topic,Clinical Studies as Topic,1
Adaptive Clinical Trials as Topic,N,N06.850.520.450.250.250.100,Clinical Trials as Topic,Clinical Studies as Topic,1
Adaptor Protein Complex alpha Subunits,D,D12.776.543.990.150.500.100,Adaptor Protein Complex Subunits,"Adaptor Proteins, Vesicular Transport",1
Adenocarcinoma of Lung,C,C04.588.894.797.520.055,Lung Neoplasms,Respiratory Tract Neoplasms,1
Adenocarcinoma of Lung,C,C04.557.470.200.025.022,Adenocarcinoma,Carcinoma,1
"Adenocarcinoma, Clear Cell",C,C04.557.470.200.025.045,Adenocarcinoma,Carcinoma,1
"Adenoma, Oxyphilic",C,C04.557.470.035.140,Adenoma,"Neoplasms, Glandular and Epithelial",1
Adenosine A1 Receptor Antagonists,D,D27.505.696.577.725.400.100.100,Purinergic P1 Receptor Antagonists,Purinergic Antagonists,1
Adenosine A1 Receptor Antagonists,D,D27.505.519.625.725.400.100.100,Purinergic P1 Receptor Antagonists,Purinergic Antagonists,1
Adenosine Diphosphate Ribose,D,D13.695.827.708.070.125,Adenosine Diphosphate Sugars,Nucleoside Diphosphate Sugars,1
Adenosine Diphosphate Ribose,D,D13.695.827.068.124.070.125,Adenosine Diphosphate Sugars,Adenosine Diphosphate,1
Adenosine Diphosphate Ribose,D,D13.695.667.138.124.070.125,Adenosine Diphosphate Sugars,Adenosine Diphosphate,1
Adenosine Diphosphate Ribose,D,D09.408.620.569.070.125,Adenosine Diphosphate Sugars,Nucleoside Diphosphate Sugars,1
Adenosine Diphosphate Ribose,D,D03.633.100.759.646.138.124.070.125,Adenosine Diphosphate Sugars,Adenosine Diphosphate,1
Adenoviridae Infections,C,C01.925.256.076,DNA Virus Infections,Virus Diseases,1
Adenovirus E1A Proteins,D,D23.050.285.062.045,"Antigens, Viral, Tumor","Antigens, Neoplasm",1
Adenovirus E1A Proteins,D,D12.776.930.100,Transcription Factors,Proteins,1
Adenovirus E1A Proteins,D,D12.776.964.700.045.050.100,Adenovirus E1 Proteins,Adenovirus Early Proteins,1
Adenovirus E1A Proteins,D,D12.776.624.664.520.045.050.100,Adenovirus E1 Proteins,Adenovirus Early Proteins,1
Adenovirus E1A Proteins,D,D12.776.460.050.100,Adenovirus E1 Proteins,Immediate-Early Proteins,1
Adenovirus E1A Proteins,D,D23.050.327.062.045,"Antigens, Viral, Tumor","Antigens, Viral",1
Adenovirus E1B Proteins,D,D23.050.327.062.050,"Antigens, Viral, Tumor","Antigens, Viral",1
Adenovirus E1B Proteins,D,D12.776.460.050.110,Adenovirus E1 Proteins,Immediate-Early Proteins,1
Adenovirus E1B Proteins,D,D12.776.624.664.520.045.050.110,Adenovirus E1 Proteins,Adenovirus Early Proteins,1
Adenovirus E1B Proteins,D,D12.776.964.700.045.050.110,Adenovirus E1 Proteins,Adenovirus Early Proteins,1
Adenovirus E1B Proteins,D,D12.776.930.110,Transcription Factors,Proteins,1
Adenovirus E1B Proteins,D,D23.050.285.062.050,"Antigens, Viral, Tumor","Antigens, Neoplasm",1
Adenovirus Vaccines,D,D20.215.894.899.024,Viral Vaccines,Vaccines,1
"Adipose Tissue, White",A,A10.165.114.830,Adipose Tissue,Connective Tissue,1
Adjustment Disorders,F,F03.950.500,Trauma and Stressor Related Disorders,Mental Disorders,1
"Administration, Mucosal",E,E02.319.267.120.655,"Administration, Topical",Drug Administration Routes,1
"Administration, Sublingual",E,E02.319.267.100.878,"Administration, Oral",Drug Administration Routes,1
Adolescent Medicine,H,H02.403.014,Medicine,Health Occupations,1
"Adolescent, Hospitalized",M,M01.643.050,Patients,Persons,1
ADP-Ribosylation Factors,D,D12.776.476.525.100,Monomeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,1
ADP-Ribosylation Factors,D,D08.811.277.040.330.300.400.100,Monomeric GTP-Binding Proteins,GTP-Binding Proteins,1
ADP-Ribosylation Factors,D,D12.644.360.525.100,Monomeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,1
ADP-Ribosylation Factors,D,D12.776.157.325.515.100,Monomeric GTP-Binding Proteins,GTP-Binding Proteins,1
Adrenergic alpha-1 Receptor Antagonists,D,D27.505.519.625.050.200.100.100,Adrenergic alpha-Antagonists,Adrenergic Antagonists,1
Adrenergic alpha-1 Receptor Antagonists,D,D27.505.696.577.050.200.100.100,Adrenergic alpha-Antagonists,Adrenergic Antagonists,1
Adrenergic alpha-Agonists,D,D27.505.696.577.050.100.100,Adrenergic Agonists,Adrenergic Agents,1
Adrenergic alpha-Agonists,D,D27.505.519.625.050.100.100,Adrenergic Agonists,Adrenergic Agents,1
Adrenergic Antagonists,D,D27.505.519.625.050.200,Adrenergic Agents,Neurotransmitter Agents,1
Adrenergic Antagonists,D,D27.505.696.577.050.200,Adrenergic Agents,Neurotransmitter Agents,1
Adrenocortical Hyperfunction,C,C19.053.800,Adrenal Gland Diseases,Endocrine System Diseases,1
Adult Survivors of Child Adverse Events,M,M01.860.300,Survivors,Persons,1
Advanced Practice Nursing,H,H02.478.676.074,"Specialties, Nursing",Nursing,1
Aerococcus,B,B03.510.400.030,Gram-Positive Cocci,Gram-Positive Bacteria,1
Aerococcus,B,B03.353.750.030.030,Aerococcaceae,Lactobacillales,1
Aerococcus,B,B03.510.550.030.030,Aerococcaceae,Lactobacillales,1
Aeromonas hydrophila,B,B03.440.450.019.025.380,Aeromonas,Aeromonadaceae,1
Afferent Pathways,A,A08.612.220,Neural Pathways,Nervous System,1
Afibrinogenemia,C,C15.378.100.100.056,"Blood Coagulation Disorders, Inherited",Blood Coagulation Disorders,1
Afibrinogenemia,C,C15.378.100.141.072,Coagulation Protein Disorders,Blood Coagulation Disorders,1
Afibrinogenemia,C,C15.378.463.067,Hemorrhagic Disorders,Hematologic Diseases,1
Afibrinogenemia,C,C16.320.099.056,"Blood Coagulation Disorders, Inherited","Genetic Diseases, Inborn",1
African Union,I,I01.615.500.125,International Cooperation,Internationality,1
African Union,N,N03.540.089,Organizations,Health Care Economics and Organizations,1
Agammaglobulinemia,C,C15.604.515.032,Lymphoproliferative Disorders,Lymphatic Diseases,1
Agammaglobulinemia,C,C15.378.147.142,Blood Protein Disorders,Hematologic Diseases,1
Agammaglobulinemia,C,C20.673.088,Immunologic Deficiency Syndromes,Immune System Diseases,1
Agenesis of Corpus Callosum,C,C23.300.008,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",1
Agenesis of Corpus Callosum,C,C16.131.666.034,Nervous System Malformations,Congenital Abnormalities,1
Agenesis of Corpus Callosum,C,C10.500.034,Nervous System Malformations,Nervous System Diseases,1
Agglutinins,D,D27.505.696.477.136,Immunologic Factors,Physiological Effects of Drugs,1
Agglutinins,D,D27.505.954.502.270.232,Coagulants,Hematologic Agents,1
Agmatine,D,D02.078.370.060,Guanidines,Amidines,1
Agouti Signaling Protein,D,D23.529.049,Intercellular Signaling Peptides and Proteins,Biological Factors,1
Agouti Signaling Protein,D,D12.776.467.049,Intercellular Signaling Peptides and Proteins,Proteins,1
Agouti Signaling Protein,D,D12.644.276.049,Intercellular Signaling Peptides and Proteins,Peptides,1
Agricultural Irrigation,J,J01.040.044,Agriculture,"Technology, Industry, and Agriculture",1
Air,G,G16.500.275.063.150,Atmosphere,Environment,1
Air,N,N06.230.300.100.150,Atmosphere,Meteorological Concepts,1
"Air Pollution, Radioactive",N,N06.850.460.100.110,Air Pollution,Environmental Pollution,1
"Air Pollution, Radioactive",N,N06.850.810.080,Radiologic Health,Public Health,1
Airway Management,E,E02.041,Therapeutics,NULL,1
Airway Remodeling,C,C23.300.017,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",1
Airway Remodeling,G,G09.772.029,Respiratory Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,1
Ajuga,B,B01.650.940.800.575.912.250.583.520.051,Lamiaceae,Lamiales,1
Alabama,Z,Z01.107.567.875.750.100,Southeastern United States,United States,1
Alabama,Z,Z01.107.567.875.075.100,Appalachian Region,United States,1
Alanine Racemase,D,D08.811.399.894.200.200,Amino Acid Isomerases,Racemases and Epimerases,1
Alaskan Natives,M,M01.686.508.150.600.250,"Indians, North American",American Native Continental Ancestry Group,1
Alaskan Natives,M,M01.686.754.254.500,Indigenous Peoples,Ethnic Groups,1
Albinism,C,C11.270.040,"Eye Diseases, Hereditary",Eye Diseases,1
Albinism,C,C16.320.290.040,"Eye Diseases, Hereditary","Genetic Diseases, Inborn",1
Albinism,C,C16.320.850.080,"Skin Diseases, Genetic","Genetic Diseases, Inborn",1
Albinism,C,C16.320.565.100.102,"Amino Acid Metabolism, Inborn Errors","Metabolism, Inborn Errors",1
Albinism,C,C18.452.648.100.102,"Amino Acid Metabolism, Inborn Errors","Metabolism, Inborn Errors",1
Albinism,C,C17.800.621.440.102,Hypopigmentation,Pigmentation Disorders,1
Albinism,C,C17.800.827.080,"Skin Diseases, Genetic",Skin Diseases,1
"Albinism, Oculocutaneous",C,C17.800.827.080.100,Albinism,"Skin Diseases, Genetic",1
"Albinism, Oculocutaneous",C,C17.800.621.440.102.100,Albinism,Hypopigmentation,1
"Albinism, Oculocutaneous",C,C18.452.648.100.102.100,Albinism,"Amino Acid Metabolism, Inborn Errors",1
"Albinism, Oculocutaneous",C,C16.320.565.100.102.100,Albinism,"Amino Acid Metabolism, Inborn Errors",1
"Albinism, Oculocutaneous",C,C16.320.850.080.100,Albinism,"Skin Diseases, Genetic",1
"Albinism, Oculocutaneous",C,C16.320.290.040.100,Albinism,"Eye Diseases, Hereditary",1
"Albinism, Oculocutaneous",C,C11.270.040.545,Albinism,"Eye Diseases, Hereditary",1
Alchemy,K,K01.672.148,Occultism,Humanities,1
Alcoholics,M,M01.066,Persons,NULL,1
Aldehyde Dehydrogenase,D,D08.811.682.657.163.249,Aldehyde Oxidoreductases,Oxidoreductases Acting on Aldehyde or Oxo Group Donors,1
Aldose-Ketose Isomerases,D,D08.811.399.475.200,Intramolecular Oxidoreductases,Isomerases,1
Alginates,D,D09.698.068,Polysaccharides,Carbohydrates,1
Aliivibrio,B,B03.440.450.900.050,Vibrionaceae,Gram-Negative Facultatively Anaerobic Rods,1
Aliivibrio,B,B03.660.250.830.050,Vibrionaceae,Gammaproteobacteria,1
Aliivibrio fischeri,B,B03.660.250.830.050.860,Aliivibrio,Vibrionaceae,1
Aliivibrio fischeri,B,B03.440.450.900.050.860,Aliivibrio,Vibrionaceae,1
Aliivibrio salmonicida,B,B03.440.450.900.050.930,Aliivibrio,Vibrionaceae,1
Aliivibrio salmonicida,B,B03.660.250.830.050.930,Aliivibrio,Vibrionaceae,1
Alitretinoin,D,D02.455.326.271.665.202.495.818.500.500,Tretinoin,Vitamin A,1
Alitretinoin,D,D02.455.426.392.368.367.379.249.700.860.500.500,Tretinoin,Vitamin A,1
Alitretinoin,D,D02.455.849.291.925.500.500,Tretinoin,Vitamin A,1
Alitretinoin,D,D02.455.849.131.495.818.800.500,Tretinoin,Vitamin A,1
Alitretinoin,D,D23.767.261.700.780.500,Tretinoin,Retinoids,1
Alkanes,D,D02.455.326.146,"Hydrocarbons, Acyclic",Hydrocarbons,1
Allosteric Site,G,G02.111.570.120.147,Binding Sites,Molecular Structure,1
Alloys,J,J01.637.051.058,Biomedical and Dental Materials,Manufactured Materials,1
Alloys,D,D01.552.033,Metals,Inorganic Chemicals,1
Alloys,D,D25.058,Biomedical and Dental Materials,NULL,1
Alopecia Areata,C,C17.800.329.937.122.147,Alopecia,Hypotrichosis,1
Alpha Particles,G,G01.750.750.055,"Radiation, Ionizing",Radiation,1
alpha-Amylases,D,D08.811.277.450.066.050,Amylases,Glycoside Hydrolases,1
alpha-Galactosidase,D,D08.811.277.450.410.050,Galactosidases,Glycoside Hydrolases,1
Alpha-Globulins,D,D12.776.124.790.106,Serum Globulins,Blood Proteins,1
Alpha-Globulins,D,D12.776.377.715.085,Serum Globulins,Globulins,1
Alphaherpesvirinae,B,B04.280.382.100,Herpesviridae,DNA Viruses,1
alpha-N-Acetylgalactosaminidase,D,D08.811.277.450.483.044,Hexosaminidases,Glycoside Hydrolases,1
Altretamine,D,D03.383.931.135,Triazines,"Heterocyclic Compounds, 1-Ring",1
Alu Elements,G,G02.111.570.080.708.330.800.800.050,Short Interspersed Nucleotide Elements,Retroelements,1
Alu Elements,G,G05.360.340.024.425.800.800.050,Short Interspersed Nucleotide Elements,Retroelements,1
Alu Elements,G,G05.360.080.708.330.800.800.050,Short Interspersed Nucleotide Elements,Retroelements,1
Aluminum Chloride,D,D01.210.450.150.025,Chlorides,Hydrochloric Acid,1
Aluminum Chloride,D,D01.056.031,Aluminum Compounds,Inorganic Chemicals,1
Aluminum Compounds,D,D01.056,Inorganic Chemicals,NULL,1
Alveolar Bone Loss,C,C05.116.264.150,Bone Resorption,Bone Diseases,1
Alveolar Bone Loss,C,C07.465.714.354.500,Periodontal Atrophy,Periodontal Diseases,1
Amacrine Cells,A,A08.675.358.050,Interneurons,Neurons,1
Amacrine Cells,A,A09.371.729.831.500,Retinal Neurons,Retina,1
Amacrine Cells,A,A08.675.650.850.500,Retinal Neurons,"Neurons, Afferent",1
Amacrine Cells,A,A11.671.358.050,Interneurons,Neurons,1
Amacrine Cells,A,A11.671.650.850.500,Retinal Neurons,"Neurons, Afferent",1
Amaranthus,B,B01.650.940.800.575.912.250.198.500.100.130,Amaranthaceae,Caryophyllales,1
Ambrosia,B,B01.650.940.800.575.912.250.100.065,Asteraceae,Magnoliopsida,1
Amdinocillin,D,D02.065.589.099.750.124,Penicillins,beta-Lactams,1
Amdinocillin,D,D03.633.100.300.750.124,Penicillins,beta-Lactams,1
Amdinocillin,D,D02.886.108.750.124,Penicillins,beta-Lactams,1
Amelogenin,D,D12.776.231.500,Dental Enamel Proteins,Proteins,1
American Cancer Society,N,N03.540.630.780.080,Voluntary Health Agencies,"Organizations, Nonprofit",1
Amifampridine,D,D03.383.725.050.060.500,4-Aminopyridine,Aminopyridines,1
Amifampridine,D,D02.092.080.060.500,4-Aminopyridine,Aminopyridines,1
Amination,G,G02.111.053,Biochemical Phenomena,Chemical Phenomena,1
Amination,G,G02.607.110,Organic Chemistry Phenomena,Chemical Phenomena,1
Amination,G,G03.068,Metabolism,NULL,1
Amino Acid Chloromethyl Ketones,D,D12.125.065,Amino Acids,"Amino Acids, Peptides, and Proteins",1
Amino Acid Transport Systems,D,D12.776.157.530.200,Membrane Transport Proteins,Carrier Proteins,1
Amino Acid Transport Systems,D,D12.776.543.585.200,Membrane Transport Proteins,Membrane Proteins,1
"Amino Acids, Branched-Chain",D,D12.125.070,Amino Acids,"Amino Acids, Peptides, and Proteins",1
Amino Alcohols,D,D02.092.063,Amines,Organic Chemicals,1
Amino Alcohols,D,D02.033.100,Alcohols,Organic Chemicals,1
Aminocoumarins,D,D03.383.663.283.446.139,Coumarins,Benzopyrans,1
Aminocoumarins,D,D03.633.100.150.446.139,Coumarins,Benzopyrans,1
Aminomethyltransferase,D,D08.811.600.391.100,Glycine Decarboxylase Complex,Multienzyme Complexes,1
Aminomethyltransferase,D,D05.500.562.452.100,Glycine Decarboxylase Complex,Multienzyme Complexes,1
Aminomethyltransferase,D,D08.811.913.555.400.100,Hydroxymethyl and Formyl Transferases,One-Carbon Group Transferases,1
Aminophylline,D,D03.633.100.759.758.824.751.075,Theophylline,Xanthines,1
Aminophylline,D,D26.310.048,Drug Combinations,Pharmaceutical Preparations,1
Aminophylline,D,D02.092.782.258.368.050,Ethylenediamines,Diamines,1
Ammonium Chloride,D,D01.625.062.249,Ammonium Compounds,Nitrogen Compounds,1
Ammonium Chloride,D,D01.210.450.150.050,Chlorides,Hydrochloric Acid,1
AMP Deaminase,D,D08.811.277.151.653.060,Nucleotide Deaminases,Aminohydrolases,1
AMP-Activated Protein Kinases,D,D08.811.913.696.620.682.700.085,Protein-Serine-Threonine Kinases,Protein Kinases,1
AMP-Activated Protein Kinases,D,D12.644.360.062,Intracellular Signaling Peptides and Proteins,Peptides,1
AMP-Activated Protein Kinases,D,D12.776.476.062,Intracellular Signaling Peptides and Proteins,Proteins,1
Amphetamine,D,D02.092.471.683.152.110,Amphetamines,Phenethylamines,1
Amphiregulin,D,D12.776.467.382.249,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,1
Amphiregulin,D,D12.776.543.029,Membrane Proteins,Proteins,1
Amphiregulin,D,D23.529.382.249,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,1
Amphiregulin,D,D12.644.276.382.249,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,1
Amyloid Precursor Protein Secretases,D,D08.811.277.656.300.032,Endopeptidases,Peptide Hydrolases,1
Anacardic Acids,D,D02.455.426.559.389.657.410.595.151,Salicylates,Hydroxybenzoates,1
Anaerobic Threshold,G,G03.680.110,Oxygen Consumption,Metabolism,1
Anaerobic Threshold,G,G11.427.680.134,Physical Endurance,Musculoskeletal Physiological Phenomena,1
Ananas,B,B01.650.940.800.575.912.250.159.099,Bromeliaceae,Magnoliopsida,1
Anaphase-Promoting Complex-Cyclosome,D,D08.811.464.938.750.092,Ubiquitin-Protein Ligases,Ubiquitin-Protein Ligase Complexes,1
Anaphase-Promoting Complex-Cyclosome,D,D12.776.167.024,Cell Cycle Proteins,Proteins,1
Anaplasma,B,B03.440.664.750.050,Anaplasmataceae,Rickettsiales,1
Anaplasma,B,B03.660.050.783.500.050,Anaplasmataceae,Rickettsiales,1
Anatomic Landmarks,A,A01.111,Body Regions,NULL,1
"Anatomy, Cross-Sectional",H,H01.158.100.185,Anatomy,Biological Science Disciplines,1
Androgen Receptor Antagonists,D,D06.347.065.249,Androgen Antagonists,Hormone Antagonists,1
Androgen Receptor Antagonists,D,D27.505.696.399.450.065.249,Androgen Antagonists,Hormone Antagonists,1
Androstenedione,D,D06.472.040.502.112,17-Ketosteroids,Adrenal Cortex Hormones,1
Androstenedione,D,D06.472.334.851.968.875,Testosterone Congeners,Gonadal Steroid Hormones,1
Androstenedione,D,D04.210.500.054.079.329,Androstenes,Androstanes,1
Androstenedione,D,D04.210.500.578.502.112,17-Ketosteroids,Ketosteroids,1
"Anemia, Macrocytic",C,C15.378.071.252,Anemia,Hematologic Diseases,1
"Anemia, Megaloblastic",C,C15.378.071.252.196,"Anemia, Macrocytic",Anemia,1
"Anemia, Sideroblastic",C,C15.378.071.419,Anemia,Hematologic Diseases,1
"Anemia, Sideroblastic",C,C15.378.190.625.070,Myelodysplastic Syndromes,Bone Marrow Diseases,1
"Anesthesia, Conduction",E,E03.155.086,Anesthesia,Anesthesia and Analgesia,1
Anesthesiologists,N,N02.360.140.040,Anesthetists,Health Personnel,1
Anesthesiologists,N,N02.360.810.040,Physicians,Health Personnel,1
Anesthesiologists,M,M01.526.485.810.040,Physicians,Health Personnel,1
Anesthesiologists,M,M01.526.485.140.040,Anesthetists,Health Personnel,1
Anesthetics,D,D27.505.696.277.100,Central Nervous System Depressants,Physiological Effects of Drugs,1
Anesthetics,D,D27.505.954.427.210.100,Central Nervous System Depressants,Central Nervous System Agents,1
"Anesthetics, Combined",D,D27.505.954.427.210.100.017,Anesthetics,Central Nervous System Depressants,1
"Anesthetics, Combined",D,D27.505.696.277.100.017,Anesthetics,Central Nervous System Depressants,1
Anesthetists,M,M01.526.485.140,Health Personnel,Occupational Groups,1
Anesthetists,N,N02.360.140,Health Personnel,"Health Care Facilities, Manpower, and Services",1
Angioid Streaks,C,C11.768.094,Retinal Diseases,Eye Diseases,1
"Angioplasty, Balloon, Laser-Assisted",E,E02.148.050.060.105,"Angioplasty, Balloon",Angioplasty,1
"Angioplasty, Balloon, Laser-Assisted",E,E02.148.050.075.080,"Angioplasty, Laser",Angioplasty,1
"Angioplasty, Balloon, Laser-Assisted",E,E02.594.060.080,"Angioplasty, Laser",Laser Therapy,1
"Angioplasty, Balloon, Laser-Assisted",E,E04.014.520.060.080,"Angioplasty, Laser",Laser Therapy,1
"Angioplasty, Balloon, Laser-Assisted",E,E04.100.814.529.124.075.080,"Angioplasty, Laser",Angioplasty,1
"Angioplasty, Balloon, Laser-Assisted",E,E04.100.814.529.124.060.105,"Angioplasty, Balloon",Angioplasty,1
"Angioplasty, Balloon, Laser-Assisted",E,E04.502.382.124.060.105,"Angioplasty, Balloon",Angioplasty,1
"Angioplasty, Balloon, Laser-Assisted",E,E04.502.382.124.075.080,"Angioplasty, Laser",Angioplasty,1
"Angioplasty, Balloon, Laser-Assisted",E,E05.157.016.060.105,"Angioplasty, Balloon",Angioplasty,1
"Angioplasty, Balloon, Laser-Assisted",E,E05.157.016.075.080,"Angioplasty, Laser",Angioplasty,1
"Angioplasty, Laser",E,E05.157.016.075,Angioplasty,Catheterization,1
"Angioplasty, Laser",E,E04.502.382.124.075,Angioplasty,Endovascular Procedures,1
"Angioplasty, Laser",E,E04.100.814.529.124.075,Angioplasty,Endovascular Procedures,1
"Angioplasty, Laser",E,E04.014.520.060,Laser Therapy,Ablation Techniques,1
"Angioplasty, Laser",E,E02.594.060,Laser Therapy,Therapeutics,1
"Angioplasty, Laser",E,E02.148.050.075,Angioplasty,Catheterization,1
Angiotensin I,D,D23.469.050.050.025,Angiotensins,Autacoids,1
Angiotensin I,D,D12.776.631.650.070.075,Angiotensins,Neuropeptides,1
Angiotensin I,D,D06.472.699.094.075,Angiotensins,Peptide Hormones,1
Angiotensin I,D,D12.644.400.070.075,Angiotensins,Neuropeptides,1
Angiotensin I,D,D12.644.456.073.021,Angiotensins,Oligopeptides,1
Angiotensin I,D,D12.644.548.058.075,Angiotensins,Peptide Hormones,1
Angiotensin II Type 2 Receptor Blockers,D,D27.505.519.162.750,Angiotensin Receptor Antagonists,Molecular Mechanisms of Pharmacological Action,1
Angiotensins,D,D23.469.050.050,Autacoids,Inflammation Mediators,1
Angiotensins,D,D12.776.631.650.070,Neuropeptides,Nerve Tissue Proteins,1
Angiotensins,D,D12.644.548.058,Peptide Hormones,Peptides,1
Angiotensins,D,D12.644.400.070,Neuropeptides,Peptides,1
Angiotensins,D,D12.644.456.073,Oligopeptides,Peptides,1
Angiotensins,D,D06.472.699.094,Peptide Hormones,Hormones,1
Anilides,D,D02.092.146.113,Aniline Compounds,Amines,1
Anilides,D,D02.065.199,Amides,Organic Chemicals,1
Animal Fins,A,A13.075,Animal Structures,NULL,1
"Animals, Congenic",B,B01.050.050.199.520.040,"Animals, Inbred Strains","Animals, Laboratory",1
"Animals, Suckling",B,B01.050.050.293,Animal Population Groups,Animals,1
"Anion Exchange Protein 1, Erythrocyte",D,D12.776.157.530.937.656.249.500,Chloride-Bicarbonate Antiporters,SLC4A Proteins,1
"Anion Exchange Protein 1, Erythrocyte",D,D12.776.157.530.450.437.249.500,Chloride-Bicarbonate Antiporters,SLC4A Proteins,1
"Anion Exchange Protein 1, Erythrocyte",D,D12.776.157.530.450.162.193.500,Chloride-Bicarbonate Antiporters,Antiporters,1
"Anion Exchange Protein 1, Erythrocyte",D,D12.776.543.550.190.276.500,Chloride-Bicarbonate Antiporters,Antiporters,1
"Anion Exchange Protein 1, Erythrocyte",D,D12.776.543.550.779.249.500,Chloride-Bicarbonate Antiporters,SLC4A Proteins,1
"Anion Exchange Protein 1, Erythrocyte",D,D12.776.543.585.450.437.249.500,Chloride-Bicarbonate Antiporters,SLC4A Proteins,1
"Anion Exchange Protein 1, Erythrocyte",D,D12.776.543.585.450.162.193.500,Chloride-Bicarbonate Antiporters,Antiporters,1
"Anion Exchange Protein 1, Erythrocyte",D,D12.776.543.585.937.776.249.500,Chloride-Bicarbonate Antiporters,SLC4A Proteins,1
Anion Exchange Resins,D,D27.720.470.420.050,Ion Exchange Resins,Laboratory Chemicals,1
Anisakiasis,C,C01.610.432.060,"Intestinal Diseases, Parasitic",Parasitic Diseases,1
Anisakiasis,C,C01.610.335.508.700.100.060,Ascaridida Infections,Secernentea Infections,1
Anisakiasis,C,C06.405.469.452.060,"Intestinal Diseases, Parasitic",Intestinal Diseases,1
Anisakis,B,B01.050.500.500.294.400.500.100.075,Ascaridoidea,Ascaridida,1
Anisomycin,D,D03.383.773.050,Pyrrolidines,"Heterocyclic Compounds, 1-Ring",1
Ankle,A,A01.378.610.050,Lower Extremity,Extremities,1
Annexins,D,D12.776.157.125.050,Calcium-Binding Proteins,Carrier Proteins,1
Anomie,F,F01.145.813.093,Social Behavior,Behavior,1
Anomie,I,I01.880.853.450.283,Social Conditions,Sociological Factors,1
Anosmia,C,C23.888.592.763.550.500,Olfaction Disorders,Sensation Disorders,1
Anosmia,C,C10.597.751.600.500,Olfaction Disorders,Sensation Disorders,1
Anseriformes,B,B01.050.150.900.248.050,Birds,Vertebrates,1
"Anterior Capsular Rupture, Ocular",C,C11.297.249,Eye Injuries,Eye Diseases,1
Anterior Wall Myocardial Infarction,C,C14.280.647.500.093,Myocardial Infarction,Myocardial Ischemia,1
Anterior Wall Myocardial Infarction,C,C14.907.585.500.093,Myocardial Infarction,Myocardial Ischemia,1
Anterior Wall Myocardial Infarction,C,C23.550.717.489.750.093,Myocardial Infarction,Infarction,1
Anterior Wall Myocardial Infarction,C,C23.550.513.355.750.093,Myocardial Infarction,Infarction,1
Anthracosilicosis,C,C24.800.834.201,Silicosis,Pneumoconiosis,1
Anthracosilicosis,C,C08.381.483.581.062.500,Anthracosis,Pneumoconiosis,1
Anthracosilicosis,C,C08.381.483.581.760.125,Silicosis,Pneumoconiosis,1
Anthracosilicosis,C,C08.381.520.702.062.500,Anthracosis,Pneumoconiosis,1
Anthracosilicosis,C,C08.381.520.702.760.125,Silicosis,Pneumoconiosis,1
Anthracosis,C,C08.381.520.702.062,Pneumoconiosis,Lung Injury,1
Anthracosis,C,C08.381.483.581.062,Pneumoconiosis,"Lung Diseases, Interstitial",1
"Antibodies, Anticardiolipin",D,D12.776.124.790.651.114.323.210.100,"Antibodies, Antiphospholipid",Autoantibodies,1
"Antibodies, Anticardiolipin",D,D12.776.124.486.485.114.323.210.100,"Antibodies, Antiphospholipid",Autoantibodies,1
"Antibodies, Anticardiolipin",D,D12.776.377.715.548.114.323.210.100,"Antibodies, Antiphospholipid",Autoantibodies,1
"Antibodies, Heterophile",D,D12.776.377.715.548.114.191,Antibodies,Immunoglobulins,1
"Antibodies, Heterophile",D,D12.776.124.486.485.114.191,Antibodies,Immunoglobulins,1
"Antibodies, Heterophile",D,D12.776.124.790.651.114.191,Antibodies,Immunoglobulins,1
Antibody-Dependent Enhancement,G,G12.113,Immune System Phenomena,NULL,1
Antibody-Dependent Enhancement,G,G06.920.095,Virus Physiological Phenomena,Microbiological Phenomena,1
Anticestodal Agents,D,D27.505.954.122.250.075.100.040,Antiplatyhelmintic Agents,Anthelmintics,1
Antidotes,D,D27.505.696.706.037,Protective Agents,Physiological Effects of Drugs,1
Antidotes,D,D27.720.799.037,Protective Agents,Specialty Uses of Chemicals,1
"Antigens, CD19",D,D23.101.100.150.119,"Antigens, Differentiation, B-Lymphocyte","Antigens, Differentiation",1
"Antigens, CD19",D,D23.101.100.110.119,"Antigens, CD","Antigens, Differentiation",1
"Antigens, CD19",D,D23.050.301.500.600.200,Minor Histocompatibility Antigens,Histocompatibility Antigens,1
"Antigens, CD19",D,D23.050.705.552.600.200,Minor Histocompatibility Antigens,Histocompatibility Antigens,1
"Antigens, CD19",D,D23.050.301.264.051.119,"Antigens, Differentiation, B-Lymphocyte","Antigens, Differentiation",1
"Antigens, CD19",D,D23.050.301.264.035.119,"Antigens, CD","Antigens, Differentiation",1
"Antigens, CD1d",D,D23.050.301.264.035.100.500,"Antigens, CD1","Antigens, CD",1
"Antigens, CD1d",D,D23.050.301.264.894.080.500,"Antigens, CD1","Antigens, Differentiation, T-Lymphocyte",1
"Antigens, CD1d",D,D23.101.100.894.080.500,"Antigens, CD1","Antigens, Differentiation, T-Lymphocyte",1
"Antigens, CD1d",D,D23.101.100.110.100.500,"Antigens, CD1","Antigens, CD",1
"Antigens, CD34",D,D23.101.100.110.134,"Antigens, CD","Antigens, Differentiation",1
"Antigens, CD34",D,D23.050.301.264.035.134,"Antigens, CD","Antigens, Differentiation",1
"Antigens, Human Platelet",D,D23.050.705.115,Isoantigens,Antigens,1
"Antigens, Tumor-Associated, Carbohydrate",D,D23.050.550.325,Epitopes,Antigens,1
"Antigens, Tumor-Associated, Carbohydrate",D,D23.101.140.075,"Biomarkers, Tumor",Biomarkers,1
"Antigens, Tumor-Associated, Carbohydrate",D,D23.050.285.050,"Antigens, Neoplasm",Antigens,1
Anti-Mullerian Hormone,D,D12.776.395.089,Glycoproteins,Proteins,1
Anti-Mullerian Hormone,D,D09.400.430.625,Glycoproteins,Glycoconjugates,1
Anti-Mullerian Hormone,D,D06.472.334.984.500,Testicular Hormones,Gonadal Hormones,1
"Antineoplastic Agents, Alkylating",D,D27.505.954.248.150,Antineoplastic Agents,Therapeutic Uses,1
"Antineoplastic Agents, Alkylating",D,D27.505.519.124.035,Alkylating Agents,Molecular Mechanisms of Pharmacological Action,1
"Antineoplastic Agents, Alkylating",D,D27.888.569.035.035,Alkylating Agents,Noxae,1
Antisense Elements (Genetics),D,D27.720.470.530.600.150,Nucleic Acid Probes,Molecular Probes,1
Antisense Elements (Genetics),D,D13.150,"Nucleic Acids, Nucleotides, and Nucleosides",NULL,1
Antisense Elements (Genetics),D,D13.444.600.150,Nucleic Acid Probes,Nucleic Acids,1
Antitrichomonal Agents,D,D27.505.954.122.250.100.115,Antiprotozoal Agents,Antiparasitic Agents,1
Antlers,A,A13.507.288,Horns,Animal Structures,1
Ants,B,B01.050.500.131.617.720.500.500.875.205,Hymenoptera,Holometabola,1
Aortic Coarctation,C,C14.240.400.090,"Heart Defects, Congenital",Cardiovascular Abnormalities,1
Aortic Coarctation,C,C14.280.400.090,"Heart Defects, Congenital",Heart Diseases,1
Aortic Coarctation,C,C16.131.240.400.090,"Heart Defects, Congenital",Cardiovascular Abnormalities,1
Aortitis,C,C14.907.109.320,Aortic Diseases,Vascular Diseases,1
Aortitis,C,C14.907.940.080,Vasculitis,Vascular Diseases,1
Aotidae,B,B01.050.150.900.649.313.988.400.600.037,Platyrrhini,Haplorhini,1
Apamin,D,D23.946.833.065.115.060,Bee Venoms,Arthropod Venoms,1
Apamin,D,D20.888.065.115.060,Bee Venoms,Arthropod Venoms,1
Apartheid,I,I01.696.050,Political Systems,Social Sciences,1
Apartheid,I,I01.880.735.820.500.125,Race Relations,Social Segregation,1
"Aphasia, Broca",C,C10.597.606.150.500.800.100.100,Aphasia,Speech Disorders,1
"Aphasia, Broca",C,C23.888.592.604.150.500.800.100.100,Aphasia,Speech Disorders,1
Aphthovirus,B,B04.820.578.750.070,Picornaviridae,Positive-Strand RNA Viruses,1
Aplysia,B,B01.050.500.644.400.060,Gastropoda,Mollusca,1
APOBEC-3G Deaminase,D,D08.811.277.151.486.250.500.750,APOBEC Deaminases,Cytidine Deaminase,1
Apolipoprotein A-II,D,D10.532.091.200.150,Apolipoproteins A,Apolipoproteins,1
Apolipoprotein A-II,D,D12.776.070.400.200.150,Apolipoproteins A,Apolipoproteins,1
Apolipoprotein A-II,D,D12.776.521.120.200.150,Apolipoproteins A,Apolipoproteins,1
Apolipoprotein B-100,D,D12.776.521.120.300.249,Apolipoproteins B,Apolipoproteins,1
Apolipoprotein B-100,D,D12.776.070.400.300.249,Apolipoproteins B,Apolipoproteins,1
Apolipoprotein B-100,D,D10.532.091.300.249,Apolipoproteins B,Apolipoproteins,1
Apolipoprotein E2,D,D10.532.091.500.249,Apolipoproteins E,Apolipoproteins,1
Apolipoprotein E2,D,D12.776.070.400.500.249,Apolipoproteins E,Apolipoproteins,1
Apolipoprotein E2,D,D12.776.521.120.500.249,Apolipoproteins E,Apolipoproteins,1
Apolipoproteins C,D,D12.776.521.120.400,Apolipoproteins,Lipoproteins,1
Apolipoproteins C,D,D12.776.070.400.400,Apolipoproteins,Apoproteins,1
Apolipoproteins C,D,D10.532.091.400,Apolipoproteins,Lipoproteins,1
Apomorphine,D,D03.633.400.095.290,Aporphines,"Heterocyclic Compounds, 4 or More Rings",1
Apomorphine,D,D03.633.100.531.085.030.290,Aporphines,Benzylisoquinolines,1
Apomorphine,D,D03.132.098.038.290,Aporphines,Benzylisoquinolines,1
Apoprotein(a),D,D10.532.350.500,Lipoprotein(a),Lipoproteins,1
Apoprotein(a),D,D12.776.521.400.500,Lipoprotein(a),Lipoproteins,1
Appalachian Region,Z,Z01.107.567.875.075,United States,North America,1
Aptitude,F,F02.784.629.131,"Psychology, Educational","Psychology, Applied",1
Apyrase,D,D08.811.277.040.050,Acid Anhydride Hydrolases,Hydrolases,1
Aquaglyceroporins,D,D12.776.157.530.400.500.040.249,Aquaporins,Porins,1
Aquaglyceroporins,D,D12.776.543.585.400.730.040.249,Aquaporins,Porins,1
Aquaglyceroporins,D,D12.776.543.550.450.730.040.249,Aquaporins,Porins,1
Aquaporin 2,D,D12.776.543.550.450.730.040.437,Aquaporins,Porins,1
Aquaporin 2,D,D12.776.543.585.400.730.040.530,Aquaporins,Porins,1
Aquaporin 2,D,D12.776.157.530.400.500.040.437,Aquaporins,Porins,1
AraC Transcription Factor,D,D12.776.097.049,Bacterial Proteins,Proteins,1
AraC Transcription Factor,D,D12.776.260.703.099,Repressor Proteins,DNA-Binding Proteins,1
AraC Transcription Factor,D,D12.776.930.780.500,Repressor Proteins,Transcription Factors,1
Arachnida,B,B01.050.500.131.166,Arthropods,Invertebrates,1
Arachnoid,A,A08.186.566.166,Meninges,Central Nervous System,1
Archaeal Proteins,D,D12.776.090,Proteins,"Amino Acids, Peptides, and Proteins",1
Architecture,J,J01.086,"Technology, Industry, and Agriculture",NULL,1
Arecaceae,B,B01.650.940.800.575.912.250.093,Magnoliopsida,Tracheophyta,1
"Arenaviruses, New World",B,B04.820.480.500.070.095,Arenavirus,Arenaviridae,1
Arginine Vasopressin,D,D12.644.400.900.100,Vasopressins,Neuropeptides,1
Arginine Vasopressin,D,D12.644.456.925.100,Vasopressins,Oligopeptides,1
Arginine Vasopressin,D,D12.644.548.691.692.781.100,Vasopressins,"Pituitary Hormones, Posterior",1
Arginine Vasopressin,D,D06.472.699.631.692.781.100,Vasopressins,"Pituitary Hormones, Posterior",1
Arginine Vasopressin,D,D12.776.631.650.937.100,Vasopressins,Neuropeptides,1
Argon,D,D01.362.641.113,Noble Gases,Gases,1
Argon,D,D01.268.613.050,Noble Gases,Elements,1
Argyria,C,C25.723.522.313,Heavy Metal Poisoning,Poisoning,1
Argyria,C,C17.800.621.166,Pigmentation Disorders,Skin Diseases,1
Arizona,Z,Z01.107.567.875.760.100,Southwestern United States,United States,1
Aromatic Amino Acid Decarboxylase Inhibitors,D,D27.505.954.427.090.050.249,Antiparkinson Agents,Anti-Dyskinesia Agents,1
Aromatic Amino Acid Decarboxylase Inhibitors,D,D27.505.519.389.124,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,1
Arsenites,D,D01.248.497.158.055,Anions,Ions,1
Arsenites,D,D01.075.050,Arsenicals,Inorganic Chemicals,1
Artemia,B,B01.050.500.131.365.060.050,Anostraca,Crustacea,1
"Arthritis, Experimental",C,C05.550.114.015,Arthritis,Joint Diseases,1
"Arthritis, Experimental",E,E05.598.500.249,"Disease Models, Animal","Models, Animal",1
"Arthritis-Encephalitis Virus, Caprine",B,B04.820.650.589.600.070,"Lentiviruses, Ovine-Caprine",Lentivirus,1
Arthrodermataceae,B,B01.300.107.650.080,Onygenales,Ascomycota,1
Arthrodesis,E,E04.555.100,Orthopedic Procedures,"Surgical Procedures, Operative",1
"Arthroplasty, Replacement, Ankle",E,E04.555.110.110.010,"Arthroplasty, Replacement",Arthroplasty,1
"Arthroplasty, Replacement, Ankle",E,E04.650.110.010,"Arthroplasty, Replacement",Prosthesis Implantation,1
"Arthroplasty, Replacement, Ankle",E,E04.680.101.110.010,"Arthroplasty, Replacement",Arthroplasty,1
"Arthroplasty, Replacement, Shoulder",E,E04.680.101.110.299,"Arthroplasty, Replacement",Arthroplasty,1
"Arthroplasty, Replacement, Shoulder",E,E04.650.110.299,"Arthroplasty, Replacement",Prosthesis Implantation,1
"Arthroplasty, Replacement, Shoulder",E,E04.555.110.110.299,"Arthroplasty, Replacement",Arthroplasty,1
Arthroscopy,E,E04.555.113,Orthopedic Procedures,"Surgical Procedures, Operative",1
Arthroscopy,E,E04.502.250.070,Endoscopy,Minimally Invasive Surgical Procedures,1
Arthroscopy,E,E01.370.388.250.070,Endoscopy,"Diagnostic Techniques, Surgical",1
Artificially Sweetened Beverages,G,G07.203.100.200,Beverages,"Diet, Food, and Nutrition",1
Artificially Sweetened Beverages,J,J02.200.200,Beverages,Food and Beverages,1
Artiodactyla,B,B01.050.150.900.649.313.500,Eutheria,Mammals,1
Arylformamidase,D,D08.811.277.087.100,Amidohydrolases,Hydrolases,1
Arylsulfotransferase,D,D08.811.913.817.400.300,Sulfotransferases,Sulfur Group Transferases,1
"Asbestos, Crocidolite",D,D01.578.725.050.050.100,"Asbestos, Amphibole",Asbestos,1
"Asbestos, Crocidolite",D,D01.837.725.700.760.070.050.090,"Asbestos, Amphibole",Asbestos,1
Ascaridiasis,C,C01.610.335.508.700.100.080,Ascaridida Infections,Secernentea Infections,1
Ascomycota,B,B01.300.107,Fungi,Eukaryota,1
Ascorbate Oxidase,D,D08.811.682.180,Oxidoreductases,Enzymes,1
Ascorbate Peroxidases,D,D08.811.682.732.165,Peroxidases,Oxidoreductases,1
Asialoglycoprotein Receptor,D,D12.776.543.750.024,"Receptors, Cell Surface",Membrane Proteins,1
Asialoglycoprotein Receptor,D,D12.776.503.280.124,"Lectins, C-Type",Lectins,1
Asian Continental Ancestry Group,M,M01.686.508.200,Continental Population Groups,Population Groups,1
Aspergillus nidulans,B,B01.300.381.081.420,Aspergillus,Mitosporic Fungi,1
"Aspirin, Dipyridamole Drug Combination",D,D02.455.426.559.389.657.410.595.176.500,Aspirin,Salicylates,1
"Aspirin, Dipyridamole Drug Combination",D,D26.310.125,Drug Combinations,Pharmaceutical Preparations,1
"Aspirin, Dipyridamole Drug Combination",D,D03.383.742.175.500,Dipyridamole,Pyrimidines,1
Assertiveness,F,F01.752.049,Personality,Behavior and Behavior Mechanisms,1
Assisted Living Facilities,N,N02.278.825.187,Residential Facilities,Health Facilities,1
Assisted Living Facilities,J,J03.775.187,Residential Facilities,Non-Medical Public and Private Facilities,1
Association,F,F02.463.425.069,Learning,Mental Processes,1
Association,F,F04.754.720.346,Psychotherapeutic Processes,Psychotherapy,1
Astacoidea,B,B01.050.500.131.365.190.070,Decapoda,Crustacea,1
Asteraceae,B,B01.650.940.800.575.912.250.100,Magnoliopsida,Tracheophyta,1
"Asthma, Occupational",C,C24.102,Occupational Diseases,NULL,1
"Asthma, Occupational",C,C20.543.480.680.095.495,Asthma,Respiratory Hypersensitivity,1
"Asthma, Occupational",C,C08.127.108.495,Asthma,Bronchial Diseases,1
"Asthma, Occupational",C,C08.674.095.495,Asthma,Respiratory Hypersensitivity,1
Astringents,D,D27.505.696.207,Physiological Effects of Drugs,Pharmacologic Actions,1
Astringents,D,D27.505.954.444.100,Dermatologic Agents,Therapeutic Uses,1
Astrocytes,A,A08.637.200,Neuroglia,Nervous System,1
Astrocytes,A,A11.650.200,Neuroglia,Cells,1
Astroviridae,B,B04.820.578.250,Positive-Strand RNA Viruses,RNA Viruses,1
Astroviridae Infections,C,C01.925.782.105,RNA Virus Infections,Virus Diseases,1
Ataxin-7,D,D12.776.660.075.900,Ataxins,Nuclear Proteins,1
Ataxin-7,D,D12.776.631.069.901,Ataxins,Nerve Tissue Proteins,1
"Atherectomy, Coronary",E,E02.148.050.120.125,Atherectomy,Angioplasty,1
"Atherectomy, Coronary",E,E04.502.382.124.120.125,Atherectomy,Angioplasty,1
"Atherectomy, Coronary",E,E04.502.382.968.060,Percutaneous Coronary Intervention,Endovascular Procedures,1
"Atherectomy, Coronary",E,E04.928.220.520.110,Myocardial Revascularization,Cardiac Surgical Procedures,1
"Atherectomy, Coronary",E,E04.100.814.529.124.120.125,Atherectomy,Angioplasty,1
"Atherectomy, Coronary",E,E04.100.814.529.968.060,Percutaneous Coronary Intervention,Endovascular Procedures,1
"Atherectomy, Coronary",E,E04.100.376.719.125,Myocardial Revascularization,Cardiac Surgical Procedures,1
"Atherectomy, Coronary",E,E05.157.016.120.125,Atherectomy,Angioplasty,1
Athletic Performance,I,I03.450.642.845.054,Sports,Recreation,1
Atmosphere Exposure Chambers,E,E07.079,Equipment and Supplies,NULL,1
Atmospheric Pressure,G,G16.500.750.274,Meteorological Concepts,Ecological and Environmental Phenomena,1
Atmospheric Pressure,N,N06.230.300.100.185,Atmosphere,Meteorological Concepts,1
"ATP Binding Cassette Transporter, Subfamily G, Member 1",D,D12.776.543.550.192.457.250,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
"ATP Binding Cassette Transporter, Subfamily G, Member 1",D,D12.776.543.585.100.228.250,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
"ATP Binding Cassette Transporter, Subfamily G, Member 1",D,D12.776.157.530.100.228.250,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
"ATP Binding Cassette Transporter, Subfamily G, Member 1",D,D12.776.395.550.020.457.250,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
"ATP Binding Cassette Transporter, Subfamily G, Member 5",D,D12.776.395.550.020.457.750,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
"ATP Binding Cassette Transporter, Subfamily G, Member 5",D,D12.776.157.530.100.228.750,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
"ATP Binding Cassette Transporter, Subfamily G, Member 5",D,D10.532.137,Lipoproteins,Lipids,1
"ATP Binding Cassette Transporter, Subfamily G, Member 5",D,D12.776.543.585.100.228.750,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
"ATP Binding Cassette Transporter, Subfamily G, Member 5",D,D12.776.543.550.192.457.750,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
"ATP Binding Cassette Transporter, Subfamily G, Member 5",D,D12.776.521.181,Lipoproteins,Proteins,1
"ATP Binding Cassette Transporter, Subfamily G, Member 8",D,D12.776.521.212,Lipoproteins,Proteins,1
"ATP Binding Cassette Transporter, Subfamily G, Member 8",D,D12.776.543.550.192.457.875,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
"ATP Binding Cassette Transporter, Subfamily G, Member 8",D,D12.776.543.585.100.228.875,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
"ATP Binding Cassette Transporter, Subfamily G, Member 8",D,D10.532.160,Lipoproteins,Lipids,1
"ATP Binding Cassette Transporter, Subfamily G, Member 8",D,D12.776.157.530.100.228.875,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
"ATP Binding Cassette Transporter, Subfamily G, Member 8",D,D12.776.395.550.020.457.875,"ATP Binding Cassette Transporter, Subfamily G",ATP-Binding Cassette Transporters,1
ATPases Associated with Diverse Cellular Activities,D,D12.776.157.025.750,AAA Proteins,Carrier Proteins,1
ATPases Associated with Diverse Cellular Activities,D,D08.811.277.040.025.024,Adenosine Triphosphatases,Acid Anhydride Hydrolases,1
ATPases Associated with Diverse Cellular Activities,D,D08.811.277.040.013.500,AAA Proteins,Acid Anhydride Hydrolases,1
"Atrial Function, Left",G,G09.330.040.100,Atrial Function,Cardiovascular Physiological Phenomena,1
Atrial Premature Complexes,C,C14.280.123.375.250,"Cardiac Complexes, Premature",Cardiac Conduction System Disease,1
Atrial Premature Complexes,C,C14.280.067.325.250,"Cardiac Complexes, Premature","Arrhythmias, Cardiac",1
Atrial Premature Complexes,C,C23.550.073.325.050,"Cardiac Complexes, Premature","Arrhythmias, Cardiac",1
Atropine,D,D02.145.074.722.229.199,Atropine Derivatives,Tropanes,1
Atropine,D,D03.605.084.500.722.229.199,Atropine Derivatives,Tropanes,1
Atropine,D,D03.605.869.229.199,Atropine Derivatives,Tropanes,1
Atropine,D,D03.132.760.180.572.199,Atropine Derivatives,Belladonna Alkaloids,1
Atropine,D,D03.132.889.180.648.199,Atropine Derivatives,Belladonna Alkaloids,1
Audiologists,N,N02.360.170,Health Personnel,"Health Care Facilities, Manpower, and Services",1
Audiologists,M,M01.526.485.170,Health Personnel,Occupational Groups,1
"Audiometry, Speech",E,E01.370.382.375.060.060,Audiometry,Hearing Tests,1
Auditory Cortex,A,A08.186.211.200.885.287.500.814.249,Sensorimotor Cortex,Cerebral Cortex,1
Auditory Cortex,A,A08.186.211.200.885.287.500.863.297,Temporal Lobe,Cerebral Cortex,1
Auditory Pathways,A,A08.612.220.110,Afferent Pathways,Neural Pathways,1
Auranofin,D,D02.691.675.249.150,Aurothioglucose,Organogold Compounds,1
Aurora Kinase B,D,D12.776.167.049.750,Aurora Kinases,Cell Cycle Proteins,1
Aurora Kinase B,D,D08.811.913.696.620.682.700.103.750,Aurora Kinases,Protein-Serine-Threonine Kinases,1
Autacoids,D,D23.469.050,Inflammation Mediators,Biological Factors,1
Autolysis,C,C23.550.260.224.617.236,Postmortem Changes,Cadaver,1
Automobile Driver Examination,I,I03.125.299,Automobile Driving,Human Activities,1
Autonomic Denervation,E,E04.525.210.105,Denervation,Neurosurgical Procedures,1
Autonomic Pathways,A,A08.800.050.050,Autonomic Nervous System,Peripheral Nervous System,1
Autonomic Pathways,A,A08.800.800.060,Peripheral Nerves,Peripheral Nervous System,1
Autophagosomes,A,A11.284.430.214.190.875.190.700.500,Phagosomes,Cytoplasmic Vesicles,1
Avastrovirus,B,B04.820.578.250.080,Astroviridae,Positive-Strand RNA Viruses,1
Avena,B,B01.650.940.800.575.912.250.822.060,Poaceae,Magnoliopsida,1
Avian Leukosis Virus,B,B04.613.807.070.100,Alpharetrovirus,Retroviridae,1
Avian leukosis virus,B,B04.820.650.070.100,Alpharetrovirus,Retroviridae,1
"Axial Length, Eye",A,A09.371.199,Eye,Sense Organs,1
"Axial Length, Eye",E,E01.370.600.115.100.660.500,Organ Size,Body Weights and Measures,1
Axillary Artery,A,A07.015.114.085,Arteries,Blood Vessels,1
Azasteroids,D,D04.210.500.925.100,"Steroids, Heterocyclic",Steroids,1
Azepines,D,D03.383.066,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,1
Azides,D,D02.159,Organic Chemicals,NULL,1
Azides,D,D01.625.100,Nitrogen Compounds,Inorganic Chemicals,1
Aziridines,D,D03.383.097.217,Azirines,"Heterocyclic Compounds, 1-Ring",1
Azo Compounds,D,D02.172,Organic Chemicals,NULL,1
Azores,Z,Z01.639.040.218,Atlantic Islands,Islands,1
Azotemia,C,C23.550.145,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",1
Azotemia,C,C13.351.968.419.936.231,Uremia,Kidney Diseases,1
Azotemia,C,C12.777.419.936.231,Uremia,Kidney Diseases,1
Azure Stains,D,D02.886.369.080,Phenothiazines,Sulfur Compounds,1
Azure Stains,D,D03.633.300.783.080,Phenothiazines,"Heterocyclic Compounds, 3-Ring",1
Baclofen,D,D02.241.081.114.500.350.100,gamma-Aminobutyric Acid,Aminobutyrates,1
"Bacteria, Aerobic",B,B03.120,Bacteria,NULL,1
Bacteriocin Plasmids,G,G05.360.600.080,Plasmids,Genetic Structures,1
Bacteriophage P1,B,B04.123.205.300,Coliphages,Bacteriophages,1
Bacteriophage P1,B,B04.123.150.500.300,Myoviridae,Caudovirales,1
Bacteriophage P1,B,B04.280.090.500.300,Myoviridae,Caudovirales,1
Bacteriophage phi 6,B,B04.123.660.550,Pseudomonas Phages,Bacteriophages,1
Bacteriophage phi 6,B,B04.123.691.230.070,Cystoviridae,RNA Phages,1
Bacteriophage phi 6,B,B04.820.223.625.070,Cystoviridae,Double Stranded RNA Viruses,1
Bacteroides,B,B03.440.425.410.194.152,Bacteroidaceae,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",1
Bacteroides,B,B03.440.080.094.152,Bacteroidaceae,Bacteroidetes,1
Bacteroides fragilis,B,B03.440.080.094.152.400,Bacteroides,Bacteroidaceae,1
Bacteroides fragilis,B,B03.440.425.410.194.152.400,Bacteroides,Bacteroidaceae,1
Bacteroidetes,B,B03.440.080,Gram-Negative Bacteria,Bacteria,1
Balanitis,C,C12.294.494.136,Penile Diseases,"Genital Diseases, Male",1
Balantidium,B,B01.043.185.375.650.650.153,Trichostomatina,Trichostomatida,1
Balkan Nephropathy,C,C12.777.419.570.643.150,"Nephritis, Interstitial",Nephritis,1
Balkan Nephropathy,C,C13.351.968.419.570.643.150,"Nephritis, Interstitial",Nephritis,1
Balloon Valvuloplasty,E,E02.148.108,Catheterization,Therapeutics,1
Balloon Valvuloplasty,E,E05.157.125,Catheterization,Investigative Techniques,1
Barbering,J,J01.576.082,Industry,"Technology, Industry, and Agriculture",1
Bariatrics,E,E02.650.500,Obesity Management,Therapeutics,1
Barium Sulfate,D,D01.875.800.800.850.075,Sulfates,Sulfuric Acids,1
Barium Sulfate,D,D01.103.075,Barium Compounds,Inorganic Chemicals,1
Bartholin's Glands,A,A05.360.319.887.220,Vulva,"Genitalia, Female",1
Bartholin's Glands,A,A10.336.095,Exocrine Glands,Tissues,1
Bartonella,B,B03.440.090.100,Bartonellaceae,Gram-Negative Bacteria,1
Bartonella,B,B03.660.050.030.040,Bartonellaceae,Alphaproteobacteria,1
Bartonella henselae,B,B03.660.050.030.040.350,Bartonella,Bartonellaceae,1
Bartonella henselae,B,B03.440.090.100.350,Bartonella,Bartonellaceae,1
Basal Ganglia Diseases,C,C10.228.140.079,Brain Diseases,Central Nervous System Diseases,1
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,D,D12.776.930.127.092,Basic-Leucine Zipper Transcription Factors,Transcription Factors,1
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,D,D12.776.930.125.500,Basic Helix-Loop-Helix Transcription Factors,Transcription Factors,1
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,D,D12.776.260.103.500,Basic Helix-Loop-Helix Transcription Factors,DNA-Binding Proteins,1
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,D,D12.776.260.108.092,Basic-Leucine Zipper Transcription Factors,DNA-Binding Proteins,1
Basidiomycota,B,B01.300.179,Fungi,Eukaryota,1
Basilar Artery,A,A07.015.114.106,Arteries,Blood Vessels,1
Batch Cell Culture Techniques,E,E05.481.500.249.124,Cell Culture Techniques,Culture Techniques,1
B-Cell Activating Factor,D,D12.776.395.191,Glycoproteins,Proteins,1
B-Cell Activating Factor,D,D12.644.276.374.750.061,Tumor Necrosis Factors,Cytokines,1
B-Cell Activating Factor,D,D12.776.543.550.193,Membrane Glycoproteins,Membrane Proteins,1
B-Cell Activating Factor,D,D12.776.467.374.750.061,Tumor Necrosis Factors,Cytokines,1
B-Cell Activating Factor,D,D23.529.374.750.061,Tumor Necrosis Factors,Cytokines,1
B-Cell Maturation Antigen,D,D12.776.543.750.705.852.760.226,"Receptors, Tumor Necrosis Factor","Receptors, Cytokine",1
bcl-2-Associated X Protein,D,D12.776.476.075.718.400,Proto-Oncogene Proteins c-bcl-2,Apoptosis Regulatory Proteins,1
bcl-2-Associated X Protein,D,D12.644.360.075.718.400,Proto-Oncogene Proteins c-bcl-2,Apoptosis Regulatory Proteins,1
Bcl-2-Like Protein 11,D,D12.644.360.075.323,Apoptosis Regulatory Proteins,Intracellular Signaling Peptides and Proteins,1
Bcl-2-Like Protein 11,D,D12.776.476.075.323,Apoptosis Regulatory Proteins,Intracellular Signaling Peptides and Proteins,1
Bcl-2-Like Protein 11,D,D12.776.543.116,Membrane Proteins,Proteins,1
Bcl-2-Like Protein 11,D,D12.776.624.664.700.025,Proto-Oncogene Proteins,Oncogene Proteins,1
bcl-X Protein,D,D12.776.476.075.718.875,Proto-Oncogene Proteins c-bcl-2,Apoptosis Regulatory Proteins,1
bcl-X Protein,D,D12.644.360.075.718.937,Proto-Oncogene Proteins c-bcl-2,Apoptosis Regulatory Proteins,1
Bdellovibrio,B,B03.440.400.425.180,Gram-Negative Aerobic Rods and Cocci,Gram-Negative Aerobic Bacteria,1
Bdellovibrio,B,B03.660.125.050,Deltaproteobacteria,Proteobacteria,1
Beauty,F,F02.463.785.477.304,Esthetics,Thinking,1
Beauty,K,K01.752.210.304,Esthetics,Philosophy,1
Beauty Culture,J,J01.576.112,Industry,"Technology, Industry, and Agriculture",1
Bed Rest,E,E02.075,Therapeutics,NULL,1
Behaviorism,F,F02.739.138,Psychological Theory,Psychological Phenomena,1
Bence Jones Protein,D,D12.776.377.715.548.900.120,Paraproteins,Immunoglobulins,1
Bence Jones Protein,D,D12.776.124.790.651.900.120,Paraproteins,Immunoglobulins,1
Bence Jones Protein,D,D12.776.124.486.485.900.120,Paraproteins,Immunoglobulins,1
Bendamustine Hydrochloride,D,D03.633.100.103.123,Benzimidazoles,"Heterocyclic Compounds, 2-Ring",1
Bendamustine Hydrochloride,D,D02.455.526.728.650.103,Nitrogen Mustard Compounds,Mustard Compounds,1
Bendamustine Hydrochloride,D,D02.241.081.114.625,Butyrates,"Acids, Acyclic",1
Benzalkonium Compounds,D,D02.092.877.096.040,Benzylammonium Compounds,Quaternary Ammonium Compounds,1
Benzalkonium Compounds,D,D02.675.276.080,Quaternary Ammonium Compounds,Onium Compounds,1
Benzamidines,D,D02.078.100,Amidines,Organic Chemicals,1
Benzidines,D,D02.455.426.559.389.185.100,Biphenyl Compounds,Benzene Derivatives,1
Benzocycloheptenes,D,D02.455.426.559.847.181,Polycyclic Aromatic Hydrocarbons,"Hydrocarbons, Aromatic",1
Benzocycloheptenes,D,D04.615.181,Polycyclic Aromatic Hydrocarbons,Polycyclic Compounds,1
Benzodiazepinones,D,D03.633.100.079.080.070,Benzodiazepines,Benzazepines,1
Benzophenones,D,D02.522.223,Ketones,Organic Chemicals,1
Benzophenones,D,D02.455.426.559.389.134,Benzene Derivatives,"Hydrocarbons, Aromatic",1
Benzopyrans,D,D03.383.663.283,Pyrans,"Heterocyclic Compounds, 1-Ring",1
Benzopyrans,D,D03.633.100.150,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",1
Benzopyrenes,D,D02.455.426.559.847.799.306,Pyrenes,Polycyclic Aromatic Hydrocarbons,1
Benzopyrenes,D,D04.615.799.306,Pyrenes,Polycyclic Aromatic Hydrocarbons,1
Benzoxazoles,D,D03.633.100.221,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",1
Benzylamines,D,D02.455.426.559.389.140.210,Benzyl Compounds,Benzene Derivatives,1
Benzylamines,D,D02.092.200,Amines,Organic Chemicals,1
Bermuda,Z,Z01.639.040.390,Atlantic Islands,Islands,1
beta Catenin,D,D12.776.091.249,Armadillo Domain Proteins,Proteins,1
beta Catenin,D,D12.776.220.145.500,Catenins,Cytoskeletal Proteins,1
beta Catenin,D,D12.776.930.130,Transcription Factors,Proteins,1
beta-Endorphin,D,D12.776.631.650.405.935.239,Pro-Opiomelanocortin,Hypothalamic Hormones,1
beta-Endorphin,D,D12.776.631.650.575.241.080,Endorphins,Opioid Peptides,1
beta-Endorphin,D,D12.644.548.365.935.239,Pro-Opiomelanocortin,Hypothalamic Hormones,1
beta-Endorphin,D,D12.644.548.691.525.690.239,Pro-Opiomelanocortin,"Pituitary Hormones, Anterior",1
beta-Endorphin,D,D12.644.400.400.935.239,Pro-Opiomelanocortin,Hypothalamic Hormones,1
beta-Endorphin,D,D12.644.400.575.241.080,Endorphins,Opioid Peptides,1
beta-Endorphin,D,D06.472.699.631.525.600.239,Pro-Opiomelanocortin,"Pituitary Hormones, Anterior",1
beta-Endorphin,D,D06.472.699.327.935.239,Pro-Opiomelanocortin,Hypothalamic Hormones,1
beta-Glucans,D,D09.698.365.089,Glucans,Polysaccharides,1
beta-Glucosidase,D,D08.811.277.450.420.200.100,Cellulases,Glucosidases,1
Betaherpesvirinae,B,B04.280.382.150,Herpesviridae,DNA Viruses,1
beta-N-Acetylhexosaminidases,D,D08.811.277.450.483.180,Hexosaminidases,Glycoside Hydrolases,1
beta-Synuclein,D,D12.776.631.860.625,Synucleins,Nerve Tissue Proteins,1
BH3 Interacting Domain Death Agonist Protein,D,D12.776.476.075.718.937,Proto-Oncogene Proteins c-bcl-2,Apoptosis Regulatory Proteins,1
BH3 Interacting Domain Death Agonist Protein,D,D12.644.360.075.718.968,Proto-Oncogene Proteins c-bcl-2,Apoptosis Regulatory Proteins,1
Bible,K,K01.517.172,Literature,Humanities,1
Bicuspid,A,A14.549.167.860.150,Tooth,Dentition,1
Biflavonoids,D,D03.383.663.283.266.450.190,Flavonoids,Chromones,1
Biflavonoids,D,D03.633.100.150.266.450.190,Flavonoids,Chromones,1
Biglycan,D,D09.698.735.700.500,Small Leucine-Rich Proteoglycans,Proteoglycans,1
Biglycan,D,D12.776.395.650.750.562,Chondroitin Sulfate Proteoglycans,Proteoglycans,1
Biglycan,D,D12.776.395.650.875.250,Small Leucine-Rich Proteoglycans,Proteoglycans,1
Biglycan,D,D12.776.860.300.806.500,Small Leucine-Rich Proteoglycans,Extracellular Matrix Proteins,1
Biguanides,D,D02.078.370.141,Guanidines,Amidines,1
Bile Canaliculi,A,A03.620.150.125,"Bile Ducts, Intrahepatic",Liver,1
Bile Canaliculi,A,A03.159.183.158.125,"Bile Ducts, Intrahepatic",Bile Ducts,1
"Bile Ducts, Extrahepatic",A,A03.159.183.079,Bile Ducts,Biliary Tract,1
"Bile Ducts, Intrahepatic",A,A03.159.183.158,Bile Ducts,Biliary Tract,1
"Bile Ducts, Intrahepatic",A,A03.620.150,Liver,Digestive System,1
Biliary Atresia,C,C06.198.125,Digestive System Abnormalities,Digestive System Diseases,1
Biliary Atresia,C,C06.130.120.123,Bile Duct Diseases,Biliary Tract Diseases,1
Biliary Atresia,C,C16.131.314.125,Digestive System Abnormalities,Congenital Abnormalities,1
Biliverdine,D,D23.767.193.184.200,Bilirubin,Bile Pigments,1
Biliverdine,D,D03.633.400.909.249.184.200,Bilirubin,Bile Pigments,1
Biliverdine,D,D03.383.129.578.840.249.184.200,Bilirubin,Bile Pigments,1
Biliverdine,D,D04.345.783.249.184.200,Bilirubin,Bile Pigments,1
Binge-Eating Disorder,F,F03.400.188,Feeding and Eating Disorders,Mental Disorders,1
Bioaccumulation,G,G03.787.024.500.187,"Absorption, Physiological",Absorption,1
Bioaccumulation,G,G03.015.500.187,"Absorption, Physiological",Absorption,1
Bioaccumulation,G,G07.690.725.015.500.187,"Absorption, Physiological",Absorption,1
Biochemical Phenomena,G,G02.111,Chemical Phenomena,NULL,1
"Biofeedback, Psychology",F,F04.754.137.301,Behavior Therapy,Psychotherapy,1
"Biofeedback, Psychology",F,F04.754.308.500,"Feedback, Psychological",Psychotherapy,1
"Biofeedback, Psychology",F,F02.830.131,Psychophysiology,Psychological Phenomena,1
"Biofeedback, Psychology",E,E02.190.525.123,Mind-Body Therapies,Complementary Therapies,1
Biohazard Release,N,N06.850.135.190,Accidents,Public Health,1
Biolistics,E,E05.393.350.100,Gene Transfer Techniques,Genetic Techniques,1
Biolistics,E,E02.319.267.530.620.570.100,"Injections, Jet","Injections, Subcutaneous",1
Biological Ontologies,L,L01.453.245.945.079,"Vocabulary, Controlled",Documentation,1
Biological Ontologies,L,L01.313.500.750.300.550.500,Knowledge Bases,Information Systems,1
Biological Ontologies,L,L01.224.050.375.480.500,Knowledge Bases,Artificial Intelligence,1
"Biological Variation, Individual",G,G16.115,Biological Phenomena,NULL,1
Biological Warfare Agents,J,J01.637.870.900.100,Weapons of Mass Destruction,Weapons,1
Biological Warfare Agents,D,D20.215.226,Biological Products,Complex Mixtures,1
Biomedical Enhancement,J,J01.897.120.050.250,Biomedical Technology,Biotechnology,1
Biomedical Enhancement,E,E05.104,Investigative Techniques,NULL,1
Biopharmaceutics,H,H02.628.049,Pharmacology,Health Occupations,1
Biopharmaceutics,H,H01.158.703.003,Pharmacology,Biological Science Disciplines,1
Biophysical Phenomena,G,G01.154,Physical Phenomena,NULL,1
Biopolymers,J,J01.637.051.720.099,Polymers,Biomedical and Dental Materials,1
Biopolymers,D,D25.720.099,Polymers,Biomedical and Dental Materials,1
Biopolymers,D,D05.750.078,Polymers,Macromolecular Substances,1
"Biopsy, Large-Core Needle",E,E01.370.388.100.100.750,"Biopsy, Needle",Biopsy,1
"Biopsy, Large-Core Needle",E,E01.370.225.500.384.100.119.750,"Biopsy, Needle",Biopsy,1
"Biopsy, Large-Core Needle",E,E01.370.225.998.054.119.750,"Biopsy, Needle",Biopsy,1
"Biopsy, Large-Core Needle",E,E05.200.500.384.100.119.750,"Biopsy, Needle",Biopsy,1
"Biopsy, Large-Core Needle",E,E05.200.998.054.119.750,"Biopsy, Needle",Biopsy,1
"Biopsy, Large-Core Needle",E,E05.242.384.100.119.750,"Biopsy, Needle",Biopsy,1
"Biopsy, Large-Core Needle",E,E04.665.100.750,"Biopsy, Needle",Punctures,1
"Biopsy, Large-Core Needle",E,E04.074.119.750,"Biopsy, Needle",Biopsy,1
Biosurveillance,N,N06.850.780.675.324,Population Surveillance,Public Health Practice,1
Bivalvia,B,B01.050.500.644.080,Mollusca,Invertebrates,1
Bladder Exstrophy,C,C16.131.939.132,Urogenital Abnormalities,Congenital Abnormalities,1
Bladder Exstrophy,C,C13.351.875.132,Urogenital Abnormalities,Female Urogenital Diseases,1
Bladder Exstrophy,C,C13.351.968.829.132,Urinary Bladder Diseases,Urologic Diseases,1
Bladder Exstrophy,C,C12.777.829.132,Urinary Bladder Diseases,Urologic Diseases,1
Bladder Exstrophy,C,C12.706.132,Urogenital Abnormalities,Male Urogenital Diseases,1
Bland White Garland Syndrome,C,C14.240.850.984.500.500,Arterio-Arterial Fistula,Vascular Fistula,1
Bland White Garland Syndrome,C,C14.240.400.210.249,Coronary Vessel Anomalies,"Heart Defects, Congenital",1
Bland White Garland Syndrome,C,C14.280.400.210.249,Coronary Vessel Anomalies,"Heart Defects, Congenital",1
Bland White Garland Syndrome,C,C14.907.933.110.500,Arterio-Arterial Fistula,Vascular Fistula,1
Bland White Garland Syndrome,C,C16.131.240.400.210.249,Coronary Vessel Anomalies,"Heart Defects, Congenital",1
Bland White Garland Syndrome,C,C16.131.240.850.500.500,Arterio-Arterial Fistula,Vascular Malformations,1
Bland White Garland Syndrome,C,C23.300.575.950.150.500,Arterio-Arterial Fistula,Vascular Fistula,1
Blast Injuries,C,C26.120.126,Barotrauma,Wounds and Injuries,1
Blastocyst,A,A16.254.500,"Embryo, Mammalian",Embryonic Structures,1
Blastocyst Inner Cell Mass,A,A16.254.500.533,Blastocyst,"Embryo, Mammalian",1
Blastomycosis,C,C01.800.200.055,Dermatomycoses,"Skin Diseases, Infectious",1
Blastomycosis,C,C01.748.435.395,"Lung Diseases, Fungal",Respiratory Tract Infections,1
Blastomycosis,C,C01.150.703.534.350,"Lung Diseases, Fungal",Mycoses,1
Blastomycosis,C,C01.150.703.302.055,Dermatomycoses,Mycoses,1
Blastomycosis,C,C17.800.838.208.055,Dermatomycoses,"Skin Diseases, Infectious",1
Blastomycosis,C,C08.730.435.395,"Lung Diseases, Fungal",Respiratory Tract Infections,1
Blastomycosis,C,C08.381.472.350,"Lung Diseases, Fungal",Lung Diseases,1
Blattellidae,B,B01.050.500.131.617.140.100,Cockroaches,Insecta,1
Blepharitis,C,C11.338.133,Eyelid Diseases,Eye Diseases,1
Blepharospasm,C,C11.338.250,Eyelid Diseases,Eye Diseases,1
"Blindness, Cortical",C,C10.597.751.941.162.250,Blindness,Vision Disorders,1
"Blindness, Cortical",C,C11.966.075.250,Blindness,Vision Disorders,1
"Blindness, Cortical",C,C23.888.592.763.941.162.250,Blindness,Vision Disorders,1
Blinking,G,G14.152,Ocular Physiological Phenomena,NULL,1
Blinking,G,G11.561.731.127,Reflex,Nervous System Physiological Phenomena,1
Blood Buffy Coat,A,A15.145.229.093,Blood Cells,Blood,1
Blood Circulation,G,G09.330.100,Cardiovascular Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,1
Blood Group Incompatibility,G,G09.188.114,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,1
Blood Group Incompatibility,G,G12.186,Immune System Phenomena,NULL,1
"Blood Transfusion, Intrauterine",E,E02.095.135.264,Blood Transfusion,Biological Therapy,1
"Blood Transfusion, Intrauterine",E,E02.467.500,Fetal Therapies,Therapeutics,1
Body Fluid Compartments,A,A10.082,Tissues,NULL,1
Body Fluid Compartments,A,A12.207.180,Body Fluids,Fluids and Secretions,1
Body Weight Maintenance,G,G07.345.249.314.120.250,Body Weight,Body Size,1
Bombyx,B,B01.050.500.131.617.720.500.500.937.650.100,Moths,Lepidoptera,1
Bone Lengthening,E,E04.555.120,Orthopedic Procedures,"Surgical Procedures, Operative",1
Bone Marrow Stromal Antigen 2,D,D12.776.543.484.500.150,GPI-Linked Proteins,Lipid-Linked Proteins,1
Bone Marrow Stromal Antigen 2,D,D12.776.543.550.418.150,GPI-Linked Proteins,Membrane Glycoproteins,1
Bone Marrow Stromal Antigen 2,D,D12.776.395.550.448.150,GPI-Linked Proteins,Membrane Glycoproteins,1
Bone Morphogenetic Protein 2,D,D12.644.276.954.200.200,Bone Morphogenetic Proteins,TGF-beta Superfamily Proteins,1
Bone Morphogenetic Protein 2,D,D12.776.467.942.200.200,Bone Morphogenetic Proteins,TGF-beta Superfamily Proteins,1
Bone Morphogenetic Protein 2,D,D23.529.942.200.200,Bone Morphogenetic Proteins,TGF-beta Superfamily Proteins,1
Bone Morphogenetic Protein 7,D,D23.529.942.200.700,Bone Morphogenetic Proteins,TGF-beta Superfamily Proteins,1
Bone Morphogenetic Protein 7,D,D12.776.467.942.200.700,Bone Morphogenetic Proteins,TGF-beta Superfamily Proteins,1
Bone Morphogenetic Protein 7,D,D12.644.276.954.200.700,Bone Morphogenetic Proteins,TGF-beta Superfamily Proteins,1
"Bone Morphogenetic Protein Receptors, Type II",D,D08.811.913.696.620.682.700.109.750,Bone Morphogenetic Protein Receptors,Protein-Serine-Threonine Kinases,1
"Bone Morphogenetic Protein Receptors, Type II",D,D12.776.543.750.750.400.049.750,Bone Morphogenetic Protein Receptors,"Receptors, Growth Factor",1
Bone Morphogenetic Proteins,D,D12.776.467.942.200,TGF-beta Superfamily Proteins,Intercellular Signaling Peptides and Proteins,1
Bone Morphogenetic Proteins,D,D23.529.942.200,TGF-beta Superfamily Proteins,Intercellular Signaling Peptides and Proteins,1
Bone Morphogenetic Proteins,D,D12.644.276.954.200,TGF-beta Superfamily Proteins,Intercellular Signaling Peptides and Proteins,1
Bone Plates,E,E07.695.370.374,Internal Fixators,Prostheses and Implants,1
Bone Plates,E,E07.858.690.725.460.374,Internal Fixators,Orthopedic Fixation Devices,1
Bone Plates,E,E07.858.442.660.460.374,Internal Fixators,Orthopedic Fixation Devices,1
Bone Screws,E,E07.858.442.660.460.437,Internal Fixators,Orthopedic Fixation Devices,1
Bone Screws,E,E07.858.690.725.460.437,Internal Fixators,Orthopedic Fixation Devices,1
Bone Screws,E,E07.695.370.437,Internal Fixators,Prostheses and Implants,1
Bordetella bronchiseptica,B,B03.440.400.425.115.425.050,Bordetella,Alcaligenaceae,1
Bordetella bronchiseptica,B,B03.660.075.090.344.425.050,Bordetella,Alcaligenaceae,1
Bordetella Infections,C,C01.150.252.400.143,Gram-Negative Bacterial Infections,Bacterial Infections,1
Boredom,F,F01.470.192,Emotions,Behavior and Behavior Mechanisms,1
Boric Acids,D,D01.132.250,Boron Compounds,Inorganic Chemicals,1
Boric Acids,D,D01.029.260.093,"Acids, Noncarboxylic",Acids,1
Boric Acids,D,D02.203.130,Boron Compounds,Organic Chemicals,1
Boronic Acids,D,D02.203.200,Boron Compounds,Organic Chemicals,1
Boronic Acids,D,D01.029.260.110,"Acids, Noncarboxylic",Acids,1
Boronic Acids,D,D01.132.285,Boron Compounds,Inorganic Chemicals,1
Borrelia burgdorferi,B,B03.851.595.193.150.125,Borrelia burgdorferi Group,Borrelia,1
Borrelia burgdorferi,B,B03.440.425.410.711.193.150.125,Borrelia burgdorferi Group,Borrelia,1
Bortezomib,D,D01.132.285.500,Boronic Acids,Boron Compounds,1
Bortezomib,D,D01.029.260.110.500,Boronic Acids,"Acids, Noncarboxylic",1
Bortezomib,D,D02.203.200.500,Boronic Acids,Boron Compounds,1
Bortezomib,D,D03.383.679.450,Pyrazines,"Heterocyclic Compounds, 1-Ring",1
Bowen's Disease,C,C04.557.470.200.400.130,"Carcinoma, Squamous Cell",Carcinoma,1
Bowen's Disease,C,C04.557.470.700.400.130,"Carcinoma, Squamous Cell","Neoplasms, Squamous Cell",1
Brachyspira hyodysenteriae,B,B03.440.425.410.220.100,Brachyspira,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",1
Brachyspira hyodysenteriae,B,B03.440.097.100,Brachyspira,Gram-Negative Bacteria,1
Bradykinin,D,D12.644.276.812.169,Kinins,Intercellular Signaling Peptides and Proteins,1
Bradykinin,D,D12.644.400.090,Neuropeptides,Peptides,1
Bradykinin,D,D12.644.456.193,Oligopeptides,Peptides,1
Bradykinin,D,D23.529.812.169,Kinins,Intercellular Signaling Peptides and Proteins,1
Bradykinin,D,D23.469.050.375.110,Kinins,Autacoids,1
Bradykinin,D,D12.776.467.812.169,Kinins,Intercellular Signaling Peptides and Proteins,1
Bradykinin,D,D12.776.631.650.090,Neuropeptides,Nerve Tissue Proteins,1
"Brain Injury, Chronic",C,C26.915.300.200.200,Brain Injuries,Craniocerebral Trauma,1
"Brain Injury, Chronic",C,C10.900.300.087.250,Brain Injuries,Craniocerebral Trauma,1
"Brain Injury, Chronic",C,C10.228.140.140.127,"Brain Damage, Chronic",Brain Diseases,1
"Brain Injury, Chronic",C,C10.228.140.199.500,Brain Injuries,Brain Diseases,1
Brain-Computer Interfaces,E,E07.305.076,Electrical Equipment and Supplies,Equipment and Supplies,1
Branched DNA Signal Amplification Assay,E,E05.393.661.124,Nucleic Acid Hybridization,Genetic Techniques,1
Branched DNA Signal Amplification Assay,E,E05.601.300,Molecular Probe Techniques,Investigative Techniques,1
Breast Diseases,C,C17.800.090,Skin Diseases,Skin and Connective Tissue Diseases,1
Breath Holding,G,G09.772.705.349,Respiration,Respiratory Physiological Phenomena,1
Brentuximab Vedotin,D,D12.644.456.217,Oligopeptides,Peptides,1
Brentuximab Vedotin,D,D12.776.377.715.548.114.224.200.469,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",1
Brentuximab Vedotin,D,D12.776.124.486.485.114.224.060.438,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",1
Brentuximab Vedotin,D,D12.776.124.790.651.114.224.060.469,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",1
Bridged Bicyclo Compounds,D,D04.075.080,Bridged-Ring Compounds,Polycyclic Compounds,1
Bridged Bicyclo Compounds,D,D02.455.426.100.080,Bridged-Ring Compounds,"Hydrocarbons, Cyclic",1
Bromodeoxyuridine,D,D03.383.742.680.852.300.150,Deoxyuridine,Uridine,1
Bromodeoxyuridine,D,D13.570.230.430.196,Deoxyuridine,Deoxyribonucleosides,1
Bromodeoxyuridine,D,D13.570.685.852.300.150,Deoxyuridine,Uridine,1
Bronchial Diseases,C,C08.127,Respiratory Tract Diseases,NULL,1
Bronchial Thermoplasty,E,E04.014.760.500.500,Catheter Ablation,Radiofrequency Ablation,1
Bronchial Thermoplasty,E,E02.808.750.500.500,Catheter Ablation,Radiofrequency Ablation,1
"Bronchiolitis, Viral",C,C08.127.446.135.321,Bronchiolitis,Bronchitis,1
"Bronchiolitis, Viral",C,C08.381.495.146.135.321,Bronchiolitis,Bronchitis,1
"Bronchiolitis, Viral",C,C08.730.099.135.321,Bronchiolitis,Bronchitis,1
"Bronchiolitis, Viral",C,C01.925.109,Virus Diseases,Infections,1
"Bronchiolitis, Viral",C,C01.748.099.135.321,Bronchiolitis,Bronchitis,1
Bronchospirometry,E,E01.370.386.700.750.100,Spirometry,Respiratory Function Tests,1
Brown-Sequard Syndrome,C,C10.597.622.669.300,Paraplegia,Paralysis,1
Brown-Sequard Syndrome,C,C23.888.592.636.637.300,Paraplegia,Paralysis,1
Brucella Vaccine,D,D20.215.894.135.134,Bacterial Vaccines,Vaccines,1
Bruch Membrane,A,A10.615.179.250,Basement Membrane,Membranes,1
Bruch Membrane,A,A09.371.894.223.250,Choroid,Uvea,1
Bruch Membrane,A,A10.272.220.250,Basement Membrane,Epithelium,1
Brugada Syndrome,C,C16.320.100,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",1
Brugada Syndrome,C,C14.280.123.250,Cardiac Conduction System Disease,Heart Diseases,1
Brugada Syndrome,C,C14.280.067.322,"Arrhythmias, Cardiac",Heart Diseases,1
Bucladesine,D,D13.695.827.068.395.250,Cyclic AMP,Adenine Nucleotides,1
Bucladesine,D,D13.695.667.138.395.250,Cyclic AMP,Adenine Nucleotides,1
Bucladesine,D,D13.695.462.200.250,Cyclic AMP,"Nucleotides, Cyclic",1
Bucladesine,D,D03.633.100.759.646.138.395.250,Cyclic AMP,Adenine Nucleotides,1
Budd-Chiari Syndrome,C,C14.907.355.830.925.275,Venous Thrombosis,Thrombosis,1
Budd-Chiari Syndrome,C,C06.552.347,Liver Diseases,Digestive System Diseases,1
"Budesonide, Formoterol Fumarate Drug Combination",D,D02.092.063.291.425.250,Formoterol Fumarate,Ethanolamines,1
"Budesonide, Formoterol Fumarate Drug Combination",D,D02.033.100.291.425.250,Formoterol Fumarate,Ethanolamines,1
"Budesonide, Formoterol Fumarate Drug Combination",D,D04.210.500.745.745.654.105.500,Budesonide,Pregnenediones,1
"Budesonide, Formoterol Fumarate Drug Combination",D,D26.310.348,Drug Combinations,Pharmaceutical Preparations,1
Bufexamac,D,D02.065.064.294.088,Benzeneacetamides,Acetamides,1
Bufexamac,D,D02.092.570.394.150,Hydroxamic Acids,Hydroxylamines,1
Bufexamac,D,D02.241.511.372.150,Hydroxamic Acids,Hydroxy Acids,1
Bufexamac,D,D02.455.426.559.389.048.088,Benzeneacetamides,Benzene Derivatives,1
Bulinus,B,B01.050.500.644.400.750.323,Snails,Gastropoda,1
Bumetanide,D,D02.455.426.559.389.127.020.452.500,meta-Aminobenzoates,Aminobenzoates,1
Bumetanide,D,D02.241.223.100.050.300.200,meta-Aminobenzoates,Aminobenzoates,1
Bumetanide,D,D02.065.884.150,Sulfonamides,Amides,1
Bumetanide,D,D02.886.590.700.150,Sulfonamides,Sulfones,1
Bungarotoxins,D,D23.946.833.850.325.139,Elapid Venoms,Snake Venoms,1
Bungarotoxins,D,D20.888.850.325.139,Elapid Venoms,Snake Venoms,1
Bunyaviridae,B,B04.820.480.750,Negative-Sense RNA Viruses,RNA Viruses,1
"Buprenorphine, Naloxone Drug Combination",D,D26.310.352,Drug Combinations,Pharmaceutical Preparations,1
"Buprenorphine, Naloxone Drug Combination",D,D03.132.577.249.706.275,Naloxone,Morphinans,1
"Buprenorphine, Naloxone Drug Combination",D,D03.132.577.249.150.500,Buprenorphine,Morphinans,1
"Buprenorphine, Naloxone Drug Combination",D,D03.633.400.686.150.500,Buprenorphine,Morphinans,1
"Buprenorphine, Naloxone Drug Combination",D,D03.633.400.686.750.275,Naloxone,Morphinans,1
"Buprenorphine, Naloxone Drug Combination",D,D03.605.497.750.275,Naloxone,Morphinans,1
"Buprenorphine, Naloxone Drug Combination",D,D03.605.497.150.500,Buprenorphine,Morphinans,1
"Buprenorphine, Naloxone Drug Combination",D,D04.615.723.795.706.275,Naloxone,Morphinans,1
"Buprenorphine, Naloxone Drug Combination",D,D04.615.723.795.150.500,Buprenorphine,Morphinans,1
Bursitis,C,C05.550.251,Joint Diseases,Musculoskeletal Diseases,1
Butter,D,D10.212.302.199,Dietary Fats,Fats,1
Butter,G,G07.203.300.350.100,Dairy Products,Food,1
Butter,G,G07.203.300.375.200,Dietary Fats,Food,1
Butter,J,J02.500.350.100,Dairy Products,Food,1
Butter,J,J02.500.375.200,Dietary Fats,Food,1
Buttocks,A,A01.378.610.100,Lower Extremity,Extremities,1
Butylene Glycols,D,D02.033.455.125,Glycols,Alcohols,1
Butyric Acid,D,D02.241.081.114.750,Butyrates,"Acids, Acyclic",1
Butyric Acid,D,D10.251.400.143.500,Butyrates,"Fatty Acids, Volatile",1
Butyrophilins,D,D12.776.395.550.114,Membrane Glycoproteins,Glycoproteins,1
Butyrophilins,D,D12.776.543.550.195,Membrane Glycoproteins,Membrane Proteins,1
Bystander Effect,G,G04.085.155,Cell Communication,Cell Physiological Phenomena,1
Cacodylic Acid,D,D02.129.100,Arsenicals,Organic Chemicals,1
Cactaceae,B,B01.650.940.800.575.912.250.198.500.200,Caryophyllales,Caryophyllanae,1
Cadmium Chloride,D,D01.142.175,Cadmium Compounds,Inorganic Chemicals,1
Cadmium Chloride,D,D01.210.450.150.125,Chlorides,Hydrochloric Acid,1
Cadmium Compounds,D,D01.142,Inorganic Chemicals,NULL,1
Cadmium Poisoning,C,C25.723.522.625,Heavy Metal Poisoning,Poisoning,1
Calcaneus,A,A02.835.232.043.300.710.300,Tarsal Bones,Foot Bones,1
Calcium Chloride,D,D01.146.300,Calcium Compounds,Inorganic Chemicals,1
Calcium Chloride,D,D01.210.450.150.150,Chlorides,Hydrochloric Acid,1
Calcium Oxalate,D,D02.241.081.337.593.750.500,Oxalic Acid,Oxalates,1
Calcium Sulfate,D,D01.875.800.800.850.125,Sulfates,Sulfuric Acids,1
Calcium Sulfate,D,D01.578.215,Minerals,Inorganic Chemicals,1
Calcium Sulfate,D,D01.146.375,Calcium Compounds,Inorganic Chemicals,1
Calcium-Calmodulin-Dependent Protein Kinase Type 2,D,D12.776.476.100.200,Calcium-Calmodulin-Dependent Protein Kinases,Intracellular Signaling Peptides and Proteins,1
Calcium-Calmodulin-Dependent Protein Kinase Type 2,D,D08.811.913.696.620.682.700.125.200,Calcium-Calmodulin-Dependent Protein Kinases,Protein-Serine-Threonine Kinases,1
Calcium-Calmodulin-Dependent Protein Kinase Type 2,D,D12.644.360.100.200,Calcium-Calmodulin-Dependent Protein Kinases,Intracellular Signaling Peptides and Proteins,1
Calcium-Transporting ATPases,D,D12.776.157.530.813.250,P-type ATPases,Membrane Transport Proteins,1
Calcium-Transporting ATPases,D,D12.776.157.530.450.250.500,Cation Transport Proteins,Ion Pumps,1
Calcium-Transporting ATPases,D,D08.811.277.040.025.314.250,P-type ATPases,Adenosine Triphosphatases,1
Calcium-Transporting ATPases,D,D12.776.543.585.450.250.500,Cation Transport Proteins,Ion Pumps,1
Calcium-Transporting ATPases,D,D12.776.543.585.813.250,P-type ATPases,Membrane Transport Proteins,1
Calgranulin A,D,D12.776.631.655.500.100,Leukocyte L1 Antigen Complex,S100 Proteins,1
Calgranulin A,D,D23.050.301.562.100,Leukocyte L1 Antigen Complex,"Antigens, Surface",1
Calgranulin A,D,D12.776.157.125.750.500.100,Leukocyte L1 Antigen Complex,S100 Proteins,1
Calgranulin B,D,D12.776.157.125.750.500.200,Leukocyte L1 Antigen Complex,S100 Proteins,1
Calgranulin B,D,D23.050.301.562.200,Leukocyte L1 Antigen Complex,"Antigens, Surface",1
Calgranulin B,D,D12.776.631.655.500.200,Leukocyte L1 Antigen Complex,S100 Proteins,1
"Calicivirus, Feline",B,B04.820.578.298.887.150,Vesivirus,Caliciviridae,1
Call Centers,N,N02.421.297.036,Emergency Medical Services,Health Services,1
Calliphoridae,B,B01.050.500.131.617.720.500.500.750.155,Diptera,Holometabola,1
Callitrichinae,B,B01.050.150.900.649.313.988.400.600.150.150,Cebidae,Platyrrhini,1
Camping,I,I03.450.642.159,Recreation,Leisure Activities,1
Camptothecin,D,D03.132.151,Alkaloids,Heterocyclic Compounds,1
Canarypox virus,B,B04.280.650.160.100.149,Avipoxvirus,Chordopoxvirinae,1
Cancer Pain,C,C23.888.592.612.212,Pain,Neurologic Manifestations,1
Cannibalism,F,F01.145.113.547.200,Feeding Behavior,"Behavior, Animal",1
Canrenoic Acid,D,D04.210.500.745.432.100,Pregnadienes,Pregnanes,1
Capillaria,B,B01.050.500.500.294.100.275.780.180,Trichuroidea,Enoplida,1
Capillary Resistance,G,G09.330.380.921.327,Vascular Resistance,Hemodynamics,1
Capital Expenditures,N,N03.219.151.450.200,Health Expenditures,Costs and Cost Analysis,1
Capnocytophaga,B,B03.440.080.190.100,Flavobacteriaceae,Bacteroidetes,1
Capnocytophaga,B,B03.440.450.340,Gram-Negative Facultatively Anaerobic Rods,Gram-Negative Bacteria,1
Capripoxvirus,B,B04.280.650.160.150,Chordopoxvirinae,Poxviridae,1
Caproates,D,D02.241.081.193,"Acids, Acyclic",Carboxylic Acids,1
Caproates,D,D10.251.400.326,"Fatty Acids, Volatile",Fatty Acids,1
Capsule Opacification,C,C11.510.245.500,Cataract,Lens Diseases,1
Carbachol,D,D02.092.877.883.333.115,Choline,Trimethyl Ammonium Compounds,1
Carbachol,D,D02.675.276.232.115,Choline,Quaternary Ammonium Compounds,1
Carbamyl Phosphate,D,D02.705.400.100,Organophosphates,Organophosphorus Compounds,1
Carbamyl Phosphate,D,D02.241.081.251.145,Carbamates,"Acids, Acyclic",1
Carbimazole,D,D03.383.129.308.108,Imidazoles,Azoles,1
Carbolines,D,D03.383.725.150,Pyridines,"Heterocyclic Compounds, 1-Ring",1
Carbolines,D,D03.633.300.154,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",1
Carbolines,D,D03.633.100.473.155,Indoles,"Heterocyclic Compounds, 2-Ring",1
Carbon Cycle,G,G16.500.150,Ecological and Environmental Phenomena,Biological Phenomena,1
Carbon Cycle,G,G02.607.125,Organic Chemistry Phenomena,Chemical Phenomena,1
Carbon Sequestration,G,G02.607.125.500,Carbon Cycle,Organic Chemistry Phenomena,1
Carbon Sequestration,G,G16.500.150.500,Carbon Cycle,Ecological and Environmental Phenomena,1
Carbonic Anhydrase Inhibitors,D,D27.505.519.389.200,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,1
Carbonic Anhydrase IV,D,D12.776.543.550.418.160,GPI-Linked Proteins,Membrane Glycoproteins,1
Carbonic Anhydrase IV,D,D12.776.543.484.500.160,GPI-Linked Proteins,Lipid-Linked Proteins,1
Carbonic Anhydrase IV,D,D08.811.520.241.300.150.400,Carbonic Anhydrases,Hydro-Lyases,1
Carbonic Anhydrase IV,D,D12.776.395.550.448.160,GPI-Linked Proteins,Membrane Glycoproteins,1
Carbon-Nitrogen Ligases,D,D08.811.464.259,Ligases,Enzymes,1
Carboxylesterase,D,D08.811.277.352.100.100,Carboxylic Ester Hydrolases,Esterases,1
Carcinogenesis,C,C23.550.727.098,Neoplastic Processes,Pathologic Processes,1
Carcinogenesis,C,C04.697.098,Neoplastic Processes,Neoplasms,1
Carcinogenicity Tests,E,E05.940.150,Toxicity Tests,Investigative Techniques,1
"Carcinoma, Adenoid Cystic",C,C04.557.470.200.025.220,Adenocarcinoma,Carcinoma,1
"Carcinoma, Bronchogenic",C,C04.588.894.797.520.109.220,Bronchial Neoplasms,Lung Neoplasms,1
"Carcinoma, Bronchogenic",C,C08.785.520.100.220,Bronchial Neoplasms,Lung Neoplasms,1
"Carcinoma, Bronchogenic",C,C08.381.540.140,Lung Neoplasms,Lung Diseases,1
"Carcinoma, Medullary",C,C04.557.465.625.650.240.315,"Carcinoma, Neuroendocrine",Neuroendocrine Tumors,1
"Carcinoma, Medullary",C,C04.557.470.615.315,"Neoplasms, Ductal, Lobular, and Medullary","Neoplasms, Glandular and Epithelial",1
"Carcinoma, Medullary",C,C04.557.470.200.025.370.315,"Carcinoma, Neuroendocrine",Adenocarcinoma,1
"Carcinoma, Medullary",C,C04.557.580.625.650.240.315,"Carcinoma, Neuroendocrine",Neuroendocrine Tumors,1
Cardia,A,A03.556.875.875.163,Stomach,Upper Gastrointestinal Tract,1
Cardiac Catheters,E,E07.132.750.249,Vascular Access Devices,Catheters,1
"Cardiac Pacing, Artificial",E,E02.331.200,Electric Stimulation Therapy,Therapeutics,1
Cardiac Resynchronization Therapy,E,E02.331.200.500,"Cardiac Pacing, Artificial",Electric Stimulation Therapy,1
Cardiac Tamponade,C,C14.280.155,Heart Diseases,Cardiovascular Diseases,1
"Cardiography, Impedance",E,E01.370.370.380.160,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",1
"Cardiography, Impedance",E,E01.370.370.610.610.200,"Plethysmography, Impedance",Plethysmography,1
Cardiologists,N,N02.360.810.128,Physicians,Health Personnel,1
Cardiologists,M,M01.526.485.810.128,Physicians,Health Personnel,1
Cardio-Renal Syndrome,C,C14.280.434.156,Heart Failure,Heart Diseases,1
Cardio-Renal Syndrome,C,C13.351.968.419.780.400,Renal Insufficiency,Kidney Diseases,1
Cardio-Renal Syndrome,C,C12.777.419.780.400,Renal Insufficiency,Kidney Diseases,1
Carmine,D,D02.455.426.559.847.117.159.200,Anthraquinones,Anthracenes,1
Carmine,D,D04.615.117.159.200,Anthraquinones,Anthracenes,1
Carmine,D,D02.806.100.200,Anthraquinones,Quinones,1
Carnosine,D,D12.644.456.345.331,Dipeptides,Oligopeptides,1
Carnosine,D,D12.644.400.100,Neuropeptides,Peptides,1
Carnosine,D,D12.776.631.650.100,Neuropeptides,Nerve Tissue Proteins,1
CASP8 and FADD-Like Apoptosis Regulating Protein,D,D12.776.476.075.421.024,Death Domain Receptor Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,1
CASP8 and FADD-Like Apoptosis Regulating Protein,D,D12.644.360.075.421.024,Death Domain Receptor Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,1
CASP8 and FADD-Like Apoptosis Regulating Protein,D,D12.644.360.024.500.024,Tumor Necrosis Factor Receptor-Associated Peptides and Proteins,"Adaptor Proteins, Signal Transducing",1
CASP8 and FADD-Like Apoptosis Regulating Protein,D,D12.644.360.024.285.024,Death Domain Receptor Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
CASP8 and FADD-Like Apoptosis Regulating Protein,D,D12.776.157.057.018.024,Death Domain Receptor Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Caspase 10,D,D12.644.360.075.405.550.910,"Caspases, Initiator",Caspases,1
Caspase 10,D,D08.811.277.656.262.500.126.550.910,"Caspases, Initiator",Caspases,1
Caspase 10,D,D08.811.277.656.300.200.126.550.910,"Caspases, Initiator",Caspases,1
Caspase 10,D,D12.776.476.075.405.550.910,"Caspases, Initiator",Caspases,1
Caspase 7,D,D12.776.476.075.405.350.700,"Caspases, Effector",Caspases,1
Caspase 7,D,D08.811.277.656.300.200.126.350.700,"Caspases, Effector",Caspases,1
Caspase 7,D,D08.811.277.656.262.500.126.350.700,"Caspases, Effector",Caspases,1
Caspase 7,D,D12.644.360.075.405.350.700,"Caspases, Effector",Caspases,1
Caspase 9,D,D12.644.360.075.358.155,CARD Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,1
Caspase 9,D,D12.644.360.075.405.550.900,"Caspases, Initiator",Caspases,1
Caspase 9,D,D12.644.360.024.131.155,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Caspase 9,D,D12.776.157.057.006.155,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Caspase 9,D,D08.811.277.656.262.500.126.550.900,"Caspases, Initiator",Caspases,1
Caspase 9,D,D08.811.277.656.300.200.126.550.900,"Caspases, Initiator",Caspases,1
Caspase 9,D,D12.776.476.075.405.550.900,"Caspases, Initiator",Caspases,1
Caspase 9,D,D12.776.476.075.358.155,CARD Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,1
Caspase 9,D,D12.776.476.024.139.155,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Caspase Inhibitors,D,D27.505.519.389.745.325.500,Cysteine Proteinase Inhibitors,Protease Inhibitors,1
Catalepsy,C,C23.888.592.350.200,Dyskinesias,Neurologic Manifestations,1
Catalepsy,C,C10.597.350.200,Dyskinesias,Neurologic Manifestations,1
Cataplexy,C,C10.886.425.800.200.750.500,Narcolepsy,Disorders of Excessive Somnolence,1
Cataplexy,F,F03.870.400.800.200.750.500,Narcolepsy,Disorders of Excessive Somnolence,1
Catechol O-Methyltransferase,D,D08.811.913.555.500.250,Methyltransferases,One-Carbon Group Transferases,1
Catfishes,B,B01.050.150.900.493.080,Fishes,Vertebrates,1
Cathepsin G,D,D08.811.277.656.224.350,Cathepsins,Peptide Hydrolases,1
Cathepsin G,D,D08.811.277.656.300.760.066,Serine Endopeptidases,Endopeptidases,1
Cathepsin G,D,D08.811.277.656.959.350.066,Serine Endopeptidases,Serine Proteases,1
Cat-Scratch Disease,C,C01.150.252.400.126.100.150,Bartonella Infections,Bartonellaceae Infections,1
Cat-Scratch Disease,C,C15.604.315.249,Lymphadenitis,Lymphatic Diseases,1
Cauda Equina,A,A08.800.800.720.725.150,Spinal Nerve Roots,Spinal Nerves,1
Caulobacter crescentus,B,B03.440.400.280.280,Caulobacter,Gram-Negative Aerobic Bacteria,1
Caulobacter crescentus,B,B03.440.400.425.288.100.100,Caulobacter,Caulobacteraceae,1
Caulobacter crescentus,B,B03.660.050.090.100.100,Caulobacter,Caulobacteraceae,1
Caveolin 1,D,D12.644.360.024.264,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
Caveolin 1,D,D12.776.157.057.010,"Adaptor Proteins, Signal Transducing",Carrier Proteins,1
Caveolin 1,D,D12.776.476.024.280,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
Caveolin 1,D,D12.776.543.990.100.500,Caveolins,Vesicular Transport Proteins,1
Caveolin 1,D,D12.776.744.287,Phosphoproteins,Proteins,1
Caveolins,D,D12.776.543.990.100,Vesicular Transport Proteins,Membrane Proteins,1
CCR5 Receptor Antagonists,D,D27.505.519.275,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,1
CCR5 Receptor Antagonists,D,D27.505.954.122.388.077.088.104,Anti-HIV Agents,Anti-Retroviral Agents,1
CD11a Antigen,D,D12.776.543.750.705.408.100.100,Integrin alpha Chains,Integrins,1
CD11a Antigen,D,D12.776.543.550.200.093.500,CD11 Antigens,Cell Adhesion Molecules,1
CD11a Antigen,D,D23.050.301.350.074.024,CD11 Antigens,Cell Adhesion Molecules,1
CD11a Antigen,D,D12.776.395.550.200.074.500,CD11 Antigens,Cell Adhesion Molecules,1
CD18 Antigens,D,D12.776.395.550.200.275.750,Integrin alphaXbeta2,Cell Adhesion Molecules,1
CD18 Antigens,D,D23.050.301.350.275.750,Integrin alphaXbeta2,Cell Adhesion Molecules,1
CD18 Antigens,D,D23.050.301.264.894.118,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",1
CD18 Antigens,D,D12.776.543.550.200.275.750,Integrin alphaXbeta2,Cell Adhesion Molecules,1
CD18 Antigens,D,D12.776.543.750.705.408.200.249,Integrin beta Chains,Integrins,1
CD18 Antigens,D,D12.776.543.750.705.408.600.100.750,Integrin alphaXbeta2,"Receptors, Leukocyte-Adhesion",1
CD18 Antigens,D,D12.776.543.750.705.833.249.750,Integrin alphaXbeta2,"Receptors, Complement",1
CD18 Antigens,D,D23.101.100.894.118,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",1
"CDC28 Protein Kinase, S cerevisiae",D,D12.776.476.250.067.500,CDC2-CDC28 Kinases,Cyclin-Dependent Kinases,1
"CDC28 Protein Kinase, S cerevisiae",D,D12.776.354.750.124,Saccharomyces cerevisiae Proteins,Fungal Proteins,1
"CDC28 Protein Kinase, S cerevisiae",D,D12.776.167.200.067.500,CDC2-CDC28 Kinases,Cyclin-Dependent Kinases,1
"CDC28 Protein Kinase, S cerevisiae",D,D12.644.360.250.067.500,CDC2-CDC28 Kinases,Cyclin-Dependent Kinases,1
"CDC28 Protein Kinase, S cerevisiae",D,D08.811.913.696.620.682.700.646.500.500.375,CDC2-CDC28 Kinases,Cyclin-Dependent Kinases,1
CDC2-CDC28 Kinases,D,D08.811.913.696.620.682.700.646.500.500,Cyclin-Dependent Kinases,Proline-Directed Protein Kinases,1
CDC2-CDC28 Kinases,D,D12.644.360.250.067,Cyclin-Dependent Kinases,Intracellular Signaling Peptides and Proteins,1
CDC2-CDC28 Kinases,D,D12.776.167.200.067,Cyclin-Dependent Kinases,Cell Cycle Proteins,1
CDC2-CDC28 Kinases,D,D12.776.476.250.067,Cyclin-Dependent Kinases,Intracellular Signaling Peptides and Proteins,1
CD-I,J,J01.897.280.500.668.800.250.100,Compact Disks,Videodisc Recording,1
CD-I,J,J01.897.280.500.898.800.250.100,Compact Disks,Videodisc Recording,1
CD-I,L,L01.224.230.260.115.475.600.325.500,Compact Disks,Optical Storage Devices,1
CD-I,L,L01.280.960.800.250.100,Compact Disks,Videodisc Recording,1
CD-I,L,L01.178.820.090.668.800.250.100,Compact Disks,Videodisc Recording,1
CD-I,L,L01.178.820.090.898.800.250.100,Compact Disks,Videodisc Recording,1
CD-I,L,L01.178.590.875.800.250.100,Compact Disks,Videodisc Recording,1
Cebidae,B,B01.050.150.900.649.313.988.400.600.150,Platyrrhini,Haplorhini,1
Cefadroxil,D,D02.065.589.099.249.200.165,Cephalexin,Cephalosporins,1
Cefadroxil,D,D02.886.665.074.200.165,Cephalexin,Cephalosporins,1
Cefadroxil,D,D03.633.100.300.249.200.165,Cephalexin,Cephalosporins,1
Cefoxitin,D,D03.633.100.300.249.250.222,Cephamycins,Cephalosporins,1
Cefoxitin,D,D02.886.665.074.250.222,Cephamycins,Cephalosporins,1
Cefoxitin,D,D02.065.589.099.249.250.222,Cephamycins,Cephalosporins,1
Ceftizoxime,D,D02.065.589.099.249.190.190.145,Cefotaxime,Cephacetrile,1
Ceftizoxime,D,D02.886.665.074.190.190.145,Cefotaxime,Cephacetrile,1
Ceftizoxime,D,D03.633.100.300.249.190.190.145,Cefotaxime,Cephacetrile,1
Celiac Artery,A,A07.015.114.207,Arteries,Blood Vessels,1
Cell Membrane Structures,A,A11.284.149.165,Cell Membrane,Cellular Structures,1
Cell Nucleolus,A,A11.284.430.106.279.345.175,Intranuclear Space,Cell Nucleus Structures,1
Cell Respiration,G,G03.197,Metabolism,NULL,1
Cell Respiration,G,G04.270,Cell Physiological Phenomena,NULL,1
Cell Surface Extensions,A,A11.284.180,Cellular Structures,Cells,1
Cell-Matrix Junctions,A,A11.284.149.165.165,Cell Membrane Structures,Cell Membrane,1
Cellobiose,D,D09.698.365.180.180,Cellulose,Glucans,1
Cellobiose,D,D09.698.629.305.200,Disaccharides,Oligosaccharides,1
Cellobiose,D,D09.947.750.200,Disaccharides,Sugars,1
"Cells, Immobilized",A,A11.270,Cells,NULL,1
Cellular Reprogramming,G,G04.152.262,Cell Differentiation,Cell Physiological Phenomena,1
Cellular Reprogramming,G,G05.135,Genetic Phenomena,NULL,1
Cellulases,D,D08.811.277.450.420.200,Glucosidases,Glycoside Hydrolases,1
Cemeteries,J,J03.150,Non-Medical Public and Private Facilities,NULL,1
Cemeteries,I,I01.076.201.450.550.150.500,Burial,Funeral Rites,1
"Censorship, Research",I,I01.880.604.238,"Social Control, Formal",Sociology,1
"Censorship, Research",K,K01.752.566.479.173.200,"Ethics, Research",Ethics,1
"Censorship, Research",N,N05.350.670.250,"Ethics, Research",Ethics,1
Central Nervous System Fungal Infections,C,C01.150.703.181,Mycoses,Bacterial Infections and Mycoses,1
Central Nervous System Fungal Infections,C,C01.207.198,Central Nervous System Infections,Infections,1
Central Nervous System Fungal Infections,C,C10.228.228.198,Central Nervous System Infections,Central Nervous System Diseases,1
Central Nervous System Vascular Malformations,C,C10.500.190,Nervous System Malformations,Nervous System Diseases,1
Central Nervous System Vascular Malformations,C,C16.131.240.850.875,Vascular Malformations,Cardiovascular Abnormalities,1
Central Nervous System Vascular Malformations,C,C16.131.666.190,Nervous System Malformations,Congenital Abnormalities,1
Central Nervous System Vascular Malformations,C,C14.240.850.875,Vascular Malformations,Cardiovascular Abnormalities,1
Central Serous Chorioretinopathy,C,C11.768.175,Retinal Diseases,Eye Diseases,1
Central Venous Pressure,G,G09.330.380.076.732.336,Venous Pressure,Blood Pressure,1
Centrioles,A,A11.284.430.214.190.750.585.160.130,Centrosome,Microtubule-Organizing Center,1
Centrioles,A,A11.284.430.214.190.750.820.500.500.130,Centrosome,Spindle Poles,1
Cephalexin,D,D02.065.589.099.249.200,Cephalosporins,beta-Lactams,1
Cephalexin,D,D03.633.100.300.249.200,Cephalosporins,beta-Lactams,1
Cephalexin,D,D02.886.665.074.200,Cephalosporins,Thiazines,1
Cephalosporinase,D,D08.811.277.087.180.229,beta-Lactamases,Amidohydrolases,1
Cephamycins,D,D02.886.665.074.250,Cephalosporins,Thiazines,1
Cephamycins,D,D03.633.100.300.249.250,Cephalosporins,beta-Lactams,1
Cephamycins,D,D02.065.589.099.249.250,Cephalosporins,beta-Lactams,1
Ceramides,D,D02.065.313,Amides,Organic Chemicals,1
Ceramides,D,D10.390.470.675.200,Neutral Glycosphingolipids,Glycosphingolipids,1
Ceramides,D,D10.570.877.360.612.200,Neutral Glycosphingolipids,Glycosphingolipids,1
Ceramides,D,D09.400.410.420.525.200,Neutral Glycosphingolipids,Glycosphingolipids,1
"Cerclage, Cervical",E,E04.520.100,Obstetric Surgical Procedures,"Surgical Procedures, Operative",1
Cercopithecinae,B,B01.050.150.900.649.313.988.400.112.199.120,Cercopithecidae,Catarrhini,1
Cerebral Aqueduct,A,A08.186.211.132.659.413.875.187,Tegmentum Mesencephali,Cerebral Peduncle,1
Cerebral Aqueduct,A,A08.186.211.140.187,Cerebral Ventricles,Brain,1
Cerebral Cortical Thinning,C,C23.888.592.206,Neurologic Manifestations,Signs and Symptoms,1
Cerebral Cortical Thinning,C,C23.300.220,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",1
Cerebral Cortical Thinning,C,C10.597.210,Neurologic Manifestations,Nervous System Diseases,1
Cerebral Veins,A,A07.015.908.155,Veins,Blood Vessels,1
Cerebrospinal Fluid Proteins,D,D12.776.178,Proteins,"Amino Acids, Peptides, and Proteins",1
Cerebrum,A,A08.186.211.200.885.287,Telencephalon,Prosencephalon,1
Certificate of Need,N,N03.349.650.120,Regional Health Planning,Health Planning,1
Ceruloplasmin,D,D12.776.377.715.085.214,Alpha-Globulins,Serum Globulins,1
Ceruloplasmin,D,D12.776.157.160,Carrier Proteins,Proteins,1
Ceruloplasmin,D,D12.776.124.790.106.214,Alpha-Globulins,Serum Globulins,1
Ceruloplasmin,D,D12.776.124.050.130,Acute-Phase Proteins,Blood Proteins,1
Ceruloplasmin,D,D08.811.682.226,Oxidoreductases,Enzymes,1
Ceruloplasmin,D,D12.776.556.151,Metalloproteins,Proteins,1
Cerumen,A,A12.200.147,Bodily Secretions,Fluids and Secretions,1
Cervical Intraepithelial Neoplasia,C,C04.557.470.200.240.250,Carcinoma in Situ,Carcinoma,1
Cervical Length Measurement,E,E01.370.350.850.865.249,"Ultrasonography, Prenatal",Ultrasonography,1
Cervical Length Measurement,E,E01.370.378.630.865.249,"Ultrasonography, Prenatal",Prenatal Diagnosis,1
Cervix Mucus,A,A12.200.503.339,Mucus,Bodily Secretions,1
Cesium Radioisotopes,D,D01.552.528.160.500.300,Cesium Isotopes,Cesium,1
Cesium Radioisotopes,D,D01.552.544.165.500.300,Cesium Isotopes,Cesium,1
Cesium Radioisotopes,D,D01.496.180.300,Cesium Isotopes,Isotopes,1
Cesium Radioisotopes,D,D01.496.749.190,Radioisotopes,Isotopes,1
Cesium Radioisotopes,D,D01.268.556.165.500.300,Cesium Isotopes,Cesium,1
Cesium Radioisotopes,D,D01.268.549.125.500.300,Cesium Isotopes,Cesium,1
Cestoda,B,B01.050.500.500.736.215,Platyhelminths,Helminths,1
Cestode Infections,C,C01.610.335.190,Helminthiasis,Parasitic Diseases,1
Cetylpyridinium,D,D03.383.725.762.232,Pyridinium Compounds,Pyridines,1
Chalones,D,D12.644.456.270,Oligopeptides,Peptides,1
Change Management,N,N04.452.610.125,Organizational Innovation,Organization and Administration,1
Chaperonin Containing TCP-1,D,D08.811.277.040.025.142.750.500,Group II Chaperonins,Chaperonins,1
Chaperonin Containing TCP-1,D,D12.776.580.216.210.795.500,Group II Chaperonins,Chaperonins,1
Charadriiformes,B,B01.050.150.900.248.150,Birds,Vertebrates,1
Charybdotoxin,D,D20.888.065.830.150,Scorpion Venoms,Arthropod Venoms,1
Charybdotoxin,D,D23.946.833.065.830.150,Scorpion Venoms,Arthropod Venoms,1
Charybdotoxin,D,D12.644.115,Peptides,"Amino Acids, Peptides, and Proteins",1
Chelation Therapy,E,E02.319.155,Drug Therapy,Therapeutics,1
"Chemistry Techniques, Synthetic",J,J01.897.836.249,"Technology, Pharmaceutical",Technology,1
"Chemistry Techniques, Synthetic",E,E05.197,Investigative Techniques,NULL,1
"Chemoembolization, Therapeutic",E,E02.926.500.150,"Embolization, Therapeutic",Therapeutic Occlusion,1
"Chemoembolization, Therapeutic",E,E02.520.360.150,"Embolization, Therapeutic",Hemostatic Techniques,1
Chemokine CCL1,D,D23.529.374.200.110.050,"Chemokines, CC",Chemokines,1
Chemokine CCL1,D,D23.469.200.110.050,"Chemokines, CC",Chemokines,1
Chemokine CCL1,D,D23.125.300.110.050,"Chemokines, CC",Chemokines,1
Chemokine CCL1,D,D12.776.467.374.200.110.050,"Chemokines, CC",Chemokines,1
Chemokine CCL1,D,D12.644.276.374.200.110.050,"Chemokines, CC",Chemokines,1
Chemokine CCL17,D,D12.644.276.374.200.110.850,"Chemokines, CC",Chemokines,1
Chemokine CCL17,D,D12.776.467.374.200.110.850,"Chemokines, CC",Chemokines,1
Chemokine CCL17,D,D23.125.300.110.850,"Chemokines, CC",Chemokines,1
Chemokine CCL17,D,D23.529.374.200.110.850,"Chemokines, CC",Chemokines,1
Chemokine CCL17,D,D23.469.200.110.850,"Chemokines, CC",Chemokines,1
Chemokine CCL19,D,D23.469.200.110.870,"Chemokines, CC",Chemokines,1
Chemokine CCL19,D,D23.469.200.600.870,Macrophage Inflammatory Proteins,Chemokines,1
Chemokine CCL19,D,D23.529.374.200.110.870,"Chemokines, CC",Chemokines,1
Chemokine CCL19,D,D23.529.374.200.600.870,Macrophage Inflammatory Proteins,Chemokines,1
Chemokine CCL19,D,D23.125.300.110.870,"Chemokines, CC",Chemokines,1
Chemokine CCL19,D,D23.125.300.600.870,Macrophage Inflammatory Proteins,Chemokines,1
Chemokine CCL19,D,D12.776.467.374.200.110.870,"Chemokines, CC",Chemokines,1
Chemokine CCL19,D,D12.776.467.374.200.600.870,Macrophage Inflammatory Proteins,Chemokines,1
Chemokine CCL19,D,D12.644.276.374.200.110.870,"Chemokines, CC",Chemokines,1
Chemokine CCL19,D,D12.644.276.374.200.600.870,Macrophage Inflammatory Proteins,Chemokines,1
Chemokine CCL20,D,D12.644.276.374.200.600.880,Macrophage Inflammatory Proteins,Chemokines,1
Chemokine CCL20,D,D12.644.276.374.200.110.880,"Chemokines, CC",Chemokines,1
Chemokine CCL20,D,D12.776.467.374.200.600.880,Macrophage Inflammatory Proteins,Chemokines,1
Chemokine CCL20,D,D12.776.467.374.200.110.880,"Chemokines, CC",Chemokines,1
Chemokine CCL20,D,D23.125.300.600.880,Macrophage Inflammatory Proteins,Chemokines,1
Chemokine CCL20,D,D23.125.300.110.880,"Chemokines, CC",Chemokines,1
Chemokine CCL20,D,D23.529.374.200.600.880,Macrophage Inflammatory Proteins,Chemokines,1
Chemokine CCL20,D,D23.529.374.200.110.880,"Chemokines, CC",Chemokines,1
Chemokine CCL20,D,D23.469.200.600.880,Macrophage Inflammatory Proteins,Chemokines,1
Chemokine CCL20,D,D23.469.200.110.880,"Chemokines, CC",Chemokines,1
Chemokine CCL8,D,D23.469.200.110.990.900,Monocyte Chemoattractant Proteins,"Chemokines, CC",1
Chemokine CCL8,D,D23.529.374.200.110.990.875,Monocyte Chemoattractant Proteins,"Chemokines, CC",1
Chemokine CCL8,D,D23.125.300.110.990.900,Monocyte Chemoattractant Proteins,"Chemokines, CC",1
Chemokine CCL8,D,D12.776.467.374.200.110.990.900,Monocyte Chemoattractant Proteins,"Chemokines, CC",1
Chemokine CCL8,D,D12.644.276.374.200.110.990.900,Monocyte Chemoattractant Proteins,"Chemokines, CC",1
Chemokine CXCL12,D,D12.644.276.374.200.120.600,"Chemokines, CXC",Chemokines,1
Chemokine CXCL12,D,D12.776.467.374.200.120.600,"Chemokines, CXC",Chemokines,1
Chemokine CXCL12,D,D23.125.300.120.600,"Chemokines, CXC",Chemokines,1
Chemokine CXCL12,D,D23.529.374.200.120.600,"Chemokines, CXC",Chemokines,1
Chemokine CXCL12,D,D23.469.200.120.600,"Chemokines, CXC",Chemokines,1
"Chemokines, C",D,D23.529.374.200.100,Chemokines,Cytokines,1
"Chemokines, C",D,D23.125.300.100,Chemokines,Chemotactic Factors,1
"Chemokines, C",D,D23.469.200.100,Chemokines,Inflammation Mediators,1
"Chemokines, C",D,D12.776.467.374.200.100,Chemokines,Cytokines,1
"Chemokines, C",D,D12.644.276.374.200.100,Chemokines,Cytokines,1
"Chemoradiotherapy, Adjuvant",E,E02.319.164.500,Chemoradiotherapy,Drug Therapy,1
"Chemoradiotherapy, Adjuvant",E,E02.186.079.500,Chemoradiotherapy,Combined Modality Therapy,1
"Chemoradiotherapy, Adjuvant",E,E02.815.160.500,Chemoradiotherapy,Radiotherapy,1
Chewing Gum,G,G07.203.300.140.200,Candy,Food,1
Chewing Gum,J,J02.500.140.200,Candy,Food,1
Chewing Gum,D,D20.215.721.249.249,Plant Gums,Plant Exudates,1
Chewing Gum,D,D09.698.700.249,Plant Gums,Polysaccharides,1
Chewing Gum,D,D05.750.078.739.249,Plant Gums,Biopolymers,1
"Chief Executive Officers, Hospital",N,N02.360.740.380.100,Hospital Administrators,"Personnel, Hospital",1
"Chief Executive Officers, Hospital",N,N02.360.430.490.100,Hospital Administrators,Health Facility Administrators,1
"Chief Executive Officers, Hospital",M,M01.526.485.740.380.100,Hospital Administrators,"Personnel, Hospital",1
"Chief Executive Officers, Hospital",M,M01.526.485.430.490.100,Hospital Administrators,Health Facility Administrators,1
"Chief Executive Officers, Hospital",M,M01.526.070.490.490.100,Hospital Administrators,Health Facility Administrators,1
Child Labor,N,N01.824.245.263,Employment,Socioeconomic Factors,1
Child Labor,I,I01.880.735.105,Social Problems,Sociology,1
Child Language,F,F01.525.200.310.250,Language Development,Child Development,1
Child Psychiatry,F,F04.096.544.193,Psychiatry,Behavioral Sciences,1
Child Psychiatry,H,H02.403.690.130,Psychiatry,Medicine,1
Child Reactive Disorders,F,F01.145.126.159,Behavioral Symptoms,Behavior,1
"Child, Adopted",M,M01.100,Persons,NULL,1
"Child, Institutionalized",M,M01.643.364,Patients,Persons,1
"Child, Unwanted",M,M01.111,Persons,NULL,1
Chimerism,G,G05.365.590.175.125,Chromosome Aberrations,Mutation,1
Chitin,D,D05.750.078.139,Biopolymers,Polymers,1
Chitin,D,D09.698.211,Polysaccharides,Carbohydrates,1
Chitinase-3-Like Protein 1,D,D08.811.277.450.207.500,Chitinases,Glycoside Hydrolases,1
Chitinase-3-Like Protein 1,D,D12.776.503.070,Lectins,Proteins,1
Chlamydia muridarum,B,B03.440.190.190.190.500,Chlamydia,Chlamydiaceae,1
Chlamydiaceae,B,B03.440.190.190,Chlamydiales,Gram-Negative Bacteria,1
Chlamydomonas reinhardtii,B,B01.650.940.150.385.650,Chlamydomonas,Chlorophyta,1
Chloride Channels,D,D12.776.543.585.400.175,Ion Channels,Membrane Transport Proteins,1
Chloride Channels,D,D12.776.543.550.450.175,Ion Channels,Membrane Glycoproteins,1
Chloride Channels,D,D12.776.157.530.400.175,Ion Channels,Membrane Transport Proteins,1
Chloroflexi,B,B03.275,Bacteria,NULL,1
Chloroform,D,D02.455.526.439.224,"Hydrocarbons, Chlorinated","Hydrocarbons, Halogenated",1
Chloroform,D,D02.455.526.913.810,Trihalomethanes,"Hydrocarbons, Halogenated",1
Chlorophyta,B,B01.650.940.150,Viridiplantae,Plants,1
Chlorpheniramine,D,D03.383.725.620.150,Pheniramine,Pyridines,1
Chlorthalidone,D,D03.633.100.513.750.500,Phthalimides,Isoindoles,1
Chlorthalidone,D,D02.522.223.500,Benzophenones,Ketones,1
Chlorthalidone,D,D02.478.600.500,Phthalimides,Imides,1
Chlorthalidone,D,D02.886.590.700.365,Sulfonamides,Sulfones,1
Chlorthalidone,D,D02.065.884.365,Sulfonamides,Amides,1
Chlorthalidone,D,D02.455.426.559.389.134.500,Benzophenones,Benzene Derivatives,1
Cholagogues and Choleretics,D,D27.505.954.483.508,Gastrointestinal Agents,Therapeutic Uses,1
Cholangitis,C,C06.130.120.200,Bile Duct Diseases,Biliary Tract Diseases,1
"Cholangitis, Sclerosing",C,C06.130.120.200.110,Cholangitis,Bile Duct Diseases,1
Choledocholithiasis,C,C06.130.120.250.174,Common Bile Duct Diseases,Bile Duct Diseases,1
Choledocholithiasis,C,C06.130.409.267,Cholelithiasis,Biliary Tract Diseases,1
Cholestasis,C,C06.130.120.135,Bile Duct Diseases,Biliary Tract Diseases,1
Cholesterol Esters,D,D04.210.500.247.808.197.200,Cholesterol,Sterols,1
Cholesterol Esters,D,D04.210.500.247.222.284.200,Cholesterol,Cholestenes,1
Cholesterol Esters,D,D10.570.938.208.250,Cholesterol,Sterols,1
"Cholesterol, VLDL",D,D10.570.938.208.285,Cholesterol,Sterols,1
"Cholesterol, VLDL",D,D10.532.599.700,"Lipoproteins, VLDL",Lipoproteins,1
"Cholesterol, VLDL",D,D04.210.500.247.808.197.247,Cholesterol,Sterols,1
"Cholesterol, VLDL",D,D12.776.521.622.700,"Lipoproteins, VLDL",Lipoproteins,1
Cholestyramine Resin,D,D25.720.716.579.159,Polystyrenes,Plastics,1
Cholestyramine Resin,D,D05.750.716.579.159,Polystyrenes,Plastics,1
Cholestyramine Resin,J,J01.637.051.720.716.579.159,Polystyrenes,Plastics,1
Choline Dehydrogenase,D,D08.811.682.047.180,Alcohol Oxidoreductases,Oxidoreductases,1
Cholinergic Fibers,A,A11.671.188.500,Cholinergic Neurons,Neurons,1
Cholinergic Fibers,A,A11.671.501.234,Nerve Fibers,Neurons,1
Cholinergic Fibers,A,A08.675.127.500,Cholinergic Neurons,Neurons,1
Cholinergic Fibers,A,A08.675.542.234,Nerve Fibers,Neurons,1
Chondrocalcinosis,C,C05.550.354.125,Crystal Arthropathies,Joint Diseases,1
Chondrocalcinosis,C,C05.550.114.264,Arthritis,Joint Diseases,1
Chondrogenesis,G,G11.427.578.180,Musculoskeletal Development,Musculoskeletal Physiological Phenomena,1
Chondrogenesis,G,G07.345.500.325.377.625.180,Musculoskeletal Development,Organogenesis,1
Chondroitin Sulfate Proteoglycans,D,D09.698.735.200,Proteoglycans,Polysaccharides,1
Chondroitin Sulfate Proteoglycans,D,D12.776.395.650.750,Proteoglycans,Glycoproteins,1
Chondrosarcoma,C,C04.557.450.795.300,Sarcoma,"Neoplasms, Connective and Soft Tissue",1
Chondrosarcoma,C,C04.557.450.565.280,"Neoplasms, Connective Tissue","Neoplasms, Connective and Soft Tissue",1
Chordata,B,B01.050.150,Animals,Eukaryota,1
Chorion,A,A16.254.750.473,Extraembryonic Membranes,"Embryo, Mammalian",1
Chorion,A,A10.615.284.473,Extraembryonic Membranes,Membranes,1
Chorionic Villi,A,A10.615.284.473.200,Chorion,Extraembryonic Membranes,1
Chorionic Villi,A,A16.254.750.473.200,Chorion,Extraembryonic Membranes,1
Chorionic Villi,A,A16.710.189,Placenta,Embryonic Structures,1
Chorionic Villi Sampling,E,E01.370.388.100.150,Biopsy,"Diagnostic Techniques, Surgical",1
Chorionic Villi Sampling,E,E01.370.378.630.150,Prenatal Diagnosis,"Diagnostic Techniques, Obstetrical and Gynecological",1
Chorionic Villi Sampling,E,E01.370.225.998.054.149,Biopsy,Specimen Handling,1
Chorionic Villi Sampling,E,E01.370.225.500.384.100.149,Biopsy,Cytodiagnosis,1
Chorionic Villi Sampling,E,E04.074.149,Biopsy,"Surgical Procedures, Operative",1
Chorionic Villi Sampling,E,E05.200.500.384.100.149,Biopsy,Cytodiagnosis,1
Chorionic Villi Sampling,E,E05.242.384.100.149,Biopsy,Cytodiagnosis,1
Chorionic Villi Sampling,E,E05.200.998.054.149,Biopsy,Specimen Handling,1
Choroid Plexus,A,A08.186.211.140.298,Cerebral Ventricles,Brain,1
Chromatin Assembly Factor-1,D,D12.776.580.219.200,Histone Chaperones,Molecular Chaperones,1
Chromium Isotopes,D,D01.268.556.175.500,Chromium,"Metals, Heavy",1
Chromium Isotopes,D,D01.268.956.124.500,Chromium,Transition Elements,1
Chromium Isotopes,D,D01.496.212,Isotopes,Inorganic Chemicals,1
Chromium Isotopes,D,D01.552.544.175.500,Chromium,"Metals, Heavy",1
Chromobacterium,B,B03.440.450.360,Gram-Negative Facultatively Anaerobic Rods,Gram-Negative Bacteria,1
Chromobacterium,B,B03.660.075.525.100,Neisseriaceae,Betaproteobacteria,1
Chromogenic Compounds,D,D27.720.470.410.200,Indicators and Reagents,Laboratory Chemicals,1
Chromogenic Compounds,D,D27.720.233.174,Coloring Agents,Specialty Uses of Chemicals,1
Chromones,D,D03.383.663.283.266,Benzopyrans,Pyrans,1
Chromones,D,D03.633.100.150.266,Benzopyrans,"Heterocyclic Compounds, 2-Ring",1
Chromosome Breakpoints,G,G05.200.210.170.500,Chromosome Breakage,DNA Breaks,1
Chromosome Fragile Sites,G,G05.360.340.024.189.610,"DNA Sequence, Unstable",Genome Components,1
Chromosome Walking,E,E05.393.183.250,Chromosome Mapping,Genetic Techniques,1
"Chromosomes, Fungal",G,G05.360.162.360,Chromosomes,Genetic Structures,1
"Chromosomes, Fungal",A,A19.311,Fungal Structures,NULL,1
"Chromosomes, Fungal",A,A11.284.187.360,Chromosomes,Cellular Structures,1
"Chromosomes, Human, 21-22 and Y",A,A11.284.187.520.300.505,"Chromosomes, Human","Chromosomes, Mammalian",1
"Chromosomes, Human, 21-22 and Y",G,G05.360.162.520.300.505,"Chromosomes, Human","Chromosomes, Mammalian",1
"Chromosomes, Mammalian",G,G05.360.162.520,Chromosomes,Genetic Structures,1
"Chromosomes, Mammalian",A,A11.284.187.520,Chromosomes,Cellular Structures,1
Chronic Disease Indicators,E,E05.318.308.980.438.475.411,Health Status Indicators,Health Surveys,1
Chronic Disease Indicators,N,N06.850.520.308.980.438.475.023,Health Status Indicators,Health Surveys,1
Chronic Disease Indicators,N,N05.715.360.300.800.438.375.091,Health Status Indicators,Health Surveys,1
Chronic Periodontitis,C,C07.465.714.533.324,Periodontitis,Periodontal Diseases,1
Chronic Urticaria,C,C20.543.480.904.533,Urticaria,"Hypersensitivity, Immediate",1
Chronic Urticaria,C,C17.800.862.945.533,Urticaria,"Skin Diseases, Vascular",1
Chronology as Topic,G,G01.910.200,Time,Physical Phenomena,1
Chryseobacterium,B,B03.440.080.190.120,Flavobacteriaceae,Bacteroidetes,1
Chryseobacterium,B,B03.440.400.425.310.120,Flavobacteriaceae,Gram-Negative Aerobic Rods and Cocci,1
Chylomicrons,D,D10.532.183,Lipoproteins,Lipids,1
Chylomicrons,D,D12.776.521.242,Lipoproteins,Proteins,1
Cidofovir,D,D03.383.742.698.421.216,Cytosine,Pyrimidinones,1
Cidofovir,D,D02.705.429.437,Organophosphonates,Organophosphorus Compounds,1
Cimetidine,D,D03.383.129.308.130,Imidazoles,Azoles,1
Cimetidine,D,D02.078.370.200,Guanidines,Amidines,1
Circadian Clocks,G,G07.180.562.094.500,Biological Clocks,Periodicity,1
Circoviridae Infections,C,C01.925.256.200,DNA Virus Infections,Virus Diseases,1
Cisapride,D,D02.241.223.100.100.135,Benzamides,Benzoates,1
Cisapride,D,D02.241.223.100.050.500.644,para-Aminobenzoates,Aminobenzoates,1
Cisapride,D,D02.241.223.100.200.374,Chlorobenzoates,Benzoates,1
Cisapride,D,D02.455.426.559.389.127.250.374,Chlorobenzoates,Benzoates,1
Cisapride,D,D02.455.426.559.389.127.085.135,Benzamides,Benzoates,1
Cisapride,D,D02.455.426.559.389.127.020.937.700,para-Aminobenzoates,Aminobenzoates,1
Cisapride,D,D02.065.277.135,Benzamides,Amides,1
Cisapride,D,D03.383.621.135,Piperidines,"Heterocyclic Compounds, 1-Ring",1
Cissampelos,B,B01.650.940.800.575.912.250.725.111,Menispermaceae,Magnoliopsida,1
cis-trans-Isomerases,D,D08.811.399.325,Isomerases,Enzymes,1
Citrobacter,B,B03.440.450.425.200,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,1
Citrobacter,B,B03.660.250.150.100,Enterobacteriaceae,Gammaproteobacteria,1
Citrobacter freundii,B,B03.660.250.150.100.210,Citrobacter,Enterobacteriaceae,1
Citrobacter freundii,B,B03.440.450.425.200.275,Citrobacter,Enterobacteriaceae,1
Citrus,B,B01.650.940.800.575.912.250.875.177,Rutaceae,Magnoliopsida,1
Citrus aurantiifolia,B,B01.650.940.800.575.912.250.875.177.077,Citrus,Rutaceae,1
Class III Phosphatidylinositol 3-Kinases,D,D08.811.913.696.620.500.100.300,Phosphatidylinositol 3-Kinase,Phosphatidylinositol 3-Kinases,1
Class III Phosphatidylinositol 3-Kinases,D,D12.776.476.171,Intracellular Signaling Peptides and Proteins,Proteins,1
Class III Phosphatidylinositol 3-Kinases,D,D12.776.543.990.175,Vesicular Transport Proteins,Membrane Proteins,1
Classical swine fever virus,B,B04.820.578.344.700.125,Pestivirus,Flaviviridae,1
Clathrin Heavy Chains,D,D12.776.543.990.200.500,Clathrin,Vesicular Transport Proteins,1
Claudins,D,D12.776.543.940.200,Tight Junction Proteins,Membrane Proteins,1
Cleavage And Polyadenylation Specificity Factor,D,D12.776.664.962.444.240,mRNA Cleavage and Polyadenylation Factors,RNA-Binding Proteins,1
Cleavage And Polyadenylation Specificity Factor,D,D12.776.157.725.124.240,mRNA Cleavage and Polyadenylation Factors,RNA-Binding Proteins,1
Click Chemistry,E,E05.197.124,"Chemistry Techniques, Synthetic",Investigative Techniques,1
Click Chemistry,J,J01.897.836.249.124,"Chemistry Techniques, Synthetic","Technology, Pharmaceutical",1
Clinical Chemistry Tests,E,E05.200.124,Clinical Laboratory Techniques,Investigative Techniques,1
Clinical Chemistry Tests,E,E01.370.225.124,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,1
Clinical Trial Protocols as Topic,N,N05.715.360.330.125.625,Clinical Protocols,Epidemiologic Study Characteristics,1
Clitoris,A,A05.360.319.887.436,Vulva,"Genitalia, Female",1
CLOCK Proteins,D,D12.776.930.125.562,Basic Helix-Loop-Helix Transcription Factors,Transcription Factors,1
CLOCK Proteins,D,D12.776.476.156.200,Circadian Rhythm Signaling Peptides and Proteins,Intracellular Signaling Peptides and Proteins,1
CLOCK Proteins,D,D12.776.260.103.562,Basic Helix-Loop-Helix Transcription Factors,DNA-Binding Proteins,1
CLOCK Proteins,D,D12.644.360.138.100,Circadian Rhythm Signaling Peptides and Proteins,Intracellular Signaling Peptides and Proteins,1
CLOCK Proteins,D,D08.811.913.050.134.415.500.049,Histone Acetyltransferases,Lysine Acetyltransferases,1
Clodronic Acid,D,D02.705.429.500.200,Diphosphonates,Organophosphonates,1
Clofibrate,D,D02.455.426.559.389.657.654.305.500.195,Clofibric Acid,Fibric Acids,1
Clofibrate,D,D02.355.726.305.500.195,Clofibric Acid,Fibric Acids,1
Clofibrate,D,D02.241.081.114.968.500.500.195,Clofibric Acid,Fibric Acids,1
Clomipramine,D,D03.633.300.240.194,Dibenzazepines,"Heterocyclic Compounds, 3-Ring",1
"Clonal Selection, Antigen-Mediated",G,G12.261,Immune System Phenomena,NULL,1
"Clonal Selection, Antigen-Mediated",G,G12.450.050.184,Adaptive Immunity,Immunity,1
Clonorchiasis,C,C01.610.335.865.148,Trematode Infections,Helminthiasis,1
Clostridiales,B,B03.353.625,Firmicutes,Bacteria,1
Clot Retraction,E,E01.370.225.625.625.160,Platelet Function Tests,Hematologic Tests,1
Clot Retraction,G,G09.188.390.600.180,Platelet Activation,Hemostasis,1
Clot Retraction,E,E05.200.625.625.160,Platelet Function Tests,Hematologic Tests,1
Clusterin,D,D12.776.580.215,Molecular Chaperones,Proteins,1
Clusterin,D,D12.776.395.207,Glycoproteins,Proteins,1
Clutch Size,G,G08.686.160,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,1
Coal Mining,J,J01.576.655.875.500.500,Mining,Extraction and Processing Industry,1
Coatomer Protein,D,D12.776.543.990.300.300,Coat Protein Complex I,Vesicular Transport Proteins,1
Cocaine Smoking,F,F01.145.805.250.250,"Smoking, Non-Tobacco Products",Smoking,1
Coccidioides,B,B01.300.381.230,Mitosporic Fungi,Fungi,1
Coccidioidomycosis,C,C01.150.703.203,Mycoses,Bacterial Infections and Mycoses,1
Coccidiostats,D,D27.505.954.122.250.100.170,Antiprotozoal Agents,Antiparasitic Agents,1
Cochlear Implantation,E,E04.650.220,Prosthesis Implantation,"Surgical Procedures, Operative",1
Cochlear Implantation,E,E04.580.450.220,Otologic Surgical Procedures,Otorhinolaryngologic Surgical Procedures,1
Cochlear Implants,E,E07.814.458.150,Hearing Aids,Sensory Aids,1
Cochlear Implants,E,E07.305.250.319.381.500.500,Neural Prostheses,Implantable Neurostimulators,1
Cochlear Implants,E,E07.695.150,Prostheses and Implants,Equipment and Supplies,1
Cochlear Implants,E,E07.695.202.381.500.500,Neural Prostheses,Implantable Neurostimulators,1
Cocos,B,B01.650.940.800.575.912.250.093.211,Arecaceae,Magnoliopsida,1
Coenzyme A Ligases,D,D08.811.464.267.500,Carbon-Sulfur Ligases,Ligases,1
Coffea,B,B01.650.940.800.575.912.250.456.937.275,Rubiaceae,Gentianales,1
Cognitive Dissonance,F,F02.463.188.305,Cognition,Mental Processes,1
Coke,N,N06.230.132.258.108.110,Coal,Fossil Fuels,1
Coke,D,D20.345.108.110,Coal,Fossil Fuels,1
Cola,B,B01.650.940.800.575.912.250.859.821.500.212,Malvaceae,Malvales,1
Cold Ischemia,E,E05.760.833.445,Tissue Preservation,"Preservation, Biological",1
Cold Ischemia,E,E04.936.337,Transplantation,"Surgical Procedures, Operative",1
Colitis-Associated Neoplasms,C,C04.588.274.476.411.307.180.400,Colonic Neoplasms,Colorectal Neoplasms,1
Colitis-Associated Neoplasms,C,C06.405.469.158.356.180.400,Colonic Neoplasms,Colorectal Neoplasms,1
Colitis-Associated Neoplasms,C,C06.405.249.411.307.180.400,Colonic Neoplasms,Colorectal Neoplasms,1
Colitis-Associated Neoplasms,C,C06.405.469.491.307.180.400,Colonic Neoplasms,Colorectal Neoplasms,1
Colitis-Associated Neoplasms,C,C06.301.371.411.307.180.400,Colonic Neoplasms,Colorectal Neoplasms,1
Collagen Type III,D,D12.776.860.300.250.300.300,Fibrillar Collagens,Collagen,1
Collagen Type III,D,D05.750.078.280.300.300,Fibrillar Collagens,Collagen,1
Collagen Type VII,D,D12.776.860.300.250.400.300,Non-Fibrillar Collagens,Collagen,1
Collagen Type VIII,D,D12.776.860.300.250.400.400,Non-Fibrillar Collagens,Collagen,1
Collagen Type XI,D,D12.776.860.300.250.300.500,Fibrillar Collagens,Collagen,1
Collagen Type XI,D,D05.750.078.280.300.500,Fibrillar Collagens,Collagen,1
College Admission Test,I,I02.399.272,Educational Measurement,Education,1
"Colon, Sigmoid",A,A03.556.249.249.356.668,Colon,"Intestine, Large",1
"Colon, Sigmoid",A,A03.556.124.526.356.668,Colon,"Intestine, Large",1
Colonic Diseases,C,C06.405.469.158,Intestinal Diseases,Gastrointestinal Diseases,1
"Colonic Diseases, Functional",C,C06.405.469.158.272,Colonic Diseases,Intestinal Diseases,1
Colony-Forming Units Assay,E,E01.370.225.500.383,Cytological Techniques,Clinical Laboratory Techniques,1
Colony-Forming Units Assay,E,E05.242.383,Cytological Techniques,Investigative Techniques,1
Colony-Forming Units Assay,E,E05.200.500.383,Cytological Techniques,Clinical Laboratory Techniques,1
Color Perception,F,F02.463.593.932.217,Visual Perception,Perception,1
Color Perception Tests,E,E01.370.380.850.150,Vision Tests,"Diagnostic Techniques, Ophthalmological",1
Colorado,Z,Z01.107.567.875.760.210,Southwestern United States,United States,1
Colorectal Surgery,H,H02.403.810.208,"Specialties, Surgical",Medicine,1
Comamonas,B,B03.660.075.090.766.150,Comamonadaceae,Burkholderiales,1
Comamonas,B,B03.440.400.425.293.150,Comamonadaceae,Gram-Negative Aerobic Rods and Cocci,1
Combinatorial Chemistry Techniques,J,J01.897.836.249.249,"Chemistry Techniques, Synthetic","Technology, Pharmaceutical",1
Combinatorial Chemistry Techniques,E,E05.197.312,"Chemistry Techniques, Synthetic",Investigative Techniques,1
Combretaceae,B,B01.650.940.800.575.912.250.228,Magnoliopsida,Tracheophyta,1
Commission on Professional and Hospital Activities,N,N05.700.175.500.200,Medical Audit,Clinical Audit,1
Commission on Professional and Hospital Activities,N,N04.761.700.250.500.100,Medical Audit,Clinical Audit,1
Communication Aids for Disabled,E,E07.796.250,Self-Help Devices,Equipment and Supplies,1
Community Dentistry,H,H02.163.876.770.357,Public Health Dentistry,"Specialties, Dental",1
Community-Based Health Insurance,N,N03.219.521.576.343.108,"Insurance, Health",Insurance,1
Comovirus,B,B04.715.700.150,Secoviridae,Plant Viruses,1
Comovirus,B,B04.715.464.150,Mosaic Viruses,Plant Viruses,1
Comovirus,B,B04.820.578.813.150,Secoviridae,Positive-Strand RNA Viruses,1
Compact Disks,J,J01.897.280.500.898.800.250,Videodisc Recording,Television,1
Compact Disks,L,L01.178.590.875.800.250,Videodisc Recording,Television,1
Compact Disks,L,L01.178.820.090.898.800.250,Videodisc Recording,Television,1
Compact Disks,L,L01.178.820.090.668.800.250,Videodisc Recording,Optical Storage Devices,1
Compact Disks,L,L01.280.960.800.250,Videodisc Recording,Video Recording,1
Compact Disks,L,L01.224.230.260.115.475.600.325,Optical Storage Devices,Computer Storage Devices,1
Compact Disks,J,J01.897.280.500.668.800.250,Videodisc Recording,Optical Storage Devices,1
Competitive Bidding,N,N03.219.463.100.110,Contract Services,Financial Management,1
Complement C1 Inactivator Proteins,D,D12.776.872.140,Serpins,Proteins,1
Complement C1 Inactivator Proteins,D,D12.644.861.140,Serpins,Peptides,1
Complement C1 Inactivator Proteins,D,D12.776.124.486.274.920.250,Complement Inactivator Proteins,Complement System Proteins,1
Complement C1s,D,D12.776.124.486.274.045.290,Complement Activating Enzymes,Complement System Proteins,1
Complement C1s,D,D12.776.124.486.274.050.290,Complement C1,Complement System Proteins,1
Complement C1s,D,D08.811.277.300.290,Complement Activating Enzymes,Hydrolases,1
Complement C3-C5 Convertases,D,D12.776.124.486.274.045.387,Complement Activating Enzymes,Complement System Proteins,1
Complement C3d,D,D12.776.124.486.274.250.260.750,Complement C3b,Complement C3,1
Complement C4b,D,D12.776.124.486.274.350.260,Complement C4,Complement System Proteins,1
Complement Factor B,D,D12.776.124.486.274.900,Complement System Proteins,Immunoproteins,1
Complement Factor B,D,D08.811.277.656.300.760.198,Serine Endopeptidases,Endopeptidases,1
Complement Factor B,D,D08.811.277.656.959.350.198,Serine Endopeptidases,Serine Proteases,1
Complement Factor B,D,D08.622.200,Enzyme Precursors,Enzymes and Coenzymes,1
Complement Factor B,D,D12.776.811.243.200,Enzyme Precursors,Protein Precursors,1
"Complement Pathway, Alternative",G,G12.274.695,Complement Activation,Immune System Phenomena,1
Compression Bandages,E,E07.101.400,Bandages,Equipment and Supplies,1
Computer Terminals,L,L01.224.230.260.115.500,Computer Peripherals,Computers,1
Computer-Aided Design,L,L01.224.108.150,Computer Graphics,Computing Methodologies,1
Computer-Aided Design,L,L01.296.110.150,Computer Graphics,Data Display,1
"Computers, Mainframe",L,L01.224.230.260.308,Computers,Computer Systems,1
"Computers, Molecular",L,L01.224.230.260.315,Computers,Computer Systems,1
"Computers, Molecular",L,L01.224.300,Computing Methodologies,Information Science,1
Computing Methodologies,L,L01.224,Information Science,NULL,1
Conalbumin,D,D12.776.556.579.750.124,Transferrins,Iron-Binding Proteins,1
Conalbumin,D,D12.776.034.180,Albumins,Proteins,1
Conalbumin,D,D12.776.157.427.750.124,Transferrins,Iron-Binding Proteins,1
Conalbumin,D,D12.776.256.159.157.180,"Egg Proteins, Dietary","Animal Proteins, Dietary",1
Conalbumin,D,D12.776.290.180,Egg Proteins,Proteins,1
Condiments,J,J02.500.250,Food,Food and Beverages,1
Condiments,G,G07.203.300.250,Food,"Diet, Food, and Nutrition",1
"Conditioning, Psychological",F,F02.463.425.179,Learning,Mental Processes,1
Congo Red,D,D04.615.638.555.300,Naphthalenesulfonates,Naphthalenes,1
Congo Red,D,D02.455.426.559.847.638.555.300,Naphthalenesulfonates,Naphthalenes,1
Congo Red,D,D02.886.645.600.080.050.650.250,Naphthalenesulfonates,Arylsulfonates,1
"Conjunctivitis, Acute Hemorrhagic",C,C01.375.725.250.250,"Conjunctivitis, Viral","Eye Infections, Viral",1
"Conjunctivitis, Acute Hemorrhagic",C,C01.925.325.250.250,"Conjunctivitis, Viral","Eye Infections, Viral",1
"Conjunctivitis, Acute Hemorrhagic",C,C01.925.782.687.359.201,Enterovirus Infections,Picornaviridae Infections,1
"Conjunctivitis, Acute Hemorrhagic",C,C11.187.183.240.216,"Conjunctivitis, Viral",Conjunctivitis,1
"Conjunctivitis, Acute Hemorrhagic",C,C11.294.800.250.250,"Conjunctivitis, Viral","Eye Infections, Viral",1
Connectome,E,E01.370.350.578.875.500.249,Brain Mapping,Functional Neuroimaging,1
Connectome,E,E01.370.376.537.625.500.249,Brain Mapping,Functional Neuroimaging,1
Connectome,E,E05.629.875.500.500,Brain Mapping,Functional Neuroimaging,1
Connexin 26,D,D12.776.543.585.250.100,Connexins,Membrane Transport Proteins,1
Consciousness Disorders,C,C10.597.606.358,Neurobehavioral Manifestations,Neurologic Manifestations,1
Consciousness Disorders,C,C23.888.592.604.359,Neurobehavioral Manifestations,Neurologic Manifestations,1
Consciousness Disorders,F,F01.700.315,Neurobehavioral Manifestations,Behavior and Behavior Mechanisms,1
Consciousness Disorders,F,F03.615.300,Neurocognitive Disorders,Mental Disorders,1
Conservation of Water Resources,N,N06.230.080.100,Conservation of Natural Resources,Environment,1
Consumer Health Informatics,L,L01.313.187,Informatics,Information Science,1
Contact Lens Solutions,D,D27.505.954.122.425.150,Disinfectants,Anti-Infective Agents,1
Contact Lens Solutions,D,D27.720.274.150,Disinfectants,Specialty Uses of Chemicals,1
Contact Lens Solutions,D,D26.776.210,Solutions,Pharmaceutical Preparations,1
"Contact Lenses, Extended-Wear",E,E07.632.500.276.360.220,"Contact Lenses, Hydrophilic",Contact Lenses,1
Continental Population Groups,M,M01.686.508,Population Groups,Persons,1
Continuous Renal Replacement Therapy,E,E04.292.438,Extracorporeal Circulation,"Surgical Procedures, Operative",1
Continuous Renal Replacement Therapy,E,E02.870.150,Renal Replacement Therapy,Therapeutics,1
Contraceptive Effectiveness,E,E02.875.194.573,Contraception,Reproductive Techniques,1
Contraceptive Prevalence Surveys,E,E05.318.308.980.313,Surveys and Questionnaires,Data Collection,1
Contraceptive Prevalence Surveys,N,N05.715.360.300.800.313,Surveys and Questionnaires,Data Collection,1
Contraceptive Prevalence Surveys,N,N06.850.520.308.980.313,Surveys and Questionnaires,Data Collection,1
"Contraceptives, Postcoital, Hormonal",D,D27.505.954.705.360.360.750,"Contraceptive Agents, Hormonal",Contraceptive Agents,1
"Contraceptives, Postcoital, Hormonal",D,D27.505.954.705.360.276.310.235,"Contraceptives, Postcoital","Contraceptive Agents, Female",1
"Contraceptives, Postcoital, Hormonal",D,D27.505.696.875.360.360.750,"Contraceptive Agents, Hormonal",Contraceptive Agents,1
"Contraceptives, Postcoital, Hormonal",D,D27.505.696.875.360.276.310.235,"Contraceptives, Postcoital","Contraceptive Agents, Female",1
Copper Radioisotopes,D,D01.496.749.270,Radioisotopes,Isotopes,1
Copper Sulfate,D,D01.875.800.800.850.150,Sulfates,Sulfuric Acids,1
Copper Transport Proteins,D,D12.776.543.585.450.250.578,Cation Transport Proteins,Ion Pumps,1
Copper Transport Proteins,D,D12.776.157.530.450.250.578,Cation Transport Proteins,Ion Pumps,1
Copulation,F,F01.145.113.252.748.200,"Sexual Behavior, Animal",Consummatory Behavior,1
Cord Factors,D,D10.390.240,Glycolipids,Lipids,1
Cord Factors,D,D23.946.123.208,Bacterial Toxins,"Toxins, Biological",1
Core Binding Factor Alpha 1 Subunit,D,D12.776.930.155.200.100,Core Binding Factor alpha Subunits,Core Binding Factors,1
Core Binding Factor alpha Subunits,D,D12.776.930.155.200,Core Binding Factors,Transcription Factors,1
Corneal Edema,C,C11.204.267,Corneal Diseases,Eye Diseases,1
Corneal Endothelial Cell Loss,C,C11.204.278,Corneal Diseases,Eye Diseases,1
Corneal Endothelial Cell Loss,C,C11.300.250,Eye Manifestations,Eye Diseases,1
Corneal Endothelial Cell Loss,C,C23.888.307.250,Eye Manifestations,Signs and Symptoms,1
Corneal Endothelial Cell Loss,C,C23.550.767.093,Postoperative Complications,Pathologic Processes,1
Corneal Injuries,C,C26.915.300.425.250.124,Eye Injuries,Facial Injuries,1
Corneal Injuries,C,C11.297.374,Eye Injuries,Eye Diseases,1
Corneal Injuries,C,C11.204.284,Corneal Diseases,Eye Diseases,1
Corneal Injuries,C,C10.900.300.284.250.124,Eye Injuries,Facial Injuries,1
Corneal Stroma,A,A09.371.060.217.228,Cornea,Anterior Eye Segment,1
"Corneal Surgery, Laser",E,E02.594.480,Laser Therapy,Therapeutics,1
"Corneal Surgery, Laser",E,E04.014.520.480,Laser Therapy,Ablation Techniques,1
"Corneal Surgery, Laser",E,E04.378.500,Keratectomy,"Surgical Procedures, Operative",1
"Corneal Surgery, Laser",E,E04.540.825.437,Refractive Surgical Procedures,Ophthalmologic Surgical Procedures,1
"Coronavirus 229E, Human",B,B04.820.578.500.540.150.075.750,Alphacoronavirus,Coronavirus,1
"Coronavirus NL63, Human",B,B04.820.578.500.540.150.075.875,Alphacoronavirus,Coronavirus,1
Coronavirus RNA-Dependent RNA Polymerase,D,D12.776.964.900.750.250,Viral Replicase Complex Proteins,Viral Nonstructural Proteins,1
Coronavirus RNA-Dependent RNA Polymerase,D,D08.811.913.696.445.735.780.500,RNA-Dependent RNA Polymerase,RNA Nucleotidyltransferases,1
"Coronavirus, Bovine",B,B04.820.578.500.540.150.113.500.750,Betacoronavirus 1,Betacoronavirus,1
"Coronavirus, Feline",B,B04.820.578.500.540.150.075.500.375,Alphacoronavirus 1,Alphacoronavirus,1
Corpus Luteum,A,A05.360.319.114.630.278,Ovary,Adnexa Uteri,1
Corpus Luteum,A,A06.300.312.497.278,Ovary,Gonads,1
Correction of Hearing Impairment,E,E02.760.169.063.500.200,Rehabilitation,Aftercare,1
Correction of Hearing Impairment,E,E02.831.200,Rehabilitation,Therapeutics,1
Correction of Hearing Impairment,N,N02.421.784.377,Rehabilitation,Health Services,1
Correction of Hearing Impairment,H,H02.403.680.600.500,Rehabilitation,Physical and Rehabilitation Medicine,1
Corrosion,G,G02.165,Chemical Phenomena,NULL,1
Cortisone,D,D04.210.500.745.745.183,Pregnenes,Pregnanes,1
Cortisone,D,D06.472.040.585.478.195,17-Hydroxycorticosteroids,Hydroxycorticosteroids,1
Corylus,B,B01.650.940.800.575.912.250.859.750.200.875,Betulaceae,Fagales,1
Cosmetics,D,D27.720.269,Specialty Uses of Chemicals,Chemical Actions and Uses,1
Cosmetics,J,J01.516.213,Household Products,"Technology, Industry, and Agriculture",1
Cosmic Radiation,G,G16.500.200,Ecological and Environmental Phenomena,Biological Phenomena,1
Cosmic Radiation,N,N06.230.300.100.300,Atmosphere,Meteorological Concepts,1
Cosmic Radiation,G,G01.750.750.235,"Radiation, Ionizing",Radiation,1
Cosmic Radiation,G,G01.060.185,Astronomical Phenomena,Physical Phenomena,1
Countercurrent Distribution,E,E05.196.181.400.555,"Chromatography, Liquid",Chromatography,1
Countercurrent Distribution,E,E05.196.278,"Chemistry Techniques, Analytical",Investigative Techniques,1
Counterpulsation,E,E04.050.215,Assisted Circulation,"Surgical Procedures, Operative",1
Courage,F,F01.470.257,Emotions,Behavior and Behavior Mechanisms,1
Coxiella,B,B03.440.400.425.297.150,Coxiellaceae,Gram-Negative Aerobic Rods and Cocci,1
Coxiella,B,B03.660.250.132.150,Coxiellaceae,Gammaproteobacteria,1
Coxsackie and Adenovirus Receptor-Like Membrane Protein,D,D23.050.301.350.537.500,Junctional Adhesion Molecules,Cell Adhesion Molecules,1
Coxsackie and Adenovirus Receptor-Like Membrane Protein,D,D12.776.543.940.600.500,Junctional Adhesion Molecules,Tight Junction Proteins,1
Coxsackie and Adenovirus Receptor-Like Membrane Protein,D,D12.776.543.750.830.124,"Receptors, Virus","Receptors, Cell Surface",1
Coxsackie and Adenovirus Receptor-Like Membrane Protein,D,D12.776.543.550.200.537.500,Junctional Adhesion Molecules,Cell Adhesion Molecules,1
Coxsackie and Adenovirus Receptor-Like Membrane Protein,D,D12.776.395.550.200.537.500,Junctional Adhesion Molecules,Cell Adhesion Molecules,1
"Cranial Fossa, Posterior",A,A02.835.232.781.750.400,Skull Base,Skull,1
"Cranial Fossa, Posterior",A,A01.456.830.200,Skull Base,Head,1
Cranial Irradiation,E,E02.815.190,Radiotherapy,Therapeutics,1
Cranial Nerve Neoplasms,C,C04.588.614.596.240,Peripheral Nervous System Neoplasms,Nervous System Neoplasms,1
Cranial Nerve Neoplasms,C,C04.588.614.300,Nervous System Neoplasms,Neoplasms by Site,1
Cranial Nerve Neoplasms,C,C10.551.360,Nervous System Neoplasms,Nervous System Diseases,1
Cranial Nerve Neoplasms,C,C10.551.775.250,Peripheral Nervous System Neoplasms,Nervous System Neoplasms,1
Cranial Nerve Neoplasms,C,C10.292.225,Cranial Nerve Diseases,Nervous System Diseases,1
Craniofacial Abnormalities,C,C16.131.621.207,Musculoskeletal Abnormalities,Congenital Abnormalities,1
Craniofacial Abnormalities,C,C05.660.207,Musculoskeletal Abnormalities,Musculoskeletal Diseases,1
Craniofacial Dysostosis,C,C05.660.207.231,Craniofacial Abnormalities,Musculoskeletal Abnormalities,1
Craniofacial Dysostosis,C,C05.116.099.370.231,Dysostoses,"Bone Diseases, Developmental",1
Craniofacial Dysostosis,C,C16.131.621.207.231,Craniofacial Abnormalities,Musculoskeletal Abnormalities,1
Craniopharyngioma,C,C04.557.580.625.200,Neuroectodermal Tumors,"Neoplasms, Nerve Tissue",1
Craniopharyngioma,C,C04.557.465.625.200,Neuroectodermal Tumors,"Neoplasms, Germ Cell and Embryonal",1
Creativity,F,F01.752.264,Personality,Behavior and Behavior Mechanisms,1
Creativity,F,F02.463.785.302,Thinking,Mental Processes,1
Criminal Behavior,F,F01.145.250,Behavior,Behavior and Behavior Mechanisms,1
Criminal Psychology,F,F02.784.240,"Psychology, Applied",Psychological Phenomena,1
CRISPR-Associated Protein 9,D,D12.776.212.500,CRISPR-Associated Proteins,Proteins,1
CRISPR-Associated Protein 9,D,D12.776.097.219,Bacterial Proteins,Proteins,1
CRISPR-Associated Protein 9,D,D08.811.277.352.355.325.150,Endodeoxyribonucleases,Endonucleases,1
Crithidia fasciculata,B,B01.268.475.868.110.350,Crithidia,Trypanosomatina,1
Cronobacter,B,B03.440.450.425.215,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,1
Cronobacter,B,B03.660.250.150.110,Enterobacteriaceae,Gammaproteobacteria,1
Crowns,E,E07.695.190.088,Dental Prosthesis,Prostheses and Implants,1
Crowns,E,E06.780.346.250,Dental Prosthesis,Prosthodontics,1
Cryoglobulinemia,C,C14.907.454.140,Hemostatic Disorders,Vascular Diseases,1
Cryoglobulinemia,C,C15.378.147.780.243,Paraproteinemias,Blood Protein Disorders,1
Cryoglobulinemia,C,C15.378.463.515.140,Hemostatic Disorders,Hemorrhagic Disorders,1
Cryoglobulinemia,C,C20.683.780.250,Paraproteinemias,Immunoproliferative Disorders,1
Cryptochromes,D,D12.776.331.180,Flavoproteins,Proteins,1
Cryptochromes,D,D12.644.360.138.150,Circadian Rhythm Signaling Peptides and Proteins,Intracellular Signaling Peptides and Proteins,1
Cryptochromes,D,D12.776.476.156.250,Circadian Rhythm Signaling Peptides and Proteins,Intracellular Signaling Peptides and Proteins,1
Cryptochromes,D,D12.776.765.593.500,"Photoreceptors, Plant",Plant Proteins,1
Crystallins,D,D12.776.306.366,Eye Proteins,Proteins,1
Cucurbita,B,B01.650.940.800.575.912.250.300.222,Cucurbitaceae,Magnoliopsida,1
"Culture Media, Serum-Free",D,D27.720.470.305.255,Culture Media,Laboratory Chemicals,1
"Culture Media, Serum-Free",E,E07.206.255,Culture Media,Equipment and Supplies,1
Cumulative Trauma Disorders,C,C26.844.150,Sprains and Strains,Wounds and Injuries,1
Cupriavidus necator,B,B03.440.400.425.251.200.200,Cupriavidus,Burkholderiaceae,1
Cupriavidus necator,B,B03.660.075.090.688.200.200,Cupriavidus,Burkholderiaceae,1
Curettage,E,E04.157,"Surgical Procedures, Operative",NULL,1
Current Procedural Terminology,L,L01.453.245.945.160,"Vocabulary, Controlled",Documentation,1
Cutis Laxa,C,C16.320.850.180,"Skin Diseases, Genetic","Genetic Diseases, Inborn",1
Cutis Laxa,C,C17.300.230,Connective Tissue Diseases,Skin and Connective Tissue Diseases,1
Cutis Laxa,C,C17.800.827.180,"Skin Diseases, Genetic",Skin Diseases,1
Cyanides,D,D01.248.497.158.291,Anions,Ions,1
Cyanides,D,D01.625.400.100,Hydrogen Cyanide,Nitrogen Compounds,1
Cyanoacrylates,D,D02.241.081.069.366,Acrylates,"Acids, Acyclic",1
Cyanoacrylates,D,D25.919.367,Tissue Adhesives,Biomedical and Dental Materials,1
Cyanoacrylates,D,D25.720.259,Polymers,Biomedical and Dental Materials,1
Cyanoacrylates,D,D05.750.259,Polymers,Macromolecular Substances,1
Cyanoacrylates,D,D02.626.290,Nitriles,Organic Chemicals,1
Cyanoacrylates,J,J01.637.051.720.259,Polymers,Biomedical and Dental Materials,1
Cyanoacrylates,J,J01.637.051.919.367,Tissue Adhesives,Biomedical and Dental Materials,1
Cyclic AMP Response Element-Binding Protein,D,D12.776.260.108.184,Basic-Leucine Zipper Transcription Factors,DNA-Binding Proteins,1
Cyclic AMP Response Element-Binding Protein,D,D12.776.930.127.184,Basic-Leucine Zipper Transcription Factors,Transcription Factors,1
"Cyclic Nucleotide Phosphodiesterases, Type 3",D,D12.776.476.008.300,"3',5'-Cyclic-AMP Phosphodiesterases",Intracellular Signaling Peptides and Proteins,1
"Cyclic Nucleotide Phosphodiesterases, Type 3",D,D12.644.360.008.300,"3',5'-Cyclic-AMP Phosphodiesterases",Intracellular Signaling Peptides and Proteins,1
"Cyclic Nucleotide Phosphodiesterases, Type 3",D,D08.811.277.352.640.150.300,"3',5'-Cyclic-AMP Phosphodiesterases",Phosphoric Diester Hydrolases,1
Cyclic Nucleotide-Gated Cation Channels,D,D12.776.157.530.400.337,Ion Channels,Membrane Transport Proteins,1
Cyclic Nucleotide-Gated Cation Channels,D,D12.776.543.585.400.452,Ion Channels,Membrane Transport Proteins,1
Cyclic Nucleotide-Gated Cation Channels,D,D12.776.543.550.450.452,Ion Channels,Membrane Glycoproteins,1
Cyclic Nucleotide-Regulated Protein Kinases,D,D12.776.476.200,Intracellular Signaling Peptides and Proteins,Proteins,1
Cyclic Nucleotide-Regulated Protein Kinases,D,D12.644.360.200,Intracellular Signaling Peptides and Proteins,Peptides,1
Cyclic Nucleotide-Regulated Protein Kinases,D,D08.811.913.696.620.682.700.150,Protein-Serine-Threonine Kinases,Protein Kinases,1
Cyclin A,D,D12.644.360.262.100,Cyclins,Intracellular Signaling Peptides and Proteins,1
Cyclin A,D,D12.776.167.218.100,Cyclins,Cell Cycle Proteins,1
Cyclin A,D,D12.776.476.262.100,Cyclins,Intracellular Signaling Peptides and Proteins,1
Cyclin A2,D,D12.776.476.262.100.200,Cyclin A,Cyclins,1
Cyclin A2,D,D12.776.167.218.100.200,Cyclin A,Cyclins,1
Cyclin A2,D,D12.644.360.262.100.200,Cyclin A,Cyclins,1
Cyclin D3,D,D12.644.360.262.150.300,Cyclin D,Cyclins,1
Cyclin D3,D,D12.776.167.218.150.300,Cyclin D,Cyclins,1
Cyclin D3,D,D12.776.476.262.150.300,Cyclin D,Cyclins,1
Cyclin-Dependent Kinase 4,D,D12.776.476.250.451,Cyclin-Dependent Kinases,Intracellular Signaling Peptides and Proteins,1
Cyclin-Dependent Kinase 4,D,D12.776.167.200.451,Cyclin-Dependent Kinases,Cell Cycle Proteins,1
Cyclin-Dependent Kinase 4,D,D12.644.360.250.451,Cyclin-Dependent Kinases,Intracellular Signaling Peptides and Proteins,1
Cyclin-Dependent Kinase 4,D,D08.811.913.696.620.682.700.646.500.875,Cyclin-Dependent Kinases,Proline-Directed Protein Kinases,1
Cyclin-Dependent Kinase Inhibitor p27,D,D12.644.360.225.600,Cyclin-Dependent Kinase Inhibitor Proteins,Intracellular Signaling Peptides and Proteins,1
Cyclin-Dependent Kinase Inhibitor p27,D,D12.776.167.187.600,Cyclin-Dependent Kinase Inhibitor Proteins,Cell Cycle Proteins,1
Cyclin-Dependent Kinase Inhibitor p27,D,D12.776.476.225.600,Cyclin-Dependent Kinase Inhibitor Proteins,Intracellular Signaling Peptides and Proteins,1
Cyclin-Dependent Kinase Inhibitor p27,D,D12.776.624.776.355.600,Cyclin-Dependent Kinase Inhibitor Proteins,Tumor Suppressor Proteins,1
Cyclodextrins,D,D09.698.365.855.400.375,Dextrins,Starch,1
Cyclodextrins,D,D09.301.915.400.375,Dextrins,Starch,1
Cyclodextrins,D,D04.345.103,Macrocyclic Compounds,Polycyclic Compounds,1
Cyclohexane Monoterpenes,D,D02.455.849.575.157,Monoterpenes,Terpenes,1
Cyclohexane Monoterpenes,D,D02.455.426.392.368.367.211,Cyclohexanes,Cycloparaffins,1
Cyclohexanes,D,D02.455.426.392.368.367,Cycloparaffins,"Hydrocarbons, Alicyclic",1
Cyclohexanones,D,D02.455.426.392.368.367.340,Cyclohexanes,Cycloparaffins,1
Cyclohexanones,D,D02.522.400,Ketones,Organic Chemicals,1
Cyclohexylamines,D,D02.455.426.392.368.367.418,Cyclohexanes,Cycloparaffins,1
Cyclohexylamines,D,D02.092.384,Amines,Organic Chemicals,1
Cyclooxygenase 1,D,D08.811.600.720.500,Prostaglandin-Endoperoxide Synthases,Multienzyme Complexes,1
Cyclopentolate,D,D02.241.223.601.200,Phenylacetates,"Acids, Carbocyclic",1
Cyclospora,B,B01.043.075.189.250.250.200,Eimeriidae,Eimeriida,1
Cyclosporiasis,C,C01.610.752.250.280,Coccidiosis,Protozoan Infections,1
Cymbopogon,B,B01.650.940.800.575.912.250.822.266,Poaceae,Magnoliopsida,1
Cymenes,D,D02.455.426.559.389.310,Benzene Derivatives,"Hydrocarbons, Aromatic",1
Cymenes,D,D02.455.849.575.219,Monoterpenes,Terpenes,1
Cystathionine beta-Synthase,D,D08.811.520.241.300.200,Hydro-Lyases,Carbon-Oxygen Lyases,1
Cysticercus,B,B01.050.500.500.736.215.895.286,Taenia,Cestoda,1
Cytidine Deaminase,D,D08.811.277.151.486.250,Nucleoside Deaminases,Aminohydrolases,1
Cytochrome P-450 CYP1A2,D,D08.811.682.690.708.170.010.443,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP1A2,D,D08.811.682.690.708.170.020.750,Cytochrome P450 Family 1,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP1A2,D,D08.244.453.005.443,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP1A2,D,D08.244.453.100.750,Cytochrome P450 Family 1,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP1A2,D,D12.776.422.220.453.010.443,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP1A2,D,D12.776.422.220.453.100.750,Cytochrome P450 Family 1,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP1B1,D,D12.776.422.220.453.100.875,Cytochrome P450 Family 1,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP1B1,D,D12.776.422.220.453.010.500,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP1B1,D,D08.244.453.100.875,Cytochrome P450 Family 1,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP1B1,D,D08.244.453.005.500,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP1B1,D,D08.811.682.690.708.170.020.875,Cytochrome P450 Family 1,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP1B1,D,D08.811.682.690.708.170.010.500,Aryl Hydrocarbon Hydroxylases,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP2C9,D,D08.811.682.690.708.170.450.500.500,Limonene Hydroxylases,Cytochrome P450 Family 2,1
Cytochrome P-450 CYP2C9,D,D08.244.453.491.500.500,Limonene Hydroxylases,Cytochrome P450 Family 2,1
Cytochrome P-450 CYP2C9,D,D12.776.422.220.453.491.500.500,Limonene Hydroxylases,Cytochrome P450 Family 2,1
Cytochrome P-450 CYP2E1,D,D12.776.422.220.453.491.375,Cytochrome P450 Family 2,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP2E1,D,D08.244.453.491.375,Cytochrome P450 Family 2,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP2E1,D,D08.811.682.690.708.170.450.375,Cytochrome P450 Family 2,Cytochrome P-450 Enzyme System,1
Cytochrome P-450 CYP2E1,D,D08.811.682.662.582.338,"Oxidoreductases, N-Demethylating",Oxidoreductases Acting on CH-NH Group Donors,1
Cytochrome P-450 CYP3A Inhibitors,D,D27.505.389.500.503,Cytochrome P-450 Enzyme Inhibitors,Metabolic Side Effects of Drugs and Substances,1
Cytochrome P-450 CYP3A Inhibitors,D,D27.505.519.389.335.503,Cytochrome P-450 Enzyme Inhibitors,Enzyme Inhibitors,1
Cytochrome P450 Family 6,D,D12.776.422.220.453.880,Cytochrome P-450 Enzyme System,Cytochromes,1
Cytochrome P450 Family 6,D,D08.811.682.690.708.170.880,Cytochrome P-450 Enzyme System,Mixed Function Oxygenases,1
Cytochrome P450 Family 6,D,D08.244.453.880,Cytochrome P-450 Enzyme System,Cytochromes,1
Cytochromes,D,D08.244,Enzymes and Coenzymes,NULL,1
Cytochromes,D,D12.776.422.220,Hemeproteins,Proteins,1
Cytoplasmic Vesicles,A,A11.284.430.214.190.875.190,Organelles,Cytoplasmic Structures,1
Cytoprotection,G,G07.690.773.500,Pharmacological Phenomena,Pharmacological and Toxicological Phenomena,1
Cytoreduction Surgical Procedures,E,E04.166,"Surgical Procedures, Operative",NULL,1
Cytosine Deaminase,D,D08.811.277.151.486.625,Nucleoside Deaminases,Aminohydrolases,1
Cytosine Nucleotides,D,D03.383.742.686.246,Pyrimidine Nucleotides,Pyrimidines,1
Cytosine Nucleotides,D,D13.695.740.246,Pyrimidine Nucleotides,Nucleotides,1
Cytosine Nucleotides,D,D13.695.827.232,Ribonucleotides,Nucleotides,1
Dabigatran,D,D03.633.100.103.280,Benzimidazoles,"Heterocyclic Compounds, 2-Ring",1
Dabigatran,D,D03.383.725.192,Pyridines,"Heterocyclic Compounds, 1-Ring",1
Dacarbazine,D,D02.925.200,Triazenes,Organic Chemicals,1
Dacarbazine,D,D03.383.129.308.240,Imidazoles,Azoles,1
Dactinomycin,D,D03.633.300.200,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",1
Dactinomycin,D,D04.345.566.252,"Peptides, Cyclic",Macrocyclic Compounds,1
Dactinomycin,D,D12.644.641.252,"Peptides, Cyclic",Peptides,1
Dalteparin,D,D09.698.373.400.300.150,"Heparin, Low-Molecular-Weight",Heparin,1
Danazol,D,D04.210.500.745.432.235,Pregnadienes,Pregnanes,1
Dance Therapy,E,E02.760.169.063.500.230,Rehabilitation,Aftercare,1
Dance Therapy,E,E02.190.888.374,Sensory Art Therapies,Complementary Therapies,1
Dance Therapy,E,E02.779.474.186,Exercise Movement Techniques,Physical Therapy Modalities,1
Dance Therapy,E,E02.831.230,Rehabilitation,Therapeutics,1
Dance Therapy,F,F04.754.278,Psychotherapy,Behavioral Disciplines and Activities,1
Dancing,I,I03.450.642.287,Recreation,Leisure Activities,1
Dandy-Walker Syndrome,C,C16.131.666.205,Nervous System Malformations,Congenital Abnormalities,1
Dandy-Walker Syndrome,C,C10.500.205,Nervous System Malformations,Nervous System Diseases,1
Dandy-Walker Syndrome,C,C10.228.140.252.300,Cerebellar Diseases,Brain Diseases,1
Dandy-Walker Syndrome,C,C10.228.140.602.500,Hydrocephalus,Brain Diseases,1
Dasatinib,D,D03.383.742.148,Pyrimidines,"Heterocyclic Compounds, 1-Ring",1
Dasatinib,D,D03.383.129.708.198,Thiazoles,Azoles,1
Dasatinib,D,D02.886.675.184,Thiazoles,Sulfur Compounds,1
Data Compression,L,L01.224.308.189,"Image Processing, Computer-Assisted",Computing Methodologies,1
Data Compression,L,L01.224.800.500,"Signal Processing, Computer-Assisted",Computing Methodologies,1
Data Compression,L,L01.470.500,Information Storage and Retrieval,Information Science,1
Data Systems,L,L01.224.068.500,Database Management Systems,Computing Methodologies,1
Data Visualization,L,L01.143.288,Communication,Information Science,1
"Databases, Chemical",L,L01.313.500.750.300.188.400.300,"Databases, Factual",Databases as Topic,1
"Databases, Chemical",L,L01.470.750.750.300,"Databases, Factual",Databases as Topic,1
DEAE-Cellulose,D,D09.698.365.180.247,Cellulose,Glucans,1
Deamination,G,G02.111.192,Biochemical Phenomena,Chemical Phenomena,1
Deamination,G,G02.607.157,Organic Chemistry Phenomena,Chemical Phenomena,1
Deamination,G,G03.222,Metabolism,NULL,1
Decapodiformes,B,B01.050.500.644.116.150,Cephalopoda,Mollusca,1
Decarboxylation,G,G03.225,Metabolism,NULL,1
Decarboxylation,G,G02.607.188,Organic Chemistry Phenomena,Chemical Phenomena,1
Decarboxylation,G,G02.111.195,Biochemical Phenomena,Chemical Phenomena,1
Deceleration,G,G01.482.107.373,Acceleration,Motion,1
Decidua,A,A16.710.289,Placenta,Embryonic Structures,1
Decidua,A,A05.360.319.679.490.373,Endometrium,Uterus,1
"Decision Support Systems, Management",N,N04.452.515.135,Management Information Systems,Organization and Administration,1
Decompressive Craniectomy,E,E04.188.200,"Decompression, Surgical","Surgical Procedures, Operative",1
Decompressive Craniectomy,E,E04.525.190.200,Craniotomy,Neurosurgical Procedures,1
Decorin,D,D09.698.735.700.750,Small Leucine-Rich Proteoglycans,Proteoglycans,1
Decorin,D,D12.776.395.650.875.500,Small Leucine-Rich Proteoglycans,Proteoglycans,1
Decorin,D,D12.776.395.650.750.625,Chondroitin Sulfate Proteoglycans,Proteoglycans,1
Decorin,D,D12.776.860.300.806.750,Small Leucine-Rich Proteoglycans,Extracellular Matrix Proteins,1
Defamation,I,I01.880.735.191.051,Crime,Social Problems,1
Defamation,I,I01.198.240.240,Crime,Criminology,1
Defecography,E,E01.370.350.700.715.250,"Radiography, Abdominal",Radiography,1
Defense Mechanisms,F,F01.393,Behavior and Behavior Mechanisms,NULL,1
Defensive Medicine,I,I01.880.604.583.524.300,Malpractice,Jurisprudence,1
Defensive Medicine,N,N03.706.535.606.300,Malpractice,Jurisprudence,1
Deferasirox,D,D03.383.129.799.363,Triazoles,Azoles,1
Deferasirox,D,D02.455.426.559.389.127.266,Benzoates,Benzene Derivatives,1
Deferasirox,D,D02.241.223.100.250,Benzoates,"Acids, Carbocyclic",1
Deferiprone,D,D03.383.725.791.298,Pyridones,Pyridines,1
Dehydroepiandrosterone,D,D04.210.500.578.502.400,17-Ketosteroids,Ketosteroids,1
Dehydroepiandrosterone,D,D04.210.500.054.079.429.625,Androstenols,Androstenes,1
Dehydroepiandrosterone,D,D06.472.040.502.400,17-Ketosteroids,Adrenal Cortex Hormones,1
Dehydroepiandrosterone,D,D06.472.334.851.968.952,Testosterone Congeners,Gonadal Steroid Hormones,1
Deja Vu,F,F02.463.425.540.203,Memory,Learning,1
Delayed Graft Function,C,C23.550.277,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",1
Delphinium,B,B01.650.940.800.575.912.250.836.750.277,Ranunculaceae,Ranunculales,1
Deltaretrovirus Antibodies,D,D12.776.377.715.548.114.254.150,"Antibodies, Viral",Antibodies,1
Deltaretrovirus Antibodies,D,D12.776.124.790.651.114.254.150,"Antibodies, Viral",Antibodies,1
Deltaretrovirus Antibodies,D,D12.776.124.486.485.114.254.150,"Antibodies, Viral",Antibodies,1
Delusions,F,F01.145.126.200,Behavioral Symptoms,Behavior,1
"Dementia, Multi-Infarct",F,F03.615.400.350.400,"Dementia, Vascular",Dementia,1
"Dementia, Multi-Infarct",C,C23.550.717.489.250.200.199,Cerebral Infarction,Brain Infarction,1
"Dementia, Multi-Infarct",C,C23.550.513.355.250.200.199,Cerebral Infarction,Brain Infarction,1
"Dementia, Multi-Infarct",C,C10.228.140.300.775.200.200.199,Cerebral Infarction,Brain Infarction,1
"Dementia, Multi-Infarct",C,C10.228.140.380.230.250,"Dementia, Vascular",Dementia,1
"Dementia, Multi-Infarct",C,C10.228.140.300.150.477.200.199,Cerebral Infarction,Brain Infarction,1
"Dementia, Multi-Infarct",C,C10.228.140.300.400.408,"Dementia, Vascular",Cerebrovascular Disorders,1
"Dementia, Multi-Infarct",C,C14.907.253.855.200.200.199,Cerebral Infarction,Brain Infarction,1
"Dementia, Multi-Infarct",C,C14.907.253.092.477.200.199,Cerebral Infarction,Brain Infarction,1
Densovirus,B,B04.525.150.150,Densovirinae,Insect Viruses,1
Densovirus,B,B04.280.580.325.200,Densovirinae,Parvoviridae,1
Dental Amalgam,D,D25.339.208.291,Dental Alloys,Dental Materials,1
Dental Amalgam,J,J01.637.051.339.208.291,Dental Alloys,Dental Materials,1
Dental Anxiety,F,F01.470.132.300,Anxiety,Emotions,1
Dental Calculus,C,C07.793.208.250,Dental Deposits,Tooth Diseases,1
Dental Calculus,C,C23.300.175.350,Calculi,"Pathological Conditions, Anatomical",1
Dental Hygienists,M,M01.526.485.067.105.376,Dental Auxiliaries,Allied Health Personnel,1
Dental Hygienists,N,N02.360.067.105.376,Dental Auxiliaries,Allied Health Personnel,1
Dental Implantation,E,E06.780.314,Prosthodontics,Dentistry,1
Dental Implantation,E,E06.645.550.280,"Oral Surgical Procedures, Preprosthetic",Oral Surgical Procedures,1
Dental Implantation,E,E04.650.230,Prosthesis Implantation,"Surgical Procedures, Operative",1
Dental Implantation,E,E04.545.550.280,"Oral Surgical Procedures, Preprosthetic",Oral Surgical Procedures,1
Dental Instruments,E,E06.186.501,Dental Equipment,Dentistry,1
Dental Instruments,E,E07.222.501,Dental Equipment,Equipment and Supplies,1
Dental Prophylaxis,E,E06.721.189,Periodontics,Dentistry,1
Dental Prophylaxis,E,E06.761.227,Preventive Dentistry,Dentistry,1
Dental Prosthesis,E,E06.780.346,Prosthodontics,Dentistry,1
Dental Prosthesis,E,E07.695.190,Prostheses and Implants,Equipment and Supplies,1
"Dental Prosthesis, Implant-Supported",E,E07.695.190.185,Dental Prosthesis,Prostheses and Implants,1
"Dental Prosthesis, Implant-Supported",E,E06.780.346.706,Dental Prosthesis,Prosthodontics,1
Dental Pulp Diseases,C,C07.793.237,Tooth Diseases,Stomatognathic Diseases,1
Dental Restoration Failure,E,E06.780.346.725,Dental Prosthesis,Prosthodontics,1
Dental Restoration Failure,E,E06.323.400,"Dentistry, Operative",Dentistry,1
Dental Stress Analysis,E,E06.308,Dentistry,NULL,1
Dental Technicians,N,N02.360.067.105.503,Dental Auxiliaries,Allied Health Personnel,1
Dental Technicians,M,M01.526.485.067.105.503,Dental Auxiliaries,Allied Health Personnel,1
Dentin Sensitivity,C,C07.793.266,Tooth Diseases,Stomatognathic Diseases,1
"Dentition, Mixed",A,A14.549.167.229,Dentition,Mouth,1
"Denture, Partial, Fixed",E,E07.695.190.200.220.220,"Denture, Partial",Dentures,1
"Denture, Partial, Fixed",E,E06.780.346.760.943.271,"Denture, Partial",Dentures,1
"Denture, Partial, Fixed, Resin-Bonded",E,E06.780.346.760.943.271.260,"Denture, Partial, Fixed","Denture, Partial",1
"Denture, Partial, Fixed, Resin-Bonded",E,E07.695.190.200.220.220.220,"Denture, Partial, Fixed","Denture, Partial",1
"Denture, Partial, Removable",E,E07.695.190.200.220.230,"Denture, Partial",Dentures,1
"Denture, Partial, Removable",E,E06.780.346.760.943.413,"Denture, Partial",Dentures,1
Deoxyglucose,D,D09.254.229,Deoxy Sugars,Carbohydrates,1
Deoxyguanosine,D,D03.633.100.759.590.454.240,Guanosine,Purine Nucleosides,1
Deoxyguanosine,D,D13.570.583.454.240,Guanosine,Purine Nucleosides,1
Deoxyguanosine,D,D13.570.230.360,Deoxyribonucleosides,Nucleosides,1
Deoxyribonuclease BamHI,D,D08.811.150.280.260.240,"Deoxyribonucleases, Type II Site-Specific",DNA Restriction Enzymes,1
Deoxyribonuclease BamHI,D,D08.811.277.352.355.325.300.260.240,"Deoxyribonucleases, Type II Site-Specific",DNA Restriction Enzymes,1
Deoxyribonuclease BamHI,D,D08.811.277.352.335.350.300.260.240,"Deoxyribonucleases, Type II Site-Specific",DNA Restriction Enzymes,1
Deoxyribonuclease HindIII,D,D08.811.277.352.335.350.300.260.260,"Deoxyribonucleases, Type II Site-Specific",DNA Restriction Enzymes,1
Deoxyribonuclease HindIII,D,D08.811.277.352.355.325.300.260.260,"Deoxyribonucleases, Type II Site-Specific",DNA Restriction Enzymes,1
Deoxyribonuclease HindIII,D,D08.811.150.280.260.400,"Deoxyribonucleases, Type II Site-Specific",DNA Restriction Enzymes,1
Deoxyribonucleotides,D,D13.695.201,Nucleotides,"Nucleic Acids, Nucleotides, and Nucleosides",1
Dependent Ambulation,G,G11.427.410.568.900.500,Walking,Locomotion,1
Dependovirus,B,B04.280.580.650.170,Parvovirinae,Parvoviridae,1
Depreciation,N,N03.219.463.030.120,Accounting,Financial Management,1
Deprescriptions,E,E02.319.243,Drug Therapy,Therapeutics,1
"Depression, Chemical",G,G07.690.773.750,Pharmacological Phenomena,Pharmacological and Toxicological Phenomena,1
"Depressive Disorder, Treatment-Resistant",F,F03.600.300.388,Depressive Disorder,Mood Disorders,1
Depth Perception,F,F02.463.593.778.255,Space Perception,Perception,1
Depth Perception,F,F02.463.593.200,Perception,Mental Processes,1
Dermatan Sulfate,D,D09.698.373.200.380,Chondroitin,Glycosaminoglycans,1
Dermatitis Herpetiformis,C,C20.111.318,Autoimmune Diseases,Immune System Diseases,1
Dermatitis Herpetiformis,C,C17.800.174.360,Dermatitis,Skin Diseases,1
Dermatitis Herpetiformis,C,C17.800.865.360,"Skin Diseases, Vesiculobullous",Skin Diseases,1
"Dermatitis, Irritant",C,C17.800.174.255.400,"Dermatitis, Contact",Dermatitis,1
"Dermatitis, Irritant",C,C17.800.815.255.400,"Dermatitis, Contact","Skin Diseases, Eczematous",1
"Dermatitis, Toxicodendron",C,C17.800.815.255.100.700,"Dermatitis, Allergic Contact","Dermatitis, Contact",1
"Dermatitis, Toxicodendron",C,C17.800.174.255.100.700,"Dermatitis, Allergic Contact","Dermatitis, Contact",1
"Dermatitis, Toxicodendron",C,C20.543.418.150.700,"Dermatitis, Allergic Contact","Hypersensitivity, Delayed",1
Dermatologists,N,N02.360.810.215,Physicians,Health Personnel,1
Dermatologists,M,M01.526.485.810.215,Physicians,Health Personnel,1
Dermatomycoses,C,C17.800.838.208,"Skin Diseases, Infectious",Skin Diseases,1
Dermatomycoses,C,C01.800.200,"Skin Diseases, Infectious",Infections,1
Dermatomycoses,C,C01.150.703.302,Mycoses,Bacterial Infections and Mycoses,1
Dermoid Cyst,C,C04.557.465.910.250,Teratoma,"Neoplasms, Germ Cell and Embryonal",1
Dermoid Cyst,C,C04.182.201,Cysts,Neoplasms,1
Desflurane,D,D02.355.417.166,Ethyl Ethers,Ethers,1
Desflurane,D,D02.355.601.325,Methyl Ethers,Ethers,1
Desflurane,D,D02.455.526.510.213,"Hydrocarbons, Fluorinated","Hydrocarbons, Halogenated",1
Desmoglein 1,D,D12.776.395.550.200.200.500.500.500,Desmogleins,Desmosomal Cadherins,1
Desmoglein 1,D,D23.050.422.124,Autoantigens,Antigens,1
Desmoglein 1,D,D23.050.301.350.200.500.500.500,Desmogleins,Desmosomal Cadherins,1
Desmoglein 1,D,D12.776.543.550.200.200.500.500.500,Desmogleins,Desmosomal Cadherins,1
Desmoglein 3,D,D12.776.543.550.200.200.500.500.750,Desmogleins,Desmosomal Cadherins,1
Desmoglein 3,D,D23.050.301.350.200.500.500.750,Desmogleins,Desmosomal Cadherins,1
Desmoglein 3,D,D23.050.422.249,Autoantigens,Antigens,1
Desmoglein 3,D,D12.776.395.550.200.200.500.500.750,Desmogleins,Desmosomal Cadherins,1
Desmogleins,D,D12.776.395.550.200.200.500.500,Desmosomal Cadherins,Cadherins,1
Desmogleins,D,D23.050.301.350.200.500.500,Desmosomal Cadherins,Cadherins,1
Desmogleins,D,D12.776.543.550.200.200.500.500,Desmosomal Cadherins,Cadherins,1
Desmosine,D,D12.125.072.200,"Amino Acids, Cyclic",Amino Acids,1
Desmosine,D,D03.383.725.762.300,Pyridinium Compounds,Pyridines,1
Desulfovibrio vulgaris,B,B03.900.350.875,Desulfovibrio,Sulfur-Reducing Bacteria,1
Desulfovibrio vulgaris,B,B03.660.125.144.500.875.875,Desulfovibrio,Desulfovibrionaceae,1
Desulfovibrio vulgaris,B,B03.440.425.410.350.875,Desulfovibrio,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",1
Developmental Biology,H,H01.158.273.200,Biology,Biological Science Disciplines,1
Dexfenfluramine,D,D02.092.471.683.338,Phenethylamines,Ethylamines,1
Dexmedetomidine,D,D03.383.129.308.245,Imidazoles,Azoles,1
Dextrins,D,D05.750.078.562.855.375,Starch,Glucans,1
Dextrins,D,D09.698.365.855.400,Starch,Glucans,1
Dextrins,D,D09.301.915.400,Starch,Dietary Carbohydrates,1
"Diagnosis, Dual (Psychiatry)",E,E01.190,Diagnosis,NULL,1
"Diagnostic Techniques, Surgical",E,E01.370.388,Diagnostic Techniques and Procedures,Diagnosis,1
Diagnostic Test Approval,N,N06.850.210.275.500,Device Approval,Consumer Product Safety,1
Diagnostic Test Approval,E,E05.337.275.500,Device Approval,Evaluation Studies as Topic,1
Dialysis Solutions,D,D27.720.752.483,Pharmaceutical Solutions,Specialty Uses of Chemicals,1
Dialysis Solutions,D,D26.776.708.322,Pharmaceutical Solutions,Solutions,1
Dialysis Solutions,D,D27.505.954.578.483,Pharmaceutical Solutions,Therapeutic Uses,1
"Diarrhea Viruses, Bovine Viral",B,B04.820.578.344.700.150,Pestivirus,Flaviviridae,1
Diathermy,E,E02.565.280,"Hyperthermia, Induced",Therapeutics,1
Diazomethane,D,D02.172.383.383,Diazonium Compounds,Azo Compounds,1
"Dibenzofurans, Polychlorinated",D,D02.309.250,Dioxins and Dioxin-like Compounds,Organic Chemicals,1
"Dibenzofurans, Polychlorinated",D,D03.633.300.258.500,Dibenzofurans,"Heterocyclic Compounds, 3-Ring",1
Dibenzothiepins,D,D03.633.300.311,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",1
Dibenzothiepins,D,D02.886.680.350,Thiepins,Sulfur Compounds,1
Dibutyl Phthalate,D,D02.241.223.805.225,Phthalic Acids,"Acids, Carbocyclic",1
Diclofenac,D,D02.241.223.601.210,Phenylacetates,"Acids, Carbocyclic",1
Dicrocoeliasis,C,C01.610.335.865.224,Trematode Infections,Helminthiasis,1
Dicrocoelium,B,B01.050.500.500.736.715.300.308,Dicrocoeliidae,Trematoda,1
"Dictionaries, Medical as Topic",L,L01.178.682.192.836.285.419,Dictionaries as Topic,Reference Books,1
"Dictionaries, Medical as Topic",L,L01.178.682.192.836.842.385,"Reference Books, Medical",Reference Books,1
"Diet, Carbohydrate Loading",G,G07.203.650.240.120,Diet,Nutritional Physiological Phenomena,1
"Diet, Carbohydrate Loading",E,E02.642.249.220,Diet Therapy,Nutrition Therapy,1
"Diet, Gluten-Free",E,E02.642.249.265,Diet Therapy,Nutrition Therapy,1
"Diet, Gluten-Free",G,G07.203.650.240.265,Diet,Nutritional Physiological Phenomena,1
"Diet, Paleolithic",G,G07.203.650.240.275,Diet,Nutritional Physiological Phenomena,1
"Diet, Paleolithic",E,E02.642.249.275,Diet Therapy,Nutrition Therapy,1
"Diet, Western",G,G07.203.650.240.310,Diet,Nutritional Physiological Phenomena,1
Dietary Exposure,N,N06.850.460.350.040,Environmental Exposure,Environmental Pollution,1
Diethylstilbestrol,D,D02.455.426.559.389.150.700.725.500,Stilbestrols,Stilbenes,1
Digestive System Abnormalities,C,C16.131.314,Congenital Abnormalities,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",1
Digestive System Abnormalities,C,C06.198,Digestive System Diseases,NULL,1
Digital Dermatitis,C,C01.800.720.180,"Skin Diseases, Bacterial","Skin Diseases, Infectious",1
Digital Dermatitis,C,C01.150.252.819.180,"Skin Diseases, Bacterial",Bacterial Infections,1
Digital Dermatitis,C,C17.800.838.765.180,"Skin Diseases, Bacterial","Skin Diseases, Infectious",1
Digital Dermatitis,C,C22.214,Animal Diseases,NULL,1
Digital Rectal Examination,E,E01.370.600.600.500,Palpation,Physical Examination,1
Digitalis Glycosides,D,D04.210.500.155.580.130.500,Cardenolides,Cardiac Glycosides,1
Digitalis Glycosides,D,D09.408.180.261,Cardiac Glycosides,Glycosides,1
Dihydrolipoamide Dehydrogenase,D,D12.776.331.192,Flavoproteins,Proteins,1
Dihydrolipoamide Dehydrogenase,D,D05.500.562.625.500,Pyruvate Dehydrogenase Complex,Multienzyme Complexes,1
Dihydrolipoamide Dehydrogenase,D,D05.500.562.468.500,Ketoglutarate Dehydrogenase Complex,Multienzyme Complexes,1
Dihydrolipoamide Dehydrogenase,D,D05.500.562.452.150,Glycine Decarboxylase Complex,Multienzyme Complexes,1
Dihydrolipoamide Dehydrogenase,D,D08.811.682.657.350.750.500,Ketoglutarate Dehydrogenase Complex,Ketone Oxidoreductases,1
Dihydrolipoamide Dehydrogenase,D,D08.811.682.667.061,Oxidoreductases Acting on Sulfur Group Donors,Oxidoreductases,1
Dihydrolipoamide Dehydrogenase,D,D08.811.600.391.150,Glycine Decarboxylase Complex,Multienzyme Complexes,1
Dihydrolipoamide Dehydrogenase,D,D08.811.600.465.500,Ketoglutarate Dehydrogenase Complex,Multienzyme Complexes,1
Dihydrolipoamide Dehydrogenase,D,D08.811.600.741.525,Pyruvate Dehydrogenase Complex,Multienzyme Complexes,1
Dihydropyridines,D,D03.383.725.203,Pyridines,"Heterocyclic Compounds, 1-Ring",1
Dihydroxyphenylalanine,D,D12.125.072.050.685.400,Phenylalanine,"Amino Acids, Aromatic",1
Dihydroxyphenylalanine,D,D12.125.072.050.875.130,Tyrosine,"Amino Acids, Aromatic",1
Dihydroxyphenylalanine,D,D02.455.426.559.389.657.166.175.200,Catecholamines,Catechols,1
Dihydroxyphenylalanine,D,D02.092.311.200,Catecholamines,Amines,1
Dilatation,E,E05.284,Investigative Techniques,NULL,1
Dilatation and Curettage,E,E04.950.300.299,Gynecologic Surgical Procedures,Urogenital Surgical Procedures,1
Dilatation and Curettage,E,E04.157.310,Curettage,"Surgical Procedures, Operative",1
Diltiazem,D,D03.633.100.079.150,Benzazepines,"Heterocyclic Compounds, 2-Ring",1
Dimensional Measurement Accuracy,E,E05.337.851.500,Reproducibility of Results,Evaluation Studies as Topic,1
Dimensional Measurement Accuracy,E,E05.318.370.725.500,Reproducibility of Results,Epidemiologic Research Design,1
Dimensional Measurement Accuracy,N,N05.715.360.325.685.500,Reproducibility of Results,Epidemiologic Research Design,1
Dimensional Measurement Accuracy,N,N06.850.520.445.725.500,Reproducibility of Results,Epidemiologic Research Design,1
Diminazene,D,D02.925.240,Triazenes,Organic Chemicals,1
Diminazene,D,D02.078.100.260,Benzamidines,Amidines,1
Dinucleoside Phosphates,D,D13.695.250,Nucleotides,"Nucleic Acids, Nucleotides, and Nucleosides",1
Dioxygenases,D,D08.811.682.690.416,Oxygenases,Oxidoreductases,1
Directed Molecular Evolution,E,E05.393.420.175,Genetic Engineering,Genetic Techniques,1
Direct-To-Consumer Screening and Testing,N,N02.421.726.233.166,Diagnostic Services,Preventive Health Services,1
Direct-To-Consumer Screening and Testing,E,E01.370.398,Diagnostic Techniques and Procedures,Diagnosis,1
Disaster Victims,M,M01.159,Persons,NULL,1
Disenfranchised Grief,F,F01.470.142.110.500,Grief,Bereavement,1
Disgust,F,F01.470.307,Emotions,Behavior and Behavior Mechanisms,1
Disks Large Homolog 4 Protein,D,D12.776.631.224,Nerve Tissue Proteins,Proteins,1
Disks Large Homolog 4 Protein,D,D12.776.543.219,Membrane Proteins,Proteins,1
Disks Large Homolog 4 Protein,D,D12.776.476.265,Intracellular Signaling Peptides and Proteins,Proteins,1
Disks Large Homolog 4 Protein,D,D12.644.360.265,Intracellular Signaling Peptides and Proteins,Peptides,1
Disks Large Homolog 4 Protein,D,D08.811.913.696.650.450.750,Guanylate Kinases,Phosphotransferases (Phosphate Group Acceptor),1
"Disruptive, Impulse Control, and Conduct Disorders",F,F03.250,Mental Disorders,NULL,1
Dissection,E,E04.221,"Surgical Procedures, Operative",NULL,1
Dissection,E,E05.200.998.221,Specimen Handling,Clinical Laboratory Techniques,1
Dissection,E,E01.370.225.998.221,Specimen Handling,Clinical Laboratory Techniques,1
"Distemper Virus, Phocine",B,B04.820.480.937.600.650.500.320,Morbillivirus,Paramyxovirinae,1
District of Columbia,Z,Z01.107.567.875.500.210,Mid-Atlantic Region,United States,1
District of Columbia,Z,Z01.433.429,Cities,Geographic Locations,1
Diving,N,N06.230.150.150,"Environment, Controlled",Environment,1
Diving,I,I03.450.642.845.945.500.110,Swimming,Water Sports,1
DNA (Cytosine-5-)-Methyltransferase 1,D,D12.776.660.720.313,Poly-ADP-Ribose Binding Proteins,Nuclear Proteins,1
DNA (Cytosine-5-)-Methyltransferase 1,D,D08.811.913.555.500.350.100.500.500,DNA (Cytosine-5-)-Methyltransferases,DNA-Cytosine Methylases,1
DNA (Cytosine-5-)-Methyltransferase 1,D,D12.776.157.687.313,Poly-ADP-Ribose Binding Proteins,Carrier Proteins,1
DNA Cleavage,G,G02.111.210,Biochemical Phenomena,Chemical Phenomena,1
DNA Cleavage,G,G05.193,Genetic Phenomena,NULL,1
DNA Footprinting,E,E05.393.300,Genetic Techniques,Investigative Techniques,1
DNA Polymerase II,D,D08.811.913.696.445.308.300.230,DNA-Directed DNA Polymerase,DNA Nucleotidyltransferases,1
DNA Primase,D,D08.811.913.696.445.735.270.375,DNA-Directed RNA Polymerases,RNA Nucleotidyltransferases,1
"DNA Topoisomerases, Type I",D,D12.776.157.687.375,Poly-ADP-Ribose Binding Proteins,Carrier Proteins,1
"DNA Topoisomerases, Type I",D,D08.811.399.403.483,DNA Topoisomerases,Isomerases,1
"DNA Topoisomerases, Type I",D,D12.776.660.720.375,Poly-ADP-Ribose Binding Proteins,Nuclear Proteins,1
DNA-(Apurinic or Apyrimidinic Site) Lyase,D,D08.811.520.241.225,Carbon-Oxygen Lyases,Lyases,1
DNA-(Apurinic or Apyrimidinic Site) Lyase,D,D08.811.074.750,DNA Repair Enzymes,Enzymes,1
"DNA, Archaeal",D,D13.444.308.180,DNA,Nucleic Acids,1
"DNA, Superhelical",D,D13.444.308.283.250,"DNA, Circular",DNA,1
"DNA, Superhelical",G,G05.360.580.156.250,"DNA, Circular",Nucleic Acid Conformation,1
"DNA, Superhelical",G,G02.111.570.820.486.212.250,"DNA, Circular",Nucleic Acid Conformation,1
Dolphins,B,B01.050.150.900.649.313.875.267,Cetacea,Eutheria,1
Dominica,Z,Z01.107.084.900.262,West Indies,Caribbean Region,1
Dominica,Z,Z01.639.880.262,West Indies,Islands,1
Domperidone,D,D03.633.100.103.370,Benzimidazoles,"Heterocyclic Compounds, 2-Ring",1
Domperidone,D,D03.383.621.210,Piperidines,"Heterocyclic Compounds, 1-Ring",1
Dopamine Agonists,D,D27.505.696.577.150.151,Dopamine Agents,Neurotransmitter Agents,1
Dopamine Agonists,D,D27.505.519.625.150.151,Dopamine Agents,Neurotransmitter Agents,1
Dopamine and cAMP-Regulated Phosphoprotein 32,D,D12.776.744.459,Phosphoproteins,Proteins,1
Dopamine and cAMP-Regulated Phosphoprotein 32,D,D12.776.631.249,Nerve Tissue Proteins,Proteins,1
Dopamine Antagonists,D,D27.505.519.625.150.175,Dopamine Agents,Neurotransmitter Agents,1
Dopamine Antagonists,D,D27.505.696.577.150.175,Dopamine Agents,Neurotransmitter Agents,1
Dothiepin,D,D03.633.300.311.250,Dibenzothiepins,"Heterocyclic Compounds, 3-Ring",1
Dothiepin,D,D02.886.680.350.250,Dibenzothiepins,Thiepins,1
Double Bind Interaction,F,F01.829.131,"Psychology, Social",Behavior and Behavior Mechanisms,1
Doulas,M,M01.526.485.345,Health Personnel,Occupational Groups,1
Doulas,N,N02.360.338,Health Personnel,"Health Care Facilities, Manpower, and Services",1
Doxazosin,D,D03.633.100.786.750.200,Prazosin,Quinazolines,1
Dronedarone,D,D03.633.100.127.075.500,Amiodarone,Benzofurans,1
Droperidol,D,D03.633.100.103.393,Benzimidazoles,"Heterocyclic Compounds, 2-Ring",1
Droperidol,D,D02.522.352.343,Butyrophenones,Ketones,1
Drosophila simulans,B,B01.050.500.131.617.720.500.500.750.310.250.750,Drosophila,Drosophilidae,1
Drug Chronotherapy,E,E02.168.500,Chronotherapy,Therapeutics,1
Drug Chronotherapy,E,E02.319.283.400,Drug Administration Schedule,Drug Therapy,1
Drug Information Services,N,N02.421.668.320,Pharmaceutical Services,Health Services,1
Drug Recalls,N,N06.850.210.637.200,Product Recalls and Withdrawals,Consumer Product Safety,1
Drug Recalls,N,N04.452.706.310.500,Drug and Narcotic Control,Pharmacy Administration,1
Drug Recalls,I,I01.880.604.605.250.625,Drug and Narcotic Control,"Legislation, Drug",1
Drug Trafficking,I,I01.880.735.191.101,Crime,Social Problems,1
Drug Trafficking,I,I01.198.240.247,Crime,Criminology,1
Dry Powder Inhalers,E,E07.605.500,Nebulizers and Vaporizers,Equipment and Supplies,1
"Ductus Arteriosus, Patent",C,C16.131.240.400.340,"Heart Defects, Congenital",Cardiovascular Abnormalities,1
"Ductus Arteriosus, Patent",C,C14.240.400.340,"Heart Defects, Congenital",Cardiovascular Abnormalities,1
"Ductus Arteriosus, Patent",C,C14.280.400.340,"Heart Defects, Congenital",Heart Diseases,1
Duloxetine Hydrochloride,D,D02.886.778.260,Thiophenes,Sulfur Compounds,1
Duloxetine Hydrochloride,D,D03.383.903.260,Thiophenes,"Heterocyclic Compounds, 1-Ring",1
Duodenal Neoplasms,C,C06.405.469.275.270,Duodenal Diseases,Intestinal Diseases,1
Duodenal Neoplasms,C,C06.405.469.491.445,Intestinal Neoplasms,Intestinal Diseases,1
Duodenal Neoplasms,C,C06.301.371.411.445,Intestinal Neoplasms,Gastrointestinal Neoplasms,1
Duodenal Neoplasms,C,C06.405.249.411.445,Intestinal Neoplasms,Gastrointestinal Neoplasms,1
Duodenal Neoplasms,C,C04.588.274.476.411.445,Intestinal Neoplasms,Gastrointestinal Neoplasms,1
Duodenoscopy,E,E01.370.388.250.250.250.200,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
Duodenoscopy,E,E01.370.372.250.250.225,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
Duodenoscopy,E,E04.210.240.250.200,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
Duodenoscopy,E,E04.502.250.250.250.200,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
Duodenum,A,A03.556.875.249,Upper Gastrointestinal Tract,Gastrointestinal Tract,1
Duodenum,A,A03.556.124.684.124,"Intestine, Small",Intestines,1
Duplicate Publications as Topic,L,L01.737.471,Publishing,Information Science,1
Duty to Warn,N,N03.706.535.230.270,Confidentiality,Jurisprudence,1
Duty to Warn,I,I01.880.604.583.080.270,Confidentiality,Jurisprudence,1
Duty to Warn,I,I01.880.604.583.080.134.800.200,Truth Disclosure,Disclosure,1
Duty to Warn,F,F01.829.401.046.800.200,Truth Disclosure,Disclosure,1
Duty to Warn,F,F04.096.544.335.240.270,Confidentiality,Forensic Psychiatry,1
"Dwarfism, Pituitary",C,C05.116.132.358,"Bone Diseases, Endocrine",Bone Diseases,1
"Dwarfism, Pituitary",C,C05.116.099.343.445,Dwarfism,"Bone Diseases, Developmental",1
"Dwarfism, Pituitary",C,C10.228.140.617.738.300.300,Hypopituitarism,Pituitary Diseases,1
"Dwarfism, Pituitary",C,C19.297.312,Dwarfism,Endocrine System Diseases,1
"Dwarfism, Pituitary",C,C19.700.482.311,Hypopituitarism,Pituitary Diseases,1
Dynamins,D,D12.776.543.990.400,Vesicular Transport Proteins,Membrane Proteins,1
Dynamins,D,D08.811.277.040.330.200,GTP Phosphohydrolases,Acid Anhydride Hydrolases,1
Dynamins,D,D12.776.220.600.450.200,Microtubule-Associated Proteins,Microtubule Proteins,1
Dyneins,D,D12.776.220.600.200,Microtubule Proteins,Cytoskeletal Proteins,1
Dyneins,D,D12.776.157.025.750.063,ATPases Associated with Diverse Cellular Activities,AAA Proteins,1
Dyneins,D,D08.811.277.040.025.193.249,Molecular Motor Proteins,Adenosine Triphosphatases,1
Dyneins,D,D08.811.277.040.013.500.063,ATPases Associated with Diverse Cellular Activities,AAA Proteins,1
Dyneins,D,D08.811.277.040.025.024.063,ATPases Associated with Diverse Cellular Activities,Adenosine Triphosphatases,1
Dysarthria,C,C23.888.592.604.150.500.800.150.200,Articulation Disorders,Speech Disorders,1
Dysarthria,C,C10.597.606.150.500.800.150.200,Articulation Disorders,Speech Disorders,1
Dyscalculia,C,C10.597.606.150.550.099,Learning Disabilities,Communication Disorders,1
Dyscalculia,C,C23.888.592.604.150.550.099,Learning Disabilities,Communication Disorders,1
Dyscalculia,F,F03.625.562.199,Learning Disabilities,Neurodevelopmental Disorders,1
Dysgammaglobulinemia,C,C20.673.430,Immunologic Deficiency Syndromes,Immune System Diseases,1
Dysgammaglobulinemia,C,C15.378.147.333,Blood Protein Disorders,Hematologic Diseases,1
Dyskinesias,C,C10.597.350,Neurologic Manifestations,Nervous System Diseases,1
Dyskinesias,C,C10.228.662.262,Movement Disorders,Central Nervous System Diseases,1
Dyskinesias,C,C23.888.592.350,Neurologic Manifestations,Signs and Symptoms,1
Dysplastic Nevus Syndrome,C,C16.320.700.305,"Neoplastic Syndromes, Hereditary","Genetic Diseases, Inborn",1
Dysplastic Nevus Syndrome,C,C04.700.305,"Neoplastic Syndromes, Hereditary",Neoplasms,1
Dysplastic Nevus Syndrome,C,C04.557.665.560.260,Nevus,Nevi and Melanomas,1
Dysthymic Disorder,F,F03.600.300.400,Depressive Disorder,Mood Disorders,1
Dystonia,C,C10.597.350.300,Dyskinesias,Neurologic Manifestations,1
Dystonia,C,C23.888.592.350.300,Dyskinesias,Neurologic Manifestations,1
Dystonin,D,D12.776.220.790.625,Plakins,Cytoskeletal Proteins,1
Dystroglycans,D,D12.776.210.500.410.500,Dystrophin-Associated Proteins,Muscle Proteins,1
Dystroglycans,D,D12.776.220.362.249,Dystrophin-Associated Proteins,Cytoskeletal Proteins,1
Dystroglycans,D,D12.776.543.268.500,Dystrophin-Associated Proteins,Membrane Proteins,1
Dysuria,C,C23.888.942.343.274,Lower Urinary Tract Symptoms,Urological Manifestations,1
E2F Transcription Factors,D,D12.776.930.211,Transcription Factors,Proteins,1
Ear,A,A01.456.313,Head,Body Regions,1
Ear,A,A09.246,Sense Organs,NULL,1
Ear Auricle,A,A09.246.272.197,"Ear, External",Ear,1
Ear Canal,A,A09.246.272.396,"Ear, External",Ear,1
"Ear, External",A,A09.246.272,Ear,Sense Organs,1
Early Warning Score,E,E05.318.308.980.438.475.456.500.375,Severity of Illness Index,Patient Acuity,1
Early Warning Score,N,N06.850.520.308.980.438.475.364.500.375,Severity of Illness Index,Patient Acuity,1
Early Warning Score,N,N05.715.360.300.800.438.375.364.500.375,Severity of Illness Index,Patient Acuity,1
"Echinococcosis, Pulmonary",C,C01.748.450.314,"Lung Diseases, Parasitic",Respiratory Tract Infections,1
"Echinococcosis, Pulmonary",C,C01.610.582.314,"Lung Diseases, Parasitic",Parasitic Diseases,1
"Echinococcosis, Pulmonary",C,C01.610.335.190.396.480,Echinococcosis,Cestode Infections,1
"Echinococcosis, Pulmonary",C,C08.381.517.314,"Lung Diseases, Parasitic",Lung Diseases,1
"Echinococcosis, Pulmonary",C,C08.730.450.314,"Lung Diseases, Parasitic",Respiratory Tract Infections,1
Echinococcus,B,B01.050.500.500.736.215.327,Cestoda,Platyhelminths,1
Echinococcus multilocularis,B,B01.050.500.500.736.215.327.500,Echinococcus,Cestoda,1
"Echocardiography, Doppler, Color",E,E01.370.370.380.220.220.220,"Echocardiography, Doppler",Echocardiography,1
"Echocardiography, Doppler, Color",E,E01.370.350.850.850.850.850.220,"Ultrasonography, Doppler, Color","Ultrasonography, Doppler, Duplex",1
"Echocardiography, Doppler, Color",E,E01.370.350.850.850.220.220,"Echocardiography, Doppler","Ultrasonography, Doppler",1
"Echocardiography, Doppler, Color",E,E01.370.350.850.220.220.220,"Echocardiography, Doppler",Echocardiography,1
"Echocardiography, Doppler, Color",E,E01.370.350.130.750.220.220,"Echocardiography, Doppler",Echocardiography,1
"Echocardiography, Transesophageal",E,E01.370.350.130.750.235,Echocardiography,Cardiac Imaging Techniques,1
"Echocardiography, Transesophageal",E,E01.370.350.850.220.235,Echocardiography,Ultrasonography,1
"Echocardiography, Transesophageal",E,E01.370.370.380.220.235,Echocardiography,Heart Function Tests,1
Echolocation,F,F01.145.113.055.400,Animal Communication,"Behavior, Animal",1
Echo-Planar Imaging,E,E01.370.350.825.500.200,Magnetic Resonance Imaging,Tomography,1
Ecological Parameter Monitoring,E,E05.298,Investigative Techniques,NULL,1
Economic Factors,I,I01.880.853.996.134,Socioeconomic Factors,Sociological Factors,1
Ecotoxicology,H,H02.884.211,Toxicology,Health Occupations,1
Ecotoxicology,H,H01.158.891.211,Toxicology,Biological Science Disciplines,1
Ecotoxicology,H,H01.277.249.500,Ecology,Earth Sciences,1
Ecotoxicology,H,H01.158.273.248.500,Ecology,Biology,1
Ecotype,G,G16.500.275.157.049.230,Biodiversity,Ecosystem,1
Ecotype,N,N06.230.124.049.230,Biodiversity,Ecosystem,1
Ecotype,G,G05.695.200,Phenotype,Genetic Phenomena,1
"Ectodermal Dysplasia 1, Anhidrotic",C,C16.320.850.250.198,Ectodermal Dysplasia,"Skin Diseases, Genetic",1
"Ectodermal Dysplasia 1, Anhidrotic",C,C16.320.322.116,"Genetic Diseases, X-Linked","Genetic Diseases, Inborn",1
"Ectodermal Dysplasia 1, Anhidrotic",C,C16.131.831.350.198,Ectodermal Dysplasia,Skin Abnormalities,1
"Ectodermal Dysplasia 1, Anhidrotic",C,C16.131.077.350.198,Ectodermal Dysplasia,"Abnormalities, Multiple",1
"Ectodermal Dysplasia 1, Anhidrotic",C,C17.800.827.250.198,Ectodermal Dysplasia,"Skin Diseases, Genetic",1
"Ectodermal Dysplasia 1, Anhidrotic",C,C17.800.804.350.198,Ectodermal Dysplasia,Skin Abnormalities,1
Education of Intellectually Disabled,F,F02.784.629.375,"Psychology, Educational","Psychology, Applied",1
Education of Intellectually Disabled,I,I02.233.213.400,"Education, Special","Education, Nonprofessional",1
"Education, Dental",I,I02.358.274,"Education, Professional",Education,1
"Education, Dental, Continuing",I,I02.358.274.316,"Education, Dental","Education, Professional",1
"Education, Dental, Continuing",I,I02.358.212.249,"Education, Continuing","Education, Professional",1
"Education, Dental, Graduate",I,I02.358.274.482,"Education, Dental","Education, Professional",1
"Education, Dental, Graduate",I,I02.358.337.249,"Education, Graduate","Education, Professional",1
"Education, Veterinary",I,I02.358.588,"Education, Professional",Education,1
"Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",D,D26.310.375,Drug Combinations,Pharmaceutical Preparations,1
"Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",D,D03.383.742.680.245.500.600.125,Emtricitabine,Deoxycytidine,1
"Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",D,D03.383.533.375,Oxazines,"Heterocyclic Compounds, 1-Ring",1
"Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",D,D03.633.100.759.138.881.125,Tenofovir,Adenine,1
"Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",D,D02.705.429.906.125,Tenofovir,Organophosphonates,1
EGF Family of Proteins,D,D12.644.276.382,Intercellular Signaling Peptides and Proteins,Peptides,1
EGF Family of Proteins,D,D23.529.382,Intercellular Signaling Peptides and Proteins,Biological Factors,1
EGF Family of Proteins,D,D12.776.467.382,Intercellular Signaling Peptides and Proteins,Proteins,1
Ego,F,F02.739.794.206,Psychoanalytic Theory,Psychological Theory,1
Ego,F,F01.752.747.189,Personality Development,Personality,1
Egtazic Acid,D,D02.092.782.258.368.257,Ethylenediamines,Diamines,1
Egtazic Acid,D,D02.241.081.018.269,Acetates,"Acids, Acyclic",1
Ejaculation,G,G08.686.784.084,Reproduction,Reproductive Physiological Phenomena,1
Ejaculatory Ducts,A,A05.360.444.251,"Genitalia, Male",Genitalia,1
Elastin,D,D12.776.860.300.350,Extracellular Matrix Proteins,Scleroproteins,1
Elastin,D,D05.750.078.421,Biopolymers,Polymers,1
Elder Nutritional Physiological Phenomena,G,G07.203.650.315,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",1
Electrical Equipment and Supplies,E,E07.305,Equipment and Supplies,NULL,1
"Electrodes, Implanted",E,E07.305.250.319,Electrodes,Electrical Equipment and Supplies,1
"Electrodes, Implanted",E,E07.695.202,Prostheses and Implants,Equipment and Supplies,1
Electron Microscope Tomography,E,E05.595.402.580.239,"Microscopy, Electron, Transmission","Microscopy, Electron",1
Electron Microscope Tomography,E,E01.370.350.825.249,Tomography,Diagnostic Imaging,1
Electron Transport Complex I,D,D12.776.556.579.374.375.140,Iron-Sulfur Proteins,Nonheme Iron Proteins,1
Electron Transport Complex I,D,D12.776.543.277.500.500,Electron-Transferring Flavoproteins,Electron Transport Chain Complex Proteins,1
Electron Transport Complex I,D,D12.776.543.585.450.250.875.437,Proton Pumps,Cation Transport Proteins,1
Electron Transport Complex I,D,D05.500.562.249,Multienzyme Complexes,Multiprotein Complexes,1
Electron Transport Complex I,D,D08.811.600.250.500.500,Electron-Transferring Flavoproteins,Electron Transport Chain Complex Proteins,1
Electron Transport Complex I,D,D08.811.682.608.504,"NADH, NADPH Oxidoreductases",Oxidoreductases,1
Electron Transport Complex I,D,D12.776.331.199.500,Electron-Transferring Flavoproteins,Flavoproteins,1
Electron Transport Complex I,D,D12.776.157.530.450.250.875.300,Proton Pumps,Cation Transport Proteins,1
Electron Transport Complex I,D,D12.776.157.427.374.375.863,Iron-Sulfur Proteins,Nonheme Iron Proteins,1
Electron Transport Complex III,D,D12.776.157.427.374.375.954,Iron-Sulfur Proteins,Nonheme Iron Proteins,1
Electron Transport Complex III,D,D12.776.157.530.450.250.875.303,Proton Pumps,Cation Transport Proteins,1
Electron Transport Complex III,D,D08.811.682.830.500,Succinate Cytochrome c Oxidoreductase,Oxidoreductases,1
Electron Transport Complex III,D,D08.811.600.250.875.500,Succinate Cytochrome c Oxidoreductase,Electron Transport Chain Complex Proteins,1
Electron Transport Complex III,D,D05.500.562.750.500,Succinate Cytochrome c Oxidoreductase,Multienzyme Complexes,1
Electron Transport Complex III,D,D12.776.543.585.450.250.875.468,Proton Pumps,Cation Transport Proteins,1
Electron Transport Complex III,D,D12.776.543.277.875.500,Succinate Cytochrome c Oxidoreductase,Electron Transport Chain Complex Proteins,1
Electron Transport Complex III,D,D12.776.556.579.374.375.142,Iron-Sulfur Proteins,Nonheme Iron Proteins,1
Electronic Nose,E,E07.305.296,Electrical Equipment and Supplies,Equipment and Supplies,1
Electronic Nose,E,E07.230.210,Diagnostic Equipment,Equipment and Supplies,1
"Electronics, Medical",H,H01.671.293.319,Electronics,Physics,1
Electrons,G,G01.358.500.750,Electromagnetic Phenomena,Magnetic Phenomena,1
Electrons,G,G01.249.335,Elementary Particles,Physical Phenomena,1
Electrophorus,B,B01.050.150.900.493.378.430.250,Gymnotiformes,Electric Fish,1
"Electrophysiologic Techniques, Cardiac",E,E01.370.370.380.245,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",1
"Electrophysiologic Techniques, Cardiac",E,E01.370.405.267,Electrodiagnosis,Diagnostic Techniques and Procedures,1
Electroshock,F,F04.669.224,Psychological Techniques,Behavioral Disciplines and Activities,1
Electroshock,E,E05.723.402.403,Electric Stimulation,Physical Stimulation,1
Electrosurgery,E,E04.262,"Surgical Procedures, Operative",NULL,1
Elephants,B,B01.050.150.900.649.833.249,Proboscidea Mammal,Mammals,1
Embarrassment,F,F01.470.483.666.500,Shame,Guilt,1
Embryo Research,E,E05.313,Investigative Techniques,NULL,1
Embryo Research,H,H01.770.644.145.250,Biomedical Research,Research,1
Embryology,H,H01.158.273.200.350,Developmental Biology,Biology,1
Embryology,H,H01.158.100.529,Anatomy,Biological Science Disciplines,1
Embryonic Stem Cells,A,A11.872.700.250,Pluripotent Stem Cells,Stem Cells,1
Emergency Medical Dispatch,N,N02.421.297.043,Emergency Medical Services,Health Services,1
Emergency Medical Dispatcher,M,M01.526.485.349,Health Personnel,Occupational Groups,1
Emergency Medical Service Communication Systems,N,N02.421.297.058,Emergency Medical Services,Health Services,1
Emmetropia,G,G14.940.750,Visual Acuity,Ocular Physiological Phenomena,1
Emmetropia,F,F02.463.593.932.901.750,Visual Acuity,Visual Perception,1
Emmetropia,E,E01.370.380.850.950.750,Visual Acuity,Vision Tests,1
Emotional Abuse,I,I01.880.735.305,Social Problems,Sociology,1
Emotional Adjustment,F,F01.752.543.500.250,Emotional Intelligence,Intelligence,1
Emotional Adjustment,F,F01.058.144,"Adaptation, Psychological",Behavior and Behavior Mechanisms,1
Emotional Regulation,F,F01.145.813.595.500,Self-Control,Social Behavior,1
Emotional Regulation,F,F01.470.311,Emotions,Behavior and Behavior Mechanisms,1
Employee Incentive Plans,N,N04.452.677.368,Personnel Management,Organization and Administration,1
Employer Health Costs,N,N05.300.375.350,Health Care Costs,Delivery of Health Care,1
Employer Health Costs,N,N03.219.151.400.375,Health Care Costs,Costs and Cost Analysis,1
"Empyema, Pleural",C,C01.748.265,Respiratory Tract Infections,Infections,1
"Empyema, Pleural",C,C01.830.305.310,Empyema,Suppuration,1
"Empyema, Pleural",C,C23.550.470.756.305.250,Empyema,Suppuration,1
"Empyema, Pleural",C,C08.730.265,Respiratory Tract Infections,Respiratory Tract Diseases,1
"Empyema, Pleural",C,C08.528.240,Pleural Diseases,Respiratory Tract Diseases,1
"Empyema, Tuberculous",C,C08.528.240.320,"Empyema, Pleural",Pleural Diseases,1
"Empyema, Tuberculous",C,C08.528.928.405,"Tuberculosis, Pleural",Pleural Diseases,1
"Empyema, Tuberculous",C,C08.730.265.320,"Empyema, Pleural",Respiratory Tract Infections,1
"Empyema, Tuberculous",C,C08.730.912.405,"Tuberculosis, Pleural",Respiratory Tract Infections,1
"Empyema, Tuberculous",C,C23.550.470.756.305.250.320,"Empyema, Pleural",Empyema,1
"Empyema, Tuberculous",C,C01.830.305.310.320,"Empyema, Pleural",Empyema,1
"Empyema, Tuberculous",C,C01.748.912.405,"Tuberculosis, Pleural",Respiratory Tract Infections,1
"Empyema, Tuberculous",C,C01.748.265.320,"Empyema, Pleural",Respiratory Tract Infections,1
"Encephalitis Virus, California",B,B04.820.230.100,Encephalitis Viruses,RNA Viruses,1
"Encephalitis Virus, California",B,B04.820.480.750.640.300,Orthobunyavirus,Bunyaviridae,1
Encephalitis Viruses,B,B04.820.230,RNA Viruses,Viruses,1
"Encephalitis, California",C,C01.207.245.340.300.200,"Encephalitis, Arbovirus","Encephalitis, Viral",1
"Encephalitis, California",C,C01.207.399.750.300.200,"Encephalitis, Arbovirus","Encephalitis, Viral",1
"Encephalitis, California",C,C01.925.782.147.340,Bunyaviridae Infections,RNA Virus Infections,1
"Encephalitis, California",C,C01.925.782.310.340,"Encephalitis, Arbovirus",RNA Virus Infections,1
"Encephalitis, California",C,C01.925.182.525.300.200,"Encephalitis, Arbovirus","Encephalitis, Viral",1
"Encephalitis, California",C,C01.920.500.343.340,"Encephalitis, Arbovirus",Arbovirus Infections,1
"Encephalitis, California",C,C01.925.081.343.340,"Encephalitis, Arbovirus",Arbovirus Infections,1
"Encephalitis, California",C,C10.228.228.399.750.300.200,"Encephalitis, Arbovirus","Encephalitis, Viral",1
"Encephalitis, California",C,C10.228.228.245.340.300.200,"Encephalitis, Arbovirus","Encephalitis, Viral",1
"Encephalitis, California",C,C10.228.140.430.520.750.300.200,"Encephalitis, Arbovirus","Encephalitis, Viral",1
"Encephalitis, Herpes Simplex",C,C10.228.140.430.520.750.350,"Encephalitis, Viral",Infectious Encephalitis,1
"Encephalitis, Herpes Simplex",C,C10.228.228.245.340.350,"Encephalitis, Viral",Central Nervous System Viral Diseases,1
"Encephalitis, Herpes Simplex",C,C10.228.228.399.750.350,"Encephalitis, Viral",Infectious Encephalitis,1
"Encephalitis, Herpes Simplex",C,C01.925.182.525.350,"Encephalitis, Viral",Central Nervous System Viral Diseases,1
"Encephalitis, Herpes Simplex",C,C01.925.256.466.262,Herpesviridae Infections,DNA Virus Infections,1
"Encephalitis, Herpes Simplex",C,C01.207.245.340.350,"Encephalitis, Viral",Central Nervous System Viral Diseases,1
"Encephalitis, Herpes Simplex",C,C01.207.399.750.350,"Encephalitis, Viral",Infectious Encephalitis,1
"Encephalitis, St. Louis",C,C01.207.245.340.300.550,"Encephalitis, Arbovirus","Encephalitis, Viral",1
"Encephalitis, St. Louis",C,C01.207.399.750.300.550,"Encephalitis, Arbovirus","Encephalitis, Viral",1
"Encephalitis, St. Louis",C,C01.925.182.525.300.300,"Encephalitis, Arbovirus","Encephalitis, Viral",1
"Encephalitis, St. Louis",C,C01.925.081.343.350,"Encephalitis, Arbovirus",Arbovirus Infections,1
"Encephalitis, St. Louis",C,C01.920.500.343.350,"Encephalitis, Arbovirus",Arbovirus Infections,1
"Encephalitis, St. Louis",C,C01.925.782.310.350,"Encephalitis, Arbovirus",RNA Virus Infections,1
"Encephalitis, St. Louis",C,C01.925.782.350.250.450,Flavivirus Infections,Flaviviridae Infections,1
"Encephalitis, St. Louis",C,C10.228.228.399.750.300.550,"Encephalitis, Arbovirus","Encephalitis, Viral",1
"Encephalitis, St. Louis",C,C10.228.228.245.340.300.550,"Encephalitis, Arbovirus","Encephalitis, Viral",1
"Encephalitis, St. Louis",C,C10.228.140.430.520.750.300.550,"Encephalitis, Arbovirus","Encephalitis, Viral",1
Encephalitozoon cuniculi,B,B01.300.360.500.500.100.175.175,Encephalitozoon,Apansporoblastina,1
Encephalocele,C,C10.500.680.488,Neural Tube Defects,Nervous System Malformations,1
Encephalocele,C,C16.131.666.680.488,Neural Tube Defects,Nervous System Malformations,1
Encephalocele,C,C23.300.707.186,Hernia,"Pathological Conditions, Anatomical",1
Endocrine Glands,A,A06.300,Endocrine System,NULL,1
Endocrinology,H,H01.158.782.323,Physiology,Biological Science Disciplines,1
Endocrinology,H,H02.403.429.323,Internal Medicine,Medicine,1
Endodermal Sinus Tumor,C,C04.557.465.510.350,Mesonephroma,"Neoplasms, Germ Cell and Embryonal",1
Endodontists,N,N02.360.330.397,Dentists,Health Personnel,1
Endodontists,M,M01.526.485.330.397,Dentists,Health Personnel,1
Endogenous Retroviruses,G,G02.111.570.080.708.330.800.175,Retroelements,Interspersed Repetitive Sequences,1
Endogenous Retroviruses,G,G05.360.340.024.425.800.175,Retroelements,Interspersed Repetitive Sequences,1
Endogenous Retroviruses,G,G05.360.080.708.330.800.175,Retroelements,Interspersed Repetitive Sequences,1
Endogenous Retroviruses,B,B04.613.807.250,Retroviridae,Oncogenic Viruses,1
Endogenous Retroviruses,B,B04.820.650.250,Retroviridae,RNA Viruses,1
Endonucleases,D,D08.811.277.352.355,Esterases,Hydrolases,1
Endopeptidase Clp,D,D08.811.277.656.149.099.500,ATP-Dependent Endopeptidases,ATP-Dependent Proteases,1
Endopeptidase Clp,D,D08.811.277.656.300.065.500,ATP-Dependent Endopeptidases,Endopeptidases,1
Endopeptidase Clp,D,D08.811.277.040.025.024.032.099.500,ATP-Dependent Endopeptidases,ATP-Dependent Proteases,1
Endopeptidase Clp,D,D08.811.277.040.013.500.032.099.500,ATP-Dependent Endopeptidases,ATP-Dependent Proteases,1
Endopeptidase Clp,D,D12.776.157.025.750.032.099.500,ATP-Dependent Endopeptidases,ATP-Dependent Proteases,1
Endopeptidase Clp,D,D12.776.575.374,Mitochondrial Proteins,Proteins,1
Endopeptidase Clp,D,D12.776.765.199.249,Chloroplast Proteins,Plant Proteins,1
Endoplasmic Reticulum Stress,G,G04.434,Cell Physiological Phenomena,NULL,1
Endoplasmic Reticulum-Associated Degradation,G,G05.308.670.600.850.500,Unfolded Protein Response,"Protein Processing, Post-Translational",1
Endoplasmic Reticulum-Associated Degradation,G,G02.111.660.871.790.600.962.500,Unfolded Protein Response,"Protein Processing, Post-Translational",1
Endoplasmic Reticulum-Associated Degradation,G,G02.111.691.600.850.500,Unfolded Protein Response,"Protein Processing, Post-Translational",1
Endoplasmic Reticulum-Associated Degradation,G,G03.734.871.790.600.850.500,Unfolded Protein Response,"Protein Processing, Post-Translational",1
Endoscopic Mucosal Resection,E,E04.210.240.250.230,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
Endoscopic Mucosal Resection,E,E04.502.250.250.250.230,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
Endoscopic Mucosal Resection,E,E01.370.388.250.250.250.230,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
Endoscopic Mucosal Resection,E,E01.370.372.250.250.250,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
"Endoscopy, Gastrointestinal",E,E01.370.372.250.250,"Endoscopy, Digestive System","Diagnostic Techniques, Digestive System",1
"Endoscopy, Gastrointestinal",E,E01.370.388.250.250.250,"Endoscopy, Digestive System",Endoscopy,1
"Endoscopy, Gastrointestinal",E,E04.502.250.250.250,"Endoscopy, Digestive System",Endoscopy,1
"Endoscopy, Gastrointestinal",E,E04.210.240.250,"Endoscopy, Digestive System",Digestive System Surgical Procedures,1
Endosulfan,D,D02.886.092.408,Benzothiepins,Sulfur Compounds,1
Endosulfan,D,D03.633.100.197.408,Benzothiepins,"Heterocyclic Compounds, 2-Ring",1
Endothelial Progenitor Cells,A,A11.436.275.182,Endothelial Cells,Epithelial Cells,1
Endothelial Progenitor Cells,A,A11.148.174,Bone Marrow Cells,Cells,1
Enema,E,E02.319.347,Drug Therapy,Therapeutics,1
Energy Drinks,G,G07.203.100.512,Beverages,"Diet, Food, and Nutrition",1
Energy Drinks,J,J02.200.512,Beverages,Food and Beverages,1
Energy Transfer,G,G02.216,Chemical Phenomena,NULL,1
Energy Transfer,G,G02.111.255,Biochemical Phenomena,Chemical Phenomena,1
Energy Transfer,G,G01.154.240,Biophysical Phenomena,Physical Phenomena,1
Enfuvirtide,D,D23.050.327.520.330.500,HIV Envelope Protein gp41,HIV Antigens,1
Enfuvirtide,D,D12.776.964.775.562.500.200.500,HIV Envelope Protein gp41,"env Gene Products, Human Immunodeficiency Virus",1
Enfuvirtide,D,D12.776.964.775.325.164.200.500,HIV Envelope Protein gp41,"env Gene Products, Human Immunodeficiency Virus",1
Enfuvirtide,D,D12.776.964.970.880.910.330.500,HIV Envelope Protein gp41,Viral Fusion Proteins,1
Enfuvirtide,D,D12.776.964.970.880.325.164.200.500,HIV Envelope Protein gp41,"env Gene Products, Human Immunodeficiency Virus",1
Enfuvirtide,D,D12.776.543.512.500.330.500,HIV Envelope Protein gp41,Viral Fusion Proteins,1
Enfuvirtide,D,D12.644.541.250,Peptide Fragments,Peptides,1
Engraving and Engravings,K,K01.093.346,Art,Humanities,1
"Enkephalin, Methionine",D,D12.644.400.575.281.381,Enkephalins,Opioid Peptides,1
"Enkephalin, Methionine",D,D12.776.631.650.575.281.381,Enkephalins,Opioid Peptides,1
Enkephalins,D,D12.776.631.650.575.281,Opioid Peptides,Neuropeptides,1
Enkephalins,D,D12.644.400.575.281,Opioid Peptides,Neuropeptides,1
Enoplida Infections,C,C01.610.335.508.100.275,Adenophorea Infections,Nematode Infections,1
Enoxacin,D,D03.633.100.810.835.322.280,Fluoroquinolones,Quinolones,1
Enoyl-CoA Hydratase,D,D08.811.520.241.300.250,Hydro-Lyases,Carbon-Oxygen Lyases,1
Enterobactin,D,D04.345.566.352,"Peptides, Cyclic",Macrocyclic Compounds,1
Enterobactin,D,D12.644.641.352,"Peptides, Cyclic",Peptides,1
Enterobactin,D,D12.125.154.800.937,Serine,"Amino Acids, Neutral",1
Enterocytozoon,B,B01.300.360.500.500.100.200,Apansporoblastina,Microsporida,1
Entorhinal Cortex,A,A08.186.211.180.590.750.225,Parahippocampal Gyrus,Limbic Lobe,1
Entorhinal Cortex,A,A08.186.211.200.885.287.750.562,Olfactory Cortex,Cerebrum,1
Entorhinal Cortex,A,A08.186.211.180.710.225,Parahippocampal Gyrus,Limbic System,1
Entorhinal Cortex,A,A08.186.211.200.885.287.500.814.695.374,Olfactory Cortex,Sensorimotor Cortex,1
Entorhinal Cortex,A,A08.186.211.200.885.287.500.382.750.225,Parahippocampal Gyrus,Limbic Lobe,1
Entorhinal Cortex,A,A08.186.211.200.885.287.500.620.562,Olfactory Cortex,Cerebral Cortex,1
Environmental Restoration and Remediation,N,N06.230.080.600,Conservation of Natural Resources,Environment,1
Environmental Restoration and Remediation,N,N06.850.460.375,Environmental Pollution,Public Health,1
Enzootic Bovine Leukosis,C,C04.557.337.100,Leukemia,Neoplasms by Histologic Type,1
Enzootic Bovine Leukosis,C,C01.925.782.815.200.260,Deltaretrovirus Infections,Retroviridae Infections,1
Enzootic Bovine Leukosis,C,C22.196.260,Cattle Diseases,Animal Diseases,1
Enzootic Bovine Leukosis,C,C20.673.483.260,Deltaretrovirus Infections,Immunologic Deficiency Syndromes,1
Enzyme Activators,D,D27.505.519.374,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,1
Enzyme Precursors,D,D12.776.811.243,Protein Precursors,Proteins,1
Enzyme Precursors,D,D08.622,Enzymes and Coenzymes,NULL,1
Enzyme Stability,G,G02.111.700.500,Protein Stability,Biochemical Phenomena,1
Enzyme Stability,E,E05.916.360,"Technology, Pharmaceutical",Investigative Techniques,1
Eosinophil Cationic Protein,D,D08.811.277.352.700.350.262,Endoribonucleases,Ribonucleases,1
Eosinophil Cationic Protein,D,D12.776.124.486.379.249,Eosinophil Granule Proteins,Immunoproteins,1
Eosinophilic Granuloma,C,C23.550.382.250,Granuloma,Pathologic Processes,1
Eosinophilic Granuloma,C,C15.378.553.231.348,Eosinophilia,Leukocyte Disorders,1
Eosinophilic Granuloma,C,C15.604.250.400.360,"Histiocytosis, Langerhans-Cell",Histiocytosis,1
Eosinophilic Granuloma,C,C08.381.483.375.500,"Histiocytosis, Langerhans-Cell","Lung Diseases, Interstitial",1
Eosinophilic Granuloma,C,C05.116.391,Bone Diseases,Musculoskeletal Diseases,1
Epidermal Cells,A,A11.409,Cells,NULL,1
Epidermal Cyst,C,C04.182.254,Cysts,Neoplasms,1
Epidermodysplasia Verruciformis,C,C01.925.825.810.260,Warts,"Skin Diseases, Viral",1
Epidermodysplasia Verruciformis,C,C01.925.928.914.345,Warts,Tumor Virus Infections,1
Epidermodysplasia Verruciformis,C,C01.925.256.650.810.345,Warts,Papillomavirus Infections,1
Epidermodysplasia Verruciformis,C,C17.800.838.790.810.260,Warts,"Skin Diseases, Viral",1
Epidermolysis Bullosa Dystrophica,C,C17.800.865.410.160,Epidermolysis Bullosa,"Skin Diseases, Vesiculobullous",1
Epidermolysis Bullosa Dystrophica,C,C17.800.804.493.160,Epidermolysis Bullosa,Skin Abnormalities,1
Epidermolysis Bullosa Dystrophica,C,C17.800.827.275.160,Epidermolysis Bullosa,"Skin Diseases, Genetic",1
Epidermolysis Bullosa Dystrophica,C,C17.300.200.367,Collagen Diseases,Connective Tissue Diseases,1
Epidermolysis Bullosa Dystrophica,C,C16.131.831.493.160,Epidermolysis Bullosa,Skin Abnormalities,1
Epidermolysis Bullosa Dystrophica,C,C16.320.850.275.160,Epidermolysis Bullosa,"Skin Diseases, Genetic",1
Epigen,D,D12.644.276.382.531,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,1
Epigen,D,D12.776.467.382.531,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,1
Epigen,D,D23.529.382.531,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,1
"Epilepsy, Complex Partial",C,C10.228.140.490.360.260,"Epilepsies, Partial",Epilepsy,1
"Epilepsy, Generalized",C,C10.228.140.490.375,Epilepsy,Brain Diseases,1
"Epilepsy, Temporal Lobe",C,C10.228.140.490.493.375,Epileptic Syndromes,Epilepsy,1
"Epilepsy, Temporal Lobe",C,C10.228.140.490.360.290,"Epilepsies, Partial",Epilepsy,1
Epiregulin,D,D23.529.382.562,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,1
Epiregulin,D,D12.776.467.382.562,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,1
Epiregulin,D,D12.644.276.382.562,EGF Family of Proteins,Intercellular Signaling Peptides and Proteins,1
Epithelial Attachment,A,A14.549.167.646.374,Periodontium,Dentition,1
Epoxide Hydrolases,D,D08.811.277.340,Hydrolases,Enzymes,1
Equidae,B,B01.050.150.900.649.313.984.235,Perissodactyla,Eutheria,1
Equipment and Supplies Utilization,E,E05.318.740.375,Statistics as Topic,Epidemiologic Methods,1
Equipment and Supplies Utilization,N,N05.715.360.750.338,Statistics as Topic,Health Care Evaluation Mechanisms,1
Equipment Safety,E,E05.330,Investigative Techniques,NULL,1
Eragrostis,B,B01.650.940.800.575.912.250.822.355,Poaceae,Magnoliopsida,1
Ergocalciferols,D,D04.210.500.812.768.462,Vitamin D,Secosteroids,1
Ergocalciferols,D,D04.210.500.247.808.412,Sterols,Cholestanes,1
Ergocalciferols,D,D04.210.500.247.222.474,Cholestenes,Cholestanes,1
Ergocalciferols,D,D10.570.938.439,Sterols,Membrane Lipids,1
Ergot Alkaloids,D,D03.132.327,Alkaloids,Heterocyclic Compounds,1
Ergotism,C,C25.723.680.262,Mycotoxicosis,Poisoning,1
Eritrea,Z,Z01.058.290.120.292,"Africa, Eastern",Africa South of the Sahara,1
Erlotinib Hydrochloride,D,D03.633.100.786.375,Quinazolines,"Heterocyclic Compounds, 2-Ring",1
Ertapenem,D,D03.633.100.300.124.225,Carbapenems,beta-Lactams,1
Ertapenem,D,D02.065.589.099.124.225,Carbapenems,beta-Lactams,1
Erucic Acids,D,D10.251.355.325.300,"Fatty Acids, Monounsaturated","Fatty Acids, Unsaturated",1
Erwinia,B,B03.440.450.425.300,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,1
Erwinia,B,B03.660.250.150.175,Enterobacteriaceae,Gammaproteobacteria,1
"Erythroblastosis, Fetal",C,C20.306,Immune System Diseases,NULL,1
"Erythroblastosis, Fetal",C,C16.614.304,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",1
"Erythroblastosis, Fetal",C,C16.300.060,Fetal Diseases,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",1
"Erythroblastosis, Fetal",C,C15.378.295,Hematologic Diseases,Hemic and Lymphatic Diseases,1
"Erythroblastosis, Fetal",C,C13.703.277.060,Fetal Diseases,Pregnancy Complications,1
Erythrocebus patas,B,B01.050.150.900.649.313.988.400.112.199.120.260.260,Erythrocebus,Cercopithecinae,1
"Erythrocytes, Abnormal",A,A15.145.229.334.330,Erythrocytes,Blood Cells,1
"Erythrocytes, Abnormal",A,A11.443.240.330,Erythrocytes,Erythroid Cells,1
"Erythrocytes, Abnormal",A,A11.118.290.330,Erythrocytes,Blood Cells,1
Escherichia,B,B03.440.450.425.325,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,1
Escherichia,B,B03.660.250.150.180,Enterobacteriaceae,Gammaproteobacteria,1
Escherichia coli K12,B,B03.660.250.150.180.100.360,Escherichia coli,Escherichia,1
Escherichia coli K12,B,B03.440.450.425.325.300.360,Escherichia coli,Escherichia,1
Esophageal Diseases,C,C06.405.117,Gastrointestinal Diseases,Digestive System Diseases,1
Esophageal Motility Disorders,C,C06.405.117.119.500,Deglutition Disorders,Esophageal Diseases,1
"Esophagitis, Peptic",C,C06.405.117.620.420,Esophagitis,Esophageal Diseases,1
"Esophagitis, Peptic",C,C06.405.205.663.420,Esophagitis,Gastroenteritis,1
"Esophagitis, Peptic",C,C06.405.469.275.800.523,Peptic Ulcer,Duodenal Diseases,1
"Esophagitis, Peptic",C,C06.405.748.586.524,Peptic Ulcer,Stomach Diseases,1
Esophagogastric Junction,A,A03.556.875.875.330,Stomach,Upper Gastrointestinal Tract,1
Esophagogastric Junction,A,A03.556.875.500.414,Esophagus,Upper Gastrointestinal Tract,1
"Esthetics, Dental",E,E06.420,Dentistry,NULL,1
Estrenes,D,D04.210.500.365.415,Estranes,Steroids,1
Estrogen Receptor beta,D,D12.776.826.750.350.262,"Receptors, Estrogen","Receptors, Steroid",1
"Estrogens, Conjugated (USP)",D,D06.472.334.851.437.988,Estradiol Congeners,Gonadal Steroid Hormones,1
Estuaries,G,G01.311.625.540,Oceans and Seas,Geological Phenomena,1
Ethane,D,D02.455.326.146.379,Alkanes,"Hydrocarbons, Acyclic",1
Ethanolamine,D,D02.092.063.291.375,Ethanolamines,Amino Alcohols,1
Ethanolamine,D,D02.033.100.291.375,Ethanolamines,Amino Alcohols,1
Ethanolamine,D,D02.033.375.291.375,Ethanolamines,Ethanol,1
Ether,D,D02.355.417.332,Ethyl Ethers,Ethers,1
Ethical Relativism,N,N05.350.247,Ethics,"Health Care Quality, Access, and Evaluation",1
Ethical Relativism,K,K01.752.566.479.116,Ethics,Morals,1
"Ethics, Dental",K,K01.752.566.479.171.132.500,"Ethics, Clinical","Ethics, Professional",1
"Ethics, Dental",K,K01.752.622.416,"Philosophy, Dental",Philosophy,1
"Ethics, Dental",N,N05.350.340.162.249,"Ethics, Clinical","Ethics, Professional",1
Ethidium,D,D03.633.300.633.416,Phenanthridines,"Heterocyclic Compounds, 3-Ring",1
Ethinyl Estradiol,D,D06.472.334.851.437.968.500,"Estrogenic Steroids, Alkylated",Estradiol Congeners,1
Ethinyl Estradiol,D,D04.210.500.668.651.568.291,Norpregnatrienes,Norpregnanes,1
Ethnobotany,H,H01.158.273.118.299,Botany,Biology,1
Ethyl Ethers,D,D02.355.417,Ethers,Organic Chemicals,1
Ethylenes,D,D02.455.326.271.367,Alkenes,"Hydrocarbons, Acyclic",1
ets-Domain Protein Elk-4,D,D12.776.260.665.600.300,Ternary Complex Factors,Proto-Oncogene Proteins c-ets,1
ets-Domain Protein Elk-4,D,D12.776.930.720.600.300,Ternary Complex Factors,Proto-Oncogene Proteins c-ets,1
ets-Domain Protein Elk-4,D,D12.776.624.664.700.175.600.300,Ternary Complex Factors,Proto-Oncogene Proteins c-ets,1
Eucalyptus,B,B01.650.940.800.575.912.250.773.366,Myrtaceae,Magnoliopsida,1
Euchromatin,A,A11.284.430.106.279.345.190.160.180.270,Chromatin,Chromosome Structures,1
Euchromatin,D,D12.776.664.224.270,Chromatin,Nucleoproteins,1
Euchromatin,G,G05.360.160.180.270,Chromatin,Chromosome Structures,1
Euglenozoa Infections,C,C01.610.752.300,Protozoan Infections,Parasitic Diseases,1
Eukaryotic Initiation Factor-3,D,D12.776.835.725.868.437,Eukaryotic Initiation Factors,Peptide Initiation Factors,1
Eukaryotic Initiation Factor-4F,D,D12.776.835.725.868.500,Eukaryotic Initiation Factors,Peptide Initiation Factors,1
Eukaryotic Initiation Factor-4F,D,D12.776.664.962.750.374,RNA Cap-Binding Proteins,RNA-Binding Proteins,1
Eukaryotic Initiation Factors,D,D12.776.835.725.868,Peptide Initiation Factors,Ribosomal Proteins,1
European Continental Ancestry Group,M,M01.686.508.400,Continental Population Groups,Population Groups,1
Euryarchaeota,B,B02.200,Archaea,NULL,1
"Euthanasia, Active",N,N02.421.585.905.199.500,Euthanasia,Terminal Care,1
"Euthanasia, Active",I,I01.880.735.344.500.249,Euthanasia,Homicide,1
"Euthanasia, Active",E,E02.760.905.199.249,Euthanasia,Terminal Care,1
"Euthanasia, Animal",E,E02.760.905.199.249.750,"Euthanasia, Active",Euthanasia,1
"Euthanasia, Animal",E,E05.335,Investigative Techniques,NULL,1
"Euthanasia, Animal",N,N02.421.585.905.199.500.750,"Euthanasia, Active",Euthanasia,1
"Event-Related Potentials, P300",G,G11.561.200.500.350,Evoked Potentials,Cortical Excitability,1
"Event-Related Potentials, P300",G,G07.265.216.500.350,Evoked Potentials,Cortical Excitability,1
Evidence-Based Emergency Medicine,H,H02.403.200.400.500,Evidence-Based Medicine,Clinical Medicine,1
Evidence-Based Emergency Medicine,H,H02.249.750.500,Evidence-Based Medicine,Evidence-Based Practice,1
"Evolution, Chemical",G,G01.060.275.500,"Evolution, Planetary",Astronomical Phenomena,1
"Evolution, Chemical",G,G02.225,Chemical Phenomena,NULL,1
Excitatory Amino Acid Agonists,D,D27.505.519.625.190.200,Excitatory Amino Acid Agents,Neurotransmitter Agents,1
Excitatory Amino Acid Agonists,D,D27.505.696.577.190.200,Excitatory Amino Acid Agents,Neurotransmitter Agents,1
Exenatide,D,D23.946.833.300,Venoms,"Toxins, Biological",1
Exenatide,D,D20.888.300,Venoms,Complex Mixtures,1
Exenatide,D,D12.644.187,Peptides,"Amino Acids, Peptides, and Proteins",1
Exocrine Glands,A,A10.336,Tissues,NULL,1
Exonucleases,D,D08.811.277.352.365,Esterases,Hydrolases,1
Exoskeleton Device,E,E07.341,Equipment and Supplies,NULL,1
Exotropia,C,C10.292.562.887.650,Strabismus,Ocular Motility Disorders,1
Exotropia,C,C11.590.810.440,Strabismus,Ocular Motility Disorders,1
Expectorants,D,D27.505.954.796.250,Respiratory System Agents,Therapeutic Uses,1
Explosions,N,N06.230.208,Environment,Environment and Public Health,1
Explosive Agents,D,D27.720.317,Specialty Uses of Chemicals,Chemical Actions and Uses,1
Exposome,N,N06.850.460.350.096,Environmental Exposure,Environmental Pollution,1
External Debt,N,N03.219.416,Economics,Health Care Economics and Organizations,1
External Fixators,E,E07.858.442.660.430,Orthopedic Fixation Devices,Orthopedic Equipment,1
External Fixators,E,E07.858.690.725.430,Orthopedic Fixation Devices,Surgical Fixation Devices,1
Extracellular Traps,A,A11.284.295.495,Extracellular Space,Cellular Structures,1
Extrachromosomal Inheritance,G,G05.420.275,Inheritance Patterns,Genetic Phenomena,1
Extraembryonic Membranes,A,A10.615.284,Membranes,Tissues,1
Extraembryonic Membranes,A,A16.254.750,"Embryo, Mammalian",Embryonic Structures,1
Eye Burns,C,C10.900.300.284.250.250,Eye Injuries,Facial Injuries,1
Eye Burns,C,C26.200.503,Burns,Wounds and Injuries,1
Eye Burns,C,C26.915.300.425.250.250,Eye Injuries,Facial Injuries,1
Eye Pain,C,C23.888.307.625,Eye Manifestations,Signs and Symptoms,1
Eye Pain,C,C23.888.592.612.316,Pain,Neurologic Manifestations,1
Eye Pain,C,C11.300.500,Eye Manifestations,Eye Diseases,1
Eye Protective Devices,J,J01.637.708.560.500,Personal Protective Equipment,Protective Devices,1
Eye Proteins,D,D12.776.306,Proteins,"Amino Acids, Peptides, and Proteins",1
Ezetimibe,D,D03.383.082.301.550,Azetidines,Azetines,1
"Ezetimibe, Simvastatin Drug Combination",D,D03.383.082.301.550.500,Ezetimibe,Azetidines,1
"Ezetimibe, Simvastatin Drug Combination",D,D02.455.426.559.847.638.400.900.500,Simvastatin,Lovastatin,1
"Ezetimibe, Simvastatin Drug Combination",D,D04.615.638.400.900.500,Simvastatin,Lovastatin,1
"Ezetimibe, Simvastatin Drug Combination",D,D26.310.431,Drug Combinations,Pharmaceutical Preparations,1
F Factor,G,G05.360.600.300,Plasmids,Genetic Structures,1
Facial Asymmetry,C,C23.300.505,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",1
Facial Nerve,A,A08.800.800.060.275,Autonomic Pathways,Peripheral Nerves,1
Facial Nerve,A,A08.800.800.120.250,Cranial Nerves,Peripheral Nerves,1
Facial Nerve,A,A08.800.050.600.149,Parasympathetic Nervous System,Autonomic Nervous System,1
Facial Nerve,A,A08.800.050.050.275,Autonomic Pathways,Autonomic Nervous System,1
Factor VIIIa,D,D23.119.350.300,Factor VIII,Blood Coagulation Factors,1
Factor VIIIa,D,D12.776.124.125.350.300,Factor VIII,Blood Coagulation Factors,1
Factor XI,D,D12.776.124.125.425,Blood Coagulation Factors,Blood Proteins,1
Factor XI,D,D08.622.490,Enzyme Precursors,Enzymes and Coenzymes,1
Factor XI,D,D23.119.425,Blood Coagulation Factors,Biological Factors,1
Factor XI,D,D12.776.811.243.490,Enzyme Precursors,Protein Precursors,1
Factor XII,D,D12.776.811.243.500,Enzyme Precursors,Protein Precursors,1
Factor XII,D,D23.119.450,Blood Coagulation Factors,Biological Factors,1
Factor XII,D,D08.622.500,Enzyme Precursors,Enzymes and Coenzymes,1
Factor XII,D,D12.776.124.125.450,Blood Coagulation Factors,Blood Proteins,1
"Faculty, Dental",N,N02.360.360,Health Personnel,"Health Care Facilities, Manpower, and Services",1
"Faculty, Dental",M,M01.526.485.360,Health Personnel,Occupational Groups,1
"Faculty, Dental",M,M01.526.702.250.273,Faculty,Educational Personnel,1
Famciclovir,D,D03.633.100.759.138.703,Adenine,Purines,1
Family Nurse Practitioners,M,M01.526.485.650.640.249,Nurse Practitioners,Nurses,1
Family Nurse Practitioners,N,N02.360.650.640.249,Nurse Practitioners,Nurses,1
Famine,J,J01.576.423.750.500,Food Supply,Food Industry,1
Fanconi Anemia,C,C15.378.190.223.500.500.280,"Anemia, Hypoplastic, Congenital",Congenital Bone Marrow Failure Syndromes,1
Fanconi Anemia,C,C15.378.071.085.080.280,"Anemia, Hypoplastic, Congenital","Anemia, Aplastic",1
Fanconi Anemia,C,C16.320.077.280,"Anemia, Hypoplastic, Congenital","Genetic Diseases, Inborn",1
Fanconi Anemia,C,C18.452.284.280,DNA Repair-Deficiency Disorders,Metabolic Diseases,1
Fanconi Anemia Complementation Group C Protein,D,D12.776.313.750,Fanconi Anemia Complementation Group Proteins,Proteins,1
Fanconi Anemia Complementation Group Proteins,D,D12.776.313,Proteins,"Amino Acids, Peptides, and Proteins",1
Fanconi Syndrome,C,C16.320.831.450,"Renal Tubular Transport, Inborn Errors","Genetic Diseases, Inborn",1
Fanconi Syndrome,C,C13.351.968.419.815.450,"Renal Tubular Transport, Inborn Errors",Kidney Diseases,1
Fanconi Syndrome,C,C12.777.419.815.450,"Renal Tubular Transport, Inborn Errors",Kidney Diseases,1
Farnesyl-Diphosphate Farnesyltransferase,D,D08.811.913.225.431,Alkyl and Aryl Transferases,Transferases,1
Fasciculation,C,C10.597.613.250,Neuromuscular Manifestations,Neurologic Manifestations,1
Fasciculation,C,C23.888.592.608.250,Neuromuscular Manifestations,Neurologic Manifestations,1
Fasciola hepatica,B,B01.050.500.500.736.715.408.380.420,Fasciola,Fasciolidae,1
Fascism,I,I01.696.480,Political Systems,Social Sciences,1
Fat Body,A,A13.365,Animal Structures,NULL,1
Fatty Acid Binding Protein 3,D,D12.776.157.170.125,Fatty Acid-Binding Proteins,Carrier Proteins,1
Fatty Acid Elongases,D,D08.811.913.050.134.343,Acetyltransferases,Acyltransferases,1
"Fatty Acids, Volatile",D,D10.251.400,Fatty Acids,Lipids,1
Feathers,A,A13.370,Animal Structures,NULL,1
Fecal Microbiota Transplantation,E,E02.095.231,Biological Therapy,Therapeutics,1
Feeder Cells,A,A11.251.538,"Cells, Cultured",Cells,1
"Fees, Pharmaceutical",N,N03.219.442.551,Fees and Charges,Economics,1
Feline Infectious Peritonitis,C,C01.925.782.600.550.200.360,Coronavirus Infections,Coronaviridae Infections,1
Feline Infectious Peritonitis,C,C22.180.440,Cat Diseases,Animal Diseases,1
Feline Panleukopenia,C,C22.180.460,Cat Diseases,Animal Diseases,1
Feline Panleukopenia,C,C01.925.256.700.363,Parvoviridae Infections,DNA Virus Infections,1
Feline Panleukopenia Virus,B,B04.280.580.650.600.325,Parvovirus,Parvovirinae,1
Femoracetabular Impingement,C,C05.550.384,Joint Diseases,Musculoskeletal Diseases,1
Femoracetabular Impingement,C,C23.550.347,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",1
Femur Head,A,A02.835.232.043.150.343,Femur,Bones of Lower Extremity,1
Ferns,B,B01.650.940.800.575.912.063,Tracheophyta,Embryophyta,1
Ferrets,B,B01.050.150.900.649.313.750.250.575.350,Mustelidae,Caniformia,1
Fertile Period,G,G08.686.605.154,Menstrual Cycle,Reproductive Physiological Phenomena,1
Fertility Preservation,E,E05.820.800.625,"Reproductive Techniques, Assisted",Reproductive Techniques,1
Fertility Preservation,E,E02.875.800.625,"Reproductive Techniques, Assisted",Reproductive Techniques,1
Fertility Preservation,E,E04.936.537.562,Tissue and Organ Harvesting,Transplantation,1
Fetal Heart,A,A16.378.303,Fetus,Embryonic Structures,1
Fetal Heart,A,A07.541.278,Heart,Cardiovascular System,1
Fetal Proteins,D,D12.776.320,Proteins,"Amino Acids, Peptides, and Proteins",1
Fetal Resorption,C,C23.550.260.585.260,Fetal Death,Death,1
Fetal Resorption,C,C13.703.223.300,Fetal Death,Pregnancy Complications,1
Fetal Tissue Transplantation,E,E02.095.147.725.300,Tissue Transplantation,Cell- and Tissue-Based Therapy,1
Fetal Tissue Transplantation,E,E04.936.580.300,Tissue Transplantation,Transplantation,1
Fetal Viability,G,G08.686.220,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,1
Fetal Viability,G,G07.345.500.325.235.875,Fetal Development,Embryonic and Fetal Development,1
Fetal Viability,G,G07.280,Physiological Phenomena,NULL,1
Fetofetal Transfusion,C,C15.378.071.363.344,"Anemia, Neonatal",Anemia,1
Fetofetal Transfusion,C,C16.614.053.344,"Anemia, Neonatal","Infant, Newborn, Diseases",1
Fibric Acids,D,D02.355.726.305,Phenyl Ethers,Ethers,1
Fibric Acids,D,D02.455.426.559.389.657.654.305,Phenyl Ethers,Phenols,1
Fibric Acids,D,D02.241.081.114.968.500,Isobutyrates,Butyrates,1
Fibrillar Collagens,D,D12.776.860.300.250.300,Collagen,Extracellular Matrix Proteins,1
Fibrillar Collagens,D,D05.750.078.280.300,Collagen,Biopolymers,1
Fibrillin-1,D,D12.776.395.341.500,Fibrillins,Glycoproteins,1
Fibrillin-1,D,D09.400.430.875.500,Fibrillins,Glycoproteins,1
Fibrillin-1,D,D12.776.860.300.400.500,Fibrillins,Extracellular Matrix Proteins,1
Fibroblast Growth Factor 5,D,D12.776.467.624.150,Fibroblast Growth Factors,Intercellular Signaling Peptides and Proteins,1
Fibroblast Growth Factor 5,D,D23.529.624.150,Fibroblast Growth Factors,Intercellular Signaling Peptides and Proteins,1
Fibroblast Growth Factor 5,D,D12.644.276.624.150,Fibroblast Growth Factors,Intercellular Signaling Peptides and Proteins,1
Fibrosarcoma,C,C04.557.450.565.590.350,"Neoplasms, Fibrous Tissue","Neoplasms, Connective Tissue",1
Fibrosarcoma,C,C04.557.450.795.350,Sarcoma,"Neoplasms, Connective and Soft Tissue",1
Filgrastim,D,D12.644.276.374.410.240.350.500,Granulocyte Colony-Stimulating Factor,Colony-Stimulating Factors,1
Filgrastim,D,D12.776.395.240.200.500,Granulocyte Colony-Stimulating Factor,Colony-Stimulating Factors,1
Filgrastim,D,D23.529.374.410.240.350.500,Granulocyte Colony-Stimulating Factor,Colony-Stimulating Factors,1
Filgrastim,D,D12.776.467.374.410.240.350.500,Granulocyte Colony-Stimulating Factor,Colony-Stimulating Factors,1
Film Dosimetry,E,E05.799.638.420,Radiation Monitoring,Radiometry,1
Film Dosimetry,N,N06.850.810.370.310,Radiation Monitoring,Radiologic Health,1
"Financial Management, Hospital",N,N03.219.463.280,Financial Management,Economics,1
"Financial Management, Hospital",N,N02.278.216.500.875,Hospital Administration,Health Facility Administration,1
"Financial Management, Hospital",N,N04.452.442.452.180,Hospital Administration,Health Facility Administration,1
Financial Statements,N,N03.219.463.030.140,Accounting,Financial Management,1
"Financing, Construction",N,N03.219.463.300,Financial Management,Economics,1
Finger Phalanges,A,A02.835.232.087.319.350,Hand Bones,Bones of Upper Extremity,1
Fingolimod Hydrochloride,D,D02.092.063.700.350,Sphingosine,Amino Alcohols,1
Fingolimod Hydrochloride,D,D02.033.100.700.350,Sphingosine,Amino Alcohols,1
Fingolimod Hydrochloride,D,D02.033.455.706.431,Propylene Glycols,Glycols,1
Fire Extinguishing Systems,N,N06.230.216.500,Fires,Environment,1
Firefly Luciferin,D,D03.383.129.708.298,Thiazoles,Azoles,1
Firefly Luciferin,D,D02.886.675.298,Thiazoles,Sulfur Compounds,1
Firmicutes,B,B03.353,Bacteria,NULL,1
Fish Proteins,D,D12.776.325,Proteins,"Amino Acids, Peptides, and Proteins",1
Fish Venoms,D,D20.888.370,Venoms,Complex Mixtures,1
Fish Venoms,D,D23.946.833.370,Venoms,"Toxins, Biological",1
Fish Venoms,D,D23.946.580.370,Marine Toxins,"Toxins, Biological",1
Fissure in Ano,C,C06.405.469.860.101.430,Anus Diseases,Rectal Diseases,1
Fitness Trackers,E,E07.230.300,Diagnostic Equipment,Equipment and Supplies,1
Fitness Trackers,E,E07.305.906.250,Wearable Electronic Devices,Electrical Equipment and Supplies,1
"Fixation, Ocular",G,G14.350.253,Eye Movements,Ocular Physiological Phenomena,1
Flatfishes,B,B01.050.150.900.493.418,Fishes,Vertebrates,1
Flavanones,D,D03.633.100.150.266.450.252,Flavonoids,Chromones,1
Flavanones,D,D03.383.663.283.266.450.252,Flavonoids,Chromones,1
Flavin-Adenine Dinucleotide,D,D03.633.100.733.315.650.249,Riboflavin,Flavins,1
Flavin-Adenine Dinucleotide,D,D03.633.300.507.650.249,Riboflavin,Flavins,1
Flavin-Adenine Dinucleotide,D,D03.633.100.759.646.138.506,Adenine Nucleotides,Purine Nucleotides,1
Flavin-Adenine Dinucleotide,D,D08.211.474.650.249,Riboflavin,Flavins,1
Flavin-Adenine Dinucleotide,D,D23.767.405.650.249,Riboflavin,Flavins,1
Flavin-Adenine Dinucleotide,D,D13.695.667.138.506,Adenine Nucleotides,Purine Nucleotides,1
Flavin-Adenine Dinucleotide,D,D13.695.827.068.506,Adenine Nucleotides,Ribonucleotides,1
Flavoproteins,D,D12.776.331,Proteins,"Amino Acids, Peptides, and Proteins",1
Flea Infestations,C,C01.610.858.211.250,Ectoparasitic Infestations,"Skin Diseases, Parasitic",1
Flecainide,D,D03.383.621.270,Piperidines,"Heterocyclic Compounds, 1-Ring",1
Flocculation,E,E05.196.150.347,Chemical Precipitation,"Chemistry Techniques, Analytical",1
Flocculation,G,G02.159.347,Chemical Precipitation,Chemical Phenomena,1
Flowers,A,A18.024.249.500,Flowering Tops,"Plant Components, Aerial",1
Floxacillin,D,D02.065.589.099.750.625.150.250,Cloxacillin,Oxacillin,1
Floxacillin,D,D03.633.100.300.750.625.150.250,Cloxacillin,Oxacillin,1
Floxacillin,D,D02.886.108.750.625.150.250,Cloxacillin,Oxacillin,1
Flufenamic Acid,D,D02.241.223.100.050.400.200.249,Fenamates,ortho-Aminobenzoates,1
Flufenamic Acid,D,D02.455.426.559.389.127.020.906.750.249,Fenamates,ortho-Aminobenzoates,1
Fluorescein,D,D02.455.426.779.347.390,Fluoresceins,Spiro Compounds,1
Fluorescein,D,D03.633.300.953.275.390,Fluoresceins,Xanthenes,1
Fluorescein,D,D04.711.347.390,Fluoresceins,Spiro Compounds,1
Flushing,C,C23.888.885.344,Skin Manifestations,Signs and Symptoms,1
Fluvoxamine,D,D02.092.570.665.250,Oximes,Hydroxylamines,1
fms-Like Tyrosine Kinase 3,D,D08.811.913.696.620.682.725.400.020,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,1
fms-Like Tyrosine Kinase 3,D,D12.776.624.664.700.114,Proto-Oncogene Proteins,Oncogene Proteins,1
fms-Like Tyrosine Kinase 3,D,D12.776.543.750.630.020,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",1
Focal Infection,C,C01.392,Infections,NULL,1
Folic Acid Transporters,D,D12.776.543.585.450.074.500.224,Organic Anion Transporters,Anion Transport Proteins,1
Folic Acid Transporters,D,D12.776.157.530.450.074.500.299,Organic Anion Transporters,Anion Transport Proteins,1
Fondaparinux,D,D09.698.629.429,Oligosaccharides,Polysaccharides,1
Food Deserts,J,J01.576.423.750.594,Food Supply,Food Industry,1
Food Deserts,J,J02.750.500,Sustenance,Food and Beverages,1
Food Inspection,J,J01.576.423.850.730.500.500,Food Safety,Food Quality,1
Food Inspection,N,N06.850.780.200.800.325,Sanitation,Communicable Disease Control,1
Food Inspection,N,N06.850.601.500.500,Food Safety,Food Quality,1
Food Irradiation,J,J01.576.423.850.700.700.500,Pasteurization,Food Preservation,1
Food Packaging,J,J01.576.423.850.600,Food Technology,Food Industry,1
Food Packaging,J,J01.576.423.200.375,Food Handling,Food Industry,1
Food Packaging,J,J01.576.761.400,Product Packaging,Industry,1
"Food Service, Hospital",J,J01.576.423.500.300,Food Services,Food Industry,1
"Food Service, Hospital",N,N04.452.442.452.422.374,Hospital Departments,Hospital Administration,1
"Food Service, Hospital",N,N02.421.242.472,Dietary Services,Health Services,1
"Food Service, Hospital",N,N02.278.216.500.968.374,Hospital Departments,Hospital Administration,1
"Foot Deformities, Acquired",C,C05.330.488,Foot Deformities,Musculoskeletal Diseases,1
Forearm Injuries,C,C26.088.268,Arm Injuries,Wounds and Injuries,1
Foreign Bodies,C,C26.392,Wounds and Injuries,NULL,1
Forensic Anthropology,I,I01.076.368.400,"Anthropology, Physical",Anthropology,1
Forensic Anthropology,I,I01.198.780.750,Forensic Sciences,Criminology,1
Forensic Genetics,I,I01.198.780.937.441,Forensic Medicine,Forensic Sciences,1
Forensic Genetics,H,H02.403.330.149,Forensic Medicine,Medicine,1
Forensic Psychiatry,H,H02.403.690.208,Psychiatry,Medicine,1
Forensic Psychiatry,I,I01.198.780.937.469,Forensic Medicine,Forensic Sciences,1
Forensic Psychiatry,I,I01.880.604.583.310,Jurisprudence,"Social Control, Formal",1
Forensic Psychiatry,N,N03.706.535.351,Jurisprudence,"Social Control, Formal",1
Forensic Psychiatry,F,F04.096.544.335,Psychiatry,Behavioral Sciences,1
Forensic Sciences,I,I01.198.780,Criminology,Social Sciences,1
Form Perception,F,F02.463.593.778.435,Space Perception,Perception,1
Form Perception,F,F02.463.593.373,Perception,Mental Processes,1
Formazans,D,D02.172.600,Azo Compounds,Organic Chemicals,1
Fossils,I,I01.076.368.584.311,Paleontology,"Anthropology, Physical",1
Fournier Gangrene,C,C12.294.229,"Genital Diseases, Male",Male Urogenital Diseases,1
Fournier Gangrene,C,C01.150.252.377,Bacterial Infections,Bacterial Infections and Mycoses,1
Fowlpox virus,B,B04.280.650.160.100.300,Avipoxvirus,Chordopoxvirinae,1
Foxes,B,B01.050.150.900.649.313.750.250.216.250,Canidae,Caniformia,1
"Fracture Fixation, Intramedullary",E,E04.555.300.300.300,"Fracture Fixation, Internal",Fracture Fixation,1
"Fractures, Closed",C,C26.404.124,"Fractures, Bone",Wounds and Injuries,1
"Fractures, Open",C,C26.404.311,"Fractures, Bone",Wounds and Injuries,1
"Fractures, Spontaneous",C,C26.404.374,"Fractures, Bone",Wounds and Injuries,1
"Fractures, Ununited",C,C26.404.468,"Fractures, Bone",Wounds and Injuries,1
Fragaria,B,B01.650.940.800.575.912.250.859.937.500.266,Rosaceae,Rosales,1
Fragile X Syndrome,C,C10.597.606.360.455.500,"Mental Retardation, X-Linked",Intellectual Disability,1
Fragile X Syndrome,C,C16.320.180.830.300,Sex Chromosome Disorders,Chromosome Disorders,1
Fragile X Syndrome,C,C16.320.322.500.500,"Mental Retardation, X-Linked","Genetic Diseases, X-Linked",1
Fragile X Syndrome,C,C16.320.400.525.500,"Mental Retardation, X-Linked","Heredodegenerative Disorders, Nervous System",1
Fragile X Syndrome,C,C16.131.260.830.300,Sex Chromosome Disorders,Chromosome Disorders,1
Free Tissue Flaps,A,A10.850.710.500,Surgical Flaps,Surgically-Created Structures,1
Free Tissue Flaps,E,E07.862.710.500,Surgical Flaps,Surgically-Created Structures,1
Freeze Etching,E,E05.200.500.620.620.260.400,Freeze Fracturing,Replica Techniques,1
Freeze Etching,E,E05.200.750.600.620.260.400,Freeze Fracturing,Replica Techniques,1
Freeze Etching,E,E01.370.225.500.620.620.260.400,Freeze Fracturing,Replica Techniques,1
Freeze Etching,E,E01.370.225.750.600.620.260.400,Freeze Fracturing,Replica Techniques,1
Freshwater Biology,H,H01.277.625.500,Limnology,Earth Sciences,1
Freshwater Biology,H,H01.277.249.750.249,Hydrobiology,Ecology,1
Freshwater Biology,H,H01.158.273.248.750.249,Hydrobiology,Ecology,1
Frozen Sections,E,E05.200.750.600.530.160.260,Cryoultramicrotomy,Microtomy,1
Frozen Sections,E,E05.200.500.620.530.160.260,Cryoultramicrotomy,Microtomy,1
Frozen Sections,E,E01.370.225.750.600.530.160.260,Cryoultramicrotomy,Microtomy,1
Frozen Sections,E,E01.370.225.500.620.530.160.260,Cryoultramicrotomy,Microtomy,1
Fructose,D,D09.947.875.359.250,Hexoses,Monosaccharides,1
Fructose,D,D09.947.875.465.354,Ketoses,Monosaccharides,1
Fructose-Bisphosphatase,D,D08.811.277.352.650.200,Phosphoric Monoester Hydrolases,Esterases,1
Fructose-Bisphosphate Aldolase,D,D08.811.520.224.062.400,Aldehyde-Lyases,Carbon-Carbon Lyases,1
Fuel Oils,D,D20.345.630.500,Petroleum,Fossil Fuels,1
Fuel Oils,N,N06.230.132.258.630.500,Petroleum,Fossil Fuels,1
Furaldehyde,D,D03.383.312.355,Furans,"Heterocyclic Compounds, 1-Ring",1
Furaldehyde,D,D02.047.466,Aldehydes,Organic Chemicals,1
Furazolidone,D,D03.383.312.649.313,Nitrofurans,Furans,1
Furazolidone,D,D02.640.600.313,Nitrofurans,Nitro Compounds,1
Furazolidone,D,D03.383.129.462.600.500,Oxazolidinones,Oxazoles,1
Furunculosis,C,C22.362.224,Fish Diseases,Animal Diseases,1
Furunculosis,C,C17.800.838.765.770.270,Staphylococcal Skin Infections,"Skin Diseases, Bacterial",1
Furunculosis,C,C01.800.720.770.270,Staphylococcal Skin Infections,"Skin Diseases, Bacterial",1
Furunculosis,C,C01.150.252.819.770.270,Staphylococcal Skin Infections,"Skin Diseases, Bacterial",1
Furunculosis,C,C01.150.252.410.868.951.270,Staphylococcal Skin Infections,Staphylococcal Infections,1
Fusariosis,C,C01.150.703.302.383.500,Hyalohyphomycosis,Dermatomycoses,1
Fusariosis,C,C01.800.200.383.500,Hyalohyphomycosis,Dermatomycoses,1
Fusariosis,C,C17.800.838.208.416.500,Hyalohyphomycosis,Dermatomycoses,1
Fusobacteria,B,B03.370,Bacteria,NULL,1
Fusobacterium,B,B03.370.250,Fusobacteria,Bacteria,1
Fusobacterium,B,B03.440.425.410.420,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",Gram-Negative Anaerobic Bacteria,1
Fusobacterium Infections,C,C01.150.252.400.388.350,Fusobacteriaceae Infections,Gram-Negative Bacterial Infections,1
Fusobacterium necrophorum,B,B03.440.425.410.420.400,Fusobacterium,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",1
Fusobacterium necrophorum,B,B03.370.250.400,Fusobacterium,Fusobacteria,1
Fusobacterium nucleatum,B,B03.370.250.500,Fusobacterium,Fusobacteria,1
Fusobacterium nucleatum,B,B03.440.425.410.420.500,Fusobacterium,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",1
G1 Phase Cell Cycle Checkpoints,G,G04.144.500.320.500,G1 Phase,Interphase,1
G1 Phase Cell Cycle Checkpoints,G,G04.144.109.249,Cell Cycle Checkpoints,Cell Cycle,1
G2 Phase,G,G04.144.500.340,Interphase,Cell Cycle,1
Galanin,D,D12.644.400.250,Neuropeptides,Peptides,1
Galanin,D,D12.776.631.650.250,Neuropeptides,Nerve Tissue Proteins,1
Galectin 1,D,D12.776.503.307.100,Galectins,Lectins,1
Gallium,D,D01.552.544.289,"Metals, Heavy",Metals,1
Gallium,D,D01.268.556.289,"Metals, Heavy",Elements,1
Gallium Radioisotopes,D,D01.268.556.289.500.400,Gallium Isotopes,Gallium,1
Gallium Radioisotopes,D,D01.552.544.289.500.400,Gallium Isotopes,Gallium,1
Gallium Radioisotopes,D,D01.496.749.360,Radioisotopes,Isotopes,1
Gallium Radioisotopes,D,D01.496.360.400,Gallium Isotopes,Isotopes,1
Galphimia,B,B01.650.940.800.575.912.250.859.797.690.355,Malpighiaceae,Malpighiales,1
gamma-Globins,D,D12.776.422.316.762.403.325.500,beta-Globins,Hemoglobin Subunits,1
gamma-Globins,D,D12.776.124.400.434.325.500,beta-Globins,Hemoglobin Subunits,1
gamma-Synuclein,D,D12.776.631.860.750,Synucleins,Nerve Tissue Proteins,1
gamma-Tocopherol,D,D03.383.663.283.909.750.500,Tocopherols,Vitamin E,1
gamma-Tocopherol,D,D03.633.100.150.909.750.500,Tocopherols,Vitamin E,1
Gangliosides,D,D10.570.877.360.025.475,Acidic Glycosphingolipids,Glycosphingolipids,1
Gangliosides,D,D10.390.470.025.475,Acidic Glycosphingolipids,Glycosphingolipids,1
Gangliosides,D,D09.400.410.420.025.475,Acidic Glycosphingolipids,Glycosphingolipids,1
Gardening,I,I03.450.642.581.500,Horticulture,Recreation,1
Gardening,J,J01.040.498.500,Horticulture,Agriculture,1
Garlic,B,B01.650.940.800.575.912.250.618.100.050.060.300,Allium,Amaryllidaceae,1
Gas Gangrene,C,C01.150.252.410.222.440,Clostridium Infections,Gram-Positive Bacterial Infections,1
Gastric Emptying,G,G10.261.360.400,Gastrointestinal Motility,Digestive System Physiological Phenomena,1
Gastric Juice,A,A12.200.307,Bodily Secretions,Fluids and Secretions,1
Gastric Lavage,E,E05.927.441,Therapeutic Irrigation,Investigative Techniques,1
Gastric Mucins,D,D12.776.395.560.631.100,Mucins,Mucoproteins,1
Gastrin-Releasing Peptide,D,D12.644.400.315,Neuropeptides,Peptides,1
Gastrin-Releasing Peptide,D,D06.472.317.410,Gastrointestinal Hormones,Hormones,1
Gastrin-Releasing Peptide,D,D12.776.631.650.315,Neuropeptides,Nerve Tissue Proteins,1
Gastrins,D,D12.776.631.650.320,Neuropeptides,Nerve Tissue Proteins,1
Gastrins,D,D06.472.317.413,Gastrointestinal Hormones,Hormones,1
Gastrins,D,D06.472.699.280,Peptide Hormones,Hormones,1
Gastrins,D,D12.644.400.320,Neuropeptides,Peptides,1
Gastrins,D,D12.644.548.280,Peptide Hormones,Peptides,1
"Gastritis, Atrophic",C,C06.405.205.697.394,Gastritis,Gastroenteritis,1
"Gastritis, Atrophic",C,C06.405.748.398.394,Gastritis,Stomach Diseases,1
Gastrointestinal Absorption,G,G07.690.725.015.500.374,"Absorption, Physiological",Absorption,1
Gastrointestinal Absorption,G,G07.203.650.372,Nutritional Physiological Phenomena,"Diet, Food, and Nutrition",1
Gastrointestinal Absorption,G,G03.787.024.500.374,"Absorption, Physiological",Absorption,1
Gastrointestinal Absorption,G,G03.015.500.374,"Absorption, Physiological",Absorption,1
Gastrointestinal Absorption,G,G10.261.353,Digestive System Physiological Phenomena,Digestive System and Oral Physiological Phenomena,1
Gastrointestinal Hormones,D,D06.472.317,Hormones,"Hormones, Hormone Substitutes, and Hormone Antagonists",1
Gastrointestinal Stromal Tumors,C,C06.405.249.308,Gastrointestinal Neoplasms,Gastrointestinal Diseases,1
Gastrointestinal Stromal Tumors,C,C06.301.371.308,Gastrointestinal Neoplasms,Digestive System Neoplasms,1
Gastrointestinal Stromal Tumors,C,C04.557.450.565.370,"Neoplasms, Connective Tissue","Neoplasms, Connective and Soft Tissue",1
Gastroplasty,E,E02.650.500.062.750,Bariatric Surgery,Bariatrics,1
Gastroplasty,E,E04.210.485,Digestive System Surgical Procedures,"Surgical Procedures, Operative",1
Gastroplasty,E,E04.062.750,Bariatric Surgery,"Surgical Procedures, Operative",1
Gastropoda,B,B01.050.500.644.400,Mollusca,Invertebrates,1
Gastroscopy,E,E01.370.388.250.250.250.320,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
Gastroscopy,E,E01.370.372.250.250.325,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
Gastroscopy,E,E04.210.240.250.320,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
Gastroscopy,E,E04.502.250.250.250.320,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
GATA Transcription Factors,D,D12.776.930.314,Transcription Factors,Proteins,1
GATA Transcription Factors,D,D12.776.260.257,DNA-Binding Proteins,Proteins,1
GATA5 Transcription Factor,D,D12.776.260.257.500,GATA Transcription Factors,DNA-Binding Proteins,1
GATA5 Transcription Factor,D,D12.776.930.314.500,GATA Transcription Factors,Transcription Factors,1
GATA6 Transcription Factor,D,D12.776.930.314.600,GATA Transcription Factors,Transcription Factors,1
GATA6 Transcription Factor,D,D12.776.260.257.600,GATA Transcription Factors,DNA-Binding Proteins,1
GB virus C,B,B04.820.578.344.588.750,Pegivirus,Flaviviridae,1
Gefitinib,D,D03.633.100.786.469,Quinazolines,"Heterocyclic Compounds, 2-Ring",1
Gelsolin,D,D05.750.078.730.350,Microfilament Proteins,Biopolymers,1
Gelsolin,D,D12.776.220.525.350,Microfilament Proteins,Cytoskeletal Proteins,1
Gelsolin,D,D12.776.157.125.412.437,Intracellular Calcium-Sensing Proteins,Calcium-Binding Proteins,1
Gelsolin,D,D12.644.360.372.437,Intracellular Calcium-Sensing Proteins,Intracellular Signaling Peptides and Proteins,1
Gelsolin,D,D12.776.476.387.437,Intracellular Calcium-Sensing Proteins,Intracellular Signaling Peptides and Proteins,1
Gene Components,G,G05.360.340.024.340.137,Genes,Genome Components,1
"Gene Expression Regulation, Fungal",G,G05.308.330,Gene Expression Regulation,Genetic Phenomena,1
"Gene Expression Regulation, Leukemic",G,G05.308.370.500,"Gene Expression Regulation, Neoplastic",Gene Expression Regulation,1
"Gene Expression Regulation, Plant",G,G05.308.375,Gene Expression Regulation,Genetic Phenomena,1
"Gene Products, nef",D,D12.776.964.775.362,Retroviridae Proteins,Viral Proteins,1
"Gene Products, nef",D,D12.776.964.925.500,Viral Regulatory and Accessory Proteins,Viral Proteins,1
"Gene Products, vpr",D,D12.776.964.925.984.430,Trans-Activators,Viral Regulatory and Accessory Proteins,1
"Gene Rearrangement, B-Lymphocyte, Heavy Chain",G,G05.344.401.501,"Gene Rearrangement, B-Lymphocyte",Gene Rearrangement,1
"Gene Rearrangement, B-Lymphocyte, Heavy Chain",G,G12.500.274.501,"Gene Rearrangement, B-Lymphocyte",Immunogenetic Phenomena,1
"Gene Rearrangement, B-Lymphocyte, Light Chain",G,G12.500.274.601,"Gene Rearrangement, B-Lymphocyte",Immunogenetic Phenomena,1
"Gene Rearrangement, B-Lymphocyte, Light Chain",G,G05.344.401.601,"Gene Rearrangement, B-Lymphocyte",Gene Rearrangement,1
Genealogy and Heraldry,K,K01.400.359,History,Humanities,1
"Genes, APC",G,G05.360.340.024.340.375.249.050,"Genes, Tumor Suppressor","Genes, Neoplasm",1
"Genes, APC",G,G05.360.340.024.340.415.400.050,"Genes, Tumor Suppressor","Genes, Recessive",1
"Genes, bcl-2",G,G05.360.340.024.340.375.500.791.150,Proto-Oncogenes,Oncogenes,1
"Genes, cdc",G,G05.360.340.024.340.220,Genes,Genome Components,1
"Genes, Developmental",G,G05.360.340.024.340.230,Genes,Genome Components,1
"Genes, erbB",G,G05.360.340.024.340.375.500.791.295,Proto-Oncogenes,Oncogenes,1
"Genes, fos",G,G05.360.340.024.340.375.500.791.330,Proto-Oncogenes,Oncogenes,1
"Genes, Homeobox",G,G05.360.340.024.340.230.500,"Genes, Developmental",Genes,1
"Genes, myc",G,G05.360.340.024.340.375.500.791.420,Proto-Oncogenes,Oncogenes,1
"Genes, Neoplasm",G,G05.360.340.024.340.375,Genes,Genome Components,1
"Genes, p16",G,G05.360.340.024.340.375.249.375,"Genes, Tumor Suppressor","Genes, Neoplasm",1
"Genes, p16",G,G05.360.340.024.340.415.400.375,"Genes, Tumor Suppressor","Genes, Recessive",1
"Genes, pX",G,G05.360.340.024.340.364.875.735,"Genes, Viral","Genes, Microbial",1
"Genes, pX",G,G05.360.340.024.340.425.416,"Genes, Regulator",Genes,1
"Genes, pX",G,G05.360.340.358.024.875.735,"Genes, Viral","Genes, Microbial",1
"Genes, pX",G,G05.360.340.358.840.500.735,"Genes, Viral","Genome, Viral",1
"Genes, Retinoblastoma",G,G05.360.340.024.340.415.400.400,"Genes, Tumor Suppressor","Genes, Recessive",1
"Genes, Retinoblastoma",G,G05.360.340.024.340.375.249.400,"Genes, Tumor Suppressor","Genes, Neoplasm",1
"Genes, Synthetic",G,G05.360.340.024.340.465,Genes,Genome Components,1
"Genes, T-Cell Receptor",G,G05.360.340.024.340.475,Genes,Genome Components,1
"Genes, T-Cell Receptor beta",G,G05.360.340.024.340.475.080,"Genes, T-Cell Receptor",Genes,1
"Genes, T-Cell Receptor gamma",G,G05.360.340.024.340.475.400,"Genes, T-Cell Receptor",Genes,1
"Genes, Y-Linked",G,G05.360.340.024.340.515,Genes,Genome Components,1
"Genes, Y-Linked",G,G05.420.523,Inheritance Patterns,Genetic Phenomena,1
Genetic Background,G,G05.346,Genetic Phenomena,NULL,1
Genetic Enhancement,E,E05.104.500,Biomedical Enhancement,Investigative Techniques,1
Genetic Enhancement,E,E05.393.420.451,Genetic Engineering,Genetic Techniques,1
Genetic Enhancement,J,J01.897.120.050.250.500,Biomedical Enhancement,Biomedical Technology,1
Genetic Introgression,E,E05.820.150.390.500,"Hybridization, Genetic",Breeding,1
Genetic Introgression,G,G05.090.390.500,"Hybridization, Genetic",Breeding,1
Genetic Privacy,I,I01.880.604.583.080.320,Confidentiality,Jurisprudence,1
Genetic Privacy,I,I01.880.604.473.650.500.320,Confidentiality,Patient Rights,1
Genetic Privacy,I,I01.880.604.473.352.500.320,Privacy,Civil Rights,1
Genetic Privacy,N,N03.706.535.230.320,Confidentiality,Jurisprudence,1
Genetic Privacy,N,N03.706.437.650.124.320,Confidentiality,Patient Rights,1
Genetic Privacy,N,N03.706.437.352.500.320,Privacy,Civil Rights,1
Genetic Structures,G,G05.360,Genetic Phenomena,NULL,1
"Genome, Chloroplast",G,G05.360.340.370.200,"Genome, Plastid",Genome,1
Geological Phenomena,G,G01.311,Physical Phenomena,NULL,1
Geology,H,H01.277.562,Earth Sciences,Natural Science Disciplines,1
Geranyltranstransferase,D,D08.811.913.225.450,Alkyl and Aryl Transferases,Transferases,1
Geriatric Nursing,H,H02.478.676.236,"Specialties, Nursing",Nursing,1
Geriatric Nursing,N,N02.421.533.245,Nursing Care,Health Services,1
Germinal Center,A,A15.382.520.604.412.500,Lymph Nodes,Lymphoid Tissue,1
Germinal Center,A,A10.549.400.500,Lymph Nodes,Lymphoid Tissue,1
Germinal Center Kinases,D,D08.811.913.696.620.682.700.397,Protein-Serine-Threonine Kinases,Protein Kinases,1
Gestational Trophoblastic Disease,C,C04.557.465.955.416,Trophoblastic Neoplasms,"Neoplasms, Germ Cell and Embryonal",1
Gestational Trophoblastic Disease,C,C04.850.908.416,Trophoblastic Neoplasms,"Pregnancy Complications, Neoplastic",1
Gestational Trophoblastic Disease,C,C13.703.720.949.416,Trophoblastic Neoplasms,"Pregnancy Complications, Neoplastic",1
Gingiva,A,A14.549.167.646.480,Periodontium,Dentition,1
Gingival Diseases,C,C07.465.714.258,Periodontal Diseases,Mouth Diseases,1
"Gingivitis, Necrotizing Ulcerative",C,C07.465.714.258.480.446,Gingivitis,Gingival Diseases,1
"Gingivitis, Necrotizing Ulcerative",C,C01.150.252.400.388.350.350,Fusobacterium Infections,Fusobacteriaceae Infections,1
"Gingivitis, Necrotizing Ulcerative",C,C01.408.446,Gingivitis,Infections,1
Glare,G,G14.400,Ocular Physiological Phenomena,NULL,1
Glare,G,G01.590.540.333,Light,Optical Phenomena,1
Glatiramer Acetate,D,D12.644.219,Peptides,"Amino Acids, Peptides, and Proteins",1
Glial Cell Line-Derived Neurotrophic Factor,D,D12.644.276.860.381.500,Glial Cell Line-Derived Neurotrophic Factors,Nerve Growth Factors,1
Glial Cell Line-Derived Neurotrophic Factor,D,D12.776.631.600.381.500,Glial Cell Line-Derived Neurotrophic Factors,Nerve Growth Factors,1
Glial Cell Line-Derived Neurotrophic Factor,D,D12.776.467.860.381.500,Glial Cell Line-Derived Neurotrophic Factors,Nerve Growth Factors,1
Glial Cell Line-Derived Neurotrophic Factor,D,D23.529.850.381.500,Glial Cell Line-Derived Neurotrophic Factors,Nerve Growth Factors,1
"Glomerulonephritis, Membranous",C,C13.351.968.419.570.363.625,Glomerulonephritis,Nephritis,1
"Glomerulonephritis, Membranous",C,C12.777.419.570.363.625,Glomerulonephritis,Nephritis,1
"Glomerulonephritis, Membranous",C,C20.111.535,Autoimmune Diseases,Immune System Diseases,1
Glucagon,D,D12.644.548.586.730.500,Proglucagon,Pancreatic Hormones,1
Glucagon,D,D06.472.699.587.730.500,Proglucagon,Pancreatic Hormones,1
Glucagon-Like Peptides,D,D06.472.317.680.500,Proglucagon,Gastrointestinal Hormones,1
Glucagonoma,C,C19.344.421.500.249,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Glucagonoma,C,C06.689.667.500.249,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Glucagonoma,C,C06.301.761.500.249,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Glucagonoma,C,C04.588.322.475.500.249,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Glucagonoma,C,C04.588.274.761.500.249,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Glucagonoma,C,C04.557.470.200.025.290.750,"Carcinoma, Islet Cell",Adenocarcinoma,1
"Glucan 1,3-beta-Glucosidase",D,D08.811.277.450.420.200.500,Cellulases,Glucosidases,1
Glucocorticoid-Induced TNFR-Related Protein,D,D12.776.543.750.705.852.760.238,"Receptors, Tumor Necrosis Factor","Receptors, Cytokine",1
Gluconates,D,D09.811.308,Sugar Acids,Carbohydrates,1
Gluconates,D,D02.241.081.844.322,Sugar Acids,"Acids, Acyclic",1
Gluconates,D,D02.241.511.902.322,Sugar Acids,Hydroxy Acids,1
Gluconeogenesis,G,G02.111.158.500,Carbohydrate Metabolism,Biochemical Phenomena,1
Gluconeogenesis,G,G03.191.500,Carbohydrate Metabolism,Metabolism,1
Glucose Clamp Technique,E,E05.200.124.100.350,Blood Chemical Analysis,Clinical Chemistry Tests,1
Glucose Clamp Technique,E,E05.196.500,"Chemistry Techniques, Analytical",Investigative Techniques,1
Glucose Clamp Technique,E,E01.370.225.124.100.350,Blood Chemical Analysis,Clinical Chemistry Tests,1
Glucose Transporter Type 1,D,D12.776.543.585.500.500.500,"Glucose Transport Proteins, Facilitative",Monosaccharide Transport Proteins,1
Glucose Transporter Type 1,D,D12.776.543.585.937.625.500,"Glucose Transport Proteins, Facilitative",Solute Carrier Proteins,1
Glucose Transporter Type 1,D,D12.776.157.530.937.563.500,"Glucose Transport Proteins, Facilitative",Solute Carrier Proteins,1
Glucose Transporter Type 1,D,D12.776.157.530.500.500.500,"Glucose Transport Proteins, Facilitative",Monosaccharide Transport Proteins,1
Glucosidases,D,D08.811.277.450.420,Glycoside Hydrolases,Hydrolases,1
Glucosinolates,D,D02.886.740.703.350,Thioglucosides,Thioglycosides,1
Glucosinolates,D,D09.408.348.820.350,Thioglucosides,Glucosides,1
Glucosinolates,D,D09.408.903.703.350,Thioglucosides,Thioglycosides,1
Glucuronates,D,D09.811.922.162,Uronic Acids,Sugar Acids,1
Glucuronates,D,D02.241.511.902.915.162,Uronic Acids,Sugar Acids,1
Glucuronates,D,D02.241.081.844.915.162,Uronic Acids,Sugar Acids,1
Glucuronates,D,D02.241.152.811.162,Uronic Acids,"Acids, Aldehydic",1
Glutamate Carboxypeptidase II,D,D08.811.277.656.350.555.500,Metalloexopeptidases,Exopeptidases,1
Glutamate Carboxypeptidase II,D,D08.811.277.656.350.245.400,Carboxypeptidases,Exopeptidases,1
Glutamate Carboxypeptidase II,D,D08.811.277.656.675.555.500,Metalloexopeptidases,Metalloproteases,1
Glutaral,D,D02.047.532,Aldehydes,Organic Chemicals,1
Glutathione Disulfide,D,D12.644.456.448.500,Glutathione,Oligopeptides,1
Glutathione S-Transferase pi,D,D08.811.913.225.500.500,Glutathione Transferase,Alkyl and Aryl Transferases,1
Glycated Hemoglobin A,D,D09.400.430.937,Glycoproteins,Glycoconjugates,1
Glycated Hemoglobin A,D,D12.776.395.381,Glycoproteins,Proteins,1
Glycated Hemoglobin A,D,D12.776.124.400.405.440,Hemoglobin A,Hemoglobins,1
Glycated Hemoglobin A,D,D12.776.422.316.762.380.440,Hemoglobin A,Hemoglobins,1
"Glycation End Products, Advanced",D,D12.776.643.500,Protein Degradation End Products,Proteins,1
Glycerol Kinase,D,D08.811.913.696.620.275,Phosphotransferases (Alcohol Group Acceptor),Phosphotransferases,1
Glycerylphosphorylcholine,D,D09.853.875.750.449,Glycerophosphates,Triose Sugar Alcohols,1
Glycerylphosphorylcholine,D,D10.570.755.375.760.400.386,Glycerophospholipids,Phosphatidic Acids,1
Glycerylphosphorylcholine,D,D10.570.755.375.760.400.800.806.500,Lecithins,Phosphatidylcholines,1
Glycerylphosphorylcholine,D,D02.033.800.875.750.449,Glycerophosphates,Triose Sugar Alcohols,1
Glycine Decarboxylase Complex,D,D08.811.682.664.500.498,Amino Acid Oxidoreductases,Oxidoreductases Acting on CH-NH2 Group Donors,1
Glycine Decarboxylase Complex,D,D08.811.600.391,Multienzyme Complexes,Enzymes,1
Glycine Decarboxylase Complex,D,D05.500.562.452,Multienzyme Complexes,Multiprotein Complexes,1
Glycine Decarboxylase Complex H-Protein,D,D05.500.562.452.175,Glycine Decarboxylase Complex,Multienzyme Complexes,1
Glycine Decarboxylase Complex H-Protein,D,D08.811.600.391.175,Glycine Decarboxylase Complex,Multienzyme Complexes,1
Glycine Dehydrogenase (Decarboxylating),D,D08.811.600.391.200,Glycine Decarboxylase Complex,Multienzyme Complexes,1
Glycine Dehydrogenase (Decarboxylating),D,D08.811.682.664.500.498.500,Glycine Decarboxylase Complex,Amino Acid Oxidoreductases,1
Glycine Dehydrogenase (Decarboxylating),D,D05.500.562.452.200,Glycine Decarboxylase Complex,Multienzyme Complexes,1
Glycine Hydroxymethyltransferase,D,D08.811.913.555.400.500,Hydroxymethyl and Formyl Transferases,One-Carbon Group Transferases,1
Glycocholic Acid,D,D12.125.481.700.249,N-substituted Glycines,Glycine,1
Glycocholic Acid,D,D04.210.500.221.430.484,Cholic Acids,Cholanes,1
Glycocholic Acid,D,D04.210.500.105.225.400,Cholic Acids,Bile Acids and Salts,1
Glycogen Storage Disease Type II,C,C18.452.648.202.449.500,Glycogen Storage Disease,"Carbohydrate Metabolism, Inborn Errors",1
Glycogen Storage Disease Type II,C,C18.452.648.595.554.340,"Lysosomal Storage Diseases, Nervous System",Lysosomal Storage Diseases,1
Glycogen Storage Disease Type II,C,C10.228.140.163.100.435.340,"Lysosomal Storage Diseases, Nervous System","Brain Diseases, Metabolic, Inborn",1
Glycogen Storage Disease Type II,C,C18.452.132.100.435.340,"Lysosomal Storage Diseases, Nervous System","Brain Diseases, Metabolic, Inborn",1
Glycogen Storage Disease Type II,C,C18.452.648.189.435.340,"Lysosomal Storage Diseases, Nervous System","Brain Diseases, Metabolic, Inborn",1
Glycogen Storage Disease Type II,C,C16.320.565.189.435.340,"Lysosomal Storage Diseases, Nervous System","Brain Diseases, Metabolic, Inborn",1
Glycogen Storage Disease Type II,C,C16.320.565.202.449.500,Glycogen Storage Disease,"Carbohydrate Metabolism, Inborn Errors",1
Glycogen Storage Disease Type II,C,C16.320.565.595.554.340,"Lysosomal Storage Diseases, Nervous System",Lysosomal Storage Diseases,1
Glycogen Synthase Kinase 3,D,D05.500.117.875,Axin Signaling Complex,Multiprotein Complexes,1
Glycogen Synthase Kinase 3,D,D12.644.360.300.500,Glycogen Synthase Kinases,Intracellular Signaling Peptides and Proteins,1
Glycogen Synthase Kinase 3,D,D08.811.913.696.620.682.700.429.500,Glycogen Synthase Kinases,Protein-Serine-Threonine Kinases,1
Glycogen Synthase Kinase 3,D,D08.811.913.696.620.682.700.646.625,Proline-Directed Protein Kinases,Protein-Serine-Threonine Kinases,1
Glycogen Synthase Kinase 3,D,D12.776.476.300.500,Glycogen Synthase Kinases,Intracellular Signaling Peptides and Proteins,1
Glycogen Synthase Kinase 3,D,D12.776.476.081.875,Axin Signaling Complex,Intracellular Signaling Peptides and Proteins,1
Glycogen Synthase Kinase 3 beta,D,D12.776.476.081.875.500,Glycogen Synthase Kinase 3,Axin Signaling Complex,1
Glycogen Synthase Kinase 3 beta,D,D12.776.476.300.500.500,Glycogen Synthase Kinase 3,Glycogen Synthase Kinases,1
Glycogen Synthase Kinase 3 beta,D,D08.811.913.696.620.682.700.646.625.500,Glycogen Synthase Kinase 3,Proline-Directed Protein Kinases,1
Glycogen Synthase Kinase 3 beta,D,D08.811.913.696.620.682.700.429.500.500,Glycogen Synthase Kinase 3,Glycogen Synthase Kinases,1
Glycogen Synthase Kinase 3 beta,D,D12.644.360.300.500.500,Glycogen Synthase Kinase 3,Glycogen Synthase Kinases,1
Glycogen Synthase Kinase 3 beta,D,D05.500.117.875.500,Glycogen Synthase Kinase 3,Axin Signaling Complex,1
Glycogenolysis,G,G03.191.625,Carbohydrate Metabolism,Metabolism,1
Glycogenolysis,G,G02.111.158.625,Carbohydrate Metabolism,Biochemical Phenomena,1
Glycols,D,D02.033.455,Alcohols,Organic Chemicals,1
Glycoside Hydrolase Inhibitors,D,D27.505.519.389.320,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,1
Glycoside Hydrolase Inhibitors,D,D27.505.696.422.249,Hypoglycemic Agents,Physiological Effects of Drugs,1
Glycoside Hydrolases,D,D08.811.277.450,Hydrolases,Enzymes,1
Goblet Cells,A,A10.615.550.444.321,Intestinal Mucosa,Mucous Membrane,1
Goblet Cells,A,A10.615.550.760.520.320,Laryngeal Mucosa,Respiratory Mucosa,1
Goblet Cells,A,A10.615.550.760.600.320,Nasal Mucosa,Respiratory Mucosa,1
Goblet Cells,A,A11.436.298,Epithelial Cells,Cells,1
Goblet Cells,A,A03.556.124.369.320,Intestinal Mucosa,Intestines,1
Goblet Cells,A,A04.760.259,Respiratory Mucosa,Respiratory System,1
Goblet Cells,A,A04.329.597.320,Laryngeal Mucosa,Larynx,1
Goblet Cells,A,A04.531.520.320,Nasal Mucosa,Nose,1
Goiter,C,C19.874.283,Thyroid Diseases,Endocrine System Diseases,1
"Goiter, Nodular",C,C19.874.283.501,Goiter,Thyroid Diseases,1
Gold Sodium Thiomalate,D,D02.241.081.337.463.703.451,Thiomalates,Malates,1
Gold Sodium Thiomalate,D,D02.886.489.891.451,Thiomalates,Sulfhydryl Compounds,1
Gold Sodium Thiomalate,D,D02.691.675.500,Organogold Compounds,Organometallic Compounds,1
Goldenhar Syndrome,C,C16.131.621.207.231.576.410,Mandibulofacial Dysostosis,Craniofacial Dysostosis,1
Goldenhar Syndrome,C,C05.116.099.370.231.576.410,Mandibulofacial Dysostosis,Craniofacial Dysostosis,1
Goldenhar Syndrome,C,C05.660.207.231.576.410,Mandibulofacial Dysostosis,Craniofacial Dysostosis,1
Gonadotropins,D,D06.472.699.322,Peptide Hormones,Hormones,1
Goserelin,D,D06.472.699.327.740.320.340,Gonadotropin-Releasing Hormone,Pituitary Hormone-Releasing Hormones,1
Goserelin,D,D12.644.456.460.315,Gonadotropin-Releasing Hormone,Oligopeptides,1
Goserelin,D,D12.644.400.400.740.320.340,Gonadotropin-Releasing Hormone,Pituitary Hormone-Releasing Hormones,1
Goserelin,D,D12.644.548.365.740.320.340,Gonadotropin-Releasing Hormone,Pituitary Hormone-Releasing Hormones,1
Goserelin,D,D12.776.631.650.405.740.320.340,Gonadotropin-Releasing Hormone,Pituitary Hormone-Releasing Hormones,1
Gossypium,B,B01.650.940.800.575.912.250.859.821.500.244,Malvaceae,Malvales,1
Gossypol,D,D02.455.849.765.444,Sesquiterpenes,Terpenes,1
Gout,C,C05.799.414,Rheumatic Diseases,Musculoskeletal Diseases,1
Gout,C,C05.550.354.500,Crystal Arthropathies,Joint Diseases,1
Gout,C,C05.550.114.423,Arthritis,Joint Diseases,1
Gout,C,C16.320.565.798.368,"Purine-Pyrimidine Metabolism, Inborn Errors","Metabolism, Inborn Errors",1
Gout,C,C18.452.648.798.368,"Purine-Pyrimidine Metabolism, Inborn Errors","Metabolism, Inborn Errors",1
G-Protein-Coupled Receptor Kinase 2,D,D12.644.360.293.249.200,beta-Adrenergic Receptor Kinases,G-Protein-Coupled Receptor Kinases,1
G-Protein-Coupled Receptor Kinase 2,D,D08.811.913.696.620.682.700.364.049.200,beta-Adrenergic Receptor Kinases,G-Protein-Coupled Receptor Kinases,1
G-Protein-Coupled Receptor Kinase 2,D,D12.776.476.293.249.200,beta-Adrenergic Receptor Kinases,G-Protein-Coupled Receptor Kinases,1
G-Protein-Coupled Receptor Kinase 5,D,D12.776.476.293.875,G-Protein-Coupled Receptor Kinases,Intracellular Signaling Peptides and Proteins,1
G-Protein-Coupled Receptor Kinase 5,D,D08.811.913.696.620.682.700.364.775,G-Protein-Coupled Receptor Kinases,Protein-Serine-Threonine Kinases,1
G-Protein-Coupled Receptor Kinase 5,D,D12.644.360.293.875,G-Protein-Coupled Receptor Kinases,Intracellular Signaling Peptides and Proteins,1
Graft vs Tumor Effect,G,G12.875.402.320,Graft vs Host Reaction,Transplantation Immunology,1
Gram-Negative Anaerobic Bacteria,B,B03.440.425,Gram-Negative Bacteria,Bacteria,1
Granular Cell Tumor,C,C04.557.450.590.350,"Neoplasms, Muscle Tissue","Neoplasms, Connective and Soft Tissue",1
Granulation Tissue,A,A10.165.450,Connective Tissue,Tissues,1
"Granulomatous Disease, Chronic",C,C20.673.774.535,Phagocyte Bactericidal Dysfunction,Immunologic Deficiency Syndromes,1
"Granulomatous Disease, Chronic",C,C16.320.322.233,"Genetic Diseases, X-Linked","Genetic Diseases, Inborn",1
"Granulomatous Disease, Chronic",C,C15.378.553.774.535,Phagocyte Bactericidal Dysfunction,Leukocyte Disorders,1
Gravitation,G,G01.060.350,Astronomical Phenomena,Physical Phenomena,1
Gravity Suits,E,E07.440,Equipment and Supplies,NULL,1
Gray Literature,L,L01.178.682.550,Publications,Communications Media,1
Griseofulvin,D,D03.633.100.127.275,Benzofurans,"Heterocyclic Compounds, 2-Ring",1
Grooming,F,F01.145.113.111.453,Appetitive Behavior,"Behavior, Animal",1
Group Homes,J,J03.775.375,Residential Facilities,Non-Medical Public and Private Facilities,1
Group Homes,N,N02.278.825.375,Residential Facilities,Health Facilities,1
Group IB Phospholipases A2,D,D08.811.277.352.100.680.750.937.750.100.750,Group I Phospholipases A2,"Phospholipases A2, Secretory",1
Group Structure,F,F01.829.316.274,Group Processes,"Psychology, Social",1
Growth Differentiation Factor 5,D,D12.644.276.954.300.500,Growth Differentiation Factors,TGF-beta Superfamily Proteins,1
Growth Differentiation Factor 5,D,D12.776.467.942.300.500,Growth Differentiation Factors,TGF-beta Superfamily Proteins,1
Growth Differentiation Factor 5,D,D23.529.942.300.500,Growth Differentiation Factors,TGF-beta Superfamily Proteins,1
Growth Plate,A,A02.835.232.251.352,Epiphyses,Bone and Bones,1
Gryllidae,B,B01.050.500.131.617.678.410,Orthoptera,Insecta,1
GTP-Binding Protein alpha Subunits,D,D12.776.476.375.100,Heterotrimeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,1
GTP-Binding Protein alpha Subunits,D,D12.776.543.325.100,Heterotrimeric GTP-Binding Proteins,Membrane Proteins,1
GTP-Binding Protein alpha Subunits,D,D12.644.360.360.100,Heterotrimeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,1
GTP-Binding Protein alpha Subunits,D,D12.776.157.325.332.100,Heterotrimeric GTP-Binding Proteins,GTP-Binding Proteins,1
GTP-Binding Protein alpha Subunits,D,D08.811.277.040.330.300.200.100,Heterotrimeric GTP-Binding Proteins,GTP-Binding Proteins,1
"GTP-Binding Protein alpha Subunits, Gq-G11",D,D08.811.277.040.330.300.200.100.300,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,1
"GTP-Binding Protein alpha Subunits, Gq-G11",D,D12.776.157.325.332.100.300,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,1
"GTP-Binding Protein alpha Subunits, Gq-G11",D,D12.644.360.360.100.300,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,1
"GTP-Binding Protein alpha Subunits, Gq-G11",D,D12.776.543.325.100.300,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,1
"GTP-Binding Protein alpha Subunits, Gq-G11",D,D12.776.476.375.100.300,GTP-Binding Protein alpha Subunits,Heterotrimeric GTP-Binding Proteins,1
GTP-Binding Protein gamma Subunits,D,D12.776.476.375.730,Heterotrimeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,1
GTP-Binding Protein gamma Subunits,D,D12.776.543.325.625,Heterotrimeric GTP-Binding Proteins,Membrane Proteins,1
GTP-Binding Protein gamma Subunits,D,D12.644.360.360.730,Heterotrimeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,1
GTP-Binding Protein gamma Subunits,D,D12.776.157.325.332.730,Heterotrimeric GTP-Binding Proteins,GTP-Binding Proteins,1
Guam,Z,Z01.639.760.680.435,Micronesia,Pacific Islands,1
Guanine,D,D03.633.100.759.758.399.454,Hypoxanthines,Purinones,1
Guanine Nucleotides,D,D03.633.100.759.646.454,Purine Nucleotides,Purines,1
Guanine Nucleotides,D,D13.695.827.426,Ribonucleotides,Nucleotides,1
Guanine Nucleotides,D,D13.695.667.454,Purine Nucleotides,Nucleotides,1
Guanosine,D,D13.570.583.454,Purine Nucleosides,Nucleosides,1
Guanosine,D,D13.570.800.453,Ribonucleosides,Nucleosides,1
Guanosine,D,D03.633.100.759.590.454,Purine Nucleosides,Purines,1
Guanosine 5'-O-(3-Thiotriphosphate),D,D02.886.765.380,Thionucleotides,Sulfur Compounds,1
Guanosine 5'-O-(3-Thiotriphosphate),D,D13.695.667.454.504.380,Guanosine Triphosphate,Guanine Nucleotides,1
Guanosine 5'-O-(3-Thiotriphosphate),D,D13.695.900.380,Thionucleotides,Nucleotides,1
Guanosine 5'-O-(3-Thiotriphosphate),D,D13.695.827.426.504.380,Guanosine Triphosphate,Guanine Nucleotides,1
Guanylate Kinases,D,D08.811.913.696.650.450,Phosphotransferases (Phosphate Group Acceptor),Phosphotransferases,1
Guanylyl Imidodiphosphate,D,D03.633.100.759.646.454.504.400,Guanosine Triphosphate,Guanine Nucleotides,1
Guanylyl Imidodiphosphate,D,D13.695.827.426.504.400,Guanosine Triphosphate,Guanine Nucleotides,1
Guanylyl Imidodiphosphate,D,D13.695.667.454.504.400,Guanosine Triphosphate,Guanine Nucleotides,1
Gun Violence,I,I01.880.735.900.632,Violence,Social Problems,1
Gun Violence,I,I01.198.240.856.519,Violence,Crime,1
Gynecological Examination,E,E01.370.600.293,Physical Examination,Diagnostic Techniques and Procedures,1
Gynecomastia,C,C17.800.090.875,Breast Diseases,Skin Diseases,1
Halothane,D,D02.455.526.340,"Hydrocarbons, Halogenated",Hydrocarbons,1
Hamartoma,C,C04.445,Neoplasms,NULL,1
"Hand Deformities, Acquired",C,C05.390.110,Hand Deformities,Musculoskeletal Diseases,1
"Handling, Psychological",F,F01.658.556,Motivation,Behavior and Behavior Mechanisms,1
Handwriting,L,L01.559.423.906.539,Writing,Language Arts,1
HapMap Project,H,H01.770.644.145.350.249,Genetic Research,Biomedical Research,1
HapMap Project,H,H01.158.273.343.385.750,Human Genetics,Genetics,1
HapMap Project,H,H01.158.273.180.350.162,Genomics,Computational Biology,1
HapMap Project,H,H01.158.273.343.350.130,Genomics,Genetics,1
HapMap Project,H,H01.158.273.343.249.199,Genetic Research,Genetics,1
Haptens,D,D23.050.550.480,Epitopes,Antigens,1
Hate,F,F01.470.548,Emotions,Behavior and Behavior Mechanisms,1
Hawaii,Z,Z01.639.760.815.482,Polynesia,Pacific Islands,1
Hawaii,Z,Z01.107.567.875.580.375,Pacific States,United States,1
"Head Injuries, Penetrating",C,C10.900.300.675,Craniocerebral Trauma,"Trauma, Nervous System",1
"Head Injuries, Penetrating",C,C26.915.300.475,Craniocerebral Trauma,"Trauma, Nervous System",1
"Head Injuries, Penetrating",C,C26.986.500,"Wounds, Penetrating",Wounds and Injuries,1
Headache Disorders,C,C10.228.140.546,Brain Diseases,Central Nervous System Diseases,1
Health Educators,M,M01.526.485.410,Health Personnel,Occupational Groups,1
Health Information Interoperability,L,L01.470.813,Information Storage and Retrieval,Information Science,1
Health Information Interoperability,L,L01.313.500.750.280.555,Information Storage and Retrieval,Medical Informatics Applications,1
Health Planning Technical Assistance,N,N03.349.325,Health Planning,Health Care Economics and Organizations,1
Health Services for Transgender Persons,N,N02.421.325,Health Services,"Health Care Facilities, Manpower, and Services",1
"Hearing Loss, High-Frequency",C,C09.218.458.341.812,Hearing Loss,Hearing Disorders,1
"Hearing Loss, High-Frequency",C,C10.597.751.418.341.812,Hearing Loss,Hearing Disorders,1
"Hearing Loss, High-Frequency",C,C23.888.592.763.393.341.812,Hearing Loss,Hearing Disorders,1
"Hearing Loss, Noise-Induced",C,C23.888.592.763.393.341.887.460,"Hearing Loss, Sensorineural",Hearing Loss,1
"Hearing Loss, Noise-Induced",C,C10.597.751.418.341.887.460,"Hearing Loss, Sensorineural",Hearing Loss,1
"Hearing Loss, Noise-Induced",C,C09.218.458.341.887.460,"Hearing Loss, Sensorineural",Hearing Loss,1
"Hearing Loss, Sudden",C,C09.218.458.341.900,Hearing Loss,Hearing Disorders,1
"Hearing Loss, Sudden",C,C10.597.751.418.341.900,Hearing Loss,Hearing Disorders,1
"Hearing Loss, Sudden",C,C23.888.592.763.393.341.900,Hearing Loss,Hearing Disorders,1
"Hearing Loss, Unilateral",C,C23.888.592.763.393.341.950,Hearing Loss,Hearing Disorders,1
"Hearing Loss, Unilateral",C,C10.597.751.418.341.950,Hearing Loss,Hearing Disorders,1
"Hearing Loss, Unilateral",C,C09.218.458.341.950,Hearing Loss,Hearing Disorders,1
"Heart Arrest, Induced",E,E04.928.220.360,Cardiac Surgical Procedures,Thoracic Surgical Procedures,1
"Heart Arrest, Induced",E,E04.100.376.374,Cardiac Surgical Procedures,Cardiovascular Surgical Procedures,1
"Heart Septal Defects, Ventricular",C,C16.131.240.400.560.540,Heart Septal Defects,"Heart Defects, Congenital",1
"Heart Septal Defects, Ventricular",C,C14.240.400.560.540,Heart Septal Defects,"Heart Defects, Congenital",1
"Heart Septal Defects, Ventricular",C,C14.280.400.560.540,Heart Septal Defects,"Heart Defects, Congenital",1
Heartburn,C,C23.888.821.525,"Signs and Symptoms, Digestive",Signs and Symptoms,1
Heart-Lung Machine,E,E07.858.082.458,Artificial Organs,Surgical Equipment,1
Heat Exhaustion,C,C26.522.250,Heat Stress Disorders,Wounds and Injuries,1
Helicobacter hepaticus,B,B03.660.150.235.500.250.410,Helicobacter,Helicobacteraceae,1
Helicobacter hepaticus,B,B03.440.500.362,Helicobacter,Gram-Negative Bacteria,1
Heliotherapy,E,E02.774.430,Phototherapy,Therapeutics,1
Helix-Loop-Helix Motifs,G,G02.111.570.820.709.275.500.360,Amino Acid Motifs,Protein Structural Elements,1
Hemarthrosis,C,C05.550.459,Joint Diseases,Musculoskeletal Diseases,1
Hemarthrosis,C,C23.550.414.794,Hemorrhage,Pathologic Processes,1
Hematemesis,C,C23.550.414.788.400,Gastrointestinal Hemorrhage,Hemorrhage,1
Hematemesis,C,C23.888.821.937.019,Vomiting,"Signs and Symptoms, Digestive",1
Hematemesis,C,C06.405.227.400,Gastrointestinal Hemorrhage,Gastrointestinal Diseases,1
Hematoma,C,C23.550.414.838,Hemorrhage,Pathologic Processes,1
"Hematoma, Subdural",C,C23.550.414.838.700,Hematoma,Hemorrhage,1
"Hematoma, Subdural",C,C23.550.414.913.700,Intracranial Hemorrhages,Hemorrhage,1
"Hematoma, Subdural",C,C26.915.300.490.450,"Intracranial Hemorrhage, Traumatic",Craniocerebral Trauma,1
"Hematoma, Subdural",C,C14.907.253.573.400.450,"Intracranial Hemorrhage, Traumatic",Intracranial Hemorrhages,1
"Hematoma, Subdural",C,C10.228.140.300.535.450.400,"Intracranial Hemorrhage, Traumatic",Intracranial Hemorrhages,1
"Hematoma, Subdural",C,C10.900.300.837.600,"Intracranial Hemorrhage, Traumatic",Craniocerebral Trauma,1
Hemiarthroplasty,E,E04.680.101.110.482,"Arthroplasty, Replacement",Arthroplasty,1
Hemiarthroplasty,E,E04.555.110.110.482,"Arthroplasty, Replacement",Arthroplasty,1
Hemiarthroplasty,E,E04.650.110.482,"Arthroplasty, Replacement",Prosthesis Implantation,1
Hemidesmosomes,A,A11.284.149.165.165.360,Cell-Matrix Junctions,Cell Membrane Structures,1
Hemiplegia,C,C10.597.622.295,Paralysis,Neurologic Manifestations,1
Hemiplegia,C,C23.888.592.636.312,Paralysis,Neurologic Manifestations,1
Hemochromatosis,C,C18.452.648.618.337,"Metal Metabolism, Inborn Errors","Metabolism, Inborn Errors",1
Hemochromatosis,C,C16.320.565.618.337,"Metal Metabolism, Inborn Errors","Metabolism, Inborn Errors",1
Hemochromatosis,C,C18.452.565.500.480,Iron Overload,Iron Metabolism Disorders,1
"Hemodialysis Units, Hospital",N,N02.278.388.200,Hospital Units,Health Facilities,1
Hemodilution,E,E02.514,Therapeutics,NULL,1
Hemolymph,A,A13.453,Animal Structures,NULL,1
"Hemorrhagic Disease Virus, Rabbit",B,B04.820.578.298.500.380,Lagovirus,Caliciviridae,1
Hemorrhagic Disorders,C,C15.378.463,Hematologic Diseases,Hemic and Lymphatic Diseases,1
Henipavirus,B,B04.820.480.937.600.650.400,Paramyxovirinae,Paramyxoviridae,1
Heparin Antagonists,D,D27.505.519.452,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,1
Heparin Antagonists,D,D27.505.954.502.270.546,Coagulants,Hematologic Agents,1
Hepatic Encephalopathy,C,C06.552.308.500.356,Liver Failure,Hepatic Insufficiency,1
Hepatic Encephalopathy,C,C18.452.132.360,"Brain Diseases, Metabolic",Metabolic Diseases,1
Hepatic Encephalopathy,C,C10.228.140.163.360,"Brain Diseases, Metabolic",Brain Diseases,1
Hepatic Stellate Cells,A,A11.561,Cells,NULL,1
Hepatitis C Antigens,D,D23.050.327.495.505,Hepatitis Antigens,"Antigens, Viral",1
"Hepatitis, Autoimmune",C,C06.552.380.350.300,"Hepatitis, Chronic",Hepatitis,1
"Hepatitis, Autoimmune",C,C20.111.567,Autoimmune Diseases,Immune System Diseases,1
Hepatocyte Nuclear Factor 1-alpha,D,D12.776.660.352.500.500,Hepatocyte Nuclear Factor 1,Hepatocyte Nuclear Factors,1
Hepatocyte Nuclear Factor 1-alpha,D,D12.776.930.318.500.500,Hepatocyte Nuclear Factor 1,Hepatocyte Nuclear Factors,1
Hepatocyte Nuclear Factor 1-alpha,D,D12.776.260.262.500.500,Hepatocyte Nuclear Factor 1,Hepatocyte Nuclear Factors,1
Hepatocyte Nuclear Factor 1-alpha,D,D12.776.260.400.218.500,Hepatocyte Nuclear Factor 1,Homeodomain Proteins,1
Hepatocyte Nuclear Factor 1-beta,D,D12.776.260.400.218.750,Hepatocyte Nuclear Factor 1,Homeodomain Proteins,1
Hepatocyte Nuclear Factor 1-beta,D,D12.776.260.262.500.750,Hepatocyte Nuclear Factor 1,Hepatocyte Nuclear Factors,1
Hepatocyte Nuclear Factor 1-beta,D,D12.776.930.318.500.750,Hepatocyte Nuclear Factor 1,Hepatocyte Nuclear Factors,1
Hepatocyte Nuclear Factor 1-beta,D,D12.776.660.352.500.750,Hepatocyte Nuclear Factor 1,Hepatocyte Nuclear Factors,1
Heptanoates,D,D10.251.450.400,Heptanoic Acids,Fatty Acids,1
Heptoses,D,D09.947.875.286,Monosaccharides,Sugars,1
Herbivory,F,F01.145.113.547.600,Feeding Behavior,"Behavior, Animal",1
Herbivory,F,F01.145.407.758,Feeding Behavior,Behavior,1
Herbivory,G,G07.203.650.353.758,Feeding Behavior,Nutritional Physiological Phenomena,1
"Hernia, Femoral",C,C23.300.707.374.750,"Hernia, Abdominal",Hernia,1
"Herpesvirus 1, Bovine",B,B04.280.382.100.900.400,Varicellovirus,Alphaherpesvirinae,1
"Herpesvirus 2, Gallid",B,B04.280.382.100.562.400,Mardivirus,Alphaherpesvirinae,1
"Heterocyclic Compounds, 2-Ring",D,D03.633.100,"Heterocyclic Compounds, Fused-Ring",Heterocyclic Compounds,1
Heterografts,A,A01.941.875,Transplants,Body Regions,1
Heteroptera,B,B01.050.500.131.617.412.420,Hemiptera,Insecta,1
Heuristics,F,F02.463.425.725.500,Problem Solving,Learning,1
Heuristics,F,F02.463.785.810.500,Problem Solving,Thinking,1
Hevea,B,B01.650.940.800.575.912.250.859.797.438.399,Euphorbiaceae,Malpighiales,1
Hexetidine,D,D03.383.742.279,Pyrimidines,"Heterocyclic Compounds, 1-Ring",1
Hexosamines,D,D09.067.342,Amino Sugars,Carbohydrates,1
Hexuronic Acids,D,D09.811.922.400,Uronic Acids,Sugar Acids,1
Hexuronic Acids,D,D02.241.081.844.915.400,Uronic Acids,Sugar Acids,1
Hexuronic Acids,D,D02.241.152.811.400,Uronic Acids,"Acids, Aldehydic",1
Hexuronic Acids,D,D02.241.511.902.915.400,Uronic Acids,Sugar Acids,1
Hibiscus,B,B01.650.940.800.575.912.250.859.821.500.288,Malvaceae,Malvales,1
Hiccup,C,C23.888.821.578,"Signs and Symptoms, Digestive",Signs and Symptoms,1
High Fidelity Simulation Training,I,I02.903.847.250,Simulation Training,Teaching,1
High Fructose Corn Syrup,J,J02.500.362.831.500,Dietary Sugars,Dietary Carbohydrates,1
High Fructose Corn Syrup,J,J02.500.514.500.400.700.750.500,Nutritive Sweeteners,Sweetening Agents,1
High Fructose Corn Syrup,G,G07.203.300.362.831.500,Dietary Sugars,Dietary Carbohydrates,1
High Fructose Corn Syrup,G,G07.203.300.514.500.400.700.750.500,Nutritive Sweeteners,Sweetening Agents,1
High Fructose Corn Syrup,D,D09.947.500.500,Dietary Sugars,Sugars,1
High Fructose Corn Syrup,D,D09.301.831.500,Dietary Sugars,Dietary Carbohydrates,1
High Fructose Corn Syrup,D,D27.720.372.300.353.609.750.500,Nutritive Sweeteners,Sweetening Agents,1
"High-Density Lipoproteins, Pre-beta",D,D12.776.521.479.602,"Lipoproteins, HDL",Lipoproteins,1
"High-Density Lipoproteins, Pre-beta",D,D10.532.432.550,"Lipoproteins, HDL",Lipoproteins,1
High-Energy Shock Waves,G,G01.750.770.776.891.500,Ultrasonic Waves,Sound,1
High-Intensity Focused Ultrasound Ablation,E,E04.014.380,Ablation Techniques,"Surgical Procedures, Operative",1
High-Intensity Focused Ultrasound Ablation,E,E02.565.280.945.399,Ultrasonic Therapy,Diathermy,1
High-Intensity Interval Training,I,I03.350.311.250,"Physical Conditioning, Human",Exercise,1
High-Intensity Interval Training,G,G11.427.410.698.277.311.250,"Physical Conditioning, Human",Exercise,1
High-Temperature Requirement A Serine Peptidase 1,D,D08.811.277.656.300.760.420,Serine Endopeptidases,Endopeptidases,1
High-Temperature Requirement A Serine Peptidase 1,D,D08.811.277.656.959.350.420,Serine Endopeptidases,Serine Proteases,1
Hindlimb,A,A13.473,Animal Structures,NULL,1
Hinduism,K,K01.844.231,Religion,Humanities,1
Hirschsprung Disease,C,C06.405.469.158.701.439,Megacolon,Colonic Diseases,1
Hirschsprung Disease,C,C06.198.439,Digestive System Abnormalities,Digestive System Diseases,1
Hirschsprung Disease,C,C16.131.314.439,Digestive System Abnormalities,Congenital Abnormalities,1
Histiocytes,A,A11.733.397.385,Macrophages,Phagocytes,1
Histiocytes,A,A11.627.482.385,Macrophages,Myeloid Cells,1
Histiocytes,A,A11.329.372.385,Macrophages,Connective Tissue Cells,1
Histiocytes,A,A15.382.670.522.385,Macrophages,Mononuclear Phagocyte System,1
Histiocytes,A,A15.382.680.397.385,Macrophages,Phagocytes,1
"Histiocytoma, Benign Fibrous",C,C04.557.450.565.590.425.350,Histiocytoma,"Neoplasms, Fibrous Tissue",1
"Histiocytosis, Langerhans-Cell",C,C15.604.250.400,Histiocytosis,Lymphatic Diseases,1
"Histiocytosis, Langerhans-Cell",C,C08.381.483.375,"Lung Diseases, Interstitial",Lung Diseases,1
Histone Chaperones,D,D12.776.580.219,Molecular Chaperones,Proteins,1
Histone Methyltransferases,D,D08.811.913.555.500.800.200,Protein Methyltransferases,Methyltransferases,1
Histoplasma,B,B01.300.381.440,Mitosporic Fungi,Fungi,1
History,K,K01.400,Humanities,NULL,1
History of Dentistry,K,K01.400.450,History,Humanities,1
HIV Long Terminal Repeat,G,G02.111.570.080.708.850.400,Terminal Repeat Sequences,"Repetitive Sequences, Nucleic Acid",1
HIV Long Terminal Repeat,G,G05.360.080.708.850.400,Terminal Repeat Sequences,"Repetitive Sequences, Nucleic Acid",1
HLA-A1 Antigen,D,D12.776.395.550.489.400.010,HLA-A Antigens,Histocompatibility Antigens Class I,1
HLA-A1 Antigen,D,D23.050.301.500.100.400.010,HLA-A Antigens,Histocompatibility Antigens Class I,1
HLA-A1 Antigen,D,D12.776.543.550.439.400.010,HLA-A Antigens,Histocompatibility Antigens Class I,1
HLA-A1 Antigen,D,D23.050.301.500.450.370.010,HLA-A Antigens,HLA Antigens,1
HLA-A1 Antigen,D,D23.050.705.552.100.400.010,HLA-A Antigens,Histocompatibility Antigens Class I,1
HLA-A1 Antigen,D,D23.050.705.552.450.370.372,HLA-A Antigens,HLA Antigens,1
HLA-DP Antigens,D,D23.050.705.552.450.400.420,HLA-D Antigens,HLA Antigens,1
HLA-DP Antigens,D,D23.050.705.552.410.400.420,HLA-D Antigens,Histocompatibility Antigens Class II,1
HLA-DP Antigens,D,D23.050.301.500.450.400.420,HLA-D Antigens,HLA Antigens,1
HLA-DP Antigens,D,D12.776.543.550.440.400.420,HLA-D Antigens,Histocompatibility Antigens Class II,1
HLA-DP Antigens,D,D23.050.301.500.400.400.420,HLA-D Antigens,Histocompatibility Antigens Class II,1
HLA-DP Antigens,D,D12.776.395.550.509.400.420,HLA-D Antigens,Histocompatibility Antigens Class II,1
HLA-DR Serological Subtypes,D,D12.776.395.550.509.400.440.400,HLA-DR Antigens,HLA-D Antigens,1
HLA-DR Serological Subtypes,D,D12.776.543.550.440.400.440.400,HLA-DR Antigens,HLA-D Antigens,1
HLA-DR Serological Subtypes,D,D23.050.301.500.450.400.440.389,HLA-DR Antigens,HLA-D Antigens,1
HLA-DR Serological Subtypes,D,D23.050.301.500.400.400.440.400,HLA-DR Antigens,HLA-D Antigens,1
HLA-DR Serological Subtypes,D,D23.050.705.552.450.400.440.389,HLA-DR Antigens,HLA-D Antigens,1
HLA-DR Serological Subtypes,D,D23.050.705.552.410.400.440.389,HLA-DR Antigens,HLA-D Antigens,1
HLA-DR1 Antigen,D,D23.050.705.552.410.400.440.389.010,HLA-DR Serological Subtypes,HLA-DR Antigens,1
HLA-DR1 Antigen,D,D23.050.705.552.450.400.440.389.500,HLA-DR Serological Subtypes,HLA-DR Antigens,1
HLA-DR1 Antigen,D,D23.050.301.500.400.400.440.400.010,HLA-DR Serological Subtypes,HLA-DR Antigens,1
HLA-DR1 Antigen,D,D23.050.301.500.450.400.440.389.500,HLA-DR Serological Subtypes,HLA-DR Antigens,1
HLA-DR1 Antigen,D,D12.776.543.550.440.400.440.400.010,HLA-DR Serological Subtypes,HLA-DR Antigens,1
HLA-DR1 Antigen,D,D12.776.395.550.509.400.440.400.010,HLA-DR Serological Subtypes,HLA-DR Antigens,1
HLA-DRB4 Chains,D,D12.776.395.550.509.400.440.200.040,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-DRB4 Chains,D,D12.776.543.550.440.400.440.200.040,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-DRB4 Chains,D,D23.050.301.500.450.400.440.333.875,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-DRB4 Chains,D,D23.050.301.500.400.400.440.200.040,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-DRB4 Chains,D,D23.050.705.552.450.400.440.333.875,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-DRB4 Chains,D,D23.050.705.552.410.400.440.200.040,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-DRB5 Chains,D,D23.050.705.552.410.400.440.200.050,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-DRB5 Chains,D,D23.050.705.552.450.400.440.333.937,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-DRB5 Chains,D,D23.050.301.500.400.400.440.200.050,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-DRB5 Chains,D,D23.050.301.500.450.400.440.333.937,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-DRB5 Chains,D,D12.776.543.550.440.400.440.200.050,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-DRB5 Chains,D,D12.776.395.550.509.400.440.200.050,HLA-DR beta-Chains,HLA-DR Antigens,1
HLA-G Antigens,D,D12.776.395.550.489.700,Histocompatibility Antigens Class I,Membrane Glycoproteins,1
HLA-G Antigens,D,D12.776.543.550.439.700,Histocompatibility Antigens Class I,Membrane Glycoproteins,1
HLA-G Antigens,D,D23.050.301.500.100.700,Histocompatibility Antigens Class I,Histocompatibility Antigens,1
HLA-G Antigens,D,D23.050.301.500.450.700,HLA Antigens,Histocompatibility Antigens,1
HLA-G Antigens,D,D23.050.705.552.450.700,HLA Antigens,Histocompatibility Antigens,1
HLA-G Antigens,D,D23.050.705.552.100.700,Histocompatibility Antigens Class I,Histocompatibility Antigens,1
HN Protein,D,D23.050.327.461.350,"Hemagglutinins, Viral","Antigens, Viral",1
HN Protein,D,D12.776.964.970.880.350,Viral Envelope Proteins,Viral Structural Proteins,1
Hoarding,F,F01.145.493,Behavior,Behavior and Behavior Mechanisms,1
Holistic Nursing,K,K01.752.712.708,"Philosophy, Nursing",Philosophy,1
Holistic Nursing,H,H02.478.676.313,"Specialties, Nursing",Nursing,1
Holistic Nursing,N,N02.421.533.282,Nursing Care,Health Services,1
Holmium,D,D01.552.550.399.492,Lanthanoid Series Elements,"Metals, Rare Earth",1
Holmium,D,D01.268.558.362.492,Lanthanoid Series Elements,"Metals, Rare Earth",1
Home Care Agencies,N,N03.540.483,Organizations,Health Care Economics and Organizations,1
Hormesis,G,G07.690.773.875.500,"Dose-Response Relationship, Drug",Pharmacological Phenomena,1
Hormesis,G,G07.690.936.500.500,"Dose-Response Relationship, Drug",Toxicological Phenomena,1
Hormone Antagonists,D,D27.505.696.399.450,"Hormones, Hormone Substitutes, and Hormone Antagonists",Physiological Effects of Drugs,1
Hormone Antagonists,D,D06.347,"Hormones, Hormone Substitutes, and Hormone Antagonists",NULL,1
Horseradish Peroxidase,D,D08.811.682.732.512,Peroxidases,Oxidoreductases,1
Horticultural Therapy,E,E02.760.169.063.500.782.500,"Rehabilitation, Vocational",Rehabilitation,1
Horticultural Therapy,E,E02.190.438,Complementary Therapies,Therapeutics,1
Horticultural Therapy,F,F04.754.392,Psychotherapy,Behavioral Disciplines and Activities,1
Horticultural Therapy,E,E02.831.782.500,"Rehabilitation, Vocational",Rehabilitation,1
Horticultural Therapy,N,N02.421.784.644.675,"Rehabilitation, Vocational",Rehabilitation,1
"Hospital Bed Capacity, under 100",N,N02.278.306.472.080,Hospital Bed Capacity,Health Facility Size,1
Hospital Medicine,H,H02.403.377,Medicine,Health Occupations,1
Hospitalists,M,M01.526.485.630.490.400,"Medical Staff, Hospital",Medical Staff,1
Hospitalists,M,M01.526.485.740.422.400,"Medical Staff, Hospital","Personnel, Hospital",1
Hospitalists,M,M01.526.485.810.580,Physicians,Health Personnel,1
Hospitalists,N,N02.360.630.490.400,"Medical Staff, Hospital",Medical Staff,1
Hospitalists,N,N02.360.740.422.400,"Medical Staff, Hospital","Personnel, Hospital",1
Hospitalists,N,N02.360.810.580,Physicians,Health Personnel,1
"Hospitals, Animal",N,N02.278.421.280,Hospitals,Health Facilities,1
"Hospitals, Animal",N,N06.230.150.360.250.200,"Housing, Animal",Housing,1
"Hospitals, Convalescent",N,N02.278.421.556.294,"Hospitals, Special",Hospitals,1
"Hospitals, Military",N,N02.278.421.510.180.250,"Hospitals, Federal","Hospitals, Public",1
"Hospitals, Satellite",N,N02.278.421.530,Hospitals,Health Facilities,1
"Hospitals, Veterans",N,N02.278.421.510.180.400,"Hospitals, Federal","Hospitals, Public",1
Host Adaptation,G,G16.527.200.190,Host-Pathogen Interactions,Host Microbial Interactions,1
Host Adaptation,G,G16.012.875,"Adaptation, Biological",Biological Phenomena,1
Host Adaptation,G,G06.462.190,Host-Pathogen Interactions,Microbiological Phenomena,1
Host Cell Factor C1,D,D12.776.660.478,Nuclear Proteins,Proteins,1
Host Cell Factor C1,D,D12.776.930.325,Transcription Factors,Proteins,1
Host Factor 1 Protein,D,D12.776.664.962.249,RNA-Binding Proteins,Nucleoproteins,1
Host Factor 1 Protein,D,D12.776.157.725.249,RNA-Binding Proteins,Carrier Proteins,1
Host Factor 1 Protein,D,D12.776.097.513.500,Integration Host Factors,Bacterial Proteins,1
Hot Springs,G,G01.311.355.750.500,Natural Springs,Groundwater,1
Hot Springs,G,G16.500.275.260.500,Extreme Environments,Environment,1
Household Products,J,J01.516,"Technology, Industry, and Agriculture",NULL,1
HSC70 Heat-Shock Proteins,D,D12.776.580.216.375.200,HSP70 Heat-Shock Proteins,Heat-Shock Proteins,1
HSP27 Heat-Shock Proteins,D,D12.776.580.216.270.625,"Heat-Shock Proteins, Small",Heat-Shock Proteins,1
Human bocavirus,B,B04.280.580.650.085.500,Bocavirus,Parvovirinae,1
Human Body,K,K01.093.378,Art,Humanities,1
Human Body,I,I01.076.201.450.560,Culture,"Anthropology, Cultural",1
Human Genetics,H,H01.158.273.343.385,Genetics,Biology,1
Human Umbilical Vein Endothelial Cells,A,A11.436.275.682,Endothelial Cells,Epithelial Cells,1
Humulus,B,B01.650.940.800.575.912.250.859.937.055.750,Cannabaceae,Rosales,1
Hutchinson's Melanotic Freckle,C,C04.557.465.625.650.510.385,Melanoma,Neuroendocrine Tumors,1
Hutchinson's Melanotic Freckle,C,C04.557.580.625.650.510.385,Melanoma,Neuroendocrine Tumors,1
Hutchinson's Melanotic Freckle,C,C04.557.665.510.385,Melanoma,Nevi and Melanomas,1
Hyalin,A,A12.580,Fluids and Secretions,NULL,1
Hyaline Membrane Disease,C,C08.618.840.500.475,"Respiratory Distress Syndrome, Newborn",Respiratory Distress Syndrome,1
Hyaline Membrane Disease,C,C08.381.840.500.475,"Respiratory Distress Syndrome, Newborn",Respiratory Distress Syndrome,1
Hyaline Membrane Disease,C,C16.614.521.563.475,"Respiratory Distress Syndrome, Newborn","Infant, Premature, Diseases",1
Hydra,B,B01.050.500.308.485.400,Hydrozoa,Cnidaria,1
"Hydrocarbons, Aromatic",D,D02.455.426.559,"Hydrocarbons, Cyclic",Hydrocarbons,1
"Hydrocarbons, Brominated",D,D02.455.526.368,"Hydrocarbons, Halogenated",Hydrocarbons,1
"Hydrocarbons, Halogenated",D,D02.455.526,Hydrocarbons,Organic Chemicals,1
Hydrogels,D,D20.280.320.375,Gels,Colloids,1
Hydrogels,D,D26.255.165.320.375,Gels,Colloids,1
Hydro-Lyases,D,D08.811.520.241.300,Carbon-Oxygen Lyases,Lyases,1
Hydronephrosis,C,C13.351.968.419.307,Kidney Diseases,Urologic Diseases,1
Hydronephrosis,C,C12.777.419.307,Kidney Diseases,Urologic Diseases,1
Hydroxyapatites,D,D01.578.122.477,Apatites,Minerals,1
Hydroxyapatites,D,D01.695.625.675.650.075.025.300,Apatites,Calcium Phosphates,1
Hydroxyapatites,D,D01.029.260.700.675.374.075.025.300,Apatites,Calcium Phosphates,1
Hydroxyapatites,D,D01.146.360.050.300,Apatites,Calcium Phosphates,1
Hydroxycholecalciferols,D,D04.210.500.247.222.159.478,Cholecalciferol,Cholestenes,1
Hydroxycholecalciferols,D,D04.210.500.247.808.146.478,Cholecalciferol,Sterols,1
Hydroxycholecalciferols,D,D04.210.500.812.768.196.478,Cholecalciferol,Vitamin D,1
Hydroxycholecalciferols,D,D10.570.938.146.478,Cholecalciferol,Sterols,1
Hydroxycholesterols,D,D10.570.938.208.825.500,Oxysterols,Cholesterol,1
Hydroxycholesterols,D,D04.210.500.247.222.284.800.500,Oxysterols,Cholesterol,1
Hydroxycholesterols,D,D04.210.500.247.808.197.800.500,Oxysterols,Cholesterol,1
Hydroxyestrones,D,D04.210.500.365.415.414.400,Estrone,Estrenes,1
Hydroxyestrones,D,D04.210.500.578.502.497.400,Estrone,17-Ketosteroids,1
Hydroxyestrones,D,D06.472.334.851.437.984.350,"Estrogens, Catechol",Estradiol Congeners,1
Hydroxyestrones,D,D02.455.426.559.389.657.166.350.350,"Estrogens, Catechol",Catechols,1
Hydroxymethyl and Formyl Transferases,D,D08.811.913.555.400,One-Carbon Group Transferases,Transferases,1
Hylobates,B,B01.050.150.900.649.313.988.400.112.420.390,Hylobatidae,Catarrhini,1
Hymenoptera,B,B01.050.500.131.617.720.500.500.875,Holometabola,Neoptera,1
Hymenostomatida,B,B01.043.185.650.375,Oligohymenophorea,Ciliophora,1
Hyper-IgM Immunodeficiency Syndrome,C,C20.673.795.625,Primary Immunodeficiency Diseases,Immunologic Deficiency Syndromes,1
Hyper-IgM Immunodeficiency Syndrome,C,C20.673.430.250,Dysgammaglobulinemia,Immunologic Deficiency Syndromes,1
Hyper-IgM Immunodeficiency Syndrome,C,C15.378.147.333.249,Dysgammaglobulinemia,Blood Protein Disorders,1
Hyper-IgM Immunodeficiency Syndrome,C,C16.320.798.625,Primary Immunodeficiency Diseases,"Genetic Diseases, Inborn",1
Hyper-IgM Immunodeficiency Syndrome,C,C16.320.413,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",1
Hyperlactatemia,C,C18.452.479,Metabolic Diseases,Nutritional and Metabolic Diseases,1
Hyperlactatemia,C,C23.888.516,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",1
Hyperostosis,C,C05.116.540,Bone Diseases,Musculoskeletal Diseases,1
Hyperparathyroidism,C,C19.642.355,Parathyroid Diseases,Endocrine System Diseases,1
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels,D,D12.776.157.530.400.368,Ion Channels,Membrane Transport Proteins,1
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels,D,D12.776.543.585.400.476,Ion Channels,Membrane Transport Proteins,1
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels,D,D12.776.543.550.450.476,Ion Channels,Membrane Glycoproteins,1
Hyperprolactinemia,C,C19.700.355.600,Hyperpituitarism,Pituitary Diseases,1
Hyperprolactinemia,C,C10.228.140.617.738.250.450,Hyperpituitarism,Pituitary Diseases,1
"Hypertension, Malignant",C,C14.907.489.330,Hypertension,Vascular Diseases,1
Hypertensive Retinopathy,C,C14.907.489.815,Hypertension,Vascular Diseases,1
Hypertensive Retinopathy,C,C11.768.346,Retinal Diseases,Eye Diseases,1
Hyperventilation,C,C08.618.501,Respiration Disorders,Respiratory Tract Diseases,1
Hyperventilation,C,C23.888.852.591,"Signs and Symptoms, Respiratory",Signs and Symptoms,1
Hypesthesia,C,C23.888.592.763.770.500,Somatosensory Disorders,Sensation Disorders,1
Hypesthesia,C,C10.597.751.791.500,Somatosensory Disorders,Sensation Disorders,1
Hypnosis,E,E02.190.525.217,Mind-Body Therapies,Complementary Therapies,1
Hypnosis,F,F04.754.424,Psychotherapy,Behavioral Disciplines and Activities,1
Hypodermoclysis,E,E02.319.360.500,Fluid Therapy,Drug Therapy,1
Hypodermoclysis,E,E02.319.267.510.795.500,"Infusions, Subcutaneous","Infusions, Parenteral",1
Hypoglycins,D,D23.946.412,"Toxins, Biological",Biological Factors,1
Hypoglycins,D,D02.455.426.392.368.533.450,Cyclopropanes,Cycloparaffins,1
Hypopigmentation,C,C17.800.621.440,Pigmentation Disorders,Skin Diseases,1
Hypopituitarism,C,C10.228.140.617.738.300,Pituitary Diseases,Hypothalamic Diseases,1
Hypopituitarism,C,C19.700.482,Pituitary Diseases,Endocrine System Diseases,1
Hypoplastic Left Heart Syndrome,C,C16.131.240.400.625,"Heart Defects, Congenital",Cardiovascular Abnormalities,1
Hypoplastic Left Heart Syndrome,C,C14.280.400.625,"Heart Defects, Congenital",Heart Diseases,1
Hypoplastic Left Heart Syndrome,C,C14.240.400.625,"Heart Defects, Congenital",Cardiovascular Abnormalities,1
Hypoproteinemia,C,C15.378.147.607,Blood Protein Disorders,Hematologic Diseases,1
Hypothalamic Diseases,C,C10.228.140.617,Brain Diseases,Central Nervous System Diseases,1
Hypotonic Solutions,D,D26.776.399,Solutions,Pharmaceutical Preparations,1
Hypoxanthines,D,D03.633.100.759.758.399,Purinones,Purines,1
Hypoxia-Inducible Factor-Proline Dioxygenases,D,D08.811.682.690.708.694.500,Prolyl Hydroxylases,Mixed Function Oxygenases,1
Hypoxia-Inducible Factor-Proline Dioxygenases,D,D08.811.682.690.416.617.500,Prolyl Hydroxylases,Dioxygenases,1
Hyraxes,B,B01.050.150.900.649.313.957,Eutheria,Mammals,1
"Hysterectomy, Vaginal",E,E04.950.300.399.380,Hysterectomy,Gynecologic Surgical Procedures,1
Ibuprofen,D,D02.241.223.701.430,Phenylpropionates,"Acids, Carbocyclic",1
Ichthyosis Vulgaris,C,C16.131.831.512.410,Ichthyosis,Skin Abnormalities,1
Ichthyosis Vulgaris,C,C16.320.850.405,"Skin Diseases, Genetic","Genetic Diseases, Inborn",1
Ichthyosis Vulgaris,C,C17.800.428.333.410,Ichthyosis,Keratosis,1
Ichthyosis Vulgaris,C,C17.800.827.405,"Skin Diseases, Genetic",Skin Diseases,1
Ichthyosis Vulgaris,C,C17.800.804.512.410,Ichthyosis,Skin Abnormalities,1
"Ichthyosis, Lamellar",C,C17.800.804.512.400.410,"Ichthyosiform Erythroderma, Congenital",Ichthyosis,1
"Ichthyosis, Lamellar",C,C17.800.827.400.410,"Ichthyosiform Erythroderma, Congenital","Skin Diseases, Genetic",1
"Ichthyosis, Lamellar",C,C17.800.428.333.250.410,"Ichthyosiform Erythroderma, Congenital",Ichthyosis,1
"Ichthyosis, Lamellar",C,C16.320.850.400.410,"Ichthyosiform Erythroderma, Congenital","Skin Diseases, Genetic",1
"Ichthyosis, Lamellar",C,C16.614.492.400.410,"Ichthyosiform Erythroderma, Congenital",Ichthyosis,1
"Ichthyosis, Lamellar",C,C16.131.831.512.400.410,"Ichthyosiform Erythroderma, Congenital",Ichthyosis,1
Ictaluridae,B,B01.050.150.900.493.080.148,Catfishes,Fishes,1
Idaho,Z,Z01.107.567.875.560.380,Northwestern United States,United States,1
Idiopathic Hypersomnia,F,F03.870.400.800.200.400,Disorders of Excessive Somnolence,"Sleep Disorders, Intrinsic",1
Idiopathic Hypersomnia,C,C10.886.425.800.200.400,Disorders of Excessive Somnolence,"Sleep Disorders, Intrinsic",1
Idoxuridine,D,D03.383.742.680.852.300.400,Deoxyuridine,Uridine,1
Idoxuridine,D,D13.570.685.852.300.400,Deoxyuridine,Uridine,1
Idoxuridine,D,D13.570.230.430.609,Deoxyuridine,Deoxyribonucleosides,1
Ileal Neoplasms,C,C06.405.469.420.501,Ileal Diseases,Intestinal Diseases,1
Ileal Neoplasms,C,C06.405.469.491.501,Intestinal Neoplasms,Intestinal Diseases,1
Ileal Neoplasms,C,C06.405.249.411.501,Intestinal Neoplasms,Gastrointestinal Neoplasms,1
Ileal Neoplasms,C,C06.301.371.411.501,Intestinal Neoplasms,Gastrointestinal Neoplasms,1
Ileal Neoplasms,C,C04.588.274.476.411.501,Intestinal Neoplasms,Gastrointestinal Neoplasms,1
Ileitis,C,C06.405.205.462.624,Enteritis,Gastroenteritis,1
Ileitis,C,C06.405.469.420.520,Ileal Diseases,Intestinal Diseases,1
Ileitis,C,C06.405.469.326.875,Enteritis,Intestinal Diseases,1
Ileostomy,E,E04.579.338.508,Enterostomy,Ostomy,1
Ileostomy,E,E04.210.338.508,Enterostomy,Digestive System Surgical Procedures,1
Iliac Artery,A,A07.015.114.444,Arteries,Blood Vessels,1
Ilizarov Technique,E,E04.555.300.380,Fracture Fixation,Orthopedic Procedures,1
Ilizarov Technique,E,E04.555.120.380,Bone Lengthening,Orthopedic Procedures,1
Iloprost,D,D23.469.700.275,"Prostaglandins, Synthetic",Inflammation Mediators,1
Iloprost,D,D23.469.050.175.725.775.125,"Prostaglandins, Synthetic",Prostaglandins,1
Iloprost,D,D10.251.355.255.550.775.125,"Prostaglandins, Synthetic",Prostaglandins,1
Imino Sugars,D,D09.553,Carbohydrates,NULL,1
Imino Sugars,D,D02.491.567,Imines,Organic Chemicals,1
Imipramine,D,D03.633.300.240.485,Dibenzazepines,"Heterocyclic Compounds, 3-Ring",1
Immune Adherence Reaction,E,E01.370.225.812.400,Immunologic Tests,Clinical Laboratory Techniques,1
Immune Adherence Reaction,E,E05.200.812.400,Immunologic Tests,Clinical Laboratory Techniques,1
Immune Adherence Reaction,E,E05.478.594.400,Immunologic Tests,Immunologic Techniques,1
Immune Checkpoint Proteins,D,D23.383,Biological Factors,NULL,1
Immune Checkpoint Proteins,D,D12.776.465,Proteins,"Amino Acids, Peptides, and Proteins",1
Immunochemistry,H,H01.181.122.605,Biochemistry,Chemistry,1
Immunochemistry,H,H02.403.044.500,Allergy and Immunology,Medicine,1
Immunochemistry,H,H01.158.201.486,Biochemistry,Biological Science Disciplines,1
"Immunoelectrophoresis, Two-Dimensional",E,E05.478.605.492.350.350.350,Immunoelectrophoresis,Immunodiffusion,1
"Immunoelectrophoresis, Two-Dimensional",E,E05.478.594.760.645.350.350.350,Immunoelectrophoresis,Immunodiffusion,1
"Immunoelectrophoresis, Two-Dimensional",E,E05.200.812.735.645.350.350.350,Immunoelectrophoresis,Immunodiffusion,1
"Immunoelectrophoresis, Two-Dimensional",E,E05.301.300.568.520,Immunoelectrophoresis,Electrophoresis,1
"Immunoelectrophoresis, Two-Dimensional",E,E05.196.401.568.520,Immunoelectrophoresis,Electrophoresis,1
"Immunoelectrophoresis, Two-Dimensional",E,E01.370.225.812.735.645.350.350.350,Immunoelectrophoresis,Immunodiffusion,1
Immunoglobulin Allotypes,D,D12.776.124.790.651.114.606,Antibodies,Immunoglobulins,1
Immunoglobulin Allotypes,D,D12.776.124.486.485.114.606,Antibodies,Immunoglobulins,1
Immunoglobulin Allotypes,D,D12.776.377.715.548.114.606,Antibodies,Immunoglobulins,1
Immunoglobulin Allotypes,G,G12.500.400,Immunogenetic Phenomena,Immune System Phenomena,1
Immunoglobulin epsilon-Chains,D,D12.776.377.715.548.114.619.312.500,Immunoglobulin E,Immunoglobulin Isotypes,1
Immunoglobulin epsilon-Chains,D,D12.776.377.715.548.705.500.370,Immunoglobulin Heavy Chains,Immunoglobulin Subunits,1
Immunoglobulin epsilon-Chains,D,D12.776.124.486.485.114.619.312.500,Immunoglobulin E,Immunoglobulin Isotypes,1
Immunoglobulin epsilon-Chains,D,D12.776.124.486.485.705.500.370,Immunoglobulin Heavy Chains,Immunoglobulin Subunits,1
Immunoglobulin epsilon-Chains,D,D12.776.124.790.651.114.619.312.500,Immunoglobulin E,Immunoglobulin Isotypes,1
Immunoglobulin epsilon-Chains,D,D12.776.124.790.651.705.500.370,Immunoglobulin Heavy Chains,Immunoglobulin Subunits,1
Immunoglobulin Idiotypes,D,D12.776.124.790.651.680.745,Immunoglobulin Fragments,Immunoglobulins,1
Immunoglobulin Idiotypes,D,D12.776.124.486.485.680.745,Immunoglobulin Fragments,Immunoglobulins,1
Immunoglobulin Idiotypes,D,D12.776.377.715.548.680.745,Immunoglobulin Fragments,Immunoglobulins,1
Immunoglobulin Idiotypes,D,D12.644.541.500.745,Immunoglobulin Fragments,Peptide Fragments,1
Immunoglobulin Idiotypes,D,D23.050.550.750,Epitopes,Antigens,1
Immunoglobulin Idiotypes,G,G12.500.450,Immunogenetic Phenomena,Immune System Phenomena,1
Immunoglobulin Idiotypes,G,G02.111.570.060.425.580,Immunoglobulin Variable Region,Amino Acid Sequence,1
Immunoglobulin J-Chains,D,D12.776.377.715.548.705.625,Immunoglobulin Subunits,Immunoglobulins,1
Immunoglobulin J-Chains,D,D12.776.124.486.485.705.625,Immunoglobulin Subunits,Immunoglobulins,1
Immunoglobulin J-Chains,D,D12.776.124.790.651.705.625,Immunoglobulin Subunits,Immunoglobulins,1
Immunoglobulin kappa-Chains,D,D12.776.124.790.651.705.750.530,Immunoglobulin Light Chains,Immunoglobulin Subunits,1
Immunoglobulin kappa-Chains,D,D12.776.124.486.485.705.750.530,Immunoglobulin Light Chains,Immunoglobulin Subunits,1
Immunoglobulin kappa-Chains,D,D12.776.377.715.548.705.750.530,Immunoglobulin Light Chains,Immunoglobulin Subunits,1
Immunoglobulin Light-chain Amyloidosis,C,C04.557.595.250,"Neoplasms, Plasma Cell",Neoplasms by Histologic Type,1
Immunoglobulin Light-chain Amyloidosis,C,C18.452.845.500.550,Amyloidosis,Proteostasis Deficiencies,1
Immunoglobulin Light-chain Amyloidosis,C,C20.683.780.565,Paraproteinemias,Immunoproliferative Disorders,1
Immunoglobulin Light-chain Amyloidosis,C,C20.683.515.507,Lymphoproliferative Disorders,Immunoproliferative Disorders,1
Immunologic Surveillance,G,G12.525,Immune System Phenomena,NULL,1
Immunologic Surveillance,G,G12.450.050.400.412,"Immunity, Cellular",Adaptive Immunity,1
Immunosenescence,G,G12.460.500,Immunocompetence,Immune System Phenomena,1
Immunosenescence,G,G07.345.124.390,Aging,Growth and Development,1
"Implants, Experimental",E,E07.695.340,Prostheses and Implants,Equipment and Supplies,1
Incest,I,I01.880.735.442,Social Problems,Sociology,1
Incontinence Pads,E,E07.325.068.500,Absorbent Pads,"Equipment and Supplies, Hospital",1
Incus,A,A09.246.397.247.362,Ear Ossicles,"Ear, Middle",1
Indiana,Z,Z01.107.567.875.510.360,Midwestern United States,United States,1
Indiana,Z,Z01.107.567.875.350.360,Great Lakes Region,United States,1
Indican,D,D03.633.100.473.393,Indoles,"Heterocyclic Compounds, 2-Ring",1
Indinavir,D,D03.383.725.385,Pyridines,"Heterocyclic Compounds, 1-Ring",1
Indium,D,D01.552.544.381,"Metals, Heavy",Metals,1
Indium,D,D01.268.556.381,"Metals, Heavy",Elements,1
Indocyanine Green,D,D03.633.100.473.400,Indoles,"Heterocyclic Compounds, 2-Ring",1
Industrial Development,J,J01.576.519,Industry,"Technology, Industry, and Agriculture",1
Industrial Development,I,I01.261.262.500,Economic Development,Economics,1
Industrial Oils,J,J01.637.450,Manufactured Materials,"Technology, Industry, and Agriculture",1
Infant Behavior,F,F01.145.179.500,Child Behavior,Behavior,1
"Infant, Extremely Premature",M,M01.060.703.520.520.500,"Infant, Premature","Infant, Newborn",1
"Infection Control, Dental",E,E06.470,Dentistry,NULL,1
"Infection Control, Dental",N,N06.850.780.200.450.500,Infection Control,Communicable Disease Control,1
Infectious bronchitis virus,B,B04.820.578.500.540.150.400.750,Gammacoronavirus,Coronavirus,1
Infectious Encephalitis,C,C01.207.399,Central Nervous System Infections,Infections,1
Infectious Encephalitis,C,C10.228.140.430.520,Encephalitis,Brain Diseases,1
Infectious Encephalitis,C,C10.228.228.399,Central Nervous System Infections,Central Nervous System Diseases,1
"Influenza A Virus, H1N2 Subtype",B,B04.820.480.968.405.400.216,Influenza A virus,Influenzavirus A,1
"Influenza A Virus, H5N8 Subtype",B,B04.820.480.968.405.400.598,Influenza A virus,Influenzavirus A,1
"Influenza A Virus, H7N1 Subtype",B,B04.820.480.968.405.400.690,Influenza A virus,Influenzavirus A,1
Influenzavirus B,B,B04.820.480.968.407,Orthomyxoviridae,Negative-Sense RNA Viruses,1
Informal Sector,I,I01.791.500,Private Sector,Social Sciences,1
Information Science,L,L01,NULL,NULL,1
Information Theory,L,L01.488,Information Science,NULL,1
"Infusions, Intra-Arterial",E,E02.319.267.510.520,"Infusions, Parenteral",Drug Administration Routes,1
Inhibitor of Differentiation Protein 1,D,D12.776.930.329.249,Inhibitor of Differentiation Proteins,Transcription Factors,1
"Injections, Epidural",E,E02.319.267.530.580.300,"Injections, Spinal",Injections,1
"Injections, Intraventricular",E,E02.319.267.530.550,Injections,Drug Administration Routes,1
"Injections, Jet",E,E02.319.267.530.620.570,"Injections, Subcutaneous",Injections,1
Ink,J,J01.637.500,Manufactured Materials,"Technology, Industry, and Agriculture",1
Inorganic Pyrophosphatase,D,D12.776.543.585.450.250.875.487,Proton Pumps,Cation Transport Proteins,1
Inorganic Pyrophosphatase,D,D08.811.277.040.600.399,Pyrophosphatases,Acid Anhydride Hydrolases,1
Inorganic Pyrophosphatase,D,D12.776.157.530.450.250.875.487,Proton Pumps,Cation Transport Proteins,1
Inosine,D,D03.633.100.759.590.616,Purine Nucleosides,Purines,1
Inosine,D,D13.570.583.616,Purine Nucleosides,Nucleosides,1
Inosine,D,D13.570.800.573,Ribonucleosides,Nucleosides,1
"Inositol 1,4,5-Trisphosphate",D,D09.894.480.350,Inositol Phosphates,Sugar Phosphates,1
"Inositol 1,4,5-Trisphosphate",D,D09.853.519.400.350,Inositol Phosphates,Inositol,1
"Inositol 1,4,5-Trisphosphate",D,D02.033.800.519.400.350,Inositol Phosphates,Inositol,1
"Inositol 1,4,5-Trisphosphate Receptors",D,D12.776.157.530.400.150.760,Calcium Channels,Ion Channels,1
"Inositol 1,4,5-Trisphosphate Receptors",D,D12.776.826.179,"Receptors, Cytoplasmic and Nuclear",Proteins,1
"Inositol 1,4,5-Trisphosphate Receptors",D,D12.776.543.585.400.150.760,Calcium Channels,Ion Channels,1
"Inositol 1,4,5-Trisphosphate Receptors",D,D12.776.543.550.450.150.760,Calcium Channels,Ion Channels,1
Insemination,G,G08.686.784.363,Reproduction,Reproductive Physiological Phenomena,1
Insulin Antibodies,D,D12.776.124.790.651.114.656,Antibodies,Immunoglobulins,1
Insulin Antibodies,D,D12.776.124.486.485.114.656,Antibodies,Immunoglobulins,1
Insulin Antibodies,D,D12.776.377.715.548.114.656,Antibodies,Immunoglobulins,1
Insulin Infusion Systems,E,E02.319.300.508,Drug Delivery Systems,Drug Therapy,1
Insulin Infusion Systems,E,E07.505.508,Infusion Pumps,Equipment and Supplies,1
Insulin Infusion Systems,E,E07.858.082.505.508,Infusion Pumps,Artificial Organs,1
Insulin Lispro,D,D12.644.548.586.200.400.500,"Insulin, Short-Acting",Insulins,1
Insulin Lispro,D,D06.472.699.587.200.400.500,"Insulin, Short-Acting",Insulins,1
"Insulin, Regular, Human",D,D06.472.699.587.200.500.625.500,Insulin,Proinsulin,1
"Insulin, Regular, Human",D,D12.644.548.586.200.500.625.500,Insulin,Proinsulin,1
"Insulin, Short-Acting",D,D12.644.548.586.200.400,Insulins,Pancreatic Hormones,1
"Insulin, Short-Acting",D,D06.472.699.587.200.400,Insulins,Pancreatic Hormones,1
Insulin-Like Growth Factor Binding Proteins,D,D12.776.157.420,Carrier Proteins,Proteins,1
"Insurance, Accident",N,N03.219.521.576.343.409,"Insurance, Health",Insurance,1
"Insurance, Disability",N,N03.219.521.576.300,Insurance,"Financing, Organized",1
"Insurance, Life",N,N03.219.521.576.543,Insurance,"Financing, Organized",1
"Insurance, Psychiatric",N,N03.219.521.576.343.658,"Insurance, Health",Insurance,1
Integrated Advanced Information Management Systems,L,L01.313.500.750.300.420,Information Systems,Medical Informatics Applications,1
Integrin alphaVbeta3,D,D12.776.395.550.625.439,Platelet Membrane Glycoproteins,Membrane Glycoproteins,1
Integrin alphaVbeta3,D,D12.776.543.550.625.439,Platelet Membrane Glycoproteins,Membrane Glycoproteins,1
Integrin alphaVbeta3,D,D12.776.543.750.705.675.541,Platelet Membrane Glycoproteins,"Receptors, Immunologic",1
Integrin alphaVbeta3,D,D12.776.543.750.705.408.460.870.500,"Receptors, Vitronectin","Receptors, Cytoadhesin",1
Integrin alphaXbeta2,D,D12.776.543.750.705.408.600.100,"Receptors, Leukocyte-Adhesion",Integrins,1
Integrin alphaXbeta2,D,D12.776.543.750.705.833.249,"Receptors, Complement","Receptors, Immunologic",1
Integrin alphaXbeta2,D,D12.776.543.550.200.275,Cell Adhesion Molecules,Membrane Glycoproteins,1
Integrin alphaXbeta2,D,D23.050.301.350.275,Cell Adhesion Molecules,"Antigens, Surface",1
Integrin alphaXbeta2,D,D12.776.395.550.200.275,Cell Adhesion Molecules,Membrane Glycoproteins,1
Interatrial Block,C,C23.550.073.425.270,Heart Block,"Arrhythmias, Cardiac",1
Interatrial Block,C,C14.280.067.558.430,Heart Block,"Arrhythmias, Cardiac",1
Interatrial Block,C,C14.280.123.500.430,Heart Block,Cardiac Conduction System Disease,1
Intercellular Junctions,A,A11.284.149.165.420,Cell Membrane Structures,Cell Membrane,1
Interdisciplinary Placement,I,I02.578,Education,NULL,1
Interferometry,E,E05.490,Investigative Techniques,NULL,1
Interferon beta-1b,D,D12.644.276.374.440.890.275.750,Interferon-beta,Interferon Type I,1
Interferon beta-1b,D,D12.776.467.374.440.890.275.750,Interferon-beta,Interferon Type I,1
Interferon beta-1b,D,D23.529.374.440.890.275.750,Interferon-beta,Interferon Type I,1
Interferon Inducers,D,D27.505.696.477.828,Immunologic Factors,Physiological Effects of Drugs,1
Interferon Regulatory Factor-7,D,D12.776.476.024.385.437,Interferon Regulatory Factors,"Adaptor Proteins, Signal Transducing",1
Interferon Regulatory Factor-7,D,D12.776.930.332.437,Interferon Regulatory Factors,Transcription Factors,1
Interferon Regulatory Factor-7,D,D12.776.744.631,Phosphoproteins,Proteins,1
Interferon Regulatory Factor-7,D,D12.644.360.024.302.437,Interferon Regulatory Factors,"Adaptor Proteins, Signal Transducing",1
Interferon Regulatory Factor-7,D,D12.776.260.504.437,Interferon Regulatory Factors,DNA-Binding Proteins,1
Interferon Regulatory Factor-7,D,D12.776.157.057.050.437,Interferon Regulatory Factors,"Adaptor Proteins, Signal Transducing",1
Interleukin-1 Receptor Accessory Protein,D,D12.776.543.750.705.852.420.300.249,"Receptors, Interleukin-1","Receptors, Interleukin",1
Interleukin-10 Receptor beta Subunit,D,D12.776.543.750.705.852.420.550.750,"Receptors, Interleukin-10","Receptors, Interleukin",1
Interleukin-11,D,D12.776.467.374.465.511,Interleukins,Cytokines,1
Interleukin-11,D,D23.529.374.465.511,Interleukins,Cytokines,1
Interleukin-11,D,D12.644.276.374.465.511,Interleukins,Cytokines,1
Interleukin-12 Subunit p35,D,D12.644.276.374.465.512.249,Interleukin-12,Interleukins,1
Interleukin-12 Subunit p35,D,D23.529.374.465.512.249,Interleukin-12,Interleukins,1
Interleukin-12 Subunit p35,D,D12.776.467.374.465.512.249,Interleukin-12,Interleukins,1
Interleukin-23 Subunit p19,D,D12.776.467.374.465.759.500,Interleukin-23,Interleukins,1
Interleukin-23 Subunit p19,D,D23.529.374.465.550.500,Interleukin-23,Interleukins,1
Interleukin-23 Subunit p19,D,D12.644.276.374.465.759.500,Interleukin-23,Interleukins,1
Interleukin-27,D,D12.644.276.374.465.800,Interleukins,Cytokines,1
Interleukin-27,D,D23.529.374.465.600,Interleukins,Cytokines,1
Interleukin-27,D,D12.776.467.374.465.800,Interleukins,Cytokines,1
Interleukin-33,D,D12.776.467.374.465.850,Interleukins,Cytokines,1
Interleukin-33,D,D23.529.374.465.850,Interleukins,Cytokines,1
Interleukin-33,D,D12.644.276.374.465.850,Interleukins,Cytokines,1
Interleukin-4 Receptor alpha Subunit,D,D12.776.543.750.705.852.420.600.800.200,"Receptors, Interleukin-4, Type II","Receptors, Interleukin-13",1
Interleukin-4 Receptor alpha Subunit,D,D12.776.543.750.705.852.420.360.300.200,"Receptors, Interleukin-4, Type I","Receptors, Interleukin-4",1
Interleukin-4 Receptor alpha Subunit,D,D12.776.543.750.705.852.420.360.600.200,"Receptors, Interleukin-4, Type II","Receptors, Interleukin-4",1
Intermediate Filaments,A,A11.284.430.214.190.750.410,Cytoskeleton,Cytoplasmic Structures,1
Intermediate-Conductance Calcium-Activated Potassium Channels,D,D12.776.543.550.450.750.150.249,"Potassium Channels, Calcium-Activated",Potassium Channels,1
Intermediate-Conductance Calcium-Activated Potassium Channels,D,D12.776.543.585.400.750.150.249,"Potassium Channels, Calcium-Activated",Potassium Channels,1
Intermediate-Conductance Calcium-Activated Potassium Channels,D,D12.776.157.530.400.600.150.249,"Potassium Channels, Calcium-Activated",Potassium Channels,1
Internal Mammary-Coronary Artery Anastomosis,E,E04.928.220.520.220.380,Coronary Artery Bypass,Myocardial Revascularization,1
Internal Mammary-Coronary Artery Anastomosis,E,E04.100.376.719.332.400,Coronary Artery Bypass,Myocardial Revascularization,1
Internal Mammary-Coronary Artery Anastomosis,E,E04.100.814.868.750.400,Coronary Artery Bypass,Vascular Grafting,1
"International Classification of Functioning, Disability and Health",L,L01.453.245.945.450,"Vocabulary, Controlled",Documentation,1
International Law,N,N03.706.535.533,Jurisprudence,"Social Control, Formal",1
International Law,I,I01.880.604.583.466,Jurisprudence,"Social Control, Formal",1
Interpersonal Psychotherapy,F,F04.754.506,Psychotherapy,Behavioral Disciplines and Activities,1
Interprofessional Education,I,I02.358.805,"Education, Professional",Education,1
Intestinal Polyps,C,C23.300.825.411,Polyps,"Pathological Conditions, Anatomical",1
Intestinal Pseudo-Obstruction,C,C06.405.469.531.492.500,Ileus,Intestinal Obstruction,1
Intestinal Secretions,A,A12.200.390,Bodily Secretions,Fluids and Secretions,1
"Intracranial Hemorrhage, Hypertensive",C,C14.907.253.573.350,Intracranial Hemorrhages,Cerebrovascular Disorders,1
"Intracranial Hemorrhage, Hypertensive",C,C10.228.140.300.535.325,Intracranial Hemorrhages,Cerebrovascular Disorders,1
Intramolecular Transferases,D,D08.811.399.520,Isomerases,Enzymes,1
Intrauterine Device Expulsion,E,E05.325.578.500,Intrauterine Device Migration,Equipment Failure,1
Intravital Microscopy,E,E05.595.185,Microscopy,Investigative Techniques,1
Intravital Microscopy,E,E01.370.350.515.277,Microscopy,Diagnostic Imaging,1
Intrinsic Factor,D,D12.776.395.560.494,Mucoproteins,Glycoproteins,1
Intubation,E,E02.585,Therapeutics,NULL,1
Intubation,E,E05.497,Investigative Techniques,NULL,1
Invasive Pulmonary Aspergillosis,C,C08.381.472.850.750,Pulmonary Aspergillosis,"Lung Diseases, Fungal",1
Invasive Pulmonary Aspergillosis,C,C01.150.703.534.850.750,Pulmonary Aspergillosis,"Lung Diseases, Fungal",1
Invasive Pulmonary Aspergillosis,C,C01.150.703.492.688,Invasive Fungal Infections,Mycoses,1
Invasive Pulmonary Aspergillosis,C,C01.150.703.080.768.750,Pulmonary Aspergillosis,Aspergillosis,1
Inverted Repeat Sequences,G,G02.111.570.080.708.800.325,Tandem Repeat Sequences,"Repetitive Sequences, Nucleic Acid",1
Inverted Repeat Sequences,G,G05.360.080.708.800.325,Tandem Repeat Sequences,"Repetitive Sequences, Nucleic Acid",1
Involuntary Treatment,I,I01.880.604.528,"Social Control, Formal",Sociology,1
"Involuntary Treatment, Psychiatric",I,I01.880.604.528.500,Involuntary Treatment,"Social Control, Formal",1
Iodide Peroxidase,D,D08.811.682.732.525,Peroxidases,Oxidoreductases,1
Iodine Isotopes,D,D01.268.380.400.500,Iodine,Halogens,1
Iodine Isotopes,D,D01.496.448,Isotopes,Inorganic Chemicals,1
Iohexol,D,D02.455.426.559.389.127.375.880.400,Triiodobenzoic Acids,Iodobenzoates,1
Iohexol,D,D02.241.223.100.400.880.400,Triiodobenzoic Acids,Iodobenzoates,1
Ion Exchange,G,G02.437,Chemical Phenomena,NULL,1
Ion Transport,G,G03.143.500,Biological Transport,Metabolism,1
Iothalamic Acid,D,D02.241.223.100.400.880.430,Triiodobenzoic Acids,Iodobenzoates,1
Iothalamic Acid,D,D02.455.426.559.389.127.375.880.430,Triiodobenzoic Acids,Iodobenzoates,1
Iowa,Z,Z01.107.567.875.510.370,Midwestern United States,United States,1
Iridocyclitis,C,C11.941.375.360,Iris Diseases,Uveal Diseases,1
Iridocyclitis,C,C11.941.879.780.880.400,"Uveitis, Anterior",Panuveitis,1
Irinotecan,D,D03.132.151.425,Camptothecin,Alkaloids,1
Iris Diseases,C,C11.941.375,Uveal Diseases,Eye Diseases,1
Irritants,D,D27.888.569.300,Noxae,Toxic Actions,1
Irritants,D,D27.720.400,Specialty Uses of Chemicals,Chemical Actions and Uses,1
ISCOMs,D,D20.215.894.860.449,"Vaccines, Subunit",Vaccines,1
Isocitrate Dehydrogenase,D,D08.811.682.047.820.475,NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases,Alcohol Oxidoreductases,1
Isocitrate Lyase,D,D08.811.520.224.600.700,Oxo-Acid-Lyases,Carbon-Carbon Lyases,1
Isoflurane,D,D02.355.601.570,Methyl Ethers,Ethers,1
Isoindoles,D,D03.633.100.513,"Heterocyclic Compounds, 2-Ring","Heterocyclic Compounds, Fused-Ring",1
Isoleucine-tRNA Ligase,D,D08.811.464.263.200.450,Amino Acyl-tRNA Synthetases,Carbon-Oxygen Ligases,1
Isomerases,D,D08.811.399,Enzymes,Enzymes and Coenzymes,1
Isomerism,G,G02.607.445,Organic Chemistry Phenomena,Chemical Phenomena,1
Isomerism,G,G02.111.570.685,Molecular Structure,Biochemical Phenomena,1
Isosorbide Dinitrate,D,D09.853.813.480.500,Isosorbide,Sorbitol,1
Isosorbide Dinitrate,D,D02.033.800.813.480.500,Isosorbide,Sorbitol,1
Isothiocyanates,D,D02.886.250,Sulfur Compounds,Organic Chemicals,1
Isothiocyanates,D,D02.500.375,Isocyanates,Organic Chemicals,1
Isoxazoles,D,D03.383.129.385,Azoles,"Heterocyclic Compounds, 1-Ring",1
Ivabradine,D,D03.633.100.079.801,Benzazepines,"Heterocyclic Compounds, 2-Ring",1
Jackals,B,B01.050.150.900.649.313.750.250.216.400,Canidae,Caniformia,1
Janus Kinase 3,D,D08.811.913.696.620.682.725.124.300,Janus Kinases,Protein-Tyrosine Kinases,1
Janus Kinase 3,D,D12.776.476.393.300,Janus Kinases,Intracellular Signaling Peptides and Proteins,1
Janus Kinase Inhibitors,D,D27.505.519.389.755.500,Protein Kinase Inhibitors,Enzyme Inhibitors,1
Jaw Diseases,C,C07.320,Stomatognathic Diseases,NULL,1
Jaw Diseases,C,C05.500,Musculoskeletal Diseases,NULL,1
Jejunal Neoplasms,C,C06.405.469.491.523,Intestinal Neoplasms,Intestinal Diseases,1
Jejunal Neoplasms,C,C06.405.469.600.523,Jejunal Diseases,Intestinal Diseases,1
Jejunal Neoplasms,C,C06.405.249.411.523,Intestinal Neoplasms,Gastrointestinal Neoplasms,1
Jejunal Neoplasms,C,C06.301.371.411.523,Intestinal Neoplasms,Gastrointestinal Neoplasms,1
Jejunal Neoplasms,C,C04.588.274.476.411.523,Intestinal Neoplasms,Gastrointestinal Neoplasms,1
Job Application,N,N04.452.677.400,Personnel Management,Organization and Administration,1
Joint Commission on Accreditation of Healthcare Organizations,N,N03.706.110.070.410,Accreditation,Credentialing,1
Joint Commission on Accreditation of Healthcare Organizations,N,N05.700.200.100.420,Accreditation,Credentialing,1
"Joint Deformities, Acquired",C,C05.550.515,Joint Diseases,Musculoskeletal Diseases,1
Jugular Veins,A,A07.015.908.498,Veins,Blood Vessels,1
Jupiter,G,G01.060.075.730.700.412,Planets,Solar System,1
Kallmann Syndrome,C,C19.391.482.600,Hypogonadism,Gonadal Disorders,1
Kallmann Syndrome,C,C19.391.119.096.750,"Disorder of Sex Development, 46,XY",Disorders of Sex Development,1
Kallmann Syndrome,C,C12.706.316.096.750,"Disorder of Sex Development, 46,XY",Disorders of Sex Development,1
Kallmann Syndrome,C,C13.351.875.253.096.750,"Disorder of Sex Development, 46,XY",Disorders of Sex Development,1
Kallmann Syndrome,C,C16.131.939.316.096.750,"Disorder of Sex Development, 46,XY",Disorders of Sex Development,1
Kallmann Syndrome,C,C16.320.467,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",1
Kaolin,D,D01.056.050.075.350,Aluminum Silicates,Aluminum Oxide,1
Kaolin,D,D01.837.725.700.760.050.400,Aluminum Silicates,Silicates,1
Kaolin,D,D01.650.550.050.075.350,Aluminum Silicates,Aluminum Oxide,1
Kaolin,D,D01.578.725.025.350,Aluminum Silicates,Silicates,1
Karnofsky Performance Status,E,E05.318.308.980.438.475.456.500.500,Severity of Illness Index,Patient Acuity,1
Karnofsky Performance Status,N,N05.715.360.300.800.438.375.364.500.500,Severity of Illness Index,Patient Acuity,1
Karnofsky Performance Status,N,N06.850.520.308.980.438.475.364.500.500,Severity of Illness Index,Patient Acuity,1
Karyotype,G,G05.360.162.679,Chromosomes,Genetic Structures,1
Kelch-Like ECH-Associated Protein 1,D,D12.776.476.024.387,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
Kelch-Like ECH-Associated Protein 1,D,D12.644.360.024.306,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
Kelch-Like ECH-Associated Protein 1,D,D12.776.157.057.067,"Adaptor Proteins, Signal Transducing",Carrier Proteins,1
Keratolytic Agents,D,D27.505.954.444.400,Dermatologic Agents,Therapeutic Uses,1
"Keratomileusis, Laser In Situ",E,E02.594.480.750,"Corneal Surgery, Laser",Laser Therapy,1
"Keratomileusis, Laser In Situ",E,E04.014.520.480.750,"Corneal Surgery, Laser",Laser Therapy,1
"Keratomileusis, Laser In Situ",E,E04.378.500.750,"Corneal Surgery, Laser",Keratectomy,1
"Keratomileusis, Laser In Situ",E,E04.540.825.437.374,"Corneal Surgery, Laser",Refractive Surgical Procedures,1
Ketoglutaric Acids,D,D02.241.755.465,Keto Acids,Carboxylic Acids,1
Ketoglutaric Acids,D,D02.241.081.337.351.502,Glutarates,Dicarboxylic Acids,1
Ketoprofen,D,D02.241.223.701.480,Phenylpropionates,"Acids, Carbocyclic",1
Ketorolac,D,D03.633.100.473.420.485,Indomethacin,Indoles,1
Ketosis,C,C18.452.076.176.652,Acidosis,Acid-Base Imbalance,1
Kidney Cortex,A,A05.810.453.324,Kidney,Urinary Tract,1
Kinesthesis,F,F02.830.816.541.504,Proprioception,Sensation,1
Kinesthesis,G,G11.561.790.541.587,Proprioception,Sensation,1
Kinetochores,G,G05.360.160.165.500,Centromere,Chromosome Structures,1
Kinetochores,A,A11.284.430.106.279.345.190.160.165.500,Centromere,Chromosome Structures,1
Kisspeptins,D,D12.644.400.430,Neuropeptides,Peptides,1
Kisspeptins,D,D12.644.276.836,Intercellular Signaling Peptides and Proteins,Peptides,1
Kisspeptins,D,D12.776.624.776.546,Tumor Suppressor Proteins,Neoplasm Proteins,1
Knee Injuries,C,C26.558.554,Leg Injuries,Wounds and Injuries,1
Knowledge Discovery,H,H01.770.644.310,Research,Science,1
Knowledge Discovery,L,L01.178.682.099.325.750,Bibliometrics,Bibliographies as Topic,1
Knowledge Management,N,N04.452.480,Organization and Administration,Health Services Administration,1
"Knowledge of Results, Psychological",F,F02.463.425.770.379,"Reinforcement, Psychology",Learning,1
Kobuvirus,B,B04.820.578.750.500,Picornaviridae,Positive-Strand RNA Viruses,1
Kringles,G,G02.111.570.820.709.275.750.375,Protein Domains,Protein Structural Elements,1
Kv1.1 Potassium Channel,D,D12.776.543.585.400.750.900.624.124,Shaker Superfamily of Potassium Channels,"Potassium Channels, Voltage-Gated",1
Kv1.1 Potassium Channel,D,D12.776.543.550.450.750.900.124.311,Delayed Rectifier Potassium Channels,"Potassium Channels, Voltage-Gated",1
Kv1.1 Potassium Channel,D,D12.776.543.550.450.750.900.500.124,Shaker Superfamily of Potassium Channels,"Potassium Channels, Voltage-Gated",1
Kv1.1 Potassium Channel,D,D12.776.157.530.400.600.900.500.124,Shaker Superfamily of Potassium Channels,"Potassium Channels, Voltage-Gated",1
Kv1.3 Potassium Channel,D,D12.776.157.530.400.600.900.500.217,Shaker Superfamily of Potassium Channels,"Potassium Channels, Voltage-Gated",1
Kv1.3 Potassium Channel,D,D12.776.543.550.450.750.900.124.358,Delayed Rectifier Potassium Channels,"Potassium Channels, Voltage-Gated",1
Kv1.3 Potassium Channel,D,D12.776.543.585.400.750.900.624.217,Shaker Superfamily of Potassium Channels,"Potassium Channels, Voltage-Gated",1
L Cells,A,A11.251.210.505,Cell Line,"Cells, Cultured",1
L Cells,A,A11.329.228.505,Fibroblasts,Connective Tissue Cells,1
Labor Onset,G,G08.686.784.769.326.500,"Labor, Obstetric",Pregnancy,1
Labor Pain,C,C23.888.592.612.451,Pain,Neurologic Manifestations,1
Labor Presentation,G,G08.686.784.769.326.520,"Labor, Obstetric",Pregnancy,1
Labor Presentation,G,G08.686.520,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,1
Laboratory Animal Science,H,H01.158.273.368,Biology,Biological Science Disciplines,1
Laccase,D,D08.811.682.494,Oxidoreductases,Enzymes,1
Lacrimal Duct Obstruction,C,C11.496.456,Lacrimal Apparatus Diseases,Eye Diseases,1
Lactase,D,D08.811.277.450.410.100.500,beta-Galactosidase,Galactosidases,1
Lactation Disorders,C,C17.800.090.937,Breast Diseases,Skin Diseases,1
Lactation Disorders,C,C13.703.844.506,Puerperal Disorders,Pregnancy Complications,1
Lactobacillales,B,B03.353.750,Firmicutes,Bacteria,1
Lactobacillales,B,B03.510.550,Gram-Positive Bacteria,Bacteria,1
Lactobacillus delbrueckii,B,B03.510.460.400.410.475.475.250,Lactobacillus,Lactobacillaceae,1
Lactobacillus delbrueckii,B,B03.353.750.450.475.250,Lactobacillus,Lactobacillaceae,1
Lactobacillus delbrueckii,B,B03.510.550.450.475.250,Lactobacillus,Lactobacillaceae,1
Lactobacillus plantarum,B,B03.510.550.450.475.612,Lactobacillus,Lactobacillaceae,1
Lactobacillus plantarum,B,B03.353.750.450.475.612,Lactobacillus,Lactobacillaceae,1
Lactobacillus plantarum,B,B03.510.460.400.410.475.475.612,Lactobacillus,Lactobacillaceae,1
Lactococcus lactis,B,B03.510.400.800.500.400,Lactococcus,Streptococcaceae,1
Lactococcus lactis,B,B03.353.750.737.500.400,Lactococcus,Streptococcaceae,1
Lactococcus lactis,B,B03.510.550.737.500.400,Lactococcus,Streptococcaceae,1
Lactoperoxidase,D,D08.811.682.732.550,Peroxidases,Oxidoreductases,1
Lagovirus,B,B04.820.578.298.500,Caliciviridae,Positive-Strand RNA Viruses,1
Langerhans Cells,A,A15.382.670.260.500,Dendritic Cells,Mononuclear Phagocyte System,1
Langerhans Cells,A,A15.382.066.270.500,Dendritic Cells,Antigen-Presenting Cells,1
Langerhans Cells,A,A11.436.270.545,Dendritic Cells,Epithelial Cells,1
Langerhans Cells,A,A11.066.270.500,Dendritic Cells,Antigen-Presenting Cells,1
Lantana,B,B01.650.940.800.575.912.250.583.990.411,Verbenaceae,Lamiales,1
Large Neutral Amino Acid-Transporter 1,D,D12.776.157.530.200.500.500.500.300.500,"Fusion Regulatory Protein 1, Light Chains",Fusion Regulatory Protein-1,1
Large Neutral Amino Acid-Transporter 1,D,D12.776.157.530.937.313.500.625.500,"Fusion Regulatory Protein 1, Light Chains",Fusion Regulatory Protein-1,1
Large Neutral Amino Acid-Transporter 1,D,D12.776.543.585.200.500.500.500.500.500,"Fusion Regulatory Protein 1, Light Chains",Fusion Regulatory Protein-1,1
Large Neutral Amino Acid-Transporter 1,D,D12.776.543.585.937.313.500.625.500,"Fusion Regulatory Protein 1, Light Chains",Fusion Regulatory Protein-1,1
Laryngeal Diseases,C,C08.360,Respiratory Tract Diseases,NULL,1
Laryngeal Diseases,C,C09.400,Otorhinolaryngologic Diseases,NULL,1
Laryngeal Mucosa,A,A10.615.550.760.520,Respiratory Mucosa,Mucous Membrane,1
Laryngeal Mucosa,A,A04.760.520,Respiratory Mucosa,Respiratory System,1
Laryngeal Mucosa,A,A04.329.597,Larynx,Respiratory System,1
Laryngectomy,E,E04.580.369,Otorhinolaryngologic Surgical Procedures,"Surgical Procedures, Operative",1
Laryngoscopy,E,E04.580.373,Otorhinolaryngologic Surgical Procedures,"Surgical Procedures, Operative",1
Laryngoscopy,E,E04.502.250.525,Endoscopy,Minimally Invasive Surgical Procedures,1
Laryngoscopy,E,E01.370.388.250.525,Endoscopy,"Diagnostic Techniques, Surgical",1
Laryngoscopy,E,E01.370.386.460,"Diagnostic Techniques, Respiratory System",Diagnostic Techniques and Procedures,1
Larynx,A,A04.329,Respiratory System,NULL,1
"Larynx, Artificial",E,E07.858.082.595,Artificial Organs,Surgical Equipment,1
"Larynx, Artificial",E,E07.695.450,Prostheses and Implants,Equipment and Supplies,1
"Lasers, Excimer",E,E07.632.490.244,Lasers,Optical Devices,1
"Lasers, Excimer",E,E07.710.520.244,Lasers,Radiation Equipment and Supplies,1
"Lasers, Solid-State",E,E07.710.520.490,Lasers,Radiation Equipment and Supplies,1
"Lasers, Solid-State",E,E07.632.490.490,Lasers,Optical Devices,1
Latent TGF-beta Binding Proteins,D,D12.776.860.300.688,Extracellular Matrix Proteins,Scleroproteins,1
Laughter,F,F01.145.209.530.614,Nonverbal Communication,Communication,1
Lauric Acids,D,D10.251.500,Fatty Acids,Lipids,1
Lawsonia Bacteria,B,B03.440.520,Gram-Negative Bacteria,Bacteria,1
Lawsonia Bacteria,B,B03.660.125.460,Deltaproteobacteria,Proteobacteria,1
Lawyers,M,M01.526.520,Occupational Groups,Persons,1
Laxatives,D,D27.505.954.483.620,Gastrointestinal Agents,Therapeutic Uses,1
LDL-Receptor Related Proteins,D,D12.776.543.750.710.450.500,"Receptors, LDL","Receptors, Lipoprotein",1
LDL-Receptor Related Proteins,D,D12.776.526,Proteins,"Amino Acids, Peptides, and Proteins",1
Legal Services,I,I01.880.604.583.482,Jurisprudence,"Social Control, Formal",1
Lemuridae,B,B01.050.150.900.649.313.988.700.508,Strepsirhini,Primates,1
"Lens Cortex, Crystalline",A,A09.371.060.500.225,"Lens, Crystalline",Anterior Eye Segment,1
Lens Diseases,C,C11.510,Eye Diseases,NULL,1
Lens Subluxation,C,C11.510.598,Lens Diseases,Eye Diseases,1
Lentinan,D,D09.698.365.089.500,beta-Glucans,Glucans,1
Leontopithecus,B,B01.050.150.900.649.313.988.400.600.150.150.450,Callitrichinae,Cebidae,1
Letrozole,D,D03.383.129.799.638,Triazoles,Azoles,1
Letrozole,D,D02.626.300,Nitriles,Organic Chemicals,1
Lettuce,B,B01.650.940.800.575.912.250.100.500,Asteraceae,Magnoliopsida,1
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,D,D08.811.913.696.620.682.700.534,Protein-Serine-Threonine Kinases,Protein Kinases,1
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,D,D12.776.637.750,Parkinson Disease Associated Proteins,Proteins,1
Leucyl Aminopeptidase,D,D08.811.277.656.675.555.700,Metalloexopeptidases,Metalloproteases,1
Leucyl Aminopeptidase,D,D08.811.277.656.350.100.511,Aminopeptidases,Exopeptidases,1
Leucyl Aminopeptidase,D,D08.811.277.656.350.555.700,Metalloexopeptidases,Exopeptidases,1
Leukemia Inhibitory Factor,D,D12.644.276.374.470,Cytokines,Intercellular Signaling Peptides and Proteins,1
Leukemia Inhibitory Factor,D,D12.776.467.374.470,Cytokines,Intercellular Signaling Peptides and Proteins,1
Leukemia Inhibitory Factor,D,D23.529.374.470,Cytokines,Intercellular Signaling Peptides and Proteins,1
"Leukemia Virus, Gibbon Ape",B,B04.613.807.375.510,Gammaretrovirus,Retroviridae,1
"Leukemia Virus, Gibbon Ape",B,B04.613.807.805.510,"Retroviruses, Simian",Retroviridae,1
"Leukemia Virus, Gibbon Ape",B,B04.820.650.375.510,Gammaretrovirus,Retroviridae,1
"Leukemia Virus, Gibbon Ape",B,B04.820.650.805.510,"Retroviruses, Simian",Retroviridae,1
"Leukemia, B-Cell",C,C04.557.337.428.080,"Leukemia, Lymphoid",Leukemia,1
"Leukemia, B-Cell",C,C15.604.515.560.080,"Leukemia, Lymphoid",Lymphoproliferative Disorders,1
"Leukemia, B-Cell",C,C20.683.515.528.080,"Leukemia, Lymphoid",Lymphoproliferative Disorders,1
"Leukemia, Hairy Cell",C,C20.683.515.517,Lymphoproliferative Disorders,Immunoproliferative Disorders,1
"Leukemia, Hairy Cell",C,C15.604.515.553,Lymphoproliferative Disorders,Lymphatic Diseases,1
"Leukemia, Hairy Cell",C,C04.557.337.415,Leukemia,Neoplasms by Histologic Type,1
"Leukemia-Lymphoma, Adult T-Cell",C,C04.557.337.428.580.100,"Leukemia, T-Cell","Leukemia, Lymphoid",1
"Leukemia-Lymphoma, Adult T-Cell",C,C15.604.515.560.575.100,"Leukemia, T-Cell","Leukemia, Lymphoid",1
"Leukemia-Lymphoma, Adult T-Cell",C,C20.683.515.528.582.100,"Leukemia, T-Cell","Leukemia, Lymphoid",1
Leukemic Infiltration,C,C23.550.727.645.500,Neoplasm Invasiveness,Neoplastic Processes,1
Leukemic Infiltration,C,C04.697.645.500,Neoplasm Invasiveness,Neoplastic Processes,1
Leukoaraiosis,C,C23.550.522,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",1
Leukocyte Immunoglobulin-like Receptor B1,D,D12.776.543.750.705.023,"Receptors, Immunologic","Receptors, Cell Surface",1
Leukocyte Reduction Procedures,E,E02.120.527,Blood Component Removal,Therapeutics,1
Leukocyte Reduction Procedures,E,E05.200.500.363.835,Cell Separation,Cytological Techniques,1
Leukocyte Reduction Procedures,E,E05.242.363.540,Cell Separation,Cytological Techniques,1
Leukoencephalopathies,C,C10.228.140.695,Brain Diseases,Central Nervous System Diseases,1
"Leukoencephalopathy, Progressive Multifocal",C,C10.228.140.695.750,Leukoencephalopathies,Brain Diseases,1
"Leukoencephalopathy, Progressive Multifocal",C,C10.228.140.430.520.750.500,"Encephalitis, Viral",Infectious Encephalitis,1
"Leukoencephalopathy, Progressive Multifocal",C,C10.228.228.245.340.500,"Encephalitis, Viral",Central Nervous System Viral Diseases,1
"Leukoencephalopathy, Progressive Multifocal",C,C10.228.228.399.750.500,"Encephalitis, Viral",Infectious Encephalitis,1
"Leukoencephalopathy, Progressive Multifocal",C,C10.314.450,Demyelinating Diseases,Nervous System Diseases,1
"Leukoencephalopathy, Progressive Multifocal",C,C01.925.839.550,Slow Virus Diseases,Virus Diseases,1
"Leukoencephalopathy, Progressive Multifocal",C,C01.925.256.721.500,Polyomavirus Infections,DNA Virus Infections,1
"Leukoencephalopathy, Progressive Multifocal",C,C01.925.182.525.500,"Encephalitis, Viral",Central Nervous System Viral Diseases,1
"Leukoencephalopathy, Progressive Multifocal",C,C01.207.245.340.500,"Encephalitis, Viral",Central Nervous System Viral Diseases,1
"Leukoencephalopathy, Progressive Multifocal",C,C01.207.399.750.500,"Encephalitis, Viral",Infectious Encephalitis,1
Leukopoiesis,G,G04.152.825.597,Hematopoiesis,Cell Differentiation,1
Leukopoiesis,G,G09.188.343.597,Hematopoiesis,Blood Physiological Phenomena,1
Leukotrienes,D,D23.469.050.175.450,Eicosanoids,Autacoids,1
Leukotrienes,D,D10.251.355.255.100.450,Arachidonic Acids,Eicosanoids,1
Leukotrienes,D,D10.251.355.310.166.887,Arachidonic Acids,"Fatty Acids, Essential",1
Leupeptins,D,D12.644.456.580,Oligopeptides,Peptides,1
Leuprolide,D,D12.644.456.460.480,Gonadotropin-Releasing Hormone,Oligopeptides,1
Leuprolide,D,D12.644.400.400.740.320.400,Gonadotropin-Releasing Hormone,Pituitary Hormone-Releasing Hormones,1
Leuprolide,D,D12.644.548.365.740.320.400,Gonadotropin-Releasing Hormone,Pituitary Hormone-Releasing Hormones,1
Leuprolide,D,D06.472.699.327.740.320.400,Gonadotropin-Releasing Hormone,Pituitary Hormone-Releasing Hormones,1
Leuprolide,D,D12.776.631.650.405.740.320.400,Gonadotropin-Releasing Hormone,Pituitary Hormone-Releasing Hormones,1
Levivirus,B,B04.820.578.438.500,Leviviridae,Positive-Strand RNA Viruses,1
Levivirus,B,B04.123.691.600.500,Leviviridae,RNA Phages,1
Levivirus,B,B04.123.205.600.500,Leviviridae,Coliphages,1
Levodopa,D,D02.455.426.559.389.657.166.175.200.480,Dihydroxyphenylalanine,Catecholamines,1
Levodopa,D,D02.092.311.200.480,Dihydroxyphenylalanine,Catecholamines,1
Levodopa,D,D12.125.072.050.875.130.500,Dihydroxyphenylalanine,Tyrosine,1
Levodopa,D,D12.125.072.050.685.400.500,Dihydroxyphenylalanine,Phenylalanine,1
Lewis X Antigen,D,D23.050.301.264.900.050,"Antigens, Differentiation, Myelomonocytic","Antigens, Differentiation",1
Lewis X Antigen,D,D23.050.301.264.965.500,Stage-Specific Embryonic Antigens,"Antigens, Differentiation",1
Lewis X Antigen,D,D23.050.301.290.544.059,Lewis Blood Group Antigens,Blood Group Antigens,1
Lewis X Antigen,D,D23.050.285.050.050,"Antigens, Tumor-Associated, Carbohydrate","Antigens, Neoplasm",1
Lewis X Antigen,D,D23.101.140.075.050,"Antigens, Tumor-Associated, Carbohydrate","Biomarkers, Tumor",1
Lewis X Antigen,D,D23.101.100.900.050,"Antigens, Differentiation, Myelomonocytic","Antigens, Differentiation",1
Lewis X Antigen,D,D23.050.705.230.544.059,Lewis Blood Group Antigens,Blood Group Antigens,1
Lewis X Antigen,D,D23.050.550.325.050,"Antigens, Tumor-Associated, Carbohydrate",Epitopes,1
Lewy Bodies,A,A11.284.420.460,Inclusion Bodies,Cellular Structures,1
Libraries,J,J03.400.596,Information Centers,Non-Medical Public and Private Facilities,1
Libraries,L,L01.346.596,Information Centers,Information Science,1
"Libraries, Digital",L,L01.346.596.719.750,"Libraries, Special",Libraries,1
"Libraries, Digital",J,J03.400.596.831.750,"Libraries, Special",Libraries,1
"Libraries, Digital",L,L01.313.500.750.300.742.470,Online Systems,Information Systems,1
"Lichen Planus, Oral",C,C07.465.397,Mouth Diseases,Stomatognathic Diseases,1
"Lichen Planus, Oral",C,C17.800.859.475.560.397,Lichen Planus,Lichenoid Eruptions,1
Lichenoid Eruptions,C,C17.800.859.475,"Skin Diseases, Papulosquamous",Skin Diseases,1
Liechtenstein,Z,Z01.542.524,Europe,Geographic Locations,1
Life,K,K01.752.400,Philosophy,Humanities,1
Li-Fraumeni Syndrome,C,C18.452.284.520,DNA Repair-Deficiency Disorders,Metabolic Diseases,1
Li-Fraumeni Syndrome,C,C16.320.700.600,"Neoplastic Syndromes, Hereditary","Genetic Diseases, Inborn",1
Li-Fraumeni Syndrome,C,C04.700.600,"Neoplastic Syndromes, Hereditary",Neoplasms,1
Lifting,G,G01.374.669,Mechanical Phenomena,Physical Phenomena,1
Lightning,G,G16.500.175.843,Climatic Processes,Ecological and Environmental Phenomena,1
Lightning,G,G16.500.750.775.375,Weather,Meteorological Concepts,1
Lightning,N,N06.230.300.100.725.375,Weather,Atmosphere,1
Liliaceae,B,B01.650.940.800.575.912.250.618.875.500,Liliales,Lilianae,1
Limbic System,A,A08.186.211.180,Brain,Central Nervous System,1
LIM-Homeodomain Proteins,D,D12.776.512.249,LIM Domain Proteins,Proteins,1
LIM-Homeodomain Proteins,D,D12.776.260.529,DNA-Binding Proteins,Proteins,1
Limulus Test,E,E01.370.225.124.470,Clinical Chemistry Tests,Clinical Laboratory Techniques,1
Limulus Test,E,E01.370.225.875.150.570,Bacteriological Techniques,Microbiological Techniques,1
Limulus Test,E,E05.200.875.150.570,Bacteriological Techniques,Microbiological Techniques,1
Limulus Test,E,E05.200.124.470,Clinical Chemistry Tests,Clinical Laboratory Techniques,1
Limulus Test,E,E05.091.570,Biological Assay,Investigative Techniques,1
Lip,A,A01.456.505.631.515,Mouth,Face,1
Lip,A,A14.549.336,Mouth,Stomatognathic System,1
Lipid Droplets,A,A11.284.430.214.190.875.393,Organelles,Cytoplasmic Structures,1
Lipid Metabolism Disorders,C,C18.452.584,Metabolic Diseases,Nutritional and Metabolic Diseases,1
Lipid Mobilization,G,G03.458.500.500,Lipolysis,Lipid Metabolism,1
Lipodystrophy,C,C18.452.584.625,Lipid Metabolism Disorders,Metabolic Diseases,1
Lipodystrophy,C,C17.800.849.391,"Skin Diseases, Metabolic",Skin Diseases,1
Lipodystrophy,C,C18.452.880.391,"Skin Diseases, Metabolic",Metabolic Diseases,1
Lipoylation,G,G03.458.875,Lipid Metabolism,Metabolism,1
Lipoylation,G,G02.111.540,Biochemical Phenomena,Chemical Phenomena,1
Lithocholic Acid,D,D04.210.500.221.430.622,Cholic Acids,Cholanes,1
Lithocholic Acid,D,D04.210.500.105.225.480,Cholic Acids,Bile Acids and Salts,1
"Lithotripsy, Laser",E,E02.594.550,Laser Therapy,Therapeutics,1
"Lithotripsy, Laser",E,E02.600.500,Lithotripsy,Therapeutics,1
"Lithotripsy, Laser",E,E04.943.500.500,Lithotripsy,Ultrasonic Surgical Procedures,1
"Lithotripsy, Laser",E,E04.014.520.550,Laser Therapy,Ablation Techniques,1
Litter Size,G,G08.686.530,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,1
Litter Size,G,G08.686.784.769.498.300,"Pregnancy, Animal",Pregnancy,1
Livedo Reticularis,C,C23.888.885.437,Skin Manifestations,Signs and Symptoms,1
Livedo Reticularis,C,C17.800.862.355,"Skin Diseases, Vascular",Skin Diseases,1
Livedo Reticularis,C,C14.907.617.625,Peripheral Vascular Diseases,Vascular Diseases,1
"Liver Abscess, Pyogenic",C,C06.552.597.758,Liver Abscess,Liver Diseases,1
"Liver Abscess, Pyogenic",C,C01.830.025.020.455.730,Liver Abscess,Abdominal Abscess,1
"Liver Neoplasms, Experimental",C,C06.552.697.580,Liver Neoplasms,Liver Diseases,1
"Liver Neoplasms, Experimental",C,C06.301.623.460,Liver Neoplasms,Digestive System Neoplasms,1
"Liver Neoplasms, Experimental",C,C04.619.540,"Neoplasms, Experimental",Neoplasms,1
"Liver Neoplasms, Experimental",C,C04.588.274.623.460,Liver Neoplasms,Digestive System Neoplasms,1
"Liver Neoplasms, Experimental",E,E05.598.500.496.750,"Neoplasms, Experimental","Disease Models, Animal",1
Liver Regeneration,G,G16.762.468,Regeneration,Biological Phenomena,1
Liver Regeneration,G,G10.261.475,Digestive System Physiological Phenomena,Digestive System and Oral Physiological Phenomena,1
Lobosea,B,B01.046.500,Amoebozoa,Eukaryota,1
Logical Observation Identifiers Names and Codes,L,L01.453.245.945.500,"Vocabulary, Controlled",Documentation,1
Lomustine,D,D02.065.950.594.440,Nitrosourea Compounds,Urea,1
Lomustine,D,D02.654.692.440,Nitrosourea Compounds,Nitroso Compounds,1
Loperamide,D,D03.383.621.440,Piperidines,"Heterocyclic Compounds, 1-Ring",1
Lordosis,C,C05.116.900.800.750,Spinal Curvatures,Spinal Diseases,1
Louisiana,Z,Z01.107.567.875.750.480,Southeastern United States,United States,1
Low Density Lipoprotein Receptor-Related Protein-1,D,D12.776.526.100,LDL-Receptor Related Proteins,Proteins,1
Low Density Lipoprotein Receptor-Related Protein-1,D,D12.776.543.750.710.450.500.100,LDL-Receptor Related Proteins,"Receptors, LDL",1
Low Density Lipoprotein Receptor-Related Protein-5,D,D12.776.543.750.710.450.500.400,LDL-Receptor Related Proteins,"Receptors, LDL",1
Low Density Lipoprotein Receptor-Related Protein-5,D,D12.776.543.750.850.687,"Receptors, Wnt","Receptors, Cell Surface",1
Low Density Lipoprotein Receptor-Related Protein-5,D,D12.776.526.500,LDL-Receptor Related Proteins,Proteins,1
Lower Gastrointestinal Tract,A,A03.556.249,Gastrointestinal Tract,Digestive System,1
Lubricant Eye Drops,D,D27.720.752.608.500,Ophthalmic Solutions,Pharmaceutical Solutions,1
Lubricant Eye Drops,D,D27.720.556.249,Lubricants,Specialty Uses of Chemicals,1
Lubricant Eye Drops,D,D27.505.954.578.645.500,Ophthalmic Solutions,Pharmaceutical Solutions,1
Lubricant Eye Drops,D,D26.776.708.645.500,Ophthalmic Solutions,Pharmaceutical Solutions,1
Lumpy Skin Disease,C,C01.925.256.743.494,Poxviridae Infections,DNA Virus Infections,1
Lumpy Skin Disease,C,C22.196.497,Cattle Diseases,Animal Diseases,1
Lumpy skin disease virus,B,B04.280.650.160.150.500,Capripoxvirus,Chordopoxvirinae,1
Lupus Vulgaris,C,C01.800.720.820.470,"Tuberculosis, Cutaneous","Skin Diseases, Bacterial",1
Lupus Vulgaris,C,C01.150.252.819.820.470,"Tuberculosis, Cutaneous","Skin Diseases, Bacterial",1
Lupus Vulgaris,C,C17.800.838.765.820.470,"Tuberculosis, Cutaneous","Skin Diseases, Bacterial",1
Luxembourg,Z,Z01.542.550,Europe,Geographic Locations,1
Lymphatic System,A,A15.382.520,Immune System,Hemic and Immune Systems,1
"Lymphocytes, Null",A,A15.382.490.555.567.622,Lymphocytes,"Leukocytes, Mononuclear",1
"Lymphocytes, Null",A,A15.145.229.637.555.567.584,Lymphocytes,"Leukocytes, Mononuclear",1
"Lymphocytes, Null",A,A11.118.637.555.567.622,Lymphocytes,"Leukocytes, Mononuclear",1
"Lymphohistiocytosis, Hemophagocytic",C,C15.604.250.410.575,"Histiocytosis, Non-Langerhans-Cell",Histiocytosis,1
"Lymphoma, T-Cell",C,C15.604.515.569.480.750,"Lymphoma, Non-Hodgkin",Lymphoma,1
"Lymphoma, T-Cell",C,C20.683.515.761.480.750,"Lymphoma, Non-Hodgkin",Lymphoma,1
"Lymphoma, T-Cell",C,C04.557.386.480.750,"Lymphoma, Non-Hodgkin",Lymphoma,1
"Lymphoma, T-Cell, Cutaneous",C,C04.557.386.480.750.800,"Lymphoma, T-Cell","Lymphoma, Non-Hodgkin",1
"Lymphoma, T-Cell, Cutaneous",C,C20.683.515.761.480.750.800,"Lymphoma, T-Cell","Lymphoma, Non-Hodgkin",1
"Lymphoma, T-Cell, Cutaneous",C,C15.604.515.569.480.750.800,"Lymphoma, T-Cell","Lymphoma, Non-Hodgkin",1
"Lymphoma, T-Cell, Peripheral",C,C15.604.515.569.480.750.825,"Lymphoma, T-Cell","Lymphoma, Non-Hodgkin",1
"Lymphoma, T-Cell, Peripheral",C,C20.683.515.761.480.750.825,"Lymphoma, T-Cell","Lymphoma, Non-Hodgkin",1
"Lymphoma, T-Cell, Peripheral",C,C04.557.386.480.750.825,"Lymphoma, T-Cell","Lymphoma, Non-Hodgkin",1
Lysophosphatidylcholines,D,D10.570.755.375.760.550.550,Lysophospholipids,Phosphatidic Acids,1
Lysophospholipase,D,D08.811.277.352.100.680.510,Phospholipases,Carboxylic Ester Hydrolases,1
Macroglobulins,D,D12.776.377.715.647,Serum Globulins,Globulins,1
Macroglobulins,D,D12.776.124.790.720,Serum Globulins,Blood Proteins,1
Macrophage Migration-Inhibitory Factors,D,D12.644.276.374.480.625,Lymphokines,Cytokines,1
Macrophage Migration-Inhibitory Factors,D,D23.125.477.500,Leukocyte Migration-Inhibitory Factors,Chemotactic Factors,1
Macrophage Migration-Inhibitory Factors,D,D23.529.374.480.625,Lymphokines,Cytokines,1
Macrophage Migration-Inhibitory Factors,D,D12.776.467.374.480.625,Lymphokines,Cytokines,1
MADS Domain Proteins,D,D12.776.930.397,Transcription Factors,Proteins,1
MADS Domain Proteins,D,D12.776.260.400.249,Homeodomain Proteins,DNA-Binding Proteins,1
Magnaporthe,B,B01.300.107.575,Ascomycota,Fungi,1
Magnoliopsida,B,B01.650.940.800.575.912.250,Tracheophyta,Embryophyta,1
Maine,Z,Z01.107.567.875.550.500,New England,United States,1
"Mainstreaming, Education",I,I02.233.213.600,"Education, Special","Education, Nonprofessional",1
"Mainstreaming, Education",I,I02.158.600,Curriculum,Education,1
Maize streak virus,B,B04.280.350.500,Geminiviridae,DNA Viruses,1
Maize streak virus,B,B04.715.270.500,Geminiviridae,Plant Viruses,1
Malabsorption Syndromes,C,C06.405.469.637,Intestinal Diseases,Gastrointestinal Diseases,1
Malabsorption Syndromes,C,C18.452.603,Metabolic Diseases,Nutritional and Metabolic Diseases,1
"Malaria, Avian",C,C22.131.498,Bird Diseases,Animal Diseases,1
"Malaria, Avian",C,C01.920.875.606,Malaria,Vector Borne Diseases,1
"Malaria, Avian",C,C01.610.752.530.606,Malaria,Protozoan Infections,1
Malformations of Cortical Development,C,C16.131.666.507,Nervous System Malformations,Congenital Abnormalities,1
Malformations of Cortical Development,C,C10.500.507,Nervous System Malformations,Nervous System Diseases,1
Mamastrovirus,B,B04.820.578.250.500,Astroviridae,Positive-Strand RNA Viruses,1
Mammalian orthoreovirus 3,B,B04.820.223.719.590.550.700,"Orthoreovirus, Mammalian",Orthoreovirus,1
"Mammary Neoplasms, Animal",C,C04.588.531,Neoplasms by Site,Neoplasms,1
"Mammary Neoplasms, Animal",C,C22.520,Animal Diseases,NULL,1
"Mammary Neoplasms, Experimental",C,C04.588.531.500,"Mammary Neoplasms, Animal",Neoplasms by Site,1
"Mammary Neoplasms, Experimental",C,C04.619.590,"Neoplasms, Experimental",Neoplasms,1
"Mammary Neoplasms, Experimental",E,E05.598.500.496.843,"Neoplasms, Experimental","Disease Models, Animal",1
Mandible,A,A14.521.632,Jaw,Stomatognathic System,1
Mandible,A,A02.835.232.781.324.502.632,Jaw,Facial Bones,1
Mandrillus,B,B01.050.150.900.649.313.988.400.112.199.120.530,Cercopithecinae,Cercopithecidae,1
Manduca,B,B01.050.500.131.617.720.500.500.937.650.525,Moths,Lepidoptera,1
Mangifera,B,B01.650.940.800.575.912.250.044.416,Anacardiaceae,Magnoliopsida,1
"Manipulation, Orthopedic",E,E02.718.625,Orthopedic Procedures,Therapeutics,1
"Manipulation, Orthopedic",E,E02.831.535.867.433,Musculoskeletal Manipulations,Physical Therapy Modalities,1
"Manipulation, Orthopedic",E,E02.779.867.433,Musculoskeletal Manipulations,Physical Therapy Modalities,1
Mannans,D,D09.698.550,Polysaccharides,Carbohydrates,1
Mannosephosphates,D,D09.894.417.650,Hexosephosphates,Sugar Phosphates,1
Manual Lymphatic Drainage,E,E02.190.599.750.750.500,Massage,"Therapy, Soft Tissue",1
Manual Lymphatic Drainage,E,E02.309.416,Drainage,Therapeutics,1
Manual Lymphatic Drainage,E,E02.779.867.880.750.500,Massage,"Therapy, Soft Tissue",1
Manual Lymphatic Drainage,E,E02.831.535.867.880.750.500,Massage,"Therapy, Soft Tissue",1
Manufactured Materials,J,J01.637,"Technology, Industry, and Agriculture",NULL,1
Manufacturing and Industrial Facilities,J,J03.540,Non-Medical Public and Private Facilities,NULL,1
Marek Disease Vaccines,D,D20.215.894.899.290.500,Herpesvirus Vaccines,Viral Vaccines,1
MART-1 Antigen,D,D23.050.285.439.750,Melanoma-Specific Antigens,"Antigens, Neoplasm",1
MART-1 Antigen,D,D12.776.624.301.750,Melanoma-Specific Antigens,Neoplasm Proteins,1
Mast-Cell Sarcoma,C,C04.557.450.565.465.124,Mastocytosis,"Neoplasms, Connective Tissue",1
"Mastectomy, Modified Radical",E,E04.466.678.476,"Mastectomy, Radical",Mastectomy,1
Mastication,G,G07.203.650.283.500,Eating,Nutritional Physiological Phenomena,1
Mastication,G,G10.261.330.500,Eating,Digestive System Physiological Phenomena,1
Mastoiditis,C,C05.116.165.495.249,Osteomyelitis,"Bone Diseases, Infectious",1
Mastoiditis,C,C01.160.495.500,Osteomyelitis,"Bone Diseases, Infectious",1
Mastoiditis,C,C09.218.705.663.652,Otitis Media,Otitis,1
Maternal-Fetal Relations,F,F01.829.263.370.290.170.500,Mother-Child Relations,Parent-Child Relations,1
Maternal-Fetal Relations,F,F01.829.263.370.215.374,Maternal Behavior,Family Relations,1
Matrix Metalloproteinase 10,D,D12.776.467.836.400,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,1
Matrix Metalloproteinase 10,D,D12.644.276.848.400,"Matrix Metalloproteinases, Secreted",Intercellular Signaling Peptides and Proteins,1
Matrix Metalloproteinase 10,D,D08.811.277.656.675.374.525.700.400,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,1
Matrix Metalloproteinase 10,D,D08.811.277.656.300.480.525.700.400,"Matrix Metalloproteinases, Secreted",Matrix Metalloproteinases,1
Matrix Metalloproteinase 14,D,D08.811.277.656.675.374.525.300.500,"Matrix Metalloproteinases, Membrane-Associated",Matrix Metalloproteinases,1
Matrix Metalloproteinase 14,D,D08.811.277.656.300.480.525.300.500,"Matrix Metalloproteinases, Membrane-Associated",Matrix Metalloproteinases,1
Matrix Metalloproteinase Inhibitors,D,D27.505.519.389.745.610,Protease Inhibitors,Enzyme Inhibitors,1
"Matrix Metalloproteinases, Secreted",D,D12.776.467.836,Intercellular Signaling Peptides and Proteins,Proteins,1
"Matrix Metalloproteinases, Secreted",D,D08.811.277.656.300.480.525.700,Matrix Metalloproteinases,Metalloendopeptidases,1
"Matrix Metalloproteinases, Secreted",D,D08.811.277.656.675.374.525.700,Matrix Metalloproteinases,Metalloendopeptidases,1
"Matrix Metalloproteinases, Secreted",D,D12.644.276.848,Intercellular Signaling Peptides and Proteins,Peptides,1
Maxillary Sinus,A,A04.531.621.578,Paranasal Sinuses,Nose,1
MDS1 and EVI1 Complex Locus Protein,D,D12.776.260.534,DNA-Binding Proteins,Proteins,1
MDS1 and EVI1 Complex Locus Protein,D,D12.776.624.664.700.129,Proto-Oncogene Proteins,Oncogene Proteins,1
MDS1 and EVI1 Complex Locus Protein,D,D12.776.930.419,Transcription Factors,Proteins,1
Meconium,A,A12.459.529,Feces,Fluids and Secretions,1
Meconium,A,A16.378.529,Fetus,Embryonic Structures,1
Mediastinal Neoplasms,C,C04.588.894.479,Thoracic Neoplasms,Neoplasms by Site,1
Mediastinal Neoplasms,C,C08.846.187.580,Mediastinal Diseases,Thoracic Diseases,1
Medicago sativa,B,B01.650.940.800.575.912.250.401.590.500,Medicago,Fabaceae,1
Medical Device Legislation,N,N03.706.615.473.500,"Legislation, Medical",Legislation as Topic,1
Medical Informatics Computing,L,L01.313.500.875,Medical Informatics,Informatics,1
Medical Marijuana,D,D26.528,Pharmaceutical Preparations,NULL,1
Medical Receptionists,M,M01.526.485.067.600.630,Medical Secretaries,Allied Health Personnel,1
Medical Receptionists,N,N02.360.067.600.630,Medical Secretaries,Allied Health Personnel,1
Medical Record Administrators,N,N02.360.067.550,Allied Health Personnel,Health Personnel,1
Medical Record Administrators,M,M01.526.485.067.550,Allied Health Personnel,Health Personnel,1
"Medical Records Department, Hospital",N,N02.278.216.500.968.465,Hospital Departments,Hospital Administration,1
"Medical Records Department, Hospital",N,N04.452.442.452.422.465,Hospital Departments,Hospital Administration,1
"Medical Records, Problem-Oriented",N,N04.452.859.564.600,Medical Records,Records,1
"Medical Records, Problem-Oriented",N,N06.850.520.308.940.968.550,Medical Records,Records,1
"Medical Records, Problem-Oriented",N,N05.715.360.300.715.500.520,Medical Records,Records,1
"Medical Records, Problem-Oriented",E,E05.318.308.940.968.550,Medical Records,Records,1
Medical Subject Headings,L,L01.453.245.945.700.500,Subject Headings,"Vocabulary, Controlled",1
Medical Writing,L,L01.559.423.906.654,Writing,Language Arts,1
Medicare Part D,N,N03.219.521.576.343.575.500,"Insurance, Pharmaceutical Services","Insurance, Health",1
Medicare Part D,N,N03.219.521.576.343.840.938,Medicare,"Insurance, Health",1
Medicare Part D,N,N03.706.615.752,Legislation as Topic,"Social Control, Formal",1
Medication Reconciliation,N,N04.452.528.460,Medication Systems,Organization and Administration,1
Medication Reconciliation,N,N04.590.656,Patient Care Management,Health Services Administration,1
Medication Reconciliation,N,N02.421.450.500.500,Medication Errors,Medical Errors,1
Medication Reconciliation,E,E02.319.529.500,Medication Errors,Drug Therapy,1
Medication Systems,N,N04.452.528,Organization and Administration,Health Services Administration,1
"Medicine, Arabic",I,I01.076.201.450.654.510,"Medicine, Traditional",Culture,1
"Medicine, Arabic",E,E02.190.488.510,"Medicine, Traditional",Complementary Therapies,1
MEDLARS,L,L01.313.500.750.300.710,Information Systems,Medical Informatics Applications,1
MEDLARS,L,L01.313.500.750.280.710,Information Storage and Retrieval,Medical Informatics Applications,1
Medulloblastoma,C,C04.557.465.625.600.380.515,Glioma,"Neoplasms, Neuroepithelial",1
Medulloblastoma,C,C04.557.465.625.600.590.500,"Neuroectodermal Tumors, Primitive","Neoplasms, Neuroepithelial",1
Medulloblastoma,C,C04.557.580.625.600.380.515,Glioma,"Neoplasms, Neuroepithelial",1
Medulloblastoma,C,C04.557.580.625.600.590.500,"Neuroectodermal Tumors, Primitive","Neoplasms, Neuroepithelial",1
Medulloblastoma,C,C04.557.470.670.380.515,Glioma,"Neoplasms, Neuroepithelial",1
Medulloblastoma,C,C04.557.470.670.590.500,"Neuroectodermal Tumors, Primitive","Neoplasms, Neuroepithelial",1
Megestrol Acetate,D,D04.210.500.745.432.531.500,Megestrol,Pregnadienes,1
Meibomian Glands,A,A10.336.827.600,Sebaceous Glands,Exocrine Glands,1
Meibomian Glands,A,A09.371.337.614,Eyelids,Eye,1
Meige Syndrome,C,C10.228.662.300.500,Dystonic Disorders,Movement Disorders,1
Meige Syndrome,C,C10.228.140.079.590,Basal Ganglia Diseases,Brain Diseases,1
Melena,C,C23.550.414.788.600,Gastrointestinal Hemorrhage,Hemorrhage,1
Melena,A,A12.459.764,Feces,Fluids and Secretions,1
Melena,C,C06.405.227.600,Gastrointestinal Hemorrhage,Gastrointestinal Diseases,1
Melkersson-Rosenthal Syndrome,C,C07.465.299.800,Facial Nerve Diseases,Mouth Diseases,1
Melkersson-Rosenthal Syndrome,C,C07.465.466,Mouth Diseases,Stomatognathic Diseases,1
Melkersson-Rosenthal Syndrome,C,C10.292.319.800,Facial Nerve Diseases,Cranial Nerve Diseases,1
Melphalan,D,D02.455.526.728.650.594,Nitrogen Mustard Compounds,Mustard Compounds,1
Melphalan,D,D12.125.072.050.685.500,Phenylalanine,"Amino Acids, Aromatic",1
Membrane Cofactor Protein,D,D12.776.124.486.274.920.124,Complement Inactivator Proteins,Complement System Proteins,1
Membrane Cofactor Protein,D,D12.776.543.750.705.833.124,"Receptors, Complement","Receptors, Immunologic",1
Membrane Lipids,D,D10.570,Lipids,NULL,1
"Memory, Long-Term",F,F02.463.425.540.305,Memory,Learning,1
Meniere Disease,C,C09.218.568.217.500,Endolymphatic Hydrops,Labyrinth Diseases,1
Meniscus,A,A10.165.382.350.163,Fibrocartilage,Cartilage,1
Meniscus,A,A02.165.308.538,Fibrocartilage,Cartilage,1
Menispermaceae,B,B01.650.940.800.575.912.250.725,Magnoliopsida,Tracheophyta,1
"Menopause, Premature",C,C13.351.500.056.630.250,Ovarian Diseases,Adnexal Diseases,1
"Menopause, Premature",G,G08.686.841.249.500.500,Menopause,Climacteric,1
"Menopause, Premature",G,G08.686.157.500.500,Menopause,Climacteric,1
Menotropins,D,D12.644.548.691.525.343.583,"Gonadotropins, Pituitary","Pituitary Hormones, Anterior",1
Menotropins,D,D06.472.699.322.576.583,"Gonadotropins, Pituitary",Gonadotropins,1
Menotropins,D,D06.472.699.631.525.343.583,"Gonadotropins, Pituitary","Pituitary Hormones, Anterior",1
Menotropins,D,D20.215.535,Biological Products,Complex Mixtures,1
Mental Fatigue,C,C23.888.369.500,Fatigue,Signs and Symptoms,1
Mental Fatigue,F,F01.145.126.937,Behavioral Symptoms,Behavior,1
Mental Processes,F,F02.463,Psychological Phenomena,NULL,1
"Mental Retardation, X-Linked",C,C10.597.606.360.455,Intellectual Disability,Neurobehavioral Manifestations,1
"Mental Retardation, X-Linked",C,C16.320.400.525,"Heredodegenerative Disorders, Nervous System","Genetic Diseases, Inborn",1
"Mental Retardation, X-Linked",C,C16.320.322.500,"Genetic Diseases, X-Linked","Genetic Diseases, Inborn",1
Menthol,D,D02.455.426.392.368.367.211.750,Cyclohexane Monoterpenes,Cyclohexanes,1
Menthol,D,D02.033.415.510.500.605,Cyclohexanols,Hexanols,1
Menthol,D,D02.455.849.575.157.500,Cyclohexane Monoterpenes,Monoterpenes,1
Menthol,D,D10.289.510.500.605,Cyclohexanols,Hexanols,1
"Mercury Poisoning, Nervous System",C,C25.723.522.875.500,Mercury Poisoning,Heavy Metal Poisoning,1
"Mercury Poisoning, Nervous System",C,C10.720.475.600,"Heavy Metal Poisoning, Nervous System",Neurotoxicity Syndromes,1
Mermithoidea,B,B01.050.500.500.294.100.275.570,Enoplida,Adenophorea,1
Mesencephalon,A,A08.186.211.132.659,Brain Stem,Brain,1
Mesenteric Arteries,A,A07.015.114.565,Arteries,Blood Vessels,1
"Mesenteric Artery, Inferior",A,A07.015.114.565.510,Mesenteric Arteries,Arteries,1
"Mesenteric Artery, Superior",A,A07.015.114.565.755,Mesenteric Arteries,Arteries,1
Mesoderm,A,A16.504.660,Germ Layers,Embryonic Structures,1
Metabolic Engineering,E,E05.481.500.311.249,Cell Engineering,Culture Techniques,1
Metabolic Engineering,E,E05.393.420.526,Genetic Engineering,Genetic Techniques,1
Metabolic Engineering,J,J01.293.069.249.249,Cell Engineering,Bioengineering,1
Metabolic Equivalent,G,G03.680.365,Oxygen Consumption,Metabolism,1
Metabolic Equivalent,E,E01.370.600.337,Physical Examination,Diagnostic Techniques and Procedures,1
"Metabolism, Inborn Errors",C,C16.320.565,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",1
"Metabolism, Inborn Errors",C,C18.452.648,Metabolic Diseases,Nutritional and Metabolic Diseases,1
Metacognition,F,F02.463.188.756,Cognition,Mental Processes,1
Metal Nanoparticles,J,J01.637.512.600.500,Nanoparticles,Nanostructures,1
Metalloproteins,D,D12.776.556,Proteins,"Amino Acids, Peptides, and Proteins",1
"Metals, Alkaline Earth",D,D01.552.539,Metals,Inorganic Chemicals,1
"Metals, Alkaline Earth",D,D01.268.552,Elements,Inorganic Chemicals,1
"Metamorphosis, Biological",G,G07.345.500.550,Morphogenesis,Growth and Development,1
Metaplasia,C,C23.550.589,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",1
Metastasectomy,E,E04.480,"Surgical Procedures, Operative",NULL,1
Metatarsal Bones,A,A02.835.232.043.300.492,Foot Bones,Bones of Lower Extremity,1
Metered Dose Inhalers,E,E07.605.750,Nebulizers and Vaporizers,Equipment and Supplies,1
Methacholine Chloride,D,D02.092.877.883.555.500,Methacholine Compounds,Trimethyl Ammonium Compounds,1
Methacholine Chloride,D,D02.675.276.534.500,Methacholine Compounds,Quaternary Ammonium Compounds,1
Methanosarcina,B,B02.200.765.550.550,Methanosarcinaceae,Methanosarcinales,1
Methemoglobinemia,C,C15.378.619,Hematologic Diseases,Hemic and Lymphatic Diseases,1
Methimazole,D,D03.383.129.308.535,Imidazoles,Azoles,1
Methimazole,D,D02.886.489.600,Sulfhydryl Compounds,Sulfur Compounds,1
Methionine Sulfoxide Reductases,D,D08.811.682.730,Oxidoreductases,Enzymes,1
Methionine Sulfoxide Reductases,D,D12.776.864.100,Selenoproteins,Proteins,1
Methohexital,D,D03.383.742.698.253.488,Barbiturates,Pyrimidinones,1
Methoxsalen,D,D03.383.663.283.446.794.500,Furocoumarins,Coumarins,1
Methoxsalen,D,D03.633.100.150.446.794.500,Furocoumarins,Coumarins,1
Methoxsalen,D,D03.633.300.770.500,Furocoumarins,"Heterocyclic Compounds, 3-Ring",1
Methyl Methanesulfonate,D,D02.886.645.600.055.050.510.500,Mesylates,Alkanesulfonates,1
Methyl Methanesulfonate,D,D02.455.326.146.100.050.500.500,Mesylates,Alkanesulfonates,1
Methylamines,D,D02.092.668,Amines,Organic Chemicals,1
Methylenetetrahydrofolate Dehydrogenase (NADP),D,D08.811.682.662.253,Oxidoreductases Acting on CH-NH Group Donors,Oxidoreductases,1
Methylnitronitrosoguanidine,D,D02.654.567.400,Nitrosoguanidines,Nitroso Compounds,1
Methylnitronitrosoguanidine,D,D02.078.370.649.400,Nitrosoguanidines,Guanidines,1
Metoclopramide,D,D02.241.223.100.300.350.625,Hydroxybenzoate Ethers,Hydroxybenzoates,1
Metoclopramide,D,D02.241.223.100.100.510,Benzamides,Benzoates,1
Metoclopramide,D,D02.241.223.100.200.750,Chlorobenzoates,Benzoates,1
Metoclopramide,D,D02.241.223.100.050.500.647,para-Aminobenzoates,Aminobenzoates,1
Metoclopramide,D,D02.241.511.390.350.625,Hydroxybenzoate Ethers,Hydroxybenzoates,1
Metoclopramide,D,D02.455.426.559.389.127.281.350.625,Hydroxybenzoate Ethers,Hydroxybenzoates,1
Metoclopramide,D,D02.455.426.559.389.127.250.750,Chlorobenzoates,Benzoates,1
Metoclopramide,D,D02.455.426.559.389.127.020.937.647,para-Aminobenzoates,Aminobenzoates,1
Metoclopramide,D,D02.455.426.559.389.127.085.510,Benzamides,Benzoates,1
Metoclopramide,D,D02.455.426.559.389.657.654.638.625,Hydroxybenzoate Ethers,Phenyl Ethers,1
Metoclopramide,D,D02.065.277.573,Benzamides,Amides,1
Metrorrhagia,C,C23.550.414.993.700,Uterine Hemorrhage,Hemorrhage,1
Metrorrhagia,C,C13.351.500.852.691.622,Uterine Hemorrhage,Uterine Diseases,1
Mianserin,D,D03.633.300.240.550,Dibenzazepines,"Heterocyclic Compounds, 3-Ring",1
"Mice, 129 Strain",B,B01.050.150.900.649.313.992.635.505.500.400.025,"Mice, Inbred Strains",Mice,1
"Mice, 129 Strain",B,B01.050.150.900.649.313.992.635.505.500.550.025,"Mice, Mutant Strains",Mice,1
"Mice, 129 Strain",B,B01.050.150.900.649.313.992.635.505.500.800.500.025,"Mice, Knockout","Mice, Transgenic",1
"Mice, Inbred AKR",B,B01.050.150.900.649.313.992.635.505.500.400.318,"Mice, Inbred Strains",Mice,1
"Mice, Inbred AKR",B,B01.050.050.199.520.520.318,"Mice, Inbred Strains","Animals, Inbred Strains",1
"Mice, Obese",B,B01.050.150.900.649.313.992.635.505.500.550.530,"Mice, Mutant Strains",Mice,1
Michigan,Z,Z01.107.567.875.510.500,Midwestern United States,United States,1
Michigan,Z,Z01.107.567.875.350.500,Great Lakes Region,United States,1
Miconazole,D,D03.383.129.308.550,Imidazoles,Azoles,1
Microclimate,G,G16.500.275.071.450,Climate,Environment,1
Microclimate,N,N06.230.300.100.250.450,Climate,Atmosphere,1
Micrococcal Nuclease,D,D08.811.277.352.335.350.500,Endodeoxyribonucleases,Deoxyribonucleases,1
Micrococcal Nuclease,D,D08.811.277.352.355.325.500,Endodeoxyribonucleases,Endonucleases,1
Micrococcal Nuclease,D,D08.811.277.352.355.350.500,Endoribonucleases,Endonucleases,1
Micrococcal Nuclease,D,D08.811.277.352.700.350.500,Endoribonucleases,Ribonucleases,1
Microcystis,B,B03.280.500,Cyanobacteria,Bacteria,1
Microcystis,B,B03.440.475.100.500,Cyanobacteria,Gram-Negative Oxygenic Photosynthetic Bacteria,1
Micropore Filters,E,E07.560,Equipment and Supplies,NULL,1
Micropore Filters,E,E05.196.454.403,Filtration,"Chemistry Techniques, Analytical",1
"Microscopy, Acoustic",E,E05.595.370,Microscopy,Investigative Techniques,1
"Microscopy, Acoustic",E,E01.370.350.515.370,Microscopy,Diagnostic Imaging,1
"Microscopy, Acoustic",E,E01.370.350.850.565,Ultrasonography,Diagnostic Imaging,1
"Microscopy, Atomic Force",E,E01.370.350.515.666.400,"Microscopy, Scanning Probe",Microscopy,1
"Microscopy, Atomic Force",E,E05.595.666.400,"Microscopy, Scanning Probe",Microscopy,1
"Microscopy, Fluorescence, Multiphoton",E,E05.595.458.500,"Microscopy, Fluorescence",Microscopy,1
"Microscopy, Fluorescence, Multiphoton",E,E05.595.717.250,Nonlinear Optical Microscopy,Microscopy,1
"Microscopy, Fluorescence, Multiphoton",E,E01.370.350.515.717.250,Nonlinear Optical Microscopy,Microscopy,1
"Microscopy, Fluorescence, Multiphoton",E,E01.370.350.515.458.500,"Microscopy, Fluorescence",Microscopy,1
Microsomes,A,A11.284.835.540,Subcellular Fractions,Cellular Structures,1
Microsporida,B,B01.300.360.500.500,Microsporea,Microsporidia,1
Microtomy,E,E01.370.225.750.600.530,Histocytological Preparation Techniques,Histological Techniques,1
Microtomy,E,E01.370.225.500.620.530,Histocytological Preparation Techniques,Cytological Techniques,1
Microtomy,E,E05.200.500.620.530,Histocytological Preparation Techniques,Cytological Techniques,1
Microtomy,E,E05.200.750.600.530,Histocytological Preparation Techniques,Histological Techniques,1
Milieu Therapy,F,F04.754.864.392,Socioenvironmental Therapy,Psychotherapy,1
Military Facilities,J,J01.086.339.445,Facility Design and Construction,Architecture,1
Military Facilities,J,J03.560,Non-Medical Public and Private Facilities,NULL,1
Milk Hypersensitivity,C,C20.543.480.370.500,Food Hypersensitivity,"Hypersensitivity, Immediate",1
Mineralocorticoids,D,D27.505.696.399.472.673,Hormones,"Hormones, Hormone Substitutes, and Hormone Antagonists",1
Mirex,D,D02.455.526.439.659,"Hydrocarbons, Chlorinated","Hydrocarbons, Halogenated",1
Mirtazapine,D,D03.633.300.240.588,Dibenzazepines,"Heterocyclic Compounds, 3-Ring",1
Mismatch Repair Endonuclease PMS2,D,D08.811.277.352.335.350.600,Endodeoxyribonucleases,Deoxyribonucleases,1
Mismatch Repair Endonuclease PMS2,D,D08.811.277.040.025.215.250,MutL Proteins,Adenosine Triphosphatases,1
Mismatch Repair Endonuclease PMS2,D,D08.811.074.766.250,MutL Proteins,DNA Repair Enzymes,1
Mismatch Repair Endonuclease PMS2,D,D12.776.260.540.250,MutL Proteins,DNA-Binding Proteins,1
Missed Diagnosis,N,N02.421.450.280.500,Diagnostic Errors,Medical Errors,1
"Mitochondria, Heart",A,A11.284.835.626.627.603,"Mitochondria, Muscle",Mitochondria,1
"Mitochondria, Heart",A,A11.284.430.214.190.875.564.627.603,"Mitochondria, Muscle",Mitochondria,1
"Mitochondria, Liver",A,A11.284.430.214.190.875.564.461,Mitochondria,Organelles,1
"Mitochondria, Liver",A,A11.284.835.626.461,Mitochondria,Subcellular Fractions,1
Mitochondrial Membrane Transport Proteins,D,D12.776.575.750,Mitochondrial Proteins,Proteins,1
Mitochondrial Membrane Transport Proteins,D,D12.776.543.585.475,Membrane Transport Proteins,Membrane Proteins,1
Mitochondrial Replacement Therapy,E,E05.200.500.380.250,Cellular Reprogramming Techniques,Cytological Techniques,1
Mitochondrial Replacement Therapy,E,E02.875.800.750.350,Fertilization in Vitro,"Reproductive Techniques, Assisted",1
Mitochondrial Replacement Therapy,E,E05.393.085.250,Cellular Reprogramming Techniques,Genetic Techniques,1
Mitochondrial Replacement Therapy,E,E05.820.800.750.350,Fertilization in Vitro,"Reproductive Techniques, Assisted",1
Mitochondrial Swelling,G,G04.590,Cell Physiological Phenomena,NULL,1
Mitogen-Activated Protein Kinase Kinases,D,D12.776.476.440,Intracellular Signaling Peptides and Proteins,Proteins,1
Mitogen-Activated Protein Kinase Kinases,D,D08.811.913.696.620.682.700.565,Protein-Serine-Threonine Kinases,Protein Kinases,1
Mitogen-Activated Protein Kinase Kinases,D,D08.811.913.696.620.682.725.200,Protein-Tyrosine Kinases,Protein Kinases,1
Mitogen-Activated Protein Kinase Kinases,D,D12.644.360.440,Intracellular Signaling Peptides and Proteins,Peptides,1
Mitotic Index,E,E01.370.225.500.385.500,Cytogenetic Analysis,Cytological Techniques,1
Mitotic Index,E,E05.200.500.385.500,Cytogenetic Analysis,Cytological Techniques,1
Mitotic Index,E,E05.242.385.500,Cytogenetic Analysis,Cytological Techniques,1
Modafinil,D,D02.455.426.559.389.115.550,Benzhydryl Compounds,Benzene Derivatives,1
"Models, Anatomic",L,L01.178.820.090.545.129,"Models, Structural",Audiovisual Aids,1
"Models, Anatomic",J,J01.897.280.500.545.129,"Models, Structural",Audiovisual Aids,1
"Molar, Third",A,A14.549.167.860.525.500,Molar,Tooth,1
Molecular Imprinting,J,J01.897.836.249.437,"Chemistry Techniques, Synthetic","Technology, Pharmaceutical",1
Molecular Imprinting,E,E05.197.453,"Chemistry Techniques, Synthetic",Investigative Techniques,1
Molecular Imprinting,E,E05.196.655,"Chemistry Techniques, Analytical",Investigative Techniques,1
Molecular Motor Proteins,D,D08.811.277.040.025.193,Adenosine Triphosphatases,Acid Anhydride Hydrolases,1
Molecular Motor Proteins,D,D05.500.500,Multiprotein Complexes,Macromolecular Substances,1
Mollusca,B,B01.050.500.644,Invertebrates,Animals,1
Molting,G,G07.345.500.550.750,"Metamorphosis, Biological",Morphogenesis,1
Monocyte Chemoattractant Proteins,D,D12.644.276.374.200.110.990,"Chemokines, CC",Chemokines,1
Monocyte Chemoattractant Proteins,D,D23.469.200.110.990,"Chemokines, CC",Chemokines,1
Monocyte Chemoattractant Proteins,D,D23.529.374.200.110.990,"Chemokines, CC",Chemokines,1
Monocyte Chemoattractant Proteins,D,D23.125.300.110.990,"Chemokines, CC",Chemokines,1
Monocyte Chemoattractant Proteins,D,D12.776.467.374.200.110.990,"Chemokines, CC",Chemokines,1
Monoglycerides,D,D10.351.676,Glycerides,Lipids,1
Mononegavirales Infections,C,C01.925.782.580,RNA Virus Infections,Virus Diseases,1
Monosomy,C,C23.550.210.050.500,Aneuploidy,Chromosome Aberrations,1
Monosomy,G,G05.700.131.500,Aneuploidy,Ploidies,1
Monosomy,G,G05.365.590.175.050.500,Aneuploidy,Chromosome Aberrations,1
Monoterpenes,D,D02.455.849.575,Terpenes,Hydrocarbons,1
Moral Development,F,F01.829.500.679,Morals,"Psychology, Social",1
Moral Development,F,F01.752.747.616,Personality Development,Personality,1
Moral Development,K,K01.752.566.739,Morals,Philosophy,1
Morale,F,F01.829.477,"Psychology, Social",Behavior and Behavior Mechanisms,1
Moritella,B,B03.660.250.021.500,Alteromonadaceae,Gammaproteobacteria,1
Moritella,B,B03.440.450.510,Gram-Negative Facultatively Anaerobic Rods,Gram-Negative Bacteria,1
Morphine Derivatives,D,D03.132.577.249.562,Morphinans,Opiate Alkaloids,1
Morphine Derivatives,D,D03.633.400.686.607,Morphinans,"Heterocyclic Compounds, 4 or More Rings",1
Morphine Derivatives,D,D03.605.497.607,Morphinans,"Heterocyclic Compounds, Bridged-Ring",1
Morphine Derivatives,D,D04.615.723.795.576,Morphinans,Phenanthrenes,1
Motion,G,G01.482,Physical Phenomena,NULL,1
"Motion Therapy, Continuous Passive",E,E02.831.535.867.761,Musculoskeletal Manipulations,Physical Therapy Modalities,1
"Motion Therapy, Continuous Passive",E,E02.831.535.483.500,Exercise Therapy,Physical Therapy Modalities,1
"Motion Therapy, Continuous Passive",E,E02.779.867.761,Musculoskeletal Manipulations,Physical Therapy Modalities,1
"Motion Therapy, Continuous Passive",E,E02.779.483.500,Exercise Therapy,Physical Therapy Modalities,1
"Motion Therapy, Continuous Passive",E,E02.760.169.063.500.387.500,Exercise Therapy,Rehabilitation,1
Motor Endplate,A,A11.284.149.165.420.780.550.550.500,Neuromuscular Junction,Neuroeffector Junction,1
Motor Endplate,A,A08.850.550.550.500,Neuromuscular Junction,Neuroeffector Junction,1
Motor Endplate,A,A08.800.550.550.550.500,Neuromuscular Junction,Neuroeffector Junction,1
Motorcycles,J,J01.937.500.500,Motor Vehicles,Transportation,1
Mountaineering,I,I03.450.642.845.582,Sports,Recreation,1
Mouse Embryonic Stem Cells,A,A11.872.700.250.875,Embryonic Stem Cells,Pluripotent Stem Cells,1
Mouth Abnormalities,C,C07.465.525,Mouth Diseases,Stomatognathic Diseases,1
Mouth Abnormalities,C,C07.650.525,Stomatognathic System Abnormalities,Stomatognathic Diseases,1
Mouth Abnormalities,C,C16.131.850.525,Stomatognathic System Abnormalities,Congenital Abnormalities,1
Mouth Breathing,C,C08.618.659,Respiration Disorders,Respiratory Tract Diseases,1
Mouth Breathing,C,C23.888.852.761,"Signs and Symptoms, Respiratory",Signs and Symptoms,1
"Mouth, Edentulous",C,C07.793.597,Tooth Diseases,Stomatognathic Diseases,1
"Mouth, Edentulous",C,C07.465.550,Mouth Diseases,Stomatognathic Diseases,1
Moxalactam,D,D02.065.589.099.625,beta-Lactams,Lactams,1
Moxalactam,D,D03.633.100.300.625,beta-Lactams,"Heterocyclic Compounds, 2-Ring",1
Moxalactam,D,D02.886.520.575,Sulfides,Sulfur Compounds,1
MPTP Poisoning,C,C25.723.705.400,Neurotoxicity Syndromes,Poisoning,1
MPTP Poisoning,C,C10.228.662.600.700.250,"Parkinson Disease, Secondary",Parkinsonian Disorders,1
MPTP Poisoning,C,C10.228.140.079.862.800.300,"Parkinson Disease, Secondary",Parkinsonian Disorders,1
MPTP Poisoning,C,C10.720.606,Neurotoxicity Syndromes,Nervous System Diseases,1
mRNA Cleavage and Polyadenylation Factors,D,D12.776.157.725.124,RNA-Binding Proteins,Carrier Proteins,1
mRNA Cleavage and Polyadenylation Factors,D,D12.776.664.962.444,RNA-Binding Proteins,Nucleoproteins,1
Mucin 5AC,D,D12.776.395.560.631.100.500,Gastric Mucins,Mucins,1
Mucin-2,D,D12.776.395.560.631.161,Mucins,Mucoproteins,1
Mucin-6,D,D12.776.395.560.631.100.750,Gastric Mucins,Mucins,1
Mucor,B,B01.300.300.500.500,Mucorales,"Fungi, Unclassified",1
Mucosal-Associated Invariant T Cells,A,A15.145.229.637.555.567.550.500.100,T-Lymphocyte Subsets,Lymphocyte Subsets,1
Mucosal-Associated Invariant T Cells,A,A15.145.229.637.555.567.569.500.100,T-Lymphocyte Subsets,T-Lymphocytes,1
Mucosal-Associated Invariant T Cells,A,A15.382.490.555.567.550.500.100,T-Lymphocyte Subsets,Lymphocyte Subsets,1
Mucosal-Associated Invariant T Cells,A,A15.382.490.555.567.569.500.100,T-Lymphocyte Subsets,T-Lymphocytes,1
Mucosal-Associated Invariant T Cells,A,A11.118.637.555.567.569.500.100,T-Lymphocyte Subsets,T-Lymphocytes,1
Mucosal-Associated Invariant T Cells,A,A11.118.637.555.567.550.500.100,T-Lymphocyte Subsets,Lymphocyte Subsets,1
Multifocal Intraocular Lenses,E,E07.632.500.460.250,"Lenses, Intraocular",Lenses,1
Multifocal Intraocular Lenses,E,E07.695.460.500,"Lenses, Intraocular",Prostheses and Implants,1
Multiparametric Magnetic Resonance Imaging,E,E01.370.350.825.500.755,Magnetic Resonance Imaging,Tomography,1
Multiple Endocrine Neoplasia Type 1,C,C04.700.630.500,Multiple Endocrine Neoplasia,"Neoplastic Syndromes, Hereditary",1
Multiple Endocrine Neoplasia Type 1,C,C04.651.600.500,Multiple Endocrine Neoplasia,"Neoplasms, Multiple Primary",1
Multiple Endocrine Neoplasia Type 1,C,C04.588.322.400.500,Multiple Endocrine Neoplasia,Endocrine Gland Neoplasms,1
Multiple Endocrine Neoplasia Type 1,C,C16.320.700.630.500,Multiple Endocrine Neoplasia,"Neoplastic Syndromes, Hereditary",1
Multiple Endocrine Neoplasia Type 1,C,C19.344.400.500,Multiple Endocrine Neoplasia,Endocrine Gland Neoplasms,1
Mummies,I,I01.076.368.584.500,Paleontology,"Anthropology, Physical",1
Murine pneumonia virus,B,B04.820.480.937.600.670.600.550,Pneumovirus,Pneumovirinae,1
Muromonab-CD3,D,D12.776.377.715.548.114.619.393.570,Immunoglobulin G,Immunoglobulin Isotypes,1
Muromonab-CD3,D,D12.776.377.715.548.114.224.284.570,"Antibodies, Monoclonal, Murine-Derived","Antibodies, Monoclonal",1
Muromonab-CD3,D,D12.776.124.486.485.114.224.075.570,"Antibodies, Monoclonal, Murine-Derived","Antibodies, Monoclonal",1
Muromonab-CD3,D,D12.776.124.486.485.114.619.393.570,Immunoglobulin G,Immunoglobulin Isotypes,1
Muromonab-CD3,D,D12.776.124.790.651.114.619.393.570,Immunoglobulin G,Immunoglobulin Isotypes,1
Muromonab-CD3,D,D12.776.124.790.651.114.224.075.570,"Antibodies, Monoclonal, Murine-Derived","Antibodies, Monoclonal",1
Muscarinic Agonists,D,D27.505.696.577.120.140.500,Cholinergic Agonists,Cholinergic Agents,1
Muscarinic Agonists,D,D27.505.519.625.120.140.500,Cholinergic Agonists,Cholinergic Agents,1
Muscle Relaxation,G,G11.427.494.554,Muscle Contraction,Musculoskeletal Physiological Phenomena,1
Muscle Strength Dynamometer,E,E07.230.460,Diagnostic Equipment,Equipment and Supplies,1
"Muscular Atrophy, Spinal",C,C10.574.562.500,Motor Neuron Disease,Neurodegenerative Diseases,1
"Muscular Atrophy, Spinal",C,C10.668.467.500,Motor Neuron Disease,Neuromuscular Diseases,1
"Muscular Atrophy, Spinal",C,C10.228.854.468,Spinal Cord Diseases,Central Nervous System Diseases,1
Muscular Dystrophies,C,C10.668.491.175.500,"Muscular Disorders, Atrophic",Muscular Diseases,1
Muscular Dystrophies,C,C16.320.577,"Genetic Diseases, Inborn","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",1
Muscular Dystrophies,C,C05.651.534.500,"Muscular Disorders, Atrophic",Muscular Diseases,1
Musculoskeletal Physiological Phenomena,G,G11.427,Musculoskeletal and Neural Physiological Phenomena,NULL,1
Musculoskeletal System,A,A02,NULL,NULL,1
Mustard Gas,D,D02.455.526.728.468,Mustard Compounds,"Hydrocarbons, Halogenated",1
Mutant Chimeric Proteins,D,D12.776.602.500,Mutant Proteins,Proteins,1
MutL Protein Homolog 1,D,D08.811.074.766.500,MutL Proteins,DNA Repair Enzymes,1
MutL Protein Homolog 1,D,D08.811.277.040.025.215.500,MutL Proteins,Adenosine Triphosphatases,1
MutL Protein Homolog 1,D,D12.776.260.540.500,MutL Proteins,DNA-Binding Proteins,1
MutS Homolog 2 Protein,D,D12.776.260.556.750,MutS Proteins,DNA-Binding Proteins,1
MutS Homolog 2 Protein,D,D08.811.277.040.025.292.750,MutS Proteins,Adenosine Triphosphatases,1
MutS Homolog 2 Protein,D,D08.811.074.844.750,MutS Proteins,DNA Repair Enzymes,1
MutS Homolog 2 Protein,D,D12.776.624.664.700.130,Proto-Oncogene Proteins,Oncogene Proteins,1
MutS Homolog 3 Protein,D,D12.776.260.556.875,MutS Proteins,DNA-Binding Proteins,1
Mycobacteriaceae,B,B03.510.024.962,Actinobacteria,Gram-Positive Bacteria,1
Mycobacteriaceae,B,B03.510.460.400.410.552,"Gram-Positive Asporogenous Rods, Regular",Gram-Positive Asporogenous Rods,1
Mycobacterium xenopi,B,B03.510.460.400.410.552.552.720.950,Nontuberculous Mycobacteria,Mycobacterium,1
Mycobacterium xenopi,B,B03.510.024.962.500.720.950,Nontuberculous Mycobacteria,Mycobacterium,1
Mycolic Acids,D,D02.241.511.621,Hydroxy Acids,Carboxylic Acids,1
Mycolic Acids,D,D10.251.572,Fatty Acids,Lipids,1
Mycoplasma gallisepticum,B,B03.440.860.580.553.553.345,Mycoplasma,Mycoplasmataceae,1
Mycotoxins,D,D23.946.587,"Toxins, Biological",Biological Factors,1
Mydriasis,C,C11.710.570,Pupil Disorders,Eye Diseases,1
Myelography,E,E01.370.376.537.750.505,Neuroradiography,Neuroimaging,1
Myelography,E,E01.370.350.578.937.505,Neuroradiography,Neuroimaging,1
Myelography,E,E01.370.350.700.560.505,Neuroradiography,Radiography,1
Myelography,E,E05.629.937.505,Neuroradiography,Neuroimaging,1
Myeloid Cell Leukemia Sequence 1 Protein,D,D12.776.624.664.700.169.500,Proto-Oncogene Proteins c-bcl-2,Proto-Oncogene Proteins,1
Myeloid Cell Leukemia Sequence 1 Protein,D,D12.776.476.075.718.968,Proto-Oncogene Proteins c-bcl-2,Apoptosis Regulatory Proteins,1
Myeloid Cell Leukemia Sequence 1 Protein,D,D12.644.360.075.718.984,Proto-Oncogene Proteins c-bcl-2,Apoptosis Regulatory Proteins,1
Myeloid-Derived Suppressor Cells,A,A11.627.817,Myeloid Cells,Cells,1
Myocardial Stunning,C,C14.280.671,Heart Diseases,Cardiovascular Diseases,1
Myocardial Stunning,C,C23.888.582,Signs and Symptoms,"Pathological Conditions, Signs and Symptoms",1
"Myoelectric Complex, Migrating",G,G07.265.675.775,Membrane Potentials,Electrophysiological Phenomena,1
"Myoelectric Complex, Migrating",G,G10.261.360.570,Gastrointestinal Motility,Digestive System Physiological Phenomena,1
"Myoelectric Complex, Migrating",G,G11.427.494.730,Muscle Contraction,Musculoskeletal Physiological Phenomena,1
"Myoelectric Complex, Migrating",G,G11.561.570.837,Membrane Potentials,Nervous System Physiological Phenomena,1
Myofunctional Therapy,E,E06.603,Dentistry,NULL,1
Myofunctional Therapy,E,E02.779.933,Physical Therapy Modalities,Therapeutics,1
Myofunctional Therapy,E,E02.831.535.933,Physical Therapy Modalities,Rehabilitation,1
Myofunctional Therapy,E,E02.831.727.442,Rehabilitation of Speech and Language Disorders,Rehabilitation,1
Myofunctional Therapy,E,E02.760.169.063.500.727.442,Rehabilitation of Speech and Language Disorders,Rehabilitation,1
Myogenic Regulatory Factors,D,D12.776.930.125.750,Basic Helix-Loop-Helix Transcription Factors,Transcription Factors,1
Myogenic Regulatory Factors,D,D12.776.260.103.750,Basic Helix-Loop-Helix Transcription Factors,DNA-Binding Proteins,1
Myogenic Regulatory Factors,D,D12.776.210.500.570,Muscle Proteins,Contractile Proteins,1
Myoglobin,D,D12.776.210.500.588,Muscle Proteins,Contractile Proteins,1
Myoglobin,D,D12.776.422.316.940,Globins,Hemeproteins,1
Myo-Inositol-1-Phosphate Synthase,D,D08.811.399.430.500,Intramolecular Lyases,Isomerases,1
Myometrium,A,A10.690.467.500,"Muscle, Smooth",Muscles,1
Myometrium,A,A02.633.570.500,"Muscle, Smooth",Muscles,1
Myometrium,A,A05.360.319.679.690,Uterus,"Genitalia, Female",1
Myoviridae,B,B04.123.150.500,Caudovirales,Bacteriophages,1
Myoviridae,B,B04.280.090.500,Caudovirales,DNA Viruses,1
Myoviridae,B,B04.100.500,Archaeal Viruses,Viruses,1
Myristates,D,D10.251.640.610,Myristic Acids,Fatty Acids,1
Myristic Acids,D,D10.251.640,Fatty Acids,Lipids,1
Myxobolus,B,B01.050.500.308.550.500,Myxozoa,Cnidaria,1
Myxoma virus,B,B04.280.210.600.550,Leporipoxvirus,DNA Tumor Viruses,1
Myxoma virus,B,B04.280.650.160.500.550,Leporipoxvirus,Chordopoxvirinae,1
Myxoma virus,B,B04.613.204.600.550,Leporipoxvirus,DNA Tumor Viruses,1
"Myxomatosis, Infectious",C,C01.925.256.743.665,Poxviridae Infections,DNA Virus Infections,1
"Myxomatosis, Infectious",C,C22.627,Animal Diseases,NULL,1
Myxomycetes,B,B01.046.550.550,Mycetozoa,Amoebozoa,1
N95 Respirators,E,E07.325.877.750,Surgical Attire,"Equipment and Supplies, Hospital",1
N95 Respirators,E,E07.700.700.500,Respiratory Protective Devices,Protective Devices,1
N95 Respirators,E,E07.858.594.875,Surgical Attire,Surgical Equipment,1
N95 Respirators,J,J01.637.708.560.937.500,Respiratory Protective Devices,Personal Protective Equipment,1
NAD(P)H Dehydrogenase (Quinone),D,D08.811.682.608.800.500,Quinone Reductases,"NADH, NADPH Oxidoreductases",1
NADPH Oxidase 2,D,D08.811.682.608.575.875,NADPH Oxidases,"NADH, NADPH Oxidoreductases",1
NADPH Oxidase 2,D,D12.776.331.894.875,NADPH Oxidases,Flavoproteins,1
NADPH Oxidase 2,D,D12.776.543.653.875,NADPH Oxidases,Membrane Proteins,1
NADPH-Ferrihemoprotein Reductase,D,D08.811.682.608.191.500,Cytochrome Reductases,"NADH, NADPH Oxidoreductases",1
Nail Diseases,C,C17.800.529,Skin Diseases,Skin and Connective Tissue Diseases,1
Naja,B,B01.050.150.900.833.672.125.875.612,Elapidae,Alethinophidia,1
Nandrolone,D,D06.472.334.851.968.976,Testosterone Congeners,Gonadal Steroid Hormones,1
Nandrolone,D,D04.210.500.365.415.638,Estrenes,Estranes,1
Nandrolone Decanoate,D,D04.210.500.365.415.638.500,Nandrolone,Estrenes,1
Nandrolone Decanoate,D,D06.472.334.851.968.976.500,Nandrolone,Testosterone Congeners,1
Nanofibers,J,J01.637.512.300,Nanostructures,Manufactured Materials,1
Nanopore Sequencing,E,E05.393.760.560,Sequence Analysis,Genetic Techniques,1
Nanospheres,E,E07.595,Equipment and Supplies,NULL,1
Nanospheres,J,J01.637.512.600.612,Nanoparticles,Nanostructures,1
Nanotubes,J,J01.637.512.850,Nanostructures,Manufactured Materials,1
Nasal Obstruction,C,C08.460.525,Nose Diseases,Respiratory Tract Diseases,1
Nasal Obstruction,C,C09.603.525,Nose Diseases,Otorhinolaryngologic Diseases,1
Nasal Obstruction,C,C08.618.846.185.525,Airway Obstruction,Respiratory Insufficiency,1
Nasopharyngitis,C,C08.730.561.500,Pharyngitis,Respiratory Tract Infections,1
Nasopharyngitis,C,C09.775.350.700,Nasopharyngeal Diseases,Pharyngeal Diseases,1
Nasopharyngitis,C,C09.775.649.500,Pharyngitis,Pharyngeal Diseases,1
Nasopharyngitis,C,C07.550.781.500,Pharyngitis,Pharyngeal Diseases,1
Nasopharyngitis,C,C07.550.350.700,Nasopharyngeal Diseases,Pharyngeal Diseases,1
Nasopharyngitis,C,C01.748.561.500,Pharyngitis,Respiratory Tract Infections,1
"National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division",N,N03.540.052.500.500,"National Academy of Sciences, U.S.",Academies and Institutes,1
"National Center for Health Statistics, U.S.",N,N03.540.348.500.500.600.650.225.260,"Centers for Disease Control and Prevention, U.S.",United States Public Health Service,1
"National Center for Health Statistics, U.S.",I,I01.409.418.750.600.650.200.260,"Centers for Disease Control and Prevention, U.S.",United States Public Health Service,1
"National Health Insurance, United States",N,N03.219.521.576.343.900,"Insurance, Health",Insurance,1
"National Health Insurance, United States",N,N03.349.550.610,National Health Programs,Health Planning,1
National Institute of Mental Health (U.S.),N,N03.540.348.500.500.600.650.496.460,National Institutes of Health (U.S.),United States Public Health Service,1
National Institute of Mental Health (U.S.),N,N03.540.052.750.460,National Institutes of Health (U.S.),Academies and Institutes,1
National Institute of Mental Health (U.S.),I,I01.409.418.750.600.650.496.460,National Institutes of Health (U.S.),United States Public Health Service,1
Natriuresis,G,G08.852.179.557,Diuresis,Urinary Tract Physiological Phenomena,1
Natriuretic Peptides,D,D06.472.699.584,Peptide Hormones,Hormones,1
Natriuretic Peptides,D,D12.644.548.585,Peptide Hormones,Peptides,1
Naturopathy,E,E02.190.655,Complementary Therapies,Therapeutics,1
NAV1.4 Voltage-Gated Sodium Channel,D,D12.776.543.585.400.875.750.400,Voltage-Gated Sodium Channels,Sodium Channels,1
NAV1.4 Voltage-Gated Sodium Channel,D,D12.776.543.550.450.875.750.400,Voltage-Gated Sodium Channels,Sodium Channels,1
NAV1.4 Voltage-Gated Sodium Channel,D,D12.776.210.500.675,Muscle Proteins,Contractile Proteins,1
NAV1.4 Voltage-Gated Sodium Channel,D,D12.776.157.530.400.875.750.400,Voltage-Gated Sodium Channels,Sodium Channels,1
NAV1.7 Voltage-Gated Sodium Channel,D,D12.776.157.530.400.875.750.700,Voltage-Gated Sodium Channels,Sodium Channels,1
NAV1.7 Voltage-Gated Sodium Channel,D,D12.776.543.550.450.875.750.700,Voltage-Gated Sodium Channels,Sodium Channels,1
NAV1.7 Voltage-Gated Sodium Channel,D,D12.776.543.585.400.875.750.700,Voltage-Gated Sodium Channels,Sodium Channels,1
NAV1.7 Voltage-Gated Sodium Channel,D,D12.776.631.960.700,Voltage-Gated Sodium Channels,Nerve Tissue Proteins,1
Near Drowning,C,C26.304.500,Drowning,Wounds and Injuries,1
Near Drowning,N,N06.850.135.696.500,Drowning,Accidents,1
Nebivolol,D,D02.092.063.291.503,Ethanolamines,Amino Alcohols,1
Nebivolol,D,D02.033.100.291.491,Ethanolamines,Amino Alcohols,1
Nebivolol,D,D03.633.100.150.755,Benzopyrans,"Heterocyclic Compounds, 2-Ring",1
Nebivolol,D,D03.383.663.283.755,Benzopyrans,Pyrans,1
Nebramycin,D,D09.408.051.476.600,Kanamycin,Aminoglycosides,1
Neck Injuries,C,C26.700,Wounds and Injuries,NULL,1
Negative Staining,E,E01.370.225.500.620.670.520,Staining and Labeling,Histocytological Preparation Techniques,1
Negative Staining,E,E01.370.225.750.600.670.520,Staining and Labeling,Histocytological Preparation Techniques,1
Negative Staining,E,E05.200.500.620.670.520,Staining and Labeling,Histocytological Preparation Techniques,1
Negative Staining,E,E05.200.750.600.670.520,Staining and Labeling,Histocytological Preparation Techniques,1
Negative-Pressure Wound Therapy,E,E04.987.550,Wound Closure Techniques,"Surgical Procedures, Operative",1
Negative-Pressure Wound Therapy,E,E04.237.444,Drainage,"Surgical Procedures, Operative",1
Negative-Pressure Wound Therapy,E,E02.309.610,Drainage,Therapeutics,1
"Neisseria meningitidis, Serogroup Y",B,B03.660.075.525.520.500.820,Neisseria meningitidis,Neisseria,1
"Neisseria meningitidis, Serogroup Y",B,B03.440.400.425.550.550.641.820,Neisseria meningitidis,Neisseria,1
Neomycin,D,D09.408.051.623,Aminoglycosides,Glycosides,1
"Neoplasm Regression, Spontaneous",C,C04.697.670,Neoplastic Processes,Neoplasms,1
"Neoplasm Regression, Spontaneous",C,C23.550.727.670,Neoplastic Processes,Pathologic Processes,1
"Neoplasm Regression, Spontaneous",G,G16.767.500,"Remission, Spontaneous",Biological Phenomena,1
"Neoplasm, Residual",C,C23.550.727.700,Neoplastic Processes,Pathologic Processes,1
"Neoplasm, Residual",C,C04.697.700,Neoplastic Processes,Neoplasms,1
"Neoplasms, Cystic, Mucinous, and Serous",C,C04.557.470.590,"Neoplasms, Glandular and Epithelial",Neoplasms by Histologic Type,1
"Neoplasms, Gonadal Tissue",C,C04.557.475,Neoplasms by Histologic Type,Neoplasms,1
"Neoplastic Cells, Circulating",C,C04.697.650.900,Neoplasm Metastasis,Neoplastic Processes,1
"Neoplastic Cells, Circulating",A,A11.642,Cells,NULL,1
"Neoplastic Cells, Circulating",C,C23.550.727.650.900,Neoplasm Metastasis,Neoplastic Processes,1
Nepeta,B,B01.650.940.800.575.912.250.583.520.538,Lamiaceae,Lamiales,1
Nephrolithiasis,C,C12.777.967.249,Urolithiasis,Urologic Diseases,1
Nephrolithiasis,C,C12.777.419.600,Kidney Diseases,Urologic Diseases,1
Nephrolithiasis,C,C13.351.968.419.600,Kidney Diseases,Urologic Diseases,1
Nephrolithiasis,C,C13.351.968.967.249,Urolithiasis,Urologic Diseases,1
Nephrosclerosis,C,C13.351.968.419.610,Kidney Diseases,Urologic Diseases,1
Nephrosclerosis,C,C12.777.419.610,Kidney Diseases,Urologic Diseases,1
Nerve Growth Factor,D,D12.644.276.860.437,Nerve Growth Factors,Intercellular Signaling Peptides and Proteins,1
Nerve Growth Factor,D,D23.529.850.437,Nerve Growth Factors,Intercellular Signaling Peptides and Proteins,1
Nerve Growth Factor,D,D12.776.631.600.437,Nerve Growth Factors,Nerve Tissue Proteins,1
Nerve Growth Factor,D,D12.776.467.860.437,Nerve Growth Factors,Intercellular Signaling Peptides and Proteins,1
Nerve Growth Factors,D,D12.776.467.860,Intercellular Signaling Peptides and Proteins,Proteins,1
Nerve Growth Factors,D,D12.776.631.600,Nerve Tissue Proteins,Proteins,1
Nerve Growth Factors,D,D23.529.850,Intercellular Signaling Peptides and Proteins,Biological Factors,1
Nerve Growth Factors,D,D12.644.276.860,Intercellular Signaling Peptides and Proteins,Peptides,1
Nerve Tissue,A,A10.755,Tissues,NULL,1
Nervous System Physiological Phenomena,G,G11.561,Musculoskeletal and Neural Physiological Phenomena,NULL,1
Nesting Behavior,F,F01.145.113.252.478,Consummatory Behavior,"Behavior, Animal",1
Netrin-1,D,D12.644.276.860.494.500,Netrins,Nerve Growth Factors,1
Netrin-1,D,D23.529.850.494.500,Netrins,Nerve Growth Factors,1
Netrin-1,D,D23.125.842.500,Netrins,Chemotactic Factors,1
Netrin-1,D,D12.776.631.600.494.500,Netrins,Nerve Growth Factors,1
Netrin-1,D,D12.776.860.300.731.500,Netrins,Extracellular Matrix Proteins,1
Netrin-1,D,D12.776.467.860.494.500,Netrins,Nerve Growth Factors,1
Neural Cell Adhesion Molecules,D,D12.776.543.550.200.250.520,"Cell Adhesion Molecules, Neuronal",Cell Adhesion Molecules,1
Neural Cell Adhesion Molecules,D,D23.050.301.350.250.520,"Cell Adhesion Molecules, Neuronal",Cell Adhesion Molecules,1
Neural Cell Adhesion Molecules,D,D12.776.395.550.200.250.520,"Cell Adhesion Molecules, Neuronal",Cell Adhesion Molecules,1
Neural Crest,A,A16.627,Embryonic Structures,NULL,1
Neural Inhibition,G,G07.265.755,Electrophysiological Phenomena,Physiological Phenomena,1
Neural Inhibition,G,G11.561.616,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,1
Neural Stem Cells,A,A11.872.653,Stem Cells,Cells,1
Neural Tube,A,A16.630,Embryonic Structures,NULL,1
Neurasthenia,F,F03.875.600,Somatoform Disorders,Mental Disorders,1
Neuregulin-1,D,D12.644.276.860.550.750,Neuregulins,Nerve Growth Factors,1
Neuregulin-1,D,D12.776.631.600.550.750,Neuregulins,Nerve Growth Factors,1
Neuregulin-1,D,D12.776.467.860.550.750,Neuregulins,Nerve Growth Factors,1
Neuregulin-1,D,D23.529.850.550.750,Neuregulins,Nerve Growth Factors,1
Neurocan,D,D12.776.543.550.200.250.520.789,Neural Cell Adhesion Molecules,"Cell Adhesion Molecules, Neuronal",1
Neurocan,D,D12.776.503.280.437.450,Hyalectins,"Lectins, C-Type",1
Neurocan,D,D23.050.301.350.250.520.789,Neural Cell Adhesion Molecules,"Cell Adhesion Molecules, Neuronal",1
Neurocan,D,D12.776.395.550.200.250.520.789,Neural Cell Adhesion Molecules,"Cell Adhesion Molecules, Neuronal",1
Neurocan,D,D12.776.395.650.750.687.450,Hyalectins,Chondroitin Sulfate Proteoglycans,1
Neurocutaneous Syndromes,C,C10.562,Nervous System Diseases,NULL,1
Neurocutaneous Syndromes,C,C17.800.827.250.712,Ectodermal Dysplasia,"Skin Diseases, Genetic",1
Neurocutaneous Syndromes,C,C17.800.804.350.712,Ectodermal Dysplasia,Skin Abnormalities,1
Neurocutaneous Syndromes,C,C16.320.850.250.712,Ectodermal Dysplasia,"Skin Diseases, Genetic",1
Neurocutaneous Syndromes,C,C16.131.831.350.712,Ectodermal Dysplasia,Skin Abnormalities,1
Neurocutaneous Syndromes,C,C16.131.077.350.712,Ectodermal Dysplasia,"Abnormalities, Multiple",1
Neurodermatitis,C,C17.800.815.660,"Skin Diseases, Eczematous",Skin Diseases,1
Neurodermatitis,C,C17.800.174.660,Dermatitis,Skin Diseases,1
Neurofibromatosis 2,C,C16.320.700.633.655,Neurofibromatoses,"Neoplastic Syndromes, Hereditary",1
Neurofibromatosis 2,C,C16.320.400.560.700,Neurofibromatoses,"Heredodegenerative Disorders, Nervous System",1
Neurofibromatosis 2,C,C10.562.600.750,Neurofibromatoses,Neurocutaneous Syndromes,1
Neurofibromatosis 2,C,C10.574.500.549.700,Neurofibromatoses,"Heredodegenerative Disorders, Nervous System",1
Neurofibromatosis 2,C,C09.647.675.500,"Neuroma, Acoustic",Otorhinolaryngologic Neoplasms,1
Neurofibromatosis 2,C,C09.218.807.800.675.500,"Neuroma, Acoustic",Vestibulocochlear Nerve Diseases,1
Neurofibromatosis 2,C,C10.292.225.750.500,"Neuroma, Acoustic",Cranial Nerve Neoplasms,1
Neurofibromatosis 2,C,C10.292.910.600.500,"Neuroma, Acoustic",Vestibulocochlear Nerve Diseases,1
Neurofibromatosis 2,C,C04.700.631.655,Neurofibromatoses,"Neoplastic Syndromes, Hereditary",1
Neurofibromatosis 2,C,C04.557.580.600.580.590.655,Neurofibromatoses,Neurofibroma,1
Neurofibromatosis 2,C,C04.557.580.600.610.595.610.500,"Neuroma, Acoustic",Neurilemmoma,1
Neurofibromatosis 2,C,C04.557.465.625.650.595.610.500,"Neuroma, Acoustic",Neurilemmoma,1
Neurogenesis,G,G07.345.500.325.377.687,Organogenesis,Embryonic and Fetal Development,1
Neurogenesis,G,G08.686.784.170.450.500,Organogenesis,Embryonic and Fetal Development,1
Neurogenesis,G,G04.152.912,Cell Differentiation,Cell Physiological Phenomena,1
Neurogenesis,G,G11.561.620,Nervous System Physiological Phenomena,Musculoskeletal and Neural Physiological Phenomena,1
Neurogranin,D,D12.776.157.142.500,Calmodulin-Binding Proteins,Carrier Proteins,1
Neurogranin,D,D12.776.631.640,Nerve Tissue Proteins,Proteins,1
"Neurons, Afferent",A,A11.671.650,Neurons,Cells,1
"Neurons, Afferent",A,A08.675.650,Neurons,Nervous System,1
Neuropharmacology,H,H02.628.280,Pharmacology,Health Occupations,1
Neuropharmacology,H,H01.158.610.208,Neurosciences,Biological Science Disciplines,1
Neuropharmacology,H,H01.158.703.030,Pharmacology,Biological Science Disciplines,1
Neurophysiology,H,H01.158.610.268,Neurosciences,Biological Science Disciplines,1
Neurophysiology,H,H01.158.782.562,Physiology,Biological Science Disciplines,1
Neuropsychiatry,H,H02.403.690.754,Psychiatry,Medicine,1
Neuropsychiatry,F,F04.096.544.504,Psychiatry,Behavioral Sciences,1
Neuropsychology,F,F04.096.795.600,Psychophysiology,Behavioral Sciences,1
Neuropsychology,H,H01.158.782.795.110,Psychophysiology,Physiology,1
Neurotrophin 3,D,D12.776.631.600.775,Nerve Growth Factors,Nerve Tissue Proteins,1
Neurotrophin 3,D,D12.776.467.860.775,Nerve Growth Factors,Intercellular Signaling Peptides and Proteins,1
Neurotrophin 3,D,D23.529.850.775,Nerve Growth Factors,Intercellular Signaling Peptides and Proteins,1
Neurotrophin 3,D,D12.644.276.860.775,Nerve Growth Factors,Intercellular Signaling Peptides and Proteins,1
Neutrophil Infiltration,G,G12.632,Immune System Phenomena,NULL,1
"Nevus, Blue",C,C04.557.665.560.615.550,"Nevus, Pigmented",Nevus,1
New Caledonia,Z,Z01.639.760.590.620,Melanesia,Pacific Islands,1
Newcastle Disease,C,C01.925.782.580.600.080.600,Avulavirus Infections,Paramyxoviridae Infections,1
Newcastle Disease,C,C22.131.630,Bird Diseases,Animal Diseases,1
Newcastle disease virus,B,B04.820.480.937.600.650.070.600,Avulavirus,Paramyxovirinae,1
Newfoundland and Labrador,Z,Z01.107.567.176.540,Canada,North America,1
NFI Transcription Factors,D,D12.776.260.605,DNA-Binding Proteins,Proteins,1
NFI Transcription Factors,D,D12.776.930.612,Transcription Factors,Proteins,1
Nigericin,D,D03.383.312.634,Furans,"Heterocyclic Compounds, 1-Ring",1
Nigericin,D,D03.383.663.620,Pyrans,"Heterocyclic Compounds, 1-Ring",1
NIMA-Related Kinases,D,D12.776.167.457,Cell Cycle Proteins,Proteins,1
NIMA-Related Kinases,D,D08.811.913.696.620.682.700.581,Protein-Serine-Threonine Kinases,Protein Kinases,1
Nipah Virus,B,B04.820.480.937.600.650.400.550,Henipavirus,Paramyxovirinae,1
Nitrendipine,D,D03.383.725.203.590,Dihydropyridines,Pyridines,1
Nitrobenzoates,D,D02.241.223.100.600,Benzoates,"Acids, Carbocyclic",1
Nitrobenzoates,D,D02.455.426.559.389.127.650,Benzoates,Benzene Derivatives,1
Nitroblue Tetrazolium,D,D03.383.129.617.700.500,Tetrazolium Salts,Tetrazoles,1
Nitrofurantoin,D,D02.640.600.566,Nitrofurans,Nitro Compounds,1
Nitrofurantoin,D,D03.383.312.649.566,Nitrofurans,Furans,1
Nitrofurazone,D,D03.383.312.649.691,Nitrofurans,Furans,1
Nitrofurazone,D,D02.640.600.691,Nitrofurans,Nitro Compounds,1
Nitrogen Fixation,G,G16.500.768.600,Nitrogen Cycle,Ecological and Environmental Phenomena,1
Nitrogen Fixation,G,G02.111.071.630,Autotrophic Processes,Biochemical Phenomena,1
Nitrogen Fixation,G,G02.607.560.750,Nitrogen Cycle,Organic Chemistry Phenomena,1
Nitrogen Fixation,G,G03.087.630,Autotrophic Processes,Metabolism,1
Nitrogen Fixation,G,G02.111.587.750,Nitrogen Cycle,Biochemical Phenomena,1
Nitrogen Fixation,G,G06.625,Microbiological Phenomena,NULL,1
Nitrogen Isotopes,D,D01.268.604.500,Nitrogen,Elements,1
Nitrogen Isotopes,D,D01.496.586,Isotopes,Inorganic Chemicals,1
Nitrogen Isotopes,D,D01.362.625.500,Nitrogen,Gases,1
Nitrogenous Group Transferases,D,D08.811.913.477,Transferases,Enzymes,1
Nivolumab,D,D12.776.377.715.548.114.224.200.829,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",1
Nivolumab,D,D12.776.124.790.651.114.224.060.829,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",1
Nivolumab,D,D12.776.124.486.485.114.224.060.829,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",1
NK Cell Lectin-Like Receptor Subfamily D,D,D12.776.543.750.705.895.800.820,"Receptors, NK Cell Lectin-Like","Receptors, Natural Killer Cell",1
N-Methylscopolamine,D,D03.132.889.601.550,Scopolamine Derivatives,Tropanes,1
N-Methylscopolamine,D,D03.605.084.500.722.822.550,Scopolamine Derivatives,Tropanes,1
N-Methylscopolamine,D,D03.605.869.822.550,Scopolamine Derivatives,Tropanes,1
N-Methylscopolamine,D,D02.145.074.722.822.550,Scopolamine Derivatives,Tropanes,1
Nobel Prize,K,K01.150.567,Awards and Prizes,Humanities,1
Nociception,F,F02.463.593.504.500,Pain Perception,Perception,1
Nod1 Signaling Adaptor Protein,D,D12.776.157.057.006.249,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Nod1 Signaling Adaptor Protein,D,D12.776.157.057.078.249,Nod Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Nod1 Signaling Adaptor Protein,D,D12.644.360.024.131.249,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Nod1 Signaling Adaptor Protein,D,D12.644.360.024.313.249,Nod Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Nod1 Signaling Adaptor Protein,D,D12.644.360.075.358.249,CARD Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,1
Nod1 Signaling Adaptor Protein,D,D12.644.360.539.500.249,Nod Signaling Adaptor Proteins,NLR Proteins,1
Nod1 Signaling Adaptor Protein,D,D12.776.476.075.358.249,CARD Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,1
Nod1 Signaling Adaptor Protein,D,D12.776.476.024.391.249,Nod Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Nod1 Signaling Adaptor Protein,D,D12.776.476.024.139.249,CARD Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Nonmuscle Myosin Type IIA,D,D12.776.210.500.600.470.374,Myosin Type II,Myosins,1
Nonmuscle Myosin Type IIA,D,D12.776.220.525.475.475.249,Myosin Type II,Myosins,1
Nonmuscle Myosin Type IIA,D,D08.811.277.040.025.193.750.750.374,Myosin Type II,Myosins,1
Nonmuscle Myosin Type IIA,D,D05.750.078.730.475.475.249,Myosin Type II,Myosins,1
Nonmuscle Myosin Type IIB,D,D05.750.078.730.475.475.500,Myosin Type II,Myosins,1
Nonmuscle Myosin Type IIB,D,D08.811.277.040.025.193.750.750.500,Myosin Type II,Myosins,1
Nonmuscle Myosin Type IIB,D,D12.776.220.525.475.475.500,Myosin Type II,Myosins,1
Nonmuscle Myosin Type IIB,D,D12.776.210.500.600.470.500,Myosin Type II,Myosins,1
Non-Smokers,M,M01.482,Persons,NULL,1
Nontherapeutic Human Experimentation,H,H01.770.644.145.365.750,Human Experimentation,Biomedical Research,1
Nontherapeutic Human Experimentation,E,E05.445.750,Human Experimentation,Investigative Techniques,1
Nootropic Agents,D,D27.505.954.427.637,Central Nervous System Agents,Therapeutic Uses,1
No-Reflow Phenomenon,C,C23.550.513.677,Ischemia,Pathologic Processes,1
Norethindrone Acetate,D,D04.210.500.668.651.693.651.500,Norethindrone,Norpregnenes,1
Norgestrel,D,D04.210.500.668.651.693.762,Norpregnenes,Norpregnanes,1
Norleucine,D,D12.125.213.568,Aminocaproates,Amino Acids,1
Norwalk virus,B,B04.820.578.298.550.500,Norovirus,Caliciviridae,1
Nose Diseases,C,C09.603,Otorhinolaryngologic Diseases,NULL,1
Nose Diseases,C,C08.460,Respiratory Tract Diseases,NULL,1
No-Show Patients,F,F01.100.150.750.500.600.750,Patient Compliance,Patient Acceptance of Health Care,1
No-Show Patients,F,F01.145.488.887.500.600.750,Patient Compliance,Patient Acceptance of Health Care,1
No-Show Patients,M,M01.643.550,Patients,Persons,1
No-Show Patients,N,N04.452.758.635.500,Office Visits,Professional Practice,1
No-Show Patients,N,N05.300.150.800.500.600.750,Patient Compliance,Patient Acceptance of Health Care,1
Nuchal Translucency Measurement,E,E01.370.378.630.865.500,"Ultrasonography, Prenatal",Prenatal Diagnosis,1
Nuchal Translucency Measurement,E,E01.370.350.850.865.500,"Ultrasonography, Prenatal",Ultrasonography,1
Nuclear Lamina,A,A11.284.835.514.700.500,Nuclear Envelope,Intracellular Membranes,1
Nuclear Lamina,A,A11.284.149.165.630.500,Nuclear Envelope,Cell Membrane Structures,1
Nuclear Lamina,A,A11.284.430.106.279.692.314,Nuclear Envelope,Cell Nucleus Structures,1
Nuclear Lamina,A,A11.284.430.106.279.345.700.700,Nuclear Matrix,Intranuclear Space,1
Nuclear Pore,A,A11.284.430.106.279.692.630,Nuclear Envelope,Cell Nucleus Structures,1
Nuclear Receptor Co-Repressor 1,D,D12.776.930.780.625.374,Co-Repressor Proteins,Repressor Proteins,1
"Nuclear Receptor Subfamily 1, Group F, Member 1",D,D12.776.826.209.100,Orphan Nuclear Receptors,"Receptors, Cytoplasmic and Nuclear",1
"Nuclear Receptor Subfamily 1, Group F, Member 1",D,D12.776.476.156.437,Circadian Rhythm Signaling Peptides and Proteins,Intracellular Signaling Peptides and Proteins,1
"Nuclear Receptor Subfamily 1, Group F, Member 1",D,D12.776.260.643.100,Orphan Nuclear Receptors,DNA-Binding Proteins,1
Nuclear Weapons,J,J01.637.870.900.575,Weapons of Mass Destruction,Weapons,1
Nuclear Weapons,J,J01.637.870.175.500,Bombs,Weapons,1
Nucleic Acid Probes,D,D13.444.600,Nucleic Acids,"Nucleic Acids, Nucleotides, and Nucleosides",1
Nucleic Acid Probes,D,D27.720.470.530.600,Molecular Probes,Laboratory Chemicals,1
Nucleic Acid Probes,D,D27.505.259.750.600,Molecular Probes,Diagnostic Uses of Chemicals,1
Nucleic Acid Synthesis Inhibitors,D,D27.505.519.389.675,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,1
Nucleobase Transport Proteins,D,D12.776.543.585.625.500,"Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins",Membrane Transport Proteins,1
Nucleobase Transport Proteins,D,D12.776.157.530.625.500,"Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins",Membrane Transport Proteins,1
Nucleoside-Triphosphatase,D,D08.811.277.040.465,Acid Anhydride Hydrolases,Hydrolases,1
Nucleotide Deaminases,D,D08.811.277.151.653,Aminohydrolases,Hydrolases,1
"Nucleotides, Cyclic",D,D13.695.462,Nucleotides,"Nucleic Acids, Nucleotides, and Nucleosides",1
"Nurses, Neonatal",M,M01.526.485.650.648.940.500,"Nurses, Pediatric",Nurse Specialists,1
"Nurses, Neonatal",N,N02.360.650.648.940.500,"Nurses, Pediatric",Nurse Specialists,1
Nursing Diagnosis,N,N04.590.233.508.480.110,Nursing Assessment,Nursing Process,1
Nursing Process,N,N04.590.233.508,Comprehensive Health Care,Patient Care Management,1
"Nursing Service, Hospital",N,N04.452.442.452.422.489,Hospital Departments,Hospital Administration,1
"Nursing Service, Hospital",N,N02.421.539.180,Nursing Services,Health Services,1
"Nursing Service, Hospital",N,N02.278.216.500.968.489,Hospital Departments,Hospital Administration,1
"Nursing, Team",N,N04.590.715.571,Patient Care Team,Patient Care Management,1
Nutrigenomics,H,H02.533.468,Nutritional Sciences,Health Occupations,1
Nutrigenomics,H,H01.158.273.343.350.349,Genomics,Genetics,1
Nutrigenomics,H,H01.158.273.180.350.349,Genomics,Computational Biology,1
Nutritionists,M,M01.526.485.695,Health Personnel,Occupational Groups,1
Nutritionists,N,N02.360.695,Health Personnel,"Health Care Facilities, Manpower, and Services",1
"Nystagmus, Congenital",C,C10.292.562.675.300,"Nystagmus, Pathologic",Ocular Motility Disorders,1
"Nystagmus, Congenital",C,C11.590.400.300,"Nystagmus, Pathologic",Ocular Motility Disorders,1
"Nystagmus, Congenital",C,C16.614.643,"Infant, Newborn, Diseases","Congenital, Hereditary, and Neonatal Diseases and Abnormalities",1
Nystatin,D,D02.540.505.575,Macrolides,Lactones,1
Obesity Management,E,E02.650,Therapeutics,NULL,1
Obesity Management,N,N02.421.726.407.579.650.500,Weight Reduction Programs,Health Promotion,1
Obesity Management,N,N04.590.607.250,Disease Management,Patient Care Management,1
Obsessive Behavior,F,F01.145.126.950,Behavioral Symptoms,Behavior,1
Obstetric Nursing,N,N02.421.533.571,Nursing Care,Health Services,1
Obstetric Nursing,H,H02.478.676.570,"Specialties, Nursing",Nursing,1
Obstetrical Forceps,E,E07.858.700.650,Surgical Instruments,Surgical Equipment,1
Occlusion Body Matrix Proteins,D,D12.776.964.970.650,Viral Structural Proteins,Viral Proteins,1
Ocimum basilicum,B,B01.650.940.800.575.912.250.583.520.647.500,Ocimum,Lamiaceae,1
Octamer Transcription Factor-1,D,D12.776.930.710.500.100,Octamer Transcription Factors,POU Domain Factors,1
Octamer Transcription Factor-1,D,D12.776.260.655.500.100,Octamer Transcription Factors,POU Domain Factors,1
Octreotide,D,D12.644.641.650,"Peptides, Cyclic",Peptides,1
Octreotide,D,D04.345.566.650,"Peptides, Cyclic",Macrocyclic Compounds,1
Ocular Hypotension,C,C11.540,Eye Diseases,NULL,1
Ocular Physiological Phenomena,G,G14,NULL,NULL,1
Office Automation,N,N04.452.515.708,Management Information Systems,Organization and Administration,1
Off-Road Motor Vehicles,J,J01.937.500.600,Motor Vehicles,Transportation,1
Olea,B,B01.650.940.800.575.912.250.583.640.666,Oleaceae,Lamiales,1
Olfaction Disorders,C,C10.597.751.600,Sensation Disorders,Neurologic Manifestations,1
Olfaction Disorders,C,C23.888.592.763.550,Sensation Disorders,Neurologic Manifestations,1
Olfactometry,E,E01.370.376.625,"Diagnostic Techniques, Neurological",Diagnostic Techniques and Procedures,1
Olfactometry,E,E05.638,Investigative Techniques,NULL,1
Oligochaeta,B,B01.050.500.091.657,Annelida,Invertebrates,1
Oligodendroglia,A,A11.650.600,Neuroglia,Cells,1
Oligodendroglia,A,A08.637.600,Neuroglia,Nervous System,1
Oligohydramnios,C,C13.703.560,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,1
Oligomenorrhea,C,C23.550.568.937,Menstruation Disturbances,Pathologic Processes,1
Oligomycins,D,D02.540.505.620,Macrolides,Lactones,1
Oliguria,C,C23.888.942.400,Urological Manifestations,Signs and Symptoms,1
Oliguria,C,C13.351.968.934.600,Urination Disorders,Urologic Diseases,1
Oliguria,C,C12.777.934.600,Urination Disorders,Urologic Diseases,1
Omalizumab,D,D12.776.377.715.548.114.224.200.844,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",1
Omalizumab,D,D12.776.377.715.548.114.071.500,"Antibodies, Anti-Idiotypic",Antibodies,1
Omalizumab,D,D12.776.124.790.651.114.224.060.844,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",1
Omalizumab,D,D12.776.124.790.651.114.071.500,"Antibodies, Anti-Idiotypic",Antibodies,1
Omalizumab,D,D12.776.124.486.485.114.224.060.844,"Antibodies, Monoclonal, Humanized","Antibodies, Monoclonal",1
Omalizumab,D,D12.776.124.486.485.114.071.500,"Antibodies, Anti-Idiotypic",Antibodies,1
Omeprazole,D,D02.886.640.074.500,2-Pyridinylmethylsulfinylbenzimidazoles,Sulfoxides,1
Omeprazole,D,D03.633.100.103.034.500,2-Pyridinylmethylsulfinylbenzimidazoles,Benzimidazoles,1
Omeprazole,D,D03.383.725.024.500,2-Pyridinylmethylsulfinylbenzimidazoles,Pyridines,1
Oncogene Protein p21(ras),D,D08.811.277.040.330.300.400.500.300,ras Proteins,Monomeric GTP-Binding Proteins,1
Oncogene Protein p21(ras),D,D12.776.157.325.515.500.300,ras Proteins,Monomeric GTP-Binding Proteins,1
Oncogene Protein p21(ras),D,D12.644.360.525.500.300,ras Proteins,Monomeric GTP-Binding Proteins,1
Oncogene Protein p21(ras),D,D12.776.964.775.750.710,"Retroviridae Proteins, Oncogenic",Retroviridae Proteins,1
Oncogene Protein p21(ras),D,D12.776.964.700.750.710,"Retroviridae Proteins, Oncogenic","Oncogene Proteins, Viral",1
Oncogene Protein p21(ras),D,D12.776.624.664.520.750.710,"Retroviridae Proteins, Oncogenic","Oncogene Proteins, Viral",1
Oncogene Protein p21(ras),D,D12.776.476.525.500.300,ras Proteins,Monomeric GTP-Binding Proteins,1
Ondansetron,D,D03.633.100.473.144.500,Carbazoles,Indoles,1
Ondansetron,D,D03.633.300.148.500,Carbazoles,"Heterocyclic Compounds, 3-Ring",1
Ondansetron,D,D03.383.129.308.690,Imidazoles,Azoles,1
Online Social Networking,L,L01.143.910.250,Social Networking,Communication,1
O'nyong-nyong Virus,B,B04.820.578.875.054.586,Alphavirus,Togaviridae,1
Open Access Publishing,L,L01.737.569,Publishing,Information Science,1
Open Bite,C,C07.793.494.825,Malocclusion,Tooth Diseases,1
Open Fracture Reduction,E,E04.555.300.690,Fracture Fixation,Orthopedic Procedures,1
Operative Blood Salvage,E,E04.936.537.687,Tissue and Organ Harvesting,Transplantation,1
Ophthalmoscopes,E,E07.230.540,Diagnostic Equipment,Equipment and Supplies,1
Opiate Alkaloids,D,D03.132.577,Alkaloids,Heterocyclic Compounds,1
Opioid Peptides,D,D12.644.400.575,Neuropeptides,Peptides,1
Opioid Peptides,D,D12.776.631.650.575,Neuropeptides,Nerve Tissue Proteins,1
Opisthorchiasis,C,C01.610.335.865.685,Trematode Infections,Helminthiasis,1
Opisthorchidae,B,B01.050.500.500.736.715.520,Trematoda,Platyhelminths,1
Opisthorchis,B,B01.050.500.500.736.715.520.700,Opisthorchidae,Trematoda,1
"Optic Atrophy, Hereditary, Leber",C,C11.640.451.451.400,"Optic Atrophies, Hereditary",Optic Atrophy,1
"Optic Atrophy, Hereditary, Leber",C,C10.574.500.662.400,"Optic Atrophies, Hereditary","Heredodegenerative Disorders, Nervous System",1
"Optic Atrophy, Hereditary, Leber",C,C11.270.564.400,"Optic Atrophies, Hereditary","Eye Diseases, Hereditary",1
"Optic Atrophy, Hereditary, Leber",C,C10.292.700.225.500.400,"Optic Atrophies, Hereditary",Optic Atrophy,1
"Optic Atrophy, Hereditary, Leber",C,C16.320.400.630.400,"Optic Atrophies, Hereditary","Heredodegenerative Disorders, Nervous System",1
"Optic Atrophy, Hereditary, Leber",C,C16.320.290.564.400,"Optic Atrophies, Hereditary","Eye Diseases, Hereditary",1
"Optic Atrophy, Hereditary, Leber",C,C18.452.660.670,Mitochondrial Diseases,Metabolic Diseases,1
ORAI1 Protein,D,D12.776.543.550.450.150.740.500,Calcium Release Activated Calcium Channels,Calcium Channels,1
ORAI1 Protein,D,D12.776.543.585.400.150.740.500,Calcium Release Activated Calcium Channels,Calcium Channels,1
ORAI1 Protein,D,D12.776.157.530.400.150.740.500,Calcium Release Activated Calcium Channels,Calcium Channels,1
Oral Surgical Procedures,E,E06.645,Dentistry,NULL,1
Oral Surgical Procedures,E,E04.545,"Surgical Procedures, Operative",NULL,1
Oral Ulcer,C,C07.465.672,Mouth Diseases,Stomatognathic Diseases,1
Orbital Myositis,C,C05.651.594.728,Myositis,Muscular Diseases,1
Orbital Myositis,C,C10.668.491.562.537,Myositis,Muscular Diseases,1
Orbital Myositis,C,C11.675.426,Orbital Diseases,Eye Diseases,1
Orbital Pseudotumor,C,C11.675.679,Orbital Diseases,Eye Diseases,1
Orchiopexy,E,E04.950.774.860.619,"Urologic Surgical Procedures, Male",Urologic Surgical Procedures,1
Organ Preservation Solutions,D,D26.776.675,Solutions,Pharmaceutical Preparations,1
"Organic Anion Transporters, Sodium-Dependent",D,D12.776.543.585.450.074.500.812,Organic Anion Transporters,Anion Transport Proteins,1
"Organic Anion Transporters, Sodium-Dependent",D,D12.776.157.530.450.074.500.687,Organic Anion Transporters,Anion Transport Proteins,1
Organizational Affiliation,N,N04.452.602,Organization and Administration,Health Services Administration,1
Organothiophosphates,D,D02.886.300.692,Organothiophosphorus Compounds,Sulfur Compounds,1
Organothiophosphates,D,D02.705.400.625,Organophosphates,Organophosphorus Compounds,1
Organothiophosphates,D,D02.705.539.345,Organothiophosphorus Compounds,Organophosphorus Compounds,1
Origin Recognition Complex,D,D12.776.260.640,DNA-Binding Proteins,Proteins,1
Ornithine Carbamoyltransferase,D,D08.811.913.555.275.600,Carboxyl and Carbamoyl Transferases,One-Carbon Group Transferases,1
Ornithine Decarboxylase,D,D08.811.520.224.125.425,Carboxy-Lyases,Carbon-Carbon Lyases,1
Orphanages,J,J03.775.640,Residential Facilities,Non-Medical Public and Private Facilities,1
ortho-Aminobenzoates,D,D02.241.223.100.050.400,Aminobenzoates,Benzoates,1
ortho-Aminobenzoates,D,D02.455.426.559.389.127.020.906,Aminobenzoates,Benzoates,1
Orthodontic Appliance Design,E,E06.658.450,Orthodontics,Dentistry,1
Orthodontic Appliance Design,E,E06.912.675,"Technology, Dental",Dentistry,1
Orthodontic Appliance Design,E,E05.320.274,Equipment Design,Investigative Techniques,1
"Orthodontic Appliances, Fixed",E,E06.658.453.255,Orthodontic Appliances,Orthodontics,1
"Orthodontic Appliances, Functional",E,E06.658.453.560,Orthodontic Appliances,Orthodontics,1
Orthopedic Equipment,E,E07.858.442,Surgical Equipment,Equipment and Supplies,1
Orthopedic Surgeons,M,M01.526.485.810.910.875,Surgeons,Physicians,1
Orthopedic Surgeons,N,N02.360.810.910.875,Surgeons,Physicians,1
Orthopoxvirus,B,B04.280.650.160.650,Chordopoxvirinae,Poxviridae,1
Oryzias,B,B01.050.150.900.493.850.139.650,Beloniformes,Smegmamorpha,1
Osteitis Deformans,C,C05.116.692,Bone Diseases,Musculoskeletal Diseases,1
Osteopetrosis,C,C05.116.099.708.702.678,Osteosclerosis,Osteochondrodysplasias,1
Ostomy,E,E04.579,"Surgical Procedures, Operative",NULL,1
Otitis,C,C09.218.705,Ear Diseases,Otorhinolaryngologic Diseases,1
"Otoacoustic Emissions, Spontaneous",G,G07.888.500.750,Hearing,Vestibulocochlear Physiological Phenomena,1
"Otoacoustic Emissions, Spontaneous",G,G11.561.790.263.570,Hearing,Sensation,1
Otorhinolaryngologic Neoplasms,C,C09.647,Otorhinolaryngologic Diseases,NULL,1
Otorhinolaryngologic Neoplasms,C,C04.588.443.665,Head and Neck Neoplasms,Neoplasms by Site,1
Ototoxicity,C,C09.218.788,Ear Diseases,Otorhinolaryngologic Diseases,1
Ototoxicity,C,C25.100.656,Drug-Related Side Effects and Adverse Reactions,Chemically-Induced Disorders,1
Ototoxicity,C,C26.733.650,Radiation Injuries,Wounds and Injuries,1
Ototoxicity,C,C23.550.753,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",1
Ototoxicity,G,G01.750.748.500.650,Radiation Injuries,Radiation Exposure,1
Ovarian Cysts,C,C19.391.630.580,Ovarian Diseases,Gonadal Disorders,1
Ovarian Cysts,C,C13.351.500.056.630.580,Ovarian Diseases,Adnexal Diseases,1
Ovarian Cysts,C,C04.182.612,Cysts,Neoplasms,1
Oviparity,G,G08.686.650,Reproductive Physiological Phenomena,Reproductive and Urinary Physiological Phenomena,1
OX40 Ligand,D,D12.644.276.374.750.531,Tumor Necrosis Factors,Cytokines,1
OX40 Ligand,D,D12.776.395.550.597,Membrane Glycoproteins,Glycoproteins,1
OX40 Ligand,D,D12.776.543.550.590,Membrane Glycoproteins,Membrane Proteins,1
OX40 Ligand,D,D12.776.467.374.750.531,Tumor Necrosis Factors,Cytokines,1
OX40 Ligand,D,D12.776.465.813,Immune Checkpoint Proteins,Proteins,1
OX40 Ligand,D,D23.529.374.750.531,Tumor Necrosis Factors,Cytokines,1
Oxazolone,D,D03.383.129.462.620,Oxazoles,Azoles,1
"Oxidants, Photochemical",D,D27.720.642.631,Oxidants,Specialty Uses of Chemicals,1
"Oxidants, Photochemical",D,D27.888.569.540.631,Oxidants,Noxae,1
Oxidopamine,D,D02.455.426.559.389.657.166.175.342.478.650,Hydroxydopamines,Dopamine,1
Oxidopamine,D,D02.092.311.342.478.650,Hydroxydopamines,Dopamine,1
Oxidoreductases Acting on CH-NH Group Donors,D,D08.811.682.662,Oxidoreductases,Enzymes,1
Oxindoles,D,D03.132.436.511,Indole Alkaloids,Alkaloids,1
Oxindoles,D,D03.633.100.473.402.528,Indole Alkaloids,Indoles,1
Oxindoles,D,D03.633.100.496.500.500.511,Indole Alkaloids,Indolizidines,1
Oxo-Acid-Lyases,D,D08.811.520.224.600,Carbon-Carbon Lyases,Lyases,1
Oxygen Radioisotopes,D,D01.362.670.300.600,Oxygen Isotopes,Oxygen,1
Oxygen Radioisotopes,D,D01.496.625.600,Oxygen Isotopes,Isotopes,1
Oxygen Radioisotopes,D,D01.496.749.635,Radioisotopes,Isotopes,1
Oxygen Radioisotopes,D,D01.268.185.550.500.600,Oxygen Isotopes,Oxygen,1
Oxygenases,D,D08.811.682.690,Oxidoreductases,Enzymes,1
"Oxygenators, Membrane",E,E07.652.582,Oxygenators,Equipment and Supplies,1
Oxylipins,D,D10.251.355.645,"Fatty Acids, Unsaturated",Fatty Acids,1
Oxysterols,D,D10.570.938.208.825,Cholesterol,Sterols,1
Oxysterols,D,D04.210.500.247.808.197.800,Cholesterol,Sterols,1
Oxysterols,D,D04.210.500.247.222.284.800,Cholesterol,Cholestenes,1
p21-Activated Kinases,D,D08.811.913.696.620.682.700.596,Protein-Serine-Threonine Kinases,Protein Kinases,1
p21-Activated Kinases,D,D12.644.360.552,Intracellular Signaling Peptides and Proteins,Peptides,1
p21-Activated Kinases,D,D12.776.476.548,Intracellular Signaling Peptides and Proteins,Proteins,1
Pacific Ocean,Z,Z01.756.700,Oceans and Seas,Geographic Locations,1
Pacific States,Z,Z01.107.567.875.580,United States,North America,1
Pain Clinics,N,N02.278.216.500.968.527.600,"Outpatient Clinics, Hospital",Hospital Departments,1
Pain Clinics,N,N02.278.035.380.600,"Outpatient Clinics, Hospital",Ambulatory Care Facilities,1
Pain Clinics,N,N04.452.442.452.422.527.600,"Outpatient Clinics, Hospital",Hospital Departments,1
Pain Threshold,G,G11.561.790.444.700,Pain,Sensation,1
Pain Threshold,F,F02.463.593.710.560,Sensory Thresholds,Perception,1
Pain Threshold,F,F02.830.816.444.700,Pain,Sensation,1
Paired Box Transcription Factors,D,D12.776.930.700,Transcription Factors,Proteins,1
Paired Box Transcription Factors,D,D12.776.260.645,DNA-Binding Proteins,Proteins,1
Palladium,D,D01.268.556.680,"Metals, Heavy",Elements,1
Palladium,D,D01.268.956.718,Transition Elements,Elements,1
Palladium,D,D01.552.544.680,"Metals, Heavy",Metals,1
Palpation,E,E01.370.600.600,Physical Examination,Diagnostic Techniques and Procedures,1
Panax,B,B01.650.940.800.575.912.250.087.500,Araliaceae,Magnoliopsida,1
Pancreas Transplantation,E,E04.936.450.650,Organ Transplantation,Transplantation,1
Pancreas Transplantation,E,E04.210.725,Digestive System Surgical Procedures,"Surgical Procedures, Operative",1
Pancreatic alpha-Amylases,D,D08.811.277.450.066.050.249,alpha-Amylases,Amylases,1
Pancreatic Elastase,D,D08.811.277.656.300.760.560,Serine Endopeptidases,Endopeptidases,1
Pancreatic Elastase,D,D08.811.277.656.959.350.560,Serine Endopeptidases,Serine Proteases,1
Panic Disorder,F,F03.080.700,Anxiety Disorders,Mental Disorders,1
Pannus,B,B03.280.622,Cyanobacteria,Bacteria,1
Pannus,B,B03.440.475.100.622,Cyanobacteria,Gram-Negative Oxygenic Photosynthetic Bacteria,1
Panophthalmitis,C,C01.150.252.289.900.675,"Uveitis, Suppurative","Eye Infections, Bacterial",1
Panophthalmitis,C,C01.375.354.900.675,"Uveitis, Suppurative","Eye Infections, Bacterial",1
Panophthalmitis,C,C01.375.450.900.675,"Uveitis, Suppurative","Eye Infections, Fungal",1
Panophthalmitis,C,C01.150.703.320.900.675,"Uveitis, Suppurative","Eye Infections, Fungal",1
Panophthalmitis,C,C11.941.879.960.580,"Uveitis, Suppurative",Uveitis,1
Panophthalmitis,C,C11.294.354.900.675,"Uveitis, Suppurative","Eye Infections, Bacterial",1
Panophthalmitis,C,C11.294.450.900.675,"Uveitis, Suppurative","Eye Infections, Fungal",1
Pantoprazole,D,D03.383.725.024.625,2-Pyridinylmethylsulfinylbenzimidazoles,Pyridines,1
Pantoprazole,D,D03.633.100.103.034.625,2-Pyridinylmethylsulfinylbenzimidazoles,Benzimidazoles,1
Pantoprazole,D,D02.886.640.074.625,2-Pyridinylmethylsulfinylbenzimidazoles,Sulfoxides,1
Papain,D,D08.811.277.656.300.200.585,Cysteine Endopeptidases,Endopeptidases,1
Papain,D,D08.811.277.656.262.500.585,Cysteine Endopeptidases,Cysteine Proteases,1
Papaver,B,B01.650.940.800.575.912.250.836.500.500,Papaveraceae,Ranunculales,1
Papillary Muscles,A,A07.541.704.750,Myocardium,Heart,1
Papillary Muscles,A,A07.541.510.619,Heart Valves,Heart,1
Papillary Muscles,A,A02.633.580.680,Myocardium,Muscles,1
Papio anubis,B,B01.050.150.900.649.313.988.400.112.199.120.610.050,Papio,Cercopithecinae,1
Para-Athletes,M,M01.150.738,Disabled Persons,Persons,1
Para-Athletes,M,M01.072.500,Athletes,Persons,1
Paracentesis,E,E04.237.667,Drainage,"Surgical Procedures, Operative",1
Paracentesis,E,E04.665.600,Punctures,"Surgical Procedures, Operative",1
Paracentesis,E,E02.800.550,Punctures,Therapeutics,1
Paracentesis,E,E05.200.998.329,Specimen Handling,Clinical Laboratory Techniques,1
Paracentesis,E,E02.309.805,Drainage,Therapeutics,1
Paracentesis,E,E01.370.225.998.329,Specimen Handling,Clinical Laboratory Techniques,1
Paracoccidioidomycosis,C,C01.150.703.700,Mycoses,Bacterial Infections and Mycoses,1
Paracrine Communication,G,G04.085.600,Cell Communication,Cell Physiological Phenomena,1
Paraffin Embedding,E,E05.200.750.600.760.440.610,Tissue Embedding,Tissue Preservation,1
Paraffin Embedding,E,E05.200.500.620.760.440.610,Tissue Embedding,Tissue Preservation,1
Paraffin Embedding,E,E01.370.225.750.600.760.440.610,Tissue Embedding,Tissue Preservation,1
Paraffin Embedding,E,E01.370.225.500.620.760.440.610,Tissue Embedding,Tissue Preservation,1
Paragonimiasis,C,C01.610.335.865.741,Trematode Infections,Helminthiasis,1
Parahippocampal Gyrus,A,A08.186.211.180.710,Limbic System,Brain,1
Parahippocampal Gyrus,A,A08.186.211.180.590.750,Limbic Lobe,Limbic System,1
Parahippocampal Gyrus,A,A08.186.211.200.885.287.500.382.750,Limbic Lobe,Cerebral Cortex,1
"Parainfluenza Virus 3, Human",B,B04.820.480.937.600.650.700.735,Respirovirus,Paramyxovirinae,1
Paraldehyde,D,D02.047.064.586,Acetaldehyde,Aldehydes,1
Paramyxovirinae,B,B04.820.480.937.600.650,Paramyxoviridae,Mononegavirales,1
Paranasal Sinus Diseases,C,C09.603.692,Nose Diseases,Otorhinolaryngologic Diseases,1
Paranasal Sinus Diseases,C,C08.460.692,Nose Diseases,Respiratory Tract Diseases,1
Paraneoplastic Syndromes,C,C04.730,Neoplasms,NULL,1
Paraplegia,C,C10.597.622.669,Paralysis,Neurologic Manifestations,1
Paraplegia,C,C23.888.592.636.637,Paralysis,Neurologic Manifestations,1
Parathyroid Hormone-Related Protein,D,D23.529.890,Intercellular Signaling Peptides and Proteins,Biological Factors,1
Parathyroid Hormone-Related Protein,D,D12.776.467.890,Intercellular Signaling Peptides and Proteins,Proteins,1
Parathyroid Hormone-Related Protein,D,D06.472.699.591,Peptide Hormones,Hormones,1
Parathyroid Hormone-Related Protein,D,D12.644.548.588,Peptide Hormones,Peptides,1
Parathyroid Hormone-Related Protein,D,D12.644.276.908,Intercellular Signaling Peptides and Proteins,Peptides,1
Parathyroid Neoplasms,C,C19.344.525,Endocrine Gland Neoplasms,Endocrine System Diseases,1
Parathyroid Neoplasms,C,C19.642.713,Parathyroid Diseases,Endocrine System Diseases,1
Parathyroid Neoplasms,C,C04.588.443.680,Head and Neck Neoplasms,Neoplasms by Site,1
Parathyroid Neoplasms,C,C04.588.322.525,Endocrine Gland Neoplasms,Neoplasms by Site,1
Paresis,C,C23.888.592.643,Neurologic Manifestations,Signs and Symptoms,1
Paresis,C,C10.597.636,Neurologic Manifestations,Nervous System Diseases,1
Parietal Bone,A,A02.835.232.781.651,Skull,Bone and Bones,1
Parking Facilities,J,J03.970.680,Transportation Facilities,Non-Medical Public and Private Facilities,1
Parotid Gland,A,A03.556.500.760.464,Salivary Glands,Mouth,1
Parotid Gland,A,A10.336.779.464,Salivary Glands,Exocrine Glands,1
Parotid Gland,A,A14.549.760.464,Salivary Glands,Mouth,1
Paroxetine,D,D03.383.621.600,Piperidines,"Heterocyclic Compounds, 1-Ring",1
Parthenogenesis,G,G15.547,Plant Physiological Phenomena,NULL,1
Parthenogenesis,G,G08.686.784.830.500,"Reproduction, Asexual",Reproduction,1
Particle Accelerators,E,E07.710.680,Radiation Equipment and Supplies,Equipment and Supplies,1
"Partnership Practice, Dental",N,N04.452.758.671.589,Partnership Practice,Professional Practice,1
"Parvovirus, Canine",B,B04.280.580.650.600.325.660,Feline Panleukopenia Virus,Parvovirus,1
Passeriformes,B,B01.050.150.900.248.620,Birds,Vertebrates,1
Passiflora,B,B01.650.940.800.575.912.250.803.500,Passifloraceae,Magnoliopsida,1
Pasteurellaceae,B,B03.440.450.600,Gram-Negative Facultatively Anaerobic Rods,Gram-Negative Bacteria,1
Pasteurellaceae,B,B03.660.250.550,Gammaproteobacteria,Proteobacteria,1
Pastoral Care,F,F02.880.410,Religion and Psychology,Psychological Phenomena,1
Pastoral Care,F,F02.784.176.560,Counseling,"Psychology, Applied",1
Patellofemoral Pain Syndrome,C,C05.550.700,Joint Diseases,Musculoskeletal Diseases,1
Paternal Inheritance,G,G05.420.623,Inheritance Patterns,Genetic Phenomena,1
Pathogen-Associated Molecular Pattern Molecules,D,D23.585,Biological Factors,NULL,1
Pathologists,M,M01.526.485.810.746,Physicians,Health Personnel,1
Pathologists,N,N02.360.810.746,Physicians,Health Personnel,1
Pathology,H,H02.403.650,Medicine,Health Occupations,1
"Pathology Department, Hospital",N,N02.278.216.500.968.535,Hospital Departments,Hospital Administration,1
"Pathology Department, Hospital",N,N04.452.442.452.422.535,Hospital Departments,Hospital Administration,1
Patient Discharge Summaries,N,N04.452.859.564.725,Medical Records,Records,1
Patient Discharge Summaries,N,N06.850.520.308.940.968.750,Medical Records,Records,1
Patient Discharge Summaries,N,N05.715.360.300.715.500.665,Medical Records,Records,1
Patient Generated Health Data,E,E05.318.308.940.968.249.625,"Health Records, Personal",Medical Records,1
Patient Isolators,E,E07.325.755,"Equipment and Supplies, Hospital",Equipment and Supplies,1
Patient Medication Knowledge,N,N02.421.726.407.229.500.500,Health Literacy,Consumer Health Information,1
Patient Navigation,N,N04.590.233.727.407.500,Patient-Centered Care,Primary Health Care,1
Patient Positioning,N,N02.421.585.700,Patient Care,Health Services,1
Patient Positioning,E,E02.760.670,Patient Care,Therapeutics,1
Patulin,D,D23.946.587.725,Mycotoxins,"Toxins, Biological",1
Patulin,D,D03.383.663.663,Pyrans,"Heterocyclic Compounds, 1-Ring",1
PC12 Cells,A,A11.251.210.190.750,"Cell Line, Tumor",Cell Line,1
PC12 Cells,A,A11.251.860.180.750,"Cell Line, Tumor","Tumor Cells, Cultured",1
PC12 Cells,A,A11.299.500,Chromaffin Cells,Cells,1
Pediatric Dentistry,H,H02.163.876.600,"Specialties, Dental",Dentistry,1
Pediatric Emergency Medicine,H,H02.403.250.500,Emergency Medicine,Medicine,1
Pediatric Emergency Medicine,H,H02.403.670.450,Pediatrics,Medicine,1
Pediatric Nursing,H,H02.478.676.631,"Specialties, Nursing",Nursing,1
Pediatric Nursing,N,N02.421.533.691,Nursing Care,Health Services,1
"Peer Review, Health Care",N,N04.761.616,Quality of Health Care,Health Services Administration,1
"Peer Review, Health Care",N,N03.706.700.690,Peer Review,"Social Control, Formal",1
"Peer Review, Health Care",N,N05.715.680,Quality of Health Care,"Health Care Quality, Access, and Evaluation",1
"Peer Review, Health Care",I,I01.880.604.640.690,Peer Review,"Social Control, Formal",1
"Peer Review, Health Care",F,F01.829.316.549.690,Peer Review,Group Processes,1
Pelvic Infection,C,C01.635,Infections,NULL,1
"Pemphigoid, Benign Mucous Membrane",C,C11.187.482,Conjunctival Diseases,Eye Diseases,1
"Pemphigoid, Benign Mucous Membrane",C,C17.800.865.670,"Skin Diseases, Vesiculobullous",Skin Diseases,1
"Pemphigus, Benign Familial",C,C17.800.865.858,"Skin Diseases, Vesiculobullous",Skin Diseases,1
"Pemphigus, Benign Familial",C,C17.800.827.700,"Skin Diseases, Genetic",Skin Diseases,1
"Pemphigus, Benign Familial",C,C16.320.850.700,"Skin Diseases, Genetic","Genetic Diseases, Inborn",1
Penbutolol,D,D02.033.755.624.698.688,Phenoxypropanolamines,Propanolamines,1
Penbutolol,D,D02.033.100.624.698.688,Phenoxypropanolamines,Propanolamines,1
Penbutolol,D,D02.092.063.624.698.688,Phenoxypropanolamines,Propanolamines,1
Penicillium,B,B01.300.381.662,Mitosporic Fungi,Fungi,1
Pennisetum,B,B01.650.940.800.575.912.250.822.755,Poaceae,Magnoliopsida,1
Pentacyclic Triterpenes,D,D02.455.849.919.530,Triterpenes,Terpenes,1
Pentetic Acid,D,D02.092.782.590,Polyamines,Amines,1
Pentetic Acid,D,D02.241.081.018.639,Acetates,"Acids, Acyclic",1
Pentobarbital,D,D03.383.742.698.253.593,Barbiturates,Pyrimidinones,1
Pentosephosphates,D,D09.894.643,Sugar Phosphates,Carbohydrates,1
Pentoxifylline,D,D03.633.100.759.758.824.651.700,Theobromine,Xanthines,1
Pepsinogens,D,D08.622.509,Enzyme Precursors,Enzymes and Coenzymes,1
Pepsinogens,D,D12.776.811.243.509,Enzyme Precursors,Protein Precursors,1
Peptic Ulcer Perforation,C,C06.405.748.586.698,Peptic Ulcer,Stomach Diseases,1
Peptic Ulcer Perforation,C,C06.405.469.275.800.698,Peptic Ulcer,Duodenal Diseases,1
Peptide Biosynthesis,G,G02.111.660,Biochemical Phenomena,Chemical Phenomena,1
Peptide Biosynthesis,G,G03.734,Metabolism,NULL,1
Peptide Elongation Factor 2,D,D12.776.835.700.350.102,GTP Phosphohydrolase-Linked Elongation Factors,Peptide Elongation Factors,1
Peptide Elongation Factor 2,D,D08.811.277.040.330.300.100.102,GTP Phosphohydrolase-Linked Elongation Factors,GTP-Binding Proteins,1
Peptide Elongation Factor 2,D,D12.776.157.325.150.102,GTP Phosphohydrolase-Linked Elongation Factors,GTP-Binding Proteins,1
Peptide Elongation Factor Tu,D,D12.776.157.325.150.700,GTP Phosphohydrolase-Linked Elongation Factors,GTP-Binding Proteins,1
Peptide Elongation Factor Tu,D,D08.811.277.040.330.300.100.700,GTP Phosphohydrolase-Linked Elongation Factors,GTP-Binding Proteins,1
Peptide Elongation Factor Tu,D,D12.776.835.700.350.700,GTP Phosphohydrolase-Linked Elongation Factors,Peptide Elongation Factors,1
Peptide Initiation Factors,D,D12.776.835.725,Ribosomal Proteins,Proteins,1
Peptide Library,D,D12.644.555,Peptides,"Amino Acids, Peptides, and Proteins",1
Peptide Library,G,G02.111.570.060.620,Amino Acid Sequence,Molecular Structure,1
Peptide Library,G,G05.360.325.640,Gene Library,Genetic Structures,1
Peptidomimetics,D,D27.505.519.828,Molecular Mechanisms of Pharmacological Action,Pharmacologic Actions,1
Peptidylprolyl Isomerase,D,D08.811.399.325.500,cis-trans-Isomerases,Isomerases,1
Peptococcus,B,B03.353.625.782.593,Peptococcaceae,Clostridiales,1
Peptococcus,B,B03.510.400.562.593,Peptococcaceae,Gram-Positive Cocci,1
Peptostreptococcus,B,B03.510.400.625,Gram-Positive Cocci,Gram-Positive Bacteria,1
Peptostreptococcus,B,B03.353.625.798,Clostridiales,Firmicutes,1
Perceptual Distortion,F,F02.463.593.603,Perception,Mental Processes,1
Periapical Diseases,C,C07.465.714.306,Periodontal Diseases,Mouth Diseases,1
Periapical Diseases,C,C07.320.830,Jaw Diseases,Stomatognathic Diseases,1
Pericardiectomy,E,E04.100.376.735,Cardiac Surgical Procedures,Cardiovascular Surgical Procedures,1
Pericardiectomy,E,E04.928.220.605,Cardiac Surgical Procedures,Thoracic Surgical Procedures,1
"Pericarditis, Constrictive",C,C14.280.720.595,Pericarditis,Heart Diseases,1
Pericoronitis,C,C07.465.714.258.771,Gingival Diseases,Periodontal Diseases,1
Period Circadian Proteins,D,D12.644.360.138.575,Circadian Rhythm Signaling Peptides and Proteins,Intracellular Signaling Peptides and Proteins,1
Period Circadian Proteins,D,D12.776.157.530.750.687,Nucleocytoplasmic Transport Proteins,Membrane Transport Proteins,1
Period Circadian Proteins,D,D12.776.476.156.625,Circadian Rhythm Signaling Peptides and Proteins,Intracellular Signaling Peptides and Proteins,1
Period Circadian Proteins,D,D12.776.543.585.750.687,Nucleocytoplasmic Transport Proteins,Membrane Transport Proteins,1
Periodic Acid,D,D01.475.705,Iodine Compounds,Inorganic Chemicals,1
Periodic Acid,D,D01.029.260.675,"Acids, Noncarboxylic",Acids,1
Periodic Acid-Schiff Reaction,E,E01.370.225.500.620.670.615,Staining and Labeling,Histocytological Preparation Techniques,1
Periodic Acid-Schiff Reaction,E,E01.370.225.500.607.790,Histocytochemistry,Cytological Techniques,1
Periodic Acid-Schiff Reaction,E,E01.370.225.750.551.790,Histocytochemistry,Histological Techniques,1
Periodic Acid-Schiff Reaction,E,E05.200.750.551.790,Histocytochemistry,Histological Techniques,1
Periodic Acid-Schiff Reaction,E,E05.200.500.620.670.620,Staining and Labeling,Histocytological Preparation Techniques,1
Periodic Acid-Schiff Reaction,E,E05.200.500.607.790,Histocytochemistry,Cytological Techniques,1
Periodontal Attachment Loss,C,C07.465.714.354.750,Periodontal Atrophy,Periodontal Diseases,1
Periodontal Pocket,C,C07.465.714.533.750,Periodontitis,Periodontal Diseases,1
Perissodactyla,B,B01.050.150.900.649.313.984,Eutheria,Mammals,1
Peritoneal Diseases,C,C06.844,Digestive System Diseases,NULL,1
Peritoneal Fibrosis,C,C06.844.610,Peritoneal Diseases,Digestive System Diseases,1
Peritoneal Fibrosis,C,C23.550.355.625,Fibrosis,Pathologic Processes,1
"Peritonitis, Tuberculous",C,C06.844.640.249,Peritonitis,Peritoneal Diseases,1
"Peritonitis, Tuberculous",C,C01.463.600.249,Peritonitis,Intraabdominal Infections,1
"Peritonitis, Tuberculous",C,C01.150.252.410.040.552.846.308,Tuberculosis,Mycobacterium Infections,1
Peritonsillar Abscess,C,C01.748.561.750.500,Tonsillitis,Pharyngitis,1
Peritonsillar Abscess,C,C01.830.025.675,Abscess,Suppuration,1
Peritonsillar Abscess,C,C07.550.781.750.500,Tonsillitis,Pharyngitis,1
Peritonsillar Abscess,C,C09.775.649.750.500,Tonsillitis,Pharyngitis,1
Peritonsillar Abscess,C,C08.730.561.750.500,Tonsillitis,Pharyngitis,1
Peroneal Nerve,A,A08.800.800.720.450.760.640,Sciatic Nerve,Lumbosacral Plexus,1
Personal Health Services,N,N02.421.631,Health Services,"Health Care Facilities, Manpower, and Services",1
Personality Tests,F,F04.711.647,Psychological Tests,Behavioral Disciplines and Activities,1
Personnel Delegation,N,N04.452.677.445,Personnel Management,Organization and Administration,1
Personnel Downsizing,N,N04.452.677.450,Personnel Management,Organization and Administration,1
Personnel Downsizing,N,N01.824.245.600,Employment,Socioeconomic Factors,1
Pessaries,E,E07.858.499,Surgical Equipment,Equipment and Supplies,1
Peste-des-Petits-Ruminants,C,C01.925.782.580.600.500.600,Morbillivirus Infections,Paramyxoviridae Infections,1
Peste-des-Petits-Ruminants,C,C22.706,Animal Diseases,NULL,1
Peutz-Jeghers Syndrome,C,C16.320.700.667,"Neoplastic Syndromes, Hereditary","Genetic Diseases, Inborn",1
Peutz-Jeghers Syndrome,C,C17.800.621.430.530.550.625,Lentigo,Melanosis,1
Peutz-Jeghers Syndrome,C,C06.405.469.578.750,Intestinal Polyposis,Intestinal Diseases,1
Peutz-Jeghers Syndrome,C,C04.700.633,"Neoplastic Syndromes, Hereditary",Neoplasms,1
Pharmaceutical Solutions,D,D27.720.752,Specialty Uses of Chemicals,Chemical Actions and Uses,1
Pharmaceutical Solutions,D,D26.776.708,Solutions,Pharmaceutical Preparations,1
Pharmaceutical Solutions,D,D27.505.954.578,Therapeutic Uses,Pharmacologic Actions,1
Pharmacology,H,H02.628,Health Occupations,NULL,1
Pharmacology,H,H01.158.703,Biological Science Disciplines,Natural Science Disciplines,1
"Pharmacology, Clinical",H,H01.158.703.152,Pharmacology,Biological Science Disciplines,1
"Pharmacology, Clinical",H,H02.628.512,Pharmacology,Health Occupations,1
Pharmacy and Therapeutics Committee,N,N04.452.758.788.682,Professional Staff Committees,Professional Practice,1
Pharmacy and Therapeutics Committee,N,N05.700.685.625,Professional Staff Committees,"Quality Assurance, Health Care",1
Pharyngeal Diseases,C,C07.550,Stomatognathic Diseases,NULL,1
Pharyngeal Diseases,C,C09.775,Otorhinolaryngologic Diseases,NULL,1
Phascolarctidae,B,B01.050.150.900.649.573.590,Marsupialia,Mammals,1
Phenanthridines,D,D03.633.300.633,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",1
Phenanthrolines,D,D03.633.300.669,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",1
Phenoxyacetates,D,D02.241.081.018.386.682,Glycolates,Acetates,1
Phenoxyacetates,D,D02.241.511.316.682,Glycolates,Hydroxy Acids,1
Phenoxypropanolamines,D,D02.092.063.624.698,Propanolamines,Amino Alcohols,1
Phenoxypropanolamines,D,D02.033.100.624.698,Propanolamines,Amino Alcohols,1
Phenoxypropanolamines,D,D02.033.755.624.698,Propanolamines,Propanols,1
Phenyl Ethers,D,D02.355.726,Ethers,Organic Chemicals,1
Phenyl Ethers,D,D02.455.426.559.389.657.654,Phenols,Benzene Derivatives,1
Phenylbutyrates,D,D02.241.223.651,"Acids, Carbocyclic",Carboxylic Acids,1
Phenylenediamines,D,D02.092.146.651,Aniline Compounds,Amines,1
Phenylenediamines,D,D02.092.782.258.651,Diamines,Polyamines,1
Phenylephrine,D,D02.092.063.291.617,Ethanolamines,Amino Alcohols,1
Phenylephrine,D,D02.033.100.291.617,Ethanolamines,Amino Alcohols,1
Phenylethyl Alcohol,D,D02.033.375.650,Ethanol,Alcohols,1
Phenylhydrazines,D,D02.442.726,Hydrazines,Organic Chemicals,1
Phenylketonurias,C,C10.228.140.163.100.687,"Brain Diseases, Metabolic, Inborn","Brain Diseases, Metabolic",1
Phenylketonurias,C,C18.452.648.189.687,"Brain Diseases, Metabolic, Inborn","Metabolism, Inborn Errors",1
Phenylketonurias,C,C18.452.648.100.766,"Amino Acid Metabolism, Inborn Errors","Metabolism, Inborn Errors",1
Phenylketonurias,C,C18.452.132.100.687,"Brain Diseases, Metabolic, Inborn","Brain Diseases, Metabolic",1
Phenylketonurias,C,C16.320.565.100.766,"Amino Acid Metabolism, Inborn Errors","Metabolism, Inborn Errors",1
Phenylketonurias,C,C16.320.565.189.687,"Brain Diseases, Metabolic, Inborn","Metabolism, Inborn Errors",1
Phenylthiohydantoin,D,D03.383.129.308.432.555.868.650,Thiohydantoins,Hydantoins,1
"Pheromones, Human",D,D23.641.399,Pheromones,Biological Factors,1
Phimosis,C,C12.294.494.684,Penile Diseases,"Genital Diseases, Male",1
Phlebovirus,B,B04.820.480.750.710,Bunyaviridae,Negative-Sense RNA Viruses,1
Phoca,B,B01.050.150.900.649.313.750.250.700.600,"Seals, Earless",Caniformia,1
"Phorbol 12,13-Dibutyrate",D,D02.455.849.291.500.510.700,Phorbol Esters,Phorbols,1
Phosphatidylethanolamine N-Methyltransferase,D,D08.811.913.555.500.712,Methyltransferases,One-Carbon Group Transferases,1
Phosphatidylglycerols,D,D10.570.755.375.760.400.885,Glycerophospholipids,Phosphatidic Acids,1
"Phosphatidylinositol 4,5-Diphosphate",D,D10.570.755.375.760.400.942.625.900,Phosphatidylinositol Phosphates,Phosphatidylinositols,1
Phosphatidylinositol Diacylglycerol-Lyase,D,D08.811.520.650.800,Phosphorus-Oxygen Lyases,Lyases,1
Phosphatidylinositol Diacylglycerol-Lyase,D,D08.811.277.352.640.700.700.500,Type C Phospholipases,Phospholipases,1
Phosphatidylinositol Phosphates,D,D10.570.755.375.760.400.942.625,Phosphatidylinositols,Glycerophospholipids,1
"Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases",D,D08.811.277.352.650.624.750,Phosphoinositide Phosphatases,Phosphoric Monoester Hydrolases,1
Phosphoenolpyruvate Carboxykinase (ATP),D,D08.811.520.224.125.500,Carboxy-Lyases,Carbon-Carbon Lyases,1
Phosphoenolpyruvate Carboxykinase (GTP),D,D08.811.520.224.125.550,Carboxy-Lyases,Carbon-Carbon Lyases,1
"Phosphofructokinase-1, Muscle Type",D,D08.811.913.696.620.225.850.500.500,Phosphofructokinase-1,Phosphofructokinases,1
Phosphoglycerate Dehydrogenase,D,D08.811.682.047.150.650,Carbohydrate Dehydrogenases,Alcohol Oxidoreductases,1
Phosphoglycerate Kinase,D,D08.811.913.696.630.700,Phosphotransferases (Carboxyl Group Acceptor),Phosphotransferases,1
Phospholipase A2 Inhibitors,D,D27.505.519.389.737,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,1
Phospholipases,D,D08.811.277.352.640.700,Phosphoric Diester Hydrolases,Esterases,1
Phospholipases,D,D08.811.277.352.100.680,Carboxylic Ester Hydrolases,Esterases,1
"Phospholipases A2, Secretory",D,D08.811.277.352.100.680.750.937.750,Phospholipases A2,Phospholipases A,1
Phosphonoacetic Acid,D,D02.705.429.875,Organophosphonates,Organophosphorus Compounds,1
Phosphonoacetic Acid,D,D02.241.081.018.677,Acetates,"Acids, Acyclic",1
Phosphopyruvate Hydratase,D,D08.811.520.241.300.500,Hydro-Lyases,Carbon-Oxygen Lyases,1
Phosphoramide Mustards,D,D02.705.672.500,Phosphoramides,Organophosphorus Compounds,1
Phosphoramide Mustards,D,D02.455.526.728.650.730,Nitrogen Mustard Compounds,Mustard Compounds,1
Phosphorus Compounds,D,D01.695,Inorganic Chemicals,NULL,1
Phosphorus Radioisotopes,D,D01.496.749.658,Radioisotopes,Isotopes,1
Phosphorus Radioisotopes,D,D01.496.669.604,Phosphorus Isotopes,Isotopes,1
Phosphorus Radioisotopes,D,D01.268.666.500.604,Phosphorus Isotopes,Phosphorus,1
Phosphorylases,D,D08.811.913.400.450.460.400,Glucosyltransferases,Hexosyltransferases,1
Photolysis,G,G02.740.685,Photochemical Processes,Chemical Phenomena,1
Photomicrography,E,E05.595.799,Microscopy,Investigative Techniques,1
Photomicrography,E,E01.370.350.600.635,Photography,Diagnostic Imaging,1
Photomicrography,E,E01.370.350.515.799,Microscopy,Diagnostic Imaging,1
Photoreceptor Cells,A,A08.800.950.937,Sensory Receptor Cells,Peripheral Nervous System,1
Photoreceptor Cells,A,A08.675.650.850.625,Retinal Neurons,"Neurons, Afferent",1
Photoreceptor Cells,A,A08.675.650.915.937,Sensory Receptor Cells,"Neurons, Afferent",1
Photoreceptor Cells,A,A09.371.729.831.625,Retinal Neurons,Retina,1
Photoreceptor Cells,A,A11.671.650.850.625,Retinal Neurons,"Neurons, Afferent",1
Photoreceptor Cells,A,A11.671.650.915.937,Sensory Receptor Cells,"Neurons, Afferent",1
"Photoreceptor Cells, Vertebrate",A,A11.671.650.915.937.670,Photoreceptor Cells,Sensory Receptor Cells,1
"Photoreceptor Cells, Vertebrate",A,A11.671.650.850.625.670,Photoreceptor Cells,Retinal Neurons,1
"Photoreceptor Cells, Vertebrate",A,A09.371.729.831.625.670,Photoreceptor Cells,Retinal Neurons,1
"Photoreceptor Cells, Vertebrate",A,A08.675.650.915.937.670,Photoreceptor Cells,Sensory Receptor Cells,1
"Photoreceptor Cells, Vertebrate",A,A08.675.650.850.625.670,Photoreceptor Cells,Retinal Neurons,1
"Photoreceptor Cells, Vertebrate",A,A08.800.950.937.670,Photoreceptor Cells,Sensory Receptor Cells,1
Photorefractive Keratectomy,E,E02.594.480.875,"Corneal Surgery, Laser",Laser Therapy,1
Photorefractive Keratectomy,E,E04.378.500.875,"Corneal Surgery, Laser",Keratectomy,1
Photorefractive Keratectomy,E,E04.540.825.437.500,"Corneal Surgery, Laser",Refractive Surgical Procedures,1
Photorefractive Keratectomy,E,E04.014.520.480.875,"Corneal Surgery, Laser",Laser Therapy,1
Photosensitivity Disorders,C,C17.800.600,Skin Diseases,Skin and Connective Tissue Diseases,1
Photosystem II Protein Complex,D,D12.776.543.930.500.750,Photosynthetic Reaction Center Complex Proteins,Thylakoid Membrane Proteins,1
Photosystem II Protein Complex,D,D12.776.765.199.750.750.750,Photosynthetic Reaction Center Complex Proteins,Thylakoid Membrane Proteins,1
Photosystem II Protein Complex,D,D08.811.600.710.750,Photosynthetic Reaction Center Complex Proteins,Multienzyme Complexes,1
Photosystem II Protein Complex,D,D05.500.562.488.750,Photosynthetic Reaction Center Complex Proteins,Multienzyme Complexes,1
Physarum,B,B01.046.550.550.600.700,Physarida,Myxomycetes,1
Physical Phenomena,G,G01,NULL,NULL,1
Physicians' Offices,N,N02.278.692,Health Facilities,"Health Care Facilities, Manpower, and Services",1
Physiology,H,H01.158.782,Biological Science Disciplines,Natural Science Disciplines,1
Phytanic Acid,D,D02.455.849.291.515,Diterpenes,Terpenes,1
Phytolacca americana,B,B01.650.940.800.575.912.250.198.500.875.500.500,Phytolacca,Phytolaccaceae,1
Phytophthora,B,B01.750.580.715,Oomycetes,Stramenopiles,1
Phytoplankton,B,B05.080.500.600,Plankton,Aquatic Organisms,1
Phytosterols,D,D04.210.500.247.808.756,Sterols,Cholestanes,1
Phytosterols,D,D10.570.938.795,Sterols,Membrane Lipids,1
Phytosterols,D,D23.704.500,Phytochemicals,Biological Factors,1
Picolinic Acids,D,D03.066.707,"Acids, Heterocyclic",Heterocyclic Compounds,1
Picolinic Acids,D,D03.383.725.705,Pyridines,"Heterocyclic Compounds, 1-Ring",1
"Pigments, Biological",D,D23.767,Biological Factors,NULL,1
PII Nitrogen Regulatory Proteins,D,D12.776.476.024.400,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
PII Nitrogen Regulatory Proteins,D,D12.644.360.024.318,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
PII Nitrogen Regulatory Proteins,D,D12.776.157.057.110,"Adaptor Proteins, Signal Transducing",Carrier Proteins,1
Pilocarpine,D,D03.132.672,Alkaloids,Heterocyclic Compounds,1
Pineal Gland,A,A08.713.733,Neurosecretory Systems,Nervous System,1
Pineal Gland,A,A08.186.211.200.317.200.620,Epithalamus,Diencephalon,1
Pineal Gland,A,A08.186.211.180.200.680,Epithalamus,Limbic System,1
Pineal Gland,A,A06.688.733,Neurosecretory Systems,Endocrine System,1
Pineal Gland,A,A06.300.635,Endocrine Glands,Endocrine System,1
Pinta,C,C01.800.720.630,"Skin Diseases, Bacterial","Skin Diseases, Infectious",1
Pinta,C,C01.150.252.819.630,"Skin Diseases, Bacterial",Bacterial Infections,1
Pinta,C,C01.150.252.400.794.840.250,Treponemal Infections,Spirochaetales Infections,1
Pinta,C,C01.150.252.400.840.250,Treponemal Infections,Gram-Negative Bacterial Infections,1
Pinta,C,C17.800.838.765.630,"Skin Diseases, Bacterial","Skin Diseases, Infectious",1
Pinus,B,B01.650.940.800.575.912.625.875.777,Pinaceae,Pinales,1
Piper,B,B01.650.940.800.575.912.250.812.666,Piperaceae,Magnoliopsida,1
Piper betle,B,B01.650.940.800.575.912.250.812.666.374,Piper,Piperaceae,1
Piperacillin,D,D02.065.589.099.750.750.050.650,Ampicillin,Penicillin G,1
Piperacillin,D,D02.886.108.750.750.050.650,Ampicillin,Penicillin G,1
Piperacillin,D,D03.633.100.300.750.750.050.650,Ampicillin,Penicillin G,1
"Piperacillin, Tazobactam Drug Combination",D,D03.633.100.300.750.750.050.650.500,Piperacillin,Ampicillin,1
"Piperacillin, Tazobactam Drug Combination",D,D03.633.100.300.750.687.750.500,Tazobactam,Penicillanic Acid,1
"Piperacillin, Tazobactam Drug Combination",D,D02.886.108.750.750.050.650.500,Piperacillin,Ampicillin,1
"Piperacillin, Tazobactam Drug Combination",D,D02.886.590.841.500,Tazobactam,Sulfones,1
"Piperacillin, Tazobactam Drug Combination",D,D02.886.108.750.687.750.500,Tazobactam,Penicillanic Acid,1
"Piperacillin, Tazobactam Drug Combination",D,D26.310.625,Drug Combinations,Pharmaceutical Preparations,1
"Piperacillin, Tazobactam Drug Combination",D,D02.065.589.099.750.750.050.650.500,Piperacillin,Ampicillin,1
"Piperacillin, Tazobactam Drug Combination",D,D02.065.589.099.750.687.750.500,Tazobactam,Penicillanic Acid,1
Piracetam,D,D02.065.064.650,Acetamides,Amides,1
Piracetam,D,D02.241.081.018.110.650,Acetamides,Acetates,1
Piracetam,D,D03.383.773.812.555,Pyrrolidinones,Pyrrolidines,1
"Pituitary Hormones, Anterior",D,D06.472.699.631.525,Pituitary Hormones,Peptide Hormones,1
"Pituitary Hormones, Anterior",D,D12.644.548.691.525,Pituitary Hormones,Peptide Hormones,1
Pituitary Neoplasms,C,C19.700.734,Pituitary Diseases,Endocrine System Diseases,1
Pituitary Neoplasms,C,C19.344.609,Endocrine Gland Neoplasms,Endocrine System Diseases,1
Pituitary Neoplasms,C,C10.228.140.211.885.500.600,Hypothalamic Neoplasms,Supratentorial Neoplasms,1
Pituitary Neoplasms,C,C10.228.140.617.738.675,Pituitary Diseases,Hypothalamic Diseases,1
Pituitary Neoplasms,C,C10.228.140.617.477.600,Hypothalamic Neoplasms,Hypothalamic Diseases,1
Pituitary Neoplasms,C,C10.551.240.250.700.500.500,Hypothalamic Neoplasms,Supratentorial Neoplasms,1
Pituitary Neoplasms,C,C04.588.322.609,Endocrine Gland Neoplasms,Neoplasms by Site,1
Pituitary Neoplasms,C,C04.588.614.250.195.885.500.600,Hypothalamic Neoplasms,Supratentorial Neoplasms,1
Pivampicillin,D,D02.065.589.099.750.750.050.700,Ampicillin,Penicillin G,1
Pivampicillin,D,D03.633.100.300.750.750.050.700,Ampicillin,Penicillin G,1
Pivampicillin,D,D02.886.108.750.750.050.700,Ampicillin,Penicillin G,1
Placenta Accreta,C,C13.703.420.643,Obstetric Labor Complications,Pregnancy Complications,1
Placenta Accreta,C,C13.703.590.609,Placenta Diseases,Pregnancy Complications,1
Plankton,B,B05.080.500,Aquatic Organisms,Organism Forms,1
Plant Breeding,J,J01.040.227.500,Crop Production,Agriculture,1
"Plant Components, Aerial",A,A18.024,Plant Structures,NULL,1
Plant Growth Regulators,D,D27.505.696.377.760,Growth Substances,Physiological Effects of Drugs,1
Plant Stems,A,A18.024.937,"Plant Components, Aerial",Plant Structures,1
Plant Structures,A,A18,NULL,NULL,1
"Plaque, Amyloid",C,C23.300.821,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",1
Plasminogen Activators,D,D08.811.277.656.959.350.635,Serine Endopeptidases,Serine Proteases,1
Plasminogen Activators,D,D08.811.277.656.300.760.635,Serine Endopeptidases,Endopeptidases,1
Plasminogen Activators,D,D12.776.124.125.662,Blood Coagulation Factors,Blood Proteins,1
Plastids,A,A11.284.430.214.190.875.700,Organelles,Cytoplasmic Structures,1
Platelet Endothelial Cell Adhesion Molecule-1,D,D12.776.395.550.200.131,Cell Adhesion Molecules,Membrane Glycoproteins,1
Platelet Endothelial Cell Adhesion Molecule-1,D,D23.101.100.900.131,"Antigens, Differentiation, Myelomonocytic","Antigens, Differentiation",1
Platelet Endothelial Cell Adhesion Molecule-1,D,D12.776.543.550.200.131,Cell Adhesion Molecules,Membrane Glycoproteins,1
Platelet Endothelial Cell Adhesion Molecule-1,D,D23.050.301.350.131,Cell Adhesion Molecules,"Antigens, Surface",1
Platelet Endothelial Cell Adhesion Molecule-1,D,D23.050.301.264.900.131,"Antigens, Differentiation, Myelomonocytic","Antigens, Differentiation",1
Platelet Factor 4,D,D12.776.467.374.200.120.900,"Chemokines, CXC",Chemokines,1
Platelet Factor 4,D,D23.125.300.120.900,"Chemokines, CXC",Chemokines,1
Platelet Factor 4,D,D23.119.940,Blood Coagulation Factors,Biological Factors,1
Platelet Factor 4,D,D23.529.374.200.120.900,"Chemokines, CXC",Chemokines,1
Platelet Factor 4,D,D23.469.200.120.900,"Chemokines, CXC",Chemokines,1
Platelet Factor 4,D,D12.776.124.125.720,Blood Coagulation Factors,Blood Proteins,1
Platelet Factor 4,D,D12.644.276.374.200.120.900,"Chemokines, CXC",Chemokines,1
Platelet-Derived Growth Factor,D,D12.644.276.910,Intercellular Signaling Peptides and Proteins,Peptides,1
Platelet-Derived Growth Factor,D,D12.776.124.625,Blood Proteins,Proteins,1
Platelet-Derived Growth Factor,D,D23.529.910,Intercellular Signaling Peptides and Proteins,Biological Factors,1
Platelet-Derived Growth Factor,D,D12.776.467.910,Intercellular Signaling Peptides and Proteins,Proteins,1
Platinum Compounds,D,D01.710,Inorganic Chemicals,NULL,1
Pleistophora,B,B01.300.360.500.500.600.650,Pansporablastina,Microsporida,1
"Plethysmography, Impedance",E,E01.370.405.610,Electrodiagnosis,Diagnostic Techniques and Procedures,1
"Plethysmography, Impedance",E,E01.370.370.610.610,Plethysmography,"Diagnostic Techniques, Cardiovascular",1
Pleuropneumonia,C,C01.748.582.473,Pleurisy,Respiratory Tract Infections,1
Pleuropneumonia,C,C01.748.610.473,Pneumonia,Respiratory Tract Infections,1
Pleuropneumonia,C,C08.730.610.473,Pneumonia,Respiratory Tract Infections,1
Pleuropneumonia,C,C08.730.582.473,Pleurisy,Respiratory Tract Infections,1
Pleuropneumonia,C,C08.528.735.473,Pleurisy,Pleural Diseases,1
Pleuropneumonia,C,C08.381.677.473,Pneumonia,Lung Diseases,1
Pluripotent Stem Cells,A,A11.872.700,Stem Cells,Cells,1
Plutonium,D,D01.268.556.700,"Metals, Heavy",Elements,1
Plutonium,D,D01.268.271.100.700,Actinoid Series Elements,"Elements, Radioactive",1
Plutonium,D,D01.496.749.305.100.700,Actinoid Series Elements,"Elements, Radioactive",1
Plutonium,D,D01.552.544.700,"Metals, Heavy",Metals,1
Plutonium,D,D01.552.020.734,Actinoid Series Elements,Metals,1
Pneumocephalus,C,C26.915.300.200.650,Brain Injuries,Craniocerebral Trauma,1
Pneumocephalus,C,C10.228.806,Central Nervous System Diseases,Nervous System Diseases,1
Pneumocephalus,C,C10.228.140.199.700,Brain Injuries,Brain Diseases,1
Pneumocephalus,C,C10.900.300.087.700,Brain Injuries,Craniocerebral Trauma,1
"Pneumonia, Aspiration",C,C08.381.677.529,Pneumonia,Lung Diseases,1
"Pneumonia, Aspiration",C,C08.730.610.529,Pneumonia,Respiratory Tract Infections,1
"Pneumonia, Aspiration",C,C01.748.610.529,Pneumonia,Respiratory Tract Infections,1
"Pneumonia, Lipid",C,C01.748.610.529.612,"Pneumonia, Aspiration",Pneumonia,1
"Pneumonia, Lipid",C,C08.730.610.529.612,"Pneumonia, Aspiration",Pneumonia,1
"Pneumonia, Lipid",C,C08.381.677.529.612,"Pneumonia, Aspiration",Pneumonia,1
"Pneumonia, Progressive Interstitial, of Sheep",C,C22.836.660,Sheep Diseases,Animal Diseases,1
"Pneumonia, Progressive Interstitial, of Sheep",C,C01.925.782.815.616.660,Lentivirus Infections,Retroviridae Infections,1
"Pneumonia, Progressive Interstitial, of Sheep",C,C01.925.839.660,Slow Virus Diseases,Virus Diseases,1
Pneumoperitoneum,C,C06.844.670,Peritoneal Diseases,Digestive System Diseases,1
Pneumovirus Infections,C,C01.925.782.580.600.550,Paramyxoviridae Infections,Mononegavirales Infections,1
POEMS Syndrome,C,C20.683.780.750,Paraproteinemias,Immunoproliferative Disorders,1
POEMS Syndrome,C,C10.668.829.800.700,Polyneuropathies,Peripheral Nervous System Diseases,1
POEMS Syndrome,C,C15.378.147.780.750,Paraproteinemias,Blood Protein Disorders,1
POEMS Syndrome,C,C16.131.077.703,"Abnormalities, Multiple",Congenital Abnormalities,1
Poison Control Centers,N,N02.278.726,Health Facilities,"Health Care Facilities, Manpower, and Services",1
Poison Control Centers,N,N02.421.297.695,Emergency Medical Services,Health Services,1
Pokeweed Mitogens,D,D12.776.503.499.875,Plant Lectins,Lectins,1
Pokeweed Mitogens,D,D12.776.765.678.875,Plant Lectins,Plant Proteins,1
Pollination,G,G15.776,Plant Physiological Phenomena,NULL,1
Pollination,G,G08.686.784.743,Reproduction,Reproductive Physiological Phenomena,1
Polonium,D,D01.496.749.305.680,"Elements, Radioactive",Radioisotopes,1
Polonium,D,D01.268.271.680,"Elements, Radioactive",Elements,1
Polonium,D,D01.268.185.600,Chalcogens,Elements,1
Polonium,D,D01.268.513.875,Metalloids,Elements,1
Poly(ADP-ribose) Polymerase Inhibitors,D,D27.505.519.389.739,Enzyme Inhibitors,Molecular Mechanisms of Pharmacological Action,1
Poly(ADP-ribose) Polymerase Inhibitors,D,D27.505.954.248.692,Antineoplastic Agents,Therapeutic Uses,1
Poly-ADP-Ribose Binding Proteins,D,D12.776.660.720,Nuclear Proteins,Proteins,1
Poly-ADP-Ribose Binding Proteins,D,D12.776.157.687,Carrier Proteins,Proteins,1
Polybrominated Biphenyls,D,D02.455.526.368.700,"Hydrocarbons, Brominated","Hydrocarbons, Halogenated",1
Polybrominated Biphenyls,D,D02.455.426.559.389.185.680,Biphenyl Compounds,Benzene Derivatives,1
Polychloroterphenyl Compounds,D,D02.455.426.559.389.805.700,Terphenyl Compounds,Benzene Derivatives,1
Polychloroterphenyl Compounds,D,D02.455.526.439.785,"Hydrocarbons, Chlorinated","Hydrocarbons, Halogenated",1
Polycomb Repressive Complex 2,D,D05.500.781.750,Polycomb-Group Proteins,Multiprotein Complexes,1
Polycomb Repressive Complex 2,D,D08.811.913.555.500.800.200.500.500,Histone-Lysine N-Methyltransferase,Histone Methyltransferases,1
Polycomb Repressive Complex 2,D,D12.776.660.235.600.200,Polycomb-Group Proteins,"Chromosomal Proteins, Non-Histone",1
Polycomb Repressive Complex 2,D,D12.776.664.235.800.200,Polycomb-Group Proteins,"Chromosomal Proteins, Non-Histone",1
Polycomb Repressive Complex 2,D,D12.776.930.780.890.200,Polycomb-Group Proteins,Repressor Proteins,1
Polycomb-Group Proteins,D,D12.776.930.780.890,Repressor Proteins,Transcription Factors,1
Polycomb-Group Proteins,D,D12.776.664.235.800,"Chromosomal Proteins, Non-Histone",Nucleoproteins,1
Polycomb-Group Proteins,D,D12.776.660.235.600,"Chromosomal Proteins, Non-Histone",Nuclear Proteins,1
Polycomb-Group Proteins,D,D05.500.781,Multiprotein Complexes,Macromolecular Substances,1
Polycystic Kidney Diseases,C,C16.131.077.717,"Abnormalities, Multiple",Congenital Abnormalities,1
Polycystic Kidney Diseases,C,C16.320.184.625,Ciliopathies,"Genetic Diseases, Inborn",1
Polycystic Kidney Diseases,C,C13.351.968.419.403.875,"Kidney Diseases, Cystic",Kidney Diseases,1
Polycystic Kidney Diseases,C,C12.777.419.403.875,"Kidney Diseases, Cystic",Kidney Diseases,1
Polydeoxyribonucleotides,D,D13.695.578.500,Polynucleotides,Nucleotides,1
Polyelectrolytes,D,D05.750.230,Polymers,Macromolecular Substances,1
Polyelectrolytes,D,D01.248.700,Electrolytes,Inorganic Chemicals,1
Polyethylenes,D,D02.455.326.271.665.550,Polyenes,Alkenes,1
Polyethylenes,D,D05.750.716.507,Plastics,Polymers,1
Polyethylenes,D,D25.720.716.507,Plastics,Polymers,1
Polyethylenes,J,J01.637.051.720.716.507,Plastics,Polymers,1
Polygalacturonase,D,D08.811.277.450.800,Glycoside Hydrolases,Hydrolases,1
Polyglycolic Acid,D,D05.750.728.780,Polyesters,Polymers,1
Polyglycolic Acid,D,D25.720.728.780,Polyesters,Polymers,1
Polyglycolic Acid,J,J01.637.051.720.728.780,Polyesters,Polymers,1
Polyhydramnios,C,C13.703.610,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,1
Polyisoprenyl Phosphates,D,D02.455.849.690,Terpenes,Hydrocarbons,1
Polyisoprenyl Phosphates,D,D02.705.400.725,Organophosphates,Organophosphorus Compounds,1
Polyketide Synthases,D,D08.811.464.257.275,Carbon-Carbon Ligases,Ligases,1
Polyketide Synthases,D,D08.811.600.715,Multienzyme Complexes,Enzymes,1
Polymethacrylic Acids,D,D05.750.716.822.111.650,Acrylic Resins,"Resins, Synthetic",1
Polymethacrylic Acids,D,D25.720.716.822.111.650,Acrylic Resins,"Resins, Synthetic",1
Polymethacrylic Acids,D,D02.241.081.069.800,Acrylates,"Acids, Acyclic",1
Polymethacrylic Acids,J,J01.637.051.720.716.822.111.650,Acrylic Resins,"Resins, Synthetic",1
Polymyositis,C,C10.668.491.562.575,Myositis,Muscular Diseases,1
Polymyositis,C,C05.651.594.819,Myositis,Muscular Diseases,1
Polyneuropathies,C,C10.668.829.800,Peripheral Nervous System Diseases,Neuromuscular Diseases,1
Polynucleotides,D,D13.695.578,Nucleotides,"Nucleic Acids, Nucleotides, and Nucleosides",1
Polypropylenes,D,D25.720.716.550,Plastics,Polymers,1
Polypropylenes,D,D05.750.716.550,Plastics,Polymers,1
Polypropylenes,D,D02.455.326.271.665.590,Polyenes,Alkenes,1
Polypropylenes,J,J01.637.051.720.716.550,Plastics,Polymers,1
Polyps,C,C23.300.825,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",1
Polyribonucleotide Nucleotidyltransferase,D,D08.811.913.696.445.735.532,RNA Nucleotidyltransferases,Nucleotidyltransferases,1
Polysaccharide-Lyases,D,D08.811.520.241.700,Carbon-Oxygen Lyases,Lyases,1
Polyubiquitin,D,D12.776.947.500.500,Ubiquitin,Ubiquitins,1
Polyuria,C,C23.888.942.600,Urological Manifestations,Signs and Symptoms,1
Polyuria,C,C12.777.934.616,Urination Disorders,Urologic Diseases,1
Polyuria,C,C13.351.968.934.616,Urination Disorders,Urologic Diseases,1
Pongo,B,B01.050.150.900.649.313.988.400.112.400.635,Hominidae,Catarrhini,1
Porcine epidemic diarrhea virus,B,B04.820.578.500.540.150.075.937,Alphacoronavirus,Coronavirus,1
Porcupines,B,B01.050.150.900.649.313.992.692,Rodentia,Eutheria,1
Porifera,B,B01.050.500.802,Invertebrates,Animals,1
Pork Meat,J,J02.500.600.813.500,Red Meat,Meat,1
Pork Meat,G,G07.203.300.600.813.500,Red Meat,Meat,1
Porphobilinogen Synthase,D,D08.811.520.241.300.550,Hydro-Lyases,Carbon-Oxygen Lyases,1
Porphyrias,C,C18.452.811,Metabolic Diseases,Nutritional and Metabolic Diseases,1
"Portoenterostomy, Hepatic",E,E04.035.775,"Anastomosis, Surgical","Surgical Procedures, Operative",1
"Portoenterostomy, Hepatic",E,E04.210.120.775,Biliary Tract Surgical Procedures,Digestive System Surgical Procedures,1
Portraits as Topic,K,K01.093.742,Art,Humanities,1
Position-Specific Scoring Matrices,E,E05.393.760.670,Sequence Analysis,Genetic Techniques,1
Position-Specific Scoring Matrices,E,E05.318.740.600.650,Probability,Statistics as Topic,1
Position-Specific Scoring Matrices,G,G02.111.570.580.175.500,Consensus Sequence,Conserved Sequence,1
Positive Transcriptional Elongation Factor B,D,D08.811.913.696.620.682.700.626,Protein-Serine-Threonine Kinases,Protein Kinases,1
Positive Transcriptional Elongation Factor B,D,D12.776.930.955.500,Transcriptional Elongation Factors,Transcription Factors,1
Post and Core Technique,E,E07.695.190.088.500,Crowns,Dental Prosthesis,1
Post and Core Technique,E,E06.780.346.250.500,Crowns,Dental Prosthesis,1
"Posterior Capsular Rupture, Ocular",C,C11.297.500,Eye Injuries,Eye Diseases,1
Postmodernism,K,K01.752.720,Philosophy,Humanities,1
Postmortem Changes,C,C23.550.260.224.617,Cadaver,Death,1
Postoperative Cognitive Complications,C,C23.550.767.831,Postoperative Complications,Pathologic Processes,1
Postoperative Cognitive Complications,F,F03.615.250.700.500,Cognitive Dysfunction,Cognition Disorders,1
Postpericardiotomy Syndrome,C,C23.550.767.863,Postoperative Complications,Pathologic Processes,1
Postpericardiotomy Syndrome,C,C14.280.793,Heart Diseases,Cardiovascular Diseases,1
Postprandial Period,G,G10.261.700,Digestive System Physiological Phenomena,Digestive System and Oral Physiological Phenomena,1
Postthrombotic Syndrome,C,C14.907.355.830.925.462,Venous Thrombosis,Thrombosis,1
Postthrombotic Syndrome,C,C14.907.952.880,Venous Insufficiency,Vascular Diseases,1
Potassium Channel Blockers,D,D27.505.954.411.645,Cardiovascular Agents,Therapeutic Uses,1
Potassium Channel Blockers,D,D27.505.519.562.500,Membrane Transport Modulators,Molecular Mechanisms of Pharmacological Action,1
"Potassium Channels, Inwardly Rectifying",D,D12.776.543.550.450.750.450,Potassium Channels,Ion Channels,1
"Potassium Channels, Inwardly Rectifying",D,D12.776.543.585.400.750.450,Potassium Channels,Ion Channels,1
"Potassium Channels, Inwardly Rectifying",D,D12.776.157.530.400.600.450,Potassium Channels,Ion Channels,1
"Potassium Channels, Tandem Pore Domain",D,D12.776.157.530.400.600.850,Potassium Channels,Ion Channels,1
"Potassium Channels, Tandem Pore Domain",D,D12.776.543.585.400.750.850,Potassium Channels,Ion Channels,1
"Potassium Channels, Tandem Pore Domain",D,D12.776.543.550.450.750.850,Potassium Channels,Ion Channels,1
"Potassium Channels, Voltage-Gated",D,D12.776.543.550.450.750.900,Potassium Channels,Ion Channels,1
"Potassium Channels, Voltage-Gated",D,D12.776.543.585.400.750.900,Potassium Channels,Ion Channels,1
"Potassium Channels, Voltage-Gated",D,D12.776.157.530.400.600.900,Potassium Channels,Ion Channels,1
Potassium Deficiency,C,C18.654.521.500.617,Deficiency Diseases,Malnutrition,1
Poxviridae,B,B04.280.650,DNA Viruses,Viruses,1
"Practice Patterns, Dentists'",N,N05.300.580,Delivery of Health Care,"Health Care Quality, Access, and Evaluation",1
"Practice Patterns, Dentists'",N,N04.590.374.505,Delivery of Health Care,Patient Care Management,1
Preanesthetic Medication,E,E03.806,Anesthesia and Analgesia,NULL,1
Preanesthetic Medication,E,E04.604.750.619,Preoperative Care,Perioperative Care,1
Preceptorship,I,I02.358.968,"Education, Professional",Education,1
Precipitating Factors,N,N05.715.350.200.650,Causality,Epidemiologic Factors,1
Precipitating Factors,N,N06.850.490.625.500,Causality,Epidemiologic Factors,1
Precipitins,D,D12.776.124.790.651.114.837,Antibodies,Immunoglobulins,1
Precipitins,D,D12.776.124.486.485.114.837,Antibodies,Immunoglobulins,1
Precipitins,D,D12.776.377.715.548.114.837,Antibodies,Immunoglobulins,1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,C,C04.557.337.428.600.600,Precursor Cell Lymphoblastic Leukemia-Lymphoma,"Leukemia, Lymphoid",1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,C,C20.683.515.528.600.600,Precursor Cell Lymphoblastic Leukemia-Lymphoma,"Leukemia, Lymphoid",1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,C,C15.604.515.560.600.600,Precursor Cell Lymphoblastic Leukemia-Lymphoma,"Leukemia, Lymphoid",1
"Precursor Cells, B-Lymphoid",A,A11.872.378.294.500,Lymphoid Progenitor Cells,Hematopoietic Stem Cells,1
"Precursor Cells, B-Lymphoid",A,A11.118.637.555.567.562.800,B-Lymphocytes,Lymphocytes,1
"Precursor Cells, B-Lymphoid",A,A11.148.378.294.374,Lymphoid Progenitor Cells,Hematopoietic Stem Cells,1
Preexisting Condition Coverage,N,N03.219.521.576.585.500,Insurance Selection Bias,Insurance,1
Preferred Provider Organizations,N,N03.219.521.576.343.800.750,Managed Care Programs,"Insurance, Health",1
Preferred Provider Organizations,N,N04.590.374.410.750,Managed Care Programs,Delivery of Health Care,1
Pregnancy Maintenance,G,G08.686.784.769.520,Pregnancy,Reproduction,1
Pregnancy Tests,E,E05.200.970,Clinical Laboratory Techniques,Investigative Techniques,1
Pregnancy Tests,E,E01.370.378.620,"Diagnostic Techniques, Obstetrical and Gynecological",Diagnostic Techniques and Procedures,1
Pregnancy Tests,E,E01.370.225.970,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,1
"Pregnancy, Prolonged",C,C13.703.805,Pregnancy Complications,Female Urogenital Diseases and Pregnancy Complications,1
"Pregnancy, Tubal",C,C13.703.733.703,"Pregnancy, Ectopic",Pregnancy Complications,1
Pregnancy-Associated Plasma Protein-A,D,D12.776.780.700,Pregnancy Proteins,Proteins,1
Pregnancy-Associated Plasma Protein-A,D,D08.811.277.656.675.374.632,Metalloendopeptidases,Metalloproteases,1
Pregnancy-Associated Plasma Protein-A,D,D08.811.277.656.300.480.632,Metalloendopeptidases,Endopeptidases,1
Pregnenediones,D,D04.210.500.745.745.654,Pregnenes,Pregnanes,1
Premature Ejaculation,C,C12.294.644.743,"Sexual Dysfunction, Physiological","Genital Diseases, Male",1
Premature Ejaculation,F,F03.835.700,"Sexual Dysfunctions, Psychological",Mental Disorders,1
Preprints as Topic,L,L01.737.736,Publishing,Information Science,1
Preprints as Topic,L,L01.178.682.733,Publications,Communications Media,1
Prescription Drug Diversion,I,I01.880.735.191.204,Crime,Social Problems,1
Prescription Drug Diversion,I,I01.198.240.609,Crime,Criminology,1
Priapism,C,C12.294.494.786,Penile Diseases,"Genital Diseases, Male",1
Primary Ovarian Insufficiency,C,C13.351.500.056.630.750,Ovarian Diseases,Adnexal Diseases,1
Primary Ovarian Insufficiency,C,C19.391.630.750,Ovarian Diseases,Gonadal Disorders,1
Pristinamycin,D,D04.345.566.802.374,Streptogramins,"Peptides, Cyclic",1
Pristinamycin,D,D12.644.641.802.374,Streptogramins,"Peptides, Cyclic",1
Proanthocyanidins,D,D05.750.078.937.429,Tannins,Biopolymers,1
Proanthocyanidins,D,D03.633.100.150.266.450.700,Flavonoids,Chromones,1
Proanthocyanidins,D,D03.383.663.283.266.450.700,Flavonoids,Chromones,1
Probability Theory,L,L01.906.394.622,Operations Research,Systems Analysis,1
Probenecid,D,D02.886.590.700.625,Sulfonamides,Sulfones,1
Probenecid,D,D02.065.884.625,Sulfonamides,Amides,1
Problem Behavior,F,F01.145.126.972,Behavioral Symptoms,Behavior,1
Problem Behavior,F,F01.145.179.750,Child Behavior,Behavior,1
Procalcitonin,D,D06.472.699.666,Peptide Hormones,Hormones,1
Procalcitonin,D,D12.644.548.744,Peptide Hormones,Peptides,1
Procalcitonin,D,D12.776.811.555,Protein Precursors,Proteins,1
Procollagen-Proline Dioxygenase,D,D08.811.682.690.708.694.750,Prolyl Hydroxylases,Mixed Function Oxygenases,1
Procollagen-Proline Dioxygenase,D,D08.811.682.690.416.617.750,Prolyl Hydroxylases,Dioxygenases,1
"Proctocolectomy, Restorative",E,E04.210.895.500,Proctectomy,Digestive System Surgical Procedures,1
"Proctocolectomy, Restorative",E,E04.210.219.620,Colectomy,Digestive System Surgical Procedures,1
Prodigiosin,D,D03.383.129.578.748,Pyrroles,Azoles,1
Prodigiosin,D,D23.767.778,"Pigments, Biological",Biological Factors,1
Professional Staff Committees,N,N05.700.685,"Quality Assurance, Health Care","Health Care Quality, Access, and Evaluation",1
Professional Staff Committees,N,N04.452.758.788,Professional Practice,Organization and Administration,1
Programmed Cell Death 1 Ligand 2 Protein,D,D23.529.168.800,B7 Antigens,Intercellular Signaling Peptides and Proteins,1
Programmed Cell Death 1 Ligand 2 Protein,D,D23.050.301.285.800,B7 Antigens,"Antigens, Surface",1
Programmed Cell Death 1 Ligand 2 Protein,D,D12.776.543.095.800,B7 Antigens,Membrane Proteins,1
Programmed Cell Death 1 Ligand 2 Protein,D,D12.776.467.150.800,B7 Antigens,Intercellular Signaling Peptides and Proteins,1
Programmed Cell Death 1 Ligand 2 Protein,D,D12.776.465.829,Immune Checkpoint Proteins,Proteins,1
Prolyl Oligopeptidases,D,D08.811.277.656.300.760.637,Serine Endopeptidases,Endopeptidases,1
Pronephros,A,A16.835,Embryonic Structures,NULL,1
Properdin,D,D12.776.377.715.182.624,Beta-Globulins,Serum Globulins,1
Properdin,D,D12.776.124.790.223.624,Beta-Globulins,Serum Globulins,1
Properdin,D,D12.776.124.486.274.965,Complement System Proteins,Immunoproteins,1
Propiolactone,D,D02.540.600,Lactones,Organic Chemicals,1
Propionates,D,D10.251.400.706,"Fatty Acids, Volatile",Fatty Acids,1
Propionates,D,D02.241.081.751,"Acids, Acyclic",Carboxylic Acids,1
Propionibacterium,B,B03.510.024.990.600,Propionibacteriaceae,Actinobacteria,1
Propionibacterium,B,B03.510.460.400.400.600.600,Propionibacteriaceae,"Gram-Positive Asporogenous Rods, Irregular",1
Propolis,D,D05.750.078.840.762,"Resins, Plant",Biopolymers,1
Propolis,D,D20.215.721.500.762,"Resins, Plant",Plant Exudates,1
Proprotein Convertases,D,D08.811.277.656.837,Peptide Hydrolases,Hydrolases,1
Propylene Glycol,D,D02.033.455.706.725,Propylene Glycols,Glycols,1
Propylene Glycols,D,D02.033.455.706,Glycols,Alcohols,1
Prospective Payment System,N,N03.219.521.710.305.200,Reimbursement Mechanisms,"Insurance, Health, Reimbursement",1
Prostaglandin D2,D,D10.251.355.255.550.200.200,Prostaglandins D,Prostaglandins,1
Prostaglandin D2,D,D23.469.050.175.725.200.200,Prostaglandins D,Prostaglandins,1
Prostaglandins E,D,D23.469.050.175.725.250,Prostaglandins,Eicosanoids,1
Prostaglandins E,D,D10.251.355.255.550.250,Prostaglandins,Eicosanoids,1
"Prostatic Neoplasms, Castration-Resistant",C,C12.758.409.750.500,Prostatic Neoplasms,"Genital Neoplasms, Male",1
"Prostatic Neoplasms, Castration-Resistant",C,C12.294.565.625.500,Prostatic Neoplasms,Prostatic Diseases,1
"Prostatic Neoplasms, Castration-Resistant",C,C12.294.260.750.500,Prostatic Neoplasms,"Genital Neoplasms, Male",1
"Prostatic Neoplasms, Castration-Resistant",C,C04.588.945.440.770.500,Prostatic Neoplasms,"Genital Neoplasms, Male",1
Prosthesis Coloring,E,E07.695.680.550,Prosthesis Design,Prostheses and Implants,1
Prosthesis Coloring,E,E05.320.550.550,Prosthesis Design,Equipment Design,1
Protein Aggregates,D,D05.875,Macromolecular Substances,NULL,1
Protein D-Aspartate-L-Isoaspartate Methyltransferase,D,D08.811.913.555.500.800.800.700,Protein O-Methyltransferase,Protein Methyltransferases,1
Protein Disulfide Reductase (Glutathione),D,D08.811.682.667.186,Oxidoreductases Acting on Sulfur Group Donors,Oxidoreductases,1
Protein Disulfide-Isomerases,D,D08.811.399.475.800.550,Sulfur-Sulfur Bond Isomerases,Intramolecular Oxidoreductases,1
Protein Kinase C beta,D,D08.811.913.696.620.682.700.725.049,Protein Kinase C,Protein-Serine-Threonine Kinases,1
Protein Kinase C-alpha,D,D08.811.913.696.620.682.700.725.100,Protein Kinase C,Protein-Serine-Threonine Kinases,1
Protein Translocation Systems,D,D05.500.890,Multiprotein Complexes,Macromolecular Substances,1
"Protein Tyrosine Phosphatase, Non-Receptor Type 11",D,D08.811.277.352.650.775.700.800,SH2 Domain-Containing Protein Tyrosine Phosphatases,Protein Tyrosine Phosphatases,1
"Protein Tyrosine Phosphatase, Non-Receptor Type 11",D,D08.811.277.352.650.775.300.800,"Protein Tyrosine Phosphatases, Non-Receptor",Protein Tyrosine Phosphatases,1
"Protein Tyrosine Phosphatase, Non-Receptor Type 11",D,D12.644.360.585.800,"Protein Tyrosine Phosphatases, Non-Receptor",Intracellular Signaling Peptides and Proteins,1
"Protein Tyrosine Phosphatase, Non-Receptor Type 11",D,D12.776.476.800.800,SH2 Domain-Containing Protein Tyrosine Phosphatases,Intracellular Signaling Peptides and Proteins,1
"Protein Tyrosine Phosphatase, Non-Receptor Type 11",D,D12.776.476.564.800,"Protein Tyrosine Phosphatases, Non-Receptor",Intracellular Signaling Peptides and Proteins,1
"Protein Tyrosine Phosphatase, Non-Receptor Type 6",D,D12.776.476.800.200,SH2 Domain-Containing Protein Tyrosine Phosphatases,Intracellular Signaling Peptides and Proteins,1
"Protein Tyrosine Phosphatase, Non-Receptor Type 6",D,D12.776.476.564.600,"Protein Tyrosine Phosphatases, Non-Receptor",Intracellular Signaling Peptides and Proteins,1
"Protein Tyrosine Phosphatase, Non-Receptor Type 6",D,D12.644.360.800.200,SH2 Domain-Containing Protein Tyrosine Phosphatases,Intracellular Signaling Peptides and Proteins,1
"Protein Tyrosine Phosphatase, Non-Receptor Type 6",D,D12.644.360.585.600,"Protein Tyrosine Phosphatases, Non-Receptor",Intracellular Signaling Peptides and Proteins,1
"Protein Tyrosine Phosphatase, Non-Receptor Type 6",D,D08.811.277.352.650.775.700.200,SH2 Domain-Containing Protein Tyrosine Phosphatases,Protein Tyrosine Phosphatases,1
"Protein Tyrosine Phosphatase, Non-Receptor Type 6",D,D08.811.277.352.650.775.300.600,"Protein Tyrosine Phosphatases, Non-Receptor",Protein Tyrosine Phosphatases,1
"Proteinase Inhibitory Proteins, Secretory",D,D12.644.822,Peptides,"Amino Acids, Peptides, and Proteins",1
"Proteinase Inhibitory Proteins, Secretory",D,D12.776.645,Proteins,"Amino Acids, Peptides, and Proteins",1
Proteobacteria,B,B03.660,Bacteria,NULL,1
Proteogenomics,H,H01.158.273.343.350.700.500,Proteomics,Genomics,1
Proteogenomics,H,H01.181.122.738.500,Proteomics,Biochemistry,1
Proteogenomics,H,H01.158.273.180.350.700.500,Proteomics,Genomics,1
Proteogenomics,H,H01.158.201.843.500,Proteomics,Biochemistry,1
Proton-Motive Force,G,G02.765,Chemical Phenomena,NULL,1
Proton-Motive Force,G,G03.295.770,Energy Metabolism,Metabolism,1
Proto-Oncogene Proteins c-abl,D,D12.776.624.664.700.167,Proto-Oncogene Proteins,Oncogene Proteins,1
Proto-Oncogene Proteins c-abl,D,D08.811.913.696.620.682.725.500,Protein-Tyrosine Kinases,Protein Kinases,1
Proto-Oncogene Proteins c-cbl,D,D08.811.464.938.750.374,Ubiquitin-Protein Ligases,Ubiquitin-Protein Ligase Complexes,1
Proto-Oncogene Proteins c-cbl,D,D12.776.624.664.700.172,Proto-Oncogene Proteins,Oncogene Proteins,1
Proto-Oncogene Proteins c-crk,D,D12.776.624.664.700.174,Proto-Oncogene Proteins,Oncogene Proteins,1
Proto-Oncogene Proteins c-crk,D,D12.776.476.024.404,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
Proto-Oncogene Proteins c-crk,D,D12.644.360.024.320,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
Proto-Oncogene Proteins c-crk,D,D12.776.157.057.139,"Adaptor Proteins, Signal Transducing",Carrier Proteins,1
Proto-Oncogene Proteins c-jun,D,D12.776.260.108.820,Basic-Leucine Zipper Transcription Factors,DNA-Binding Proteins,1
Proto-Oncogene Proteins c-jun,D,D12.776.624.664.700.182,Proto-Oncogene Proteins,Oncogene Proteins,1
Proto-Oncogene Proteins c-jun,D,D12.776.660.763,Nuclear Proteins,Proteins,1
Proto-Oncogene Proteins c-jun,D,D12.776.930.127.820,Basic-Leucine Zipper Transcription Factors,Transcription Factors,1
Proto-Oncogene Proteins c-maf,D,D12.776.930.127.500.061.750,"Maf Transcription Factors, Large",Maf Transcription Factors,1
Proto-Oncogene Proteins c-maf,D,D12.776.624.664.700.184,Proto-Oncogene Proteins,Oncogene Proteins,1
Proto-Oncogene Proteins c-maf,D,D12.776.260.108.500.061.750,"Maf Transcription Factors, Large",Maf Transcription Factors,1
Proto-Oncogene Proteins c-mdm2,D,D08.811.464.938.750.562,Ubiquitin-Protein Ligases,Ubiquitin-Protein Ligase Complexes,1
Proto-Oncogene Proteins c-mdm2,D,D12.776.624.664.700.185,Proto-Oncogene Proteins,Oncogene Proteins,1
Proto-Oncogene Proteins c-mdm2,D,D12.776.660.764,Nuclear Proteins,Proteins,1
Proto-Oncogene Proteins c-rel,D,D12.776.660.767,Nuclear Proteins,Proteins,1
Proto-Oncogene Proteins c-rel,D,D12.776.624.664.700.192,Proto-Oncogene Proteins,Oncogene Proteins,1
Proto-Oncogene Proteins c-rel,D,D12.776.930.730,Transcription Factors,Proteins,1
Proto-Oncogene Proteins c-rel,D,D12.776.260.682,DNA-Binding Proteins,Proteins,1
Proto-Oncogene Proteins c-ret,D,D12.776.395.550.200.188.500,Cadherin Related Proteins,Cell Adhesion Molecules,1
Proto-Oncogene Proteins c-ret,D,D08.811.913.696.620.682.725.400.087,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,1
Proto-Oncogene Proteins c-ret,D,D12.776.624.664.700.194,Proto-Oncogene Proteins,Oncogene Proteins,1
Proto-Oncogene Proteins c-ret,D,D12.776.543.131.500,Cadherin Related Proteins,Membrane Proteins,1
Proto-Oncogene Proteins c-ret,D,D12.776.543.750.630.217,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",1
Proto-Oncogene Proteins c-vav,D,D12.776.476.325.300.099.750,Rho Guanine Nucleotide Exchange Factors,Guanine Nucleotide Exchange Factors,1
Proto-Oncogene Proteins c-vav,D,D12.776.476.024.407,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
Proto-Oncogene Proteins c-vav,D,D12.776.624.664.700.198,Proto-Oncogene Proteins,Oncogene Proteins,1
Proto-Oncogene Proteins c-vav,D,D12.644.360.024.321,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
Proto-Oncogene Proteins c-vav,D,D12.644.360.325.300.099.750,Rho Guanine Nucleotide Exchange Factors,Guanine Nucleotide Exchange Factors,1
Proto-Oncogene Proteins c-vav,D,D12.776.157.057.155,"Adaptor Proteins, Signal Transducing",Carrier Proteins,1
Proto-Oncogene Proteins pp60(c-src),D,D08.811.913.696.620.682.725.800.630,src-Family Kinases,Protein-Tyrosine Kinases,1
Proto-Oncogene Proteins pp60(c-src),D,D12.776.624.664.700.202,Proto-Oncogene Proteins,Oncogene Proteins,1
PrPC Proteins,D,D12.776.785.340.500,Prion Proteins,Prions,1
Prunus avium,B,B01.650.940.800.575.912.250.859.937.500.625.400,Prunus,Rosaceae,1
Pseudolymphoma,C,C15.604.613,Lymphatic Diseases,Hemic and Lymphatic Diseases,1
Pseudomonas Phages,B,B04.123.660,Bacteriophages,Viruses,1
Pseudomonas syringae,B,B03.660.250.580.590.770,Pseudomonas,Pseudomonadaceae,1
Pseudomonas syringae,B,B03.440.400.425.625.625.770,Pseudomonas,Pseudomonadaceae,1
Pseudoxanthoma Elasticum,C,C16.131.831.766,Skin Abnormalities,Congenital Abnormalities,1
Pseudoxanthoma Elasticum,C,C16.320.850.750,"Skin Diseases, Genetic","Genetic Diseases, Inborn",1
Pseudoxanthoma Elasticum,C,C17.800.827.750,"Skin Diseases, Genetic",Skin Diseases,1
Pseudoxanthoma Elasticum,C,C17.800.804.766,Skin Abnormalities,Skin Diseases,1
Pseudoxanthoma Elasticum,C,C17.300.766,Connective Tissue Diseases,Skin and Connective Tissue Diseases,1
Pseudoxanthoma Elasticum,C,C15.378.463.515.530,Hemostatic Disorders,Hemorrhagic Disorders,1
Pseudoxanthoma Elasticum,C,C14.907.454.530,Hemostatic Disorders,Vascular Diseases,1
Psychiatric Rehabilitation,H,H02.403.680.600.875,Rehabilitation,Physical and Rehabilitation Medicine,1
Psychiatric Rehabilitation,N,N02.421.784.578,Rehabilitation,Health Services,1
Psychoacoustics,F,F04.096.753.628,Psychophysics,Behavioral Sciences,1
Psychoacoustics,E,E01.370.382.375.060.530,Audiometry,Hearing Tests,1
Psychoacoustics,E,E01.370.685.628,Psychophysics,Diagnostic Techniques and Procedures,1
"Psychology, Clinical",F,F04.096.628.579,Psychology,Behavioral Sciences,1
"Psychology, Educational",F,F04.096.628.679,Psychology,Behavioral Sciences,1
"Psychology, Educational",F,F02.784.629,"Psychology, Applied",Psychological Phenomena,1
Psychophysiology,F,F02.830,Psychological Phenomena,NULL,1
Psychophysiology,F,F04.096.795,Behavioral Sciences,Behavioral Disciplines and Activities,1
Psychophysiology,H,H01.158.782.795,Physiology,Biological Science Disciplines,1
Psychophysiology,E,E02.190.525.812,Mind-Body Therapies,Complementary Therapies,1
Psychosexual Development,F,F02.739.794.793,Psychoanalytic Theory,Psychological Theory,1
Psychosexual Development,F,F01.752.747.722,Personality Development,Personality,1
Psychotherapists,M,M01.526.485.858,Health Personnel,Occupational Groups,1
Pteroylpolyglutamic Acids,D,D03.633.100.733.631.400.600,Folic Acid,Pterins,1
"Puberty, Delayed",C,C19.391.690,Gonadal Disorders,Endocrine System Diseases,1
Public Health Dentistry,H,H02.163.876.770,"Specialties, Dental",Dentistry,1
Public Health Dentistry,N,N06.890,Environment and Public Health,NULL,1
Public Health Systems Research,H,H01.770.644.608,Research,Science,1
Public Health Systems Research,N,N05.632,"Health Care Quality, Access, and Evaluation",NULL,1
Pulmonary Arterial Hypertension,C,C08.381.423.847,"Hypertension, Pulmonary",Lung Diseases,1
Pulmonary Atelectasis,C,C08.381.730,Lung Diseases,Respiratory Tract Diseases,1
Pulmonary Atresia,C,C14.240.850.937,Vascular Malformations,Cardiovascular Abnormalities,1
Pulmonary Atresia,C,C14.280.484.640,Heart Valve Diseases,Heart Diseases,1
Pulmonary Atresia,C,C16.131.240.850.906,Vascular Malformations,Cardiovascular Abnormalities,1
Pulmonary Surfactant-Associated Protein D,D,D12.776.823.249,Pulmonary Surfactant-Associated Proteins,Proteins,1
Pulmonary Surfactant-Associated Protein D,D,D12.776.503.280.249.625,Collectins,"Lectins, C-Type",1
Pulmonary Surgical Procedures,E,E04.928.600,Thoracic Surgical Procedures,"Surgical Procedures, Operative",1
Pulmonary Veins,A,A07.015.908.713,Veins,Blood Vessels,1
Pulmonary Wedge Pressure,G,G09.330.380.076.695,Blood Pressure,Hemodynamics,1
Pulpotomy,E,E06.397.695,Endodontics,Dentistry,1
"Pulse Therapy, Drug",E,E02.319.283.600,Drug Administration Schedule,Drug Therapy,1
Punctures,E,E04.665,"Surgical Procedures, Operative",NULL,1
Punctures,E,E02.800,Therapeutics,NULL,1
Purine Nucleosides,D,D13.570.583,Nucleosides,"Nucleic Acids, Nucleotides, and Nucleosides",1
Purine Nucleosides,D,D03.633.100.759.590,Purines,"Heterocyclic Compounds, 2-Ring",1
Purinergic P2 Receptor Agonists,D,D27.505.519.625.725.200.200,Purinergic Agonists,Purinergic Agents,1
Purinergic P2 Receptor Agonists,D,D27.505.696.577.725.200.200,Purinergic Agonists,Purinergic Agents,1
Purinones,D,D03.633.100.759.758,Purines,"Heterocyclic Compounds, 2-Ring",1
"Purpura, Thrombocytopenic",C,C15.378.100.802.687,Purpura,Blood Coagulation Disorders,1
"Purpura, Thrombocytopenic",C,C15.378.140.855.925.750,Thrombotic Microangiopathies,Thrombocytopenia,1
"Purpura, Thrombocytopenic",C,C23.550.414.950.687,Purpura,Hemorrhage,1
"Purpura, Thrombocytopenic",C,C20.841,Immune System Diseases,NULL,1
"Purpura, Thrombocytopenic",C,C23.888.885.687.687,Purpura,Skin Manifestations,1
"Purpura, Thrombotic Thrombocytopenic",C,C23.888.885.687.687.680,"Purpura, Thrombocytopenic",Purpura,1
"Purpura, Thrombotic Thrombocytopenic",C,C23.550.414.950.687.680,"Purpura, Thrombocytopenic",Purpura,1
"Purpura, Thrombotic Thrombocytopenic",C,C15.378.140.855.925.750.680,"Purpura, Thrombocytopenic",Thrombotic Microangiopathies,1
"Purpura, Thrombotic Thrombocytopenic",C,C15.378.100.802.687.680,"Purpura, Thrombocytopenic",Purpura,1
"Purpura, Thrombotic Thrombocytopenic",C,C15.378.925.850,Thrombophilia,Hematologic Diseases,1
Puumala virus,B,B04.820.480.750.440.600,Hantavirus,Bunyaviridae,1
Pyloric Antrum,A,A03.556.875.875.716,Stomach,Upper Gastrointestinal Tract,1
"Pyloric Stenosis, Hypertrophic",C,C06.405.748.340.690.500,Pyloric Stenosis,Gastric Outlet Obstruction,1
Pyrans,D,D03.383.663,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,1
Pyridinium Compounds,D,D03.383.725.762,Pyridines,"Heterocyclic Compounds, 1-Ring",1
Pyridinolcarbamate,D,D02.241.081.251.583.799,Phenylcarbamates,Carbamates,1
Pyridoxic Acid,D,D03.383.725.705.645,Picolinic Acids,Pyridines,1
Pyridoxic Acid,D,D03.383.725.394.700,Isonicotinic Acids,Pyridines,1
Pyridoxic Acid,D,D03.066.349.600,Isonicotinic Acids,"Acids, Heterocyclic",1
Pyriform Sinus,A,A04.623.490.600,Hypopharynx,Pharynx,1
Pyrogens,D,D27.888.569.673,Noxae,Toxic Actions,1
Pyrones,D,D03.383.663.718,Pyrans,"Heterocyclic Compounds, 1-Ring",1
Pyrrolidines,D,D03.383.773,"Heterocyclic Compounds, 1-Ring",Heterocyclic Compounds,1
Pyruvate Dehydrogenase (Lipoamide)-Phosphatase,D,D08.811.277.352.650.625.725,Phosphoprotein Phosphatases,Phosphoric Monoester Hydrolases,1
Pyruvate Kinase,D,D08.811.913.696.620.695,Phosphotransferases (Alcohol Group Acceptor),Phosphotransferases,1
Q-SNARE Proteins,D,D12.776.543.990.775.500,SNARE Proteins,Vesicular Transport Proteins,1
Q-SNARE Proteins,D,D12.776.543.512.249.500,SNARE Proteins,Membrane Fusion Proteins,1
Quadriceps Muscle,A,A02.633.567.850,"Muscle, Skeletal",Muscles,1
Quadriplegia,C,C23.888.592.636.786,Paralysis,Neurologic Manifestations,1
Quadriplegia,C,C10.597.622.760,Paralysis,Neurologic Manifestations,1
Quantum Dots,E,E07.705,Equipment and Supplies,NULL,1
Quantum Dots,J,J01.637.512.600.650,Nanoparticles,Nanostructures,1
Quantum Theory,H,H01.671.579.800,Nuclear Physics,Physics,1
Quasispecies,G,G05.365.897,Genetic Variation,Genetic Phenomena,1
Quassins,D,D02.455.849.919.570,Triterpenes,Terpenes,1
Quinapril,D,D03.633.100.531.820.250,Tetrahydroisoquinolines,Isoquinolines,1
Quinic Acid,D,D02.241.223.268.637,Cyclohexanecarboxylic Acids,"Acids, Carbocyclic",1
Quinic Acid,D,D02.241.511.764,Hydroxy Acids,Carboxylic Acids,1
Quinolizidines,D,D03.633.100.834.737,Quinolizines,"Heterocyclic Compounds, 2-Ring",1
Quinpirole,D,D03.633.100.810.842,Quinolines,"Heterocyclic Compounds, 2-Ring",1
Quinpirole,D,D03.633.300.802,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",1
Quisqualic Acid,D,D03.383.129.462.580.600,Oxadiazoles,Oxazoles,1
Quisqualic Acid,D,D12.125.755,Amino Acids,"Amino Acids, Peptides, and Proteins",1
rab27 GTP-Binding Proteins,D,D12.644.360.525.400.075,rab GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rab27 GTP-Binding Proteins,D,D12.776.157.325.515.400.075,rab GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rab27 GTP-Binding Proteins,D,D08.811.277.040.330.300.400.400.075,rab GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rab27 GTP-Binding Proteins,D,D12.776.476.525.400.075,rab GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rab3 GTP-Binding Proteins,D,D12.776.476.525.400.100,rab GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rab3 GTP-Binding Proteins,D,D08.811.277.040.330.300.400.400.100,rab GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rab3 GTP-Binding Proteins,D,D12.776.157.325.515.400.100,rab GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rab3 GTP-Binding Proteins,D,D12.644.360.525.400.100,rab GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rac GTP-Binding Proteins,D,D12.644.360.525.700.100,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rac GTP-Binding Proteins,D,D12.776.157.325.515.700.100,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rac GTP-Binding Proteins,D,D08.811.277.040.330.300.400.700.100,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rac GTP-Binding Proteins,D,D12.776.476.525.700.100,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
Raccoons,B,B01.050.150.900.649.313.750.250.623.700,Procyonidae,Caniformia,1
Radiation Chimera,B,B05.200.750.760,Transplantation Chimera,Chimera,1
Radiation Chimera,G,G12.470.500,Immunocompromised Host,Immune System Phenomena,1
Radiation Genetics,H,H01.158.273.343.800,Genetics,Biology,1
Radiation Genetics,N,N06.850.810.335,Radiologic Health,Public Health,1
Radiation Tolerance,G,G04.712,Cell Physiological Phenomena,NULL,1
Radiation Tolerance,G,G07.738,Physiological Phenomena,NULL,1
Radiation-Sensitizing Agents,D,D27.505.954.600,Therapeutic Uses,Pharmacologic Actions,1
Radiculopathy,C,C10.668.829.820,Peripheral Nervous System Diseases,Neuromuscular Diseases,1
Radio Frequency Identification Device,E,E07.715,Equipment and Supplies,NULL,1
Radio Frequency Identification Device,N,N04.452.653.500,Patient Identification Systems,Organization and Administration,1
Radioactive Fallout,N,N06.850.810.460,Radiologic Health,Public Health,1
Radioactive Fallout,D,D20.693.555,Radioactive Pollutants,Complex Mixtures,1
Radioallergosorbent Test,E,E01.370.225.812.735.830,Serologic Tests,Immunologic Tests,1
Radioallergosorbent Test,E,E05.478.566.380.810,Immunosorbent Techniques,Immunoassay,1
Radioallergosorbent Test,E,E05.478.594.760.830,Serologic Tests,Immunologic Tests,1
Radioallergosorbent Test,E,E05.478.566.639.810,Radioimmunoassay,Immunoassay,1
Radioallergosorbent Test,E,E05.601.470.639.810,Radioimmunoassay,Immunoassay,1
Radioallergosorbent Test,E,E05.601.470.380.810,Immunosorbent Techniques,Immunoassay,1
Radioallergosorbent Test,E,E05.200.812.735.830,Serologic Tests,Immunologic Tests,1
Radiochemistry,H,H01.181.529.776,"Chemistry, Physical",Chemistry,1
Radiofrequency Ablation,E,E02.808.750,Radiofrequency Therapy,Therapeutics,1
Radiofrequency Ablation,E,E04.014.760,Ablation Techniques,"Surgical Procedures, Operative",1
"Radiography, Interventional",E,E04.502.780,Minimally Invasive Surgical Procedures,"Surgical Procedures, Operative",1
"Radiography, Interventional",E,E01.370.350.700.725,Radiography,Diagnostic Imaging,1
Radioimmunotherapy,E,E02.095.465.425.750,Immunotherapy,Immunomodulation,1
Radioimmunotherapy,E,E02.186.750,Combined Modality Therapy,Therapeutics,1
Radioimmunotherapy,E,E02.815.520,Radiotherapy,Therapeutics,1
Radioisotope Dilution Technique,E,E05.484.650,Indicator Dilution Techniques,Investigative Techniques,1
Radioisotope Dilution Technique,E,E01.370.384.710,"Diagnostic Techniques, Radioisotope",Diagnostic Techniques and Procedures,1
Radioligand Assay,E,E01.370.384.720,"Diagnostic Techniques, Radioisotope",Diagnostic Techniques and Procedures,1
Radioligand Assay,E,E01.370.225.985,Clinical Laboratory Techniques,Diagnostic Techniques and Procedures,1
Radioligand Assay,E,E01.370.374.650,"Diagnostic Techniques, Endocrine",Diagnostic Techniques and Procedures,1
Radioligand Assay,E,E05.200.985,Clinical Laboratory Techniques,Investigative Techniques,1
Radionuclide Ventriculography,E,E01.370.370.380.710,Heart Function Tests,"Diagnostic Techniques, Cardiovascular",1
Radionuclide Ventriculography,E,E01.370.370.050.650.650,Radionuclide Angiography,Angiography,1
Radionuclide Ventriculography,E,E01.370.350.710.715.710,Radionuclide Angiography,Radionuclide Imaging,1
Radionuclide Ventriculography,E,E01.370.350.130.937,Cardiac Imaging Techniques,Diagnostic Imaging,1
Radionuclide Ventriculography,E,E01.370.384.730.715.710,Radionuclide Angiography,Radionuclide Imaging,1
Radius Fractures,C,C26.404.562,"Fractures, Bone",Wounds and Injuries,1
Radius Fractures,C,C26.088.268.556,Forearm Injuries,Arm Injuries,1
Raloxifene Hydrochloride,D,D02.455.426.559.389.150.700.900.775,Tamoxifen,Stilbenes,1
Ralstonia,B,B03.660.075.090.688.600,Burkholderiaceae,Burkholderiales,1
Rapeseed Oil,D,D20.215.784.750.066,Plant Oils,Plant Preparations,1
Rapeseed Oil,D,D10.627.700.066,Plant Oils,Oils,1
ras GTPase-Activating Proteins,D,D12.644.360.325.150.500,GTPase-Activating Proteins,GTP-Binding Protein Regulators,1
ras GTPase-Activating Proteins,D,D12.776.476.325.150.500,GTPase-Activating Proteins,GTP-Binding Protein Regulators,1
Ras Homolog Enriched in Brain Protein,D,D12.776.476.525.488,Monomeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,1
Ras Homolog Enriched in Brain Protein,D,D12.776.631.650.665,Neuropeptides,Nerve Tissue Proteins,1
Ras Homolog Enriched in Brain Protein,D,D12.644.360.525.488,Monomeric GTP-Binding Proteins,Intracellular Signaling Peptides and Proteins,1
Ras Homolog Enriched in Brain Protein,D,D12.776.157.325.515.488,Monomeric GTP-Binding Proteins,GTP-Binding Proteins,1
Ras Homolog Enriched in Brain Protein,D,D08.811.277.040.330.300.400.488,Monomeric GTP-Binding Proteins,GTP-Binding Proteins,1
Rate Setting and Review,N,N03.219.463.060.800,Budgets,Financial Management,1
Rate Setting and Review,N,N03.219.442.800,Fees and Charges,Economics,1
"Rats, Inbred BN",B,B01.050.050.199.520.760.110,"Rats, Inbred Strains","Animals, Inbred Strains",1
"Rats, Inbred BN",B,B01.050.150.900.649.313.992.635.505.700.400.110,"Rats, Inbred Strains",Rats,1
Rauscher Virus,B,B04.820.650.375.525.770,"Leukemia Virus, Murine",Gammaretrovirus,1
Rauscher Virus,B,B04.613.807.375.525.770,"Leukemia Virus, Murine",Gammaretrovirus,1
RAW 264.7 Cells,A,A11.251.210.172.875,"Cell Line, Transformed",Cell Line,1
RAW 264.7 Cells,A,A11.733.397.815,Macrophages,Phagocytes,1
Reactive Attachment Disorder,F,F03.625.937,Neurodevelopmental Disorders,Mental Disorders,1
Reactive Nitrogen Species,D,D01.625.700,Nitrogen Compounds,Inorganic Chemicals,1
Reactive Nitrogen Species,D,D02.654.846,Nitroso Compounds,Organic Chemicals,1
"Receptor, Adenosine A1",D,D12.776.543.750.695.700.700.100,"Receptors, Purinergic P1","Receptors, Purinergic",1
"Receptor, Adenosine A1",D,D12.776.543.750.720.700.700.100,"Receptors, Purinergic P1","Receptors, Purinergic",1
"Receptor, Adenosine A2A",D,D12.776.543.750.720.700.700.200.100,"Receptors, Adenosine A2","Receptors, Purinergic P1",1
"Receptor, Adenosine A2A",D,D12.776.543.750.695.700.700.200.100,"Receptors, Adenosine A2","Receptors, Purinergic P1",1
"Receptor, Adenosine A3",D,D12.776.543.750.695.700.700.300,"Receptors, Purinergic P1","Receptors, Purinergic",1
"Receptor, Adenosine A3",D,D12.776.543.750.720.700.700.300,"Receptors, Purinergic P1","Receptors, Purinergic",1
"Receptor, Angiotensin, Type 1",D,D12.776.543.750.750.130.750,"Receptors, Angiotensin","Receptors, Peptide",1
"Receptor, Angiotensin, Type 1",D,D12.776.543.750.695.047.625,"Receptors, Angiotensin","Receptors, G-Protein-Coupled",1
"Receptor, EphA2",D,D12.776.543.750.630.500.100,"Receptors, Eph Family",Receptor Protein-Tyrosine Kinases,1
"Receptor, EphA2",D,D08.811.913.696.620.682.725.400.850.100,"Receptors, Eph Family",Receptor Protein-Tyrosine Kinases,1
"Receptor, Fibroblast Growth Factor, Type 1",D,D08.811.913.696.620.682.725.400.177,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,1
"Receptor, Fibroblast Growth Factor, Type 1",D,D12.776.543.750.630.440,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",1
"Receptor, Fibroblast Growth Factor, Type 1",D,D12.776.543.750.750.400.370.500,"Receptors, Fibroblast Growth Factor","Receptors, Growth Factor",1
"Receptor, Fibroblast Growth Factor, Type 3",D,D12.776.543.750.750.400.370.875,"Receptors, Fibroblast Growth Factor","Receptors, Growth Factor",1
"Receptor, Fibroblast Growth Factor, Type 3",D,D12.776.543.750.630.442,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",1
"Receptor, Fibroblast Growth Factor, Type 3",D,D12.776.624.664.700.792,Proto-Oncogene Proteins,Oncogene Proteins,1
"Receptor, Fibroblast Growth Factor, Type 3",D,D08.811.913.696.620.682.725.400.179,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,1
"Receptor, Fibroblast Growth Factor, Type 5",D,D12.776.543.750.750.400.370.968,"Receptors, Fibroblast Growth Factor","Receptors, Growth Factor",1
"Receptor, IGF Type 1",D,D12.776.543.750.750.400.780.400,"Receptors, Somatomedin","Receptors, Growth Factor",1
"Receptor, IGF Type 1",D,D12.776.543.750.630.468,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",1
"Receptor, IGF Type 1",D,D08.811.913.696.620.682.725.400.185,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,1
"Receptor, Melanocortin, Type 3",D,D12.776.543.750.695.430.875,"Receptors, Melanocortin","Receptors, G-Protein-Coupled",1
"Receptor, Melanocortin, Type 3",D,D12.776.543.750.750.555.285.500.875,"Receptors, Melanocortin","Receptors, Corticotropin",1
"Receptor, Melanocortin, Type 3",D,D12.776.543.750.750.660.285.500.875,"Receptors, Melanocortin","Receptors, Corticotropin",1
"Receptor, Melanocortin, Type 3",D,D12.776.543.750.720.600.285.500.875,"Receptors, Melanocortin","Receptors, Corticotropin",1
"Receptor, Melatonin, MT1",D,D12.776.543.750.695.440.500,"Receptors, Melatonin","Receptors, G-Protein-Coupled",1
"Receptor, Melatonin, MT2",D,D12.776.543.750.695.440.750,"Receptors, Melatonin","Receptors, G-Protein-Coupled",1
"Receptor, Parathyroid Hormone, Type 1",D,D12.776.543.750.695.650.100,"Receptors, Parathyroid Hormone","Receptors, G-Protein-Coupled",1
"Receptor, Parathyroid Hormone, Type 1",D,D12.776.543.750.750.600.100,"Receptors, Parathyroid Hormone","Receptors, Peptide",1
"Receptor, Parathyroid Hormone, Type 2",D,D12.776.543.750.750.600.200,"Receptors, Parathyroid Hormone","Receptors, Peptide",1
"Receptor, Parathyroid Hormone, Type 2",D,D12.776.543.750.695.650.200,"Receptors, Parathyroid Hormone","Receptors, G-Protein-Coupled",1
"Receptor, TIE-2",D,D12.776.543.750.630.687.500,"Receptors, TIE",Receptor Protein-Tyrosine Kinases,1
"Receptor, TIE-2",D,D08.811.913.696.620.682.725.400.925.500,"Receptors, TIE",Receptor Protein-Tyrosine Kinases,1
"Receptor, trkA",D,D08.811.913.696.620.682.725.400.660,Receptor Protein-Tyrosine Kinases,Protein-Tyrosine Kinases,1
"Receptor, trkA",D,D12.776.543.750.630.496,Receptor Protein-Tyrosine Kinases,"Receptors, Cell Surface",1
"Receptor, trkA",D,D12.776.543.750.750.400.550.550,"Receptors, Nerve Growth Factor","Receptors, Growth Factor",1
"Receptor-CD3 Complex, Antigen, T-Cell",D,D12.776.543.750.705.816.824.800,"Receptors, Antigen, T-Cell","Receptors, Antigen",1
"Receptor-CD3 Complex, Antigen, T-Cell",D,D23.050.301.264.894.095.800,CD3 Complex,"Antigens, Differentiation, T-Lymphocyte",1
"Receptor-CD3 Complex, Antigen, T-Cell",D,D23.101.100.894.095.800,CD3 Complex,"Antigens, Differentiation, T-Lymphocyte",1
Receptor-Interacting Protein Serine-Threonine Kinases,D,D12.776.476.024.320.662,Death Domain Receptor Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Receptor-Interacting Protein Serine-Threonine Kinases,D,D12.776.476.024.500.186,Tumor Necrosis Factor Receptor-Associated Peptides and Proteins,"Adaptor Proteins, Signal Transducing",1
Receptor-Interacting Protein Serine-Threonine Kinases,D,D12.776.476.075.421.400,Death Domain Receptor Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,1
Receptor-Interacting Protein Serine-Threonine Kinases,D,D08.811.913.696.620.682.700.801,Protein-Serine-Threonine Kinases,Protein Kinases,1
Receptor-Interacting Protein Serine-Threonine Kinases,D,D12.644.360.024.500.186,Tumor Necrosis Factor Receptor-Associated Peptides and Proteins,"Adaptor Proteins, Signal Transducing",1
Receptor-Interacting Protein Serine-Threonine Kinases,D,D12.644.360.075.421.400,Death Domain Receptor Signaling Adaptor Proteins,Apoptosis Regulatory Proteins,1
Receptor-Interacting Protein Serine-Threonine Kinases,D,D12.644.360.024.285.400,Death Domain Receptor Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Receptor-Interacting Protein Serine-Threonine Kinases,D,D12.776.157.057.018.400,Death Domain Receptor Signaling Adaptor Proteins,"Adaptor Proteins, Signal Transducing",1
Receptor-Interacting Protein Serine-Threonine Kinases,D,D12.776.157.057.500.186,Tumor Necrosis Factor Receptor-Associated Peptides and Proteins,"Adaptor Proteins, Signal Transducing",1
"Receptor-Like Protein Tyrosine Phosphatases, Class 2",D,D12.644.360.587.200,Receptor-Like Protein Tyrosine Phosphatases,Intracellular Signaling Peptides and Proteins,1
"Receptor-Like Protein Tyrosine Phosphatases, Class 2",D,D08.811.277.352.650.775.400.200,Receptor-Like Protein Tyrosine Phosphatases,Protein Tyrosine Phosphatases,1
"Receptor-Like Protein Tyrosine Phosphatases, Class 2",D,D12.776.476.592.200,Receptor-Like Protein Tyrosine Phosphatases,Intracellular Signaling Peptides and Proteins,1
"Receptors, Adrenergic, alpha-2",D,D12.776.543.750.720.330.300.300.200,"Receptors, Adrenergic, alpha","Receptors, Adrenergic",1
"Receptors, Adrenergic, alpha-2",D,D12.776.543.750.670.300.300.300.200,"Receptors, Adrenergic, alpha","Receptors, Adrenergic",1
"Receptors, Adrenergic, alpha-2",D,D12.776.543.750.695.150.300.300.725,"Receptors, Adrenergic, alpha","Receptors, Adrenergic",1
"Receptors, Adrenergic, beta",D,D12.776.543.750.695.150.300.340,"Receptors, Adrenergic","Receptors, Catecholamine",1
"Receptors, Adrenergic, beta",D,D12.776.543.750.670.300.300.340,"Receptors, Adrenergic","Receptors, Catecholamine",1
"Receptors, Adrenergic, beta",D,D12.776.543.750.720.330.300.340,"Receptors, Adrenergic","Receptors, Catecholamine",1
"Receptors, CCR",D,D12.776.543.750.705.852.125.150,"Receptors, Chemokine","Receptors, Cytokine",1
"Receptors, CCR",D,D12.776.543.750.695.160.150,"Receptors, Chemokine","Receptors, G-Protein-Coupled",1
"Receptors, Cholinergic",D,D12.776.543.750.720.360,"Receptors, Neurotransmitter","Receptors, Cell Surface",1
"Receptors, Collagen",D,D12.776.543.750.685,"Receptors, Cell Surface",Membrane Proteins,1
"Receptors, Complement",D,D12.776.543.750.705.833,"Receptors, Immunologic","Receptors, Cell Surface",1
"Receptors, Complement 3d",D,D12.776.543.750.705.833.610,"Receptors, Complement","Receptors, Immunologic",1
"Receptors, Complement 3d",D,D12.776.543.750.830.250,"Receptors, Virus","Receptors, Cell Surface",1
"Receptors, Corticotropin",D,D12.776.543.750.750.660.285,"Receptors, Pituitary Hormone","Receptors, Peptide",1
"Receptors, Corticotropin",D,D12.776.543.750.750.555.285,"Receptors, Neuropeptide","Receptors, Peptide",1
"Receptors, Corticotropin",D,D12.776.543.750.720.600.285,"Receptors, Neuropeptide","Receptors, Neurotransmitter",1
"Receptors, CXCR5",D,D12.776.543.750.705.852.125.500.500,"Receptors, CXCR","Receptors, Chemokine",1
"Receptors, CXCR5",D,D12.776.543.750.695.160.500.500,"Receptors, CXCR","Receptors, Chemokine",1
"Receptors, Dopamine",D,D12.776.543.750.695.150.400,"Receptors, Catecholamine","Receptors, G-Protein-Coupled",1
"Receptors, Dopamine",D,D12.776.543.750.670.300.400,"Receptors, Catecholamine","Receptors, Biogenic Amine",1
"Receptors, Dopamine",D,D12.776.543.750.720.330.400,"Receptors, Catecholamine","Receptors, Neurotransmitter",1
"Receptors, Dopamine D3",D,D12.776.543.750.720.330.400.500.249,"Receptors, Dopamine D2","Receptors, Dopamine",1
"Receptors, Dopamine D3",D,D12.776.543.750.670.300.400.500.249,"Receptors, Dopamine D2","Receptors, Dopamine",1
"Receptors, Dopamine D3",D,D12.776.543.750.695.150.400.500.500,"Receptors, Dopamine D2","Receptors, Dopamine",1
"Receptors, Drug",D,D12.776.827,Proteins,"Amino Acids, Peptides, and Proteins",1
"Receptors, Endothelin",D,D12.776.543.750.695.220,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",1
"Receptors, Endothelin",D,D12.776.543.750.750.320,"Receptors, Peptide","Receptors, Cell Surface",1
"Receptors, GABA-A",D,D12.776.543.750.720.200.300.300,"Receptors, GABA","Receptors, Amino Acid",1
"Receptors, GABA-A",D,D12.776.543.750.130.500,Cysteine Loop Ligand-Gated Ion Channel Receptors,"Receptors, Cell Surface",1
"Receptors, GABA-A",D,D12.776.543.585.400.175.562,Chloride Channels,Ion Channels,1
"Receptors, GABA-A",D,D12.776.543.585.400.500.100.100,Cysteine Loop Ligand-Gated Ion Channel Receptors,Ligand-Gated Ion Channels,1
"Receptors, GABA-A",D,D12.776.543.550.450.500.100.100,Cysteine Loop Ligand-Gated Ion Channel Receptors,Ligand-Gated Ion Channels,1
"Receptors, GABA-A",D,D12.776.543.550.450.175.562,Chloride Channels,Ion Channels,1
"Receptors, GABA-A",D,D12.776.157.530.400.400.100.100,Cysteine Loop Ligand-Gated Ion Channel Receptors,Ligand-Gated Ion Channels,1
"Receptors, GABA-A",D,D12.776.157.530.400.175.562,Chloride Channels,Ion Channels,1
"Receptors, GABA-B",D,D12.776.543.750.695.300,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",1
"Receptors, GABA-B",D,D12.776.543.750.720.200.300.320,"Receptors, GABA","Receptors, Amino Acid",1
"Receptors, Ghrelin",D,D12.776.543.750.695.322,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",1
"Receptors, Interleukin-18",D,D12.776.543.750.705.852.420.830,"Receptors, Interleukin","Receptors, Cytokine",1
"Receptors, Interleukin-8A",D,D12.776.543.750.705.852.420.421.500,"Receptors, Interleukin-8","Receptors, Interleukin",1
"Receptors, Interleukin-8A",D,D12.776.543.750.705.852.125.500.750.500,"Receptors, Interleukin-8","Receptors, CXCR",1
"Receptors, Interleukin-8A",D,D12.776.543.750.695.160.500.750.500,"Receptors, Interleukin-8","Receptors, CXCR",1
"Receptors, KIR2DL2",D,D12.776.543.750.705.895.500.374,"Receptors, KIR","Receptors, Natural Killer Cell",1
"Receptors, KIR2DL3",D,D12.776.543.750.705.895.500.437,"Receptors, KIR","Receptors, Natural Killer Cell",1
"Receptors, KIR2DL5",D,D12.776.543.750.705.895.500.484,"Receptors, KIR","Receptors, Natural Killer Cell",1
"Receptors, KIR3DS1",D,D12.776.543.750.705.895.500.890,"Receptors, KIR","Receptors, Natural Killer Cell",1
"Receptors, Lipoprotein",D,D12.776.543.750.710,"Receptors, Cell Surface",Membrane Proteins,1
"Receptors, Melanocortin",D,D12.776.543.750.720.600.285.500,"Receptors, Corticotropin","Receptors, Neuropeptide",1
"Receptors, Melanocortin",D,D12.776.543.750.750.555.285.500,"Receptors, Corticotropin","Receptors, Neuropeptide",1
"Receptors, Melanocortin",D,D12.776.543.750.750.660.285.500,"Receptors, Corticotropin","Receptors, Pituitary Hormone",1
"Receptors, Melanocortin",D,D12.776.543.750.695.430,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",1
"Receptors, Mitogen",D,D12.776.543.750.705.880,"Receptors, Immunologic","Receptors, Cell Surface",1
"Receptors, Nerve Growth Factor",D,D12.776.543.750.750.400.550,"Receptors, Growth Factor","Receptors, Peptide",1
"Receptors, Neurokinin-1",D,D12.776.543.750.720.600.830.500,"Receptors, Tachykinin","Receptors, Neuropeptide",1
"Receptors, Neurokinin-1",D,D12.776.543.750.750.555.830.500,"Receptors, Tachykinin","Receptors, Neuropeptide",1
"Receptors, Neurokinin-1",D,D12.776.543.750.695.862.500,"Receptors, Tachykinin","Receptors, G-Protein-Coupled",1
"Receptors, Neuropeptide",D,D12.776.543.750.750.555,"Receptors, Peptide","Receptors, Cell Surface",1
"Receptors, Neuropeptide",D,D12.776.543.750.720.600,"Receptors, Neurotransmitter","Receptors, Cell Surface",1
"Receptors, Notch",D,D12.776.543.750.725,"Receptors, Cell Surface",Membrane Proteins,1
"Receptors, Notch",D,D12.776.930.770,Transcription Factors,Proteins,1
"Receptors, Odorant",D,D12.776.543.750.695.600,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",1
"Receptors, Opioid",D,D12.776.543.750.695.620,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",1
"Receptors, Opioid",D,D12.776.543.750.720.600.610,"Receptors, Neuropeptide","Receptors, Neurotransmitter",1
"Receptors, Opioid",D,D12.776.543.750.750.555.610,"Receptors, Neuropeptide","Receptors, Peptide",1
"Receptors, Parathyroid Hormone",D,D12.776.543.750.750.600,"Receptors, Peptide","Receptors, Cell Surface",1
"Receptors, Parathyroid Hormone",D,D12.776.543.750.695.650,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",1
"Receptors, Peptide",D,D12.776.543.750.750,"Receptors, Cell Surface",Membrane Proteins,1
"Receptors, Presynaptic",D,D12.776.543.750.720.670,"Receptors, Neurotransmitter","Receptors, Cell Surface",1
"Receptors, Prolactin",D,D12.776.543.750.720.600.710,"Receptors, Neuropeptide","Receptors, Neurotransmitter",1
"Receptors, Prolactin",D,D12.776.543.750.750.660.350.725,"Receptors, Gonadotropin","Receptors, Pituitary Hormone",1
"Receptors, Prolactin",D,D12.776.543.750.750.555.710,"Receptors, Neuropeptide","Receptors, Peptide",1
"Receptors, Prostaglandin E, EP4 Subtype",D,D12.776.543.750.695.200.700.600.400,"Receptors, Prostaglandin E","Receptors, Prostaglandin",1
"Receptors, Purinergic P2Y12",D,D12.776.543.750.695.700.720.500.300,"Receptors, Purinergic P2Y","Receptors, Purinergic P2",1
"Receptors, Purinergic P2Y12",D,D12.776.543.750.720.700.720.750.300,"Receptors, Purinergic P2Y","Receptors, Purinergic P2",1
"Receptors, Serotonin, 5-HT4",D,D12.776.543.750.720.850.400,"Receptors, Serotonin","Receptors, Neurotransmitter",1
"Receptors, Serotonin, 5-HT4",D,D12.776.543.750.695.800.400,"Receptors, Serotonin","Receptors, G-Protein-Coupled",1
"Receptors, Serotonin, 5-HT4",D,D12.776.543.750.670.800.400,"Receptors, Serotonin","Receptors, Biogenic Amine",1
"Receptors, Somatomedin",D,D12.776.543.750.750.400.780,"Receptors, Growth Factor","Receptors, Peptide",1
"Receptors, Somatostatin",D,D12.776.543.750.720.600.760,"Receptors, Neuropeptide","Receptors, Neurotransmitter",1
"Receptors, Somatostatin",D,D12.776.543.750.750.555.760,"Receptors, Neuropeptide","Receptors, Peptide",1
"Receptors, Somatostatin",D,D12.776.543.750.750.580.720,"Receptors, Pancreatic Hormone","Receptors, Peptide",1
"Receptors, Somatostatin",D,D12.776.543.750.750.700.800,"Receptors, Pituitary Hormone-Regulating Hormone","Receptors, Peptide",1
"Receptors, Somatostatin",D,D12.776.543.750.695.850,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",1
"Receptors, Steroid",D,D12.776.930.778,Transcription Factors,Proteins,1
"Receptors, Steroid",D,D12.776.826.750,"Receptors, Cytoplasmic and Nuclear",Proteins,1
"Receptors, Thrombopoietin",D,D12.776.543.750.705.852.610,"Receptors, Cytokine","Receptors, Immunologic",1
"Recruitment, Neurophysiological",G,G07.265.753.760,Neural Conduction,Electrophysiological Phenomena,1
"Recruitment, Neurophysiological",G,G11.561.601.760,Neural Conduction,Nervous System Physiological Phenomena,1
Rectal Fistula,C,C23.300.575.185.550.600,Intestinal Fistula,Digestive System Fistula,1
Rectal Fistula,C,C06.405.469.860.752,Rectal Diseases,Intestinal Diseases,1
Rectal Fistula,C,C06.405.469.471.600,Intestinal Fistula,Intestinal Diseases,1
Rectal Fistula,C,C06.267.550.600,Intestinal Fistula,Digestive System Fistula,1
Reduviidae,B,B01.050.500.131.617.412.420.700,Heteroptera,Hemiptera,1
"Reflex, Startle",E,E01.370.600.550.650.800,Reflex,Neurologic Examination,1
"Reflex, Startle",E,E01.370.376.550.650.800,Reflex,Neurologic Examination,1
"Reflex, Startle",G,G11.561.731.869,Reflex,Nervous System Physiological Phenomena,1
"Reflex, Startle",F,F02.830.702.807,Reflex,Psychophysiology,1
Refractive Surgical Procedures,E,E04.540.825,Ophthalmologic Surgical Procedures,"Surgical Procedures, Operative",1
Regenerative Medicine,H,H02.403.750,Medicine,Health Occupations,1
"Regression, Psychology",F,F01.393.784,Defense Mechanisms,Behavior and Behavior Mechanisms,1
"Regulatory Sequences, Ribonucleic Acid",G,G02.111.570.080.689.687,"Regulatory Sequences, Nucleic Acid",Base Sequence,1
"Regulatory Sequences, Ribonucleic Acid",G,G05.360.080.689.687,"Regulatory Sequences, Nucleic Acid",Base Sequence,1
"Regulatory Sequences, Ribonucleic Acid",D,D13.444.735.790.878.942,Untranslated Regions,"RNA, Untranslated",1
Reinforcement Schedule,F,F02.463.425.770.644,"Reinforcement, Psychology",Learning,1
Re-Irradiation,E,E02.815.791,Radiotherapy,Therapeutics,1
Re-Irradiation,E,E02.887.500,Retreatment,Therapeutics,1
"Rejection, Psychology",F,F01.145.813.565,Social Behavior,Behavior,1
Relative Value Scales,N,N03.219.521.710.305.500,Reimbursement Mechanisms,"Insurance, Health, Reimbursement",1
Relative Value Scales,N,N04.452.313.500,Fee Schedules,Organization and Administration,1
Relaxation Therapy,F,F04.754.137.750,Behavior Therapy,Psychotherapy,1
Relaxation Therapy,E,E02.190.525.875,Mind-Body Therapies,Complementary Therapies,1
Religious Personnel,M,M01.526.799,Occupational Groups,Persons,1
Remedial Teaching,I,I02.903.694,Teaching,Education,1
Remedial Teaching,F,F02.784.629.709,"Psychology, Educational","Psychology, Applied",1
Remifentanil,D,D03.383.621.828,Piperidines,"Heterocyclic Compounds, 1-Ring",1
Remifentanil,D,D02.241.081.751.756,Propionates,"Acids, Acyclic",1
Renibacterium,B,B03.510.400.500.750,Micrococcaceae,Gram-Positive Cocci,1
Renibacterium,B,B03.510.024.850.750,Micrococcaceae,Actinobacteria,1
Reperfusion,E,E05.680.730,Perfusion,Investigative Techniques,1
Reperfusion,E,E04.100.700,Cardiovascular Surgical Procedures,"Surgical Procedures, Operative",1
Replication Origin,G,G05.360.340.024.745.725,Replicon,Genome Components,1
Replication Origin,G,G05.360.340.024.220.760,"DNA, Intergenic",Genome Components,1
Research Embryo Creation,E,E05.313.750,Embryo Research,Investigative Techniques,1
Reserpine,D,D03.633.100.496.500.500.681.933.500,Yohimbine,Secologanin Tryptamine Alkaloids,1
Reserpine,D,D03.633.100.473.402.681.933.500,Yohimbine,Secologanin Tryptamine Alkaloids,1
Reserpine,D,D03.132.436.681.933.500,Yohimbine,Secologanin Tryptamine Alkaloids,1
Residential Treatment,F,F04.754.864.696,Socioenvironmental Therapy,Psychotherapy,1
Residual Volume,G,G09.772.850.390.820,Functional Residual Capacity,Total Lung Capacity,1
Residual Volume,E,E01.370.386.700.485.750.275.650,Functional Residual Capacity,Total Lung Capacity,1
"Resins, Plant",D,D20.215.721.500,Plant Exudates,Biological Products,1
"Resins, Plant",D,D05.750.078.840,Biopolymers,Polymers,1
Respiratory Care Units,N,N02.278.388.493.696,Intensive Care Units,Hospital Units,1
Respiratory Muscles,A,A02.633.567.900,"Muscle, Skeletal",Muscles,1
Respirovirus,B,B04.820.480.937.600.650.700,Paramyxovirinae,Paramyxoviridae,1
Response Evaluation Criteria in Solid Tumors,E,E01.789.800.379,Treatment Outcome,Prognosis,1
Response Evaluation Criteria in Solid Tumors,N,N04.761.559.590.800.569,Treatment Outcome,"Outcome Assessment, Health Care",1
Response Evaluation Criteria in Solid Tumors,N,N05.715.360.575.575.800.569,Treatment Outcome,"Outcome Assessment, Health Care",1
Reticulocyte Count,G,G09.188.105.330.725,Erythrocyte Count,Blood Cell Count,1
Reticulocyte Count,G,G04.140.107.330.725,Erythrocyte Count,Blood Cell Count,1
Reticulocyte Count,E,E05.242.195.107.330.725,Erythrocyte Count,Blood Cell Count,1
Reticulocyte Count,E,E05.200.625.107.330.725,Erythrocyte Count,Blood Cell Count,1
Reticulocyte Count,E,E05.200.500.195.107.330.725,Erythrocyte Count,Blood Cell Count,1
Reticulocyte Count,E,E01.370.225.625.107.330.725,Erythrocyte Count,Blood Cell Count,1
Reticulocyte Count,E,E01.370.225.500.195.107.330.725,Erythrocyte Count,Blood Cell Count,1
Retinal Artery,A,A07.015.611.647,Retinal Vessels,Blood Vessels,1
Retinal Artery,A,A07.015.114.765,Arteries,Blood Vessels,1
Retinal Dystrophies,C,C11.768.585.658,Retinal Degeneration,Retinal Diseases,1
Retinal Pigment Epithelium,A,A09.371.670.500,Pigment Epithelium of Eye,Eye,1
Retinal Pigment Epithelium,A,A09.371.729.887,Retina,Eye,1
Retinal Rod Photoreceptor Cells,A,A09.371.729.831.625.670.650,"Photoreceptor Cells, Vertebrate",Photoreceptor Cells,1
Retinal Rod Photoreceptor Cells,A,A08.675.650.850.625.670.650,"Photoreceptor Cells, Vertebrate",Photoreceptor Cells,1
Retinal Rod Photoreceptor Cells,A,A08.675.650.915.937.670.650,"Photoreceptor Cells, Vertebrate",Photoreceptor Cells,1
Retinal Rod Photoreceptor Cells,A,A08.800.950.937.670.650,"Photoreceptor Cells, Vertebrate",Photoreceptor Cells,1
Retinal Rod Photoreceptor Cells,A,A11.671.650.915.937.670.650,"Photoreceptor Cells, Vertebrate",Photoreceptor Cells,1
Retinal Rod Photoreceptor Cells,A,A11.671.650.850.625.670.650,"Photoreceptor Cells, Vertebrate",Photoreceptor Cells,1
Retinal Telangiectasis,C,C11.768.748,Retinal Diseases,Eye Diseases,1
Retinal Telangiectasis,C,C14.907.823.502,Telangiectasis,Vascular Diseases,1
Retinoblastoma-Binding Protein 1,D,D12.776.660.769.100,Retinoblastoma Binding Proteins,Nuclear Proteins,1
Retinoblastoma-Binding Protein 1,D,D12.776.476.024.420.100,Retinoblastoma Binding Proteins,"Adaptor Proteins, Signal Transducing",1
Retinoblastoma-Binding Protein 1,D,D12.776.157.057.158.100,Retinoblastoma Binding Proteins,"Adaptor Proteins, Signal Transducing",1
Retinoblastoma-Binding Protein 1,D,D12.644.360.024.328.100,Retinoblastoma Binding Proteins,"Adaptor Proteins, Signal Transducing",1
Retraction of Publication as Topic,L,L01.737.840,Publishing,Information Science,1
Retrograde Degeneration,C,C23.550.737.500,Nerve Degeneration,Pathologic Processes,1
Retropharyngeal Abscess,C,C08.730.561.625,Pharyngitis,Respiratory Tract Infections,1
Retropharyngeal Abscess,C,C09.775.649.625,Pharyngitis,Pharyngeal Diseases,1
Retropharyngeal Abscess,C,C01.748.561.625,Pharyngitis,Respiratory Tract Infections,1
Retropharyngeal Abscess,C,C01.830.025.780,Abscess,Suppuration,1
Retropharyngeal Abscess,C,C07.550.781.625,Pharyngitis,Pharyngeal Diseases,1
Retroviridae Proteins,D,D12.776.964.775,Viral Proteins,Proteins,1
"Retroviridae Proteins, Oncogenic",D,D12.776.964.700.750,"Oncogene Proteins, Viral",Viral Proteins,1
"Retroviridae Proteins, Oncogenic",D,D12.776.964.775.750,Retroviridae Proteins,Viral Proteins,1
"Retroviridae Proteins, Oncogenic",D,D12.776.624.664.520.750,"Oncogene Proteins, Viral",Oncogene Proteins,1
RGS Proteins,D,D12.776.476.325.150.750,GTPase-Activating Proteins,GTP-Binding Protein Regulators,1
RGS Proteins,D,D12.644.360.325.150.750,GTPase-Activating Proteins,GTP-Binding Protein Regulators,1
"Rhabdomyosarcoma, Embryonal",C,C04.557.450.590.550.660.675,Rhabdomyosarcoma,Myosarcoma,1
"Rhabdomyosarcoma, Embryonal",C,C04.557.450.795.550.660.675,Rhabdomyosarcoma,Myosarcoma,1
Rhabdoviridae Infections,C,C01.925.782.580.830,Mononegavirales Infections,RNA Virus Infections,1
Rhinomanometry,E,E01.370.386.740,"Diagnostic Techniques, Respiratory System",Diagnostic Techniques and Procedures,1
Rhinomanometry,E,E05.559.740,Manometry,Investigative Techniques,1
Rhinosporidiosis,C,C01.610.600.700,Mesomycetozoea Infections,Parasitic Diseases,1
Rhinosporidium,B,B01.500.700,Mesomycetozoea,Eukaryota,1
Rhipicephalus,B,B01.050.500.131.166.132.832.400.712,Ixodidae,Ticks,1
Rhizobiaceae,B,B03.440.400.425.700,Gram-Negative Aerobic Rods and Cocci,Gram-Negative Aerobic Bacteria,1
Rhizobiaceae,B,B03.660.050.662,Alphaproteobacteria,Proteobacteria,1
Rhizobium leguminosarum,B,B03.660.050.662.670.450,Rhizobium,Rhizobiaceae,1
Rhizobium leguminosarum,B,B03.585.900.450,Rhizobium,Nitrogen-Fixing Bacteria,1
Rhizobium leguminosarum,B,B03.440.400.425.700.800.450,Rhizobium,Rhizobiaceae,1
rho-Associated Kinases,D,D12.776.476.595,Intracellular Signaling Peptides and Proteins,Proteins,1
rho-Associated Kinases,D,D12.644.360.590,Intracellular Signaling Peptides and Proteins,Peptides,1
rho-Associated Kinases,D,D08.811.913.696.620.682.700.814,Protein-Serine-Threonine Kinases,Protein Kinases,1
rhoB GTP-Binding Protein,D,D12.644.360.525.700.300,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rhoB GTP-Binding Protein,D,D12.776.157.325.515.700.300,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rhoB GTP-Binding Protein,D,D08.811.277.040.330.300.400.700.300,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
rhoB GTP-Binding Protein,D,D12.776.476.525.700.300,rho GTP-Binding Proteins,Monomeric GTP-Binding Proteins,1
Rhodamines,D,D03.633.300.953.600,Xanthenes,"Heterocyclic Compounds, 3-Ring",1
Rhode Island,Z,Z01.107.567.875.550.680,New England,United States,1
Rhodium,D,D01.268.556.793,"Metals, Heavy",Elements,1
Rhodium,D,D01.268.956.781,Transition Elements,Elements,1
Rhodium,D,D01.552.544.793,"Metals, Heavy",Metals,1
Rhodococcus equi,B,B03.510.024.981.775.700,Rhodococcus,Nocardiaceae,1
Rhodopsin,D,D12.776.543.750.695.955,"Receptors, G-Protein-Coupled","Receptors, Cell Surface",1
Rhodopsin,D,D23.767.930.750.500.500,Rod Opsins,Opsins,1
Rhodospirillum rubrum,B,B03.440.400.425.708.733.650,Rhodospirillum,Rhodospirillaceae,1
Rhodospirillum rubrum,B,B03.660.050.755.750.733.650,Rhodospirillum,Rhodospirillaceae,1
"Ribonucleoprotein, U1 Small Nuclear",D,D12.776.664.962.500.875.600,"Ribonucleoproteins, Small Nuclear",Ribonucleoproteins,1
"Ribonucleoprotein, U1 Small Nuclear",D,D12.776.664.962.829.313,RNA Splicing Factors,RNA-Binding Proteins,1
"Ribonucleoprotein, U1 Small Nuclear",D,D12.776.157.725.500.875.600,"Ribonucleoproteins, Small Nuclear",Ribonucleoproteins,1
"Ribonucleoprotein, U1 Small Nuclear",D,D12.776.157.725.829.313,RNA Splicing Factors,RNA-Binding Proteins,1
"Ribonucleoprotein, U5 Small Nuclear",D,D12.776.157.725.829.375,RNA Splicing Factors,RNA-Binding Proteins,1
"Ribonucleoprotein, U5 Small Nuclear",D,D12.776.157.725.500.875.620,"Ribonucleoproteins, Small Nuclear",Ribonucleoproteins,1
"Ribonucleoprotein, U5 Small Nuclear",D,D12.776.664.962.829.375,RNA Splicing Factors,RNA-Binding Proteins,1
"Ribonucleoprotein, U5 Small Nuclear",D,D12.776.664.962.500.875.620,"Ribonucleoproteins, Small Nuclear",Ribonucleoproteins,1
Ribonucleosides,D,D13.570.800,Nucleosides,"Nucleic Acids, Nucleotides, and Nucleosides",1
"Ribosomal Protein S6 Kinases, 90-kDa",D,D12.776.476.600.500,Ribosomal Protein S6 Kinases,Intracellular Signaling Peptides and Proteins,1
"Ribosomal Protein S6 Kinases, 90-kDa",D,D12.644.360.600.500,Ribosomal Protein S6 Kinases,Intracellular Signaling Peptides and Proteins,1
"Ribosomal Protein S6 Kinases, 90-kDa",D,D08.811.913.696.620.682.700.862.500,Ribosomal Protein S6 Kinases,Protein-Serine-Threonine Kinases,1
"Ribosome Subunits, Large",A,A11.284.430.214.190.875.811.870.700,Ribosome Subunits,Ribosomes,1
"Ribosome Subunits, Small, Eukaryotic",A,A11.284.430.214.190.875.811.870.750.750,"Ribosome Subunits, Small",Ribosome Subunits,1
Riboswitch,D,D13.444.735.790.878.942.500,"Regulatory Sequences, Ribonucleic Acid",Untranslated Regions,1
Riboswitch,D,D13.444.735.544.427,"RNA, Messenger",RNA,1
Riboswitch,G,G05.360.080.689.687.124,"Regulatory Sequences, Ribonucleic Acid","Regulatory Sequences, Nucleic Acid",1
Riboswitch,G,G02.111.570.080.689.687.124,"Regulatory Sequences, Ribonucleic Acid","Regulatory Sequences, Nucleic Acid",1
Rickettsia conorii,B,B03.660.050.783.875.650.650.180,Rickettsia,Rickettsieae,1
Rickettsia rickettsii,B,B03.660.050.783.875.650.650.650,Rickettsia,Rickettsieae,1
Rickettsiaceae,B,B03.660.050.783.875,Rickettsiales,Alphaproteobacteria,1
Rifaximin,D,D03.633.400.811.850,Rifamycins,"Heterocyclic Compounds, 4 or More Rings",1
Rifaximin,D,D04.345.295.750.850,Rifamycins,"Lactams, Macrocyclic",1
RNA Polymerase II,D,D08.811.913.696.445.735.270.762,DNA-Directed RNA Polymerases,RNA Nucleotidyltransferases,1
RNA Polymerase Sigma 54,D,D08.811.913.696.445.735.270.887,DNA-Directed RNA Polymerases,RNA Nucleotidyltransferases,1
RNA Polymerase Sigma 54,D,D12.776.097.698,Bacterial Proteins,Proteins,1
RNA Virus Infections,C,C01.925.782,Virus Diseases,Infections,1
"RNA, Archaeal",D,D13.444.735.300,RNA,Nucleic Acids,1
"RNA, Fungal",D,D13.444.735.500,RNA,Nucleic Acids,1
"RNA, Ribosomal, 5.8S",D,D13.444.735.686.660,"RNA, Ribosomal",RNA,1
"RNA, Small Cytoplasmic",D,D13.444.735.790.552.750,"RNA, Small Untranslated","RNA, Untranslated",1
"RNA, Transfer, Glu",D,D13.444.735.757.700.410,"RNA, Transfer, Amino Acid-Specific","RNA, Transfer",1
"RNA, Transfer, His",D,D13.444.735.757.700.450,"RNA, Transfer, Amino Acid-Specific","RNA, Transfer",1
RNA-Binding Motifs,G,G02.111.570.820.709.275.500.869,Amino Acid Motifs,Protein Structural Elements,1
RNA-Binding Protein FUS,D,D12.776.664.962.813.750.902,Heterogeneous-Nuclear Ribonucleoproteins,RNA Recognition Motif Proteins,1
RNA-Binding Protein FUS,D,D12.776.624.664.700.915,Proto-Oncogene Proteins,Oncogene Proteins,1
RNA-Binding Protein FUS,D,D12.776.157.725.813.750.905,Heterogeneous-Nuclear Ribonucleoproteins,RNA Recognition Motif Proteins,1
RNA-Induced Silencing Complex,D,D12.776.157.725.500.906,Ribonucleoproteins,RNA-Binding Proteins,1
RNA-Induced Silencing Complex,D,D08.811.277.352.355.350.810,Endoribonucleases,Endonucleases,1
RNA-Induced Silencing Complex,D,D08.811.277.352.700.350.810,Endoribonucleases,Ribonucleases,1
RNA-Induced Silencing Complex,D,D12.776.664.962.500.906,Ribonucleoproteins,RNA-Binding Proteins,1
Rodent Control,N,N06.850.780.200.650.700,Pest Control,Communicable Disease Control,1
Root Caries,C,C07.793.720.210.650,Dental Caries,Tooth Demineralization,1
Root Planing,E,E06.761.227.350.650,Dental Scaling,Dental Prophylaxis,1
Root Planing,E,E06.721.189.350.650,Dental Scaling,Dental Prophylaxis,1
Root Planing,E,E06.721.874.650,Subgingival Curettage,Periodontics,1
Rosales,B,B01.650.940.800.575.912.250.859.937,Rosanae,Magnoliopsida,1
Roxithromycin,D,D02.540.576.500.992.630,Erythromycin,Macrolides,1
Rubulavirus,B,B04.820.480.937.600.650.750,Paramyxovirinae,Paramyxoviridae,1
Rubulavirus Infections,C,C01.925.782.580.600.680,Paramyxoviridae Infections,Mononegavirales Infections,1
Rumen,A,A13.869.804,"Stomach, Ruminant",Animal Structures,1
S Phase,G,G02.111.225.880,DNA Replication,Biochemical Phenomena,1
S Phase,G,G04.144.500.800,Interphase,Cell Cycle,1
S Phase,G,G05.226.880,DNA Replication,Genetic Phenomena,1
S100 Calcium Binding Protein A6,D,D12.776.167.481,Cell Cycle Proteins,Proteins,1
S100 Calcium Binding Protein A6,D,D12.776.157.125.750.532,S100 Proteins,Calcium-Binding Proteins,1
Saccades,G,G14.350.500,Eye Movements,Ocular Physiological Phenomena,1
Saccharomycetales,B,B01.300.107.795,Ascomycota,Fungi,1
Sacroiliac Joint,A,A02.835.583.707,Joints,Skeleton,1
Sacroiliitis,C,C05.550.114.854,Arthritis,Joint Diseases,1
Sacrum,A,A02.835.232.834.717,Spine,Bone and Bones,1
Saimiri,B,B01.050.150.900.649.313.988.400.600.150.710.710,Saimirinae,Cebidae,1
Saint Lucia,Z,Z01.107.084.900.825,West Indies,Caribbean Region,1
Saint Lucia,Z,Z01.639.880.825,West Indies,Islands,1
Salicylamides,D,D02.065.793,Amides,Organic Chemicals,1
Saline Waters,G,G16.500.275.725,Environment,Ecological and Environmental Phenomena,1
"Salivary Glands, Minor",A,A14.549.760.650,Salivary Glands,Mouth,1
"Salivary Glands, Minor",A,A03.556.500.760.650,Salivary Glands,Mouth,1
"Salivary Glands, Minor",A,A10.336.779.650,Salivary Glands,Exocrine Glands,1
Salivation,G,G10.261.190.800,Digestion,Digestive System Physiological Phenomena,1
Salivation,G,G07.203.650.250.800,Digestion,Nutritional Physiological Phenomena,1
Salmon,B,B01.050.150.900.493.817.750.705,Salmonidae,Salmoniformes,1
Salmonella paratyphi B,B,B03.440.450.425.800.200.700,Salmonella enterica,Salmonella,1
Salmonella paratyphi B,B,B03.660.250.150.710.160.710,Salmonella enterica,Salmonella,1
SAM Domain and HD Domain-Containing Protein 1,D,D08.811.277.352.700.843,Ribonucleases,Esterases,1
SAM Domain and HD Domain-Containing Protein 1,D,D08.811.277.040.725,Acid Anhydride Hydrolases,Hydrolases,1
Sapovirus,B,B04.820.578.298.775,Caliciviridae,Positive-Strand RNA Viruses,1
Sarcocystosis,C,C01.610.752.250.634,Coccidiosis,Protozoan Infections,1
"Sarcoma, Synovial",C,C04.557.450.795.875,Sarcoma,"Neoplasms, Connective and Soft Tissue",1
"Sarcoma, Synovial",C,C04.557.450.565.835,"Neoplasms, Connective Tissue","Neoplasms, Connective and Soft Tissue",1
Sarcoplasmic Reticulum,A,A10.690.552.500.500.850,"Muscle Fibers, Skeletal","Muscle, Skeletal",1
Sarcoplasmic Reticulum,A,A11.284.430.214.190.875.248.310.800,"Endoplasmic Reticulum, Smooth",Endoplasmic Reticulum,1
Sarcosine,D,D12.125.481.700.374,N-substituted Glycines,Glycine,1
Satiety Response,F,F02.830.749.658,Satiation,Psychophysiology,1
Scanning Laser Polarimetry,E,E01.370.380.655,"Diagnostic Techniques, Ophthalmological",Diagnostic Techniques and Procedures,1
Scarlet Fever,C,C01.150.252.410.890.823,Streptococcal Infections,Gram-Positive Bacterial Infections,1
"Scavenger Receptors, Class F",D,D12.776.543.750.705.940.742,"Receptors, Scavenger","Receptors, Immunologic",1
"Scavenger Receptors, Class F",D,D12.776.543.750.710.450.750.742,"Receptors, Scavenger","Receptors, LDL",1
Scent Glands,A,A13.820,Animal Structures,NULL,1
"Schools, Health Occupations",I,I02.783.495,Schools,Education,1
"Schools, Pharmacy",I,I02.783.495.694,"Schools, Health Occupations",Schools,1
"Schools, Veterinary",I,I02.783.495.836,"Schools, Health Occupations",Schools,1
Schwann Cells,A,A11.650.800,Neuroglia,Cells,1
Schwann Cells,A,A08.800.800.690,Peripheral Nerves,Peripheral Nervous System,1
Schwann Cells,A,A08.637.800,Neuroglia,Nervous System,1
Scleral Diseases,C,C11.790,Eye Diseases,NULL,1
Scoliosis,C,C05.116.900.800.875,Spinal Curvatures,Spinal Diseases,1
Scopolamine,D,D02.145.074.722.822.775,Scopolamine Derivatives,Tropanes,1
Scopolamine,D,D03.132.760.180.848,Belladonna Alkaloids,Solanaceous Alkaloids,1
Scopolamine,D,D03.132.889.601.775,Scopolamine Derivatives,Tropanes,1
Scopolamine,D,D03.605.869.822.775,Scopolamine Derivatives,Tropanes,1
Scopolamine,D,D03.605.084.500.722.822.775,Scopolamine Derivatives,Tropanes,1
Screen Time,I,I03.723,Human Activities,NULL,1
Scrotum,A,A05.360.444.661,"Genitalia, Male",Genitalia,1
Seat Belts,E,E07.700.800,Protective Devices,Equipment and Supplies,1
Secretory Leukocyte Peptidase Inhibitor,D,D12.644.822.500,"Proteinase Inhibitory Proteins, Secretory",Peptides,1
Secretory Leukocyte Peptidase Inhibitor,D,D12.776.645.500,"Proteinase Inhibitory Proteins, Secretory",Proteins,1
Secretory Pathway,G,G03.143.925,Biological Transport,Metabolism,1
Secretory Pathway,G,G04.468.580,Exocytosis,Cell Physiological Phenomena,1
Secretory Rate,G,G03.857,Metabolism,NULL,1
Selegiline,D,D02.092.471.683.915,Phenethylamines,Ethylamines,1
SELEX Aptamer Technique,E,E05.197.312.500,Combinatorial Chemistry Techniques,"Chemistry Techniques, Synthetic",1
SELEX Aptamer Technique,J,J01.897.836.249.249.500,Combinatorial Chemistry Techniques,"Chemistry Techniques, Synthetic",1
Seminiferous Tubules,A,A05.360.444.849.700,Testis,"Genitalia, Male",1
Semliki forest virus,B,B04.820.578.875.054.840,Alphavirus,Togaviridae,1
Sense of Coherence,F,F01.058.788,"Adaptation, Psychological",Behavior and Behavior Mechanisms,1
Sense of Coherence,F,F01.752.747.792.925,Self Concept,Personality Development,1
Sense Organs,A,A09,NULL,NULL,1
Sensilla,A,A13.093.500,Arthropod Antennae,Animal Structures,1
Sensitivity Training Groups,F,F01.829.316.697,Group Processes,"Psychology, Social",1
Sensitivity Training Groups,F,F04.754.864.581.813,"Psychotherapy, Group",Socioenvironmental Therapy,1
Sensorimotor Cortex,A,A08.186.211.200.885.287.500.814,Cerebral Cortex,Cerebrum,1
Sensory Deprivation,F,F02.463.593.696,Perception,Mental Processes,1
Sensory Receptor Cells,A,A08.800.950,Peripheral Nervous System,Nervous System,1
Sensory Receptor Cells,A,A08.675.650.915,"Neurons, Afferent",Neurons,1
Sensory Receptor Cells,A,A11.671.650.915,"Neurons, Afferent",Neurons,1
Sentinel Lymph Node,A,A10.549.400.750,Lymph Nodes,Lymphoid Tissue,1
Sentinel Lymph Node,A,A15.382.520.604.412.750,Lymph Nodes,Lymphoid Tissue,1
Sentinel Species,B,B05.698,Organism Forms,NULL,1
Sepsis-Associated Encephalopathy,C,C10.228.140.807,Brain Diseases,Central Nervous System Diseases,1
Septum of Brain,A,A08.186.211.180.750,Limbic System,Brain,1
Septum of Brain,A,A08.186.211.200.885.750,Telencephalon,Prosencephalon,1
Sequence Tagged Sites,G,G05.360.340.024.810,Genome Components,Genome,1
Serial Passage,E,E05.200.875.837,Microbiological Techniques,Clinical Laboratory Techniques,1
Serial Passage,E,E01.370.225.875.837,Microbiological Techniques,Clinical Laboratory Techniques,1
Serine Peptidase Inhibitor Kazal-Type 5,D,D12.776.645.688.250,"Serine Peptidase Inhibitors, Kazal Type","Proteinase Inhibitory Proteins, Secretory",1
Serine Peptidase Inhibitor Kazal-Type 5,D,D12.644.822.750.250,"Serine Peptidase Inhibitors, Kazal Type","Proteinase Inhibitory Proteins, Secretory",1
Serotonin Antagonists,D,D27.505.696.577.850.850,Serotonin Agents,Neurotransmitter Agents,1
Serotonin Antagonists,D,D27.505.519.625.850.850,Serotonin Agents,Neurotransmitter Agents,1
Serpin E2,D,D12.776.645.468.750,Protease Nexins,"Proteinase Inhibitory Proteins, Secretory",1
Serpin E2,D,D12.776.872.695.850,Plasminogen Inactivators,Serpins,1
Serpin E2,D,D12.644.822.468.750,Protease Nexins,"Proteinase Inhibitory Proteins, Secretory",1
Serpin E2,D,D12.644.861.695.850,Plasminogen Inactivators,Serpins,1
Serratia liquefaciens,B,B03.440.450.425.814.620,Serratia,Enterobacteriaceae,1
Serratia liquefaciens,B,B03.660.250.150.720.480,Serratia,Enterobacteriaceae,1
Sex Chromosome Aberrations,C,C23.550.210.815,Chromosome Aberrations,Pathologic Processes,1
Sex Chromosome Aberrations,G,G05.365.590.175.815,Chromosome Aberrations,Mutation,1
Sex Cord-Gonadal Stromal Tumors,C,C04.557.475.750,"Neoplasms, Gonadal Tissue",Neoplasms by Histologic Type,1
Sex Reassignment Procedures,E,E02.906,Therapeutics,NULL,1
Sezary Syndrome,C,C04.557.386.480.750.800.775,"Lymphoma, T-Cell, Cutaneous","Lymphoma, T-Cell",1
Sezary Syndrome,C,C20.683.515.761.480.750.800.775,"Lymphoma, T-Cell, Cutaneous","Lymphoma, T-Cell",1
Sezary Syndrome,C,C20.683.515.920,Lymphoproliferative Disorders,Immunoproliferative Disorders,1
Sezary Syndrome,C,C15.604.515.841,Lymphoproliferative Disorders,Lymphatic Diseases,1
Sezary Syndrome,C,C15.604.515.569.480.750.800.775,"Lymphoma, T-Cell, Cutaneous","Lymphoma, T-Cell",1
Shellfish,G,G07.203.300.600.875.700,Seafood,Meat,1
Shellfish,J,J02.500.600.875.700,Seafood,Meat,1
Shewanella putrefaciens,B,B03.660.250.021.755.750,Shewanella,Alteromonadaceae,1
Shewanella putrefaciens,B,B03.440.450.690.590,Shewanella,Gram-Negative Facultatively Anaerobic Rods,1
Shiga Toxin 1,D,D12.776.097.275.877,Escherichia coli Proteins,Bacterial Proteins,1
Shiga Toxin 1,D,D08.811.277.450.430.700.750.750.120,Shiga Toxins,"Ribosome Inactivating Proteins, Type 2",1
Shiga Toxin 1,D,D23.946.123.794.100,Shiga Toxins,Bacterial Toxins,1
Shiga Toxin 1,D,D23.946.330.575.120,Shiga Toxins,Enterotoxins,1
Shigella boydii,B,B03.440.450.425.850.175,Shigella,Enterobacteriaceae,1
Shigella boydii,B,B03.660.250.150.730.050,Shigella,Enterobacteriaceae,1
Shiitake Mushrooms,B,B01.300.179.100.515.810,Lentinula,Agaricales,1
Shikimic Acid,D,D02.455.426.392.368.367.379.750,Cyclohexenes,Cyclohexanes,1
Shikimic Acid,D,D02.241.511.852,Hydroxy Acids,Carboxylic Acids,1
Shikimic Acid,D,D02.241.223.268.792,Cyclohexanecarboxylic Acids,"Acids, Carbocyclic",1
"Shock, Traumatic",C,C23.550.835.888,Shock,Pathologic Processes,1
"Shock, Traumatic",C,C26.797,Wounds and Injuries,NULL,1
Shoulder Fractures,C,C26.803.250,Shoulder Injuries,Wounds and Injuries,1
Shoulder Fractures,C,C26.404.625,"Fractures, Bone",Wounds and Injuries,1
Shoulder Injuries,C,C26.803,Wounds and Injuries,NULL,1
Shoulder Pain,C,C23.888.592.612.094.700,Arthralgia,Pain,1
Shoulder Pain,C,C05.550.091.700,Arthralgia,Joint Diseases,1
Shoulder Pain,G,G11.561.790.444.350.500,Arthralgia,Pain,1
Shoulder Pain,F,F02.830.816.444.350.500,Arthralgia,Pain,1
Shyness,F,F01.145.813.617,Social Behavior,Behavior,1
Sialic Acid Binding Ig-like Lectin 1,D,D12.776.503.921.100,Sialic Acid Binding Immunoglobulin-like Lectins,Lectins,1
Sialic Acid Binding Ig-like Lectin 3,D,D12.776.503.921.400,Sialic Acid Binding Immunoglobulin-like Lectins,Lectins,1
Sialic Acid Binding Ig-like Lectin 3,D,D23.050.301.264.900.565,"Antigens, Differentiation, Myelomonocytic","Antigens, Differentiation",1
Sialic Acid Binding Ig-like Lectin 3,D,D23.101.100.900.565,"Antigens, Differentiation, Myelomonocytic","Antigens, Differentiation",1
Sialic Acid Binding Immunoglobulin-like Lectins,D,D12.776.503.921,Lectins,Proteins,1
Sialyltransferases,D,D08.811.913.400.800,Glycosyltransferases,Transferases,1
Sicily,Z,Z01.639.640.751,Mediterranean Islands,Islands,1
Sicily,Z,Z01.542.489.751,Italy,Europe,1
Sicily,Z,Z01.542.580.500.751,Mediterranean Islands,Mediterranean Region,1
Signaling Lymphocytic Activation Molecule Associated Protein,D,D12.776.157.057.166,"Adaptor Proteins, Signal Transducing",Carrier Proteins,1
Signaling Lymphocytic Activation Molecule Associated Protein,D,D12.644.360.024.332,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
Signaling Lymphocytic Activation Molecule Associated Protein,D,D12.776.476.024.426,"Adaptor Proteins, Signal Transducing",Intracellular Signaling Peptides and Proteins,1
Signaling Lymphocytic Activation Molecule Family Member 1,D,D12.776.543.750.705.970.500,Signaling Lymphocytic Activation Molecule Family,"Receptors, Immunologic",1
Signaling Lymphocytic Activation Molecule Family Member 1,D,D12.776.543.550.746.500,Signaling Lymphocytic Activation Molecule Family,Membrane Glycoproteins,1
Signaling Lymphocytic Activation Molecule Family Member 1,D,D12.776.395.550.736.500,Signaling Lymphocytic Activation Molecule Family,Membrane Glycoproteins,1
Signal-To-Noise Ratio,N,N06.850.520.830.872.750,Sensitivity and Specificity,Statistics as Topic,1
Signal-To-Noise Ratio,N,N06.850.520.445.800.875,Sensitivity and Specificity,Epidemiologic Research Design,1
Signal-To-Noise Ratio,E,E05.318.740.872.875,Sensitivity and Specificity,Statistics as Topic,1
Signal-To-Noise Ratio,E,E05.318.370.800.875,Sensitivity and Specificity,Epidemiologic Research Design,1
Signal-To-Noise Ratio,G,G17.800.500,Sensitivity and Specificity,Mathematical Concepts,1
Signal-To-Noise Ratio,N,N05.715.360.325.700.840,Sensitivity and Specificity,Epidemiologic Research Design,1
Signal-To-Noise Ratio,N,N05.715.360.750.725.750,Sensitivity and Specificity,Statistics as Topic,1
"Silencer Elements, Transcriptional",G,G02.111.570.080.689.755,"Regulatory Sequences, Nucleic Acid",Base Sequence,1
"Silencer Elements, Transcriptional",G,G05.360.340.024.815,Genome Components,Genome,1
"Silencer Elements, Transcriptional",G,G05.360.080.689.755,"Regulatory Sequences, Nucleic Acid",Base Sequence,1
Silent Mutation,G,G05.365.590.803,Mutation,Genetic Variation,1
Silicates,D,D01.837.725.700.760,Silicic Acid,Silicon Dioxide,1
Silicates,D,D01.578.725,Minerals,Inorganic Chemicals,1
Silicone Gels,D,D05.750.900.850.905,Silicones,Siloxanes,1
Silicone Gels,D,D02.756.650.700.755,Silicones,Siloxanes,1
Silicone Gels,D,D25.720.900.850.905,Silicones,Siloxanes,1
Silicone Gels,J,J01.637.051.720.900.850.905,Silicones,Siloxanes,1
Silicone Oils,J,J01.637.051.720.900.850.950,Silicones,Siloxanes,1
Silicone Oils,D,D25.720.900.850.950,Silicones,Siloxanes,1
Silicone Oils,D,D02.756.650.700.800,Silicones,Siloxanes,1
Silicone Oils,D,D05.750.900.850.950,Silicones,Siloxanes,1
Simbu virus,B,B04.820.480.750.640.855,Orthobunyavirus,Bunyaviridae,1
Simeprevir,D,D02.886.590.700.700,Sulfonamides,Sulfones,1
Simeprevir,D,D03.633.300.819,"Heterocyclic Compounds, 3-Ring","Heterocyclic Compounds, Fused-Ring",1
Simian foamy virus,B,B04.820.650.850.750,Spumavirus,Retroviridae,1
Simian virus 40,B,B04.613.204.670.615.700,Polyomavirus,Polyomaviridae,1
Simian virus 40,B,B04.280.210.700.615.700,Polyomavirus,Polyomaviridae,1
Sin3 Histone Deacetylase and Corepressor Complex,D,D08.811.600.795,Multienzyme Complexes,Enzymes,1
Sin3 Histone Deacetylase and Corepressor Complex,D,D08.811.277.087.520.750,Histone Deacetylases,Amidohydrolases,1
Sin3 Histone Deacetylase and Corepressor Complex,D,D12.776.930.780.625.750,Co-Repressor Proteins,Repressor Proteins,1
Singing,G,G09.772.585.500,Phonation,Respiratory Physiological Phenomena,1
Single Embryo Transfer,E,E05.820.800.500.500,Embryo Transfer,"Reproductive Techniques, Assisted",1
Single Embryo Transfer,E,E02.875.800.500.500,Embryo Transfer,"Reproductive Techniques, Assisted",1
"Sinus Thrombosis, Intracranial",C,C14.907.355.590.213.350.500,Intracranial Thrombosis,Intracranial Embolism and Thrombosis,1
"Sinus Thrombosis, Intracranial",C,C14.907.253.566.350.500,Intracranial Thrombosis,Intracranial Embolism and Thrombosis,1
"Sinus Thrombosis, Intracranial",C,C10.228.140.300.525.425.500,Intracranial Thrombosis,Intracranial Embolism and Thrombosis,1
Sirtuin 1,D,D12.776.476.900.100,Sirtuins,Intracellular Signaling Peptides and Proteins,1
Sirtuin 1,D,D08.811.277.087.520.200.650.100,Sirtuins,Group III Histone Deacetylases,1
Sitagliptin Phosphate,D,D03.383.679.875,Pyrazines,"Heterocyclic Compounds, 1-Ring",1
Sitagliptin Phosphate,D,D03.383.129.799.725,Triazoles,Azoles,1
Skin Cream,E,E02.547.800.500,Skin Care,Hygiene,1
Skin Cream,J,J01.516.213.249,Cosmetics,Household Products,1
"Skin Diseases, Vascular",C,C17.800.862,Skin Diseases,Skin and Connective Tissue Diseases,1
"Skin Diseases, Vesiculobullous",C,C17.800.865,Skin Diseases,Skin and Connective Tissue Diseases,1
Skin Lightening Preparations,D,D27.720.269.750,Cosmetics,Specialty Uses of Chemicals,1
Skin Lightening Preparations,J,J01.516.213.500,Cosmetics,Household Products,1
Skin Window Technique,E,E05.200.812.871.705,Skin Tests,Immunologic Tests,1
Skin Window Technique,E,E05.200.812.125.875,Cell Migration Assays,Immunologic Tests,1
Skin Window Technique,E,E05.242.335.875,Cell Migration Assays,Cytological Techniques,1
Skin Window Technique,E,E05.200.500.335.875,Cell Migration Assays,Cytological Techniques,1
Skin Window Technique,E,E05.478.594.122.875,Cell Migration Assays,Immunologic Tests,1
Skin Window Technique,E,E05.478.594.890.705,Skin Tests,Immunologic Tests,1
Skin Window Technique,E,E01.370.225.812.871.705,Skin Tests,Immunologic Tests,1
Skin Window Technique,E,E01.370.225.812.125.875,Cell Migration Assays,Immunologic Tests,1
Skin Window Technique,E,E01.370.225.500.335.875,Cell Migration Assays,Cytological Techniques,1
Skull Base,A,A02.835.232.781.750,Skull,Bone and Bones,1
Skull Base,A,A01.456.830,Head,Body Regions,1
Skull Base Neoplasms,C,C05.116.231.754.829,Skull Neoplasms,Bone Neoplasms,1
Skull Base Neoplasms,C,C04.588.149.721.828,Skull Neoplasms,Bone Neoplasms,1
Sleep Medicine Specialty,H,H02.403.429.865,Internal Medicine,Medicine,1
Slit Lamp,E,E07.230.540.750,Ophthalmoscopes,Diagnostic Equipment,1
Slit Lamp Microscopy,E,E01.370.380.727,"Diagnostic Techniques, Ophthalmological",Diagnostic Techniques and Procedures,1
Smegmamorpha,B,B01.050.150.900.493.850,Fishes,Vertebrates,1
Smoking Cessation Agents,D,D27.505.954.810,Therapeutic Uses,Pharmacologic Actions,1
"Smoking, Non-Tobacco Products",F,F01.145.805.250,Smoking,Behavior,1
"Social Validity, Research",H,H01.770.644.932,Research,Science,1
"Social Work, Psychiatric",I,I01.880.792.410,Social Work,Sociology,1
"Social Work, Psychiatric",N,N02.421.849.673,Social Work,Health Services,1
"Social Work, Psychiatric",N,N02.421.461.798,Mental Health Services,Health Services,1
"Social Work, Psychiatric",F,F04.408.823,Mental Health Services,Behavioral Disciplines and Activities,1
Socialism,I,I01.696.798,Political Systems,Social Sciences,1
Socialization,I,I01.880.853.934,Sociological Factors,Sociology,1
Sociobiology,H,H01.158.273.866,Biology,Biological Science Disciplines,1
Sociobiology,F,F04.096.939,Behavioral Sciences,Behavioral Disciplines and Activities,1
Sodium Azide,D,D01.625.100.750,Azides,Nitrogen Compounds,1
Sodium Azide,D,D01.857.462,Sodium Compounds,Inorganic Chemicals,1
Sodium Channel Blockers,D,D27.505.954.411.720,Cardiovascular Agents,Therapeutic Uses,1
Sodium Channel Blockers,D,D27.505.519.562.750,Membrane Transport Modulators,Molecular Mechanisms of Pharmacological Action,1
Sodium-Calcium Exchanger,D,D12.776.543.585.450.162.442,Antiporters,Ion Pumps,1
Sodium-Calcium Exchanger,D,D12.776.157.530.450.162.442,Antiporters,Ion Pumps,1
Sodium-Glucose Transporter 2,D,D12.776.157.530.500.750.750,Sodium-Glucose Transport Proteins,Monosaccharide Transport Proteins,1
Sodium-Glucose Transporter 2,D,D12.776.157.530.450.625.437.750,Sodium-Glucose Transport Proteins,Symporters,1
Sodium-Glucose Transporter 2,D,D12.776.157.530.937.700,Solute Carrier Proteins,Membrane Transport Proteins,1
Sodium-Glucose Transporter 2,D,D12.776.543.585.500.750.750,Sodium-Glucose Transport Proteins,Monosaccharide Transport Proteins,1
Sodium-Glucose Transporter 2,D,D12.776.543.585.450.625.562.750,Sodium-Glucose Transport Proteins,Symporters,1
Sodium-Glucose Transporter 2,D,D12.776.543.585.937.825,Solute Carrier Proteins,Membrane Transport Proteins,1
"Sodium-Phosphate Cotransporter Proteins, Type I",D,D12.776.543.585.450.625.625.500,Sodium-Phosphate Cotransporter Proteins,Symporters,1
"Sodium-Phosphate Cotransporter Proteins, Type I",D,D12.776.543.585.450.074.750.750.500,Sodium-Phosphate Cotransporter Proteins,Phosphate Transport Proteins,1
"Sodium-Phosphate Cotransporter Proteins, Type I",D,D12.776.157.648.500.750.500,Sodium-Phosphate Cotransporter Proteins,Phosphate Transport Proteins,1
"Sodium-Phosphate Cotransporter Proteins, Type I",D,D12.776.157.530.450.625.625.500,Sodium-Phosphate Cotransporter Proteins,Symporters,1
"Sodium-Phosphate Cotransporter Proteins, Type I",D,D12.776.157.530.450.074.750.750.500,Sodium-Phosphate Cotransporter Proteins,Phosphate Transport Proteins,1
"Sodium-Phosphate Cotransporter Proteins, Type IIa",D,D12.776.157.530.450.074.750.750.750.124,"Sodium-Phosphate Cotransporter Proteins, Type II",Sodium-Phosphate Cotransporter Proteins,1
"Sodium-Phosphate Cotransporter Proteins, Type IIa",D,D12.776.157.530.450.625.625.750.124,"Sodium-Phosphate Cotransporter Proteins, Type II",Sodium-Phosphate Cotransporter Proteins,1
"Sodium-Phosphate Cotransporter Proteins, Type IIa",D,D12.776.157.648.500.750.750.124,"Sodium-Phosphate Cotransporter Proteins, Type II",Sodium-Phosphate Cotransporter Proteins,1
"Sodium-Phosphate Cotransporter Proteins, Type IIa",D,D12.776.157.530.937.704.124,"Sodium-Phosphate Cotransporter Proteins, Type II",Solute Carrier Proteins,1
"Sodium-Phosphate Cotransporter Proteins, Type IIa",D,D12.776.543.585.450.074.750.750.750.124,"Sodium-Phosphate Cotransporter Proteins, Type II",Sodium-Phosphate Cotransporter Proteins,1
"Sodium-Phosphate Cotransporter Proteins, Type IIa",D,D12.776.543.585.450.625.625.750.124,"Sodium-Phosphate Cotransporter Proteins, Type II",Sodium-Phosphate Cotransporter Proteins,1
"Sodium-Phosphate Cotransporter Proteins, Type IIa",D,D12.776.543.585.937.829.124,"Sodium-Phosphate Cotransporter Proteins, Type II",Solute Carrier Proteins,1
Soft Tissue Injuries,C,C26.808,Wounds and Injuries,NULL,1
Solar Energy,G,G01.750.897,Radiation,Physical Phenomena,1
Solar Energy,N,N06.230.132.644.500,Renewable Energy,Energy-Generating Resources,1
Solitary Pulmonary Nodule,C,C08.381.884,Lung Diseases,Respiratory Tract Diseases,1
"Somatic Hypermutation, Immunoglobulin",G,G12.500.780,Immunogenetic Phenomena,Immune System Phenomena,1
"Somatic Hypermutation, Immunoglobulin",G,G05.558.810,Mutagenesis,Genetic Phenomena,1
Somatosensory Cortex,A,A08.186.211.200.885.287.500.814.906,Sensorimotor Cortex,Cerebral Cortex,1
Somatosensory Cortex,A,A08.186.211.200.885.287.500.670.675,Parietal Lobe,Cerebral Cortex,1
Somatostatinoma,C,C04.588.322.475.500.500,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Somatostatinoma,C,C04.588.274.761.500.500,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Somatostatinoma,C,C04.557.470.200.025.370.695,"Carcinoma, Neuroendocrine",Adenocarcinoma,1
Somatostatinoma,C,C04.557.465.625.650.240.695,"Carcinoma, Neuroendocrine",Neuroendocrine Tumors,1
Somatostatinoma,C,C06.689.667.500.500,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Somatostatinoma,C,C06.301.761.500.500,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Somatostatinoma,C,C19.344.421.500.500,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Somatotypes,E,E01.370.600.115.800,Body Constitution,Physical Examination,1
Somatotypes,G,G07.100.800,Body Constitution,Physiological Phenomena,1
Sorbitol,D,D09.853.813,Sugar Alcohols,Carbohydrates,1
Sorbitol,D,D02.033.800.813,Sugar Alcohols,Alcohols,1
Sorption Detoxification,E,E02.912,Therapeutics,NULL,1
Sorting Nexins,D,D12.776.543.990.150.875,"Adaptor Proteins, Vesicular Transport",Vesicular Transport Proteins,1
"SOS Response, Genetics",G,G05.219.830,DNA Repair,Genetic Phenomena,1
"SOS Response, Genetics",G,G02.111.222.830,DNA Repair,Biochemical Phenomena,1
Sound Localization,F,F02.463.593.071.869,Auditory Perception,Perception,1
Sound Localization,G,G07.888.125.869,Auditory Perception,Vestibulocochlear Physiological Phenomena,1
Southeastern United States,Z,Z01.107.567.875.750,United States,North America,1
Southwestern United States,Z,Z01.107.567.875.760,United States,North America,1
SOXB1 Transcription Factors,D,D12.776.930.823.100,SOX Transcription Factors,Transcription Factors,1
SOXB1 Transcription Factors,D,D12.776.660.235.400.750.100,SOX Transcription Factors,High Mobility Group Proteins,1
SOXB1 Transcription Factors,D,D12.776.664.235.400.750.100,SOX Transcription Factors,High Mobility Group Proteins,1
SOXB1 Transcription Factors,D,D12.776.260.719.100,SOX Transcription Factors,DNA-Binding Proteins,1
Soybean Oil,D,D10.212.302.380.800,"Dietary Fats, Unsaturated",Dietary Fats,1
Soybean Oil,D,D10.212.507.800,"Fats, Unsaturated",Fats,1
Soybean Oil,D,D10.627.700.880,Plant Oils,Oils,1
Soybean Oil,D,D20.215.784.750.880,Plant Oils,Plant Preparations,1
Soybean Oil,G,G07.203.300.375.400.750,"Dietary Fats, Unsaturated",Dietary Fats,1
Soybean Oil,J,J02.500.375.400.750,"Dietary Fats, Unsaturated",Dietary Fats,1
Sparrows,B,B01.050.150.900.248.620.750.700,Songbirds,Passeriformes,1
Sparteine,D,D03.132.786,Alkaloids,Heterocyclic Compounds,1
Sparteine,D,D03.633.100.834.737.500,Quinolizidines,Quinolizines,1
Spatial Behavior,F,F01.145.875,Behavior,Behavior and Behavior Mechanisms,1
Spatial Memory,F,F02.463.425.540.886,Memory,Learning,1
Specialty Boards,N,N05.700.200.190.750,Certification,Credentialing,1
Specialty Boards,N,N03.706.110.120.580,Certification,Credentialing,1
Specific Gravity,G,G02.819,Chemical Phenomena,NULL,1
"Spectrometry, Mass, Fast Atom Bombardment",E,E05.196.566.750,Mass Spectrometry,"Chemistry Techniques, Analytical",1
"Spectroscopy, Mossbauer",E,E05.196.867.776.751,"Spectrometry, Gamma",Spectrum Analysis,1
Speech Production Measurement,E,E01.370.760,Diagnostic Techniques and Procedures,Diagnosis,1
Speech Recognition Software,L,L01.224.900.889,Software,Computing Methodologies,1
"Speech, Esophageal",E,E02.831.727.541.677,"Speech, Alaryngeal",Rehabilitation of Speech and Language Disorders,1
"Speech, Esophageal",E,E02.760.169.063.500.727.541.677,"Speech, Alaryngeal",Rehabilitation of Speech and Language Disorders,1
Speech-Language Pathology,H,H02.010.750,Allied Health Occupations,Health Occupations,1
Sperm Tail,A,A05.360.490.890.840,Spermatozoa,Germ Cells,1
Sperm Tail,A,A11.284.180.290.835,Flagella,Cell Surface Extensions,1
Sperm Tail,A,A11.497.760.500,Spermatozoa,Germ Cells,1
Spermidine Synthase,D,D08.811.913.225.825,Alkyl and Aryl Transferases,Transferases,1
"Sphincterotomy, Endoscopic",E,E04.210.120.850,Biliary Tract Surgical Procedures,Digestive System Surgical Procedures,1
"Sphincterotomy, Endoscopic",E,E04.515.750.500,Sphincterotomy,Myotomy,1
"Sphincterotomy, Endoscopic",E,E04.502.250.250.250.840,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
"Sphincterotomy, Endoscopic",E,E04.210.240.250.840,"Endoscopy, Gastrointestinal","Endoscopy, Digestive System",1
Sphingolipids,D,D10.570.877,Membrane Lipids,Lipids,1
Sphingomyelin Phosphodiesterase,D,D08.811.277.352.640.750,Phosphoric Diester Hydrolases,Esterases,1
Sphingomyelins,D,D10.570.755.893,Phospholipids,Membrane Lipids,1
Sphingomyelins,D,D10.570.877.360.612.870,Neutral Glycosphingolipids,Glycosphingolipids,1
Sphingomyelins,D,D10.390.470.675.870,Neutral Glycosphingolipids,Glycosphingolipids,1
Sphingomyelins,D,D09.400.410.420.525.870,Neutral Glycosphingolipids,Glycosphingolipids,1
Sphingosine,D,D02.033.455.843,Glycols,Alcohols,1
Sphingosine,D,D02.033.100.700,Amino Alcohols,Alcohols,1
Sphingosine,D,D02.092.063.700,Amino Alcohols,Amines,1
Spices,G,G07.203.300.250.725,Condiments,Food,1
Spices,J,J02.500.250.725,Condiments,Food,1
Spider Bites,C,C26.176.790,Bites and Stings,Wounds and Injuries,1
Spider Bites,C,C25.723.127.723,Bites and Stings,Poisoning,1
Spiders,B,B01.050.500.131.166.803,Arachnida,Arthropods,1
Spina Bifida Occulta,C,C10.500.680.800.750,Spinal Dysraphism,Neural Tube Defects,1
Spina Bifida Occulta,C,C16.131.666.680.800.750,Spinal Dysraphism,Neural Tube Defects,1
Spinal Cord Neoplasms,C,C10.551.240.750,Central Nervous System Neoplasms,Nervous System Neoplasms,1
Spinal Cord Neoplasms,C,C10.228.854.765,Spinal Cord Diseases,Central Nervous System Diseases,1
Spinal Cord Neoplasms,C,C04.588.614.250.803,Central Nervous System Neoplasms,Nervous System Neoplasms,1
Spinal Injuries,C,C26.117.500,Back Injuries,Wounds and Injuries,1
Spinal Neoplasms,C,C05.116.231.828,Bone Neoplasms,Bone Diseases,1
Spinal Neoplasms,C,C05.116.900.801,Spinal Diseases,Bone Diseases,1
Spinal Neoplasms,C,C04.588.149.828,Bone Neoplasms,Neoplasms by Site,1
Spinal Nerve Roots,A,A08.800.800.720.725,Spinal Nerves,Peripheral Nerves,1
Spinal Nerves,A,A08.800.800.720,Peripheral Nerves,Peripheral Nervous System,1
Spindle Apparatus,A,A11.284.430.214.190.750.820,Cytoskeleton,Cytoplasmic Structures,1
Spirochaetales Infections,C,C01.150.252.400.794,Gram-Negative Bacterial Infections,Bacterial Infections,1
Splanchnic Circulation,G,G09.330.100.881,Blood Circulation,Cardiovascular Physiological Phenomena,1
Splenic Artery,A,A07.015.114.814,Arteries,Blood Vessels,1
Spondylarthritis,C,C05.116.900.853.625,Spondylitis,Spinal Diseases,1
Spondylarthritis,C,C05.550.114.865,Arthritis,Joint Diseases,1
Sports Medicine,H,H02.403.830,Medicine,Health Occupations,1
Sprains and Strains,C,C26.844,Wounds and Injuries,NULL,1
"Sprue, Tropical",C,C18.452.603.850,Malabsorption Syndromes,Metabolic Diseases,1
"Sprue, Tropical",C,C06.405.469.637.850,Malabsorption Syndromes,Intestinal Diseases,1
Squamous Intraepithelial Lesions,C,C23.149.688,Morphological and Microscopic Findings,"Pathological Conditions, Signs and Symptoms",1
Stapes,A,A09.246.397.247.806,Ear Ossicles,"Ear, Middle",1
Staphylococcus lugdunensis,B,B03.300.390.400.800.750.500,Staphylococcus,Staphylococcaceae,1
Staphylococcus lugdunensis,B,B03.353.500.750.750.500,Staphylococcus,Staphylococcaceae,1
Staphylococcus lugdunensis,B,B03.510.100.750.750.500,Staphylococcus,Staphylococcaceae,1
Staphylococcus lugdunensis,B,B03.510.400.790.750.500,Staphylococcus,Staphylococcaceae,1
Staphylococcus Phages,B,B04.123.831,Bacteriophages,Viruses,1
STAT2 Transcription Factor,D,D12.644.360.024.342.200,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",1
STAT2 Transcription Factor,D,D12.644.360.024.303.500.750,"Interferon-Stimulated Gene Factor 3, alpha Subunit",Interferon-Stimulated Gene Factor 3,1
STAT2 Transcription Factor,D,D12.776.260.513.249.750,"Interferon-Stimulated Gene Factor 3, alpha Subunit",Interferon-Stimulated Gene Factor 3,1
STAT2 Transcription Factor,D,D12.776.157.057.186.200,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",1
STAT2 Transcription Factor,D,D12.776.157.057.061.500.750,"Interferon-Stimulated Gene Factor 3, alpha Subunit",Interferon-Stimulated Gene Factor 3,1
STAT2 Transcription Factor,D,D12.776.930.840.200,STAT Transcription Factors,Transcription Factors,1
STAT2 Transcription Factor,D,D12.776.930.354.249.750,"Interferon-Stimulated Gene Factor 3, alpha Subunit",Interferon-Stimulated Gene Factor 3,1
STAT2 Transcription Factor,D,D12.776.476.024.386.500.750,"Interferon-Stimulated Gene Factor 3, alpha Subunit",Interferon-Stimulated Gene Factor 3,1
STAT2 Transcription Factor,D,D12.776.476.024.430.200,STAT Transcription Factors,"Adaptor Proteins, Signal Transducing",1
State Health Plans,N,N03.349.650.480,Regional Health Planning,Health Planning,1
Stathmin,D,D12.776.744.772,Phosphoproteins,Proteins,1
Stathmin,D,D12.776.624.664.700.957,Proto-Oncogene Proteins,Oncogene Proteins,1
Stathmin,D,D12.776.220.600.450.480,Microtubule-Associated Proteins,Microtubule Proteins,1
Steam,D,D01.045.250.875.800,Water,Hydroxides,1
Steam,D,D01.248.497.158.459.650.800,Water,Hydroxides,1
Steam,D,D01.650.550.925.800,Water,Oxides,1
Steam,N,N06.230.650,Environment,Environment and Public Health,1
Steam,G,G16.500.887,Ecological and Environmental Phenomena,Biological Phenomena,1
Stearic Acids,D,D10.251.882,Fatty Acids,Lipids,1
Steatorrhea,C,C18.452.603.887,Malabsorption Syndromes,Metabolic Diseases,1
Steatorrhea,C,C06.405.469.637.887,Malabsorption Syndromes,Intestinal Diseases,1
Stem Cell Research,H,H01.770.644.145.512,Biomedical Research,Research,1
Stem Cell Research,E,E05.242.950,Cytological Techniques,Investigative Techniques,1
Stenotrophomonas maltophilia,B,B03.660.250.915.750.500,Stenotrophomonas,Xanthomonadaceae,1
Stenotrophomonas maltophilia,B,B03.440.400.425.967.750.500,Stenotrophomonas,Xanthomonadaceae,1
Stereotaxic Techniques,E,E04.525.800,Neurosurgical Procedures,"Surgical Procedures, Operative",1
Stereotaxic Techniques,E,E05.873,Investigative Techniques,NULL,1
Stereotyped Behavior,F,F01.145.896,Behavior,Behavior and Behavior Mechanisms,1
Sterilization Reversal,E,E04.950.599.500,"Sterilization, Reproductive",Urogenital Surgical Procedures,1
Sternoclavicular Joint,A,A02.835.583.781,Joints,Skeleton,1
Sternum,A,A02.835.232.570.750,Rib Cage,Bone and Bones,1
Steroid 11-beta-Hydroxylase,D,D08.811.682.690.708.170.915.750,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,1
Steroid 11-beta-Hydroxylase,D,D08.811.682.690.708.170.425.750,Cytochrome P450 Family 11,Cytochrome P-450 Enzyme System,1
Steroid 11-beta-Hydroxylase,D,D08.244.453.915.750,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,1
Steroid 11-beta-Hydroxylase,D,D08.244.453.484.750,Cytochrome P450 Family 11,Cytochrome P-450 Enzyme System,1
Steroid 11-beta-Hydroxylase,D,D12.776.422.220.453.915.750,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,1
Steroid 11-beta-Hydroxylase,D,D12.776.422.220.453.484.750,Cytochrome P450 Family 11,Cytochrome P-450 Enzyme System,1
Steroid 16-alpha-Hydroxylase,D,D12.776.422.220.453.915.737,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,1
Steroid 16-alpha-Hydroxylase,D,D08.244.453.915.737,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,1
Steroid 16-alpha-Hydroxylase,D,D08.811.682.690.708.170.915.737,Steroid Hydroxylases,Cytochrome P-450 Enzyme System,1
Steroid Hydroxylases,D,D08.811.682.690.708.170.915,Cytochrome P-450 Enzyme System,Mixed Function Oxygenases,1
Steroid Hydroxylases,D,D08.244.453.915,Cytochrome P-450 Enzyme System,Cytochromes,1
Steroid Hydroxylases,D,D12.776.422.220.453.915,Cytochrome P-450 Enzyme System,Cytochromes,1
"Still's Disease, Adult-Onset",C,C05.550.114.154.870,"Arthritis, Rheumatoid",Arthritis,1
"Still's Disease, Adult-Onset",C,C05.799.114.870,"Arthritis, Rheumatoid",Rheumatic Diseases,1
"Still's Disease, Adult-Onset",C,C17.300.775.099.870,"Arthritis, Rheumatoid",Rheumatic Diseases,1
"Still's Disease, Adult-Onset",C,C20.111.199.870,"Arthritis, Rheumatoid",Autoimmune Diseases,1
Stomach Ulcer,C,C06.405.469.275.800.849,Peptic Ulcer,Duodenal Diseases,1
Stomach Ulcer,C,C06.405.748.586.849,Peptic Ulcer,Stomach Diseases,1
Stomatognathic Diseases,C,C07,NULL,NULL,1
Strepsirhini,B,B01.050.150.900.649.313.988.700,Primates,Eutheria,1
Streptococcus mitis,B,B03.510.400.800.872.875.500,Viridans Streptococci,Streptococcus,1
Streptococcus mitis,B,B03.353.750.737.872.875.500,Viridans Streptococci,Streptococcus,1
Streptococcus mitis,B,B03.510.550.737.872.875.500,Viridans Streptococci,Streptococcus,1
Streptococcus oralis,B,B03.510.550.737.872.875.600,Viridans Streptococci,Streptococcus,1
Streptococcus oralis,B,B03.353.750.737.872.875.600,Viridans Streptococci,Streptococcus,1
Streptococcus oralis,B,B03.510.400.800.872.875.600,Viridans Streptococci,Streptococcus,1
Streptogramin B,D,D04.345.566.802.750.500,Streptogramin Group B,Streptogramins,1
Streptogramin B,D,D12.644.641.802.750.500,Streptogramin Group B,Streptogramins,1
Streptogramins,D,D12.644.641.802,"Peptides, Cyclic",Peptides,1
Streptogramins,D,D04.345.566.802,"Peptides, Cyclic",Macrocyclic Compounds,1
Streptozocin,D,D02.654.692.768,Nitrosourea Compounds,Nitroso Compounds,1
Streptozocin,D,D09.408.051.900,Aminoglycosides,Glycosides,1
Streptozocin,D,D02.065.950.594.768,Nitrosourea Compounds,Urea,1
Striae Distensae,C,C23.888.885.800,Skin Manifestations,Signs and Symptoms,1
Strongyloidea,B,B01.050.500.500.294.400.968.710,Strongylida,Chromadorea,1
Strongyloides,B,B01.050.500.500.294.400.875.640.680,Rhabdiasoidea,Rhabditida,1
"Students, Dental",M,M01.848.769.519,"Students, Health Occupations",Students,1
"Students, Health Occupations",M,M01.848.769,Students,Persons,1
"Students, Public Health",M,M01.848.769.925,"Students, Health Occupations",Students,1
Stuttering,C,C23.888.592.604.150.500.800.750,Speech Disorders,Language Disorders,1
Stuttering,C,C10.597.606.150.500.800.750,Speech Disorders,Language Disorders,1
Styrene,D,D02.455.426.559.389.150.750.800,Styrenes,Benzylidene Compounds,1
Subclavian Vein,A,A07.015.908.877,Veins,Blood Vessels,1
"Subcutaneous Fat, Abdominal",A,A10.165.114.830.500.750,Abdominal Fat,"Adipose Tissue, White",1
"Subcutaneous Fat, Abdominal",A,A10.165.114.830.750.500,Subcutaneous Fat,"Adipose Tissue, White",1
Sublingual Immunotherapy,E,E02.095.465.425.450.310.500,"Desensitization, Immunologic",Immunosuppression,1
Sublingual Immunotherapy,E,E05.478.610.310.500,"Desensitization, Immunologic",Immunosuppression,1
Submandibular Gland Diseases,C,C07.465.815.882,Salivary Gland Diseases,Mouth Diseases,1
Submandibular Gland Neoplasms,C,C07.465.815.882.500,Submandibular Gland Diseases,Salivary Gland Diseases,1
Submandibular Gland Neoplasms,C,C07.465.815.718.885,Salivary Gland Neoplasms,Salivary Gland Diseases,1
Submandibular Gland Neoplasms,C,C07.465.530.824.885,Salivary Gland Neoplasms,Mouth Neoplasms,1
Submandibular Gland Neoplasms,C,C04.588.443.591.824.885,Salivary Gland Neoplasms,Mouth Neoplasms,1
Subrenal Capsule Assay,E,E05.624.850.830,Xenograft Model Antitumor Assays,Neoplasm Transplantation,1
Subrenal Capsule Assay,E,E05.337.550.200.900.830,Xenograft Model Antitumor Assays,"Drug Screening Assays, Antitumor",1
Substance P,D,D23.469.050.375.850.890,Tachykinins,Kinins,1
Substance P,D,D23.529.812.900.866,Tachykinins,Kinins,1
Substance P,D,D12.776.467.812.900.866,Tachykinins,Kinins,1
Substance P,D,D12.776.631.650.800.750,Tachykinins,Neuropeptides,1
Substance P,D,D12.644.400.800.750,Tachykinins,Neuropeptides,1
Substance P,D,D12.644.456.800.866,Tachykinins,Oligopeptides,1
Substance P,D,D12.644.276.812.900.866,Tachykinins,Kinins,1
Suburban Health Services,N,N02.421.908,Health Services,"Health Care Facilities, Manpower, and Services",1
Succimer,D,D02.886.489.750,Sulfhydryl Compounds,Sulfur Compounds,1
Succimer,D,D02.241.081.337.759.500,Succinates,Dicarboxylic Acids,1
Succinates,D,D02.241.081.337.759,Dicarboxylic Acids,"Acids, Acyclic",1
Sucking Behavior,F,F01.145.916,Behavior,Behavior and Behavior Mechanisms,1
Sufentanil,D,D03.383.621.265.900,Fentanyl,Piperidines,1
Sugar Alcohol Dehydrogenases,D,D08.811.682.047.150.700,Carbohydrate Dehydrogenases,Alcohol Oxidoreductases,1
Suggestion,E,E02.190.525.217.771,Hypnosis,Mind-Body Therapies,1
Suggestion,F,F04.754.424.771,Hypnosis,Psychotherapy,1
"Suicide, Completed",F,F01.145.126.980.875.800,Suicide,Self-Injurious Behavior,1
"Suicide, Completed",I,I01.880.735.856.800,Suicide,Social Problems,1
Sulfamethazine,D,D02.886.590.700.725.862,Sulfanilamides,Sulfonamides,1
Sulfamethazine,D,D02.092.146.807.862,Sulfanilamides,Aniline Compounds,1
Sulfamethazine,D,D02.065.884.725.862,Sulfanilamides,Sulfonamides,1
Sulfamethizole,D,D02.065.884.725.935.813,Sulfathiazoles,Sulfanilamides,1
Sulfamethizole,D,D02.092.146.807.935.813,Sulfathiazoles,Sulfanilamides,1
Sulfamethizole,D,D02.886.590.700.725.935.813,Sulfathiazoles,Sulfanilamides,1
Sulfatases,D,D08.811.277.352.827,Esterases,Hydrolases,1
Sulfate Transporters,D,D12.776.157.530.937.929,Solute Carrier Proteins,Membrane Transport Proteins,1
Sulfate Transporters,D,D12.776.157.530.450.074.875,Anion Transport Proteins,Ion Pumps,1
Sulfate Transporters,D,D12.776.543.585.937.963,Solute Carrier Proteins,Membrane Transport Proteins,1
Sulfate Transporters,D,D12.776.543.585.450.074.875,Anion Transport Proteins,Ion Pumps,1
Sulfhydryl Reagents,D,D27.720.470.410.700,Indicators and Reagents,Laboratory Chemicals,1
Sulfinic Acids,D,D02.886.645.585,Sulfur Acids,Sulfur Compounds,1
Sulfinic Acids,D,D01.875.800.700,Sulfur Acids,Sulfur Compounds,1
Sulfinic Acids,D,D01.029.260.877.700,Sulfur Acids,"Acids, Noncarboxylic",1
Sulfisoxazole,D,D02.065.884.725.945,Sulfanilamides,Sulfonamides,1
Sulfisoxazole,D,D02.092.146.807.945,Sulfanilamides,Aniline Compounds,1
Sulfisoxazole,D,D02.886.590.700.725.945,Sulfanilamides,Sulfonamides,1
Sulfites,D,D01.875.750,Sulfur Compounds,Inorganic Chemicals,1
Sulfites,D,D01.248.497.158.904,Anions,Ions,1
Sulfoglycosphingolipids,D,D09.400.410.420.025.837,Acidic Glycosphingolipids,Glycosphingolipids,1
Sulfoglycosphingolipids,D,D10.390.470.025.837,Acidic Glycosphingolipids,Glycosphingolipids,1
Sulfoglycosphingolipids,D,D10.570.877.360.025.837,Acidic Glycosphingolipids,Glycosphingolipids,1
Sulfotransferases,D,D08.811.913.817.400,Sulfur Group Transferases,Transferases,1
Sulfur,D,D01.268.185.900,Chalcogens,Elements,1
Sulfur Compounds,D,D01.875,Inorganic Chemicals,NULL,1
Sulfur Compounds,D,D02.886,Organic Chemicals,NULL,1
Sulfuric Acids,D,D02.886.645.655,Sulfur Acids,Sulfur Compounds,1
Sulfuric Acids,D,D01.875.800.800,Sulfur Acids,Sulfur Compounds,1
Sulfuric Acids,D,D01.029.260.877.800,Sulfur Acids,"Acids, Noncarboxylic",1
Sulfurtransferases,D,D08.811.913.817.500,Sulfur Group Transferases,Transferases,1
Sunbathing,I,I03.450.642.922,Recreation,Leisure Activities,1
Sunburn,C,C26.200.855,Burns,Wounds and Injuries,1
Sunburn,C,C17.800.600.725,Photosensitivity Disorders,Skin Diseases,1
Sunflower Oil,D,D20.215.784.750.910,Plant Oils,Plant Preparations,1
Sunstroke,C,C26.522.500.500,Heat Stroke,Heat Stress Disorders,1
Superficial Back Muscles,A,A02.633.567.175.875,Back Muscles,"Muscle, Skeletal",1
Suppressor of Cytokine Signaling 1 Protein,D,D12.776.476.024.437.500,Suppressor of Cytokine Signaling Proteins,"Adaptor Proteins, Signal Transducing",1
Suppressor of Cytokine Signaling 1 Protein,D,D12.644.360.024.374.500,Suppressor of Cytokine Signaling Proteins,"Adaptor Proteins, Signal Transducing",1
Suppressor of Cytokine Signaling 1 Protein,D,D12.776.157.057.249.500,Suppressor of Cytokine Signaling Proteins,"Adaptor Proteins, Signal Transducing",1
Suppressor of Cytokine Signaling 3 Protein,D,D12.776.157.057.249.750,Suppressor of Cytokine Signaling Proteins,"Adaptor Proteins, Signal Transducing",1
Suppressor of Cytokine Signaling 3 Protein,D,D12.644.360.024.374.750,Suppressor of Cytokine Signaling Proteins,"Adaptor Proteins, Signal Transducing",1
Suppressor of Cytokine Signaling 3 Protein,D,D12.776.476.024.437.750,Suppressor of Cytokine Signaling Proteins,"Adaptor Proteins, Signal Transducing",1
Suppuration,C,C01.830,Infections,NULL,1
Suppuration,C,C23.550.470.756,Inflammation,Pathologic Processes,1
"Supranuclear Palsy, Progressive",C,C23.888.592.636.447.690,Ophthalmoplegia,Paralysis,1
"Supranuclear Palsy, Progressive",C,C10.574.945.500,Tauopathies,Neurodegenerative Diseases,1
"Supranuclear Palsy, Progressive",C,C10.597.622.447.690,Ophthalmoplegia,Paralysis,1
"Supranuclear Palsy, Progressive",C,C11.590.472.500,Ophthalmoplegia,Ocular Motility Disorders,1
"Supranuclear Palsy, Progressive",C,C10.228.662.700,Movement Disorders,Central Nervous System Diseases,1
"Supranuclear Palsy, Progressive",C,C10.292.562.750.500,Ophthalmoplegia,Ocular Motility Disorders,1
"Supranuclear Palsy, Progressive",C,C10.228.140.079.882,Basal Ganglia Diseases,Brain Diseases,1
"Surgery, Oral",H,H02.163.876.886,"Specialties, Dental",Dentistry,1
"Surgery, Oral",E,E06.892,Dentistry,NULL,1
Surgical Equipment,E,E07.858,Equipment and Supplies,NULL,1
Surgical Sponges,E,E07.858.740,Surgical Equipment,Equipment and Supplies,1
Surgical Wound,C,C26.859,Wounds and Injuries,NULL,1
Sustainable Growth,J,J01.839,"Technology, Industry, and Agriculture",NULL,1
Sweat Glands,A,A10.336.899,Exocrine Glands,Tissues,1
Sweat Glands,A,A17.815.830,Skin,Integumentary System,1
Swine Erysipelas,C,C01.150.252.410.334.776,Erysipelothrix Infections,Gram-Positive Bacterial Infections,1
Swine Erysipelas,C,C22.905.832,Swine Diseases,Animal Diseases,1
Swine Erysipelas,C,C22.331.693,Erysipelothrix Infections,Animal Diseases,1
"Swine, Miniature",B,B01.050.150.900.649.313.500.880.399.800,Sus scrofa,Swine,1
Swiss 3T3 Cells,A,A11.251.210.100.775,3T3 Cells,Cell Line,1
Swiss 3T3 Cells,A,A11.329.228.100.775,3T3 Cells,Fibroblasts,1
Syk Kinase,D,D12.776.476.913,Intracellular Signaling Peptides and Proteins,Proteins,1
Syk Kinase,D,D12.644.360.900,Intracellular Signaling Peptides and Proteins,Peptides,1
Syk Kinase,D,D08.811.913.696.620.682.725.650,Protein-Tyrosine Kinases,Protein Kinases,1
Sympathetic Nervous System,A,A08.800.050.800,Autonomic Nervous System,Peripheral Nervous System,1
Synaptic Membranes,A,A08.850.800,Synapses,Nervous System,1
Synaptic Membranes,A,A11.284.149.165.420.780.800,Synapses,Intercellular Junctions,1
Synaptic Membranes,A,A11.284.149.844,Cell Membrane,Cellular Structures,1
Syndecan-1,D,D12.776.395.550.847.100,Syndecans,Membrane Glycoproteins,1
Syndecan-1,D,D12.776.395.650.350.500.100,Syndecans,Heparan Sulfate Proteoglycans,1
Syndecan-1,D,D12.776.543.550.847.100,Syndecans,Membrane Glycoproteins,1
Synechococcus,B,B03.280.745,Cyanobacteria,Bacteria,1
Synechococcus,B,B03.440.475.100.745,Cyanobacteria,Gram-Negative Oxygenic Photosynthetic Bacteria,1
Synovitis,C,C05.550.870,Joint Diseases,Musculoskeletal Diseases,1
Syntaxin 1,D,D12.776.543.512.249.500.500.700,Qa-SNARE Proteins,Q-SNARE Proteins,1
Syntaxin 1,D,D12.776.543.990.775.500.500.700,Qa-SNARE Proteins,Q-SNARE Proteins,1
Synthetic Biology,J,J01.293.069.500,Bioengineering,Engineering,1
Synthetic Biology,H,H01.158.273.904,Biology,Biological Science Disciplines,1
"Syphilis, Cutaneous",C,C01.150.252.819.790,"Skin Diseases, Bacterial",Bacterial Infections,1
"Syphilis, Cutaneous",C,C01.150.252.400.794.840.500.968,Syphilis,Treponemal Infections,1
"Syphilis, Cutaneous",C,C01.150.252.400.840.500.968,Syphilis,Treponemal Infections,1
"Syphilis, Cutaneous",C,C01.800.720.790,"Skin Diseases, Bacterial","Skin Diseases, Infectious",1
"Syphilis, Cutaneous",C,C17.800.838.765.790,"Skin Diseases, Bacterial","Skin Diseases, Infectious",1
"Syphilis, Latent",C,C01.550.750,Latent Infection,Infections,1
"Syphilis, Latent",C,C01.150.252.400.840.500.984,Syphilis,Treponemal Infections,1
"Syphilis, Latent",C,C01.150.252.400.794.840.500.984,Syphilis,Treponemal Infections,1
"Tachycardia, Sinus",C,C14.280.067.845.880.845,"Tachycardia, Supraventricular",Tachycardia,1
"Tachycardia, Sinus",C,C14.280.123.875.880.845,"Tachycardia, Supraventricular",Tachycardia,1
"Tachycardia, Sinus",C,C23.550.073.845.880.845,"Tachycardia, Supraventricular",Tachycardia,1
Talipes,C,C16.131.621.585.512.500.681,"Foot Deformities, Congenital","Lower Extremity Deformities, Congenital",1
Talipes,C,C05.330.488.655,"Foot Deformities, Acquired",Foot Deformities,1
Talipes,C,C05.330.495.681,"Foot Deformities, Congenital",Foot Deformities,1
Talipes,C,C05.660.585.512.380.813,"Foot Deformities, Congenital","Lower Extremity Deformities, Congenital",1
Tannins,D,D05.750.078.937,Biopolymers,Polymers,1
T-Cell Intracellular Antigen-1,D,D12.776.157.725.452.750,Poly(A)-Binding Proteins,RNA-Binding Proteins,1
T-Cell Intracellular Antigen-1,D,D12.776.157.725.813.937,RNA Recognition Motif Proteins,RNA-Binding Proteins,1
T-Cell Intracellular Antigen-1,D,D12.776.157.725.829.875,RNA Splicing Factors,RNA-Binding Proteins,1
T-Cell Intracellular Antigen-1,D,D12.776.664.962.829.875,RNA Splicing Factors,RNA-Binding Proteins,1
T-Cell Intracellular Antigen-1,D,D12.776.664.962.813.937,RNA Recognition Motif Proteins,RNA-Binding Proteins,1
T-Cell Intracellular Antigen-1,D,D12.776.664.962.452.750,Poly(A)-Binding Proteins,RNA-Binding Proteins,1
Teacher Training,I,I02.358.984,"Education, Professional",Education,1
Team Sports,I,I03.450.642.845.880,Sports,Recreation,1
Tear Gases,J,J01.637.870.800,Weapons,Manufactured Materials,1
Tear Gases,D,D27.888.569.734.500,"Riot Control Agents, Chemical",Noxae,1
Tear Gases,D,D27.720.821.500,"Riot Control Agents, Chemical",Specialty Uses of Chemicals,1
Technetium,D,D01.268.271.870,"Elements, Radioactive",Elements,1
Technetium,D,D01.268.956.875,Transition Elements,Elements,1
Technetium,D,D01.268.556.843,"Metals, Heavy",Elements,1
Technetium,D,D01.552.544.843,"Metals, Heavy",Metals,1
Technetium,D,D01.496.749.305.870,"Elements, Radioactive",Radioisotopes,1
Technetium Tc 99m Sestamibi,D,D02.691.825.937,Organotechnetium Compounds,Organometallic Compounds,1
Technetium Tc 99m Sestamibi,D,D02.626.872,Nitriles,Organic Chemicals,1
"Technology, High-Cost",N,N03.880.502,"Technology Assessment, Biomedical",Health Care Economics and Organizations,1
Teichoic Acids,D,D09.408.872,Glycosides,Carbohydrates,1
Teichoic Acids,D,D09.698.718.825,"Polysaccharides, Bacterial",Polysaccharides,1
Teichoic Acids,D,D09.894.847,Sugar Phosphates,Carbohydrates,1
Teichoic Acids,D,D23.050.161.616.797,"Polysaccharides, Bacterial","Antigens, Bacterial",1
Telefacsimile,L,L01.280.950,Copying Processes,Information Science,1
Telefacsimile,L,L01.178.847.606,Telecommunications,Communications Media,1
Telepathology,L,L01.178.847.652.600,Telemedicine,Telecommunications,1
Telepathology,H,H02.403.840.600,Telemedicine,Medicine,1
Telepathology,H,H02.403.650.600,Pathology,Medicine,1
Telepathology,N,N04.590.374.800.600,Telemedicine,Delivery of Health Care,1
Teleradiology,N,N04.590.374.800.700,Telemedicine,Delivery of Health Care,1
Teleradiology,N,N04.452.515.825.500,Radiology Information Systems,Management Information Systems,1
Teleradiology,H,H02.403.840.700,Telemedicine,Medicine,1
Teleradiology,H,H02.010.850.700,"Technology, Radiologic",Allied Health Occupations,1
Teleradiology,L,L01.178.847.652.700,Telemedicine,Telecommunications,1
Teleradiology,E,E05.920.700,"Technology, Radiologic",Investigative Techniques,1
Tenosynovitis,C,C05.651.869.870,Tendinopathy,Muscular Diseases,1
Teratogenesis,C,C23.550.863,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",1
Terbinafine,D,D02.455.426.559.847.638.953,Naphthalenes,Polycyclic Aromatic Hydrocarbons,1
Terbinafine,D,D04.615.638.953,Naphthalenes,Polycyclic Aromatic Hydrocarbons,1
"Terminator Regions, Genetic",G,G02.111.570.080.689.810,"Regulatory Sequences, Nucleic Acid",Base Sequence,1
"Terminator Regions, Genetic",G,G05.360.080.689.810,"Regulatory Sequences, Nucleic Acid",Base Sequence,1
"Terminator Regions, Genetic",G,G05.360.340.024.340.137.750.830,"Regulatory Elements, Transcriptional",Gene Components,1
Territoriality,F,F01.145.875.864,Spatial Behavior,Behavior,1
Testicular Diseases,C,C19.391.829,Gonadal Disorders,Endocrine System Diseases,1
Testicular Diseases,C,C12.294.829,"Genital Diseases, Male",Male Urogenital Diseases,1
Tetrahydroisoquinolines,D,D03.633.100.531.820,Isoquinolines,"Heterocyclic Compounds, 2-Ring",1
Tetraspanin 28,D,D12.776.543.900.070,Tetraspanins,Membrane Proteins,1
Tetraspanin 30,D,D12.776.543.900.163,Tetraspanins,Membrane Proteins,1
Tetraspanin 30,D,D12.776.543.990.024,Vesicular Transport Proteins,Membrane Proteins,1
Tetraspanin 30,D,D12.776.543.550.527.249,Lysosome-Associated Membrane Glycoproteins,Membrane Glycoproteins,1
Tetraspanin 30,D,D12.776.395.550.550.249,Lysosome-Associated Membrane Glycoproteins,Membrane Glycoproteins,1
Tetrodotoxin,D,D03.633.100.786.910,Quinazolines,"Heterocyclic Compounds, 2-Ring",1
Tetrodotoxin,D,D23.946.580.910,Marine Toxins,"Toxins, Biological",1
Texas,Z,Z01.107.567.875.760.750,Southwestern United States,United States,1
Thalamic Nuclei,A,A08.186.211.200.317.826.701,Thalamus,Diencephalon,1
Thapsigargin,D,D02.455.426.392.368.284.500.888,"Sesquiterpenes, Guaiane",Cycloheptanes,1
Thapsigargin,D,D02.455.849.765.674.500.750.888,"Sesquiterpenes, Guaiane","Sesquiterpenes, Eudesmane",1
Thapsigargin,D,D04.663.500.750.888,"Sesquiterpenes, Guaiane","Sesquiterpenes, Eudesmane",1
Theory of Mind,F,F02.739.897,Psychological Theory,Psychological Phenomena,1
Theory of Mind,F,F02.463.689,Mental Processes,Psychological Phenomena,1
Therapeutic Alliance,F,F01.829.401.650.918,Professional-Patient Relations,Interpersonal Relations,1
Therapeutic Alliance,F,F04.754.932,Psychotherapy,Behavioral Disciplines and Activities,1
Therapeutic Alliance,F,F04.754.720.605,Psychotherapeutic Processes,Psychotherapy,1
Thermogenesis,G,G07.110.232.778,Body Temperature Regulation,Body Temperature,1
Thermogenesis,G,G07.410.421.778,Body Temperature Regulation,Homeostasis,1
Thermogenesis,G,G16.012.500.535.778,Body Temperature Regulation,"Adaptation, Physiological",1
Thermoproteaceae,B,B02.075.800.800,Thermoproteales,Crenarchaeota,1
Thiadiazines,D,D02.886.665.785,Thiazines,Sulfur Compounds,1
Thiadiazines,D,D03.383.855.785,Thiazines,"Heterocyclic Compounds, 1-Ring",1
Thiadiazoles,D,D02.886.675.867,Thiazoles,Sulfur Compounds,1
Thiadiazoles,D,D03.383.129.708.867,Thiazoles,Azoles,1
Thioamides,D,D02.886.685,Sulfur Compounds,Organic Chemicals,1
Thioamides,D,D02.065.900,Amides,Organic Chemicals,1
Thiocyanates,D,D02.262.775,Cyanates,Organic Chemicals,1
Thiocyanates,D,D02.886.728,Sulfur Compounds,Organic Chemicals,1
Thioguanine,D,D03.633.100.759.854,Purines,"Heterocyclic Compounds, 2-Ring",1
Thiomalates,D,D02.886.489.891,Sulfhydryl Compounds,Sulfur Compounds,1
Thiomalates,D,D02.241.081.337.463.703,Malates,Dicarboxylic Acids,1
Thiones,D,D01.928,Inorganic Chemicals,NULL,1
Thiones,D,D02.886.753,Sulfur Compounds,Organic Chemicals,1
Thioredoxin-Disulfide Reductase,D,D08.811.682.667.750,Oxidoreductases Acting on Sulfur Group Donors,Oxidoreductases,1
Thioredoxin-Disulfide Reductase,D,D12.776.331.971,Flavoproteins,Proteins,1
Thioredoxins,D,D12.776.915,Proteins,"Amino Acids, Peptides, and Proteins",1
Thioridazine,D,D02.886.369.843,Phenothiazines,Sulfur Compounds,1
Thioridazine,D,D03.633.300.783.843,Phenothiazines,"Heterocyclic Compounds, 3-Ring",1
Thiorphan,D,D02.886.030.893,"Amino Acids, Sulfur",Sulfur Compounds,1
Thiorphan,D,D12.125.481.700.750,N-substituted Glycines,Glycine,1
Thiorphan,D,D12.125.166.893,"Amino Acids, Sulfur",Amino Acids,1
Thiouridine,D,D02.886.759.829,Thionucleosides,Sulfur Compounds,1
Thiouridine,D,D03.383.742.680.852.829,Uridine,Pyrimidine Nucleosides,1
Thiouridine,D,D13.570.800.892.829,Uridine,Ribonucleosides,1
Thiouridine,D,D13.570.900.829,Thionucleosides,Nucleosides,1
Thiouridine,D,D13.570.685.852.829,Uridine,Pyrimidine Nucleosides,1
Thirst,F,F01.658.293.787,Drive,Motivation,1
Thoracic Neoplasms,C,C04.588.894,Neoplasms by Site,Neoplasms,1
Thoracic Vertebrae,A,A02.835.232.834.892,Spine,Bone and Bones,1
Thoracotomy,E,E04.928.760,Thoracic Surgical Procedures,"Surgical Procedures, Operative",1
Thorium Dioxide,D,D01.930.930,Thorium Compounds,Inorganic Chemicals,1
Thorium Dioxide,D,D01.650.550.875,Oxides,Oxygen Compounds,1
Thrombomodulin,D,D12.776.543.550.625.800.800,"Receptors, Thrombin",Platelet Membrane Glycoproteins,1
Thrombomodulin,D,D12.776.543.750.750.850.800,"Receptors, Thrombin","Receptors, Peptide",1
Thrombomodulin,D,D12.776.543.750.705.675.892.800,"Receptors, Thrombin",Platelet Membrane Glycoproteins,1
Thrombomodulin,D,D12.776.395.550.625.800.800,"Receptors, Thrombin",Platelet Membrane Glycoproteins,1
Thrombospondins,D,D12.776.395.550.895,Membrane Glycoproteins,Glycoproteins,1
Thrombospondins,D,D12.776.543.550.895,Membrane Glycoproteins,Membrane Proteins,1
Thromboxane A2,D,D10.251.355.255.100.825.800,Thromboxanes,Arachidonic Acids,1
Thromboxane A2,D,D10.251.355.310.166.971.800,Thromboxanes,Arachidonic Acids,1
Thromboxane B2,D,D10.251.355.310.166.971.810,Thromboxanes,Arachidonic Acids,1
Thromboxane B2,D,D10.251.355.255.100.825.810,Thromboxanes,Arachidonic Acids,1
Thy-1 Antigens,D,D12.776.395.550.050,Membrane Glycoproteins,Glycoproteins,1
Thy-1 Antigens,D,D12.776.543.550.189,Membrane Glycoproteins,Membrane Proteins,1
Thy-1 Antigens,D,D23.050.301.264.894.123,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",1
Thy-1 Antigens,D,D23.101.100.894.123,"Antigens, Differentiation, T-Lymphocyte","Antigens, Differentiation",1
Thymidine Kinase,D,D08.811.913.696.620.750,Phosphotransferases (Alcohol Group Acceptor),Phosphotransferases,1
Thymine,D,D03.383.742.698.875.899,Uracil,Pyrimidinones,1
Thymoma,C,C15.604.861.800,Thymus Neoplasms,Lymphatic Diseases,1
Thymoma,C,C04.588.894.949.500,Thymus Neoplasms,Thoracic Neoplasms,1
Thymoma,C,C04.557.435.850,"Neoplasms, Complex and Mixed",Neoplasms by Histologic Type,1
Thyroidectomy,E,E04.270.856,Endocrine Surgical Procedures,"Surgical Procedures, Operative",1
Thyroiditis,C,C19.874.871,Thyroid Diseases,Endocrine System Diseases,1
Thyrotoxicosis,C,C19.874.397.685,Hyperthyroidism,Thyroid Diseases,1
Tibial Fractures,C,C26.558.857,Leg Injuries,Wounds and Injuries,1
Tibial Fractures,C,C26.404.875,"Fractures, Bone",Wounds and Injuries,1
Tics,C,C23.888.592.350.700,Dyskinesias,Neurologic Manifestations,1
Tics,C,C10.597.350.700,Dyskinesias,Neurologic Manifestations,1
Tigecycline,D,D02.455.426.559.847.562.900.937,Tetracyclines,Naphthacenes,1
Tigecycline,D,D04.615.562.900.937,Tetracyclines,Naphthacenes,1
Tigers,B,B01.050.150.900.649.313.750.377.750.600.800,Panthera,Felidae,1
Tilapia,B,B01.050.150.900.493.602.200.800,Cichlids,Perciformes,1
Tilt-Table Test,E,E01.370.370.750,"Diagnostic Techniques, Cardiovascular",Diagnostic Techniques and Procedures,1
Time Perception,F,F02.463.593.857,Perception,Mental Processes,1
Time-to-Pregnancy,G,G08.686.210.500,Fertility,Reproductive Physiological Phenomena,1
Tinidazole,D,D02.640.672.900,Nitroimidazoles,Nitro Compounds,1
Tinidazole,D,D03.383.129.308.658.900,Nitroimidazoles,Imidazoles,1
Tirofiban,D,D12.125.072.050.875.875,Tyrosine,"Amino Acids, Aromatic",1
Tissue Adhesives,D,D27.720.102.919,Biomedical and Dental Materials,Specialty Uses of Chemicals,1
Tissue Adhesives,D,D25.919,Biomedical and Dental Materials,NULL,1
Tissue Adhesives,E,E07.858.690.860,Surgical Fixation Devices,Surgical Equipment,1
Tissue Adhesives,J,J01.637.051.919,Biomedical and Dental Materials,Manufactured Materials,1
Tissue Embedding,E,E05.200.750.600.760.440,Tissue Preservation,Histocytological Preparation Techniques,1
Tissue Embedding,E,E05.200.500.620.760.440,Tissue Preservation,Histocytological Preparation Techniques,1
Tissue Embedding,E,E01.370.225.750.600.760.440,Tissue Preservation,Histocytological Preparation Techniques,1
Tissue Embedding,E,E01.370.225.500.620.760.440,Tissue Preservation,Histocytological Preparation Techniques,1
Tissue Expansion,E,E04.680.800,Reconstructive Surgical Procedures,"Surgical Procedures, Operative",1
Tissue Extracts,D,D20.777,Complex Mixtures,NULL,1
Tissue Inhibitor of Metalloproteinase-3,D,D12.776.645.875.550,Tissue Inhibitor of Metalloproteinases,"Proteinase Inhibitory Proteins, Secretory",1
Tissue Inhibitor of Metalloproteinases,D,D12.776.645.875,"Proteinase Inhibitory Proteins, Secretory",Proteins,1
Tissue Survival,G,G16.920,Biological Phenomena,NULL,1
Tissue Transplantation,E,E04.936.580,Transplantation,"Surgical Procedures, Operative",1
Tissue Transplantation,E,E02.095.147.725,Cell- and Tissue-Based Therapy,Biological Therapy,1
"T-Lymphocytopenia, Idiopathic CD4-Positive",C,C15.378.553.546.605.800,Lymphopenia,Leukopenia,1
"T-Lymphocytopenia, Idiopathic CD4-Positive",C,C20.673.627.800,Lymphopenia,Immunologic Deficiency Syndromes,1
TNF-Related Apoptosis-Inducing Ligand,D,D23.529.374.750.625,Tumor Necrosis Factors,Cytokines,1
TNF-Related Apoptosis-Inducing Ligand,D,D12.776.467.374.750.625,Tumor Necrosis Factors,Cytokines,1
TNF-Related Apoptosis-Inducing Ligand,D,D12.644.276.374.750.625,Tumor Necrosis Factors,Cytokines,1
"Tobacco, Waterpipe",J,J01.637.767.844.750,Tobacco Products,Smoking Devices,1
Tobramycin,D,D09.408.051.476.600.800,Nebramycin,Kanamycin,1
Tocolytic Agents,D,D27.505.954.705.825,Reproductive Control Agents,Therapeutic Uses,1
Tocolytic Agents,D,D27.505.696.875.825,Reproductive Control Agents,Physiological Effects of Drugs,1
Toes,A,A01.378.610.250.300.792,"Forefoot, Human",Foot,1
Togaviridae,B,B04.820.578.875,Positive-Strand RNA Viruses,RNA Viruses,1
Toilet Training,F,F01.318.709,Child Rearing,Behavior and Behavior Mechanisms,1
Tokyo,Z,Z01.433.900,Cities,Geographic Locations,1
Tokyo,Z,Z01.252.474.463.709,Japan,Far East,1
Tolonium Chloride,D,D02.886.369.869,Phenothiazines,Sulfur Compounds,1
Tolonium Chloride,D,D03.633.300.783.869,Phenothiazines,"Heterocyclic Compounds, 3-Ring",1
"Tomography Scanners, X-Ray Computed",E,E07.913,Equipment and Supplies,NULL,1
Tongue Neoplasms,C,C04.588.443.591.925,Mouth Neoplasms,Head and Neck Neoplasms,1
Tongue Neoplasms,C,C07.465.530.925,Mouth Neoplasms,Mouth Diseases,1
Tongue Neoplasms,C,C07.465.910.470,Tongue Diseases,Mouth Diseases,1
Tooth Demineralization,C,C07.793.720,Tooth Diseases,Stomatognathic Diseases,1
Tooth Socket,A,A02.835.232.781.324.502.125.800,Alveolar Process,Jaw,1
Tooth Socket,A,A14.521.125.800,Alveolar Process,Jaw,1
Tooth Socket,A,A14.549.167.646.094.800,Alveolar Process,Periodontium,1
"Tooth, Impacted",C,C07.793.905,Tooth Diseases,Stomatognathic Diseases,1
Topoisomerase II Inhibitors,D,D27.505.954.248.794.750,Topoisomerase Inhibitors,Antineoplastic Agents,1
Topoisomerase II Inhibitors,D,D27.505.519.389.892.750,Topoisomerase Inhibitors,Enzyme Inhibitors,1
Torsion Abnormality,C,C23.300.970,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",1
Total Lung Capacity,E,E01.370.386.700.485.750,Lung Volume Measurements,Respiratory Function Tests,1
Total Lung Capacity,G,G09.772.850,Respiratory Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,1
Tourniquets,E,E07.926,Equipment and Supplies,NULL,1
Toxicology,H,H01.158.891,Biological Science Disciplines,Natural Science Disciplines,1
Toxicology,H,H02.884,Health Occupations,NULL,1
Toxoids,D,D20.215.894.691,Vaccines,Biological Products,1
Tracheal Neoplasms,C,C08.907.563,Tracheal Diseases,Respiratory Tract Diseases,1
Tracheal Neoplasms,C,C08.785.760,Respiratory Tract Neoplasms,Respiratory Tract Diseases,1
Tracheal Neoplasms,C,C04.588.443.925,Head and Neck Neoplasms,Neoplasms by Site,1
Tracheal Neoplasms,C,C04.588.894.797.760,Respiratory Tract Neoplasms,Thoracic Neoplasms,1
Traction,E,E04.555.720,Orthopedic Procedures,"Surgical Procedures, Operative",1
Tramadol,D,D02.033.415.510.500.802,Cyclohexanols,Hexanols,1
Tramadol,D,D02.092.668.387.750,Dimethylamines,Methylamines,1
Tramadol,D,D10.289.510.500.802,Cyclohexanols,Hexanols,1
Transcortin,D,D12.776.395.901,Glycoproteins,Proteins,1
Transcortin,D,D12.776.377.715.085.901,Alpha-Globulins,Serum Globulins,1
Transcortin,D,D12.776.157.818,Carrier Proteins,Proteins,1
Transcortin,D,D12.644.861.923,Serpins,Peptides,1
Transcortin,D,D12.776.124.790.106.901,Alpha-Globulins,Serum Globulins,1
Transcortin,D,D12.776.872.923,Serpins,Proteins,1
"Transcription Elongation, Genetic",G,G02.111.873.562,"Transcription, Genetic",Biochemical Phenomena,1
"Transcription Elongation, Genetic",G,G05.297.700.562,"Transcription, Genetic",Gene Expression,1
Transcription Factor AP-2,D,D12.776.930.907,Transcription Factors,Proteins,1
Transcription Factor AP-2,D,D12.776.260.760,DNA-Binding Proteins,Proteins,1
Transcription Factor DP1,D,D12.776.930.908,Transcription Factors,Proteins,1
Transducers,E,E07.305.812,Electrical Equipment and Supplies,Equipment and Supplies,1
"Transducers, Pressure",E,E07.305.812.901,Transducers,Electrical Equipment and Supplies,1
"Transfer, Psychology",F,F02.463.425.910,Learning,Mental Processes,1
Transferases (Other Substituted Phosphate Groups),D,D08.811.913.696.900,Phosphotransferases,Transferases,1
Transferrins,D,D12.776.157.427.750,Iron-Binding Proteins,Carrier Proteins,1
Transferrins,D,D12.776.556.579.750,Iron-Binding Proteins,Metalloproteins,1
Transient Receptor Potential Channels,D,D12.776.543.585.400.901,Ion Channels,Membrane Transport Proteins,1
Transient Receptor Potential Channels,D,D12.776.157.530.400.901,Ion Channels,Membrane Transport Proteins,1
Transition Elements,D,D01.268.956,Elements,Inorganic Chemicals,1
Transitional Care,E,E02.760.169.812,Continuity of Patient Care,Patient Care,1
Transitional Care,E,E02.760.940,Patient Care,Therapeutics,1
Transitional Care,N,N04.590.233.727.210.812,Continuity of Patient Care,Primary Health Care,1
Transitional Care,N,N02.421.585.940,Patient Care,Health Services,1
Transitional Care,N,N02.421.585.169.812,Continuity of Patient Care,Patient Care,1
Transketolase,D,D08.811.913.200.825,Aldehyde-Ketone Transferases,Transferases,1
Transplant Donor Site,A,A01.935,Body Regions,NULL,1
Transplantation Conditioning,E,E02.095.465.425.450.800,Immunosuppression,Immunotherapy,1
Transplantation Conditioning,E,E05.478.610.800,Immunosuppression,Immunologic Techniques,1
Transportation Facilities,J,J03.970,Non-Medical Public and Private Facilities,NULL,1
Transposases,D,D08.811.739.500.667,Integrases,Recombinases,1
Transposases,D,D08.811.913.696.445.825,Nucleotidyltransferases,Phosphotransferases,1
Transvestism,F,F03.657.800,Paraphilic Disorders,Mental Disorders,1
Traumatology,H,H02.403.810.850,"Specialties, Surgical",Medicine,1
Trefoil Factor-1,D,D12.644.937.500,Trefoil Factors,Peptides,1
Trefoil Factor-2,D,D12.644.937.750,Trefoil Factors,Peptides,1
Trefoil Factor-3,D,D12.644.937.875,Trefoil Factors,Peptides,1
Trehalose,D,D09.698.629.305.880,Disaccharides,Oligosaccharides,1
Trehalose,D,D09.698.365.900,Glucans,Polysaccharides,1
Trehalose,D,D09.947.750.880,Disaccharides,Sugars,1
Trematoda,B,B01.050.500.500.736.715,Platyhelminths,Helminths,1
Treponema Immobilization Test,E,E01.370.225.812.735.850.800,Syphilis Serodiagnosis,Serologic Tests,1
Treponema Immobilization Test,E,E05.478.594.760.850.800,Syphilis Serodiagnosis,Serologic Tests,1
Treponema Immobilization Test,E,E05.200.812.735.850.800,Syphilis Serodiagnosis,Serologic Tests,1
Trial of Labor,G,G08.686.784.769.326.660,"Labor, Obstetric",Pregnancy,1
Triamcinolone Acetonide,D,D04.210.500.908.891.927,Triamcinolone,"Steroids, Fluorinated",1
Triamcinolone Acetonide,D,D04.210.500.745.432.915.715,Triamcinolone,Pregnadienes,1
Triazenes,D,D02.925,Organic Chemicals,NULL,1
Trichinella,B,B01.050.500.500.294.100.275.780.608,Trichuroidea,Enoplida,1
Trichomonadida,B,B01.630.800,Parabasalidea,Eukaryota,1
Trichostrongyloidiasis,C,C01.610.335.508.700.775.825,Strongylida Infections,Secernentea Infections,1
Trichostrongylosis,C,C01.610.335.508.700.775.825.842,Trichostrongyloidiasis,Strongylida Infections,1
Triclabendazole,D,D03.633.100.103.925,Benzimidazoles,"Heterocyclic Compounds, 2-Ring",1
Trifluoroacetic Acid,D,D02.455.526.510.286.500,Fluoroacetates,"Hydrocarbons, Fluorinated",1
Trifluoroacetic Acid,D,D02.241.081.018.285.500,Fluoroacetates,Acetates,1
Trigeminal Nerve,A,A08.800.800.120.760,Cranial Nerves,Peripheral Nerves,1
Triggering Receptor Expressed on Myeloid Cells-1,D,D12.776.395.550.919,Membrane Glycoproteins,Glycoproteins,1
Triggering Receptor Expressed on Myeloid Cells-1,D,D12.776.543.550.919,Membrane Glycoproteins,Membrane Proteins,1
Triggering Receptor Expressed on Myeloid Cells-1,D,D12.776.543.750.705.985,"Receptors, Immunologic","Receptors, Cell Surface",1
Triiodobenzoic Acids,D,D02.241.223.100.400.880,Iodobenzoates,Benzoates,1
Triiodobenzoic Acids,D,D02.455.426.559.389.127.375.880,Iodobenzoates,Benzoates,1
Trimethoprim Resistance,G,G07.690.773.984.269.347.968,"Drug Resistance, Bacterial","Drug Resistance, Microbial",1
Trimethoprim Resistance,G,G06.225.347.968,"Drug Resistance, Bacterial","Drug Resistance, Microbial",1
Trimethoprim Resistance,G,G06.099.225.968,"Drug Resistance, Bacterial",Bacterial Physiological Phenomena,1
Trinucleotide Repeats,G,G05.360.080.708.800.500.850,Microsatellite Repeats,Tandem Repeat Sequences,1
Trinucleotide Repeats,G,G05.360.340.024.850.500.850,Microsatellite Repeats,Tandem Repeat Sequences,1
Trinucleotide Repeats,G,G02.111.570.080.708.800.500.850,Microsatellite Repeats,Tandem Repeat Sequences,1
Triplets,M,M01.438.768,Multiple Birth Offspring,Persons,1
Trisaccharides,D,D09.698.629.802,Oligosaccharides,Polysaccharides,1
Trisomy,C,C23.550.210.182.500,Chromosome Duplication,Chromosome Aberrations,1
Trisomy,C,C23.550.210.050.750,Aneuploidy,Chromosome Aberrations,1
Trisomy,G,G05.700.131.750,Aneuploidy,Ploidies,1
Trisomy,G,G05.365.590.175.183.500,Chromosome Duplication,Chromosome Aberrations,1
Trisomy,G,G05.365.590.175.050.750,Aneuploidy,Chromosome Aberrations,1
Trochlear Nerve Diseases,C,C10.292.850,Cranial Nerve Diseases,Nervous System Diseases,1
Tropicamide,D,D03.383.725.942,Pyridines,"Heterocyclic Compounds, 1-Ring",1
Tropism,G,G07.345.249.845,Growth,Growth and Development,1
Tropism,G,G15.920,Plant Physiological Phenomena,NULL,1
Trypan Blue,D,D02.455.426.559.847.638.555.875,Naphthalenesulfonates,Naphthalenes,1
Trypan Blue,D,D02.886.645.600.080.050.650.875,Naphthalenesulfonates,Arylsulfonates,1
Trypan Blue,D,D04.615.638.555.875,Naphthalenesulfonates,Naphthalenes,1
Trypan Blue,D,D02.172.975,Azo Compounds,Organic Chemicals,1
Trypanosoma lewisi,B,B01.268.475.868.887.410,Trypanosoma,Trypanosomatina,1
Tryptophan Synthase,D,D08.811.600.896,Multienzyme Complexes,Enzymes,1
Tryptophan Synthase,D,D08.811.520.241.300.850,Hydro-Lyases,Carbon-Oxygen Lyases,1
Tsunamis,G,G01.311.933,Geological Phenomena,Physical Phenomena,1
"Tuberculosis, Cardiovascular",C,C01.150.252.410.040.552.846.554,Tuberculosis,Mycobacterium Infections,1
"Tuberculosis, Cardiovascular",C,C01.190.750,Cardiovascular Infections,Infections,1
"Tuberculosis, Cardiovascular",C,C14.260.750,Cardiovascular Infections,Cardiovascular Diseases,1
"Tuberculosis, Female Genital",C,C13.351.750.940,"Tuberculosis, Urogenital",Female Urogenital Diseases,1
"Tuberculosis, Female Genital",C,C13.351.500.758,"Genital Diseases, Female",Female Urogenital Diseases,1
"Tuberculosis, Female Genital",C,C01.150.252.410.040.552.846.944.596,"Tuberculosis, Urogenital",Tuberculosis,1
"Tuberculosis, Ocular",C,C01.375.354.800,"Eye Infections, Bacterial",Eye Infections,1
"Tuberculosis, Ocular",C,C01.150.252.289.800,"Eye Infections, Bacterial",Bacterial Infections,1
"Tuberculosis, Ocular",C,C11.294.354.800,"Eye Infections, Bacterial",Eye Infections,1
Tubulin Modulators,D,D27.505.519.593.249.500,Antimitotic Agents,Mitosis Modulators,1
Tumor Escape,G,G12.900,Immune System Phenomena,NULL,1
Tumor Necrosis Factors,D,D23.529.374.750,Cytokines,Intercellular Signaling Peptides and Proteins,1
Tumor Necrosis Factors,D,D12.776.467.374.750,Cytokines,Intercellular Signaling Peptides and Proteins,1
Tumor Necrosis Factors,D,D12.644.276.374.750,Cytokines,Intercellular Signaling Peptides and Proteins,1
Tunga,B,B01.050.500.131.617.720.500.500.968.800,Siphonaptera,Holometabola,1
Tungiasis,C,C01.610.858.211.250.800,Flea Infestations,Ectoparasitic Infestations,1
Tungsten,D,D01.268.956.882,Transition Elements,Elements,1
Tungsten,D,D01.268.556.887,"Metals, Heavy",Elements,1
Tungsten,D,D01.552.544.887,"Metals, Heavy",Metals,1
Tunicamycin,D,D03.383.742.680.725,Pyrimidine Nucleosides,Pyrimidines,1
Tunicamycin,D,D13.570.685.725,Pyrimidine Nucleosides,Nucleosides,1
Turbinates,A,A02.835.232.781.324.948,Facial Bones,Skull,1
Turbinates,A,A04.531.898,Nose,Respiratory System,1
"Twinning, Dizygotic",G,G08.686.784.170.104.625.500,"Twinning, Embryonic",Embryonic Development,1
"Twins, Conjoined",C,C16.131.085.806,"Abnormalities, Severe Teratoid",Congenital Abnormalities,1
Tympanocentesis,E,E01.370.225.998.329.905,Paracentesis,Specimen Handling,1
Tympanocentesis,E,E05.200.998.329.905,Paracentesis,Specimen Handling,1
Tympanocentesis,E,E02.800.550.905,Paracentesis,Punctures,1
Tympanocentesis,E,E04.665.600.905,Paracentesis,Punctures,1
Type VII Secretion Systems,D,D05.500.890.500.992,Bacterial Secretion Systems,Protein Translocation Systems,1
Typhlitis,C,C01.463.850,Intraabdominal Infections,Infections,1
Typhlitis,C,C06.405.469.110.708,Cecal Diseases,Intestinal Diseases,1
Typhlitis,C,C06.405.205.596.750.500,"Enterocolitis, Neutropenic",Enterocolitis,1
"Typhus, Epidemic Louse-Borne",C,C01.920.914.725.805,Rickettsia Infections,Rickettsiaceae Infections,1
"Typhus, Epidemic Louse-Borne",C,C01.150.252.400.789.725.805,Rickettsia Infections,Rickettsiaceae Infections,1
Tyramine,D,D02.092.211.215.811,Biogenic Monoamines,Biogenic Amines,1
Tyrosine 3-Monooxygenase,D,D08.811.682.690.708.923,Mixed Function Oxygenases,Oxygenases,1
Tyrosine 3-Monooxygenase,D,D12.776.556.579.374.925,Nonheme Iron Proteins,Iron-Binding Proteins,1
Ubiquitin,D,D12.776.947.500,Ubiquitins,Proteins,1
Ubiquitin-Conjugating Enzymes,D,D08.811.464.938.500,Ubiquitin-Protein Ligase Complexes,Ligases,1
Ubiquitin-Specific Proteases,D,D08.811.277.656.300.887,Endopeptidases,Peptide Hydrolases,1
Ubiquitin-Specific Proteases,D,D08.811.037.750,Deubiquitinating Enzymes,Enzymes,1
Ultrasonic Surgical Procedures,E,E04.943,"Surgical Procedures, Operative",NULL,1
Ultrasonic Waves,G,G01.750.770.776.891,Sound,"Radiation, Nonionizing",1
"Ultrasonography, Doppler, Color",E,E01.370.350.850.850.850.850,"Ultrasonography, Doppler, Duplex","Ultrasonography, Doppler",1
"Ultrasonography, Doppler, Duplex",E,E01.370.350.850.850.850,"Ultrasonography, Doppler",Ultrasonography,1
"Ultrasonography, Doppler, Pulsed",E,E01.370.350.850.850.860,"Ultrasonography, Doppler",Ultrasonography,1
Umbilicus,A,A01.923.047.849,Abdomen,Torso,1
Uncoupling Protein 2,D,D12.776.575.750.688.750,Mitochondrial Uncoupling Proteins,Mitochondrial Membrane Transport Proteins,1
Uncoupling Protein 2,D,D12.776.543.585.475.688.750,Mitochondrial Uncoupling Proteins,Mitochondrial Membrane Transport Proteins,1
Uncoupling Protein 2,D,D12.776.543.585.937.696.750,Mitochondrial Uncoupling Proteins,Solute Carrier Proteins,1
Uncoupling Protein 2,D,D12.776.157.530.937.598.750,Mitochondrial Uncoupling Proteins,Solute Carrier Proteins,1
Underachievement,F,F02.784.629.880,"Psychology, Educational","Psychology, Applied",1
Undiagnosed Diseases,C,C23.550.291.968,Disease Attributes,Pathologic Processes,1
Unfolded Protein Response,G,G02.111.660.871.790.600.962,"Protein Processing, Post-Translational","Protein Modification, Translational",1
Unfolded Protein Response,G,G02.111.691.600.850,"Protein Processing, Post-Translational","Protein Modification, Translational",1
Unfolded Protein Response,G,G03.734.871.790.600.850,"Protein Processing, Post-Translational","Protein Modification, Translational",1
Unfolded Protein Response,G,G05.308.670.600.850,"Protein Processing, Post-Translational","Protein Modification, Translational",1
United States Department of Defense,I,I01.409.418.750.500,United States Government Agencies,Government Agencies,1
United States Department of Defense,N,N03.540.348.500.500.500,United States Government Agencies,Federal Government,1
United States Environmental Protection Agency,N,N03.540.348.500.500.937,United States Government Agencies,Federal Government,1
United States Environmental Protection Agency,I,I01.409.418.750.937,United States Government Agencies,Government Agencies,1
United States Government Agencies,I,I01.409.418.750,Government Agencies,Government,1
United States Government Agencies,N,N03.540.348.500.500,Federal Government,Government,1
United States National Aeronautics and Space Administration,N,N03.540.348.500.500.984,United States Government Agencies,Federal Government,1
United States National Aeronautics and Space Administration,I,I01.409.418.750.984,United States Government Agencies,Government Agencies,1
Untranslated Regions,G,G05.360.340.024.340.137.910,Gene Components,Genes,1
Untranslated Regions,G,G05.360.340.024.220.880,"DNA, Intergenic",Genome Components,1
Untranslated Regions,D,D13.444.735.790.878,"RNA, Untranslated",RNA,1
Untranslated Regions,D,D13.444.735.544.875,"RNA, Messenger",RNA,1
Upper Gastrointestinal Tract,A,A03.556.875,Gastrointestinal Tract,Digestive System,1
Uranium,D,D01.552.544.900,"Metals, Heavy",Metals,1
Uranium,D,D01.552.020.940,Actinoid Series Elements,Metals,1
Uranium,D,D01.496.749.305.100.950,Actinoid Series Elements,"Elements, Radioactive",1
Uranium,D,D01.268.556.900,"Metals, Heavy",Elements,1
Uranium,D,D01.268.271.100.950,Actinoid Series Elements,"Elements, Radioactive",1
Urethral Neoplasms,C,C13.351.937.820.890,Urologic Neoplasms,Urogenital Neoplasms,1
Urethral Neoplasms,C,C13.351.968.767.601,Urethral Diseases,Urologic Diseases,1
Urethral Neoplasms,C,C12.758.820.937,Urologic Neoplasms,Urogenital Neoplasms,1
Urethral Neoplasms,C,C12.777.767.601,Urethral Diseases,Urologic Diseases,1
Urethral Neoplasms,C,C04.588.945.947.945,Urologic Neoplasms,Urogenital Neoplasms,1
Urethral Obstruction,C,C12.777.767.700,Urethral Diseases,Urologic Diseases,1
Urethral Obstruction,C,C13.351.968.767.700,Urethral Diseases,Urologic Diseases,1
Urethral Stricture,C,C13.351.968.767.700.700,Urethral Obstruction,Urethral Diseases,1
Urethral Stricture,C,C12.777.767.700.700,Urethral Obstruction,Urethral Diseases,1
Uricosuric Agents,D,D27.505.954.329.337.900,Gout Suppressants,Antirheumatic Agents,1
Uricosuric Agents,D,D27.505.954.613.860,Renal Agents,Therapeutic Uses,1
Uridine Diphosphate N-Acetylglucosamine,D,D13.695.827.708.727.120,Uridine Diphosphate Sugars,Nucleoside Diphosphate Sugars,1
Uridine Diphosphate N-Acetylglucosamine,D,D13.695.827.919.600.677.120,Uridine Diphosphate Sugars,Uridine Diphosphate,1
Uridine Diphosphate N-Acetylglucosamine,D,D13.695.740.850.600.677.120,Uridine Diphosphate Sugars,Uridine Diphosphate,1
Uridine Diphosphate N-Acetylglucosamine,D,D09.408.620.569.727.120,Uridine Diphosphate Sugars,Nucleoside Diphosphate Sugars,1
Uridine Diphosphate N-Acetylglucosamine,D,D03.383.742.686.850.600.677.120,Uridine Diphosphate Sugars,Uridine Diphosphate,1
Urinary Bladder Calculi,C,C12.777.829.720,Urinary Bladder Diseases,Urologic Diseases,1
Urinary Bladder Calculi,C,C12.777.967.500.925,Urinary Calculi,Urolithiasis,1
Urinary Bladder Calculi,C,C13.351.968.829.521,Urinary Bladder Diseases,Urologic Diseases,1
Urinary Bladder Calculi,C,C13.351.968.967.500.925,Urinary Calculi,Urolithiasis,1
Urinary Bladder Calculi,C,C23.300.175.850.875,Urinary Calculi,Calculi,1
Urinary Bladder Neck Obstruction,C,C13.351.968.829.601,Urinary Bladder Diseases,Urologic Diseases,1
Urinary Bladder Neck Obstruction,C,C13.351.968.767.700.850,Urethral Obstruction,Urethral Diseases,1
Urinary Bladder Neck Obstruction,C,C12.777.829.760,Urinary Bladder Diseases,Urologic Diseases,1
Urinary Bladder Neck Obstruction,C,C12.777.767.700.962,Urethral Obstruction,Urethral Diseases,1
Urinary Tract Physiological Phenomena,G,G08.852,Reproductive and Urinary Physiological Phenomena,NULL,1
Urokinase-Type Plasminogen Activator,D,D08.811.277.656.300.760.910,Serine Endopeptidases,Endopeptidases,1
Urokinase-Type Plasminogen Activator,D,D08.811.277.656.959.350.910,Serine Endopeptidases,Serine Proteases,1
Urokinase-Type Plasminogen Activator,D,D12.776.124.125.662.884,Plasminogen Activators,Blood Coagulation Factors,1
"Urologic Surgical Procedures, Male",E,E04.950.774.860,Urologic Surgical Procedures,Urogenital Surgical Procedures,1
"Urology Department, Hospital",N,N02.278.216.500.968.790,Hospital Departments,Hospital Administration,1
"Urology Department, Hospital",N,N04.452.442.452.422.790,Hospital Departments,Hospital Administration,1
Ursidae,B,B01.050.150.900.649.313.750.250.761,Caniformia,Carnivora,1
Uterine Myomectomy,E,E04.950.300.941,Gynecologic Surgical Procedures,Urogenital Surgical Procedures,1
Uterine Perforation,C,C13.351.500.852.904.500,Uterine Rupture,Uterine Diseases,1
Uterine Perforation,C,C26.761.853.500,Uterine Rupture,Rupture,1
Uterine Prolapse,C,C23.300.842.624.750,Pelvic Organ Prolapse,Prolapse,1
Uterine Prolapse,C,C13.351.500.852.833,Uterine Diseases,"Genital Diseases, Female",1
"Uveitis, Posterior",C,C11.941.879.780.900,Panuveitis,Uveitis,1
Vaccinology,H,H02.403.894,Medicine,Health Occupations,1
Vagus Nerve Stimulation,E,E02.331.900,Electric Stimulation Therapy,Therapeutics,1
Valganciclovir,D,D03.633.100.759.758.399.454.250.300.500,Ganciclovir,Acyclovir,1
Valsartan,D,D03.383.129.617.850,Tetrazoles,Azoles,1
Valsartan,D,D12.125.070.950.550,Valine,"Amino Acids, Branched-Chain",1
Valsartan,D,D12.125.142.930.500,Valine,"Amino Acids, Essential",1
Value-Based Health Insurance,N,N04.761.744.750,Quality Improvement,Quality of Health Care,1
Value-Based Health Insurance,N,N03.219.521.576.343.972,"Insurance, Health",Insurance,1
Vanadium,D,D01.268.556.920,"Metals, Heavy",Elements,1
Vanadium,D,D01.268.956.886,Transition Elements,Elements,1
Vanadium,D,D01.552.544.920,"Metals, Heavy",Metals,1
Variola virus,B,B04.280.650.160.650.930,Orthopoxvirus,Chordopoxvirinae,1
Vas Deferens,A,A05.360.444.930,"Genitalia, Male",Genitalia,1
Vascular Access Devices,E,E07.132.750,Catheters,Equipment and Supplies,1
Vascular Grafting,E,E04.100.814.868,Vascular Surgical Procedures,Cardiovascular Surgical Procedures,1
Vascular Patency,G,G09.330.920,Cardiovascular Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,1
Vascular Remodeling,G,G09.330.930,Cardiovascular Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,1
Vascular Remodeling,C,C23.300.977,"Pathological Conditions, Anatomical","Pathological Conditions, Signs and Symptoms",1
Vascular Remodeling,C,C23.550.918,Pathologic Processes,"Pathological Conditions, Signs and Symptoms",1
"Vasospasm, Intracranial",C,C10.228.140.300.900,Cerebrovascular Disorders,Brain Diseases,1
"Vasospasm, Intracranial",C,C14.907.253.951,Cerebrovascular Disorders,Vascular Diseases,1
Vasovasostomy,E,E04.035.956,"Anastomosis, Surgical","Surgical Procedures, Operative",1
Vasovasostomy,E,E04.950.599.500.800,Sterilization Reversal,"Sterilization, Reproductive",1
Vasovasostomy,E,E04.950.774.860.956,"Urologic Surgical Procedures, Male",Urologic Surgical Procedures,1
Vegetarians,M,M01.928,Persons,NULL,1
Veillonella,B,B03.440.425.410.800.938,Veillonellaceae,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",1
Vemurafenib,D,D02.065.884.919,Sulfonamides,Amides,1
Vemurafenib,D,D02.886.590.700.919,Sulfonamides,Sulfones,1
Vemurafenib,D,D03.633.100.473.936,Indoles,"Heterocyclic Compounds, 2-Ring",1
Venoms,D,D23.946.833,"Toxins, Biological",Biological Factors,1
Venoms,D,D20.888,Complex Mixtures,NULL,1
Venoms,A,A12.200.935,Bodily Secretions,Fluids and Secretions,1
Venous Insufficiency,C,C14.907.952,Vascular Diseases,Cardiovascular Diseases,1
Venous Pressure,G,G09.330.380.076.732,Blood Pressure,Hemodynamics,1
Ventilation-Perfusion Ratio,G,G09.772.920,Respiratory Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,1
Ventilation-Perfusion Ratio,E,E01.370.386.700.650.900,Pulmonary Gas Exchange,Respiratory Function Tests,1
Ventilator Weaning,E,E02.041.625.950,"Respiration, Artificial",Airway Management,1
Ventilator Weaning,E,E02.880.820.950,"Respiration, Artificial",Respiratory Therapy,1
Ventricular Septal Rupture,C,C14.280.470.475.900,"Heart Rupture, Post-Infarction",Heart Rupture,1
Ventricular Septum,A,A07.541.459.750,Heart Septum,Heart,1
Ventriculostomy,E,E04.035.188.957,Cerebrospinal Fluid Shunts,"Anastomosis, Surgical",1
Ventriculostomy,E,E04.525.170.860,Cerebrospinal Fluid Shunts,Neurosurgical Procedures,1
Verbal Learning,F,F02.463.425.952,Learning,Mental Processes,1
Vesico-Ureteral Reflux,C,C13.351.968.829.920,Urinary Bladder Diseases,Urologic Diseases,1
Vesico-Ureteral Reflux,C,C12.777.829.920,Urinary Bladder Diseases,Urologic Diseases,1
Vibrio parahaemolyticus,B,B03.440.450.900.859.550,Vibrio,Vibrionaceae,1
Vibrio parahaemolyticus,B,B03.660.250.830.830.590,Vibrio,Vibrionaceae,1
Vidarabine,D,D13.570.065.950,Arabinonucleosides,Nucleosides,1
Vidarabine,D,D13.570.583.138.900,Adenosine,Purine Nucleosides,1
Vidarabine,D,D03.633.100.759.590.138.900,Adenosine,Purine Nucleosides,1
"vif Gene Products, Human Immunodeficiency Virus",D,D12.776.964.925.875.500,"Gene Products, vif",Viral Regulatory and Accessory Proteins,1
"vif Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.468.500,"Gene Products, vif",Retroviridae Proteins,1
"vif Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.562.781,Human Immunodeficiency Virus Proteins,Retroviridae Proteins,1
Vigabatrin,D,D12.125.190.350.900,gamma-Aminobutyric Acid,Aminobutyrates,1
Vigabatrin,D,D02.241.081.114.500.350.900,gamma-Aminobutyric Acid,Aminobutyrates,1
Vinca Alkaloids,D,D03.633.100.473.402.681.827,Secologanin Tryptamine Alkaloids,Indole Alkaloids,1
Vinca Alkaloids,D,D03.633.100.496.500.500.681.827,Secologanin Tryptamine Alkaloids,Indole Alkaloids,1
Vinca Alkaloids,D,D03.132.436.681.827,Secologanin Tryptamine Alkaloids,Indole Alkaloids,1
Vinculin,D,D12.776.220.990,Cytoskeletal Proteins,Proteins,1
Vinyl Compounds,D,D02.455.326.271.884,Alkenes,"Hydrocarbons, Acyclic",1
Viper Venoms,D,D20.888.850.960,Snake Venoms,Venoms,1
Viper Venoms,D,D23.946.833.850.960,Snake Venoms,Venoms,1
Viperidae,B,B01.050.150.900.833.672.125.937,Alethinophidia,Snakes,1
Vipoma,C,C06.301.761.500.750,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Vipoma,C,C06.689.667.500.750,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Vipoma,C,C04.557.465.625.650.240.847,"Carcinoma, Neuroendocrine",Neuroendocrine Tumors,1
Vipoma,C,C04.588.274.761.500.750,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Vipoma,C,C04.588.322.475.500.750,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Vipoma,C,C04.557.470.200.025.370.847,"Carcinoma, Neuroendocrine",Adenocarcinoma,1
Vipoma,C,C19.344.421.500.750,"Carcinoma, Islet Cell",Pancreatic Neoplasms,1
Viral Genome Packaging,G,G06.920.925.950.500,Virus Assembly,Virus Replication,1
Viral Structures,A,A21,NULL,NULL,1
Virome,G,G06.591.968,Microbiota,Microbiological Phenomena,1
Virome,G,G16.500.275.157.049.100.500.968,Microbiota,Biota,1
Virome,N,N06.230.124.049.100.500.937,Microbiota,Biota,1
Viroporin Proteins,D,D12.776.964.970.880.970,Viral Envelope Proteins,Viral Structural Proteins,1
Virosomes,D,D25.479.900,"Membranes, Artificial",Biomedical and Dental Materials,1
Virosomes,D,D26.255.260.900,Drug Carriers,Dosage Forms,1
Virosomes,J,J01.637.087.500.900,"Membranes, Artificial",Biomimetic Materials,1
Virosomes,J,J01.637.051.479.900,"Membranes, Artificial",Biomedical and Dental Materials,1
Virtues,K,K01.752.566.934,Morals,Philosophy,1
Virtues,F,F01.829.500.840,Morals,"Psychology, Social",1
Virus Uncoating,G,G06.920.950,Virus Physiological Phenomena,Microbiological Phenomena,1
Visna-maedi virus,B,B04.820.650.589.600.900,"Lentiviruses, Ovine-Caprine",Lentivirus,1
Vitamin E Deficiency,C,C18.654.521.500.133.841,Avitaminosis,Deficiency Diseases,1
Vitamin K 3,D,D02.455.426.559.847.638.721.374.922,Vitamin K,Naphthoquinones,1
Vitamin K 3,D,D02.455.849.291.523.500.922,Vitamin K,Phytol,1
Vitamin K 3,D,D02.806.550.875,Naphthoquinones,Quinones,1
Vitamin K 3,D,D04.615.638.721.374.922,Vitamin K,Naphthoquinones,1
Vitellogenins,D,D12.776.290.812.500,Vitellins,Egg Proteins,1
Vitellogenins,D,D12.776.093.500.925,Insect Proteins,Arthropod Proteins,1
Vitellogenins,D,D12.776.744.925,Phosphoproteins,Proteins,1
Vitiligo,C,C17.800.621.440.895,Hypopigmentation,Pigmentation Disorders,1
Vitreoretinal Surgery,E,E04.540.980,Ophthalmologic Surgical Procedures,"Surgical Procedures, Operative",1
Vitreous Detachment,C,C11.980,Eye Diseases,NULL,1
Viverridae,B,B01.050.150.900.649.313.750.377.984,Feliformia,Carnivora,1
Vivisection,E,E05.017.900,Animal Experimentation,Investigative Techniques,1
Vocabulary,L,L01.559.598.901,Linguistics,Language,1
Vocational Education,I,I02.233.862,"Education, Nonprofessional",Education,1
Voice Quality,G,G09.772.925.960,Voice,Respiratory Physiological Phenomena,1
Voltage-Gated Sodium Channel Blockers,D,D27.505.519.562.750.500,Sodium Channel Blockers,Membrane Transport Modulators,1
Voltage-Gated Sodium Channel Blockers,D,D27.505.954.411.720.500,Sodium Channel Blockers,Cardiovascular Agents,1
Von Hippel-Lindau Tumor Suppressor Protein,D,D12.776.624.776.865,Tumor Suppressor Proteins,Neoplasm Proteins,1
Von Hippel-Lindau Tumor Suppressor Protein,D,D08.811.464.938.750.875,Ubiquitin-Protein Ligases,Ubiquitin-Protein Ligase Complexes,1
Vorinostat,D,D02.241.511.372.690,Hydroxamic Acids,Hydroxy Acids,1
Vorinostat,D,D02.092.570.394.690,Hydroxamic Acids,Hydroxylamines,1
Vorinostat,D,D02.092.146.113.960,Anilides,Aniline Compounds,1
Vorinostat,D,D02.065.199.960,Anilides,Amides,1
"vpr Gene Products, Human Immunodeficiency Virus",D,D12.776.964.775.562.937,Human Immunodeficiency Virus Proteins,Retroviridae Proteins,1
"vpr Gene Products, Human Immunodeficiency Virus",D,D12.776.964.925.984.430.500,"Gene Products, vpr",Trans-Activators,1
Vulvitis,C,C13.351.500.944.902,Vulvar Diseases,"Genital Diseases, Female",1
Vulvovaginitis,C,C13.351.500.944.902.737,Vulvitis,Vulvar Diseases,1
Vulvovaginitis,C,C13.351.500.894.906.820,Vaginitis,Vaginal Diseases,1
Waardenburg Syndrome,C,C16.131.077.938,"Abnormalities, Multiple",Congenital Abnormalities,1
Waldenstrom Macroglobulinemia,C,C15.604.515.925,Lymphoproliferative Disorders,Lymphatic Diseases,1
Waldenstrom Macroglobulinemia,C,C15.378.463.515.960,Hemostatic Disorders,Hemorrhagic Disorders,1
Waldenstrom Macroglobulinemia,C,C15.378.147.780.925,Paraproteinemias,Blood Protein Disorders,1
Waldenstrom Macroglobulinemia,C,C14.907.454.960,Hemostatic Disorders,Vascular Diseases,1
Waldenstrom Macroglobulinemia,C,C20.683.780.925,Paraproteinemias,Immunoproliferative Disorders,1
Waldenstrom Macroglobulinemia,C,C04.557.595.925,"Neoplasms, Plasma Cell",Neoplasms by Histologic Type,1
Warfare and Armed Conflicts,I,I01.880.735.950,Social Problems,Sociology,1
Warm Ischemia,E,E04.936.932,Transplantation,"Surgical Procedures, Operative",1
War-Related Injuries,I,I01.880.735.950.500.951.500,War Exposure,Warfare,1
War-Related Injuries,N,N06.850.460.350.600.903.500,War Exposure,Occupational Exposure,1
War-Related Injuries,C,C26.946,Wounds and Injuries,NULL,1
Water Cycle,G,G16.500.943,Ecological and Environmental Phenomena,Biological Phenomena,1
Water Cycle,G,G01.311.977,Geological Phenomena,Physical Phenomena,1
Water Intoxication,C,C25.723.932,Poisoning,Chemically-Induced Disorders,1
Water Intoxication,C,C18.452.950.932,Water-Electrolyte Imbalance,Metabolic Diseases,1
Waterborne Diseases,C,C01.936,Infections,NULL,1
Webcasts as Topic,L,L01.178.847.900.500,Videoconferencing,Telecommunications,1
Wechsler Scales,F,F04.711.141.493.822,Intelligence Tests,Aptitude Tests,1
Weight Lifting,I,I03.450.642.845.950,Sports,Recreation,1
Weight Perception,F,F02.463.593.959,Perception,Mental Processes,1
Weil Disease,C,C01.150.252.400.794.511.739,Leptospirosis,Spirochaetales Infections,1
Wheat Germ Agglutinins,D,D12.776.765.678.968,Plant Lectins,Plant Proteins,1
Wheat Germ Agglutinins,D,D12.776.503.499.968,Plant Lectins,Lectins,1
White Coat Hypertension,C,C14.907.489.907,Hypertension,Vascular Diseases,1
Whole Blood Coagulation Time,E,E01.370.225.625.115.950,Blood Coagulation Tests,Hematologic Tests,1
Whole Blood Coagulation Time,E,E05.200.625.115.950,Blood Coagulation Tests,Hematologic Tests,1
Whole Blood Coagulation Time,G,G09.188.960,Blood Physiological Phenomena,Circulatory and Respiratory Physiological Phenomena,1
Whole-Body Irradiation,E,E02.815.814,Radiotherapy,Therapeutics,1
Whole-Body Irradiation,E,E05.980,Investigative Techniques,NULL,1
Williams Syndrome,C,C14.280.484.048.750.535.960,"Aortic Stenosis, Supravalvular",Aortic Valve Stenosis,1
Williams Syndrome,C,C16.131.260.970,Chromosome Disorders,Congenital Abnormalities,1
Williams Syndrome,C,C16.320.180.970,Chromosome Disorders,"Genetic Diseases, Inborn",1
Williams Syndrome,C,C10.597.606.360.970,Intellectual Disability,Neurobehavioral Manifestations,1
Wills,I,I01.880.604.583.927,Jurisprudence,"Social Control, Formal",1
Wireless Technology,L,L01.178.847.950,Telecommunications,Communications Media,1
Wiskott-Aldrich Syndrome Protein,D,D05.750.078.730.912.500,Wiskott-Aldrich Syndrome Protein Family,Microfilament Proteins,1
Wiskott-Aldrich Syndrome Protein,D,D12.776.220.525.912.500,Wiskott-Aldrich Syndrome Protein Family,Microfilament Proteins,1
Wiskott-Aldrich Syndrome Protein Family,D,D12.776.220.525.912,Microfilament Proteins,Cytoskeletal Proteins,1
Wiskott-Aldrich Syndrome Protein Family,D,D05.750.078.730.912,Microfilament Proteins,Biopolymers,1
"Wiskott-Aldrich Syndrome Protein, Neuronal",D,D05.750.078.730.912.550,Wiskott-Aldrich Syndrome Protein Family,Microfilament Proteins,1
"Wiskott-Aldrich Syndrome Protein, Neuronal",D,D12.776.220.525.912.550,Wiskott-Aldrich Syndrome Protein Family,Microfilament Proteins,1
Wnt Proteins,D,D23.529.984,Intercellular Signaling Peptides and Proteins,Biological Factors,1
Wnt Proteins,D,D12.776.467.984,Intercellular Signaling Peptides and Proteins,Proteins,1
Wnt Signaling Pathway,G,G02.111.820.925,Signal Transduction,Biochemical Phenomena,1
Wnt Signaling Pathway,G,G04.835.925,Signal Transduction,Cell Physiological Phenomena,1
Wolfram Syndrome,C,C10.574.500.662.980,"Optic Atrophies, Hereditary","Heredodegenerative Disorders, Nervous System",1
Wolfram Syndrome,C,C10.597.751.418.341.186.500.750,Deaf-Blind Disorders,Deafness,1
Wolfram Syndrome,C,C10.597.751.941.162.625.750,Deaf-Blind Disorders,Blindness,1
Wolfram Syndrome,C,C11.270.564.980,"Optic Atrophies, Hereditary","Eye Diseases, Hereditary",1
Wolfram Syndrome,C,C11.966.075.375.750,Deaf-Blind Disorders,Blindness,1
Wolfram Syndrome,C,C11.640.451.451.980,"Optic Atrophies, Hereditary",Optic Atrophy,1
Wolfram Syndrome,C,C12.777.419.135.875,Diabetes Insipidus,Kidney Diseases,1
Wolfram Syndrome,C,C10.292.700.225.500.980,"Optic Atrophies, Hereditary",Optic Atrophy,1
Wolfram Syndrome,C,C09.218.458.341.186.500.750,Deaf-Blind Disorders,Deafness,1
Wolfram Syndrome,C,C16.320.290.564.980,"Optic Atrophies, Hereditary","Eye Diseases, Hereditary",1
Wolfram Syndrome,C,C16.320.400.630.980,"Optic Atrophies, Hereditary","Heredodegenerative Disorders, Nervous System",1
Wolfram Syndrome,C,C16.131.077.299.750,Deaf-Blind Disorders,"Abnormalities, Multiple",1
Wolfram Syndrome,C,C18.452.394.750.124.960,"Diabetes Mellitus, Type 1",Diabetes Mellitus,1
Wolfram Syndrome,C,C13.351.968.419.135.875,Diabetes Insipidus,Kidney Diseases,1
Wolfram Syndrome,C,C19.246.267.960,"Diabetes Mellitus, Type 1",Diabetes Mellitus,1
Wolfram Syndrome,C,C19.700.159.875,Diabetes Insipidus,Pituitary Diseases,1
Wolinella,B,B03.660.150.235.500.500,Helicobacteraceae,Campylobacterales,1
Wolinella,B,B03.440.425.410.875,"Gram-Negative Anaerobic Straight, Curved, and Helical Rods",Gram-Negative Anaerobic Bacteria,1
Wool,A,A17.360.855,Hair,Integumentary System,1
Wool,A,A13.970,Animal Structures,NULL,1
Work Capacity Evaluation,E,E01.370.400.925,Disability Evaluation,Diagnostic Techniques and Procedures,1
Working Dogs,B,B01.050.050.116.906,"Animals, Domestic",Animal Population Groups,1
Wrist Joint,A,A02.835.583.405.930,Hand Joints,Joints,1
Xamoterol,D,D02.033.755.624.698.855,Phenoxypropanolamines,Propanolamines,1
Xamoterol,D,D02.033.100.624.698.855,Phenoxypropanolamines,Propanolamines,1
Xamoterol,D,D02.092.063.624.698.855,Phenoxypropanolamines,Propanolamines,1
Xamoterol,D,D03.383.533.640.950,Morpholines,Oxazines,1
Xanthomonas,B,B03.440.400.425.967.930,Xanthomonadaceae,Gram-Negative Aerobic Rods and Cocci,1
Xanthomonas,B,B03.660.250.915.930,Xanthomonadaceae,Gammaproteobacteria,1
Xanthomonas campestris,B,B03.660.250.915.930.100,Xanthomonas,Xanthomonadaceae,1
Xanthomonas campestris,B,B03.440.400.425.967.930.100,Xanthomonas,Xanthomonadaceae,1
Xenorhabdus,B,B03.440.450.425.890,Enterobacteriaceae,Gram-Negative Facultatively Anaerobic Rods,1
Xenorhabdus,B,B03.660.250.150.910,Enterobacteriaceae,Gammaproteobacteria,1
Xeroderma Pigmentosum,C,C04.834.867,Precancerous Conditions,Neoplasms,1
Xeroderma Pigmentosum,C,C18.452.284.975,DNA Repair-Deficiency Disorders,Metabolic Diseases,1
Xeroderma Pigmentosum,C,C17.800.621.936,Pigmentation Disorders,Skin Diseases,1
Xeroderma Pigmentosum,C,C17.800.600.925,Photosensitivity Disorders,Skin Diseases,1
Xeroderma Pigmentosum,C,C17.800.804.936,Skin Abnormalities,Skin Diseases,1
Xeroderma Pigmentosum,C,C17.800.827.970,"Skin Diseases, Genetic",Skin Diseases,1
Xeroderma Pigmentosum,C,C16.131.831.936,Skin Abnormalities,Congenital Abnormalities,1
Xeroderma Pigmentosum,C,C16.320.850.970,"Skin Diseases, Genetic","Genetic Diseases, Inborn",1
Xerostomia,C,C07.465.815.929,Salivary Gland Diseases,Mouth Diseases,1
X-Linked Combined Immunodeficiency Diseases,C,C16.320.798.750.500,Severe Combined Immunodeficiency,Primary Immunodeficiency Diseases,1
X-Linked Combined Immunodeficiency Diseases,C,C16.320.322.968,"Genetic Diseases, X-Linked","Genetic Diseases, Inborn",1
X-Linked Combined Immunodeficiency Diseases,C,C16.614.815.500,Severe Combined Immunodeficiency,"Infant, Newborn, Diseases",1
X-Linked Combined Immunodeficiency Diseases,C,C20.673.795.750.500,Severe Combined Immunodeficiency,Primary Immunodeficiency Diseases,1
X-Ray Film,E,E07.960,Equipment and Supplies,NULL,1
Xylitol,D,D02.033.800.936,Sugar Alcohols,Alcohols,1
Xylitol,D,D09.853.936,Sugar Alcohols,Carbohydrates,1
XYY Karyotype,C,C23.550.210.024.500,Abnormal Karyotype,Chromosome Aberrations,1
XYY Karyotype,C,C23.550.210.815.970,Sex Chromosome Aberrations,Chromosome Aberrations,1
XYY Karyotype,G,G05.360.162.679.500.500,Abnormal Karyotype,Karyotype,1
XYY Karyotype,G,G05.365.590.175.024.500,Abnormal Karyotype,Chromosome Aberrations,1
XYY Karyotype,G,G05.365.590.175.815.970,Sex Chromosome Aberrations,Chromosome Aberrations,1
"Yeast, Dried",G,G07.203.300.456.933,Dietary Supplements,Food,1
"Yeast, Dried",J,J02.500.456.933,Dietary Supplements,Food,1
Yukon Territory,Z,Z01.107.567.176.929,Canada,North America,1
Zalcitabine,D,D03.383.742.680.245.500.950,Deoxycytidine,Cytidine,1
Zalcitabine,D,D13.570.230.500.925,Dideoxynucleosides,Deoxyribonucleosides,1
Zalcitabine,D,D13.570.230.329.950,Deoxycytidine,Deoxyribonucleosides,1
Zalcitabine,D,D13.570.685.245.500.950,Deoxycytidine,Cytidine,1
Zinc Compounds,D,D01.975,Inorganic Chemicals,NULL,1
Zinc Finger Protein GLI1,D,D12.776.624.664.700.989,Proto-Oncogene Proteins,Oncogene Proteins,1
Zinc Finger Protein GLI1,D,D12.776.930.900.700,Trans-Activators,Transcription Factors,1
Zinc Finger Protein GLI1,D,D12.776.260.755.850,Trans-Activators,DNA-Binding Proteins,1
Zinc Finger Protein Gli2,D,D12.776.260.755.925,Trans-Activators,DNA-Binding Proteins,1
Zinc Finger Protein Gli2,D,D12.776.930.900.850,Trans-Activators,Transcription Factors,1
Zinc Finger Protein Gli3,D,D12.776.930.780.972,Repressor Proteins,Transcription Factors,1
Zinc Finger Protein Gli3,D,D12.776.930.375.875,Kruppel-Like Transcription Factors,Transcription Factors,1
Zinc Finger Protein Gli3,D,D12.776.260.522.875,Kruppel-Like Transcription Factors,DNA-Binding Proteins,1
Zinc Finger Protein Gli3,D,D12.776.260.703.900,Repressor Proteins,DNA-Binding Proteins,1
Zinc Isotopes,D,D01.552.544.940.500,Zinc,"Metals, Heavy",1
Zinc Isotopes,D,D01.496.966,Isotopes,Inorganic Chemicals,1
Zinc Isotopes,D,D01.268.956.906.500,Zinc,Transition Elements,1
Zinc Isotopes,D,D01.268.556.940.500,Zinc,"Metals, Heavy",1
Zolpidem,D,D03.383.725.971,Pyridines,"Heterocyclic Compounds, 1-Ring",1
Zona Pellucida,A,A16.690.900,Ovum,Embryonic Structures,1
Zona Pellucida,A,A05.360.490.690.950,Ovum,Germ Cells,1
Zona Pellucida,A,A11.497.497.900,Ovum,Germ Cells,1
Zona Pellucida,A,A11.284.295.310.990,Extracellular Matrix,Extracellular Space,1
Zymosan,D,D09.698.365.089.750,beta-Glucans,Glucans,1
